0	admission	b-OCCURRENCE
1	date	O
2	:	O
3	09/29/1993	b-ADMISSION
4	discharge	b-OCCURRENCE
5	date	O
6	:	O
7	10/04/1993	b-DISCHARGE
8	history	O
9	of	O
10	present	O
11	illness	O
12	:	O
13	the	O
14	patient	O
15	is	O
16	a	O
17	28-year-old	O
18	woman	O
19	who	O
20	is	O
21	hiv	b-PROBLEM
22	positive	i-PROBLEM
23	for	O
24	two	b-DURATION
25	years	i-DURATION
26	.	O
27	she	O
28	presented	b-EVIDENTIAL
29	with	O
30	left	b-PROBLEM
31	upper	i-PROBLEM
32	quadrant	i-PROBLEM
33	pain	i-PROBLEM
34	as	O
35	well	O
36	as	O
37	nausea	b-PROBLEM
38	and	O
39	vomiting	b-PROBLEM
40	which	O
41	is	O
42	a	b-PROBLEM
43	long-standing	i-PROBLEM
44	complaint	i-PROBLEM
45	.	O
46	she	O
47	was	O
48	diagnosed	b-OCCURRENCE
49	in	O
50	1991	b-DATE
51	during	O
52	the	b-OCCURRENCE
53	birth	i-OCCURRENCE
54	of	i-OCCURRENCE
55	her	i-OCCURRENCE
56	child	i-OCCURRENCE
57	.	O
58	she	O
59	claims	O
60	she	O
61	does	O
62	not	O
63	know	O
64	why	O
65	she	O
66	is	O
67	hiv	b-PROBLEM
68	positive	i-PROBLEM
69	.	O
70	she	O
71	is	O
72	from	O
73	maryland	O
74	,	O
75	apparently	O
76	had	O
77	no	O
78	blood	b-TREATMENT
79	transfusions	i-TREATMENT
80	before	O
81	the	b-OCCURRENCE
82	birth	i-OCCURRENCE
83	of	i-OCCURRENCE
84	her	i-OCCURRENCE
85	children	i-OCCURRENCE
86	so	O
87	it	O
88	is	O
89	presumed	O
90	heterosexual	b-PROBLEM
91	transmission	i-PROBLEM
92	.	O
93	at	O
94	that	b-DATE
95	time	i-DATE
96	,	O
97	she	O
98	also	O
99	had	O
100	cat	b-PROBLEM
101	scratch	i-PROBLEM
102	fever	i-PROBLEM
103	and	O
104	she	O
105	had	O
106	resection	b-TREATMENT
107	of	O
108	an	b-PROBLEM
109	abscess	i-PROBLEM
110	in	i-PROBLEM
111	the	i-PROBLEM
112	left	i-PROBLEM
113	lower	i-PROBLEM
114	extremity	i-PROBLEM
115	.	O
116	she	O
117	has	O
118	not	O
119	used	O
120	any	b-TREATMENT
121	anti	i-TREATMENT
122	retroviral	i-TREATMENT
123	therapy	i-TREATMENT
124	since	O
125	then	O
126	,	O
127	because	O
128	of	O
129	pancytopenia	b-PROBLEM
130	and	O
131	vomiting	b-PROBLEM
132	on	O
133	ddi	b-TREATMENT
134	.	O
135	she	O
136	has	O
137	complaints	O
138	of	O
139	nausea	b-PROBLEM
140	and	O
141	vomiting	b-PROBLEM
142	as	O
143	well	O
144	as	O
145	left	b-PROBLEM
146	upper	i-PROBLEM
147	quadrant	i-PROBLEM
148	pain	i-PROBLEM
149	on	O
150	and	O
151	off	O
152	getting	O
153	progressively	O
154	worse	b-OCCURRENCE
155	over	O
156	the	b-DURATION
157	past	i-DURATION
158	month	i-DURATION
159	.	O
160	she	O
161	has	O
162	had	O
163	similar	b-PROBLEM
164	pain	i-PROBLEM
165	intermittently	O
166	for	O
167	last	b-DURATION
168	year	i-DURATION
169	.	O
170	she	O
171	described	O
172	the	b-PROBLEM
173	pain	i-PROBLEM
174	as	O
175	a	b-PROBLEM
176	burning	i-PROBLEM
177	pain	i-PROBLEM
178	which	O
179	is	O
180	positional	O
181	,	O
182	worse	b-OCCURRENCE
183	when	O
184	she	O
185	walks	b-OCCURRENCE
186	or	O
187	does	O
188	any	O
189	type	O
190	of	O
191	exercise	b-OCCURRENCE
192	.	O
193	she	O
194	has	O
195	no	O
196	relief	b-OCCURRENCE
197	from	O
198	antacids	b-TREATMENT
199	or	O
200	h2	b-TREATMENT
201	blockers	i-TREATMENT
202	.	O
203	in	O
204	10/92	b-DATE
205	,	O
206	she	O
207	had	O
208	a	b-TEST
209	ct	i-TEST
210	scan	i-TEST
211	which	O
212	showed	O
213	fatty	b-PROBLEM
214	infiltration	i-PROBLEM
215	of	i-PROBLEM
216	her	i-PROBLEM
217	liver	i-PROBLEM
218	diffusely	i-PROBLEM
219	with	O
220	a	b-PROBLEM
221	1	i-PROBLEM
222	cm	i-PROBLEM
223	cyst	i-PROBLEM
224	in	i-PROBLEM
225	the	i-PROBLEM
226	right	i-PROBLEM
227	lobe	i-PROBLEM
228	of	i-PROBLEM
229	the	i-PROBLEM
230	liver	i-PROBLEM
231	.	O
232	she	O
233	had	O
234	a	b-OCCURRENCE
235	normal	i-OCCURRENCE
236	pancreas	i-OCCURRENCE
237	at	O
238	that	b-DATE
239	time	i-DATE
240	,	O
241	however	O
242	,	O
243	hyperdense	b-PROBLEM
244	kidneys	i-PROBLEM
245	.	O
246	her	b-TEST
247	alkaline	i-TEST
248	phosphatase	i-TEST
249	was	O
250	slightly	b-PROBLEM
251	elevated	i-PROBLEM
252	but	O
253	otherwise	O
254	relatively	O
255	normal	b-OCCURRENCE
256	.	O
257	her	b-TEST
258	amylase	i-TEST
259	was	O
260	mildly	b-PROBLEM
261	elevated	i-PROBLEM
262	but	O
263	has	O
264	been	O
265	down	b-OCCURRENCE
266	since	O
267	then	O
268	.	O
269	the	O
270	patient	O
271	has	O
272	had	O
273	progressive	b-PROBLEM
274	failure	i-PROBLEM
275	to	i-PROBLEM
276	thrive	i-PROBLEM
277	and	O
278	steady	b-PROBLEM
279	weight	i-PROBLEM
280	loss	i-PROBLEM
281	.	O
282	she	O
283	was	O
284	brought	O
285	in	O
286	for	O
287	an	b-TEST
288	esophagogastroduodenoscopy	i-TEST
289	on	O
290	9/26	b-DATE
291	but	O
292	she	O
293	basically	O
294	was	O
295	not	O
296	sufficiently	O
297	sedated	b-TREATMENT
298	and	O
299	readmitted	b-OCCURRENCE
300	at	O
301	this	b-DATE
302	time	i-DATE
303	for	O
304	a	b-TEST
305	gi	i-TEST
306	work-up	i-TEST
307	as	O
308	well	O
309	as	O
310	an	b-TEST
311	evaluation	i-TEST
312	of	O
313	new	b-PROBLEM
314	abscess	i-PROBLEM
315	in	i-PROBLEM
316	her	i-PROBLEM
317	left	i-PROBLEM
318	lower	i-PROBLEM
319	calf	i-PROBLEM
320	and	O
321	right	O
322	medial	O
323	lower	O
324	extremity	O
325	quadriceps	O
326	muscle	O
327	.	O
328	she	O
329	was	O
330	also	O
331	admitted	b-OCCURRENCE
332	to	O
333	be	O
334	connected	b-OCCURRENCE
335	up	i-OCCURRENCE
336	with	i-OCCURRENCE
337	social	i-OCCURRENCE
338	services	i-OCCURRENCE
339	for	O
340	hiv	b-PROBLEM
341	patients	O
342	.	O
343	hospital	O
344	course	O
345	:	O
346	the	O
347	patient	O
348	was	O
349	admitted	b-OCCURRENCE
350	and	O
351	many	b-TEST
352	cultures	i-TEST
353	were	O
354	sent	O
355	which	O
356	were	O
357	all	b-OCCURRENCE
358	negative	i-OCCURRENCE
359	.	O
360	she	O
361	did	O
362	not	O
363	have	O
364	any	O
365	of	O
366	her	b-PROBLEM
367	pain	i-PROBLEM
368	in	O
369	the	b-CLINICAL_DEPT
370	hospital	i-CLINICAL_DEPT
371	.	O
372	on	O
373	the	b-DATE
374	third	i-DATE
375	hospital	i-DATE
376	day	i-DATE
377	,	O
378	she	O
379	did	O
380	have	O
381	some	b-PROBLEM
382	pain	i-PROBLEM
383	and	O
384	was	O
385	treated	O
386	with	O
387	percocet	b-TREATMENT
388	.	O
389	she	O
390	went	O
391	for	O
392	a	b-TREATMENT
393	debridement	i-TREATMENT
394	of	O
395	her	b-PROBLEM
396	left	i-PROBLEM
397	calf	i-PROBLEM
398	lesion	i-PROBLEM
399	on	O
400	10/2/93	b-DATE
401	and	O
402	was	O
403	started	O
404	empirically	O
405	on	O
406	iv	b-TREATMENT
407	ceftriaxone	i-TREATMENT
408	which	O
409	was	O
410	changed	O
411	to	O
412	po	b-TREATMENT
413	doxycycline	i-TREATMENT
414	on	O
415	the	b-DATE
416	day	i-DATE
417	of	i-DATE
418	discharge	i-DATE
419	.	i-DATE
420	a	b-TEST
421	follow-up	i-TEST
422	ct	i-TEST
423	scan	i-TEST
424	was	O
425	done	O
426	which	O
427	did	O
428	not	O
429	show	b-EVIDENTIAL
430	any	O
431	evidence	b-PROBLEM
432	for	O
433	splenomegaly	b-PROBLEM
434	or	O
435	hepatomegaly	b-PROBLEM
436	.	O
437	the	b-PROBLEM
438	1	i-PROBLEM
439	cm	i-PROBLEM
440	cyst	i-PROBLEM
441	which	O
442	was	O
443	seen	O
444	in	O
445	10/92	b-DATE
446	was	O
447	still	O
448	present	O
449	.	O
450	there	O
451	was	O
452	a	O
453	question	O
454	of	O
455	a	b-PROBLEM
456	cyst	i-PROBLEM
457	in	i-PROBLEM
458	her	i-PROBLEM
459	kidney	i-PROBLEM
460	with	O
461	a	b-PROBLEM
462	stone	i-PROBLEM
463	right	O
464	below	O
465	the	b-PROBLEM
466	cyst	i-PROBLEM
467	,	O
468	although	O
469	this	O
470	did	O
471	not	O
472	seem	O
473	to	O
474	be	O
475	clinically	O
476	significant	O
477	.	O
478		O
479	admission	b-OCCURRENCE
480	date	O
481	:	O
482	02/01/2000	b-ADMISSION
483	discharge	b-OCCURRENCE
484	date	O
485	:	O
486	02/08/2000	b-DISCHARGE
487	history	O
488	of	O
489	present	O
490	illness	O
491	:	O
492	this	O
493	patient	O
494	is	O
495	an	O
496	seventy	O
497	eight	O
498	year	O
499	old	O
500	female	O
501	with	O
502	history	O
503	of	O
504	peripheral	b-PROBLEM
505	vascular	i-PROBLEM
506	disease	i-PROBLEM
507	who	O
508	is	O
509	status	O
510	post	O
511	above	O
512	knee	b-TREATMENT
513	to	i-TREATMENT
514	fem	i-TREATMENT
515	pop	i-TREATMENT
516	bypass	i-TREATMENT
517	graft	i-TREATMENT
518	with	O
519	6	b-TREATMENT
520	millimeter	i-TREATMENT
521	ptfe	i-TREATMENT
522	.	O
523	this	b-TREATMENT
524	operation	i-TREATMENT
525	was	O
526	performed	O
527	for	O
528	two	b-DURATION
529	months	i-DURATION
530	of	O
531	increased	b-PROBLEM
532	rest	i-PROBLEM
533	pain	i-PROBLEM
534	.	O
535	her	b-PROBLEM
536	pain	i-PROBLEM
537	resolved	b-OCCURRENCE
538	after	O
539	surgery	b-TREATMENT
540	and	O
541	she	O
542	has	O
543	been	O
544	doing	O
545	well	b-OCCURRENCE
546	since	O
547	,	O
548	although	O
549	at	O
550	baseline	O
551	now	b-DATE
552	she	O
553	is	O
554	minimally	b-PROBLEM
555	ambulatory	i-PROBLEM
556	from	O
557	bed	O
558	to	O
559	commode	O
560	.	O
561	for	O
562	the	O
563	past	O
564	couple	b-DURATION
565	of	i-DURATION
566	months	i-DURATION
567	the	O
568	patient	O
569	has	O
570	had	O
571	a	b-PROBLEM
572	non-healing	i-PROBLEM
573	right	i-PROBLEM
574	dorsal	i-PROBLEM
575	foot	i-PROBLEM
576	ulcer	i-PROBLEM
577	which	O
578	has	O
579	been	O
580	increasing	b-PROBLEM
581	in	i-PROBLEM
582	size	i-PROBLEM
583	and	O
584	started	O
585	as	O
586	a	b-PROBLEM
587	pin	i-PROBLEM
588	hole	i-PROBLEM
589	and	O
590	she	O
591	does	O
592	not	O
593	recollect	b-EVIDENTIAL
594	any	b-PROBLEM
595	trauma	i-PROBLEM
596	,	O
597	as	O
598	similar	b-PROBLEM
599	small	i-PROBLEM
600	ulcers	i-PROBLEM
601	developed	O
602	on	O
603	the	O
604	left	O
605	foot	O
606	as	O
607	well	O
608	around	O
609	the	b-DATE
610	same	i-DATE
611	time	i-DATE
612	,	O
613	but	O
614	that	O
615	has	O
616	subsequently	O
617	healed	b-OCCURRENCE
618	.	O
619	the	b-PROBLEM
620	ulcer	i-PROBLEM
621	was	O
622	managed	b-TREATMENT
623	conservatively	i-TREATMENT
624	at	O
625	har	b-CLINICAL_DEPT
626	hospital	i-CLINICAL_DEPT
627	by	O
628	doctor	O
629	holes	O
630	with	O
631	silvadene	b-TREATMENT
632	b.i.d.	b-FREQUENCY
633	lower	b-TEST
634	extremity	i-TEST
635	non-invasive	i-TEST
636	study	i-TEST
637	obtained	O
638	at	O
639	that	O
640	time	O
641	showed	b-EVIDENTIAL
642	poor	b-PROBLEM
643	distal	i-PROBLEM
644	right	i-PROBLEM
645	extremity	i-PROBLEM
646	perfusion	i-PROBLEM
647	.	O
648	the	O
649	patient	O
650	was	O
651	referred	O
652	back	O
653	to	O
654	doctor	O
655	pop	O
656	for	O
657	the	O
658	possibility	O
659	of	O
660	a	b-TREATMENT
661	revascularization	i-TREATMENT
662	procedure	i-TREATMENT
663	.	O
664	she	O
665	is	O
666	status	O
667	post	O
668	angiography	b-TEST
669	today	b-DATE
670	.	O
671	she	O
672	has	O
673	just	O
674	finished	O
675	a	b-DURATION
676	ten	i-DURATION
677	day	i-DURATION
678	course	O
679	of	O
680	ciprofloxacin	b-TREATMENT
681	.	O
682	she	O
683	denies	b-EVIDENTIAL
684	any	O
685	fevers	b-PROBLEM
686	or	O
687	chills	b-PROBLEM
688	.	O
689	she	O
690	does	O
691	have	O
692	rest	b-PROBLEM
693	pain	i-PROBLEM
694	in	i-PROBLEM
695	the	i-PROBLEM
696	right	i-PROBLEM
697	foot	i-PROBLEM
698	and	i-PROBLEM
699	ankle	i-PROBLEM
700	.	O
701	hospital	O
702	course	O
703	and	O
704	treatment	O
705	:	O
706	the	O
707	patient	O
708	was	O
709	admitted	b-OCCURRENCE
710	and	O
711	taken	O
712	to	O
713	the	b-CLINICAL_DEPT
714	operating	i-CLINICAL_DEPT
715	room	i-CLINICAL_DEPT
716	on	O
717	the	b-DATE
718	following	i-DATE
719	day	i-DATE
720	and	O
721	she	O
722	underwent	O
723	a	b-TREATMENT
724	right	i-TREATMENT
725	fem	i-TREATMENT
726	to	i-TREATMENT
727	below	i-TREATMENT
728	knee	i-TREATMENT
729	popliteal	i-TREATMENT
730	bypass	i-TREATMENT
731	graft	i-TREATMENT
732	using	O
733	a	b-TREATMENT
734	six	i-TREATMENT
735	millimeter	i-TREATMENT
736	ring	i-TREATMENT
737	ptfe	i-TREATMENT
738	.	O
739	she	O
740	had	O
741	a	O
742	strong	O
743	popliteal	b-TEST
744	doppler	i-TEST
745	pulse	i-TEST
746	intraoperatively	O
747	and	O
748	good	O
749	pvr	b-TEST
750	on	O
751	the	O
752	right	O
753	postoperatively	O
754	.	O
755	the	O
756	patient	O
757	did	O
758	well	b-OCCURRENCE
759	in	O
760	the	b-DURATION
761	postoperative	i-DURATION
762	period	i-DURATION
763	.	O
764	she	O
765	was	O
766	afebrile	b-PROBLEM
767	,	O
768	her	b-TEST
769	vital	i-TEST
770	signs	i-TEST
771	were	O
772	stable	b-OCCURRENCE
773	.	O
774	she	O
775	was	O
776	making	O
777	adequate	O
778	urine	b-TEST
779	output	i-TEST
780	anywhere	O
781	between	O
782	20	O
783	to	O
784	50	O
785	ccs	O
786	an	b-FREQUENCY
787	hour	i-FREQUENCY
788	.	O
789	her	b-TEST
790	hematocrit	i-TEST
791	was	O
792	26.8	O
793	and	O
794	she	O
795	was	O
796	transfused	b-TREATMENT
797	1	O
798	unit	O
799	of	O
800	packed	b-TREATMENT
801	red	i-TREATMENT
802	blood	i-TREATMENT
803	cells	i-TREATMENT
804	.	O
805	her	b-TREATMENT
806	diet	i-TREATMENT
807	was	O
808	advanced	O
809	from	O
810	clears	b-TREATMENT
811	to	O
812	a	b-TREATMENT
813	diet	i-TREATMENT
814	as	i-TREATMENT
815	tolerated	i-TREATMENT
816	.	O
817	on	O
818	postoperative	b-DATE
819	day	i-DATE
820	two	i-DATE
821	the	O
822	patient	O
823	was	O
824	noted	b-EVIDENTIAL
825	to	O
826	have	O
827	some	b-PROBLEM
828	swelling	i-PROBLEM
829	in	i-PROBLEM
830	her	i-PROBLEM
831	left	i-PROBLEM
832	lower	i-PROBLEM
833	extremity	i-PROBLEM
834	and	O
835	this	O
836	was	O
837	felt	O
838	to	O
839	be	O
840	a	b-PROBLEM
841	hematoma	i-PROBLEM
842	secondary	O
843	to	O
844	her	b-TEST
845	pvr	i-TEST
846	cuff	i-TEST
847	.	O
848	there	O
849	is	O
850	mild	O
851	amount	O
852	of	O
853	surrounding	b-PROBLEM
854	erythema	i-PROBLEM
855	and	O
856	the	O
857	patient	O
858	was	O
859	started	O
860	on	O
861	ancef	b-TREATMENT
862	at	O
863	that	O
864	time	O
865	.	O
866	the	O
867	patient	O
868	was	O
869	seen	O
870	by	O
871	physical	b-CLINICAL_DEPT
872	therapy	i-CLINICAL_DEPT
873	.	O
874	the	O
875	area	O
876	of	O
877	erythema	b-PROBLEM
878	on	i-PROBLEM
879	her	i-PROBLEM
880	left	i-PROBLEM
881	leg	i-PROBLEM
882	enlarged	O
883	slightly	O
884	and	O
885	the	O
886	patient	O
887	was	O
888	placed	O
889	on	O
890	vancomycin	b-TREATMENT
891	for	O
892	several	b-DATE
893	days	i-DATE
894	after	O
895	which	O
896	time	O
897	her	b-PROBLEM
898	erythema	i-PROBLEM
899	again	O
900	began	b-OCCURRENCE
901	to	i-OCCURRENCE
902	decrease	i-OCCURRENCE
903	.	O
904	her	O
905	right	O
906	foot	O
907	remained	O
908	warm	b-OCCURRENCE
909	.	O
910	she	O
911	had	O
912	wounds	b-PROBLEM
913	which	O
914	were	O
915	clean	b-OCCURRENCE
916	,	O
917	dry	b-OCCURRENCE
918	and	O
919	intact	b-OCCURRENCE
920	and	O
921	the	O
922	patient	O
923	was	O
924	stable	b-OCCURRENCE
925	from	O
926	a	O
927	respiratory	O
928	standpoint	O
929	using	O
930	her	b-TREATMENT
931	respirator	i-TREATMENT
932	at	O
933	night	O
934	.	O
935	the	O
936	patient	O
937	required	O
938	an	b-TREATMENT
939	additional	i-TREATMENT
940	blood	i-TREATMENT
941	transfusion	i-TREATMENT
942	during	O
943	her	b-OCCURRENCE
944	hospital	i-OCCURRENCE
945	stay	i-OCCURRENCE
946	as	O
947	her	b-TEST
948	hematocrit	i-TEST
949	had	O
950	decreased	O
951	to	O
952	27	O
953	on	O
954	postoperative	b-DATE
955	day	i-DATE
956	three	i-DATE
957	.	O
958	the	O
959	patient	O
960	while	O
961	in	O
962	bed	O
963	had	O
964	her	O
965	legs	O
966	elevated	b-TREATMENT
967	.	O
968	the	O
969	patient	O
970	was	O
971	tolerating	O
972	a	b-TREATMENT
973	general	i-TREATMENT
974	diet	i-TREATMENT
975	,	O
976	she	O
977	was	O
978	voiding	b-OCCURRENCE
979	on	i-OCCURRENCE
980	her	i-OCCURRENCE
981	own	i-OCCURRENCE
982	and	O
983	the	O
984	patient	O
985	was	O
986	discharged	b-OCCURRENCE
987	to	O
988	home	O
989	as	O
990	her	O
991	daughter	O
992	is	O
993	a	O
994	nurse	O
995	.	O
996	she	O
997	was	O
998	discharged	b-OCCURRENCE
999	with	O
1000	po	b-TREATMENT
1001	keflex	i-TREATMENT
1002	that	O
1003	she	O
1004	was	O
1005	to	O
1006	take	O
1007	for	O
1008	the	O
1009	next	O
1010	ten	b-DURATION
1011	days	i-DURATION
1012	.	O
1013	the	O
1014	patient	O
1015	is	O
1016	to	O
1017	follow	b-TREATMENT
1018	up	i-TREATMENT
1019	with	O
1020	doctor	O
1021	pop	O
1022	in	O
1023	one	b-DATE
1024	week	i-DATE
1025	and	O
1026	the	O
1027	patient	O
1028	was	O
1029	afebrile	b-PROBLEM
1030	with	O
1031	stable	b-TEST
1032	vital	i-TEST
1033	signs	i-TEST
1034	at	O
1035	the	b-DATE
1036	time	i-DATE
1037	of	O
1038	discharge	b-OCCURRENCE
1039	.	O
1040	laymie	O
1041	aslinke	O
1042	,	O
1043	md	O
1044		O
1045	admission	b-OCCURRENCE
1046	date	O
1047	:	O
1048	06/11/1991	b-ADMISSION
1049	discharge	b-OCCURRENCE
1050	date	O
1051	:	O
1052	06/22/1991	b-DISCHARGE
1053	history	O
1054	of	O
1055	present	O
1056	illness	O
1057	:	O
1058	patient	O
1059	is	O
1060	a	O
1061	28	O
1062	year	O
1063	old	O
1064	gravida	b-OCCURRENCE
1065	iv	i-OCCURRENCE
1066	,	O
1067	para	b-OCCURRENCE
1068	2	i-OCCURRENCE
1069	with	O
1070	metastatic	b-PROBLEM
1071	cervical	i-PROBLEM
1072	cancer	i-PROBLEM
1073	admitted	b-OCCURRENCE
1074	with	O
1075	a	O
1076	question	O
1077	of	O
1078	malignant	b-PROBLEM
1079	pericardial	i-PROBLEM
1080	effusion	i-PROBLEM
1081	.	O
1082	patient	O
1083	underwent	O
1084	a	b-TREATMENT
1085	total	i-TREATMENT
1086	abdominal	i-TREATMENT
1087	hysterectomy	i-TREATMENT
1088	in	O
1089	02/90	b-DATE
1090	for	O
1091	a	b-PROBLEM
1092	4x3.6x2	i-PROBLEM
1093	cm	i-PROBLEM
1094	cervical	i-PROBLEM
1095	mass	i-PROBLEM
1096	felt	O
1097	to	O
1098	be	O
1099	a	b-PROBLEM
1100	fibroid	i-PROBLEM
1101	at	O
1102	vanor	b-CLINICAL_DEPT
1103	.	O
1104	pathology	b-TEST
1105	revealed	b-EVIDENTIAL
1106	poorly	b-PROBLEM
1107	differentiated	i-PROBLEM
1108	squamous	i-PROBLEM
1109	cell	i-PROBLEM
1110	carcinoma	i-PROBLEM
1111	of	i-PROBLEM
1112	the	i-PROBLEM
1113	cervix	i-PROBLEM
1114	with	O
1115	spots	O
1116	of	O
1117	vaginal	b-OCCURRENCE
1118	margins	i-OCCURRENCE
1119	and	O
1120	metastatic	b-PROBLEM
1121	squamous	i-PROBLEM
1122	cell	i-PROBLEM
1123	carcinoma	i-PROBLEM
1124	in	i-PROBLEM
1125	the	i-PROBLEM
1126	cardinal	i-PROBLEM
1127	ligaments	i-PROBLEM
1128	with	O
1129	extensive	b-PROBLEM
1130	lymphatic	i-PROBLEM
1131	invasion	i-PROBLEM
1132	.	O
1133	patient	O
1134	was	O
1135	felt	O
1136	to	O
1137	have	O
1138	stage	b-PROBLEM
1139	2b	i-PROBLEM
1140	disease	i-PROBLEM
1141	and	O
1142	post-operatively	O
1143	,	O
1144	she	O
1145	was	O
1146	treated	O
1147	with	O
1148	intracavitary	b-TREATMENT
1149	and	i-TREATMENT
1150	external	i-TREATMENT
1151	beam	i-TREATMENT
1152	radiation	i-TREATMENT
1153	therapy	i-TREATMENT
1154	and	O
1155	low	b-TREATMENT
1156	dose	i-TREATMENT
1157	cisplatin	i-TREATMENT
1158	.	O
1159	on	O
1160	ultrasound	b-TEST
1161	in	O
1162	02/91	b-DATE
1163	,	O
1164	the	O
1165	patient	O
1166	was	O
1167	found	O
1168	to	O
1169	have	O
1170	bilateral	b-PROBLEM
1171	cystic	i-PROBLEM
1172	adnexal	i-PROBLEM
1173	masses	i-PROBLEM
1174	confirmed	b-OCCURRENCE
1175	on	O
1176	physical	b-TEST
1177	examination	i-TEST
1178	.	O
1179	she	O
1180	underwent	O
1181	exploratory	b-TEST
1182	laparotomy	i-TEST
1183	and	O
1184	had	O
1185	a	b-TREATMENT
1186	bilateral	i-TREATMENT
1187	salpingo-oophorectomy	i-TREATMENT
1188	and	O
1189	appendectomy	b-TREATMENT
1190	.	O
1191	pathology	b-TEST
1192	was	O
1193	negative	O
1194	for	O
1195	tumor	b-PROBLEM
1196	and	O
1197	showed	b-EVIDENTIAL
1198	peritubal	b-PROBLEM
1199	and	i-PROBLEM
1200	periovarian	i-PROBLEM
1201	adhesions	i-PROBLEM
1202	.	O
1203	the	O
1204	patient	O
1205	now	O
1206	presents	b-EVIDENTIAL
1207	with	O
1208	a	b-DURATION
1209	three	i-DURATION
1210	to	i-DURATION
1211	four	i-DURATION
1212	week	i-DURATION
1213	history	O
1214	of	O
1215	shortness	b-PROBLEM
1216	of	i-PROBLEM
1217	breath	i-PROBLEM
1218	and	O
1219	a	b-PROBLEM
1220	dry	i-PROBLEM
1221	non-productive	i-PROBLEM
1222	cough	i-PROBLEM
1223	.	O
1224	she	O
1225	was	O
1226	evaluated	b-TEST
1227	by	O
1228	doctor	O
1229	mielke	O
1230	,	O
1231	a	O
1232	pulmonologist	O
1233	,	O
1234	who	O
1235	found	O
1236	her	O
1237	to	O
1238	be	O
1239	wheezing	b-PROBLEM
1240	and	O
1241	performed	O
1242	pulmonary	b-TEST
1243	function	i-TEST
1244	tests	i-TEST
1245	which	O
1246	showed	b-EVIDENTIAL
1247	an	b-TEST
1248	fev1	i-TEST
1249	of	O
1250	1.1	O
1251	and	O
1252	an	b-TEST
1253	fvc	i-TEST
1254	of	O
1255	1.8	O
1256	.	O
1257	she	O
1258	was	O
1259	admitted	b-OCCURRENCE
1260	to	O
1261	weekscook	b-CLINICAL_DEPT
1262	university	i-CLINICAL_DEPT
1263	medical	i-CLINICAL_DEPT
1264	center	i-CLINICAL_DEPT
1265	with	O
1266	a	O
1267	diagnosis	O
1268	of	O
1269	possible	O
1270	asthma	b-PROBLEM
1271	.	O
1272	room	b-TEST
1273	air	i-TEST
1274	arterial	i-TEST
1275	blood	i-TEST
1276	gas	i-TEST
1277	showed	b-EVIDENTIAL
1278	a	b-TEST
1279	po2	i-TEST
1280	of	O
1281	56	O
1282	,	O
1283	a	b-TEST
1284	pco2	i-TEST
1285	of	O
1286	35	O
1287	,	O
1288	and	O
1289	a	b-TEST
1290	ph	i-TEST
1291	of	O
1292	7.52	O
1293	.	O
1294	ekg	b-TEST
1295	showed	b-EVIDENTIAL
1296	sinus	b-PROBLEM
1297	tachycardia	i-PROBLEM
1298	at	O
1299	100	O
1300	and	O
1301	echo	b-TEST
1302	revealed	b-EVIDENTIAL
1303	pericardial	b-PROBLEM
1304	effusion	i-PROBLEM
1305	,	O
1306	a	b-PROBLEM
1307	10	i-PROBLEM
1308	mm	i-PROBLEM
1309	pulsus	i-PROBLEM
1310	paradoxus	i-PROBLEM
1311	was	O
1312	noted	O
1313	,	O
1314	and	O
1315	no	O
1316	evidence	b-OCCURRENCE
1317	of	O
1318	tamponade	b-PROBLEM
1319	.	O
1320	given	O
1321	the	O
1322	patient	O
1323	&apos;s	O
1324	history	O
1325	of	O
1326	cervical	b-PROBLEM
1327	cancer	i-PROBLEM
1328	,	O
1329	the	b-PROBLEM
1330	pericardial	i-PROBLEM
1331	effusion	i-PROBLEM
1332	was	O
1333	felt	O
1334	most	O
1335	likely	O
1336	to	O
1337	be	O
1338	malignant	b-PROBLEM
1339	.	O
1340	she	O
1341	was	O
1342	therefore	O
1343	transferred	b-OCCURRENCE
1344	to	O
1345	the	b-CLINICAL_DEPT
1346	retelk	i-CLINICAL_DEPT
1347	county	i-CLINICAL_DEPT
1348	medical	i-CLINICAL_DEPT
1349	center	i-CLINICAL_DEPT
1350	for	O
1351	further	b-TREATMENT
1352	care	i-TREATMENT
1353	.	O
1354	hospital	O
1355	course	O
1356	:	O
1357	the	O
1358	patient	O
1359	was	O
1360	admitted	b-OCCURRENCE
1361	for	O
1362	a	b-PROBLEM
1363	new	i-PROBLEM
1364	pericardial	i-PROBLEM
1365	effusion	i-PROBLEM
1366	which	O
1367	was	O
1368	felt	O
1369	most	O
1370	likely	O
1371	to	O
1372	be	O
1373	secondary	O
1374	to	O
1375	metastatic	b-PROBLEM
1376	cervical	i-PROBLEM
1377	cancer	i-PROBLEM
1378	.	O
1379	there	O
1380	was	O
1381	no	O
1382	evidence	b-EVIDENTIAL
1383	of	O
1384	tamponade	b-PROBLEM
1385	.	O
1386	an	b-TEST
1387	echocardiogram	i-TEST
1388	was	O
1389	scheduled	b-OCCURRENCE
1390	and	O
1391	cardiology	b-OCCURRENCE
1392	was	O
1393	consulted	b-OCCURRENCE
1394	.	O
1395	echocardiogram	b-TEST
1396	showed	b-EVIDENTIAL
1397	moderate	b-PROBLEM
1398	anterior	i-PROBLEM
1399	pericardial	i-PROBLEM
1400	effusion	i-PROBLEM
1401	of	O
1402	approximately	O
1403	600	O
1404	cc	O
1405	with	O
1406	diastolic	b-PROBLEM
1407	indications	i-PROBLEM
1408	of	i-PROBLEM
1409	the	i-PROBLEM
1410	right	i-PROBLEM
1411	ventricle	i-PROBLEM
1412	and	O
1413	low	b-PROBLEM
1414	velocity	i-PROBLEM
1415	paradox	i-PROBLEM
1416	.	O
1417	cardiology	b-OCCURRENCE
1418	did	O
1419	not	O
1420	feel	O
1421	that	O
1422	tamponade	b-PROBLEM
1423	at	O
1424	this	O
1425	time	O
1426	was	O
1427	a	O
1428	concern	O
1429	and	O
1430	that	O
1431	a	b-TREATMENT
1432	tap	i-TREATMENT
1433	need	O
1434	not	O
1435	be	O
1436	performed	O
1437	.	O
1438	she	O
1439	continued	O
1440	to	O
1441	have	O
1442	pulmonary	b-PROBLEM
1443	wheezing	i-PROBLEM
1444	,	O
1445	unknown	O
1446	origin	O
1447	,	O
1448	without	O
1449	history	O
1450	of	O
1451	asthma	b-PROBLEM
1452	.	O
1453	her	b-TREATMENT
1454	steroids	i-TREATMENT
1455	were	O
1456	tapered	b-OCCURRENCE
1457	and	O
1458	pulmonary	b-OCCURRENCE
1459	was	O
1460	consulted	b-OCCURRENCE
1461	who	O
1462	recommended	O
1463	a	b-TEST
1464	ct	i-TEST
1465	scan	i-TEST
1466	of	i-TEST
1467	the	i-TEST
1468	chest	i-TEST
1469	to	O
1470	evaluate	O
1471	the	O
1472	lung	O
1473	parenchyma	O
1474	,	O
1475	induce	O
1476	sputum	b-OCCURRENCE
1477	for	O
1478	cbc	b-TEST
1479	,	O
1480	arterial	b-TEST
1481	blood	i-TEST
1482	gas	i-TEST
1483	,	O
1484	continuing	O
1485	of	O
1486	the	b-TREATMENT
1487	beta	i-TREATMENT
1488	agonist	i-TREATMENT
1489	inhalers	i-TREATMENT
1490	,	O
1491	and	O
1492	trial	O
1493	of	O
1494	steroid	b-TREATMENT
1495	inhalers	i-TREATMENT
1496	.	O
1497	they	O
1498	felt	O
1499	it	O
1500	was	O
1501	most	O
1502	likely	O
1503	a	b-PROBLEM
1504	malignant	i-PROBLEM
1505	lymphangitic	i-PROBLEM
1506	spread	i-PROBLEM
1507	with	O
1508	pericardial	b-PROBLEM
1509	involvement	i-PROBLEM
1510	versus	O
1511	infectious	b-PROBLEM
1512	,	O
1513	other	b-PROBLEM
1514	cardiovascular	i-PROBLEM
1515	causes	i-PROBLEM
1516	,	O
1517	or	O
1518	viral	b-PROBLEM
1519	bronchiolitis	i-PROBLEM
1520	.	O
1521	she	O
1522	had	O
1523	pulmonary	b-TEST
1524	function	i-TEST
1525	tests	i-TEST
1526	repeated	O
1527	which	O
1528	showed	b-EVIDENTIAL
1529	an	b-TEST
1530	fev1	i-TEST
1531	of	O
1532	36%	O
1533	of	O
1534	predicted	O
1535	and	O
1536	fvc	b-TEST
1537	of	O
1538	56%	O
1539	of	O
1540	predicted	O
1541	.	O
1542	room	b-TEST
1543	air	i-TEST
1544	arterial	i-TEST
1545	blood	i-TEST
1546	gas	i-TEST
1547	showed	b-EVIDENTIAL
1548	a	b-TEST
1549	ph	i-TEST
1550	of	O
1551	7.45	O
1552	,	O
1553	po2	b-TEST
1554	of	O
1555	63	O
1556	,	O
1557	a	b-TEST
1558	pco2	i-TEST
1559	of	O
1560	41	O
1561	,	O
1562	and	O
1563	fairly	b-PROBLEM
1564	significant	i-PROBLEM
1565	aa	i-PROBLEM
1566	gradient	i-PROBLEM
1567	.	O
1568	she	O
1569	was	O
1570	continued	O
1571	on	O
1572	two	O
1573	liters	O
1574	of	O
1575	oxygen	b-TREATMENT
1576	awaiting	O
1577	her	b-TEST
1578	ct	i-TEST
1579	scan	i-TEST
1580	on	O
1581	06/14	b-DATE
1582	and	O
1583	she	O
1584	developed	O
1585	a	b-PROBLEM
1586	new	i-PROBLEM
1587	junctional	i-PROBLEM
1588	rhythm	i-PROBLEM
1589	with	O
1590	a	O
1591	question	O
1592	of	O
1593	a	b-PROBLEM
1594	new	i-PROBLEM
1595	rub	i-PROBLEM
1596	versus	O
1597	murmur	b-PROBLEM
1598	on	O
1599	examination	b-TEST
1600	.	O
1601	cardiology	b-OCCURRENCE
1602	felt	O
1603	she	O
1604	had	O
1605	a	b-PROBLEM
1606	rub	i-PROBLEM
1607	and	O
1608	her	b-TEST
1609	pulsus	i-TEST
1610	was	O
1611	still	O
1612	10	O
1613	.	O
1614	ekg	b-TEST
1615	showed	b-EVIDENTIAL
1616	an	b-PROBLEM
1617	ectopic	i-PROBLEM
1618	low	i-PROBLEM
1619	atrial	i-PROBLEM
1620	p	i-PROBLEM
1621	and	O
1622	they	O
1623	thought	O
1624	she	O
1625	was	O
1626	still	O
1627	stable	b-OCCURRENCE
1628	without	O
1629	evidence	O
1630	of	O
1631	tamponade	b-PROBLEM
1632	.	O
1633	she	O
1634	should	O
1635	have	O
1636	a	b-TEST
1637	follow-up	i-TEST
1638	echocardiogram	i-TEST
1639	.	O
1640	echocardiogram	b-TEST
1641	showed	b-EVIDENTIAL
1642	left	O
1643	ventricle	O
1644	at	O
1645	the	b-PROBLEM
1646	upper	i-PROBLEM
1647	limits	i-PROBLEM
1648	of	i-PROBLEM
1649	normal	i-PROBLEM
1650	for	i-PROBLEM
1651	size	i-PROBLEM
1652	,	O
1653	low	b-PROBLEM
1654	normal	i-PROBLEM
1655	function	i-PROBLEM
1656	,	O
1657	moderate	b-PROBLEM
1658	to	i-PROBLEM
1659	mild	i-PROBLEM
1660	effusion	i-PROBLEM
1661	with	O
1662	pericardial	b-TEST
1663	pressures	i-TEST
1664	exceeding	O
1665	right	b-TEST
1666	atrial	i-TEST
1667	pressures	i-TEST
1668	,	O
1669	and	O
1670	right	b-TEST
1671	ventricular	i-TEST
1672	pressures	i-TEST
1673	at	O
1674	various	O
1675	points	O
1676	of	O
1677	patient	O
1678	&apos;s	O
1679	cycle	O
1680	without	O
1681	any	O
1682	change	O
1683	in	O
1684	the	b-PROBLEM
1685	effusion	i-PROBLEM
1686	from	O
1687	06/11	b-DATE
1688	.	O
1689	thoracic	b-OCCURRENCE
1690	surgery	i-OCCURRENCE
1691	was	O
1692	also	O
1693	consulted	b-OCCURRENCE
1694	and	O
1695	they	O
1696	felt	O
1697	that	O
1698	there	O
1699	was	O
1700	no	O
1701	need	O
1702	for	O
1703	a	b-TREATMENT
1704	pericardial	i-TREATMENT
1705	window	i-TREATMENT
1706	at	O
1707	the	O
1708	time	O
1709	.	O
1710	she	O
1711	should	O
1712	be	O
1713	continued	O
1714	with	O
1715	pulmonary	b-TEST
1716	oximetry	i-TEST
1717	testing	i-TEST
1718	.	O
1719	she	O
1720	underwent	O
1721	her	b-TEST
1722	ct	i-TEST
1723	scan	i-TEST
1724	.	O
1725	this	b-EVIDENTIAL
1726	showed	i-EVIDENTIAL
1727	lymphangitic	b-PROBLEM
1728	spread	i-PROBLEM
1729	of	O
1730	cancer	b-PROBLEM
1731	in	i-PROBLEM
1732	the	i-PROBLEM
1733	chest	i-PROBLEM
1734	,	O
1735	question	O
1736	of	O
1737	pulmonary	b-PROBLEM
1738	nodules	i-PROBLEM
1739	in	i-PROBLEM
1740	the	i-PROBLEM
1741	chest	i-PROBLEM
1742	,	O
1743	pericardial	b-PROBLEM
1744	effusion	i-PROBLEM
1745	,	O
1746	multiple	b-PROBLEM
1747	liver	i-PROBLEM
1748	metastases	i-PROBLEM
1749	,	O
1750	decreased	b-PROBLEM
1751	function	i-PROBLEM
1752	of	i-PROBLEM
1753	the	i-PROBLEM
1754	left	i-PROBLEM
1755	kidney	i-PROBLEM
1756	,	O
1757	dilated	b-PROBLEM
1758	left	i-PROBLEM
1759	intrarenal	i-PROBLEM
1760	collecting	i-PROBLEM
1761	system	i-PROBLEM
1762	and	i-PROBLEM
1763	proximal	i-PROBLEM
1764	ureter	i-PROBLEM
1765	,	O
1766	and	O
1767	periaortic	b-PROBLEM
1768	lymphadenopathy	i-PROBLEM
1769	.	O
1770	pulmonary	b-OCCURRENCE
1771	felt	O
1772	this	O
1773	was	O
1774	consistent	O
1775	also	O
1776	with	O
1777	lymphangitic	b-PROBLEM
1778	spread	i-PROBLEM
1779	and	O
1780	they	O
1781	did	O
1782	not	O
1783	feel	O
1784	that	O
1785	a	b-TEST
1786	bronchoscopy	i-TEST
1787	would	O
1788	be	O
1789	of	O
1790	any	O
1791	assistance	O
1792	at	O
1793	this	O
1794	time	O
1795	.	O
1796	chemotherapy	b-TREATMENT
1797	for	O
1798	metastatic	b-PROBLEM
1799	cervical	i-PROBLEM
1800	cancer	i-PROBLEM
1801	was	O
1802	discussed	b-OCCURRENCE
1803	with	O
1804	the	O
1805	patient	O
1806	and	O
1807	she	O
1808	was	O
1809	started	O
1810	on	O
1811	5-fu	b-TREATMENT
1812	800	O
1813	mg	O
1814	per	O
1815	meter	O
1816	squared	O
1817	days	O
1818	06/18	b-DATE
1819	,	O
1820	06/19	b-DATE
1821	,	O
1822	and	O
1823	06/20	b-DATE
1824	.	O
1825	she	O
1826	also	O
1827	received	O
1828	cisplatin	b-TREATMENT
1829	35	O
1830	per	O
1831	meter	O
1832	squared	O
1833	on	O
1834	06/19	b-DATE
1835	and	O
1836	ifex	b-TREATMENT
1837	and	O
1838	mesna	b-TREATMENT
1839	on	O
1840	06/18	b-DATE
1841	.	O
1842	she	O
1843	was	O
1844	noted	b-EVIDENTIAL
1845	,	O
1846	on	O
1847	06/16	b-DATE
1848	,	O
1849	to	O
1850	have	O
1851	numerous	b-PROBLEM
1852	erythematous	i-PROBLEM
1853	maculopapules	i-PROBLEM
1854	on	i-PROBLEM
1855	her	i-PROBLEM
1856	back	i-PROBLEM
1857	and	O
1858	chest	O
1859	.	O
1860	dermatology	b-OCCURRENCE
1861	was	O
1862	consulted	b-OCCURRENCE
1863	and	O
1864	they	O
1865	felt	O
1866	that	O
1867	this	O
1868	was	O
1869	most	O
1870	likely	O
1871	steroid	b-PROBLEM
1872	acne	i-PROBLEM
1873	.	O
1874	they	O
1875	therefore	O
1876	felt	O
1877	a	b-TREATMENT
1878	rapid	i-TREATMENT
1879	steroid	i-TREATMENT
1880	taper	i-TREATMENT
1881	was	O
1882	indicated	O
1883	and	O
1884	topical	b-TREATMENT
1885	erythromycin	i-TREATMENT
1886	if	O
1887	desired	O
1888	by	O
1889	the	O
1890	patient	O
1891	.	O
1892	the	b-PROBLEM
1893	patient	i-PROBLEM
1894	&apos;s	i-PROBLEM
1895	shortness	i-PROBLEM
1896	of	i-PROBLEM
1897	breath	i-PROBLEM
1898	and	O
1899	wheezing	b-PROBLEM
1900	continued	O
1901	but	O
1902	without	O
1903	change	O
1904	.	O
1905	her	b-TEST
1906	cardiac	i-TEST
1907	examination	i-TEST
1908	remained	O
1909	the	O
1910	same	O
1911	and	O
1912	there	O
1913	continued	O
1914	to	O
1915	be	O
1916	no	O
1917	evidence	O
1918	of	O
1919	tamponade	b-PROBLEM
1920	.	O
1921	cardiology	b-OCCURRENCE
1922	felt	O
1923	that	O
1924	follow-up	b-TEST
1925	echo	i-TEST
1926	was	O
1927	indicated	O
1928	on	O
1929	06/18	b-DATE
1930	as	O
1931	she	O
1932	had	O
1933	another	b-TEST
1934	echocardiogram	i-TEST
1935	which	O
1936	showed	b-EVIDENTIAL
1937	no	O
1938	change	O
1939	or	O
1940	evidence	O
1941	of	O
1942	tamponade	b-PROBLEM
1943	.	O
1944	they	O
1945	therefore	O
1946	felt	O
1947	that	O
1948	she	O
1949	could	O
1950	be	O
1951	continued	O
1952	to	O
1953	be	O
1954	followed	O
1955	by	O
1956	examination	b-TEST
1957	.	O
1958	she	O
1959	had	O
1960	some	b-PROBLEM
1961	mental	i-PROBLEM
1962	status	i-PROBLEM
1963	changes	i-PROBLEM
1964	with	O
1965	confusion	b-PROBLEM
1966	and	O
1967	hallucinations	b-PROBLEM
1968	on	O
1969	06/18	b-DATE
1970	originating	O
1971	from	O
1972	narcotics	b-TREATMENT
1973	versus	O
1974	decreased	b-PROBLEM
1975	po2	i-PROBLEM
1976	.	O
1977	the	b-TREATMENT
1978	ifex	i-TREATMENT
1979	was	O
1980	held	b-OCCURRENCE
1981	as	O
1982	it	O
1983	was	O
1984	felt	O
1985	that	O
1986	it	O
1987	could	O
1988	have	O
1989	precipitated	O
1990	the	b-PROBLEM
1991	mental	i-PROBLEM
1992	status	i-PROBLEM
1993	changes	i-PROBLEM
1994	and	O
1995	that	O
1996	she	O
1997	was	O
1998	to	O
1999	receive	O
2000	no	O
2001	further	b-TREATMENT
2002	ifex	i-TREATMENT
2003	.	O
2004	she	O
2005	had	O
2006	no	O
2007	further	b-PROBLEM
2008	hallucinations	i-PROBLEM
2009	since	O
2010	stopping	O
2011	the	b-TREATMENT
2012	ifex	i-TREATMENT
2013	.	O
2014	psychiatry	b-OCCURRENCE
2015	was	O
2016	also	O
2017	consulted	b-OCCURRENCE
2018	to	O
2019	help	O
2020	her	O
2021	with	O
2022	the	b-OCCURRENCE
2023	changes	i-OCCURRENCE
2024	she	O
2025	was	O
2026	feeling	O
2027	since	O
2028	her	b-PROBLEM
2029	new	i-PROBLEM
2030	diagnosis	i-PROBLEM
2031	.	O
2032	she	O
2033	was	O
2034	hooked	b-OCCURRENCE
2035	up	i-OCCURRENCE
2036	with	O
2037	support	b-OCCURRENCE
2038	services	i-OCCURRENCE
2039	in	O
2040	collot	O
2041	ln	O
2042	,	O
2043	dugo	O
2044	,	O
2045	indiana	O
2046	68961	O
2047	for	O
2048	further	b-TREATMENT
2049	counselling	i-TREATMENT
2050	and	O
2051	given	O
2052	xanax	b-TREATMENT
2053	for	O
2054	symptoms	b-PROBLEM
2055	of	O
2056	anxiety	b-PROBLEM
2057	.	O
2058	she	O
2059	continued	O
2060	to	O
2061	have	O
2062	no	O
2063	change	b-OCCURRENCE
2064	in	O
2065	her	b-PROBLEM
2066	shortness	i-PROBLEM
2067	of	i-PROBLEM
2068	breath	i-PROBLEM
2069	or	O
2070	cardiac	b-TEST
2071	examination	i-TEST
2072	and	O
2073	was	O
2074	discharged	b-OCCURRENCE
2075	home	i-OCCURRENCE
2076	on	O
2077	06/22/91	b-DATE
2078	after	O
2079	completing	O
2080	her	b-TREATMENT
2081	5-fu	i-TREATMENT
2082	and	O
2083	cisplatin	b-TREATMENT
2084	chemotherapy	i-TREATMENT
2085	.	O
2086		O
2087	admission	b-OCCURRENCE
2088	date	O
2089	:	O
2090	11/30/1993	b-ADMISSION
2091	discharge	b-OCCURRENCE
2092	date	O
2093	:	O
2094	12/07/1993	b-DISCHARGE
2095	history	O
2096	of	O
2097	present	O
2098	illness	O
2099	:	O
2100	the	O
2101	patient	O
2102	is	O
2103	a	O
2104	40	O
2105	year	O
2106	old	O
2107	woman	O
2108	with	O
2109	end	b-PROBLEM
2110	stage	i-PROBLEM
2111	renal	i-PROBLEM
2112	disease	i-PROBLEM
2113	,	O
2114	on	O
2115	hemodialysis	b-TREATMENT
2116	since	O
2117	12/91	b-DATE
2118	.	O
2119	this	O
2120	was	O
2121	secondary	O
2122	to	O
2123	polycystic	b-PROBLEM
2124	kidneydisease	i-PROBLEM
2125	,	O
2126	which	O
2127	was	O
2128	noted	b-EVIDENTIAL
2129	since	O
2130	age	b-DATE
2131	12	i-DATE
2132	.	O
2133	she	O
2134	is	O
2135	status	O
2136	post	O
2137	cadaveric	b-TREATMENT
2138	renal	i-TREATMENT
2139	allograft	i-TREATMENT
2140	in	O
2141	03/93	b-DATE
2142	,	O
2143	and	O
2144	she	O
2145	subsequently	O
2146	underwent	O
2147	an	b-TREATMENT
2148	early	i-TREATMENT
2149	postoperative	i-TREATMENT
2150	transplant	i-TREATMENT
2151	nephrectomy	i-TREATMENT
2152	secondary	O
2153	to	O
2154	rupture	b-PROBLEM
2155	.	O
2156	he	O
2157	has	O
2158	been	O
2159	having	O
2160	difficult	b-PROBLEM
2161	access	i-PROBLEM
2162	problems	i-PROBLEM
2163	and	O
2164	now	O
2165	has	O
2166	a	b-TREATMENT
2167	left	i-TREATMENT
2168	upper	i-TREATMENT
2169	arm	i-TREATMENT
2170	ptfe	i-TREATMENT
2171	.	O
2172	she	O
2173	had	O
2174	been	O
2175	placed	O
2176	on	O
2177	emergency	b-TREATMENT
2178	transplant	i-TREATMENT
2179	for	O
2180	this	b-PROBLEM
2181	difficult	i-PROBLEM
2182	access	i-PROBLEM
2183	problem	i-PROBLEM
2184	.	O
2185	otherwise	O
2186	,	O
2187	she	O
2188	has	O
2189	been	O
2190	healthy	O
2191	and	O
2192	her	b-TREATMENT
2193	last	i-TREATMENT
2194	hemodialysis	i-TREATMENT
2195	was	O
2196	the	b-DATE
2197	day	i-DATE
2198	prior	O
2199	to	O
2200	transplant	b-TREATMENT
2201	.	O
2202	hospital	O
2203	course	O
2204	:	O
2205	she	O
2206	was	O
2207	taken	O
2208	to	O
2209	the	b-CLINICAL_DEPT
2210	operating	i-CLINICAL_DEPT
2211	room	i-CLINICAL_DEPT
2212	on	O
2213	11/30/93	b-DATE
2214	where	O
2215	doctor	O
2216	tiveloydherdes	O
2217	performed	O
2218	a	b-TREATMENT
2219	cadaveric	i-TREATMENT
2220	renal	i-TREATMENT
2221	allograft	i-TREATMENT
2222	to	i-TREATMENT
2223	the	i-TREATMENT
2224	left	i-TREATMENT
2225	iliac	i-TREATMENT
2226	fossa	i-TREATMENT
2227	which	O
2228	she	O
2229	tolerated	b-OCCURRENCE
2230	well	i-OCCURRENCE
2231	.	O
2232	postoperative	b-OCCURRENCE
2233	course	i-OCCURRENCE
2234	was	O
2235	unremarkable	b-OCCURRENCE
2236	.	O
2237	she	O
2238	was	O
2239	started	O
2240	on	O
2241	her	b-TREATMENT
2242	immunosuppressive	i-TREATMENT
2243	agents	i-TREATMENT
2244	as	O
2245	per	O
2246	protocol	O
2247	.	O
2248	her	b-TEST
2249	creatinine	i-TEST
2250	fell	O
2251	to	O
2252	the	O
2253	normal	O
2254	range	O
2255	early	O
2256	.	O
2257	over	O
2258	several	b-DURATION
2259	days	i-DURATION
2260	she	O
2261	continued	O
2262	to	O
2263	make	O
2264	good	b-TEST
2265	amounts	i-TEST
2266	or	i-TEST
2267	urine	i-TEST
2268	.	O
2269	she	O
2270	was	O
2271	gradually	O
2272	advanced	O
2273	to	O
2274	a	b-TREATMENT
2275	regular	i-TREATMENT
2276	diet	i-TREATMENT
2277	.	O
2278	her	b-TREATMENT
2279	prednisone	i-TREATMENT
2280	was	O
2281	tapered	b-OCCURRENCE
2282	to	O
2283	a	b-TREATMENT
2284	stable	i-TREATMENT
2285	dose	i-TREATMENT
2286	.	O
2287		O
2288	admission	b-OCCURRENCE
2289	date	O
2290	:	O
2291	09-07-93	b-ADMISSION
2292	discharge	b-OCCURRENCE
2293	date	O
2294	:	O
2295	09-08-93	b-DATE
2296	patient	O
2297	died	b-OCCURRENCE
2298	on	O
2299	9/8/93	b-DATE
2300	.	O
2301	history	O
2302	of	O
2303	present	O
2304	illness	O
2305	:	O
2306	date	O
2307	of	O
2308	birth	b-OCCURRENCE
2309	:	O
2310	10/4/88	b-DATE
2311	.	O
2312	this	O
2313	patient	O
2314	is	O
2315	a	O
2316	5	O
2317	year	O
2318	old	O
2319	white	O
2320	female	O
2321	with	O
2322	a	O
2323	history	O
2324	of	O
2325	type	b-PROBLEM
2326	i	i-PROBLEM
2327	renal	i-PROBLEM
2328	tubular	i-PROBLEM
2329	acidosis	i-PROBLEM
2330	on	O
2331	nephrocalcinosis	b-PROBLEM
2332	who	O
2333	was	O
2334	admitted	b-OCCURRENCE
2335	to	O
2336	noughwell	b-CLINICAL_DEPT
2337	entanbon	i-CLINICAL_DEPT
2338	health	i-CLINICAL_DEPT
2339	of	i-CLINICAL_DEPT
2340	washington	i-CLINICAL_DEPT
2341	on	O
2342	9/5/93	b-DATE
2343	at	i-DATE
2344	21:16	i-DATE
2345	hours	i-DATE
2346	with	O
2347	a	O
2348	2-3	b-DURATION
2349	day	i-DURATION
2350	history	O
2351	of	O
2352	chills	b-PROBLEM
2353	,	O
2354	fevers	b-PROBLEM
2355	,	O
2356	cough	b-PROBLEM
2357	,	O
2358	vomiting	b-PROBLEM
2359	and	O
2360	weakness	b-PROBLEM
2361	(	O
2362	unable	b-PROBLEM
2363	to	i-PROBLEM
2364	walk	i-PROBLEM
2365	)	O
2366	.	O
2367	at	O
2368	noughwell	b-CLINICAL_DEPT
2369	entanbon	i-CLINICAL_DEPT
2370	health	i-CLINICAL_DEPT
2371	,	O
2372	her	b-TEST
2373	temperature	i-TEST
2374	was	O
2375	101	O
2376	,	O
2377	pulse	b-TEST
2378	135	O
2379	,	O
2380	blood	b-TEST
2381	pressure	i-TEST
2382	94/74	O
2383	,	O
2384	respiratory	b-TEST
2385	rate	i-TEST
2386	20	O
2387	.	O
2388	positive	O
2389	findings	O
2390	of	O
2391	physical	b-TEST
2392	examination	i-TEST
2393	include	O
2394	chicken	b-PROBLEM
2395	pox	i-PROBLEM
2396	lesions	i-PROBLEM
2397	on	i-PROBLEM
2398	thorax	i-PROBLEM
2399	,	O
2400	sunken	b-PROBLEM
2401	eyes	i-PROBLEM
2402	,	O
2403	thick	b-PROBLEM
2404	nasal	i-PROBLEM
2405	discharge	i-PROBLEM
2406	,	O
2407	dry	b-PROBLEM
2408	lips	i-PROBLEM
2409	,	i-PROBLEM
2410	tongue	i-PROBLEM
2411	and	i-PROBLEM
2412	mucous	i-PROBLEM
2413	membranes	i-PROBLEM
2414	,	O
2415	red	b-PROBLEM
2416	tonsils	i-PROBLEM
2417	.	O
2418	the	O
2419	remainder	O
2420	of	O
2421	the	b-TEST
2422	physical	i-TEST
2423	examination	i-TEST
2424	was	O
2425	considered	O
2426	within	O
2427	normal	O
2428	limits	O
2429	.	O
2430	admission	O
2431	diagnosis	O
2432	at	O
2433	ni	b-CLINICAL_DEPT
2434	hospital	i-CLINICAL_DEPT
2435	&apos;s	O
2436	:	O
2437	vomiting	b-PROBLEM
2438	and	O
2439	dehydration	b-PROBLEM
2440	,	O
2441	hypokalemia	b-PROBLEM
2442	,	O
2443	hyponatremia	b-PROBLEM
2444	,	O
2445	tonsillitis	b-PROBLEM
2446	.	O
2447	a	b-TREATMENT
2448	peripheral	i-TREATMENT
2449	intravenous	i-TREATMENT
2450	line	i-TREATMENT
2451	was	O
2452	started	O
2453	on	O
2454	labor	b-DATE
2455	day	i-DATE
2456	in	O
2457	the	O
2458	a.m.	O
2459	no	O
2460	respiratory	b-PROBLEM
2461	distress	i-PROBLEM
2462	was	O
2463	noted	O
2464	.	O
2465	oral	b-PROBLEM
2466	cyanosis	i-PROBLEM
2467	and	O
2468	shallow	b-PROBLEM
2469	respirations	i-PROBLEM
2470	were	O
2471	noted	O
2472	on	O
2473	9/7/93	b-TIME
2474	at	i-TIME
2475	2:45	i-TIME
2476	a.m.	i-TIME
2477	therefore	O
2478	the	O
2479	patient	O
2480	was	O
2481	intubated	b-TREATMENT
2482	at	O
2483	3:45	b-TIME
2484	a.m.	i-TIME
2485	on	i-TIME
2486	9/7/93	i-TIME
2487	.	O
2488	chest	b-TEST
2489	x-ray	i-TEST
2490	was	O
2491	unremarkable	O
2492	.	O
2493	cardiovascular	b-OCCURRENCE
2494	stable	i-OCCURRENCE
2495	,	O
2496	significant	b-PROBLEM
2497	hypertension	i-PROBLEM
2498	was	O
2499	noted	O
2500	on	O
2501	9/7/93	b-TIME
2502	at	i-TIME
2503	5:10	i-TIME
2504	a.m.	i-TIME
2505	and	O
2506	therefore	O
2507	10	O
2508	cc&apos;s	O
2509	per	O
2510	kilo	O
2511	albumin	b-TREATMENT
2512	was	O
2513	given	O
2514	.	O
2515	the	O
2516	patient	O
2517	was	O
2518	admitted	b-OCCURRENCE
2519	was	O
2520	started	O
2521	on	O
2522	clear	b-TREATMENT
2523	fluids	i-TREATMENT
2524	,	O
2525	tolerated	b-OCCURRENCE
2526	,	O
2527	with	O
2528	d5	b-TREATMENT
2529	normal	i-TREATMENT
2530	saline	i-TREATMENT
2531	plus	O
2532	40	O
2533	meq	O
2534	per	O
2535	liter	O
2536	of	O
2537	kcl	b-TREATMENT
2538	at	O
2539	a	O
2540	rate	O
2541	of	O
2542	50	O
2543	cc	O
2544	&apos;s	O
2545	per	O
2546	hour	O
2547	for	O
2548	9	b-DURATION
2549	hours	i-DURATION
2550	.	O
2551	(	O
2552	100	O
2553	cc&apos;s	O
2554	per	O
2555	kilo	O
2556	)	O
2557	.	O
2558	sodium	b-TEST
2559	and	O
2560	potassium	b-TEST
2561	at	O
2562	this	O
2563	time	O
2564	were	O
2565	128/1.5	O
2566	.	O
2567	at	O
2568	labor	b-TIME
2569	day	i-TIME
2570	,	i-TIME
2571	9:30	i-TIME
2572	a.m.	i-TIME
2573	,	O
2574	the	b-TREATMENT
2575	fluids	i-TREATMENT
2576	were	O
2577	increased	O
2578	to	O
2579	100	O
2580	cc&apos;s	O
2581	per	O
2582	hour	O
2583	(	O
2584	200	O
2585	cc&apos;s	O
2586	per	O
2587	kilo	O
2588	for	O
2589	5	b-DURATION
2590	hours	i-DURATION
2591	)	O
2592	.	O
2593	electrolytes	b-TEST
2594	at	O
2595	this	O
2596	point	O
2597	were	O
2598	sodium	b-TEST
2599	132	O
2600	,	O
2601	potassium	b-TEST
2602	1.8	O
2603	.	O
2604	at	O
2605	9/6/93	b-TIME
2606	,	i-TIME
2607	2:30	i-TIME
2608	p.m.	i-TIME
2609	,	O
2610	fluids	b-TREATMENT
2611	were	O
2612	decreased	O
2613	to	O
2614	75	O
2615	cc&apos;s	O
2616	per	O
2617	hour	O
2618	,	O
2619	150	O
2620	cc&apos;s	O
2621	per	O
2622	kilo	O
2623	,	O
2624	40	O
2625	meq	O
2626	of	O
2627	k	b-TREATMENT
2628	phosphate	i-TREATMENT
2629	added	O
2630	to	O
2631	the	b-TREATMENT
2632	intravenous	i-TREATMENT
2633	fluids	i-TREATMENT
2634	.	O
2635	electrolytes	b-TEST
2636	at	O
2637	this	O
2638	point	O
2639	were	O
2640	a	b-TEST
2641	sodium	i-TEST
2642	of	O
2643	143	O
2644	and	O
2645	potassium	b-TEST
2646	1.7	O
2647	.	O
2648	on	O
2649	9/6/93	b-TIME
2650	,	i-TIME
2651	22:00	i-TIME
2652	,	O
2653	fluids	b-TREATMENT
2654	were	O
2655	changed	O
2656	to	O
2657	d5	b-TREATMENT
2658	normal	i-TREATMENT
2659	saline	i-TREATMENT
2660	plus	O
2661	40	O
2662	kcl	b-TREATMENT
2663	and	O
2664	40	O
2665	k	b-TREATMENT
2666	phosphate	i-TREATMENT
2667	at	O
2668	75	O
2669	cc	O
2670	&apos;s	O
2671	per	O
2672	hour	O
2673	.	O
2674	this	O
2675	rate	O
2676	was	O
2677	maintained	O
2678	for	O
2679	11	b-DURATION
2680	hours	i-DURATION
2681	.	O
2682	electrolytes	b-TEST
2683	at	O
2684	this	O
2685	time	O
2686	were	O
2687	a	b-TEST
2688	sodium	i-TEST
2689	of	O
2690	148	O
2691	,	O
2692	potassium	b-TEST
2693	1.7	O
2694	.	O
2695	at	O
2696	9/7/93	b-TIME
2697	,	i-TIME
2698	1:00	i-TIME
2699	a.m.	i-TIME
2700	,	O
2701	intravenous	b-TREATMENT
2702	fluids	i-TREATMENT
2703	rate	O
2704	was	O
2705	decreased	b-OCCURRENCE
2706	to	O
2707	50	O
2708	cc&apos;s	O
2709	per	O
2710	hour	O
2711	,	O
2712	total	b-TREATMENT
2713	fluids	i-TREATMENT
2714	given	O
2715	during	O
2716	the	O
2717	first	O
2718	24	b-DURATION
2719	hours	i-DURATION
2720	were	O
2721	140	O
2722	to	O
2723	150	O
2724	cc&apos;s	O
2725	per	O
2726	kilo	O
2727	per	O
2728	day	O
2729	.	O
2730	at	O
2731	this	b-TIME
2732	time	i-TIME
2733	,	O
2734	sodium	b-TEST
2735	was	O
2736	147	O
2737	,	O
2738	potassium	b-TEST
2739	2.6	O
2740	,	O
2741	total	b-TREATMENT
2742	sodium	i-TREATMENT
2743	given	O
2744	during	O
2745	the	O
2746	first	O
2747	24	b-DURATION
2748	hours	i-DURATION
2749	20	O
2750	meq	O
2751	per	O
2752	kilo	O
2753	per	O
2754	day	O
2755	.	O
2756	on	O
2757	9/7/93	b-TIME
2758	at	i-TIME
2759	4:00	i-TIME
2760	a.m.	i-TIME
2761	,	O
2762	albumin	b-TREATMENT
2763	bolus	i-TREATMENT
2764	5%	O
2765	10	O
2766	cc&apos;s	O
2767	per	O
2768	kilo	O
2769	was	O
2770	given	O
2771	,	O
2772	a	O
2773	total	O
2774	of	O
2775	120	O
2776	cc&apos;s	O
2777	,	O
2778	electrolytes	b-TEST
2779	were	O
2780	sodium	b-TEST
2781	155	O
2782	,	O
2783	potassium	b-TEST
2784	3.1	O
2785	.	O
2786	at	O
2787	9/7/93	b-TIME
2788	at	i-TIME
2789	5:00	i-TIME
2790	a.m.	i-TIME
2791	,	O
2792	sodium	b-TREATMENT
2793	bicarbonate	i-TREATMENT
2794	given	O
2795	60	O
2796	meq	O
2797	,	O
2798	calcium	b-TREATMENT
2799	bolus	i-TREATMENT
2800	10	O
2801	cc&apos;s	O
2802	given	O
2803	.	O
2804	on	O
2805	9/7	b-TIME
2806	,	i-TIME
2807	5:30	i-TIME
2808	a.m.	i-TIME
2809	,	O
2810	d5	b-TREATMENT
2811	quarter	i-TREATMENT
2812	normal	i-TREATMENT
2813	saline	i-TREATMENT
2814	,	O
2815	and	O
2816	40	O
2817	of	O
2818	k	b-TREATMENT
2819	phosphate	i-TREATMENT
2820	at	O
2821	100	O
2822	cc&apos;s	O
2823	per	O
2824	hour	O
2825	was	O
2826	given	O
2827	.	O
2828	the	O
2829	patient	O
2830	was	O
2831	taking	b-OCCURRENCE
2832	po	i-OCCURRENCE
2833	initially	O
2834	until	O
2835	9/6/93	b-TIME
2836	at	i-TIME
2837	17:45	i-TIME
2838	.	O
2839	there	O
2840	were	O
2841	no	O
2842	abnormal	b-PROBLEM
2843	findings	i-PROBLEM
2844	in	O
2845	abdominal	b-TEST
2846	exam	i-TEST
2847	.	O
2848	on	O
2849	9/5/93	b-DATE
2850	,	O
2851	hematocrit	b-TEST
2852	48	O
2853	,	O
2854	white	b-TEST
2855	blood	i-TEST
2856	count	i-TEST
2857	11.2	O
2858	,	O
2859	neutrophiles	b-TEST
2860	67	O
2861	,	O
2862	bands	b-TEST
2863	14	O
2864	,	O
2865	lymphs	b-TEST
2866	11	O
2867	,	O
2868	monos	b-TEST
2869	6%	O
2870	,	O
2871	meta	b-TEST
2872	2%	O
2873	,	O
2874	platelets	b-TEST
2875	220,000	O
2876	.	O
2877	copious	b-PROBLEM
2878	urine	i-PROBLEM
2879	output	i-PROBLEM
2880	,	O
2881	bun	b-TEST
2882	1.0	O
2883	,	O
2884	creatinine	b-TEST
2885	.8	O
2886	.	O
2887	normal	b-OCCURRENCE
2888	neurologic	i-OCCURRENCE
2889	exam	i-OCCURRENCE
2890	on	O
2891	admission	b-OCCURRENCE
2892	,	O
2893	then	O
2894	lethargic	b-PROBLEM
2895	on	O
2896	9/6/93	b-TIME
2897	at	i-TIME
2898	17:45	i-TIME
2899	,	O
2900	then	O
2901	patient	O
2902	became	O
2903	unresponsive	b-PROBLEM
2904	,	O
2905	areflexic	b-PROBLEM
2906	and	O
2907	limp	b-PROBLEM
2908	at	O
2909	9/6/93	b-TIME
2910	,	i-TIME
2911	at	i-TIME
2912	17:45	i-TIME
2913	to	O
2914	22:00	b-TIME
2915	.	O
2916	patient	O
2917	was	O
2918	having	O
2919	seizures	b-PROBLEM
2920	,	O
2921	twitching	b-PROBLEM
2922	of	i-PROBLEM
2923	face	i-PROBLEM
2924	and	O
2925	rapid	b-PROBLEM
2926	movements	i-PROBLEM
2927	of	i-PROBLEM
2928	eyes	i-PROBLEM
2929	.	O
2930	pupils	b-PROBLEM
2931	dilated	i-PROBLEM
2932	and	i-PROBLEM
2933	sluggish	i-PROBLEM
2934	.	O
2935	valium	b-TREATMENT
2936	was	O
2937	given	O
2938	at	O
2939	9/7/93	b-TIME
2940	,	i-TIME
2941	00:02	i-TIME
2942	.	O
2943	iv	b-TREATMENT
2944	ampicillin	i-TREATMENT
2945	,	O
2946	chloramphenicol	b-TREATMENT
2947	,	O
2948	ceftriaxone	b-TREATMENT
2949	,	O
2950	and	O
2951	culture	b-TEST
2952	were	O
2953	sent	O
2954	.	O
2955	finally	O
2956	,	O
2957	fairm	O
2958	of	O
2959	ijordcompmac	O
2960	hospital	O
2961	transport	O
2962	team	O
2963	was	O
2964	called	b-OCCURRENCE
2965	and	O
2966	transport	O
2967	team	O
2968	arrived	O
2969	on	O
2970	9/7/93	b-TIME
2971	,	i-TIME
2972	6:30	i-TIME
2973	a.m.	i-TIME
2974	,	O
2975	and	O
2976	on	O
2977	arrival	b-OCCURRENCE
2978	patient	O
2979	was	O
2980	seizing	b-OCCURRENCE
2981	with	O
2982	rhythmic	b-PROBLEM
2983	eye	i-PROBLEM
2984	movement	i-PROBLEM
2985	to	i-PROBLEM
2986	left	i-PROBLEM
2987	.	O
2988	the	O
2989	patient	O
2990	was	O
2991	unresponsive	b-PROBLEM
2992	,	O
2993	poor	b-PROBLEM
2994	perfusion	i-PROBLEM
2995	.	O
2996	temperature	b-TEST
2997	was	O
2998	101.8	O
2999	.	O
3000	a	b-TREATMENT
3001	second	i-TREATMENT
3002	intravenous	i-TREATMENT
3003	was	O
3004	started	O
3005	and	O
3006	given	O
3007	normal	b-TREATMENT
3008	saline	i-TREATMENT
3009	bolus	i-TREATMENT
3010	,	O
3011	change	O
3012	in	O
3013	intravenous	b-TREATMENT
3014	fluids	i-TREATMENT
3015	to	O
3016	d5	b-TREATMENT
3017	water	i-TREATMENT
3018	with	O
3019	80	O
3020	meq	O
3021	of	O
3022	bicarbonate	b-TREATMENT
3023	,	O
3024	plus	O
3025	40	O
3026	meq	O
3027	of	O
3028	kcl	b-TREATMENT
3029	at	O
3030	45	O
3031	cc&apos;s	O
3032	per	O
3033	hour	O
3034	,	O
3035	bicarbonate	b-TREATMENT
3036	given	O
3037	2	O
3038	meq	O
3039	per	O
3040	kilo	O
3041	,	O
3042	attempted	O
3043	to	O
3044	start	O
3045	dopa	b-TREATMENT
3046	for	O
3047	poor	b-PROBLEM
3048	perfusion	i-PROBLEM
3049	but	O
3050	worsening	b-PROBLEM
3051	perfusion	i-PROBLEM
3052	.	O
3053	therefore	O
3054	,	O
3055	dopa	b-TREATMENT
3056	was	O
3057	stopped	O
3058	.	O
3059	total	O
3060	volume	O
3061	given	O
3062	as	O
3063	bolus	b-TREATMENT
3064	50	O
3065	cc&apos;s	O
3066	per	O
3067	kilo	O
3068	,	O
3069	sodium	b-TREATMENT
3070	bicarbonate	i-TREATMENT
3071	at	O
3072	2	O
3073	meq	O
3074	per	O
3075	kilo	O
3076	was	O
3077	given	O
3078	.	O
3079	last	O
3080	abg	b-TEST
3081	there	O
3082	was	O
3083	6.98	O
3084	,	O
3085	31	O
3086	,	O
3087	171	O
3088	,	O
3089	bicarbonate	b-TEST
3090	of	O
3091	7	O
3092	.	O
3093	phenobarbital	b-TREATMENT
3094	and	O
3095	dilantin	b-TREATMENT
3096	given	O
3097	for	O
3098	seizure	b-TREATMENT
3099	control	i-TREATMENT
3100	.	O
3101	electrolytes	b-TEST
3102	before	O
3103	departure	b-OCCURRENCE
3104	for	O
3105	fairm	b-CLINICAL_DEPT
3106	of	i-CLINICAL_DEPT
3107	ijordcompmac	i-CLINICAL_DEPT
3108	hospital	i-CLINICAL_DEPT
3109	was	O
3110	a	b-TEST
3111	sodium	i-TEST
3112	of	O
3113	176	O
3114	,	O
3115	potassium	b-TEST
3116	2.5	O
3117	,	O
3118	chloride	b-TEST
3119	140	O
3120	,	O
3121	bicarbonate	b-TEST
3122	14	O
3123	,	O
3124	calcium	b-TEST
3125	7.2	O
3126	,	O
3127	magnesium	b-TEST
3128	2.7	O
3129	.	O
3130	admission	b-OCCURRENCE
3131	to	O
3132	the	b-CLINICAL_DEPT
3133	pediatric	i-CLINICAL_DEPT
3134	intensive	i-CLINICAL_DEPT
3135	care	i-CLINICAL_DEPT
3136	unit	i-CLINICAL_DEPT
3137	at	O
3138	fairm	b-CLINICAL_DEPT
3139	of	i-CLINICAL_DEPT
3140	ijordcompmac	i-CLINICAL_DEPT
3141	hospital	i-CLINICAL_DEPT
3142	was	O
3143	9/7/93	b-TIME
3144	,	i-TIME
3145	11:15	i-TIME
3146	a.m.	i-TIME
3147	lines	b-TREATMENT
3148	placed	O
3149	were	O
3150	a	b-TREATMENT
3151	right	i-TREATMENT
3152	femoral	i-TREATMENT
3153	triple	i-TREATMENT
3154	lumen	i-TREATMENT
3155	,	O
3156	endotracheal	b-TREATMENT
3157	tube	i-TREATMENT
3158	4.0	O
3159	,	O
3160	arterial	b-TREATMENT
3161	line	i-TREATMENT
3162	,	O
3163	right	b-TREATMENT
3164	radial	i-TREATMENT
3165	line	i-TREATMENT
3166	,	O
3167	foley	b-TREATMENT
3168	placed	O
3169	,	O
3170	peripheral	b-TREATMENT
3171	intravenous	i-TREATMENT
3172	line	i-TREATMENT
3173	,	O
3174	nasogastric	b-TREATMENT
3175	tube	i-TREATMENT
3176	.	O
3177	on	O
3178	admission	b-OCCURRENCE
3179	to	O
3180	fairm	b-CLINICAL_DEPT
3181	of	i-CLINICAL_DEPT
3182	ijordcompmac	i-CLINICAL_DEPT
3183	hospital	i-CLINICAL_DEPT
3184	,	O
3185	temperature	b-TEST
3186	100.2	O
3187	,	O
3188	pulse	b-TEST
3189	149	O
3190	,	O
3191	respiratory	b-TEST
3192	rate	i-TEST
3193	50	O
3194	,	O
3195	blood	b-TEST
3196	pressure	i-TEST
3197	98/66	O
3198	,	O
3199	mean	b-TEST
3200	arterial	i-TEST
3201	pressure	i-TEST
3202	of	O
3203	73	O
3204	,	O
3205	weight	b-TEST
3206	12	O
3207	kilos	O
3208	.	O
3209	hospital	O
3210	course	O
3211	:	O
3212	on	O
3213	admission	b-OCCURRENCE
3214	,	O
3215	fi02	b-TREATMENT
3216	was	O
3217	50-60%	O
3218	,	O
3219	pid	b-TREATMENT
3220	30-32/peep	b-TREATMENT
3221	of	O
3222	5.7	O
3223	,	O
3224	total	b-TEST
3225	volume	i-TEST
3226	was	O
3227	between	O
3228	140	O
3229	to	O
3230	210	O
3231	during	O
3232	intensive	b-OCCURRENCE
3233	care	i-OCCURRENCE
3234	unit	i-OCCURRENCE
3235	stay	i-OCCURRENCE
3236	.	O
3237	chest	b-TEST
3238	x-ray	i-TEST
3239	showed	b-EVIDENTIAL
3240	right	b-PROBLEM
3241	upper	i-PROBLEM
3242	lobe	i-PROBLEM
3243	pneumonia	i-PROBLEM
3244	.	O
3245	cardiovascular	O
3246	:	O
3247	cvp	b-TEST
3248	on	O
3249	admission	b-OCCURRENCE
3250	was	O
3251	1	O
3252	cm	O
3253	of	O
3254	water	O
3255	.	O
3256	then	O
3257	during	O
3258	the	b-OCCURRENCE
3259	intensive	i-OCCURRENCE
3260	care	i-OCCURRENCE
3261	unit	i-OCCURRENCE
3262	stay	i-OCCURRENCE
3263	,	O
3264	the	b-TEST
3265	cvp	i-TEST
3266	remained	O
3267	between	O
3268	7	O
3269	to	O
3270	8	O
3271	after	O
3272	volume	b-TREATMENT
3273	resuscitation	i-TREATMENT
3274	.	O
3275	dopamine	b-TREATMENT
3276	and	O
3277	epinephrine	b-TREATMENT
3278	given	O
3279	for	O
3280	cardiovascular	b-TREATMENT
3281	support	i-TREATMENT
3282	.	O
3283	her	b-TEST
3284	electrocardiogram	i-TEST
3285	findings	O
3286	were	O
3287	compatible	O
3288	with	O
3289	hypokalemia	b-PROBLEM
3290	(	O
3291	flattening	b-PROBLEM
3292	t	i-PROBLEM
3293	waves	i-PROBLEM
3294	and	O
3295	st	b-PROBLEM
3296	changes	i-PROBLEM
3297	)	O
3298	.	O
3299	fluids	O
3300	/	O
3301	electrolytes/nutrition	O
3302	:	O
3303	on	O
3304	admission	b-OCCURRENCE
3305	to	O
3306	fairm	b-CLINICAL_DEPT
3307	of	i-CLINICAL_DEPT
3308	ijordcompmac	i-CLINICAL_DEPT
3309	hospital	i-CLINICAL_DEPT
3310	,	O
3311	hypernatremia	b-PROBLEM
3312	and	O
3313	hypovolemic	b-PROBLEM
3314	shock	i-PROBLEM
3315	.	O
3316	fluids	b-TREATMENT
3317	of	i-TREATMENT
3318	d5	i-TREATMENT
3319	water	i-TREATMENT
3320	with	O
3321	30	O
3322	meq	O
3323	of	O
3324	sodium	b-TREATMENT
3325	acetate	i-TREATMENT
3326	per	O
3327	liter	O
3328	,	O
3329	30	O
3330	ml	O
3331	per	O
3332	liter	O
3333	of	O
3334	phosphate	b-TREATMENT
3335	,	O
3336	and	O
3337	30	O
3338	meq	O
3339	of	O
3340	k	b-TREATMENT
3341	acetate	i-TREATMENT
3342	per	O
3343	liter	O
3344	at	O
3345	90	O
3346	cc&apos;s	O
3347	per	O
3348	hour	O
3349	was	O
3350	given	O
3351	.	O
3352	free	b-TREATMENT
3353	water	i-TREATMENT
3354	deficit	i-TREATMENT
3355	over	O
3356	48	b-DURATION
3357	hours	i-DURATION
3358	was	O
3359	given	O
3360	,	O
3361	plus	O
3362	maintenance	b-TREATMENT
3363	,	O
3364	plus	O
3365	adjusting	b-TREATMENT
3366	the	i-TREATMENT
3367	ongoing	i-TREATMENT
3368	losses	i-TREATMENT
3369	.	O
3370	pediatric	O
3371	nephrology	O
3372	recommended	O
3373	on	O
3374	9/7/93	b-TIME
3375	,	i-TIME
3376	5:50	i-TIME
3377	p.m.	i-TIME
3378	,	O
3379	10	O
3380	cc	O
3381	&apos;s	O
3382	per	O
3383	kilo	O
3384	of	O
3385	150	O
3386	meq	O
3387	of	O
3388	sodium	b-TREATMENT
3389	bicarbonate	i-TREATMENT
3390	per	O
3391	liter	O
3392	,	O
3393	(	O
3394	1.5	O
3395	meq	O
3396	per	O
3397	kilo	O
3398	bicarbonate	b-TREATMENT
3399	,	O
3400	one	O
3401	dose	O
3402	of	O
3403	lasix	b-TREATMENT
3404	and	O
3405	volume	b-TREATMENT
3406	as	O
3407	needed	O
3408	)	O
3409	.	O
3410	the	O
3411	patient	O
3412	required	O
3413	multiple	b-TREATMENT
3414	boluses	i-TREATMENT
3415	of	i-TREATMENT
3416	albumin	i-TREATMENT
3417	for	O
3418	hypotension	b-PROBLEM
3419	,	O
3420	patient	O
3421	also	O
3422	required	O
3423	multiple	b-TREATMENT
3424	boluses	i-TREATMENT
3425	of	i-TREATMENT
3426	calcium	i-TREATMENT
3427	because	O
3428	of	O
3429	hypocalcemia	b-PROBLEM
3430	and	O
3431	hypotension	b-PROBLEM
3432	.	O
3433	magnesium	b-TREATMENT
3434	2.0	O
3435	meq	O
3436	per	O
3437	liter	O
3438	,	O
3439	phosphate	b-TREATMENT
3440	8	O
3441	mg	O
3442	/	O
3443	dl	O
3444	.	O
3445	gastrointestinal	O
3446	:	O
3447	normal	O
3448	.	O
3449	npo	b-TREATMENT
3450	.	O
3451	albumin	b-TEST
3452	was	O
3453	4.9	O
3454	.	O
3455	globulin	b-TEST
3456	was	O
3457	1.6	O
3458	,	O
3459	uric	b-TEST
3460	acid	i-TEST
3461	was	O
3462	6.5	O
3463	,	O
3464	alkaline	b-TEST
3465	phosphatase	i-TEST
3466	150	O
3467	,	O
3468	sgpt	b-TEST
3469	11	O
3470	,	O
3471	sgot	b-TEST
3472	85	O
3473	,	O
3474	ldh	b-TEST
3475	524	O
3476	,	O
3477	ck	b-TEST
3478	152	O
3479	,	O
3480	nh3	b-TEST
3481	81	O
3482	.	O
3483	hematologic	O
3484	:	O
3485	white	b-TEST
3486	cell	i-TEST
3487	count	i-TEST
3488	9.4	O
3489	,	O
3490	hematocrit	b-TEST
3491	42	O
3492	,	O
3493	platelets	b-TEST
3494	151,000	O
3495	.	O
3496	differential	b-TEST
3497	was	O
3498	polys	b-TEST
3499	59	O
3500	,	O
3501	bands	b-TEST
3502	3	O
3503	,	O
3504	lymphs	b-TEST
3505	25	O
3506	.	O
3507	repeat	b-TEST
3508	white	i-TEST
3509	cell	i-TEST
3510	count	i-TEST
3511	6.4	O
3512	,	O
3513	hematocrit	b-TEST
3514	34	O
3515	,	O
3516	platelets	b-TEST
3517	103	O
3518	.	O
3519	pt	b-TEST
3520	11.6/10.1	O
3521	,	O
3522	repeat	b-TEST
3523	pt	i-TEST
3524	12.8/10.5	O
3525	.	O
3526	ptt	b-TEST
3527	36.4	O
3528	,	O
3529	repeat	b-TEST
3530	ptt	i-TEST
3531	50.9	O
3532	.	O
3533	fibrinogen	b-TEST
3534	211	O
3535	.	O
3536	renal	O
3537	:	O
3538	urine	b-TEST
3539	output	i-TEST
3540	was	O
3541	about	O
3542	5	O
3543	to	O
3544	8	O
3545	cc&apos;s	O
3546	per	O
3547	kilo	O
3548	per	O
3549	hour	O
3550	.	O
3551	renal	b-TEST
3552	ultrasound	i-TEST
3553	was	O
3554	scheduled	O
3555	during	O
3556	the	b-OCCURRENCE
3557	intensive	i-OCCURRENCE
3558	care	i-OCCURRENCE
3559	unit	i-OCCURRENCE
3560	stay	i-OCCURRENCE
3561	.	O
3562	urinalysis	b-TEST
3563	showed	b-EVIDENTIAL
3564	specific	b-TEST
3565	gravity	i-TEST
3566	1.005	O
3567	,	O
3568	ph	b-TEST
3569	8.0	O
3570	,	O
3571	positive	b-PROBLEM
3572	proteins	i-PROBLEM
3573	,	O
3574	positive	b-PROBLEM
3575	red	i-PROBLEM
3576	blood	i-PROBLEM
3577	cells	i-PROBLEM
3578	,	O
3579	negative	O
3580	white	b-PROBLEM
3581	cell	i-PROBLEM
3582	count	i-PROBLEM
3583	,	O
3584	positive	b-PROBLEM
3585	glucose	i-PROBLEM
3586	.	O
3587	neurologic	O
3588	:	O
3589	patient	O
3590	did	O
3591	not	O
3592	receive	O
3593	sedation	b-TREATMENT
3594	or	O
3595	muscle	b-TREATMENT
3596	relaxant	i-TREATMENT
3597	since	O
3598	admission	b-OCCURRENCE
3599	to	O
3600	the	b-CLINICAL_DEPT
3601	pediatric	i-CLINICAL_DEPT
3602	intensive	i-CLINICAL_DEPT
3603	care	i-CLINICAL_DEPT
3604	unit	i-CLINICAL_DEPT
3605	.	O
3606	phenobarbital	b-TEST
3607	levels	i-TEST
3608	were	O
3609	31.4	O
3610	,	O
3611	30.2	O
3612	,	O
3613	and	O
3614	50	O
3615	.	O
3616	dilantin	b-TEST
3617	level	i-TEST
3618	was	O
3619	22.6	O
3620	,	O
3621	20.2	O
3622	,	O
3623	20	O
3624	.	O
3625	neurology	b-OCCURRENCE
3626	consultation	i-OCCURRENCE
3627	on	O
3628	the	b-DATE
3629	evening	i-DATE
3630	of	i-DATE
3631	9/7/93	i-DATE
3632	revealed	b-EVIDENTIAL
3633	supple	b-OCCURRENCE
3634	neck	i-OCCURRENCE
3635	,	O
3636	no	b-PROBLEM
3637	response	i-PROBLEM
3638	to	O
3639	external	b-TEST
3640	rub	i-TEST
3641	.	O
3642	pupils	O
3643	were	O
3644	3.5	O
3645	od	O
3646	,	O
3647	and	O
3648	3.0	O
3649	os	O
3650	,	O
3651	irregular	b-PROBLEM
3652	and	O
3653	non	b-PROBLEM
3654	reactive	i-PROBLEM
3655	.	O
3656	corneal	b-TEST
3657	reflexes	i-TEST
3658	and	O
3659	oculocephalic	b-TEST
3660	reflexes	i-TEST
3661	were	O
3662	absent	b-PROBLEM
3663	.	O
3664	there	O
3665	was	O
3666	no	b-PROBLEM
3667	gag	i-PROBLEM
3668	.	O
3669	muscle	b-TEST
3670	tone	i-TEST
3671	was	O
3672	increased	b-PROBLEM
3673	throughout	i-PROBLEM
3674	,	O
3675	and	O
3676	the	O
3677	legs	O
3678	were	O
3679	both	b-PROBLEM
3680	extended	i-PROBLEM
3681	and	i-PROBLEM
3682	internally	i-PROBLEM
3683	rotated	i-PROBLEM
3684	.	O
3685	deep	b-TEST
3686	tendon	i-TEST
3687	reflexes	i-TEST
3688	could	O
3689	not	O
3690	be	O
3691	elicited	O
3692	and	O
3693	plantar	b-TEST
3694	responses	i-TEST
3695	were	O
3696	silent	b-PROBLEM
3697	.	O
3698	repeat	b-TEST
3699	neurological	i-TEST
3700	examination	i-TEST
3701	revealed	O
3702	no	b-PROBLEM
3703	spontaneous	i-PROBLEM
3704	movement	i-PROBLEM
3705	and	O
3706	no	b-PROBLEM
3707	response	i-PROBLEM
3708	to	O
3709	voice	b-TEST
3710	or	i-TEST
3711	noxious	i-TEST
3712	stimulation	i-TEST
3713	.	O
3714	pupils	O
3715	were	O
3716	dilated	b-PROBLEM
3717	and	O
3718	non	b-PROBLEM
3719	reactive	i-PROBLEM
3720	.	O
3721	disc	O
3722	margins	O
3723	appeared	O
3724	blurred	b-PROBLEM
3725	on	O
3726	funduscopic	b-TEST
3727	exam	i-TEST
3728	.	O
3729	a	b-TEST
3730	non	i-TEST
3731	contrast	i-TEST
3732	head	i-TEST
3733	ct	i-TEST
3734	scan	i-TEST
3735	was	O
3736	obtained	O
3737	and	O
3738	ct	b-TEST
3739	revealed	b-EVIDENTIAL
3740	severe	b-PROBLEM
3741	cerebral	i-PROBLEM
3742	edema	i-PROBLEM
3743	with	O
3744	thalamic	b-PROBLEM
3745	mid	i-PROBLEM
3746	brain	i-PROBLEM
3747	,	i-PROBLEM
3748	pons	i-PROBLEM
3749	,	i-PROBLEM
3750	medullar	i-PROBLEM
3751	low	i-PROBLEM
3752	attenuation	i-PROBLEM
3753	,	O
3754	diffuse	b-PROBLEM
3755	cerebral	i-PROBLEM
3756	edema	i-PROBLEM
3757	,	O
3758	loss	b-PROBLEM
3759	of	i-PROBLEM
3760	gray	i-PROBLEM
3761	white	i-PROBLEM
3762	matter	i-PROBLEM
3763	differentiation	i-PROBLEM
3764	.	O
3765	cerebral	b-TEST
3766	blood	i-TEST
3767	flow	i-TEST
3768	was	O
3769	done	O
3770	on	O
3771	9/7/93	b-TIME
3772	at	i-TIME
3773	2:30	i-TIME
3774	p.m.	i-TIME
3775	,	O
3776	revealed	b-EVIDENTIAL
3777	complete	b-PROBLEM
3778	absence	i-PROBLEM
3779	of	i-PROBLEM
3780	blood	i-PROBLEM
3781	flow	i-PROBLEM
3782	to	i-PROBLEM
3783	brain	i-PROBLEM
3784	.	O
3785	there	O
3786	was	O
3787	a	b-PROBLEM
3788	tiny	i-PROBLEM
3789	region	i-PROBLEM
3790	of	i-PROBLEM
3791	activity	i-PROBLEM
3792	in	O
3793	what	O
3794	appears	O
3795	to	O
3796	be	O
3797	anterior	O
3798	scalp	O
3799	.	O
3800	infectious	O
3801	disease	O
3802	:	O
3803	ampicillin	b-TREATMENT
3804	and	O
3805	chloramphenicol	b-TREATMENT
3806	were	O
3807	given	O
3808	at	O
3809	noughwell	b-CLINICAL_DEPT
3810	entanbon	i-CLINICAL_DEPT
3811	health	i-CLINICAL_DEPT
3812	,	O
3813	and	O
3814	ceftriaxone	b-TREATMENT
3815	was	O
3816	given	O
3817	at	O
3818	fairm	b-CLINICAL_DEPT
3819	of	i-CLINICAL_DEPT
3820	ijordcompmac	i-CLINICAL_DEPT
3821	hospital	i-CLINICAL_DEPT
3822	.	O
3823	acyclovir	b-TREATMENT
3824	was	O
3825	started	O
3826	,	O
3827	also	O
3828	considering	O
3829	the	b-PROBLEM
3830	varicella	i-PROBLEM
3831	at	O
3832	120	O
3833	mg	O
3834	intravenously	O
3835	every	b-FREQUENCY
3836	8	i-FREQUENCY
3837	hours	i-FREQUENCY
3838	.	O
3839	urine	b-TEST
3840	cultures	i-TEST
3841	,	O
3842	blood	b-TEST
3843	cultures	i-TEST
3844	and	O
3845	sputum	b-TEST
3846	cultures	i-TEST
3847	were	O
3848	sent	O
3849	.	O
3850	the	O
3851	patient	O
3852	finally	O
3853	died	b-OCCURRENCE
3854	.	O
3855	the	O
3856	situation	O
3857	of	O
3858	the	O
3859	patient	O
3860	was	O
3861	extensively	O
3862	discussed	O
3863	with	O
3864	the	O
3865	parents	O
3866	,	O
3867	and	O
3868	the	O
3869	attending	O
3870	physician	O
3871	from	O
3872	neurology	O
3873	,	O
3874	doctor	O
3875	breunkote	O
3876	,	O
3877	and	O
3878	the	O
3879	attending	O
3880	physician	O
3881	from	O
3882	pediatric	O
3883	intensive	O
3884	care	O
3885	unit	O
3886	,	O
3887	doctor	O
3888	boormcose	O
3889	,	O
3890	and	O
3891	the	O
3892	decision	O
3893	was	O
3894	finally	O
3895	made	O
3896	with	O
3897	the	O
3898	family	O
3899	and	O
3900	attendings	O
3901	to	O
3902	disconnect	b-OCCURRENCE
3903	the	O
3904	patient	O
3905	from	O
3906	the	b-TREATMENT
3907	mechanical	i-TREATMENT
3908	ventilation	i-TREATMENT
3909	due	O
3910	to	O
3911	severe	b-PROBLEM
3912	neurological	i-PROBLEM
3913	injury	i-PROBLEM
3914	and	O
3915	poor	b-PROBLEM
3916	prognosis	i-PROBLEM
3917	.	O
3918	zakay	O
3919	cough	O
3920	,	O
3921	md	O
3922	tr	O
3923	:	O
3924	jx	O
3925	/	O
3926	bmot	O
3927	dd	O
3928	:	O
3929	10-20-93	O
3930	td	O
3931	:	O
3932	10/21/93	O
3933	cc	O
3934	:	O
3935	edited	O
3936	10/24/93	O
3937	rc	O
3938		O
3939	admission	b-OCCURRENCE
3940	date	O
3941	:	O
3942	05/09/2004	b-ADMISSION
3943	discharge	b-OCCURRENCE
3944	date	O
3945	:	O
3946	05/16/2004	b-DISCHARGE
3947	history	O
3948	of	O
3949	present	O
3950	illness	O
3951	:	O
3952	the	O
3953	patient	O
3954	is	O
3955	an	O
3956	84-year-old	O
3957	woman	O
3958	with	O
3959	a	O
3960	history	O
3961	of	O
3962	diverticulitis	b-PROBLEM
3963	who	O
3964	was	O
3965	found	O
3966	to	O
3967	have	O
3968	colon	b-PROBLEM
3969	cancer	i-PROBLEM
3970	on	O
3971	colonoscopy	b-TEST
3972	,	O
3973	which	O
3974	was	O
3975	performed	O
3976	in	O
3977	march	b-DATE
3978	of	i-DATE
3979	2004	i-DATE
3980	.	O
3981	an	b-PROBLEM
3982	invasive	i-PROBLEM
3983	moderately	i-PROBLEM
3984	differentiated	i-PROBLEM
3985	adenocarcinoma	i-PROBLEM
3986	was	O
3987	noted	b-EVIDENTIAL
3988	in	O
3989	the	O
3990	transverse	O
3991	colon	O
3992	at	O
3993	80	O
3994	cm	O
3995	.	O
3996	the	O
3997	patient	O
3998	reports	b-EVIDENTIAL
3999	a	O
4000	history	O
4001	of	O
4002	bloating	b-PROBLEM
4003	and	O
4004	flatulence	b-PROBLEM
4005	as	O
4006	well	O
4007	as	O
4008	increased	b-PROBLEM
4009	fatigue	i-PROBLEM
4010	.	O
4011	she	O
4012	has	O
4013	also	O
4014	had	O
4015	some	b-PROBLEM
4016	discomfort	i-PROBLEM
4017	in	i-PROBLEM
4018	her	i-PROBLEM
4019	left	i-PROBLEM
4020	lower	i-PROBLEM
4021	abdomen	i-PROBLEM
4022	and	O
4023	notes	b-EVIDENTIAL
4024	diarrhea	b-PROBLEM
4025	every	O
4026	4-5	b-FREQUENCY
4027	days	i-FREQUENCY
4028	.	O
4029	she	O
4030	says	O
4031	that	O
4032	her	O
4033	appetite	O
4034	is	O
4035	good	O
4036	and	O
4037	has	O
4038	noted	b-EVIDENTIAL
4039	no	O
4040	weight	b-PROBLEM
4041	loss	i-PROBLEM
4042	.	O
4043	hospital	O
4044	course	O
4045	:	O
4046	the	O
4047	patient	O
4048	was	O
4049	consented	O
4050	for	O
4051	surgery	b-TREATMENT
4052	and	O
4053	on	O
4054	the	b-DATE
4055	day	i-DATE
4056	of	O
4057	admission	b-OCCURRENCE
4058	was	O
4059	taken	b-OCCURRENCE
4060	to	O
4061	the	b-CLINICAL_DEPT
4062	operating	i-CLINICAL_DEPT
4063	room	i-CLINICAL_DEPT
4064	for	O
4065	transverse	b-TREATMENT
4066	colectomy	i-TREATMENT
4067	for	O
4068	tumor	b-PROBLEM
4069	.	O
4070	the	O
4071	patient	O
4072	tolerated	O
4073	the	b-TREATMENT
4074	procedure	i-TREATMENT
4075	well	b-OCCURRENCE
4076	and	O
4077	there	O
4078	are	O
4079	no	O
4080	complications	b-PROBLEM
4081	.	O
4082	her	b-OCCURRENCE
4083	postoperative	i-OCCURRENCE
4084	course	i-OCCURRENCE
4085	was	O
4086	unremarkable	b-PROBLEM
4087	.	O
4088	she	O
4089	was	O
4090	maintained	O
4091	on	O
4092	an	b-TREATMENT
4093	epidural	i-TREATMENT
4094	and	O
4095	pca	b-TREATMENT
4096	for	O
4097	pain	b-PROBLEM
4098	control	i-PROBLEM
4099	.	O
4100	she	O
4101	was	O
4102	kept	O
4103	npo	b-TREATMENT
4104	initially	O
4105	and	O
4106	her	b-TREATMENT
4107	diet	i-TREATMENT
4108	was	O
4109	slowly	O
4110	advanced	b-TREATMENT
4111	as	i-TREATMENT
4112	tolerated	i-TREATMENT
4113	.	O
4114	when	O
4115	she	O
4116	was	O
4117	taking	O
4118	clear	b-TREATMENT
4119	liquids	i-TREATMENT
4120	,	O
4121	her	b-TREATMENT
4122	pain	i-TREATMENT
4123	medication	i-TREATMENT
4124	was	O
4125	switched	O
4126	to	O
4127	p.o.	b-TREATMENT
4128	pain	i-TREATMENT
4129	regimen	i-TREATMENT
4130	with	O
4131	good	O
4132	affect	O
4133	.	O
4134	for	O
4135	blood	b-TREATMENT
4136	pressure	i-TREATMENT
4137	control	i-TREATMENT
4138	she	O
4139	was	O
4140	maintained	O
4141	on	O
4142	metoprolol	b-TREATMENT
4143	at	O
4144	the	O
4145	request	O
4146	of	O
4147	her	O
4148	primary	O
4149	care	O
4150	physician	O
4151	and	O
4152	enalapril	b-TREATMENT
4153	was	O
4154	discontinued	O
4155	.	O
4156	with	O
4157	the	O
4158	help	O
4159	of	O
4160	physical	b-CLINICAL_DEPT
4161	therapy	i-CLINICAL_DEPT
4162	the	O
4163	patient	O
4164	was	O
4165	ambulated	b-OCCURRENCE
4166	and	O
4167	on	O
4168	postoperative	b-DATE
4169	seven	i-DATE
4170	,	O
4171	with	O
4172	the	O
4173	patient	O
4174	tolerating	O
4175	a	b-TREATMENT
4176	post	i-TREATMENT
4177	surgical	i-TREATMENT
4178	soft	i-TREATMENT
4179	diet	i-TREATMENT
4180	and	O
4181	with	O
4182	pain	b-PROBLEM
4183	well	b-OCCURRENCE
4184	controlled	i-OCCURRENCE
4185	on	O
4186	oral	b-TREATMENT
4187	pain	i-TREATMENT
4188	medications	i-TREATMENT
4189	,	O
4190	she	O
4191	was	O
4192	discharged	b-OCCURRENCE
4193	to	O
4194	rehabilitation	b-CLINICAL_DEPT
4195	facility	i-CLINICAL_DEPT
4196	.	O
4197		O
4198	admission	b-OCCURRENCE
4199	date	O
4200	:	O
4201	2013-11-21	b-ADMISSION
4202	discharge	b-OCCURRENCE
4203	date	O
4204	:	O
4205	2013-11-26	b-DISCHARGE
4206	service	O
4207	:	O
4208	plastic	O
4209	history	O
4210	of	O
4211	present	O
4212	illness	O
4213	:	O
4214	ms.	O
4215	marshall	O
4216	is	O
4217	a	O
4218	64-year	O
4219	old	O
4220	,	O
4221	mentally	b-PROBLEM
4222	retarded	i-PROBLEM
4223	,	O
4224	female	O
4225	who	O
4226	presented	b-OCCURRENCE
4227	with	O
4228	an	b-PROBLEM
4229	aquired	i-PROBLEM
4230	defect	i-PROBLEM
4231	of	i-PROBLEM
4232	the	i-PROBLEM
4233	right	i-PROBLEM
4234	nasal	i-PROBLEM
4235	ala	i-PROBLEM
4236	and	i-PROBLEM
4237	medial	i-PROBLEM
4238	cheek	i-PROBLEM
4239	region	i-PROBLEM
4240	after	O
4241	basal	b-PROBLEM
4242	cell	i-PROBLEM
4243	carcinoma	i-PROBLEM
4244	was	O
4245	resected	b-TREATMENT
4246	by	O
4247	dermatology	b-CLINICAL_DEPT
4248	.	O
4249	brief	O
4250	hospital	O
4251	course	O
4252	:	O
4253	upon	O
4254	admission	b-OCCURRENCE
4255	,	O
4256	the	O
4257	patient	O
4258	was	O
4259	pre-op	b-OCCURRENCE
4260	'd	i-OCCURRENCE
4261	and	O
4262	made	O
4263	npo	b-TREATMENT
4264	/	O
4265	ivf	b-TREATMENT
4266	.	O
4267	she	O
4268	went	O
4269	to	O
4270	surgery	b-CLINICAL_DEPT
4271	the	b-DATE
4272	next	i-DATE
4273	morning	i-DATE
4274	and	O
4275	tolerated	b-OCCURRENCE
4276	the	b-TREATMENT
4277	surgery	i-TREATMENT
4278	well	b-OCCURRENCE
4279	.	O
4280	however	O
4281	,	O
4282	she	O
4283	was	O
4284	slow	b-PROBLEM
4285	to	i-PROBLEM
4286	awake	i-PROBLEM
4287	from	O
4288	anesthesia	b-TREATMENT
4289	,	O
4290	and	O
4291	was	O
4292	admitted	b-OCCURRENCE
4293	to	O
4294	the	b-CLINICAL_DEPT
4295	cmed	i-CLINICAL_DEPT
4296	ccu	i-CLINICAL_DEPT
4297	observation	i-CLINICAL_DEPT
4298	.	O
4299	she	O
4300	was	O
4301	transfered	b-OCCURRENCE
4302	to	O
4303	the	b-CLINICAL_DEPT
4304	floor	i-CLINICAL_DEPT
4305	post-op	b-DATE
4306	day	i-DATE
4307	2	i-DATE
4308	where	O
4309	she	O
4310	had	O
4311	been	O
4312	afebrile	b-PROBLEM
4313	with	O
4314	normal	b-OCCURRENCE
4315	vitals	i-OCCURRENCE
4316	,	O
4317	making	b-OCCURRENCE
4318	good	i-OCCURRENCE
4319	urine	i-OCCURRENCE
4320	,	O
4321	and	O
4322	tolerating	b-OCCURRENCE
4323	a	b-TREATMENT
4324	regular	i-TREATMENT
4325	diet	i-TREATMENT
4326	.	O
4327	her	b-PROBLEM
4328	wound	i-PROBLEM
4329	has	O
4330	remaind	O
4331	dry	b-OCCURRENCE
4332	and	O
4333	closed	b-OCCURRENCE
4334	,	O
4335	without	O
4336	evidence	O
4337	of	O
4338	infection	b-PROBLEM
4339	or	O
4340	breakdown	b-PROBLEM
4341	.	O
4342	she	O
4343	has	O
4344	been	O
4345	watched	b-OCCURRENCE
4346	by	O
4347	a	b-TREATMENT
4348	sitter	i-TREATMENT
4349	at	O
4350	all	b-DURATION
4351	times	i-DURATION
4352	.	O
4353		O
4354	admission	b-OCCURRENCE
4355	date	O
4356	:	O
4357	09/08/96	b-ADMISSION
4358	discharge	b-OCCURRENCE
4359	date	O
4360	:	O
4361	09/17/96	b-DISCHARGE
4362	history	O
4363	of	O
4364	present	O
4365	illness	O
4366	:	O
4367	this	O
4368	82	O
4369	year	O
4370	old	O
4371	retired	O
4372	engineer	O
4373	has	O
4374	had	O
4375	multiple	b-OCCURRENCE
4376	admissions	i-OCCURRENCE
4377	to	O
4378	the	b-CLINICAL_DEPT
4379	ph	i-CLINICAL_DEPT
4380	university	i-CLINICAL_DEPT
4381	of	i-CLINICAL_DEPT
4382	medical	i-CLINICAL_DEPT
4383	center	i-CLINICAL_DEPT
4384	for	O
4385	multiple	b-PROBLEM
4386	strokes	i-PROBLEM
4387	and	O
4388	a	b-PROBLEM
4389	spontaneous	i-PROBLEM
4390	subdural	i-PROBLEM
4391	hematoma	i-PROBLEM
4392	and	O
4393	prostatic	b-PROBLEM
4394	hypertrophy	i-PROBLEM
4395	.	O
4396	he	O
4397	has	O
4398	been	O
4399	managing	b-OCCURRENCE
4400	at	O
4401	home	O
4402	on	O
4403	restricted	b-TREATMENT
4404	activity	i-TREATMENT
4405	but	O
4406	able	O
4407	to	O
4408	get	O
4409	around	O
4410	with	O
4411	a	b-TREATMENT
4412	walker	i-TREATMENT
4413	but	O
4414	on	O
4415	the	b-DATE
4416	day	i-DATE
4417	before	O
4418	admission	b-OCCURRENCE
4419	he	O
4420	became	O
4421	increasing	b-PROBLEM
4422	dyspneic	i-PROBLEM
4423	and	O
4424	on	O
4425	the	b-DATE
4426	day	i-DATE
4427	of	O
4428	admission	b-OCCURRENCE
4429	he	O
4430	collapsed	b-PROBLEM
4431	and	O
4432	was	O
4433	unable	b-PROBLEM
4434	to	i-PROBLEM
4435	walk	i-PROBLEM
4436	to	O
4437	his	O
4438	bed	O
4439	.	O
4440	for	O
4441	this	O
4442	he	O
4443	was	O
4444	admitted	b-OCCURRENCE
4445	.	O
4446	hospital	O
4447	course	O
4448	and	O
4449	treatment	O
4450	:	O
4451	the	O
4452	patient	O
4453	was	O
4454	started	O
4455	on	O
4456	clindamycin	b-TREATMENT
4457	intravenous	i-TREATMENT
4458	and	O
4459	cefuroxime	b-TREATMENT
4460	intravenous	i-TREATMENT
4461	with	O
4462	clearing	O
4463	of	O
4464	his	b-PROBLEM
4465	fever	i-PROBLEM
4466	but	O
4467	persistence	O
4468	of	O
4469	cough	b-PROBLEM
4470	,	O
4471	choking	b-PROBLEM
4472	,	O
4473	and	O
4474	intermittently	b-PROBLEM
4475	many	i-PROBLEM
4476	coarse	i-PROBLEM
4477	rales	i-PROBLEM
4478	in	i-PROBLEM
4479	his	i-PROBLEM
4480	base	i-PROBLEM
4481	with	O
4482	no	O
4483	clearing	b-PROBLEM
4484	by	O
4485	x-ray	b-TEST
4486	.	O
4487	his	b-OCCURRENCE
4488	ambulation	i-OCCURRENCE
4489	was	O
4490	minimal	b-PROBLEM
4491	and	O
4492	always	O
4493	with	O
4494	assistance	b-TREATMENT
4495	but	O
4496	he	O
4497	had	O
4498	a	b-TREATMENT
4499	transurethral	i-TREATMENT
4500	resection	i-TREATMENT
4501	of	i-TREATMENT
4502	the	i-TREATMENT
4503	prostate	i-TREATMENT
4504	on	O
4505	09/14/96	b-DATE
4506	.	O
4507	he	O
4508	is	O
4509	transferred	b-OCCURRENCE
4510	to	O
4511	louline	b-CLINICAL_DEPT
4512	mauikings	i-CLINICAL_DEPT
4513	medical	i-CLINICAL_DEPT
4514	center	i-CLINICAL_DEPT
4515	for	O
4516	future	b-TREATMENT
4517	rehabilitation	i-TREATMENT
4518	and	O
4519	hopeful	O
4520	return	b-OCCURRENCE
4521	home	i-OCCURRENCE
4522	with	O
4523	considerable	O
4524	support	b-TREATMENT
4525	and	O
4526	assistance	b-TREATMENT
4527	.	O
4528		O
4529	admission	b-OCCURRENCE
4530	date	O
4531	:	O
4532	10/25/1997	b-ADMISSION
4533	discharge	b-OCCURRENCE
4534	date	O
4535	:	O
4536	11/03/1997	b-DISCHARGE
4537	history	O
4538	of	O
4539	present	O
4540	illness	O
4541	:	O
4542	the	O
4543	patient	O
4544	is	O
4545	a	O
4546	67-year-old	O
4547	woman	O
4548	with	O
4549	occasional	O
4550	abdominal	b-PROBLEM
4551	pain	i-PROBLEM
4552	in	O
4553	the	O
4554	right	O
4555	lower	O
4556	quadrant	O
4557	and	O
4558	left	O
4559	lower	O
4560	quadrant	O
4561	.	O
4562	she	O
4563	has	O
4564	not	O
4565	complained	b-EVIDENTIAL
4566	of	O
4567	any	O
4568	fever	b-PROBLEM
4569	,	O
4570	shaking	b-PROBLEM
4571	,	O
4572	or	O
4573	chills	b-PROBLEM
4574	.	O
4575	no	O
4576	nausea	b-PROBLEM
4577	or	O
4578	vomiting	b-PROBLEM
4579	,	O
4580	no	O
4581	change	b-PROBLEM
4582	in	i-PROBLEM
4583	her	i-PROBLEM
4584	bowel	i-PROBLEM
4585	movements	i-PROBLEM
4586	.	O
4587	she	O
4588	has	O
4589	had	O
4590	attacks	b-PROBLEM
4591	treated	O
4592	with	O
4593	antibiotics	b-TREATMENT
4594	in	O
4595	the	O
4596	past	O
4597	notably	O
4598	in	O
4599	12/96	b-DATE
4600	and	O
4601	08/97	b-DATE
4602	.	O
4603	she	O
4604	has	O
4605	had	O
4606	a	O
4607	diagnosis	O
4608	of	O
4609	diverticulitis	b-PROBLEM
4610	flairs	i-PROBLEM
4611	and	O
4612	baseline	b-PROBLEM
4613	diverticulosis	i-PROBLEM
4614	flairing	i-PROBLEM
4615	in	O
4616	09/96	b-DATE
4617	.	O
4618	also	O
4619	,	O
4620	three	b-DATE
4621	years	i-DATE
4622	prior	i-DATE
4623	in	O
4624	1993	b-DATE
4625	,	O
4626	she	O
4627	had	O
4628	an	b-PROBLEM
4629	attack	i-PROBLEM
4630	of	i-PROBLEM
4631	diverticulitis	i-PROBLEM
4632	.	O
4633	she	O
4634	has	O
4635	been	O
4636	worked	O
4637	up	O
4638	with	O
4639	barium	b-TEST
4640	enema	i-TEST
4641	in	O
4642	09/97	b-DATE
4643	which	O
4644	showed	b-EVIDENTIAL
4645	multiple	b-PROBLEM
4646	diverticula	i-PROBLEM
4647	throughout	O
4648	the	O
4649	colon	O
4650	,	O
4651	but	O
4652	mostly	O
4653	in	O
4654	the	O
4655	sigmoid	O
4656	.	O
4657	at	O
4658	this	b-DATE
4659	time	i-DATE
4660	,	O
4661	there	O
4662	was	O
4663	diverticulosis	b-PROBLEM
4664	with	O
4665	no	O
4666	acute	b-PROBLEM
4667	diverticulitis	i-PROBLEM
4668	.	O
4669	there	O
4670	was	O
4671	also	O
4672	no	O
4673	obstruction	b-PROBLEM
4674	.	O
4675	the	O
4676	patient	O
4677	is	O
4678	also	O
4679	status	O
4680	post	O
4681	aortic	b-TREATMENT
4682	valve	i-TREATMENT
4683	replacement	i-TREATMENT
4684	in	O
4685	1996	b-DATE
4686	,	O
4687	and	O
4688	presented	b-OCCURRENCE
4689	for	O
4690	heparinization	b-TREATMENT
4691	prior	O
4692	to	O
4693	her	b-TREATMENT
4694	elective	i-TREATMENT
4695	valve	i-TREATMENT
4696	surgery	i-TREATMENT
4697	.	O
4698	hospital	O
4699	course	O
4700	:	O
4701	the	O
4702	patient	O
4703	was	O
4704	admitted	b-OCCURRENCE
4705	and	O
4706	begun	O
4707	on	O
4708	cefotetan	b-TREATMENT
4709	and	O
4710	flagyl	b-TREATMENT
4711	,	O
4712	as	O
4713	well	O
4714	as	O
4715	heparin	b-TREATMENT
4716	.	O
4717	her	b-TEST
4718	inr	i-TEST
4719	dropped	O
4720	to	O
4721	1.6	O
4722	prior	O
4723	to	O
4724	surgery	b-TREATMENT
4725	,	O
4726	and	O
4727	her	b-TEST
4728	ptt	i-TEST
4729	was	O
4730	in	O
4731	the	O
4732	mid	O
4733	80s	O
4734	prior	O
4735	to	O
4736	surgery	b-TREATMENT
4737	.	O
4738	she	O
4739	was	O
4740	admitted	b-OCCURRENCE
4741	and	O
4742	placed	O
4743	on	O
4744	a	b-TREATMENT
4745	bowel	i-TREATMENT
4746	prep	i-TREATMENT
4747	two	b-DATE
4748	days	i-DATE
4749	before	i-DATE
4750	surgery	b-TREATMENT
4751	and	O
4752	was	O
4753	taken	O
4754	to	O
4755	the	b-CLINICAL_DEPT
4756	operating	i-CLINICAL_DEPT
4757	room	i-CLINICAL_DEPT
4758	on	O
4759	hospital	b-DATE
4760	day	i-DATE
4761	#	i-DATE
4762	3	i-DATE
4763	,	O
4764	10/28/97	b-DATE
4765	.	O
4766	at	O
4767	that	b-DATE
4768	time	i-DATE
4769	,	O
4770	she	O
4771	underwent	O
4772	sigmoid	b-TREATMENT
4773	colectomy	i-TREATMENT
4774	and	O
4775	ventral	b-TREATMENT
4776	hernia	i-TREATMENT
4777	repair	i-TREATMENT
4778	.	O
4779	(	O
4780	a	b-EVIDENTIAL
4781	full	i-EVIDENTIAL
4782	account	i-EVIDENTIAL
4783	of	O
4784	this	b-TREATMENT
4785	operation	i-TREATMENT
4786	can	O
4787	be	O
4788	found	O
4789	in	O
4790	the	b-EVIDENTIAL
4791	operative	i-EVIDENTIAL
4792	note	i-EVIDENTIAL
4793	)	O
4794	.	O
4795	she	O
4796	tolerated	O
4797	this	b-TREATMENT
4798	procedure	i-TREATMENT
4799	without	O
4800	complications	b-PROBLEM
4801	initially	O
4802	and	O
4803	was	O
4804	taken	b-OCCURRENCE
4805	to	O
4806	the	b-CLINICAL_DEPT
4807	recovery	i-CLINICAL_DEPT
4808	room	i-CLINICAL_DEPT
4809	in	O
4810	stable	b-OCCURRENCE
4811	condition	i-OCCURRENCE
4812	.	O
4813	postoperatively	O
4814	,	O
4815	she	O
4816	had	O
4817	her	b-TREATMENT
4818	heparin	i-TREATMENT
4819	restarted	O
4820	,	O
4821	and	O
4822	had	O
4823	a	b-TEST
4824	ptt	i-TEST
4825	rising	O
4826	to	O
4827	142.8	O
4828	and	O
4829	then	O
4830	down	O
4831	to	O
4832	92	O
4833	.	O
4834	her	O
4835	primary	O
4836	postoperative	O
4837	development	O
4838	was	O
4839	the	b-PROBLEM
4840	passage	i-PROBLEM
4841	of	i-PROBLEM
4842	some	i-PROBLEM
4843	blood	i-PROBLEM
4844	clots	i-PROBLEM
4845	and	O
4846	blood	b-PROBLEM
4847	per	i-PROBLEM
4848	rectum	i-PROBLEM
4849	on	O
4850	postoperative	b-DATE
4851	day	i-DATE
4852	#	i-DATE
4853	2	i-DATE
4854	.	O
4855	she	O
4856	continued	O
4857	to	O
4858	pass	O
4859	blood	b-PROBLEM
4860	per	i-PROBLEM
4861	rectum	i-PROBLEM
4862	and	O
4863	was	O
4864	transfused	b-TREATMENT
4865	with	O
4866	one	b-TREATMENT
4867	unit	i-TREATMENT
4868	of	i-TREATMENT
4869	packed	i-TREATMENT
4870	red	i-TREATMENT
4871	blood	i-TREATMENT
4872	cells	i-TREATMENT
4873	.	O
4874	her	b-TEST
4875	preoperative	i-TEST
4876	hematocrit	i-TEST
4877	was	O
4878	41	O
4879	and	O
4880	her	b-TEST
4881	hematocrit	i-TEST
4882	dropped	b-TEST
4883	to	O
4884	30.4	O
4885	on	O
4886	postoperative	b-DATE
4887	day	i-DATE
4888	#	i-DATE
4889	2	i-DATE
4890	.	O
4891	this	O
4892	was	O
4893	a	b-TEST
4894	drop	i-TEST
4895	from	O
4896	an	b-TEST
4897	immediate	i-TEST
4898	postoperative	i-TEST
4899	hematocrit	i-TEST
4900	of	O
4901	35.4	O
4902	.	O
4903	upon	O
4904	receiving	O
4905	the	b-TREATMENT
4906	one	i-TREATMENT
4907	unit	i-TREATMENT
4908	of	i-TREATMENT
4909	red	i-TREATMENT
4910	blood	i-TREATMENT
4911	cells	i-TREATMENT
4912	,	O
4913	her	b-TEST
4914	hematocrit	i-TEST
4915	returned	b-TEST
4916	to	O
4917	33	O
4918	,	O
4919	and	O
4920	in	O
4921	the	b-DURATION
4922	two	i-DURATION
4923	days	i-DURATION
4924	subsequent	O
4925	to	O
4926	the	b-TREATMENT
4927	transfusion	i-TREATMENT
4928	,	O
4929	returned	b-TEST
4930	to	O
4931	34	O
4932	.	O
4933	otherwise	O
4934	,	O
4935	her	b-OCCURRENCE
4936	postoperative	i-OCCURRENCE
4937	course	i-OCCURRENCE
4938	was	O
4939	uneventful	O
4940	with	O
4941	gradual	O
4942	resolution	O
4943	of	O
4944	the	O
4945	passage	O
4946	of	O
4947	blood	b-PROBLEM
4948	per	i-PROBLEM
4949	rectum	i-PROBLEM
4950	.	O
4951	her	b-TREATMENT
4952	heparin	i-TREATMENT
4953	was	O
4954	discontinued	O
4955	when	O
4956	it	O
4957	was	O
4958	noted	b-EVIDENTIAL
4959	that	O
4960	she	O
4961	was	O
4962	bleeding	b-PROBLEM
4963	per	i-PROBLEM
4964	rectum	i-PROBLEM
4965	and	O
4966	her	b-TEST
4967	ptt	i-TEST
4968	drifted	b-TEST
4969	to	O
4970	a	O
4971	normal	O
4972	range	O
4973	of	O
4974	35	O
4975	by	O
4976	postoperative	b-DATE
4977	day	i-DATE
4978	#	i-DATE
4979	3	i-DATE
4980	.	O
4981	on	O
4982	postoperative	b-DATE
4983	day	i-DATE
4984	#	i-DATE
4985	1	i-DATE
4986	,	O
4987	the	O
4988	patient	O
4989	was	O
4990	restarted	O
4991	on	O
4992	2	O
4993	mg	O
4994	of	O
4995	coumadin	b-TREATMENT
4996	.	O
4997	however	O
4998	,	O
4999	due	O
5000	to	O
5001	the	O
5002	episode	O
5003	of	O
5004	bleeding	b-PROBLEM
5005	on	O
5006	postoperative	b-DATE
5007	day	i-DATE
5008	#	i-DATE
5009	2	i-DATE
5010	,	O
5011	the	b-TREATMENT
5012	coumadin	i-TREATMENT
5013	was	O
5014	held	O
5015	for	O
5016	two	b-DURATION
5017	consecutive	i-DURATION
5018	days	i-DURATION
5019	,	O
5020	and	O
5021	then	O
5022	restarted	O
5023	on	O
5024	postoperative	b-DATE
5025	day	i-DATE
5026	#	i-DATE
5027	4	i-DATE
5028	.	O
5029	at	O
5030	this	b-DATE
5031	time	i-DATE
5032	,	O
5033	she	O
5034	is	O
5035	given	O
5036	3	O
5037	mg	O
5038	and	O
5039	was	O
5040	gradually	O
5041	increased	b-OCCURRENCE
5042	to	O
5043	her	b-TREATMENT
5044	regular	i-TREATMENT
5045	regimen	i-TREATMENT
5046	of	O
5047	4	O
5048	mg	O
5049	alternating	O
5050	with	O
5051	3	O
5052	mg.	O
5053	the	b-TEST
5054	patient	i-TEST
5055	&apos;s	i-TEST
5056	inr	i-TEST
5057	had	O
5058	dropped	b-TEST
5059	to	O
5060	1.7	O
5061	at	O
5062	the	b-DATE
5063	time	i-DATE
5064	of	i-DATE
5065	operation	i-DATE
5066	,	O
5067	and	O
5068	remained	O
5069	in	O
5070	this	O
5071	range	O
5072	initially	O
5073	,	O
5074	but	O
5075	began	b-TEST
5076	to	i-TEST
5077	rise	i-TEST
5078	to	O
5079	2.0	O
5080	with	O
5081	her	b-TREATMENT
5082	coumadin	i-TREATMENT
5083	dosing	i-TREATMENT
5084	.	O
5085	at	O
5086	the	b-DATE
5087	time	i-DATE
5088	of	O
5089	discharge	b-OCCURRENCE
5090	,	O
5091	it	O
5092	was	O
5093	1.9	O
5094	,	O
5095	for	O
5096	which	O
5097	she	O
5098	received	O
5099	4	O
5100	mg.	O
5101	on	O
5102	the	b-DATE
5103	next	i-DATE
5104	day	i-DATE
5105	,	O
5106	it	O
5107	was	O
5108	1.6	O
5109	and	O
5110	she	O
5111	returned	O
5112	to	O
5113	a	b-TREATMENT
5114	normal	i-TREATMENT
5115	dosing	i-TREATMENT
5116	of	O
5117	4	O
5118	mg	O
5119	followed	O
5120	by	O
5121	outpatient	b-TEST
5122	draws	i-TEST
5123	to	O
5124	determine	O
5125	the	b-TREATMENT
5126	further	i-TREATMENT
5127	coumadin	i-TREATMENT
5128	dosing	i-TREATMENT
5129	.	O
5130	this	O
5131	was	O
5132	postoperative	b-DATE
5133	day	i-DATE
5134	#	i-DATE
5135	6	i-DATE
5136	,	O
5137	at	O
5138	which	O
5139	time	b-DATE
5140	she	O
5141	is	O
5142	ready	O
5143	for	O
5144	discharge	b-OCCURRENCE
5145	.	O
5146	the	O
5147	rest	O
5148	of	O
5149	her	b-OCCURRENCE
5150	hospital	i-OCCURRENCE
5151	course	i-OCCURRENCE
5152	was	O
5153	unremarkable	O
5154	,	O
5155	with	O
5156	perioperative	b-TREATMENT
5157	ampicillin	i-TREATMENT
5158	,	O
5159	gentamicin	b-TREATMENT
5160	and	O
5161	flagyl	b-TREATMENT
5162	discontinued	O
5163	on	O
5164	postoperative	b-DATE
5165	day	i-DATE
5166	#	i-DATE
5167	1	i-DATE
5168	.	O
5169	she	O
5170	had	O
5171	some	b-PROBLEM
5172	initial	b-OCCURRENCE
5173	nausea	i-OCCURRENCE
5174	but	O
5175	had	O
5176	no	O
5177	emesis	b-PROBLEM
5178	.	O
5179	her	b-TREATMENT
5180	nasogastric	i-TREATMENT
5181	tube	i-TREATMENT
5182	was	O
5183	discontinued	O
5184	on	O
5185	postoperative	b-DATE
5186	day	i-DATE
5187	#	i-DATE
5188	1	i-DATE
5189	,	O
5190	and	O
5191	she	O
5192	tolerated	O
5193	a	b-OCCURRENCE
5194	regular	i-OCCURRENCE
5195	diet	i-OCCURRENCE
5196	by	O
5197	postoperative	b-DATE
5198	day	i-DATE
5199	#	i-DATE
5200	3	i-DATE
5201	.	O
5202	she	O
5203	had	O
5204	flatus	b-OCCURRENCE
5205	and	O
5206	regular	b-OCCURRENCE
5207	bowel	i-OCCURRENCE
5208	movements	i-OCCURRENCE
5209	by	O
5210	postoperative	b-DATE
5211	day	i-DATE
5212	#	i-DATE
5213	5	i-DATE
5214	.	O
5215	she	O
5216	also	O
5217	complained	b-EVIDENTIAL
5218	of	O
5219	some	O
5220	slight	O
5221	dizziness	b-PROBLEM
5222	upon	O
5223	getting	O
5224	up	O
5225	.	O
5226	for	O
5227	this	O
5228	reason	O
5229	,	O
5230	her	b-TREATMENT
5231	normal	i-TREATMENT
5232	lopressor	i-TREATMENT
5233	and	O
5234	norvasc	b-TREATMENT
5235	were	O
5236	held	O
5237	.	O
5238	it	O
5239	was	O
5240	felt	O
5241	that	O
5242	this	O
5243	was	O
5244	re-equalibration	b-OCCURRENCE
5245	after	O
5246	being	O
5247	sedentary	b-OCCURRENCE
5248	and	O
5249	mostly	b-OCCURRENCE
5250	in	i-OCCURRENCE
5251	bed	i-OCCURRENCE
5252	following	O
5253	the	b-TREATMENT
5254	operation	i-TREATMENT
5255	.	O
5256	she	O
5257	had	O
5258	some	b-PROBLEM
5259	slight	i-PROBLEM
5260	headaches	b-PROBLEM
5261	which	O
5262	resolved	O
5263	with	O
5264	tylenol	b-TREATMENT
5265	,	O
5266	and	O
5267	the	b-PROBLEM
5268	dizziness	i-PROBLEM
5269	resolved	O
5270	as	O
5271	well	O
5272	.	O
5273	she	O
5274	was	O
5275	ready	O
5276	for	O
5277	discharge	b-OCCURRENCE
5278	on	O
5279	postoperative	b-DATE
5280	day	i-DATE
5281	#	i-DATE
5282	6	i-DATE
5283	.	O
5284	her	b-PROBLEM
5285	wound	i-PROBLEM
5286	remained	O
5287	benign	b-OCCURRENCE
5288	and	O
5289	was	O
5290	healing	b-OCCURRENCE
5291	nicely	O
5292	at	O
5293	the	b-DATE
5294	time	i-DATE
5295	of	O
5296	discharge	b-OCCURRENCE
5297	.	O
5298		O
5299	admission	b-OCCURRENCE
5300	date	O
5301	:	O
5302	2011-01-19	b-ADMISSION
5303	discharge	b-OCCURRENCE
5304	date	O
5305	:	O
5306	2011-01-25	b-DISCHARGE
5307	service	O
5308	:	O
5309	medicine	O
5310	history	O
5311	of	O
5312	present	O
5313	illness	O
5314	:	O
5315	mr.	O
5316	eugene	O
5317	is	O
5318	a	O
5319	67	O
5320	year	O
5321	old	O
5322	male	O
5323	with	O
5324	a	O
5325	remote	O
5326	history	O
5327	of	O
5328	chronic	b-PROBLEM
5329	pancreatitis	i-PROBLEM
5330	due	O
5331	to	O
5332	alcohol	b-PROBLEM
5333	abuse	i-PROBLEM
5334	30	b-DATE
5335	years	i-DATE
5336	ago	i-DATE
5337	,	O
5338	who	O
5339	is	O
5340	transferred	b-OCCURRENCE
5341	now	O
5342	from	O
5343	rehab	b-CLINICAL_DEPT
5344	hospital	i-CLINICAL_DEPT
5345	of	i-CLINICAL_DEPT
5346	the	i-CLINICAL_DEPT
5347	cape	i-CLINICAL_DEPT
5348	&	i-CLINICAL_DEPT
5349	islands	i-CLINICAL_DEPT
5350	hospital	i-CLINICAL_DEPT
5351	for	O
5352	an	b-TEST
5353	ercp	i-TEST
5354	and	O
5355	work-up	b-TEST
5356	for	O
5357	a	b-PROBLEM
5358	cystic	i-PROBLEM
5359	lesion	i-PROBLEM
5360	at	O
5361	the	O
5362	head	O
5363	of	O
5364	his	O
5365	pancreas	O
5366	on	O
5367	ct	b-TEST
5368	scan	i-TEST
5369	shown	b-EVIDENTIAL
5370	at	O
5371	the	b-OCCURRENCE
5372	outside	i-OCCURRENCE
5373	hospital	i-OCCURRENCE
5374	.	O
5375	the	O
5376	patient	O
5377	presented	b-OCCURRENCE
5378	initially	O
5379	to	O
5380	rehab	b-CLINICAL_DEPT
5381	hospital	i-CLINICAL_DEPT
5382	of	i-CLINICAL_DEPT
5383	the	i-CLINICAL_DEPT
5384	cape	i-CLINICAL_DEPT
5385	&	i-CLINICAL_DEPT
5386	islands	i-CLINICAL_DEPT
5387	hospital	i-CLINICAL_DEPT
5388	at	O
5389	the	b-DATE
5390	end	i-DATE
5391	of	i-DATE
5392	december	i-DATE
5393	for	O
5394	abdominal	b-PROBLEM
5395	pain	i-PROBLEM
5396	,	O
5397	and	O
5398	was	O
5399	found	b-EVIDENTIAL
5400	to	O
5401	have	O
5402	pancreatitis	b-PROBLEM
5403	.	O
5404	during	O
5405	this	b-OCCURRENCE
5406	admission	i-OCCURRENCE
5407	,	O
5408	two	b-TEST
5409	ct	i-TEST
5410	scans	i-TEST
5411	had	b-EVIDENTIAL
5412	shown	i-EVIDENTIAL
5413	a	O
5414	question	O
5415	of	O
5416	an	b-PROBLEM
5417	enlargement	i-PROBLEM
5418	of	i-PROBLEM
5419	the	i-PROBLEM
5420	head	i-PROBLEM
5421	of	i-PROBLEM
5422	his	i-PROBLEM
5423	pancreas	i-PROBLEM
5424	versus	O
5425	early	b-PROBLEM
5426	pseudocyst	i-PROBLEM
5427	.	O
5428	the	O
5429	patient	O
5430	was	O
5431	discharged	b-OCCURRENCE
5432	home	O
5433	early	O
5434	from	O
5435	this	b-OCCURRENCE
5436	admission	i-OCCURRENCE
5437	due	O
5438	to	O
5439	family	O
5440	needs	O
5441	.	O
5442	while	O
5443	at	O
5444	home	b-CLINICAL_DEPT
5445	,	O
5446	the	O
5447	patient	O
5448	did	O
5449	not	b-PROBLEM
5450	do	i-PROBLEM
5451	well	i-PROBLEM
5452	and	O
5453	could	O
5454	tolerate	O
5455	minimal	b-PROBLEM
5456	food	i-PROBLEM
5457	intake	i-PROBLEM
5458	and	O
5459	lost	b-PROBLEM
5460	about	i-PROBLEM
5461	20	i-PROBLEM
5462	pounds	i-PROBLEM
5463	in	O
5464	one	b-DURATION
5465	month	i-DURATION
5466	.	O
5467	on	O
5468	an	O
5469	office	O
5470	visit	O
5471	on	O
5472	01-14	b-DATE
5473	,	O
5474	the	O
5475	patient	O
5476	was	O
5477	found	b-EVIDENTIAL
5478	to	O
5479	have	O
5480	significantly	b-PROBLEM
5481	elevated	i-PROBLEM
5482	alkaline	i-PROBLEM
5483	phosphatase	i-PROBLEM
5484	.	O
5485	that	b-DATE
5486	evening	i-DATE
5487	,	O
5488	the	O
5489	patient	O
5490	again	O
5491	developed	O
5492	abdominal	b-PROBLEM
5493	pain	i-PROBLEM
5494	""""	O
5495	like	O
5496	his	b-PROBLEM
5497	pancreatitis	i-PROBLEM
5498	""""	O
5499	with	O
5500	nausea	b-PROBLEM
5501	and	O
5502	vomiting	b-PROBLEM
5503	,	O
5504	for	O
5505	which	O
5506	he	O
5507	was	O
5508	admitted	b-OCCURRENCE
5509	to	O
5510	the	b-CLINICAL_DEPT
5511	rehab	i-CLINICAL_DEPT
5512	hospital	i-CLINICAL_DEPT
5513	of	i-CLINICAL_DEPT
5514	the	i-CLINICAL_DEPT
5515	cape	i-CLINICAL_DEPT
5516	&	i-CLINICAL_DEPT
5517	islands	i-CLINICAL_DEPT
5518	hospital	i-CLINICAL_DEPT
5519	.	O
5520	in	O
5521	the	b-CLINICAL_DEPT
5522	emergency	i-CLINICAL_DEPT
5523	department	i-CLINICAL_DEPT
5524	at	O
5525	the	b-CLINICAL_DEPT
5526	rehab	i-CLINICAL_DEPT
5527	hospital	i-CLINICAL_DEPT
5528	of	i-CLINICAL_DEPT
5529	the	i-CLINICAL_DEPT
5530	cape	i-CLINICAL_DEPT
5531	&	i-CLINICAL_DEPT
5532	islands	i-CLINICAL_DEPT
5533	hospital	i-CLINICAL_DEPT
5534	,	O
5535	the	O
5536	patient	O
5537	was	O
5538	noted	b-EVIDENTIAL
5539	to	O
5540	have	O
5541	vomited	b-PROBLEM
5542	some	O
5543	heme	b-PROBLEM
5544	positive	i-PROBLEM
5545	material	i-PROBLEM
5546	.	O
5547	his	b-TEST
5548	complete	i-TEST
5549	blood	i-TEST
5550	count	i-TEST
5551	showed	b-EVIDENTIAL
5552	11%	b-PROBLEM
5553	bandemia	i-PROBLEM
5554	with	O
5555	a	b-TEST
5556	total	i-TEST
5557	white	i-TEST
5558	count	i-TEST
5559	of	O
5560	10	O
5561	.	O
5562	a	b-TEST
5563	hida	i-TEST
5564	scan	i-TEST
5565	showed	b-EVIDENTIAL
5566	no	O
5567	flow	b-PROBLEM
5568	,	O
5569	question	O
5570	of	O
5571	pancreatitis	b-PROBLEM
5572	versus	O
5573	common	b-PROBLEM
5574	bile	i-PROBLEM
5575	duct	i-PROBLEM
5576	obstruction	i-PROBLEM
5577	.	O
5578	his	b-TEST
5579	electrocardiogram	i-TEST
5580	showed	b-EVIDENTIAL
5581	a	b-OCCURRENCE
5582	normal	i-OCCURRENCE
5583	sinus	i-OCCURRENCE
5584	rhythm	i-OCCURRENCE
5585	.	O
5586	a	b-TEST
5587	chest	i-TEST
5588	x-ray	i-TEST
5589	was	O
5590	unremarkable	O
5591	.	O
5592	during	O
5593	his	b-OCCURRENCE
5594	admission	i-OCCURRENCE
5595	to	O
5596	rehab	b-CLINICAL_DEPT
5597	hospital	i-CLINICAL_DEPT
5598	of	i-CLINICAL_DEPT
5599	the	i-CLINICAL_DEPT
5600	cape	i-CLINICAL_DEPT
5601	&	i-CLINICAL_DEPT
5602	islands	i-CLINICAL_DEPT
5603	hospital	i-CLINICAL_DEPT
5604	,	O
5605	the	O
5606	patient	O
5607	had	O
5608	dropped	b-PROBLEM
5609	his	b-TEST
5610	hematocrit	i-TEST
5611	to	O
5612	the	O
5613	30	O
5614	s	O
5615	with	O
5616	recorded	b-PROBLEM
5617	melena	i-PROBLEM
5618	.	O
5619	he	O
5620	received	O
5621	an	b-TEST
5622	mrcp	i-TEST
5623	which	O
5624	was	O
5625	negative	O
5626	for	O
5627	evidence	O
5628	of	O
5629	stones	b-PROBLEM
5630	.	O
5631	an	b-TEST
5632	ultrasound	i-TEST
5633	showed	b-EVIDENTIAL
5634	normal	b-OCCURRENCE
5635	gallbladder	i-OCCURRENCE
5636	with	O
5637	no	O
5638	wall	b-PROBLEM
5639	thickening	i-PROBLEM
5640	but	O
5641	a	b-PROBLEM
5642	dilated	i-PROBLEM
5643	common	i-PROBLEM
5644	bile	i-PROBLEM
5645	duct	i-PROBLEM
5646	of	O
5647	8	O
5648	mm	O
5649	measured	O
5650	on	O
5651	ct	b-TEST
5652	scan	i-TEST
5653	.	O
5654	the	O
5655	patient	O
5656	had	O
5657	an	O
5658	attempted	O
5659	ercp	b-TEST
5660	on	O
5661	01-18	b-DATE
5662	,	O
5663	which	O
5664	was	O
5665	unsuccessful	O
5666	due	O
5667	to	O
5668	a	b-PROBLEM
5669	long	i-PROBLEM
5670	nipple	i-PROBLEM
5671	like	i-PROBLEM
5672	papilla	i-PROBLEM
5673	.	O
5674	he	O
5675	was	O
5676	therefore	O
5677	transferred	b-OCCURRENCE
5678	to	O
5679	saints	b-CLINICAL_DEPT
5680	medical	i-CLINICAL_DEPT
5681	center	i-CLINICAL_DEPT
5682	for	O
5683	endoscopic	b-TEST
5684	retrogram	i-TEST
5685	cholangiopancreatography	i-TEST
5686	.	O
5687	the	b-TEST
5688	patient	i-TEST
5689	's	i-TEST
5690	blood	i-TEST
5691	cultures	i-TEST
5692	at	O
5693	outside	b-CLINICAL_DEPT
5694	hospital	i-CLINICAL_DEPT
5695	grew	O
5696	out	O
5697	streptococcus	b-PROBLEM
5698	sanguis-gordonii	i-PROBLEM
5699	on	O
5700	01-18	b-DATE
5701	.	O
5702	this	O
5703	was	O
5704	sensitive	O
5705	to	O
5706	clindamycin	b-TREATMENT
5707	,	O
5708	erythromycin	b-TREATMENT
5709	,	O
5710	penicillin	b-TREATMENT
5711	s	i-TREATMENT
5712	and	O
5713	vancomycin	b-TREATMENT
5714	.	O
5715	prior	O
5716	to	O
5717	this	O
5718	result	O
5719	,	O
5720	the	O
5721	patient	O
5722	had	O
5723	already	O
5724	been	O
5725	on	O
5726	ampicillin	b-TREATMENT
5727	,	O
5728	sulbactam	b-TREATMENT
5729	and	O
5730	gentamycin	b-TREATMENT
5731	.	O
5732	it	O
5733	appears	O
5734	from	O
5735	the	b-OCCURRENCE
5736	discharge	i-OCCURRENCE
5737	summary	O
5738	that	O
5739	the	O
5740	patient	O
5741	was	O
5742	placed	O
5743	on	O
5744	unasyn	b-TREATMENT
5745	3	O
5746	grams	O
5747	intravenously	O
5748	every	b-FREQUENCY
5749	six	i-FREQUENCY
5750	hours	i-FREQUENCY
5751	after	O
5752	his	b-TEST
5753	ercp	i-TEST
5754	.	O
5755		O
5756	admission	b-OCCURRENCE
5757	date	O
5758	:	O
5759	09/20/2000	b-ADMISSION
5760	discharge	b-OCCURRENCE
5761	date	O
5762	:	O
5763	09/22/2000	b-DISCHARGE
5764	history	O
5765	of	O
5766	present	O
5767	illness	O
5768	:	O
5769	this	O
5770	is	O
5771	a	O
5772	48-year-old	O
5773	g	O
5774	3	O
5775	p	O
5776	3	O
5777	who	O
5778	presented	b-OCCURRENCE
5779	to	O
5780	doctor	O
5781	fuscmadril	b-CLINICAL_DEPT
5782	&apos;s	i-CLINICAL_DEPT
5783	clinic	i-CLINICAL_DEPT
5784	after	O
5785	having	O
5786	an	b-PROBLEM
5787	abnormal	i-PROBLEM
5788	pap	i-PROBLEM
5789	smear	i-PROBLEM
5790	followed	O
5791	by	O
5792	an	b-TEST
5793	endometrial	i-TEST
5794	biopsy	i-TEST
5795	that	O
5796	was	O
5797	suggestive	O
5798	of	O
5799	grade	b-PROBLEM
5800	1	i-PROBLEM
5801	endometrial	i-PROBLEM
5802	cancer	i-PROBLEM
5803	.	O
5804	this	O
5805	is	O
5806	a	O
5807	patient	O
5808	who	O
5809	,	O
5810	over	O
5811	the	b-DURATION
5812	past	i-DURATION
5813	year	i-DURATION
5814	,	O
5815	has	O
5816	had	O
5817	no	O
5818	menses	b-PROBLEM
5819	and	O
5820	thought	O
5821	she	O
5822	had	O
5823	become	O
5824	menopausal	b-PROBLEM
5825	.	O
5826	she	O
5827	then	O
5828	began	O
5829	spotting	b-PROBLEM
5830	for	O
5831	several	b-DURATION
5832	months	i-DURATION
5833	with	O
5834	some	b-PROBLEM
5835	constant	b-PROBLEM
5836	brown	i-PROBLEM
5837	discharge	i-PROBLEM
5838	.	O
5839	a	b-TEST
5840	pap	i-TEST
5841	smear	i-TEST
5842	that	O
5843	was	O
5844	obtained	O
5845	by	O
5846	her	O
5847	primary	O
5848	care	O
5849	physician	O
5850	showed	b-EVIDENTIAL
5851	an	b-PROBLEM
5852	endometrial	i-PROBLEM
5853	cell	i-PROBLEM
5854	and	O
5855	thus	O
5856	she	O
5857	was	O
5858	referred	O
5859	to	O
5860	a	O
5861	gynecologist	O
5862	for	O
5863	an	b-TEST
5864	endometrial	i-TEST
5865	biopsy	i-TEST
5866	.	O
5867	the	b-TEST
5868	endometrial	i-TEST
5869	biopsy	i-TEST
5870	showed	b-EVIDENTIAL
5871	grade	b-PROBLEM
5872	1	i-PROBLEM
5873	endometrial	i-PROBLEM
5874	cancer	i-PROBLEM
5875	.	O
5876	a	O
5877	decision	O
5878	was	O
5879	made	O
5880	to	O
5881	proceed	O
5882	with	O
5883	surgical	b-TREATMENT
5884	management	i-TREATMENT
5885	for	O
5886	this	O
5887	finding	O
5888	.	O
5889	hospital	O
5890	course	O
5891	:	O
5892	the	O
5893	patient	O
5894	was	O
5895	admitted	b-OCCURRENCE
5896	on	O
5897	the	b-DATE
5898	day	i-DATE
5899	of	O
5900	her	b-TREATMENT
5901	surgery	i-TREATMENT
5902	which	O
5903	was	O
5904	09/20/00	b-DATE
5905	.	O
5906	she	O
5907	underwent	O
5908	a	b-TREATMENT
5909	tah-bso	i-TREATMENT
5910	which	O
5911	was	O
5912	uncomplicated	O
5913	.	O
5914	details	O
5915	of	O
5916	the	b-TREATMENT
5917	procedure	i-TREATMENT
5918	can	O
5919	be	O
5920	found	O
5921	in	O
5922	the	b-EVIDENTIAL
5923	operative	i-EVIDENTIAL
5924	dictation	i-EVIDENTIAL
5925	.	O
5926	in	O
5927	short	O
5928	,	O
5929	frozen	b-TEST
5930	pathology	i-TEST
5931	from	i-TEST
5932	the	i-TEST
5933	uterus	i-TEST
5934	showed	b-EVIDENTIAL
5935	that	O
5936	there	O
5937	was	O
5938	a	b-PROBLEM
5939	grade	i-PROBLEM
5940	1	i-PROBLEM
5941	cancer	i-PROBLEM
5942	with	O
5943	no	O
5944	invasion	b-PROBLEM
5945	of	i-PROBLEM
5946	the	i-PROBLEM
5947	myometrium	i-PROBLEM
5948	.	O
5949	there	O
5950	was	O
5951	no	O
5952	nodal	b-TEST
5953	dissection	i-TEST
5954	done	O
5955	at	O
5956	that	b-DATE
5957	time	i-DATE
5958	.	O
5959	the	O
5960	patient	O
5961	tolerated	O
5962	the	b-TREATMENT
5963	procedure	i-TREATMENT
5964	extremely	b-OCCURRENCE
5965	well	i-OCCURRENCE
5966	and	O
5967	did	O
5968	well	b-OCCURRENCE
5969	during	O
5970	her	b-OCCURRENCE
5971	postoperative	i-OCCURRENCE
5972	course	i-OCCURRENCE
5973	.	O
5974	by	O
5975	postoperative	b-DATE
5976	day	i-DATE
5977	#2	i-DATE
5978	she	O
5979	was	O
5980	eating	b-OCCURRENCE
5981	,	O
5982	ambulating	b-OCCURRENCE
5983	and	O
5984	voiding	b-OCCURRENCE
5985	on	O
5986	her	O
5987	own	O
5988	.	O
5989	she	O
5990	decided	O
5991	to	O
5992	now	O
5993	be	O
5994	discharged	b-OCCURRENCE
5995	home	O
5996	at	O
5997	this	b-DATE
5998	time	i-DATE
5999	.	O
6000	she	O
6001	was	O
6002	discharged	b-OCCURRENCE
6003	home	O
6004	with	O
6005	the	b-TREATMENT
6006	following	i-TREATMENT
6007	medications	i-TREATMENT
6008	:	O
6009		O
6010	admission	b-OCCURRENCE
6011	date	O
6012	:	O
6013	2010-08-30	b-ADMISSION
6014	discharge	b-OCCURRENCE
6015	date	O
6016	:	O
6017	2010-09-06	b-DISCHARGE
6018	service	O
6019	:	O
6020	cardiothoracic	O
6021	history	O
6022	of	O
6023	present	O
6024	illness	O
6025	:	O
6026	this	O
6027	is	O
6028	a	O
6029	64-year-old	O
6030	man	O
6031	with	O
6032	a	O
6033	history	O
6034	of	O
6035	coronary	b-PROBLEM
6036	artery	i-PROBLEM
6037	disease	i-PROBLEM
6038	,	O
6039	endocarditis	b-PROBLEM
6040	status	O
6041	post	O
6042	coronary	b-TREATMENT
6043	artery	i-TREATMENT
6044	bypass	i-TREATMENT
6045	grafting	i-TREATMENT
6046	and	O
6047	mitral	b-TREATMENT
6048	valve	i-TREATMENT
6049	replacement	i-TREATMENT
6050	on	O
6051	2010-08-13	b-DATE
6052	.	O
6053	he	O
6054	was	O
6055	transferred	b-OCCURRENCE
6056	to	O
6057	erich	b-CLINICAL_DEPT
6058	lindemann	i-CLINICAL_DEPT
6059	mental	i-CLINICAL_DEPT
6060	health	i-CLINICAL_DEPT
6061	center	i-CLINICAL_DEPT
6062	from	O
6063	the	b-CLINICAL_DEPT
6064	rehabilitation	i-CLINICAL_DEPT
6065	center	i-CLINICAL_DEPT
6066	where	O
6067	he	O
6068	had	O
6069	been	O
6070	discharged	b-OCCURRENCE
6071	to	O
6072	on	O
6073	2010-08-25	b-DATE
6074	following	O
6075	his	b-TREATMENT
6076	cabg/mvr	i-TREATMENT
6077	.	O
6078	at	O
6079	the	b-CLINICAL_DEPT
6080	rehabilitation	i-CLINICAL_DEPT
6081	center	i-CLINICAL_DEPT
6082	the	O
6083	patient	O
6084	developed	O
6085	shortness	b-PROBLEM
6086	of	i-PROBLEM
6087	breath	i-PROBLEM
6088	.	O
6089	a	b-TEST
6090	chest	i-TEST
6091	x-ray	i-TEST
6092	done	O
6093	at	O
6094	that	O
6095	time	O
6096	revealed	b-EVIDENTIAL
6097	a	b-PROBLEM
6098	left-sided	i-PROBLEM
6099	infiltrate	i-PROBLEM
6100	versus	O
6101	effusion	b-PROBLEM
6102	.	O
6103	he	O
6104	was	O
6105	transferred	b-OCCURRENCE
6106	to	O
6107	mass.	b-CLINICAL_DEPT
6108	eye	i-CLINICAL_DEPT
6109	&	i-CLINICAL_DEPT
6110	ear	i-CLINICAL_DEPT
6111	infirmary	i-CLINICAL_DEPT
6112	for	O
6113	treatment	b-TREATMENT
6114	.	O
6115	at	O
6116	the	O
6117	time	O
6118	he	O
6119	complained	b-EVIDENTIAL
6120	of	O
6121	no	O
6122	chest	b-PROBLEM
6123	pain	i-PROBLEM
6124	,	O
6125	weakness	b-PROBLEM
6126	or	O
6127	cough	b-PROBLEM
6128	,	O
6129	although	O
6130	he	O
6131	is	O
6132	intermittently	b-PROBLEM
6133	short	i-PROBLEM
6134	of	i-PROBLEM
6135	breath	i-PROBLEM
6136	.	O
6137	he	O
6138	had	O
6139	been	O
6140	anticoagulated	b-TREATMENT
6141	during	O
6142	his	O
6143	stay	O
6144	at	O
6145	rehabilitation	b-CLINICAL_DEPT
6146	for	O
6147	atrial	b-PROBLEM
6148	fibrillation	i-PROBLEM
6149	.	O
6150	hospital	O
6151	course	O
6152	:	O
6153	the	O
6154	patient	O
6155	was	O
6156	admitted	b-OCCURRENCE
6157	to	O
6158	vencor	b-CLINICAL_DEPT
6159	hospital	i-CLINICAL_DEPT
6160	.	O
6161	he	O
6162	was	O
6163	given	O
6164	fresh	b-TREATMENT
6165	frozen	i-TREATMENT
6166	plasma	i-TREATMENT
6167	to	O
6168	correct	O
6169	his	b-TEST
6170	inr	i-TEST
6171	and	O
6172	a	b-TREATMENT
6173	left	i-TREATMENT
6174	chest	i-TREATMENT
6175	tube	i-TREATMENT
6176	was	O
6177	placed	O
6178	.	O
6179	over	O
6180	the	b-DURATION
6181	first	i-DURATION
6182	12	i-DURATION
6183	hours	i-DURATION
6184	the	b-TREATMENT
6185	chest	i-TREATMENT
6186	tube	i-TREATMENT
6187	drained	b-OCCURRENCE
6188	2,500	O
6189	cc	O
6190	.	O
6191	on	O
6192	hospital	b-DATE
6193	day	i-DATE
6194	two	i-DATE
6195	the	O
6196	patient	O
6197	was	O
6198	transferred	b-OCCURRENCE
6199	from	O
6200	the	b-CLINICAL_DEPT
6201	cardiac	i-CLINICAL_DEPT
6202	surgery	i-CLINICAL_DEPT
6203	recovery	i-CLINICAL_DEPT
6204	unit	i-CLINICAL_DEPT
6205	to	O
6206	07-02	b-CLINICAL_DEPT
6207	for	O
6208	continuing	b-OCCURRENCE
6209	care	i-OCCURRENCE
6210	.	O
6211	he	O
6212	remained	O
6213	hemodynamically	b-OCCURRENCE
6214	stable	i-OCCURRENCE
6215	.	O
6216	his	b-OCCURRENCE
6217	chest	i-OCCURRENCE
6218	tube	i-OCCURRENCE
6219	drainage	i-OCCURRENCE
6220	reduced	b-OCCURRENCE
6221	significantly	O
6222	after	O
6223	the	b-DURATION
6224	first	i-DURATION
6225	24	i-DURATION
6226	hours	i-DURATION
6227	and	O
6228	on	O
6229	hospital	b-DATE
6230	day	i-DATE
6231	three	i-DATE
6232	his	b-TREATMENT
6233	chest	i-TREATMENT
6234	tube	i-TREATMENT
6235	was	O
6236	discontinued	O
6237	.	O
6238	over	O
6239	the	b-DURATION
6240	next	i-DURATION
6241	several	i-DURATION
6242	days	i-DURATION
6243	the	O
6244	patient	O
6245	remained	O
6246	in	O
6247	the	b-CLINICAL_DEPT
6248	hospital	i-CLINICAL_DEPT
6249	to	O
6250	reassess	b-TEST
6251	for	O
6252	recurrent	b-PROBLEM
6253	pleural	i-PROBLEM
6254	effusion	i-PROBLEM
6255	.	O
6256	on	O
6257	09-02	b-DATE
6258	it	O
6259	was	O
6260	decided	O
6261	that	O
6262	the	O
6263	patient	O
6264	was	O
6265	stable	b-OCCURRENCE
6266	and	O
6267	ready	O
6268	to	O
6269	be	O
6270	transferred	b-OCCURRENCE
6271	back	O
6272	to	O
6273	rehabilitation	b-CLINICAL_DEPT
6274	,	O
6275	however	O
6276	case	O
6277	management	O
6278	was	O
6279	unable	O
6280	to	O
6281	get	O
6282	authorization	b-OCCURRENCE
6283	from	O
6284	the	O
6285	patient	O
6286	's	O
6287	insurance	O
6288	company	O
6289	and	O
6290	he	O
6291	remained	O
6292	in	O
6293	the	b-CLINICAL_DEPT
6294	hospital	i-CLINICAL_DEPT
6295	throughout	O
6296	the	b-DURATION
6297	holiday	i-DURATION
6298	weekend	i-DURATION
6299	awaiting	b-OCCURRENCE
6300	insurance	i-OCCURRENCE
6301	authorization	i-OCCURRENCE
6302	for	O
6303	transfer	b-OCCURRENCE
6304	back	O
6305	to	O
6306	rehabilitation	b-CLINICAL_DEPT
6307	.	O
6308	at	O
6309	this	O
6310	time	O
6311	the	b-TEST
6312	patient	i-TEST
6313	's	i-TEST
6314	physical	i-TEST
6315	examination	i-TEST
6316	is	O
6317	as	O
6318	follows	O
6319	:	O
6320	vital	b-TEST
6321	signs	i-TEST
6322	were	O
6323	temperature	b-TEST
6324	97.8	O
6325	,	O
6326	heart	b-TEST
6327	rate	i-TEST
6328	80	O
6329	and	O
6330	sinus	b-OCCURRENCE
6331	rhythm	i-OCCURRENCE
6332	,	O
6333	blood	b-TEST
6334	pressure	i-TEST
6335	140/82	O
6336	,	O
6337	respiratory	b-TEST
6338	rate	i-TEST
6339	18	O
6340	,	O
6341	o2	b-TEST
6342	saturation	i-TEST
6343	96%	O
6344	on	O
6345	room	O
6346	air	O
6347	.	O
6348	weight	b-TEST
6349	on	O
6350	admission	b-OCCURRENCE
6351	was	O
6352	64	O
6353	kg	O
6354	,	O
6355	at	O
6356	discharge	b-OCCURRENCE
6357	was	O
6358	51.6	O
6359	kg	O
6360	.	O
6361	laboratory	b-TEST
6362	data	i-TEST
6363	showed	b-EVIDENTIAL
6364	an	b-TEST
6365	hematocrit	i-TEST
6366	of	O
6367	31.6	O
6368	,	O
6369	pt	b-TEST
6370	13	O
6371	,	O
6372	inr	b-TEST
6373	1.2	O
6374	,	O
6375	potassium	b-TEST
6376	4.5	O
6377	,	O
6378	bun	b-TEST
6379	18	O
6380	,	O
6381	creatinine	b-TEST
6382	0.9	O
6383	.	O
6384	he	O
6385	was	O
6386	alert	b-OCCURRENCE
6387	and	O
6388	oriented	b-OCCURRENCE
6389	x	i-OCCURRENCE
6390	3	i-OCCURRENCE
6391	,	O
6392	moved	b-OCCURRENCE
6393	all	i-OCCURRENCE
6394	extremities	i-OCCURRENCE
6395	,	O
6396	followed	b-OCCURRENCE
6397	commands	i-OCCURRENCE
6398	.	O
6399	respiratory	b-TEST
6400	examination	i-TEST
6401	was	O
6402	clear	b-OCCURRENCE
6403	to	O
6404	auscultation	b-TEST
6405	bilaterally	i-TEST
6406	.	O
6407	cardiac	O
6408	showed	O
6409	a	b-OCCURRENCE
6410	regular	i-OCCURRENCE
6411	rate	i-OCCURRENCE
6412	and	O
6413	rhythm	b-OCCURRENCE
6414	,	O
6415	s1	O
6416	and	O
6417	s2	O
6418	.	O
6419	sternum	O
6420	was	O
6421	stable	b-OCCURRENCE
6422	.	O
6423	incisions	b-PROBLEM
6424	had	O
6425	steri-strips	b-TREATMENT
6426	,	O
6427	open	b-OCCURRENCE
6428	to	i-OCCURRENCE
6429	air	i-OCCURRENCE
6430	,	O
6431	clean	b-OCCURRENCE
6432	and	O
6433	dry	b-OCCURRENCE
6434	.	O
6435	abdomen	O
6436	was	O
6437	soft	b-OCCURRENCE
6438	,	O
6439	nontender	b-PROBLEM
6440	,	O
6441	nondistended	b-PROBLEM
6442	,	O
6443	with	O
6444	normal	b-OCCURRENCE
6445	active	i-OCCURRENCE
6446	bowel	i-OCCURRENCE
6447	sounds	i-OCCURRENCE
6448	.	O
6449	extremities	O
6450	were	O
6451	warm	b-OCCURRENCE
6452	and	O
6453	well	b-OCCURRENCE
6454	perfused	i-OCCURRENCE
6455	with	O
6456	no	O
6457	edema	b-PROBLEM
6458	.	O
6459	right	b-PROBLEM
6460	lower	i-PROBLEM
6461	extremity	i-PROBLEM
6462	incision	i-PROBLEM
6463	with	O
6464	steri-strips	b-TREATMENT
6465	,	O
6466	open	b-OCCURRENCE
6467	to	i-OCCURRENCE
6468	air	i-OCCURRENCE
6469	,	O
6470	clean	b-OCCURRENCE
6471	and	O
6472	dry	b-OCCURRENCE
6473	.	O
6474		O
6475	admission	b-OCCURRENCE
6476	date	O
6477	:	O
6478	2019-01-19	b-ADMISSION
6479	discharge	b-OCCURRENCE
6480	date	O
6481	:	O
6482	2019-01-24	b-DISCHARGE
6483	service	O
6484	:	O
6485	medicine	O
6486	allergies	O
6487	:	O
6488	history	O
6489	of	O
6490	present	O
6491	illness	O
6492	:	O
6493	this	O
6494	is	O
6495	a	O
6496	37	O
6497	y/o	O
6498	male	O
6499	patient	O
6500	with	O
6501	pmh	O
6502	type	b-PROBLEM
6503	i	i-PROBLEM
6504	dm	i-PROBLEM
6505	,	O
6506	htn	b-PROBLEM
6507	,	O
6508	gastroparesis	b-PROBLEM
6509	,	O
6510	esrd	b-PROBLEM
6511	on	O
6512	hd	b-TREATMENT
6513	(	O
6514	last	O
6515	in	O
6516	12/26	b-DATE
6517	per	O
6518	patient	O
6519	)	O
6520	who	O
6521	presents	b-OCCURRENCE
6522	to	O
6523	cmed	b-CLINICAL_DEPT
6524	ccu	i-CLINICAL_DEPT
6525	with	O
6526	hypertensive	b-PROBLEM
6527	urgency	i-PROBLEM
6528	unable	O
6529	from	O
6530	the	b-CLINICAL_DEPT
6531	larry	i-CLINICAL_DEPT
6532	.	O
6533	the	O
6534	patient	O
6535	early	O
6536	this	b-DATE
6537	morning	i-DATE
6538	to	O
6539	the	b-CLINICAL_DEPT
6540	ruthie	i-CLINICAL_DEPT
6541	with	O
6542	his	b-PROBLEM
6543	usual	i-PROBLEM
6544	nausea	i-PROBLEM
6545	,	O
6546	vomiting	b-PROBLEM
6547	,	O
6548	abdominal	b-PROBLEM
6549	pain	i-PROBLEM
6550	and	O
6551	was	O
6552	found	O
6553	to	O
6554	be	O
6555	hypertensive	b-PROBLEM
6556	to	O
6557	256/110	O
6558	,	O
6559	hr	b-TEST
6560	102	O
6561	,	O
6562	t	b-TEST
6563	99.2	O
6564	,	O
6565	rr	b-TEST
6566	22	O
6567	,	O
6568	92%	O
6569	ra	O
6570	.	O
6571	history	O
6572	is	O
6573	difficult	O
6574	to	O
6575	obtain	O
6576	from	O
6577	patient	O
6578	d/t	O
6579	somnolence	b-PROBLEM
6580	and	O
6581	lack	b-PROBLEM
6582	of	i-PROBLEM
6583	desire	i-PROBLEM
6584	to	O
6585	participate	O
6586	in	O
6587	interview	O
6588	,	O
6589	but	O
6590	per	O
6591	frank	O
6592	note	O
6593	he	O
6594	was	O
6595	diaphoretic	b-PROBLEM
6596	and	O
6597	'	O
6598	writing	O
6599	in	O
6600	pain	b-PROBLEM
6601	',	O
6602	vomiting	b-PROBLEM
6603	clear	i-PROBLEM
6604	substance	i-PROBLEM
6605	.	O
6606	he	O
6607	was	O
6608	given	O
6609	ativan	b-TREATMENT
6610	a	O
6611	total	O
6612	of	O
6613	4	O
6614	mg	O
6615	of	O
6616	ativan	b-TREATMENT
6617	,	O
6618	6	O
6619	mg	O
6620	of	O
6621	dilaudid	b-TREATMENT
6622	,	O
6623	labetolol	b-TREATMENT
6624	20	O
6625	mg	O
6626	iv	O
6627	x	O
6628	1	O
6629	and	O
6630	hydralazine	b-TREATMENT
6631	10	O
6632	mg	O
6633	iv	O
6634	x	O
6635	1	O
6636	without	O
6637	good	b-OCCURRENCE
6638	response	i-OCCURRENCE
6639	(	O
6640	200/99	O
6641	).	O
6642	he	O
6643	recieved	O
6644	2l	O
6645	ns	b-TREATMENT
6646	and	O
6647	was	O
6648	started	O
6649	on	O
6650	labetolol	b-TREATMENT
6651	gtt	i-TREATMENT
6652	and	O
6653	bp	b-TEST
6654	decreased	b-OCCURRENCE
6655	to	O
6656	161/79	O
6657	.	O
6658	tranferred	b-OCCURRENCE
6659	to	O
6660	cmed	b-CLINICAL_DEPT
6661	ccu	i-CLINICAL_DEPT
6662	for	O
6663	further	b-TREATMENT
6664	management	i-TREATMENT
6665	while	O
6666	on	O
6667	labetolol	b-TREATMENT
6668	gtt	i-TREATMENT
6669	.	O
6670	of	O
6671	note	O
6672	,	O
6673	the	O
6674	patient	O
6675	is	O
6676	admitted	b-OCCURRENCE
6677	to	O
6678	hospital	b-CLINICAL_DEPT
6679	3	b-FREQUENCY
6680	times	i-FREQUENCY
6681	every	i-FREQUENCY
6682	month	i-FREQUENCY
6683	for	O
6684	similar	b-PROBLEM
6685	complaints	i-PROBLEM
6686	with	O
6687	last	b-OCCURRENCE
6688	admission	i-OCCURRENCE
6689	1/20-2/1/07	b-DURATION
6690	.	O
6691	at	O
6692	that	O
6693	time	O
6694	bp	b-TEST
6695	was	O
6696	attributed	O
6697	to	O
6698	abdominal	b-PROBLEM
6699	pain	i-PROBLEM
6700	and	O
6701	inability	O
6702	to	O
6703	take	O
6704	po	b-TREATMENT
6705	meds	i-TREATMENT
6706	d/t	O
6707	nausea	b-PROBLEM
6708	/	O
6709	vomiting	b-PROBLEM
6710	.	O
6711	also	O
6712	had	O
6713	labile	b-PROBLEM
6714	blood	i-PROBLEM
6715	sugars	i-PROBLEM
6716	with	O
6717	repeated	O
6718	episodes	O
6719	of	O
6720	hypoglycemia	b-PROBLEM
6721	,	O
6722	and	O
6723	strickland	O
6724	recommended	O
6725	sugars	O
6726	in	O
6727	the	O
6728	range	O
6729	of	O
6730	150-200	O
6731	.	O
6732	he	O
6733	eloped	b-OCCURRENCE
6734	prior	O
6735	to	O
6736	formal	b-OCCURRENCE
6737	discharge	i-OCCURRENCE
6738	when	O
6739	his	b-TEST
6740	fs	i-TEST
6741	was	O
6742	found	O
6743	to	O
6744	be	O
6745	critically	b-PROBLEM
6746	high	i-PROBLEM
6747	-	O
6748	recommended	O
6749	to	O
6750	patient	O
6751	that	O
6752	he	O
6753	stay	b-OCCURRENCE
6754	for	O
6755	repeat	b-TREATMENT
6756	,	O
6757	but	O
6758	left	b-OCCURRENCE
6759	ama	i-OCCURRENCE
6760	without	O
6761	signing	b-OCCURRENCE
6762	any	O
6763	forms	O
6764	.	O
6765	upon	O
6766	transfer	b-OCCURRENCE
6767	to	O
6768	the	b-CLINICAL_DEPT
6769	cmed	i-CLINICAL_DEPT
6770	ccu	i-CLINICAL_DEPT
6771	the	O
6772	patient	O
6773	appears	O
6774	somewhat	b-PROBLEM
6775	uncomfortable	i-PROBLEM
6776	,	O
6777	reporting	b-EVIDENTIAL
6778	nausea	b-PROBLEM
6779	and	O
6780	abdominal	b-PROBLEM
6781	pain	i-PROBLEM
6782	,	O
6783	but	O
6784	when	O
6785	questioned	b-OCCURRENCE
6786	he	O
6787	was	O
6788	unable	b-OCCURRENCE
6789	/	i-OCCURRENCE
6790	unwilling	i-OCCURRENCE
6791	to	i-OCCURRENCE
6792	participate	i-OCCURRENCE
6793	in	O
6794	hpi	b-OCCURRENCE
6795	or	O
6796	exam	b-TEST
6797	d/t	O
6798	sleepiness	b-PROBLEM
6799	.	O
6800	he	O
6801	denied	b-EVIDENTIAL
6802	cp	b-PROBLEM
6803	,	O
6804	sob	b-PROBLEM
6805	,	O
6806	ha	b-PROBLEM
6807	,	O
6808	vision	b-PROBLEM
6809	changes	i-PROBLEM
6810	,	O
6811	neck	b-PROBLEM
6812	stiffness	i-PROBLEM
6813	,	O
6814	dysuria	b-PROBLEM
6815	,	O
6816	or	O
6817	other	b-PROBLEM
6818	symptoms	i-PROBLEM
6819	.	O
6820	in	O
6821	the	b-CLINICAL_DEPT
6822	cmed	i-CLINICAL_DEPT
6823	ccu	i-CLINICAL_DEPT
6824	he	O
6825	became	O
6826	hypotensive	b-PROBLEM
6827	to	O
6828	sbp	b-TEST
6829	80	O
6830	s.	O
6831	labetalol	b-TREATMENT
6832	was	O
6833	stopped	O
6834	and	O
6835	he	O
6836	received	O
6837	a	b-TREATMENT
6838	500	i-TREATMENT
6839	cc	i-TREATMENT
6840	fluid	i-TREATMENT
6841	bolus	i-TREATMENT
6842	and	O
6843	his	b-TEST
6844	blood	i-TEST
6845	pressure	i-TEST
6846	rose	b-OCCURRENCE
6847	to	O
6848	sbp	b-TEST
6849	90	O
6850	s.	O
6851	cardiac	O
6852	and	O
6853	infectious	O
6854	sources	O
6855	of	O
6856	hypotension	b-PROBLEM
6857	were	O
6858	considered	O
6859	,	O
6860	but	O
6861	cardiac	b-TEST
6862	enzymes	i-TEST
6863	were	O
6864	not	O
6865	changed	b-OCCURRENCE
6866	from	O
6867	prior	b-TEST
6868	studies	i-TEST
6869	and	O
6870	he	O
6871	had	O
6872	no	O
6873	localizing	b-PROBLEM
6874	signs	i-PROBLEM
6875	of	i-PROBLEM
6876	infection	i-PROBLEM
6877	;	O
6878	blood	b-TEST
6879	cultures	i-TEST
6880	were	O
6881	sent	O
6882	and	O
6883	a	b-TEST
6884	ultrasound	i-TEST
6885	of	O
6886	the	b-TREATMENT
6887	l	i-TREATMENT
6888	arm	i-TREATMENT
6889	avf	i-TREATMENT
6890	ordered	O
6891	to	O
6892	rule	O
6893	out	O
6894	abscess	b-PROBLEM
6895	at	i-PROBLEM
6896	the	i-PROBLEM
6897	site	i-PROBLEM
6898	.	O
6899	he	O
6900	received	O
6901	a	b-TREATMENT
6902	partial	i-TREATMENT
6903	hd	i-TREATMENT
6904	session	i-TREATMENT
6905	,	O
6906	limited	O
6907	by	O
6908	hypotension	b-PROBLEM
6909	.	O
6910	over	O
6911	night	b-DURATION
6912	,	O
6913	his	b-TEST
6914	blood	i-TEST
6915	pressure	i-TEST
6916	trended	b-OCCURRENCE
6917	up	i-OCCURRENCE
6918	to	O
6919	130	O
6920	s	O
6921	systolic	O
6922	.	O
6923	he	O
6924	was	O
6925	restarted	O
6926	on	O
6927	his	b-TREATMENT
6928	home	i-TREATMENT
6929	blood	i-TREATMENT
6930	pressure	i-TREATMENT
6931	regimen	i-TREATMENT
6932	.	O
6933	renal	b-CLINICAL_DEPT
6934	consult	i-CLINICAL_DEPT
6935	team	i-CLINICAL_DEPT
6936	saw	O
6937	him	O
6938	2019-01-20	b-DATE
6939	and	O
6940	plan	O
6941	to	O
6942	next	O
6943	dialyze	b-TREATMENT
6944	him	O
6945	on	O
6946	2019-01-21	b-DATE
6947	.	O
6948	he	O
6949	was	O
6950	to	O
6951	be	O
6952	called	O
6953	out	O
6954	to	O
6955	the	b-CLINICAL_DEPT
6956	medical	i-CLINICAL_DEPT
6957	floor	i-CLINICAL_DEPT
6958	on	O
6959	2019-01-20	b-DATE
6960	but	O
6961	became	O
6962	somnolent	b-PROBLEM
6963	after	O
6964	receiving	O
6965	pain	b-TREATMENT
6966	and	i-TREATMENT
6967	anti-nausea	i-TREATMENT
6968	meds	i-TREATMENT
6969	,	O
6970	so	O
6971	he	O
6972	stayed	O
6973	in	O
6974	the	b-CLINICAL_DEPT
6975	icu	i-CLINICAL_DEPT
6976	for	O
6977	closer	O
6978	monitoring	b-TEST
6979	of	O
6980	respiratory	b-TEST
6981	status	i-TEST
6982	,	O
6983	which	O
6984	spontaneously	O
6985	improved	b-OCCURRENCE
6986	.	O
6987	his	b-TEST
6988	blood	i-TEST
6989	sugar	i-TEST
6990	at	O
6991	10	b-TIME
6992	pm	i-TIME
6993	was	O
6994	low	b-PROBLEM
6995	at	O
6996	22	O
6997	and	O
6998	he	O
6999	was	O
7000	disoriented	b-PROBLEM
7001	,	O
7002	which	O
7003	resolved	O
7004	with	O
7005	two	b-TREATMENT
7006	glasses	i-TREATMENT
7007	of	i-TREATMENT
7008	juice	i-TREATMENT
7009	;	O
7010	he	O
7011	did	O
7012	not	O
7013	receive	O
7014	his	O
7015	standing	O
7016	dose	O
7017	of	O
7018	nph	b-TREATMENT
7019	that	b-DATE
7020	evening	i-DATE
7021	.	O
7022	blood	b-TEST
7023	cultures	i-TEST
7024	returned	O
7025	positive	O
7026	with	O
7027	gpc	b-PROBLEM
7028	in	i-PROBLEM
7029	pairs	i-PROBLEM
7030	and	i-PROBLEM
7031	clusters	i-PROBLEM
7032	,	O
7033	so	O
7034	a	b-TEST
7035	tte	i-TEST
7036	and	O
7037	surveillance	b-TEST
7038	cultures	i-TEST
7039	were	O
7040	ordered	O
7041	and	O
7042	vancomycin	b-TREATMENT
7043	was	O
7044	started	O
7045	.	O
7046	he	O
7047	was	O
7048	then	O
7049	called	O
7050	out	O
7051	to	O
7052	the	b-CLINICAL_DEPT
7053	medical	i-CLINICAL_DEPT
7054	floor	i-CLINICAL_DEPT
7055	on	O
7056	01-21	b-DATE
7057	.	O
7058	brief	O
7059	hospital	O
7060	course	O
7061	:	O
7062	pt	O
7063	admitted	b-OCCURRENCE
7064	to	O
7065	medical	b-CLINICAL_DEPT
7066	floor	i-CLINICAL_DEPT
7067	in	O
7068	hemodynamically	b-OCCURRENCE
7069	stable	i-OCCURRENCE
7070	condition	i-OCCURRENCE
7071	without	O
7072	specific	b-PROBLEM
7073	complaints	i-PROBLEM
7074	.	O
7075	#	O
7076	hypertensive	b-PROBLEM
7077	urgency	i-PROBLEM
7078	:	O
7079	upon	O
7080	presentation	b-OCCURRENCE
7081	it	O
7082	was	O
7083	unclear	O
7084	when	O
7085	last	O
7086	time	O
7087	was	O
7088	that	O
7089	patient	O
7090	took	O
7091	meds	b-TREATMENT
7092	,	O
7093	but	O
7094	hypertension	b-PROBLEM
7095	likely	O
7096	d/t	O
7097	inability	b-PROBLEM
7098	to	i-PROBLEM
7099	take	i-PROBLEM
7100	meds	i-PROBLEM
7101	in	O
7102	setting	O
7103	of	O
7104	n/v	b-PROBLEM
7105	.	O
7106	also	O
7107	contribution	O
7108	of	O
7109	autonomic	b-PROBLEM
7110	dysfunction	i-PROBLEM
7111	.	O
7112	no	O
7113	evidence	O
7114	of	O
7115	active	b-PROBLEM
7116	end	i-PROBLEM
7117	organ	i-PROBLEM
7118	damage	i-PROBLEM
7119	.	O
7120	pt	O
7121	was	O
7122	treated	O
7123	with	O
7124	labetalol	b-TREATMENT
7125	gtt	i-TREATMENT
7126	in	O
7127	cmed	b-CLINICAL_DEPT
7128	ccu	i-CLINICAL_DEPT
7129	which	O
7130	was	O
7131	weaned	O
7132	off	O
7133	on	O
7134	01-20	b-DATE
7135	.	O
7136	carduac	b-TEST
7137	enzymes	i-TEST
7138	mildly	b-PROBLEM
7139	elevated	i-PROBLEM
7140	,	O
7141	felt	O
7142	02-08	O
7143	demand	b-PROBLEM
7144	ischemia	i-PROBLEM
7145	in	O
7146	setting	O
7147	of	O
7148	hypertensive	b-PROBLEM
7149	urgency	i-PROBLEM
7150	,	O
7151	ck	b-TEST
7152	and	O
7153	mb	b-TEST
7154	trended	O
7155	mcewen	O
7156	at	O
7157	time	O
7158	of	O
7159	admission	b-OCCURRENCE
7160	to	O
7161	medical	b-CLINICAL_DEPT
7162	floor	i-CLINICAL_DEPT
7163	.	O
7164	pt	b-PROBLEM
7165	's	i-PROBLEM
7166	hypertensive	i-PROBLEM
7167	urgency	i-PROBLEM
7168	was	O
7169	resolved	O
7170	upon	O
7171	admission	b-OCCURRENCE
7172	to	O
7173	the	b-CLINICAL_DEPT
7174	medical	i-CLINICAL_DEPT
7175	floor	i-CLINICAL_DEPT
7176	.	O
7177	his	b-TEST
7178	sbp	i-TEST
7179	s	i-TEST
7180	ranged	O
7181	140	O
7182	s-	O
7183	170	O
7184	s	O
7185	.	O
7186	he	O
7187	was	O
7188	restarted	O
7189	on	O
7190	his	O
7191	home	O
7192	regimen	O
7193	of	O
7194	antihypertensives	b-TREATMENT
7195	without	O
7196	difficulty	b-PROBLEM
7197	(	O
7198	metoprolol	b-TREATMENT
7199	75	O
7200	tid	b-FREQUENCY
7201	,	O
7202	clonidine	b-TREATMENT
7203	patch	i-TREATMENT
7204	and	i-TREATMENT
7205	oral	i-TREATMENT
7206	,	O
7207	nifedipine	b-TREATMENT
7208	30	O
7209	sr	O
7210	q	b-FREQUENCY
7211	daily	i-FREQUENCY
7212	).	O
7213	he	O
7214	was	O
7215	discharged	b-OCCURRENCE
7216	home	O
7217	with	O
7218	change	O
7219	in	O
7220	his	O
7221	regimen	O
7222	.	O
7223	#	O
7224	bacteremia	b-PROBLEM
7225	:	O
7226	pt	O
7227	with	O
7228	2/4	O
7229	bottles	O
7230	coag	b-PROBLEM
7231	neg	i-PROBLEM
7232	staph	i-PROBLEM
7233	on	O
7234	01-19	b-DATE
7235	and	O
7236	again	O
7237	on	O
7238	01-20	b-DATE
7239	.	O
7240	port	b-TREATMENT
7241	was	O
7242	felt	O
7243	most	O
7244	likely	O
7245	source	O
7246	,	O
7247	and	O
7248	pt	O
7249	has	O
7250	had	O
7251	at	O
7252	least	O
7253	2	O
7254	sets	O
7255	of	O
7256	+	b-PROBLEM
7257	blood	i-PROBLEM
7258	cultures	i-PROBLEM
7259	since	O
7260	it	O
7261	was	O
7262	placed	O
7263	.	O
7264	tte	b-TEST
7265	was	O
7266	obtained	O
7267	which	O
7268	was	O
7269	not	O
7270	concerning	O
7271	for	O
7272	endocarditis	b-PROBLEM
7273	.	O
7274	pt	O
7275	without	O
7276	stigmata	b-PROBLEM
7277	of	i-PROBLEM
7278	sbe	i-PROBLEM
7279	.	O
7280	id	O
7281	consult	O
7282	obtained	O
7283	which	O
7284	recommended	O
7285	removal	b-TREATMENT
7286	of	i-TREATMENT
7287	port	i-TREATMENT
7288	,	O
7289	which	O
7290	was	O
7291	taken	O
7292	out	O
7293	on	O
7294	01-23	b-DATE
7295	.	O
7296	pt	O
7297	will	O
7298	compelete	O
7299	a	b-DURATION
7300	2	i-DURATION
7301	week	i-DURATION
7302	course	i-DURATION
7303	of	O
7304	vancomycin	b-TREATMENT
7305	at	O
7306	hemodialysis	b-TREATMENT
7307	,	O
7308	which	O
7309	has	O
7310	been	O
7311	arranged	O
7312	by	O
7313	renal	O
7314	service	O
7315	.	O
7316	a	b-TREATMENT
7317	picc	i-TREATMENT
7318	was	O
7319	breifly	O
7320	placed	O
7321	,	O
7322	however	O
7323	removed	O
7324	as	O
7325	it	O
7326	is	O
7327	unclear	O
7328	if	O
7329	pt	O
7330	can	O
7331	reliably	O
7332	flush	O
7333	this	O
7334	.	O
7335	port	b-TREATMENT
7336	will	O
7337	be	O
7338	replaced	O
7339	on	O
7340	2019-02-11	b-DATE
7341	per	O
7342	ir	O
7343	(	O
7344	doctor	O
7345	welsh	O
7346	placed	O
7347	last	O
7348	port	b-TREATMENT
7349	,	O
7350	then	O
7351	removed	O
7352	it	O
7353	on	O
7354	01-23	b-DATE
7355	),	O
7356	ordered	O
7357	placed	O
7358	in	O
7359	omr	O
7360	.	O
7361	indication	O
7362	:	O
7363	diabetic	b-PROBLEM
7364	gastropathy	i-PROBLEM
7365	causing	O
7366	inability	b-PROBLEM
7367	to	i-PROBLEM
7368	toleral	i-PROBLEM
7369	oral	i-PROBLEM
7370	antihypertensive	i-PROBLEM
7371	medication	i-PROBLEM
7372	prompting	O
7373	repeated	b-OCCURRENCE
7374	donald	i-OCCURRENCE
7375	presentation	i-OCCURRENCE
7376	for	O
7377	hypertensive	b-PROBLEM
7378	urgency	i-PROBLEM
7379	.	O
7380	pt	O
7381	with	O
7382	surveillance	b-TEST
7383	cultures	i-TEST
7384	and	O
7385	port	b-TEST
7386	tip	i-TEST
7387	cultures	i-TEST
7388	showing	b-EVIDENTIAL
7389	ngtd	O
7390	on	O
7391	01-24	b-DATE
7392	,	O
7393	he	O
7394	will	O
7395	have	O
7396	futher	b-TEST
7397	surveillance	i-TEST
7398	cultures	i-TEST
7399	drawn	O
7400	at	O
7401	hemodialysis	b-CLINICAL_DEPT
7402	and	O
7403	followed	O
7404	by	O
7405	his	O
7406	nephrologist	O
7407	.	O
7408	#	O
7409	n/v/	b-PROBLEM
7410	abdominal	b-PROBLEM
7411	pain	i-PROBLEM
7412	:	O
7413	pt	O
7414	with	O
7415	multiple	O
7416	admissions	b-OCCURRENCE
7417	with	O
7418	similar	b-PROBLEM
7419	complaints	i-PROBLEM
7420	,	O
7421	etiology	O
7422	02-08	O
7423	gastroparesis	b-PROBLEM
7424	,	O
7425	improves	O
7426	considerably	O
7427	with	O
7428	ativan	b-TREATMENT
7429	,	O
7430	dilaudid	b-TREATMENT
7431	,	O
7432	reglan	b-TREATMENT
7433	,	O
7434	pt	O
7435	was	O
7436	tolerating	b-OCCURRENCE
7437	po	b-TREATMENT
7438	meds	i-TREATMENT
7439	/	O
7440	diet	b-TREATMENT
7441	at	O
7442	time	O
7443	of	O
7444	admission	b-OCCURRENCE
7445	to	O
7446	medical	b-CLINICAL_DEPT
7447	service	i-CLINICAL_DEPT
7448	and	O
7449	was	O
7450	restarted	O
7451	on	O
7452	oral	b-TREATMENT
7453	reglan	i-TREATMENT
7454	.	O
7455	#	O
7456	dmi	b-PROBLEM
7457	:	O
7458	pt	O
7459	on	O
7460	sliding	b-TREATMENT
7461	scale	i-TREATMENT
7462	as	O
7463	inpatient	O
7464	and	O
7465	taking	O
7466	nph	b-TREATMENT
7467	2	O
7468	units	O
7469	bid	b-FREQUENCY
7470	at	O
7471	home	O
7472	.	O
7473	pt	O
7474	with	O
7475	two	O
7476	episodes	O
7477	of	O
7478	hypoglycemia	b-PROBLEM
7479	(	O
7480	fsbs	b-TEST
7481	22	O
7482	and	O
7483	27	O
7484	),	O
7485	etiology	O
7486	unclear	O
7487	,	O
7488	pt	O
7489	followed	O
7490	by	O
7491	strickland	O
7492	,	O
7493	who	O
7494	recommend	O
7495	no	O
7496	changes	O
7497	to	O
7498	current	b-TREATMENT
7499	insulin	i-TREATMENT
7500	regimen	i-TREATMENT
7501	.	O
7502	will	O
7503	discharge	b-OCCURRENCE
7504	pt	O
7505	with	O
7506	instructions	O
7507	to	O
7508	continue	O
7509	nph	b-TREATMENT
7510	2	O
7511	units	O
7512	bid	b-FREQUENCY
7513	as	O
7514	frederick	O
7515	tracey	O
7516	recs	O
7517	.	O
7518	#	O
7519	cad	b-PROBLEM
7520	-	O
7521	pt	O
7522	denied	b-EVIDENTIAL
7523	cp	b-PROBLEM
7524	/	O
7525	sob	b-PROBLEM
7526	throughout	O
7527	hospitalization	b-OCCURRENCE
7528	.	O
7529	troponins	b-TEST
7530	rose	b-OCCURRENCE
7531	at	O
7532	admission	b-OCCURRENCE
7533	,	O
7534	however	O
7535	ck	b-TEST
7536	and	O
7537	mb	b-TEST
7538	trending	O
7539	mcewen	O
7540	wat	O
7541	time	O
7542	of	O
7543	admission	b-OCCURRENCE
7544	to	O
7545	medical	b-CLINICAL_DEPT
7546	service	i-CLINICAL_DEPT
7547	.	O
7548	etiology	O
7549	felt	O
7550	most	O
7551	likely	O
7552	demand	b-PROBLEM
7553	ischemia	i-PROBLEM
7554	in	O
7555	setting	O
7556	of	O
7557	original	b-PROBLEM
7558	hypertensive	i-PROBLEM
7559	urgency	i-PROBLEM
7560	with	O
7561	persistent	b-PROBLEM
7562	elevation	i-PROBLEM
7563	of	i-PROBLEM
7564	trop	i-PROBLEM
7565	02-08	O
7566	esrd	b-PROBLEM
7567	.	O
7568	pt	O
7569	was	O
7570	continued	O
7571	on	O
7572	aspirin	b-TREATMENT
7573	,	O
7574	metoprolol	b-TREATMENT
7575	,	O
7576	nifedipine	b-TREATMENT
7577	.	O
7578	#	O
7579	esrd	b-PROBLEM
7580	:	O
7581	etiology	O
7582	likely	O
7583	02-08	O
7584	dm	b-PROBLEM
7585	and	O
7586	htn	b-PROBLEM
7587	,	O
7588	pt	O
7589	tolerating	b-OCCURRENCE
7590	hd	b-TREATMENT
7591	well	b-OCCURRENCE
7592	,	O
7593	and	O
7594	underwent	O
7595	dialysis	b-TREATMENT
7596	without	O
7597	difficulty	b-PROBLEM
7598	on	O
7599	01-24	b-DATE
7600	.	O
7601	pt	O
7602	will	O
7603	be	O
7604	discharged	b-OCCURRENCE
7605	home	O
7606	with	O
7607	plan	O
7608	to	O
7609	continue	O
7610	current	b-TREATMENT
7611	dialysis	i-TREATMENT
7612	schedule	i-TREATMENT
7613	(	O
7614	tue	b-FREQUENCY
7615	/	i-FREQUENCY
7616	th	i-FREQUENCY
7617	/	i-FREQUENCY
7618	sat	i-FREQUENCY
7619	).	O
7620	in	O
7621	addition	O
7622	pt	O
7623	will	O
7624	be	O
7625	given	O
7626	vancomycin	b-TREATMENT
7627	at	O
7628	dialysis	b-CLINICAL_DEPT
7629	x	O
7630	2	b-DURATION
7631	week	i-DURATION
7632	course	i-DURATION
7633	(	O
7634	last	O
7635	day	O
7636	2019-02-05	b-DATE
7637	)	O
7638	given	O
7639	his	b-PROBLEM
7640	port	i-PROBLEM
7641	line	i-PROBLEM
7642	infection	i-PROBLEM
7643	.	O
7644	he	O
7645	will	O
7646	have	O
7647	levels	b-TEST
7648	drawn	O
7649	at	O
7650	dialysis	b-CLINICAL_DEPT
7651	and	O
7652	be	O
7653	dosed	O
7654	with	O
7655	vancomycin	b-TREATMENT
7656	as	O
7657	appropriate	O
7658	.	O
7659	plan	O
7660	is	O
7661	for	O
7662	surveillance	b-TEST
7663	cultures	i-TEST
7664	to	O
7665	be	O
7666	drawn	O
7667	at	O
7668	dialysis	b-CLINICAL_DEPT
7669	.	O
7670	if	O
7671	negative	O
7672	,	O
7673	pt	O
7674	is	O
7675	scheduled	O
7676	for	O
7677	presumptively	b-TREATMENT
7678	replacement	i-TREATMENT
7679	of	i-TREATMENT
7680	port	i-TREATMENT
7681	on	O
7682	2019-02-11	b-DATE
7683	with	O
7684	interventional	b-CLINICAL_DEPT
7685	radiology	i-CLINICAL_DEPT
7686	(	O
7687	doctor	O
7688	arevalo	O
7689	).	O
7690	pt	O
7691	continued	O
7692	on	O
7693	home	O
7694	regimen	O
7695	of	O
7696	calcium	b-TREATMENT
7697	acetate	i-TREATMENT
7698	667	O
7699	mg	O
7700	,	O
7701	3	O
7702	capsules	O
7703	tid	b-FREQUENCY
7704	.	O
7705	#	O
7706	av	b-TREATMENT
7707	fistula	i-TREATMENT
7708	:	O
7709	pt	O
7710	with	O
7711	h/o	O
7712	numerous	b-PROBLEM
7713	clots	i-PROBLEM
7714	in	O
7715	av	b-TREATMENT
7716	fistula	i-TREATMENT
7717	.	O
7718	no	O
7719	signs	O
7720	of	O
7721	infection	b-PROBLEM
7722	presently	O
7723	,	O
7724	and	O
7725	tolerating	b-OCCURRENCE
7726	dialysis	b-TREATMENT
7727	without	O
7728	difficulty	b-PROBLEM
7729	.	O
7730	pt	O
7731	was	O
7732	subtherapeuticon	b-PROBLEM
7733	inr	i-PROBLEM
7734	on	O
7735	admission	b-OCCURRENCE
7736	,	O
7737	thus	O
7738	treated	O
7739	with	O
7740	heparin	b-TREATMENT
7741	gtt	i-TREATMENT
7742	.	O
7743	coumadin	b-TREATMENT
7744	held	O
7745	on	O
7746	01-22	b-DATE
7747	for	O
7748	port	b-TREATMENT
7749	removal	i-TREATMENT
7750	,	O
7751	and	O
7752	restarted	O
7753	on	O
7754	01-24	b-DATE
7755	.	O
7756	pt	O
7757	discharged	b-OCCURRENCE
7758	with	O
7759	instructions	O
7760	to	O
7761	continue	O
7762	coumadin	b-TREATMENT
7763	1.5	O
7764	mg	O
7765	po	O
7766	q	b-FREQUENCY
7767	daily	i-FREQUENCY
7768	with	O
7769	goal	b-TEST
7770	inr	i-TEST
7771	02-09	O
7772	.	O
7773	#	O
7774	dispo	O
7775	:	O
7776	pt	O
7777	discharged	b-OCCURRENCE
7778	home	O
7779	on	O
7780	01-24	b-DATE
7781	with	O
7782	instructions	O
7783	to	O
7784	complete	O
7785	2	b-DURATION
7786	week	i-DURATION
7787	course	i-DURATION
7788	of	O
7789	vancomycin	b-TREATMENT
7790	at	O
7791	hemodialysis	b-CLINICAL_DEPT
7792	for	O
7793	his	b-PROBLEM
7794	port	i-PROBLEM
7795	line	i-PROBLEM
7796	infection	i-PROBLEM
7797	.	O
7798	an	O
7799	appointment	O
7800	was	O
7801	made	O
7802	with	O
7803	interventional	b-CLINICAL_DEPT
7804	radiology	i-CLINICAL_DEPT
7805	on	O
7806	2019-02-11	b-DATE
7807	to	O
7808	replace	O
7809	his	b-TREATMENT
7810	port	i-TREATMENT
7811	,	O
7812	under	O
7813	the	O
7814	assumption	O
7815	that	O
7816	his	b-TEST
7817	surveillance	i-TEST
7818	cultures	i-TEST
7819	from	O
7820	dialysis	b-TREATMENT
7821	remain	O
7822	negative	b-OCCURRENCE
7823	.	O
7824	discussed	O
7825	this	O
7826	plan	O
7827	with	O
7828	renal	O
7829	service	O
7830	(	O
7831	anthony	O
7832	mcknight	O
7833	)	O
7834	who	O
7835	will	O
7836	communicate	O
7837	with	O
7838	pt	O
7839	's	O
7840	outpatient	O
7841	dialysis	O
7842	service	O
7843	.	O
7844		O
7845	admission	b-OCCURRENCE
7846	date	O
7847	:	O
7848	5-30-93	b-DATE
7849	discharge	b-OCCURRENCE
7850	date	O
7851	:	O
7852	6-2-93	b-DATE
7853	discharge	O
7854	date	O
7855	:	O
7856	6-2-93	b-DATE
7857	history	O
7858	of	O
7859	present	O
7860	illness	O
7861	:	O
7862	the	O
7863	patient	O
7864	is	O
7865	a	O
7866	63	O
7867	year	O
7868	old	O
7869	woman	O
7870	with	O
7871	a	O
7872	history	O
7873	of	O
7874	mixed	b-PROBLEM
7875	adenocarcinoma	i-PROBLEM
7876	and	O
7877	large	b-PROBLEM
7878	cell	i-PROBLEM
7879	carcinoma	i-PROBLEM
7880	of	i-PROBLEM
7881	the	i-PROBLEM
7882	left	i-PROBLEM
7883	upper	i-PROBLEM
7884	lobe	i-PROBLEM
7885	of	O
7886	the	O
7887	lung	O
7888	who	O
7889	is	O
7890	being	O
7891	admitted	b-OCCURRENCE
7892	for	O
7893	neoadjuvant	b-TREATMENT
7894	chemotherapy	i-TREATMENT
7895	with	O
7896	cisplatinum	b-TREATMENT
7897	,	O
7898	5-fu	b-TREATMENT
7899	and	O
7900	velban	b-TREATMENT
7901	.	O
7902	her	O
7903	history	O
7904	has	O
7905	been	O
7906	well	O
7907	documented	O
7908	in	O
7909	her	O
7910	previous	O
7911	notes	O
7912	.	O
7913	briefly	O
7914	,	O
7915	she	O
7916	was	O
7917	originally	O
7918	diagnosed	b-OCCURRENCE
7919	in	O
7920	april	b-DATE
7921	1993	i-DATE
7922	with	O
7923	lung	b-PROBLEM
7924	carcinoma	i-PROBLEM
7925	.	O
7926	bronchoscopy	b-TEST
7927	and	O
7928	mediastinoscopy	b-TEST
7929	revealed	b-EVIDENTIAL
7930	an	b-PROBLEM
7931	unresectable	i-PROBLEM
7932	mediastinal	i-PROBLEM
7933	tumor	i-PROBLEM
7934	with	O
7935	the	O
7936	left	O
7937	tracheobronchial	O
7938	angle	O
7939	node	O
7940	positive	O
7941	for	O
7942	cancer	b-PROBLEM
7943	,	O
7944	and	O
7945	the	O
7946	right	O
7947	paratracheal	O
7948	node	O
7949	positive	O
7950	for	O
7951	anthracosis	b-PROBLEM
7952	.	O
7953	formal	b-TEST
7954	pathology	i-TEST
7955	revealed	b-EVIDENTIAL
7956	a	b-PROBLEM
7957	poorly	i-PROBLEM
7958	differentiated	i-PROBLEM
7959	adenocarcinoma	i-PROBLEM
7960	with	O
7961	focal	b-PROBLEM
7962	giant	i-PROBLEM
7963	cells	i-PROBLEM
7964	.	O
7965	bone	b-TEST
7966	scan	i-TEST
7967	,	O
7968	head	b-TEST
7969	ct	i-TEST
7970	and	O
7971	other	O
7972	staging	b-TEST
7973	studies	i-TEST
7974	were	O
7975	all	O
7976	negative	O
7977	for	O
7978	evidence	O
7979	of	O
7980	metastatic	b-PROBLEM
7981	disease	i-PROBLEM
7982	.	O
7983	the	O
7984	patient	O
7985	is	O
7986	being	O
7987	treated	O
7988	with	O
7989	preoperative	b-TREATMENT
7990	neoadjuvant	i-TREATMENT
7991	chemotherapy	i-TREATMENT
7992	using	O
7993	5	b-TREATMENT
7994	fu	i-TREATMENT
7995	,	O
7996	vinblastine	b-TREATMENT
7997	,	O
7998	cisplatinum	b-TREATMENT
7999	and	O
8000	concomitant	b-TREATMENT
8001	radiation	i-TREATMENT
8002	therapy	i-TREATMENT
8003	.	O
8004	she	O
8005	is	O
8006	now	O
8007	admitted	b-OCCURRENCE
8008	for	O
8009	her	b-TREATMENT
8010	second	i-TREATMENT
8011	course	i-TREATMENT
8012	of	i-TREATMENT
8013	that	i-TREATMENT
8014	therapy	i-TREATMENT
8015	.	O
8016	hospital	O
8017	course	O
8018	:	O
8019	the	O
8020	patient	O
8021	was	O
8022	admitted	b-OCCURRENCE
8023	to	O
8024	the	b-CLINICAL_DEPT
8025	oncology	i-CLINICAL_DEPT
8026	service	i-CLINICAL_DEPT
8027	on	O
8028	founder	O
8029	&apos;s	O
8030	7	O
8031	and	O
8032	received	O
8033	intravenous	b-TREATMENT
8034	chemotherapy	i-TREATMENT
8035	with	O
8036	a	b-DURATION
8037	72	i-DURATION
8038	hour	i-DURATION
8039	continuous	O
8040	infusion	b-TREATMENT
8041	of	i-TREATMENT
8042	5-fu	i-TREATMENT
8043	,	i-TREATMENT
8044	vinblastine	b-TREATMENT
8045	on	O
8046	day	b-DATE
8047	1	i-DATE
8048	and	O
8049	day	b-DATE
8050	3	i-DATE
8051	,	O
8052	and	O
8053	cisplatinum	b-TREATMENT
8054	on	O
8055	day	b-DATE
8056	1	i-DATE
8057	.	O
8058	she	O
8059	tolerated	b-OCCURRENCE
8060	the	b-TREATMENT
8061	chemotherapy	i-TREATMENT
8062	well	b-OCCURRENCE
8063	with	O
8064	mild	O
8065	nausea	b-PROBLEM
8066	and	O
8067	vomiting	b-PROBLEM
8068	.	O
8069	she	O
8070	had	O
8071	mild	b-PROBLEM
8072	increase	b-PROBLEM
8073	in	O
8074	her	b-PROBLEM
8075	hypertension	i-PROBLEM
8076	during	O
8077	the	b-OCCURRENCE
8078	hospitalization	i-OCCURRENCE
8079	,	O
8080	likely	O
8081	secondary	O
8082	to	O
8083	fluid	b-PROBLEM
8084	overload	i-PROBLEM
8085	.	O
8086	she	O
8087	also	O
8088	had	O
8089	some	O
8090	modest	b-PROBLEM
8091	anemia	i-PROBLEM
8092	,	O
8093	at	O
8094	the	b-DATE
8095	time	i-DATE
8096	of	O
8097	discharge	b-OCCURRENCE
8098	her	b-TEST
8099	hematocrit	i-TEST
8100	was	O
8101	30.9	O
8102	.	O
8103	overall	O
8104	there	O
8105	were	O
8106	no	O
8107	unanticipated	b-PROBLEM
8108	side	i-PROBLEM
8109	effects	i-PROBLEM
8110	of	O
8111	this	b-TREATMENT
8112	chemotherapy	i-TREATMENT
8113	.	O
8114	following	O
8115	her	b-OCCURRENCE
8116	recovery	i-OCCURRENCE
8117	from	O
8118	chemotherapy	b-TREATMENT
8119	,	O
8120	she	O
8121	will	O
8122	proceed	O
8123	to	O
8124	surgical	b-TREATMENT
8125	resection	i-TREATMENT
8126	.	O
8127		O
8128	admission	b-OCCURRENCE
8129	date	O
8130	:	O
8131	02/21/1991	b-ADMISSION
8132	discharge	b-OCCURRENCE
8133	date	O
8134	:	O
8135	02/26/1991	b-DISCHARGE
8136	history	O
8137	of	O
8138	present	O
8139	illness	O
8140	:	O
8141	the	O
8142	patient	O
8143	was	O
8144	a	O
8145	63	O
8146	year	O
8147	old	O
8148	female	O
8149	with	O
8150	long-standing	O
8151	history	O
8152	of	O
8153	polycythemia	b-PROBLEM
8154	vera	i-PROBLEM
8155	,	O
8156	managed	O
8157	medically	O
8158	,	O
8159	who	O
8160	on	O
8161	a	b-TEST
8162	routine	i-TEST
8163	follow-up	i-TEST
8164	examination	i-TEST
8165	complained	b-EVIDENTIAL
8166	of	O
8167	left	b-PROBLEM
8168	side	i-PROBLEM
8169	pain	i-PROBLEM
8170	and	O
8171	had	O
8172	an	b-TEST
8173	ultrasound	i-TEST
8174	that	O
8175	demonstrated	b-EVIDENTIAL
8176	a	b-PROBLEM
8177	complex	i-PROBLEM
8178	left	i-PROBLEM
8179	renal	i-PROBLEM
8180	mass	i-PROBLEM
8181	.	O
8182	a	b-TEST
8183	computerized	i-TEST
8184	tomography	i-TEST
8185	scan	i-TEST
8186	demonstrated	b-EVIDENTIAL
8187	a	b-TEST
8188	contrast	i-TEST
8189	enhancing	i-TEST
8190	complex	b-PROBLEM
8191	left	i-PROBLEM
8192	renal	i-PROBLEM
8193	mass	i-PROBLEM
8194	.	O
8195	metastatic	b-TEST
8196	work-up	i-TEST
8197	was	O
8198	negative	O
8199	.	O
8200	the	O
8201	patient	O
8202	presented	b-EVIDENTIAL
8203	for	O
8204	nephrectomy	b-TREATMENT
8205	.	O
8206	hospital	O
8207	course	O
8208	:	O
8209	the	O
8210	patient	O
8211	was	O
8212	taken	O
8213	to	O
8214	the	b-CLINICAL_DEPT
8215	operating	i-CLINICAL_DEPT
8216	room	i-CLINICAL_DEPT
8217	by	O
8218	doctor	O
8219	suot	O
8220	n.	O
8221	dragtente	O
8222	on	O
8223	02-21-91	b-DATE
8224	,	O
8225	where	O
8226	a	b-TREATMENT
8227	left	i-TREATMENT
8228	radical	i-TREATMENT
8229	nephrectomy	i-TREATMENT
8230	was	O
8231	performed	O
8232	.	O
8233	at	O
8234	operation	b-TREATMENT
8235	,	O
8236	there	O
8237	was	O
8238	no	O
8239	gross	b-PROBLEM
8240	adenopathy	i-PROBLEM
8241	or	O
8242	renal	b-PROBLEM
8243	vein	i-PROBLEM
8244	involvement	i-PROBLEM
8245	,	O
8246	and	O
8247	it	O
8248	was	O
8249	felt	O
8250	that	O
8251	the	b-PROBLEM
8252	tumor	i-PROBLEM
8253	was	O
8254	completely	O
8255	excised	b-TREATMENT
8256	.	O
8257	the	O
8258	patient	O
8259	thereafter	O
8260	had	O
8261	a	b-OCCURRENCE
8262	benign	i-OCCURRENCE
8263	convalescence	i-OCCURRENCE
8264	,	O
8265	and	O
8266	was	O
8267	discharged	b-OCCURRENCE
8268	on	O
8269	the	b-DATE
8270	5th	i-DATE
8271	postoperative	i-DATE
8272	day	i-DATE
8273	.	O
8274	the	b-OCCURRENCE
8275	oncology	i-OCCURRENCE
8276	fellows	i-OCCURRENCE
8277	from	O
8278	venbonlea	b-CLINICAL_DEPT
8279	health	i-CLINICAL_DEPT
8280	followed	b-OCCURRENCE
8281	her	b-OCCURRENCE
8282	course	i-OCCURRENCE
8283	and	O
8284	recommended	O
8285	holding	b-OCCURRENCE
8286	off	O
8287	on	O
8288	her	b-TREATMENT
8289	hydrea	i-TREATMENT
8290	while	O
8291	she	O
8292	is	O
8293	hospitalized	b-OCCURRENCE
8294	,	O
8295	and	O
8296	they	O
8297	will	O
8298	follow	b-OCCURRENCE
8299	her	O
8300	as	O
8301	an	b-OCCURRENCE
8302	outpatient	i-OCCURRENCE
8303	and	O
8304	restart	O
8305	her	b-TREATMENT
8306	hydrea	i-TREATMENT
8307	when	O
8308	her	b-OCCURRENCE
8309	hematocrit	i-OCCURRENCE
8310	is	i-OCCURRENCE
8311	over	i-OCCURRENCE
8312	40%	i-OCCURRENCE
8313	.	O
8314		O
8315	admission	b-OCCURRENCE
8316	date	O
8317	:	O
8318	2015-09-14	b-ADMISSION
8319	discharge	b-OCCURRENCE
8320	date	O
8321	:	O
8322	2015-09-19	b-DISCHARGE
8323	service	O
8324	:	O
8325	neonatology	O
8326	history	O
8327	of	O
8328	present	O
8329	illness	O
8330	:	O
8331	the	O
8332	patient	O
8333	is	O
8334	a	O
8335	3285	O
8336	gm	O
8337	infant	O
8338	born	b-OCCURRENCE
8339	at	O
8340	37	b-DURATION
8341	5/7	i-DURATION
8342	weeks	i-DURATION
8343	to	O
8344	a	O
8345	21	O
8346	year	O
8347	old	O
8348	g3	O
8349	p1	O
8350	now	O
8351	2	O
8352	mother	O
8353	with	O
8354	prenatal	b-TEST
8355	screens	i-TEST
8356	as	O
8357	follows	O
8358	:	O
8359	o	b-OCCURRENCE
8360	positive	i-OCCURRENCE
8361	,	O
8362	antibody	b-TEST
8363	negative	O
8364	,	O
8365	hepatitis	b-TEST
8366	b	i-TEST
8367	surface	i-TEST
8368	antigen	i-TEST
8369	negative	O
8370	,	O
8371	rpr	b-TEST
8372	nonreactive	O
8373	,	O
8374	gbs	b-TEST
8375	negative	O
8376	.	O
8377	unremarkable	O
8378	pregnancy	O
8379	except	O
8380	for	O
8381	minor	b-PROBLEM
8382	fullness	i-PROBLEM
8383	of	i-PROBLEM
8384	the	i-PROBLEM
8385	left	i-PROBLEM
8386	renal	i-PROBLEM
8387	pelvis	i-PROBLEM
8388	reported	b-EVIDENTIAL
8389	during	O
8390	the	b-DURATION
8391	week	i-DURATION
8392	prior	O
8393	to	O
8394	delivery	b-TREATMENT
8395	.	O
8396	past	O
8397	ob	O
8398	history	O
8399	remarkable	O
8400	for	O
8401	postpartum	b-PROBLEM
8402	depression	i-PROBLEM
8403	.	O
8404	mother	O
8405	was	O
8406	admitted	b-OCCURRENCE
8407	in	O
8408	labor	b-PROBLEM
8409	.	O
8410	baby	O
8411	was	O
8412	delivered	b-TREATMENT
8413	by	O
8414	repeat	b-TREATMENT
8415	c-section	i-TREATMENT
8416	with	O
8417	rupture	b-TREATMENT
8418	of	i-TREATMENT
8419	membranes	i-TREATMENT
8420	at	O
8421	delivery	b-TREATMENT
8422	.	O
8423	apgars	b-TEST
8424	were	O
8425	8	O
8426	and	O
8427	9	O
8428	.	O
8429	cmed	b-CLINICAL_DEPT
8430	csru	i-CLINICAL_DEPT
8431	staff	O
8432	was	O
8433	called	O
8434	about	O
8435	30	b-DURATION
8436	minutes	i-DURATION
8437	of	O
8438	age	O
8439	for	O
8440	grunting	b-PROBLEM
8441	,	O
8442	flaring	b-PROBLEM
8443	and	O
8444	retractions	b-PROBLEM
8445	and	O
8446	the	O
8447	baby	O
8448	was	O
8449	admitted	b-OCCURRENCE
8450	to	O
8451	the	b-CLINICAL_DEPT
8452	cmed	i-CLINICAL_DEPT
8453	csru	i-CLINICAL_DEPT
8454	.	O
8455	hospital	O
8456	course:	O
8457	1.	O
8458	respiratory	O
8459	.	O
8460	the	b-CLINICAL_DEPT
8461	athol	i-CLINICAL_DEPT
8462	memorial	i-CLINICAL_DEPT
8463	hospital	i-CLINICAL_DEPT
8464	hospital	b-OCCURRENCE
8465	course	i-OCCURRENCE
8466	was	O
8467	initially	O
8468	consistent	O
8469	with	O
8470	transient	b-PROBLEM
8471	tachypnea	i-PROBLEM
8472	of	i-PROBLEM
8473	the	i-PROBLEM
8474	newborn	i-PROBLEM
8475	.	O
8476	chest	b-TEST
8477	x-ray	i-TEST
8478	revealed	b-EVIDENTIAL
8479	mild	b-PROBLEM
8480	streakiness	i-PROBLEM
8481	of	i-PROBLEM
8482	the	i-PROBLEM
8483	lung	i-PROBLEM
8484	fields	i-PROBLEM
8485	.	O
8486	he	O
8487	was	O
8488	initially	O
8489	placed	O
8490	on	O
8491	nasal	b-TREATMENT
8492	cannula	i-TREATMENT
8493	with	O
8494	subsequent	O
8495	resolution	b-OCCURRENCE
8496	of	O
8497	respiratory	b-PROBLEM
8498	distress	i-PROBLEM
8499	.	O
8500	nasal	b-TREATMENT
8501	cannula	i-TREATMENT
8502	was	O
8503	weaned	b-OCCURRENCE
8504	off	i-OCCURRENCE
8505	on	O
8506	day	b-DATE
8507	of	i-DATE
8508	life	i-DATE
8509	3	i-DATE
8510	and	O
8511	he	O
8512	initially	O
8513	was	O
8514	maintaining	O
8515	o2	b-TEST
8516	sat	i-TEST
8517	above	O
8518	94%	O
8519	and	O
8520	breathing	b-OCCURRENCE
8521	comfortably	i-OCCURRENCE
8522	.	O
8523	he	O
8524	was	O
8525	subsequently	O
8526	placed	O
8527	back	O
8528	on	O
8529	nasal	b-TREATMENT
8530	cannula	i-TREATMENT
8531	for	O
8532	mild	b-PROBLEM
8533	oxygen	i-PROBLEM
8534	desaturation	i-PROBLEM
8535	and	O
8536	was	O
8537	requiring	O
8538	25	O
8539	c/min	O
8540	flow	O
8541	at	O
8542	the	O
8543	time	O
8544	of	O
8545	discharge	b-OCCURRENCE
8546	.	O
8547	no	O
8548	apneic	b-PROBLEM
8549	or	i-PROBLEM
8550	brady	i-PROBLEM
8551	episodes	i-PROBLEM
8552	.	O
8553	2.	O
8554	cardiovascular	O
8555	.	O
8556	the	O
8557	patient	O
8558	's	O
8559	cardiovascular	O
8560	status	O
8561	has	O
8562	been	O
8563	stable	b-OCCURRENCE
8564	throughout	O
8565	his	b-OCCURRENCE
8566	cmed	i-OCCURRENCE
8567	csru	i-OCCURRENCE
8568	stay	i-OCCURRENCE
8569	.	O
8570	no	O
8571	murmur	b-PROBLEM
8572	on	O
8573	exam	b-TEST
8574	.	O
8575	3.	O
8576	fen	O
8577	.	O
8578	the	O
8579	patient	O
8580	had	O
8581	been	O
8582	tolerating	b-OCCURRENCE
8583	oral	i-OCCURRENCE
8584	feeding	i-OCCURRENCE
8585	as	O
8586	of	O
8587	day	b-DATE
8588	of	i-DATE
8589	life	i-DATE
8590	2	i-DATE
8591	and	O
8592	is	O
8593	currently	O
8594	taking	O
8595	enfamil	b-TREATMENT
8596	20	O
8597	p.o.	O
8598	ad	O
8599	lib	O
8600	.	O
8601	he	O
8602	has	O
8603	been	O
8604	weaned	b-OCCURRENCE
8605	off	i-OCCURRENCE
8606	iv	b-TREATMENT
8607	fluids	i-TREATMENT
8608	and	O
8609	has	O
8610	been	O
8611	maintaining	O
8612	good	b-TEST
8613	blood	i-TEST
8614	glucose	i-TEST
8615	.	O
8616	his	b-TEST
8617	birth	i-TEST
8618	weight	i-TEST
8619	was	O
8620	3285	O
8621	gm	O
8622	.	O
8623	his	b-TEST
8624	weight	i-TEST
8625	is	O
8626	3015	O
8627	gm	O
8628	on	O
8629	day	b-DATE
8630	of	i-DATE
8631	life	i-DATE
8632	5	i-DATE
8633	.	O
8634	4.	O
8635	gi	O
8636	.	O
8637	the	b-TEST
8638	patient	i-TEST
8639	's	i-TEST
8640	bilirubin	i-TEST
8641	level	i-TEST
8642	at	O
8643	24	b-DATE
8644	hours	i-DATE
8645	of	O
8646	life	O
8647	was	O
8648	4.6.	O
8649	no	O
8650	phototherapy	b-TREATMENT
8651	was	O
8652	started	O
8653	.	O
8654	5.	O
8655	id	O
8656	.	O
8657	the	O
8658	patient	O
8659	was	O
8660	not	O
8661	started	O
8662	on	O
8663	antibiotics	b-TREATMENT
8664	,	O
8665	given	O
8666	lack	O
8667	of	O
8668	sepsis	b-PROBLEM
8669	risk	i-PROBLEM
8670	factors	i-PROBLEM
8671	.	O
8672	his	b-TEST
8673	initial	i-TEST
8674	cbc	i-TEST
8675	showed	b-EVIDENTIAL
8676	no	O
8677	left	b-PROBLEM
8678	shift	i-PROBLEM
8679	.	O
8680	blood	b-TEST
8681	culture	i-TEST
8682	had	O
8683	remained	O
8684	no	O
8685	growth	b-PROBLEM
8686	to	O
8687	date	O
8688	.	O
8689	6.	O
8690	heme	O
8691	.	O
8692	the	b-TEST
8693	patient	i-TEST
8694	's	i-TEST
8695	initial	i-TEST
8696	hematocrit	i-TEST
8697	was	O
8698	35.8	O
8699	.	O
8700	no	O
8701	transfusion	b-TREATMENT
8702	during	O
8703	this	b-TREATMENT
8704	admission	i-TREATMENT
8705	.	O
8706	condition	O
8707	on	O
8708	transfer	b-OCCURRENCE
8709	:	O
8710	the	O
8711	patient	O
8712	has	O
8713	been	O
8714	doing	O
8715	well	b-OCCURRENCE
8716	on	O
8717	low	b-TREATMENT
8718	flow	i-TREATMENT
8719	nasal	i-TREATMENT
8720	cannula.	i-TREATMENT
8721	he	O
8722	has	O
8723	been	O
8724	tolerating	O
8725	p.o.	b-OCCURRENCE
8726	ad	i-OCCURRENCE
8727	lib	i-OCCURRENCE
8728	feeds	i-OCCURRENCE
8729	.	O
8730		O
8731	admission	b-OCCURRENCE
8732	date	O
8733	:	O
8734	2010-05-17	b-ADMISSION
8735	discharge	b-OCCURRENCE
8736	date	O
8737	:	O
8738	2010-05-29	b-DISCHARGE
8739	service	O
8740	:	O
8741	history	O
8742	of	O
8743	present	O
8744	illness	O
8745	:	O
8746	history	O
8747	of	O
8748	present	O
8749	illness	O
8750	:	O
8751	this	O
8752	is	O
8753	an	O
8754	86-year-old	O
8755	female	O
8756	with	O
8757	a	O
8758	past	O
8759	medical	O
8760	history	O
8761	of	O
8762	diabetes	b-PROBLEM
8763	and	O
8764	hypertension	b-PROBLEM
8765	who	O
8766	presented	b-OCCURRENCE
8767	to	O
8768	the	b-CLINICAL_DEPT
8769	emergency	i-CLINICAL_DEPT
8770	department	i-CLINICAL_DEPT
8771	with	O
8772	a	b-DURATION
8773	two	i-DURATION
8774	day	i-DURATION
8775	history	O
8776	of	O
8777	shortness	b-PROBLEM
8778	of	i-PROBLEM
8779	breath	i-PROBLEM
8780	and	O
8781	easy	b-PROBLEM
8782	fatigability	i-PROBLEM
8783	.	O
8784	she	O
8785	also	O
8786	noted	b-EVIDENTIAL
8787	increased	b-PROBLEM
8788	dyspnea	i-PROBLEM
8789	on	O
8790	exertion	O
8791	.	O
8792	prior	O
8793	to	O
8794	this	O
8795	patient	O
8796	could	b-OCCURRENCE
8797	walk	i-OCCURRENCE
8798	upstairs	i-OCCURRENCE
8799	but	O
8800	now	b-DATE
8801	cannot	b-PROBLEM
8802	.	O
8803	she	O
8804	denies	b-EVIDENTIAL
8805	chest	b-PROBLEM
8806	pain	i-PROBLEM
8807	,	O
8808	orthopnea	b-PROBLEM
8809	,	O
8810	paroxysmal	b-PROBLEM
8811	nocturnal	i-PROBLEM
8812	dyspnea	i-PROBLEM
8813	.	O
8814	however	O
8815	,	O
8816	the	O
8817	patient	O
8818	has	O
8819	noted	b-EVIDENTIAL
8820	some	O
8821	abdominal	b-PROBLEM
8822	pain	i-PROBLEM
8823	,	O
8824	intermittent	O
8825	times	O
8826	a	b-DURATION
8827	couple	i-DURATION
8828	of	i-DURATION
8829	days	i-DURATION
8830	,	O
8831	none	O
8832	on	O
8833	the	b-DATE
8834	day	i-DATE
8835	of	O
8836	admission	b-OCCURRENCE
8837	.	O
8838	denied	b-EVIDENTIAL
8839	nausea	b-PROBLEM
8840	,	O
8841	vomiting	b-PROBLEM
8842	,	O
8843	diaphoresis	b-PROBLEM
8844	,	O
8845	bowel	b-PROBLEM
8846	movement	i-PROBLEM
8847	changes	i-PROBLEM
8848	.	O
8849	she	O
8850	has	O
8851	noted	b-EVIDENTIAL
8852	increased	b-PROBLEM
8853	urinary	i-PROBLEM
8854	frequency	i-PROBLEM
8855	.	O
8856	denies	b-EVIDENTIAL
8857	fever	b-PROBLEM
8858	or	O
8859	chills	b-PROBLEM
8860	.	O
8861	of	O
8862	note	O
8863	,	O
8864	she	O
8865	has	O
8866	had	O
8867	recent	b-TREATMENT
8868	medication	i-TREATMENT
8869	changes	i-TREATMENT
8870	which	O
8871	included	O
8872	discontinuing	O
8873	diovan	b-TREATMENT
8874	and	O
8875	starting	O
8876	terazosin	b-TREATMENT
8877	.	O
8878	hospital	O
8879	course	O
8880	:	O
8881	the	O
8882	patient	O
8883	was	O
8884	admitted	b-OCCURRENCE
8885	to	O
8886	the	b-OCCURRENCE
8887	cardiac	i-OCCURRENCE
8888	medicine	i-OCCURRENCE
8889	service	i-OCCURRENCE
8890	and	O
8891	treated	b-TREATMENT
8892	for	O
8893	presumed	O
8894	diastolic	b-PROBLEM
8895	and	i-PROBLEM
8896	systolic	i-PROBLEM
8897	dysfunction	i-PROBLEM
8898	.	O
8899	echocardiogram	b-TEST
8900	was	O
8901	obtained	O
8902	which	O
8903	showed	b-EVIDENTIAL
8904	moderately	b-PROBLEM
8905	depressed	i-PROBLEM
8906	left	i-PROBLEM
8907	ventricular	i-PROBLEM
8908	systolic	i-PROBLEM
8909	function	i-PROBLEM
8910	as	O
8911	well	O
8912	as	O
8913	hypokinesis	b-PROBLEM
8914	of	i-PROBLEM
8915	the	i-PROBLEM
8916	lower	i-PROBLEM
8917	half	i-PROBLEM
8918	of	i-PROBLEM
8919	septum	i-PROBLEM
8920	and	i-PROBLEM
8921	apex	i-PROBLEM
8922	.	O
8923	also	O
8924	of	O
8925	note	O
8926	was	O
8927	the	b-PROBLEM
8928	distal	i-PROBLEM
8929	lateral	i-PROBLEM
8930	wall	i-PROBLEM
8931	hypokinesis	i-PROBLEM
8932	.	O
8933	the	b-PROBLEM
8934	wall	i-PROBLEM
8935	motion	i-PROBLEM
8936	abnormalities	i-PROBLEM
8937	were	O
8938	noted	O
8939	to	O
8940	be	O
8941	new	O
8942	.	O
8943	it	O
8944	was	O
8945	believed	O
8946	that	O
8947	a	b-TEST
8948	troponin	i-TEST
8949	on	O
8950	admission	b-OCCURRENCE
8951	in	O
8952	addition	O
8953	to	O
8954	the	b-PROBLEM
8955	wall	i-PROBLEM
8956	motion	i-PROBLEM
8957	abnormalities	i-PROBLEM
8958	she	O
8959	underwent	O
8960	a	b-PROBLEM
8961	non-q	i-PROBLEM
8962	wave	i-PROBLEM
8963	myocardial	i-PROBLEM
8964	infarction	i-PROBLEM
8965	prior	O
8966	to	O
8967	resulted	O
8968	in	O
8969	her	b-PROBLEM
8970	current	i-PROBLEM
8971	cardiac	i-PROBLEM
8972	failure	i-PROBLEM
8973	.	O
8974	throughout	O
8975	hospital	b-OCCURRENCE
8976	course	i-OCCURRENCE
8977	patient	b-TEST
8978	's	i-TEST
8979	troponin	i-TEST
8980	trended	O
8981	down	O
8982	to	O
8983	less	O
8984	than	O
8985	0.3	O
8986	.	O
8987	heart	b-CLINICAL_DEPT
8988	failure	i-CLINICAL_DEPT
8989	service	i-CLINICAL_DEPT
8990	was	O
8991	involved	O
8992	.	O
8993	she	O
8994	was	O
8995	continued	O
8996	with	O
8997	aggressive	b-TREATMENT
8998	diuresis	i-TREATMENT
8999	.	O
9000	she	O
9001	was	O
9002	started	O
9003	on	O
9004	_________	O
9005	with	O
9006	excellent	O
9007	diuresis	b-TREATMENT
9008	,	O
9009	however	O
9010	,	O
9011	her	b-PROBLEM
9012	renal	i-PROBLEM
9013	functioning	i-PROBLEM
9014	worsening	i-PROBLEM
9015	.	O
9016	a	b-TEST
9017	cardiac	i-TEST
9018	catheterization	i-TEST
9019	was	O
9020	deferred	O
9021	until	O
9022	the	b-PROBLEM
9023	renal	i-PROBLEM
9024	issue	i-PROBLEM
9025	could	O
9026	be	O
9027	resolved	O
9028	.	O
9029	however	O
9030	,	O
9031	her	b-TEST
9032	creatinine	i-TEST
9033	continued	O
9034	to	O
9035	increase	b-PROBLEM
9036	.	O
9037	diuresis	b-TREATMENT
9038	was	O
9039	halted	O
9040	and	O
9041	without	O
9042	improvement	b-OCCURRENCE
9043	in	O
9044	creatinine	b-TEST
9045	.	O
9046	renal	b-CLINICAL_DEPT
9047	was	O
9048	consulted	b-OCCURRENCE
9049	.	O
9050	a	b-TEST
9051	renal	i-TEST
9052	ultrasound	i-TEST
9053	was	O
9054	obtained	O
9055	.	O
9056	it	O
9057	showed	b-EVIDENTIAL
9058	a	b-TEST
9059	right	i-TEST
9060	kidney	i-TEST
9061	size	i-TEST
9062	of	O
9063	6.3	O
9064	cm	O
9065	and	O
9066	a	b-TEST
9067	left	i-TEST
9068	kidney	i-TEST
9069	size	i-TEST
9070	of	O
9071	8.4	O
9072	cm	O
9073	.	O
9074	given	O
9075	her	b-PROBLEM
9076	hypertension	i-PROBLEM
9077	which	O
9078	was	O
9079	very	O
9080	difficult	O
9081	to	O
9082	control	O
9083	,	O
9084	it	O
9085	was	O
9086	felt	O
9087	that	O
9088	she	O
9089	had	O
9090	renal	b-PROBLEM
9091	artery	i-PROBLEM
9092	stenosis	i-PROBLEM
9093	and	O
9094	thus	O
9095	she	O
9096	underwent	O
9097	mra	b-TEST
9098	of	i-TEST
9099	the	i-TEST
9100	kidney	i-TEST
9101	which	O
9102	showed	b-EVIDENTIAL
9103	severe	b-PROBLEM
9104	right	i-PROBLEM
9105	renal	i-PROBLEM
9106	artery	i-PROBLEM
9107	stenosis	i-PROBLEM
9108	at	O
9109	its	O
9110	origin	O
9111	.	O
9112	there	O
9113	was	O
9114	also	O
9115	moderate	b-PROBLEM
9116	to	i-PROBLEM
9117	severe	i-PROBLEM
9118	focal	i-PROBLEM
9119	stenosis	i-PROBLEM
9120	of	i-PROBLEM
9121	the	i-PROBLEM
9122	left	i-PROBLEM
9123	renal	i-PROBLEM
9124	artery	i-PROBLEM
9125	approximately	O
9126	1.3	O
9127	cm	O
9128	from	O
9129	its	O
9130	origin	O
9131	.	O
9132	doctor	O
9133	______________	O
9134	consulted	O
9135	on	O
9136	the	O
9137	case	O
9138	.	O
9139	she	O
9140	was	O
9141	transferred	b-OCCURRENCE
9142	to	O
9143	the	b-CLINICAL_DEPT
9144	unit	i-CLINICAL_DEPT
9145	overnight	b-DURATION
9146	to	O
9147	assess	O
9148	volume	b-TEST
9149	which	O
9150	was	O
9151	noted	b-EVIDENTIAL
9152	to	O
9153	be	O
9154	optimal	O
9155	.	O
9156	on	O
9157	05-25	b-DATE
9158	she	O
9159	underwent	O
9160	catheterization	b-TEST
9161	and	O
9162	subsequent	b-TREATMENT
9163	stenting	i-TREATMENT
9164	of	i-TREATMENT
9165	the	i-TREATMENT
9166	left	i-TREATMENT
9167	renal	i-TREATMENT
9168	artery	i-TREATMENT
9169	.	O
9170	due	O
9171	to	O
9172	dye	b-TREATMENT
9173	load	i-TREATMENT
9174	required	O
9175	to	O
9176	assess	O
9177	the	b-PROBLEM
9178	coronary	i-PROBLEM
9179	disease	i-PROBLEM
9180	were	O
9181	not	O
9182	visualized	O
9183	.	O
9184	after	O
9185	the	b-TREATMENT
9186	procedure	i-TREATMENT
9187	the	O
9188	patient	O
9189	did	O
9190	well	b-OCCURRENCE
9191	.	O
9192	however	O
9193	,	O
9194	her	b-TEST
9195	creatinine	i-TEST
9196	has	O
9197	worsened	b-PROBLEM
9198	up	O
9199	to	O
9200	4.2	O
9201	.	O
9202	however	O
9203	,	O
9204	her	b-TEST
9205	urine	i-TEST
9206	output	i-TEST
9207	has	O
9208	improved	b-OCCURRENCE
9209	.	O
9210	she	O
9211	has	O
9212	not	O
9213	required	O
9214	hemodialysis	b-TREATMENT
9215	at	O
9216	this	b-DATE
9217	time	i-DATE
9218	.	O
9219	she	O
9220	will	O
9221	need	O
9222	close	O
9223	follow	b-TREATMENT
9224	up	i-TREATMENT
9225	of	O
9226	her	b-TEST
9227	renal	i-TEST
9228	functioning	i-TEST
9229	.	O
9230	the	O
9231	patient	O
9232	is	O
9233	discharged	b-OCCURRENCE
9234	to	O
9235	an	O
9236	extended	O
9237	discharge	O
9238	facility	O
9239	.	O
9240		O
9241	admission	b-OCCURRENCE
9242	date	O
9243	:	O
9244	07/04/1999	b-ADMISSION
9245	discharge	b-OCCURRENCE
9246	date	O
9247	:	O
9248	07/09/1999	b-DISCHARGE
9249	discharge	O
9250	date	O
9251	:	O
9252	07/09/1999	O
9253	history	O
9254	of	O
9255	the	O
9256	present	O
9257	illness	O
9258	:	O
9259	this	O
9260	is	O
9261	a	O
9262	49	O
9263	year-old	O
9264	male	O
9265	with	O
9266	a	O
9267	history	O
9268	of	O
9269	a	b-TREATMENT
9270	low	i-TREATMENT
9271	anterior	i-TREATMENT
9272	resection	i-TREATMENT
9273	in	O
9274	may	b-DATE
9275	of	i-DATE
9276	1998	i-DATE
9277	and	O
9278	a	b-PROBLEM
9279	recurrence	i-PROBLEM
9280	of	O
9281	metastasis	b-PROBLEM
9282	with	O
9283	asleeve	O
9284	of	O
9285	section	O
9286	of	O
9287	left	b-TREATMENT
9288	colon	i-TREATMENT
9289	diverting	i-TREATMENT
9290	ileostomy	i-TREATMENT
9291	for	O
9292	recurrent	b-PROBLEM
9293	metastasis	i-PROBLEM
9294	later	O
9295	in	O
9296	may	b-DATE
9297	of	i-DATE
9298	1999	i-DATE
9299	who	O
9300	presents	b-EVIDENTIAL
9301	with	O
9302	anterior	b-PROBLEM
9303	midepigastric	i-PROBLEM
9304	abdominal	i-PROBLEM
9305	pain	i-PROBLEM
9306	.	O
9307	the	O
9308	patient	O
9309	states	b-EVIDENTIAL
9310	that	O
9311	the	b-PROBLEM
9312	pain	i-PROBLEM
9313	began	O
9314	at	O
9315	10:30	b-TIME
9316	on	i-TIME
9317	the	i-TIME
9318	day	i-TIME
9319	of	O
9320	admission	b-OCCURRENCE
9321	with	O
9322	increase	b-OCCURRENCE
9323	during	O
9324	the	b-DATE
9325	day	i-DATE
9326	of	O
9327	admission	b-OCCURRENCE
9328	with	O
9329	positive	O
9330	nausea	b-PROBLEM
9331	and	O
9332	vomiting	b-PROBLEM
9333	,	O
9334	no	O
9335	diarrhea	b-PROBLEM
9336	,	O
9337	decreased	b-PROBLEM
9338	output	i-PROBLEM
9339	from	i-PROBLEM
9340	the	i-PROBLEM
9341	ostomy	i-PROBLEM
9342	,	O
9343	and	O
9344	the	b-PROBLEM
9345	pain	i-PROBLEM
9346	was	O
9347	radiating	b-PROBLEM
9348	to	i-PROBLEM
9349	the	i-PROBLEM
9350	back	i-PROBLEM
9351	.	O
9352	hospital	O
9353	course	O
9354	:	O
9355	assessment	b-TEST
9356	was	O
9357	continued	O
9358	with	O
9359	laboratory	b-TEST
9360	studies	i-TEST
9361	which	O
9362	showed	b-EVIDENTIAL
9363	the	O
9364	patient	O
9365	to	O
9366	have	O
9367	a	b-TEST
9368	white	i-TEST
9369	blood	i-TEST
9370	cell	i-TEST
9371	count	i-TEST
9372	of	O
9373	9	O
9374	,	O
9375	hematocrit	b-TEST
9376	39	O
9377	,	O
9378	and	O
9379	platelets	b-TEST
9380	470	O
9381	.	O
9382	the	O
9383	patient	O
9384	had	O
9385	a	O
9386	normal	O
9387	amylase	b-TEST
9388	and	O
9389	lipase	b-TEST
9390	,	O
9391	and	O
9392	a	O
9393	normal	O
9394	basic	O
9395	metabolic	b-TEST
9396	panel	i-TEST
9397	.	O
9398	the	O
9399	patient	O
9400	had	O
9401	kub	b-TEST
9402	that	O
9403	showed	b-EVIDENTIAL
9404	multiple	b-PROBLEM
9405	dilated	i-PROBLEM
9406	loops	i-PROBLEM
9407	of	i-PROBLEM
9408	small	i-PROBLEM
9409	bowel	i-PROBLEM
9410	and	O
9411	was	O
9412	admitted	b-OCCURRENCE
9413	for	O
9414	a	b-PROBLEM
9415	partial	i-PROBLEM
9416	small	i-PROBLEM
9417	bowel	i-PROBLEM
9418	obstruction	i-PROBLEM
9419	.	O
9420	an	b-TREATMENT
9421	nasogastric	i-TREATMENT
9422	tube	i-TREATMENT
9423	was	O
9424	placed	O
9425	and	O
9426	had	O
9427	an	b-TREATMENT
9428	h2	i-TREATMENT
9429	blocker	i-TREATMENT
9430	started	O
9431	,	O
9432	and	O
9433	was	O
9434	admitted	b-OCCURRENCE
9435	for	O
9436	bowel	b-TREATMENT
9437	rest	i-TREATMENT
9438	and	O
9439	decompression	b-TREATMENT
9440	.	O
9441	the	O
9442	patient	O
9443	tolerated	O
9444	the	b-TREATMENT
9445	nasogastric	i-TREATMENT
9446	tube	i-TREATMENT
9447	well	b-OCCURRENCE
9448	.	O
9449	the	b-TREATMENT
9450	nasogastric	i-TREATMENT
9451	tube	i-TREATMENT
9452	was	O
9453	removed	O
9454	on	O
9455	hsp	b-DATE
9456	day	i-DATE
9457	#	i-DATE
9458	3	i-DATE
9459	.	O
9460	the	b-PROBLEM
9461	pain	i-PROBLEM
9462	improved	b-OCCURRENCE
9463	quickly	O
9464	and	O
9465	the	O
9466	patient	O
9467	was	O
9468	started	O
9469	on	O
9470	a	b-TREATMENT
9471	clear	i-TREATMENT
9472	liquid	i-TREATMENT
9473	diet	i-TREATMENT
9474	which	O
9475	was	O
9476	advanced	b-TREATMENT
9477	as	i-TREATMENT
9478	tolerated	i-TREATMENT
9479	.	O
9480	on	O
9481	7/9/99	b-DATE
9482	,	O
9483	the	O
9484	patient	O
9485	was	O
9486	tolerating	O
9487	a	b-OCCURRENCE
9488	house	i-OCCURRENCE
9489	diet	i-OCCURRENCE
9490	.	O
9491	the	O
9492	patient	O
9493	had	O
9494	some	O
9495	minimal	O
9496	back	b-PROBLEM
9497	pain	i-PROBLEM
9498	that	O
9499	occurred	O
9500	after	O
9501	food	b-OCCURRENCE
9502	but	O
9503	with	O
9504	negative	O
9505	urinalysis	b-TEST
9506	and	O
9507	negative	O
9508	fever	b-PROBLEM
9509	spikes	i-PROBLEM
9510	over	O
9511	the	b-OCCURRENCE
9512	entire	i-OCCURRENCE
9513	course	i-OCCURRENCE
9514	of	i-OCCURRENCE
9515	this	i-OCCURRENCE
9516	stay	i-OCCURRENCE
9517	.	O
9518	the	O
9519	patient	O
9520	will	O
9521	be	O
9522	discharged	b-OCCURRENCE
9523	home	O
9524	on	O
9525	zantac	b-TREATMENT
9526	,	O
9527	simethicone	b-TREATMENT
9528	,	O
9529	and	O
9530	preoperative	b-TREATMENT
9531	medications	i-TREATMENT
9532	with	O
9533	follow-up	b-OCCURRENCE
9534	with	O
9535	doctor	O
9536	ur	O
9537	in	O
9538	two	b-DURATION
9539	weeks	i-DURATION
9540	.	O
9541	dictated	O
9542	by	O
9543	:	O
9544	niste	O
9545	blocker	O
9546	,	O
9547	md	O
9548	aq36	O
9549	attending	O
9550	:	O
9551	stie	O
9552	fyfe	O
9553	,	O
9554	md	O
9555	bw3	O
9556	bl436/5666	O
9557	batch	O
9558	:	O
9559	85114	O
9560	index	O
9561	no.	O
9562	fnqxcx58	O
9563	em	O
9564	d	O
9565	:	O
9566	07/09/99	O
9567	t	O
9568	:	O
9569	07/09/99	O
9570	hp8	O
9571		O
9572	admission	b-OCCURRENCE
9573	date	O
9574	:	O
9575	2019-06-25	b-ADMISSION
9576	discharge	b-OCCURRENCE
9577	date	O
9578	:	O
9579	2019-07-01	b-DISCHARGE
9580	service	O
9581	:	O
9582	cardiothoracic	O
9583	history	O
9584	of	O
9585	present	O
9586	illness	O
9587	:	O
9588	69yom	O
9589	with	O
9590	oa	b-PROBLEM
9591	having	O
9592	workup	b-TEST
9593	for	O
9594	knee	b-TREATMENT
9595	replacements	i-TREATMENT
9596	found	b-EVIDENTIAL
9597	to	O
9598	be	O
9599	in	O
9600	afib	b-PROBLEM
9601	,	O
9602	had	O
9603	stress	b-TEST
9604	test	i-TEST
9605	that	O
9606	was	O
9607	positive	O
9608	followed	O
9609	by	O
9610	cardiac	b-TEST
9611	catheterization	i-TEST
9612	which	O
9613	revealed	b-EVIDENTIAL
9614	severe	b-PROBLEM
9615	3vd	i-PROBLEM
9616	.	O
9617	then	O
9618	referred	b-OCCURRENCE
9619	for	O
9620	cabg	b-TREATMENT
9621	brief	O
9622	hospital	O
9623	course	O
9624	:	O
9625	69	O
9626	yo	O
9627	m	O
9628	with	O
9629	known	b-PROBLEM
9630	atrial	i-PROBLEM
9631	fibrillation	i-PROBLEM
9632	and	O
9633	coronary	b-PROBLEM
9634	artery	i-PROBLEM
9635	disease	i-PROBLEM
9636	admitted	b-OCCURRENCE
9637	preop	O
9638	for	O
9639	transition	O
9640	fro	O
9641	coumadin	b-TREATMENT
9642	to	O
9643	heparin	b-TREATMENT
9644	.	O
9645	brought	O
9646	to	O
9647	the	b-CLINICAL_DEPT
9648	or	i-CLINICAL_DEPT
9649	on	O
9650	06-26	b-DATE
9651	for	O
9652	cabg	b-TREATMENT
9653	,	O
9654	please	O
9655	see	O
9656	or	b-EVIDENTIAL
9657	report	i-EVIDENTIAL
9658	for	O
9659	details	O
9660	.	O
9661	in	O
9662	summary	O
9663	pt	O
9664	had	O
9665	off	b-TREATMENT
9666	pump	i-TREATMENT
9667	cabgx4	i-TREATMENT
9668	with	O
9669	lima-lad	b-TREATMENT
9670	,	O
9671	svg	b-TREATMENT
9672	om-y	i-TREATMENT
9673	graft	i-TREATMENT
9674	-	i-TREATMENT
9675	diag	i-TREATMENT
9676	,	O
9677	svg-pda	b-TREATMENT
9678	.	O
9679	pt	O
9680	tolerated	O
9681	surgery	b-TREATMENT
9682	well	O
9683	and	O
9684	was	O
9685	transferred	b-OCCURRENCE
9686	to	O
9687	ct	b-CLINICAL_DEPT
9688	cmed	i-CLINICAL_DEPT
9689	icu	i-CLINICAL_DEPT
9690	.	O
9691	he	O
9692	did	O
9693	well	b-OCCURRENCE
9694	in	O
9695	immediate	b-DURATION
9696	post-op	i-DURATION
9697	period	i-DURATION
9698	was	O
9699	extubated	b-TREATMENT
9700	and	O
9701	on	O
9702	pod1	b-DATE
9703	he	O
9704	was	O
9705	transferred	b-OCCURRENCE
9706	to	O
9707	the	b-CLINICAL_DEPT
9708	step	i-CLINICAL_DEPT
9709	down	i-CLINICAL_DEPT
9710	floor	i-CLINICAL_DEPT
9711	.	O
9712	on	O
9713	pod2	b-DATE
9714	his	b-TREATMENT
9715	chest	i-TREATMENT
9716	tubes	i-TREATMENT
9717	and	O
9718	epicardial	b-TREATMENT
9719	pacing	i-TREATMENT
9720	wires	i-TREATMENT
9721	were	O
9722	removed	O
9723	and	O
9724	his	b-TREATMENT
9725	coumadin	i-TREATMENT
9726	was	O
9727	restarted	O
9728	.	O
9729	over	O
9730	the	O
9731	next	O
9732	several	b-DURATION
9733	days	i-DURATION
9734	his	O
9735	activity	O
9736	was	O
9737	advanced	b-OCCURRENCE
9738	on	O
9739	pod5	b-DATE
9740	it	O
9741	was	O
9742	decided	O
9743	he	O
9744	was	O
9745	stable	b-OCCURRENCE
9746	and	O
9747	ready	O
9748	to	O
9749	be	O
9750	discharged	b-OCCURRENCE
9751	home	O
9752	with	O
9753	visiting	b-TREATMENT
9754	nurses	i-TREATMENT
9755	.	O
9756		O
9757	admission	b-OCCURRENCE
9758	date	O
9759	:	O
9760	2017-08-12	b-ADMISSION
9761	discharge	b-OCCURRENCE
9762	date	O
9763	:	O
9764	2017-08-16	b-DISCHARGE
9765	service	O
9766	:	O
9767	surgery	O
9768	allergies	O
9769	:	O
9770	history	O
9771	of	O
9772	present	O
9773	illness	O
9774	:	O
9775	22	O
9776	year	O
9777	old	O
9778	female	O
9779	transfer	b-OCCURRENCE
9780	from	O
9781	outside	b-CLINICAL_DEPT
9782	hospital	i-CLINICAL_DEPT
9783	after	O
9784	a	b-PROBLEM
9785	motor	i-PROBLEM
9786	vehicle	i-PROBLEM
9787	accident	i-PROBLEM
9788	with	O
9789	diagnosed	b-EVIDENTIAL
9790	liver	b-PROBLEM
9791	laceration	i-PROBLEM
9792	by	O
9793	ct	b-TEST
9794	scan	i-TEST
9795	.	O
9796	brief	O
9797	hospital	O
9798	course	O
9799	:	O
9800	patient	O
9801	was	O
9802	admited	b-OCCURRENCE
9803	,	O
9804	pain	b-PROBLEM
9805	was	O
9806	managed	O
9807	with	O
9808	a	b-TREATMENT
9809	pca	i-TREATMENT
9810	and	O
9811	later	O
9812	with	O
9813	po	b-TREATMENT
9814	medication	i-TREATMENT
9815	.	O
9816	the	b-PROBLEM
9817	liver	i-PROBLEM
9818	laceration	i-PROBLEM
9819	was	O
9820	stable	b-OCCURRENCE
9821	,	O
9822	no	O
9823	sign	O
9824	of	O
9825	rupture	b-PROBLEM
9826	or	O
9827	further	b-PROBLEM
9828	complication	i-PROBLEM
9829	,	O
9830	did	O
9831	not	O
9832	required	O
9833	surgical	b-TREATMENT
9834	managment	i-TREATMENT
9835	.	O
9836	the	b-TEST
9837	liver	i-TEST
9838	enzimes	i-TEST
9839	come	O
9840	down	O
9841	,	O
9842	no	O
9843	signs	O
9844	of	O
9845	biliary	b-PROBLEM
9846	stasis	i-PROBLEM
9847	.	O
9848	she	O
9849	was	O
9850	able	O
9851	to	O
9852	tolerate	b-OCCURRENCE
9853	diet	i-OCCURRENCE
9854	,	O
9855	ambulate	b-OCCURRENCE
9856	,	O
9857	having	b-OCCURRENCE
9858	a	i-OCCURRENCE
9859	bowel	i-OCCURRENCE
9860	movement	i-OCCURRENCE
9861	and	O
9862	dischargo	b-OCCURRENCE
9863	home	O
9864	in	O
9865	good	b-OCCURRENCE
9866	conditions	i-OCCURRENCE
9867	.	O
9868		O
9869	admission	b-OCCURRENCE
9870	date	O
9871	:	O
9872	2018-04-23	b-ADMISSION
9873	discharge	b-OCCURRENCE
9874	date	O
9875	:	O
9876	2018-05-01	b-DISCHARGE
9877	service	O
9878	:	O
9879	medicine	O
9880	history	O
9881	of	O
9882	present	O
9883	illness	O
9884	:	O
9885	95	O
9886	yo	O
9887	male	O
9888	with	O
9889	pmh	O
9890	large	b-PROBLEM
9891	right	i-PROBLEM
9892	thyroid	i-PROBLEM
9893	cystic	i-PROBLEM
9894	mass	i-PROBLEM
9895	eroding	b-PROBLEM
9896	into	O
9897	trachea	O
9898	,	O
9899	who	O
9900	presented	b-OCCURRENCE
9901	to	O
9902	st.	b-CLINICAL_DEPT
9903	anne	i-CLINICAL_DEPT
9904	's	i-CLINICAL_DEPT
9905	hospital	i-CLINICAL_DEPT
9906	2018-04-22	b-DATE
9907	with	O
9908	hemoptysis	b-PROBLEM
9909	and	O
9910	respiratory	b-PROBLEM
9911	distress	i-PROBLEM
9912	,	O
9913	now	O
9914	diagnosed	O
9915	with	O
9916	anaplastic	b-PROBLEM
9917	thyroid	i-PROBLEM
9918	carcinoma	i-PROBLEM
9919	.	O
9920	.	O
9921	pt	O
9922	reports	b-EVIDENTIAL
9923	that	O
9924	he	O
9925	noticed	O
9926	a	b-PROBLEM
9927	right	i-PROBLEM
9928	neck	i-PROBLEM
9929	mass	i-PROBLEM
9930	last	b-DATE
9931	october	i-DATE
9932	.	O
9933	the	b-PROBLEM
9934	mass	i-PROBLEM
9935	grew	b-OCCURRENCE
9936	larger	i-OCCURRENCE
9937	,	O
9938	to	O
9939	the	O
9940	size	O
9941	of	O
9942	a	O
9943	baseball	O
9944	.	O
9945	it	O
9946	appears	O
9947	that	O
9948	fna	b-TEST
9949	was	O
9950	performed	O
9951	but	O
9952	was	O
9953	non-diagnostic	O
9954	(	O
9955	probably	O
9956	because	O
9957	anaplastic	b-PROBLEM
9958	tumors	i-PROBLEM
9959	tend	O
9960	to	O
9961	be	O
9962	necrotic	b-PROBLEM
9963	)	O
9964	.	O
9965	the	b-PROBLEM
9966	mass	i-PROBLEM
9967	appears	O
9968	to	O
9969	be	O
9970	cystic	b-PROBLEM
9971	in	O
9972	nature	O
9973	and	O
9974	has	O
9975	been	O
9976	aspirated	b-TREATMENT
9977	at	O
9978	least	O
9979	3	b-FREQUENCY
9980	times	i-FREQUENCY
9981	,	O
9982	which	O
9983	decrease	b-OCCURRENCE
9984	in	O
9985	size	O
9986	each	O
9987	time	O
9988	.	O
9989	now	O
9990	size	O
9991	is	O
9992	6.5cm*6.5cm	O
9993	.	O
9994	plan	O
9995	for	O
9996	surgery	b-TREATMENT
9997	in	O
9998	oct	b-DATE
9999	was	O
10000	deferred	b-OCCURRENCE
10001	04-05	b-DATE
10002	syncope	b-PROBLEM
10003	and	O
10004	pacer	b-TREATMENT
10005	placement	i-TREATMENT
10006	for	O
10007	sss;	b-PROBLEM
10008	again	b-OCCURRENCE
10009	deferred	i-OCCURRENCE
10010	2	b-DATE
10011	weeks	i-DATE
10012	ago	i-DATE
10013	04-05	i-DATE
10014	uri;	b-PROBLEM
10015	was	O
10016	planned	O
10017	for	O
10018	surgery	b-TREATMENT
10019	this	b-DATE
10020	thurday	i-DATE
10021	.	O
10022	.	O
10023	pt	O
10024	was	O
10025	o/w	O
10026	in	O
10027	his	b-OCCURRENCE
10028	usoh	i-OCCURRENCE
10029	until	O
10030	2-3	b-DATE
10031	weeks	i-DATE
10032	ago	i-DATE
10033	when	O
10034	he	O
10035	developed	O
10036	a	b-PROBLEM
10037	uri	i-PROBLEM
10038	with	O
10039	symptoms	O
10040	of	O
10041	dry	b-PROBLEM
10042	cough;	i-PROBLEM
10043	no	O
10044	fever	b-PROBLEM
10045	,	O
10046	chills	b-PROBLEM
10047	,	O
10048	sore	b-PROBLEM
10049	throat	i-PROBLEM
10050	,	O
10051	myalgias	b-PROBLEM
10052	.	O
10053	pt	O
10054	was	O
10055	treated	O
10056	with	O
10057	3	b-DURATION
10058	days	i-DURATION
10059	of	O
10060	an	b-TREATMENT
10061	antibiotics	i-TREATMENT
10062	,	O
10063	followed	O
10064	by	O
10065	a	b-DURATION
10066	10	i-DURATION
10067	day	i-DURATION
10068	course	i-DURATION
10069	of	O
10070	levaquin	b-TREATMENT
10071	(	O
10072	completed	O
10073	2	b-DATE
10074	days	i-DATE
10075	pta	O
10076	)	O
10077	.	O
10078	per	O
10079	pt	O
10080	and	O
10081	son	O
10082	,	O
10083	no	O
10084	james	b-PROBLEM
10085	pna	i-PROBLEM
10086	.	O
10087	2	b-DATE
10088	days	i-DATE
10089	prior	O
10090	to	O
10091	admission	O
10092	,	O
10093	pt	O
10094	developed	O
10095	hemoptysis;	b-PROBLEM
10096	states	b-EVIDENTIAL
10097	he	O
10098	coughed	b-PROBLEM
10099	up	i-PROBLEM
10100	4	O
10101	tsp	O
10102	of	O
10103	blood	b-PROBLEM
10104	.	O
10105	1	b-DATE
10106	day	i-DATE
10107	pta	O
10108	,	O
10109	pt	O
10110	developed	O
10111	stridorous	b-PROBLEM
10112	breathing	i-PROBLEM
10113	and	O
10114	respiratory	b-PROBLEM
10115	distress	i-PROBLEM
10116	.	O
10117	pt	O
10118	was	O
10119	initially	O
10120	seen	O
10121	at	O
10122	lahey	b-CLINICAL_DEPT
10123	north	i-CLINICAL_DEPT
10124	,	O
10125	where	O
10126	he	O
10127	was	O
10128	given	O
10129	steroids	b-TREATMENT
10130	,	O
10131	with	O
10132	improvement	b-OCCURRENCE
10133	in	O
10134	respiratory	b-OCCURRENCE
10135	status	i-OCCURRENCE
10136	.	O
10137	pt	O
10138	was	O
10139	transferred	b-OCCURRENCE
10140	to	O
10141	new	b-CLINICAL_DEPT
10142	england	i-CLINICAL_DEPT
10143	baptist	i-CLINICAL_DEPT
10144	hospital	i-CLINICAL_DEPT
10145	,	O
10146	where	O
10147	his	O
10148	surgeon	O
10149	is	O
10150	located	O
10151	.	O
10152	there	b-CLINICAL_DEPT
10153	he	O
10154	was	O
10155	admitted	b-OCCURRENCE
10156	to	O
10157	the	b-CLINICAL_DEPT
10158	cmed	i-CLINICAL_DEPT
10159	.	O
10160	thyroid	b-PROBLEM
10161	cyst	i-PROBLEM
10162	was	O
10163	aspirated	b-TREATMENT
10164	with	O
10165	removal	b-TREATMENT
10166	of	O
10167	300cc	O
10168	of	O
10169	fluid	O
10170	.	O
10171		O
10172	pt	O
10173	was	O
10174	given	O
10175	racemic	b-TREATMENT
10176	epinephrine	i-TREATMENT
10177	and	O
10178	decadron	b-TREATMENT
10179	10mg	O
10180	iv	O
10181	x1.	b-FREQUENCY
10182	ct	b-TEST
10183	neck	i-TEST
10184	showed	b-EVIDENTIAL
10185	tracheal	b-PROBLEM
10186	mass	i-PROBLEM
10187	per	O
10188	nursing	O
10189	s/o	O
10190	(	O
10191	pt	O
10192	brought	O
10193	ct	b-TEST
10194	)	O
10195	.	O
10196	.	O
10197	pt	O
10198	now	O
10199	breathing	b-OCCURRENCE
10200	more	i-OCCURRENCE
10201	comfortably	i-OCCURRENCE
10202	.	O
10203	he	O
10204	has	O
10205	not	O
10206	had	O
10207	fever	b-PROBLEM
10208	and	O
10209	night	b-PROBLEM
10210	sweats	i-PROBLEM
10211	but	O
10212	reports	b-EVIDENTIAL
10213	weakness	b-PROBLEM
10214	and	O
10215	weight	b-PROBLEM
10216	loss	i-PROBLEM
10217	for	O
10218	several	b-DURATION
10219	months	i-DURATION
10220	recently	O
10221	.	O
10222	brief	O
10223	hospital	O
10224	course	O
10225	:	O
10226	pt	O
10227	was	O
10228	transferred	b-OCCURRENCE
10229	here	b-CLINICAL_DEPT
10230	for	O
10231	further	b-TREATMENT
10232	mgmt	i-TREATMENT
10233	of	i-TREATMENT
10234	airway	i-TREATMENT
10235	and	O
10236	large	b-PROBLEM
10237	thyroid	i-PROBLEM
10238	mass	i-PROBLEM
10239	by	O
10240	our	O
10241	ip	O
10242	team	O
10243	.	O
10244	ip	O
10245	found	O
10246	endotracheal	b-PROBLEM
10247	obstructing	i-PROBLEM
10248	tumor	i-PROBLEM
10249	and	O
10250	extrinsic	b-PROBLEM
10251	compression	i-PROBLEM
10252	of	i-PROBLEM
10253	the	i-PROBLEM
10254	high	i-PROBLEM
10255	trachea	i-PROBLEM
10256	by	O
10257	thyroid	b-PROBLEM
10258	mass	i-PROBLEM
10259	.	O
10260	after	O
10261	rigid	b-TEST
10262	bronchoscopy	i-TEST
10263	with	O
10264	removal	b-TREATMENT
10265	of	O
10266	the	b-PROBLEM
10267	intratracheal	i-PROBLEM
10268	tumor	i-PROBLEM
10269	component	i-PROBLEM
10270	on	O
10271	2018-04-24	b-DATE
10272	,	O
10273	stat	b-TEST
10274	pathology	i-TEST
10275	showed	b-EVIDENTIAL
10276	anaplastic	b-PROBLEM
10277	tumor	i-PROBLEM
10278	.	O
10279	he	O
10280	was	O
10281	tranferred	b-OCCURRENCE
10282	to	O
10283	the	b-CLINICAL_DEPT
10284	cmed	i-CLINICAL_DEPT
10285	.	O
10286	subsequently	O
10287	extubated	b-TREATMENT
10288	and	O
10289	his	b-PROBLEM
10290	respiratory	i-PROBLEM
10291	sx	i-PROBLEM
10292	are	O
10293	now	O
10294	improved	b-OCCURRENCE
10295	.	O
10296	pt	O
10297	was	O
10298	seen	O
10299	by	O
10300	rad	b-CLINICAL_DEPT
10301	onc	i-CLINICAL_DEPT
10302	,	O
10303	who	O
10304	recommended	O
10305	transfer	b-OCCURRENCE
10306	to	O
10307	the	b-CLINICAL_DEPT
10308	east	i-CLINICAL_DEPT
10309	campus	i-CLINICAL_DEPT
10310	for	O
10311	xrt	b-TREATMENT
10312	.	O
10313	on	O
10314	the	b-DATE
10315	morning	i-DATE
10316	of	O
10317	possible	b-TREATMENT
10318	radiation	i-TREATMENT
10319	,	O
10320	patient	O
10321	and	O
10322	family	O
10323	met	O
10324	with	O
10325	interventional	O
10326	pulmonary	O
10327	team	O
10328	who	O
10329	explained	O
10330	that	O
10331	the	b-TEST
10332	most	i-TEST
10333	recent	i-TEST
10334	ct	i-TEST
10335	showed	b-EVIDENTIAL
10336	further	b-OCCURRENCE
10337	invasion	i-OCCURRENCE
10338	of	O
10339	the	b-PROBLEM
10340	tumor	i-PROBLEM
10341	into	O
10342	the	O
10343	trachea	O
10344	.	O
10345	after	O
10346	a	O
10347	long	O
10348	discussion	O
10349	,	O
10350	patient	O
10351	and	O
10352	family	O
10353	asked	O
10354	to	O
10355	be	O
10356	made	O
10357	cmo	b-TREATMENT
10358	.	O
10359	patient	O
10360	was	O
10361	started	O
10362	on	O
10363	morphine	b-TREATMENT
10364	drip	i-TREATMENT
10365	and	O
10366	palliative	O
10367	care	O
10368	team	O
10369	was	O
10370	consulted	O
10371	with	O
10372	recommendations	O
10373	to	O
10374	ensure	O
10375	comfort	O
10376	.	O
10377	mr	O
10378	.	O
10379	davison	O
10380	died	b-OCCURRENCE
10381	approximately	O
10382	24	b-DURATION
10383	hours	i-DURATION
10384	after	O
10385	decision	O
10386	to	O
10387	be	O
10388	cmo	b-TREATMENT
10389	,	O
10390	on	O
10391	2018-05-01	b-DATE
10392	.	O
10393	discharge	O
10394	disposition	O
10395	:	O
10396	expired	O
10397	discharge	O
10398	diagnosis	O
10399	:	O
10400	nc	O
10401	discharge	O
10402	condition	O
10403	:	O
10404	nc	O
10405	discharge	O
10406	instructions	O
10407	:	O
10408	nc	O
10409	followup	O
10410	instructions	O
10411	:	O
10412	nc	O
10413	john	O
10414	iris	O
10415	md	O
10416	70-363	O
10417	completed	O
10418	by	O
10419	:	O
10420	patricia	O
10421	rojas	O
10422	md	O
10423	73-701	O
10424	2018-05-06	O
10425	@	O
10426	1434	O
10427	signed	O
10428	electronically	O
10429	by	O
10430	:	O
10431	doctor	O
10432	john	O
10433	j.	O
10434	booker	O
10435	on	O
10436	:	O
10437	wed	O
10438	2018-05-30	O
10439	5:50	O
10440	pm	O
10441	(	O
10442	end	O
10443	of	O
10444	report	O
10445	)	O
10446		O
10447	admission	b-OCCURRENCE
10448	date	O
10449	:	O
10450	2009-05-01	b-ADMISSION
10451	discharge	b-OCCURRENCE
10452	date	O
10453	:	O
10454	date	O
10455	of	O
10456	birth	O
10457	:	O
10458	service	O
10459	:	O
10460	surgery	O
10461	history	O
10462	of	O
10463	present	O
10464	illness	O
10465	:	O
10466	the	O
10467	patient	O
10468	is	O
10469	a	O
10470	39	O
10471	year-old	O
10472	gentleman	O
10473	admitted	b-OCCURRENCE
10474	on	O
10475	2009-05-01	b-DATE
10476	to	O
10477	the	b-CLINICAL_DEPT
10478	jewish	i-CLINICAL_DEPT
10479	memorial	i-CLINICAL_DEPT
10480	hospital	i-CLINICAL_DEPT
10481	referred	O
10482	from	O
10483	south	b-CLINICAL_DEPT
10484	cove	i-CLINICAL_DEPT
10485	community	i-CLINICAL_DEPT
10486	health	i-CLINICAL_DEPT
10487	center	i-CLINICAL_DEPT
10488	.	O
10489	he	O
10490	is	O
10491	a	O
10492	39	O
10493	year-old	O
10494	gentleman	O
10495	with	O
10496	hyperlipidemia	b-PROBLEM
10497	and	O
10498	smoking	b-OCCURRENCE
10499	who	O
10500	presented	b-OCCURRENCE
10501	with	O
10502	acute	O
10503	onset	O
10504	of	O
10505	chest	b-PROBLEM
10506	pain	i-PROBLEM
10507	since	O
10508	five	b-TIME
10509	in	i-TIME
10510	the	i-TIME
10511	morning	i-TIME
10512	with	O
10513	radiation	b-PROBLEM
10514	to	O
10515	the	O
10516	left	O
10517	arm	O
10518	and	O
10519	nausea	b-PROBLEM
10520	.	O
10521	symptoms	b-PROBLEM
10522	resolved	O
10523	spontaneously	O
10524	.	O
10525	he	O
10526	was	O
10527	taken	b-OCCURRENCE
10528	to	O
10529	the	b-CLINICAL_DEPT
10530	cath	i-CLINICAL_DEPT
10531	lab	i-CLINICAL_DEPT
10532	at	O
10533	the	b-CLINICAL_DEPT
10534	pinewood	i-CLINICAL_DEPT
10535	,	i-CLINICAL_DEPT
10536	norfolk	i-CLINICAL_DEPT
10537	that	O
10538	evening	b-DATE
10539	where	O
10540	a	b-TEST
10541	stent	i-TEST
10542	procedure	i-TEST
10543	to	O
10544	the	O
10545	rca	O
10546	was	O
10547	complicated	O
10548	by	O
10549	guidewire	b-PROBLEM
10550	entrapment	i-PROBLEM
10551	inside	O
10552	of	O
10553	a	b-TREATMENT
10554	stent	i-TREATMENT
10555	requiring	O
10556	ct	b-TREATMENT
10557	surgery	i-TREATMENT
10558	to	O
10559	do	O
10560	a	b-TREATMENT
10561	thoracotomy	i-TREATMENT
10562	with	O
10563	bypass	b-TREATMENT
10564	and	O
10565	excision	b-TREATMENT
10566	of	O
10567	the	b-PROBLEM
10568	wire	i-PROBLEM
10569	.	O
10570	the	O
10571	case	O
10572	was	O
10573	complicated	O
10574	by	O
10575	an	O
10576	episode	O
10577	of	O
10578	coffee	b-PROBLEM
10579	ground	i-PROBLEM
10580	emesis	i-PROBLEM
10581	and	O
10582	a	b-PROBLEM
10583	bleed	i-PROBLEM
10584	from	O
10585	femoral	b-OCCURRENCE
10586	access	i-OCCURRENCE
10587	site	i-OCCURRENCE
10588	prior	O
10589	to	O
10590	ct	b-TREATMENT
10591	surgery	i-TREATMENT
10592	.	O
10593	gastroenterology	O
10594	was	O
10595	consulted	O
10596	and	O
10597	they	O
10598	recommended	O
10599	protonix	b-TREATMENT
10600	and	O
10601	felt	O
10602	it	O
10603	was	O
10604	due	O
10605	to	O
10606	peptic	b-PROBLEM
10607	ulcer	i-PROBLEM
10608	disease	i-PROBLEM
10609	.	O
10610	hospital	O
10611	course	O
10612	:	O
10613	the	O
10614	patient	O
10615	was	O
10616	diagnosed	O
10617	as	O
10618	having	O
10619	an	b-PROBLEM
10620	acute	i-PROBLEM
10621	myocardial	i-PROBLEM
10622	infarction	i-PROBLEM
10623	.	O
10624	the	O
10625	patient	O
10626	was	O
10627	taken	b-OCCURRENCE
10628	emergently	O
10629	to	O
10630	the	b-CLINICAL_DEPT
10631	operating	i-CLINICAL_DEPT
10632	room	i-CLINICAL_DEPT
10633	on	O
10634	2009-05-02	b-DATE
10635	for	O
10636	his	b-TREATMENT
10637	cabg	i-TREATMENT
10638	,	O
10639	right	b-TREATMENT
10640	coronary	i-TREATMENT
10641	endarterectomy	i-TREATMENT
10642	,	O
10643	removal	b-TREATMENT
10644	of	O
10645	rca	b-TREATMENT
10646	stents	i-TREATMENT
10647	and	O
10648	retrieval	b-TREATMENT
10649	of	O
10650	the	b-TREATMENT
10651	aortic	i-TREATMENT
10652	guidewire	i-TREATMENT
10653	.	O
10654	postoperatively	O
10655	he	O
10656	did	b-OCCURRENCE
10657	well	i-OCCURRENCE
10658	and	O
10659	was	O
10660	transferred	b-OCCURRENCE
10661	to	O
10662	the	b-CLINICAL_DEPT
10663	cardiac	i-CLINICAL_DEPT
10664	surgery	i-CLINICAL_DEPT
10665	intensive	i-CLINICAL_DEPT
10666	care	i-CLINICAL_DEPT
10667	unit	i-CLINICAL_DEPT
10668	where	O
10669	he	O
10670	was	O
10671	on	O
10672	pressor	b-TREATMENT
10673	support	i-TREATMENT
10674	of	O
10675	neo-synephrine	b-TREATMENT
10676	and	O
10677	he	O
10678	was	O
10679	extubated	b-OCCURRENCE
10680	.	O
10681	the	O
10682	patient	O
10683	slowly	O
10684	weaned	O
10685	off	O
10686	neo-synephrine	b-TREATMENT
10687	as	O
10688	tolerated	O
10689	.	O
10690	he	O
10691	was	O
10692	transferred	b-OCCURRENCE
10693	to	O
10694	the	b-CLINICAL_DEPT
10695	floor	i-CLINICAL_DEPT
10696	on	O
10697	2009-05-04	b-DATE
10698	.	O
10699	his	b-TREATMENT
10700	chest	i-TREATMENT
10701	tube	i-TREATMENT
10702	had	O
10703	been	O
10704	discontinued	O
10705	.	O
10706	upon	O
10707	arrival	b-OCCURRENCE
10708	to	O
10709	the	b-CLINICAL_DEPT
10710	floor	i-CLINICAL_DEPT
10711	the	b-TREATMENT
10712	patient	i-TREATMENT
10713	's	i-TREATMENT
10714	wires	i-TREATMENT
10715	were	O
10716	discontinued	O
10717	on	O
10718	2009-05-05	b-DATE
10719	and	O
10720	his	b-TREATMENT
10721	foley	i-TREATMENT
10722	catheter	i-TREATMENT
10723	was	O
10724	discontinued	O
10725	.	O
10726	the	O
10727	patient	O
10728	was	O
10729	seen	O
10730	by	O
10731	physical	O
10732	therapy	O
10733	.	O
10734	his	b-TEST
10735	electrolytes	i-TEST
10736	were	O
10737	repleted	b-TREATMENT
10738	and	O
10739	the	O
10740	patient	O
10741	was	O
10742	discharged	b-OCCURRENCE
10743	home	O
10744	on	O
10745	2009-05-06	b-DATE
10746	after	O
10747	tolerating	b-OCCURRENCE
10748	a	i-OCCURRENCE
10749	level	i-OCCURRENCE
10750	v	i-OCCURRENCE
10751	.	O
10752	medications	O
10753	:	O
10754	his	b-TREATMENT
10755	prescriptions	i-TREATMENT
10756	shall	O
10757	include	O
10758	1.	O
10759	lopressor	b-TREATMENT
10760	25	O
10761	milligrams	O
10762	po	O
10763	bid	b-FREQUENCY
10764	.	O
10765	2.	O
10766	lipitor	b-TREATMENT
10767	20	O
10768	milligrams	O
10769	po	O
10770	q	b-FREQUENCY
10771	hs	i-FREQUENCY
10772	.	O
10773	3.	O
10774	niferex	b-TREATMENT
10775	150	O
10776	milligrams	O
10777	caplet	O
10778	one	O
10779	cap	O
10780	per	b-FREQUENCY
10781	day	i-FREQUENCY
10782	.	O
10783	4.	O
10784	protonix	b-TREATMENT
10785	40	O
10786	milligrams	O
10787	po	O
10788	q	b-FREQUENCY
10789	day	i-FREQUENCY
10790	.	O
10791	5.	O
10792	colace	b-TREATMENT
10793	100	O
10794	milligrams	O
10795	po	O
10796	bid	b-FREQUENCY
10797	.	O
10798	6.	O
10799	percocet	b-TREATMENT
10800	one	O
10801	to	O
10802	two	O
10803	tablets	O
10804	q	b-FREQUENCY
10805	four	i-FREQUENCY
10806	h	i-FREQUENCY
10807	prn	b-FREQUENCY
10808	for	O
10809	pain	b-PROBLEM
10810	.	O
10811	he	O
10812	will	O
10813	get	O
10814	60	O
10815	of	O
10816	those	O
10817	.	O
10818	7.	O
10819	plavix	b-TREATMENT
10820	75	O
10821	milligrams	O
10822	po	O
10823	q	b-FREQUENCY
10824	day	i-FREQUENCY
10825	times	i-FREQUENCY
10826	three	i-FREQUENCY
10827	months	i-FREQUENCY
10828	.	O
10829	8.	O
10830	aspirin	b-TREATMENT
10831	325	O
10832	milligrams	O
10833	po	O
10834	q	b-FREQUENCY
10835	day	i-FREQUENCY
10836	.	O
10837	9.	O
10838	lasix	b-TREATMENT
10839	20	O
10840	milligrams	O
10841	po	O
10842	times	b-FREQUENCY
10843	30	i-FREQUENCY
10844	days	i-FREQUENCY
10845	.	O
10846	10.	O
10847	kcl	b-TREATMENT
10848	20	O
10849	milliequivalents	O
10850	po	O
10851	q	b-FREQUENCY
10852	d	i-FREQUENCY
10853	times	i-FREQUENCY
10854	three	i-FREQUENCY
10855	days	i-FREQUENCY
10856	.	O
10857		O
10858	admission	b-OCCURRENCE
10859	date	O
10860	:	O
10861	2012-11-21	b-ADMISSION
10862	discharge	b-OCCURRENCE
10863	date	O
10864	:	O
10865	2012-11-28	b-DISCHARGE
10866	service	O
10867	:	O
10868	transplant	O
10869	history	O
10870	of	O
10871	present	O
10872	illness	O
10873	:	O
10874	this	O
10875	is	O
10876	a	O
10877	37-year-old	O
10878	female	O
10879	who	O
10880	presents	b-OCCURRENCE
10881	on	O
10882	an	O
10883	elective	O
10884	basis	O
10885	for	O
10886	a	b-TREATMENT
10887	living-related	i-TREATMENT
10888	kidney	i-TREATMENT
10889	transplant	i-TREATMENT
10890	.	O
10891	the	O
10892	patient	O
10893	has	O
10894	a	O
10895	history	O
10896	of	O
10897	end-stage	b-PROBLEM
10898	renal	i-PROBLEM
10899	failure	i-PROBLEM
10900	secondary	O
10901	to	O
10902	type	b-PROBLEM
10903	1	i-PROBLEM
10904	diabetes	i-PROBLEM
10905	with	O
10906	a	b-TEST
10907	baseline	i-TEST
10908	creatinine	i-TEST
10909	of	O
10910	around	O
10911	5	O
10912	.	O
10913	she	O
10914	is	O
10915	receiving	O
10916	a	b-TREATMENT
10917	kidney	i-TREATMENT
10918	from	O
10919	her	O
10920	sister	O
10921	.	O
10922	the	O
10923	patient	O
10924	has	O
10925	a	O
10926	history	O
10927	of	O
10928	hypertension	b-PROBLEM
10929	,	O
10930	coronary	b-PROBLEM
10931	artery	i-PROBLEM
10932	disease	i-PROBLEM
10933	,	O
10934	and	O
10935	insulin-dependent	b-PROBLEM
10936	diabetes	i-PROBLEM
10937	for	O
10938	32	b-DURATION
10939	years	i-DURATION
10940	.	O
10941	she	O
10942	is	O
10943	status	O
10944	post	O
10945	myocardial	b-PROBLEM
10946	infarction	i-PROBLEM
10947	in	O
10948	april	b-DATE
10949	of	i-DATE
10950	this	i-DATE
10951	year	i-DATE
10952	and	O
10953	subsequently	O
10954	underwent	O
10955	coronary	b-TREATMENT
10956	artery	i-TREATMENT
10957	bypass	i-TREATMENT
10958	surgery	i-TREATMENT
10959	.	O
10960	she	O
10961	present	b-OCCURRENCE
10962	electively	O
10963	on	O
10964	the	b-DATE
10965	morning	i-DATE
10966	of	O
10967	her	b-TREATMENT
10968	surgery	i-TREATMENT
10969	with	O
10970	no	O
10971	recent	b-OCCURRENCE
10972	changes	i-OCCURRENCE
10973	in	O
10974	her	b-PROBLEM
10975	medical	i-PROBLEM
10976	problems	i-PROBLEM
10977	.	O
10978	hospital	O
10979	course	O
10980	:	O
10981	the	O
10982	patient	O
10983	was	O
10984	admitted	b-OCCURRENCE
10985	to	O
10986	the	b-CLINICAL_DEPT
10987	preoperative	i-CLINICAL_DEPT
10988	holding	i-CLINICAL_DEPT
10989	area	i-CLINICAL_DEPT
10990	and	O
10991	taken	b-OCCURRENCE
10992	electively	O
10993	to	O
10994	the	b-CLINICAL_DEPT
10995	operating	i-CLINICAL_DEPT
10996	room	i-CLINICAL_DEPT
10997	.	O
10998	she	O
10999	underwent	O
11000	a	b-TREATMENT
11001	living-related	i-TREATMENT
11002	renal	i-TREATMENT
11003	transplant	i-TREATMENT
11004	in	O
11005	the	O
11006	right	O
11007	iliac	O
11008	fossa	O
11009	.	O
11010	the	b-TREATMENT
11011	operation	i-TREATMENT
11012	was	O
11013	somewhat	O
11014	technically	O
11015	difficult	O
11016	secondary	O
11017	to	O
11018	a	b-PROBLEM
11019	short	i-PROBLEM
11020	segment	i-PROBLEM
11021	of	i-PROBLEM
11022	ureter	i-PROBLEM
11023	which	O
11024	was	O
11025	anastomosed	b-PROBLEM
11026	over	O
11027	a	b-TREATMENT
11028	stent	i-TREATMENT
11029	to	O
11030	the	O
11031	bladder	O
11032	.	O
11033	otherwise	O
11034	,	O
11035	there	O
11036	were	O
11037	difficulties	b-PROBLEM
11038	,	O
11039	and	O
11040	estimated	b-TEST
11041	blood	i-TEST
11042	loss	i-TEST
11043	was	O
11044	minimal	O
11045	.	O
11046	she	O
11047	was	O
11048	taken	b-OCCURRENCE
11049	postoperatively	O
11050	to	O
11051	the	b-CLINICAL_DEPT
11052	recovery	i-CLINICAL_DEPT
11053	room	i-CLINICAL_DEPT
11054	already	O
11055	making	b-OCCURRENCE
11056	a	i-OCCURRENCE
11057	large	i-OCCURRENCE
11058	amount	i-OCCURRENCE
11059	of	i-OCCURRENCE
11060	urine	i-OCCURRENCE
11061	.	O
11062	intraoperatively	O
11063	,	O
11064	for	O
11065	immunosuppression	b-TREATMENT
11066	she	O
11067	received	O
11068	thymoglobulin	b-TREATMENT
11069	and	O
11070	solu-medrol	b-TREATMENT
11071	.	O
11072	she	O
11073	was	O
11074	started	O
11075	on	O
11076	prograf	b-TREATMENT
11077	and	O
11078	cellcept	b-TREATMENT
11079	in	O
11080	the	O
11081	postoperative	O
11082	period	O
11083	.	O
11084	she	O
11085	was	O
11086	also	O
11087	maintained	O
11088	on	O
11089	bactrim	b-TREATMENT
11090	postoperatively	O
11091	and	O
11092	did	O
11093	not	O
11094	require	O
11095	ganciclovir	b-TREATMENT
11096	,	O
11097	as	O
11098	she	O
11099	and	O
11100	her	O
11101	sister	O
11102	were	O
11103	cytomegalovirus	b-PROBLEM
11104	negative	O
11105	.	O
11106	the	O
11107	patient	O
11108	's	O
11109	initial	O
11110	postoperative	O
11111	course	O
11112	was	O
11113	relatively	O
11114	uneventful	b-OCCURRENCE
11115	.	O
11116	her	b-TEST
11117	creatinine	i-TEST
11118	,	O
11119	which	O
11120	was	O
11121	5	O
11122	initially	O
11123	postoperatively	O
11124	,	O
11125	slowly	O
11126	dropped	b-OCCURRENCE
11127	over	O
11128	the	b-DURATION
11129	next	i-DURATION
11130	few	i-DURATION
11131	days	i-DURATION
11132	until	O
11133	eventually	O
11134	reaching	O
11135	a	b-OCCURRENCE
11136	low	i-OCCURRENCE
11137	of	O
11138	1	O
11139	.	O
11140	she	O
11141	did	O
11142	receive	O
11143	pamidronate	b-TREATMENT
11144	on	O
11145	postoperative	b-DATE
11146	day	i-DATE
11147	one	i-DATE
11148	and	O
11149	received	O
11150	a	O
11151	total	O
11152	of	O
11153	four	b-FREQUENCY
11154	doses	i-FREQUENCY
11155	thymoglobulin	b-TREATMENT
11156	.	O
11157	her	b-TREATMENT
11158	steroid	i-TREATMENT
11159	doses	i-TREATMENT
11160	were	O
11161	slowly	b-OCCURRENCE
11162	tapered	i-OCCURRENCE
11163	over	O
11164	her	O
11165	hospital	O
11166	course	O
11167	,	O
11168	and	O
11169	her	b-TEST
11170	prograf	i-TEST
11171	level	i-TEST
11172	was	O
11173	adjusted	b-OCCURRENCE
11174	to	O
11175	maintain	O
11176	therapeutic	O
11177	values	O
11178	between	O
11179	10	O
11180	and	O
11181	15	O
11182	.	O
11183	she	O
11184	continued	O
11185	to	O
11186	make	b-OCCURRENCE
11187	good	i-OCCURRENCE
11188	urine	i-OCCURRENCE
11189	over	O
11190	the	b-DURATION
11191	first	i-DURATION
11192	few	i-DURATION
11193	days	i-DURATION
11194	and	O
11195	had	O
11196	her	b-OCCURRENCE
11197	urine	i-OCCURRENCE
11198	losses	i-OCCURRENCE
11199	replaced	O
11200	with	O
11201	intravenous	b-TREATMENT
11202	fluids	i-TREATMENT
11203	.	O
11204	on	O
11205	postoperative	b-DATE
11206	day	i-DATE
11207	three	i-DATE
11208	,	O
11209	the	O
11210	patient	O
11211	had	O
11212	an	O
11213	episode	O
11214	of	O
11215	shortness	b-PROBLEM
11216	of	i-PROBLEM
11217	breath	i-PROBLEM
11218	that	O
11219	was	O
11220	evaluated	O
11221	by	O
11222	both	O
11223	the	b-CLINICAL_DEPT
11224	renal	i-CLINICAL_DEPT
11225	and	O
11226	surgical	b-CLINICAL_DEPT
11227	residents	i-CLINICAL_DEPT
11228	.	O
11229	it	O
11230	was	O
11231	found	O
11232	that	O
11233	she	O
11234	was	O
11235	in	O
11236	acute	b-PROBLEM
11237	pulmonary	i-PROBLEM
11238	edema	i-PROBLEM
11239	and	O
11240	required	O
11241	transfer	b-OCCURRENCE
11242	to	O
11243	the	b-CLINICAL_DEPT
11244	surgical	i-CLINICAL_DEPT
11245	intensive	i-CLINICAL_DEPT
11246	care	i-CLINICAL_DEPT
11247	unit	i-CLINICAL_DEPT
11248	.	O
11249	her	b-TEST
11250	blood	i-TEST
11251	pressure	i-TEST
11252	at	O
11253	the	O
11254	time	O
11255	of	O
11256	this	b-PROBLEM
11257	incident	i-PROBLEM
11258	was	O
11259	in	O
11260	the	O
11261	range	O
11262	of	O
11263	200/120	O
11264	.	O
11265	her	b-TEST
11266	electrocardiogram	i-TEST
11267	showed	b-EVIDENTIAL
11268	no	O
11269	specific	b-PROBLEM
11270	st	i-PROBLEM
11271	changes	i-PROBLEM
11272	,	O
11273	but	O
11274	there	O
11275	was	O
11276	some	b-PROBLEM
11277	loss	i-PROBLEM
11278	of	i-PROBLEM
11279	her	i-PROBLEM
11280	r	i-PROBLEM
11281	wave	i-PROBLEM
11282	progression	i-PROBLEM
11283	laterally	i-PROBLEM
11284	.	O
11285	serial	b-TEST
11286	enzymes	i-TEST
11287	were	O
11288	drawn	O
11289	,	O
11290	and	O
11291	cardiology	O
11292	was	O
11293	consulted	O
11294	.	O
11295	with	O
11296	blood	b-TREATMENT
11297	pressure	i-TREATMENT
11298	control	i-TREATMENT
11299	via	O
11300	a	b-TREATMENT
11301	nitroglycerin	i-TREATMENT
11302	drip	i-TREATMENT
11303	and	O
11304	fluid	b-TREATMENT
11305	restriction	i-TREATMENT
11306	,	O
11307	the	O
11308	patient	O
11309	quickly	O
11310	improved	b-OCCURRENCE
11311	and	O
11312	a	O
11313	had	O
11314	a	O
11315	relatively	O
11316	short	O
11317	stay	O
11318	in	O
11319	the	b-CLINICAL_DEPT
11320	intensive	i-CLINICAL_DEPT
11321	care	i-CLINICAL_DEPT
11322	unit	i-CLINICAL_DEPT
11323	.	O
11324	throughout	O
11325	this	O
11326	time	O
11327	,	O
11328	her	b-TEST
11329	creatinine	i-TEST
11330	continued	O
11331	to	O
11332	drop	b-OCCURRENCE
11333	,	O
11334	and	O
11335	there	O
11336	was	O
11337	no	O
11338	apparent	b-PROBLEM
11339	deleterious	i-PROBLEM
11340	effect	i-PROBLEM
11341	on	O
11342	her	b-TREATMENT
11343	transplant	i-TREATMENT
11344	from	O
11345	this	b-PROBLEM
11346	episode	i-PROBLEM
11347	.	O
11348	her	b-TREATMENT
11349	beta	i-TREATMENT
11350	blocker	i-TREATMENT
11351	was	O
11352	progressively	O
11353	increased	b-OCCURRENCE
11354	,	O
11355	and	O
11356	her	b-TREATMENT
11357	nitroglycerin	i-TREATMENT
11358	drip	i-TREATMENT
11359	was	O
11360	weaned	b-OCCURRENCE
11361	down	i-OCCURRENCE
11362	.	O
11363	two	b-DATE
11364	days	i-DATE
11365	after	O
11366	this	b-PROBLEM
11367	event	i-PROBLEM
11368	,	O
11369	she	O
11370	underwent	O
11371	an	b-TEST
11372	echocardiogram	i-TEST
11373	which	O
11374	was	O
11375	significant	O
11376	for	O
11377	slightly	b-PROBLEM
11378	depressed	i-PROBLEM
11379	left	i-PROBLEM
11380	ventricular	i-PROBLEM
11381	systolic	i-PROBLEM
11382	function	i-PROBLEM
11383	with	O
11384	severe	b-PROBLEM
11385	posterior	i-PROBLEM
11386	wall	i-PROBLEM
11387	hypokinesis	i-PROBLEM
11388	.	O
11389	this	O
11390	was	O
11391	a	b-OCCURRENCE
11392	change	i-OCCURRENCE
11393	from	O
11394	her	b-TEST
11395	prior	i-TEST
11396	echocardiogram	i-TEST
11397	and	O
11398	demonstrated	b-EVIDENTIAL
11399	evidence	O
11400	of	O
11401	a	b-PROBLEM
11402	small	i-PROBLEM
11403	myocardial	i-PROBLEM
11404	infarction	i-PROBLEM
11405	.	O
11406	clinically	O
11407	,	O
11408	she	O
11409	did	O
11410	much	b-OCCURRENCE
11411	better	i-OCCURRENCE
11412	and	O
11413	her	b-TEST
11414	blood	i-TEST
11415	pressure	i-TEST
11416	was	O
11417	optimized	b-TREATMENT
11418	prior	O
11419	to	O
11420	discharge	b-OCCURRENCE
11421	.	O
11422	she	O
11423	was	O
11424	transferred	b-OCCURRENCE
11425	out	O
11426	of	O
11427	the	b-CLINICAL_DEPT
11428	intensive	i-CLINICAL_DEPT
11429	care	i-CLINICAL_DEPT
11430	unit	i-CLINICAL_DEPT
11431	on	O
11432	postoperative	b-DATE
11433	day	i-DATE
11434	five	i-DATE
11435	and	O
11436	was	O
11437	stable	b-OCCURRENCE
11438	on	O
11439	the	b-CLINICAL_DEPT
11440	floor	i-CLINICAL_DEPT
11441	for	O
11442	the	b-DURATION
11443	next	i-DURATION
11444	two	i-DURATION
11445	days	i-DURATION
11446	.	i-DURATION
11447		O
11448	admission	b-OCCURRENCE
11449	date	O
11450	:	O
11451	2012-01-20	b-ADMISSION
11452	discharge	b-OCCURRENCE
11453	date	O
11454	:	O
11455	2012-01-23	b-DISCHARGE
11456	service	O
11457	:	O
11458	urology	O
11459	history	O
11460	of	O
11461	present	O
11462	illness	O
11463	:	O
11464	the	O
11465	patient	O
11466	is	O
11467	a	O
11468	64	O
11469	year	O
11470	old	O
11471	gentleman	O
11472	with	O
11473	a	O
11474	history	O
11475	of	O
11476	elevated	b-PROBLEM
11477	psa	i-PROBLEM
11478	,	O
11479	prostate	b-PROBLEM
11480	cancer	i-PROBLEM
11481	.	O
11482	he	O
11483	was	O
11484	diagnosed	b-OCCURRENCE
11485	with	O
11486	needle	b-TEST
11487	biopsy	i-TEST
11488	on	O
11489	either	O
11490	side	O
11491	of	O
11492	the	O
11493	prostate	O
11494	with	O
11495	3+3	O
11496	equals	O
11497	6	O
11498	on	O
11499	the	O
11500	right	O
11501	side	O
11502	and	O
11503	3+4	O
11504	equals	O
11505	7	O
11506	on	O
11507	the	O
11508	left	O
11509	side	O
11510	.	O
11511	hospital	O
11512	course	O
11513	:	O
11514	the	O
11515	patient	O
11516	underwent	O
11517	radical	b-TREATMENT
11518	retropubic	i-TREATMENT
11519	prostatectomy	i-TREATMENT
11520	on	O
11521	2012-01-20	b-DATE
11522	.	O
11523	doctor	O
11524	marie	O
11525	anderson	O
11526	performed	O
11527	the	b-TREATMENT
11528	surgery	i-TREATMENT
11529	.	O
11530	the	O
11531	patient	O
11532	tolerated	b-OCCURRENCE
11533	the	b-TREATMENT
11534	procedure	i-TREATMENT
11535	well	b-OCCURRENCE
11536	.	O
11537	on	O
11538	postoperative	b-DATE
11539	day	i-DATE
11540	number	i-DATE
11541	one	i-DATE
11542	,	O
11543	he	O
11544	was	O
11545	administered	O
11546	1	O
11547	mg	O
11548	coumadin	b-TREATMENT
11549	per	O
11550	protocol	O
11551	as	O
11552	well	O
11553	as	O
11554	on	O
11555	the	b-DATE
11556	operative	i-DATE
11557	day	i-DATE
11558	1	O
11559	mg	O
11560	of	O
11561	coumadin	b-TREATMENT
11562	.	O
11563	the	O
11564	patient	O
11565	was	O
11566	advanced	b-OCCURRENCE
11567	to	O
11568	regular	b-OCCURRENCE
11569	diet	i-OCCURRENCE
11570	on	O
11571	postoperative	b-DATE
11572	day	i-DATE
11573	one	i-DATE
11574	.	O
11575	his	b-TEST
11576	laboratories	i-TEST
11577	were	O
11578	checked	O
11579	and	O
11580	his	b-TEST
11581	hematocrit	i-TEST
11582	was	O
11583	noted	b-EVIDENTIAL
11584	to	O
11585	be	O
11586	stable	b-OCCURRENCE
11587	.	O
11588	he	O
11589	was	O
11590	made	O
11591	to	O
11592	ambulate	b-OCCURRENCE
11593	on	O
11594	postoperative	b-DATE
11595	day	i-DATE
11596	one	i-DATE
11597	.	O
11598	his	b-PROBLEM
11599	pain	i-PROBLEM
11600	was	O
11601	well	b-OCCURRENCE
11602	controlled	i-OCCURRENCE
11603	with	O
11604	oral	b-TREATMENT
11605	medication	i-TREATMENT
11606	at	O
11607	this	O
11608	time	O
11609	.	O
11610	on	O
11611	postoperative	b-DATE
11612	day	i-DATE
11613	two	i-DATE
11614	,	O
11615	he	O
11616	continued	O
11617	to	O
11618	convalesce	b-OCCURRENCE
11619	as	O
11620	planned	O
11621	.	O
11622	his	b-TREATMENT
11623	intravenous	i-TREATMENT
11624	fluids	i-TREATMENT
11625	were	O
11626	discontinued	O
11627	at	O
11628	this	O
11629	time	O
11630	.	O
11631	he	O
11632	was	O
11633	on	O
11634	a	b-OCCURRENCE
11635	house	i-OCCURRENCE
11636	diet	i-OCCURRENCE
11637	and	O
11638	tolerating	b-OCCURRENCE
11639	it	b-OCCURRENCE
11640	well	i-OCCURRENCE
11641	at	O
11642	this	O
11643	time	O
11644	as	O
11645	well	O
11646	.	O
11647	his	b-TREATMENT
11648	penrose	i-TREATMENT
11649	drain	i-TREATMENT
11650	was	O
11651	discontinued	O
11652	at	O
11653	this	O
11654	time	O
11655	.	O
11656	he	O
11657	was	O
11658	ready	O
11659	for	O
11660	discharge	b-OCCURRENCE
11661	home	O
11662	on	O
11663	postoperative	b-DATE
11664	day	i-DATE
11665	three	i-DATE
11666	.	O
11667	he	O
11668	was	O
11669	discharged	b-OCCURRENCE
11670	home	O
11671	with	O
11672	a	b-TREATMENT
11673	foley	i-TREATMENT
11674	catheter	i-TREATMENT
11675	and	O
11676	he	O
11677	will	O
11678	follow-up	b-OCCURRENCE
11679	with	O
11680	doctor	O
11681	ross	O
11682	in	O
11683	one	b-DATE
11684	to	i-DATE
11685	two	i-DATE
11686	weeks	i-DATE
11687	.	O
11688	complications	O
11689	during	O
11690	stay	O
11691	:	O
11692	none	O
11693	.	O
11694	condition	O
11695	on	O
11696	discharge	b-OCCURRENCE
11697	:	O
11698	stable	b-OCCURRENCE
11699	.	O
11700	discharge	O
11701	status	O
11702	:	O
11703	to	O
11704	home	O
11705	.	O
11706	terry	O
11707	cr	O
11708	dennis	O
11709	,	O
11710	md	O
11711	68-233	O
11712	dictated	O
11713	by	O
11714	:	O
11715	tracy	O
11716	c	O
11717	rea	O
11718	,	O
11719	md	O
11720	medquist36	O
11721	d	O
11722	:	O
11723	2012-04-28	O
11724	17:18	O
11725	t	O
11726	:	O
11727	2012-05-01	O
11728	20:32	O
11729	job	O
11730	#:	O
11731	21454	O
11732	signed	O
11733	electronically	O
11734	by	O
11735	:	O
11736	doctor	O
11737	antonio	O
11738	hall	O
11739	on	O
11740	:	O
11741	fri	O
11742	2012-05-04	O
11743	7:48	O
11744	am	O
11745	(	O
11746	end	O
11747	of	O
11748	report	O
11749	)	O
11750		O
11751	admission	b-OCCURRENCE
11752	date	O
11753	:	O
11754	2016-08-08	b-ADMISSION
11755	discharge	b-OCCURRENCE
11756	date	O
11757	:	O
11758	2016-08-15	b-DISCHARGE
11759	discharge	b-OCCURRENCE
11760	date	O
11761	:	O
11762	2016-08-15	b-DATE
11763	history	O
11764	of	O
11765	present	O
11766	illness	O
11767	:	O
11768	the	O
11769	patient	O
11770	is	O
11771	a	O
11772	37	O
11773	year	O
11774	old	O
11775	lady	O
11776	with	O
11777	type	b-PROBLEM
11778	1	i-PROBLEM
11779	diabetes	i-PROBLEM
11780	mellitus	i-PROBLEM
11781	,	O
11782	who	O
11783	is	O
11784	four	b-DURATION
11785	months	i-DURATION
11786	postcadaveric	b-TREATMENT
11787	kidney	i-TREATMENT
11788	transplantation	i-TREATMENT
11789	and	O
11790	now	O
11791	has	O
11792	good	b-OCCURRENCE
11793	graft	i-OCCURRENCE
11794	function	i-OCCURRENCE
11795	.	O
11796	she	O
11797	presents	b-EVIDENTIAL
11798	for	O
11799	cadaveric	b-TREATMENT
11800	pancreas	i-TREATMENT
11801	transplantation	i-TREATMENT
11802	.	O
11803	her	b-PROBLEM
11804	diabetes	i-PROBLEM
11805	mellitus	i-PROBLEM
11806	has	O
11807	been	O
11808	complicated	O
11809	by	O
11810	retinopathy	b-PROBLEM
11811	and	O
11812	nephropathy	b-PROBLEM
11813	as	O
11814	well	O
11815	as	O
11816	peripheral	b-PROBLEM
11817	neuropathy	i-PROBLEM
11818	.	O
11819	she	O
11820	takes	O
11821	14	O
11822	units	O
11823	of	O
11824	nph	b-TREATMENT
11825	insulin	i-TREATMENT
11826	twice	b-FREQUENCY
11827	a	i-FREQUENCY
11828	day	i-FREQUENCY
11829	supplementing	O
11830	with	O
11831	a	b-TREATMENT
11832	sliding	i-TREATMENT
11833	scale	i-TREATMENT
11834	.	O
11835	hospital	O
11836	course	O
11837	:	O
11838	she	O
11839	underwent	O
11840	cadaveric	b-TREATMENT
11841	pancreas	i-TREATMENT
11842	transplantation	i-TREATMENT
11843	without	O
11844	complication	b-PROBLEM
11845	.	O
11846	she	O
11847	received	O
11848	induction	b-TREATMENT
11849	therapy	i-TREATMENT
11850	with	O
11851	thymoglobulin	b-TREATMENT
11852	intraoperative	O
11853	and	O
11854	postoperatively	O
11855	for	O
11856	five	b-DURATION
11857	days	i-DURATION
11858	.	O
11859	she	O
11860	was	O
11861	kept	O
11862	on	O
11863	a	b-TREATMENT
11864	similar	i-TREATMENT
11865	immunosuppressive	i-TREATMENT
11866	regimen	i-TREATMENT
11867	as	O
11868	with	O
11869	her	b-TREATMENT
11870	kidney	i-TREATMENT
11871	transplant	i-TREATMENT
11872	.	O
11873	she	O
11874	had	O
11875	excellent	b-OCCURRENCE
11876	pancreas	i-OCCURRENCE
11877	graft	i-OCCURRENCE
11878	function	i-OCCURRENCE
11879	immediately	O
11880	.	O
11881	her	b-OCCURRENCE
11882	renal	i-OCCURRENCE
11883	function	i-OCCURRENCE
11884	also	O
11885	remained	b-OCCURRENCE
11886	stable	i-OCCURRENCE
11887	in	O
11888	the	O
11889	perioperative	O
11890	period	O
11891	.	O
11892	she	O
11893	was	O
11894	quickly	O
11895	placed	O
11896	on	O
11897	a	b-TREATMENT
11898	diet	i-TREATMENT
11899	and	O
11900	advanced	b-TREATMENT
11901	to	i-TREATMENT
11902	regular	i-TREATMENT
11903	diet	i-TREATMENT
11904	.	O
11905	she	O
11906	was	O
11907	discharged	b-OCCURRENCE
11908	home	O
11909	in	O
11910	stable	b-TEST
11911	condition	i-TEST
11912	on	O
11913	postoperative	b-DATE
11914	day	i-DATE
11915	six	i-DATE
11916	.	O
11917		O
11918	admission	b-OCCURRENCE
11919	date	O
11920	:	O
11921	2018-12-04	b-ADMISSION
11922	discharge	b-OCCURRENCE
11923	date	O
11924	:	O
11925	2018-12-12	b-DISCHARGE
11926	service	O
11927	:	O
11928	obstetrics/gynecology	O
11929	history	O
11930	of	O
11931	present	O
11932	illness	O
11933	:	O
11934	34	O
11935	yo	O
11936	g3p3	b-OCCURRENCE
11937	with	O
11938	pelvic	b-PROBLEM
11939	organ	i-PROBLEM
11940	prolapse	i-PROBLEM
11941	after	O
11942	her	b-OCCURRENCE
11943	second	i-OCCURRENCE
11944	delivery;	i-OCCURRENCE
11945	after	O
11946	her	b-OCCURRENCE
11947	third	i-OCCURRENCE
11948	delivery	i-OCCURRENCE
11949	it	O
11950	became	O
11951	much	b-PROBLEM
11952	worse	i-PROBLEM
11953	.	O
11954	she	O
11955	feels	b-EVIDENTIAL
11956	like_	O
11957	everything	O
11958	is	O
11959	falling	b-PROBLEM
11960	out.	i-PROBLEM
11961		O
11962	she	O
11963	urinates	b-PROBLEM
11964	frequently	i-PROBLEM
11965	,	O
11966	but	O
11967	occasionally	O
11968	the	O
11969	urine	O
11970	is	O
11971	very	b-PROBLEM
11972	slow	i-PROBLEM
11973	to	i-PROBLEM
11974	start	i-PROBLEM
11975	.	O
11976	she	O
11977	is	O
11978	unable	O
11979	to	O
11980	run	b-OCCURRENCE
11981	without	O
11982	losing	b-PROBLEM
11983	urine	i-PROBLEM
11984	.	O
11985	the	b-PROBLEM
11986	prolapse	i-PROBLEM
11987	is	O
11988	especailly	O
11989	large	b-PROBLEM
11990	and	i-PROBLEM
11991	uncomfotable	i-PROBLEM
11992	when	O
11993	she	O
11994	tries	b-OCCURRENCE
11995	to	i-OCCURRENCE
11996	move	i-OCCURRENCE
11997	her	i-OCCURRENCE
11998	bowels	i-OCCURRENCE
11999	and	O
12000	it	O
12001	is	O
12002	easier	O
12003	for	O
12004	her	O
12005	to	O
12006	do	O
12007	sowhile	O
12008	standing	b-OCCURRENCE
12009	rather	O
12010	than	O
12011	sitting	O
12012	.	O
12013	she	O
12014	has	O
12015	deep	b-PROBLEM
12016	pain	i-PROBLEM
12017	in	O
12018	intercourse	b-OCCURRENCE
12019	.	O
12020	brief	O
12021	hospital	O
12022	course	O
12023	:	O
12024	the	O
12025	patient	O
12026	was	O
12027	taken	O
12028	to	O
12029	the	b-CLINICAL_DEPT
12030	operating	i-CLINICAL_DEPT
12031	room	i-CLINICAL_DEPT
12032	on	O
12033	2018-12-04	b-DATE
12034	for	O
12035	tvh	b-TREATMENT
12036	,	O
12037	sacrospinous	b-TREATMENT
12038	fixation	i-TREATMENT
12039	,	O
12040	sparc	b-TREATMENT
12041	,	O
12042	anterior	b-TREATMENT
12043	and	i-TREATMENT
12044	posterior	i-TREATMENT
12045	repair	i-TREATMENT
12046	with	i-TREATMENT
12047	mesh	i-TREATMENT
12048	,	O
12049	cystoscopy;	b-TEST
12050	for	O
12051	pelvic	b-PROBLEM
12052	organ	i-PROBLEM
12053	prolapse	i-PROBLEM
12054	.	O
12055	there	O
12056	were	O
12057	no	O
12058	intraoperative	b-PROBLEM
12059	complications	i-PROBLEM
12060	and	O
12061	the	O
12062	surgical	O
12063	field	O
12064	was	O
12065	hemostatic	b-OCCURRENCE
12066	at	O
12067	the	O
12068	conclusion	O
12069	of	O
12070	the	O
12071	case	O
12072	(	O
12073	see	O
12074	operative	O
12075	report	O
12076	for	O
12077	full	O
12078	description	O
12079	)	O
12080	.	O
12081	the	O
12082	patient	O
12083	tolerated	b-OCCURRENCE
12084	the	b-TREATMENT
12085	procedure	i-TREATMENT
12086	well	O
12087	and	O
12088	was	O
12089	stable	b-OCCURRENCE
12090	in	O
12091	the	b-CLINICAL_DEPT
12092	pacu	i-CLINICAL_DEPT
12093	and	O
12094	admitted	b-OCCURRENCE
12095	to	O
12096	the	b-CLINICAL_DEPT
12097	cmed	i-CLINICAL_DEPT
12098	ccu	i-CLINICAL_DEPT
12099	floor	i-CLINICAL_DEPT
12100	for	O
12101	routine	b-TREATMENT
12102	care	i-TREATMENT
12103	.	O
12104	at	O
12105	1645	b-TIME
12106	12-04	i-TIME
12107	,	O
12108	the	O
12109	patient	O
12110	was	O
12111	noted	O
12112	to	O
12113	be	O
12114	hypotensive	b-PROBLEM
12115	to	O
12116	70/40	O
12117	hr	b-TEST
12118	84	O
12119	with	O
12120	symptoms	b-PROBLEM
12121	of	i-PROBLEM
12122	lightheadedness	i-PROBLEM
12123	while	O
12124	lying	O
12125	supine	O
12126	.	O
12127	there	O
12128	was	O
12129	no	O
12130	active	b-PROBLEM
12131	bleeding	i-PROBLEM
12132	noted	O
12133	at	O
12134	the	O
12135	surgical	O
12136	site	O
12137	on	O
12138	examination	b-TEST
12139	.	O
12140	a	b-TEST
12141	stat	i-TEST
12142	hct	i-TEST
12143	drawn	O
12144	at	O
12145	this	O
12146	time	O
12147	was	O
12148	31.2	O
12149	.	O
12150	the	O
12151	patient	O
12152	was	O
12153	re-evalutated	b-TEST
12154	at	O
12155	2000	b-TIME
12156	and	O
12157	was	O
12158	found	O
12159	to	O
12160	be	O
12161	tacchycardic	b-PROBLEM
12162	to	O
12163	115	O
12164	with	O
12165	bp	b-TEST
12166	104/50	O
12167	using	O
12168	a	O
12169	manual	O
12170	cuff	O
12171	.	O
12172	urine	b-TEST
12173	output	i-TEST
12174	during	O
12175	the	b-DURATION
12176	prior	i-DURATION
12177	two	i-DURATION
12178	hours	i-DURATION
12179	had	O
12180	been	O
12181	50cc	O
12182	and	O
12183	24cc	O
12184	.	O
12185	a	b-TEST
12186	stat	i-TEST
12187	hct	i-TEST
12188	drawn	O
12189	at	O
12190	this	O
12191	time	O
12192	was	O
12193	19.5	O
12194	.	O
12195	the	O
12196	clinical	O
12197	picture	O
12198	was	O
12199	concerning	O
12200	for	O
12201	a	b-PROBLEM
12202	post-operative	i-PROBLEM
12203	hematoma	i-PROBLEM
12204	.	O
12205	the	b-CLINICAL_DEPT
12206	icu	i-CLINICAL_DEPT
12207	was	O
12208	alerted	b-OCCURRENCE
12209	to	O
12210	the	O
12211	patient	O
12212	's	O
12213	disposition	O
12214	and	O
12215	the	b-CLINICAL_DEPT
12216	operating	i-CLINICAL_DEPT
12217	room	i-CLINICAL_DEPT
12218	was	O
12219	activated	b-OCCURRENCE
12220	for	O
12221	urgent	b-TEST
12222	re-exploration	i-TEST
12223	.	O
12224	the	O
12225	patient	O
12226	was	O
12227	taken	O
12228	to	O
12229	the	b-CLINICAL_DEPT
12230	or	i-CLINICAL_DEPT
12231	on	O
12232	pod#0	b-DATE
12233	for	O
12234	re-exploration	b-TEST
12235	with	i-TEST
12236	incision	i-TEST
12237	at	O
12238	2243	b-DATE
12239	.	O
12240	exploratory	b-TEST
12241	laparotomy	i-TEST
12242	revealed	b-EVIDENTIAL
12243	hemoperitonium	b-PROBLEM
12244	and	O
12245	approximately	O
12246	1	O
12247	l	O
12248	of	O
12249	blood	b-PROBLEM
12250	was	O
12251	evacuated	b-TREATMENT
12252	.	O
12253	there	O
12254	was	O
12255	approximately	O
12256	500cc	O
12257	of	O
12258	retroperitoneal	b-PROBLEM
12259	clot	i-PROBLEM
12260	.	O
12261	despite	O
12262	laparotomy	b-TEST
12263	and	O
12264	re-exploration	b-TEST
12265	through	i-TEST
12266	the	i-TEST
12267	vaginal	i-TEST
12268	cuff	i-TEST
12269	,	O
12270	no	O
12271	source	b-PROBLEM
12272	for	O
12273	the	b-PROBLEM
12274	bleeding	i-PROBLEM
12275	could	O
12276	be	O
12277	found	O
12278	.	O
12279	at	O
12280	the	O
12281	conclusion	O
12282	of	O
12283	the	O
12284	case	O
12285	,	O
12286	the	O
12287	patient	O
12288	continued	b-PROBLEM
12289	to	i-PROBLEM
12290	bleed	i-PROBLEM
12291	,	O
12292	allbeit	O
12293	at	O
12294	a	O
12295	less	O
12296	brisk	O
12297	pace	O
12298	.	O
12299	the	b-TREATMENT
12300	endotracheal	i-TREATMENT
12301	tube	i-TREATMENT
12302	was	O
12303	left	O
12304	in	O
12305	place	O
12306	.	O
12307	intraoperatively	b-TREATMENT
12308	,	O
12309	the	O
12310	patient	O
12311	recieved	O
12312	5u	O
12313	prbc	b-TREATMENT
12314	.	O
12315	ir	O
12316	was	O
12317	consulted	b-OCCURRENCE
12318	to	O
12319	identify	b-OCCURRENCE
12320	the	b-PROBLEM
12321	bleeding	i-PROBLEM
12322	vessel	i-PROBLEM
12323	with	O
12324	angiography	b-TEST
12325	,	O
12326	then	O
12327	perform	O
12328	embolization	b-TREATMENT
12329	.	O
12330	tagged	b-TEST
12331	cell	i-TEST
12332	and	i-TEST
12333	angiographic	i-TEST
12334	studies	i-TEST
12335	performed	O
12336	immediately	O
12337	after	O
12338	re-exploration	b-TEST
12339	on	O
12340	12-05	b-DATE
12341	did	O
12342	not	O
12343	indetify	b-OCCURRENCE
12344	active	b-PROBLEM
12345	bleeding	i-PROBLEM
12346	and	O
12347	no	O
12348	emobolization	b-TREATMENT
12349	was	O
12350	indicated	O
12351	.	O
12352	the	O
12353	patient	O
12354	was	O
12355	stable	b-OCCURRENCE
12356	and	O
12357	remained	O
12358	intubated	b-TREATMENT
12359	.	O
12360	the	O
12361	patient	O
12362	was	O
12363	admitted	b-OCCURRENCE
12364	to	O
12365	the	b-CLINICAL_DEPT
12366	icu	i-CLINICAL_DEPT
12367	for	O
12368	further	b-TREATMENT
12369	care	i-TREATMENT
12370	.	O
12371	the	O
12372	patient	O
12373	's	O
12374	icu	b-OCCURRENCE
12375	course	i-OCCURRENCE
12376	was	O
12377	uneventful	b-OCCURRENCE
12378	.	O
12379	there	O
12380	was	O
12381	no	O
12382	evidence	O
12383	of	O
12384	continued	O
12385	bleeding	b-PROBLEM
12386	and	O
12387	her	b-TEST
12388	hct	i-TEST
12389	remained	O
12390	stable	b-OCCURRENCE
12391	around	O
12392	30	O
12393	.	O
12394	the	O
12395	pt	O
12396	self-extubated	b-PROBLEM
12397	on	O
12398	pod	b-DATE
12399	#1	i-DATE
12400	.	O
12401	the	O
12402	patient	O
12403	developed	O
12404	a	b-PROBLEM
12405	low	i-PROBLEM
12406	grade	i-PROBLEM
12407	fever	i-PROBLEM
12408	to	O
12409	100.1	O
12410	on	O
12411	pod#1	b-DATE
12412	which	O
12413	persisted	O
12414	to	O
12415	pod#2	b-DATE
12416	and	O
12417	imperic	b-TREATMENT
12418	treatment	i-TREATMENT
12419	with	O
12420	gent/clinda	b-TREATMENT
12421	was	O
12422	started	O
12423	.	O
12424	the	O
12425	patient	O
12426	was	O
12427	stable	b-OCCURRENCE
12428	for	O
12429	transfer	b-OCCURRENCE
12430	to	O
12431	the	b-CLINICAL_DEPT
12432	cmed	i-CLINICAL_DEPT
12433	floor	i-CLINICAL_DEPT
12434	on	O
12435	pod#3	b-DATE
12436	.	O
12437	antibiotics	b-TREATMENT
12438	were	O
12439	discontinued	O
12440	on	O
12441	pod#8	b-DATE
12442	and	O
12443	pt	O
12444	remained	O
12445	afebrile	b-PROBLEM
12446	thereafter	O
12447	.	O
12448	on	O
12449	pod#9	b-DATE
12450	,	O
12451	the	O
12452	patient	O
12453	was	O
12454	afebrile	b-PROBLEM
12455	,	O
12456	tolerating	b-OCCURRENCE
12457	a	b-TREATMENT
12458	regular	i-TREATMENT
12459	diet	i-TREATMENT
12460	,	O
12461	ambultating	b-OCCURRENCE
12462	without	O
12463	difficulty	b-PROBLEM
12464	and	O
12465	voiding	b-OCCURRENCE
12466	spontaneously	O
12467	.	O
12468	she	O
12469	was	O
12470	discharged	b-OCCURRENCE
12471	home	O
12472	with	O
12473	follow-up	b-OCCURRENCE
12474	in	O
12475	two	b-DURATION
12476	weeks	i-DURATION
12477	.	O
12478		O
12479	admission	b-OCCURRENCE
12480	date	O
12481	:	O
12482	01/03/1997	b-ADMISSION
12483	discharge	b-OCCURRENCE
12484	date	O
12485	:	O
12486	01/07/1997	b-DISCHARGE
12487	discharge	b-OCCURRENCE
12488	date	O
12489	:	O
12490	01/07/1997	b-DATE
12491	history	O
12492	of	O
12493	present	O
12494	illness	O
12495	:	O
12496	the	O
12497	patient	O
12498	is	O
12499	a	O
12500	59	O
12501	year	O
12502	old	O
12503	gentleman	O
12504	who	O
12505	experienced	O
12506	a	b-PROBLEM
12507	flash	i-PROBLEM
12508	burn	i-PROBLEM
12509	from	O
12510	grease	O
12511	while	O
12512	working	O
12513	on	O
12514	a	O
12515	stove	O
12516	on	O
12517	the	b-DATE
12518	night	i-DATE
12519	prior	O
12520	to	O
12521	admission	b-OCCURRENCE
12522	.	O
12523	the	O
12524	patient	O
12525	at	O
12526	that	O
12527	time	O
12528	treated	b-TREATMENT
12529	himself	O
12530	symptomatically	O
12531	at	O
12532	home	O
12533	but	O
12534	presented	b-OCCURRENCE
12535	to	O
12536	roing	b-CLINICAL_DEPT
12537	hospital	i-CLINICAL_DEPT
12538	on	O
12539	the	b-DATE
12540	day	i-DATE
12541	after	O
12542	the	b-PROBLEM
12543	event	i-PROBLEM
12544	and	O
12545	was	O
12546	transferred	b-OCCURRENCE
12547	to	O
12548	the	b-CLINICAL_DEPT
12549	nimaconwood	i-CLINICAL_DEPT
12550	valley	i-CLINICAL_DEPT
12551	hospital	i-CLINICAL_DEPT
12552	immediately	O
12553	for	O
12554	evaluation	b-TEST
12555	because	O
12556	of	O
12557	his	b-PROBLEM
12558	extensive	i-PROBLEM
12559	burns	i-PROBLEM
12560	.	O
12561	the	O
12562	patient	O
12563	was	O
12564	walking	b-OCCURRENCE
12565	,	O
12566	talking	b-OCCURRENCE
12567	,	O
12568	and	O
12569	was	O
12570	breathing	b-OCCURRENCE
12571	without	O
12572	difficulty	b-PROBLEM
12573	on	O
12574	arrival	b-OCCURRENCE
12575	.	O
12576	past	O
12577	surgical	O
12578	history	O
12579	:	O
12580	no	O
12581	significant	O
12582	history	O
12583	.	O
12584	hospital	O
12585	course	O
12586	:	O
12587	the	O
12588	patient	O
12589	was	O
12590	taken	O
12591	from	O
12592	the	b-CLINICAL_DEPT
12593	emergency	i-CLINICAL_DEPT
12594	room	i-CLINICAL_DEPT
12595	and	O
12596	transferred	b-OCCURRENCE
12597	to	O
12598	the	b-CLINICAL_DEPT
12599	surgical	i-CLINICAL_DEPT
12600	intensive	i-CLINICAL_DEPT
12601	care	i-CLINICAL_DEPT
12602	unit	i-CLINICAL_DEPT
12603	for	O
12604	airway	b-TEST
12605	observation	i-TEST
12606	.	O
12607	he	O
12608	was	O
12609	given	O
12610	three	O
12611	liters	O
12612	of	O
12613	iv	b-TREATMENT
12614	hydration	i-TREATMENT
12615	with	O
12616	good	b-OCCURRENCE
12617	urine	i-OCCURRENCE
12618	output	i-OCCURRENCE
12619	response	i-OCCURRENCE
12620	.	O
12621	his	b-PROBLEM
12622	wounds	i-PROBLEM
12623	were	O
12624	dressed	O
12625	with	O
12626	antiointment	b-TREATMENT
12627	and	O
12628	xeroform	b-TREATMENT
12629	with	O
12630	the	O
12631	plan	O
12632	to	O
12633	take	O
12634	him	O
12635	to	O
12636	the	b-CLINICAL_DEPT
12637	operating	i-CLINICAL_DEPT
12638	room	i-CLINICAL_DEPT
12639	for	O
12640	debridement	b-TREATMENT
12641	under	O
12642	general	b-TREATMENT
12643	anesthesia	i-TREATMENT
12644	and	O
12645	application	b-TREATMENT
12646	of	i-TREATMENT
12647	artificial	i-TREATMENT
12648	skin	i-TREATMENT
12649	.	O
12650	the	O
12651	patient	O
12652	remained	O
12653	hemodynamically	b-OCCURRENCE
12654	stable	i-OCCURRENCE
12655	with	O
12656	good	b-OCCURRENCE
12657	urine	i-OCCURRENCE
12658	output	i-OCCURRENCE
12659	.	O
12660	while	O
12661	in	O
12662	the	b-CLINICAL_DEPT
12663	intensive	i-CLINICAL_DEPT
12664	care	i-CLINICAL_DEPT
12665	unit	i-CLINICAL_DEPT
12666	the	O
12667	patient	O
12668	was	O
12669	put	O
12670	on	O
12671	delirium	b-TREATMENT
12672	tremons	i-TREATMENT
12673	prophylaxis	i-TREATMENT
12674	with	O
12675	serax	b-TREATMENT
12676	around	O
12677	the	O
12678	clock	O
12679	.	O
12680	there	O
12681	was	O
12682	no	O
12683	evidence	b-PROBLEM
12684	while	O
12685	in	O
12686	the	b-CLINICAL_DEPT
12687	hospital	i-CLINICAL_DEPT
12688	.	O
12689	the	O
12690	patient	O
12691	was	O
12692	taken	O
12693	to	O
12694	the	b-CLINICAL_DEPT
12695	operating	i-CLINICAL_DEPT
12696	room	i-CLINICAL_DEPT
12697	on	O
12698	1/5/97	b-DATE
12699	.	O
12700	at	O
12701	that	O
12702	time	O
12703	the	O
12704	patient	O
12705	underwent	O
12706	debridement	b-TREATMENT
12707	of	O
12708	his	b-PROBLEM
12709	facial	i-PROBLEM
12710	wounds	i-PROBLEM
12711	and	O
12712	debridement	b-TREATMENT
12713	of	i-TREATMENT
12714	his	i-TREATMENT
12715	right	i-TREATMENT
12716	hand	i-TREATMENT
12717	and	i-TREATMENT
12718	forearm	i-TREATMENT
12719	with	O
12720	application	b-TREATMENT
12721	of	i-TREATMENT
12722	artificial	i-TREATMENT
12723	skin	i-TREATMENT
12724	which	O
12725	is	O
12726	the	b-TREATMENT
12727	dermagraft	i-TREATMENT
12728	tc	i-TREATMENT
12729	.	O
12730	the	O
12731	patient	O
12732	tolerated	b-OCCURRENCE
12733	the	b-TREATMENT
12734	procedure	i-TREATMENT
12735	well	b-OCCURRENCE
12736	.	O
12737	there	O
12738	were	O
12739	no	O
12740	complications	b-PROBLEM
12741	.	O
12742	postoperatively	O
12743	the	O
12744	patient	O
12745	was	O
12746	transferred	b-OCCURRENCE
12747	out	O
12748	of	O
12749	the	b-CLINICAL_DEPT
12750	intensive	i-CLINICAL_DEPT
12751	care	i-CLINICAL_DEPT
12752	unit	i-CLINICAL_DEPT
12753	to	O
12754	the	b-CLINICAL_DEPT
12755	burn	i-CLINICAL_DEPT
12756	floor	i-CLINICAL_DEPT
12757	where	O
12758	he	O
12759	received	O
12760	dressing	b-TREATMENT
12761	changes	i-TREATMENT
12762	p.r.n.	b-FREQUENCY
12763	the	O
12764	patient	O
12765	remained	O
12766	afebrile	b-PROBLEM
12767	and	O
12768	other	b-TEST
12769	vital	i-TEST
12770	signs	i-TEST
12771	were	O
12772	within	O
12773	normal	O
12774	limits	O
12775	.	O
12776	on	O
12777	the	b-DATE
12778	day	i-DATE
12779	of	O
12780	discharge	b-OCCURRENCE
12781	the	b-TREATMENT
12782	patient	i-TREATMENT
12783	&apos;s	i-TREATMENT
12784	dressing	i-TREATMENT
12785	was	O
12786	taken	O
12787	down	O
12788	completely	O
12789	and	O
12790	evaluation	b-TEST
12791	of	O
12792	the	b-TREATMENT
12793	derma	i-TREATMENT
12794	graft	i-TREATMENT
12795	was	O
12796	made	O
12797	.	O
12798	at	O
12799	that	O
12800	time	O
12801	it	b-TREATMENT
12802	appeared	O
12803	well	b-OCCURRENCE
12804	adhered	i-OCCURRENCE
12805	to	O
12806	the	O
12807	underlying	O
12808	skin	O
12809	.	O
12810	there	O
12811	was	O
12812	no	O
12813	evidence	O
12814	of	O
12815	infection	b-PROBLEM
12816	.	O
12817	the	O
12818	patient	O
12819	was	O
12820	screened	b-TEST
12821	by	O
12822	the	O
12823	rehabilitation	O
12824	facility	O
12825	and	O
12826	felt	O
12827	to	O
12828	be	O
12829	an	O
12830	acceptable	O
12831	candidate	O
12832	.	O
12833	the	O
12834	patient	O
12835	and	O
12836	his	O
12837	family	O
12838	agreed	O
12839	to	O
12840	transfer	b-OCCURRENCE
12841	from	O
12842	nimaconwood	b-CLINICAL_DEPT
12843	valley	i-CLINICAL_DEPT
12844	hospital	i-CLINICAL_DEPT
12845	to	O
12846	ianehutche	b-CLINICAL_DEPT
12847	medical	i-CLINICAL_DEPT
12848	center	i-CLINICAL_DEPT
12849	.	O
12850		O
12851	admission	b-OCCURRENCE
12852	date	O
12853	:	O
12854	2015-10-26	b-ADMISSION
12855	discharge	b-OCCURRENCE
12856	date	O
12857	:	O
12858	2015-10-30	b-DISCHARGE
12859	service	O
12860	:	O
12861	surgery	O
12862	history	O
12863	of	O
12864	present	O
12865	illness	O
12866	:	O
12867	17	O
12868	yo	O
12869	male	O
12870	pedestrian	O
12871	who	O
12872	was	O
12873	struck	b-OCCURRENCE
12874	by	i-OCCURRENCE
12875	auto	i-OCCURRENCE
12876	at	O
12877	unknown	O
12878	speed	O
12879	;	O
12880	+loc	b-PROBLEM
12881	.	O
12882	he	O
12883	was	O
12884	medflighted	b-OCCURRENCE
12885	to	O
12886	the	b-CLINICAL_DEPT
12887	hospital	i-CLINICAL_DEPT
12888	for	i-CLINICAL_DEPT
12889	orthopedics	i-CLINICAL_DEPT
12890	for	O
12891	ongoing	b-TREATMENT
12892	trauma	i-TREATMENT
12893	care	i-TREATMENT
12894	.	O
12895	upon	O
12896	arrival	b-OCCURRENCE
12897	gcs	b-TEST
12898	15	O
12899	,	O
12900	alert	b-OCCURRENCE
12901	and	O
12902	oriented	b-OCCURRENCE
12903	x3	O
12904	.	O
12905	brief	O
12906	hospital	O
12907	course	O
12908	:	O
12909	he	O
12910	was	O
12911	admitted	b-OCCURRENCE
12912	to	O
12913	the	b-CLINICAL_DEPT
12914	trauma	i-CLINICAL_DEPT
12915	service	i-CLINICAL_DEPT
12916	.	O
12917	orthopedics	b-CLINICAL_DEPT
12918	and	i-CLINICAL_DEPT
12919	neurosurgery	i-CLINICAL_DEPT
12920	were	O
12921	consulted	b-OCCURRENCE
12922	because	O
12923	of	O
12924	his	b-PROBLEM
12925	injuries	i-PROBLEM
12926	.	O
12927	his	b-PROBLEM
12928	neurosurgical	i-PROBLEM
12929	issues	i-PROBLEM
12930	were	O
12931	nonoperative	b-OCCURRENCE
12932	;	O
12933	he	O
12934	was	O
12935	loaded	O
12936	with	O
12937	dilantin	b-TREATMENT
12938	;	O
12939	serial	b-TEST
12940	head	i-TEST
12941	ct	i-TEST
12942	scans	i-TEST
12943	were	O
12944	performed	O
12945	and	O
12946	were	O
12947	stable	b-OCCURRENCE
12948	.	O
12949	he	O
12950	will	O
12951	need	O
12952	to	O
12953	follow	b-OCCURRENCE
12954	up	i-OCCURRENCE
12955	with	O
12956	doctor	O
12957	mckinney	O
12958	in	O
12959	4	b-DATE
12960	weeks	i-DATE
12961	for	O
12962	repeat	b-TEST
12963	head	i-TEST
12964	imaging	i-TEST
12965	and	O
12966	continue	O
12967	with	O
12968	dilantin	b-TREATMENT
12969	for	O
12970	one	b-DURATION
12971	month	i-DURATION
12972	.	O
12973	his	b-PROBLEM
12974	right	i-PROBLEM
12975	tib	i-PROBLEM
12976	/	i-PROBLEM
12977	fib	i-PROBLEM
12978	fracture	i-PROBLEM
12979	was	O
12980	repaired	b-TREATMENT
12981	by	O
12982	orthopedics	b-CLINICAL_DEPT
12983	on	O
12984	10-27	b-DATE
12985	;	O
12986	postoperatively	O
12987	there	O
12988	were	O
12989	no	O
12990	complications	b-PROBLEM
12991	.	O
12992	weight	b-OCCURRENCE
12993	bearing	i-OCCURRENCE
12994	status	i-OCCURRENCE
12995	was	O
12996	increased	b-OCCURRENCE
12997	to	O
12998	weight	b-OCCURRENCE
12999	bearing	i-OCCURRENCE
13000	as	i-OCCURRENCE
13001	tolerated	i-OCCURRENCE
13002	.	O
13003	he	O
13004	was	O
13005	fitted	b-TREATMENT
13006	with	O
13007	a	b-TREATMENT
13008	hinged	i-TREATMENT
13009	mcdonald	i-TREATMENT
13010	brace	i-TREATMENT
13011	for	O
13012	his	O
13013	lle	O
13014	.	O
13015	he	O
13016	will	O
13017	need	O
13018	to	O
13019	continue	O
13020	on	O
13021	lovenox	b-TREATMENT
13022	injections	i-TREATMENT
13023	for	O
13024	at	O
13025	least	O
13026	4-6	b-DURATION
13027	weeks	i-DURATION
13028	.	O
13029	he	O
13030	was	O
13031	transfused	b-TREATMENT
13032	with	O
13033	3	b-TREATMENT
13034	u	i-TREATMENT
13035	packed	i-TREATMENT
13036	cells	i-TREATMENT
13037	for	O
13038	a	b-TEST
13039	hematocrit	i-TEST
13040	of	O
13041	21	O
13042	,	O
13043	post	b-TEST
13044	transfusion	i-TEST
13045	hct	i-TEST
13046	was	O
13047	26.1	O
13048	;	O
13049	there	O
13050	was	O
13051	a	O
13052	questionable	O
13053	transfusion	b-PROBLEM
13054	reaction	i-PROBLEM
13055	at	O
13056	the	O
13057	end	O
13058	of	O
13059	his	b-TREATMENT
13060	first	i-TREATMENT
13061	unit	i-TREATMENT
13062	of	i-TREATMENT
13063	packed	i-TREATMENT
13064	cells	i-TREATMENT
13065	;	O
13066	he	O
13067	did	O
13068	subsequently	O
13069	receive	O
13070	the	b-TREATMENT
13071	remaining	i-TREATMENT
13072	2	i-TREATMENT
13073	units	i-TREATMENT
13074	without	O
13075	any	b-PROBLEM
13076	further	i-PROBLEM
13077	reaction	i-PROBLEM
13078	.	O
13079	physical	b-CLINICAL_DEPT
13080	and	i-CLINICAL_DEPT
13081	occupational	i-CLINICAL_DEPT
13082	therapy	i-CLINICAL_DEPT
13083	were	O
13084	consulted	b-OCCURRENCE
13085	and	O
13086	have	O
13087	recommended	O
13088	home	b-TREATMENT
13089	with	i-TREATMENT
13090	services	i-TREATMENT
13091	.	O
13092		O
13093	admission	b-OCCURRENCE
13094	date	O
13095	:	O
13096	01/01/98	b-ADMISSION
13097	discharge	b-OCCURRENCE
13098	date	O
13099	:	O
13100	01/07/98	b-DISCHARGE
13101	discharge	b-OCCURRENCE
13102	date	O
13103	:	O
13104	01/07/98	b-DATE
13105	history	O
13106	of	O
13107	present	O
13108	illness	O
13109	:	O
13110	mr.	O
13111	gach	O
13112	is	O
13113	an	O
13114	80	O
13115	year	O
13116	old	O
13117	man	O
13118	with	O
13119	aprevious	O
13120	history	O
13121	of	O
13122	coronary	b-PROBLEM
13123	artery	i-PROBLEM
13124	disease	i-PROBLEM
13125	who	O
13126	was	O
13127	transferred	b-OCCURRENCE
13128	from	O
13129	linghs	b-CLINICAL_DEPT
13130	county	i-CLINICAL_DEPT
13131	medical	i-CLINICAL_DEPT
13132	center	i-CLINICAL_DEPT
13133	to	O
13134	oaksgekesser/	b-CLINICAL_DEPT
13135	memorial	i-CLINICAL_DEPT
13136	hospital	i-CLINICAL_DEPT
13137	because	O
13138	of	O
13139	an	b-PROBLEM
13140	apparent	i-PROBLEM
13141	infected	i-PROBLEM
13142	wound	i-PROBLEM
13143	,	O
13144	including	O
13145	the	b-TREATMENT
13146	picc	i-TREATMENT
13147	line	i-TREATMENT
13148	in	O
13149	his	O
13150	right	O
13151	elbow	O
13152	and	O
13153	positive	b-PROBLEM
13154	blood	i-PROBLEM
13155	cultures	i-PROBLEM
13156	for	O
13157	staph.	b-PROBLEM
13158	aureus	i-PROBLEM
13159	associated	O
13160	with	O
13161	fever	b-PROBLEM
13162	.	O
13163	he	O
13164	has	O
13165	a	O
13166	history	O
13167	of	O
13168	myocardial	b-PROBLEM
13169	infarctions	i-PROBLEM
13170	in	O
13171	1981	b-DATE
13172	,	O
13173	1992	b-DATE
13174	and	O
13175	08/97	b-DATE
13176	with	O
13177	thelast	b-PROBLEM
13178	episode	i-PROBLEM
13179	complicated	O
13180	by	O
13181	anoxic	b-PROBLEM
13182	encephalopathy	i-PROBLEM
13183	.	O
13184	he	O
13185	gradually	O
13186	improved	b-OCCURRENCE
13187	but	O
13188	had	O
13189	recurrent	b-PROBLEM
13190	angina	i-PROBLEM
13191	requiring	O
13192	cardiac	b-TEST
13193	catheterization	i-TEST
13194	,	O
13195	demonstrating	b-EVIDENTIAL
13196	90%	O
13197	left	O
13198	main	O
13199	,	O
13200	95%	O
13201	ostial	O
13202	lad	O
13203	and	O
13204	30	O
13205	to	O
13206	40%	O
13207	mid-lad	O
13208	with	O
13209	an	b-PROBLEM
13210	occluded	i-PROBLEM
13211	rca	i-PROBLEM
13212	.	O
13213	cabg	b-TREATMENT
13214	surgery	i-TREATMENT
13215	with	O
13216	two	b-TREATMENT
13217	vessel	i-TREATMENT
13218	bypass	i-TREATMENT
13219	was	O
13220	done	O
13221	on	O
13222	11/18/97	b-DATE
13223	.	O
13224	he	O
13225	was	O
13226	then	O
13227	transferred	b-OCCURRENCE
13228	to	O
13229	linghs	b-CLINICAL_DEPT
13230	county	i-CLINICAL_DEPT
13231	medical	i-CLINICAL_DEPT
13232	center	i-CLINICAL_DEPT
13233	.	O
13234	a	b-TREATMENT
13235	picc	i-TREATMENT
13236	line	i-TREATMENT
13237	was	O
13238	placed	O
13239	in	O
13240	his	O
13241	left	O
13242	antecubital	O
13243	fossa	O
13244	and	O
13245	on	O
13246	the	b-DATE
13247	day	i-DATE
13248	of	O
13249	new	b-DATE
13250	years	i-DATE
13251	eve	i-DATE
13252	he	O
13253	developed	O
13254	a	b-PROBLEM
13255	fever	i-PROBLEM
13256	of	O
13257	102	O
13258	and	O
13259	became	O
13260	lethargic	b-PROBLEM
13261	.	O
13262	the	b-TREATMENT
13263	picc	i-TREATMENT
13264	line	i-TREATMENT
13265	site	i-TREATMENT
13266	was	O
13267	erythematous	b-PROBLEM
13268	.	O
13269	blood	b-TEST
13270	cultures	i-TEST
13271	grew	O
13272	out	O
13273	4	O
13274	out	O
13275	of	O
13276	4	O
13277	bottles	O
13278	for	O
13279	gram	b-PROBLEM
13280	positive	i-PROBLEM
13281	cocci	i-PROBLEM
13282	,	O
13283	which	O
13284	thereafter	O
13285	proved	O
13286	to	O
13287	be	O
13288	staph.	b-PROBLEM
13289	aureus	i-PROBLEM
13290	methicillin	b-TREATMENT
13291	sensitive	O
13292	.	O
13293	he	O
13294	had	O
13295	no	O
13296	chest	b-PROBLEM
13297	pain	i-PROBLEM
13298	,	O
13299	shortness	b-PROBLEM
13300	of	i-PROBLEM
13301	breath	i-PROBLEM
13302	or	O
13303	diarrhea	b-PROBLEM
13304	.	O
13305	hospital	O
13306	course	O
13307	and	O
13308	treatment	O
13309	:	O
13310	the	O
13311	patient	O
13312	was	O
13313	treated	O
13314	with	O
13315	intravenous	b-TREATMENT
13316	antibiotics	i-TREATMENT
13317	.	O
13318	a	b-TEST
13319	lumbar	i-TEST
13320	puncture	i-TEST
13321	was	O
13322	obtained	O
13323	which	O
13324	showed	b-EVIDENTIAL
13325	normal	b-OCCURRENCE
13326	pressure	i-OCCURRENCE
13327	and	O
13328	no	O
13329	cells	b-PROBLEM
13330	.	O
13331	the	b-TEST
13332	csf	i-TEST
13333	culture	i-TEST
13334	was	O
13335	negative	O
13336	.	O
13337	a	b-TEST
13338	stool	i-TEST
13339	assay	i-TEST
13340	was	O
13341	taken	O
13342	for	O
13343	clostridium	b-PROBLEM
13344	difficile	i-PROBLEM
13345	which	O
13346	was	O
13347	negative	O
13348	.	O
13349	the	O
13350	patient	O
13351	gradually	b-OCCURRENCE
13352	improved	i-OCCURRENCE
13353	on	O
13354	the	b-TREATMENT
13355	current	i-TREATMENT
13356	therapy	i-TREATMENT
13357	and	O
13358	was	O
13359	quite	b-OCCURRENCE
13360	awake	i-OCCURRENCE
13361	and	i-OCCURRENCE
13362	alert	i-OCCURRENCE
13363	,	O
13364	though	O
13365	still	O
13366	appeared	O
13367	to	O
13368	have	O
13369	some	O
13370	evidence	O
13371	of	O
13372	dementia	b-PROBLEM
13373	and	O
13374	disorientation	b-PROBLEM
13375	.	O
13376	he	O
13377	was	O
13378	encouraged	b-TREATMENT
13379	to	i-TREATMENT
13380	eat	i-TREATMENT
13381	and	O
13382	it	O
13383	was	O
13384	decided	O
13385	not	O
13386	to	O
13387	place	O
13388	either	O
13389	a	b-TREATMENT
13390	feeding	i-TREATMENT
13391	tube	i-TREATMENT
13392	or	O
13393	to	O
13394	start	O
13395	tpn	b-TREATMENT
13396	.	O
13397	doctor	O
13398	rhalttland	O
13399	was	O
13400	called	O
13401	at	O
13402	sondi	O
13403	memorial	O
13404	to	O
13405	update	O
13406	him	O
13407	on	O
13408	the	O
13409	patient	O
13410	&apos;s	O
13411	condition	O
13412	.	O
13413	he	O
13414	still	O
13415	needs	O
13416	much	b-TREATMENT
13417	intensive	i-TREATMENT
13418	rehabilitation	i-TREATMENT
13419	,	O
13420	encouragement	b-TREATMENT
13421	to	i-TREATMENT
13422	eat	i-TREATMENT
13423	and	O
13424	encouragement	b-TREATMENT
13425	to	i-TREATMENT
13426	get	i-TREATMENT
13427	out	i-TREATMENT
13428	of	i-TREATMENT
13429	bed	i-TREATMENT
13430	to	O
13431	use	O
13432	the	O
13433	bathroom	O
13434	rather	O
13435	than	O
13436	abed	b-TREATMENT
13437	pain	i-TREATMENT
13438	or	O
13439	a	b-TREATMENT
13440	diaper	i-TREATMENT
13441	.	O
13442	he	O
13443	is	O
13444	being	O
13445	transferred	b-OCCURRENCE
13446	to	O
13447	linghs	b-CLINICAL_DEPT
13448	county	i-CLINICAL_DEPT
13449	medical	i-CLINICAL_DEPT
13450	center	i-CLINICAL_DEPT
13451	for	O
13452	further	b-TREATMENT
13453	care	i-TREATMENT
13454	.	O
13455	condition	O
13456	:	O
13457	stable	b-OCCURRENCE
13458	and	i-OCCURRENCE
13459	improved	i-OCCURRENCE
13460	.	O
13461	lako	O
13462	c.	O
13463	warm	O
13464	,	O
13465	md	O
13466	stat	O
13467	tr	O
13468	:	O
13469	lv	O
13470	dd	O
13471	:	O
13472	01/06/98	O
13473	td	O
13474	:	O
13475	01/06/98	O
13476	7:41	O
13477	pcc	O
13478	:	O
13479	lako	O
13480	c	O
13481	warm	O
13482	,	O
13483	md	O
13484		O
13485	admission	b-OCCURRENCE
13486	date	O
13487	:	O
13488	2014-05-08	b-ADMISSION
13489	discharge	b-OCCURRENCE
13490	date	O
13491	:	O
13492	2014-05-19	b-DISCHARGE
13493	service	O
13494	:	O
13495	cardiothoracic	O
13496	history	O
13497	of	O
13498	present	O
13499	illness	O
13500	:	O
13501	68	O
13502	yo	O
13503	female	O
13504	trasnferred	b-OCCURRENCE
13505	in	O
13506	from	O
13507	catholic	b-CLINICAL_DEPT
13508	cmed	i-CLINICAL_DEPT
13509	csru.	i-CLINICAL_DEPT
13510	ctr.	i-CLINICAL_DEPT
13511	with	O
13512	periprosthetic	b-PROBLEM
13513	aortic	i-PROBLEM
13514	valve	i-PROBLEM
13515	stenosis	i-PROBLEM
13516	and	O
13517	aortic	b-PROBLEM
13518	valve	i-PROBLEM
13519	thrombus	i-PROBLEM
13520	.	O
13521	no	O
13522	cath	b-TEST
13523	done	O
13524	,	O
13525	but	O
13526	echo	b-TEST
13527	05-07	b-DATE
13528	showed	b-EVIDENTIAL
13529	ef	b-TEST
13530	60-65%	O
13531	,	O
13532	stenotic	b-PROBLEM
13533	mech.	i-PROBLEM
13534	valve	i-PROBLEM
13535	,	O
13536	mean	b-TEST
13537	gradient	i-TEST
13538	33	O
13539	mm	O
13540	,	O
13541	decreased	b-PROBLEM
13542	disc	i-PROBLEM
13543	motion	i-PROBLEM
13544	,	O
13545	mobile	b-PROBLEM
13546	mass	i-PROBLEM
13547	in	i-PROBLEM
13548	lvot	i-PROBLEM
13549	,	O
13550	mild	b-PROBLEM
13551	ai	i-PROBLEM
13552	,	O
13553	mild	b-PROBLEM
13554	to	i-PROBLEM
13555	moderate	i-PROBLEM
13556	mr	i-PROBLEM
13557	,	O
13558	trace	b-PROBLEM
13559	tr.	i-PROBLEM
13560	referred	O
13561	for	O
13562	surgical	b-TEST
13563	evaluation	i-TEST
13564	.	O
13565	brief	O
13566	hospital	O
13567	course	O
13568	:	O
13569	admitted	b-OCCURRENCE
13570	05-08	b-DATE
13571	to	O
13572	cardiology	b-CLINICAL_DEPT
13573	service	i-CLINICAL_DEPT
13574	for	O
13575	surgical	b-TEST
13576	work-up	i-TEST
13577	.	O
13578	inr	b-TEST
13579	2.7	O
13580	and	O
13581	echo	b-TEST
13582	repeated	O
13583	,	O
13584	coumadin	b-TREATMENT
13585	held	O
13586	,	O
13587	and	O
13588	heparin	b-TREATMENT
13589	drips	i-TREATMENT
13590	started	O
13591	.	O
13592	review	O
13593	of	O
13594	osh	b-TEST
13595	echo	i-TEST
13596	revealed	b-EVIDENTIAL
13597	peak	b-TEST
13598	gradient	i-TEST
13599	of	O
13600	64mm	O
13601	(	O
13602		O
13603	not	O
13604	30	O
13605	's	O
13606	)	O
13607	.	O
13608	new	b-TEST
13609	echo	i-TEST
13610	showed	b-EVIDENTIAL
13611	pannus	b-PROBLEM
13612	involving	O
13613	the	O
13614	valve	O
13615	and	O
13616	?	O
13617	thrombus	b-PROBLEM
13618	.	O
13619	seen	O
13620	by	O
13621	doctor	O
13622	laura	O
13623	of	O
13624	cardiac	O
13625	surgery	O
13626	and	O
13627	underwent	O
13628	redo	b-TREATMENT
13629	avr	i-TREATMENT
13630	with	O
13631	aortic	b-TREATMENT
13632	root	i-TREATMENT
13633	enlargement	i-TREATMENT
13634	on	O
13635	05-11	b-DATE
13636	.	O
13637	transferred	b-OCCURRENCE
13638	to	O
13639	the	b-CLINICAL_DEPT
13640	csru	i-CLINICAL_DEPT
13641	in	O
13642	stable	b-OCCURRENCE
13643	condition	i-OCCURRENCE
13644	on	O
13645	phenylephrine	b-TREATMENT
13646	and	O
13647	propofol	b-TREATMENT
13648	drips	i-TREATMENT
13649	.	O
13650	weaned	b-OCCURRENCE
13651	to	i-OCCURRENCE
13652	extubation	i-OCCURRENCE
13653	on	O
13654	pod	b-DATE
13655	#2	i-DATE
13656	and	O
13657	off	O
13658	all	b-TREATMENT
13659	drips	i-TREATMENT
13660	.	O
13661	episode	b-PROBLEM
13662	of	i-PROBLEM
13663	afib	i-PROBLEM
13664	that	b-DATE
13665	evening	i-DATE
13666	treated	O
13667	with	O
13668	amiodarone	b-TREATMENT
13669	and	O
13670	converted	O
13671	to	O
13672	sr	b-OCCURRENCE
13673	.	O
13674	transferred	b-OCCURRENCE
13675	to	O
13676	the	b-CLINICAL_DEPT
13677	floor	i-CLINICAL_DEPT
13678	on	O
13679	pod	b-DATE
13680	#3	i-DATE
13681	to	O
13682	begin	O
13683	increasing	O
13684	her	O
13685	activity	O
13686	level	O
13687	.	O
13688	chest	b-TREATMENT
13689	tubes	i-TREATMENT
13690	and	O
13691	wires	b-TREATMENT
13692	removed	b-OCCURRENCE
13693	without	O
13694	incident	b-PROBLEM
13695	.	O
13696	cleared	O
13697	for	O
13698	discharge	b-OCCURRENCE
13699	to	O
13700	home	O
13701	with	O
13702	services	O
13703	.	O
13704	pt.	O
13705	to	O
13706	make	O
13707	all	b-OCCURRENCE
13708	follow-up	i-OCCURRENCE
13709	appts.	i-OCCURRENCE
13710	per	O
13711	discharge	O
13712	instructions	O
13713	.	O
13714		O
13715	admission	b-OCCURRENCE
13716	date	O
13717	:	O
13718	2014-03-31	b-ADMISSION
13719	discharge	b-OCCURRENCE
13720	date	O
13721	:	O
13722	2014-04-09	b-DISCHARGE
13723	service	O
13724	:	O
13725	liver	O
13726	transplant	O
13727	surgery	O
13728	service	O
13729	history	O
13730	of	O
13731	present	O
13732	illness	O
13733	:	O
13734	the	O
13735	patient	O
13736	is	O
13737	a	O
13738	49	O
13739	year-old	O
13740	man	O
13741	with	O
13742	hepatitis	b-PROBLEM
13743	c	i-PROBLEM
13744	cirrhosis	i-PROBLEM
13745	complicated	O
13746	by	O
13747	encephalopathy	b-PROBLEM
13748	,	O
13749	positive	b-PROBLEM
13750	esophageal	i-PROBLEM
13751	varices	i-PROBLEM
13752	,	O
13753	now	O
13754	with	O
13755	worsening	b-PROBLEM
13756	confusion	i-PROBLEM
13757	and	O
13758	lethargy	b-PROBLEM
13759	.	O
13760	the	O
13761	patient	O
13762	has	O
13763	been	O
13764	admitted	b-OCCURRENCE
13765	5	b-FREQUENCY
13766	x	i-FREQUENCY
13767	in	O
13768	the	O
13769	past	O
13770	to	O
13771	nantucket	b-CLINICAL_DEPT
13772	cottage	i-CLINICAL_DEPT
13773	hospital	i-CLINICAL_DEPT
13774	since	O
13775	11-30	b-DATE
13776	for	O
13777	encephalopathy	b-PROBLEM
13778	.	O
13779	most	O
13780	recently	O
13781	admitted	b-OCCURRENCE
13782	on	O
13783	2014-03-19	b-DATE
13784	to	O
13785	2014-03-22	b-DATE
13786	.	O
13787	infectious	b-TEST
13788	work-up	i-TEST
13789	was	O
13790	negative	O
13791	.	O
13792	trazodone	b-TREATMENT
13793	stopped	O
13794	.	O
13795	patient	O
13796	was	O
13797	started	O
13798	on	O
13799	lactulose	b-TREATMENT
13800	and	O
13801	rifaximine	b-TREATMENT
13802	which	O
13803	improved	b-OCCURRENCE
13804	his	O
13805	mental	O
13806	status	O
13807	.	O
13808	today	b-DATE
13809	,	O
13810	on	O
13811	2014-03-03	b-DATE
13812	,	O
13813	the	O
13814	patient	O
13815	was	O
13816	seen	O
13817	in	O
13818	clinic	b-CLINICAL_DEPT
13819	with	O
13820	increased	b-PROBLEM
13821	lethargy	i-PROBLEM
13822	,	O
13823	confusion	b-PROBLEM
13824	.	O
13825	wife	O
13826	reports	b-EVIDENTIAL
13827	that	O
13828	the	O
13829	patient	O
13830	has	O
13831	a	O
13832	history	O
13833	of	O
13834	lethargy	b-PROBLEM
13835	and	O
13836	confusion	b-PROBLEM
13837	,	O
13838	similar	O
13839	to	O
13840	the	b-PROBLEM
13841	symptoms	i-PROBLEM
13842	for	O
13843	which	O
13844	the	O
13845	patient	O
13846	was	O
13847	recently	O
13848	admitted	b-OCCURRENCE
13849	.	O
13850	the	O
13851	patient	O
13852	also	O
13853	reports	b-EVIDENTIAL
13854	that	O
13855	he	O
13856	has	O
13857	had	O
13858	""""	O
13859	yellowish	b-PROBLEM
13860	eyes	i-PROBLEM
13861	,	O
13862	some	b-PROBLEM
13863	shaking	i-PROBLEM
13864	and	O
13865	his	b-OCCURRENCE
13866	breath	i-OCCURRENCE
13867	smelled	i-OCCURRENCE
13868	more	i-OCCURRENCE
13869	like	i-OCCURRENCE
13870	ammonia	i-OCCURRENCE
13871	over	O
13872	the	b-DURATION
13873	past	i-DURATION
13874	3	i-DURATION
13875	days	i-DURATION
13876	"."""	O
13877	the	O
13878	patient	O
13879	has	O
13880	been	O
13881	compliant	O
13882	with	O
13883	his	b-TREATMENT
13884	medications	i-TREATMENT
13885	.	O
13886	he	O
13887	has	O
13888	had	O
13889	one	O
13890	bowel	b-OCCURRENCE
13891	movement	i-OCCURRENCE
13892	today	b-DATE
13893	which	O
13894	is	O
13895	on	O
13896	2014-03-31	b-DATE
13897	.	O
13898	he	O
13899	has	O
13900	had	O
13901	night	b-PROBLEM
13902	sweats	i-PROBLEM
13903	for	O
13904	the	b-DURATION
13905	past	i-DURATION
13906	2	i-DURATION
13907	weeks	i-DURATION
13908	.	O
13909	he	O
13910	denies	b-EVIDENTIAL
13911	any	b-PROBLEM
13912	abdominal	i-PROBLEM
13913	pain	i-PROBLEM
13914	.	O
13915	he	O
13916	gets	O
13917	cold	b-PROBLEM
13918	easily	O
13919	but	O
13920	denies	b-EVIDENTIAL
13921	fevers	b-PROBLEM
13922	.	O
13923	his	O
13924	stools	O
13925	have	O
13926	been	O
13927	brown	O
13928	to	O
13929	green	O
13930	.	O
13931	hospital	O
13932	course	O
13933	:	O
13934	the	O
13935	patient	O
13936	was	O
13937	admitted	b-OCCURRENCE
13938	.	O
13939	patient	O
13940	continued	O
13941	on	O
13942	lactulose	b-TREATMENT
13943	.	O
13944	the	O
13945	goal	O
13946	was	O
13947	3	b-FREQUENCY
13948	to	i-FREQUENCY
13949	4	i-FREQUENCY
13950	stools	i-FREQUENCY
13951	per	i-FREQUENCY
13952	day	i-FREQUENCY
13953	.	O
13954	continue	O
13955	on	O
13956	rifaximine	b-TREATMENT
13957	.	O
13958	continue	O
13959	lasix	b-TREATMENT
13960	.	O
13961	physical	b-CLINICAL_DEPT
13962	therapy	i-CLINICAL_DEPT
13963	was	O
13964	consulted	O
13965	on	O
13966	2014-04-01	b-DATE
13967	.	O
13968	on	O
13969	2014-04-02	b-DATE
13970	,	O
13971	the	O
13972	patient	O
13973	was	O
13974	awake	b-OCCURRENCE
13975	,	O
13976	alert	b-OCCURRENCE
13977	and	O
13978	oriented	b-OCCURRENCE
13979	,	O
13980	taking	O
13981	lactulose	b-TREATMENT
13982	.	O
13983	difficulty	b-PROBLEM
13984	with	i-PROBLEM
13985	word	i-PROBLEM
13986	finding	i-PROBLEM
13987	at	O
13988	times	O
13989	.	O
13990	denies	b-EVIDENTIAL
13991	any	b-PROBLEM
13992	pain	i-PROBLEM
13993	or	O
13994	discomfort	b-PROBLEM
13995	.	O
13996	abdomen	O
13997	:	O
13998	slightly	b-PROBLEM
13999	distended	i-PROBLEM
14000	,	O
14001	nontender	b-PROBLEM
14002	.	O
14003	positive	O
14004	bowel	b-OCCURRENCE
14005	sounds	i-OCCURRENCE
14006	.	O
14007	positive	O
14008	flatus	b-OCCURRENCE
14009	.	O
14010	good	O
14011	op	O
14012	site	O
14013	.	O
14014	ultrasound	b-TEST
14015	was	O
14016	performed	O
14017	on	O
14018	2014-04-01	b-DATE
14019	demonstrating	b-EVIDENTIAL
14020	severe	b-PROBLEM
14021	portal	i-PROBLEM
14022	hypertension	i-PROBLEM
14023	with	O
14024	massive	b-PROBLEM
14025	peri	i-PROBLEM
14026	splenic	i-PROBLEM
14027	varices	i-PROBLEM
14028	and	O
14029	splenorenal	b-PROBLEM
14030	shunt	i-PROBLEM
14031	.	O
14032	portal	O
14033	vein	O
14034	was	O
14035	fully	O
14036	patent	O
14037	.	O
14038	repeat	b-PROBLEM
14039	hepato	i-PROBLEM
14040	fungal	i-PROBLEM
14041	flare	i-PROBLEM
14042	.	O
14043	on	O
14044	2014-04-04	b-DATE
14045	,	O
14046	the	b-CLINICAL_DEPT
14047	transplant	i-CLINICAL_DEPT
14048	service	i-CLINICAL_DEPT
14049	was	O
14050	consulted	O
14051	because	O
14052	the	O
14053	patient	O
14054	was	O
14055	possibly	O
14056	going	O
14057	to	O
14058	the	b-CLINICAL_DEPT
14059	operating	i-CLINICAL_DEPT
14060	room	i-CLINICAL_DEPT
14061	for	O
14062	transplant	b-TREATMENT
14063	on	O
14064	2014-04-04	b-DATE
14065	.	O
14066	the	O
14067	patient	O
14068	did	O
14069	go	O
14070	to	O
14071	operating	b-CLINICAL_DEPT
14072	room	i-CLINICAL_DEPT
14073	on	O
14074	2014-04-04	b-DATE
14075	and	O
14076	the	O
14077	patient	O
14078	had	O
14079	cadaveric	b-TREATMENT
14080	liver	i-TREATMENT
14081	transplant	i-TREATMENT
14082	performed	O
14083	by	O
14084	doctor	O
14085	michael	O
14086	sanders	O
14087	.	O
14088	please	O
14089	see	O
14090	detailed	O
14091	operative	O
14092	note	O
14093	for	O
14094	more	O
14095	information	O
14096	about	O
14097	the	b-TREATMENT
14098	procedure	i-TREATMENT
14099	.	O
14100	postoperatively	O
14101	,	O
14102	the	O
14103	patient	O
14104	was	O
14105	transferred	b-OCCURRENCE
14106	to	O
14107	the	b-CLINICAL_DEPT
14108	icu	i-CLINICAL_DEPT
14109	.	O
14110	the	O
14111	patient	O
14112	received	O
14113	mmf	b-TREATMENT
14114	1	O
14115	gram	O
14116	b.i.d.	b-FREQUENCY
14117	,	O
14118	flagyl	b-TREATMENT
14119	500	O
14120	mg	O
14121	iv	O
14122	x1	O
14123	.	O
14124	the	O
14125	patient	O
14126	also	O
14127	received	O
14128	unasyn	b-TREATMENT
14129	for	O
14130	2	b-DURATION
14131	days	i-DURATION
14132	,	O
14133	fluconazole	b-TREATMENT
14134	,	O
14135	heparin	b-TREATMENT
14136	,	O
14137	protonix	b-TREATMENT
14138	,	O
14139	insulin	b-TREATMENT
14140	,	O
14141	morphine	b-TREATMENT
14142	,	O
14143	bactrim	b-TREATMENT
14144	.	O
14145	the	O
14146	patient	O
14147	was	O
14148	on	O
14149	propofol	b-TREATMENT
14150	for	O
14151	2	b-DURATION
14152	days	i-DURATION
14153	.	O
14154	laboratory	O
14155	data	O
14156	:	O
14157	on	O
14158	2014-04-04	b-DATE
14159	,	O
14160	labs	b-TEST
14161	were	O
14162	as	O
14163	follows	O
14164	:	O
14165	wbc	b-TEST
14166	of	O
14167	8.3	O
14168	;	O
14169	hematocrit	b-TEST
14170	of	O
14171	30.6	O
14172	;	O
14173	platelets	b-TEST
14174	69	O
14175	;	O
14176	sodium	b-TEST
14177	132	O
14178	;	O
14179	3.9	O
14180	,	O
14181	102	O
14182	,	O
14183	22	O
14184	,	O
14185	serum	b-TEST
14186	creatinine	i-TEST
14187	of	O
14188	13	O
14189	and	O
14190	1.1	O
14191	.	O
14192	glucose	b-TEST
14193	114	O
14194	.	O
14195	ast	b-TEST
14196	87	O
14197	.	O
14198	alt	b-TEST
14199	44	O
14200	.	O
14201	alkaline	b-TEST
14202	phosphatase	i-TEST
14203	169	O
14204	.	O
14205	pt	b-TEST
14206	of	O
14207	20.6	O
14208	.	O
14209	ptt	b-TEST
14210	of	O
14211	38.7	O
14212	.	O
14213	inr	b-TEST
14214	of	O
14215	2.0	O
14216	.	O
14217	on	O
14218	postoperative	b-DATE
14219	day	i-DATE
14220	number	i-DATE
14221	1	i-DATE
14222	,	O
14223	duplex	b-TEST
14224	ultrasound	i-TEST
14225	of	i-TEST
14226	the	i-TEST
14227	patient	i-TEST
14228	's	i-TEST
14229	liver	i-TEST
14230	was	O
14231	performed	O
14232	demonstrating	b-EVIDENTIAL
14233	normal	b-OCCURRENCE
14234	appearing	i-OCCURRENCE
14235	portal	i-OCCURRENCE
14236	veins	i-OCCURRENCE
14237	and	i-OCCURRENCE
14238	hepatic	i-OCCURRENCE
14239	arteries	i-OCCURRENCE
14240	.	O
14241	there	O
14242	was	O
14243	normal	b-OCCURRENCE
14244	flow	i-OCCURRENCE
14245	within	O
14246	the	O
14247	middle	O
14248	hepatic	O
14249	vein	O
14250	.	O
14251	there	O
14252	appears	O
14253	to	O
14254	be	O
14255	a	b-PROBLEM
14256	decreased	i-PROBLEM
14257	and	i-PROBLEM
14258	sluggish	i-PROBLEM
14259	flow	i-PROBLEM
14260	within	i-PROBLEM
14261	the	i-PROBLEM
14262	right	i-PROBLEM
14263	and	i-PROBLEM
14264	left	i-PROBLEM
14265	hepatic	i-PROBLEM
14266	veins	i-PROBLEM
14267	with	O
14268	loss	b-PROBLEM
14269	of	i-PROBLEM
14270	normal	i-PROBLEM
14271	respiratory	i-PROBLEM
14272	variations	i-PROBLEM
14273	,	i-PROBLEM
14274	wave	i-PROBLEM
14275	forms	i-PROBLEM
14276	and	i-PROBLEM
14277	the	i-PROBLEM
14278	intrahepatic	i-PROBLEM
14279	portion	i-PROBLEM
14280	.	O
14281	additionally	O
14282	,	O
14283	there	O
14284	is	O
14285	diminished	b-PROBLEM
14286	color	i-PROBLEM
14287	flow	i-PROBLEM
14288	with	O
14289	confluence	O
14290	of	O
14291	the	O
14292	hepatic	O
14293	veins	O
14294	.	O
14295	these	O
14296	findings	O
14297	may	O
14298	reflect	O
14299	thrombus	b-PROBLEM
14300	within	i-PROBLEM
14301	the	i-PROBLEM
14302	left	i-PROBLEM
14303	and	i-PROBLEM
14304	right	i-PROBLEM
14305	hepatic	i-PROBLEM
14306	veins	i-PROBLEM
14307	.	O
14308	caval	b-PROBLEM
14309	narrowing	i-PROBLEM
14310	is	O
14311	seen	O
14312	,	O
14313	most	O
14314	likely	O
14315	correlation	O
14316	to	O
14317	clinical	O
14318	history	O
14319	is	O
14320	recommended	O
14321	and	O
14322	further	O
14323	evaluation	O
14324	of	O
14325	the	b-TEST
14326	ct	i-TEST
14327	or	O
14328	short-term	b-TEST
14329	ultrasounds	i-TEST
14330	for	O
14331	follow-up	O
14332	was	O
14333	recommended	O
14334	.	O
14335	the	b-TREATMENT
14336	feeney	i-TREATMENT
14337	gann-burlington	i-TREATMENT
14338	drain	i-TREATMENT
14339	on	O
14340	postoperative	b-DATE
14341	day	i-DATE
14342	number	i-DATE
14343	demonstrated	b-EVIDENTIAL
14344	medial	b-TEST
14345	output	i-TEST
14346	of	O
14347	780	O
14348	with	O
14349	lateral	b-TEST
14350	output	i-TEST
14351	of	O
14352	150	O
14353	.	O
14354	patient	O
14355	went	O
14356	to	O
14357	the	b-CLINICAL_DEPT
14358	floor	i-CLINICAL_DEPT
14359	and	O
14360	patient	O
14361	was	O
14362	on	O
14363	the	b-CLINICAL_DEPT
14364	floor	i-CLINICAL_DEPT
14365	on	O
14366	2014-04-07	b-DATE
14367	.	O
14368	patient	O
14369	continued	O
14370	getting	O
14371	acyclovir	b-TREATMENT
14372	,	O
14373	prednisone	b-TREATMENT
14374	,	O
14375	mmf	b-TREATMENT
14376	one	O
14377	gram	O
14378	b.i.d	b-FREQUENCY
14379	.	O
14380	the	O
14381	patient	O
14382	was	O
14383	on	O
14384	fk	b-TREATMENT
14385	2	i-TREATMENT
14386	and	O
14387	2	O
14388	that	O
14389	was	O
14390	started	O
14391	on	O
14392	postoperative	b-DATE
14393	day	i-DATE
14394	number	i-DATE
14395	2	i-DATE
14396	.	O
14397	diet	b-TREATMENT
14398	was	O
14399	advanced	b-OCCURRENCE
14400	.	O
14401	patient	O
14402	was	O
14403	ambulating	b-OCCURRENCE
14404	.	O
14405	waltham-ludlow	b-TREATMENT
14406	drains	i-TREATMENT
14407	put	O
14408	out	O
14409	on	O
14410	the	O
14411	13th	O
14412	620	O
14413	and	O
14414	380	O
14415	.	O
14416	physical	O
14417	therapy	O
14418	was	O
14419	re	O
14420	consulted	O
14421	.	O
14422	omalley	O
14423	was	O
14424	consulted	O
14425	on	O
14426	2014-04-08	b-DATE
14427	for	O
14428	better	O
14429	glucose	b-TREATMENT
14430	control	i-TREATMENT
14431	since	O
14432	the	O
14433	patient	O
14434	was	O
14435	on	O
14436	steroids	b-TREATMENT
14437	.	O
14438	social	O
14439	work	O
14440	was	O
14441	consulted	O
14442	.	O
14443	patient	O
14444	continued	O
14445	to	O
14446	do	b-OCCURRENCE
14447	very	i-OCCURRENCE
14448	well	i-OCCURRENCE
14449	,	O
14450	ambulating	b-OCCURRENCE
14451	,	O
14452	following	b-OCCURRENCE
14453	the	i-OCCURRENCE
14454	diet	i-OCCURRENCE
14455	.	O
14456	patient	O
14457	was	O
14458	transfused	O
14459	1	O
14460	unit	O
14461	of	O
14462	platelets	b-TREATMENT
14463	on	O
14464	2014-04-08	b-DATE
14465	for	O
14466	platelet	b-TEST
14467	count	i-TEST
14468	of	O
14469	66	O
14470	.	O
14471	a	b-TEST
14472	heparin	i-TEST
14473	independent	i-TEST
14474	antibody	i-TEST
14475	was	O
14476	sent	O
14477	off	O
14478	on	O
14479	2014-04-07	b-DATE
14480	which	O
14481	was	O
14482	unremarkable	O
14483	.	O
14484	on	O
14485	2014-04-09	b-DATE
14486	,	O
14487	patient	O
14488	continued	O
14489	to	O
14490	do	b-OCCURRENCE
14491	very	i-OCCURRENCE
14492	well	i-OCCURRENCE
14493	,	O
14494	ambulating	b-OCCURRENCE
14495	,	O
14496	tolerating	b-OCCURRENCE
14497	a	i-OCCURRENCE
14498	diet	i-OCCURRENCE
14499	,	O
14500	urinating	b-OCCURRENCE
14501	without	O
14502	difficulty	b-PROBLEM
14503	.	O
14504	drains	b-TREATMENT
14505	continued	O
14506	to	O
14507	put	O
14508	out	O
14509	significant	O
14510	amount	O
14511	of	O
14512	fluid	O
14513	.	O
14514	patient	b-TEST
14515	's	i-TEST
14516	labs	i-TEST
14517	from	O
14518	2014-04-10	b-DATE
14519	were	O
14520	the	O
14521	following	O
14522	:	O
14523	7.1	O
14524	,	O
14525	hematocrit	b-TEST
14526	of	O
14527	30.8	O
14528	,	O
14529	platelets	b-TEST
14530	90	O
14531	.	O
14532	sodium	b-TEST
14533	of	O
14534	138	O
14535	;	O
14536	potassium	b-TEST
14537	3.5	O
14538	;	O
14539	106	O
14540	,	O
14541	28	O
14542	,	O
14543	31	O
14544	,	O
14545	1.0	O
14546	,	O
14547	glucose	b-TEST
14548	134	O
14549	.	O
14550	ast	b-TEST
14551	82	O
14552	.	O
14553	alt	b-TEST
14554	176	O
14555	.	O
14556	alkaline	b-TEST
14557	phosphatase	i-TEST
14558	78	O
14559	which	O
14560	all	O
14561	have	O
14562	significantly	O
14563	decreased	O
14564	since	O
14565	postoperative	b-DATE
14566	day	i-DATE
14567	number	i-DATE
14568	1	i-DATE
14569	.	O
14570	total	b-TEST
14571	bilirubin	i-TEST
14572	was	O
14573	0.9	O
14574	.	O
14575	on	O
14576	2014-04-09	b-DATE
14577	,	O
14578	fk	b-TEST
14579	level	i-TEST
14580	was	O
14581	10.3	O
14582	.	O
14583	patient	O
14584	left	b-OCCURRENCE
14585	on	O
14586	2014-04-09	b-DATE
14587	with	O
14588	vna	O
14589	to	O
14590	home	O
14591	.	O
14592		O
14593	admission	b-OCCURRENCE
14594	date	O
14595	:	O
14596	2014-04-21	b-ADMISSION
14597	discharge	b-OCCURRENCE
14598	date	O
14599	:	O
14600	2014-04-24	b-DISCHARGE
14601	service	O
14602	:	O
14603	cardiothoracic	O
14604	history	O
14605	of	O
14606	present	O
14607	illness	O
14608	:	O
14609	this	O
14610	53-year-old	O
14611	with	O
14612	a	O
14613	history	O
14614	of	O
14615	multiple	b-PROBLEM
14616	transient	i-PROBLEM
14617	ischemic	i-PROBLEM
14618	attacks	i-PROBLEM
14619	in	O
14620	the	O
14621	past	O
14622	was	O
14623	investigated	b-TEST
14624	and	O
14625	was	O
14626	found	O
14627	to	O
14628	have	O
14629	a	b-PROBLEM
14630	small	i-PROBLEM
14631	patent	i-PROBLEM
14632	foramen	i-PROBLEM
14633	ovale	i-PROBLEM
14634	,	O
14635	and	O
14636	he	O
14637	was	O
14638	electively	b-OCCURRENCE
14639	admitted	i-OCCURRENCE
14640	for	O
14641	closure	b-TREATMENT
14642	of	O
14643	the	O
14644	same	O
14645	.	O
14646	his	b-TEST
14647	preoperative	i-TEST
14648	investigations	i-TEST
14649	with	O
14650	coronary	b-TEST
14651	angiogram	i-TEST
14652	showed	b-EVIDENTIAL
14653	normal	b-OCCURRENCE
14654	coronary	i-OCCURRENCE
14655	arteries	i-OCCURRENCE
14656	.	O
14657	his	O
14658	left	O
14659	ventricular	O
14660	function	O
14661	was	O
14662	well	O
14663	preserved	O
14664	.	O
14665	he	O
14666	had	O
14667	no	O
14668	valvular	b-PROBLEM
14669	disease	i-PROBLEM
14670	.	O
14671	brief	O
14672	hospital	O
14673	course	O
14674	:	O
14675	mr.	O
14676	freeman	O
14677	was	O
14678	admitted	b-OCCURRENCE
14679	to	O
14680	the	b-CLINICAL_DEPT
14681	nantucket	i-CLINICAL_DEPT
14682	cottage	i-CLINICAL_DEPT
14683	hospital	i-CLINICAL_DEPT
14684	on	O
14685	2014-04-21	b-DATE
14686	for	O
14687	surgical	b-TREATMENT
14688	management	i-TREATMENT
14689	of	O
14690	his	b-PROBLEM
14691	pfo	i-PROBLEM
14692	.	O
14693	he	O
14694	was	O
14695	taken	O
14696	to	O
14697	the	b-CLINICAL_DEPT
14698	operating	i-CLINICAL_DEPT
14699	room	i-CLINICAL_DEPT
14700	where	O
14701	he	O
14702	underwent	O
14703	a	b-TREATMENT
14704	mini-thoracotomy	i-TREATMENT
14705	with	O
14706	closure	b-TREATMENT
14707	of	O
14708	his	b-PROBLEM
14709	patent	i-PROBLEM
14710	foramen	i-PROBLEM
14711	ovale	i-PROBLEM
14712	(	i-PROBLEM
14713	pfo	i-PROBLEM
14714	)	i-PROBLEM
14715	.	O
14716	postoperatively	O
14717	he	O
14718	was	O
14719	taken	O
14720	to	O
14721	the	b-CLINICAL_DEPT
14722	cardiac	i-CLINICAL_DEPT
14723	surgical	i-CLINICAL_DEPT
14724	intensive	i-CLINICAL_DEPT
14725	care	i-CLINICAL_DEPT
14726	unit	i-CLINICAL_DEPT
14727	for	O
14728	monitoring	b-TEST
14729	.	O
14730	within	O
14731	a	b-DURATION
14732	few	i-DURATION
14733	hours	i-DURATION
14734	,	O
14735	he	O
14736	woke	b-OCCURRENCE
14737	neurologically	O
14738	intact	O
14739	and	O
14740	was	O
14741	extubated	b-TREATMENT
14742	.	O
14743	aspirin	b-TREATMENT
14744	was	O
14745	resumed.	O
14746	on	O
14747	postoperative	b-DATE
14748	day	i-DATE
14749	one	i-DATE
14750	,	O
14751	he	O
14752	was	O
14753	transferred	b-OCCURRENCE
14754	to	O
14755	the	b-CLINICAL_DEPT
14756	cardiac	i-CLINICAL_DEPT
14757	surgical	i-CLINICAL_DEPT
14758	step	i-CLINICAL_DEPT
14759	down	i-CLINICAL_DEPT
14760	unit	i-CLINICAL_DEPT
14761	.	O
14762	he	O
14763	was	O
14764	gently	O
14765	diuresed	b-TREATMENT
14766	towards	O
14767	his	O
14768	preoperative	O
14769	weight	b-TEST
14770	.	O
14771	the	O
14772	physical	O
14773	therapy	O
14774	service	O
14775	was	O
14776	consulted	b-OCCURRENCE
14777	for	O
14778	assistance	O
14779	with	O
14780	his	O
14781	postoperative	O
14782	strength	O
14783	and	O
14784	mobility	O
14785	.	O
14786	iron	b-TREATMENT
14787	and	O
14788	vitamin	b-TREATMENT
14789	c	i-TREATMENT
14790	were	O
14791	started	O
14792	for	O
14793	postoperative	b-PROBLEM
14794	anemia	i-PROBLEM
14795	.	O
14796	mr.	O
14797	freeman	O
14798	maintained	O
14799	stable	b-OCCURRENCE
14800	hemodynamics	i-OCCURRENCE
14801	with	O
14802	a	b-OCCURRENCE
14803	normal	i-OCCURRENCE
14804	sinus	i-OCCURRENCE
14805	rhythm	i-OCCURRENCE
14806	throughout	O
14807	his	b-OCCURRENCE
14808	postoperative	i-OCCURRENCE
14809	course	i-OCCURRENCE
14810	.	O
14811	he	O
14812	continued	O
14813	to	O
14814	make	b-OCCURRENCE
14815	steady	i-OCCURRENCE
14816	progress	i-OCCURRENCE
14817	and	O
14818	was	O
14819	discharged	b-OCCURRENCE
14820	home	O
14821	on	O
14822	postoperative	b-DATE
14823	day	i-DATE
14824	three	i-DATE
14825	.	O
14826	he	O
14827	will	O
14828	follow-up	b-OCCURRENCE
14829	with	O
14830	doctor	O
14831	de	O
14832	la	O
14833	cisneros	O
14834	,	O
14835	doctor	O
14836	belt	O
14837	,	O
14838	his	O
14839	cardiologist	O
14840	and	O
14841	his	O
14842	primary	O
14843	care	O
14844	physician	O
14845	as	O
14846	an	O
14847	outpatient	O
14848	.	O
14849		O
14850	admission	b-OCCURRENCE
14851	date	O
14852	:	O
14853	03/30/1999	b-ADMISSION
14854	discharge	b-OCCURRENCE
14855	date	O
14856	:	O
14857	09/16/2006	b-DISCHARGE
14858	history	O
14859	of	O
14860	present	O
14861	illness	O
14862	:	O
14863	this	O
14864	is	O
14865	a	O
14866	76	O
14867	year	O
14868	old	O
14869	white	O
14870	male	O
14871	with	O
14872	severe	b-PROBLEM
14873	chronic	i-PROBLEM
14874	obstructive	i-PROBLEM
14875	pulmonary	i-PROBLEM
14876	disease	i-PROBLEM
14877	who	O
14878	has	O
14879	had	O
14880	several	O
14881	recent	O
14882	admissions	b-OCCURRENCE
14883	to	O
14884	oaksgekesser/	b-CLINICAL_DEPT
14885	memorial	i-CLINICAL_DEPT
14886	hospital	i-CLINICAL_DEPT
14887	for	O
14888	respiratory	b-PROBLEM
14889	insuffiencey	i-PROBLEM
14890	most	O
14891	often	O
14892	secondary	O
14893	to	O
14894	pneumonia	b-PROBLEM
14895	.	O
14896	he	O
14897	was	O
14898	most	O
14899	recently	O
14900	discharged	b-OCCURRENCE
14901	from	O
14902	oaksgekesser/	b-CLINICAL_DEPT
14903	memorial	i-CLINICAL_DEPT
14904	hospital	i-CLINICAL_DEPT
14905	on	O
14906	03/06/99	b-DATE
14907	and	O
14908	was	O
14909	then	O
14910	transferred	b-OCCURRENCE
14911	to	O
14912	linghs	b-CLINICAL_DEPT
14913	county	i-CLINICAL_DEPT
14914	medical	i-CLINICAL_DEPT
14915	center	i-CLINICAL_DEPT
14916	from	O
14917	which	O
14918	he	O
14919	was	O
14920	discharged	b-OCCURRENCE
14921	on	O
14922	03/20/99	b-DATE
14923	.	O
14924	the	O
14925	patient	O
14926	was	O
14927	doing	O
14928	relatively	O
14929	at	O
14930	home	O
14931	until	O
14932	one	b-DATE
14933	day	i-DATE
14934	prior	i-DATE
14935	to	i-DATE
14936	admission	i-DATE
14937	he	O
14938	complained	O
14939	discomfort	b-PROBLEM
14940	over	O
14941	a	b-TREATMENT
14942	suprapubic	i-TREATMENT
14943	catheter	i-TREATMENT
14944	area	i-TREATMENT
14945	.	O
14946	the	O
14947	patient	O
14948	had	O
14949	missed	b-OCCURRENCE
14950	his	b-TREATMENT
14951	usual	i-TREATMENT
14952	monthly	b-FREQUENCY
14953	change	i-TREATMENT
14954	of	O
14955	his	b-TREATMENT
14956	suprapubic	i-TREATMENT
14957	catheter	i-TREATMENT
14958	and	O
14959	felt	O
14960	discomfort	b-PROBLEM
14961	and	O
14962	noticed	O
14963	some	b-PROBLEM
14964	blood	i-PROBLEM
14965	at	i-PROBLEM
14966	the	i-PROBLEM
14967	site	i-PROBLEM
14968	of	O
14969	the	b-TREATMENT
14970	catheter	i-TREATMENT
14971	.	O
14972	the	O
14973	patient	O
14974	was	O
14975	brought	O
14976	to	O
14977	the	b-CLINICAL_DEPT
14978	emergency	i-CLINICAL_DEPT
14979	room	i-CLINICAL_DEPT
14980	one	b-DATE
14981	day	i-DATE
14982	prior	i-DATE
14983	to	i-DATE
14984	admission	i-DATE
14985	where	O
14986	he	O
14987	was	O
14988	evaluated	b-OCCURRENCE
14989	by	O
14990	urology	b-OCCURRENCE
14991	and	O
14992	had	O
14993	his	b-TREATMENT
14994	catheter	i-TREATMENT
14995	changed	O
14996	.	O
14997	the	O
14998	patient	O
14999	at	O
15000	that	b-DATE
15001	time	i-DATE
15002	noted	O
15003	slight	b-PROBLEM
15004	shortness	i-PROBLEM
15005	of	i-PROBLEM
15006	breath	i-PROBLEM
15007	but	O
15008	was	O
15009	sent	b-OCCURRENCE
15010	home	i-OCCURRENCE
15011	anyway	O
15012	.	O
15013	on	O
15014	the	b-DATE
15015	day	i-DATE
15016	of	i-DATE
15017	admission	i-DATE
15018	the	O
15019	patient	O
15020	noticed	O
15021	increasing	b-PROBLEM
15022	shortness	i-PROBLEM
15023	of	i-PROBLEM
15024	breath	i-PROBLEM
15025	.	O
15026	the	O
15027	patient	O
15028	was	O
15029	noted	b-EVIDENTIAL
15030	to	O
15031	be	O
15032	confused	b-PROBLEM
15033	and	O
15034	to	O
15035	be	O
15036	disoriented	b-PROBLEM
15037	toward	O
15038	the	O
15039	end	O
15040	of	O
15041	the	b-DATE
15042	day	i-DATE
15043	after	O
15044	complaining	b-EVIDENTIAL
15045	of	O
15046	shortness	b-PROBLEM
15047	of	i-PROBLEM
15048	breath	i-PROBLEM
15049	for	O
15050	most	b-DURATION
15051	of	i-DURATION
15052	the	i-DURATION
15053	day	i-DURATION
15054	.	O
15055	the	O
15056	patient	O
15057	denies	b-EVIDENTIAL
15058	any	O
15059	recent	b-PROBLEM
15060	upper	i-PROBLEM
15061	respiratory	i-PROBLEM
15062	infections	i-PROBLEM
15063	,	O
15064	no	O
15065	fevers	b-PROBLEM
15066	,	O
15067	no	O
15068	chills	b-PROBLEM
15069	,	O
15070	no	O
15071	change	b-PROBLEM
15072	in	i-PROBLEM
15073	cough	i-PROBLEM
15074	,	O
15075	sputum	b-PROBLEM
15076	.	O
15077	he	O
15078	also	O
15079	denies	b-EVIDENTIAL
15080	any	O
15081	chest	b-PROBLEM
15082	pain	i-PROBLEM
15083	.	O
15084	no	O
15085	orthopnea	b-PROBLEM
15086	.	O
15087	no	O
15088	paroxysmal	b-PROBLEM
15089	nocturnal	i-PROBLEM
15090	dyspnea	i-PROBLEM
15091	.	O
15092	the	O
15093	patient	O
15094	had	O
15095	been	O
15096	taking	O
15097	his	b-TREATMENT
15098	usual	i-TREATMENT
15099	medications	i-TREATMENT
15100	and	O
15101	using	O
15102	his	b-TREATMENT
15103	nasal	i-TREATMENT
15104	oxygen	i-TREATMENT
15105	at	O
15106	home	O
15107	.	O
15108	by	O
15109	the	O
15110	time	O
15111	the	O
15112	patient	O
15113	arrived	b-OCCURRENCE
15114	at	O
15115	the	b-CLINICAL_DEPT
15116	oaksgekesser/	i-CLINICAL_DEPT
15117	memorial	i-CLINICAL_DEPT
15118	hospital	i-CLINICAL_DEPT
15119	emergency	i-CLINICAL_DEPT
15120	room	i-CLINICAL_DEPT
15121	he	O
15122	was	O
15123	in	O
15124	moderate	b-PROBLEM
15125	respiratory	i-PROBLEM
15126	distress	i-PROBLEM
15127	.	O
15128	his	b-TEST
15129	initial	i-TEST
15130	blood	i-TEST
15131	gases	i-TEST
15132	on	O
15133	40%	b-TREATMENT
15134	02	i-TREATMENT
15135	was	O
15136	p02	b-TEST
15137	102	O
15138	,	O
15139	pc02	b-TEST
15140	115	O
15141	,	O
15142	ph	b-TEST
15143	7.11	O
15144	.	O
15145	the	O
15146	patient	O
15147	was	O
15148	given	O
15149	respiratory	b-TREATMENT
15150	therapy	i-TREATMENT
15151	in	O
15152	the	O
15153	way	O
15154	of	O
15155	nebulizer	b-TREATMENT
15156	treatments	i-TREATMENT
15157	in	O
15158	the	b-CLINICAL_DEPT
15159	oaksgekesser/	i-CLINICAL_DEPT
15160	memorial	i-CLINICAL_DEPT
15161	hospital	i-CLINICAL_DEPT
15162	emergency	i-CLINICAL_DEPT
15163	room	i-CLINICAL_DEPT
15164	because	O
15165	of	O
15166	a	O
15167	longstanding	O
15168	desire	O
15169	by	O
15170	patient	O
15171	and	O
15172	family	O
15173	to	O
15174	refrain	O
15175	from	O
15176	intubation	b-TREATMENT
15177	to	O
15178	be	O
15179	considered	O
15180	do	b-TREATMENT
15181	not	i-TREATMENT
15182	resuscitate	i-TREATMENT
15183	.	O
15184	the	O
15185	patient	O
15186	was	O
15187	not	O
15188	intubated	b-TREATMENT
15189	.	O
15190	however	O
15191	he	O
15192	was	O
15193	transferred	b-OCCURRENCE
15194	to	O
15195	the	b-CLINICAL_DEPT
15196	medical	i-CLINICAL_DEPT
15197	intensive	i-CLINICAL_DEPT
15198	care	i-CLINICAL_DEPT
15199	unit	i-CLINICAL_DEPT
15200	where	O
15201	he	O
15202	received	O
15203	continuous	b-TREATMENT
15204	respiratory	i-TREATMENT
15205	therapy	i-TREATMENT
15206	in	O
15207	theway	O
15208	of	O
15209	albuterol	b-TREATMENT
15210	nebulizers	i-TREATMENT
15211	as	O
15212	well	O
15213	as	O
15214	nasal	b-TREATMENT
15215	oxygen	i-TREATMENT
15216	,	O
15217	intravenous	b-TREATMENT
15218	steroids	i-TREATMENT
15219	and	O
15220	intravenous	b-TREATMENT
15221	antibiotics	i-TREATMENT
15222	.	O
15223	a	b-TEST
15224	chest	i-TEST
15225	x-ray	i-TEST
15226	in	O
15227	the	b-CLINICAL_DEPT
15228	oaksgekesser/	i-CLINICAL_DEPT
15229	memorial	i-CLINICAL_DEPT
15230	hospital	i-CLINICAL_DEPT
15231	emergency	i-CLINICAL_DEPT
15232	room	i-CLINICAL_DEPT
15233	showed	O
15234	new	b-PROBLEM
15235	changes	i-PROBLEM
15236	on	O
15237	his	b-TEST
15238	chest	i-TEST
15239	x-ray	i-TEST
15240	on	O
15241	top	O
15242	of	O
15243	his	b-PROBLEM
15244	usual	i-PROBLEM
15245	severe	i-PROBLEM
15246	bilateral	i-PROBLEM
15247	emphysema_____	i-PROBLEM
15248	with	O
15249	scarring	b-PROBLEM
15250	in	i-PROBLEM
15251	both	i-PROBLEM
15252	lungs	i-PROBLEM
15253	.	O
15254	there	O
15255	were	O
15256	new	b-PROBLEM
15257	air	i-PROBLEM
15258	space	i-PROBLEM
15259	opacifications	i-PROBLEM
15260	in	i-PROBLEM
15261	the	i-PROBLEM
15262	left	i-PROBLEM
15263	apex	i-PROBLEM
15264	and	i-PROBLEM
15265	the	i-PROBLEM
15266	right	i-PROBLEM
15267	lower	i-PROBLEM
15268	lobe	i-PROBLEM
15269	.	O
15270	these	O
15271	were	O
15272	thought	O
15273	to	O
15274	be	O
15275	consistent	O
15276	either	O
15277	with	O
15278	pneumonia	b-PROBLEM
15279	or	O
15280	asymmetric	b-PROBLEM
15281	pulmonary	i-PROBLEM
15282	edema	i-PROBLEM
15283	.	O
15284	hospital	O
15285	course	O
15286	:	O
15287	the	O
15288	patient	O
15289	was	O
15290	stabilized	b-OCCURRENCE
15291	in	O
15292	the	b-CLINICAL_DEPT
15293	medical	i-CLINICAL_DEPT
15294	intensive	i-CLINICAL_DEPT
15295	care	i-CLINICAL_DEPT
15296	unit	i-CLINICAL_DEPT
15297	.	O
15298	he	O
15299	stayed	O
15300	in	O
15301	the	b-CLINICAL_DEPT
15302	unit	i-CLINICAL_DEPT
15303	for	O
15304	about	O
15305	one	b-DURATION
15306	day	i-DURATION
15307	.	O
15308	during	O
15309	that	O
15310	period	b-DURATION
15311	of	i-DURATION
15312	time	i-DURATION
15313	he	O
15314	received	O
15315	nebulizer	b-TREATMENT
15316	treatments	i-TREATMENT
15317	with	O
15318	albuterol	b-TREATMENT
15319	.	O
15320	he	O
15321	was	O
15322	also	O
15323	started	O
15324	on	O
15325	intravenous	b-TREATMENT
15326	ticarcillin	i-TREATMENT
15327	for	O
15328	possible	O
15329	gram	b-PROBLEM
15330	negative	i-PROBLEM
15331	pneumonia	i-PROBLEM
15332	.	O
15333	he	O
15334	was	O
15335	diuresed	b-TREATMENT
15336	with	O
15337	intravenous	b-TREATMENT
15338	lasix	i-TREATMENT
15339	to	O
15340	which	O
15341	he	O
15342	responded	b-OCCURRENCE
15343	with	O
15344	at	O
15345	lease	O
15346	a	O
15347	2l	O
15348	urine	b-TEST
15349	output	i-TEST
15350	on	O
15351	the	b-DATE
15352	first	i-DATE
15353	day	i-DATE
15354	and	O
15355	1.5l	O
15356	the	b-DATE
15357	second	i-DATE
15358	day	i-DATE
15359	.	O
15360	after	O
15361	one	b-DURATION
15362	day	i-DURATION
15363	in	O
15364	the	b-CLINICAL_DEPT
15365	medical	i-CLINICAL_DEPT
15366	intensive	i-CLINICAL_DEPT
15367	care	i-CLINICAL_DEPT
15368	unit	i-CLINICAL_DEPT
15369	the	O
15370	patient	O
15371	was	O
15372	stable	b-OCCURRENCE
15373	enough	i-OCCURRENCE
15374	to	O
15375	go	O
15376	to	O
15377	the	b-CLINICAL_DEPT
15378	floor	i-CLINICAL_DEPT
15379	where	O
15380	he	O
15381	continued	O
15382	the	O
15383	rest	O
15384	of	O
15385	his	b-TREATMENT
15386	treatment	i-TREATMENT
15387	.	O
15388	this	O
15389	consisted	O
15390	of	O
15391	continued	O
15392	nebulizer	b-TREATMENT
15393	treatments	i-TREATMENT
15394	as	O
15395	well	O
15396	as	O
15397	intravenous	b-TREATMENT
15398	antibiotics	i-TREATMENT
15399	and	O
15400	intravenous	b-TREATMENT
15401	solu-medrol	i-TREATMENT
15402	.	O
15403	as	O
15404	the	b-TREATMENT
15405	patient	i-TREATMENT
15406	&apos;s	i-TREATMENT
15407	diuresis	i-TREATMENT
15408	continued	O
15409	his	b-OCCURRENCE
15410	respiratory	i-OCCURRENCE
15411	status	i-OCCURRENCE
15412	improved	i-OCCURRENCE
15413	.	O
15414	a	b-TEST
15415	chest	i-TEST
15416	x-ray	i-TEST
15417	showed	b-EVIDENTIAL
15418	clearing	O
15419	of	O
15420	the	b-PROBLEM
15421	opacities	i-PROBLEM
15422	in	O
15423	the	b-TEST
15424	chest	i-TEST
15425	x-ray	i-TEST
15426	that	O
15427	were	O
15428	consistent	O
15429	with	O
15430	pulmonary	b-PROBLEM
15431	edema	i-PROBLEM
15432	because	O
15433	he	O
15434	continued	O
15435	to	O
15436	have	O
15437	some	b-PROBLEM
15438	abnormality	i-PROBLEM
15439	in	i-PROBLEM
15440	the	i-PROBLEM
15441	right	i-PROBLEM
15442	lower	i-PROBLEM
15443	lobe	i-PROBLEM
15444	.	O
15445	the	O
15446	patient	O
15447	was	O
15448	continued	O
15449	on	O
15450	antibiotics	b-TREATMENT
15451	for	O
15452	possible	O
15453	pneumonia	b-PROBLEM
15454	.	O
15455	the	b-TREATMENT
15456	antibiotic	i-TREATMENT
15457	chosen	O
15458	was	O
15459	levaquin	b-TREATMENT
15460	500	O
15461	mg	O
15462	1	O
15463	tab	O
15464	per	b-FREQUENCY
15465	day	i-FREQUENCY
15466	.	O
15467	this	O
15468	was	O
15469	started	O
15470	on	O
15471	4/2/99	b-DATE
15472	and	O
15473	should	O
15474	be	O
15475	continued	O
15476	for	O
15477	ten	b-DURATION
15478	days	i-DURATION
15479	.	O
15480	the	b-TREATMENT
15481	ticarcillin	i-TREATMENT
15482	was	O
15483	stopped	O
15484	after	O
15485	two	b-DURATION
15486	days	i-DURATION
15487	when	O
15488	it	O
15489	was	O
15490	felt	O
15491	that	O
15492	he	O
15493	did	O
15494	not	O
15495	have	O
15496	a	b-PROBLEM
15497	serious	i-PROBLEM
15498	pneumonia	i-PROBLEM
15499	.	O
15500	the	O
15501	patient	O
15502	&apos;s	O
15503	respiratory	b-OCCURRENCE
15504	status	i-OCCURRENCE
15505	continued	O
15506	to	O
15507	improve	b-OCCURRENCE
15508	but	O
15509	towards	O
15510	the	b-DURATION
15511	last	i-DURATION
15512	2-3	i-DURATION
15513	days	i-DURATION
15514	of	O
15515	his	b-OCCURRENCE
15516	hospitalization	i-OCCURRENCE
15517	the	O
15518	amount	O
15519	of	O
15520	improvement	b-OCCURRENCE
15521	was	O
15522	minimal	b-OCCURRENCE
15523	.	O
15524	it	O
15525	was	O
15526	felt	O
15527	that	O
15528	his	b-OCCURRENCE
15529	respiratory	i-OCCURRENCE
15530	status	i-OCCURRENCE
15531	has	O
15532	been	O
15533	maximally	b-TREATMENT
15534	treated	i-TREATMENT
15535	by	O
15536	then	O
15537	.	O
15538	the	O
15539	patient	O
15540	&apos;s	O
15541	major	O
15542	improvement	b-OCCURRENCE
15543	came	O
15544	after	O
15545	the	b-DURATION
15546	first	i-DURATION
15547	two	i-DURATION
15548	days	i-DURATION
15549	with	O
15550	brisk	b-TREATMENT
15551	diuresis	i-TREATMENT
15552	with	O
15553	lasix	b-TREATMENT
15554	.	O
15555	while	O
15556	in	O
15557	the	b-CLINICAL_DEPT
15558	oaksgekesser/	i-CLINICAL_DEPT
15559	memorial	i-CLINICAL_DEPT
15560	hospital	i-CLINICAL_DEPT
15561	the	O
15562	patient	O
15563	on	O
15564	4/4/99	b-DATE
15565	complained	b-EVIDENTIAL
15566	of	O
15567	mild	b-PROBLEM
15568	epigastric	i-PROBLEM
15569	discomfort	i-PROBLEM
15570	because	O
15571	he	O
15572	was	O
15573	put	O
15574	in	O
15575	cimetidine	b-TREATMENT
15576	while	O
15577	in	O
15578	the	b-CLINICAL_DEPT
15579	intensive	i-CLINICAL_DEPT
15580	care	i-CLINICAL_DEPT
15581	unit	i-CLINICAL_DEPT
15582	for	O
15583	prophylaxis	b-TREATMENT
15584	against	O
15585	peptic	b-PROBLEM
15586	ulcer	i-PROBLEM
15587	disease	i-PROBLEM
15588	.	O
15589	the	O
15590	patient	O
15591	was	O
15592	upgraded	O
15593	to	O
15594	prilosec	b-TREATMENT
15595	20	O
15596	mg	O
15597	per	b-FREQUENCY
15598	day	i-FREQUENCY
15599	for	O
15600	possible	O
15601	treatment	O
15602	of	O
15603	gastritis	b-PROBLEM
15604	or	O
15605	gastroesophageal	b-PROBLEM
15606	reflux	i-PROBLEM
15607	disease	i-PROBLEM
15608	.	O
15609	the	O
15610	patient	O
15611	did	O
15612	have	O
15613	any	O
15614	nausea	b-PROBLEM
15615	,	O
15616	vomiting	b-PROBLEM
15617	or	O
15618	evidence	O
15619	of	O
15620	gastrointestinal	b-PROBLEM
15621	bleeding	i-PROBLEM
15622	.	O
15623	the	b-PROBLEM
15624	patient	i-PROBLEM
15625	&apos;s	i-PROBLEM
15626	abdominal	i-PROBLEM
15627	pain	i-PROBLEM
15628	should	O
15629	be	O
15630	followed	b-OCCURRENCE
15631	over	O
15632	the	b-DURATION
15633	next	i-DURATION
15634	week	i-DURATION
15635	or	O
15636	so	O
15637	in	O
15638	case	O
15639	it	O
15640	does	b-OCCURRENCE
15641	not	i-OCCURRENCE
15642	respond	i-OCCURRENCE
15643	to	O
15644	prilosec	b-TREATMENT
15645	.	O
15646	while	O
15647	in	O
15648	oaksgekesser/	b-CLINICAL_DEPT
15649	memorial	i-CLINICAL_DEPT
15650	hospital	i-CLINICAL_DEPT
15651	the	O
15652	patient	O
15653	was	O
15654	never	O
15655	able	O
15656	to	O
15657	get	b-OCCURRENCE
15658	out	i-OCCURRENCE
15659	of	i-OCCURRENCE
15660	bed	i-OCCURRENCE
15661	and	i-OCCURRENCE
15662	walk	i-OCCURRENCE
15663	independently	i-OCCURRENCE
15664	.	O
15665	it	O
15666	is	O
15667	hoped	O
15668	that	O
15669	when	O
15670	he	O
15671	is	O
15672	transferred	b-OCCURRENCE
15673	to	O
15674	a	b-OCCURRENCE
15675	rehab	i-OCCURRENCE
15676	facility	i-OCCURRENCE
15677	that	O
15678	he	O
15679	will	O
15680	continue	O
15681	with	O
15682	physical	b-TREATMENT
15683	therapy	i-TREATMENT
15684	to	O
15685	regain	O
15686	his	b-OCCURRENCE
15687	strength	i-OCCURRENCE
15688	and	O
15689	regain	O
15690	independence	b-OCCURRENCE
15691	in	O
15692	activities	O
15693	of	O
15694	daily	O
15695	living	O
15696	.	O
15697	discussion	b-OCCURRENCE
15698	with	O
15699	the	O
15700	family	O
15701	regarding	O
15702	the	O
15703	possibility	O
15704	of	O
15705	sending	b-OCCURRENCE
15706	him	O
15707	to	O
15708	a	b-OCCURRENCE
15709	nursing	i-OCCURRENCE
15710	home	i-OCCURRENCE
15711	was	O
15712	entertained	O
15713	however	O
15714	the	O
15715	family	O
15716	strongly	O
15717	refused	b-OCCURRENCE
15718	to	O
15719	allow	O
15720	him	O
15721	to	O
15722	go	b-OCCURRENCE
15723	a	b-OCCURRENCE
15724	nursing	i-OCCURRENCE
15725	home	i-OCCURRENCE
15726	.	O
15727	they	O
15728	wanted	O
15729	the	O
15730	patient	O
15731	to	O
15732	return	b-OCCURRENCE
15733	to	O
15734	his	b-OCCURRENCE
15735	home	i-OCCURRENCE
15736	after	O
15737	a	b-OCCURRENCE
15738	stay	i-OCCURRENCE
15739	at	O
15740	a	b-OCCURRENCE
15741	rehab	i-OCCURRENCE
15742	facility	i-OCCURRENCE
15743	.	O
15744		O
15745	admission	b-OCCURRENCE
15746	date	O
15747	:	O
15748	03/11/2002	b-ADMISSION
15749	discharge	b-OCCURRENCE
15750	date	O
15751	:	O
15752	03/14/2002	b-DISCHARGE
15753	discharge	b-OCCURRENCE
15754	date	O
15755	:	O
15756	03/14/2002	b-DATE
15757	history	O
15758	of	O
15759	present	O
15760	illness	O
15761	:	O
15762	this	O
15763	is	O
15764	a	O
15765	62-year-old	O
15766	hospice	O
15767	chaplain	O
15768	who	O
15769	was	O
15770	referred	b-OCCURRENCE
15771	by	O
15772	doctor	O
15773	tomedankell	O
15774	flowayles	O
15775	and	O
15776	doctor	O
15777	es	O
15778	oarekote	O
15779	for	O
15780	evaluation	b-TEST
15781	of	O
15782	his	b-PROBLEM
15783	right	i-PROBLEM
15784	hip	i-PROBLEM
15785	pain	i-PROBLEM
15786	.	O
15787	he	O
15788	states	b-EVIDENTIAL
15789	that	O
15790	his	b-PROBLEM
15791	pain	i-PROBLEM
15792	has	O
15793	been	O
15794	of	O
15795	seven	O
15796	to	O
15797	eight	O
15798	durations	O
15799	,	O
15800	and	O
15801	rated	O
15802	as	O
15803	moderate	O
15804	to	O
15805	severe	O
15806	(	O
15807	7/10	O
15808	)	O
15809	.	O
15810	he	O
15811	does	O
15812	limp	b-PROBLEM
15813	.	O
15814	he	O
15815	does	O
15816	not	O
15817	use	O
15818	a	b-TREATMENT
15819	cane	i-TREATMENT
15820	and	O
15821	he	O
15822	requires	b-PROBLEM
15823	a	i-PROBLEM
15824	bannister	i-PROBLEM
15825	for	O
15826	going	O
15827	up	O
15828	and	O
15829	down	O
15830	stairs	O
15831	.	O
15832	he	O
15833	has	O
15834	trouble	b-PROBLEM
15835	with	i-PROBLEM
15836	his	i-PROBLEM
15837	shoes	i-PROBLEM
15838	and	i-PROBLEM
15839	socks	i-PROBLEM
15840	.	O
15841	he	O
15842	uses	O
15843	a	b-TREATMENT
15844	walker	i-TREATMENT
15845	.	O
15846	he	O
15847	can	O
15848	walk	b-OCCURRENCE
15849	about	i-OCCURRENCE
15850	a	i-OCCURRENCE
15851	quarter	i-OCCURRENCE
15852	of	O
15853	a	O
15854	mile	O
15855	without	O
15856	stopping	O
15857	.	O
15858	hospital	O
15859	course	O
15860	:	O
15861	the	O
15862	patient	O
15863	was	O
15864	taken	O
15865	to	O
15866	the	b-CLINICAL_DEPT
15867	operating	i-CLINICAL_DEPT
15868	room	i-CLINICAL_DEPT
15869	on	O
15870	march	b-DATE
15871	11	i-DATE
15872	,	i-DATE
15873	2002	i-DATE
15874	,	O
15875	and	O
15876	underwent	O
15877	an	b-TREATMENT
15878	uncomplicated	i-TREATMENT
15879	right	i-TREATMENT
15880	total	i-TREATMENT
15881	hip	i-TREATMENT
15882	replacement	i-TREATMENT
15883	.	O
15884	the	O
15885	patient	O
15886	tolerated	b-OCCURRENCE
15887	the	b-TREATMENT
15888	procedure	i-TREATMENT
15889	well	O
15890	and	O
15891	was	O
15892	transferred	b-OCCURRENCE
15893	to	O
15894	the	b-CLINICAL_DEPT
15895	post	i-CLINICAL_DEPT
15896	anesthesia	i-CLINICAL_DEPT
15897	care	i-CLINICAL_DEPT
15898	unit	i-CLINICAL_DEPT
15899	and	O
15900	then	O
15901	to	O
15902	the	b-CLINICAL_DEPT
15903	floor	i-CLINICAL_DEPT
15904	in	O
15905	stable	b-OCCURRENCE
15906	condition	i-OCCURRENCE
15907	.	O
15908	on	O
15909	postoperative	b-TEST
15910	check	i-TEST
15911	,	O
15912	he	O
15913	was	O
15914	doing	b-OCCURRENCE
15915	well	i-OCCURRENCE
15916	.	O
15917	he	O
15918	was	O
15919	afebrile	b-PROBLEM
15920	and	O
15921	his	b-TEST
15922	vital	i-TEST
15923	signs	i-TEST
15924	were	O
15925	stable	b-OCCURRENCE
15926	.	O
15927	he	O
15928	was	O
15929	neurovascularly	b-OCCURRENCE
15930	intact	i-OCCURRENCE
15931	.	O
15932	his	b-TEST
15933	hematocrit	i-TEST
15934	was	O
15935	34.7	O
15936	.	O
15937	he	O
15938	was	O
15939	started	O
15940	on	O
15941	coumadin	b-TREATMENT
15942	for	O
15943	dvt	b-TREATMENT
15944	prophylaxis	i-TREATMENT
15945	and	O
15946	ancef	b-TREATMENT
15947	for	O
15948	routine	b-TREATMENT
15949	antimicrobial	i-TREATMENT
15950	coverage	i-TREATMENT
15951	.	O
15952	he	O
15953	was	O
15954	made	O
15955	partial	b-TREATMENT
15956	weight-bearing	i-TREATMENT
15957	for	O
15958	his	O
15959	right	O
15960	lower	O
15961	extremity	O
15962	.	O
15963	he	O
15964	was	O
15965	placed	O
15966	on	O
15967	posterior	b-TREATMENT
15968	hip	i-TREATMENT
15969	dislocation	i-TREATMENT
15970	precautions	i-TREATMENT
15971	and	O
15972	was	O
15973	out	b-TREATMENT
15974	of	i-TREATMENT
15975	bed	i-TREATMENT
15976	with	O
15977	physical	O
15978	therapy	O
15979	and	O
15980	occupational	O
15981	therapy	O
15982	.	O
15983	on	O
15984	postoperative	O
15985	day	b-DATE
15986	one	i-DATE
15987	,	O
15988	there	O
15989	were	O
15990	no	O
15991	active	b-PROBLEM
15992	issues	i-PROBLEM
15993	.	O
15994	he	O
15995	was	O
15996	afebrile	b-PROBLEM
15997	.	O
15998	his	b-TEST
15999	vital	i-TEST
16000	signs	i-TEST
16001	were	O
16002	stable	b-OCCURRENCE
16003	.	O
16004	he	O
16005	was	O
16006	neurovascularly	b-OCCURRENCE
16007	intact	i-OCCURRENCE
16008	.	O
16009	on	O
16010	postoperative	O
16011	day	b-DATE
16012	two	i-DATE
16013	,	O
16014	he	O
16015	was	O
16016	afebrile	b-PROBLEM
16017	,	O
16018	vital	b-TEST
16019	signs	i-TEST
16020	were	O
16021	stable	b-OCCURRENCE
16022	.	O
16023	his	b-PROBLEM
16024	incision	i-PROBLEM
16025	was	O
16026	clean	b-OCCURRENCE
16027	,	i-OCCURRENCE
16028	dry	i-OCCURRENCE
16029	and	i-OCCURRENCE
16030	intact	i-OCCURRENCE
16031	with	O
16032	no	O
16033	erythema	b-PROBLEM
16034	.	O
16035	he	O
16036	remained	O
16037	neurovascularly	b-OCCURRENCE
16038	intact	i-OCCURRENCE
16039	.	O
16040	his	b-TEST
16041	hematocrit	i-TEST
16042	was	O
16043	34.8	O
16044	.	O
16045	on	O
16046	postoperative	O
16047	day	b-DATE
16048	three	i-DATE
16049	,	O
16050	lower	b-TEST
16051	extremity	i-TEST
16052	noninvasive	i-TEST
16053	ultrasounds	i-TEST
16054	were	O
16055	performed	O
16056	,	O
16057	which	O
16058	showed	b-EVIDENTIAL
16059	no	O
16060	evidence	O
16061	of	O
16062	deep	b-PROBLEM
16063	venous	i-PROBLEM
16064	thrombosis	i-PROBLEM
16065	in	i-PROBLEM
16066	the	i-PROBLEM
16067	lower	i-PROBLEM
16068	extremities	i-PROBLEM
16069	.	O
16070	the	O
16071	remainder	O
16072	of	O
16073	his	b-OCCURRENCE
16074	hospitalization	i-OCCURRENCE
16075	was	O
16076	uncomplicated	b-OCCURRENCE
16077	.	i-OCCURRENCE
16078		O
16079	admission	b-OCCURRENCE
16080	date	O
16081	:	O
16082	2015-11-09	b-ADMISSION
16083	discharge	b-OCCURRENCE
16084	date	O
16085	:	O
16086	2015-11-16	b-DISCHARGE
16087	service	O
16088	:	O
16089	cmed	O
16090	ccu	O
16091	history	O
16092	of	O
16093	present	O
16094	illness	O
16095	:	O
16096	baby	O
16097	girl	O
16098	fritsche	O
16099	is	O
16100	the	O
16101	1670	O
16102	gram	O
16103	product	O
16104	of	O
16105	a	O
16106	31	b-DURATION
16107	and	i-DURATION
16108	06-17	i-DURATION
16109	week	i-DURATION
16110	gestation	b-OCCURRENCE
16111	born	b-OCCURRENCE
16112	to	O
16113	a	O
16114	34	O
16115	-	O
16116	year-old	O
16117	g2	O
16118	p1	O
16119	now	O
16120	2	O
16121	woman	O
16122	.	O
16123	fetal	b-TEST
16124	screens	i-TEST
16125	,	O
16126	o	b-TEST
16127	positive	i-TEST
16128	,	O
16129	antibody	b-TEST
16130	negative	O
16131	,	O
16132	rpr	b-TEST
16133	nonreactive	O
16134	,	O
16135	rubella	b-TEST
16136	immune	O
16137	,	O
16138	hepatitis	b-TEST
16139	surface	i-TEST
16140	antigen	i-TEST
16141	negative	O
16142	,	O
16143	gbs	b-TEST
16144	unknown	O
16145	.	O
16146	ivf	b-PROBLEM
16147	pregnancy	i-PROBLEM
16148	complicated	O
16149	by	O
16150	iugr	b-PROBLEM
16151	,	O
16152	2	b-PROBLEM
16153	vessel	i-PROBLEM
16154	cord	i-PROBLEM
16155	,	O
16156	normal	b-OCCURRENCE
16157	fetal	i-OCCURRENCE
16158	echo	i-OCCURRENCE
16159	reverse	i-OCCURRENCE
16160	diastolic	i-OCCURRENCE
16161	flow	i-OCCURRENCE
16162	and	O
16163	demise	b-PROBLEM
16164	of	i-PROBLEM
16165	twin	i-PROBLEM
16166	a	i-PROBLEM
16167	at	O
16168	27	b-DATE
16169	weeks	i-DATE
16170	.	O
16171	twin	O
16172	b	O
16173	with	O
16174	normal	b-OCCURRENCE
16175	fetal	i-OCCURRENCE
16176	survey	i-OCCURRENCE
16177	was	O
16178	transferred	b-OCCURRENCE
16179	to	O
16180	boston	b-CLINICAL_DEPT
16181	medical	i-CLINICAL_DEPT
16182	center	i-CLINICAL_DEPT
16183	at	O
16184	26	b-DURATION
16185	and	i-DURATION
16186	2/7	i-DURATION
16187	weeks	i-DURATION
16188	with	O
16189	iugr	b-PROBLEM
16190	of	i-PROBLEM
16191	twin	i-PROBLEM
16192	a	i-PROBLEM
16193	was	O
16194	first	O
16195	noted	O
16196	,	O
16197	presented	b-OCCURRENCE
16198	with	O
16199	preterm	b-PROBLEM
16200	labor	i-PROBLEM
16201	at	O
16202	31	b-DATE
16203	weeks	i-DATE
16204	.	O
16205	betamethasone	b-TREATMENT
16206	complete	O
16207	at	O
16208	approximately	O
16209	26	b-DATE
16210	weeks	i-DATE
16211	and	O
16212	31	b-DATE
16213	weeks	i-DATE
16214	.	O
16215	mother	O
16216	was	O
16217	on	O
16218	clindamycin	b-TREATMENT
16219	since	O
16220	11-04	b-DATE
16221	.	O
16222	pprom	b-PROBLEM
16223	with	O
16224	bleeding	b-PROBLEM
16225	and	O
16226	transverse	b-PROBLEM
16227	lie	i-PROBLEM
16228	prompted	O
16229	cesarean	b-TREATMENT
16230	section	i-TREATMENT
16231	.	O
16232	abruption	b-PROBLEM
16233	noted	b-EVIDENTIAL
16234	.	O
16235	apgars	b-TEST
16236	were	O
16237	6	O
16238	and	O
16239	9	O
16240	.	O
16241	hospital	O
16242	course	O
16243	:	O
16244	respiratory	O
16245	.	O
16246	mills	O
16247	was	O
16248	admitted	b-OCCURRENCE
16249	to	O
16250	the	b-CLINICAL_DEPT
16251	newborn	i-CLINICAL_DEPT
16252	intensive	i-CLINICAL_DEPT
16253	care	i-CLINICAL_DEPT
16254	unit	i-CLINICAL_DEPT
16255	with	O
16256	moderate	b-PROBLEM
16257	respiratory	i-PROBLEM
16258	distress	i-PROBLEM
16259	.	O
16260	infant	O
16261	placed	O
16262	on	O
16263	cpap	b-TREATMENT
16264	.	O
16265	x-ray	b-TEST
16266	revealed	b-EVIDENTIAL
16267	mild	b-PROBLEM
16268	respiratory	i-PROBLEM
16269	distress	i-PROBLEM
16270	syndrome	i-PROBLEM
16271	.	O
16272	she	O
16273	remained	O
16274	on	O
16275	cpap	b-TREATMENT
16276	for	O
16277	a	O
16278	total	O
16279	of	O
16280	24	b-DURATION
16281	hours	i-DURATION
16282	at	O
16283	which	O
16284	time	O
16285	she	O
16286	transitioned	O
16287	to	O
16288	room	b-TREATMENT
16289	air	i-TREATMENT
16290	and	O
16291	continues	O
16292	to	O
16293	be	O
16294	stable	b-OCCURRENCE
16295	in	O
16296	room	b-TREATMENT
16297	air	i-TREATMENT
16298	.	O
16299	caffeine	b-TREATMENT
16300	citrate	i-TREATMENT
16301	was	O
16302	initiated	O
16303	on	O
16304	11-14	b-DATE
16305	for	O
16306	apnea	b-PROBLEM
16307	and	O
16308	bradycardia	b-PROBLEM
16309	of	i-PROBLEM
16310	prematurity	i-PROBLEM
16311	.	O
16312	she	O
16313	is	O
16314	currently	O
16315	receiving	O
16316	11	O
16317	mg	O
16318	po	O
16319	every	b-FREQUENCY
16320	day	i-FREQUENCY
16321	.	O
16322	cardiovascular	O
16323	.	O
16324	has	O
16325	been	O
16326	cardiovascular	b-OCCURRENCE
16327	stable	i-OCCURRENCE
16328	throughout	O
16329	hospital	b-OCCURRENCE
16330	course	i-OCCURRENCE
16331	.	O
16332	heart	b-TEST
16333	ranges	i-TEST
16334	130	O
16335	s	O
16336	to	O
16337	160	O
16338	s.	O
16339	blood	b-TEST
16340	pressure	i-TEST
16341	most	O
16342	recently	O
16343	60/37	O
16344	with	O
16345	a	O
16346	mean	O
16347	of	O
16348	44	O
16349	.	O
16350	fluid	O
16351	and	O
16352	electrolyte	O
16353	.	O
16354	birth	b-TEST
16355	weight	i-TEST
16356	was	O
16357	1670	O
16358	grams	O
16359	50	O
16360	th	O
16361	percentile	O
16362	,	O
16363	length	b-TEST
16364	43	O
16365	cm	O
16366	50	O
16367	th	O
16368	percentile	O
16369	.	O
16370	head	b-TEST
16371	circumference	i-TEST
16372	not	O
16373	done	O
16374	.	O
16375	infant	O
16376	was	O
16377	initially	O
16378	started	O
16379	on	O
16380	80	O
16381	cc	O
16382	per	O
16383	kilo	O
16384	per	O
16385	day	O
16386	of	O
16387	d10w	b-TREATMENT
16388	.	O
16389	enteral	b-TREATMENT
16390	feedings	i-TREATMENT
16391	were	O
16392	initiated	O
16393	on	O
16394	day	b-DATE
16395	of	i-DATE
16396	life	i-DATE
16397	#1	i-DATE
16398	.	O
16399	infant	O
16400	achieved	O
16401	full	b-TREATMENT
16402	enteral	i-TREATMENT
16403	feedings	i-TREATMENT
16404	by	O
16405	day	b-DATE
16406	of	i-DATE
16407	life	i-DATE
16408	6	i-DATE
16409	.	O
16410	she	O
16411	is	O
16412	currently	O
16413	receiving	O
16414	150	O
16415	cc	O
16416	per	O
16417	kilo	O
16418	per	O
16419	day	O
16420	of	O
16421	special	b-TREATMENT
16422	care	i-TREATMENT
16423	20	i-TREATMENT
16424	.	O
16425	her	b-TEST
16426	discharge	i-TEST
16427	weight	i-TEST
16428	is	O
16429	1477	O
16430	gm	O
16431	.	O
16432	her	O
16433	most	O
16434	recent	O
16435	set	O
16436	of	O
16437	electrolytes	b-TEST
16438	were	O
16439	on	O
16440	2015-11-13	b-DATE
16441	with	O
16442	a	b-TEST
16443	sodium	i-TEST
16444	of	O
16445	143	O
16446	,	O
16447	a	b-TEST
16448	potassium	i-TEST
16449	of	O
16450	6.3	O
16451	hemolyzed	O
16452	,	O
16453	a	b-TEST
16454	chloride	i-TEST
16455	of	O
16456	113	O
16457	and	O
16458	a	b-TEST
16459	total	i-TEST
16460	co2	i-TEST
16461	of	O
16462	17	O
16463	.	O
16464	she	O
16465	will	O
16466	need	O
16467	advance	b-TREATMENT
16468	calorie	i-TREATMENT
16469	density	i-TREATMENT
16470	for	O
16471	better	b-OCCURRENCE
16472	growth	i-OCCURRENCE
16473	.	O
16474	gi	b-TEST
16475	.	i-TEST
16476	bilirubin	i-TEST
16477	peaked	b-OCCURRENCE
16478	on	O
16479	day	b-DATE
16480	of	i-DATE
16481	life	i-DATE
16482	#2	i-DATE
16483	of	O
16484	9.0	O
16485	/	O
16486	0.3	O
16487	.	O
16488	infant	O
16489	is	O
16490	under	O
16491	phototherapy	b-TREATMENT
16492	,	O
16493	which	O
16494	was	O
16495	discontinued	O
16496	on	O
16497	11-13	b-DATE
16498	.	O
16499	most	b-TEST
16500	recent	i-TEST
16501	bilirubin	i-TEST
16502	was	O
16503	on	O
16504	11-14	b-DATE
16505	of	O
16506	4.8	O
16507	/	O
16508	0.3	O
16509	.	O
16510	hematology	O
16511	.	O
16512	hematocrit	b-TEST
16513	on	O
16514	admission	b-OCCURRENCE
16515	was	O
16516	53.7	O
16517	.	O
16518	she	O
16519	has	O
16520	not	O
16521	required	O
16522	any	b-TREATMENT
16523	blood	i-TREATMENT
16524	transfusions	i-TREATMENT
16525	.	O
16526	infectious	O
16527	disease	O
16528	.	O
16529	a	b-TEST
16530	cbc	i-TEST
16531	and	O
16532	blood	b-TEST
16533	culture	i-TEST
16534	obtained	O
16535	on	O
16536	admission	b-OCCURRENCE
16537	.	O
16538	cbc	b-TEST
16539	had	O
16540	a	b-TEST
16541	white	i-TEST
16542	blood	i-TEST
16543	cell	i-TEST
16544	count	i-TEST
16545	of	O
16546	9	O
16547	,	O
16548	17	O
16549	polys	b-TEST
16550	,	O
16551	0	O
16552	bands	b-TEST
16553	,	O
16554	platelets	b-TEST
16555	of	O
16556	326	O
16557	.	O
16558	she	O
16559	received	O
16560	48	b-DURATION
16561	hours	i-DURATION
16562	of	O
16563	ampicillin	b-TREATMENT
16564	and	O
16565	gentamycin	b-TREATMENT
16566	with	O
16567	negative	O
16568	blood	b-TEST
16569	cultures	i-TEST
16570	and	O
16571	antibiotics	b-TREATMENT
16572	were	O
16573	discontinued	O
16574	.	O
16575	neurological	O
16576	.	O
16577	she	O
16578	has	O
16579	been	O
16580	appropriate	b-OCCURRENCE
16581	for	i-OCCURRENCE
16582	gestational	i-OCCURRENCE
16583	age	i-OCCURRENCE
16584	.	O
16585	head	b-TEST
16586	ultrasound	i-TEST
16587	was	O
16588	performed	O
16589	on	O
16590	2015-11-16	b-DATE
16591	and	O
16592	was	O
16593	normal	O
16594	.	O
16595	sensory	b-TEST
16596	,	i-TEST
16597	hearing	i-TEST
16598	screen	i-TEST
16599	has	O
16600	not	O
16601	yet	O
16602	been	O
16603	performed	O
16604	,	O
16605	but	O
16606	should	O
16607	be	O
16608	done	O
16609	prior	O
16610	to	O
16611	discharge	b-OCCURRENCE
16612	.	O
16613		O
16614	admission	b-OCCURRENCE
16615	date	O
16616	:	O
16617	2017-06-28	b-ADMISSION
16618	discharge	b-OCCURRENCE
16619	date	O
16620	:	O
16621	2017-07-02	b-DISCHARGE
16622	service	O
16623	:	O
16624	cmed	O
16625	ccu	O
16626	history	O
16627	of	O
16628	present	O
16629	illness	O
16630	:	O
16631	a	O
16632	40-year-old	O
16633	female	O
16634	with	O
16635	history	O
16636	of	O
16637	non-st-elevation	b-PROBLEM
16638	myocardial	i-PROBLEM
16639	infarction	i-PROBLEM
16640	in	O
16641	2016-09-30	b-DATE
16642	with	O
16643	stent	b-TREATMENT
16644	to	i-TREATMENT
16645	the	i-TREATMENT
16646	lad	i-TREATMENT
16647	and	O
16648	50%	O
16649	to	O
16650	the	O
16651	mid	O
16652	lad	O
16653	,	O
16654	had	O
16655	instent	b-PROBLEM
16656	restenosis	i-PROBLEM
16657	in	O
16658	2017-04-02	b-DATE
16659	and	O
16660	then	O
16661	underwent	O
16662	brachytherapy	b-TREATMENT
16663	to	i-TREATMENT
16664	the	i-TREATMENT
16665	rca	i-TREATMENT
16666	,	O
16667	who	O
16668	presented	b-OCCURRENCE
16669	to	O
16670	baldpate	b-CLINICAL_DEPT
16671	hospital	i-CLINICAL_DEPT
16672	with	O
16673	several	b-DURATION
16674	weeks	i-DURATION
16675	of	O
16676	chest	b-PROBLEM
16677	pain	i-PROBLEM
16678	similar	O
16679	to	O
16680	her	b-PROBLEM
16681	anginal	i-PROBLEM
16682	equivalent	i-PROBLEM
16683	and	O
16684	mi	b-PROBLEM
16685	in	O
16686	the	O
16687	past	O
16688	.	O
16689	it	b-PROBLEM
16690	started	O
16691	at	O
16692	rest	b-OCCURRENCE
16693	.	O
16694	no	O
16695	relief	b-OCCURRENCE
16696	with	O
16697	nitroglycerin	b-TREATMENT
16698	x3	b-FREQUENCY
16699	.	O
16700	radiates	b-PROBLEM
16701	to	O
16702	the	O
16703	left	O
16704	arm	O
16705	.	O
16706	positive	O
16707	shortness	b-PROBLEM
16708	of	i-PROBLEM
16709	breath	i-PROBLEM
16710	.	O
16711	troponins	b-TEST
16712	have	O
16713	been	O
16714	less	O
16715	than	O
16716	0.01.	O
16717	with	O
16718	history	O
16719	,	O
16720	will	O
16721	go	O
16722	for	O
16723	cardiac	b-TEST
16724	catheterization	i-TEST
16725	evaluation	i-TEST
16726	.	O
16727	still	O
16728	getting	O
16729	chest	b-PROBLEM
16730	pain	i-PROBLEM
16731	intermittently	O
16732	,	O
16733	but	O
16734	relieved	O
16735	by	O
16736	morphine	b-TREATMENT
16737	sulfate	i-TREATMENT
16738	.	O
16739	was	O
16740	on	O
16741	a	b-TREATMENT
16742	heparin	i-TREATMENT
16743	and	O
16744	nitroglycerin	b-TREATMENT
16745	drip	i-TREATMENT
16746	with	O
16747	only	O
16748	intermittent	O
16749	relief	b-OCCURRENCE
16750	.	O
16751	hospital	O
16752	course:	O
16753	1.	O
16754	chest	b-PROBLEM
16755	pain	i-PROBLEM
16756	:	O
16757	the	O
16758	patient	O
16759	ruled	O
16760	out	O
16761	for	O
16762	myocardial	b-PROBLEM
16763	infarction	i-PROBLEM
16764	.	O
16765	however	O
16766	,	O
16767	with	O
16768	her	O
16769	history	O
16770	of	O
16771	disease	b-PROBLEM
16772	,	O
16773	patient	O
16774	underwent	O
16775	a	b-TEST
16776	cardiac	i-TEST
16777	catheterization	i-TEST
16778	.	O
16779	the	O
16780	patient	O
16781	was	O
16782	found	O
16783	at	O
16784	cardiac	b-TEST
16785	catheterization	i-TEST
16786	to	O
16787	have	O
16788	mild	b-PROBLEM
16789	diffuse	i-PROBLEM
16790	instent	i-PROBLEM
16791	restenosis	i-PROBLEM
16792	in	i-PROBLEM
16793	the	i-PROBLEM
16794	mid	i-PROBLEM
16795	stent	i-PROBLEM
16796	,	O
16797	otherwise	O
16798	hemodynamically	b-OCCURRENCE
16799	normal	i-OCCURRENCE
16800	and	O
16801	the	O
16802	coronary	O
16803	arteries	O
16804	otherwise	O
16805	were	O
16806	without	O
16807	flow-limiting	b-PROBLEM
16808	stenoses	i-PROBLEM
16809	.	O
16810	the	O
16811	patient	O
16812	was	O
16813	then	O
16814	continued	O
16815	on	O
16816	her	b-TREATMENT
16817	cardiac	i-TREATMENT
16818	medications	i-TREATMENT
16819	.	O
16820	it	O
16821	was	O
16822	felt	O
16823	that	O
16824	if	O
16825	we	O
16826	attempted	O
16827	aspirin	b-TREATMENT
16828	desensitize	i-TREATMENT
16829	her	O
16830	while	O
16831	an	O
16832	inpatient	O
16833	,	O
16834	then	O
16835	she	O
16836	would	O
16837	benefit	O
16838	from	O
16839	the	O
16840	use	O
16841	of	O
16842	aspirin	b-TREATMENT
16843	and	O
16844	plavix	b-TREATMENT
16845	.	O
16846	the	O
16847	patient	O
16848	was	O
16849	sent	O
16850	to	O
16851	the	b-CLINICAL_DEPT
16852	ccu	i-CLINICAL_DEPT
16853	and	O
16854	underwent	O
16855	aspirin	b-TREATMENT
16856	desensitization	i-TREATMENT
16857	protocol	i-TREATMENT
16858	,	O
16859	which	O
16860	she	O
16861	tolerated	b-OCCURRENCE
16862	well	i-OCCURRENCE
16863	.	O
16864	she	O
16865	had	O
16866	mild	b-PROBLEM
16867	worsening	i-PROBLEM
16868	of	O
16869	her	b-PROBLEM
16870	asthma	i-PROBLEM
16871	attacks	i-PROBLEM
16872	,	O
16873	which	O
16874	was	O
16875	relieved	O
16876	by	O
16877	benadryl	b-TREATMENT
16878	and	O
16879	occasionally	O
16880	albuterol	b-TREATMENT
16881	.	O
16882	the	O
16883	patient	O
16884	found	O
16885	that	O
16886	if	O
16887	she	O
16888	took	O
16889	the	b-TREATMENT
16890	aspirin	i-TREATMENT
16891	in	O
16892	the	O
16893	evening	O
16894	with	O
16895	her	b-TREATMENT
16896	benadryl	i-TREATMENT
16897	that	O
16898	she	O
16899	takes	O
16900	for	O
16901	sleep	O
16902	,	O
16903	that	O
16904	the	b-PROBLEM
16905	asthma	i-PROBLEM
16906	exacerbation	i-PROBLEM
16907	did	O
16908	not	O
16909	occur	O
16910	.	O
16911	aspirin	b-TREATMENT
16912	no	O
16913	longer	O
16914	should	O
16915	be	O
16916	considered	O
16917	an	b-PROBLEM
16918	allergy	i-PROBLEM
16919	for	O
16920	this	O
16921	patient	O
16922	,	O
16923	and	O
16924	she	O
16925	is	O
16926	going	O
16927	to	O
16928	take	O
16929	this	O
16930	as	O
16931	an	O
16932	outpatient	O
16933	.	O
16934	2.	O
16935	hyperlipidemia	b-PROBLEM
16936	:	O
16937	the	b-TREATMENT
16938	patient	i-TREATMENT
16939	's	i-TREATMENT
16940	lipitor	i-TREATMENT
16941	was	O
16942	increased	O
16943	to	O
16944	80	O
16945	mg	O
16946	q.d.	b-FREQUENCY
16947	3.	O
16948	back	b-PROBLEM
16949	pain	i-PROBLEM
16950	:	O
16951	this	O
16952	is	O
16953	a	b-PROBLEM
16954	chronic	i-PROBLEM
16955	issue	i-PROBLEM
16956	and	O
16957	was	O
16958	controlled	O
16959	with	O
16960	flexeril	b-TREATMENT
16961	and	O
16962	vicodin	b-TREATMENT
16963	.	O
16964		O
16965	admission	b-OCCURRENCE
16966	date	O
16967	:	O
16968	2016-07-18	b-ADMISSION
16969	discharge	b-OCCURRENCE
16970	date	O
16971	:	O
16972	2016-07-21	b-DISCHARGE
16973	service	O
16974	:	O
16975	medicine	O
16976	history	O
16977	of	O
16978	present	O
16979	illness	O
16980	:	O
16981	46	O
16982	-	O
16983	yo-man	O
16984	w/	O
16985	active	O
16986	cocaine	b-PROBLEM
16987	use	i-PROBLEM
16988	presents	b-OCCURRENCE
16989	w/	O
16990	le	b-PROBLEM
16991	edema	i-PROBLEM
16992	.	O
16993	10	b-DATE
16994	days	i-DATE
16995	ago	i-DATE
16996	,	O
16997	he	O
16998	developed	O
16999	b/l	b-PROBLEM
17000	le	i-PROBLEM
17001	edema	i-PROBLEM
17002	that	O
17003	has	O
17004	gotten	O
17005	progressively	O
17006	worse	b-OCCURRENCE
17007	until	O
17008	now	O
17009	.	O
17010	three	b-DATE
17011	days	i-DATE
17012	ago	i-DATE
17013	,	O
17014	he	O
17015	developed	O
17016	dyspnea	b-PROBLEM
17017	on	O
17018	exertion	b-OCCURRENCE
17019	when	O
17020	climbing	b-OCCURRENCE
17021	stairs	i-OCCURRENCE
17022	,	O
17023	assoc	O
17024	w/	O
17025	2-pillow	b-PROBLEM
17026	orthopnea	i-PROBLEM
17027	and	O
17028	pnd	b-PROBLEM
17029	.	O
17030	he	O
17031	denies	b-EVIDENTIAL
17032	any	b-PROBLEM
17033	recent	i-PROBLEM
17034	chest	i-PROBLEM
17035	pain	i-PROBLEM
17036	,	O
17037	palpitations	b-PROBLEM
17038	,	O
17039	headache	b-PROBLEM
17040	,	O
17041	confusion	b-PROBLEM
17042	,	O
17043	weakness	b-PROBLEM
17044	,	O
17045	numbness	b-PROBLEM
17046	,	O
17047	abd	b-PROBLEM
17048	pain	i-PROBLEM
17049	,	O
17050	or	O
17051	hematuria	b-PROBLEM
17052	.	O
17053	no	O
17054	recent	b-PROBLEM
17055	viral	i-PROBLEM
17056	syndromes	i-PROBLEM
17057	or	O
17058	uri	b-PROBLEM
17059	s.	i-PROBLEM
17060	he	O
17061	does	O
17062	admit	b-EVIDENTIAL
17063	to	O
17064	cocaine	b-PROBLEM
17065	use	i-PROBLEM
17066	last	b-DATE
17067	night	i-DATE
17068	.	O
17069	today	b-DATE
17070	,	O
17071	his	O
17072	wife	O
17073	convinced	b-OCCURRENCE
17074	him	O
17075	to	O
17076	present	b-OCCURRENCE
17077	to	O
17078	the	b-CLINICAL_DEPT
17079	deanna	i-CLINICAL_DEPT
17080	for	O
17081	evaluation	b-TEST
17082	.	O
17083	in	O
17084	the	b-CLINICAL_DEPT
17085	deanna	i-CLINICAL_DEPT
17086	,	O
17087	his	b-TEST
17088	bp	i-TEST
17089	was	O
17090	230/170	O
17091	.	O
17092	bnp	b-TEST
17093	was	O
17094	elevated	b-PROBLEM
17095	at	O
17096	7500	O
17097	.	O
17098	cxr	b-TEST
17099	revealed	b-EVIDENTIAL
17100	evidence	O
17101	of	O
17102	cardiomegaly	b-PROBLEM
17103	and	O
17104	pulm	b-PROBLEM
17105	edema	i-PROBLEM
17106	.	O
17107	he	O
17108	was	O
17109	treated	O
17110	w/	O
17111	asa	b-TREATMENT
17112	325	O
17113	mg	O
17114	,	O
17115	lasix	b-TREATMENT
17116	10	O
17117	mg	O
17118	iv	O
17119	,	O
17120	and	O
17121	hydralazine	b-TREATMENT
17122	10	O
17123	mg	O
17124	iv	O
17125	x	b-FREQUENCY
17126	2	i-FREQUENCY
17127	.	O
17128	he	O
17129	responded	b-OCCURRENCE
17130	well	i-OCCURRENCE
17131	to	O
17132	lasix	b-TREATMENT
17133	w/	O
17134	good	O
17135	uop	b-TEST
17136	,	O
17137	but	O
17138	diastolic	b-TEST
17139	bp	i-TEST
17140	remained	O
17141	elevated	b-PROBLEM
17142	at	O
17143	170	O
17144	,	O
17145	prompting	O
17146	initiation	O
17147	of	O
17148	nitroprusside	b-TREATMENT
17149	gtt	i-TREATMENT
17150	.	O
17151	he	O
17152	is	O
17153	now	O
17154	admitted	b-OCCURRENCE
17155	to	O
17156	the	b-CLINICAL_DEPT
17157	ccu	i-CLINICAL_DEPT
17158	for	O
17159	further	b-TREATMENT
17160	care	i-TREATMENT
17161	.	O
17162	brief	O
17163	hospital	O
17164	course	O
17165	:	O
17166	46	O
17167	-	O
17168	yo-man	O
17169	w/	O
17170	cocaine	b-PROBLEM
17171	abuse	i-PROBLEM
17172	presents	b-OCCURRENCE
17173	w/	O
17174	le	b-PROBLEM
17175	edema	i-PROBLEM
17176	and	O
17177	doe	b-PROBLEM
17178	likely	O
17179	from	O
17180	diastolic	b-PROBLEM
17181	heart	i-PROBLEM
17182	failure	i-PROBLEM
17183	in	O
17184	the	O
17185	setting	O
17186	of	O
17187	cocaine	b-PROBLEM
17188	use	i-PROBLEM
17189	complicated	O
17190	by	O
17191	hypertensive	b-PROBLEM
17192	urgency	i-PROBLEM
17193	.	O
17194	hypertensive	b-PROBLEM
17195	urgency	i-PROBLEM
17196	:	O
17197	bp	b-TEST
17198	230/170	O
17199	on	O
17200	presentation	b-OCCURRENCE
17201	,	O
17202	most	O
17203	likely	O
17204	from	O
17205	chronic	b-PROBLEM
17206	htn	i-PROBLEM
17207	exacerbated	O
17208	by	O
17209	cocaine	b-PROBLEM
17210	use	i-PROBLEM
17211	.	O
17212	no	O
17213	signs	O
17214	of	O
17215	end-organ	b-PROBLEM
17216	damage	i-PROBLEM
17217	at	O
17218	present	O
17219	except	O
17220	for	O
17221	elevated	b-PROBLEM
17222	creatinine	i-PROBLEM
17223	,	O
17224	which	O
17225	is	O
17226	more	O
17227	likely	O
17228	a	b-PROBLEM
17229	chronic	i-PROBLEM
17230	problem	i-PROBLEM
17231	.	O
17232	the	O
17233	patient	O
17234	was	O
17235	started	O
17236	on	O
17237	labetalol	b-TREATMENT
17238	and	O
17239	lisinopril	b-TREATMENT
17240	.	O
17241	his	b-TEST
17242	blood	i-TEST
17243	pressure	i-TEST
17244	was	O
17245	taken	b-OCCURRENCE
17246	down	i-OCCURRENCE
17247	from	O
17248	230	O
17249	systolic	b-TEST
17250	to	O
17251	approx	O
17252	160	O
17253	systolic	b-TEST
17254	/	O
17255	100	O
17256	diastolic	b-TEST
17257	on	O
17258	discharge	b-OCCURRENCE
17259	.	O
17260	his	b-PROBLEM
17261	lower	i-PROBLEM
17262	extremity	i-PROBLEM
17263	edema	i-PROBLEM
17264	improved	b-OCCURRENCE
17265	with	O
17266	diuresis	b-TREATMENT
17267	.	O
17268	an	b-TEST
17269	echo	i-TEST
17270	performed	O
17271	on	O
17272	admission	b-OCCURRENCE
17273	showed	b-EVIDENTIAL
17274	an	b-TEST
17275	lf	i-TEST
17276	ef	i-TEST
17277	of	O
17278	25%	O
17279	.	O
17280	it	O
17281	is	O
17282	hoped	O
17283	with	O
17284	good	b-TREATMENT
17285	blood	i-TREATMENT
17286	pressure	i-TREATMENT
17287	control	i-TREATMENT
17288	and	O
17289	use	O
17290	of	O
17291	an	b-TREATMENT
17292	ace-i	i-TREATMENT
17293	with	O
17294	follow	b-OCCURRENCE
17295	up	i-OCCURRENCE
17296	in	O
17297	addition	O
17298	to	O
17299	cocaine	b-OCCURRENCE
17300	abstaining	i-OCCURRENCE
17301	will	O
17302	improved	O
17303	his	b-OCCURRENCE
17304	cardiac	i-OCCURRENCE
17305	function	i-OCCURRENCE
17306	.	O
17307	renal	b-PROBLEM
17308	failure	i-PROBLEM
17309	:	O
17310	creatinine	b-TEST
17311	on	O
17312	admission	b-OCCURRENCE
17313	was	O
17314	1.6	O
17315	likely	O
17316	acute	b-PROBLEM
17317	hypertensive	i-PROBLEM
17318	nephropathy	i-PROBLEM
17319	plus	O
17320	probalbe	O
17321	long-standing	b-PROBLEM
17322	hypertensive	i-PROBLEM
17323	disease	i-PROBLEM
17324	.	O
17325	discharged	b-OCCURRENCE
17326	on	O
17327	ace-i	b-TREATMENT
17328	.	O
17329	substance	O
17330	use	O
17331	:	O
17332	social	O
17333	work	O
17334	saw	b-OCCURRENCE
17335	patient	O
17336	and	O
17337	counceled	b-TREATMENT
17338	him	O
17339	regarding	O
17340	substance	b-PROBLEM
17341	abuse	i-PROBLEM
17342	.	O
17343	discharged	b-OCCURRENCE
17344	with	O
17345	margaret	O
17346	hallock	O
17347	,	O
17348	cardiology	b-OCCURRENCE
17349	follow	i-OCCURRENCE
17350	up	i-OCCURRENCE
17351	as	O
17352	well	O
17353	as	O
17354	scheduled	b-OCCURRENCE
17355	appointment	O
17356	with	O
17357	a	O
17358	new	O
17359	pcp	O
17360	@	O
17361	newton	b-CLINICAL_DEPT
17362	health	i-CLINICAL_DEPT
17363	center	i-CLINICAL_DEPT
17364	.	O
17365		O
17366	admission	b-OCCURRENCE
17367	date	O
17368	:	O
17369	5/14/92	b-ADMISSION
17370	discharge	b-OCCURRENCE
17371	date	O
17372	:	O
17373	5/19/92	b-DISCHARGE
17374	discharge	b-OCCURRENCE
17375	date	O
17376	:	O
17377	5/19/92	b-DATE
17378	history	O
17379	of	O
17380	present	O
17381	illness	O
17382	:	O
17383	the	O
17384	patient	O
17385	is	O
17386	a	O
17387	71	O
17388	year	O
17389	old	O
17390	white	O
17391	female	O
17392	with	O
17393	metastatic	b-PROBLEM
17394	ovarian	i-PROBLEM
17395	carcinoma	i-PROBLEM
17396	,	O
17397	who	O
17398	recently	O
17399	underwent	O
17400	an	b-TEST
17401	exploratory	i-TEST
17402	laparotomy	i-TEST
17403	on	O
17404	5/2	b-DATE
17405	by	O
17406	doctor	O
17407	korcblinknud	O
17408	.	O
17409	she	O
17410	was	O
17411	found	O
17412	to	O
17413	have	O
17414	widely	b-PROBLEM
17415	metastatic	i-PROBLEM
17416	ovarian	i-PROBLEM
17417	carcinoma	i-PROBLEM
17418	.	O
17419	there	O
17420	was	O
17421	sigmoid	b-PROBLEM
17422	narrowing	i-PROBLEM
17423	near	O
17424	a	b-PROBLEM
17425	large	i-PROBLEM
17426	left	i-PROBLEM
17427	ovarian	i-PROBLEM
17428	mass	i-PROBLEM
17429	,	O
17430	and	O
17431	distal	b-PROBLEM
17432	ileal	i-PROBLEM
17433	narrowing	i-PROBLEM
17434	by	O
17435	a	b-PROBLEM
17436	right	i-PROBLEM
17437	ovarian	i-PROBLEM
17438	mass	i-PROBLEM
17439	.	O
17440	the	O
17441	patient	O
17442	had	O
17443	an	b-TREATMENT
17444	ileostomy	i-TREATMENT
17445	performed	O
17446	and	O
17447	had	O
17448	had	O
17449	her	O
17450	first	O
17451	course	O
17452	of	O
17453	chemotherapy	b-TREATMENT
17454	and	O
17455	later	O
17456	debulking	b-TREATMENT
17457	operation	i-TREATMENT
17458	by	O
17459	doctor	O
17460	median	O
17461	.	O
17462	she	O
17463	was	O
17464	well	b-OCCURRENCE
17465	at	O
17466	home	O
17467	until	O
17468	8:30	b-TIME
17469	p.m.	i-TIME
17470	on	i-TIME
17471	the	i-TIME
17472	day	i-TIME
17473	of	O
17474	admission	b-OCCURRENCE
17475	,	O
17476	when	O
17477	she	O
17478	developed	O
17479	acute	O
17480	onset	O
17481	of	O
17482	right	b-PROBLEM
17483	foot	i-PROBLEM
17484	pain	i-PROBLEM
17485	,	O
17486	which	O
17487	was	O
17488	worse	b-OCCURRENCE
17489	with	O
17490	walking	b-OCCURRENCE
17491	.	O
17492	she	O
17493	complained	b-EVIDENTIAL
17494	of	O
17495	increased	b-PROBLEM
17496	numbness	i-PROBLEM
17497	of	i-PROBLEM
17498	the	i-PROBLEM
17499	right	i-PROBLEM
17500	foot	i-PROBLEM
17501	over	O
17502	time	O
17503	,	O
17504	and	O
17505	was	O
17506	seen	O
17507	at	O
17508	sephsandpot	b-CLINICAL_DEPT
17509	center	i-CLINICAL_DEPT
17510	,	O
17511	where	O
17512	she	O
17513	was	O
17514	found	O
17515	to	O
17516	have	O
17517	palpable	b-OCCURRENCE
17518	right	i-OCCURRENCE
17519	femoral	i-OCCURRENCE
17520	and	i-OCCURRENCE
17521	popliteal	i-OCCURRENCE
17522	pulses	i-OCCURRENCE
17523	,	O
17524	and	O
17525	no	b-PROBLEM
17526	pedal	i-PROBLEM
17527	pulses	i-PROBLEM
17528	.	O
17529	the	O
17530	patient	O
17531	was	O
17532	transferred	b-OCCURRENCE
17533	to	O
17534	the	b-CLINICAL_DEPT
17535	fairm	i-CLINICAL_DEPT
17536	of	i-CLINICAL_DEPT
17537	ijordcompmac	i-CLINICAL_DEPT
17538	hospital	i-CLINICAL_DEPT
17539	.	O
17540	she	O
17541	had	O
17542	previous	O
17543	history	O
17544	of	O
17545	claudication	b-PROBLEM
17546	.	O
17547	hospital	O
17548	course	O
17549	:	O
17550	on	O
17551	5/14/92	b-DATE
17552	,	O
17553	the	O
17554	patient	O
17555	received	O
17556	an	b-TEST
17557	arteriogram	i-TEST
17558	which	O
17559	demonstrated	b-EVIDENTIAL
17560	an	b-PROBLEM
17561	embolus	i-PROBLEM
17562	in	i-PROBLEM
17563	the	i-PROBLEM
17564	right	i-PROBLEM
17565	profunda	i-PROBLEM
17566	/	i-PROBLEM
17567	femoral	i-PROBLEM
17568	artery	i-PROBLEM
17569	.	O
17570	there	O
17571	was	O
17572	an	b-PROBLEM
17573	occlusion	i-PROBLEM
17574	in	i-PROBLEM
17575	the	i-PROBLEM
17576	proximal	i-PROBLEM
17577	calf	i-PROBLEM
17578	,	O
17579	of	O
17580	the	O
17581	peroneal	O
17582	and	O
17583	anterior	O
17584	tibial	O
17585	arteries	O
17586	.	O
17587	there	O
17588	was	O
17589	an	b-PROBLEM
17590	occlusion	i-PROBLEM
17591	of	i-PROBLEM
17592	posterior	i-PROBLEM
17593	tibial	i-PROBLEM
17594	artery	i-PROBLEM
17595	at	O
17596	the	O
17597	ankle	O
17598	.	O
17599	she	O
17600	was	O
17601	taken	O
17602	urgently	O
17603	to	O
17604	the	b-CLINICAL_DEPT
17605	operating	i-CLINICAL_DEPT
17606	room	i-CLINICAL_DEPT
17607	,	O
17608	where	O
17609	she	O
17610	underwent	O
17611	embolectomy	b-TREATMENT
17612	of	i-TREATMENT
17613	the	i-TREATMENT
17614	profunda	i-TREATMENT
17615	superficial	i-TREATMENT
17616	femoral	i-TREATMENT
17617	vessels	i-TREATMENT
17618	.	O
17619	the	b-PROBLEM
17620	estimated	i-PROBLEM
17621	blood	i-PROBLEM
17622	loss	i-PROBLEM
17623	was	O
17624	200	O
17625	cc.	O
17626	and	O
17627	she	O
17628	tolerated	b-OCCURRENCE
17629	the	b-TREATMENT
17630	procedure	i-TREATMENT
17631	well	O
17632	.	O
17633	postoperatively	O
17634	,	O
17635	she	O
17636	was	O
17637	again	O
17638	noted	O
17639	to	O
17640	have	O
17641	a	b-PROBLEM
17642	cold	i-PROBLEM
17643	right	i-PROBLEM
17644	lower	i-PROBLEM
17645	extremity	i-PROBLEM
17646	with	O
17647	diminished	b-PROBLEM
17648	pulses	i-PROBLEM
17649	and	O
17650	was	O
17651	again	O
17652	taken	O
17653	to	O
17654	the	b-CLINICAL_DEPT
17655	operating	i-CLINICAL_DEPT
17656	room	i-CLINICAL_DEPT
17657	,	O
17658	where	O
17659	she	O
17660	underwent	O
17661	a	b-TEST
17662	right	i-TEST
17663	popliteal	i-TEST
17664	exploration	i-TEST
17665	and	O
17666	thrombectomy	b-TREATMENT
17667	.	O
17668	she	O
17669	again	O
17670	tolerated	b-OCCURRENCE
17671	the	b-TREATMENT
17672	procedure	i-TREATMENT
17673	well	O
17674	and	O
17675	did	b-OCCURRENCE
17676	well	i-OCCURRENCE
17677	postoperatively	O
17678	.	O
17679	on	O
17680	5/19	b-DATE
17681	,	O
17682	she	O
17683	had	O
17684	an	b-TEST
17685	echocardiogram	i-TEST
17686	done	O
17687	which	O
17688	was	O
17689	to	O
17690	be	O
17691	evaluated	b-OCCURRENCE
17692	as	O
17693	an	O
17694	out	O
17695	patient	O
17696	.	O
17697	by	O
17698	discharge	b-OCCURRENCE
17699	she	O
17700	was	O
17701	walking	b-OCCURRENCE
17702	and	O
17703	taking	O
17704	po&apos;s	b-OCCURRENCE
17705	without	O
17706	problem	b-PROBLEM
17707	.	O
17708		O
17709	admission	b-OCCURRENCE
17710	date	O
17711	:	O
17712	2011-09-23	b-ADMISSION
17713	discharge	b-OCCURRENCE
17714	date	O
17715	:	O
17716	2011-10-06	b-DISCHARGE
17717	service	O
17718	:	O
17719	neonatology	O
17720	history	O
17721	of	O
17722	present	O
17723	illness	O
17724	:	O
17725	ken	O
17726	nansteel-miller	O
17727	is	O
17728	the	O
17729	triplet	O
17730	#3	O
17731	of	O
17732	a	b-PROBLEM
17733	spontaneous	i-PROBLEM
17734	triamniotic-trichorionic	i-PROBLEM
17735	triplet	i-PROBLEM
17736	pregnancy	i-PROBLEM
17737	born	b-TREATMENT
17738	to	O
17739	a	O
17740	39-year-old	O
17741	g4	b-OCCURRENCE
17742	p1	i-OCCURRENCE
17743	spontaneous	b-PROBLEM
17744	abortion	i-PROBLEM
17745	2	O
17746	woman	O
17747	.	O
17748	prenatal	b-TEST
17749	screens	i-TEST
17750	:	O
17751	blood	b-TEST
17752	type	i-TEST
17753	a	O
17754	positive	O
17755	,	O
17756	antibody	b-TEST
17757	negative	O
17758	,	O
17759	rubella	b-TEST
17760	immune	O
17761	,	O
17762	rpr	b-TEST
17763	nonreactive	O
17764	,	O
17765	hepatitis	b-TEST
17766	b	i-TEST
17767	surface	i-TEST
17768	antigen	i-TEST
17769	negative	O
17770	,	O
17771	group	b-TEST
17772	beta	i-TEST
17773	strep	i-TEST
17774	status	i-TEST
17775	unknown	O
17776	.	O
17777	the	O
17778	mother	O
17779	was	O
17780	followed	b-OCCURRENCE
17781	closely	i-OCCURRENCE
17782	and	O
17783	received	O
17784	betamethasone	b-TREATMENT
17785	2011-08-22	b-DATE
17786	.	O
17787	she	O
17788	was	O
17789	admitted	b-OCCURRENCE
17790	on	O
17791	2011-08-25	b-DATE
17792	for	O
17793	nausea	b-PROBLEM
17794	,	O
17795	vomiting	b-PROBLEM
17796	,	O
17797	and	O
17798	a	b-PROBLEM
17799	shortened	i-PROBLEM
17800	cervix	i-PROBLEM
17801	.	O
17802	she	O
17803	was	O
17804	treated	O
17805	with	O
17806	bed	b-TREATMENT
17807	rest	i-TREATMENT
17808	and	O
17809	prn	O
17810	terbutaline	b-TREATMENT
17811	.	O
17812	other	b-TREATMENT
17813	medications	i-TREATMENT
17814	including	O
17815	prozac	b-TREATMENT
17816	.	O
17817	the	O
17818	babies	O
17819	were	O
17820	born	b-TREATMENT
17821	by	O
17822	elective	b-TREATMENT
17823	cesarean	i-TREATMENT
17824	section	i-TREATMENT
17825	at	O
17826	34	b-DURATION
17827	weeks	i-DURATION
17828	gestation	b-OCCURRENCE
17829	.	O
17830	this	O
17831	triplet	O
17832	#3	O
17833	emerged	O
17834	with	O
17835	spontaneous	b-OCCURRENCE
17836	respirations	i-OCCURRENCE
17837	,	O
17838	and	O
17839	required	O
17840	blow-by	b-TREATMENT
17841	oxygen	i-TREATMENT
17842	in	O
17843	the	b-CLINICAL_DEPT
17844	delivery	i-CLINICAL_DEPT
17845	room	i-CLINICAL_DEPT
17846	.	O
17847	apgars	b-TEST
17848	were	O
17849	seven	O
17850	at	O
17851	one	b-DURATION
17852	minute	i-DURATION
17853	and	O
17854	eight	O
17855	at	O
17856	five	b-DURATION
17857	minutes	i-DURATION
17858	.	O
17859	he	O
17860	was	O
17861	admitted	b-OCCURRENCE
17862	to	O
17863	the	b-CLINICAL_DEPT
17864	neonatal	i-CLINICAL_DEPT
17865	intensive	i-CLINICAL_DEPT
17866	care	i-CLINICAL_DEPT
17867	unit	i-CLINICAL_DEPT
17868	for	O
17869	treatment	b-TREATMENT
17870	of	O
17871	prematurity	b-PROBLEM
17872	.	O
17873	physical	b-TEST
17874	exam	i-TEST
17875	upon	O
17876	admission	b-OCCURRENCE
17877	to	O
17878	the	b-CLINICAL_DEPT
17879	neonatal	i-CLINICAL_DEPT
17880	intensive	i-CLINICAL_DEPT
17881	care	i-CLINICAL_DEPT
17882	unit	i-CLINICAL_DEPT
17883	:	i-CLINICAL_DEPT
17884	weight	b-TEST
17885	1.7	O
17886	kg	O
17887	,	O
17888	length	b-TEST
17889	41.5	O
17890	cm	O
17891	,	O
17892	head	b-TEST
17893	circumference	i-TEST
17894	29	O
17895	cm	O
17896	,	O
17897	all	O
17898	10th-25th	O
17899	percentile	O
17900	for	O
17901	34	b-DURATION
17902	weeks	i-DURATION
17903	.	O
17904	general	O
17905	:	O
17906	nondysmorphic	b-PROBLEM
17907	preterm	b-PROBLEM
17908	male	O
17909	in	O
17910	mild	b-PROBLEM
17911	respiratory	i-PROBLEM
17912	distress	i-PROBLEM
17913	.	O
17914	head	O
17915	,	O
17916	eyes	O
17917	,	O
17918	ears	O
17919	,	O
17920	nose	O
17921	,	O
17922	and	O
17923	throat	O
17924	:	O
17925	anterior	O
17926	fontanel	O
17927	open	b-OCCURRENCE
17928	and	i-OCCURRENCE
17929	flat	i-OCCURRENCE
17930	.	O
17931	symmetric	O
17932	facial	O
17933	features	O
17934	.	O
17935	positive	O
17936	red	b-TEST
17937	reflex	i-TEST
17938	bilaterally	O
17939	.	O
17940	palate	O
17941	intact	O
17942	.	O
17943	chest	O
17944	:	O
17945	mild	b-PROBLEM
17946	intercostal	i-PROBLEM
17947	and	i-PROBLEM
17948	sternal	i-PROBLEM
17949	retractions	i-PROBLEM
17950	.	O
17951	breath	b-TEST
17952	sounds	i-TEST
17953	equal	O
17954	with	O
17955	fair	O
17956	aeration	O
17957	.	O
17958	cardiovascular	O
17959	:	O
17960	regular	O
17961	,	O
17962	rate	O
17963	,	O
17964	and	O
17965	rhythm	O
17966	,	O
17967	no	O
17968	murmur	b-PROBLEM
17969	.	O
17970	femoral	b-TEST
17971	pulses	i-TEST
17972	+2	O
17973	.	O
17974	abdomen	O
17975	is	O
17976	soft	O
17977	,	O
17978	nontender	b-PROBLEM
17979	,	O
17980	nondistended	b-PROBLEM
17981	,	O
17982	no	O
17983	masses	b-PROBLEM
17984	,	O
17985	positive	O
17986	bowel	O
17987	sounds	O
17988	.	O
17989	genitourinary	O
17990	:	O
17991	normal	O
17992	preterm	O
17993	male	O
17994	.	O
17995	testes	b-OCCURRENCE
17996	descended	i-OCCURRENCE
17997	bilaterally	O
17998	.	O
17999	spine	b-OCCURRENCE
18000	straight	i-OCCURRENCE
18001	with	O
18002	normal	b-OCCURRENCE
18003	sacrum	i-OCCURRENCE
18004	.	O
18005	hips	b-OCCURRENCE
18006	stable	i-OCCURRENCE
18007	.	O
18008	neurologic	O
18009	:	O
18010	appropriate	b-OCCURRENCE
18011	tone	i-OCCURRENCE
18012	and	i-OCCURRENCE
18013	reflexes	i-OCCURRENCE
18014	.	O
18015	hospital	O
18016	course	O
18017	by	O
18018	systems	O
18019	including	O
18020	pertinent	O
18021	laboratory	O
18022	data	O
18023	:	O
18024	1.	O
18025	respiratory	O
18026	:	O
18027	lincoln	O
18028	required	O
18029	nasal	b-TREATMENT
18030	cannula	i-TREATMENT
18031	o2	i-TREATMENT
18032	for	O
18033	approximately	O
18034	the	O
18035	first	O
18036	8-12	b-DURATION
18037	hours	i-DURATION
18038	of	O
18039	life	O
18040	.	O
18041	he	O
18042	weaned	b-TREATMENT
18043	to	O
18044	room	b-TREATMENT
18045	air	i-TREATMENT
18046	and	O
18047	remained	O
18048	on	O
18049	room	b-TREATMENT
18050	air	i-TREATMENT
18051	the	O
18052	rest	O
18053	of	O
18054	his	b-CLINICAL_DEPT
18055	neonatal	i-CLINICAL_DEPT
18056	intensive	i-CLINICAL_DEPT
18057	care	i-CLINICAL_DEPT
18058	unit	i-CLINICAL_DEPT
18059	admission	b-OCCURRENCE
18060	.	O
18061	he	O
18062	has	O
18063	had	O
18064	no	O
18065	episodes	O
18066	of	O
18067	spontaneous	b-PROBLEM
18068	apnea	i-PROBLEM
18069	during	O
18070	admission	b-OCCURRENCE
18071	.	O
18072	2.	O
18073	cardiovascular	O
18074	:	O
18075	falmouth	O
18076	has	O
18077	maintained	O
18078	normal	O
18079	heart	b-TEST
18080	rates	i-TEST
18081	and	O
18082	blood	b-TEST
18083	pressures	i-TEST
18084	.	O
18085	no	O
18086	murmurs	b-PROBLEM
18087	have	O
18088	been	O
18089	noted	O
18090	.	O
18091	3.	O
18092	fluids	b-TREATMENT
18093	,	O
18094	electrolytes	b-TREATMENT
18095	,	O
18096	and	O
18097	nutrition	b-TREATMENT
18098	:	O
18099	beverly	O
18100	was	O
18101	initially	O
18102	npo	b-TREATMENT
18103	and	O
18104	maintained	O
18105	on	O
18106	intravenous	b-TREATMENT
18107	fluids	i-TREATMENT
18108	.	O
18109	enteral	b-TREATMENT
18110	feeds	i-TREATMENT
18111	were	O
18112	started	O
18113	on	O
18114	day	b-DATE
18115	of	i-DATE
18116	life	i-DATE
18117	#1	i-DATE
18118	,	O
18119	and	O
18120	gradually	O
18121	advanced	b-TREATMENT
18122	to	O
18123	full	b-TREATMENT
18124	volume	i-TREATMENT
18125	.	O
18126	his	O
18127	maximum	O
18128	caloric	O
18129	intake	O
18130	was	O
18131	24	b-TREATMENT
18132	calories	i-TREATMENT
18133	per	i-TREATMENT
18134	ounce	i-TREATMENT
18135	.	O
18136	at	O
18137	the	O
18138	time	O
18139	of	O
18140	discharge	b-OCCURRENCE
18141	,	O
18142	he	O
18143	is	O
18144	breastfeeding	b-OCCURRENCE
18145	or	O
18146	taking	O
18147	enfamil	b-TREATMENT
18148	fortified	O
18149	to	O
18150	24	O
18151	calories	O
18152	/	O
18153	ounce	O
18154	with	O
18155	intake	O
18156	approximately	O
18157	150	O
18158	cc	O
18159	/	O
18160	kg	O
18161	/	O
18162	day	O
18163	.	O
18164	discharge	b-TEST
18165	weight	i-TEST
18166	is	O
18167	1.89	O
18168	kg	O
18169	.	O
18170	4.	O
18171	gastrointestinal	O
18172	:	O
18173	boston	O
18174	required	O
18175	treatment	b-TREATMENT
18176	for	O
18177	unconjungated	b-PROBLEM
18178	hyperbilirubinemia	i-PROBLEM
18179	with	O
18180	phototherapy	b-TREATMENT
18181	.	O
18182	his	b-TEST
18183	peak	i-TEST
18184	serum	i-TEST
18185	bilirubin	i-TEST
18186	occurred	O
18187	on	O
18188	day	b-DATE
18189	of	i-DATE
18190	life	i-DATE
18191	three	i-DATE
18192	with	O
18193	a	O
18194	total	O
18195	of	O
18196	8.3	O
18197	/	O
18198	0.2	O
18199	direct	O
18200	,	O
18201	8.1	O
18202	indirect	O
18203	mg/dl	O
18204	.	O
18205	he	O
18206	received	O
18207	phototherapy	b-TREATMENT
18208	for	O
18209	approximately	O
18210	72	b-DURATION
18211	hours	i-DURATION
18212	.	O
18213	rebound	b-TEST
18214	bilirubin	i-TEST
18215	on	O
18216	day	b-DATE
18217	of	i-DATE
18218	life	i-DATE
18219	#7	i-DATE
18220	was	O
18221	6.6	O
18222	,	O
18223	and	O
18224	total	O
18225	was	O
18226	0.2	O
18227	direct	O
18228	.	O
18229	5.	O
18230	neurological	O
18231	:	O
18232	wellesley	O
18233	has	O
18234	maintained	O
18235	a	b-OCCURRENCE
18236	normal	i-OCCURRENCE
18237	neurological	i-OCCURRENCE
18238	examination	i-OCCURRENCE
18239	.	O
18240	throughout	O
18241	admission	b-OCCURRENCE
18242	,	O
18243	there	O
18244	are	O
18245	no	O
18246	neurological	b-PROBLEM
18247	concerns	i-PROBLEM
18248	at	O
18249	the	O
18250	time	O
18251	of	O
18252	discharge	b-OCCURRENCE
18253	.	O
18254	6.	O
18255	sensory	O
18256	:	O
18257	audiology	O
18258	:	O
18259	hearing	b-TEST
18260	screening	i-TEST
18261	was	O
18262	performed	O
18263	with	O
18264	automated	b-OCCURRENCE
18265	auditory	i-OCCURRENCE
18266	brain	i-OCCURRENCE
18267	stem	i-OCCURRENCE
18268	responses	i-OCCURRENCE
18269	.	O
18270	nantucket	O
18271	passed	O
18272	in	O
18273	both	O
18274	ears	O
18275	.	O
18276	condition	O
18277	on	O
18278	discharge	O
18279	:	O
18280	good	O
18281	.	O
18282	discharge	O
18283	/	O
18284	disposition	O
18285	:	O
18286	home	O
18287	with	O
18288	parents	O
18289	.	O
18290	primary	O
18291	pediatrician	O
18292	:	O
18293	doctor	O
18294	penny	O
18295	scott	O
18296	,	O
18297	8400	O
18298	s.	O
18299	maple	O
18300	blvd.	O
18301	,	O
18302	arbour-fuller	O
18303	hospital	O
18304	,	O
18305	new	O
18306	hampshire	O
18307	25344	O
18308	,	O
18309	phone	O
18310	number	O
18311	617-6198	O
18312	.	O
18313	fax	O
18314	number	O
18315	(	O
18316	317	O
18317	)	O
18318	497-7408	O
18319	.	O
18320	care	O
18321	and	O
18322	recommendations	O
18323	at	O
18324	the	O
18325	time	O
18326	of	O
18327	discharge	b-OCCURRENCE
18328	:	O
18329	1.	O
18330	feeding	O
18331	:	O
18332	breast	b-OCCURRENCE
18333	feeding	i-OCCURRENCE
18334	or	O
18335	enfamil	b-OCCURRENCE
18336	24	O
18337	calories	O
18338	/	O
18339	ounce	O
18340	.	O
18341	2.	O
18342	medications	b-TREATMENT
18343	:	O
18344	ferrous	b-TREATMENT
18345	sulfate	i-TREATMENT
18346	0.15	O
18347	cc	O
18348	po	O
18349	q	O
18350	day	O
18351	25	O
18352	mg	O
18353	/	O
18354	ml	O
18355	dilution	O
18356	.	O
18357	3.	O
18358	car	b-TEST
18359	seat	i-TEST
18360	position	i-TEST
18361	screening	i-TEST
18362	was	O
18363	performed	O
18364	.	O
18365	waltham	O
18366	was	O
18367	monitored	O
18368	for	O
18369	90	b-DURATION
18370	minutes	i-DURATION
18371	without	O
18372	any	O
18373	episodes	O
18374	of	O
18375	apnea	b-PROBLEM
18376	or	O
18377	oxygen	b-PROBLEM
18378	desaturation	i-PROBLEM
18379	.	O
18380	4.	O
18381	state	b-TEST
18382	newborn	i-TEST
18383	screens	i-TEST
18384	were	O
18385	sent	O
18386	on	O
18387	09-27	b-DATE
18388	and	O
18389	2011-10-05	b-DATE
18390	with	O
18391	no	O
18392	notification	O
18393	of	O
18394	abnormal	b-PROBLEM
18395	results	i-PROBLEM
18396	to	O
18397	date	O
18398	.	O
18399	5.	O
18400	no	O
18401	immunizations	b-TREATMENT
18402	administered	O
18403	.	O
18404	plan	O
18405	is	O
18406	to	O
18407	receive	O
18408	hepatitis	b-TREATMENT
18409	b	i-TREATMENT
18410	in	O
18411	the	O
18412	pediatrician	O
18413	's	O
18414	office	O
18415	,	O
18416	once	O
18417	he	O
18418	reaches	O
18419	a	O
18420	weight	O
18421	of	O
18422	2	O
18423	kg	O
18424	.	O
18425	6.	O
18426	immunizations	b-TREATMENT
18427	recommended	O
18428	:	O
18429	synagis	b-TREATMENT
18430	rsv	i-TREATMENT
18431	prophylaxis	i-TREATMENT
18432	should	O
18433	be	O
18434	considered	O
18435	from	O
18436	october	b-DURATION
18437	through	i-DURATION
18438	april	i-DURATION
18439	for	O
18440	infants	O
18441	who	O
18442	meet	O
18443	any	O
18444	of	O
18445	the	O
18446	following	O
18447	three	O
18448	criteria	O
18449	:	O
18450	1)	O
18451	born	O
18452	at	O
18453	less	O
18454	than	O
18455	32	b-DURATION
18456	weeks	i-DURATION
18457	,	O
18458	2)	O
18459	born	O
18460	between	O
18461	32	b-DURATION
18462	and	i-DURATION
18463	35	i-DURATION
18464	weeks	i-DURATION
18465	with	O
18466	plans	O
18467	for	O
18468	daycare	O
18469	during	O
18470	rsv	O
18471	season	O
18472	,	O
18473	with	O
18474	a	O
18475	smoker	O
18476	in	O
18477	the	O
18478	household	O
18479	,	O
18480	or	O
18481	with	O
18482	preschool	O
18483	siblings	O
18484	,	O
18485	or	O
18486	3)	O
18487	with	O
18488	chronic	b-PROBLEM
18489	lung	i-PROBLEM
18490	disease	i-PROBLEM
18491	.	O
18492	influenza	b-TREATMENT
18493	immunization	i-TREATMENT
18494	should	O
18495	be	O
18496	considered	O
18497	annually	b-FREQUENCY
18498	in	O
18499	the	O
18500	fall	O
18501	for	O
18502	preterm	O
18503	infants	O
18504	with	O
18505	chronic	b-PROBLEM
18506	lung	i-PROBLEM
18507	disease	i-PROBLEM
18508	once	O
18509	they	O
18510	reach	O
18511	six	b-DATE
18512	months	i-DATE
18513	of	O
18514	age	O
18515	.	O
18516	before	O
18517	this	O
18518	age	O
18519	,	O
18520	the	O
18521	family	O
18522	and	O
18523	other	O
18524	caregivers	O
18525	should	O
18526	be	O
18527	considered	O
18528	for	O
18529	immunization	b-TREATMENT
18530	against	O
18531	influenza	b-PROBLEM
18532	to	O
18533	protect	O
18534	the	O
18535	infant	O
18536	.	O
18537	follow-up	O
18538	appointments	O
18539	:	O
18540	doctor	O
18541	parramore	O
18542	on	O
18543	10-10	O
18544	.	O
18545	discharge	O
18546	diagnoses	O
18547	:	O
18548	1.	O
18549	prematurity	b-PROBLEM
18550	at	i-PROBLEM
18551	34	i-PROBLEM
18552	weeks	i-PROBLEM
18553	gestation	i-PROBLEM
18554	.	O
18555	2.	O
18556	triplet	O
18557	#3	O
18558	of	O
18559	triplet	O
18560	gestation	O
18561	.	O
18562	3.	O
18563	unconjugated	b-PROBLEM
18564	hyperbilirubinemia	i-PROBLEM
18565	.	O
18566	reviewed	O
18567	by	O
18568	:	O
18569	janna	O
18570	l.	O
18571	desorbo	O
18572	,	O
18573	md	O
18574	00-112	O
18575	dictated	O
18576	by	O
18577	:	O
18578	jeannette	O
18579	d.	O
18580	rede	O
18581	,	O
18582	md	O
18583	medquist36	O
18584	d	O
18585	:	O
18586	2011-10-06	O
18587	04:03	O
18588	t	O
18589	:	O
18590	2011-10-06	O
18591	06:19	O
18592	job	O
18593	#:	O
18594	02566	O
18595	signed	O
18596	electronically	O
18597	by	O
18598	:	O
18599	doctor	O
18600	bernice	O
18601	jenkins	O
18602	on	O
18603	:	O
18604	fri	O
18605	2011-10-07	O
18606	4:01	O
18607	pm	O
18608	(	O
18609	end	O
18610	of	O
18611	report	O
18612	)	O
18613		O
18614	admission	b-OCCURRENCE
18615	date	O
18616	:	O
18617	2014-04-23	b-ADMISSION
18618	discharge	b-OCCURRENCE
18619	date	O
18620	:	O
18621	2014-04-28	b-DISCHARGE
18622	service	O
18623	:	O
18624	medicine	O
18625	history	O
18626	of	O
18627	present	O
18628	illness	O
18629	:	O
18630	hpi	O
18631	:	O
18632	ms.	O
18633	franklin	O
18634	is	O
18635	a	O
18636	34	O
18637	-	O
18638	year-old	O
18639	woman	O
18640	with	O
18641	bipolar	b-PROBLEM
18642	disorder	i-PROBLEM
18643	and	O
18644	group	O
18645	home	O
18646	resident	O
18647	who	O
18648	by	O
18649	way	O
18650	of	O
18651	ems	b-OCCURRENCE
18652	for	O
18653	apparent	b-PROBLEM
18654	alprazolam	i-PROBLEM
18655	overdose	i-PROBLEM
18656	.	O
18657	in	O
18658	the	b-CLINICAL_DEPT
18659	st.	i-CLINICAL_DEPT
18660	margaret	i-CLINICAL_DEPT
18661	's	i-CLINICAL_DEPT
18662	center	i-CLINICAL_DEPT
18663	for	i-CLINICAL_DEPT
18664	women	i-CLINICAL_DEPT
18665	&	i-CLINICAL_DEPT
18666	infants	i-CLINICAL_DEPT
18667	,	O
18668	the	O
18669	patient	O
18670	was	O
18671	lethargic	b-PROBLEM
18672	and	O
18673	unable	b-PROBLEM
18674	to	i-PROBLEM
18675	give	i-PROBLEM
18676	a	i-PROBLEM
18677	history	i-PROBLEM
18678	.	O
18679	she	O
18680	was	O
18681	promptly	O
18682	intubated	b-TREATMENT
18683	for	O
18684	airway	b-TREATMENT
18685	protection	i-TREATMENT
18686	and	O
18687	in	O
18688	order	O
18689	to	O
18690	administer	O
18691	charcoal	b-TREATMENT
18692	.	O
18693	patient	O
18694	was	O
18695	found	b-EVIDENTIAL
18696	at	O
18697	group	O
18698	home	O
18699	in	O
18700	am	b-DATE
18701	laying	O
18702	on	O
18703	floor	O
18704	by	O
18705	bed	O
18706	unresponsive	b-PROBLEM
18707	,	O
18708	last	O
18709	seen	O
18710	awake	b-OCCURRENCE
18711	8	b-DURATION
18712	hours	i-DURATION
18713	prior	O
18714	at	O
18715	dinner	b-OCCURRENCE
18716	.	O
18717	group	O
18718	home	O
18719	states	b-EVIDENTIAL
18720	that	O
18721	patient	O
18722	""""	O
18723	may	O
18724	have	O
18725	taken	O
18726	too	O
18727	many	O
18728	xanax	b-TREATMENT
18729	.	O
18730	patient	O
18731	has	O
18732	a	O
18733	history	O
18734	of	O
18735	suicidal	b-PROBLEM
18736	ideations	i-PROBLEM
18737	and	O
18738	self	b-PROBLEM
18739	mutilation	i-PROBLEM
18740	.	O
18741	later	O
18742	patient	O
18743	told	b-EVIDENTIAL
18744	cmed	b-CLINICAL_DEPT
18745	ccu	i-CLINICAL_DEPT
18746	that	O
18747	she	O
18748	was	O
18749	feeling	b-PROBLEM
18750	down	i-PROBLEM
18751	and	O
18752	impulsively	O
18753	ingested	b-OCCURRENCE
18754	5	b-DURATION
18755	days	i-DURATION
18756	worth	i-OCCURRENCE
18757	of	O
18758	medications	b-TREATMENT
18759	,	O
18760	she	O
18761	states	b-EVIDENTIAL
18762	that	O
18763	her	b-OCCURRENCE
18764	intent	i-OCCURRENCE
18765	at	O
18766	that	O
18767	time	O
18768	was	O
18769	to	O
18770	end	b-OCCURRENCE
18771	her	i-OCCURRENCE
18772	life	i-OCCURRENCE
18773	.	O
18774	brief	O
18775	hospital	O
18776	course	O
18777	:	O
18778	cmed	O
18779	csru	O
18780	course	O
18781	:	O
18782	patient	O
18783	was	O
18784	intubated	b-TREATMENT
18785	in	O
18786	john	b-CLINICAL_DEPT
18787	for	O
18788	airway	b-TREATMENT
18789	protection	i-TREATMENT
18790	and	O
18791	administation	O
18792	of	O
18793	charcoal	b-TREATMENT
18794	.	O
18795	toxicology	b-OCCURRENCE
18796	consulted	i-OCCURRENCE
18797	and	O
18798	felt	O
18799	that	O
18800	patient	O
18801	most	O
18802	likely	O
18803	had	O
18804	benzo	b-PROBLEM
18805	overdose	i-PROBLEM
18806	.	O
18807	abg	b-TEST
18808	revealed	b-EVIDENTIAL
18809	widened	b-PROBLEM
18810	a-a	i-PROBLEM
18811	gradient	i-PROBLEM
18812	so	O
18813	a	b-TEST
18814	d-dimer	i-TEST
18815	was	O
18816	sent	O
18817	which	O
18818	was	O
18819	elevated	b-PROBLEM
18820	.	O
18821	patient	O
18822	had	O
18823	cta	b-TEST
18824	which	O
18825	showed	b-EVIDENTIAL
18826	bilateral	b-PROBLEM
18827	pulmonary	i-PROBLEM
18828	embolisms	i-PROBLEM
18829	.	O
18830	patient	O
18831	was	O
18832	started	O
18833	on	O
18834	heparin	b-TREATMENT
18835	drip	i-TREATMENT
18836	and	O
18837	bilateral	b-TEST
18838	lower	i-TEST
18839	extremeties	i-TEST
18840	were	O
18841	done	O
18842	which	O
18843	were	O
18844	negative	O
18845	for	O
18846	dvt	b-PROBLEM
18847	.	O
18848	patient	O
18849	was	O
18850	exubated	b-TREATMENT
18851	after	O
18852	1	b-DURATION
18853	day	i-DURATION
18854	in	O
18855	icu	b-CLINICAL_DEPT
18856	after	O
18857	waking	b-OCCURRENCE
18858	up	i-OCCURRENCE
18859	.	O
18860	overnight	b-DURATION
18861	in	O
18862	the	b-CLINICAL_DEPT
18863	icu	i-CLINICAL_DEPT
18864	patient	O
18865	was	O
18866	noticed	b-EVIDENTIAL
18867	to	O
18868	have	O
18869	painful	b-PROBLEM
18870	bullae	i-PROBLEM
18871	on	i-PROBLEM
18872	hands	i-PROBLEM
18873	and	i-PROBLEM
18874	arm	i-PROBLEM
18875	along	O
18876	with	O
18877	swelling	b-PROBLEM
18878	.	O
18879	dermatology	b-OCCURRENCE
18880	and	O
18881	plastic	b-OCCURRENCE
18882	surgery	i-OCCURRENCE
18883	were	O
18884	consulted	b-OCCURRENCE
18885	who	O
18886	felt	O
18887	that	O
18888	symptoms	b-PROBLEM
18889	were	O
18890	due	O
18891	to	O
18892	trauma	b-PROBLEM
18893	;	O
18894	it	O
18895	was	O
18896	not	O
18897	felt	O
18898	that	O
18899	patient	O
18900	had	O
18901	compartment	b-PROBLEM
18902	syndrome	i-PROBLEM
18903	.	O
18904	patient	O
18905	was	O
18906	splinted	b-TREATMENT
18907	and	O
18908	ue	O
18909	were	O
18910	kept	b-TREATMENT
18911	elevated	i-TREATMENT
18912	.	O
18913	patient	O
18914	was	O
18915	gradually	O
18916	put	O
18917	back	O
18918	on	O
18919	her	b-TREATMENT
18920	outpatient	i-TREATMENT
18921	xanax	i-TREATMENT
18922	dose	i-TREATMENT
18923	of	O
18924	1	O
18925	mg	O
18926	qid	b-FREQUENCY
18927	and	O
18928	clozaril	b-TREATMENT
18929	was	O
18930	restarted	O
18931	.	O
18932	patient	O
18933	was	O
18934	transferred	b-OCCURRENCE
18935	to	O
18936	floor	b-CLINICAL_DEPT
18937	after	O
18938	spending	O
18939	1	b-DURATION
18940	day	i-DURATION
18941	in	O
18942	the	b-CLINICAL_DEPT
18943	icu	i-CLINICAL_DEPT
18944	.	O
18945	once	O
18946	on	O
18947	the	b-CLINICAL_DEPT
18948	floor	i-CLINICAL_DEPT
18949	patient	O
18950	stable	b-OCCURRENCE
18951	.	O
18952	plastic	b-OCCURRENCE
18953	did	O
18954	not	O
18955	feel	O
18956	that	O
18957	patient	O
18958	had	O
18959	any	b-PROBLEM
18960	compartment	i-PROBLEM
18961	syndrome	i-PROBLEM
18962	and	O
18963	recommended	O
18964	aggresive	b-TREATMENT
18965	upper	i-TREATMENT
18966	extremity	i-TREATMENT
18967	elevation	i-TREATMENT
18968	for	O
18969	swelling	b-TREATMENT
18970	reduction	i-TREATMENT
18971	.	O
18972	while	O
18973	on	O
18974	the	b-CLINICAL_DEPT
18975	floor	i-CLINICAL_DEPT
18976	patient	O
18977	's	O
18978	hands	O
18979	improved	b-OCCURRENCE
18980	with	O
18981	good	b-OCCURRENCE
18982	range	i-OCCURRENCE
18983	of	i-OCCURRENCE
18984	motion	i-OCCURRENCE
18985	of	O
18986	left	O
18987	hand	O
18988	,	O
18989	however	O
18990	jones	O
18991	some	b-PROBLEM
18992	poor	i-PROBLEM
18993	range	i-PROBLEM
18994	of	i-PROBLEM
18995	motion	i-PROBLEM
18996	of	O
18997	right	O
18998	.	O
18999	x-ray	b-TEST
19000	of	i-TEST
19001	the	i-TEST
19002	hands	i-TEST
19003	and	i-TEST
19004	wrist	i-TEST
19005	were	O
19006	obtained	O
19007	which	O
19008	were	O
19009	negative	O
19010	.	O
19011	patient	O
19012	seen	b-OCCURRENCE
19013	by	i-OCCURRENCE
19014	pt	i-OCCURRENCE
19015	and	i-OCCURRENCE
19016	ot	i-OCCURRENCE
19017	who	O
19018	recommended	O
19019	hand	b-TREATMENT
19020	exercises	i-TREATMENT
19021	and	O
19022	splints	b-TREATMENT
19023	for	O
19024	patient	O
19025	.	O
19026	patient	O
19027	was	O
19028	put	O
19029	on	O
19030	coumadin	b-TREATMENT
19031	that	O
19032	was	O
19033	bridged	O
19034	with	O
19035	lovenox	b-TREATMENT
19036	unti	O
19037	linr	b-TREATMENT
19038	theraputic	i-TREATMENT
19039	01-23	O
19040	.	O
19041	patient	O
19042	conitnued	O
19043	to	O
19044	have	O
19045	si	b-PROBLEM
19046	while	O
19047	on	O
19048	floor	b-CLINICAL_DEPT
19049	and	O
19050	was	O
19051	transferred	b-OCCURRENCE
19052	to	O
19053	psychiatry	b-CLINICAL_DEPT
19054	.	O
19055	while	O
19056	on	O
19057	the	b-CLINICAL_DEPT
19058	floor	i-CLINICAL_DEPT
19059	patient	b-TEST
19060	's	i-TEST
19061	urinalysis	i-TEST
19062	suggestive	O
19063	of	O
19064	uti	b-PROBLEM
19065	and	O
19066	was	O
19067	put	O
19068	on	O
19069	6	b-DURATION
19070	day	i-DURATION
19071	course	O
19072	of	O
19073	levofloxacin	b-TREATMENT
19074	.	O
19075		O
19076	admission	b-OCCURRENCE
19077	date	O
19078	:	O
19079	08/15/1998	b-ADMISSION
19080	discharge	b-OCCURRENCE
19081	date	O
19082	:	O
19083	08/22/1998	b-DISCHARGE
19084	discharge	b-OCCURRENCE
19085	date	O
19086	:	O
19087	08/22/1998	b-DATE
19088	history	O
19089	of	O
19090	present	O
19091	illness	O
19092	:	O
19093	breunlinke	O
19094	is	O
19095	a	O
19096	70-year-old	O
19097	patient	O
19098	of	O
19099	doctor	O
19100	brendniungand	O
19101	asilbekote	O
19102	in	O
19103	california	O
19104	.	O
19105	she	O
19106	is	O
19107	referred	b-OCCURRENCE
19108	for	O
19109	progressive	b-PROBLEM
19110	angina	i-PROBLEM
19111	.	O
19112	she	O
19113	had	O
19114	rheumatoid	b-PROBLEM
19115	fever	i-PROBLEM
19116	as	O
19117	a	O
19118	child	O
19119	and	O
19120	a	b-PROBLEM
19121	heart	i-PROBLEM
19122	murmur	i-PROBLEM
19123	noted	O
19124	but	O
19125	no	O
19126	further	b-TEST
19127	testing	i-TEST
19128	.	O
19129	she	O
19130	has	O
19131	used	O
19132	antibiotic	b-TREATMENT
19133	prophylaxis	i-TREATMENT
19134	since	O
19135	1980	b-DATE
19136	.	O
19137	in	O
19138	1980	b-DATE
19139	she	O
19140	had	O
19141	quadruple	b-TREATMENT
19142	coronary	i-TREATMENT
19143	artery	i-TREATMENT
19144	bypass	i-TREATMENT
19145	graft	i-TREATMENT
19146	surgery	i-TREATMENT
19147	by	O
19148	doctor	O
19149	elks	O
19150	at	O
19151	feargunwake	b-CLINICAL_DEPT
19152	otacaa	i-CLINICAL_DEPT
19153	community	i-CLINICAL_DEPT
19154	hospital	i-CLINICAL_DEPT
19155	and	O
19156	did	b-OCCURRENCE
19157	well	i-OCCURRENCE
19158	until	O
19159	1988	b-DATE
19160	when	O
19161	she	O
19162	had	O
19163	exertional	b-PROBLEM
19164	angina	i-PROBLEM
19165	and	O
19166	a	b-PROBLEM
19167	positive	i-PROBLEM
19168	stress	i-PROBLEM
19169	test	i-PROBLEM
19170	and	O
19171	found	O
19172	that	O
19173	three	b-TREATMENT
19174	or	i-TREATMENT
19175	four	i-TREATMENT
19176	grafts	i-TREATMENT
19177	were	O
19178	occluded	b-PROBLEM
19179	.	O
19180	in	O
19181	october	b-DATE
19182	,	i-DATE
19183	1989	i-DATE
19184	,	O
19185	doctor	O
19186	no	O
19187	re-did	O
19188	her	b-TREATMENT
19189	bypass	i-TREATMENT
19190	operation	i-TREATMENT
19191	.	O
19192	she	O
19193	had	O
19194	a	b-TREATMENT
19195	left	i-TREATMENT
19196	internal	i-TREATMENT
19197	mammary	i-TREATMENT
19198	artery	i-TREATMENT
19199	graft	i-TREATMENT
19200	to	i-TREATMENT
19201	the	i-TREATMENT
19202	left	i-TREATMENT
19203	anterior	i-TREATMENT
19204	descending	i-TREATMENT
19205	,	O
19206	saphenous	b-TREATMENT
19207	vein	i-TREATMENT
19208	graft	i-TREATMENT
19209	to	i-TREATMENT
19210	the	i-TREATMENT
19211	obtuse	i-TREATMENT
19212	marginal	i-TREATMENT
19213	1	i-TREATMENT
19214	and	O
19215	a	b-TREATMENT
19216	saphenous	i-TREATMENT
19217	vein	i-TREATMENT
19218	graft	i-TREATMENT
19219	to	i-TREATMENT
19220	the	i-TREATMENT
19221	obtuse	i-TREATMENT
19222	marginal	i-TREATMENT
19223	2	i-TREATMENT
19224	.	O
19225	in	O
19226	1993	b-DATE
19227	she	O
19228	had	O
19229	a	b-TREATMENT
19230	ddd	i-TREATMENT
19231	pacemaker	i-TREATMENT
19232	for	O
19233	complete	b-PROBLEM
19234	heart	i-PROBLEM
19235	block	i-PROBLEM
19236	.	O
19237	she	O
19238	had	O
19239	exertional	b-PROBLEM
19240	angina	i-PROBLEM
19241	at	O
19242	that	O
19243	time	O
19244	.	O
19245	in	O
19246	november	b-DATE
19247	,	i-DATE
19248	1997	i-DATE
19249	she	O
19250	had	O
19251	a	b-PROBLEM
19252	small	i-PROBLEM
19253	myocardial	i-PROBLEM
19254	infarction	i-PROBLEM
19255	as	O
19256	was	O
19257	transferred	b-OCCURRENCE
19258	to	O
19259	ona	b-CLINICAL_DEPT
19260	hospital	i-CLINICAL_DEPT
19261	where	O
19262	a	b-TEST
19263	cardiac	i-TEST
19264	catheterization	i-TEST
19265	showed	b-EVIDENTIAL
19266	a	b-PROBLEM
19267	tight	i-PROBLEM
19268	left	i-PROBLEM
19269	internal	i-PROBLEM
19270	mammary	i-PROBLEM
19271	artery	i-PROBLEM
19272	to	O
19273	left	b-PROBLEM
19274	anterior	i-PROBLEM
19275	descending	i-PROBLEM
19276	stenosis	i-PROBLEM
19277	,	O
19278	high	b-TREATMENT
19279	grade	i-TREATMENT
19280	saphenous	i-TREATMENT
19281	vein	i-TREATMENT
19282	graft	i-TREATMENT
19283	to	O
19284	obtuse	b-PROBLEM
19285	marginal	i-PROBLEM
19286	1	i-PROBLEM
19287	stenosis	i-PROBLEM
19288	and	O
19289	patent	b-TREATMENT
19290	obtuse	i-TREATMENT
19291	marginal	i-TREATMENT
19292	2	i-TREATMENT
19293	graft	i-TREATMENT
19294	.	O
19295	she	O
19296	had	O
19297	normal	b-OCCURRENCE
19298	left	i-OCCURRENCE
19299	ventricular	i-OCCURRENCE
19300	function	i-OCCURRENCE
19301	with	O
19302	apical	b-PROBLEM
19303	tip	i-PROBLEM
19304	akinesis	i-PROBLEM
19305	.	O
19306	since	O
19307	that	O
19308	time	O
19309	she	O
19310	has	O
19311	continued	O
19312	to	O
19313	have	O
19314	exertional	b-PROBLEM
19315	left	i-PROBLEM
19316	chest	i-PROBLEM
19317	burning	i-PROBLEM
19318	,	O
19319	radiating	b-PROBLEM
19320	to	i-PROBLEM
19321	the	i-PROBLEM
19322	left	i-PROBLEM
19323	neck	i-PROBLEM
19324	and	i-PROBLEM
19325	arm	i-PROBLEM
19326	,	O
19327	relieved	O
19328	by	O
19329	nitroglycerin	b-TREATMENT
19330	.	O
19331	she	O
19332	was	O
19333	turned	O
19334	down	O
19335	for	O
19336	re-do	b-TREATMENT
19337	surgery	i-TREATMENT
19338	at	O
19339	that	O
19340	time	O
19341	and	O
19342	did	O
19343	not	O
19344	have	O
19345	a	b-TREATMENT
19346	percutaneous	i-TREATMENT
19347	transluminal	i-TREATMENT
19348	coronary	i-TREATMENT
19349	angioplasty	i-TREATMENT
19350	.	O
19351	because	O
19352	these	b-PROBLEM
19353	symptoms	i-PROBLEM
19354	have	O
19355	been	O
19356	increasing	b-OCCURRENCE
19357	,	O
19358	particularly	O
19359	at	O
19360	cardiac	b-TREATMENT
19361	rehabilitation	i-TREATMENT
19362	,	O
19363	she	O
19364	was	O
19365	referred	b-OCCURRENCE
19366	here	O
19367	.	O
19368	in	O
19369	may	b-DATE
19370	,	i-DATE
19371	1998	i-DATE
19372	she	O
19373	had	O
19374	an	b-TEST
19375	exercise	i-TEST
19376	tolerance	i-TEST
19377	test	i-TEST
19378	in	O
19379	which	O
19380	her	b-TEST
19381	heart	i-TEST
19382	rate	i-TEST
19383	went	O
19384	to	O
19385	112	O
19386	and	O
19387	her	b-TEST
19388	blood	i-TEST
19389	pressure	i-TEST
19390	fell	O
19391	to	O
19392	95	O
19393	systolic	O
19394	.	O
19395	she	O
19396	had	O
19397	diffuse	b-PROBLEM
19398	ischemic	i-PROBLEM
19399	st	i-PROBLEM
19400	segment	i-PROBLEM
19401	changes	i-PROBLEM
19402	and	O
19403	increased	b-PROBLEM
19404	lung	i-PROBLEM
19405	uptake	i-PROBLEM
19406	and	O
19407	a	b-PROBLEM
19408	reversible	i-PROBLEM
19409	anterior	i-PROBLEM
19410	and	i-PROBLEM
19411	lateral	i-PROBLEM
19412	defect	i-PROBLEM
19413	.	O
19414	she	O
19415	has	O
19416	had	O
19417	no	O
19418	syncope	b-PROBLEM
19419	.	O
19420	her	b-PROBLEM
19421	cardiac	i-PROBLEM
19422	risk	i-PROBLEM
19423	factors	i-PROBLEM
19424	are	O
19425	hypertension	b-PROBLEM
19426	and	O
19427	elevated	b-PROBLEM
19428	cholesterol	i-PROBLEM
19429	.	O
19430	she	O
19431	has	O
19432	a	O
19433	very	O
19434	strong	O
19435	family	O
19436	history	O
19437	of	O
19438	coronary	b-PROBLEM
19439	artery	i-PROBLEM
19440	disease	i-PROBLEM
19441	with	O
19442	a	O
19443	mother	O
19444	,	O
19445	sister	O
19446	and	O
19447	brother	O
19448	dying	O
19449	of	O
19450	myocardial	b-PROBLEM
19451	infarction	i-PROBLEM
19452	.	O
19453	she	O
19454	is	O
19455	a	O
19456	remote	O
19457	cigarette	b-OCCURRENCE
19458	smoker	i-OCCURRENCE
19459	.	O
19460	she	O
19461	also	O
19462	has	O
19463	a	O
19464	history	O
19465	of	O
19466	lactose	b-PROBLEM
19467	intolerance	i-PROBLEM
19468	,	O
19469	peptic	b-PROBLEM
19470	ulcer	i-PROBLEM
19471	disease	i-PROBLEM
19472	,	O
19473	with	O
19474	a	b-PROBLEM
19475	remote	i-PROBLEM
19476	gastrointestinal	i-PROBLEM
19477	bleed	i-PROBLEM
19478	and	O
19479	multiple	b-PROBLEM
19480	ectopic	i-PROBLEM
19481	pregnancies	i-PROBLEM
19482	and	O
19483	mid	b-PROBLEM
19484	term	i-PROBLEM
19485	miscarriages	i-PROBLEM
19486	.	O
19487	she	O
19488	has	O
19489	had	O
19490	a	b-TREATMENT
19491	total	i-TREATMENT
19492	abdominal	i-TREATMENT
19493	hysterectomy	i-TREATMENT
19494	.	O
19495	social	O
19496	history	O
19497	:	O
19498	she	O
19499	is	O
19500	a	b-OCCURRENCE
19501	widow	i-OCCURRENCE
19502	for	O
19503	20	b-DURATION
19504	years	i-DURATION
19505	and	O
19506	retired	b-OCCURRENCE
19507	18	b-DURATION
19508	years	i-DURATION
19509	from	O
19510	palmci	O
19511	she	O
19512	lives	O
19513	alone	O
19514	.	O
19515	her	O
19516	son	O
19517	,	O
19518	nertland	O
19519	is	O
19520	nearby	O
19521	and	O
19522	he	O
19523	works	O
19524	at	O
19525	the	O
19526	em	O
19527	nysonken	O
19528	medical	O
19529	center	O
19530	on	O
19531	verville	O
19532	.	O
19533	they	O
19534	live	O
19535	in	O
19536	ohio	O
19537	.	O
19538	hospital	O
19539	course	O
19540	and	O
19541	treatment	O
19542	:	O
19543	the	O
19544	patient	O
19545	was	O
19546	admitted	b-OCCURRENCE
19547	to	O
19548	the	b-CLINICAL_DEPT
19549	cardiac	i-CLINICAL_DEPT
19550	catheterization	i-CLINICAL_DEPT
19551	laboratory	i-CLINICAL_DEPT
19552	.	O
19553	there	O
19554	,	O
19555	her	b-TEST
19556	pulmonary	i-TEST
19557	wedge	i-TEST
19558	pressure	i-TEST
19559	was	O
19560	12	O
19561	and	O
19562	her	b-TEST
19563	right	i-TEST
19564	atrial	i-TEST
19565	pressure	i-TEST
19566	was	O
19567	4	O
19568	and	O
19569	pulmonary	b-TEST
19570	artery	i-TEST
19571	pressure	i-TEST
19572	44/17	O
19573	.	O
19574	her	b-TEST
19575	left	i-TEST
19576	ventricular	i-TEST
19577	contraction	i-TEST
19578	showed	b-EVIDENTIAL
19579	akinesis	b-PROBLEM
19580	of	i-PROBLEM
19581	the	i-PROBLEM
19582	anterior	i-PROBLEM
19583	wall	i-PROBLEM
19584	with	O
19585	dyskinesis	b-PROBLEM
19586	of	i-PROBLEM
19587	the	i-PROBLEM
19588	apex	i-PROBLEM
19589	.	O
19590	she	O
19591	had	O
19592	preserved	b-OCCURRENCE
19593	inferior	i-OCCURRENCE
19594	contraction	i-OCCURRENCE
19595	and	i-OCCURRENCE
19596	basal	i-OCCURRENCE
19597	contraction	i-OCCURRENCE
19598	.	O
19599	her	O
19600	native	O
19601	right	O
19602	and	O
19603	left	O
19604	anterior	O
19605	descending	O
19606	vessels	O
19607	were	O
19608	occluded	b-PROBLEM
19609	as	O
19610	was	O
19611	an	O
19612	obtuse	O
19613	marginal	O
19614	branch	O
19615	.	O
19616	the	b-TREATMENT
19617	saphenous	i-TREATMENT
19618	vein	i-TREATMENT
19619	to	i-TREATMENT
19620	the	i-TREATMENT
19621	high	i-TREATMENT
19622	diagonal	i-TREATMENT
19623	or	i-TREATMENT
19624	high	i-TREATMENT
19625	obtuse	i-TREATMENT
19626	marginal	i-TREATMENT
19627	was	O
19628	occluded	b-PROBLEM
19629	.	O
19630	the	b-TREATMENT
19631	left	i-TREATMENT
19632	internal	i-TREATMENT
19633	mammary	i-TREATMENT
19634	artery	i-TREATMENT
19635	to	i-TREATMENT
19636	the	i-TREATMENT
19637	left	i-TREATMENT
19638	anterior	i-TREATMENT
19639	descending	i-TREATMENT
19640	was	O
19641	also	O
19642	occluded	b-PROBLEM
19643	.	O
19644	the	b-TREATMENT
19645	saphenous	i-TREATMENT
19646	vein	i-TREATMENT
19647	graft	i-TREATMENT
19648	to	i-TREATMENT
19649	the	i-TREATMENT
19650	second	i-TREATMENT
19651	obtuse	i-TREATMENT
19652	marginal	i-TREATMENT
19653	was	O
19654	open	O
19655	with	O
19656	no	O
19657	significant	b-PROBLEM
19658	stenosis	i-PROBLEM
19659	,	O
19660	but	O
19661	there	O
19662	was	O
19663	an	b-PROBLEM
19664	outflow	i-PROBLEM
19665	lesion	i-PROBLEM
19666	in	i-PROBLEM
19667	the	i-PROBLEM
19668	obtuse	i-PROBLEM
19669	marginal	i-PROBLEM
19670	2	i-PROBLEM
19671	as	O
19672	well	O
19673	as	O
19674	severe	b-PROBLEM
19675	distal	i-PROBLEM
19676	lesion	i-PROBLEM
19677	as	O
19678	the	O
19679	obtuse	O
19680	marginal	O
19681	2	O
19682	fed	O
19683	the	O
19684	posterior	O
19685	descending	O
19686	artery	O
19687	.	O
19688	this	O
19689	was	O
19690	considered	O
19691	her	b-PROBLEM
19692	culprit	i-PROBLEM
19693	lesion	i-PROBLEM
19694	.	O
19695	this	O
19696	was	O
19697	considered	O
19698	too	b-OCCURRENCE
19699	high	i-OCCURRENCE
19700	risk	i-OCCURRENCE
19701	for	O
19702	angioplasty	b-TREATMENT
19703	because	O
19704	of	O
19705	the	b-PROBLEM
19706	severe	i-PROBLEM
19707	disease	i-PROBLEM
19708	in	O
19709	the	b-TREATMENT
19710	graft	i-TREATMENT
19711	.	O
19712	in	O
19713	addition	O
19714	,	O
19715	it	O
19716	was	O
19717	noted	O
19718	that	O
19719	she	O
19720	had	O
19721	saphenous	b-TREATMENT
19722	vein	i-TREATMENT
19723	harvested	i-TREATMENT
19724	from	O
19725	both	O
19726	thighs	O
19727	.	O
19728	her	O
19729	left	O
19730	internal	O
19731	mammary	O
19732	artery	O
19733	was	O
19734	also	O
19735	unused	O
19736	.	O
19737	it	O
19738	was	O
19739	also	O
19740	noted	O
19741	that	O
19742	she	O
19743	had	O
19744	failure	b-PROBLEM
19745	to	i-PROBLEM
19746	sense	i-PROBLEM
19747	with	O
19748	the	O
19749	atrial	O
19750	lead	O
19751	.	O
19752	she	O
19753	would	O
19754	not	b-PROBLEM
19755	sense	i-PROBLEM
19756	the	i-PROBLEM
19757	atrial	i-PROBLEM
19758	contraction	i-PROBLEM
19759	and	O
19760	the	O
19761	fire	O
19762	and	O
19763	this	O
19764	occasionally	O
19765	led	O
19766	to	O
19767	competition	b-PROBLEM
19768	of	i-PROBLEM
19769	firing	i-PROBLEM
19770	.	O
19771	this	O
19772	was	O
19773	intermittent	O
19774	.	O
19775	the	b-TEST
19776	p	i-TEST
19777	wave	i-TEST
19778	amplitude	i-TEST
19779	was	O
19780	.6	O
19781	and	O
19782	this	O
19783	could	O
19784	not	O
19785	be	O
19786	totally	O
19787	sensed	O
19788	.	O
19789	the	O
19790	patient	O
19791	was	O
19792	admitted	b-OCCURRENCE
19793	for	O
19794	management	b-TREATMENT
19795	of	O
19796	her	b-PROBLEM
19797	coronary	i-PROBLEM
19798	artery	i-PROBLEM
19799	disease	i-PROBLEM
19800	and	O
19801	evaluation	b-TEST
19802	of	O
19803	her	b-TREATMENT
19804	pacemaker	i-TREATMENT
19805	.	O
19806	it	O
19807	was	O
19808	noted	O
19809	that	O
19810	she	O
19811	became	O
19812	very	b-PROBLEM
19813	symptomatic	i-PROBLEM
19814	when	O
19815	she	O
19816	was	O
19817	not	O
19818	on	O
19819	a	b-TREATMENT
19820	beta	i-TREATMENT
19821	blocker	i-TREATMENT
19822	but	O
19823	that	O
19824	on	O
19825	a	b-TREATMENT
19826	beta	i-TREATMENT
19827	blocker	i-TREATMENT
19828	she	O
19829	had	O
19830	significant	b-PROBLEM
19831	pacemaker	i-PROBLEM
19832	failure	i-PROBLEM
19833	.	O
19834	her	b-TREATMENT
19835	pacemaker	i-TREATMENT
19836	was	O
19837	set	b-TREATMENT
19838	to	i-TREATMENT
19839	a	i-TREATMENT
19840	vvi	i-TREATMENT
19841	mode	i-TREATMENT
19842	which	O
19843	sensed	b-OCCURRENCE
19844	appropriately	i-OCCURRENCE
19845	.	O
19846	she	O
19847	was	O
19848	in	O
19849	sinus	b-OCCURRENCE
19850	rhythm	i-OCCURRENCE
19851	with	O
19852	most	O
19853	of	O
19854	the	O
19855	time	O
19856	.	O
19857	when	O
19858	her	b-TREATMENT
19859	pacemaker	i-TREATMENT
19860	was	O
19861	in	O
19862	a	b-OCCURRENCE
19863	sinus	i-OCCURRENCE
19864	rhythm	i-OCCURRENCE
19865	without	O
19866	a	b-TREATMENT
19867	beta	i-TREATMENT
19868	blocker	i-TREATMENT
19869	,	O
19870	she	O
19871	had	O
19872	significant	b-PROBLEM
19873	angina	i-PROBLEM
19874	.	O
19875	carotid	b-TEST
19876	non-invasive	i-TEST
19877	testing	i-TEST
19878	was	O
19879	unremarkable	O
19880	.	O
19881	the	O
19882	situation	O
19883	was	O
19884	reviewed	b-OCCURRENCE
19885	with	O
19886	doctor	O
19887	niste	O
19888	graft	O
19889	.	O
19890	he	O
19891	felt	O
19892	the	O
19893	patient	O
19894	was	O
19895	not	O
19896	a	b-TREATMENT
19897	coronary	i-TREATMENT
19898	artery	i-TREATMENT
19899	bypass	i-TREATMENT
19900	graft	i-TREATMENT
19901	candidate	O
19902	because	O
19903	of	O
19904	the	b-PROBLEM
19905	lack	i-PROBLEM
19906	of	i-PROBLEM
19907	conduit	i-PROBLEM
19908	and	O
19909	because	O
19910	of	O
19911	the	O
19912	presence	O
19913	of	O
19914	a	b-PROBLEM
19915	large	i-PROBLEM
19916	anterior	i-PROBLEM
19917	myocardial	i-PROBLEM
19918	infarction	i-PROBLEM
19919	.	O
19920	for	O
19921	this	O
19922	reason	O
19923	,	O
19924	it	O
19925	was	O
19926	decided	O
19927	to	O
19928	maximize	O
19929	her	b-TREATMENT
19930	beta	i-TREATMENT
19931	blockers	i-TREATMENT
19932	and	O
19933	nitrates	b-TREATMENT
19934	.	O
19935	the	O
19936	situation	O
19937	was	O
19938	reviewed	b-OCCURRENCE
19939	with	O
19940	doctor	O
19941	no	O
19942	of	O
19943	the	O
19944	pacemaker	O
19945	service	O
19946	.	O
19947	on	O
19948	august	b-DATE
19949	20	i-DATE
19950	,	O
19951	under	O
19952	local	b-TREATMENT
19953	anesthesia	i-TREATMENT
19954	the	O
19955	right	O
19956	pectoral	O
19957	region	O
19958	was	O
19959	explored	b-TREATMENT
19960	and	O
19961	the	b-TREATMENT
19962	leads	i-TREATMENT
19963	disconnected	i-TREATMENT
19964	and	O
19965	the	b-TREATMENT
19966	pulse	i-TREATMENT
19967	generator	i-TREATMENT
19968	changed	O
19969	to	O
19970	a	b-TREATMENT
19971	cpi	i-TREATMENT
19972	unit	i-TREATMENT
19973	in	O
19974	which	O
19975	the	O
19976	sensitivity	O
19977	could	O
19978	be	O
19979	adjusted	O
19980	to	O
19981	.15	O
19982	mm.	O
19983	,	O
19984	which	O
19985	permitted	O
19986	appropriate	b-TREATMENT
19987	atrial	i-TREATMENT
19988	sensing	i-TREATMENT
19989	.	O
19990	there	O
19991	was	O
19992	nothing	O
19993	wrong	O
19994	with	O
19995	the	b-TREATMENT
19996	prior	i-TREATMENT
19997	generator	i-TREATMENT
19998	and	O
19999	nothing	O
20000	wrong	O
20001	with	O
20002	the	b-TREATMENT
20003	leads	i-TREATMENT
20004	.	O
20005	it	O
20006	just	O
20007	needed	O
20008	a	O
20009	unit	O
20010	that	O
20011	could	O
20012	have	O
20013	more	O
20014	sensitivity	O
20015	in	O
20016	the	O
20017	atrial	O
20018	mode	O
20019	.	O
20020	she	O
20021	tolerated	b-OCCURRENCE
20022	this	i-OCCURRENCE
20023	well	i-OCCURRENCE
20024	.	O
20025	her	b-TREATMENT
20026	medications	i-TREATMENT
20027	were	O
20028	resumed	O
20029	.	O
20030	she	O
20031	ambulated	b-OCCURRENCE
20032	without	O
20033	difficulty	b-OCCURRENCE
20034	and	O
20035	was	O
20036	discharged	b-OCCURRENCE
20037	to	O
20038	home	O
20039	to	O
20040	be	O
20041	followed	b-TREATMENT
20042	medically	i-TREATMENT
20043	for	O
20044	her	b-PROBLEM
20045	coronary	i-PROBLEM
20046	artery	i-PROBLEM
20047	disease	i-PROBLEM
20048	following	O
20049	two	b-TREATMENT
20050	failed	i-TREATMENT
20051	bypass	i-TREATMENT
20052	graft	i-TREATMENT
20053	procedure	i-TREATMENT
20054	by	O
20055	doctor	O
20056	brendniungand	O
20057	asilbekote	O
20058	in	O
20059	bi	O
20060	masase	O
20061	,	O
20062	ks	O
20063	.	O
20064	achastha	O
20065	n.	O
20066	graft	O
20067	,	O
20068	md	O
20069	tr	O
20070	:	O
20071	hfr	O
20072	dd	O
20073	:	O
20074	08/22/1998	O
20075	td	O
20076	:	O
20077	08/27/1998	O
20078	3:56	O
20079	p	O
20080	cc	O
20081	:	O
20082	achastha	O
20083	nicemaen	O
20084	graft	O
20085	,	O
20086	md	O
20087	gittetumn	O
20088	darnnaman	O
20089	no	O
20090	,	O
20091	md	O
20092		O
20093	admission	b-OCCURRENCE
20094	date	O
20095	:	O
20096	2016-03-31	b-ADMISSION
20097	discharge	b-OCCURRENCE
20098	date	O
20099	:	O
20100	2016-04-01	b-DISCHARGE
20101	service	O
20102	:	O
20103	medicine	O
20104	history	O
20105	of	O
20106	present	O
20107	illness	O
20108	:	O
20109	50	O
20110	yo	O
20111	male	O
20112	,	O
20113	h/o	O
20114	cad	b-PROBLEM
20115	s/p	O
20116	stent	b-TREATMENT
20117	to	i-TREATMENT
20118	lad	i-TREATMENT
20119	in	O
20120	2011	b-DATE
20121	,	O
20122	hypercholesterolemia	b-PROBLEM
20123	,	O
20124	dm	b-PROBLEM
20125	,	O
20126	cocaine	b-PROBLEM
20127	abuse	i-PROBLEM
20128	,	O
20129	presenting	b-EVIDENTIAL
20130	with	O
20131	chest	b-PROBLEM
20132	pain	i-PROBLEM
20133	.	O
20134	he	O
20135	states	b-EVIDENTIAL
20136	he	O
20137	had	O
20138	onset	O
20139	of	O
20140	this	b-PROBLEM
20141	pain	i-PROBLEM
20142	today	b-DATE
20143	;	O
20144	described	b-EVIDENTIAL
20145	as	O
20146	anterior	b-PROBLEM
20147	chest	i-PROBLEM
20148	pain	i-PROBLEM
20149	with	O
20150	radiation	b-PROBLEM
20151	to	i-PROBLEM
20152	right	i-PROBLEM
20153	shoulder	i-PROBLEM
20154	,	O
20155	09-26	O
20156	,	O
20157	was	O
20158	increasing	b-OCCURRENCE
20159	over	O
20160	the	O
20161	course	O
20162	of	O
20163	45	b-DURATION
20164	minutes	i-DURATION
20165	to	i-DURATION
20166	1	i-DURATION
20167	hour	i-DURATION
20168	(	O
20169	occurred	O
20170	after	O
20171	arrested	b-OCCURRENCE
20172	).	O
20173	he	O
20174	states	b-EVIDENTIAL
20175	that	O
20176	he	O
20177	also	O
20178	felt	O
20179	sob	b-PROBLEM
20180	and	O
20181	diaphoretic	b-PROBLEM
20182	but	O
20183	denies	O
20184	n/v/palpitations	b-PROBLEM
20185	.	O
20186	he	O
20187	reports	b-EVIDENTIAL
20188	that	O
20189	the	b-PROBLEM
20190	pain	i-PROBLEM
20191	was	O
20192	increasing	b-OCCURRENCE
20193	in	O
20194	intensity	O
20195	.	O
20196	he	O
20197	was	O
20198	brought	O
20199	to	O
20200	providence	b-CLINICAL_DEPT
20201	behavioral	i-CLINICAL_DEPT
20202	health	i-CLINICAL_DEPT
20203	hospital	i-CLINICAL_DEPT
20204	where	O
20205	he	O
20206	was	O
20207	found	O
20208	to	O
20209	have	O
20210	positive	O
20211	urine	b-PROBLEM
20212	cocaine	i-PROBLEM
20213	,	O
20214	ekg	b-TEST
20215	with	O
20216	new	O
20217	2-7392	O
20218	w.	O
20219	second	O
20220	cr.	O
20221	elevations	b-PROBLEM
20222	in	i-PROBLEM
20223	the	i-PROBLEM
20224	anterior	i-PROBLEM
20225	leads	i-PROBLEM
20226	(	i-PROBLEM
20227	v2-5	i-PROBLEM
20228	)	i-PROBLEM
20229	and	O
20230	some	b-PROBLEM
20231	st	i-PROBLEM
20232	depressions	i-PROBLEM
20233	in	i-PROBLEM
20234	ii	i-PROBLEM
20235	,	i-PROBLEM
20236	iii	i-PROBLEM
20237	,	i-PROBLEM
20238	avf	i-PROBLEM
20239	.	O
20240	he	O
20241	was	O
20242	given	O
20243	lopressor	b-TREATMENT
20244	5	O
20245	mg	O
20246	x	O
20247	2	O
20248	(	O
20249	3rd	O
20250	dose	O
20251	given	O
20252	by	O
20253	medflight	O
20254	,	O
20255	5	O
20256	mg	O
20257	morphine	b-TREATMENT
20258	,	O
20259	ativan	b-TREATMENT
20260	,	O
20261	nitro	b-TREATMENT
20262	gtt	i-TREATMENT
20263	,	O
20264	heparin	b-TREATMENT
20265	,	O
20266	and	O
20267	integrillin	b-TREATMENT
20268	.	O
20269	pain	b-PROBLEM
20270	was	O
20271	12-28	O
20272	at	O
20273	time	O
20274	of	O
20275	transfer	b-OCCURRENCE
20276	.	O
20277	in	O
20278	the	b-CLINICAL_DEPT
20279	cath	i-CLINICAL_DEPT
20280	lab	i-CLINICAL_DEPT
20281	,	O
20282	he	O
20283	was	O
20284	found	O
20285	to	O
20286	have	O
20287	hazy	b-PROBLEM
20288	plaque	i-PROBLEM
20289	in	i-PROBLEM
20290	lad	i-PROBLEM
20291	(	O
20292	prior	b-TREATMENT
20293	stent	i-TREATMENT
20294	)	O
20295	,	O
20296	80%	b-PROBLEM
20297	hazy	i-PROBLEM
20298	plaque	i-PROBLEM
20299	in	i-PROBLEM
20300	circumflex	i-PROBLEM
20301	,	O
20302	and	O
20303	a	b-PROBLEM
20304	totally	i-PROBLEM
20305	occluded	i-PROBLEM
20306	plb	i-PROBLEM
20307	(	i-PROBLEM
20308	with	i-PROBLEM
20309	collaterals	i-PROBLEM
20310	)	i-PROBLEM
20311	.	O
20312	1	b-TREATMENT
20313	cypher	i-TREATMENT
20314	stent	i-TREATMENT
20315	was	O
20316	place	O
20317	in	O
20318	the	O
20319	lad	O
20320	while	O
20321	2	O
20322	were	O
20323	placed	O
20324	in	O
20325	lcx	O
20326	.	O
20327	right	O
20328	system	O
20329	was	O
20330	not	O
20331	intervened	b-TREATMENT
20332	upon	O
20333	,	O
20334	for	O
20335	the	O
20336	plb	O
20337	was	O
20338	unable	O
20339	to	O
20340	be	O
20341	crossed	O
20342	by	O
20343	wire	b-TREATMENT
20344	.	O
20345	he	O
20346	was	O
20347	transferred	b-OCCURRENCE
20348	to	O
20349	the	b-CLINICAL_DEPT
20350	ccu	i-CLINICAL_DEPT
20351	for	O
20352	observation	b-TEST
20353	.	O
20354	brief	O
20355	hospital	O
20356	course	O
20357	:	O
20358	1.	O
20359	cad	b-PROBLEM
20360	:	O
20361	presented	b-OCCURRENCE
20362	with	O
20363	anginal	b-PROBLEM
20364	symptoms	i-PROBLEM
20365	and	O
20366	ekg	b-PROBLEM
20367	changes	i-PROBLEM
20368	(	O
20369	stemi	b-PROBLEM
20370	)	O
20371	,	O
20372	with	O
20373	cardiac	b-TEST
20374	catheterization	i-TEST
20375	revealing	O
20376	lesions	b-PROBLEM
20377	in	i-PROBLEM
20378	lad	i-PROBLEM
20379	,	i-PROBLEM
20380	lcx	i-PROBLEM
20381	,	i-PROBLEM
20382	and	i-PROBLEM
20383	plb	i-PROBLEM
20384	.	O
20385	unclear	O
20386	if	O
20387	hazy	b-PROBLEM
20388	lesions	i-PROBLEM
20389	significant	O
20390	or	O
20391	if	O
20392	this	O
20393	was	O
20394	cocaine	b-PROBLEM
20395	induced	i-PROBLEM
20396	vasospasm	i-PROBLEM
20397	.	O
20398	lad	O
20399	and	O
20400	lcx	O
20401	were	O
20402	stented	b-TREATMENT
20403	,	O
20404	but	O
20405	plb	O
20406	could	O
20407	not	O
20408	be	O
20409	crossed	O
20410	by	O
20411	guidewire	b-TREATMENT
20412	(	O
20413	were	O
20414	collaterals	O
20415	)	O
20416	.	O
20417	-	O
20418	continue	O
20419	asa	b-TREATMENT
20420	,	O
20421	statin	b-TREATMENT
20422	,	O
20423	plavix	b-TREATMENT
20424	;	O
20425	will	O
20426	hold	O
20427	bb	b-TREATMENT
20428	given	O
20429	recent	O
20430	cocaine	b-PROBLEM
20431	use	i-PROBLEM
20432	(	O
20433	?	O
20434	can	O
20435	consider	O
20436	labetalol	b-TREATMENT
20437	if	O
20438	necessary	O
20439	)	O
20440	,	O
20441	integrillin	b-TREATMENT
20442	for	O
20443	18	b-DURATION
20444	hours	i-DURATION
20445	-	O
20446	ck	b-TEST
20447	negative	O
20448	.	O
20449	tn	b-TEST
20450	wnl	O
20451	.	O
20452	-	O
20453	post	b-TEST
20454	cath	i-TEST
20455	check	i-TEST
20456	normal	O
20457	2.	O
20458	chf	b-PROBLEM
20459	:	O
20460	ef	b-TEST
20461	25%	O
20462	on	O
20463	echo	b-TEST
20464	,	O
20465	states	O
20466	he	O
20467	takes	O
20468	lasix	b-TREATMENT
20469	at	O
20470	home	O
20471	-	O
20472	started	O
20473	lisinopril	b-TREATMENT
20474	.	O
20475	-	O
20476	consider	O
20477	repeat	b-TEST
20478	echo	i-TEST
20479	in	O
20480	1	b-DATE
20481	month	i-DATE
20482	and	O
20483	quincy	b-CLINICAL_DEPT
20484	medical	i-CLINICAL_DEPT
20485	center	i-CLINICAL_DEPT
20486	-	O
20487	v/icd	b-TREATMENT
20488	per	O
20489	discretion	O
20490	of	O
20491	primary	O
20492	cardiologist	O
20493	.	O
20494	-	O
20495	kept	O
20496	euvolemic	b-OCCURRENCE
20497	and	O
20498	monitored	b-TEST
20499	for	O
20500	signs	O
20501	of	O
20502	overload	b-PROBLEM
20503	-	O
20504	low	b-TREATMENT
20505	na	i-TREATMENT
20506	diet	i-TREATMENT
20507	with	O
20508	1	b-TREATMENT
20509	liter	i-TREATMENT
20510	fluid	i-TREATMENT
20511	restriction	i-TREATMENT
20512	-	O
20513	may	O
20514	need	O
20515	to	O
20516	diurese	b-TREATMENT
20517	based	O
20518	on	O
20519	clinical	O
20520	status	O
20521	,	O
20522	swan	b-TEST
20523	numbers	i-TEST
20524	3.	O
20525	rhythm	b-TEST
20526	:	O
20527	no	O
20528	ectopy	b-PROBLEM
20529	post	O
20530	cath	b-TREATMENT
20531	mi	b-PROBLEM
20532	4.	O
20533	dm	b-PROBLEM
20534	:	O
20535	on	O
20536	metformin	b-TREATMENT
20537	at	O
20538	home	O
20539	,	O
20540	will	O
20541	hold	O
20542	given	O
20543	cath	b-TREATMENT
20544	/	i-TREATMENT
20545	dye	i-TREATMENT
20546	adn	O
20547	cover	O
20548	with	O
20549	ssi	b-TREATMENT
20550	5.	O
20551	cocaine	b-PROBLEM
20552	use	i-PROBLEM
20553	:	O
20554	last	O
20555	use	O
20556	this	b-DATE
20557	morning	i-DATE
20558	,	O
20559	no	O
20560	bb	b-TREATMENT
20561	given	O
20562	this	O
20563	;	O
20564	considered	O
20565	using	O
20566	ccb	b-TREATMENT
20567	/	O
20568	phentolamine	b-TREATMENT
20569	if	O
20570	chest	b-PROBLEM
20571	pain	i-PROBLEM
20572	recurs	O
20573	.	O
20574	--	O
20575	will	O
20576	discuss	O
20577	beta-blocker	b-TREATMENT
20578	risks	O
20579	and	O
20580	benefits	O
20581	with	O
20582	primary	O
20583	cardiologist	O
20584	--	O
20585	pt	O
20586	advised	b-OCCURRENCE
20587	of	O
20588	medical	O
20589	risks	O
20590	of	O
20591	using	b-PROBLEM
20592	cocaine	i-PROBLEM
20593	6.	O
20594	etoh	b-PROBLEM
20595	use	i-PROBLEM
20596	:	O
20597	unclear	O
20598	how	O
20599	much	O
20600	,	O
20601	monitor	O
20602	on	O
20603	ciwa	b-TEST
20604	for	O
20605	signs	O
20606	of	O
20607	withdrawal	b-PROBLEM
20608	,	O
20609	ativan	b-TREATMENT
20610	prn	O
20611	--	O
20612	ciwas	b-TEST
20613	were	O
20614	0	O
20615	throughout	O
20616	admission	b-OCCURRENCE
20617	7.	O
20618	hyperlipidemia	b-PROBLEM
20619	:	O
20620	on	O
20621	lipitor	b-TREATMENT
20622	80	O
20623	.	O
20624	ldl	b-TEST
20625	79	O
20626	,	O
20627	hdl	b-TEST
20628	51	O
20629	8.	O
20630	social	O
20631	:	O
20632	in	O
20633	police	b-OCCURRENCE
20634	custody	i-OCCURRENCE
20635	,	O
20636	with	O
20637	24	b-DURATION
20638	hr	i-DURATION
20639	guard	O
20640	,	O
20641	handcuffed	b-OCCURRENCE
20642	to	i-OCCURRENCE
20643	bed	i-OCCURRENCE
20644	9.	O
20645	fen	O
20646	:	O
20647	cardiac	b-TREATMENT
20648	diet	i-TREATMENT
20649	,	O
20650	watch	O
20651	for	O
20652	aspiration	b-PROBLEM
20653	given	O
20654	somnolent	b-PROBLEM
20655	status	i-PROBLEM
20656	at	O
20657	this	O
20658	time	O
20659	,	O
20660	ck	b-TEST
20661	and	O
20662	replete	O
20663	mg/k/ca	b-TREATMENT
20664	aggressively	O
20665	10.	O
20666	code	O
20667	:	O
20668	full	O
20669	11.	O
20670	dispo	O
20671	:	O
20672	back	O
20673	to	O
20674	prison;	O
20675	?	O
20676	extradition	O
20677	to	O
20678	hawaii	O
20679		O
20680	admission	b-OCCURRENCE
20681	date	O
20682	:	O
20683	2017-01-10	b-ADMISSION
20684	discharge	b-OCCURRENCE
20685	date	O
20686	:	O
20687	2017-01-16	b-DISCHARGE
20688	service	O
20689	:	O
20690	medical	O
20691	icu	O
20692	history	O
20693	of	O
20694	present	O
20695	illness	O
20696	:	O
20697	patient	O
20698	is	O
20699	a	O
20700	53	O
20701	-	O
20702	year-old	O
20703	female	O
20704	found	b-OCCURRENCE
20705	down	i-OCCURRENCE
20706	in	O
20707	hotel	O
20708	room	O
20709	by	O
20710	ems	O
20711	with	O
20712	change	b-PROBLEM
20713	in	i-PROBLEM
20714	mental	i-PROBLEM
20715	status	i-PROBLEM
20716	and	O
20717	lethargy	b-PROBLEM
20718	.	O
20719	a	O
20720	suicide	O
20721	note	O
20722	found	O
20723	at	O
20724	the	O
20725	scene	O
20726	referenced	O
20727	multiple	b-PROBLEM
20728	medical	i-PROBLEM
20729	problems	i-PROBLEM
20730	as	O
20731	well	O
20732	as	O
20733	suggested	O
20734	ingestion	O
20735	of	O
20736	beta	b-TREATMENT
20737	blocker	i-TREATMENT
20738	,	O
20739	muscle	b-TREATMENT
20740	relaxant	i-TREATMENT
20741	,	O
20742	and	O
20743	neurontin	b-TREATMENT
20744	.	O
20745	vital	b-TEST
20746	signs	i-TEST
20747	were	O
20748	stable	b-OCCURRENCE
20749	on	O
20750	arrival	O
20751	in	O
20752	the	b-CLINICAL_DEPT
20753	david	i-CLINICAL_DEPT
20754	,	O
20755	but	O
20756	the	O
20757	patient	O
20758	was	O
20759	minimally	b-PROBLEM
20760	responsive	i-PROBLEM
20761	and	O
20762	subsequently	O
20763	intubated	b-TREATMENT
20764	for	O
20765	airway	b-TREATMENT
20766	protection	i-TREATMENT
20767	.	O
20768	patient	O
20769	initially	O
20770	given	O
20771	2	O
20772	mg	O
20773	of	O
20774	narcan	b-TREATMENT
20775	,	O
20776	4	O
20777	amps	O
20778	of	O
20779	sodium	b-TREATMENT
20780	bicarb	i-TREATMENT
20781	,	O
20782	and	O
20783	5	O
20784	grams	O
20785	of	O
20786	activated	b-TREATMENT
20787	charcoal	i-TREATMENT
20788	.	O
20789	patient	b-TEST
20790	's	i-TEST
20791	blood	i-TEST
20792	pressures	i-TEST
20793	were	O
20794	noted	O
20795	to	O
20796	decrease	b-PROBLEM
20797	systolics	i-PROBLEM
20798	to	O
20799	the	O
20800	80s	O
20801	,	O
20802	which	O
20803	responded	b-OCCURRENCE
20804	to	O
20805	iv	b-TREATMENT
20806	fluids	i-TREATMENT
20807	and	O
20808	insulin	b-TREATMENT
20809	/	O
20810	glucose	b-TREATMENT
20811	drips	i-TREATMENT
20812	.	O
20813	also	O
20814	noted	O
20815	to	O
20816	be	O
20817	bradycardic	b-PROBLEM
20818	to	O
20819	the	O
20820	50s	O
20821	,	O
20822	which	O
20823	responded	b-OCCURRENCE
20824	to	O
20825	atropine	b-TREATMENT
20826	.	O
20827	hospital	O
20828	course	O
20829	:	O
20830	in	O
20831	summary	O
20832	,	O
20833	patient	O
20834	is	O
20835	a	O
20836	53	O
20837	-	O
20838	year-old	O
20839	female	O
20840	with	O
20841	multiple	b-PROBLEM
20842	medical	i-PROBLEM
20843	problems	i-PROBLEM
20844	and	O
20845	history	O
20846	of	O
20847	depression	b-PROBLEM
20848	with	O
20849	intentional	b-PROBLEM
20850	overdose	i-PROBLEM
20851	of	O
20852	barbiturates	b-TREATMENT
20853	,	O
20854	opiates	b-TREATMENT
20855	,	O
20856	tylenol	b-TREATMENT
20857	,	O
20858	and	O
20859	beta	b-TREATMENT
20860	blocker	i-TREATMENT
20861	.	O
20862	cmed	O
20863	:	O
20864	patient	O
20865	was	O
20866	maintained	O
20867	on	O
20868	insulin	b-TREATMENT
20869	,	O
20870	d10	b-TREATMENT
20871	and	O
20872	glucagon	b-TREATMENT
20873	drips	i-TREATMENT
20874	to	O
20875	maintain	O
20876	her	O
20877	hemodynamics	O
20878	.	O
20879	this	O
20880	was	O
20881	achieved	O
20882	with	O
20883	good	b-OCCURRENCE
20884	effect	i-OCCURRENCE
20885	,	O
20886	and	O
20887	they	O
20888	were	O
20889	subsequently	O
20890	weaned	b-TREATMENT
20891	off	i-TREATMENT
20892	.	O
20893	patient	O
20894	was	O
20895	able	O
20896	to	O
20897	be	O
20898	extubated	b-TREATMENT
20899	on	O
20900	hospital	b-DATE
20901	day	i-DATE
20902	three	i-DATE
20903	.	O
20904	psychiatry	O
20905	was	O
20906	consulted	b-OCCURRENCE
20907	after	O
20908	the	O
20909	patient	O
20910	was	O
20911	extubated	b-TREATMENT
20912	,	O
20913	and	O
20914	felt	O
20915	that	O
20916	patient	O
20917	had	O
20918	a	b-PROBLEM
20919	high	i-PROBLEM
20920	suicide	i-PROBLEM
20921	risk	i-PROBLEM
20922	,	O
20923	and	O
20924	plan	O
20925	was	O
20926	for	O
20927	her	O
20928	to	O
20929	be	O
20930	admitted	b-OCCURRENCE
20931	to	O
20932	the	b-CLINICAL_DEPT
20933	psychiatry	i-CLINICAL_DEPT
20934	service	i-CLINICAL_DEPT
20935	once	O
20936	medically	b-OCCURRENCE
20937	stable	i-OCCURRENCE
20938	.	O
20939	patient	O
20940	's	O
20941	renal	O
20942	function	O
20943	remained	O
20944	stable	b-OCCURRENCE
20945	and	O
20946	her	b-TEST
20947	cks	i-TEST
20948	trended	b-OCCURRENCE
20949	down	i-OCCURRENCE
20950	gradually	O
20951	.	O
20952	patient	O
20953	remained	O
20954	on	O
20955	suicide	b-TREATMENT
20956	precautions	i-TREATMENT
20957	,	O
20958	but	O
20959	was	O
20960	deemed	O
20961	not	O
20962	to	O
20963	need	O
20964	icu	b-TEST
20965	level	i-TEST
20966	monitoring	i-TEST
20967	,	O
20968	and	O
20969	was	O
20970	transferred	b-OCCURRENCE
20971	to	O
20972	the	b-CLINICAL_DEPT
20973	floor	i-CLINICAL_DEPT
20974	on	O
20975	01-11	b-DATE
20976	.	O
20977	in	O
20978	the	b-DATE
20979	a.m.	i-DATE
20980	of	i-DATE
20981	01/08	i-DATE
20982	,	O
20983	the	O
20984	patient	O
20985	experienced	O
20986	episode	O
20987	of	O
20988	tongue	b-PROBLEM
20989	biting	i-PROBLEM
20990	,	O
20991	unresponsiveness	b-PROBLEM
20992	,	O
20993	disorientation	b-PROBLEM
20994	.	O
20995	was	O
20996	loaded	O
20997	on	O
20998	dilantin	b-TREATMENT
20999	.	O
21000	became	O
21001	progressively	O
21002	hypoxic	b-PROBLEM
21003	and	O
21004	tachypneic	b-PROBLEM
21005	throughout	O
21006	the	b-DATE
21007	day	i-DATE
21008	with	O
21009	respiratory	b-TEST
21010	rates	i-TEST
21011	of	O
21012	30-40	O
21013	with	O
21014	a	b-TEST
21015	max	i-TEST
21016	respiratory	i-TEST
21017	rate	i-TEST
21018	of	O
21019	116	O
21020	,	O
21021	tachycardia	b-PROBLEM
21022	to	O
21023	120s	O
21024	.	O
21025	patient	O
21026	subsequently	O
21027	was	O
21028	transferred	b-OCCURRENCE
21029	back	O
21030	to	O
21031	the	b-CLINICAL_DEPT
21032	cmed	i-CLINICAL_DEPT
21033	ccu	i-CLINICAL_DEPT
21034	on	O
21035	2017-01-13	b-DATE
21036	for	O
21037	further	b-TEST
21038	monitoring	i-TEST
21039	.	O
21040	patient	b-PROBLEM
21041	's	i-PROBLEM
21042	hypoxia	i-PROBLEM
21043	was	O
21044	felt	O
21045	most	O
21046	likely	O
21047	to	O
21048	be	O
21049	caused	O
21050	by	O
21051	pneumonia	b-PROBLEM
21052	.	O
21053	she	O
21054	was	O
21055	started	O
21056	on	O
21057	appropriate	b-TREATMENT
21058	antibiotics	i-TREATMENT
21059	.	O
21060	etiology	O
21061	of	O
21062	patient	b-PROBLEM
21063	's	i-PROBLEM
21064	tachypnea	i-PROBLEM
21065	was	O
21066	unclear	O
21067	.	O
21068	initially	O
21069	,	O
21070	the	O
21071	patient	O
21072	's	O
21073	etiology	O
21074	of	O
21075	seizure	b-PROBLEM
21076	was	O
21077	not	O
21078	quite	O
21079	clear	O
21080	,	O
21081	but	O
21082	thought	O
21083	possibly	O
21084	secondary	O
21085	to	O
21086	alcohol	b-PROBLEM
21087	and	i-PROBLEM
21088	benzodiazepine	i-PROBLEM
21089	withdrawal	i-PROBLEM
21090	.	O
21091	she	O
21092	received	O
21093	eeg	b-TEST
21094	,	O
21095	mri	b-TEST
21096	,	O
21097	lp	b-TEST
21098	.	O
21099	subsequently	O
21100	eeg	b-TEST
21101	was	O
21102	noted	O
21103	to	O
21104	have	O
21105	no	O
21106	seizure	b-PROBLEM
21107	activity	i-PROBLEM
21108	.	O
21109	mri	b-TEST
21110	was	O
21111	suboptimal	O
21112	due	O
21113	to	O
21114	motion	O
21115	artifact	O
21116	and	O
21117	lp	b-TEST
21118	was	O
21119	unremarkable	O
21120	.	O
21121	despite	O
21122	absence	O
21123	of	O
21124	seizure	b-PROBLEM
21125	activity	i-PROBLEM
21126	on	O
21127	eeg	b-TEST
21128	,	O
21129	patient	O
21130	was	O
21131	continued	O
21132	on	O
21133	dilantin	b-TREATMENT
21134	.	O
21135	her	b-PROBLEM
21136	delirium	i-PROBLEM
21137	was	O
21138	felt	O
21139	possibly	O
21140	secondary	O
21141	to	O
21142	withdrawal	b-PROBLEM
21143	versus	O
21144	toxic	b-PROBLEM
21145	metabolic	i-PROBLEM
21146	,	O
21147	but	O
21148	gradually	O
21149	improved	b-OCCURRENCE
21150	slowly	O
21151	,	O
21152	and	O
21153	therefore	O
21154	patient	O
21155	did	O
21156	not	O
21157	receive	O
21158	treatment	b-TREATMENT
21159	for	O
21160	barbiturate	b-PROBLEM
21161	withdrawal	i-PROBLEM
21162	.	O
21163	her	O
21164	mental	O
21165	status	O
21166	,	O
21167	tachypnea	b-PROBLEM
21168	,	O
21169	and	O
21170	hypoxia	b-PROBLEM
21171	all	O
21172	improved	b-OCCURRENCE
21173	,	O
21174	and	O
21175	patient	O
21176	was	O
21177	subsequently	O
21178	transferred	b-OCCURRENCE
21179	back	O
21180	to	O
21181	the	b-CLINICAL_DEPT
21182	floor	i-CLINICAL_DEPT
21183	medical	O
21184	team	O
21185	on	O
21186	2017-01-15	b-DATE
21187	.	O
21188	while	O
21189	on	O
21190	the	b-CLINICAL_DEPT
21191	floor	i-CLINICAL_DEPT
21192	,	O
21193	the	O
21194	patient	O
21195	's	O
21196	mental	O
21197	status	O
21198	was	O
21199	noted	O
21200	to	O
21201	be	O
21202	improved	b-OCCURRENCE
21203	back	i-OCCURRENCE
21204	at	i-OCCURRENCE
21205	baseline	i-OCCURRENCE
21206	compared	O
21207	to	O
21208	that	O
21209	back	O
21210	to	O
21211	the	b-CLINICAL_DEPT
21212	cmed	i-CLINICAL_DEPT
21213	ccu	i-CLINICAL_DEPT
21214	,	O
21215	and	O
21216	she	O
21217	exhibited	O
21218	no	O
21219	evidence	O
21220	of	O
21221	barbiturate	b-PROBLEM
21222	withdrawal	i-PROBLEM
21223	.	O
21224	she	O
21225	was	O
21226	continued	O
21227	on	O
21228	suicide	b-TREATMENT
21229	precautions	i-TREATMENT
21230	with	O
21231	a	b-TREATMENT
21232	one-to-one	i-TREATMENT
21233	sitter	i-TREATMENT
21234	,	O
21235	and	O
21236	plan	O
21237	was	O
21238	for	O
21239	psychiatric	b-OCCURRENCE
21240	admission	i-OCCURRENCE
21241	when	O
21242	medical	b-PROBLEM
21243	issues	i-PROBLEM
21244	had	O
21245	resolved	b-OCCURRENCE
21246	.	O
21247	on	O
21248	2017-01-16	b-DATE
21249	,	O
21250	the	O
21251	night	O
21252	float	O
21253	intern	O
21254	was	O
21255	called	b-OCCURRENCE
21256	to	i-OCCURRENCE
21257	see	i-OCCURRENCE
21258	the	i-OCCURRENCE
21259	patient	i-OCCURRENCE
21260	as	O
21261	she	O
21262	was	O
21263	unresponsive	b-PROBLEM
21264	.	O
21265	patient	O
21266	unresponsive	b-PROBLEM
21267	to	O
21268	verbal	b-TEST
21269	command	i-TEST
21270	,	O
21271	sternal	b-TEST
21272	rub	i-TEST
21273	.	O
21274	pupils	O
21275	were	O
21276	fixed	b-PROBLEM
21277	and	O
21278	dilated	b-PROBLEM
21279	.	O
21280	patient	O
21281	noted	O
21282	to	O
21283	be	O
21284	without	O
21285	corneal	b-PROBLEM
21286	reflexes	i-PROBLEM
21287	,	i-PROBLEM
21288	spontaneous	i-PROBLEM
21289	breathing	i-PROBLEM
21290	,	i-PROBLEM
21291	heart	i-PROBLEM
21292	sounds	i-PROBLEM
21293	,	i-PROBLEM
21294	or	i-PROBLEM
21295	palpable	i-PROBLEM
21296	pulses	i-PROBLEM
21297	.	O
21298	patient	O
21299	was	O
21300	pronounced	b-OCCURRENCE
21301	dead	i-OCCURRENCE
21302	at	O
21303	6:15	b-TIME
21304	a.m.	i-TIME
21305	on	i-TIME
21306	2017-01-16	i-TIME
21307	.	O
21308	patient	O
21309	's	O
21310	family	O
21311	was	O
21312	notified	b-OCCURRENCE
21313	and	O
21314	declined	b-OCCURRENCE
21315	autopsy	i-OCCURRENCE
21316	.	O
21317	given	O
21318	the	O
21319	sudden	O
21320	unexpected	O
21321	nature	O
21322	of	O
21323	patient	b-PROBLEM
21324	's	i-PROBLEM
21325	death	i-PROBLEM
21326	,	O
21327	the	O
21328	medical	O
21329	examiner	O
21330	was	O
21331	contacted	b-OCCURRENCE
21332	and	O
21333	the	O
21334	case	O
21335	was	O
21336	accepted	O
21337	.	O
21338	of	O
21339	note	O
21340	at	O
21341	time	O
21342	of	O
21343	death	b-PROBLEM
21344	,	O
21345	patient	O
21346	was	O
21347	dnr	b-TREATMENT
21348	/	O
21349	dni	b-TREATMENT
21350	.	O
21351	this	O
21352	was	O
21353	initiated	O
21354	after	O
21355	several	O
21356	conversations	b-OCCURRENCE
21357	with	O
21358	the	O
21359	patient	O
21360	's	O
21361	mother	O
21362	,	O
21363	who	O
21364	stated	b-EVIDENTIAL
21365	that	O
21366	the	O
21367	patient	O
21368	had	O
21369	desired	O
21370	to	O
21371	be	O
21372	dnr	b-TREATMENT
21373	/	O
21374	dni	b-TREATMENT
21375	for	O
21376	many	b-DURATION
21377	years	i-DURATION
21378	,	O
21379	not	O
21380	just	O
21381	in	O
21382	the	O
21383	recent	O
21384	past	O
21385	.	O
21386	these	O
21387	facts	O
21388	were	O
21389	confirmed	b-OCCURRENCE
21390	via	O
21391	separate	O
21392	conversations	b-OCCURRENCE
21393	with	O
21394	both	O
21395	the	O
21396	patient	O
21397	's	O
21398	lawyer	O
21399	and	O
21400	her	O
21401	primary	O
21402	care	O
21403	physician	O
21404	.	O
21405	michael	O
21406	n	O
21407	sawyer	O
21408	,	O
21409	md	O
21410	86-331	O
21411	dictated	O
21412	by	O
21413	:	O
21414	rebecca	O
21415	s	O
21416	jefcoat	O
21417	,	O
21418	md	O
21419	medquist36	O
21420	d	O
21421	:	O
21422	2017-03-08	O
21423	10:57	O
21424	t	O
21425	:	O
21426	2017-03-10	O
21427	07:01	O
21428	job	O
21429	#	O
21430	:	O
21431	53408	O
21432	(	O
21433	cclist	O
21434	)	O
21435	***************************	O
21436	please	O
21437	note	O
21438	that	O
21439	all	O
21440	of	O
21441	the	O
21442	conversations	O
21443	regarding	O
21444	code	O
21445	status	O
21446	took	O
21447	place	O
21448	during	O
21449	we	O
21450	icu	O
21451	admit	O
21452	;	O
21453	and	O
21454	that	O
21455	this	O
21456	patient	O
21457	passed	O
21458	away	O
21459	in	O
21460	early	O
21461	am	O
21462	hours	O
21463	of	O
21464	night	O
21465	she	O
21466	was	O
21467	called	O
21468	back	O
21469	out	O
21470	to	O
21471	the	O
21472	medicine	O
21473	floor	O
21474	,	O
21475	therefore	O
21476	she	O
21477	had	O
21478	not	O
21479	yet	O
21480	been	O
21481	re-evaluated	O
21482	by	O
21483	the	O
21484	floor	O
21485	medicine	O
21486	attending	O
21487	,	O
21488	but	O
21489	had	O
21490	been	O
21491	earlier	O
21492	that	O
21493	day	O
21494	by	O
21495	the	O
21496	icu	O
21497	attending	O
21498	.	O
21499	signed	O
21500	electronically	O
21501	by	O
21502	:	O
21503	doctor	O
21504	dorothy	O
21505	desalvo	O
21506	on	O
21507	:	O
21508	wed	O
21509	2017-04-26	O
21510	7:22	O
21511	am	O
21512	(	O
21513	end	O
21514	of	O
21515	report	O
21516	)	O
21517		O
21518	admission	b-OCCURRENCE
21519	date	O
21520	:	O
21521	2011-01-21	b-ADMISSION
21522	discharge	b-OCCURRENCE
21523	date	O
21524	:	O
21525	2011-02-23	b-DISCHARGE
21526	service	O
21527	:	O
21528	trauma	O
21529	ser	O
21530	history	O
21531	of	O
21532	present	O
21533	illness	O
21534	:	O
21535	this	O
21536	20	O
21537	year	O
21538	old	O
21539	driver	O
21540	was	O
21541	in	O
21542	a	O
21543	major	O
21544	motor	b-PROBLEM
21545	vehicle	i-PROBLEM
21546	accident	i-PROBLEM
21547	and	O
21548	brought	O
21549	to	O
21550	the	b-CLINICAL_DEPT
21551	emergency	i-CLINICAL_DEPT
21552	saints	i-CLINICAL_DEPT
21553	medical	i-CLINICAL_DEPT
21554	center	i-CLINICAL_DEPT
21555	following	O
21556	this	O
21557	,	O
21558	with	O
21559	multiple	b-PROBLEM
21560	trauma	i-PROBLEM
21561	.	O
21562	the	O
21563	patient	O
21564	was	O
21565	an	b-OCCURRENCE
21566	unrestrained	i-OCCURRENCE
21567	driver	i-OCCURRENCE
21568	in	O
21569	a	O
21570	car	O
21571	versus	O
21572	tree	O
21573	.	O
21574	he	O
21575	was	O
21576	involved	O
21577	in	O
21578	a	b-OCCURRENCE
21579	long	i-OCCURRENCE
21580	extrication	i-OCCURRENCE
21581	with	O
21582	a	b-TEST
21583	blood	i-TEST
21584	pressure	i-TEST
21585	of	O
21586	88	O
21587	at	O
21588	the	O
21589	scene	O
21590	.	O
21591	upon	O
21592	extrication	b-OCCURRENCE
21593	from	O
21594	the	O
21595	vehicle	O
21596	,	O
21597	he	O
21598	was	O
21599	intubated	b-TREATMENT
21600	and	O
21601	transported	b-OCCURRENCE
21602	to	O
21603	the	b-CLINICAL_DEPT
21604	emergency	i-CLINICAL_DEPT
21605	room	i-CLINICAL_DEPT
21606	.	O
21607	he	O
21608	was	O
21609	tachycardic	b-PROBLEM
21610	with	O
21611	an	b-TEST
21612	initial	i-TEST
21613	blood	i-TEST
21614	pressure	i-TEST
21615	of	O
21616	120	O
21617	/	O
21618	palpable	O
21619	.	O
21620	a	b-TREATMENT
21621	groin	i-TREATMENT
21622	line	i-TREATMENT
21623	was	O
21624	placed	O
21625	and	O
21626	the	O
21627	patient	O
21628	was	O
21629	sedated	b-TREATMENT
21630	and	O
21631	paralyzed	b-TREATMENT
21632	.	O
21633	he	O
21634	was	O
21635	resuscitated	O
21636	with	O
21637	crystalloid	b-TREATMENT
21638	and	O
21639	remained	O
21640	hemodynamically	b-OCCURRENCE
21641	stable	i-OCCURRENCE
21642	.	O
21643	he	O
21644	had	O
21645	a	b-PROBLEM
21646	grossly	i-PROBLEM
21647	deformed	i-PROBLEM
21648	left	i-PROBLEM
21649	lower	i-PROBLEM
21650	extremity	i-PROBLEM
21651	.	O
21652	on	O
21653	examination	b-TEST
21654	,	O
21655	belmont	b-TEST
21656	coma	i-TEST
21657	scale	i-TEST
21658	was	O
21659	6t	O
21660	;	O
21661	blood	b-TEST
21662	pressure	i-TEST
21663	was	O
21664	120	O
21665	/	O
21666	palpable	O
21667	with	O
21668	a	b-TEST
21669	heart	i-TEST
21670	rate	i-TEST
21671	of	O
21672	122	O
21673	.	O
21674	the	O
21675	trachea	O
21676	was	O
21677	midline	O
21678	.	O
21679	the	O
21680	abdomen	O
21681	was	O
21682	soft	O
21683	.	O
21684	rectal	O
21685	was	O
21686	heme	b-PROBLEM
21687	positive	i-PROBLEM
21688	with	O
21689	normal	O
21690	prostate	O
21691	.	O
21692	there	O
21693	were	O
21694	no	O
21695	meatal	b-PROBLEM
21696	blood	i-PROBLEM
21697	.	O
21698	the	O
21699	left	O
21700	femur	O
21701	was	O
21702	grossly	b-PROBLEM
21703	deformed	i-PROBLEM
21704	with	O
21705	a	b-PROBLEM
21706	pinhole	i-PROBLEM
21707	opening	i-PROBLEM
21708	in	i-PROBLEM
21709	the	i-PROBLEM
21710	lateral	i-PROBLEM
21711	thigh	i-PROBLEM
21712	.	O
21713	his	O
21714	left	O
21715	forearm	O
21716	was	O
21717	also	O
21718	grossly	b-PROBLEM
21719	deformed	i-PROBLEM
21720	.	O
21721	there	O
21722	is	O
21723	no	O
21724	step-off	b-PROBLEM
21725	at	i-PROBLEM
21726	the	i-PROBLEM
21727	back	i-PROBLEM
21728	.	O
21729	admission	b-TEST
21730	laboratories	i-TEST
21731	included	O
21732	a	b-TEST
21733	hematocrit	i-TEST
21734	of	O
21735	43.3	O
21736	and	O
21737	white	b-TEST
21738	blood	i-TEST
21739	cell	i-TEST
21740	count	i-TEST
21741	of	O
21742	25.2	O
21743	,	O
21744	normal	O
21745	electrolytes	O
21746	and	O
21747	amylase	b-TEST
21748	of	O
21749	98	O
21750	.	O
21751	arterial	b-TEST
21752	blood	i-TEST
21753	gas	i-TEST
21754	showed	O
21755	a	b-PROBLEM
21756	mild	i-PROBLEM
21757	metabolic	i-PROBLEM
21758	acidosis	i-PROBLEM
21759	.	O
21760	additional	b-TEST
21761	assay	i-TEST
21762	shows	O
21763	slight	b-PROBLEM
21764	widening	i-PROBLEM
21765	of	i-PROBLEM
21766	the	i-PROBLEM
21767	mediastinum	i-PROBLEM
21768	on	O
21769	chest	b-TEST
21770	x-ray	i-TEST
21771	.	O
21772	the	b-TEST
21773	ct	i-TEST
21774	scan	i-TEST
21775	of	i-TEST
21776	the	i-TEST
21777	head	i-TEST
21778	and	i-TEST
21779	chest	i-TEST
21780	were	O
21781	negative	O
21782	.	O
21783	there	O
21784	was	O
21785	a	b-PROBLEM
21786	small	i-PROBLEM
21787	liver	i-PROBLEM
21788	laceration	i-PROBLEM
21789	seen	O
21790	on	O
21791	the	b-TEST
21792	a/p	i-TEST
21793	pelvis	i-TEST
21794	.	O
21795	there	O
21796	was	O
21797	a	b-PROBLEM
21798	distal	i-PROBLEM
21799	ulnar	i-PROBLEM
21800	and	i-PROBLEM
21801	radial	i-PROBLEM
21802	fracture	i-PROBLEM
21803	as	O
21804	well	O
21805	as	O
21806	a	b-PROBLEM
21807	left	i-PROBLEM
21808	mid-shaft	i-PROBLEM
21809	comminuted	i-PROBLEM
21810	fracture	i-PROBLEM
21811	of	i-PROBLEM
21812	the	i-PROBLEM
21813	femur	i-PROBLEM
21814	.	O
21815	hospital	O
21816	course	O
21817	:	O
21818	the	O
21819	patient	O
21820	was	O
21821	admitted	b-OCCURRENCE
21822	to	O
21823	the	b-CLINICAL_DEPT
21824	intensive	i-CLINICAL_DEPT
21825	care	i-CLINICAL_DEPT
21826	unit	i-CLINICAL_DEPT
21827	.	O
21828	he	O
21829	was	O
21830	also	O
21831	seen	b-OCCURRENCE
21832	by	O
21833	the	O
21834	orthopedics	O
21835	service	O
21836	and	O
21837	neurosurgical	O
21838	service	O
21839	.	O
21840	he	O
21841	went	O
21842	to	O
21843	the	b-CLINICAL_DEPT
21844	operating	i-CLINICAL_DEPT
21845	room	i-CLINICAL_DEPT
21846	quickly	O
21847	and	O
21848	had	O
21849	an	b-TREATMENT
21850	intramedullary	i-TREATMENT
21851	rodding	i-TREATMENT
21852	of	i-TREATMENT
21853	the	i-TREATMENT
21854	femur	i-TREATMENT
21855	and	O
21856	open	b-TREATMENT
21857	reduction	i-TREATMENT
21858	and	O
21859	internal	b-TREATMENT
21860	fixation	i-TREATMENT
21861	of	i-TREATMENT
21862	the	i-TREATMENT
21863	radius	i-TREATMENT
21864	and	i-TREATMENT
21865	ulna	i-TREATMENT
21866	.	O
21867	he	O
21868	was	O
21869	evaluated	b-TEST
21870	by	O
21871	neurosurgery	O
21872	for	O
21873	his	b-PROBLEM
21874	head	i-PROBLEM
21875	injury	i-PROBLEM
21876	which	O
21877	showed	O
21878	multiple	b-PROBLEM
21879	contusions	i-PROBLEM
21880	in	i-PROBLEM
21881	the	i-PROBLEM
21882	frontal	i-PROBLEM
21883	lobe	i-PROBLEM
21884	.	O
21885	he	O
21886	was	O
21887	extubated	b-TREATMENT
21888	on	O
21889	postoperative	b-DATE
21890	day	i-DATE
21891	two	i-DATE
21892	.	O
21893	he	O
21894	did	O
21895	have	O
21896	some	b-PROBLEM
21897	blood	i-PROBLEM
21898	loss	i-PROBLEM
21899	anemia	i-PROBLEM
21900	with	O
21901	a	b-TEST
21902	hematocrit	i-TEST
21903	of	O
21904	20.9	O
21905	.	O
21906	a	b-TEST
21907	repeat	i-TEST
21908	ct	i-TEST
21909	scan	i-TEST
21910	showed	O
21911	no	O
21912	change	b-OCCURRENCE
21913	.	O
21914	he	O
21915	was	O
21916	begun	O
21917	on	O
21918	physical	b-TREATMENT
21919	therapy	i-TREATMENT
21920	but	O
21921	remained	O
21922	agitated	b-PROBLEM
21923	.	O
21924	he	O
21925	was	O
21926	discharged	b-OCCURRENCE
21927	to	O
21928	the	b-CLINICAL_DEPT
21929	floor	i-CLINICAL_DEPT
21930	.	O
21931	his	b-TEST
21932	hematocrit	i-TEST
21933	remained	O
21934	stable	b-OCCURRENCE
21935	.	O
21936	his	O
21937	cervical	O
21938	spine	O
21939	was	O
21940	cleared	b-OCCURRENCE
21941	.	O
21942	the	O
21943	patient	O
21944	was	O
21945	seen	b-OCCURRENCE
21946	by	O
21947	psychiatry	O
21948	due	O
21949	to	O
21950	some	b-PROBLEM
21951	delirium	i-PROBLEM
21952	and	O
21953	question	O
21954	of	O
21955	suicidal	b-PROBLEM
21956	ideation	i-PROBLEM
21957	.	O
21958	he	O
21959	was	O
21960	also	O
21961	evaluated	b-TEST
21962	by	O
21963	the	O
21964	neuro-rehabilitation	O
21965	service	O
21966	who	O
21967	thought	O
21968	that	O
21969	he	O
21970	had	O
21971	a	b-PROBLEM
21972	post-head	i-PROBLEM
21973	injury	i-PROBLEM
21974	syndrome	i-PROBLEM
21975	with	O
21976	diffuse	b-PROBLEM
21977	cognitive	i-PROBLEM
21978	deficits	i-PROBLEM
21979	.	O
21980	he	O
21981	continued	O
21982	to	O
21983	have	O
21984	some	O
21985	episodes	O
21986	of	O
21987	agitation	b-PROBLEM
21988	which	O
21989	were	O
21990	treated	O
21991	with	O
21992	medication	b-TREATMENT
21993	.	O
21994	he	O
21995	required	O
21996	some	b-TREATMENT
21997	sedation	i-TREATMENT
21998	and	O
21999	restraint	b-TREATMENT
22000	and	O
22001	was	O
22002	begun	O
22003	on	O
22004	whatever	O
22005	physical	b-TREATMENT
22006	therapy	i-TREATMENT
22007	he	O
22008	could	O
22009	have	O
22010	given	O
22011	his	b-PROBLEM
22012	head	i-PROBLEM
22013	injury	i-PROBLEM
22014	.	O
22015	he	O
22016	was	O
22017	continued	O
22018	to	O
22019	be	O
22020	followed	b-OCCURRENCE
22021	by	O
22022	psychiatry	O
22023	and	O
22024	then	O
22025	was	O
22026	casted	b-TREATMENT
22027	by	O
22028	orthopedics	O
22029	.	O
22030	he	O
22031	continued	O
22032	to	O
22033	have	O
22034	episodes	O
22035	of	O
22036	confusion	b-PROBLEM
22037	.	O
22038	he	O
22039	removed	O
22040	the	b-TREATMENT
22041	cast	i-TREATMENT
22042	that	O
22043	had	O
22044	been	O
22045	placed	O
22046	and	O
22047	then	O
22048	a	b-TREATMENT
22049	long-leg	i-TREATMENT
22050	cast	i-TREATMENT
22051	was	O
22052	then	O
22053	placed	O
22054	so	O
22055	it	O
22056	would	O
22057	be	O
22058	difficult	O
22059	for	O
22060	him	O
22061	to	O
22062	remove	O
22063	or	O
22064	to	O
22065	ambulate	O
22066	on	O
22067	his	O
22068	leg	O
22069	,	O
22070	which	O
22071	might	O
22072	jeopardize	O
22073	his	O
22074	closure	O
22075	.	O
22076	it	O
22077	continued	O
22078	to	O
22079	be	O
22080	somewhat	O
22081	difficult	b-PROBLEM
22082	to	i-PROBLEM
22083	control	i-PROBLEM
22084	his	O
22085	activity	O
22086	and	O
22087	rehabilitation	O
22088	screen	O
22089	was	O
22090	in	O
22091	place	O
22092	but	O
22093	there	O
22094	was	O
22095	difficulty	O
22096	finding	O
22097	the	O
22098	appropriate	O
22099	facility	O
22100	.	O
22101	his	O
22102	family	O
22103	was	O
22104	also	O
22105	involved	O
22106	in	O
22107	his	b-TREATMENT
22108	care	i-TREATMENT
22109	and	O
22110	orientation	O
22111	.	O
22112	he	O
22113	does	O
22114	of	O
22115	buspar	b-TREATMENT
22116	,	O
22117	trazodone	b-TREATMENT
22118	and	O
22119	haldol	b-TREATMENT
22120	were	O
22121	continued	O
22122	and	O
22123	were	O
22124	adjusted	b-OCCURRENCE
22125	by	O
22126	psychiatry	O
22127	.	O
22128	he	O
22129	was	O
22130	continued	O
22131	on	O
22132	observation	b-TEST
22133	and	O
22134	sitters	b-TREATMENT
22135	and	O
22136	finally	O
22137	became	O
22138	more	b-OCCURRENCE
22139	docile	i-OCCURRENCE
22140	and	i-OCCURRENCE
22141	cooperative	i-OCCURRENCE
22142	.	O
22143	he	O
22144	was	O
22145	continued	O
22146	on	O
22147	physical	b-TREATMENT
22148	therapy	i-TREATMENT
22149	and	O
22150	with	O
22151	his	O
22152	mother	O
22153	present	O
22154	,	O
22155	he	O
22156	began	b-OCCURRENCE
22157	to	i-OCCURRENCE
22158	follow	i-OCCURRENCE
22159	commands	i-OCCURRENCE
22160	much	O
22161	more	O
22162	appropriately	O
22163	and	O
22164	was	O
22165	able	O
22166	to	O
22167	be	O
22168	rehabilitated	b-TREATMENT
22169	.	O
22170	he	O
22171	was	O
22172	finally	O
22173	sent	b-OCCURRENCE
22174	home	i-OCCURRENCE
22175	for	O
22176	home	b-TREATMENT
22177	rehabilitation	i-TREATMENT
22178	on	O
22179	2011-02-23	b-DATE
22180	.	O
22181	final	O
22182	diagnoses	O
22183	:	O
22184	1.	O
22185	multiple	b-PROBLEM
22186	trauma	i-PROBLEM
22187	with	O
22188	severe	b-PROBLEM
22189	frontal	i-PROBLEM
22190	head	i-PROBLEM
22191	injury	i-PROBLEM
22192	.	O
22193	2.	O
22194	open	b-PROBLEM
22195	fracture	i-PROBLEM
22196	of	i-PROBLEM
22197	the	i-PROBLEM
22198	femur	i-PROBLEM
22199	.	O
22200	3.	O
22201	radial	b-PROBLEM
22202	and	i-PROBLEM
22203	ulnar	i-PROBLEM
22204	fractures	i-PROBLEM
22205	.	O
22206	4.	O
22207	liver	b-PROBLEM
22208	laceration	i-PROBLEM
22209	.	O
22210	surgical	O
22211	procedures	O
22212	:	O
22213	1.	O
22214	open	b-TREATMENT
22215	reduction	i-TREATMENT
22216	and	O
22217	internal	b-TREATMENT
22218	fixation	i-TREATMENT
22219	of	i-TREATMENT
22220	femur	i-TREATMENT
22221	2011-01-21	b-DATE
22222	.	O
22223	2.	O
22224	open	b-TREATMENT
22225	reduction	i-TREATMENT
22226	and	O
22227	internal	b-TREATMENT
22228	fixation	i-TREATMENT
22229	of	i-TREATMENT
22230	radius	i-TREATMENT
22231	and	i-TREATMENT
22232	ulna	i-TREATMENT
22233	2011-01-21	b-DATE
22234	.	O
22235	discharge	O
22236	medications	O
22237	:	O
22238	1.	O
22239	percocet	b-TREATMENT
22240	,	O
22241	one	O
22242	p.o.	O
22243	q.	b-FREQUENCY
22244	four	i-FREQUENCY
22245	hours	i-FREQUENCY
22246	p.r.n.	O
22247	pain	b-PROBLEM
22248	.	O
22249	2.	O
22250	haldol	b-TREATMENT
22251	1	O
22252	mg	O
22253	p.o.	O
22254	q.	b-FREQUENCY
22255	four	i-FREQUENCY
22256	to	i-FREQUENCY
22257	six	i-FREQUENCY
22258	hours	i-FREQUENCY
22259	p.r.n.	O
22260	agitation	b-PROBLEM
22261	.	O
22262	3.	O
22263	trazodone	b-TREATMENT
22264	50	O
22265	mg	O
22266	p.o.	O
22267	q.	b-FREQUENCY
22268	h.s.	i-FREQUENCY
22269	4.	O
22270	droperidol	b-TREATMENT
22271	1.5	O
22272	to	O
22273	2.5	O
22274	mg	O
22275	p.r.n.	O
22276	agitation	b-PROBLEM
22277	.	O
22278	disposition	O
22279	:	O
22280	the	O
22281	patient	O
22282	is	O
22283	discharged	b-OCCURRENCE
22284	home	O
22285	with	O
22286	home	b-TREATMENT
22287	rehabilitation	i-TREATMENT
22288	.	O
22289	discharge	O
22290	instructions	O
22291	:	O
22292	1.	O
22293	the	O
22294	patient	O
22295	will	O
22296	be	O
22297	followed	b-OCCURRENCE
22298	by	O
22299	orthopedics	O
22300	,	O
22301	doctor	O
22302	johnson	O
22303	.	O
22304	2.	O
22305	to	O
22306	be	O
22307	followed	b-OCCURRENCE
22308	by	O
22309	william	O
22310	scheidel	O
22311	of	O
22312	neurological	O
22313	rehabilitation	O
22314	.	O
22315	maria	O
22316	l.	O
22317	bell	O
22318	,	O
22319	md	O
22320	05-084	O
22321	dictated	O
22322	by	O
22323	:	O
22324	michael	O
22325	x.	O
22326	fisher	O
22327	,	O
22328	md	O
22329	medquist36	O
22330	d	O
22331	:	O
22332	2011-04-08	O
22333	14:01	O
22334	t	O
22335	:	O
22336	2011-04-10	O
22337	08:09	O
22338	job	O
22339	#	O
22340	:	O
22341	48774	O
22342	signed	O
22343	electronically	O
22344	by	O
22345	:	O
22346	doctor	O
22347	fredrick	O
22348	rossi	O
22349	on	O
22350	:	O
22351	wed	O
22352	2011-04-13	O
22353	1:45	O
22354	pm	O
22355	(	O
22356	end	O
22357	of	O
22358	report	O
22359	)	O
22360		O
22361	admission	b-OCCURRENCE
22362	date	O
22363	:	O
22364	2016-04-05	b-ADMISSION
22365	discharge	b-OCCURRENCE
22366	date	O
22367	:	O
22368	2016-04-11	b-DISCHARGE
22369	service	O
22370	:	O
22371	cardiothoracic	O
22372	surgery	O
22373	history	O
22374	of	O
22375	present	O
22376	illness	O
22377	:	O
22378	this	O
22379	is	O
22380	a	O
22381	67	O
22382	-	O
22383	year-old	O
22384	male	O
22385	with	O
22386	a	O
22387	history	O
22388	of	O
22389	high	b-PROBLEM
22390	cholesterol	i-PROBLEM
22391	who	O
22392	was	O
22393	in	O
22394	his	b-OCCURRENCE
22395	usual	i-OCCURRENCE
22396	state	i-OCCURRENCE
22397	of	i-OCCURRENCE
22398	health	i-OCCURRENCE
22399	until	O
22400	2016-04-03	b-DATE
22401	.	O
22402	he	O
22403	was	O
22404	raking	b-OCCURRENCE
22405	leaves	i-OCCURRENCE
22406	on	O
22407	04-02	b-DATE
22408	and	O
22409	then	O
22410	developed	O
22411	episodes	O
22412	of	O
22413	mid	b-PROBLEM
22414	chest	i-PROBLEM
22415	pain	i-PROBLEM
22416	and	O
22417	burning	b-PROBLEM
22418	which	O
22419	radiated	b-PROBLEM
22420	to	i-PROBLEM
22421	the	i-PROBLEM
22422	left	i-PROBLEM
22423	arm	i-PROBLEM
22424	.	O
22425	that	b-DATE
22426	night	i-DATE
22427	he	O
22428	reportedly	O
22429	stopped	b-PROBLEM
22430	breathing	i-PROBLEM
22431	and	O
22432	was	O
22433	unresponsive	b-PROBLEM
22434	.	O
22435	his	O
22436	wife	O
22437	gave	O
22438	him	O
22439	mouth-to-mouth	b-TREATMENT
22440	resuscitation	i-TREATMENT
22441	and	O
22442	he	O
22443	regained	b-OCCURRENCE
22444	consciousness	i-OCCURRENCE
22445	.	O
22446	he	O
22447	presented	b-EVIDENTIAL
22448	to	O
22449	an	b-CLINICAL_DEPT
22450	outside	i-CLINICAL_DEPT
22451	hospital	i-CLINICAL_DEPT
22452	with	O
22453	an	b-PROBLEM
22454	acute	i-PROBLEM
22455	inferior	i-PROBLEM
22456	myocardial	i-PROBLEM
22457	infarction	i-PROBLEM
22458	and	O
22459	was	O
22460	treated	O
22461	with	O
22462	thrombolytic	b-TREATMENT
22463	therapy	i-TREATMENT
22464	.	O
22465	his	b-TEST
22466	troponin	i-TEST
22467	was	O
22468	20	O
22469	and	O
22470	he	O
22471	had	O
22472	ekg	b-PROBLEM
22473	changes	i-PROBLEM
22474	.	O
22475	he	O
22476	underwent	O
22477	catheterization	b-TEST
22478	on	O
22479	2016-04-05	b-DATE
22480	which	O
22481	revealed	b-EVIDENTIAL
22482	a	b-TEST
22483	left	i-TEST
22484	ventricular	i-TEST
22485	ejection	i-TEST
22486	fraction	i-TEST
22487	of	O
22488	50%	O
22489	,	O
22490	no	O
22491	mitral	b-PROBLEM
22492	regurgitation	i-PROBLEM
22493	,	O
22494	insufficiency	b-PROBLEM
22495	or	O
22496	hypokinesis	b-PROBLEM
22497	.	O
22498	left	O
22499	main	O
22500	coronary	O
22501	artery	O
22502	was	O
22503	narrowed	b-PROBLEM
22504	50-60%	O
22505	,	O
22506	left	O
22507	anterior	O
22508	descending	O
22509	coronary	O
22510	artery	O
22511	70%	O
22512	proximally	O
22513	,	O
22514	right	b-PROBLEM
22515	coronary	i-PROBLEM
22516	artery	i-PROBLEM
22517	dominant	i-PROBLEM
22518	diseased	i-PROBLEM
22519	up	O
22520	to	O
22521	90%	O
22522	proximally	O
22523	in	O
22524	the	O
22525	midportion	O
22526	,	O
22527	70%	O
22528	distally	O
22529	.	O
22530	the	O
22531	left	O
22532	circumflex	O
22533	coronary	O
22534	artery	O
22535	was	O
22536	50%	O
22537	proximally	O
22538	,	O
22539	90%	O
22540	obtuse	O
22541	marginal	O
22542	#3	O
22543	.	O
22544	hospital	O
22545	course	O
22546	:	O
22547	the	O
22548	patient	O
22549	was	O
22550	admitted	b-OCCURRENCE
22551	to	O
22552	the	b-CLINICAL_DEPT
22553	hospital	i-CLINICAL_DEPT
22554	and	O
22555	on	O
22556	2016-04-06	b-DATE
22557	the	O
22558	patient	O
22559	underwent	O
22560	coronary	b-TREATMENT
22561	artery	i-TREATMENT
22562	bypass	i-TREATMENT
22563	grafting	i-TREATMENT
22564	x	b-FREQUENCY
22565	4	i-FREQUENCY
22566	with	O
22567	left	O
22568	internal	O
22569	mammary	O
22570	artery	O
22571	to	O
22572	the	O
22573	left	O
22574	anterior	O
22575	descending	O
22576	coronary	O
22577	artery	O
22578	,	O
22579	saphenous	b-TREATMENT
22580	vein	i-TREATMENT
22581	graft	i-TREATMENT
22582	to	i-TREATMENT
22583	the	i-TREATMENT
22584	diagonal	i-TREATMENT
22585	,	O
22586	saphenous	b-TREATMENT
22587	vein	i-TREATMENT
22588	graft	i-TREATMENT
22589	to	i-TREATMENT
22590	obtuse	i-TREATMENT
22591	marginal	i-TREATMENT
22592	,	O
22593	saphenous	b-TREATMENT
22594	vein	i-TREATMENT
22595	graft	i-TREATMENT
22596	to	i-TREATMENT
22597	right	i-TREATMENT
22598	coronary	i-TREATMENT
22599	artery	i-TREATMENT
22600	,	O
22601	posterior	O
22602	descending	O
22603	coronary	O
22604	artery	O
22605	.	O
22606	the	O
22607	patient	O
22608	appeared	O
22609	to	O
22610	have	O
22611	tolerated	b-OCCURRENCE
22612	the	b-TREATMENT
22613	procedure	i-TREATMENT
22614	and	O
22615	was	O
22616	transferred	b-OCCURRENCE
22617	to	O
22618	the	b-CLINICAL_DEPT
22619	cardiac	i-CLINICAL_DEPT
22620	intensive	i-CLINICAL_DEPT
22621	care	i-CLINICAL_DEPT
22622	unit	i-CLINICAL_DEPT
22623	for	O
22624	postoperative	b-TREATMENT
22625	management	i-TREATMENT
22626	.	O
22627	he	O
22628	was	O
22629	started	O
22630	on	O
22631	beta	b-TREATMENT
22632	blockers	i-TREATMENT
22633	.	O
22634	the	O
22635	patient	O
22636	had	O
22637	pacing	b-TREATMENT
22638	wires	i-TREATMENT
22639	and	O
22640	chest	b-TREATMENT
22641	tubes	i-TREATMENT
22642	in	O
22643	place	O
22644	,	O
22645	both	O
22646	of	O
22647	which	O
22648	over	O
22649	the	b-OCCURRENCE
22650	course	i-OCCURRENCE
22651	of	i-OCCURRENCE
22652	his	i-OCCURRENCE
22653	stay	i-OCCURRENCE
22654	were	O
22655	removed	O
22656	successfully	O
22657	.	O
22658	the	O
22659	patient	O
22660	did	b-OCCURRENCE
22661	well	i-OCCURRENCE
22662	postoperatively	O
22663	and	O
22664	was	O
22665	transported	b-OCCURRENCE
22666	to	O
22667	the	b-CLINICAL_DEPT
22668	regular	i-CLINICAL_DEPT
22669	cardiac	i-CLINICAL_DEPT
22670	surgery	i-CLINICAL_DEPT
22671	floor	i-CLINICAL_DEPT
22672	where	O
22673	he	O
22674	tolerated	b-OCCURRENCE
22675	a	b-OCCURRENCE
22676	regular	i-OCCURRENCE
22677	diet	i-OCCURRENCE
22678	,	O
22679	ambulated	b-OCCURRENCE
22680	well	i-OCCURRENCE
22681	,	O
22682	did	b-OCCURRENCE
22683	well	i-OCCURRENCE
22684	with	O
22685	his	b-OCCURRENCE
22686	activities	i-OCCURRENCE
22687	of	i-OCCURRENCE
22688	daily	i-OCCURRENCE
22689	living	i-OCCURRENCE
22690	.	O
22691	he	O
22692	was	O
22693	seen	b-OCCURRENCE
22694	by	i-OCCURRENCE
22695	physical	i-OCCURRENCE
22696	therapy	i-OCCURRENCE
22697	and	O
22698	cleared	O
22699	.	O
22700	they	O
22701	requested	O
22702	that	O
22703	he	O
22704	follow	b-TREATMENT
22705	up	i-TREATMENT
22706	in	O
22707	three	b-DURATION
22708	to	i-DURATION
22709	five	i-DURATION
22710	weeks	i-DURATION
22711	for	O
22712	endurance	b-TREATMENT
22713	training	i-TREATMENT
22714	,	O
22715	however	O
22716	then	O
22717	physical	O
22718	therapy	O
22719	followed	O
22720	him	O
22721	a	O
22722	number	O
22723	of	O
22724	times	O
22725	afterward	O
22726	and	O
22727	decided	O
22728	that	O
22729	he	O
22730	was	O
22731	in	O
22732	good	O
22733	condition	O
22734	and	O
22735	did	O
22736	not	O
22737	need	O
22738	further	b-TREATMENT
22739	physical	i-TREATMENT
22740	therapy	i-TREATMENT
22741	.	O
22742	on	O
22743	2016-04-11	b-DATE
22744	the	O
22745	patient	O
22746	was	O
22747	in	O
22748	good	b-OCCURRENCE
22749	condition	i-OCCURRENCE
22750	and	O
22751	he	O
22752	is	O
22753	being	O
22754	discharged	b-OCCURRENCE
22755	on	O
22756	a	b-OCCURRENCE
22757	regular	i-OCCURRENCE
22758	heart-healthy	i-OCCURRENCE
22759	diet	i-OCCURRENCE
22760	.	O
22761	he	O
22762	may	O
22763	observe	O
22764	regular	b-OCCURRENCE
22765	activity	i-OCCURRENCE
22766	although	O
22767	he	O
22768	should	O
22769	avoid	O
22770	strenuous	b-OCCURRENCE
22771	activity	i-OCCURRENCE
22772	and	O
22773	should	O
22774	not	O
22775	drive	b-OCCURRENCE
22776	while	O
22777	on	O
22778	pain	b-TREATMENT
22779	medications	i-TREATMENT
22780	.	O
22781	he	O
22782	should	O
22783	follow	b-OCCURRENCE
22784	up	i-OCCURRENCE
22785	with	O
22786	doctor	O
22787	dushaj	O
22788	in	O
22789	four	b-DURATION
22790	weeks	i-DURATION
22791	.	O
22792	he	O
22793	should	O
22794	follow	b-OCCURRENCE
22795	up	i-OCCURRENCE
22796	with	O
22797	his	O
22798	cardiologist	O
22799	in	O
22800	two	b-DURATION
22801	to	i-DURATION
22802	three	i-DURATION
22803	weeks	i-DURATION
22804	and	O
22805	he	O
22806	should	O
22807	follow	b-OCCURRENCE
22808	up	i-OCCURRENCE
22809	with	O
22810	his	O
22811	primary	O
22812	care	O
22813	physician	O
22814	in	O
22815	one	b-DURATION
22816	to	i-DURATION
22817	two	i-DURATION
22818	weeks	i-DURATION
22819	.	O
22820		O
22821	admission	b-OCCURRENCE
22822	date	O
22823	:	O
22824	2015-05-13	b-ADMISSION
22825	discharge	b-OCCURRENCE
22826	date	O
22827	:	O
22828	2015-05-20	b-DISCHARGE
22829	service	O
22830	:	O
22831	cme	O
22832	history	O
22833	of	O
22834	present	O
22835	illness	O
22836	:	O
22837	this	O
22838	is	O
22839	a	O
22840	104	O
22841	year	O
22842	old	O
22843	female	O
22844	patient	O
22845	with	O
22846	a	O
22847	history	O
22848	of	O
22849	chronic	b-PROBLEM
22850	obstructive	i-PROBLEM
22851	pulmonary	i-PROBLEM
22852	disease	i-PROBLEM
22853	,	O
22854	coronary	b-PROBLEM
22855	artery	i-PROBLEM
22856	disease	i-PROBLEM
22857	,	O
22858	hypertension	b-PROBLEM
22859	and	O
22860	cerebrovascular	b-PROBLEM
22861	accident	i-PROBLEM
22862	who	O
22863	presents	b-EVIDENTIAL
22864	with	O
22865	shortness	b-PROBLEM
22866	of	i-PROBLEM
22867	breath	i-PROBLEM
22868	and	O
22869	cough	b-PROBLEM
22870	.	O
22871	the	O
22872	patient	O
22873	states	b-EVIDENTIAL
22874	that	O
22875	she	O
22876	has	O
22877	no	b-OCCURRENCE
22878	idea	i-OCCURRENCE
22879	why	i-OCCURRENCE
22880	she	i-OCCURRENCE
22881	was	i-OCCURRENCE
22882	brought	i-OCCURRENCE
22883	to	O
22884	the	b-CLINICAL_DEPT
22885	emergency	i-CLINICAL_DEPT
22886	department	i-CLINICAL_DEPT
22887	and	O
22888	denies	b-EVIDENTIAL
22889	any	b-PROBLEM
22890	symptoms	i-PROBLEM
22891	.	O
22892	she	O
22893	reports	b-EVIDENTIAL
22894	an	b-PROBLEM
22895	occasional	i-PROBLEM
22896	nonproductive	i-PROBLEM
22897	cough	i-PROBLEM
22898	that	O
22899	she	O
22900	has	O
22901	had_	O
22902	for	b-DURATION
22903	years	i-DURATION
22904	_and	O
22905	feels	b-EVIDENTIAL
22906	that	O
22907	she	O
22908	has	O
22909	been	O
22910	experiencing	O
22911	alternating	b-PROBLEM
22912	chills	i-PROBLEM
22913	and	i-PROBLEM
22914	feeling	i-PROBLEM
22915	hot	i-PROBLEM
22916	.	O
22917	a	O
22918	progress	O
22919	note	O
22920	in	O
22921	the	O
22922	patient	O
22923	's	O
22924	chart	O
22925	from	O
22926	her	b-CLINICAL_DEPT
22927	assisted	i-CLINICAL_DEPT
22928	living	i-CLINICAL_DEPT
22929	facility	i-CLINICAL_DEPT
22930	indicates	O
22931	that	O
22932	the	O
22933	patient	O
22934	has	O
22935	had	O
22936	shortness	b-PROBLEM
22937	of	i-PROBLEM
22938	breath	i-PROBLEM
22939	and	O
22940	cough	b-PROBLEM
22941	for	O
22942	one	b-DURATION
22943	day	i-DURATION
22944	with	O
22945	chills	b-PROBLEM
22946	but	O
22947	no	O
22948	fever	b-PROBLEM
22949	.	O
22950	she	O
22951	has	O
22952	been	O
22953	recently	O
22954	evaluated	b-TEST
22955	as	O
22956	an	O
22957	outpatient	O
22958	for	O
22959	bradycardia	b-PROBLEM
22960	.	O
22961	she	O
22962	was	O
22963	seen	O
22964	by	O
22965	her	O
22966	cardiologist	O
22967	,	O
22968	doctor	O
22969	clements	O
22970	and	O
22971	had	O
22972	a	b-TEST
22973	holter	i-TEST
22974	monitor	i-TEST
22975	on	O
22976	2015-05-01	b-DATE
22977	,	O
22978	that	O
22979	showed	b-EVIDENTIAL
22980	first	b-PROBLEM
22981	degree	i-PROBLEM
22982	av	i-PROBLEM
22983	block	i-PROBLEM
22984	with	O
22985	a	b-TEST
22986	rate	i-TEST
22987	that	O
22988	ranged	O
22989	between	O
22990	35	O
22991	to	O
22992	53	O
22993	beats	O
22994	per	O
22995	minute	O
22996	.	O
22997	in	O
22998	the	b-CLINICAL_DEPT
22999	emergency	i-CLINICAL_DEPT
23000	department	i-CLINICAL_DEPT
23001	,	O
23002	the	O
23003	patient	O
23004	was	O
23005	given	O
23006	nebulizer	b-TREATMENT
23007	treatment	i-TREATMENT
23008	,	O
23009	started	O
23010	on	O
23011	antibiotics	b-TREATMENT
23012	for	O
23013	presumed	O
23014	chronic	b-PROBLEM
23015	obstructive	i-PROBLEM
23016	pulmonary	i-PROBLEM
23017	disease	i-PROBLEM
23018	exacerbation	i-PROBLEM
23019	.	O
23020	she	O
23021	was	O
23022	noted	O
23023	to	O
23024	have	O
23025	lateral	b-PROBLEM
23026	st	i-PROBLEM
23027	depressions	i-PROBLEM
23028	and	O
23029	given	O
23030	aspirin	b-TREATMENT
23031	.	O
23032	she	O
23033	continues	O
23034	to	O
23035	deny	b-EVIDENTIAL
23036	chest	b-PROBLEM
23037	pain	i-PROBLEM
23038	,	O
23039	palpitations	b-PROBLEM
23040	,	O
23041	shortness	b-PROBLEM
23042	of	i-PROBLEM
23043	breath	i-PROBLEM
23044	,	O
23045	fevers	b-PROBLEM
23046	,	O
23047	nausea	b-PROBLEM
23048	,	O
23049	vomiting	b-PROBLEM
23050	,	O
23051	abdominal	b-PROBLEM
23052	pain	i-PROBLEM
23053	,	O
23054	bright	b-PROBLEM
23055	red	i-PROBLEM
23056	blood	i-PROBLEM
23057	per	i-PROBLEM
23058	rectum	i-PROBLEM
23059	,	O
23060	melena	b-PROBLEM
23061	,	O
23062	dysuria	b-PROBLEM
23063	,	O
23064	urinary	b-PROBLEM
23065	frequency	i-PROBLEM
23066	and	i-PROBLEM
23067	urgency	i-PROBLEM
23068	.	O
23069	hospital	O
23070	course	O
23071	:	O
23072	shortness	b-PROBLEM
23073	of	i-PROBLEM
23074	breath	i-PROBLEM
23075	-	O
23076	though	O
23077	the	O
23078	patient	O
23079	denied	b-EVIDENTIAL
23080	shortness	b-PROBLEM
23081	of	i-PROBLEM
23082	breath	i-PROBLEM
23083	on	O
23084	admission	b-OCCURRENCE
23085	,	O
23086	a	O
23087	progress	O
23088	note	O
23089	from	O
23090	norwood	b-CLINICAL_DEPT
23091	nursing	i-CLINICAL_DEPT
23092	facility	i-CLINICAL_DEPT
23093	suggested	O
23094	that	O
23095	the	O
23096	patient	O
23097	had	O
23098	been	O
23099	having	O
23100	shortness	b-PROBLEM
23101	of	i-PROBLEM
23102	breath	i-PROBLEM
23103	and	O
23104	cough	b-PROBLEM
23105	for	O
23106	approximately	O
23107	one	b-DURATION
23108	day	i-DURATION
23109	with	O
23110	difficulty	b-PROBLEM
23111	ambulating	i-PROBLEM
23112	,	O
23113	needing	O
23114	to	O
23115	travel	O
23116	in	O
23117	a	b-TREATMENT
23118	wheelchair	i-TREATMENT
23119	.	O
23120	the	O
23121	patient	O
23122	was	O
23123	afebrile	b-PROBLEM
23124	on	O
23125	admission	b-OCCURRENCE
23126	with	O
23127	a	b-OCCURRENCE
23128	normal	i-OCCURRENCE
23129	white	i-OCCURRENCE
23130	blood	i-OCCURRENCE
23131	cell	i-OCCURRENCE
23132	count	i-OCCURRENCE
23133	but	O
23134	had	O
23135	significant	b-PROBLEM
23136	wheezing	i-PROBLEM
23137	and	O
23138	rales	b-PROBLEM
23139	on	O
23140	physical	b-TEST
23141	examination	i-TEST
23142	with	O
23143	a	O
23144	possible	O
23145	left	b-PROBLEM
23146	lower	i-PROBLEM
23147	lobe	i-PROBLEM
23148	opacity	i-PROBLEM
23149	seen	O
23150	on	O
23151	chest	b-TEST
23152	x-ray	i-TEST
23153	.	O
23154	the	O
23155	etiology	O
23156	of	O
23157	the	b-PROBLEM
23158	patient	i-PROBLEM
23159	's	i-PROBLEM
23160	shortness	i-PROBLEM
23161	of	i-PROBLEM
23162	breath	i-PROBLEM
23163	was	O
23164	considered	O
23165	a	O
23166	likely	O
23167	chronic	b-PROBLEM
23168	obstructive	i-PROBLEM
23169	pulmonary	i-PROBLEM
23170	disease	i-PROBLEM
23171	exacerbation	i-PROBLEM
23172	and	O
23173	the	O
23174	patient	O
23175	was	O
23176	started	O
23177	on	O
23178	albuterol	b-TREATMENT
23179	and	O
23180	atrovent	b-TREATMENT
23181	nebulizers	i-TREATMENT
23182	.	O
23183	the	O
23184	patient	O
23185	was	O
23186	also	O
23187	started	O
23188	on	O
23189	doxycycline	b-TREATMENT
23190	given	O
23191	the	O
23192	concern	O
23193	for	O
23194	pneumonia	b-PROBLEM
23195	on	O
23196	chest	b-TEST
23197	x-ray	i-TEST
23198	.	O
23199	she	O
23200	was	O
23201	also	O
23202	continued	O
23203	on	O
23204	steroids	b-TREATMENT
23205	given	O
23206	evidence	O
23207	of	O
23208	severe	b-PROBLEM
23209	airway	i-PROBLEM
23210	obstruction	i-PROBLEM
23211	.	O
23212	the	b-PROBLEM
23213	patient	i-PROBLEM
23214	's	i-PROBLEM
23215	shortness	i-PROBLEM
23216	of	i-PROBLEM
23217	breath	i-PROBLEM
23218	was	O
23219	also	O
23220	considered	O
23221	possibly	O
23222	related	O
23223	to	O
23224	a	b-PROBLEM
23225	coronary	i-PROBLEM
23226	event	i-PROBLEM
23227	and	O
23228	she	O
23229	was	O
23230	admitted	b-OCCURRENCE
23231	for	O
23232	rule	O
23233	out	O
23234	myocardial	b-PROBLEM
23235	infarction	i-PROBLEM
23236	.	O
23237	the	b-TEST
23238	patient	i-TEST
23239	's	i-TEST
23240	enzymes	i-TEST
23241	were	O
23242	cycled	O
23243	and	O
23244	were	O
23245	negative	O
23246	.	O
23247	the	b-TEST
23248	patient	i-TEST
23249	's	i-TEST
23250	electrocardiogram	i-TEST
23251	performed	O
23252	on	O
23253	hospital	b-DATE
23254	day	i-DATE
23255	number	i-DATE
23256	two	i-DATE
23257	was	O
23258	concerning	O
23259	for	O
23260	2:1	b-PROBLEM
23261	heart	i-PROBLEM
23262	block	i-PROBLEM
23263	and	O
23264	the	O
23265	cardiology	O
23266	consult	O
23267	service	O
23268	was	O
23269	contacted	O
23270	for	O
23271	evaluation	b-TEST
23272	.	O
23273	the	O
23274	patient	O
23275	was	O
23276	taken	O
23277	to	O
23278	the	b-CLINICAL_DEPT
23279	coronary	i-CLINICAL_DEPT
23280	care	i-CLINICAL_DEPT
23281	unit	i-CLINICAL_DEPT
23282	late	O
23283	on	O
23284	hospital	b-DATE
23285	day	i-DATE
23286	number	i-DATE
23287	two	i-DATE
23288	and	O
23289	received	O
23290	a	b-TREATMENT
23291	temporary	i-TREATMENT
23292	wire	i-TREATMENT
23293	.	O
23294	the	b-DATE
23295	following	i-DATE
23296	day	i-DATE
23297	the	O
23298	patient	O
23299	received	O
23300	a	b-TREATMENT
23301	permanent	i-TREATMENT
23302	dual	i-TREATMENT
23303	chamber	i-TREATMENT
23304	rate	i-TREATMENT
23305	responsive	i-TREATMENT
23306	pacemaker	i-TREATMENT
23307	.	O
23308	the	O
23309	patient	O
23310	was	O
23311	transferred	b-OCCURRENCE
23312	back	O
23313	to	O
23314	the	b-CLINICAL_DEPT
23315	general	i-CLINICAL_DEPT
23316	medicine	i-CLINICAL_DEPT
23317	service	i-CLINICAL_DEPT
23318	where	O
23319	she	O
23320	continued	O
23321	to	O
23322	exhibit	O
23323	signs	O
23324	of	O
23325	chronic	b-PROBLEM
23326	obstructive	i-PROBLEM
23327	pulmonary	i-PROBLEM
23328	disease	i-PROBLEM
23329	exacerbation	i-PROBLEM
23330	and	O
23331	nebulizers	b-TREATMENT
23332	,	O
23333	steroids	b-TREATMENT
23334	and	O
23335	antibiotics	b-TREATMENT
23336	were	O
23337	continued	O
23338	.	O
23339	the	b-OCCURRENCE
23340	patient	i-OCCURRENCE
23341	's	i-OCCURRENCE
23342	respiratory	i-OCCURRENCE
23343	status	i-OCCURRENCE
23344	improved	i-OCCURRENCE
23345	throughout	O
23346	the	O
23347	remainder	O
23348	of	O
23349	her	b-OCCURRENCE
23350	hospitalization	i-OCCURRENCE
23351	and	O
23352	oxygen	b-TREATMENT
23353	was	O
23354	eventually	O
23355	weaned	b-TREATMENT
23356	.	O
23357	once	O
23358	the	O
23359	patient	O
23360	was	O
23361	transferred	b-OCCURRENCE
23362	out	O
23363	of	O
23364	the	b-CLINICAL_DEPT
23365	coronary	i-CLINICAL_DEPT
23366	care	i-CLINICAL_DEPT
23367	unit	i-CLINICAL_DEPT
23368	,	O
23369	she	O
23370	appeared	O
23371	to	O
23372	have	O
23373	an	b-PROBLEM
23374	element	i-PROBLEM
23375	of	i-PROBLEM
23376	heart	i-PROBLEM
23377	failure	i-PROBLEM
23378	in	O
23379	addition	O
23380	to	O
23381	her	b-PROBLEM
23382	chronic	i-PROBLEM
23383	obstructive	i-PROBLEM
23384	pulmonary	i-PROBLEM
23385	disease	i-PROBLEM
23386	.	O
23387	she	O
23388	was	O
23389	given	O
23390	20	O
23391	mg	O
23392	of	O
23393	intravenous	b-TREATMENT
23394	lasix	i-TREATMENT
23395	with	O
23396	impressive	O
23397	urine	b-OCCURRENCE
23398	output	i-OCCURRENCE
23399	and	O
23400	improvement	b-OCCURRENCE
23401	in	O
23402	her	b-TEST
23403	overall	i-TEST
23404	fluid	i-TEST
23405	status	i-TEST
23406	.	O
23407	the	O
23408	patient	O
23409	was	O
23410	eventually	O
23411	restarted	O
23412	on	O
23413	her	O
23414	outpatient	O
23415	dose	O
23416	of	O
23417	lasix	b-TREATMENT
23418	once	O
23419	her	b-TEST
23420	renal	i-TEST
23421	function	i-TEST
23422	improved	b-OCCURRENCE
23423	to	i-OCCURRENCE
23424	baseline	i-OCCURRENCE
23425	and	O
23426	remained	O
23427	hemodynamically	b-OCCURRENCE
23428	stable	i-OCCURRENCE
23429	throughout	O
23430	the	O
23431	remainder	O
23432	of	O
23433	her	b-TREATMENT
23434	hospitalization	i-TREATMENT
23435	.	O
23436	heart	b-PROBLEM
23437	block	i-PROBLEM
23438	-	O
23439	as	O
23440	noted	O
23441	previously	O
23442	,	O
23443	the	b-TEST
23444	patient	i-TEST
23445	's	i-TEST
23446	electrocardiogram	i-TEST
23447	was	O
23448	significant	O
23449	for	O
23450	a	b-PROBLEM
23451	2:1	i-PROBLEM
23452	heart	i-PROBLEM
23453	block	i-PROBLEM
23454	and	O
23455	cardiology	O
23456	consult	O
23457	service	O
23458	was	O
23459	contacted	O
23460	for	O
23461	evaluation	b-TEST
23462	.	O
23463	the	O
23464	patient	O
23465	received	O
23466	a	b-TREATMENT
23467	temporary	i-TREATMENT
23468	pacing	i-TREATMENT
23469	wire	i-TREATMENT
23470	on	O
23471	the	O
23472	evening	O
23473	of	O
23474	hospital	b-DATE
23475	day	i-DATE
23476	number	i-DATE
23477	two	i-DATE
23478	and	O
23479	on	O
23480	hospital	b-DATE
23481	day	i-DATE
23482	number	i-DATE
23483	three	i-DATE
23484	received	O
23485	a	b-TREATMENT
23486	dual	i-TREATMENT
23487	chamber	i-TREATMENT
23488	pacemaker	i-TREATMENT
23489	.	O
23490	renal	O
23491	-	O
23492	the	O
23493	patient	O
23494	was	O
23495	admitted	b-OCCURRENCE
23496	with	O
23497	a	b-TEST
23498	creatinine	i-TEST
23499	of	O
23500	1.8	O
23501	,	O
23502	considered	O
23503	likely	O
23504	secondary	O
23505	to	O
23506	hypovolemia	b-PROBLEM
23507	.	O
23508	her	b-TEST
23509	calculated	i-TEST
23510	fractional	i-TEST
23511	excretion	i-TEST
23512	of	i-TEST
23513	sodium	i-TEST
23514	was	O
23515	0.13	O
23516	percent	O
23517	suggesting	O
23518	a	b-PROBLEM
23519	prerenal	i-PROBLEM
23520	cause	i-PROBLEM
23521	.	O
23522	the	b-TEST
23523	patient	i-TEST
23524	's	i-TEST
23525	creatinine	i-TEST
23526	improved	b-OCCURRENCE
23527	to	O
23528	1.1	O
23529	with	O
23530	hydration	b-TREATMENT
23531	.	O
23532	once	O
23533	the	b-TEST
23534	patient	i-TEST
23535	's	i-TEST
23536	creatinine	i-TEST
23537	had	O
23538	improved	b-OCCURRENCE
23539	to	i-OCCURRENCE
23540	baseline	i-OCCURRENCE
23541	,	O
23542	her	b-TREATMENT
23543	lasix	i-TREATMENT
23544	and	O
23545	ace	b-TREATMENT
23546	inhibitor	i-TREATMENT
23547	were	O
23548	restarted	O
23549	and	O
23550	the	b-TEST
23551	patient	i-TEST
23552	's	i-TEST
23553	creatinine	i-TEST
23554	was	O
23555	noted	O
23556	to	O
23557	be	O
23558	stable	b-OCCURRENCE
23559	.	O
23560	gastrointestinal	O
23561	-	O
23562	the	O
23563	patient	O
23564	was	O
23565	admitted	b-OCCURRENCE
23566	with	O
23567	a	O
23568	history	O
23569	of	O
23570	gastrointestinal	b-PROBLEM
23571	bleed	i-PROBLEM
23572	with	O
23573	guaiac	b-PROBLEM
23574	positive	i-PROBLEM
23575	stools	i-PROBLEM
23576	on	O
23577	admission	b-OCCURRENCE
23578	.	O
23579	her	b-TEST
23580	hematocrit	i-TEST
23581	was	O
23582	noted	O
23583	to	O
23584	trend	b-PROBLEM
23585	down	i-PROBLEM
23586	after	O
23587	transfusion	b-TREATMENT
23588	of	O
23589	one	O
23590	unit	O
23591	of	O
23592	packed	b-TREATMENT
23593	red	i-TREATMENT
23594	blood	i-TREATMENT
23595	cells	i-TREATMENT
23596	on	O
23597	admission	b-OCCURRENCE
23598	.	O
23599	given	O
23600	guaiac	b-PROBLEM
23601	positive	i-PROBLEM
23602	stools	i-PROBLEM
23603	and	O
23604	her	O
23605	history	O
23606	of	O
23607	gastrointestinal	b-PROBLEM
23608	bleed	i-PROBLEM
23609	in	O
23610	addition	O
23611	to	O
23612	use	O
23613	of	O
23614	steroids	b-TREATMENT
23615	for	O
23616	chronic	b-PROBLEM
23617	obstructive	i-PROBLEM
23618	pulmonary	i-PROBLEM
23619	disease	i-PROBLEM
23620	exacerbation	i-PROBLEM
23621	,	O
23622	the	O
23623	gastroenterology	O
23624	consult	O
23625	service	O
23626	was	O
23627	contacted	b-OCCURRENCE
23628	.	O
23629	the	O
23630	results	O
23631	of	O
23632	that	O
23633	consultation	b-OCCURRENCE
23634	and	O
23635	potential	O
23636	esophagogastroduodenoscopy	b-TEST
23637	are	O
23638	pending	O
23639	at	O
23640	the	O
23641	time	O
23642	of	O
23643	dictation	O
23644	.	O
23645	hypertension	b-PROBLEM
23646	-	O
23647	the	O
23648	patient	O
23649	had	O
23650	moderate	b-OCCURRENCE
23651	control	i-OCCURRENCE
23652	of	O
23653	her	b-TEST
23654	blood	i-TEST
23655	pressure	i-TEST
23656	throughout	O
23657	her	b-OCCURRENCE
23658	admission	i-OCCURRENCE
23659	.	O
23660	her	b-TREATMENT
23661	calcium	i-TREATMENT
23662	channel	i-TREATMENT
23663	blocker	i-TREATMENT
23664	and	O
23665	ace	b-TREATMENT
23666	inhibitor	i-TREATMENT
23667	were	O
23668	continued	O
23669	.	O
23670	hematology	O
23671	-	O
23672	as	O
23673	noted	O
23674	previously	O
23675	,	O
23676	the	b-TEST
23677	patient	i-TEST
23678	's	i-TEST
23679	hematocrit	i-TEST
23680	was	O
23681	noted	O
23682	to	O
23683	drop	b-PROBLEM
23684	after	O
23685	transfusion	b-TREATMENT
23686	with	O
23687	one	O
23688	unit	O
23689	of	O
23690	packed	b-TREATMENT
23691	red	i-TREATMENT
23692	blood	i-TREATMENT
23693	cells	i-TREATMENT
23694	on	O
23695	admission	b-OCCURRENCE
23696	.	O
23697	given	O
23698	guaiac	b-PROBLEM
23699	positive	i-PROBLEM
23700	stools	i-PROBLEM
23701	and	O
23702	the	O
23703	patient	O
23704	's	O
23705	history	O
23706	of	O
23707	gastrointestinal	b-PROBLEM
23708	bleed	i-PROBLEM
23709	,	O
23710	gastroenterology	O
23711	consult	O
23712	service	O
23713	was	O
23714	contacted	b-OCCURRENCE
23715	for	O
23716	possible	O
23717	esophagogastroduodenoscopy	b-TEST
23718	and/or	O
23719	colonoscopy	b-TEST
23720	.	O
23721	the	O
23722	results	O
23723	of	O
23724	this	b-OCCURRENCE
23725	consultation	i-OCCURRENCE
23726	are	O
23727	pending	O
23728	at	O
23729	the	O
23730	time	O
23731	of	O
23732	dictation	O
23733	.	O
23734	the	O
23735	remainder	O
23736	of	O
23737	the	b-CLINICAL_DEPT
23738	hubbard	i-CLINICAL_DEPT
23739	regional	i-CLINICAL_DEPT
23740	hospital	i-CLINICAL_DEPT
23741	hospital	b-OCCURRENCE
23742	course	i-OCCURRENCE
23743	,	O
23744	discharge	b-OCCURRENCE
23745	diagnoses	i-OCCURRENCE
23746	,	O
23747	medications	b-TREATMENT
23748	and	O
23749	follow-up	b-OCCURRENCE
23750	will	O
23751	be	O
23752	dictated	O
23753	at	O
23754	the	O
23755	time	O
23756	of	O
23757	discharge	b-OCCURRENCE
23758	.	O
23759	justin	O
23760	q.	O
23761	yagi	O
23762	,	O
23763	md	O
23764	12akk	O
23765	dictated	O
23766	by:miriam	O
23767	h	O
23768	hines	O
23769	,	O
23770	md	O
23771	medquist36	O
23772	d	O
23773	:	O
23774	2015-05-18	O
23775	11:24:17	O
23776	t	O
23777	:	O
23778	2015-05-18	O
23779	14:58:16	O
23780	job#	O
23781	:	O
23782	21080	O
23783	signed	O
23784	electronically	O
23785	by	O
23786	:	O
23787	doctor	O
23788	jose	O
23789	m.	O
23790	rosales	O
23791	on	O
23792	:	O
23793	mon	O
23794	2015-07-27	O
23795	9:58	O
23796	am	O
23797	(	O
23798	end	O
23799	of	O
23800	report	O
23801	)	O
23802		O
23803	admission	b-OCCURRENCE
23804	date	O
23805	:	O
23806	4/14/94	b-ADMISSION
23807	discharge	b-OCCURRENCE
23808	date	O
23809	:	O
23810	4/20/94	b-DISCHARGE
23811	discharge	b-OCCURRENCE
23812	date	O
23813	:	O
23814	4/20/94	b-DATE
23815	history	O
23816	of	O
23817	present	O
23818	illness	O
23819	:	O
23820	mr.	O
23821	le	O
23822	is	O
23823	a	O
23824	seventy	O
23825	three	O
23826	year	O
23827	old	O
23828	male	O
23829	who	O
23830	presents	b-EVIDENTIAL
23831	to	O
23832	the	b-CLINICAL_DEPT
23833	fairm	i-CLINICAL_DEPT
23834	of	i-CLINICAL_DEPT
23835	ijordcompmac	i-CLINICAL_DEPT
23836	hospital	i-CLINICAL_DEPT
23837	,	O
23838	following	O
23839	a	b-PROBLEM
23840	self	i-PROBLEM
23841	inflicted	i-PROBLEM
23842	gunshot	i-PROBLEM
23843	wound	i-PROBLEM
23844	to	i-PROBLEM
23845	the	i-PROBLEM
23846	head	i-PROBLEM
23847	.	O
23848	mr.	O
23849	le	O
23850	was	O
23851	found	b-OCCURRENCE
23852	in	i-OCCURRENCE
23853	bed	i-OCCURRENCE
23854	with	O
23855	a	O
23856	32	O
23857	caliber	O
23858	revolver	O
23859	at	O
23860	his	O
23861	side	O
23862	.	O
23863	the	O
23864	patient	O
23865	was	O
23866	apparently	O
23867	alone	b-OCCURRENCE
23868	at	i-OCCURRENCE
23869	home	i-OCCURRENCE
23870	,	O
23871	his	O
23872	neighbors	O
23873	heard	b-OCCURRENCE
23874	a	i-OCCURRENCE
23875	single	i-OCCURRENCE
23876	shot	i-OCCURRENCE
23877	,	O
23878	and	O
23879	the	b-OCCURRENCE
23880	paramedics	i-OCCURRENCE
23881	were	i-OCCURRENCE
23882	called	i-OCCURRENCE
23883	.	O
23884	upon	O
23885	arrival	O
23886	,	O
23887	they	O
23888	found	b-OCCURRENCE
23889	the	i-OCCURRENCE
23890	patient	i-OCCURRENCE
23891	in	i-OCCURRENCE
23892	bed	i-OCCURRENCE
23893	,	O
23894	with	O
23895	notes	O
23896	nearby	O
23897	,	O
23898	listing	O
23899	his	O
23900	funeral	O
23901	home	O
23902	preferences	O
23903	and	O
23904	information	O
23905	on	O
23906	his	O
23907	next	O
23908	of	O
23909	kin	O
23910	.	O
23911	the	O
23912	patient	O
23913	indicates	b-EVIDENTIAL
23914	that	O
23915	his	b-OCCURRENCE
23916	neighbors	i-OCCURRENCE
23917	were	i-OCCURRENCE
23918	making	i-OCCURRENCE
23919	excessive	i-OCCURRENCE
23920	noise	i-OCCURRENCE
23921	upstairs	O
23922	from	O
23923	his	O
23924	dwelling	O
23925	,	O
23926	and	O
23927	he	O
23928	found	O
23929	it	O
23930	unbearable	O
23931	.	O
23932	he	O
23933	therefore	O
23934	decided	b-PROBLEM
23935	to	i-PROBLEM
23936	take	i-PROBLEM
23937	his	i-PROBLEM
23938	life	i-PROBLEM
23939	with	O
23940	a	O
23941	gun	O
23942	which	O
23943	he	O
23944	had	O
23945	found	b-OCCURRENCE
23946	in	i-OCCURRENCE
23947	the	i-OCCURRENCE
23948	house	i-OCCURRENCE
23949	.	O
23950	apparently	O
23951	,	O
23952	the	O
23953	gun	O
23954	belonged	O
23955	to	O
23956	his	O
23957	father	O
23958	.	O
23959	on	O
23960	further	b-TEST
23961	questioning	i-TEST
23962	,	O
23963	the	O
23964	patient	O
23965	described	b-EVIDENTIAL
23966	that	O
23967	his	b-OCCURRENCE
23968	father	i-OCCURRENCE
23969	passed	i-OCCURRENCE
23970	away	i-OCCURRENCE
23971	approximately	O
23972	forty	b-DURATION
23973	to	i-DURATION
23974	fifty	i-DURATION
23975	years	i-DURATION
23976	prior	i-DURATION
23977	to	O
23978	his	b-OCCURRENCE
23979	admission	i-OCCURRENCE
23980	,	O
23981	and	O
23982	the	b-OCCURRENCE
23983	gun	i-OCCURRENCE
23984	was	i-OCCURRENCE
23985	found	i-OCCURRENCE
23986	in	O
23987	a	O
23988	box	O
23989	in	O
23990	their	O
23991	home	O
23992	.	O
23993	the	O
23994	patient	O
23995	expressed	b-EVIDENTIAL
23996	concern	i-EVIDENTIAL
23997	that	O
23998	he	O
23999	had	O
24000	several	O
24001	utility	O
24002	bills	O
24003	that	O
24004	he	O
24005	was	O
24006	unable	b-PROBLEM
24007	to	i-PROBLEM
24008	pay	i-PROBLEM
24009	.	O
24010	the	b-OCCURRENCE
24011	patient	i-OCCURRENCE
24012	&apos;s	i-OCCURRENCE
24013	sister	i-OCCURRENCE
24014	died	i-OCCURRENCE
24015	eight	b-DURATION
24016	years	i-DURATION
24017	prior	O
24018	to	O
24019	the	O
24020	patient	O
24021	&apos;s	O
24022	admission	b-OCCURRENCE
24023	of	O
24024	leukemia	b-PROBLEM
24025	,	O
24026	and	O
24027	he	O
24028	otherwise	O
24029	has	O
24030	no	O
24031	next	O
24032	of	O
24033	kin	O
24034	with	O
24035	the	O
24036	exception	O
24037	of	O
24038	one	O
24039	brother	O
24040	in	O
24041	washington	O
24042	,	O
24043	with	O
24044	whom	O
24045	his	O
24046	relationship	O
24047	is	O
24048	tenuous	O
24049	.	O
24050	on	O
24051	initial	b-OCCURRENCE
24052	questioning	i-OCCURRENCE
24053	,	O
24054	however	O
24055	,	O
24056	the	O
24057	patient	O
24058	denies	b-EVIDENTIAL
24059	any	b-OCCURRENCE
24060	recent	i-OCCURRENCE
24061	losses	i-OCCURRENCE
24062	.	O
24063	on	O
24064	admission	b-OCCURRENCE
24065	,	O
24066	the	O
24067	patient	O
24068	denies	b-EVIDENTIAL
24069	any	b-PROBLEM
24070	suicidal	i-PROBLEM
24071	or	i-PROBLEM
24072	homicidal	i-PROBLEM
24073	ideation	i-PROBLEM
24074	.	O
24075	hospital	O
24076	course	O
24077	:	O
24078	the	O
24079	patient	O
24080	was	O
24081	admitted	b-OCCURRENCE
24082	to	O
24083	the	b-CLINICAL_DEPT
24084	fairm	i-CLINICAL_DEPT
24085	of	i-CLINICAL_DEPT
24086	ijordcompmac	i-CLINICAL_DEPT
24087	hospital	i-CLINICAL_DEPT
24088	,	O
24089	on	O
24090	the	O
24091	neurological	O
24092	surgery	O
24093	service	O
24094	of	O
24095	lupevickette	O
24096	l.	O
24097	ca	O
24098	,	O
24099	md	O
24100	prior	O
24101	to	O
24102	his	b-OCCURRENCE
24103	admission	i-OCCURRENCE
24104	,	O
24105	the	b-PROBLEM
24106	patient	i-PROBLEM
24107	&apos;s	i-PROBLEM
24108	gunshot	i-PROBLEM
24109	wound	i-PROBLEM
24110	was	O
24111	sutured	b-TREATMENT
24112	close	i-TREATMENT
24113	in	O
24114	the	b-CLINICAL_DEPT
24115	emergency	i-CLINICAL_DEPT
24116	room	i-CLINICAL_DEPT
24117	.	O
24118	the	O
24119	patient	O
24120	was	O
24121	placed	O
24122	on	O
24123	suicide	b-TREATMENT
24124	precautions	i-TREATMENT
24125	,	O
24126	and	O
24127	was	O
24128	hydrated	O
24129	with	O
24130	an	b-TREATMENT
24131	infusion	i-TREATMENT
24132	of	i-TREATMENT
24133	intravenous	i-TREATMENT
24134	fluid	i-TREATMENT
24135	.	O
24136	the	O
24137	patient	O
24138	was	O
24139	seen	b-OCCURRENCE
24140	in	i-OCCURRENCE
24141	consultation	i-OCCURRENCE
24142	by	O
24143	the	O
24144	psychiatry	O
24145	service	O
24146	,	O
24147	who	O
24148	began	O
24149	a	O
24150	battery	O
24151	of	O
24152	testing	b-TEST
24153	,	O
24154	which	O
24155	continues	O
24156	at	O
24157	the	O
24158	time	O
24159	of	O
24160	discharge	b-OCCURRENCE
24161	.	O
24162	the	O
24163	consulting	O
24164	psychiatrist	O
24165	recommended	O
24166	a	O
24167	minimum	O
24168	of	O
24169	2	b-TREATMENT
24170	point	i-TREATMENT
24171	restraints	i-TREATMENT
24172	at	O
24173	all	O
24174	times	O
24175	,	O
24176	and	O
24177	recommended	O
24178	the	O
24179	patient	O
24180	be	O
24181	monitored	b-TREATMENT
24182	by	i-TREATMENT
24183	a	i-TREATMENT
24184	sitter	i-TREATMENT
24185	.	O
24186	allowing	O
24187	the	O
24188	patient	O
24189	to	O
24190	ambulate	b-OCCURRENCE
24191	was	O
24192	not	O
24193	recommended	O
24194	.	O
24195	from	O
24196	a	O
24197	medical	O
24198	standpoint	O
24199	,	O
24200	the	O
24201	patient	O
24202	did	O
24203	well	b-OCCURRENCE
24204	.	O
24205	he	O
24206	was	O
24207	initially	O
24208	admitted	b-OCCURRENCE
24209	to	O
24210	the	b-CLINICAL_DEPT
24211	neurological	i-CLINICAL_DEPT
24212	intensive	i-CLINICAL_DEPT
24213	care	i-CLINICAL_DEPT
24214	unit	i-CLINICAL_DEPT
24215	where	O
24216	he	O
24217	was	O
24218	closely	b-TEST
24219	monitored	i-TEST
24220	during	O
24221	the	b-DATE
24222	first	i-DATE
24223	two	i-DATE
24224	days	i-DATE
24225	of	O
24226	his	b-OCCURRENCE
24227	hospitalization	i-OCCURRENCE
24228	.	O
24229	the	O
24230	chief	O
24231	obstacle	O
24232	was	O
24233	bringing	O
24234	his	b-TEST
24235	blood	i-TEST
24236	pressure	i-TEST
24237	under	O
24238	control	O
24239	and	O
24240	this	O
24241	was	O
24242	ultimately	O
24243	achieved	O
24244	with	O
24245	a	O
24246	combination	O
24247	of	O
24248	captopril	b-TREATMENT
24249	and	O
24250	nifedipine	b-TREATMENT
24251	.	O
24252	after	O
24253	his	b-TEST
24254	blood	i-TEST
24255	pressure	i-TEST
24256	had	O
24257	stabilized	b-OCCURRENCE
24258	,	O
24259	the	O
24260	patient	O
24261	was	O
24262	transferred	b-OCCURRENCE
24263	to	O
24264	the	b-CLINICAL_DEPT
24265	neurology	i-CLINICAL_DEPT
24266	ward	i-CLINICAL_DEPT
24267	.	O
24268	close	b-TEST
24269	monitoring	i-TEST
24270	demonstrated	b-EVIDENTIAL
24271	his	b-TEST
24272	blood	i-TEST
24273	pressure	i-TEST
24274	to	O
24275	be	O
24276	stable	b-OCCURRENCE
24277	and	O
24278	within	O
24279	an	O
24280	acceptable	O
24281	rang	O
24282	on	O
24283	his	b-TREATMENT
24284	dosage	i-TREATMENT
24285	regimen	i-TREATMENT
24286	.	O
24287	the	b-OCCURRENCE
24288	psychiatry	i-OCCURRENCE
24289	service	i-OCCURRENCE
24290	followed	i-OCCURRENCE
24291	up	i-OCCURRENCE
24292	extensively	i-OCCURRENCE
24293	with	O
24294	the	O
24295	patient	O
24296	,	O
24297	and	O
24298	his	b-OCCURRENCE
24299	psychiatric	i-OCCURRENCE
24300	progress	i-OCCURRENCE
24301	is	O
24302	detailed	O
24303	in	O
24304	the	O
24305	psychiatry	O
24306	transfer	O
24307	note	O
24308	.	O
24309	by	O
24310	the	b-DATE
24311	7th	i-DATE
24312	hospital	i-DATE
24313	day	i-DATE
24314	,	O
24315	the	O
24316	patient	O
24317	was	O
24318	medically	b-OCCURRENCE
24319	stable	i-OCCURRENCE
24320	.	O
24321	he	O
24322	had	O
24323	undergone	O
24324	full	b-TEST
24325	psychiatric	i-TEST
24326	evaluation	i-TEST
24327	,	O
24328	and	O
24329	was	O
24330	prepared	b-OCCURRENCE
24331	for	i-OCCURRENCE
24332	transfer	i-OCCURRENCE
24333	to	O
24334	a	b-CLINICAL_DEPT
24335	psychiatric	i-CLINICAL_DEPT
24336	hospital	i-CLINICAL_DEPT
24337	.	O
24338	therefore	O
24339	,	O
24340	because	O
24341	of	O
24342	his	O
24343	need	O
24344	for	O
24345	intense	b-TREATMENT
24346	psychiatric	i-TREATMENT
24347	care	i-TREATMENT
24348	,	O
24349	the	O
24350	patient	O
24351	is	O
24352	discharged	b-OCCURRENCE
24353	to	O
24354	the	b-CLINICAL_DEPT
24355	vo	i-CLINICAL_DEPT
24356	black	i-CLINICAL_DEPT
24357	doylestrictshore	i-CLINICAL_DEPT
24358	ft.	i-CLINICAL_DEPT
24359	clinics	i-CLINICAL_DEPT
24360	medical	i-CLINICAL_DEPT
24361	center	i-CLINICAL_DEPT
24362	on	O
24363	the	b-DATE
24364	7th	i-DATE
24365	hospital	i-DATE
24366	day	i-DATE
24367	.	O
24368		O
24369	admission	b-OCCURRENCE
24370	date	O
24371	:	O
24372	12/11/2005	b-ADMISSION
24373	discharge	b-OCCURRENCE
24374	date	O
24375	:	O
24376	12/13/2005	b-DISCHARGE
24377	service	O
24378	:	O
24379	ort	O
24380	hpi	O
24381	:	O
24382	hibbskote	O
24383	has	O
24384	severe	b-PROBLEM
24385	low	i-PROBLEM
24386	back	i-PROBLEM
24387	pain	i-PROBLEM
24388	radiating	b-PROBLEM
24389	down	i-PROBLEM
24390	the	i-PROBLEM
24391	right	i-PROBLEM
24392	leg	i-PROBLEM
24393	.	O
24394	she	O
24395	has	O
24396	been	O
24397	suffering	O
24398	from	O
24399	this	b-PROBLEM
24400	problem	i-PROBLEM
24401	for	O
24402	the	O
24403	last	O
24404	few	b-DURATION
24405	weeks	i-DURATION
24406	.	O
24407	a	b-DURATION
24408	week	i-DURATION
24409	and	i-DURATION
24410	half	i-DURATION
24411	ago	i-DURATION
24412	,	O
24413	she	O
24414	had	O
24415	a	b-TREATMENT
24416	steroid	i-TREATMENT
24417	injection	i-TREATMENT
24418	in	O
24419	an	O
24420	efforts	O
24421	to	O
24422	ameliorate	O
24423	the	b-PROBLEM
24424	pain	i-PROBLEM
24425	.	O
24426	she	O
24427	presents	b-OCCURRENCE
24428	now	O
24429	with	O
24430	worsening	b-PROBLEM
24431	low	i-PROBLEM
24432	back	i-PROBLEM
24433	pain	i-PROBLEM
24434	radiating	b-PROBLEM
24435	down	i-PROBLEM
24436	the	i-PROBLEM
24437	right	i-PROBLEM
24438	leg	i-PROBLEM
24439	.	O
24440	she	O
24441	denies	b-EVIDENTIAL
24442	numbness	b-PROBLEM
24443	or	O
24444	weakness	b-PROBLEM
24445	in	O
24446	any	O
24447	part	O
24448	of	O
24449	the	O
24450	body	O
24451	.	O
24452	she	O
24453	denies	b-EVIDENTIAL
24454	fever	b-PROBLEM
24455	.	O
24456	she	O
24457	denies	b-EVIDENTIAL
24458	nausea	b-PROBLEM
24459	,	O
24460	vomiting	b-PROBLEM
24461	,	O
24462	and	O
24463	diarrhea	b-PROBLEM
24464	.	O
24465	she	O
24466	denies	b-EVIDENTIAL
24467	chest	b-PROBLEM
24468	pain	i-PROBLEM
24469	.	O
24470	she	O
24471	says	O
24472	the	b-PROBLEM
24473	pain	i-PROBLEM
24474	is	O
24475	sharp	b-OCCURRENCE
24476	in	O
24477	character	O
24478	,	O
24479	and	O
24480	radiates	b-PROBLEM
24481	with	O
24482	a	b-PROBLEM
24483	shock	i-PROBLEM
24484	like	i-PROBLEM
24485	intensity	i-PROBLEM
24486	down	i-PROBLEM
24487	the	i-PROBLEM
24488	right	i-PROBLEM
24489	leg	i-PROBLEM
24490	.	O
24491	she	O
24492	says	O
24493	that	O
24494	oral	b-TREATMENT
24495	analgesics	i-TREATMENT
24496	have	O
24497	been	O
24498	of	O
24499	little	b-OCCURRENCE
24500	help	i-OCCURRENCE
24501	.	O
24502	on	O
24503	detailed	b-TEST
24504	review	i-TEST
24505	of	i-TEST
24506	systems	i-TEST
24507	,	O
24508	she	O
24509	admitted	b-EVIDENTIAL
24510	to	O
24511	one	O
24512	episode	O
24513	of	O
24514	urinary	b-PROBLEM
24515	incontinence	i-PROBLEM
24516	.	O
24517	she	O
24518	denied	b-EVIDENTIAL
24519	any	b-PROBLEM
24520	changes	i-PROBLEM
24521	in	i-PROBLEM
24522	bowel	i-PROBLEM
24523	habits	i-PROBLEM
24524	.	O
24525	hospital	O
24526	course	O
24527	:	O
24528	patient	O
24529	was	O
24530	evaluated	b-TEST
24531	by	O
24532	the	O
24533	orthopedic	O
24534	service	O
24535	.	O
24536	an	b-TEST
24537	mri	i-TEST
24538	of	i-TEST
24539	the	i-TEST
24540	spine	i-TEST
24541	showed	b-EVIDENTIAL
24542	l4/5	b-PROBLEM
24543	facet	i-PROBLEM
24544	enhancement	i-PROBLEM
24545	.	O
24546	it	O
24547	was	O
24548	evaluated	b-TEST
24549	by	O
24550	the	O
24551	ir	O
24552	radiology	O
24553	.	O
24554	thad	b-PROBLEM
24555	lesion	i-PROBLEM
24556	was	O
24557	read	b-EVIDENTIAL
24558	as	O
24559	a	b-PROBLEM
24560	facet	i-PROBLEM
24561	hypertrophy	i-PROBLEM
24562	and	O
24563	not	O
24564	an	b-PROBLEM
24565	infectious	i-PROBLEM
24566	process	i-PROBLEM
24567	.	O
24568	patient	O
24569	remained	O
24570	afebrile	b-PROBLEM
24571	.	O
24572	esr	b-TEST
24573	was	O
24574	within	O
24575	normal	b-OCCURRENCE
24576	limits	i-OCCURRENCE
24577	and	O
24578	cpr	b-TEST
24579	was	O
24580	mildly	b-PROBLEM
24581	elevated	i-PROBLEM
24582	.	O
24583	an	b-TEST
24584	ap	i-TEST
24585	of	i-TEST
24586	pelvis	i-TEST
24587	and	O
24588	r	b-TEST
24589	hip	i-TEST
24590	films	i-TEST
24591	were	O
24592	unremarkable	b-EVIDENTIAL
24593	.	O
24594	physical	b-TEST
24595	examination	i-TEST
24596	of	i-TEST
24597	the	i-TEST
24598	rle	i-TEST
24599	showed	b-EVIDENTIAL
24600	mild	b-PROBLEM
24601	pain	i-PROBLEM
24602	in	i-PROBLEM
24603	right	i-PROBLEM
24604	hip	i-PROBLEM
24605	with	O
24606	some	O
24607	movements	b-OCCURRENCE
24608	.	O
24609	when	O
24610	patient	O
24611	was	O
24612	distracted	b-OCCURRENCE
24613	,	O
24614	some	O
24615	maneuvers	b-OCCURRENCE
24616	were	O
24617	not	O
24618	painful	b-PROBLEM
24619	.	O
24620	patient	O
24621	remained	O
24622	cardiovascularly	b-OCCURRENCE
24623	stable	i-OCCURRENCE
24624	.	O
24625	patient	O
24626	was	O
24627	weaned	O
24628	from	O
24629	supplemental	b-TREATMENT
24630	oxygen	i-TREATMENT
24631	and	O
24632	tolerated	b-OCCURRENCE
24633	a	i-OCCURRENCE
24634	regular	i-OCCURRENCE
24635	diet	i-OCCURRENCE
24636	prior	O
24637	to	O
24638	discharge	b-OCCURRENCE
24639	.	O
24640	the	O
24641	patient	O
24642	received	O
24643	pneumoboots	b-TREATMENT
24644	and	O
24645	lovenox	b-TREATMENT
24646	for	O
24647	dvt	b-TREATMENT
24648	prophylaxis	i-TREATMENT
24649	.	O
24650	.	O
24651	patient	O
24652	was	O
24653	instructed	b-OCCURRENCE
24654	by	i-OCCURRENCE
24655	pt	i-OCCURRENCE
24656	on	O
24657	the	b-OCCURRENCE
24658	correct	i-OCCURRENCE
24659	way	i-OCCURRENCE
24660	to	i-OCCURRENCE
24661	ambulate	i-OCCURRENCE
24662	,	O
24663	weight	b-OCCURRENCE
24664	bearing	i-OCCURRENCE
24665	as	O
24666	tolerated	b-OCCURRENCE
24667	in	O
24668	the	b-OCCURRENCE
24669	rle	i-OCCURRENCE
24670	.	O
24671	.	O
24672	patient	O
24673	was	O
24674	able	O
24675	to	O
24676	void	b-OCCURRENCE
24677	and	O
24678	ambulated	b-OCCURRENCE
24679	without	O
24680	assistance	b-TREATMENT
24681	as	O
24682	directed	O
24683	by	O
24684	p.t.	O
24685	the	O
24686	team	O
24687	decided	b-OCCURRENCE
24688	that	O
24689	the	O
24690	patient	O
24691	was	O
24692	ready	O
24693	for	O
24694	discharge	b-OCCURRENCE
24695	.	O
24696	patient	O
24697	should	O
24698	follow	b-OCCURRENCE
24699	up	i-OCCURRENCE
24700	with	O
24701	her	O
24702	pain	O
24703	doctor	O
24704	,	O
24705	doctor	O
24706	maa	O
24707	bloch	O
24708	381-389-5852	O
24709	,	O
24710	for	O
24711	her	b-TREATMENT
24712	chronic	i-TREATMENT
24713	pain	i-TREATMENT
24714	management	i-TREATMENT
24715		O
24716	admission	b-OCCURRENCE
24717	date	O
24718	:	O
24719	2013-09-22	b-ADMISSION
24720	discharge	b-OCCURRENCE
24721	date	O
24722	:	O
24723	2013-09-26	b-DISCHARGE
24724	service	O
24725	:	O
24726	surgery	O
24727	history	O
24728	of	O
24729	present	O
24730	illness	O
24731	:	O
24732	79f	O
24733	pmhx	O
24734	chf,copd	b-PROBLEM
24735	,	O
24736	found	O
24737	down	O
24738	at	O
24739	home	O
24740	,	O
24741	pulseless	b-PROBLEM
24742	-	O
24743	cpr	b-TREATMENT
24744	initiated	O
24745	w/	O
24746	conciousness	b-OCCURRENCE
24747	regained	i-OCCURRENCE
24748	on	O
24749	scene	O
24750	.	O
24751	at	O
24752	osh	b-CLINICAL_DEPT
24753	abg	b-TEST
24754	7.19/94/110	O
24755	,	O
24756	bipap	b-TREATMENT
24757	started	O
24758	.	O
24759	pt	O
24760	found	O
24761	to	O
24762	be	O
24763	hypothermic	b-PROBLEM
24764	w/	O
24765	wbc	b-TEST
24766	17	O
24767	(	O
24768	pt	O
24769	on	O
24770	steroids	b-TREATMENT
24771	)	O
24772	pnuemobilia	b-PROBLEM
24773	and	O
24774	thickening	b-PROBLEM
24775	of	i-PROBLEM
24776	sigmoid	i-PROBLEM
24777	.	O
24778	currently	O
24779	on	O
24780	nasal	b-TREATMENT
24781	cannula	i-TREATMENT
24782	02	i-TREATMENT
24783	+	O
24784	hemodymamically	b-EVIDENTIAL
24785	stable	i-EVIDENTIAL
24786	.	O
24787	brief	O
24788	hospital	O
24789	course	O
24790	:	O
24791	79f	O
24792	w/	O
24793	a	b-PROBLEM
24794	multiple	i-PROBLEM
24795	medical	i-PROBLEM
24796	problems	i-PROBLEM
24797	including	O
24798	sylvia	b-PROBLEM
24799	(	O
24800	ef20%	b-TEST
24801	)	O
24802	,	O
24803	copd	b-PROBLEM
24804	(	O
24805	on	O
24806	home	b-TREATMENT
24807	o2	i-TREATMENT
24808	)	O
24809	,	O
24810	found	O
24811	down	O
24812	at	O
24813	home	O
24814	,	O
24815	pulseless	b-PROBLEM
24816	-	O
24817	cpr	b-TREATMENT
24818	initiated	O
24819	w	O
24820	conciousness	b-EVIDENTIAL
24821	regained	i-EVIDENTIAL
24822	on	O
24823	scene	O
24824	.	O
24825	at	O
24826	osh	b-CLINICAL_DEPT
24827	abg	b-TEST
24828	7.19/94/110	O
24829	,	O
24830	bipap	b-TREATMENT
24831	started	O
24832	.	O
24833	pt	O
24834	found	O
24835	to	O
24836	be	O
24837	hypothermic	b-PROBLEM
24838	w/	O
24839	wbc	b-TEST
24840	17	O
24841	(	O
24842	pt	O
24843	on	O
24844	steroids	b-TREATMENT
24845	)	O
24846	pnuemobilia	b-PROBLEM
24847	and	O
24848	thickening	b-PROBLEM
24849	of	i-PROBLEM
24850	sigmoid	i-PROBLEM
24851	.	O
24852	pt	O
24853	was	O
24854	transferred	b-OCCURRENCE
24855	to	O
24856	the	b-CLINICAL_DEPT
24857	hospital	i-CLINICAL_DEPT
24858	for	i-CLINICAL_DEPT
24859	orthopedics	i-CLINICAL_DEPT
24860	for	O
24861	further	b-TREATMENT
24862	management	i-TREATMENT
24863	with	O
24864	wishes	O
24865	from	O
24866	the	O
24867	pt	O
24868	and	O
24869	family	O
24870	to	O
24871	reverse	O
24872	dnr/dni	b-TREATMENT
24873	status	O
24874	if	O
24875	surgery	b-TREATMENT
24876	was	O
24877	indicated	O
24878	.	O
24879	on	O
24880	transfer	b-OCCURRENCE
24881	,	O
24882	the	O
24883	pt	O
24884	had	O
24885	vss	b-TEST
24886	with	O
24887	a	b-PROBLEM
24888	mildly	i-PROBLEM
24889	tender	i-PROBLEM
24890	abdomen	i-PROBLEM
24891	without	O
24892	peritoneal	b-PROBLEM
24893	signs	i-PROBLEM
24894	.	O
24895	it	O
24896	was	O
24897	decided	b-EVIDENTIAL
24898	to	O
24899	treat	b-TREATMENT
24900	her	i-TREATMENT
24901	conservatively	i-TREATMENT
24902	with	O
24903	bowel	b-TREATMENT
24904	and	i-TREATMENT
24905	iv	i-TREATMENT
24906	antibiotics	i-TREATMENT
24907	.	O
24908	she	O
24909	improved	b-EVIDENTIAL
24910	and	O
24911	was	O
24912	tolerating	b-OCCURRENCE
24913	po	i-OCCURRENCE
24914	's	O
24915	without	O
24916	difficulty	O
24917	after	O
24918	passing	O
24919	a	b-TEST
24920	swallow	i-TEST
24921	study	i-TEST
24922	.	O
24923	her	b-TEST
24924	cpine	i-TEST
24925	was	O
24926	clearly	O
24927	with	O
24928	both	O
24929	a	O
24930	negative	O
24931	ct	b-TEST
24932	cspine	i-TEST
24933	and	O
24934	clinical	b-TEST
24935	exam	i-TEST
24936	.	O
24937	her	b-TREATMENT
24938	groin	i-TREATMENT
24939	cvl	i-TREATMENT
24940	was	O
24941	dc	O
24942	'd	O
24943	after	O
24944	a	b-TREATMENT
24945	l	i-TREATMENT
24946	sc	i-TREATMENT
24947	svl	i-TREATMENT
24948	was	O
24949	palced	O
24950	.	O
24951	cxr	b-TEST
24952	confirmed	b-EVIDENTIAL
24953	good	b-OCCURRENCE
24954	position	i-OCCURRENCE
24955	and	O
24956	no	O
24957	ptx	b-PROBLEM
24958	.	O
24959	overnight	b-TIME
24960	on	O
24961	hd	O
24962	3	O
24963	,	O
24964	pt	O
24965	became	O
24966	mildly	b-PROBLEM
24967	agitated	i-PROBLEM
24968	and	O
24969	an	b-TEST
24970	abg	i-TEST
24971	was	O
24972	drawn	O
24973	which	O
24974	showed	b-EVIDENTIAL
24975	a	b-PROBLEM
24976	severe	i-PROBLEM
24977	resp	i-PROBLEM
24978	acidosis	i-PROBLEM
24979	and	O
24980	bipap	b-TREATMENT
24981	was	O
24982	initiated	O
24983	.	O
24984	the	O
24985	pt	O
24986	subsequently	O
24987	developed	O
24988	severe	b-PROBLEM
24989	hypoxia	i-PROBLEM
24990	with	O
24991	hypotension	b-PROBLEM
24992	.	O
24993	a	b-TEST
24994	cxr	i-TEST
24995	was	O
24996	obtained	O
24997	which	O
24998	showed	b-EVIDENTIAL
24999	complete	b-PROBLEM
25000	collapse	i-PROBLEM
25001	of	i-PROBLEM
25002	the	i-PROBLEM
25003	l	i-PROBLEM
25004	lung	i-PROBLEM
25005	thought	O
25006	to	O
25007	be	O
25008	a	O
25009	result	O
25010	of	O
25011	bursting	O
25012	a	b-PROBLEM
25013	bleb	i-PROBLEM
25014	associated	O
25015	with	O
25016	her	b-PROBLEM
25017	severe	i-PROBLEM
25018	copd	i-PROBLEM
25019	.	O
25020	family	O
25021	did	O
25022	not	O
25023	want	O
25024	a	b-TREATMENT
25025	chest	i-TREATMENT
25026	tube	i-TREATMENT
25027	placed	O
25028	and	O
25029	decided	O
25030	to	O
25031	make	O
25032	the	O
25033	pt	O
25034	cmo	b-TREATMENT
25035	measures	i-TREATMENT
25036	.	O
25037	on	O
25038	hd	b-DATE
25039	4	i-DATE
25040	pt	O
25041	continued	O
25042	to	O
25043	show	O
25044	a	b-PROBLEM
25045	severe	i-PROBLEM
25046	respiratory	i-PROBLEM
25047	acidosis	i-PROBLEM
25048	,	O
25049	was	O
25050	continued	O
25051	on	O
25052	a	b-TREATMENT
25053	morphine	i-TREATMENT
25054	drip	i-TREATMENT
25055	,	O
25056	and	O
25057	was	O
25058	difficult	b-OCCURRENCE
25059	to	i-OCCURRENCE
25060	arouse	i-OCCURRENCE
25061	.	O
25062	at	O
25063	6pm	b-TIME
25064	pt	O
25065	's	O
25066	respiratory	b-OCCURRENCE
25067	status	i-OCCURRENCE
25068	worsened	i-OCCURRENCE
25069	and	O
25070	she	O
25071	died	b-OCCURRENCE
25072	.	O
25073		O
25074	admission	b-OCCURRENCE
25075	date	O
25076	:	O
25077	10/30/2006	b-ADMISSION
25078	discharge	b-OCCURRENCE
25079	date	O
25080	:	O
25081	11/03/2006	b-DISCHARGE
25082	service	O
25083	:	O
25084	rnm	O
25085	hpi	O
25086	:	O
25087	62	O
25088	yo	O
25089	m	O
25090	w	O
25091	/	O
25092	iga	b-PROBLEM
25093	nephropathy	i-PROBLEM
25094	,	O
25095	developmental	b-PROBLEM
25096	delay	i-PROBLEM
25097	,	O
25098	began	O
25099	hd	b-TREATMENT
25100	7/31	b-DATE
25101	.	O
25102	was	O
25103	seen	O
25104	in	O
25105	dialysis	b-OCCURRENCE
25106	on	O
25107	day	b-DATE
25108	of	i-DATE
25109	admission	i-DATE
25110	and	O
25111	was	O
25112	seen	O
25113	to	O
25114	have	O
25115	&quot;	b-PROBLEM
25116	raccoon	i-PROBLEM
25117	eyes	i-PROBLEM
25118	&quot;	i-PROBLEM
25119	and	O
25120	hd	O
25121	staff	O
25122	was	O
25123	worried	O
25124	about	O
25125	sending	O
25126	home	O
25127	.	O
25128	head	b-TEST
25129	ct	i-TEST
25130	w	O
25131	/	O
25132	o	O
25133	bleed	b-PROBLEM
25134	.	O
25135	trauma	b-TEST
25136	series	i-TEST
25137	normal	O
25138	.	O
25139	pt	O
25140	denies	b-EVIDENTIAL
25141	abuse	b-OCCURRENCE
25142	or	O
25143	loc	b-PROBLEM
25144	associated	O
25145	w	O
25146	/	O
25147	fall	b-OCCURRENCE
25148	,	O
25149	but	O
25150	has	O
25151	noticed	O
25152	several	O
25153	recent	O
25154	falls	b-OCCURRENCE
25155	.	O
25156	recent	b-TEST
25157	neuro	i-TEST
25158	w	i-TEST
25159	/	i-TEST
25160	u	i-TEST
25161	including	O
25162	eeg	b-TEST
25163	,	O
25164	carotid	b-TEST
25165	u	i-TEST
25166	/	i-TEST
25167	s	i-TEST
25168	,	O
25169	head	b-TEST
25170	ct	i-TEST
25171	(	O
25172	old	b-PROBLEM
25173	stroke	i-PROBLEM
25174	)	O
25175	,	O
25176	dobutamine-mibi	b-TEST
25177	(	O
25178	fixed	b-PROBLEM
25179	defect	i-PROBLEM
25180	and	O
25181	small	b-PROBLEM
25182	inferolateral	i-PROBLEM
25183	reversible	i-PROBLEM
25184	)	O
25185	were	O
25186	all	O
25187	negative	b-EVIDENTIAL
25188	.	O
25189	notable	O
25190	hospital	O
25191	course	O
25192	:	O
25193	1.	O
25194	falls	b-OCCURRENCE
25195	a	O
25196	pt	b-OCCURRENCE
25197	consult	i-OCCURRENCE
25198	was	O
25199	obtained	O
25200	to	O
25201	assist	b-OCCURRENCE
25202	with	O
25203	ambulation	b-OCCURRENCE
25204	.	O
25205	a	b-OCCURRENCE
25206	social	i-OCCURRENCE
25207	work	i-OCCURRENCE
25208	consult	i-OCCURRENCE
25209	was	O
25210	also	O
25211	obtained	O
25212	and	O
25213	deemed	O
25214	that	O
25215	the	O
25216	patient	O
25217	has	O
25218	appropriate	b-OCCURRENCE
25219	support	i-OCCURRENCE
25220	at	O
25221	home	O
25222	and	O
25223	is	O
25224	safe	b-OCCURRENCE
25225	at	O
25226	home	O
25227	.	O
25228	the	O
25229	patient	O
25230	was	O
25231	placed	O
25232	on	O
25233	telemetry	b-TEST
25234	and	O
25235	had	O
25236	no	O
25237	telemetry	b-PROBLEM
25238	events	i-PROBLEM
25239	while	O
25240	an	O
25241	inpatient	O
25242	.	O
25243	he	O
25244	was	O
25245	also	O
25246	seen	O
25247	by	O
25248	the	O
25249	electrophysiology	O
25250	service	O
25251	,	O
25252	his	b-TREATMENT
25253	pacemaker	i-TREATMENT
25254	was	O
25255	interrogated	b-OCCURRENCE
25256	and	O
25257	working	b-OCCURRENCE
25258	fine	i-OCCURRENCE
25259	,	O
25260	with	O
25261	no	O
25262	signs	O
25263	of	O
25264	recent	b-PROBLEM
25265	ventricular	i-PROBLEM
25266	arrhythmia	i-PROBLEM
25267	.	O
25268	the	O
25269	patient	O
25270	his	O
25271	undergoing	O
25272	a	b-TEST
25273	tte	i-TEST
25274	prior	O
25275	to	O
25276	discharge	b-OCCURRENCE
25277	to	O
25278	rule	O
25279	out	O
25280	a	b-PROBLEM
25281	thrombus	i-PROBLEM
25282	.	O
25283	his	b-TEST
25284	tte	i-TEST
25285	showed	O
25286	ef	b-TEST
25287	45-50%	O
25288	,	O
25289	moderate	b-PROBLEM
25290	clvh	i-PROBLEM
25291	,	O
25292	abnormal	b-PROBLEM
25293	diastolic	i-PROBLEM
25294	function	i-PROBLEM
25295	,	O
25296	moderate	b-PROBLEM
25297	mr	i-PROBLEM
25298	,	O
25299	moderate	b-PROBLEM
25300	tr	i-PROBLEM
25301	and	O
25302	severe	b-PROBLEM
25303	lae	i-PROBLEM
25304	.	O
25305	there	O
25306	was	O
25307	a	O
25308	question	O
25309	of	O
25310	ionfiltrative	b-PROBLEM
25311	cardiomyopathy	i-PROBLEM
25312	,	O
25313	and	O
25314	the	O
25315	patient	O
25316	underwent	O
25317	abdominal	b-TEST
25318	fat	i-TEST
25319	pad	i-TEST
25320	biopsy	i-TEST
25321	to	O
25322	assess	O
25323	for	O
25324	amyloidosis	b-PROBLEM
25325	.	O
25326	he	O
25327	also	O
25328	currently	O
25329	has	O
25330	an	b-TEST
25331	spep	i-TEST
25332	/	O
25333	upep/beta	b-TEST
25334	2	i-TEST
25335	microglobulin	i-TEST
25336	/	O
25337	ace	b-TEST
25338	test	i-TEST
25339	that	O
25340	are	O
25341	currently	O
25342	pending	O
25343	.	O
25344	these	O
25345	should	O
25346	be	O
25347	followed	b-OCCURRENCE
25348	up	i-OCCURRENCE
25349	as	O
25350	an	O
25351	outaptient	O
25352	.	O
25353	he	O
25354	had	O
25355	carotid	b-TEST
25356	ultrasound	i-TEST
25357	studies	i-TEST
25358	3	b-DURATION
25359	months	i-DURATION
25360	ago	O
25361	that	O
25362	were	O
25363	normal	O
25364	without	O
25365	evidence	O
25366	for	O
25367	stenosis	b-PROBLEM
25368	.	O
25369	2.	O
25370	renal	O
25371	-	O
25372	cont	O
25373	mwf	O
25374	hd	b-TREATMENT
25375	;	O
25376	electrolytes	b-TEST
25377	have	O
25378	been	O
25379	stable	b-OCCURRENCE
25380	.	O
25381	perhaps	O
25382	his	b-OCCURRENCE
25383	recent	i-OCCURRENCE
25384	falls	i-OCCURRENCE
25385	are	O
25386	related	O
25387	to	O
25388	orthostatic	b-PROBLEM
25389	hypotension	i-PROBLEM
25390	after	O
25391	dialysis	b-TREATMENT
25392	.	O
25393	3.	O
25394	cv	O
25395	-the	O
25396	pt	O
25397	has	O
25398	a	O
25399	small	O
25400	area	O
25401	of	O
25402	reversible	b-PROBLEM
25403	ischemia	i-PROBLEM
25404	on	O
25405	recent	b-TEST
25406	mibi	i-TEST
25407	,	O
25408	and	O
25409	has	O
25410	troponins	b-PROBLEM
25411	persistently	i-PROBLEM
25412	elevated	i-PROBLEM
25413	in	O
25414	the	O
25415	setting	O
25416	of	O
25417	his	b-PROBLEM
25418	renal	i-PROBLEM
25419	disease	i-PROBLEM
25420	.	O
25421	his	b-TEST
25422	troponins	i-TEST
25423	remained	O
25424	lower	O
25425	than	O
25426	his	O
25427	baseline	O
25428	levels	O
25429	and	O
25430	there	O
25431	was	O
25432	no	O
25433	suspicion	O
25434	of	O
25435	acs	b-PROBLEM
25436	causing	O
25437	syncope	b-PROBLEM
25438	.	O
25439	he	O
25440	continued	O
25441	on	O
25442	his	b-TREATMENT
25443	zocor	i-TREATMENT
25444	,	O
25445	cozaar	b-TREATMENT
25446	and	O
25447	labetalol	b-TREATMENT
25448	.	O
25449	we	O
25450	will	O
25451	now	O
25452	hold	b-OCCURRENCE
25453	his	b-TREATMENT
25454	coumadin	i-TREATMENT
25455	given	O
25456	his	b-OCCURRENCE
25457	recent	i-OCCURRENCE
25458	falls	i-OCCURRENCE
25459	and	O
25460	bleeding	b-PROBLEM
25461	risk	i-PROBLEM
25462	.	O
25463	his	b-TREATMENT
25464	aspirin	i-TREATMENT
25465	was	O
25466	restarted	b-OCCURRENCE
25467	prior	O
25468	to	O
25469	discharge	b-OCCURRENCE
25470	.	O
25471	4.	O
25472	endo	O
25473	-	O
25474	tsh	b-TEST
25475	was	O
25476	4.7	O
25477	and	O
25478	normal	O
25479	.	O
25480	5.	O
25481	heme	O
25482	:	O
25483	the	O
25484	patient	O
25485	has	O
25486	a	b-PROBLEM
25487	macrocytosis	i-PROBLEM
25488	.	O
25489	his	b-TEST
25490	b12	i-TEST
25491	level	i-TEST
25492	was	O
25493	418	O
25494	and	O
25495	normal	O
25496	.	O
25497	he	O
25498	does	O
25499	have	O
25500	a	O
25501	history	O
25502	of	O
25503	b12	b-PROBLEM
25504	deficiency	i-PROBLEM
25505	in	O
25506	the	O
25507	past	O
25508	,	O
25509	and	O
25510	evidence	O
25511	for	O
25512	peripheral	b-PROBLEM
25513	neuropathy	i-PROBLEM
25514	ble	i-PROBLEM
25515	which	O
25516	may	O
25517	also	O
25518	be	O
25519	contributing	O
25520	to	O
25521	his	b-OCCURRENCE
25522	recent	i-OCCURRENCE
25523	falls	i-OCCURRENCE
25524	.	O
25525	?	O
25526	etoh	O
25527	6.	O
25528	psych	O
25529	:	O
25530	watch	O
25531	for	O
25532	etoh	b-PROBLEM
25533	wd	i-PROBLEM
25534	.	O
25535	the	O
25536	patient	O
25537	had	O
25538	no	O
25539	signs	O
25540	of	O
25541	alcohol	b-PROBLEM
25542	withdrawal	i-PROBLEM
25543	.	O
25544	his	b-TEST
25545	serum	i-TEST
25546	toxicology	i-TEST
25547	screen	i-TEST
25548	was	O
25549	negative	O
25550	.	O
25551	7.	O
25552	pulm	O
25553	:	O
25554	copd	b-PROBLEM
25555	and	O
25556	r	b-PROBLEM
25557	pleural	i-PROBLEM
25558	effusion	i-PROBLEM
25559	,	O
25560	off	O
25561	oxygen	b-TREATMENT
25562	and	O
25563	stable	b-OCCURRENCE
25564	.	O
25565	8.	O
25566	gu	O
25567	:	O
25568	r	b-PROBLEM
25569	complex	i-PROBLEM
25570	renal	i-PROBLEM
25571	cyst	i-PROBLEM
25572	,	O
25573	bladder	b-PROBLEM
25574	diverticula	i-PROBLEM
25575	.	O
25576	the	O
25577	patient	O
25578	will	O
25579	need	O
25580	a	b-TEST
25581	follow	i-TEST
25582	up	i-TEST
25583	ultrasound	i-TEST
25584	to	O
25585	further	O
25586	evaluate	O
25587	these	b-PROBLEM
25588	incidental	i-PROBLEM
25589	findings	i-PROBLEM
25590	seen	O
25591	on	O
25592	imaging	b-TEST
25593	upon	O
25594	admission	b-OCCURRENCE
25595	.	O
25596	9.	O
25597	id	O
25598	:	O
25599	the	b-TEST
25600	patient	i-TEST
25601	&apos;s	i-TEST
25602	urinalysis	i-TEST
25603	was	O
25604	normal	O
25605	.	O
25606	he	O
25607	had	O
25608	no	O
25609	fecal	b-PROBLEM
25610	leukocytes	i-PROBLEM
25611	.	O
25612	a	b-TEST
25613	c.difficile	i-TEST
25614	test	i-TEST
25615	is	O
25616	negative	O
25617	on	O
25618	prelim	O
25619	read	O
25620	,	O
25621	however	O
25622	very	O
25623	low	O
25624	suspicion	O
25625	given	O
25626	no	O
25627	recent	b-TREATMENT
25628	antibiotic	i-TREATMENT
25629	use	i-TREATMENT
25630	.	O
25631		O
25632	admission	b-OCCURRENCE
25633	date	O
25634	:	O
25635	2011-09-24	b-ADMISSION
25636	discharge	b-OCCURRENCE
25637	date	O
25638	:	O
25639	2011-09-27	b-DISCHARGE
25640	service	O
25641	:	O
25642	admission	O
25643	diagnosis	O
25644	:	O
25645	history	O
25646	of	O
25647	present	O
25648	illness	O
25649	:	O
25650	the	O
25651	patient	O
25652	was	O
25653	a	O
25654	79	O
25655	-	O
25656	year-old	O
25657	gentleman	O
25658	found	O
25659	down	O
25660	at	O
25661	home	O
25662	unresponsive	b-PROBLEM
25663	by	O
25664	his	O
25665	wife	O
25666	after	O
25667	lunch	b-TIME
25668	.	O
25669	he	O
25670	had	O
25671	an	b-OCCURRENCE
25672	unwitnessed	i-OCCURRENCE
25673	fall	i-OCCURRENCE
25674	.	O
25675	he	O
25676	had	O
25677	no	O
25678	history	O
25679	of	O
25680	headaches	b-PROBLEM
25681	or	O
25682	recent	b-PROBLEM
25683	illness	i-PROBLEM
25684	.	O
25685	he	O
25686	remained	O
25687	unresponsive	b-PROBLEM
25688	when	O
25689	the	O
25690	ambulance	O
25691	arrived	O
25692	.	O
25693	systolic	b-TEST
25694	blood	i-TEST
25695	pressure	i-TEST
25696	was	O
25697	reported	O
25698	250	O
25699	on	O
25700	arrival	b-OCCURRENCE
25701	to	O
25702	the	b-CLINICAL_DEPT
25703	mass.	i-CLINICAL_DEPT
25704	eye	i-CLINICAL_DEPT
25705	&	i-CLINICAL_DEPT
25706	ear	i-CLINICAL_DEPT
25707	infirmary	i-CLINICAL_DEPT
25708	emergency	i-CLINICAL_DEPT
25709	department	i-CLINICAL_DEPT
25710	.	O
25711	he	O
25712	was	O
25713	intubated	b-TREATMENT
25714	and	O
25715	given	O
25716	versed	b-TREATMENT
25717	and	O
25718	fentanyl	b-TREATMENT
25719	.	O
25720	his	b-TEST
25721	gcs	i-TEST
25722	was	O
25723	reported	O
25724	as	O
25725	3	O
25726	on	O
25727	arrival	b-OCCURRENCE
25728	to	O
25729	the	b-CLINICAL_DEPT
25730	emergency	i-CLINICAL_DEPT
25731	department	i-CLINICAL_DEPT
25732	.	O
25733	hospital	O
25734	course	O
25735	:	O
25736	he	O
25737	was	O
25738	admitted	b-OCCURRENCE
25739	to	O
25740	the	b-CLINICAL_DEPT
25741	neuro	i-CLINICAL_DEPT
25742	surgical	i-CLINICAL_DEPT
25743	intensive	i-CLINICAL_DEPT
25744	care	i-CLINICAL_DEPT
25745	unit	i-CLINICAL_DEPT
25746	for	O
25747	close	b-TEST
25748	monitoring	i-TEST
25749	and	O
25750	neuro-checks	b-TEST
25751	.	O
25752	a	b-TREATMENT
25753	vent	i-TREATMENT
25754	drain	i-TREATMENT
25755	was	O
25756	placed	O
25757	to	O
25758	monitor	O
25759	and	O
25760	cp	O
25761	and	O
25762	relieved	O
25763	fluid	O
25764	.	O
25765	he	O
25766	received	O
25767	12	O
25768	u	O
25769	of	O
25770	platelets	b-TREATMENT
25771	.	O
25772	his	b-CLINICAL_DEPT
25773	intensive	i-CLINICAL_DEPT
25774	care	i-CLINICAL_DEPT
25775	unit	i-CLINICAL_DEPT
25776	stay	O
25777	was	O
25778	unremarkable	b-EVIDENTIAL
25779	.	O
25780	his	b-TEST
25781	neurologic	i-TEST
25782	exam	i-TEST
25783	did	O
25784	not	O
25785	change	b-OCCURRENCE
25786	significantly	O
25787	.	O
25788	his	b-TEST
25789	icps	i-TEST
25790	were	O
25791	in	O
25792	the	O
25793	range	O
25794	of	O
25795	11-22	O
25796	,	O
25797	and	O
25798	he	O
25799	was	O
25800	weaned	O
25801	off	O
25802	the	b-TREATMENT
25803	nipride	i-TREATMENT
25804	drip	i-TREATMENT
25805	.	O
25806	he	O
25807	developed	O
25808	extensive	b-PROBLEM
25809	posturing	i-PROBLEM
25810	.	O
25811	a	b-TEST
25812	cta	i-TEST
25813	showed	b-EVIDENTIAL
25814	diffuse	b-PROBLEM
25815	subarachnoid	i-PROBLEM
25816	hemorrhage	i-PROBLEM
25817	and	O
25818	intraventricular	b-PROBLEM
25819	blood	i-PROBLEM
25820	but	O
25821	no	O
25822	evidence	O
25823	of	O
25824	an	b-PROBLEM
25825	aneurysm	i-PROBLEM
25826	.	O
25827	a	b-TEST
25828	repeat	i-TEST
25829	ct	i-TEST
25830	on	O
25831	09-26	b-DATE
25832	showed	b-EVIDENTIAL
25833	worsening	O
25834	of	O
25835	the	b-PROBLEM
25836	diffuse	i-PROBLEM
25837	subarachnoid	i-PROBLEM
25838	hemorrhage	i-PROBLEM
25839	and	O
25840	a	b-PROBLEM
25841	new	i-PROBLEM
25842	cerebellar	i-PROBLEM
25843	hemorrhage	i-PROBLEM
25844	.	O
25845	the	O
25846	family	O
25847	was	O
25848	informed	b-EVIDENTIAL
25849	of	O
25850	the	O
25851	patient	O
25852	's	O
25853	condition	O
25854	and	O
25855	repeat	b-TEST
25856	scan	i-TEST
25857	.	O
25858	a	O
25859	family	O
25860	discussion	O
25861	resulted	O
25862	in	O
25863	the	b-OCCURRENCE
25864	decision	i-OCCURRENCE
25865	to	O
25866	make	O
25867	the	O
25868	patient	O
25869	comfort	b-TREATMENT
25870	measures	i-TREATMENT
25871	only	i-TREATMENT
25872	.	O
25873	the	O
25874	patient	O
25875	was	O
25876	placed	O
25877	on	O
25878	a	b-TREATMENT
25879	morphine	i-TREATMENT
25880	drip	i-TREATMENT
25881	and	O
25882	extubated	b-TREATMENT
25883	and	O
25884	passed	b-OCCURRENCE
25885	away	i-OCCURRENCE
25886	at	O
25887	10:55	b-TIME
25888	a.m.	i-TIME
25889	on	O
25890	2011-09-27	O
25891	.	O
25892	the	O
25893	family	O
25894	was	O
25895	notified	O
25896	of	O
25897	the	O
25898	patient	O
25899	's	O
25900	passing	O
25901	.	O
25902	the	O
25903	medical	O
25904	examiner	O
25905	has	O
25906	also	O
25907	been	O
25908	notified	O
25909	of	O
25910	the	O
25911	passing	O
25912	of	O
25913	the	O
25914	patient	O
25915	.	O
25916	shawn	O
25917	b	O
25918	crawford	O
25919	,	O
25920	md	O
25921	46-411	O
25922	dictated	O
25923	by	O
25924	:	O
25925	linda	O
25926	p.f.	O
25927	clark	O
25928	,	O
25929	md	O
25930	medquist36	O
25931	d	O
25932	:	O
25933	2011-09-27	O
25934	11:53	O
25935	t	O
25936	:	O
25937	2011-09-27	O
25938	12:41	O
25939	job	O
25940	#	O
25941	:	O
25942	63722	O
25943	signed	O
25944	electronically	O
25945	by	O
25946	:	O
25947	doctor	O
25948	carlos	O
25949	warner	O
25950	on	O
25951	:	O
25952	tue	O
25953	2011-09-27	O
25954	3:42	O
25955	pm	O
25956	(	O
25957	end	O
25958	of	O
25959	report	O
25960	)	O
25961		O
25962	admission	b-OCCURRENCE
25963	date	O
25964	:	O
25965	2014-10-14	b-ADMISSION
25966	discharge	b-OCCURRENCE
25967	date	O
25968	:	O
25969	2014-10-17	b-DISCHARGE
25970	service	O
25971	:	O
25972	ccu	O
25973	history	O
25974	of	O
25975	present	O
25976	illness	O
25977	:	O
25978	this	O
25979	is	O
25980	a	O
25981	55	O
25982	-	O
25983	year-old	O
25984	caucasian	O
25985	speaking	O
25986	male	O
25987	who	O
25988	is	O
25989	a	b-PROBLEM
25990	smoker	i-PROBLEM
25991	and	O
25992	has	O
25993	a	O
25994	family	O
25995	history	O
25996	of	O
25997	coronary	b-PROBLEM
25998	artery	i-PROBLEM
25999	disease	i-PROBLEM
26000	,	O
26001	as	O
26002	well	O
26003	as	O
26004	a	O
26005	personal	O
26006	history	O
26007	of	O
26008	hypertension	b-PROBLEM
26009	,	O
26010	who	O
26011	experienced	O
26012	multiple	O
26013	episodes	O
26014	of	O
26015	10/10	b-PROBLEM
26016	substernal	i-PROBLEM
26017	chest	i-PROBLEM
26018	pain	i-PROBLEM
26019	radiating	O
26020	down	O
26021	his	O
26022	left	O
26023	arm	O
26024	last	b-DATE
26025	night	i-DATE
26026	with	O
26027	his	O
26028	daily	O
26029	activities	O
26030	.	O
26031	each	b-PROBLEM
26032	episode	i-PROBLEM
26033	lasted	O
26034	approximately	O
26035	15	b-DURATION
26036	minutes	i-DURATION
26037	in	O
26038	duration	O
26039	and	O
26040	resolved	O
26041	on	O
26042	their	O
26043	own	O
26044	.	O
26045	this	b-DATE
26046	morning	i-DATE
26047	while	O
26048	landscaping	O
26049	the	O
26050	patient	O
26051	had	O
26052	unremitting	b-PROBLEM
26053	12-05	i-PROBLEM
26054	pain	i-PROBLEM
26055	with	O
26056	shortness	b-PROBLEM
26057	of	i-PROBLEM
26058	breath	i-PROBLEM
26059	and	O
26060	diaphoresis	b-PROBLEM
26061	.	O
26062	he	O
26063	presented	b-EVIDENTIAL
26064	to	O
26065	deaconess-nashoba	b-CLINICAL_DEPT
26066	hospital	i-CLINICAL_DEPT
26067	hospital	i-CLINICAL_DEPT
26068	and	O
26069	the	b-TEST
26070	first	i-TEST
26071	ekg	i-TEST
26072	was	O
26073	found	O
26074	to	O
26075	have	O
26076	st	b-PROBLEM
26077	elevations	i-PROBLEM
26078	in	i-PROBLEM
26079	v1-v3	i-PROBLEM
26080	of	O
26081	1-2	O
26082	mm	O
26083	with	O
26084	t	b-PROBLEM
26085	wave	i-PROBLEM
26086	inversions	i-PROBLEM
26087	in	O
26088	v4-6	O
26089	,	O
26090	i	O
26091	and	O
26092	l	O
26093	,	O
26094	which	O
26095	progressed	O
26096	to	O
26097	3-0167	O
26098	w.	O
26099	seventh	O
26100	ave.	O
26101	elevations	b-PROBLEM
26102	within	O
26103	20	b-DURATION
26104	minutes	i-DURATION
26105	.	O
26106	heparin	b-TREATMENT
26107	and	O
26108	nitroglycerin	b-TREATMENT
26109	drip	i-TREATMENT
26110	were	O
26111	started	O
26112	with	O
26113	10	O
26114	mg	O
26115	of	O
26116	iv	b-TREATMENT
26117	retavase	i-TREATMENT
26118	half	O
26119	dose	O
26120	.	O
26121	he	O
26122	was	O
26123	transferred	b-OCCURRENCE
26124	to	O
26125	the	b-CLINICAL_DEPT
26126	north	i-CLINICAL_DEPT
26127	adams	i-CLINICAL_DEPT
26128	regional	i-CLINICAL_DEPT
26129	hospital	i-CLINICAL_DEPT
26130	for	O
26131	catheterization	b-TEST
26132	.	O
26133	once	O
26134	at	O
26135	hahnemann	b-CLINICAL_DEPT
26136	general	i-CLINICAL_DEPT
26137	hospital	i-CLINICAL_DEPT
26138	he	O
26139	received	O
26140	heparin	b-TREATMENT
26141	and	O
26142	integrilin	b-TREATMENT
26143	.	O
26144	coronary	b-TEST
26145	angiography	i-TEST
26146	revealed	b-EVIDENTIAL
26147	left	O
26148	main	O
26149	,	O
26150	left	O
26151	circumflex	O
26152	and	O
26153	rca	O
26154	normal	O
26155	and	O
26156	left	b-PROBLEM
26157	lad	i-PROBLEM
26158	with	i-PROBLEM
26159	99%	i-PROBLEM
26160	midstenosis	i-PROBLEM
26161	.	O
26162	a	b-TREATMENT
26163	hepacoat	i-TREATMENT
26164	stent	i-TREATMENT
26165	was	O
26166	placed	O
26167	with	O
26168	no	O
26169	residuals	b-TEST
26170	but	O
26171	good	b-OCCURRENCE
26172	flow	i-OCCURRENCE
26173	after	O
26174	nitroglycerin	b-TREATMENT
26175	and	O
26176	diltiazem	b-TREATMENT
26177	.	O
26178	the	b-PROBLEM
26179	chest	i-PROBLEM
26180	pain	i-PROBLEM
26181	persisted	O
26182	afterwards	O
26183	and	O
26184	a	b-TEST
26185	relook	i-TEST
26186	catheterization	i-TEST
26187	was	O
26188	performed	O
26189	that	O
26190	revealed	b-EVIDENTIAL
26191	no	O
26192	occlusions	b-PROBLEM
26193	.	O
26194	the	b-TEST
26195	right	i-TEST
26196	heart	i-TEST
26197	catheterization	i-TEST
26198	revealed	b-EVIDENTIAL
26199	a	b-TEST
26200	cardiac	i-TEST
26201	output	i-TEST
26202	index	i-TEST
26203	of	O
26204	4.11	O
26205	and	O
26206	2.15	O
26207	respectively	O
26208	.	O
26209	ra	b-TEST
26210	pressure	i-TEST
26211	was	O
26212	13	O
26213	,	O
26214	rv	b-TEST
26215	pressure	i-TEST
26216	45/7	O
26217	,	O
26218	wedge	b-TEST
26219	27	O
26220	and	O
26221	pa	b-TEST
26222	pressures	i-TEST
26223	of	O
26224	42/21	O
26225	.	O
26226	he	O
26227	was	O
26228	transferred	b-OCCURRENCE
26229	to	O
26230	the	b-CLINICAL_DEPT
26231	cc	i-CLINICAL_DEPT
26232	for	O
26233	monitoring	b-TEST
26234	and	O
26235	he	O
26236	denied	b-EVIDENTIAL
26237	having	O
26238	further	b-PROBLEM
26239	pain	i-PROBLEM
26240	,	O
26241	shortness	b-PROBLEM
26242	of	i-PROBLEM
26243	breath	i-PROBLEM
26244	,	O
26245	nausea	b-PROBLEM
26246	or	O
26247	vomiting	b-PROBLEM
26248	.	O
26249	at	O
26250	baseline	O
26251	the	O
26252	patient	O
26253	denies	b-EVIDENTIAL
26254	any	O
26255	previous	b-PROBLEM
26256	chest	i-PROBLEM
26257	pain	i-PROBLEM
26258	,	O
26259	pressure	b-PROBLEM
26260	,	O
26261	dyspnea	b-PROBLEM
26262	on	O
26263	exertion	O
26264	,	O
26265	orthopnea	b-PROBLEM
26266	,	O
26267	pnd	b-PROBLEM
26268	or	O
26269	palpitations	b-PROBLEM
26270	.	O
26271	hospital	O
26272	course	O
26273	:	O
26274	for	O
26275	his	b-PROBLEM
26276	coronary	i-PROBLEM
26277	artery	i-PROBLEM
26278	disease	i-PROBLEM
26279	,	O
26280	aspirin	b-TREATMENT
26281	was	O
26282	started	O
26283	at	O
26284	325	O
26285	.	O
26286	plavix	b-TREATMENT
26287	was	O
26288	started	O
26289	at	O
26290	75	O
26291	mg	O
26292	a	b-FREQUENCY
26293	day	i-FREQUENCY
26294	,	O
26295	lipitor	b-TREATMENT
26296	20	O
26297	mg	O
26298	per	b-FREQUENCY
26299	day	i-FREQUENCY
26300	,	O
26301	metoprolol	b-TREATMENT
26302	25	O
26303	mg	O
26304	twice	b-FREQUENCY
26305	a	i-FREQUENCY
26306	day	i-FREQUENCY
26307	to	O
26308	be	O
26309	titrated	O
26310	up	O
26311	as	O
26312	tolerated	O
26313	and	O
26314	on	O
26315	day	b-DATE
26316	two	i-DATE
26317	of	i-DATE
26318	admission	i-DATE
26319	an	b-TREATMENT
26320	ace	i-TREATMENT
26321	inhibitor	i-TREATMENT
26322	was	O
26323	started	O
26324	.	O
26325	captopril	b-TREATMENT
26326	6.2	O
26327	3	b-FREQUENCY
26328	x	i-FREQUENCY
26329	a	i-FREQUENCY
26330	day	i-FREQUENCY
26331	and	O
26332	titrated	O
26333	up	O
26334	.	O
26335	a	b-TEST
26336	lipid	i-TEST
26337	panel	i-TEST
26338	was	O
26339	checked	O
26340	and	O
26341	found	O
26342	to	O
26343	be	O
26344	within	O
26345	normal	b-OCCURRENCE
26346	limits	i-OCCURRENCE
26347	,	O
26348	although	O
26349	it	O
26350	was	O
26351	noted	O
26352	this	O
26353	was	O
26354	in	O
26355	the	O
26356	post	O
26357	mi	b-PROBLEM
26358	setting	O
26359	and	O
26360	the	b-TEST
26361	lipid	i-TEST
26362	panel	i-TEST
26363	could	O
26364	be	O
26365	falsely	O
26366	low	O
26367	.	O
26368	serial	b-TEST
26369	ck	i-TEST
26370	s	i-TEST
26371	were	O
26372	followed	O
26373	with	O
26374	a	b-TEST
26375	ck	i-TEST
26376	peak	i-TEST
26377	of	O
26378	433	O
26379	.	O
26380	hypertension	b-PROBLEM
26381	was	O
26382	managed	O
26383	with	O
26384	beta	b-TREATMENT
26385	blocker	i-TREATMENT
26386	and	O
26387	ace	b-TREATMENT
26388	inhibitor	i-TREATMENT
26389	and	O
26390	integrilin	b-TREATMENT
26391	was	O
26392	continued	O
26393	post	O
26394	mi	b-PROBLEM
26395	for	O
26396	18	b-DURATION
26397	hours	i-DURATION
26398	.	O
26399	rhythm	O
26400	was	O
26401	maintained	O
26402	at	O
26403	normal	b-TEST
26404	sinus	i-TEST
26405	,	O
26406	monitored	O
26407	on	O
26408	telemetry	b-TEST
26409	without	O
26410	ectopy	b-PROBLEM
26411	.	O
26412	ekg	b-TEST
26413	s	i-TEST
26414	were	O
26415	followed	O
26416	for	O
26417	normalization	b-OCCURRENCE
26418	.	O
26419	the	O
26420	patient	O
26421	had	O
26422	an	b-TEST
26423	echocardiogram	i-TEST
26424	on	O
26425	day	b-DATE
26426	two	i-DATE
26427	of	i-DATE
26428	admission	i-DATE
26429	,	O
26430	which	O
26431	revealed	b-EVIDENTIAL
26432	a	b-PROBLEM
26433	mildly	i-PROBLEM
26434	dilated	i-PROBLEM
26435	left	i-PROBLEM
26436	atrium	i-PROBLEM
26437	,	O
26438	mild	b-PROBLEM
26439	symmetric	i-PROBLEM
26440	lvh	i-PROBLEM
26441	,	O
26442	normal	O
26443	lv	O
26444	cavity	O
26445	size	O
26446	,	O
26447	mild	b-PROBLEM
26448	region	i-PROBLEM
26449	lv	i-PROBLEM
26450	systolic	i-PROBLEM
26451	dysfunction	i-PROBLEM
26452	,	O
26453	arresting	b-PROBLEM
26454	regional	i-PROBLEM
26455	wall	i-PROBLEM
26456	motion	i-PROBLEM
26457	abnormality	i-PROBLEM
26458	including	O
26459	focal	b-PROBLEM
26460	apical	i-PROBLEM
26461	hypokinesis	i-PROBLEM
26462	,	O
26463	a	O
26464	normal	O
26465	right	O
26466	ventricular	O
26467	chamber	O
26468	size	O
26469	and	O
26470	free	O
26471	wall	O
26472	motion	O
26473	,	O
26474	a	b-PROBLEM
26475	moderately	i-PROBLEM
26476	dilated	i-PROBLEM
26477	aortic	i-PROBLEM
26478	root	i-PROBLEM
26479	,	O
26480	a	b-PROBLEM
26481	mildly	i-PROBLEM
26482	dilated	i-PROBLEM
26483	ascending	i-PROBLEM
26484	aorta	i-PROBLEM
26485	,	O
26486	normal	O
26487	aortic	O
26488	valve	O
26489	leaflet	O
26490	,	O
26491	normal	O
26492	mitral	O
26493	valve	O
26494	leaflet	O
26495	and	O
26496	no	O
26497	pericardial	b-PROBLEM
26498	effusions	i-PROBLEM
26499	.	O
26500	the	O
26501	patient	O
26502	was	O
26503	normal	O
26504	volume	O
26505	and	O
26506	displayed	O
26507	no	O
26508	evidence	O
26509	chf	b-PROBLEM
26510	signs	i-PROBLEM
26511	or	i-PROBLEM
26512	symptoms	i-PROBLEM
26513	.	O
26514	the	b-PROBLEM
26515	risk	i-PROBLEM
26516	factors	i-PROBLEM
26517	were	O
26518	addressed	O
26519	.	O
26520	the	O
26521	patient	O
26522	was	O
26523	told	O
26524	repeatedly	O
26525	that	O
26526	he	O
26527	needed	O
26528	to	O
26529	stop	O
26530	smoking	O
26531	and	O
26532	was	O
26533	given	O
26534	a	b-TREATMENT
26535	nicotine	i-TREATMENT
26536	patch	i-TREATMENT
26537	and	O
26538	his	O
26539	primary	O
26540	care	O
26541	provider	O
26542	was	O
26543	called	O
26544	to	O
26545	discuss	O
26546	outpatient	O
26547	plans	O
26548	to	O
26549	help	O
26550	the	O
26551	patient	O
26552	stop	b-OCCURRENCE
26553	smoking	i-OCCURRENCE
26554	.	O
26555	the	O
26556	patient	O
26557	was	O
26558	advised	O
26559	to	O
26560	have	O
26561	a	b-TREATMENT
26562	low	i-TREATMENT
26563	fat	i-TREATMENT
26564	/	i-TREATMENT
26565	low	i-TREATMENT
26566	cholesterol	i-TREATMENT
26567	diet	i-TREATMENT
26568	,	O
26569	was	O
26570	cleared	O
26571	by	O
26572	pt	O
26573	and	O
26574	advised	O
26575	to	O
26576	do	O
26577	cardiac	b-TREATMENT
26578	rehabilitation	i-TREATMENT
26579	.	O
26580	he	O
26581	was	O
26582	advised	O
26583	the	O
26584	importance	O
26585	of	O
26586	each	O
26587	of	O
26588	his	O
26589	and	O
26590	compliance	b-OCCURRENCE
26591	with	O
26592	each	O
26593	of	O
26594	these	b-TREATMENT
26595	medications	i-TREATMENT
26596	and	O
26597	was	O
26598	told	O
26599	he	O
26600	needed	O
26601	close	O
26602	followup	b-OCCURRENCE
26603	with	O
26604	a	O
26605	cardiologist	O
26606	.	O
26607	for	O
26608	renal	O
26609	,	O
26610	his	b-TEST
26611	creatinine	i-TEST
26612	was	O
26613	monitored	b-TEST
26614	and	O
26615	the	b-TEST
26616	dye	i-TEST
26617	load	i-TEST
26618	and	O
26619	the	b-TEST
26620	catheterization	i-TEST
26621	.	O
26622	it	O
26623	was	O
26624	normal	O
26625	and	O
26626	did	O
26627	not	O
26628	increase	b-PROBLEM
26629	.	O
26630	gastrointestinal	O
26631	:	O
26632	the	O
26633	patient	O
26634	was	O
26635	given	O
26636	a	b-TREATMENT
26637	low	i-TREATMENT
26638	fat	i-TREATMENT
26639	/	i-TREATMENT
26640	low	i-TREATMENT
26641	cholesterol	i-TREATMENT
26642	diet	i-TREATMENT
26643	.	O
26644	his	b-TEST
26645	electrolytes	i-TEST
26646	were	O
26647	monitored	O
26648	and	O
26649	repleted	O
26650	carefully	O
26651	.	O
26652	he	O
26653	had	O
26654	normal	O
26655	bowel	O
26656	movements	O
26657	and	O
26658	had	O
26659	gi	b-TREATMENT
26660	prophylaxis	i-TREATMENT
26661	throughout	O
26662	his	b-OCCURRENCE
26663	stay	i-OCCURRENCE
26664	.	O
26665	for	O
26666	hematology	O
26667	,	O
26668	the	b-TEST
26669	patient	i-TEST
26670	's	i-TEST
26671	hematocrit	i-TEST
26672	and	O
26673	platelets	b-TEST
26674	were	O
26675	monitored	b-TEST
26676	after	O
26677	the	b-TEST
26678	catheterization	i-TEST
26679	.	O
26680	they	O
26681	were	O
26682	normal	O
26683	and	O
26684	did	O
26685	not	O
26686	change	O
26687	and	O
26688	the	O
26689	patient	O
26690	received	O
26691	pneumatic	b-TREATMENT
26692	boots	i-TREATMENT
26693	for	O
26694	dvt	b-TREATMENT
26695	prophylaxis	i-TREATMENT
26696	.	O
26697	on	O
26698	day	b-DATE
26699	two	i-DATE
26700	of	i-DATE
26701	admission	i-DATE
26702	,	O
26703	the	O
26704	patient	O
26705	ambulated	b-OCCURRENCE
26706	with	O
26707	pt	b-TREATMENT
26708	and	O
26709	was	O
26710	moved	O
26711	to	O
26712	the	b-CLINICAL_DEPT
26713	regular	i-CLINICAL_DEPT
26714	floor	i-CLINICAL_DEPT
26715	.	O
26716	on	O
26717	day	b-DATE
26718	three	i-DATE
26719	of	i-DATE
26720	admission	i-DATE
26721	,	O
26722	the	O
26723	patient	O
26724	felt	O
26725	that	O
26726	his	O
26727	strength	O
26728	was	O
26729	back	O
26730	to	O
26731	baseline	O
26732	.	O
26733	he	O
26734	denied	b-EVIDENTIAL
26735	ever	O
26736	having	O
26737	any	b-PROBLEM
26738	chest	i-PROBLEM
26739	pain	i-PROBLEM
26740	,	O
26741	chest	b-PROBLEM
26742	pressure	i-PROBLEM
26743	,	O
26744	shortness	b-PROBLEM
26745	of	i-PROBLEM
26746	breath	i-PROBLEM
26747	,	O
26748	dyspnea	b-PROBLEM
26749	on	O
26750	exertion	O
26751	and	O
26752	he	O
26753	was	O
26754	discharged	b-OCCURRENCE
26755	to	i-OCCURRENCE
26756	home	i-OCCURRENCE
26757	.	O
26758	he	O
26759	was	O
26760	told	O
26761	to	O
26762	return	O
26763	to	O
26764	the	b-OCCURRENCE
26765	emergency	i-OCCURRENCE
26766	department	i-OCCURRENCE
26767	if	O
26768	he	O
26769	had	O
26770	any	b-PROBLEM
26771	chest	i-PROBLEM
26772	pain	i-PROBLEM
26773	,	O
26774	pressure	b-PROBLEM
26775	,	O
26776	difficulty	b-PROBLEM
26777	breathing	i-PROBLEM
26778	,	O
26779	nausea	b-PROBLEM
26780	,	O
26781	light-headiness	b-PROBLEM
26782	or	O
26783	dizziness	b-PROBLEM
26784	.	O
26785	he	O
26786	was	O
26787	advised	O
26788	to	O
26789	take	O
26790	all	O
26791	of	O
26792	his	b-TREATMENT
26793	medications	i-TREATMENT
26794	.	O
26795	an	O
26796	appointment	O
26797	was	O
26798	established	O
26799	for	O
26800	him	O
26801	to	O
26802	see	b-OCCURRENCE
26803	his	i-OCCURRENCE
26804	primary	i-OCCURRENCE
26805	care	i-OCCURRENCE
26806	doctor	i-OCCURRENCE
26807	,	O
26808	doctor	O
26809	stella	O
26810	booth	O
26811	on	O
26812	maynard	O
26813	,	O
26814	2014-10-20	b-DATE
26815	and	O
26816	the	O
26817	patient	O
26818	was	O
26819	referred	O
26820	to	O
26821	doctor	O
26822	granville	O
26823	hamers	O
26824	,	O
26825	at	O
26826	ware	O
26827	in	O
26828	cardiology	O
26829	to	O
26830	be	b-OCCURRENCE
26831	seen	i-OCCURRENCE
26832	in	O
26833	two	b-DURATION
26834	weeks	i-DURATION
26835	.	O
26836	dr	O
26837	marcus	O
26838	assistant	O
26839	was	O
26840	called	O
26841	and	O
26842	she	O
26843	stated	O
26844	that	O
26845	she	O
26846	would	O
26847	call	O
26848	the	O
26849	patient	O
26850	with	O
26851	an	O
26852	appointment	O
26853	.	O
26854	final	O
26855	diagnoses	O
26856	:	O
26857	1.	O
26858	st	b-PROBLEM
26859	elevation	i-PROBLEM
26860	myocardial	i-PROBLEM
26861	infarction	i-PROBLEM
26862	.	O
26863	2.	O
26864	hypertension	b-PROBLEM
26865	.	O
26866	major	O
26867	surgical	O
26868	and	O
26869	invasive	O
26870	procedures	O
26871	:	O
26872	cardiac	b-TEST
26873	catheterization	i-TEST
26874	and	O
26875	stent	b-TREATMENT
26876	placement	i-TREATMENT
26877	in	i-TREATMENT
26878	the	i-TREATMENT
26879	mid	i-TREATMENT
26880	left	i-TREATMENT
26881	anterior	i-TREATMENT
26882	descending	i-TREATMENT
26883	artery	i-TREATMENT
26884	.	O
26885		O
26886	admission	b-OCCURRENCE
26887	date	O
26888	:	O
26889	2012-04-30	b-ADMISSION
26890	discharge	b-OCCURRENCE
26891	date	O
26892	:	O
26893	2012-05-14	b-DISCHARGE
26894	service	O
26895	:	O
26896	o-cmed	O
26897	ccu	O
26898	history	O
26899	of	O
26900	present	O
26901	illness	O
26902	:	O
26903	the	O
26904	patient	O
26905	is	O
26906	a	O
26907	55	O
26908	-	O
26909	year-old	O
26910	male	O
26911	with	O
26912	recently	b-PROBLEM
26913	diagnosed	i-PROBLEM
26914	abdominal	i-PROBLEM
26915	carcinomatosis	i-PROBLEM
26916	.	O
26917	the	O
26918	patient	O
26919	presented	b-EVIDENTIAL
26920	with	O
26921	abdominal	b-PROBLEM
26922	pain	i-PROBLEM
26923	and	O
26924	bloating	b-PROBLEM
26925	and	O
26926	was	O
26927	found	b-EVIDENTIAL
26928	to	O
26929	have	O
26930	a	b-PROBLEM
26931	large	i-PROBLEM
26932	omental	i-PROBLEM
26933	mass	i-PROBLEM
26934	.	O
26935	biopsy	b-TEST
26936	revealed	b-EVIDENTIAL
26937	adenocarcinoma	b-PROBLEM
26938	.	O
26939	histochemical	b-TEST
26940	stains	i-TEST
26941	are	O
26942	consistent	O
26943	with	O
26944	hepatobiliary	b-PROBLEM
26945	origin	i-PROBLEM
26946	.	O
26947	endoscopies	b-TEST
26948	were	O
26949	negative	O
26950	except	O
26951	for	O
26952	an	b-PROBLEM
26953	extrinsic	i-PROBLEM
26954	mass	i-PROBLEM
26955	present	i-PROBLEM
26956	on	i-PROBLEM
26957	the	i-PROBLEM
26958	stomach	i-PROBLEM
26959	.	O
26960	the	O
26961	patient	O
26962	presents	b-EVIDENTIAL
26963	with	O
26964	increased	b-PROBLEM
26965	abdominal	i-PROBLEM
26966	pain	i-PROBLEM
26967	and	O
26968	poor	b-PROBLEM
26969	oral	i-PROBLEM
26970	intake	i-PROBLEM
26971	as	O
26972	well	O
26973	as	O
26974	generalized	b-PROBLEM
26975	weakness	i-PROBLEM
26976	.	O
26977	on	O
26978	presentation	b-EVIDENTIAL
26979	,	O
26980	the	O
26981	patient	O
26982	denied	b-EVIDENTIAL
26983	chest	b-PROBLEM
26984	pain	i-PROBLEM
26985	,	O
26986	shortness	b-PROBLEM
26987	of	i-PROBLEM
26988	breath	i-PROBLEM
26989	,	O
26990	and	O
26991	cough	b-PROBLEM
26992	.	O
26993	hospital	O
26994	course	O
26995	:	O
26996	the	O
26997	patient	O
26998	was	O
26999	admitted	b-OCCURRENCE
27000	to	O
27001	the	b-CLINICAL_DEPT
27002	o-cmed	i-CLINICAL_DEPT
27003	service	O
27004	.	O
27005	he	O
27006	was	O
27007	placed	O
27008	on	O
27009	a	b-TREATMENT
27010	patient-controlled	i-TREATMENT
27011	analgesia	i-TREATMENT
27012	for	O
27013	pain	b-TREATMENT
27014	control	i-TREATMENT
27015	.	O
27016	he	O
27017	was	O
27018	administered	O
27019	intravenous	b-TREATMENT
27020	fluids	i-TREATMENT
27021	and	O
27022	oral	b-TREATMENT
27023	diet	i-TREATMENT
27024	as	O
27025	tolerated	O
27026	.	O
27027	on	O
27028	the	b-DATE
27029	night	i-DATE
27030	of	i-DATE
27031	05-01	i-DATE
27032	,	O
27033	the	O
27034	patient	O
27035	complained	b-EVIDENTIAL
27036	of	O
27037	increased	b-PROBLEM
27038	vomiting	i-PROBLEM
27039	.	O
27040	he	O
27041	also	O
27042	complained	b-EVIDENTIAL
27043	of	O
27044	increased	b-PROBLEM
27045	shortness	i-PROBLEM
27046	of	i-PROBLEM
27047	breath	i-PROBLEM
27048	and	O
27049	""""	O
27050	difficulty	b-PROBLEM
27051	catching	i-PROBLEM
27052	his	i-PROBLEM
27053	breath	i-PROBLEM
27054	"."""	O
27055	on	O
27056	room	O
27057	air	O
27058	,	O
27059	the	b-TEST
27060	patient	i-TEST
27061	's	i-TEST
27062	oxygen	i-TEST
27063	saturation	i-TEST
27064	was	O
27065	80%	O
27066	.	O
27067	his	b-TEST
27068	saturation	i-TEST
27069	increased	O
27070	to	O
27071	87%	O
27072	on	O
27073	a	b-TREATMENT
27074	nonrebreather	i-TREATMENT
27075	.	O
27076	a	b-TEST
27077	chest	i-TEST
27078	x-ray	i-TEST
27079	disclosed	b-EVIDENTIAL
27080	a	b-PROBLEM
27081	left	i-PROBLEM
27082	pleural	i-PROBLEM
27083	effusion	i-PROBLEM
27084	.	O
27085	the	O
27086	patient	O
27087	was	O
27088	bolused	O
27089	with	O
27090	intravenous	b-TREATMENT
27091	heparin	i-TREATMENT
27092	due	O
27093	to	O
27094	concern	O
27095	for	O
27096	pulmonary	b-PROBLEM
27097	embolism	i-PROBLEM
27098	.	O
27099	the	O
27100	patient	O
27101	expressed	b-EVIDENTIAL
27102	a	b-OCCURRENCE
27103	desire	i-OCCURRENCE
27104	to	O
27105	be	O
27106	full	b-TREATMENT
27107	code	i-TREATMENT
27108	,	O
27109	so	O
27110	he	O
27111	was	O
27112	transferred	b-OCCURRENCE
27113	to	O
27114	the	b-CLINICAL_DEPT
27115	intensive	i-CLINICAL_DEPT
27116	care	i-CLINICAL_DEPT
27117	unit	i-CLINICAL_DEPT
27118	.	O
27119	the	O
27120	patient	O
27121	became	O
27122	more	O
27123	comfortable	b-OCCURRENCE
27124	being	O
27125	seated	O
27126	upright	b-OCCURRENCE
27127	with	O
27128	nebulizer	b-TREATMENT
27129	treatments	i-TREATMENT
27130	.	O
27131	an	b-TEST
27132	angiogram	i-TEST
27133	was	O
27134	done	O
27135	which	O
27136	disclosed	b-EVIDENTIAL
27137	possible	O
27138	subsegmental	b-PROBLEM
27139	pulmonary	i-PROBLEM
27140	emboli	i-PROBLEM
27141	of	i-PROBLEM
27142	the	i-PROBLEM
27143	upper	i-PROBLEM
27144	lobes	i-PROBLEM
27145	as	O
27146	well	O
27147	as	O
27148	infiltrates	b-PROBLEM
27149	consistent	O
27150	with	O
27151	aspiration	b-PROBLEM
27152	pneumonia	i-PROBLEM
27153	.	O
27154	the	O
27155	patient	O
27156	was	O
27157	placed	O
27158	on	O
27159	flagyl	b-TREATMENT
27160	and	O
27161	levaquin	b-TREATMENT
27162	for	O
27163	treatment	b-TREATMENT
27164	of	O
27165	pneumonia	b-PROBLEM
27166	.	O
27167	he	O
27168	was	O
27169	continued	O
27170	on	O
27171	heparin	b-TREATMENT
27172	for	O
27173	treatment	b-TREATMENT
27174	of	O
27175	the	b-PROBLEM
27176	pulmonary	i-PROBLEM
27177	emboli	i-PROBLEM
27178	.	O
27179	while	O
27180	in	O
27181	the	b-CLINICAL_DEPT
27182	intensive	i-CLINICAL_DEPT
27183	care	i-CLINICAL_DEPT
27184	unit	i-CLINICAL_DEPT
27185	,	O
27186	the	O
27187	patient	O
27188	was	O
27189	noted	b-EVIDENTIAL
27190	to	O
27191	have	O
27192	increasing	b-PROBLEM
27193	abdominal	i-PROBLEM
27194	distention	i-PROBLEM
27195	.	O
27196	on	O
27197	05-03	b-DATE
27198	the	O
27199	patient	O
27200	underwent	O
27201	an	b-TEST
27202	abdominal	i-TEST
27203	ultrasound	i-TEST
27204	with	O
27205	paracentesis	b-TREATMENT
27206	,	O
27207	and	O
27208	5	O
27209	liters	O
27210	of	O
27211	fluid	b-PROBLEM
27212	were	O
27213	removed	b-TREATMENT
27214	.	O
27215	on	O
27216	05-04	b-DATE
27217	,	O
27218	the	O
27219	patient	O
27220	was	O
27221	transferred	b-OCCURRENCE
27222	back	O
27223	to	O
27224	the	b-CLINICAL_DEPT
27225	o-cmed	i-CLINICAL_DEPT
27226	csru	i-CLINICAL_DEPT
27227	service	O
27228	.	O
27229	due	O
27230	to	O
27231	persistent	b-PROBLEM
27232	gastric	i-PROBLEM
27233	secretions	i-PROBLEM
27234	,	O
27235	an	b-TREATMENT
27236	nasogastric	i-TREATMENT
27237	tube	i-TREATMENT
27238	was	O
27239	placed	O
27240	for	O
27241	decompression	b-TREATMENT
27242	.	O
27243	the	O
27244	patient	O
27245	was	O
27246	noted	b-EVIDENTIAL
27247	to	O
27248	have	O
27249	a	b-OCCURRENCE
27250	functional	i-OCCURRENCE
27251	ileus	i-OCCURRENCE
27252	.	O
27253	octreotide	b-TREATMENT
27254	was	O
27255	initiated	O
27256	in	O
27257	an	O
27258	attempt	O
27259	to	O
27260	decrease	O
27261	the	b-PROBLEM
27262	gastric	i-PROBLEM
27263	secretions	i-PROBLEM
27264	.	O
27265	on	O
27266	05-13	b-DATE
27267	,	O
27268	the	O
27269	patient	O
27270	's	O
27271	respiratory	b-PROBLEM
27272	status	i-PROBLEM
27273	declined	i-PROBLEM
27274	further	i-PROBLEM
27275	.	O
27276	he	O
27277	was	O
27278	noted	b-EVIDENTIAL
27279	not	O
27280	have	O
27281	an	b-PROBLEM
27282	increasing	i-PROBLEM
27283	left-sided	i-PROBLEM
27284	pleural	i-PROBLEM
27285	effusion	i-PROBLEM
27286	.	O
27287	a	b-TREATMENT
27288	thoracentesis	i-TREATMENT
27289	was	O
27290	done	O
27291	with	O
27292	removal	b-TREATMENT
27293	of	O
27294	1.5	O
27295	liters	O
27296	of	O
27297	fluid	b-PROBLEM
27298	.	O
27299	a	b-TREATMENT
27300	paracentesis	i-TREATMENT
27301	was	O
27302	repeated	O
27303	with	O
27304	removal	b-TREATMENT
27305	of	O
27306	2.5	O
27307	liters	O
27308	of	O
27309	fluid	b-PROBLEM
27310	.	O
27311	on	O
27312	the	b-DATE
27313	night	i-DATE
27314	of	i-DATE
27315	05-13	i-DATE
27316	,	O
27317	the	O
27318	patient	O
27319	continued	O
27320	to	O
27321	decline	b-PROBLEM
27322	.	O
27323	the	b-OCCURRENCE
27324	family	i-OCCURRENCE
27325	decided	i-OCCURRENCE
27326	to	O
27327	pursue	O
27328	comfort	b-TREATMENT
27329	measures	i-TREATMENT
27330	.	O
27331	morphine	b-TREATMENT
27332	was	O
27333	administered	O
27334	to	O
27335	insure	O
27336	patient	b-OCCURRENCE
27337	's	i-OCCURRENCE
27338	comfort	i-OCCURRENCE
27339	.	O
27340	the	O
27341	patient	O
27342	expired	b-OCCURRENCE
27343	at	O
27344	6	b-TIME
27345	p.m.	i-TIME
27346	on	i-TIME
27347	05-14	i-TIME
27348	.	O
27349		O
27350	admission	b-OCCURRENCE
27351	date	O
27352	:	O
27353	4/6/95	b-DATE
27354	discharge	b-OCCURRENCE
27355	date	O
27356	:	O
27357	4/16/95	b-DATE
27358	history	O
27359	of	O
27360	present	O
27361	illness	O
27362	:	O
27363	the	O
27364	patient	O
27365	is	O
27366	a	O
27367	seventy	O
27368	two	O
27369	year	O
27370	old	O
27371	man	O
27372	who	O
27373	a	b-DURATION
27374	number	i-DURATION
27375	of	i-DURATION
27376	years	i-DURATION
27377	ago	O
27378	underwent	O
27379	coronary	b-TREATMENT
27380	bypass	i-TREATMENT
27381	surgery	i-TREATMENT
27382	at	O
27383	another	b-CLINICAL_DEPT
27384	institution	i-CLINICAL_DEPT
27385	.	O
27386	this	O
27387	took	O
27388	place	O
27389	in	O
27390	1983	b-DATE
27391	.	O
27392	in	O
27393	1992	b-DATE
27394	he	O
27395	underwent	O
27396	redo	b-TREATMENT
27397	surgery	i-TREATMENT
27398	and	O
27399	aortic	b-TREATMENT
27400	valve	i-TREATMENT
27401	replacement	i-TREATMENT
27402	.	O
27403	in	O
27404	april	b-DATE
27405	1994	i-DATE
27406	he	O
27407	presented	b-EVIDENTIAL
27408	with	O
27409	an	b-PROBLEM
27410	acute	i-PROBLEM
27411	inferior	i-PROBLEM
27412	myocardial	i-PROBLEM
27413	infarction	i-PROBLEM
27414	and	O
27415	was	O
27416	given	O
27417	streptokinase	b-TREATMENT
27418	.	O
27419	he	O
27420	had	O
27421	recurrent	b-PROBLEM
27422	pain	i-PROBLEM
27423	and	O
27424	went	O
27425	to	O
27426	the	b-CLINICAL_DEPT
27427	catheter	i-CLINICAL_DEPT
27428	laboratory	i-CLINICAL_DEPT
27429	where	O
27430	a	b-PROBLEM
27431	proximal	i-PROBLEM
27432	right	i-PROBLEM
27433	coronary	i-PROBLEM
27434	artery	i-PROBLEM
27435	lesion	i-PROBLEM
27436	was	O
27437	angioplastied	b-TREATMENT
27438	.	O
27439	a	b-TEST
27440	relook	i-TEST
27441	several	b-DURATION
27442	days	i-DURATION
27443	later	O
27444	led	O
27445	to	O
27446	a	b-TREATMENT
27447	repeat	i-TREATMENT
27448	percutaneous	i-TREATMENT
27449	transluminal	i-TREATMENT
27450	coronary	i-TREATMENT
27451	angioplasty	i-TREATMENT
27452	.	O
27453	he	O
27454	has	O
27455	has	O
27456	stable	b-PROBLEM
27457	,	i-PROBLEM
27458	mild	i-PROBLEM
27459	angina	i-PROBLEM
27460	,	O
27461	subsequently	O
27462	,	O
27463	mostly	O
27464	in	O
27465	the	O
27466	setting	O
27467	of	O
27468	stress	b-PROBLEM
27469	.	O
27470	slightly	O
27471	increased	O
27472	in	O
27473	recent	b-DURATION
27474	months	i-DURATION
27475	.	O
27476	on	O
27477	the	b-DATE
27478	day	i-DATE
27479	of	O
27480	admission	b-OCCURRENCE
27481	,	O
27482	he	O
27483	was	O
27484	involved	O
27485	in	O
27486	a	b-OCCURRENCE
27487	minor	i-OCCURRENCE
27488	motor	i-OCCURRENCE
27489	vehicle	i-OCCURRENCE
27490	accident	i-OCCURRENCE
27491	,	O
27492	and	O
27493	there	O
27494	was	O
27495	some	b-OCCURRENCE
27496	apparent	i-OCCURRENCE
27497	controversy	i-OCCURRENCE
27498	with	i-OCCURRENCE
27499	the	i-OCCURRENCE
27500	driver	i-OCCURRENCE
27501	of	i-OCCURRENCE
27502	the	i-OCCURRENCE
27503	other	i-OCCURRENCE
27504	vehicle	i-OCCURRENCE
27505	,	O
27506	during	O
27507	the	O
27508	course	O
27509	of	O
27510	which	O
27511	he	O
27512	developed	O
27513	substernal	b-PROBLEM
27514	chest	i-PROBLEM
27515	pain	i-PROBLEM
27516	radiating	O
27517	to	O
27518	the	O
27519	left	O
27520	arm	O
27521	and	O
27522	shoulder	O
27523	.	O
27524	this	b-PROBLEM
27525	waxed	i-PROBLEM
27526	and	i-PROBLEM
27527	waned	i-PROBLEM
27528	for	O
27529	thirty	b-DURATION
27530	to	i-DURATION
27531	sixty	i-DURATION
27532	minutes	i-DURATION
27533	,	O
27534	and	O
27535	he	O
27536	took	O
27537	a	O
27538	number	O
27539	of	O
27540	nitroglycerins	b-TREATMENT
27541	.	O
27542	after	O
27543	returning	O
27544	home	O
27545	after	O
27546	conferring	O
27547	with	O
27548	his	O
27549	wife	O
27550	,	O
27551	and	O
27552	the	b-PROBLEM
27553	pain	i-PROBLEM
27554	lasted	O
27555	another	b-DURATION
27556	half	i-DURATION
27557	hour	i-DURATION
27558	,	O
27559	he	O
27560	came	O
27561	to	O
27562	the	b-CLINICAL_DEPT
27563	emergency	i-CLINICAL_DEPT
27564	room	i-CLINICAL_DEPT
27565	.	O
27566	his	b-TEST
27567	electrocardiogram	i-TEST
27568	showed	b-EVIDENTIAL
27569	increased	b-PROBLEM
27570	t	i-PROBLEM
27571	wave	i-PROBLEM
27572	inversions	i-PROBLEM
27573	in	i-PROBLEM
27574	v3	i-PROBLEM
27575	and	O
27576	v4	O
27577	and	O
27578	1	O
27579	mm	O
27580	.	O
27581	st	b-PROBLEM
27582	segment	i-PROBLEM
27583	depression	i-PROBLEM
27584	in	i-PROBLEM
27585	v3	i-PROBLEM
27586	through	O
27587	v6	O
27588	.	O
27589	his	b-TEST
27590	examination	i-TEST
27591	was	O
27592	largely	b-OCCURRENCE
27593	benign	i-OCCURRENCE
27594	after	O
27595	he	O
27596	was	O
27597	made	O
27598	pain	b-PROBLEM
27599	free	O
27600	.	O
27601	the	b-TEST
27602	pulse	i-TEST
27603	was	O
27604	75	O
27605	,	O
27606	blood	b-TEST
27607	pressure	i-TEST
27608	120/80	O
27609	,	O
27610	respirations	b-TEST
27611	18	O
27612	,	O
27613	and	O
27614	he	O
27615	was	O
27616	afebrile	b-PROBLEM
27617	.	O
27618	the	O
27619	jugular	O
27620	veins	O
27621	were	O
27622	not	O
27623	distended	b-PROBLEM
27624	,	O
27625	the	b-TEST
27626	carotid	i-TEST
27627	volume	i-TEST
27628	was	O
27629	diminished	b-PROBLEM
27630	.	O
27631	the	O
27632	chest	O
27633	was	O
27634	clear	O
27635	and	O
27636	the	O
27637	cardiac	O
27638	rhythm	O
27639	was	O
27640	regular	O
27641	.	O
27642	there	O
27643	were	O
27644	normal	b-TREATMENT
27645	prothetic	i-TREATMENT
27646	valves	i-TREATMENT
27647	.	O
27648	there	O
27649	was	O
27650	a	b-PROBLEM
27651	grade	i-PROBLEM
27652	ii-ii	i-PROBLEM
27653	apical	i-PROBLEM
27654	and	i-PROBLEM
27655	systolic	i-PROBLEM
27656	murmur	i-PROBLEM
27657	.	O
27658	the	O
27659	abdomen	O
27660	was	O
27661	negative	O
27662	and	O
27663	there	O
27664	was	O
27665	no	O
27666	edema	b-PROBLEM
27667	of	i-PROBLEM
27668	the	i-PROBLEM
27669	feet	i-PROBLEM
27670	.	O
27671	the	b-TEST
27672	electrocardiogram	i-TEST
27673	demonstrated	b-EVIDENTIAL
27674	normal	b-OCCURRENCE
27675	sinus	i-OCCURRENCE
27676	rhythm	i-OCCURRENCE
27677	with	O
27678	poor	b-PROBLEM
27679	r	i-PROBLEM
27680	wave	i-PROBLEM
27681	progression	i-PROBLEM
27682	,	O
27683	left	b-PROBLEM
27684	atrial	i-PROBLEM
27685	enlargement	i-PROBLEM
27686	and	O
27687	t	b-PROBLEM
27688	wave	i-PROBLEM
27689	inversion	i-PROBLEM
27690	in	i-PROBLEM
27691	leads	i-PROBLEM
27692	v	i-PROBLEM
27693	4	i-PROBLEM
27694	,	i-PROBLEM
27695	5	i-PROBLEM
27696	,	O
27697	and	O
27698		O
27699	admission	b-OCCURRENCE
27700	date	O
27701	:	O
27702	2015-10-28	b-ADMISSION
27703	discharge	b-OCCURRENCE
27704	date	O
27705	:	O
27706	2015-11-13	b-DISCHARGE
27707	service	O
27708	:	O
27709	cardiothoracic	O
27710	allergies	O
27711	:	O
27712	history	O
27713	of	O
27714	present	O
27715	illness	O
27716	:	O
27717	ms.	O
27718	bridge	O
27719	is	O
27720	a	O
27721	74	O
27722	y/o	O
27723	female	O
27724	admitted	b-OCCURRENCE
27725	to	O
27726	outside	b-CLINICAL_DEPT
27727	hospital	i-CLINICAL_DEPT
27728	on	O
27729	2015-10-21	b-DATE
27730	with	O
27731	chest	b-PROBLEM
27732	discomfort	i-PROBLEM
27733	,	O
27734	vomiting	b-PROBLEM
27735	and	O
27736	shortness	b-PROBLEM
27737	of	i-PROBLEM
27738	breath	i-PROBLEM
27739	.	O
27740	initial	O
27741	ekg	b-TEST
27742	showed	b-EVIDENTIAL
27743	st	b-PROBLEM
27744	depressions	i-PROBLEM
27745	,	O
27746	but	O
27747	cardiac	b-TEST
27748	enzymes	i-TEST
27749	were	O
27750	not	O
27751	elevated	b-PROBLEM
27752	.	O
27753	she	O
27754	eventually	O
27755	underwent	O
27756	a	b-TEST
27757	cardiac	i-TEST
27758	cath	i-TEST
27759	to	O
27760	assess	O
27761	coronary	b-PROBLEM
27762	disease	i-PROBLEM
27763	which	O
27764	revealed	b-EVIDENTIAL
27765	three	b-PROBLEM
27766	vessel	i-PROBLEM
27767	coronary	i-PROBLEM
27768	artery	i-PROBLEM
27769	disease	i-PROBLEM
27770	.	O
27771	she	O
27772	was	O
27773	then	O
27774	transferred	b-OCCURRENCE
27775	to	O
27776	the	b-CLINICAL_DEPT
27777	hospital	i-CLINICAL_DEPT
27778	for	i-CLINICAL_DEPT
27779	orthopedics	i-CLINICAL_DEPT
27780	for	O
27781	surgical	b-TREATMENT
27782	intervention	i-TREATMENT
27783	.	O
27784	brief	O
27785	hospital	O
27786	course	O
27787	:	O
27788	ms.	O
27789	bridge	O
27790	was	O
27791	admitted	b-OCCURRENCE
27792	from	O
27793	osh	b-CLINICAL_DEPT
27794	for	O
27795	coronary	b-TREATMENT
27796	artery	i-TREATMENT
27797	bypass	i-TREATMENT
27798	surgery	i-TREATMENT
27799	.	O
27800	she	O
27801	underwent	O
27802	usual	b-TEST
27803	pre-operative	i-TEST
27804	testing	i-TEST
27805	along	O
27806	with	O
27807	carotid	b-TEST
27808	ultrasound	i-TEST
27809	.	O
27810	cnis	b-TEST
27811	revealed	b-OCCURRENCE
27812	carotid	b-PROBLEM
27813	stenosis	i-PROBLEM
27814	and	O
27815	she	O
27816	ultimately	O
27817	underwent	O
27818	left	b-TREATMENT
27819	carotid	i-TREATMENT
27820	stenting	i-TREATMENT
27821	by	O
27822	vascular	b-OCCURRENCE
27823	surgery	i-OCCURRENCE
27824	on	O
27825	10-30	b-DATE
27826	.	O
27827	please	O
27828	see	O
27829	report	O
27830	for	O
27831	details	O
27832	.	O
27833	on	O
27834	11-02	b-DATE
27835	she	O
27836	was	O
27837	brought	O
27838	to	O
27839	the	b-CLINICAL_DEPT
27840	operating	i-CLINICAL_DEPT
27841	room	i-CLINICAL_DEPT
27842	where	O
27843	she	O
27844	underwent	O
27845	a	b-TREATMENT
27846	coronary	i-TREATMENT
27847	artery	i-TREATMENT
27848	bypass	i-TREATMENT
27849	graft	i-TREATMENT
27850	x	b-FREQUENCY
27851	2	i-FREQUENCY
27852	.	O
27853	please	O
27854	see	O
27855	operative	O
27856	report	O
27857	for	O
27858	surgical	O
27859	details	O
27860	.	O
27861	she	O
27862	tolerated	O
27863	the	b-TREATMENT
27864	procedure	i-TREATMENT
27865	well	b-OCCURRENCE
27866	and	O
27867	was	O
27868	transferred	b-OCCURRENCE
27869	to	O
27870	the	b-CLINICAL_DEPT
27871	csru	i-CLINICAL_DEPT
27872	for	O
27873	invasive	b-TEST
27874	monitoring	i-TEST
27875	in	O
27876	stable	b-EVIDENTIAL
27877	condition	i-EVIDENTIAL
27878	.	O
27879	later	O
27880	on	O
27881	op	b-DATE
27882	day	i-DATE
27883	sedation	b-TREATMENT
27884	was	O
27885	weaned	b-TREATMENT
27886	,	O
27887	she	O
27888	awoke	b-OCCURRENCE
27889	neurologically	i-OCCURRENCE
27890	intact	i-OCCURRENCE
27891	and	O
27892	was	O
27893	extubated	b-TREATMENT
27894	.	O
27895	on	O
27896	post-op	b-DATE
27897	day	i-DATE
27898	one	i-DATE
27899	chest	b-TREATMENT
27900	tubes	i-TREATMENT
27901	were	O
27902	removed	O
27903	and	O
27904	beta	b-TREATMENT
27905	blockers	i-TREATMENT
27906	and	O
27907	diuretics	b-TREATMENT
27908	were	O
27909	initiated	O
27910	.	O
27911	she	O
27912	was	O
27913	gently	b-TREATMENT
27914	diuresed	i-TREATMENT
27915	towards	O
27916	her	O
27917	pre-op	O
27918	weight	O
27919	.	O
27920	also	O
27921	on	O
27922	this	b-DATE
27923	day	i-DATE
27924	she	O
27925	was	O
27926	transferred	b-OCCURRENCE
27927	to	O
27928	the	b-CLINICAL_DEPT
27929	sdu	i-CLINICAL_DEPT
27930	.	O
27931	early	O
27932	on	O
27933	post-op	b-DATE
27934	day	i-DATE
27935	two	i-DATE
27936	ms.	O
27937	bridge	O
27938	had	O
27939	an	O
27940	episode	O
27941	of	O
27942	aphasia	b-PROBLEM
27943	.	O
27944	she	O
27945	underwent	O
27946	an	b-TEST
27947	immediate	i-TEST
27948	head	i-TEST
27949	ct	i-TEST
27950	and	O
27951	neuro	b-OCCURRENCE
27952	consult	i-OCCURRENCE
27953	and	O
27954	was	O
27955	transferred	b-OCCURRENCE
27956	back	O
27957	to	O
27958	the	b-CLINICAL_DEPT
27959	csru	i-CLINICAL_DEPT
27960	.	O
27961	ct	b-TEST
27962	was	O
27963	negative	O
27964	and	O
27965	she	O
27966	returned	O
27967	to	O
27968	baseline	b-OCCURRENCE
27969	neuro	i-OCCURRENCE
27970	status	i-OCCURRENCE
27971	without	O
27972	deficits	b-PROBLEM
27973	by	O
27974	arrival	O
27975	to	O
27976	csru	b-CLINICAL_DEPT
27977	.	O
27978	neurology	b-OCCURRENCE
27979	concluded	O
27980	episode	b-EVIDENTIAL
27981	was	O
27982	most	O
27983	concerning	O
27984	for	O
27985	tia	b-PROBLEM
27986	.	O
27987	epicardial	b-TREATMENT
27988	pacing	i-TREATMENT
27989	wires	i-TREATMENT
27990	were	O
27991	removed	O
27992	on	O
27993	post-op	b-DATE
27994	day	i-DATE
27995	four	i-DATE
27996	.	O
27997	after	O
27998	remaining	O
27999	stable	b-OCCURRENCE
28000	in	O
28001	the	b-CLINICAL_DEPT
28002	csru	i-CLINICAL_DEPT
28003	for	O
28004	several	b-DURATION
28005	days	i-DURATION
28006	without	O
28007	change	b-PROBLEM
28008	in	i-PROBLEM
28009	neuro	i-PROBLEM
28010	status	i-PROBLEM
28011	she	O
28012	was	O
28013	transferred	b-OCCURRENCE
28014	back	O
28015	to	O
28016	the	b-CLINICAL_DEPT
28017	sdu	i-CLINICAL_DEPT
28018	on	O
28019	post-op	b-DATE
28020	day	i-DATE
28021	four	i-DATE
28022	.	O
28023	she	O
28024	was	O
28025	then	O
28026	started	O
28027	on	O
28028	heparin	b-TREATMENT
28029	with	O
28030	transition	b-OCCURRENCE
28031	to	O
28032	coumadin	b-TREATMENT
28033	(	O
28034	goal	O
28035	inr	b-TEST
28036	of	O
28037	2-3	O
28038	secondary	O
28039	to	O
28040	h/o	O
28041	bilateral	b-PROBLEM
28042	dvt	i-PROBLEM
28043	's).	O
28044	during	O
28045	entire	b-OCCURRENCE
28046	post-op	i-OCCURRENCE
28047	course	i-OCCURRENCE
28048	she	O
28049	was	O
28050	followed	b-OCCURRENCE
28051	by	O
28052	physical	b-TREATMENT
28053	therapy	i-TREATMENT
28054	for	O
28055	strength	O
28056	and	O
28057	mobility	O
28058	.	O
28059	she	O
28060	continued	O
28061	to	O
28062	improve	b-OCCURRENCE
28063	steadily	O
28064	over	O
28065	the	O
28066	next	O
28067	several	b-DURATION
28068	days	i-DURATION
28069	without	O
28070	any	O
28071	other	O
28072	post-op	O
28073		O
28074	complications	b-PROBLEM
28075	.	O
28076	she	O
28077	was	O
28078	discharged	b-OCCURRENCE
28079	on	O
28080	post-op	b-DATE
28081	day	i-DATE
28082	11	i-DATE
28083	.	O
28084		O
28085	admission	b-OCCURRENCE
28086	date	O
28087	:	O
28088	03/30/97	b-ADMISSION
28089	discharge	b-OCCURRENCE
28090	date	O
28091	:	O
28092	04/01/97	b-DISCHARGE
28093	history	O
28094	of	O
28095	present	O
28096	illness	O
28097	and	O
28098	reason	O
28099	for	O
28100	hospitalization	O
28101	:	O
28102	the	O
28103	patient	O
28104	was	O
28105	a	O
28106	108-year-old	O
28107	nursing	O
28108	home	O
28109	resident	O
28110	,	O
28111	who	O
28112	was	O
28113	admitted	b-OCCURRENCE
28114	with	O
28115	a	b-DURATION
28116	two-day	i-DURATION
28117	history	O
28118	of	O
28119	increased	b-PROBLEM
28120	respiratory	i-PROBLEM
28121	secretions	i-PROBLEM
28122	and	O
28123	a	b-DURATION
28124	24-hour	i-DURATION
28125	history	O
28126	of	O
28127	elevated	b-PROBLEM
28128	fever	i-PROBLEM
28129	.	O
28130	despite	O
28131	augmentin	b-TREATMENT
28132	,	O
28133	the	b-PROBLEM
28134	patient	i-PROBLEM
28135	&apos;s	i-PROBLEM
28136	delirium	i-PROBLEM
28137	worsened	b-OCCURRENCE
28138	in	O
28139	the	b-DURATION
28140	24	i-DURATION
28141	hours	i-DURATION
28142	prior	O
28143	to	O
28144	admission	b-OCCURRENCE
28145	,	O
28146	and	O
28147	her	b-TEST
28148	temperature	i-TEST
28149	was	O
28150	up	O
28151	to	O
28152	102	O
28153	.	O
28154	she	O
28155	was	O
28156	refusing	b-OCCURRENCE
28157	to	O
28158	take	b-OCCURRENCE
28159	p.o.&apos;s	i-OCCURRENCE
28160	.	O
28161	hospital	O
28162	course	O
28163	and	O
28164	treatment	O
28165	:	O
28166	the	O
28167	patient	O
28168	was	O
28169	admitted	b-OCCURRENCE
28170	for	O
28171	treatment	b-TREATMENT
28172	of	O
28173	a	O
28174	presumed	O
28175	aspiration	b-PROBLEM
28176	pneumonia	i-PROBLEM
28177	and	O
28178	for	O
28179	rehydration	b-TREATMENT
28180	.	O
28181	she	O
28182	was	O
28183	started	O
28184	on	O
28185	clindamycin	b-TREATMENT
28186	and	O
28187	ofloxacin	b-TREATMENT
28188	at	O
28189	renal	O
28190	dose	O
28191	to	O
28192	cover	O
28193	the	b-PROBLEM
28194	aspiration	i-PROBLEM
28195	pneumonia	i-PROBLEM
28196	and	O
28197	positive	b-PROBLEM
28198	urine	i-PROBLEM
28199	culture	i-PROBLEM
28200	,	O
28201	which	O
28202	subsequently	O
28203	came	b-OCCURRENCE
28204	back	i-OCCURRENCE
28205	.	O
28206	she	O
28207	had	O
28208	some	b-PROBLEM
28209	wheezing	i-PROBLEM
28210	,	O
28211	which	O
28212	responded	b-OCCURRENCE
28213	well	i-OCCURRENCE
28214	to	O
28215	albuterol	b-TREATMENT
28216	nebulizers	i-TREATMENT
28217	.	O
28218	she	O
28219	was	O
28220	generally	O
28221	doing	O
28222	well	b-OCCURRENCE
28223	with	O
28224	resolution	b-OCCURRENCE
28225	of	O
28226	her	b-TEST
28227	temperature	i-TEST
28228	until	O
28229	4/1/97	b-TIME
28230	at	i-TIME
28231	9:20	i-TIME
28232	p.m.	i-TIME
28233	,	O
28234	when	O
28235	she	O
28236	was	O
28237	noted	b-EVIDENTIAL
28238	to	O
28239	be	O
28240	unresponsive	b-PROBLEM
28241	with	O
28242	fixed	b-PROBLEM
28243	dilated	i-PROBLEM
28244	pupils	i-PROBLEM
28245	.	O
28246	she	O
28247	was	O
28248	certified	b-PROBLEM
28249	dead	i-PROBLEM
28250	at	O
28251	9:20	b-TIME
28252	p.m.	i-TIME
28253	mi	O
28254	cuchsli	O
28255	,	O
28256	md	O
28257	tr	O
28258	:	O
28259	vgo	O
28260	dd	O
28261	:	O
28262	05/11/97	O
28263	td	O
28264	:	O
28265	05/15/97	O
28266	8:26	O
28267	acc	O
28268	:	O
28269	mi	O
28270	cuchsli	O
28271	,	O
28272	md	O
28273	cc	O
28274	:	O
28275	nursing	O
28276	director	O
28277	pcaer,ter	O
28278	medical	O
28279	center	O
28280	sco	O
28281	,	O
28282	ohio	O
28283		O
28284	admission	b-OCCURRENCE
28285	date	O
28286	:	O
28287	2010-02-05	b-ADMISSION
28288	discharge	b-OCCURRENCE
28289	date	O
28290	:	O
28291	2010-02-06	b-DISCHARGE
28292	service	O
28293	:	O
28294	trauma	O
28295	history	O
28296	of	O
28297	present	O
28298	illness	O
28299	:	O
28300	the	O
28301	patient	O
28302	is	O
28303	a	O
28304	23	O
28305	year	O
28306	old	O
28307	female	O
28308	,	O
28309	status	O
28310	post	O
28311	fall	b-PROBLEM
28312	from	O
28313	standing	O
28314	position	O
28315	after	O
28316	slipping	O
28317	on	O
28318	ice	O
28319	.	O
28320	she	O
28321	had	O
28322	no	O
28323	loss	b-PROBLEM
28324	of	i-PROBLEM
28325	consciousness	i-PROBLEM
28326	.	O
28327	she	O
28328	recalled	O
28329	the	O
28330	entire	O
28331	event	b-PROBLEM
28332	.	O
28333	she	O
28334	was	O
28335	found	O
28336	by	O
28337	family	O
28338	and	O
28339	friends	O
28340	to	O
28341	be	O
28342	somewhat	O
28343	confused	b-PROBLEM
28344	and	O
28345	was	O
28346	therefore	O
28347	taken	O
28348	to	O
28349	newton-wellesley	b-CLINICAL_DEPT
28350	hospital	i-CLINICAL_DEPT
28351	thereafter	O
28352	.	O
28353	workup	b-TEST
28354	at	O
28355	the	b-CLINICAL_DEPT
28356	outside	i-CLINICAL_DEPT
28357	hospital	i-CLINICAL_DEPT
28358	included	O
28359	a	b-TEST
28360	ct	i-TEST
28361	scan	i-TEST
28362	of	i-TEST
28363	the	i-TEST
28364	head	i-TEST
28365	revealing	b-EVIDENTIAL
28366	a	O
28367	possible	O
28368	parietal	b-PROBLEM
28369	subdural	i-PROBLEM
28370	bleed	i-PROBLEM
28371	on	i-PROBLEM
28372	the	i-PROBLEM
28373	right	i-PROBLEM
28374	side	i-PROBLEM
28375	.	O
28376	the	b-TEST
28377	patient	i-TEST
28378	's	i-TEST
28379	gcs	i-TEST
28380	was	O
28381	15	O
28382	.	O
28383	she	O
28384	was	O
28385	hemodynamically	O
28386	stable	O
28387	.	O
28388	she	O
28389	was	O
28390	thereafter	O
28391	transferred	b-OCCURRENCE
28392	to	O
28393	beverly	b-CLINICAL_DEPT
28394	hospital	i-CLINICAL_DEPT
28395	for	O
28396	further	b-TEST
28397	evaluation	i-TEST
28398	and	O
28399	management	b-TREATMENT
28400	.	O
28401		O
28402	admission	b-OCCURRENCE
28403	date	O
28404	:	O
28405	2014-04-19	b-ADMISSION
28406	discharge	b-OCCURRENCE
28407	date	O
28408	:	O
28409	2014-04-20	b-DISCHARGE
28410	service	O
28411	:	O
28412	cmed	O
28413	csru	O
28414	history	O
28415	of	O
28416	present	O
28417	illness	O
28418	:	O
28419	baby	O
28420	thomas	O
28421	moss	O
28422	was	O
28423	born	b-OCCURRENCE
28424	at	O
28425	39	b-DURATION
28426	and	i-DURATION
28427	1/2	i-DURATION
28428	weeks	i-DURATION
28429	gestation	b-OCCURRENCE
28430	to	O
28431	a	O
28432	20-year-old	O
28433	gravida	b-OCCURRENCE
28434	iv	b-FREQUENCY
28435	,	O
28436	para	b-OCCURRENCE
28437	iii	b-FREQUENCY
28438	,	O
28439	now	O
28440	iv	b-FREQUENCY
28441	woman	O
28442	.	O
28443	the	b-TEST
28444	mother	i-TEST
28445	's	i-TEST
28446	prenatal	i-TEST
28447	screens	i-TEST
28448	were	O
28449	blood	b-TEST
28450	type	i-TEST
28451	b	O
28452	positive	O
28453	,	O
28454	antibody	b-TEST
28455	negative	O
28456	,	O
28457	rubella	b-TEST
28458	immune	O
28459	,	O
28460	rpr	b-TEST
28461	nonreactive	O
28462	,	O
28463	hepatitis	b-TEST
28464	surface	i-TEST
28465	antigen	i-TEST
28466	negative	O
28467	and	O
28468	group	b-TEST
28469	b	i-TEST
28470	strep	i-TEST
28471	negative	O
28472	.	O
28473	this	b-OCCURRENCE
28474	pregnancy	i-OCCURRENCE
28475	was	O
28476	complicated	b-PROBLEM
28477	by	O
28478	a	b-OCCURRENCE
28479	prenatal	i-OCCURRENCE
28480	diagnosis	i-OCCURRENCE
28481	of	O
28482	a	b-PROBLEM
28483	congenital	i-PROBLEM
28484	cystic	i-PROBLEM
28485	adenomatoid	i-PROBLEM
28486	malformation	i-PROBLEM
28487	(	O
28488	ccam	b-PROBLEM
28489	).	O
28490	the	O
28491	mother	O
28492	was	O
28493	followed	b-OCCURRENCE
28494	in	O
28495	the	b-CLINICAL_DEPT
28496	massachusetts	i-CLINICAL_DEPT
28497	general	i-CLINICAL_DEPT
28498	hospital	i-CLINICAL_DEPT
28499	advanced	i-CLINICAL_DEPT
28500	fetal	i-CLINICAL_DEPT
28501	care	i-CLINICAL_DEPT
28502	center	i-CLINICAL_DEPT
28503	and	O
28504	was	O
28505	followed	O
28506	by	O
28507	doctor	O
28508	ralph	O
28509	wilson	O
28510	.	O
28511	the	O
28512	mother	O
28513	had	O
28514	spontaneous	b-OCCURRENCE
28515	onset	i-OCCURRENCE
28516	of	i-OCCURRENCE
28517	labor	i-OCCURRENCE
28518	and	O
28519	progressed	O
28520	to	O
28521	a	b-OCCURRENCE
28522	spontaneous	i-OCCURRENCE
28523	vaginal	i-OCCURRENCE
28524	delivery	i-OCCURRENCE
28525	.	O
28526	the	O
28527	infant	O
28528	emerged	b-OCCURRENCE
28529	vigorous	b-OCCURRENCE
28530	with	O
28531	apgars	b-TEST
28532	of	O
28533	9	O
28534	at	O
28535	one	b-DURATION
28536	and	O
28537	five	b-DURATION
28538	minutes	i-DURATION
28539	.	O
28540	his	b-TEST
28541	birth	i-TEST
28542	weight	i-TEST
28543	was	O
28544	2905	O
28545	grams	O
28546	.	O
28547		O
28548	admission	b-OCCURRENCE
28549	date	O
28550	:	O
28551	12/02/2002	b-ADMISSION
28552	discharge	b-OCCURRENCE
28553	date	O
28554	:	O
28555	12/04/2002	b-DISCHARGE
28556	history	O
28557	of	O
28558	present	O
28559	illness	O
28560	:	O
28561	the	O
28562	patient	O
28563	is	O
28564	an	O
28565	81	O
28566	year	O
28567	old	O
28568	female	O
28569	with	O
28570	a	O
28571	history	O
28572	of	O
28573	cerebrovascular	b-PROBLEM
28574	accident	i-PROBLEM
28575	,	O
28576	atrial	b-PROBLEM
28577	fibrillation	i-PROBLEM
28578	,	O
28579	hypothyroidism	b-PROBLEM
28580	and	O
28581	dementia	b-PROBLEM
28582	who	O
28583	is	O
28584	status	O
28585	post	O
28586	laparoscopic	b-TREATMENT
28587	cholecystectomy	i-TREATMENT
28588	one	b-DATE
28589	week	i-DATE
28590	ago	i-DATE
28591	who	O
28592	currently	O
28593	presents	b-OCCURRENCE
28594	with	O
28595	a	b-DURATION
28596	4	i-DURATION
28597	day	i-DURATION
28598	history	O
28599	of	O
28600	no	O
28601	bowel	b-OCCURRENCE
28602	movement	i-OCCURRENCE
28603	.	O
28604	she	O
28605	has	O
28606	complaints	b-EVIDENTIAL
28607	of	O
28608	abdominal	b-PROBLEM
28609	distention	i-PROBLEM
28610	,	O
28611	emesis	b-PROBLEM
28612	,	O
28613	and	O
28614	constipation	b-PROBLEM
28615	.	O
28616	she	O
28617	has	O
28618	no	O
28619	chest	b-PROBLEM
28620	pain	i-PROBLEM
28621	,	O
28622	shortness	b-PROBLEM
28623	of	i-PROBLEM
28624	breath	i-PROBLEM
28625	or	O
28626	fever	b-PROBLEM
28627	.	O
28628	she	O
28629	has	O
28630	no	O
28631	nausea	b-PROBLEM
28632	or	O
28633	vomiting	b-PROBLEM
28634	,	O
28635	chills	b-PROBLEM
28636	,	O
28637	dysuria	b-PROBLEM
28638	,	O
28639	hematochezia	b-PROBLEM
28640	,	O
28641	or	O
28642	melena	b-PROBLEM
28643	.	O
28644	she	O
28645	was	O
28646	discharged	b-OCCURRENCE
28647	from	O
28648	the	b-CLINICAL_DEPT
28649	hospital	i-CLINICAL_DEPT
28650	on	O
28651	11/28/02	b-DATE
28652	to	O
28653	a	b-CLINICAL_DEPT
28654	short	i-CLINICAL_DEPT
28655	term	i-CLINICAL_DEPT
28656	rehabilitation	i-CLINICAL_DEPT
28657	facility	i-CLINICAL_DEPT
28658	.	O
28659	she	O
28660	was	O
28661	found	O
28662	to	O
28663	have	O
28664	normal	O
28665	bowel	O
28666	sounds	O
28667	.	O
28668	she	O
28669	presented	O
28670	to	O
28671	the	b-CLINICAL_DEPT
28672	ponta,itri-	i-CLINICAL_DEPT
28673	university	i-CLINICAL_DEPT
28674	medical	i-CLINICAL_DEPT
28675	center	i-CLINICAL_DEPT
28676	emergency	i-CLINICAL_DEPT
28677	department	i-CLINICAL_DEPT
28678	on	O
28679	12/01/02	b-DATE
28680	for	O
28681	evaluation	b-TEST
28682	of	O
28683	this	b-PROBLEM
28684	constipation	i-PROBLEM
28685	.	O
28686	hospital	O
28687	course	O
28688	:	O
28689	the	O
28690	patient	O
28691	presented	O
28692	to	O
28693	the	b-CLINICAL_DEPT
28694	operating	i-CLINICAL_DEPT
28695	room	i-CLINICAL_DEPT
28696	late	b-DATE
28697	at	i-DATE
28698	night	i-DATE
28699	on	i-DATE
28700	12/01/02	i-DATE
28701	and	O
28702	was	O
28703	admitted	O
28704	to	O
28705	the	b-CLINICAL_DEPT
28706	floor	i-CLINICAL_DEPT
28707	early	O
28708	on	O
28709	the	b-DATE
28710	morning	i-DATE
28711	on	i-DATE
28712	12/02/02	i-DATE
28713	.	O
28714	she	O
28715	was	O
28716	placed	O
28717	on	O
28718	a	b-TREATMENT
28719	bowel	i-TREATMENT
28720	regimen	i-TREATMENT
28721	of	O
28722	dulcolax	b-TREATMENT
28723	,	O
28724	fleet	b-TREATMENT
28725	enema	i-TREATMENT
28726	,	O
28727	and	O
28728	colace	b-TREATMENT
28729	.	O
28730	on	O
28731	12/03/02	b-DATE
28732	the	O
28733	patient	O
28734	underwent	O
28735	a	b-TEST
28736	repeat	i-TEST
28737	kub	i-TEST
28738	which	O
28739	was	O
28740	suggestive	O
28741	of	O
28742	volvulus	b-PROBLEM
28743	.	O
28744	she	O
28745	then	O
28746	underwent	O
28747	a	b-TEST
28748	ct	i-TEST
28749	scan	i-TEST
28750	which	O
28751	showed	b-EVIDENTIAL
28752	no	O
28753	evidence	O
28754	of	O
28755	volvulus	b-PROBLEM
28756	.	O
28757	rigid	b-TEST
28758	sigmoidoscopy	i-TEST
28759	revealed	b-EVIDENTIAL
28760	no	O
28761	obvious	b-PROBLEM
28762	mucosal	i-PROBLEM
28763	abnormalities	i-PROBLEM
28764	but	O
28765	during	O
28766	the	O
28767	time	O
28768	of	O
28769	the	b-TEST
28770	procedure	i-TEST
28771	22cc	O
28772	of	O
28773	mucous	b-PROBLEM
28774	like	i-PROBLEM
28775	stool	i-PROBLEM
28776	was	O
28777	evacuated	b-TREATMENT
28778	with	O
28779	a	b-PROBLEM
28780	large	i-PROBLEM
28781	amount	i-PROBLEM
28782	of	i-PROBLEM
28783	gas	i-PROBLEM
28784	.	O
28785	subsequent	O
28786	to	O
28787	that	O
28788	the	O
28789	patients	O
28790	abdomen	O
28791	was	O
28792	significantly	b-PROBLEM
28793	less	i-PROBLEM
28794	distended	i-PROBLEM
28795	and	O
28796	her	b-PROBLEM
28797	pain	i-PROBLEM
28798	decreased	O
28799	as	O
28800	well	O
28801	.	O
28802	on	O
28803	the	b-DATE
28804	following	i-DATE
28805	day	i-DATE
28806	,	O
28807	hospital	O
28808	day	O
28809	number	O
28810	3	O
28811	,	O
28812	the	O
28813	patient	O
28814	was	O
28815	doing	b-EVIDENTIAL
28816	well	i-EVIDENTIAL
28817	.	O
28818	the	O
28819	abdomen	O
28820	was	O
28821	again	O
28822	far	b-PROBLEM
28823	less	i-PROBLEM
28824	distended	i-PROBLEM
28825	.	O
28826	she	O
28827	was	O
28828	tolerating	O
28829	clear	b-TREATMENT
28830	liquids	i-TREATMENT
28831	ad	O
28832	lib	O
28833	.	O
28834	she	O
28835	was	O
28836	afebrile	b-PROBLEM
28837	with	O
28838	stable	O
28839	vital	O
28840	signs	O
28841	.	O
28842	a	b-TEST
28843	repeat	i-TEST
28844	kub	i-TEST
28845	was	O
28846	performed	O
28847	which	O
28848	showed	b-EVIDENTIAL
28849	no	O
28850	evidence	O
28851	of	O
28852	volvulus	b-PROBLEM
28853	.	O
28854	she	O
28855	was	O
28856	discharged	b-OCCURRENCE
28857	back	O
28858	to	O
28859	a	b-CLINICAL_DEPT
28860	rehabilitation	i-CLINICAL_DEPT
28861	facility	i-CLINICAL_DEPT
28862	in	O
28863	good	b-OCCURRENCE
28864	condition	i-OCCURRENCE
28865	.	O
28866		O
28867	admission	b-OCCURRENCE
28868	date	O
28869	:	O
28870	04/07/97	b-ADMISSION
28871	discharge	b-OCCURRENCE
28872	date	O
28873	:	O
28874	04/08/97	b-DISCHARGE
28875	history	O
28876	of	O
28877	present	O
28878	illness	O
28879	:	O
28880	mr.	O
28881	vessels	O
28882	is	O
28883	a	O
28884	49-year-old	O
28885	man	O
28886	status	O
28887	post	O
28888	orthotopic	b-TREATMENT
28889	heart	i-TREATMENT
28890	transplantation	i-TREATMENT
28891	in	O
28892	1991	b-DATE
28893	at	O
28894	dautenorwe	b-CLINICAL_DEPT
28895	stuart	i-CLINICAL_DEPT
28896	erec	i-CLINICAL_DEPT
28897	hillpa	i-CLINICAL_DEPT
28898	of	i-CLINICAL_DEPT
28899	hospital	i-CLINICAL_DEPT
28900	who	O
28901	is	O
28902	admitted	b-OCCURRENCE
28903	with	O
28904	dyspnea	b-PROBLEM
28905	and	O
28906	severe	b-PROBLEM
28907	heart	i-PROBLEM
28908	failure	i-PROBLEM
28909	.	O
28910	mr.	O
28911	vessels	O
28912	&apos;s	O
28913	postoperative	b-OCCURRENCE
28914	course	i-OCCURRENCE
28915	has	O
28916	been	O
28917	marked	O
28918	by	O
28919	cmv	b-PROBLEM
28920	infection	i-PROBLEM
28921	,	O
28922	hypertension	b-PROBLEM
28923	,	O
28924	poorly	b-PROBLEM
28925	controlled	i-PROBLEM
28926	lipids	i-PROBLEM
28927	,	O
28928	peripheral	b-PROBLEM
28929	vascular	i-PROBLEM
28930	disease	i-PROBLEM
28931	,	O
28932	and	O
28933	chronic	b-PROBLEM
28934	renal	i-PROBLEM
28935	insufficiency	i-PROBLEM
28936	with	O
28937	a	b-TEST
28938	creatinine	i-TEST
28939	of	O
28940	1.8	O
28941	or	O
28942	so	O
28943	.	O
28944	recently	O
28945	he	O
28946	had	O
28947	documented	O
28948	coronary	b-PROBLEM
28949	angiography	i-PROBLEM
28950	based	O
28951	on	O
28952	a	b-TEST
28953	catheterization	i-TEST
28954	performed	O
28955	in	O
28956	january	b-DATE
28957	1996	i-DATE
28958	with	O
28959	moderate	O
28960	to	O
28961	diffuse	O
28962	atherosclerosis	b-PROBLEM
28963	.	O
28964	a	b-TEST
28965	repeat	i-TEST
28966	angiogram	i-TEST
28967	performed	O
28968	a	b-DURATION
28969	year	i-DURATION
28970	later	O
28971	showed	b-EVIDENTIAL
28972	marked	O
28973	progression	b-PROBLEM
28974	of	i-PROBLEM
28975	coronary	i-PROBLEM
28976	allograft	i-PROBLEM
28977	disease	i-PROBLEM
28978	.	O
28979	a	b-TEST
28980	biopsy	i-TEST
28981	at	O
28982	that	O
28983	time	O
28984	revealed	b-EVIDENTIAL
28985	grade	b-PROBLEM
28986	1b	i-PROBLEM
28987	rejection	i-PROBLEM
28988	with	O
28989	endothelialitis	b-PROBLEM
28990	and	O
28991	eosinophils	b-PROBLEM
28992	.	O
28993	he	O
28994	was	O
28995	treated	O
28996	with	O
28997	pulsed	b-TREATMENT
28998	iv	i-TREATMENT
28999	steroids	i-TREATMENT
29000	and	O
29001	imuran	b-TREATMENT
29002	,	O
29003	was	O
29004	augmented	O
29005	with	O
29006	mycophenolate	b-TREATMENT
29007	mofetil	i-TREATMENT
29008	.	O
29009	chest	b-TEST
29010	x-ray	i-TEST
29011	showed	b-EVIDENTIAL
29012	cariogenic	b-PROBLEM
29013	pulmonary	i-PROBLEM
29014	edema	i-PROBLEM
29015	and	O
29016	he	O
29017	was	O
29018	faring	O
29019	poorly	O
29020	.	O
29021	prior	O
29022	to	O
29023	admission	b-OCCURRENCE
29024	he	O
29025	was	O
29026	seen	O
29027	approximately	O
29028	1	b-DATE
29029	week	i-DATE
29030	in	O
29031	the	O
29032	office	O
29033	with	O
29034	mild	b-PROBLEM
29035	congestive	i-PROBLEM
29036	heart	i-PROBLEM
29037	failure	i-PROBLEM
29038	.	O
29039	an	b-TEST
29040	echocardiogram	i-TEST
29041	then	O
29042	revealed	b-EVIDENTIAL
29043	an	b-OCCURRENCE
29044	ejection	i-OCCURRENCE
29045	fraction	i-OCCURRENCE
29046	of	O
29047	40%	O
29048	and	O
29049	an	b-TEST
29050	endomyocardial	i-TEST
29051	biopsy	i-TEST
29052	revealed	O
29053	no	O
29054	ejection	b-TEST
29055	.	O
29056	hospital	O
29057	course	O
29058	and	O
29059	treatment	O
29060	:	O
29061	the	O
29062	patient	O
29063	was	O
29064	admitted	b-OCCURRENCE
29065	to	O
29066	the	b-CLINICAL_DEPT
29067	hospital	i-CLINICAL_DEPT
29068	via	O
29069	the	b-CLINICAL_DEPT
29070	emergency	i-CLINICAL_DEPT
29071	room	i-CLINICAL_DEPT
29072	where	O
29073	a	b-TEST
29074	bedside	i-TEST
29075	echocardiogram	i-TEST
29076	was	O
29077	performed	O
29078	.	O
29079	the	b-OCCURRENCE
29080	echocardiogram	i-OCCURRENCE
29081	revealed	b-EVIDENTIAL
29082	no	O
29083	pericardial	b-PROBLEM
29084	effusion	i-PROBLEM
29085	,	O
29086	an	b-OCCURRENCE
29087	ejection	i-OCCURRENCE
29088	fraction	i-OCCURRENCE
29089	of	O
29090	30%	O
29091	and	O
29092	worsening	b-OCCURRENCE
29093	systolic	i-OCCURRENCE
29094	dysfunction	i-OCCURRENCE
29095	.	O
29096	hydrocortisone	b-TREATMENT
29097	was	O
29098	given	O
29099	1	O
29100	g	O
29101	in	O
29102	an	O
29103	attempt	O
29104	to	O
29105	reverse	O
29106	what	O
29107	was	O
29108	thought	O
29109	to	O
29110	be	O
29111	aggressive	b-PROBLEM
29112	coronary	i-PROBLEM
29113	allograft	i-PROBLEM
29114	vasculopathy	i-PROBLEM
29115	.	O
29116	the	O
29117	patient	O
29118	diuresed	b-OCCURRENCE
29119	and	O
29120	responded	O
29121	to	O
29122	lasix	b-TREATMENT
29123	100	O
29124	mg	O
29125	administered	O
29126	in	O
29127	the	b-CLINICAL_DEPT
29128	emergency	i-CLINICAL_DEPT
29129	room	i-CLINICAL_DEPT
29130	and	O
29131	was	O
29132	admitted	b-OCCURRENCE
29133	to	O
29134	a	b-OCCURRENCE
29135	monitored	i-OCCURRENCE
29136	bed	i-OCCURRENCE
29137	.	O
29138	at	O
29139	2:30	b-TIME
29140	am	i-TIME
29141	the	b-DATE
29142	following	i-DATE
29143	morning	i-DATE
29144	the	O
29145	patient	O
29146	was	O
29147	found	b-EVIDENTIAL
29148	in	O
29149	cardiac	b-PROBLEM
29150	arrest	i-PROBLEM
29151	.	O
29152	despite	O
29153	intravenous	b-TREATMENT
29154	fluids	i-TREATMENT
29155	,	O
29156	intravenous	b-TREATMENT
29157	epinephrine	i-TREATMENT
29158	,	O
29159	and	O
29160	multiple	O
29161	attempts	O
29162	at	O
29163	defibrillation	b-TREATMENT
29164	,	O
29165	the	O
29166	patient	O
29167	was	O
29168	unable	O
29169	to	O
29170	be	O
29171	resuscitated	b-TEST
29172	.	O
29173	upon	O
29174	arrival	O
29175	of	O
29176	the	O
29177	covering	O
29178	access	O
29179	physician	O
29180	the	O
29181	patient	O
29182	was	O
29183	being	O
29184	ventilated	b-TREATMENT
29185	mechanically	i-TREATMENT
29186	and	O
29187	cpr	b-TREATMENT
29188	was	O
29189	being	O
29190	performed	O
29191	.	O
29192	the	b-TEST
29193	rhythm	i-TEST
29194	revealed	b-EVIDENTIAL
29195	sinus	b-PROBLEM
29196	tachycardia	i-PROBLEM
29197	with	O
29198	no	O
29199	palpable	O
29200	or	O
29201	measurable	b-TEST
29202	blood	i-TEST
29203	pressure	i-TEST
29204	.	O
29205	there	O
29206	were	O
29207	also	O
29208	runs	O
29209	of	O
29210	ventricular	b-PROBLEM
29211	tachycardia	i-PROBLEM
29212	which	O
29213	generated	O
29214	into	O
29215	ventricular	b-PROBLEM
29216	fibrillation	i-PROBLEM
29217	that	O
29218	was	O
29219	refractory	O
29220	to	O
29221	multiple	b-TREATMENT
29222	cardioversions	i-TREATMENT
29223	.	O
29224	a	b-TEST
29225	pericardiocentesis	i-TEST
29226	was	O
29227	attempted	O
29228	with	O
29229	no	O
29230	yield	O
29231	of	O
29232	pericardial	O
29233	fluid	O
29234	.	O
29235	a	b-TREATMENT
29236	transvenous	i-TREATMENT
29237	pacing	i-TREATMENT
29238	wire	i-TREATMENT
29239	was	O
29240	attempted	O
29241	and	O
29242	a	O
29243	pacing	O
29244	rhythm	O
29245	was	O
29246	obtained	O
29247	but	O
29248	with	O
29249	no	O
29250	palpable	b-TEST
29251	blood	i-TEST
29252	pressure	i-TEST
29253	.	O
29254	in	O
29255	total	O
29256	,	O
29257	the	O
29258	patient	O
29259	was	O
29260	defibrillated	b-TREATMENT
29261	10	O
29262	times	O
29263	,	O
29264	given	O
29265	5	O
29266	courses	O
29267	of	O
29268	intravenous	b-TREATMENT
29269	epinephrine	i-TREATMENT
29270	,	O
29271	one	O
29272	course	O
29273	of	O
29274	intravenous	b-TREATMENT
29275	atropine	i-TREATMENT
29276	and	O
29277	intravenous	b-TREATMENT
29278	calcium	i-TREATMENT
29279	x	O
29280	1	O
29281	in	O
29282	addition	O
29283	to	O
29284	an	b-TREATMENT
29285	amp	i-TREATMENT
29286	of	i-TREATMENT
29287	bicarbonate	i-TREATMENT
29288	.	O
29289	the	b-TREATMENT
29290	resuscitation	i-TREATMENT
29291	efforts	i-TREATMENT
29292	were	O
29293	discontinued	O
29294	at	O
29295	4:15	b-TIME
29296	am	i-TIME
29297	and	O
29298	were	O
29299	begun	O
29300	at	O
29301	3:38	b-TIME
29302	am	i-TIME
29303	.	O
29304	the	O
29305	patient	O
29306	was	O
29307	pronounced	b-EVIDENTIAL
29308	dead	b-PROBLEM
29309	.	O
29310	patient	O
29311	&apos;s	O
29312	mother	O
29313	was	O
29314	informed	O
29315	by	O
29316	doctor	O
29317	vessels	O
29318	.	O
29319	an	b-TEST
29320	autopsy	i-TEST
29321	permission	O
29322	was	O
29323	granted	O
29324	.	O
29325		O
29326	admission	b-OCCURRENCE
29327	date	O
29328	:	O
29329		O
29330	06/22/94	b-DATE
29331		O
29332	discharge	b-OCCURRENCE
29333	date	O
29334	:	O
29335		O
29336	07/04/94	b-DATE
29337		b-DISCHARGE
29338	history	O
29339	of	O
29340	present	O
29341	illness	O
29342	:	O
29343		O
29344	this	O
29345	68	O
29346	year	O
29347	old	O
29348	female	O
29349	had	O
29350	rheumatic	b-PROBLEM
29351	fever	i-PROBLEM
29352	in	O
29353	the	O
29354	past	O
29355	,	O
29356	and	O
29357	has	O
29358	had	O
29359	chronic	b-PROBLEM
29360	atrial	i-PROBLEM
29361	fibrillation	i-PROBLEM
29362	.	O
29363		O
29364	she	O
29365	has	O
29366	had	O
29367	progressive	b-PROBLEM
29368	heart	i-PROBLEM
29369	failure	i-PROBLEM
29370	and	O
29371	an	b-TEST
29372	evaluation	i-TEST
29373	demonstrated	O
29374	worsening	b-PROBLEM
29375	mitral	i-PROBLEM
29376	stenosis	i-PROBLEM
29377	with	O
29378	severe	b-PROBLEM
29379	pulmonary	i-PROBLEM
29380	hypertension	i-PROBLEM
29381	.	O
29382		O
29383	because	O
29384	of	O
29385	her	b-EVIDENTIAL
29386	deteriorating	i-EVIDENTIAL
29387	status	O
29388	,	O
29389	she	O
29390	underwent	O
29391	prior	b-TEST
29392	cardiac	i-TEST
29393	catheterization	i-TEST
29394	,	O
29395	which	O
29396	confirmed	O
29397	severe	b-PROBLEM
29398	mitral	i-PROBLEM
29399	stenosis	i-PROBLEM
29400	with	O
29401	secondary	b-PROBLEM
29402	tricuspid	i-PROBLEM
29403	valve	i-PROBLEM
29404	regurgitation	i-PROBLEM
29405	due	O
29406	to	O
29407	pulmonary	b-PROBLEM
29408	hypertension	i-PROBLEM
29409	.	O
29410		O
29411	she	O
29412	was	O
29413	referred	b-OCCURRENCE
29414	for	O
29415	valve	b-TREATMENT
29416	surgery	i-TREATMENT
29417	.	O
29418		O
29419	hospital	O
29420	course	O
29421	:	O
29422		O
29423	the	O
29424	patient	O
29425	was	O
29426	brought	O
29427	to	O
29428	the	b-CLINICAL_DEPT
29429	operating	i-CLINICAL_DEPT
29430	room	i-CLINICAL_DEPT
29431	,	O
29432	on	O
29433	april	b-DATE
29434	22	i-DATE
29435	.	O
29436		O
29437	she	O
29438	underwent	O
29439	a	b-TREATMENT
29440	mitral	i-TREATMENT
29441	valve	i-TREATMENT
29442	replacement	i-TREATMENT
29443	,	O
29444	utilizing	O
29445	a	O
29446	27	O
29447	mm	O
29448	.	O
29449		O
29450	st.	O
29451	jude	O
29452	prosthesis	b-TREATMENT
29453	,	O
29454	and	O
29455	tricuspid	b-TREATMENT
29456	valve	i-TREATMENT
29457	reconstruction	i-TREATMENT
29458	by	O
29459	ring	b-TREATMENT
29460	anuloplasty	i-TREATMENT
29461	.	O
29462		O
29463	she	O
29464	weaned	b-OCCURRENCE
29465	from	O
29466	cardiopulmonary	b-TREATMENT
29467	bypass	i-TREATMENT
29468	with	O
29469	good	b-EVIDENTIAL
29470	hemodynamics	i-EVIDENTIAL
29471	.	O
29472		O
29473	she	O
29474	initially	O
29475	awoke	b-OCCURRENCE
29476	after	O
29477	surgery	b-TREATMENT
29478	,	O
29479	with	O
29480	good	b-EVIDENTIAL
29481	hemodynamics	i-EVIDENTIAL
29482	.	O
29483		O
29484	she	O
29485	was	O
29486	transiently	O
29487	in	O
29488	sinus	b-PROBLEM
29489	rhythm	i-PROBLEM
29490	,	O
29491	but	O
29492	atrial	b-PROBLEM
29493	fibrillation	i-PROBLEM
29494	recurred	O
29495	.	O
29496		O
29497	she	O
29498	was	O
29499	extubated	b-TREATMENT
29500	on	O
29501	the	b-DATE
29502	third	i-DATE
29503	postoperative	i-DATE
29504	day	i-DATE
29505	,	O
29506	and	O
29507	was	O
29508	initially	b-PROBLEM
29509	slightly	i-PROBLEM
29510	agitated	i-PROBLEM
29511	and	O
29512	confused	b-PROBLEM
29513	,	O
29514	largely	O
29515	due	O
29516	to	O
29517	an	b-PROBLEM
29518	intensive	i-PROBLEM
29519	care	i-PROBLEM
29520	unit	i-PROBLEM
29521	psychosis	i-PROBLEM
29522	.	O
29523		O
29524	she	O
29525	continued	O
29526	to	O
29527	improve	O
29528	,	O
29529	with	O
29530	mobilization	O
29531	of	O
29532	fluid	O
29533	.	O
29534		O
29535	she	O
29536	was	O
29537	initially	O
29538	noted	b-EVIDENTIAL
29539	to	O
29540	have	O
29541	a	b-PROBLEM
29542	slow	i-PROBLEM
29543	ventricular	i-PROBLEM
29544	response	i-PROBLEM
29545	in	O
29546	atrial	b-PROBLEM
29547	fibrillation	i-PROBLEM
29548	,	O
29549	but	O
29550	this	O
29551	gradually	O
29552	improved	b-OCCURRENCE
29553	over	O
29554	time	O
29555	.	O
29556		O
29557	she	O
29558	was	O
29559	initially	O
29560	noted	O
29561	to	O
29562	be	O
29563	somewhat	b-PROBLEM
29564	anemic	i-PROBLEM
29565	,	O
29566	and	O
29567	received	O
29568	transfusions	b-TREATMENT
29569	.	O
29570		O
29571	coumadin	b-TREATMENT
29572	was	O
29573	restarted	O
29574	,	O
29575	and	O
29576	her	b-TREATMENT
29577	anticoagulation	i-TREATMENT
29578	came	O
29579	into	O
29580	range	O
29581	.	O
29582		O
29583	she	O
29584	was	O
29585	ultimately	O
29586	discharged	b-OCCURRENCE
29587	with	O
29588	a	b-TEST
29589	heart	i-TEST
29590	rate	i-TEST
29591	in	O
29592	the	O
29593	90	O
29594	's	O
29595	,	O
29596	and	O
29597	with	O
29598	resolving	b-PROBLEM
29599	edema	i-PROBLEM
29600	and	O
29601	a	b-PROBLEM
29602	clear	i-PROBLEM
29603	chest	i-PROBLEM
29604	.	O
29605		O
29606		O
29607	admission	b-OCCURRENCE
29608	date	O
29609	:	O
29610	03/07/2002	b-ADMISSION
29611	discharge	b-OCCURRENCE
29612	date	O
29613	:	O
29614	03/13/2002	b-DISCHARGE
29615	history	O
29616	of	O
29617	present	O
29618	illness	O
29619	:	O
29620	the	O
29621	patient	O
29622	is	O
29623	a	O
29624	79-year-old	O
29625	man	O
29626	status	O
29627	postradical	b-TREATMENT
29628	cystoprostatectomy	i-TREATMENT
29629	with	i-TREATMENT
29630	ileal	i-TREATMENT
29631	loop	i-TREATMENT
29632	for	O
29633	locally	b-PROBLEM
29634	invasive	i-PROBLEM
29635	prostate	i-PROBLEM
29636	cancer	i-PROBLEM
29637	.	O
29638	this	b-TREATMENT
29639	operation	i-TREATMENT
29640	was	O
29641	performed	O
29642	2/11/02	b-DATE
29643	by	O
29644	doctor	O
29645	doje	O
29646	para	O
29647	.	O
29648	the	O
29649	postoperative	O
29650	course	O
29651	was	O
29652	complicated	O
29653	by	O
29654	atrial	b-PROBLEM
29655	fibrillation	i-PROBLEM
29656	with	O
29657	transfer	b-OCCURRENCE
29658	to	O
29659	the	b-CLINICAL_DEPT
29660	cardiac	i-CLINICAL_DEPT
29661	step-down	i-CLINICAL_DEPT
29662	unit	i-CLINICAL_DEPT
29663	.	O
29664	this	b-OCCURRENCE
29665	transfer	i-OCCURRENCE
29666	occurred	O
29667	around	O
29668	postoperative	b-DATE
29669	day	i-DATE
29670	8	i-DATE
29671	for	O
29672	anticoagulation	b-TREATMENT
29673	and	O
29674	amiodarone	b-TREATMENT
29675	load	i-TREATMENT
29676	.	O
29677	the	b-TREATMENT
29678	anticoagulation	i-TREATMENT
29679	was	O
29680	stopped	O
29681	due	O
29682	to	O
29683	concern	O
29684	for	O
29685	postoperative	b-PROBLEM
29686	bleeding	i-PROBLEM
29687	.	O
29688	the	O
29689	patient	O
29690	complained	b-EVIDENTIAL
29691	of	O
29692	fevers	b-PROBLEM
29693	.	O
29694	the	O
29695	patient	O
29696	presented	b-OCCURRENCE
29697	to	O
29698	the	b-CLINICAL_DEPT
29699	emergency	i-CLINICAL_DEPT
29700	room	i-CLINICAL_DEPT
29701	on	O
29702	3/7/02	b-DATE
29703	,	O
29704	complaining	b-EVIDENTIAL
29705	of	O
29706	fevers	b-PROBLEM
29707	since	O
29708	monday	O
29709	3/2/02	b-DATE
29710	.	O
29711	he	O
29712	developed	O
29713	erythema	b-PROBLEM
29714	around	O
29715	the	b-PROBLEM
29716	wound	i-PROBLEM
29717	on	O
29718	wednesday	b-DATE
29719	and	O
29720	was	O
29721	seen	b-OCCURRENCE
29722	by	O
29723	doctor	O
29724	para	O
29725	,	O
29726	who	O
29727	started	O
29728	keflex	b-TREATMENT
29729	and	O
29730	obtained	O
29731	a	b-TEST
29732	ct	i-TEST
29733	scan	i-TEST
29734	which	O
29735	demonstrated	b-EVIDENTIAL
29736	a	b-PROBLEM
29737	fluid	i-PROBLEM
29738	collection	i-PROBLEM
29739	at	O
29740	the	O
29741	site	O
29742	of	O
29743	erythema	b-PROBLEM
29744	.	O
29745	the	b-PROBLEM
29746	fevers	i-PROBLEM
29747	continued	O
29748	as	O
29749	high	O
29750	as	O
29751	102.5	O
29752	degrees	O
29753	f	O
29754	with	O
29755	chills	b-PROBLEM
29756	on	O
29757	the	b-DATE
29758	morning	i-DATE
29759	of	i-DATE
29760	admission	i-DATE
29761	.	O
29762	he	O
29763	was	O
29764	draining	O
29765	pus	b-PROBLEM
29766	from	O
29767	the	b-PROBLEM
29768	wound	i-PROBLEM
29769	site	i-PROBLEM
29770	with	O
29771	subsequent	O
29772	relief	O
29773	of	O
29774	discomfort	b-PROBLEM
29775	at	O
29776	the	O
29777	site	O
29778	.	O
29779	hospital	O
29780	course	O
29781	:	O
29782	the	O
29783	patient	O
29784	was	O
29785	admitted	b-OCCURRENCE
29786	to	O
29787	urology	b-CLINICAL_DEPT
29788	.	O
29789	after	O
29790	the	b-OCCURRENCE
29791	wound	i-OCCURRENCE
29792	was	i-OCCURRENCE
29793	further	i-OCCURRENCE
29794	opened	i-OCCURRENCE
29795	,	O
29796	he	O
29797	was	O
29798	started	O
29799	on	O
29800	ampicillin	b-TREATMENT
29801	,	O
29802	gentamicin	b-TREATMENT
29803	,	O
29804	and	O
29805	flagyl	b-TREATMENT
29806	antibiotics	i-TREATMENT
29807	and	O
29808	he	O
29809	was	O
29810	placed	O
29811	on	O
29812	a	b-TREATMENT
29813	bid	i-TREATMENT
29814	dressing	i-TREATMENT
29815	change	i-TREATMENT
29816	and	O
29817	packing	b-TREATMENT
29818	.	O
29819	on	O
29820	hospital	b-DATE
29821	day	i-DATE
29822	2	i-DATE
29823	,	O
29824	the	O
29825	patient	O
29826	had	O
29827	no	O
29828	complaints	b-EVIDENTIAL
29829	.	O
29830	he	O
29831	was	O
29832	afebrile	b-PROBLEM
29833	with	O
29834	stable	b-OCCURRENCE
29835	vital	i-OCCURRENCE
29836	signs	i-OCCURRENCE
29837	and	O
29838	good	b-OCCURRENCE
29839	urine	i-OCCURRENCE
29840	output	i-OCCURRENCE
29841	.	O
29842	the	b-PROBLEM
29843	wound	i-PROBLEM
29844	erythema	i-PROBLEM
29845	was	O
29846	improving	b-OCCURRENCE
29847	and	O
29848	the	b-PROBLEM
29849	wound	i-PROBLEM
29850	was	O
29851	packed	b-TREATMENT
29852	twice	b-FREQUENCY
29853	a	i-FREQUENCY
29854	day	i-FREQUENCY
29855	.	O
29856	wound	b-TEST
29857	cultures	i-TEST
29858	remained	O
29859	negative	O
29860	at	O
29861	that	O
29862	time	O
29863	.	O
29864	we	O
29865	continued	O
29866	his	b-TREATMENT
29867	ampicillin	i-TREATMENT
29868	,	O
29869	gentamicin	b-TREATMENT
29870	,	O
29871	and	O
29872	flagyl	b-TREATMENT
29873	.	O
29874	by	O
29875	hospital	b-DATE
29876	day	i-DATE
29877	4	i-DATE
29878	,	O
29879	he	O
29880	remained	O
29881	afebrile	b-PROBLEM
29882	throughout	O
29883	his	b-OCCURRENCE
29884	hospital	i-OCCURRENCE
29885	course	i-OCCURRENCE
29886	.	O
29887	the	b-TEST
29888	wound	i-TEST
29889	cultures	i-TEST
29890	demonstrated	b-EVIDENTIAL
29891	gram-positive	b-PROBLEM
29892	cocci	i-PROBLEM
29893	in	i-PROBLEM
29894	clusters	i-PROBLEM
29895	and	O
29896	gram-negative	b-PROBLEM
29897	rods	i-PROBLEM
29898	.	O
29899	blood	b-TEST
29900	cultures	i-TEST
29901	remained	O
29902	negative	O
29903	.	O
29904	the	O
29905	patient	O
29906	was	O
29907	continued	O
29908	on	O
29909	antibiotics	b-TREATMENT
29910	and	O
29911	we	O
29912	obtained	O
29913	a	b-TEST
29914	ct	i-TEST
29915	scan	i-TEST
29916	to	O
29917	check	O
29918	for	O
29919	an	b-PROBLEM
29920	enterocutaneous	i-PROBLEM
29921	fistula	i-PROBLEM
29922	.	O
29923	we	O
29924	discontinued	O
29925	his	b-TREATMENT
29926	flagyl	i-TREATMENT
29927	on	O
29928	that	b-DATE
29929	day	i-DATE
29930	.	O
29931	we	O
29932	contacted	O
29933	the	O
29934	patient	O
29935	&apos;s	O
29936	primary	O
29937	care	O
29938	physician	O
29939	,	O
29940	doctor	O
29941	aslinke	O
29942	______	O
29943	,	O
29944	regarding	O
29945	his	b-TREATMENT
29946	cardiac	i-TREATMENT
29947	medication	i-TREATMENT
29948	management	i-TREATMENT
29949	.	O
29950	we	O
29951	agreed	O
29952	that	O
29953	he	O
29954	should	O
29955	resume	O
29956	his	b-TREATMENT
29957	atenolol	i-TREATMENT
29958	.	O
29959	he	O
29960	was	O
29961	started	O
29962	on	O
29963	2.5	O
29964	mg	O
29965	po	O
29966	qd	b-FREQUENCY
29967	.	O
29968	he	O
29969	was	O
29970	continued	O
29971	on	O
29972	his	b-TREATMENT
29973	dressing	i-TREATMENT
29974	changes	i-TREATMENT
29975	.	O
29976	we	O
29977	changed	O
29978	the	b-TREATMENT
29979	dressings	i-TREATMENT
29980	tid	b-FREQUENCY
29981	instead	O
29982	of	O
29983	bid	b-FREQUENCY
29984	for	O
29985	continued	b-PROBLEM
29986	drainage	i-PROBLEM
29987	.	O
29988	the	b-TEST
29989	ct	i-TEST
29990	scan	i-TEST
29991	that	O
29992	was	O
29993	obtained	O
29994	on	O
29995	3/10/02	b-DATE
29996	demonstrated	b-EVIDENTIAL
29997	no	O
29998	connection	b-OCCURRENCE
29999	between	O
30000	bowel	b-OCCURRENCE
30001	and	O
30002	the	b-PROBLEM
30003	wound	i-PROBLEM
30004	.	O
30005	the	b-PROBLEM
30006	drainage	i-PROBLEM
30007	had	O
30008	been	O
30009	decreasing	O
30010	and	O
30011	the	O
30012	patient	O
30013	continued	O
30014	to	O
30015	be	O
30016	afebrile	b-PROBLEM
30017	.	O
30018	on	O
30019	the	O
30020	following	O
30021	day	O
30022	,	O
30023	3/11/02	b-DATE
30024	,	O
30025	a	b-TEST
30026	fistulogram	i-TEST
30027	was	O
30028	obtained	O
30029	which	O
30030	was	O
30031	negative	O
30032	for	O
30033	a	b-PROBLEM
30034	fistula	i-PROBLEM
30035	from	i-PROBLEM
30036	the	i-PROBLEM
30037	bowel	i-PROBLEM
30038	to	O
30039	the	b-PROBLEM
30040	wound	i-PROBLEM
30041	.	O
30042	the	O
30043	patient	O
30044	was	O
30045	continued	O
30046	on	O
30047	ampicillin	b-TREATMENT
30048	and	O
30049	gentamicin	b-TREATMENT
30050	.	O
30051	her	O
30052	remained	O
30053	afebrile	b-PROBLEM
30054	with	O
30055	stable	O
30056	vital	O
30057	signs	O
30058	.	O
30059	he	O
30060	was	O
30061	comfortable	O
30062	and	O
30063	erythema	b-PROBLEM
30064	continued	O
30065	to	O
30066	decrease	b-OCCURRENCE
30067	with	O
30068	improvemeent	b-OCCURRENCE
30069	in	O
30070	the	O
30071	appearance	O
30072	of	O
30073	the	b-PROBLEM
30074	wound	i-PROBLEM
30075	.	O
30076	in	O
30077	consultation	O
30078	with	O
30079	infectious	b-CLINICAL_DEPT
30080	disease	i-CLINICAL_DEPT
30081	,	O
30082	it	O
30083	was	O
30084	agreed	O
30085	to	O
30086	discharge	b-OCCURRENCE
30087	the	O
30088	patient	O
30089	on	O
30090	augmentin	b-TREATMENT
30091	for	O
30092	coverage	O
30093	.	O
30094	we	O
30095	obtained	O
30096	sensitivities	b-TEST
30097	of	O
30098	his	b-PROBLEM
30099	wound	i-PROBLEM
30100	bacteria	i-PROBLEM
30101	.	O
30102	his	b-TREATMENT
30103	intravenous	i-TREATMENT
30104	antibiotics	i-TREATMENT
30105	were	O
30106	discontinued	b-OCCURRENCE
30107	.	O
30108	he	O
30109	remaineda	b-PROBLEM
30110	febrile	i-PROBLEM
30111	with	O
30112	daily	O
30113	improvement	O
30114	in	O
30115	the	O
30116	appearance	O
30117	of	O
30118	his	b-PROBLEM
30119	wound	i-PROBLEM
30120	.	O
30121	on	O
30122	hospital	b-DATE
30123	day	i-DATE
30124	7	i-DATE
30125	,	O
30126	the	O
30127	patient	O
30128	remained	O
30129	afebrile	b-PROBLEM
30130	with	O
30131	stable	O
30132	vital	O
30133	signs	O
30134	.	O
30135	his	b-PROBLEM
30136	wound	i-PROBLEM
30137	demonstrated	O
30138	no	O
30139	erythema	b-PROBLEM
30140	with	O
30141	moderate	b-PROBLEM
30142	dark	i-PROBLEM
30143	drainage	i-PROBLEM
30144	.	O
30145	the	O
30146	patient	O
30147	will	O
30148	be	O
30149	discharged	b-OCCURRENCE
30150	with	O
30151	wh	O
30152	and	O
30153	continued	b-TREATMENT
30154	dressing	i-TREATMENT
30155	changes	i-TREATMENT
30156	bid	b-FREQUENCY
30157	.	O
30158		O
30159	admission	b-OCCURRENCE
30160	date	O
30161	:	O
30162	8/21/93	b-DATE
30163	discharge	b-OCCURRENCE
30164	date	O
30165	:	O
30166	8/23/93	b-DATE
30167	history	O
30168	of	O
30169	present	O
30170	illness	O
30171	:	O
30172	this	O
30173	68	O
30174	year	O
30175	old	O
30176	female	O
30177	has	O
30178	rheumatic	b-PROBLEM
30179	heart	i-PROBLEM
30180	disease	i-PROBLEM
30181	.	O
30182	mitral	b-TREATMENT
30183	and	i-TREATMENT
30184	possibly	i-TREATMENT
30185	tricuspid	i-TREATMENT
30186	valve	i-TREATMENT
30187	surgery	i-TREATMENT
30188	is	O
30189	scheduled	O
30190	for	O
30191	labor	b-DATE
30192	day	i-DATE
30193	by	O
30194	doctor	O
30195	riemund	O
30196	c.	O
30197	kennedy	O
30198	.	O
30199	her	O
30200	history	O
30201	is	O
30202	detailed	O
30203	in	O
30204	the	b-EVIDENTIAL
30205	discharge	i-EVIDENTIAL
30206	summary	i-EVIDENTIAL
30207	of	O
30208	august	b-DATE
30209	10	i-DATE
30210	of	O
30211	this	O
30212	year	O
30213	.	O
30214	she	O
30215	is	O
30216	admitted	b-OCCURRENCE
30217	now	O
30218	for	O
30219	a	b-TREATMENT
30220	neuro-interventional	i-TREATMENT
30221	radiology	i-TREATMENT
30222	procedure	i-TREATMENT
30223	to	O
30224	decrease	O
30225	the	O
30226	likelihood	O
30227	of	O
30228	epistaxis	b-PROBLEM
30229	on	O
30230	coumadin	b-TREATMENT
30231	.	O
30232	hospital	O
30233	course	O
30234	:	O
30235	the	b-TREATMENT
30236	interventional	i-TREATMENT
30237	neuro-radiology	i-TREATMENT
30238	procedure	i-TREATMENT
30239	was	O
30240	performed	O
30241	by	O
30242	doctor	O
30243	a	O
30244	skizeis	O
30245	,	O
30246	on	O
30247	august	b-DATE
30248	22	i-DATE
30249	,	O
30250	via	O
30251	the	O
30252	right	O
30253	femoral	O
30254	artery	O
30255	.	O
30256	the	O
30257	right	O
30258	internal	O
30259	maxillary	O
30260	artery	O
30261	supply	O
30262	to	O
30263	the	O
30264	nasal	O
30265	mucosa	O
30266	was	O
30267	embolized	b-TREATMENT
30268	.	O
30269	the	O
30270	left	O
30271	external	O
30272	carotid	O
30273	artery	O
30274	was	O
30275	occluded	b-PROBLEM
30276	at	O
30277	its	O
30278	origin	O
30279	,	O
30280	with	O
30281	collaterals	b-PROBLEM
30282	from	O
30283	the	O
30284	internal	O
30285	carotid	O
30286	artery	O
30287	.	O
30288	thus	O
30289	,	O
30290	embolization	b-TREATMENT
30291	on	i-TREATMENT
30292	the	i-TREATMENT
30293	left	i-TREATMENT
30294	side	i-TREATMENT
30295	was	O
30296	not	O
30297	possible	O
30298	.	O
30299	the	O
30300	patient	O
30301	received	O
30302	coumadin	b-TREATMENT
30303	,	O
30304	10	O
30305	mg.	O
30306	,	O
30307	on	O
30308	the	b-TIME
30309	evening	i-TIME
30310	following	i-TIME
30311	the	i-TIME
30312	procedure	i-TIME
30313	,	O
30314	and	O
30315	is	O
30316	discharged	b-OCCURRENCE
30317	the	b-DATE
30318	next	i-DATE
30319	day	i-DATE
30320	.	O
30321	her	b-TEST
30322	prothrombin	i-TEST
30323	time	i-TEST
30324	will	O
30325	be	O
30326	rechecked	O
30327	on	O
30328	august	b-DATE
30329	27	i-DATE
30330	by	O
30331	her	O
30332	primary	O
30333	care	O
30334	physician	O
30335	,	O
30336	doctor	O
30337	naka	O
30338	gift	O
30339	.	O
30340	once	O
30341	her	b-TEST
30342	prothrombin	i-TEST
30343	time	i-TEST
30344	is	O
30345	in	O
30346	therapeutic	b-TREATMENT
30347	range	i-TREATMENT
30348	,	O
30349	she	O
30350	will	O
30351	be	O
30352	observed	b-OCCURRENCE
30353	for	O
30354	epistaxis	b-PROBLEM
30355	.	O
30356	she	O
30357	will	O
30358	take	b-OCCURRENCE
30359	her	i-OCCURRENCE
30360	last	i-OCCURRENCE
30361	dose	i-OCCURRENCE
30362	of	O
30363	coumadin	b-TREATMENT
30364	on	O
30365	september	b-DATE
30366	1	i-DATE
30367	in	O
30368	anticipation	O
30369	of	O
30370	cardiac	b-TREATMENT
30371	surgery	i-TREATMENT
30372	.	O
30373	if	O
30374	her	b-TEST
30375	prothrombin	i-TEST
30376	time	i-TEST
30377	does	O
30378	not	O
30379	come	b-OCCURRENCE
30380	into	i-OCCURRENCE
30381	therapeutic	i-OCCURRENCE
30382	range	i-OCCURRENCE
30383	promptly	O
30384	,	O
30385	then	O
30386	surgery	b-TREATMENT
30387	may	O
30388	be	O
30389	delayed	b-OCCURRENCE
30390	.	O
30391		O
30392	admission	b-OCCURRENCE
30393	date	O
30394	:	O
30395	01/04/96	b-ADMISSION
30396	discharge	b-OCCURRENCE
30397	date	O
30398	:	O
30399	01/10/96	b-DISCHARGE
30400	history	O
30401	of	O
30402	present	O
30403	illness	O
30404	:	O
30405	this	O
30406	78-year-old	O
30407	woman	O
30408	had	O
30409	stage	b-PROBLEM
30410	iiib	i-PROBLEM
30411	carcinoma	i-PROBLEM
30412	of	i-PROBLEM
30413	the	i-PROBLEM
30414	cervix	i-PROBLEM
30415	and	O
30416	she	O
30417	has	O
30418	known	b-PROBLEM
30419	periaortic	i-PROBLEM
30420	and	i-PROBLEM
30421	splenic	i-PROBLEM
30422	metastases	i-PROBLEM
30423	.	O
30424	she	O
30425	was	O
30426	discharged	b-OCCURRENCE
30427	from	O
30428	the	b-CLINICAL_DEPT
30429	hospital	i-CLINICAL_DEPT
30430	about	O
30431	18	b-DURATION
30432	days	i-DURATION
30433	prior	O
30434	to	O
30435	her	b-OCCURRENCE
30436	admission	i-OCCURRENCE
30437	,	O
30438	following	O
30439	a	b-DURATION
30440	month	i-DURATION
30441	long	i-DURATION
30442	stay	b-OCCURRENCE
30443	.	O
30444	when	O
30445	her	b-PROBLEM
30446	cancer	i-PROBLEM
30447	was	O
30448	diagnosed	b-EVIDENTIAL
30449	,	O
30450	she	O
30451	underwent	O
30452	total	b-TREATMENT
30453	abdominal	i-TREATMENT
30454	hysterectomy	i-TREATMENT
30455	and	O
30456	bilateral	b-TREATMENT
30457	salpingo-oophorectomy	i-TREATMENT
30458	and	O
30459	pelvic	b-TREATMENT
30460	lymphadenectomy	i-TREATMENT
30461	.	O
30462	she	O
30463	had	O
30464	extensive	b-PROBLEM
30465	disease	i-PROBLEM
30466	of	i-PROBLEM
30467	the	i-PROBLEM
30468	uterus	i-PROBLEM
30469	,	i-PROBLEM
30470	ovarian	i-PROBLEM
30471	tubes	i-PROBLEM
30472	,	i-PROBLEM
30473	omentum	i-PROBLEM
30474	and	i-PROBLEM
30475	the	i-PROBLEM
30476	periaortic	i-PROBLEM
30477	lymph	i-PROBLEM
30478	nodes	i-PROBLEM
30479	.	O
30480	postoperatively	O
30481	,	O
30482	she	O
30483	developed	O
30484	ileus	b-PROBLEM
30485	,	O
30486	then	O
30487	finally	O
30488	she	O
30489	recovered	b-OCCURRENCE
30490	and	O
30491	she	O
30492	was	O
30493	discharged	b-OCCURRENCE
30494	to	O
30495	the	b-CLINICAL_DEPT
30496	nursing	i-CLINICAL_DEPT
30497	home	i-CLINICAL_DEPT
30498	.	O
30499	she	O
30500	was	O
30501	readmitted	b-OCCURRENCE
30502	because	O
30503	of	O
30504	a	O
30505	problem	O
30506	with	O
30507	uremia	b-PROBLEM
30508	and	O
30509	high	b-PROBLEM
30510	bun	i-PROBLEM
30511	and	i-PROBLEM
30512	creatinine	i-PROBLEM
30513	when	O
30514	she	O
30515	seen	O
30516	in	O
30517	the	b-CLINICAL_DEPT
30518	office	i-CLINICAL_DEPT
30519	and	O
30520	the	b-TEST
30521	bun	i-TEST
30522	and	O
30523	creatinine	b-TEST
30524	was	O
30525	ordered	O
30526	.	O
30527	the	b-TEST
30528	bun	i-TEST
30529	was	O
30530	70	O
30531	and	O
30532	creatinine	b-TEST
30533	was	O
30534	4.6	O
30535	and	O
30536	for	O
30537	this	O
30538	reason	O
30539	she	O
30540	had	O
30541	ultrasound	b-TEST
30542	of	i-TEST
30543	the	i-TEST
30544	kidney	i-TEST
30545	which	O
30546	showed	b-EVIDENTIAL
30547	bilateral	b-PROBLEM
30548	hydronephrosis	i-PROBLEM
30549	.	O
30550	the	O
30551	patient	O
30552	was	O
30553	admitted	b-OCCURRENCE
30554	to	O
30555	the	b-CLINICAL_DEPT
30556	hospital	i-CLINICAL_DEPT
30557	for	O
30558	ureteral	b-TREATMENT
30559	stent	i-TREATMENT
30560	placement	i-TREATMENT
30561	.	O
30562	on	O
30563	the	b-DATE
30564	day	i-DATE
30565	of	i-DATE
30566	admission	i-DATE
30567	,	O
30568	she	O
30569	was	O
30570	generally	b-OCCURRENCE
30571	stable	i-OCCURRENCE
30572	and	O
30573	she	O
30574	had	O
30575	no	O
30576	evidence	O
30577	of	O
30578	disease	b-PROBLEM
30579	in	i-PROBLEM
30580	the	i-PROBLEM
30581	pelvis	i-PROBLEM
30582	,	O
30583	no	O
30584	bleeding	b-PROBLEM
30585	and	O
30586	no	O
30587	other	b-PROBLEM
30588	abnormality	i-PROBLEM
30589	.	O
30590	hospital	O
30591	course	O
30592	:	O
30593	doctor	O
30594	jescdrig	O
30595	was	O
30596	called	O
30597	and	O
30598	a	b-OCCURRENCE
30599	consultation	i-OCCURRENCE
30600	was	O
30601	done	O
30602	and	O
30603	he	O
30604	placed	O
30605	bilateral	b-TREATMENT
30606	ureteral	i-TREATMENT
30607	stents	i-TREATMENT
30608	in	i-TREATMENT
30609	her	i-TREATMENT
30610	kidneys	i-TREATMENT
30611	.	O
30612	postoperatively	O
30613	,	O
30614	she	O
30615	diuresed	b-OCCURRENCE
30616	very	O
30617	well	O
30618	.	O
30619	she	O
30620	had	O
30621	dropped	O
30622	her	b-TEST
30623	bun	i-TEST
30624	and	O
30625	creatinine	b-TEST
30626	to	O
30627	normal	b-OCCURRENCE
30628	and	O
30629	she	O
30630	was	O
30631	found	b-EVIDENTIAL
30632	to	O
30633	have	O
30634	may	O
30635	be	O
30636	metastatic	b-PROBLEM
30637	disease	i-PROBLEM
30638	to	i-PROBLEM
30639	her	i-PROBLEM
30640	skin	i-PROBLEM
30641	on	O
30642	the	O
30643	right	O
30644	paraumbilical	O
30645	area	O
30646	.	O
30647	because	O
30648	of	O
30649	her	O
30650	age	O
30651	and	O
30652	mental	O
30653	condition	O
30654	and	O
30655	the	O
30656	fact	O
30657	that	O
30658	she	O
30659	had	O
30660	cerebral	b-PROBLEM
30661	atrophy	i-PROBLEM
30662	,	O
30663	the	O
30664	decision	O
30665	was	O
30666	made	O
30667	for	O
30668	comfort	b-TREATMENT
30669	unless	O
30670	she	O
30671	has	O
30672	any	b-PROBLEM
30673	further	i-PROBLEM
30674	problem	i-PROBLEM
30675	and	O
30676	no	O
30677	further	O
30678	chemotherapy	b-TREATMENT
30679	or	O
30680	treatment	b-TREATMENT
30681	will	O
30682	be	O
30683	given	O
30684	.	O
30685	the	O
30686	possibility	O
30687	that	O
30688	she	O
30689	may	O
30690	need	O
30691	to	O
30692	receive	O
30693	radiation	b-TREATMENT
30694	therapy	i-TREATMENT
30695	to	O
30696	this	O
30697	area	O
30698	to	O
30699	prevent	O
30700	her	O
30701	from	O
30702	getting	O
30703	further	b-PROBLEM
30704	obstruction	i-PROBLEM
30705	was	O
30706	also	O
30707	brought	O
30708	up	O
30709	.	O
30710	her	O
30711	family	O
30712	felt	O
30713	that	O
30714	at	O
30715	the	b-DATE
30716	present	i-DATE
30717	time	i-DATE
30718	,	O
30719	because	O
30720	her	O
30721	condition	O
30722	was	O
30723	no	O
30724	good	b-PROBLEM
30725	,	O
30726	they	O
30727	would	O
30728	like	O
30729	to	O
30730	just	O
30731	take	b-OCCURRENCE
30732	her	i-OCCURRENCE
30733	home	i-OCCURRENCE
30734	so	O
30735	that	O
30736	she	O
30737	could	O
30738	enjoy	O
30739	the	O
30740	quality	O
30741	of	O
30742	life	O
30743	.	O
30744	indeed	O
30745	,	O
30746	at	O
30747	the	b-DATE
30748	time	i-DATE
30749	of	i-DATE
30750	discharge	i-DATE
30751	she	O
30752	was	O
30753	conscious	b-OCCURRENCE
30754	and	O
30755	she	O
30756	was	O
30757	cooperative	b-OCCURRENCE
30758	and	O
30759	she	O
30760	was	O
30761	able	O
30762	to	O
30763	communicate	b-OCCURRENCE
30764	very	O
30765	nicely	O
30766	with	O
30767	everyone	O
30768	including	O
30769	her	O
30770	family	O
30771	,	O
30772	except	O
30773	for	O
30774	the	b-PROBLEM
30775	mental	i-PROBLEM
30776	instability	i-PROBLEM
30777	that	O
30778	she	O
30779	had	O
30780	because	O
30781	of	O
30782	her	b-PROBLEM
30783	cerebral	i-PROBLEM
30784	atrophy	i-PROBLEM
30785	due	O
30786	to	O
30787	senility	b-PROBLEM
30788	.	O
30789	follow-up	O
30790	:	O
30791	she	O
30792	will	O
30793	be	O
30794	followed	O
30795	in	O
30796	the	O
30797	centu	O
30798	fairgmer	O
30799	queen	O
30800	medical	O
30801	center	O
30802	.	O
30803	azel	O
30804	u.	O
30805	hibbskays	O
30806	,	O
30807	md	O
30808	dictating	O
30809	for	O
30810	:	O
30811	earnra	O
30812	hawnspantkote	O
30813	,	O
30814	md	O
30815	tr	O
30816	:	O
30817	yq	O
30818	dd	O
30819	:	O
30820	01/26/96	O
30821	td	O
30822	:	O
30823	01/30/96	O
30824	12:18	O
30825	p	O
30826	cc	O
30827	:	O
30828	azel	O
30829	usanne	O
30830	hibbskays	O
30831	,	O
30832	md	O
30833	earnra	O
30834	hawnspantkote	O
30835	,	O
30836	md	O
30837		O
30838	admission	b-OCCURRENCE
30839	date	O
30840	:	O
30841	10/15/1999	b-ADMISSION
30842	discharge	b-OCCURRENCE
30843	date	O
30844	:	O
30845	10/18/1999	b-DISCHARGE
30846	history	O
30847	of	O
30848	present	O
30849	illness	O
30850	:	O
30851	mr.	O
30852	factor	O
30853	is	O
30854	a	O
30855	76	O
30856	year	O
30857	old	O
30858	white	O
30859	male	O
30860	with	O
30861	acute	b-PROBLEM
30862	inferior	i-PROBLEM
30863	myocardial	i-PROBLEM
30864	infarction	i-PROBLEM
30865	,	O
30866	who	O
30867	was	O
30868	urgently	O
30869	transferred	b-OCCURRENCE
30870	by	O
30871	doctor	O
30872	lenni	O
30873	factor	O
30874	for	O
30875	cardiac	b-TEST
30876	catheterization	i-TEST
30877	and	O
30878	possible	O
30879	angioplasty	b-TREATMENT
30880	.	O
30881	his	O
30882	only	O
30883	cardiac	O
30884	risk	O
30885	factor	O
30886	includes	O
30887	hypertension	b-PROBLEM
30888	.	O
30889	the	O
30890	night	O
30891	of	O
30892	oct	b-DATE
30893	14	i-DATE
30894	,	i-DATE
30895	1999	i-DATE
30896	the	O
30897	patient	O
30898	developed	b-OCCURRENCE
30899	chest	b-PROBLEM
30900	discomfort	i-PROBLEM
30901	associated	O
30902	with	O
30903	shortness	b-PROBLEM
30904	of	i-PROBLEM
30905	breath	i-PROBLEM
30906	.	O
30907	on	O
30908	october	b-TIME
30909	15	i-TIME
30910	,	i-TIME
30911	1999	i-TIME
30912	at	i-TIME
30913	6	i-TIME
30914	am	i-TIME
30915	the	O
30916	patient	O
30917	was	O
30918	admitted	b-OCCURRENCE
30919	to	O
30920	no	b-CLINICAL_DEPT
30921	verlmerver	i-CLINICAL_DEPT
30922	medical	i-CLINICAL_DEPT
30923	center	i-CLINICAL_DEPT
30924	.	O
30925	an	b-TEST
30926	electrocardiogram	i-TEST
30927	showed	b-EVIDENTIAL
30928	acute	b-PROBLEM
30929	inferior	i-PROBLEM
30930	myocardial	i-PROBLEM
30931	infarction	i-PROBLEM
30932	.	O
30933	due	O
30934	to	O
30935	unknown	O
30936	duration	O
30937	of	O
30938	the	b-PROBLEM
30939	chest	i-PROBLEM
30940	pain	i-PROBLEM
30941	thepatient	O
30942	was	O
30943	transferred	b-OCCURRENCE
30944	urgently	O
30945	to	O
30946	the	b-CLINICAL_DEPT
30947	tgcho	i-CLINICAL_DEPT
30948	for	O
30949	cardiac	b-TEST
30950	catheterization	i-TEST
30951	.	O
30952	shortly	O
30953	after	O
30954	aggrastat	b-TREATMENT
30955	was	O
30956	started	O
30957	,	O
30958	the	O
30959	patient	O
30960	became	O
30961	pain	b-PROBLEM
30962	free	O
30963	.	O
30964	hospital	O
30965	course	O
30966	and	O
30967	treatment	O
30968	:	O
30969	the	O
30970	patient	O
30971	was	O
30972	directly	O
30973	admitted	b-OCCURRENCE
30974	to	O
30975	the	b-CLINICAL_DEPT
30976	cardiac	i-CLINICAL_DEPT
30977	catheterization	i-CLINICAL_DEPT
30978	laboratory	i-CLINICAL_DEPT
30979	.	O
30980	coronary	b-TEST
30981	angiography	i-TEST
30982	,	O
30983	right	b-TEST
30984	heart	i-TEST
30985	catheterization	i-TEST
30986	and	O
30987	percutaneous	b-TREATMENT
30988	intervention	i-TREATMENT
30989	of	i-TREATMENT
30990	the	i-TREATMENT
30991	rca	i-TREATMENT
30992	were	O
30993	performed	O
30994	from	O
30995	the	O
30996	right	O
30997	groin	O
30998	without	O
30999	complications	b-PROBLEM
31000	.	O
31001	the	O
31002	proximal	O
31003	rca	O
31004	was	O
31005	totally	b-PROBLEM
31006	occluded	i-PROBLEM
31007	with	O
31008	good	O
31009	left	O
31010	to	O
31011	right	O
31012	collaterals	O
31013	.	O
31014	the	O
31015	lad	O
31016	showed	b-EVIDENTIAL
31017	a	b-PROBLEM
31018	40%	i-PROBLEM
31019	stenosis	i-PROBLEM
31020	in	i-PROBLEM
31021	the	i-PROBLEM
31022	proximal	i-PROBLEM
31023	segment	i-PROBLEM
31024	.	O
31025	the	O
31026	circumflex	O
31027	showed	b-EVIDENTIAL
31028	mild	b-PROBLEM
31029	atherosclerotic	i-PROBLEM
31030	.	O
31031	the	b-PROBLEM
31032	rca	i-PROBLEM
31033	occlusion	i-PROBLEM
31034	was	O
31035	successfully	O
31036	dilated	b-TREATMENT
31037	and	O
31038	sent	b-OCCURRENCE
31039	using	O
31040	a	b-TREATMENT
31041	3.0	i-TREATMENT
31042	x	i-TREATMENT
31043	23	i-TREATMENT
31044	mm	i-TREATMENT
31045	duet	i-TREATMENT
31046	with	O
31047	post	b-TREATMENT
31048	stent	i-TREATMENT
31049	dilatation	i-TREATMENT
31050	up	O
31051	to	O
31052	16	O
31053	atmospheres	O
31054	.	O
31055	following	O
31056	intervention	b-TREATMENT
31057	right	b-TEST
31058	heart	i-TEST
31059	catheterization	i-TEST
31060	was	O
31061	performed	O
31062	to	O
31063	rule	O
31064	out	O
31065	rv	b-PROBLEM
31066	infarct	i-PROBLEM
31067	.	O
31068	the	b-TEST
31069	ra	i-TEST
31070	was	O
31071	5	O
31072	.	O
31073	pa	b-TEST
31074	was	O
31075	19/7	O
31076	with	O
31077	a	O
31078	mean	O
31079	of	O
31080	13	O
31081	.	O
31082	pcw	b-TEST
31083	was	O
31084	11	O
31085	.	O
31086	of	O
31087	note	O
31088	there	O
31089	was	O
31090	a	b-PROBLEM
31091	clear	i-PROBLEM
31092	a	i-PROBLEM
31093	wave	i-PROBLEM
31094	in	O
31095	the	b-TEST
31096	rv	i-TEST
31097	tracing	i-TEST
31098	,	O
31099	suggestive	O
31100	of	O
31101	rv	b-PROBLEM
31102	infarct	i-PROBLEM
31103	.	O
31104	the	b-DATE
31105	next	i-DATE
31106	day	i-DATE
31107	the	O
31108	patient	O
31109	was	O
31110	quite	b-PROBLEM
31111	confused	i-PROBLEM
31112	and	O
31113	disoriented	b-PROBLEM
31114	,	O
31115	which	O
31116	gradually	O
31117	disappeared	b-OCCURRENCE
31118	.	O
31119	an	b-TEST
31120	echocardiogram	i-TEST
31121	was	O
31122	performed	O
31123	to	O
31124	evaluate	b-OCCURRENCE
31125	the	b-TEST
31126	lv	i-TEST
31127	function	i-TEST
31128	,	O
31129	which	O
31130	showed	b-EVIDENTIAL
31131	an	b-TEST
31132	ejection	i-TEST
31133	fraction	i-TEST
31134	of	O
31135	53%	O
31136	with	O
31137	inferoposteriorakinesis	b-PROBLEM
31138	/	O
31139	hypokinesis	b-PROBLEM
31140	.	O
31141	the	b-DATE
31142	next	i-DATE
31143	day	i-DATE
31144	the	b-PROBLEM
31145	patient	i-PROBLEM
31146	&apos;s	i-PROBLEM
31147	mental	i-PROBLEM
31148	status	i-PROBLEM
31149	came	O
31150	back	O
31151	to	O
31152	baseline	O
31153	and	O
31154	he	O
31155	remained	O
31156	free	O
31157	of	O
31158	angina	b-PROBLEM
31159	.	O
31160	ashee	O
31161	shoultsner	O
31162	,	O
31163	md	O
31164	electronically	O
31165	signed	O
31166	ashee	O
31167	shoultsner	O
31168	,	O
31169	md	O
31170	11/07/1999	O
31171	11:06	O
31172	tr	O
31173	:	O
31174	ghu	O
31175	dd	O
31176	:	O
31177	10/18/1999	O
31178	td	O
31179	:	O
31180	10/18/1999	O
31181	10:59	O
31182	acc	O
31183	:	O
31184	ashee	O
31185	shoultsner	O
31186	,	O
31187	md	O
31188	doctor	O
31189	lenni	O
31190	factor	O
31191	no	O
31192	verlmerver	O
31193	medical	O
31194	center	O
31195	doctor	O
31196	tomedankell	O
31197	flowayles	O
31198	no	O
31199	verlmerver	O
31200	medical	O
31201	center	O
31202	stat	O
31203		O
31204	admission	b-OCCURRENCE
31205	date	O
31206	:	O
31207	2019-07-17	b-ADMISSION
31208	discharge	b-OCCURRENCE
31209	date	O
31210	:	O
31211	2019-07-27	b-DISCHARGE
31212	service	O
31213	:	O
31214	medicine	O
31215	history	O
31216	of	O
31217	present	O
31218	illness	O
31219	:	O
31220	this	O
31221	is	O
31222	a	O
31223	39	O
31224	year-old	O
31225	female	O
31226	with	O
31227	a	O
31228	history	O
31229	of	O
31230	diabetes	b-PROBLEM
31231	type	i-PROBLEM
31232	i	i-PROBLEM
31233	on	O
31234	an	b-TREATMENT
31235	insulin	i-TREATMENT
31236	pump	i-TREATMENT
31237	,	O
31238	anemia	b-PROBLEM
31239	,	O
31240	hypothyroidism	b-PROBLEM
31241	,	O
31242	gastroparesis	b-PROBLEM
31243	,	O
31244	gerd	b-PROBLEM
31245	,	O
31246	who	O
31247	was	O
31248	transferred	b-OCCURRENCE
31249	from	O
31250	mediplex	b-CLINICAL_DEPT
31251	rehab	i-CLINICAL_DEPT
31252	hospital	i-CLINICAL_DEPT
31253	hospital	i-CLINICAL_DEPT
31254	for	O
31255	further	b-TREATMENT
31256	management	i-TREATMENT
31257	of	O
31258	hypoxic	b-PROBLEM
31259	respiratory	i-PROBLEM
31260	failure	i-PROBLEM
31261	.	O
31262	she	O
31263	arrived	b-OCCURRENCE
31264	at	O
31265	mediplex	b-CLINICAL_DEPT
31266	rehab	i-CLINICAL_DEPT
31267	hospital	i-CLINICAL_DEPT
31268	hospital	i-CLINICAL_DEPT
31269	on	O
31270	07-01	b-DATE
31271	for	O
31272	1	b-DURATION
31273	day	i-DURATION
31274	of	O
31275	nausea	b-PROBLEM
31276	and	O
31277	vomiting	b-PROBLEM
31278	and	O
31279	was	O
31280	found	O
31281	to	O
31282	be	O
31283	febrile	b-PROBLEM
31284	to	O
31285	99	O
31286	at	O
31287	that	b-DATE
31288	time	i-DATE
31289	.	O
31290	she	O
31291	was	O
31292	admitted	b-OCCURRENCE
31293	for	O
31294	likely	O
31295	gastroparesis	b-PROBLEM
31296	and	O
31297	eventually	O
31298	had	O
31299	a	b-TEST
31300	complete	i-TEST
31301	fever	i-TEST
31302	work-up	i-TEST
31303	that	O
31304	included	O
31305	a	O
31306	negative	O
31307	chest	b-TEST
31308	x-ray	i-TEST
31309	,	O
31310	blood	b-TEST
31311	cultures	i-TEST
31312	,	O
31313	and	O
31314	urine	b-TEST
31315	culture	i-TEST
31316	.	O
31317	she	O
31318	was	O
31319	discharged	b-OCCURRENCE
31320	on	O
31321	07-02	b-DATE
31322	and	O
31323	represented	b-OCCURRENCE
31324	that	b-DATE
31325	day	i-DATE
31326	with	O
31327	continued	b-PROBLEM
31328	nause	i-PROBLEM
31329	,	O
31330	vomiting	b-PROBLEM
31331	,	O
31332	and	O
31333	fever	b-PROBLEM
31334	.	O
31335	she	O
31336	was	O
31337	readmitted	b-OCCURRENCE
31338	and	O
31339	had	O
31340	a	b-TEST
31341	complete	i-TEST
31342	febrile	i-TEST
31343	work-up	i-TEST
31344	that	O
31345	included	O
31346	ct	b-TEST
31347	abdomene	i-TEST
31348	/	i-TEST
31349	pelvis	i-TEST
31350	,	O
31351	chest	b-TEST
31352	x-ray	i-TEST
31353	,	O
31354	blood	b-TEST
31355	culture	i-TEST
31356	's	O
31357	,	O
31358	urine	b-TEST
31359	cultures	i-TEST
31360	,	O
31361	all	O
31362	of	O
31363	which	O
31364	were	O
31365	unremarkable	O
31366	.	O
31367	she	O
31368	was	O
31369	intubated	b-TREATMENT
31370	on	O
31371	07-03	b-DATE
31372	for	O
31373	progressive	b-PROBLEM
31374	respiratory	i-PROBLEM
31375	failure	i-PROBLEM
31376	.	O
31377	workup	b-TEST
31378	continued	O
31379	to	O
31380	be	O
31381	negative	O
31382	.	O
31383	extubation	b-TREATMENT
31384	was	O
31385	attempted	O
31386	on	O
31387	07-14	b-DATE
31388	,	O
31389	but	O
31390	she	O
31391	was	O
31392	re-intubated	b-TREATMENT
31393	due	O
31394	to	O
31395	inspiratory	b-PROBLEM
31396	stridor	i-PROBLEM
31397	.	O
31398	a	b-TEST
31399	ct	i-TEST
31400	neck	i-TEST
31401	showed	b-EVIDENTIAL
31402	soft	b-PROBLEM
31403	tissue	i-PROBLEM
31404	swelling	i-PROBLEM
31405	obliterating	O
31406	the	O
31407	airway	O
31408	surrounding	O
31409	the	O
31410	ett	O
31411	tube	O
31412	.	O
31413	she	O
31414	was	O
31415	transferred	b-OCCURRENCE
31416	to	O
31417	providence	b-CLINICAL_DEPT
31418	behavioral	i-CLINICAL_DEPT
31419	health	i-CLINICAL_DEPT
31420	hospital	i-CLINICAL_DEPT
31421	for	O
31422	further	b-TREATMENT
31423	management	i-TREATMENT
31424	.	O
31425	brief	O
31426	hospital	O
31427	course	O
31428	:	O
31429	this	O
31430	is	O
31431	a	O
31432	39	O
31433	year-old	O
31434	female	O
31435	with	O
31436	diabetes	b-PROBLEM
31437	type	i-PROBLEM
31438	i	i-PROBLEM
31439	,	O
31440	hypothyroidism	b-PROBLEM
31441	,	O
31442	gastroparesis	b-PROBLEM
31443	who	O
31444	was	O
31445	transfered	b-OCCURRENCE
31446	for	O
31447	hypoxic	b-PROBLEM
31448	respiratory	i-PROBLEM
31449	failure	i-PROBLEM
31450	.	O
31451	1.	O
31452	hypoxic	O
31453	rspiratory	O
31454	failure	O
31455	:	O
31456	she	O
31457	arrived	b-OCCURRENCE
31458	intubated	b-TREATMENT
31459	and	O
31460	sedated	b-TREATMENT
31461	from	O
31462	esteban	b-CLINICAL_DEPT
31463	hospital	i-CLINICAL_DEPT
31464	.	O
31465	on	O
31466	arrival	b-OCCURRENCE
31467	a	b-TEST
31468	chest	i-TEST
31469	x-ray	i-TEST
31470	showed	b-EVIDENTIAL
31471	perihilar	b-PROBLEM
31472	and	i-PROBLEM
31473	bibasilar	i-PROBLEM
31474	opacities	i-PROBLEM
31475	,	O
31476	which	O
31477	appeared	O
31478	conistent	O
31479	with	O
31480	pulmonary	b-PROBLEM
31481	edema	i-PROBLEM
31482	but	O
31483	also	O
31484	possibly	O
31485	consistent	O
31486	with	O
31487	a	b-PROBLEM
31488	pneumonia	i-PROBLEM
31489	.	O
31490	there	O
31491	was	O
31492	no	O
31493	evidence	O
31494	of	O
31495	ards	b-PROBLEM
31496	.	O
31497	she	O
31498	was	O
31499	known	O
31500	to	O
31501	have	O
31502	gram-positive	b-PROBLEM
31503	cocci	i-PROBLEM
31504	in	i-PROBLEM
31505	her	i-PROBLEM
31506	sputum	i-PROBLEM
31507	at	O
31508	the	b-CLINICAL_DEPT
31509	outside	i-CLINICAL_DEPT
31510	hospital	i-CLINICAL_DEPT
31511	.	O
31512	a	b-TEST
31513	bronchoscopy	i-TEST
31514	with	O
31515	bal	b-TEST
31516	was	O
31517	performed	O
31518	and	O
31519	a	b-TEST
31520	sputum	i-TEST
31521	sample	i-TEST
31522	eventually	O
31523	grew	O
31524	out	O
31525	mrsa	b-PROBLEM
31526	.	O
31527	she	O
31528	was	O
31529	treated	O
31530	with	O
31531	vancomycin	b-TREATMENT
31532	to	O
31533	cover	O
31534	her	b-PROBLEM
31535	mrsa	i-PROBLEM
31536	pneumonia	i-PROBLEM
31537	.	O
31538	a	b-TEST
31539	ct	i-TEST
31540	scan	i-TEST
31541	was	O
31542	performed	O
31543	on	O
31544	07-17	b-DATE
31545	to	O
31546	evaluate	O
31547	the	b-PROBLEM
31548	soft	i-PROBLEM
31549	tissue	i-PROBLEM
31550	swelling	i-PROBLEM
31551	seen	O
31552	on	O
31553	ct	b-TEST
31554	at	O
31555	the	b-CLINICAL_DEPT
31556	outside	i-CLINICAL_DEPT
31557	hospital	i-CLINICAL_DEPT
31558	.	O
31559	the	b-TEST
31560	ct	i-TEST
31561	showed	b-EVIDENTIAL
31562	increased	b-PROBLEM
31563	soft	i-PROBLEM
31564	tissues	i-PROBLEM
31565	within	i-PROBLEM
31566	the	i-PROBLEM
31567	pharynx	i-PROBLEM
31568	which	O
31569	was	O
31570	felt	O
31571	to	O
31572	be	O
31573	secondary	O
31574	to	O
31575	prolonged	b-TREATMENT
31576	intubation	i-TREATMENT
31577	/	O
31578	trauma	b-PROBLEM
31579	.	O
31580	she	O
31581	was	O
31582	treated	O
31583	with	O
31584	steroids	b-TREATMENT
31585	for	O
31586	this	b-PROBLEM
31587	swelling	i-PROBLEM
31588	at	O
31589	the	b-CLINICAL_DEPT
31590	outside	i-CLINICAL_DEPT
31591	hospital	i-CLINICAL_DEPT
31592	,	O
31593	and	O
31594	these	O
31595	were	O
31596	continued	b-OCCURRENCE
31597	.	O
31598	it	O
31599	was	O
31600	decided	O
31601	that	O
31602	patient	O
31603	should	O
31604	receive	O
31605	one	O
31606	more	O
31607	trial	O
31608	off	O
31609	the	b-TREATMENT
31610	vent	i-TREATMENT
31611	before	O
31612	committing	O
31613	her	O
31614	to	O
31615	a	b-TREATMENT
31616	tracheotomy	i-TREATMENT
31617	.	O
31618	she	O
31619	did	O
31620	well	O
31621	on	O
31622	minimal	b-TREATMENT
31623	vent	i-TREATMENT
31624	settings	i-TREATMENT
31625	but	O
31626	it	O
31627	was	O
31628	decided	O
31629	to	O
31630	delay	O
31631	extubating	b-TEST
31632	the	O
31633	patient	O
31634	until	O
31635	the	b-TIME
31636	morning	i-TIME
31637	of	i-TIME
31638	6/2	i-TIME
31639	.	O
31640	overnight	b-DURATION
31641	,	O
31642	the	O
31643	patient	O
31644	became	O
31645	hypoxic	b-PROBLEM
31646	,	O
31647	dropping	O
31648	to	O
31649	the	O
31650	80	O
31651	's	O
31652	.	O
31653	a	b-TEST
31654	chest	i-TEST
31655	x-ray	i-TEST
31656	showed	b-EVIDENTIAL
31657	that	O
31658	the	b-TREATMENT
31659	et	i-TREATMENT
31660	tube	i-TREATMENT
31661	was	O
31662	displaced	b-PROBLEM
31663	to	O
31664	very	O
31665	high	O
31666	in	O
31667	the	O
31668	trachea	O
31669	.	O
31670	the	b-TREATMENT
31671	cuff	i-TREATMENT
31672	was	O
31673	deflated	b-OCCURRENCE
31674	and	O
31675	the	O
31676	patient	O
31677	was	O
31678	extubated	b-TREATMENT
31679	.	O
31680	she	O
31681	was	O
31682	placed	O
31683	in	O
31684	supplemental	b-TREATMENT
31685	oxygen	i-TREATMENT
31686	by	O
31687	shovel	b-TREATMENT
31688	mask	i-TREATMENT
31689	and	O
31690	her	b-TEST
31691	sats	i-TEST
31692	immediately	O
31693	improved	O
31694	.	O
31695	she	O
31696	was	O
31697	weaned	b-OCCURRENCE
31698	down	i-OCCURRENCE
31699	until	O
31700	she	O
31701	was	O
31702	maintaining	O
31703	her	b-TEST
31704	oxygen	i-TEST
31705	saturation	i-TEST
31706	above	O
31707	90%	O
31708	on	O
31709	6l	O
31710	by	O
31711	nasal	b-TREATMENT
31712	cannuala	i-TREATMENT
31713	.	O
31714	as	O
31715	she	O
31716	was	O
31717	doing	b-OCCURRENCE
31718	well	i-OCCURRENCE
31719	without	O
31720	evidence	O
31721	of	O
31722	stridor	b-PROBLEM
31723	,	O
31724	the	b-TREATMENT
31725	steroids	i-TREATMENT
31726	were	O
31727	stopped	O
31728	.	O
31729	she	O
31730	did	b-OCCURRENCE
31731	well	i-OCCURRENCE
31732	and	O
31733	was	O
31734	weaned	b-OCCURRENCE
31735	from	O
31736	supplemental	b-TREATMENT
31737	oxygen	i-TREATMENT
31738	.	O
31739	at	O
31740	the	b-DATE
31741	time	i-DATE
31742	of	i-DATE
31743	discharge	i-DATE
31744	,	O
31745	she	O
31746	was	O
31747	oxygenating	b-OCCURRENCE
31748	well	O
31749	on	O
31750	room	O
31751	air	O
31752	.	O
31753	she	O
31754	will	O
31755	need	O
31756	to	O
31757	complete	O
31758	a	b-DURATION
31759	14	i-DURATION
31760	day	i-DURATION
31761	course	i-DURATION
31762	of	O
31763	vancomycin	b-TREATMENT
31764	for	O
31765	her	b-PROBLEM
31766	mrsa	i-PROBLEM
31767	pneumonia	i-PROBLEM
31768	on	O
31769	2019-07-30	b-DATE
31770	.	O
31771	2.	O
31772	enterobacter	O
31773	bacteremia	O
31774	:	O
31775	she	O
31776	was	O
31777	initially	O
31778	covered	O
31779	broadly	O
31780	with	O
31781	vancomycin	b-TREATMENT
31782	,	O
31783	ciprofloxacin	b-TREATMENT
31784	,	O
31785	and	O
31786	falgyl	b-TREATMENT
31787	.	O
31788	she	O
31789	had	O
31790	positive	b-PROBLEM
31791	blood	i-PROBLEM
31792	cultures	i-PROBLEM
31793	at	O
31794	mediplex	b-CLINICAL_DEPT
31795	rehab	i-CLINICAL_DEPT
31796	hospital	i-CLINICAL_DEPT
31797	hospital	i-CLINICAL_DEPT
31798	for	O
31799	gram	b-PROBLEM
31800	negative	i-PROBLEM
31801	rods	i-PROBLEM
31802	.	O
31803	subsequently	O
31804	,	O
31805	zosyn	b-TREATMENT
31806	was	O
31807	added	O
31808	.	O
31809	the	b-TEST
31810	cultures	i-TEST
31811	grew	O
31812	out	O
31813	enterobacter	b-PROBLEM
31814	cloacae	i-PROBLEM
31815	.	O
31816	it	O
31817	was	O
31818	unclear	O
31819	the	O
31820	source	O
31821	of	O
31822	her	b-PROBLEM
31823	bacteremia	i-PROBLEM
31824	.	O
31825	her	b-TEST
31826	stool	i-TEST
31827	cultures	i-TEST
31828	were	O
31829	negative	O
31830	.	O
31831	her	b-TREATMENT
31832	central	i-TREATMENT
31833	line	i-TREATMENT
31834	was	O
31835	removed	b-TREATMENT
31836	and	O
31837	the	b-TREATMENT
31838	tip	i-TREATMENT
31839	was	O
31840	culture	O
31841	negative	O
31842	.	O
31843	she	O
31844	was	O
31845	transitioned	b-OCCURRENCE
31846	to	O
31847	on	O
31848	levofloxacin	b-TREATMENT
31849	for	O
31850	her	b-PROBLEM
31851	bacteremia	i-PROBLEM
31852	.	O
31853	she	O
31854	had	O
31855	no	O
31856	positive	b-PROBLEM
31857	cultures	i-PROBLEM
31858	during	O
31859	this	b-OCCURRENCE
31860	admission	i-OCCURRENCE
31861	.	O
31862	once	O
31863	she	O
31864	was	O
31865	more	O
31866	stable	O
31867	,	O
31868	an	b-TEST
31869	abdominal	i-TEST
31870	ct	i-TEST
31871	was	O
31872	performed	O
31873	to	O
31874	look	O
31875	for	O
31876	an	b-PROBLEM
31877	abscess	i-PROBLEM
31878	.	O
31879	this	b-TEST
31880	study	i-TEST
31881	was	O
31882	negative	O
31883	.	O
31884	however	O
31885	,	O
31886	the	b-TEST
31887	study	i-TEST
31888	was	O
31889	limited	O
31890	due	O
31891	to	O
31892	inadequate	b-PROBLEM
31893	po	i-PROBLEM
31894	contrast	i-PROBLEM
31895	intake	i-PROBLEM
31896	by	O
31897	the	O
31898	patient	O
31899	;	O
31900	it	O
31901	did	O
31902	show	O
31903	a	O
31904	question	O
31905	of	O
31906	a	b-PROBLEM
31907	cecal	i-PROBLEM
31908	cystic	i-PROBLEM
31909	lesion	i-PROBLEM
31910	verse	O
31911	normal	O
31912	loop	O
31913	of	O
31914	bowel	O
31915	.	O
31916	this	b-TEST
31917	study	i-TEST
31918	will	O
31919	need	O
31920	to	O
31921	be	O
31922	repeated	b-OCCURRENCE
31923	once	O
31924	she	O
31925	is	O
31926	tolerating	O
31927	po	O
31928	's	O
31929	.	O
31930	she	O
31931	will	O
31932	complete	O
31933	a	b-DURATION
31934	14	i-DURATION
31935	day	i-DURATION
31936	course	i-DURATION
31937	of	O
31938	levofloxacin	b-TREATMENT
31939	for	O
31940	her	b-PROBLEM
31941	bacteremia	i-PROBLEM
31942	on	O
31943	2019-07-30	b-DATE
31944	.	O
31945	3.	O
31946	diabetes	O
31947	type	O
31948	i	O
31949	:	O
31950	she	O
31951	was	O
31952	intially	O
31953	maintained	O
31954	on	O
31955	an	b-TREATMENT
31956	insulin	i-TREATMENT
31957	drip	i-TREATMENT
31958	for	O
31959	tight	b-TREATMENT
31960	glycemic	i-TREATMENT
31961	control	i-TREATMENT
31962	.	O
31963	she	O
31964	was	O
31965	followed	O
31966	by	O
31967	albano	b-CLINICAL_DEPT
31968	during	O
31969	the	b-OCCURRENCE
31970	admission	i-OCCURRENCE
31971	.	O
31972	she	O
31973	was	O
31974	initially	O
31975	maintained	O
31976	on	O
31977	d5w	b-TREATMENT
31978	,	O
31979	which	O
31980	was	O
31981	increased	O
31982	to	O
31983	d10w	b-TREATMENT
31984	as	O
31985	the	O
31986	patient	O
31987	was	O
31988	persistently	b-PROBLEM
31989	borderline	i-PROBLEM
31990	hypoglycemic	i-PROBLEM
31991	while	O
31992	on	O
31993	insulin	b-TREATMENT
31994	drip	i-TREATMENT
31995	.	O
31996	once	O
31997	she	O
31998	began	b-TREATMENT
31999	to	i-TREATMENT
32000	take	i-TREATMENT
32001	po	i-TREATMENT
32002	's	i-TREATMENT
32003	,	O
32004	the	b-TREATMENT
32005	insulin	i-TREATMENT
32006	drip	i-TREATMENT
32007	was	O
32008	stopped	O
32009	and	O
32010	patient	O
32011	was	O
32012	started	O
32013	on	O
32014	glargine	b-TREATMENT
32015	with	O
32016	a	b-TREATMENT
32017	humalog	i-TREATMENT
32018	sliding	i-TREATMENT
32019	scale	i-TREATMENT
32020	.	O
32021	while	O
32022	her	O
32023	po	O
32024	intake	O
32025	was	O
32026	minimal	O
32027	she	O
32028	was	O
32029	maintained	O
32030	on	O
32031	supplemental	b-TREATMENT
32032	iv	i-TREATMENT
32033	dextrose	i-TREATMENT
32034	to	O
32035	suppress	O
32036	ketosis	b-PROBLEM
32037	.	O
32038	while	O
32039	she	O
32040	was	O
32041	on	O
32042	the	b-TREATMENT
32043	iv	i-TREATMENT
32044	dextrose	i-TREATMENT
32045	,	O
32046	she	O
32047	required	O
32048	up	O
32049	to	O
32050	26	O
32051	units	O
32052	of	O
32053	glargine	b-TREATMENT
32054	for	O
32055	glycemic	b-TREATMENT
32056	control	i-TREATMENT
32057	.	O
32058	as	O
32059	she	O
32060	starting	O
32061	taking	O
32062	some	O
32063	foods	O
32064	,	O
32065	her	b-TREATMENT
32066	glargine	i-TREATMENT
32067	was	O
32068	decrease	b-OCCURRENCE
32069	.	O
32070	at	O
32071	the	b-DATE
32072	time	i-DATE
32073	of	O
32074	discharge	O
32075	her	b-TREATMENT
32076	glargine	i-TREATMENT
32077	was	O
32078	10	O
32079	.	O
32080	her	b-TEST
32081	blood	i-TEST
32082	glucose	i-TEST
32083	were	O
32084	under	O
32085	good	O
32086	control	O
32087	.	O
32088	the	b-DATE
32089	day	i-DATE
32090	prior	i-DATE
32091	to	i-DATE
32092	discharge	i-DATE
32093	,	O
32094	she	O
32095	was	O
32096	nauseated	b-PROBLEM
32097	and	O
32098	not	O
32099	taking	b-PROBLEM
32100	pos	i-PROBLEM
32101	.	O
32102	therefore	O
32103	,	O
32104	she	O
32105	received	O
32106	1l	O
32107	of	O
32108	d5	b-TREATMENT
32109	,	O
32110	and	O
32111	her	b-TEST
32112	sugars	i-TEST
32113	were	O
32114	elevated	O
32115	to	O
32116	400	O
32117	the	b-DATE
32118	day	i-DATE
32119	of	i-DATE
32120	discharge	i-DATE
32121	.	O
32122	4.	O
32123	gastroparesis	O
32124	:	O
32125	she	O
32126	has	O
32127	a	O
32128	history	O
32129	of	O
32130	gastroparesis	b-PROBLEM
32131	secondary	O
32132	to	O
32133	long-standing	b-PROBLEM
32134	type	i-PROBLEM
32135	i	i-PROBLEM
32136	diabetes	i-PROBLEM
32137	.	O
32138	once	O
32139	she	O
32140	was	O
32141	extubated	b-TREATMENT
32142	,	O
32143	she	O
32144	was	O
32145	nauseated	b-PROBLEM
32146	with	O
32147	emesis	b-PROBLEM
32148	.	O
32149	she	O
32150	was	O
32151	intially	O
32152	treated	O
32153	with	O
32154	erythromycin	b-TREATMENT
32155	for	O
32156	pro-motility	b-PROBLEM
32157	as	O
32158	she	O
32159	had	O
32160	a	b-PROBLEM
32161	bad	i-PROBLEM
32162	reaction	i-PROBLEM
32163	to	O
32164	reglan	b-TREATMENT
32165	in	O
32166	the	O
32167	past	O
32168	.	O
32169	she	O
32170	continued	O
32171	to	O
32172	remained	O
32173	nauseated	b-PROBLEM
32174	so	O
32175	she	O
32176	was	O
32177	treated	O
32178	with	O
32179	phenergan	b-TREATMENT
32180	,	O
32181	anzemet	b-TREATMENT
32182	,	O
32183	zofran	b-TREATMENT
32184	,	O
32185	and	O
32186	ativan	b-TREATMENT
32187	.	O
32188	she	O
32189	intermittently	O
32190	was	O
32191	able	b-OCCURRENCE
32192	tolerate	i-OCCURRENCE
32193	pos	i-OCCURRENCE
32194	.	O
32195	her	b-PROBLEM
32196	nausea	i-PROBLEM
32197	was	O
32198	accompanied	O
32199	by	O
32200	abdominal	b-PROBLEM
32201	pain	i-PROBLEM
32202	for	O
32203	which	O
32204	she	O
32205	was	O
32206	treated	O
32207	with	O
32208	morphine	b-TREATMENT
32209	.	O
32210	she	O
32211	was	O
32212	transitioned	b-OCCURRENCE
32213	to	O
32214	a	b-TREATMENT
32215	pca	i-TREATMENT
32216	for	O
32217	better	b-TREATMENT
32218	pain	i-TREATMENT
32219	control	i-TREATMENT
32220	.	O
32221	she	O
32222	continued	O
32223	to	O
32224	have	O
32225	nausea	b-PROBLEM
32226	despite	O
32227	an	b-TREATMENT
32228	agressive	i-TREATMENT
32229	anti-emetic	i-TREATMENT
32230	regimen	i-TREATMENT
32231	.	O
32232	it	O
32233	was	O
32234	felt	O
32235	that	O
32236	her	b-PROBLEM
32237	symptoms	i-PROBLEM
32238	were	O
32239	secondary	O
32240	to	O
32241	gastroparesis	b-PROBLEM
32242	.	O
32243	however	O
32244	,	O
32245	other	O
32246	causes	O
32247	were	O
32248	looked	O
32249	for	O
32250	including	O
32251	adrenal	b-PROBLEM
32252	insufficiency	i-PROBLEM
32253	and	O
32254	bowel	b-PROBLEM
32255	obstruction	i-PROBLEM
32256	.	O
32257	she	O
32258	had	O
32259	a	O
32260	normal	O
32261	cortisol	b-TEST
32262	stimulation	i-TEST
32263	test	i-TEST
32264	.	O
32265	a	b-TEST
32266	abdominal	i-TEST
32267	plain	i-TEST
32268	film	i-TEST
32269	showed	b-EVIDENTIAL
32270	non-specific	b-PROBLEM
32271	bowel	i-PROBLEM
32272	gas	i-PROBLEM
32273	patterns	i-PROBLEM
32274	that	O
32275	may	O
32276	represent	O
32277	an	b-PROBLEM
32278	early	i-PROBLEM
32279	obstruction	i-PROBLEM
32280	.	O
32281	a	b-TREATMENT
32282	ng	i-TREATMENT
32283	tube	i-TREATMENT
32284	was	O
32285	placed	O
32286	for	O
32287	decompression	b-TREATMENT
32288	given	O
32289	the	O
32290	signs	O
32291	of	O
32292	early	b-PROBLEM
32293	obstruction	i-PROBLEM
32294	the	b-DATE
32295	day	i-DATE
32296	of	i-DATE
32297	transfer	i-DATE
32298	.	O
32299	the	b-CLINICAL_DEPT
32300	gi	i-CLINICAL_DEPT
32301	service	i-CLINICAL_DEPT
32302	was	O
32303	consulted	O
32304	and	O
32305	they	O
32306	felt	O
32307	that	O
32308	her	b-PROBLEM
32309	symptoms	i-PROBLEM
32310	were	O
32311	all	O
32312	gastroparesis	b-PROBLEM
32313	.	O
32314	they	O
32315	recommended	O
32316	erythromycin	b-TREATMENT
32317	and	O
32318	zelnorm	b-TREATMENT
32319	.	O
32320	she	O
32321	should	O
32322	eventually	O
32323	have	O
32324	a	b-TEST
32325	tissue	i-TEST
32326	transglutaminase	i-TEST
32327	to	O
32328	rule	O
32329	out	O
32330	celiac	b-PROBLEM
32331	disease	i-PROBLEM
32332	.	O
32333	5.	O
32334	transaminitis	O
32335	:	O
32336	per	O
32337	report	O
32338	,	O
32339	she	O
32340	had	O
32341	elevated	b-PROBLEM
32342	lfts	i-PROBLEM
32343	at	O
32344	the	b-CLINICAL_DEPT
32345	outside	i-CLINICAL_DEPT
32346	hospital	i-CLINICAL_DEPT
32347	.	O
32348	a	b-TEST
32349	right	i-TEST
32350	upper	i-TEST
32351	quadrant	i-TEST
32352	ultrasound	i-TEST
32353	was	O
32354	performed	O
32355	and	O
32356	was	O
32357	negative	O
32358	for	O
32359	any	b-PROBLEM
32360	acute	i-PROBLEM
32361	pathology	i-PROBLEM
32362	.	O
32363	her	b-TEST
32364	lfts	i-TEST
32365	trended	b-OCCURRENCE
32366	down	i-OCCURRENCE
32367	during	O
32368	this	b-OCCURRENCE
32369	admission	i-OCCURRENCE
32370	.	O
32371	6.	O
32372	hypothyroidism	O
32373	:	O
32374	she	O
32375	was	O
32376	maintained	O
32377	on	O
32378	her	b-TREATMENT
32379	levothyroxine	i-TREATMENT
32380	.	O
32381	while	O
32382	she	O
32383	was	O
32384	not	O
32385	taking	O
32386	adequate	O
32387	pos	O
32388	,	O
32389	she	O
32390	was	O
32391	on	O
32392	iv	b-TREATMENT
32393	levothyroxine	i-TREATMENT
32394	.	O
32395	7.	O
32396	f/e/n	O
32397	:	O
32398	she	O
32399	was	O
32400	npo	b-TREATMENT
32401	while	O
32402	intubated	b-TREATMENT
32403	and	O
32404	recived	O
32405	tube	b-TREATMENT
32406	feedings	i-TREATMENT
32407	for	O
32408	nutrition	O
32409	.	O
32410	after	O
32411	extubation	b-TREATMENT
32412	,	O
32413	patient	O
32414	was	O
32415	started	O
32416	on	O
32417	sips	O
32418	and	O
32419	had	O
32420	a	b-TEST
32421	speech	i-TEST
32422	and	i-TEST
32423	swallow	i-TEST
32424	evaluation	i-TEST
32425	.	O
32426	she	O
32427	was	O
32428	cleared	O
32429	to	O
32430	advance	O
32431	her	O
32432	diet	O
32433	as	O
32434	tolerated	O
32435	.	O
32436	she	O
32437	only	O
32438	tolerated	O
32439	some	O
32440	clear	O
32441	liquids	O
32442	.	O
32443	at	O
32444	the	b-DATE
32445	time	i-DATE
32446	of	i-DATE
32447	transfer	i-DATE
32448	,	O
32449	she	O
32450	was	O
32451	npo	b-TREATMENT
32452	given	O
32453	her	b-TREATMENT
32454	ng	i-TREATMENT
32455	tube	i-TREATMENT
32456	.	O
32457	8.	O
32458	prophylaxis	O
32459	:	O
32460	ppi	b-TREATMENT
32461	,	O
32462	heparin	b-TREATMENT
32463	sq	i-TREATMENT
32464	.	O
32465	9.	O
32466	access	O
32467	:	O
32468	her	b-TREATMENT
32469	central	i-TREATMENT
32470	line	i-TREATMENT
32471	was	O
32472	removed	O
32473	given	O
32474	the	O
32475	concern	O
32476	for	O
32477	a	b-PROBLEM
32478	line	i-PROBLEM
32479	infection	i-PROBLEM
32480	.	O
32481	she	O
32482	had	O
32483	a	b-TREATMENT
32484	double	i-TREATMENT
32485	lumen	i-TREATMENT
32486	picc	i-TREATMENT
32487	place	O
32488	.	O
32489	10.	O
32490	code	O
32491	:	O
32492	full	O
32493	11.	O
32494	dispo	O
32495	:	O
32496	she	O
32497	was	O
32498	transfered	b-OCCURRENCE
32499	back	O
32500	to	O
32501	mediplex	b-CLINICAL_DEPT
32502	rehab	i-CLINICAL_DEPT
32503	hospital	i-CLINICAL_DEPT
32504	hospital	i-CLINICAL_DEPT
32505	per	O
32506	the	O
32507	patient	O
32508	's	O
32509	and	O
32510	husband	O
32511	's	O
32512	request	O
32513	so	O
32514	that	O
32515	she	O
32516	would	O
32517	be	O
32518	closer	O
32519	to	O
32520	home	O
32521	once	O
32522	her	b-TEST
32523	respiratory	i-TEST
32524	status	i-TEST
32525	was	O
32526	stable	O
32527	.	O
32528	anti-gbm	b-TEST
32529	is	O
32530	pending	O
32531	.	O
32532		O
32533	admission	b-OCCURRENCE
32534	date	O
32535	:	O
32536	11/04/2000	b-ADMISSION
32537	discharge	b-OCCURRENCE
32538	date	O
32539	:	O
32540	11/09/2000	b-DISCHARGE
32541	history	O
32542	of	O
32543	present	O
32544	illness	O
32545	:	O
32546	mr.	O
32547	state	O
32548	is	O
32549	an	O
32550	81-year-old	O
32551	man	O
32552	with	O
32553	a	O
32554	history	O
32555	of	O
32556	restrictive	b-PROBLEM
32557	and	i-PROBLEM
32558	obstructive	i-PROBLEM
32559	lung	i-PROBLEM
32560	disease	i-PROBLEM
32561	,	O
32562	dilated	b-PROBLEM
32563	cardiomyopathy	i-PROBLEM
32564	,	O
32565	inferior	b-PROBLEM
32566	myocardial	i-PROBLEM
32567	infarction	i-PROBLEM
32568	,	O
32569	and	O
32570	anterior	b-PROBLEM
32571	mediastinal	i-PROBLEM
32572	masses	i-PROBLEM
32573	admitted	b-OCCURRENCE
32574	with	O
32575	acute	O
32576	onset	O
32577	of	O
32578	pulmonary	b-PROBLEM
32579	edema	i-PROBLEM
32580	.	O
32581	in	O
32582	the	O
32583	setting	O
32584	of	O
32585	inadvertently	b-OCCURRENCE
32586	decreasing	i-OCCURRENCE
32587	lasix	b-TREATMENT
32588	from	O
32589	80	O
32590	mg.	O
32591	po	O
32592	40	O
32593	mg.	O
32594	a	b-FREQUENCY
32595	day	i-FREQUENCY
32596	mr.	O
32597	state	O
32598	had	O
32599	sudden	b-PROBLEM
32600	onset	i-PROBLEM
32601	dyspnea	i-PROBLEM
32602	after	O
32603	approximate	O
32604	day	b-DURATION
32605	and	i-DURATION
32606	a	i-DURATION
32607	half	i-DURATION
32608	prodrome	O
32609	culminating	O
32610	in	O
32611	severe	b-PROBLEM
32612	dyspnea	i-PROBLEM
32613	.	O
32614	upon	O
32615	arrival	b-OCCURRENCE
32616	in	O
32617	the	b-CLINICAL_DEPT
32618	emergency	i-CLINICAL_DEPT
32619	room	i-CLINICAL_DEPT
32620	mr.	b-TEST
32621	state	i-TEST
32622	&apos;s	i-TEST
32623	saturations	i-TEST
32624	were	O
32625	in	O
32626	the	O
32627	mid	O
32628	80s	O
32629	and	O
32630	he	O
32631	was	O
32632	promptly	O
32633	rendered	O
32634	more	b-OCCURRENCE
32635	comfortable	i-OCCURRENCE
32636	with	O
32637	high	b-TREATMENT
32638	flow	i-TREATMENT
32639	oxygen	i-TREATMENT
32640	,	O
32641	morphine	b-TREATMENT
32642	,	O
32643	and	O
32644	nitrates	b-TREATMENT
32645	and	O
32646	intravenous	b-TREATMENT
32647	lasix	i-TREATMENT
32648	.	O
32649	chest	b-TEST
32650	x-ray	i-TEST
32651	was	O
32652	relatively	O
32653	unrevealing	O
32654	for	O
32655	interstitial	b-PROBLEM
32656	or	i-PROBLEM
32657	alveolar	i-PROBLEM
32658	edema	i-PROBLEM
32659	and	O
32660	with	O
32661	clinical	b-OCCURRENCE
32662	improvement	i-OCCURRENCE
32663	ensued	O
32664	with	O
32665	the	b-TREATMENT
32666	immediate	i-TREATMENT
32667	therapy	i-TREATMENT
32668	in	O
32669	the	b-CLINICAL_DEPT
32670	emergency	i-CLINICAL_DEPT
32671	room	i-CLINICAL_DEPT
32672	as	O
32673	noted	b-EVIDENTIAL
32674	.	O
32675	the	O
32676	patient	O
32677	denied	b-EVIDENTIAL
32678	angina	b-PROBLEM
32679	,	O
32680	syncope	b-PROBLEM
32681	,	O
32682	preceding	b-PROBLEM
32683	worsening	i-PROBLEM
32684	orthopnea	i-PROBLEM
32685	,	O
32686	paroxysmal	b-PROBLEM
32687	nocturnal	i-PROBLEM
32688	dyspnea	i-PROBLEM
32689	,	O
32690	palpitations	b-PROBLEM
32691	,	O
32692	chest	b-PROBLEM
32693	pain	i-PROBLEM
32694	,	O
32695	hematemesis	b-PROBLEM
32696	or	O
32697	melena	b-PROBLEM
32698	.	O
32699	hospital	O
32700	course	O
32701	:	O
32702	the	O
32703	patient	O
32704	was	O
32705	admitted	b-OCCURRENCE
32706	to	O
32707	the	b-CLINICAL_DEPT
32708	hospital	i-CLINICAL_DEPT
32709	and	O
32710	underwent	O
32711	an	b-TREATMENT
32712	approximate	i-TREATMENT
32713	1.5	i-TREATMENT
32714	liter	i-TREATMENT
32715	diuresis	i-TREATMENT
32716	within	O
32717	the	b-DURATION
32718	first	i-DURATION
32719	24	i-DURATION
32720	hours	i-DURATION
32721	with	O
32722	improvement	b-OCCURRENCE
32723	in	O
32724	his	b-PROBLEM
32725	symptoms	i-PROBLEM
32726	and	O
32727	improvement	b-OCCURRENCE
32728	in	O
32729	his	b-TEST
32730	oxygen	i-TEST
32731	saturations	i-TEST
32732	.	O
32733	after	O
32734	a	b-OCCURRENCE
32735	long	i-OCCURRENCE
32736	discussion	i-OCCURRENCE
32737	with	O
32738	the	O
32739	patient	O
32740	and	O
32741	his	O
32742	family	O
32743	it	O
32744	was	O
32745	determined	O
32746	that	O
32747	a	b-TEST
32748	cardiac	i-TEST
32749	catheterization	i-TEST
32750	would	O
32751	be	O
32752	prudent	O
32753	.	O
32754	prior	O
32755	to	O
32756	catheterization	b-TEST
32757	a	b-TEST
32758	vq	i-TEST
32759	scan	i-TEST
32760	was	O
32761	performed	O
32762	which	O
32763	revealed	b-EVIDENTIAL
32764	a	O
32765	moderate	O
32766	probability	O
32767	for	O
32768	pe	b-PROBLEM
32769	with	O
32770	a	b-PROBLEM
32771	subsegmental	i-PROBLEM
32772	defect	i-PROBLEM
32773	in	i-PROBLEM
32774	the	i-PROBLEM
32775	lingular	i-PROBLEM
32776	on	O
32777	the	O
32778	left	O
32779	lung	O
32780	.	O
32781	subsequent	b-TEST
32782	lower	i-TEST
32783	extremities	i-TEST
32784	noninvasive	i-TEST
32785	studies	i-TEST
32786	and	O
32787	d-dimer	b-TEST
32788	test	i-TEST
32789	were	O
32790	both	O
32791	negative	O
32792	rendering	O
32793	the	O
32794	probability	O
32795	of	O
32796	acute	b-PROBLEM
32797	pulmonary	i-PROBLEM
32798	embolism	i-PROBLEM
32799	less	O
32800	than	O
32801	2	O
32802	percent	O
32803	.	O
32804	it	O
32805	was	O
32806	not	O
32807	felt	b-EVIDENTIAL
32808	that	O
32809	the	O
32810	patient	O
32811	would	O
32812	be	O
32813	in	O
32814	need	O
32815	of	O
32816	chronic	b-TREATMENT
32817	coumadin	i-TREATMENT
32818	therapy	i-TREATMENT
32819	in	O
32820	lieu	O
32821	of	O
32822	this	O
32823	low	O
32824	probability	O
32825	findings	O
32826	in	O
32827	toto	O
32828	.	O
32829	coronary	b-TEST
32830	angiography	i-TEST
32831	revealed	b-EVIDENTIAL
32832	occlusion	b-PROBLEM
32833	of	i-PROBLEM
32834	the	i-PROBLEM
32835	right	i-PROBLEM
32836	coronary	i-PROBLEM
32837	artery	i-PROBLEM
32838	proximally	i-PROBLEM
32839	with	O
32840	insignificant	b-PROBLEM
32841	plaquing	i-PROBLEM
32842	in	i-PROBLEM
32843	the	i-PROBLEM
32844	left	i-PROBLEM
32845	anterior	i-PROBLEM
32846	descending	i-PROBLEM
32847	artery	i-PROBLEM
32848	and	O
32849	circumflex	O
32850	arteries	O
32851	.	O
32852	after	O
32853	a	b-TREATMENT
32854	approximate	i-TREATMENT
32855	3	i-TREATMENT
32856	liter	i-TREATMENT
32857	total	i-TREATMENT
32858	diuresis	i-TREATMENT
32859	the	b-TEST
32860	right	i-TEST
32861	atrial	i-TEST
32862	pressure	i-TEST
32863	was	O
32864	5	O
32865	,	O
32866	pulmonary	b-TEST
32867	capillary	i-TEST
32868	wedge	i-TEST
32869	pressure	i-TEST
32870	14	O
32871	,	O
32872	pulmonary	b-TEST
32873	vacuolar	i-TEST
32874	resistance	i-TEST
32875	353	O
32876	and	O
32877	the	b-TEST
32878	cardiac	i-TEST
32879	output	i-TEST
32880	depressed	O
32881	at	O
32882	2.95	O
32883	liters	O
32884	per	b-FREQUENCY
32885	minute	i-FREQUENCY
32886	,	O
32887	or	O
32888	a	b-TEST
32889	cardiac	i-TEST
32890	index	i-TEST
32891	of	O
32892	1.7	O
32893	liters	O
32894	per	b-FREQUENCY
32895	minute	i-FREQUENCY
32896	.	O
32897	based	O
32898	upon	O
32899	these	O
32900	findings	O
32901	it	O
32902	was	O
32903	felt	O
32904	that	O
32905	mr.	O
32906	state	O
32907	most	O
32908	likely	O
32909	has	O
32910	multi-factorial	b-PROBLEM
32911	dyspnea	i-PROBLEM
32912	owing	O
32913	to	O
32914	both	O
32915	his	b-PROBLEM
32916	ventilatory	i-PROBLEM
32917	limitation	i-PROBLEM
32918	and	O
32919	to	O
32920	a	b-PROBLEM
32921	chronic	i-PROBLEM
32922	low	i-PROBLEM
32923	output	i-PROBLEM
32924	state	i-PROBLEM
32925	.	O
32926	in	O
32927	hospital	b-CLINICAL_DEPT
32928	he	O
32929	was	O
32930	seen	O
32931	by	O
32932	both	O
32933	speech	O
32934	therapy	O
32935	,	O
32936	physical	O
32937	therapy	O
32938	,	O
32939	and	O
32940	the	O
32941	uspend	O
32942	harmemewood	O
32943	medical	O
32944	center	O
32945	congestive	O
32946	heart	O
32947	failure	O
32948	nurse	O
32949	practitioner	O
32950	program	O
32951	.	O
32952	his	b-TREATMENT
32953	isordil	i-TREATMENT
32954	was	O
32955	increased	b-OCCURRENCE
32956	in	O
32957	hospital	b-CLINICAL_DEPT
32958	and	O
32959	blood	b-TREATMENT
32960	pressure	i-TREATMENT
32961	control	i-TREATMENT
32962	was	O
32963	relative	O
32964	episodic	O
32965	with	O
32966	systolic	b-TEST
32967	pressures	i-TEST
32968	ranging	O
32969	between	O
32970	100	O
32971	and	O
32972	160	O
32973	.	O
32974	future	b-OCCURRENCE
32975	adjustments	i-OCCURRENCE
32976	will	O
32977	be	O
32978	made	O
32979	at	O
32980	home	b-OCCURRENCE
32981	pending	O
32982	his	b-TEST
32983	blood	i-TEST
32984	pressure	i-TEST
32985	measures	i-TEST
32986	.	O
32987	at	O
32988	a	O
32989	goal	O
32990	weight	b-TEST
32991	of	O
32992	142	O
32993	pounds	O
32994	,	O
32995	mr.	b-TEST
32996	state	i-TEST
32997	&apos;s	i-TEST
32998	filling	i-TEST
32999	pressures	i-TEST
33000	appeared	O
33001	ideal	O
33002	with	O
33003	a	b-TEST
33004	wedge	i-TEST
33005	pressure	i-TEST
33006	of	O
33007	14	O
33008	and	O
33009	his	O
33010	goal	O
33011	weight	O
33012	range	O
33013	will	O
33014	be	O
33015	between	O
33016	142	O
33017	and	O
33018	44	O
33019	pounds	O
33020	at	O
33021	home	O
33022	.	O
33023	the	O
33024	patient	O
33025	will	O
33026	be	O
33027	followed	b-OCCURRENCE
33028	by	O
33029	doctor	O
33030	state	O
33031	within	O
33032	a	b-DURATION
33033	week	i-DURATION
33034	of	O
33035	discharge	b-OCCURRENCE
33036	and	O
33037	by	O
33038	nieie	O
33039	naebrand	O
33040	freierm	O
33041	of	O
33042	the	b-CLINICAL_DEPT
33043	dyathenslycha	i-CLINICAL_DEPT
33044	medical	i-CLINICAL_DEPT
33045	center	i-CLINICAL_DEPT
33046	.	O
33047		O
33048	admission	b-OCCURRENCE
33049	date	O
33050	:	O
33051	2017-06-12	b-ADMISSION
33052	discharge	b-OCCURRENCE
33053	date	O
33054	:	O
33055	2017-06-14	b-DISCHARGE
33056	service	O
33057	:	O
33058	medicine	O
33059	history	O
33060	of	O
33061	present	O
33062	illness	O
33063	:	O
33064	70	O
33065	y/o	O
33066	f	O
33067	w/	O
33068	tracheobronchomalacia	b-PROBLEM
33069	,	O
33070	copd	b-PROBLEM
33071	,	O
33072	pmr	b-PROBLEM
33073	,	O
33074	recurrent	b-PROBLEM
33075	pneumonias	i-PROBLEM
33076	who	O
33077	was	O
33078	recently	O
33079	discharged	b-OCCURRENCE
33080	from	O
33081	hallmark	b-CLINICAL_DEPT
33082	health	i-CLINICAL_DEPT
33083	system	i-CLINICAL_DEPT
33084	to	O
33085	pocasset	b-CLINICAL_DEPT
33086	mental	i-CLINICAL_DEPT
33087	health	i-CLINICAL_DEPT
33088	center	i-CLINICAL_DEPT
33089	06-07	b-DATE
33090	after	O
33091	tracheobronchoplasty	b-TREATMENT
33092	/	O
33093	tracheostomy	b-TREATMENT
33094	and	O
33095	pigtail	b-TREATMENT
33096	catheter	i-TREATMENT
33097	placement	i-TREATMENT
33098	for	O
33099	pleural	b-PROBLEM
33100	effusions	i-PROBLEM
33101	.	O
33102	since	O
33103	discharge	b-OCCURRENCE
33104	pt	O
33105	has	O
33106	continued	O
33107	at	O
33108	rehab	b-CLINICAL_DEPT
33109	on	O
33110	ps	b-TREATMENT
33111	vent	i-TREATMENT
33112	settings	i-TREATMENT
33113	but	O
33114	pigtail	b-TREATMENT
33115	catheter	i-TREATMENT
33116	fell	O
33117	out	O
33118	today	b-DATE
33119	so	O
33120	pt	O
33121	was	O
33122	referred	b-OCCURRENCE
33123	here	O
33124	for	O
33125	monitoring	b-TEST
33126	.	O
33127	on	O
33128	ros	b-TEST
33129	,	O
33130	she	O
33131	notes	b-EVIDENTIAL
33132	feeling	O
33133	poorly	b-PROBLEM
33134	,	O
33135	nausea	b-PROBLEM
33136	,	O
33137	and	O
33138	diarrhea	b-PROBLEM
33139	since	O
33140	d/c	b-OCCURRENCE
33141	.	O
33142	she	O
33143	has	O
33144	pleuritic	b-PROBLEM
33145	chest	i-PROBLEM
33146	pain	i-PROBLEM
33147	which	O
33148	she	O
33149	has	O
33150	had	O
33151	since	O
33152	she	O
33153	arrested	b-OCCURRENCE
33154	during	O
33155	her	b-OCCURRENCE
33156	admission	i-OCCURRENCE
33157	here	O
33158	and	O
33159	had	O
33160	cpr	b-TREATMENT
33161	.	O
33162	per	O
33163	husband	O
33164	she	O
33165	has	O
33166	no	O
33167	cardiac	b-PROBLEM
33168	history	i-PROBLEM
33169	,	O
33170	and	O
33171	had	O
33172	a	b-TEST
33173	stress	i-TEST
33174	test	i-TEST
33175	(	O
33176	unclr	O
33177	how	O
33178	recent	O
33179	)	O
33180	that	O
33181	was	O
33182	normal	O
33183	brief	O
33184	hospital	O
33185	course:	O
33186	pleural	b-PROBLEM
33187	effusion	i-PROBLEM
33188	:	O
33189	s/p	O
33190	pigtail	b-TREATMENT
33191	cath	i-TREATMENT
33192	drain	i-TREATMENT
33193	.	O
33194	imaging	b-TEST
33195	indicated	b-EVIDENTIAL
33196	that	O
33197	the	b-PROBLEM
33198	pleural	i-PROBLEM
33199	effusions	i-PROBLEM
33200	had	O
33201	resolved	O
33202	.	O
33203	thoracics	b-CLINICAL_DEPT
33204	agreed	O
33205	to	O
33206	no	O
33207	need	O
33208	for	O
33209	pigtail	b-TREATMENT
33210	placement	i-TREATMENT
33211	.	O
33212	chf	b-PROBLEM
33213	:	O
33214	patient	O
33215	was	O
33216	seen	O
33217	by	O
33218	chf	b-CLINICAL_DEPT
33219	(	O
33220	echo	O
33221	results	O
33222	are	O
33223	detailed	O
33224	above	O
33225	)	O
33226	.	O
33227	they	O
33228	recommended	O
33229	continuing	O
33230	beta-blocker	b-TREATMENT
33231	and	O
33232	titarting	O
33233	ace	b-TREATMENT
33234	as	O
33235	tolerated	O
33236	.	O
33237	patient	O
33238	should	O
33239	be	O
33240	kept	O
33241	euvolemic	b-TREATMENT
33242	once	O
33243	peripheral	b-PROBLEM
33244	edema	i-PROBLEM
33245	resolves	b-OCCURRENCE
33246	(	O
33247	may	O
33248	use	O
33249	lasix	b-TREATMENT
33250	to	O
33251	decrease	O
33252	edema	b-PROBLEM
33253	).	O
33254	she	O
33255	will	O
33256	need	O
33257	a	b-TEST
33258	repeat	i-TEST
33259	echo	i-TEST
33260	in	O
33261	3-6	b-DATE
33262	months	i-DATE
33263	(	O
33264	since	O
33265	this	b-TEST
33266	echo	i-TEST
33267	showed	b-OCCURRENCE
33268	a	O
33269	question	O
33270	of	O
33271	focal	b-PROBLEM
33272	wall	i-PROBLEM
33273	motion	i-PROBLEM
33274	abnormality	i-PROBLEM
33275	).	O
33276	also	O
33277	,	O
33278	patient	O
33279	was	O
33280	started	O
33281	on	O
33282	amiodarone	b-TREATMENT
33283	and	O
33284	digoxin	b-TREATMENT
33285	was	O
33286	held	O
33287	secondary	O
33288	to	O
33289	high	b-PROBLEM
33290	levels	i-PROBLEM
33291	(	O
33292	please	O
33293	restart	b-TREATMENT
33294	when	O
33295	level	O
33296	less	O
33297	than	O
33298	2	O
33299	)	O
33300	diarrhea	O
33301	:	O
33302	stool	b-TEST
33303	c.	i-TEST
33304	diff	i-TEST
33305	neg	O
33306	x1	O
33307	.	O
33308	she	O
33309	will	O
33310	need	O
33311	two	b-TEST
33312	more	i-TEST
33313	specimens	i-TEST
33314	.	O
33315	copd	O
33316	:	O
33317	cont	O
33318	nebs	b-TREATMENT
33319	.	O
33320	paf	O
33321	:	O
33322	started	O
33323	on	O
33324	amio	b-TREATMENT
33325	,	O
33326	cont	O
33327	b-blocker	b-TREATMENT
33328	,	O
33329	and	O
33330	patient	O
33331	was	O
33332	started	O
33333	on	O
33334	coumadin	b-TREATMENT
33335	-	O
33336	levels	O
33337	(	O
33338	inr	O
33339	)	O
33340	should	O
33341	be	O
33342	monitored	b-TEST
33343	.	O
33344	nutrition	O
33345	:	O
33346	patient	O
33347	should	O
33348	be	O
33349	started	O
33350	on	O
33351	tube	b-TREATMENT
33352	feeds	i-TREATMENT
33353	at	O
33354	rehab	b-CLINICAL_DEPT
33355	rash	O
33356	:	O
33357	patient	O
33358	developed	O
33359	a	b-PROBLEM
33360	diffuse	i-PROBLEM
33361	erythematous	i-PROBLEM
33362	rash	i-PROBLEM
33363	,	O
33364	though	O
33365	to	O
33366	be	O
33367	an	b-PROBLEM
33368	id	i-PROBLEM
33369	reaction	i-PROBLEM
33370	to	O
33371	a	b-PROBLEM
33372	recent	i-PROBLEM
33373	fungal	i-PROBLEM
33374	infection	i-PROBLEM
33375	.	O
33376	she	O
33377	has	O
33378	been	O
33379	satrted	O
33380	on	O
33381	benadryl	b-TREATMENT
33382	and	O
33383	hydrocort	b-TREATMENT
33384	for	O
33385	sx	O
33386	relief	O
33387	.	O
33388	please	O
33389	monitor	b-TEST
33390	this	O
33391	(	O
33392	may	O
33393	need	O
33394	dermatology	b-CLINICAL_DEPT
33395	consult	i-CLINICAL_DEPT
33396	).	O
33397	also	O
33398	a	b-PROBLEM
33399	drug	i-PROBLEM
33400	reaction	i-PROBLEM
33401	is	O
33402	in	O
33403	the	O
33404	ddx	O
33405	but	O
33406	unlikely	O
33407	as	O
33408	rash	b-PROBLEM
33409	started	O
33410	at	O
33411	rehab	b-CLINICAL_DEPT
33412	prior	O
33413	to	O
33414	receiving	O
33415	drugs	b-TREATMENT
33416	here	O
33417	.	O
33418		O
33419	admission	b-OCCURRENCE
33420	date	O
33421	:	O
33422	08-27-92	b-ADMISSION
33423	discharge	b-OCCURRENCE
33424	date	O
33425	:	O
33426	09-08-92	b-DISCHARGE
33427	history	O
33428	of	O
33429	present	O
33430	illness	O
33431	:	O
33432	the	O
33433	patient	O
33434	is	O
33435	a	O
33436	75	O
33437	year	O
33438	old	O
33439	hispanic	O
33440	male	O
33441	with	O
33442	insulin	b-PROBLEM
33443	dependent	i-PROBLEM
33444	diabetes	i-PROBLEM
33445	mellitus	i-PROBLEM
33446	,	O
33447	status	O
33448	post	O
33449	a	b-PROBLEM
33450	right	i-PROBLEM
33451	above-knee	i-PROBLEM
33452	amputation	i-PROBLEM
33453	about	O
33454	five	b-DURATION
33455	years	i-DURATION
33456	ago	O
33457	,	O
33458	who	O
33459	reportedly	O
33460	approximately	O
33461	four	b-DURATION
33462	months	i-DURATION
33463	ago	O
33464	,	O
33465	he	O
33466	developed	O
33467	a	b-PROBLEM
33468	small	i-PROBLEM
33469	ulceration	i-PROBLEM
33470	in	i-PROBLEM
33471	the	i-PROBLEM
33472	left	i-PROBLEM
33473	great	i-PROBLEM
33474	toe	i-PROBLEM
33475	,	O
33476	which	O
33477	progressively	b-OCCURRENCE
33478	worsened	i-OCCURRENCE
33479	.	O
33480	he	O
33481	was	O
33482	seen	b-OCCURRENCE
33483	by	i-OCCURRENCE
33484	a	i-OCCURRENCE
33485	doctor	i-OCCURRENCE
33486	in	O
33487	arizona	O
33488	and	O
33489	treated	O
33490	with	O
33491	dressing	b-TREATMENT
33492	changes	i-TREATMENT
33493	and	O
33494	debridement	b-TREATMENT
33495	until	O
33496	approximately	O
33497	six	b-DURATION
33498	weeks	i-DURATION
33499	ago	i-DURATION
33500	,	O
33501	when	O
33502	antibiotics	b-TREATMENT
33503	were	O
33504	started	O
33505	with	O
33506	ciprofloxacin	b-TREATMENT
33507	.	O
33508	the	O
33509	patient	O
33510	was	O
33511	seen	O
33512	and	O
33513	it	O
33514	was	O
33515	suggested	O
33516	that	O
33517	he	O
33518	should	O
33519	have	O
33520	an	b-TREATMENT
33521	amputation	i-TREATMENT
33522	and	O
33523	he	O
33524	decided	O
33525	to	O
33526	come	O
33527	to	O
33528	fairm	b-CLINICAL_DEPT
33529	of	i-CLINICAL_DEPT
33530	ijordcompmac	i-CLINICAL_DEPT
33531	hospital	i-CLINICAL_DEPT
33532	for	O
33533	further	b-TEST
33534	evaluation	i-TEST
33535	.	O
33536	hospital	O
33537	course	O
33538	:	O
33539	the	O
33540	patient	O
33541	was	O
33542	admitted	b-OCCURRENCE
33543	for	O
33544	intravenous	b-TREATMENT
33545	antibiotics	i-TREATMENT
33546	and	O
33547	a	O
33548	question	O
33549	of	O
33550	evaluation	b-TEST
33551	of	i-TEST
33552	circulation	i-TEST
33553	to	O
33554	the	O
33555	left	O
33556	great	O
33557	toe	O
33558	and	O
33559	also	O
33560	possible	O
33561	debridement	b-TREATMENT
33562	and	O
33563	possibly	O
33564	a	b-TREATMENT
33565	toe	i-TREATMENT
33566	amputation	i-TREATMENT
33567	.	O
33568	the	O
33569	patient	O
33570	had	O
33571	the	O
33572	following	O
33573	radiological	b-TEST
33574	studies	i-TEST
33575	:	O
33576	08-27-92	b-DATE
33577	,	O
33578	left	b-TEST
33579	foot	i-TEST
33580	film	i-TEST
33581	,	O
33582	correlation	O
33583	,	O
33584	patient	O
33585	consistent	O
33586	with	O
33587	osteomyelitis	b-PROBLEM
33588	involving	i-PROBLEM
33589	the	i-PROBLEM
33590	first	i-PROBLEM
33591	digit	i-PROBLEM
33592	and	O
33593	possibly	O
33594	the	O
33595	second	O
33596	digit	O
33597	of	O
33598	the	O
33599	left	O
33600	foot	O
33601	.	O
33602	the	b-TEST
33603	chest	i-TEST
33604	x-ray	i-TEST
33605	reveals	b-EVIDENTIAL
33606	no	O
33607	evidence	b-PROBLEM
33608	of	i-PROBLEM
33609	acute	i-PROBLEM
33610	disease	i-PROBLEM
33611	.	O
33612	the	O
33613	patient	O
33614	had	O
33615	lower	O
33616	extremity	O
33617	arterial	b-TEST
33618	non-invasive	i-TEST
33619	study	i-TEST
33620	which	O
33621	showed	b-EVIDENTIAL
33622	good	b-OCCURRENCE
33623	arterial	i-OCCURRENCE
33624	hemodynamics	i-OCCURRENCE
33625	of	O
33626	the	O
33627	left	O
33628	lower	O
33629	extremity	O
33630	,	O
33631	perfusion	b-OCCURRENCE
33632	to	i-OCCURRENCE
33633	the	i-OCCURRENCE
33634	tm	i-OCCURRENCE
33635	level	i-OCCURRENCE
33636	,	O
33637	but	O
33638	there	O
33639	was	O
33640	evidence	O
33641	of	O
33642	diabetic	b-PROBLEM
33643	small	i-PROBLEM
33644	vessel	i-PROBLEM
33645	disease	i-PROBLEM
33646	and	O
33647	spasm	b-PROBLEM
33648	of	i-PROBLEM
33649	his	i-PROBLEM
33650	digits	i-PROBLEM
33651	.	O
33652	the	b-OCCURRENCE
33653	arterial	i-OCCURRENCE
33654	circulation	i-OCCURRENCE
33655	is	i-OCCURRENCE
33656	adequate	i-OCCURRENCE
33657	for	O
33658	healing	b-OCCURRENCE
33659	of	O
33660	his	b-PROBLEM
33661	left	i-PROBLEM
33662	great	i-PROBLEM
33663	toe	i-PROBLEM
33664	ulcer	i-PROBLEM
33665	,	O
33666	noncompressible	O
33667	left	O
33668	thigh	O
33669	and	O
33670	calf	O
33671	pressures	O
33672	highly	O
33673	calcified	O
33674	arterial	O
33675	system	O
33676	.	O
33677	on	O
33678	09-03-92	b-DATE
33679	,	O
33680	patient	O
33681	underwent	O
33682	a	b-TREATMENT
33683	left	i-TREATMENT
33684	great	i-TREATMENT
33685	toe	i-TREATMENT
33686	buttontoe	i-TREATMENT
33687	amputation	i-TREATMENT
33688	under	O
33689	regional	b-TREATMENT
33690	ankle	i-TREATMENT
33691	block	i-TREATMENT
33692	for	O
33693	chronic	b-OCCURRENCE
33694	ulcer	i-OCCURRENCE
33695	and	O
33696	osteomyelitis	b-PROBLEM
33697	of	O
33698	the	O
33699	left	O
33700	great	O
33701	toe	O
33702	.	O
33703	the	O
33704	patient	O
33705	tolerated	O
33706	the	b-TREATMENT
33707	procedure	i-TREATMENT
33708	well	b-OCCURRENCE
33709	.	O
33710	there	O
33711	were	O
33712	no	O
33713	complications	b-PROBLEM
33714	during	O
33715	the	b-TREATMENT
33716	procedure	i-TREATMENT
33717	.	O
33718	there	O
33719	was	O
33720	a	b-TREATMENT
33721	small	i-TREATMENT
33722	penrose	i-TREATMENT
33723	drain	i-TREATMENT
33724	postoperatively	O
33725	that	O
33726	was	O
33727	placed	O
33728	intraoperatively	b-OCCURRENCE
33729	and	O
33730	discontinued	O
33731	on	O
33732	approximately	O
33733	postoperative	O
33734	day	b-DATE
33735	number	i-DATE
33736	three	i-DATE
33737	.	O
33738	the	O
33739	patient	O
33740	was	O
33741	preoperatively	O
33742	treated	O
33743	with	O
33744	about	O
33745	a	O
33746	seven	b-DURATION
33747	day	i-DURATION
33748	course	i-DURATION
33749	of	O
33750	intravenous	b-TREATMENT
33751	unasyn	i-TREATMENT
33752	and	O
33753	postoperatively	O
33754	treated	O
33755	for	O
33756	approximately	O
33757	four	b-DURATION
33758	days	i-DURATION
33759	of	O
33760	intravenous	b-TREATMENT
33761	unasyn	i-TREATMENT
33762	.	O
33763	the	O
33764	patient	O
33765	was	O
33766	discharged	b-OCCURRENCE
33767	home	O
33768	in	O
33769	stable	b-OCCURRENCE
33770	condition	i-OCCURRENCE
33771	on	O
33772	postoperative	O
33773	day	b-DATE
33774	number	i-DATE
33775	five	i-DATE
33776	,	O
33777	without	O
33778	any	O
33779	complications	b-PROBLEM
33780	.	O
33781	the	b-PROBLEM
33782	incision	i-PROBLEM
33783	from	O
33784	buttontoe	b-TREATMENT
33785	amputation	i-TREATMENT
33786	of	O
33787	the	O
33788	left	O
33789	foot	O
33790	healing	b-OCCURRENCE
33791	well	i-OCCURRENCE
33792	,	O
33793	without	O
33794	any	O
33795	further	O
33796	complications	b-PROBLEM
33797	.	O
33798	followup	O
33799	:	O
33800	the	O
33801	patient	O
33802	is	O
33803	to	O
33804	follow	b-OCCURRENCE
33805	up	i-OCCURRENCE
33806	in	O
33807	clinic	b-CLINICAL_DEPT
33808	.	O
33809		O
33810	admission	b-OCCURRENCE
33811	date	O
33812	:	O
33813	12/05/1997	b-ADMISSION
33814	discharge	b-OCCURRENCE
33815	date	O
33816	:	O
33817	12/07/1997	b-DISCHARGE
33818	history	O
33819	of	O
33820	present	O
33821	illness	O
33822	:	O
33823	the	O
33824	patient	O
33825	is	O
33826	a	O
33827	50	O
33828	year-old	O
33829	female	O
33830	with	O
33831	a	O
33832	history	O
33833	of	O
33834	bilateral	b-PROBLEM
33835	lung	i-PROBLEM
33836	nodules	i-PROBLEM
33837	dating	O
33838	back	O
33839	to	O
33840	the	b-DATE
33841	july	i-DATE
33842	of	i-DATE
33843	1995	i-DATE
33844	discovered	O
33845	on	O
33846	a	b-TEST
33847	work-up	i-TEST
33848	for	O
33849	an	b-PROBLEM
33850	adrenal	i-PROBLEM
33851	abnormality	i-PROBLEM
33852	.	O
33853	diffuse	b-PROBLEM
33854	adenopathy	i-PROBLEM
33855	was	O
33856	noted	O
33857	at	O
33858	that	b-DATE
33859	time	i-DATE
33860	and	O
33861	an	O
33862	attempt	O
33863	was	O
33864	made	O
33865	at	O
33866	axillary	b-TEST
33867	node	i-TEST
33868	biopsy	i-TEST
33869	which	O
33870	was	O
33871	aborted	O
33872	secondary	O
33873	to	O
33874	positioning	b-PROBLEM
33875	difficulty	i-PROBLEM
33876	and	O
33877	difficult	b-PROBLEM
33878	intubation	i-PROBLEM
33879	.	O
33880	she	O
33881	was	O
33882	since	O
33883	then	O
33884	lost	O
33885	to	O
33886	follow-up	b-TEST
33887	with	O
33888	a	O
33889	recently	O
33890	re-establish	O
33891	primary	O
33892	care	O
33893	practitioner	O
33894	contact	O
33895	.	O
33896	follow-up	b-TEST
33897	chest	i-TEST
33898	ct	i-TEST
33899	on	O
33900	october	b-DATE
33901	26	i-DATE
33902	,	i-DATE
33903	1997	i-DATE
33904	at	O
33905	the	b-CLINICAL_DEPT
33906	ver	i-CLINICAL_DEPT
33907	medical	i-CLINICAL_DEPT
33908	center	i-CLINICAL_DEPT
33909	showed	b-EVIDENTIAL
33910	multiple	b-PROBLEM
33911	pulmonary	i-PROBLEM
33912	nodules	i-PROBLEM
33913	in	O
33914	abundant	O
33915	number	O
33916	,	O
33917	very	b-PROBLEM
33918	small	i-PROBLEM
33919	nodes	i-PROBLEM
33920	seen	O
33921	in	O
33922	the	O
33923	mediastinum	O
33924	but	O
33925	no	O
33926	hilar	b-PROBLEM
33927	adenopathy	i-PROBLEM
33928	,	O
33929	no	O
33930	hepatosplenomegaly	b-PROBLEM
33931	or	O
33932	adrenal	b-PROBLEM
33933	mass	i-PROBLEM
33934	was	O
33935	noted	O
33936	.	O
33937	chest	b-TEST
33938	x-ray	i-TEST
33939	on	O
33940	august	b-DATE
33941	6	i-DATE
33942	,	i-DATE
33943	1997	i-DATE
33944	revealed	O
33945	multiple	b-PROBLEM
33946	pulmonary	i-PROBLEM
33947	nodules	i-PROBLEM
33948	increasing	O
33949	in	O
33950	size	O
33951	since	O
33952	july	b-DATE
33953	22	i-DATE
33954	,	i-DATE
33955	1995	i-DATE
33956	.	O
33957	hospital	O
33958	course	O
33959	:	O
33960	the	O
33961	patient	O
33962	was	O
33963	admitted	b-OCCURRENCE
33964	on	O
33965	december	b-DATE
33966	5	i-DATE
33967	,	i-DATE
33968	1997	i-DATE
33969	and	O
33970	underwent	O
33971	left	b-TREATMENT
33972	lung	i-TREATMENT
33973	wedge	i-TREATMENT
33974	thoracoscopic	i-TREATMENT
33975	resection	i-TREATMENT
33976	and	O
33977	bronchoscopy	b-TREATMENT
33978	.	O
33979	she	O
33980	was	O
33981	transferred	b-OCCURRENCE
33982	to	O
33983	the	b-CLINICAL_DEPT
33984	post	i-CLINICAL_DEPT
33985	anesthesia	i-CLINICAL_DEPT
33986	care	i-CLINICAL_DEPT
33987	unit	i-CLINICAL_DEPT
33988	postoperatively	O
33989	in	O
33990	stable	O
33991	condition	O
33992	.	O
33993	her	b-TREATMENT
33994	chest	i-TREATMENT
33995	tube	i-TREATMENT
33996	was	O
33997	pulled	O
33998	on	O
33999	postoperative	b-DATE
34000	day	i-DATE
34001	number	i-DATE
34002	one	i-DATE
34003	and	O
34004	the	O
34005	patient	O
34006	did	b-OCCURRENCE
34007	quite	i-OCCURRENCE
34008	well	i-OCCURRENCE
34009	and	O
34010	remained	O
34011	inhouse	O
34012	for	O
34013	observation	b-TEST
34014	until	O
34015	december	b-DATE
34016	7	i-DATE
34017	,	i-DATE
34018	1997	i-DATE
34019	and	O
34020	the	O
34021	patient	O
34022	was	O
34023	discharged	b-OCCURRENCE
34024	to	O
34025	home	O
34026	in	O
34027	stable	O
34028	condition	O
34029	.	O
34030		O
34031	admission	b-OCCURRENCE
34032	date	O
34033	:	O
34034		O
34035	3-26-93	b-DATE
34036		O
34037	discharge	b-OCCURRENCE
34038	date	O
34039	:	O
34040		O
34041	4-3-93	b-DATE
34042		O
34043	history	O
34044	of	O
34045	present	O
34046	illness	O
34047	:	O
34048		O
34049	the	O
34050	patient	O
34051	is	O
34052	a	O
34053	73	O
34054	year	O
34055	old	O
34056	female	O
34057	who	O
34058	was	O
34059	transferred	b-OCCURRENCE
34060	for	O
34061	cardiac	b-TEST
34062	catheterization	i-TEST
34063	after	O
34064	ventricular	b-PROBLEM
34065	fibrillation	i-PROBLEM
34066	arrest	i-PROBLEM
34067	in	O
34068	the	O
34069	setting	O
34070	of	O
34071	an	b-PROBLEM
34072	acute	i-PROBLEM
34073	inferior	i-PROBLEM
34074	myocardial	i-PROBLEM
34075	infarction	i-PROBLEM
34076	and	O
34077	a	b-PROBLEM
34078	urinary	i-PROBLEM
34079	tract	i-PROBLEM
34080	infection	i-PROBLEM
34081	.	O
34082		O
34083	the	O
34084	patient	O
34085	was	O
34086	admitted	b-OCCURRENCE
34087	on	O
34088	3-16-93	b-DATE
34089	to	O
34090	diy	b-CLINICAL_DEPT
34091	hospital	i-CLINICAL_DEPT
34092	for	O
34093	an	b-PROBLEM
34094	e.	i-PROBLEM
34095	coli	i-PROBLEM
34096	urinary	i-PROBLEM
34097	tract	i-PROBLEM
34098	infection	i-PROBLEM
34099	.	O
34100		O
34101	the	O
34102	patient	O
34103	was	O
34104	readmitted	b-OCCURRENCE
34105	on	O
34106	3-20-93	b-DATE
34107	because	O
34108	of	O
34109	fever	b-PROBLEM
34110	,	O
34111	chills	b-PROBLEM
34112	and	O
34113	a	O
34114	sudden	O
34115	onset	O
34116	of	O
34117	ventricular	b-PROBLEM
34118	fibrillation	i-PROBLEM
34119	arrest	i-PROBLEM
34120	,	O
34121	successfully	O
34122	cardioverted	b-TREATMENT
34123	back	O
34124	to	O
34125	rapid	b-PROBLEM
34126	atrial	i-PROBLEM
34127	fibrillation	i-PROBLEM
34128	and	O
34129	finally	O
34130	to	O
34131	sinus	b-PROBLEM
34132	rhythm	i-PROBLEM
34133	,	O
34134	where	O
34135	an	b-TEST
34136	electrocardiogram	i-TEST
34137	then	O
34138	showed	b-EVIDENTIAL
34139	st	b-PROBLEM
34140	elevation	i-PROBLEM
34141	in	i-PROBLEM
34142	inferior	i-PROBLEM
34143	leads	i-PROBLEM
34144	.	O
34145		O
34146	peak	b-TEST
34147	cpk	i-TEST
34148	was	O
34149	2494	O
34150	with	O
34151	18%	O
34152	mb	b-TEST
34153	's	i-TEST
34154	.	O
34155		O
34156	she	O
34157	required	O
34158	intubation	b-TREATMENT
34159	for	O
34160	mild	b-PROBLEM
34161	to	i-PROBLEM
34162	moderate	i-PROBLEM
34163	congestive	i-PROBLEM
34164	heart	i-PROBLEM
34165	failure	i-PROBLEM
34166	,	O
34167	treated	O
34168	with	O
34169	diuretics	b-TREATMENT
34170	,	O
34171	intravenous	b-TREATMENT
34172	nitroglycerin	i-TREATMENT
34173	and	O
34174	heparin	b-TREATMENT
34175	.	O
34176		O
34177	she	O
34178	had	O
34179	post-infarction	b-PROBLEM
34180	angina	i-PROBLEM
34181	,	O
34182	was	O
34183	transferred	b-OCCURRENCE
34184	here	O
34185	for	O
34186	angiography	b-TEST
34187	and	O
34188	possible	O
34189	percutaneous	b-TREATMENT
34190	transluminal	i-TREATMENT
34191	coronary	i-TREATMENT
34192	angioplasty	i-TREATMENT
34193	.	O
34194		O
34195	hospital	O
34196	course	O
34197	:	O
34198		O
34199	on	O
34200	3-27-93	b-DATE
34201	,	O
34202	patient	O
34203	underwent	O
34204	cardiac	b-TEST
34205	catheterization	i-TEST
34206	,	O
34207	coronary	b-TEST
34208	and	i-TEST
34209	left	i-TEST
34210	ventricular	i-TEST
34211	angiography	i-TEST
34212	without	O
34213	complications	b-PROBLEM
34214	.	O
34215		O
34216	review	O
34217	of	O
34218	these	b-TEST
34219	angiograms	i-TEST
34220	demonstrated	b-EVIDENTIAL
34221	a	O
34222	dominant	O
34223	right	O
34224	coronary	O
34225	artery	O
34226	with	O
34227	a	b-PROBLEM
34228	focal	i-PROBLEM
34229	50%	i-PROBLEM
34230	stenosis	i-PROBLEM
34231	in	i-PROBLEM
34232	the	i-PROBLEM
34233	mid-portion	i-PROBLEM
34234	.	O
34235		O
34236	the	O
34237	left	O
34238	main	O
34239	coronary	O
34240	artery	O
34241	was	O
34242	clear	O
34243	.	O
34244		O
34245	the	O
34246	left	O
34247	anterior	O
34248	descending	O
34249	had	O
34250	moderate	b-PROBLEM
34251	plaques	i-PROBLEM
34252	with	O
34253	a	b-PROBLEM
34254	50%	i-PROBLEM
34255	proximal	i-PROBLEM
34256	stenosis	i-PROBLEM
34257	of	i-PROBLEM
34258	the	i-PROBLEM
34259	right	i-PROBLEM
34260	anterior	i-PROBLEM
34261	oblique	i-PROBLEM
34262	caudal	i-PROBLEM
34263	view	O
34264	.	O
34265		O
34266	the	O
34267	proximal	O
34268	diagonal	O
34269	d1	O
34270	had	O
34271	a	b-PROBLEM
34272	50%	i-PROBLEM
34273	stenosis	i-PROBLEM
34274	.	O
34275		O
34276	the	O
34277	circumflex	O
34278	had	O
34279	a	b-PROBLEM
34280	long	i-PROBLEM
34281	30%	i-PROBLEM
34282	stenosis	i-PROBLEM
34283	proximally	O
34284	and	O
34285	an	b-PROBLEM
34286	80%	i-PROBLEM
34287	stenosis	i-PROBLEM
34288	at	O
34289	the	O
34290	origin	O
34291	of	O
34292	the	O
34293	second	O
34294	major	O
34295	marginal	O
34296	artery	O
34297	.	O
34298		O
34299	the	b-TEST
34300	left	i-TEST
34301	ventricular	i-TEST
34302	angiogram	i-TEST
34303	showed	b-EVIDENTIAL
34304	akinesis	b-PROBLEM
34305	of	i-PROBLEM
34306	the	i-PROBLEM
34307	posterobasal	i-PROBLEM
34308	walls	i-PROBLEM
34309	,	O
34310	severe	b-PROBLEM
34311	hypokinesis	i-PROBLEM
34312	of	i-PROBLEM
34313	the	i-PROBLEM
34314	diaphragmatic	i-PROBLEM
34315	wall	i-PROBLEM
34316	and	O
34317	trace	b-PROBLEM
34318	mitral	i-PROBLEM
34319	regurgitation	i-PROBLEM
34320	.	O
34321		O
34322	the	O
34323	patient	O
34324	was	O
34325	maintained	b-OCCURRENCE
34326	on	O
34327	heparin	b-TREATMENT
34328	anticoagulation	i-TREATMENT
34329	.	O
34330		O
34331	an	b-TEST
34332	exercise	i-TEST
34333	tolerance	i-TEST
34334	test	i-TEST
34335	with	i-TEST
34336	thallium	i-TEST
34337	was	O
34338	to	O
34339	be	O
34340	performed	O
34341	in	O
34342	order	O
34343	to	O
34344	assess	O
34345	myocardial	b-PROBLEM
34346	viability	i-PROBLEM
34347	in	O
34348	the	b-PROBLEM
34349	infarct	i-PROBLEM
34350	zone	i-PROBLEM
34351	.	O
34352		O
34353	the	b-PROBLEM
34354	right	i-PROBLEM
34355	coronary	i-PROBLEM
34356	artery	i-PROBLEM
34357	lesion	i-PROBLEM
34358	was	O
34359	complex	O
34360	and	O
34361	there	O
34362	was	O
34363	severe	b-PROBLEM
34364	stenosis	i-PROBLEM
34365	in	i-PROBLEM
34366	the	i-PROBLEM
34367	obtuse	i-PROBLEM
34368	marginal	i-PROBLEM
34369	1	i-PROBLEM
34370	.	O
34371		O
34372	the	O
34373	patient	O
34374	had	O
34375	no	O
34376	further	b-PROBLEM
34377	angina	i-PROBLEM
34378	.	O
34379		O
34380	on	O
34381	4-2-93	b-DATE
34382	,	O
34383	she	O
34384	underwent	O
34385	a	b-TEST
34386	persantine	i-TEST
34387	thallium	i-TEST
34388	study	i-TEST
34389	.	O
34390		O
34391	this	b-EVIDENTIAL
34392	showed	i-EVIDENTIAL
34393	no	O
34394	diagnostic	b-PROBLEM
34395	electrocardiogram	i-PROBLEM
34396	changes	i-PROBLEM
34397	for	O
34398	ischemia	b-PROBLEM
34399	and	O
34400	no	O
34401	angina	b-PROBLEM
34402	pectoris	i-PROBLEM
34403	.	O
34404		O
34405	the	b-TEST
34406	thallium	i-TEST
34407	images	i-TEST
34408	showed	b-EVIDENTIAL
34409	a	b-PROBLEM
34410	large	i-PROBLEM
34411	region	i-PROBLEM
34412	of	i-PROBLEM
34413	persistently	i-PROBLEM
34414	reduced	i-PROBLEM
34415	blood	i-PROBLEM
34416	flow	i-PROBLEM
34417	involving	O
34418	the	O
34419	apex	O
34420	and	O
34421	inferoposterior	O
34422	segments	O
34423	of	O
34424	the	O
34425	left	O
34426	ventricular	O
34427	wall	O
34428	.	O
34429		O
34430	this	O
34431	was	O
34432	consistent	O
34433	with	O
34434	scar	b-PROBLEM
34435	.	O
34436		O
34437	there	O
34438	was	O
34439	no	O
34440	definite	b-PROBLEM
34441	perfusion	i-PROBLEM
34442	abnormality	i-PROBLEM
34443	in	i-PROBLEM
34444	the	i-PROBLEM
34445	circumflex	i-PROBLEM
34446	zone	i-PROBLEM
34447	.	O
34448		O
34449	in	O
34450	view	O
34451	of	O
34452	these	O
34453	findings	O
34454	,	O
34455	it	O
34456	was	O
34457	elected	O
34458	to	O
34459	discharge	b-OCCURRENCE
34460	her	O
34461	on	O
34462	her	b-TREATMENT
34463	present	i-TREATMENT
34464	medical	i-TREATMENT
34465	program	i-TREATMENT
34466	.	O
34467		O
34468	the	O
34469	patient	O
34470	is	O
34471	to	O
34472	return	b-OCCURRENCE
34473	to	O
34474	the	b-TREATMENT
34475	follow	i-TREATMENT
34476	up	i-TREATMENT
34477	care	i-TREATMENT
34478	of	O
34479	doctor	O
34480	ko	O
34481	kollciem	O
34482	at	O
34483	the	b-CLINICAL_DEPT
34484	diy	i-CLINICAL_DEPT
34485	hospital	i-CLINICAL_DEPT
34486	.	O
34487		O
34488	chpo	O
34489	e.	O
34490	jescobea	O
34491	,	O
34492	md	O
34493		O
34494	tr	O
34495	:	O
34496		O
34497	sq	O
34498	/	O
34499	bmot	O
34500		O
34501	dd	O
34502	:	O
34503		O
34504	06-13-93	O
34505		O
34506	td	O
34507	:	O
34508		O
34509	06/15/93	O
34510		O
34511	cc	O
34512	:	O
34513		O
34514	doctor	O
34515	ko	O
34516	kollciem	O
34517	,	O
34518	retchard	O
34519	healthcare	O
34520	to	O
34521	doctor	O
34522	wall	O
34523		O
34524		O
34525	admission	b-OCCURRENCE
34526	date	O
34527	:	O
34528	4/28/93	b-DATE
34529	discharge	b-OCCURRENCE
34530	date	O
34531	:	O
34532	5/15/93	b-DATE
34533	history	O
34534	of	O
34535	present	O
34536	illness	O
34537	:	O
34538	the	O
34539	patient	O
34540	is	O
34541	a	O
34542	74	O
34543	year	O
34544	old	O
34545	female	O
34546	with	O
34547	metastatic	b-PROBLEM
34548	papillary	i-PROBLEM
34549	carcinoma	i-PROBLEM
34550	of	i-PROBLEM
34551	the	i-PROBLEM
34552	thyroid	i-PROBLEM
34553	who	O
34554	presented	b-OCCURRENCE
34555	to	O
34556	the	b-CLINICAL_DEPT
34557	fairm	i-CLINICAL_DEPT
34558	of	i-CLINICAL_DEPT
34559	ijordcompmac	i-CLINICAL_DEPT
34560	hospital	i-CLINICAL_DEPT
34561	on	O
34562	4/28/93	b-DATE
34563	with	O
34564	progressive	b-PROBLEM
34565	weakness	i-PROBLEM
34566	,	O
34567	weight	b-PROBLEM
34568	loss	i-PROBLEM
34569	and	O
34570	shortness	b-PROBLEM
34571	of	i-PROBLEM
34572	breath	i-PROBLEM
34573	.	O
34574	the	O
34575	patient	O
34576	was	O
34577	in	O
34578	a	b-OCCURRENCE
34579	good	i-OCCURRENCE
34580	state	i-OCCURRENCE
34581	of	i-OCCURRENCE
34582	health	i-OCCURRENCE
34583	until	O
34584	january	b-DATE
34585	of	i-DATE
34586	1993	i-DATE
34587	when	O
34588	she	O
34589	developed	O
34590	a	b-PROBLEM
34591	serious	i-PROBLEM
34592	upper	i-PROBLEM
34593	respiratory	i-PROBLEM
34594	tract	i-PROBLEM
34595	infection	i-PROBLEM
34596	associated	O
34597	with	O
34598	weakness	b-PROBLEM
34599	and	O
34600	fatigue	b-PROBLEM
34601	.	O
34602	she	O
34603	had	O
34604	also	O
34605	reported	b-EVIDENTIAL
34606	a	b-PROBLEM
34607	weight	i-PROBLEM
34608	loss	i-PROBLEM
34609	of	i-PROBLEM
34610	15	i-PROBLEM
34611	pounds	i-PROBLEM
34612	over	O
34613	the	O
34614	past	O
34615	two	b-DURATION
34616	months	i-DURATION
34617	.	O
34618	although	O
34619	her	b-PROBLEM
34620	upper	i-PROBLEM
34621	respiratory	i-PROBLEM
34622	tract	i-PROBLEM
34623	infection	i-PROBLEM
34624	seemed	O
34625	to	O
34626	be	O
34627	resolving	O
34628	,	O
34629	her	b-PROBLEM
34630	weakness	i-PROBLEM
34631	persisted	O
34632	.	O
34633	a	b-TEST
34634	work	i-TEST
34635	up	i-TEST
34636	begun	O
34637	by	O
34638	her	O
34639	internist	O
34640	,	O
34641	doctor	O
34642	brain	O
34643	,	O
34644	revealed	O
34645	a	b-TEST
34646	white	i-TEST
34647	blood	i-TEST
34648	cell	i-TEST
34649	count	i-TEST
34650	of	O
34651	49,000	O
34652	with	O
34653	50%	O
34654	eosinophils	O
34655	.	O
34656	she	O
34657	was	O
34658	admitted	b-OCCURRENCE
34659	to	O
34660	box	b-CLINICAL_DEPT
34661	memorial	i-CLINICAL_DEPT
34662	hospital	i-CLINICAL_DEPT
34663	nursing	i-CLINICAL_DEPT
34664	home	i-CLINICAL_DEPT
34665	for	O
34666	further	b-TEST
34667	evaluation	i-TEST
34668	.	O
34669	data	O
34670	collected	O
34671	there	O
34672	included	O
34673	a	b-TEST
34674	chest	i-TEST
34675	x-ray	i-TEST
34676	which	O
34677	was	O
34678	unremarkable	O
34679	.	O
34680	the	b-TEST
34681	liver	i-TEST
34682	function	i-TEST
34683	tests	i-TEST
34684	showed	b-EVIDENTIAL
34685	an	b-TEST
34686	alkaline	i-TEST
34687	phosphatase	i-TEST
34688	of	O
34689	303	O
34690	,	O
34691	ldh	b-TEST
34692	310	O
34693	,	O
34694	sgot	b-TEST
34695	66	O
34696	,	O
34697	albumin	b-TEST
34698	2.5	O
34699	.	O
34700	a	b-TEST
34701	peripheral	i-TEST
34702	blood	i-TEST
34703	smear	i-TEST
34704	showed	b-EVIDENTIAL
34705	mature	b-OCCURRENCE
34706	eosinophils	i-OCCURRENCE
34707	in	O
34708	increased	O
34709	numbers	O
34710	.	O
34711	chromosomal	b-TEST
34712	studies	i-TEST
34713	were	O
34714	negative	O
34715	.	O
34716	a	b-TEST
34717	bone	i-TEST
34718	scan	i-TEST
34719	showed	b-EVIDENTIAL
34720	increased	b-PROBLEM
34721	uptake	i-PROBLEM
34722	at	i-PROBLEM
34723	the	i-PROBLEM
34724	manubrium	i-PROBLEM
34725	at	O
34726	the	O
34727	site	O
34728	of	O
34729	an	b-PROBLEM
34730	old	i-PROBLEM
34731	fracture	i-PROBLEM
34732	,	O
34733	as	O
34734	well	O
34735	as	O
34736	in	O
34737	the	O
34738	right	O
34739	supraclavicular	O
34740	area	O
34741	.	O
34742	a	b-TEST
34743	thyroid	i-TEST
34744	ultrasound	i-TEST
34745	showed	b-EVIDENTIAL
34746	an	b-PROBLEM
34747	inferior	i-PROBLEM
34748	thyroid	i-PROBLEM
34749	mass	i-PROBLEM
34750	.	O
34751	this	O
34752	was	O
34753	followed	O
34754	by	O
34755	an	b-TEST
34756	abdominal	i-TEST
34757	ct	i-TEST
34758	which	O
34759	showed	b-EVIDENTIAL
34760	an	b-PROBLEM
34761	enlarged	i-PROBLEM
34762	spleen	i-PROBLEM
34763	,	O
34764	a	b-PROBLEM
34765	lytic	i-PROBLEM
34766	lesion	i-PROBLEM
34767	on	i-PROBLEM
34768	the	i-PROBLEM
34769	right	i-PROBLEM
34770	iliac	i-PROBLEM
34771	bone	i-PROBLEM
34772	and	O
34773	a	b-PROBLEM
34774	benign	i-PROBLEM
34775	renal	i-PROBLEM
34776	cyst	i-PROBLEM
34777	.	O
34778	biopsy	b-TEST
34779	of	i-TEST
34780	the	i-TEST
34781	lytic	i-TEST
34782	lesion	i-TEST
34783	was	O
34784	consistent	O
34785	with	O
34786	metastases	b-PROBLEM
34787	papillary	i-PROBLEM
34788	carcinoma	i-PROBLEM
34789	of	i-PROBLEM
34790	the	i-PROBLEM
34791	thyroid	i-PROBLEM
34792	.	O
34793	an	b-TEST
34794	upper	i-TEST
34795	gastrointestinal	i-TEST
34796	was	O
34797	unremarkable	O
34798	.	O
34799	the	b-TEST
34800	small	i-TEST
34801	bowel	i-TEST
34802	follow	i-TEST
34803	through	i-TEST
34804	was	O
34805	within	O
34806	normal	O
34807	limits	O
34808	.	O
34809	a	b-TEST
34810	thyroid	i-TEST
34811	scan	i-TEST
34812	revealed	b-EVIDENTIAL
34813	decreased	b-PROBLEM
34814	function	i-PROBLEM
34815	and	O
34816	displacement	b-PROBLEM
34817	of	i-PROBLEM
34818	the	i-PROBLEM
34819	thyroid	i-PROBLEM
34820	by	O
34821	a	b-PROBLEM
34822	cold	i-PROBLEM
34823	mass	i-PROBLEM
34824	located	O
34825	inferiorly	O
34826	with	O
34827	calcifications	b-PROBLEM
34828	on	i-PROBLEM
34829	the	i-PROBLEM
34830	right	i-PROBLEM
34831	side	i-PROBLEM
34832	.	O
34833	a	b-TEST
34834	chest	i-TEST
34835	ct	i-TEST
34836	also	O
34837	revealed	b-EVIDENTIAL
34838	a	b-PROBLEM
34839	small	i-PROBLEM
34840	pulmonary	i-PROBLEM
34841	nodule	i-PROBLEM
34842	with	O
34843	a	b-PROBLEM
34844	necrotic	i-PROBLEM
34845	mass	i-PROBLEM
34846	involving	O
34847	the	b-EVIDENTIAL
34848	right	i-EVIDENTIAL
34849	lung	i-EVIDENTIAL
34850	posteriorly	i-EVIDENTIAL
34851	.	O
34852	the	O
34853	patient	O
34854	was	O
34855	subsequently	O
34856	referred	b-OCCURRENCE
34857	to	O
34858	the	b-CLINICAL_DEPT
34859	fairm	i-CLINICAL_DEPT
34860	of	i-CLINICAL_DEPT
34861	ijordcompmac	i-CLINICAL_DEPT
34862	hospital	i-CLINICAL_DEPT
34863	under	O
34864	the	O
34865	service	O
34866	of	O
34867	doctor	O
34868	brain	O
34869	.	O
34870	she	O
34871	continued	O
34872	to	O
34873	have	O
34874	profound	b-PROBLEM
34875	weakness	i-PROBLEM
34876	,	O
34877	a	b-PROBLEM
34878	decreased	i-PROBLEM
34879	appetite	i-PROBLEM
34880	and	O
34881	weight	b-PROBLEM
34882	loss	i-PROBLEM
34883	.	O
34884	she	O
34885	also	O
34886	developed	O
34887	lower	b-PROBLEM
34888	extremity	i-PROBLEM
34889	edema	i-PROBLEM
34890	as	O
34891	well	O
34892	as	O
34893	left	b-PROBLEM
34894	upper	i-PROBLEM
34895	extremity	i-PROBLEM
34896	swelling	i-PROBLEM
34897	associated	O
34898	with	O
34899	increased	b-PROBLEM
34900	shortness	i-PROBLEM
34901	of	i-PROBLEM
34902	breath	i-PROBLEM
34903	on	O
34904	exertion	O
34905	.	O
34906	a	b-TEST
34907	needle	i-TEST
34908	biopsy	i-TEST
34909	of	i-TEST
34910	the	i-TEST
34911	right	i-TEST
34912	thyroid	i-TEST
34913	nodule	i-TEST
34914	showed	b-EVIDENTIAL
34915	papillary	b-PROBLEM
34916	thyroid	i-PROBLEM
34917	carcinoma	i-PROBLEM
34918	.	O
34919	the	O
34920	patient	O
34921	reports	b-OCCURRENCE
34922	no	O
34923	history	O
34924	of	O
34925	radiation	b-PROBLEM
34926	exposure	i-PROBLEM
34927	,	O
34928	no	O
34929	family	O
34930	history	O
34931	of	O
34932	thyroid	b-PROBLEM
34933	carcinoma	i-PROBLEM
34934	,	O
34935	no	O
34936	recent	b-OCCURRENCE
34937	travels	i-OCCURRENCE
34938	or	O
34939	exposure	b-PROBLEM
34940	to	i-PROBLEM
34941	tuberculosis	i-PROBLEM
34942	.	O
34943	hospital	O
34944	course	O
34945	:	O
34946	the	O
34947	patient	O
34948	was	O
34949	admitted	b-OCCURRENCE
34950	to	O
34951	doctor	O
34952	shatermivaet	O
34953	s	O
34954	brain	O
34955	on	O
34956	4/28/93	b-DATE
34957	with	O
34958	a	O
34959	history	O
34960	of	O
34961	papillary	b-PROBLEM
34962	carcinoma	i-PROBLEM
34963	of	i-PROBLEM
34964	the	i-PROBLEM
34965	thyroid	i-PROBLEM
34966	with	O
34967	bone	b-PROBLEM
34968	involvement	i-PROBLEM
34969	and	O
34970	possible	O
34971	lung	b-PROBLEM
34972	involvement	i-PROBLEM
34973	.	O
34974	work	b-TEST
34975	up	i-TEST
34976	was	O
34977	begun	O
34978	for	O
34979	the	O
34980	possible	O
34981	myeloproliferative	b-PROBLEM
34982	/	i-PROBLEM
34983	myelodysplastic	i-PROBLEM
34984	disorder	i-PROBLEM
34985	associated	O
34986	with	O
34987	the	b-PROBLEM
34988	hyper-eosinophilic	i-PROBLEM
34989	syndrome	i-PROBLEM
34990	.	O
34991	accordingly	O
34992	,	O
34993	an	b-CLINICAL_DEPT
34994	oncology	i-CLINICAL_DEPT
34995	consult	i-CLINICAL_DEPT
34996	was	O
34997	called	O
34998	on	O
34999	4/29/93	b-DATE
35000	and	O
35001	a	b-TEST
35002	bone	i-TEST
35003	marrow	i-TEST
35004	aspirate	i-TEST
35005	biopsy	i-TEST
35006	was	O
35007	performed	O
35008	.	O
35009	this	b-EVIDENTIAL
35010	revealed	i-EVIDENTIAL
35011	maturation	b-PROBLEM
35012	of	i-PROBLEM
35013	leukocytes	i-PROBLEM
35014	to	O
35015	all	O
35016	stages	O
35017	with	O
35018	markedly	b-PROBLEM
35019	increased	i-PROBLEM
35020	eosinophilic	i-PROBLEM
35021	proliferation	i-PROBLEM
35022	.	O
35023	a	b-TEST
35024	lung	i-TEST
35025	biopsy	i-TEST
35026	was	O
35027	performed	O
35028	on	O
35029	4/30/93	b-DATE
35030	without	O
35031	definitive	b-OCCURRENCE
35032	results	i-OCCURRENCE
35033	.	O
35034	during	O
35035	this	O
35036	time	O
35037	the	b-OCCURRENCE
35038	patient	i-OCCURRENCE
35039	&apos;s	i-OCCURRENCE
35040	coagulation	i-OCCURRENCE
35041	status	i-OCCURRENCE
35042	had	O
35043	improved	O
35044	with	O
35045	vitamin	b-TREATMENT
35046	k	i-TREATMENT
35047	therapy	i-TREATMENT
35048	with	O
35049	pts	b-TEST
35050	normalizing	O
35051	.	O
35052	anca	b-TEST
35053	serum	O
35054	results	O
35055	were	O
35056	negative	O
35057	.	O
35058	ana	b-TEST
35059	results	O
35060	were	O
35061	also	O
35062	nonsuggestive	O
35063	.	O
35064	the	O
35065	patient	O
35066	continued	O
35067	to	O
35068	suffer	O
35069	from	O
35070	edema	b-PROBLEM
35071	of	i-PROBLEM
35072	the	i-PROBLEM
35073	left	i-PROBLEM
35074	upper	i-PROBLEM
35075	extremity	i-PROBLEM
35076	and	O
35077	a	b-CLINICAL_DEPT
35078	vascular	i-CLINICAL_DEPT
35079	radiology	i-CLINICAL_DEPT
35080	consult	O
35081	revealed	b-EVIDENTIAL
35082	a	b-PROBLEM
35083	thrombosis	i-PROBLEM
35084	of	i-PROBLEM
35085	the	i-PROBLEM
35086	left	i-PROBLEM
35087	subclavian	i-PROBLEM
35088	vein	i-PROBLEM
35089	extending	O
35090	into	O
35091	the	O
35092	axillary	O
35093	vein	O
35094	.	O
35095	there	O
35096	was	O
35097	some	b-PROBLEM
35098	thrombosis	i-PROBLEM
35099	of	i-PROBLEM
35100	the	i-PROBLEM
35101	left	i-PROBLEM
35102	internal	i-PROBLEM
35103	jugular	i-PROBLEM
35104	vein	i-PROBLEM
35105	as	O
35106	well	O
35107	.	O
35108	a	b-TEST
35109	head	i-TEST
35110	ct	i-TEST
35111	was	O
35112	performed	O
35113	and	O
35114	was	O
35115	completely	O
35116	negative	O
35117	for	O
35118	any	b-PROBLEM
35119	metastatic	i-PROBLEM
35120	process	i-PROBLEM
35121	involving	O
35122	the	O
35123	brain	O
35124	.	O
35125	thus	O
35126	,	O
35127	a	b-TREATMENT
35128	heparin	i-TREATMENT
35129	sliding	i-TREATMENT
35130	scale	i-TREATMENT
35131	was	O
35132	begun	O
35133	.	O
35134	meanwhile	O
35135	,	O
35136	the	b-PROBLEM
35137	patient	i-PROBLEM
35138	&apos;s	i-PROBLEM
35139	eosinophilia	i-PROBLEM
35140	was	O
35141	treated	O
35142	with	O
35143	a	b-TREATMENT
35144	trial	i-TREATMENT
35145	of	i-TREATMENT
35146	prednisone	i-TREATMENT
35147	.	O
35148	she	O
35149	also	O
35150	developed	O
35151	a	b-PROBLEM
35152	mild	i-PROBLEM
35153	urinary	i-PROBLEM
35154	tract	i-PROBLEM
35155	infection	i-PROBLEM
35156	which	O
35157	responded	O
35158	to	O
35159	bactrim	b-TREATMENT
35160	,	O
35161	but	O
35162	which	O
35163	was	O
35164	subsequently	O
35165	stopped	O
35166	because	O
35167	of	O
35168	diarrhea	b-PROBLEM
35169	.	O
35170	the	O
35171	conclusions	O
35172	at	O
35173	this	O
35174	time	O
35175	of	O
35176	the	b-CLINICAL_DEPT
35177	thyroid	i-CLINICAL_DEPT
35178	cytologist	i-CLINICAL_DEPT
35179	,	O
35180	as	O
35181	well	O
35182	as	O
35183	the	b-CLINICAL_DEPT
35184	bone	i-CLINICAL_DEPT
35185	pathologist	i-CLINICAL_DEPT
35186	,	O
35187	were	O
35188	that	O
35189	the	O
35190	findings	O
35191	were	O
35192	diagnostic	O
35193	of	O
35194	papillary	b-PROBLEM
35195	thyroid	i-PROBLEM
35196	carcinoma	i-PROBLEM
35197	with	O
35198	pulmonary	b-PROBLEM
35199	metastases	i-PROBLEM
35200	.	O
35201	doctor	O
35202	trial	O
35203	was	O
35204	subsequently	O
35205	consulted	b-OCCURRENCE
35206	on	O
35207	5/5	b-DATE
35208	for	O
35209	surgical	b-TREATMENT
35210	intervention	i-TREATMENT
35211	.	O
35212	on	O
35213	5/6/93	b-DATE
35214	the	O
35215	patient	O
35216	underwent	O
35217	a	b-TREATMENT
35218	right	i-TREATMENT
35219	thyroidectomy	i-TREATMENT
35220	with	O
35221	sacrifice	b-TREATMENT
35222	of	i-TREATMENT
35223	the	i-TREATMENT
35224	right	i-TREATMENT
35225	recurrent	i-TREATMENT
35226	laryngeal	i-TREATMENT
35227	nerve	i-TREATMENT
35228	as	O
35229	well	O
35230	as	O
35231	the	O
35232	right	O
35233	sternothyroid	O
35234	muscle	O
35235	and	O
35236	lower	O
35237	parathyroid	O
35238	gland	O
35239	.	O
35240	she	O
35241	underwent	O
35242	autotransplantation	b-TREATMENT
35243	of	i-TREATMENT
35244	the	i-TREATMENT
35245	right	i-TREATMENT
35246	upper	i-TREATMENT
35247	parathyroid	i-TREATMENT
35248	gland	i-TREATMENT
35249	,	O
35250	as	O
35251	well	O
35252	as	O
35253	repair	b-TREATMENT
35254	of	O
35255	a	b-TREATMENT
35256	right	i-TREATMENT
35257	posterior	i-TREATMENT
35258	membranous	i-TREATMENT
35259	tracheotomy	i-TREATMENT
35260	.	O
35261	she	O
35262	was	O
35263	received	O
35264	in	O
35265	the	b-CLINICAL_DEPT
35266	respiratory	i-CLINICAL_DEPT
35267	intensive	i-CLINICAL_DEPT
35268	care	i-CLINICAL_DEPT
35269	unit	i-CLINICAL_DEPT
35270	immediately	O
35271	postoperatively	O
35272	in	O
35273	stable	O
35274	condition	O
35275	.	O
35276	her	b-TEST
35277	rate	i-TEST
35278	was	O
35279	well	O
35280	controlled	O
35281	on	O
35282	digoxin	b-TREATMENT
35283	.	O
35284	the	O
35285	patient	O
35286	was	O
35287	transferred	b-OCCURRENCE
35288	to	O
35289	the	b-CLINICAL_DEPT
35290	floor	i-CLINICAL_DEPT
35291	on	O
35292	5/7	b-DATE
35293	.	O
35294	on	O
35295	the	b-CLINICAL_DEPT
35296	ward	i-CLINICAL_DEPT
35297	she	O
35298	continued	O
35299	a	b-TREATMENT
35300	gentle	i-TREATMENT
35301	diuresis	i-TREATMENT
35302	as	O
35303	well	O
35304	as	O
35305	solu-medrol	b-TREATMENT
35306	therapy	i-TREATMENT
35307	.	O
35308	calcium	b-TEST
35309	levels	i-TEST
35310	remained	O
35311	7.2	O
35312	to	O
35313	7.5	O
35314	postoperatively	O
35315	.	O
35316	she	O
35317	continued	O
35318	to	O
35319	improve	O
35320	with	O
35321	a	b-PROBLEM
35322	slight	i-PROBLEM
35323	hoarseness	i-PROBLEM
35324	in	i-PROBLEM
35325	her	i-PROBLEM
35326	voice	i-PROBLEM
35327	that	O
35328	was	O
35329	expected	O
35330	.	O
35331	she	O
35332	continued	O
35333	to	O
35334	exhibit	O
35335	asymptomatic	b-PROBLEM
35336	atrial	i-PROBLEM
35337	fibrillation	i-PROBLEM
35338	.	O
35339	anticoagulation	b-TREATMENT
35340	was	O
35341	begun	O
35342	on	O
35343	the	b-DATE
35344	third	i-DATE
35345	postoperative	i-DATE
35346	day	i-DATE
35347	with	O
35348	coumadin	b-TREATMENT
35349	.	O
35350	she	O
35351	was	O
35352	effectively	b-TREATMENT
35353	anticoagulated	i-TREATMENT
35354	with	O
35355	a	b-TEST
35356	pt	i-TEST
35357	in	O
35358	the	O
35359	range	O
35360	between	O
35361	15	O
35362	and	O
35363	17	O
35364	over	O
35365	a	O
35366	control	O
35367	of	O
35368	10	O
35369	.	O
35370	she	O
35371	also	O
35372	received	O
35373	a	b-CLINICAL_DEPT
35374	radiation	i-CLINICAL_DEPT
35375	therapy	i-CLINICAL_DEPT
35376	consult	O
35377	for	O
35378	local	b-TREATMENT
35379	control	i-TREATMENT
35380	of	O
35381	her	b-PROBLEM
35382	invasive	i-PROBLEM
35383	carcinoma	i-PROBLEM
35384	.	O
35385	she	O
35386	did	O
35387	well	O
35388	on	O
35389	the	b-CLINICAL_DEPT
35390	ward	i-CLINICAL_DEPT
35391	and	O
35392	was	O
35393	discharged	b-OCCURRENCE
35394	on	O
35395	her	b-DATE
35396	ninth	i-DATE
35397	postoperative	i-DATE
35398	day	i-DATE
35399	.	O
35400		O
35401	admission	b-OCCURRENCE
35402	date	O
35403	:	O
35404	2010-03-11	b-ADMISSION
35405	discharge	b-OCCURRENCE
35406	date	O
35407	:	O
35408	2010-03-28	b-DISCHARGE
35409	history	O
35410	of	O
35411	the	O
35412	present	O
35413	illness	O
35414	:	O
35415	the	O
35416	patient	O
35417	is	O
35418	a	O
35419	63	O
35420	-	O
35421	year-old	O
35422	man	O
35423	with	O
35424	a	O
35425	history	O
35426	of	O
35427	hypertension	b-PROBLEM
35428	and	O
35429	prior	O
35430	history	O
35431	of	O
35432	atrial	b-PROBLEM
35433	fibrillation	i-PROBLEM
35434	secondary	O
35435	to	O
35436	hyperthyroidism	b-PROBLEM
35437	who	O
35438	presented	b-OCCURRENCE
35439	to	O
35440	an	b-CLINICAL_DEPT
35441	outside	i-CLINICAL_DEPT
35442	hospital	i-CLINICAL_DEPT
35443	with	O
35444	a	O
35445	history	O
35446	of	O
35447	left-sided	b-PROBLEM
35448	chest	i-PROBLEM
35449	pain	i-PROBLEM
35450	at	O
35451	rest	b-OCCURRENCE
35452	.	O
35453	the	O
35454	patient	O
35455	awoke	b-OCCURRENCE
35456	with	O
35457	chest	b-PROBLEM
35458	pressure	i-PROBLEM
35459	radiating	b-PROBLEM
35460	to	i-PROBLEM
35461	the	i-PROBLEM
35462	right	i-PROBLEM
35463	chest	i-PROBLEM
35464	associated	O
35465	with	O
35466	diaphoresis	b-PROBLEM
35467	.	O
35468	the	O
35469	patient	O
35470	was	O
35471	found	b-EVIDENTIAL
35472	to	O
35473	have	O
35474	a	b-TEST
35475	blood	i-TEST
35476	pressure	i-TEST
35477	of	O
35478	170/108	O
35479	with	O
35480	atrial	b-PROBLEM
35481	fibrillation	i-PROBLEM
35482	and	O
35483	rapid	b-PROBLEM
35484	ventricular	i-PROBLEM
35485	response	i-PROBLEM
35486	to	O
35487	a	b-TEST
35488	heart	i-TEST
35489	rate	i-TEST
35490	of	O
35491	140s	O
35492	.	O
35493	the	O
35494	patient	O
35495	was	O
35496	rate	b-TREATMENT
35497	controlled	i-TREATMENT
35498	and	O
35499	transferred	b-OCCURRENCE
35500	to	O
35501	the	b-CLINICAL_DEPT
35502	stillman	i-CLINICAL_DEPT
35503	infirmary	i-CLINICAL_DEPT
35504	for	O
35505	emergent	b-TEST
35506	cardiac	i-TEST
35507	catheterization	i-TEST
35508	.	O
35509	hospital	O
35510	course	O
35511	:	O
35512	the	O
35513	patient	O
35514	was	O
35515	transferred	b-OCCURRENCE
35516	for	O
35517	cardiac	b-TEST
35518	catheterization	i-TEST
35519	.	O
35520	emergent	b-TEST
35521	cardiac	i-TEST
35522	catheterization	i-TEST
35523	revealed	b-EVIDENTIAL
35524	an	b-TEST
35525	ejection	i-TEST
35526	fraction	i-TEST
35527	of	O
35528	45%	O
35529	,	O
35530	right	b-PROBLEM
35531	dominant	i-PROBLEM
35532	coronary	i-PROBLEM
35533	artery	i-PROBLEM
35534	system	i-PROBLEM
35535	with	O
35536	occlusive	b-PROBLEM
35537	single	i-PROBLEM
35538	vessel	i-PROBLEM
35539	disease	i-PROBLEM
35540	of	i-PROBLEM
35541	the	i-PROBLEM
35542	lad	i-PROBLEM
35543	.	O
35544	multiple	b-TREATMENT
35545	wires	i-TREATMENT
35546	were	O
35547	used	O
35548	to	O
35549	attempt	O
35550	to	O
35551	cross	O
35552	the	b-PROBLEM
35553	total	i-PROBLEM
35554	occlusion	i-PROBLEM
35555	,	O
35556	but	O
35557	were	O
35558	ultimately	O
35559	unsuccessful	O
35560	.	O
35561	the	O
35562	patient	O
35563	was	O
35564	continued	O
35565	on	O
35566	a	b-TREATMENT
35567	heparin	i-TREATMENT
35568	drip	i-TREATMENT
35569	for	O
35570	atrial	b-PROBLEM
35571	fibrillation	i-PROBLEM
35572	.	O
35573	cardiothoracic	b-OCCURRENCE
35574	surgery	i-OCCURRENCE
35575	consultation	i-OCCURRENCE
35576	was	O
35577	obtained	O
35578	and	O
35579	the	O
35580	patient	O
35581	was	O
35582	taken	b-OCCURRENCE
35583	to	O
35584	the	b-CLINICAL_DEPT
35585	operating	i-CLINICAL_DEPT
35586	room	i-CLINICAL_DEPT
35587	on	O
35588	2010-03-12	b-DATE
35589	for	O
35590	coronary	b-TREATMENT
35591	artery	i-TREATMENT
35592	bypass	i-TREATMENT
35593	grafting	i-TREATMENT
35594	times	O
35595	two	O
35596	;	O
35597	lima	b-TREATMENT
35598	to	i-TREATMENT
35599	the	i-TREATMENT
35600	lad	i-TREATMENT
35601	,	O
35602	saphenous	b-TREATMENT
35603	vein	i-TREATMENT
35604	graft	i-TREATMENT
35605	to	i-TREATMENT
35606	the	i-TREATMENT
35607	diagonal	i-TREATMENT
35608	artery	i-TREATMENT
35609	.	O
35610	subsequent	O
35611	to	O
35612	this	O
35613	,	O
35614	the	O
35615	patient	O
35616	was	O
35617	transferred	b-OCCURRENCE
35618	to	O
35619	the	b-CLINICAL_DEPT
35620	crsu	i-CLINICAL_DEPT
35621	for	O
35622	closer	b-OCCURRENCE
35623	monitoring	i-OCCURRENCE
35624	.	O
35625	he	O
35626	was	O
35627	deemed	O
35628	to	O
35629	be	O
35630	too	b-PROBLEM
35631	lethargic	i-PROBLEM
35632	and	O
35633	sleepy	b-PROBLEM
35634	to	O
35635	be	O
35636	extubated	b-TREATMENT
35637	on	O
35638	postoperative	b-DATE
35639	day	i-DATE
35640	number	i-DATE
35641	zero	i-DATE
35642	.	O
35643	the	O
35644	patient	O
35645	was	O
35646	extubated	b-TREATMENT
35647	early	O
35648	on	O
35649	postoperative	b-DATE
35650	day	i-DATE
35651	number	i-DATE
35652	one	i-DATE
35653	without	O
35654	significant	b-PROBLEM
35655	complication	i-PROBLEM
35656	.	O
35657	he	O
35658	remained	O
35659	in	O
35660	atrial	b-PROBLEM
35661	fibrillation	i-PROBLEM
35662	.	O
35663	the	O
35664	ep	O
35665	service	O
35666	was	O
35667	consulted	O
35668	regarding	O
35669	the	b-PROBLEM
35670	patient	i-PROBLEM
35671	's	i-PROBLEM
35672	atrial	i-PROBLEM
35673	fibrillation	i-PROBLEM
35674	.	O
35675	this	O
35676	was	O
35677	his	b-PROBLEM
35678	main	i-PROBLEM
35679	issue	i-PROBLEM
35680	in	O
35681	the	b-OCCURRENCE
35682	postoperative	i-OCCURRENCE
35683	course	i-OCCURRENCE
35684	.	O
35685	he	O
35686	was	O
35687	attempted	O
35688	on	O
35689	multiple	b-TREATMENT
35690	different	i-TREATMENT
35691	drugs	i-TREATMENT
35692	including	O
35693	procainamide	b-TREATMENT
35694	,	O
35695	diltiazem	b-TREATMENT
35696	,	O
35697	esmolol	b-TREATMENT
35698	,	O
35699	sotalol	b-TREATMENT
35700	,	O
35701	amiodarone	b-TREATMENT
35702	.	O
35703	the	O
35704	patient	O
35705	was	O
35706	kept	O
35707	therapeutically	b-TREATMENT
35708	anticoagulated	i-TREATMENT
35709	throughout	O
35710	this	O
35711	period	O
35712	.	O
35713	the	O
35714	patient	O
35715	was	O
35716	also	O
35717	started	O
35718	on	O
35719	digoxin	b-TREATMENT
35720	.	O
35721	ultimately	O
35722	,	O
35723	the	O
35724	patient	O
35725	was	O
35726	transferred	b-OCCURRENCE
35727	to	O
35728	the	b-CLINICAL_DEPT
35729	floor	i-CLINICAL_DEPT
35730	and	O
35731	anticoagulation	b-TREATMENT
35732	with	O
35733	coumadin	b-TREATMENT
35734	was	O
35735	begun	O
35736	.	O
35737	the	O
35738	patient	O
35739	arrived	b-OCCURRENCE
35740	on	O
35741	the	b-CLINICAL_DEPT
35742	floor	i-CLINICAL_DEPT
35743	with	O
35744	medications	b-TREATMENT
35745	as	O
35746	follows	O
35747	:	O
35748	sotalol	b-TREATMENT
35749	180	O
35750	mg	O
35751	b.i.d.	b-FREQUENCY
35752	,	O
35753	diltiazem	b-TREATMENT
35754	90	O
35755	mg	O
35756	q.i.d.	b-FREQUENCY
35757	,	O
35758	digoxin	b-TREATMENT
35759	0.125	O
35760	mg	O
35761	q.d.	b-FREQUENCY
35762	while	O
35763	the	O
35764	patient	O
35765	was	O
35766	awaiting	O
35767	therapeutic	b-TREATMENT
35768	anticoagulation	i-TREATMENT
35769	with	O
35770	coumadin	b-TREATMENT
35771	,	O
35772	he	O
35773	spontaneously	b-OCCURRENCE
35774	converted	i-OCCURRENCE
35775	into	i-OCCURRENCE
35776	normal	i-OCCURRENCE
35777	sinus	i-OCCURRENCE
35778	rhythm	i-OCCURRENCE
35779	.	O
35780	the	O
35781	patient	O
35782	was	O
35783	found	b-EVIDENTIAL
35784	to	O
35785	have	O
35786	a	b-TEST
35787	resting	i-TEST
35788	heart	i-TEST
35789	rate	i-TEST
35790	of	O
35791	approximately	O
35792	50	O
35793	subsequent	O
35794	to	O
35795	this	O
35796	.	O
35797	in	O
35798	consultation	O
35799	with	O
35800	the	O
35801	ep	O
35802	service	O
35803	,	O
35804	diltiazem	b-TREATMENT
35805	was	O
35806	stopped	O
35807	.	O
35808	after	O
35809	approximately	O
35810	24	b-DURATION
35811	hours	i-DURATION
35812	,	O
35813	the	O
35814	patient	O
35815	converted	b-OCCURRENCE
35816	back	O
35817	into	O
35818	atrial	b-PROBLEM
35819	fibrillation	i-PROBLEM
35820	and	O
35821	diltiazem	b-TREATMENT
35822	was	O
35823	restarted	O
35824	at	O
35825	60	O
35826	mg	O
35827	q.i.d.	b-FREQUENCY
35828	the	O
35829	patient	O
35830	then	O
35831	had	O
35832	one	b-PROBLEM
35833	more	i-PROBLEM
35834	episode	i-PROBLEM
35835	where	O
35836	he	O
35837	was	O
35838	converted	b-OCCURRENCE
35839	to	i-OCCURRENCE
35840	normal	i-OCCURRENCE
35841	sinus	i-OCCURRENCE
35842	rhythm	i-OCCURRENCE
35843	but	O
35844	this	O
35845	lasted	O
35846	only	O
35847	a	b-DURATION
35848	few	i-DURATION
35849	hours	i-DURATION
35850	before	O
35851	reverting	b-OCCURRENCE
35852	back	i-OCCURRENCE
35853	to	O
35854	atrial	b-PROBLEM
35855	fibrillation	i-PROBLEM
35856	.	O
35857	the	O
35858	patient	O
35859	was	O
35860	ultimately	O
35861	discharged	b-OCCURRENCE
35862	on	O
35863	postoperative	b-DATE
35864	day	i-DATE
35865	number	i-DATE
35866	16	i-DATE
35867	,	O
35868	tolerating	b-OCCURRENCE
35869	a	i-OCCURRENCE
35870	regular	i-OCCURRENCE
35871	diet	i-OCCURRENCE
35872	,	O
35873	and	O
35874	adequate	b-OCCURRENCE
35875	pain	i-OCCURRENCE
35876	control	i-OCCURRENCE
35877	on	O
35878	p.o.	b-TREATMENT
35879	pain	i-TREATMENT
35880	medications	i-TREATMENT
35881	,	O
35882	having	O
35883	no	O
35884	anginal	b-PROBLEM
35885	symptoms	i-PROBLEM
35886	and	O
35887	with	O
35888	an	b-TEST
35889	inr	i-TEST
35890	of	O
35891	2.0	O
35892	.	O
35893	the	O
35894	patient	O
35895	failed	b-OCCURRENCE
35896	multiple	O
35897	attempts	b-OCCURRENCE
35898	at	O
35899	cardioversion	b-TREATMENT
35900	.	O
35901		O
35902	admission	b-OCCURRENCE
35903	date	O
35904	:	O
35905	10-24-93	b-DATE
35906	discharge	b-OCCURRENCE
35907	date	O
35908	:	O
35909	11-2-93	b-DATE
35910	history	O
35911	of	O
35912	present	O
35913	illness	O
35914	:	O
35915	the	O
35916	patient	O
35917	is	O
35918	a	O
35919	65	O
35920	year	O
35921	old	O
35922	portuguese	O
35923	male	O
35924	with	O
35925	a	O
35926	history	O
35927	of	O
35928	an	b-PROBLEM
35929	anterior	i-PROBLEM
35930	myocardial	i-PROBLEM
35931	infarction	i-PROBLEM
35932	i	O
35933	may	b-DATE
35934	1993	i-DATE
35935	and	O
35936	is	O
35937	status	O
35938	post	O
35939	a	b-TREATMENT
35940	percutaneous	i-TREATMENT
35941	transluminal	i-TREATMENT
35942	coronary	i-TREATMENT
35943	angioplasty	i-TREATMENT
35944	of	i-TREATMENT
35945	the	i-TREATMENT
35946	lad	i-TREATMENT
35947	who	O
35948	presented	b-OCCURRENCE
35949	on	O
35950	10-24-93	b-DATE
35951	with	O
35952	crushing	b-PROBLEM
35953	substernal	i-PROBLEM
35954	chest	i-PROBLEM
35955	pain	i-PROBLEM
35956	and	O
35957	shortness	b-PROBLEM
35958	of	i-PROBLEM
35959	breath	i-PROBLEM
35960	.	O
35961	he	O
35962	had	O
35963	no	O
35964	prior	O
35965	cardiac	b-PROBLEM
35966	history	i-PROBLEM
35967	until	O
35968	may	b-DATE
35969	1993	i-DATE
35970	when	O
35971	on	O
35972	5-24	b-DATE
35973	he	O
35974	had	O
35975	crushing	b-PROBLEM
35976	chest	i-PROBLEM
35977	pain	i-PROBLEM
35978	which	O
35979	radiated	O
35980	to	O
35981	his	O
35982	left	O
35983	arm	O
35984	.	O
35985	he	O
35986	was	O
35987	found	O
35988	at	O
35989	that	b-DATE
35990	time	i-DATE
35991	to	O
35992	have	O
35993	3-4	b-PROBLEM
35994	mm	i-PROBLEM
35995	st	i-PROBLEM
35996	segment	i-PROBLEM
35997	elevations	i-PROBLEM
35998	in	i-PROBLEM
35999	v1	i-PROBLEM
36000	through	O
36001	v4	O
36002	at	O
36003	pre	b-CLINICAL_DEPT
36004	health	i-CLINICAL_DEPT
36005	.	O
36006	the	O
36007	patient	O
36008	was	O
36009	transferred	b-OCCURRENCE
36010	to	O
36011	fairm	b-CLINICAL_DEPT
36012	of	i-CLINICAL_DEPT
36013	ijordcompmac	i-CLINICAL_DEPT
36014	hospital	i-CLINICAL_DEPT
36015	and	O
36016	had	O
36017	4-7	b-PROBLEM
36018	mm	i-PROBLEM
36019	st	i-PROBLEM
36020	segment	i-PROBLEM
36021	elevations	i-PROBLEM
36022	across	i-PROBLEM
36023	the	i-PROBLEM
36024	precordium	i-PROBLEM
36025	with	O
36026	q&apos;s	b-PROBLEM
36027	in	i-PROBLEM
36028	v1	i-PROBLEM
36029	and	i-PROBLEM
36030	v2	i-PROBLEM
36031	,	O
36032	2	b-PROBLEM
36033	mm	i-PROBLEM
36034	st	i-PROBLEM
36035	elevation	i-PROBLEM
36036	in	i-PROBLEM
36037	avl	i-PROBLEM
36038	,	O
36039	and	O
36040	1-2	b-PROBLEM
36041	mm	i-PROBLEM
36042	reciprocal	i-PROBLEM
36043	st	i-PROBLEM
36044	depression	i-PROBLEM
36045	in	i-PROBLEM
36046	ii	i-PROBLEM
36047	,	i-PROBLEM
36048	iii	i-PROBLEM
36049	,	i-PROBLEM
36050	and	i-PROBLEM
36051	f.	i-PROBLEM
36052	on	O
36053	physical	b-TEST
36054	examination	i-TEST
36055	at	O
36056	that	b-DATE
36057	time	i-DATE
36058	he	O
36059	had	O
36060	bright	b-PROBLEM
36061	red	i-PROBLEM
36062	blood	i-PROBLEM
36063	per	i-PROBLEM
36064	rectum	i-PROBLEM
36065	and	O
36066	therefore	O
36067	lysis	b-TREATMENT
36068	was	O
36069	deferred	O
36070	and	O
36071	he	O
36072	was	O
36073	taken	O
36074	directly	O
36075	to	O
36076	the	b-CLINICAL_DEPT
36077	cardiac	i-CLINICAL_DEPT
36078	catheterization	i-CLINICAL_DEPT
36079	lab	i-CLINICAL_DEPT
36080	.	O
36081	the	b-TEST
36082	cardiac	i-TEST
36083	catheterization	i-TEST
36084	results	O
36085	at	O
36086	that	b-DATE
36087	time	i-DATE
36088	revealed	b-EVIDENTIAL
36089	a	b-TEST
36090	right	i-TEST
36091	atrial	i-TEST
36092	pressure	i-TEST
36093	of	O
36094	7	O
36095	,	O
36096	pulmonary	b-TEST
36097	artery	i-TEST
36098	pressure	i-TEST
36099	of	O
36100	29/16	O
36101	,	O
36102	rv	b-TEST
36103	33/8	O
36104	,	O
36105	pulmonary	b-TEST
36106	capillary	i-TEST
36107	wedge	i-TEST
36108	pressure	i-TEST
36109	of	O
36110	16	O
36111	.	O
36112	he	O
36113	had	O
36114	a	b-PROBLEM
36115	95%	i-PROBLEM
36116	proximal	i-PROBLEM
36117	left	i-PROBLEM
36118	anterior	i-PROBLEM
36119	descending	i-PROBLEM
36120	lesion	i-PROBLEM
36121	which	O
36122	was	O
36123	ptca	O
36124	&apos;d	O
36125	to	O
36126	a	O
36127	residual	O
36128	of	O
36129	30%	O
36130	and	O
36131	an	b-TREATMENT
36132	intra-aortic	i-TREATMENT
36133	balloon	i-TREATMENT
36134	pump	i-TREATMENT
36135	was	O
36136	placed	O
36137	.	O
36138	he	O
36139	also	O
36140	had	O
36141	some	b-PROBLEM
36142	mild	i-PROBLEM
36143	to	i-PROBLEM
36144	moderate	i-PROBLEM
36145	disease	i-PROBLEM
36146	at	O
36147	the	O
36148	om1	O
36149	noted	O
36150	at	O
36151	that	b-DATE
36152	time	i-DATE
36153	.	O
36154	the	O
36155	patient	O
36156	was	O
36157	transferred	b-OCCURRENCE
36158	to	O
36159	the	b-CLINICAL_DEPT
36160	cardiac	i-CLINICAL_DEPT
36161	care	i-CLINICAL_DEPT
36162	unit	i-CLINICAL_DEPT
36163	where	O
36164	he	O
36165	had	O
36166	a	b-TEST
36167	peak	i-TEST
36168	cpk	i-TEST
36169	of	O
36170	5,042	O
36171	and	O
36172	26.7%	O
36173	mb&apos;s	b-TEST
36174	.	O
36175	his	b-TREATMENT
36176	intra-aortic	i-TREATMENT
36177	balloon	i-TREATMENT
36178	pump	i-TREATMENT
36179	was	O
36180	weaned	O
36181	without	O
36182	problems	b-PROBLEM
36183	.	O
36184	he	O
36185	had	O
36186	hypotension	b-PROBLEM
36187	with	O
36188	beta	b-TREATMENT
36189	blockers	i-TREATMENT
36190	and	O
36191	therefore	O
36192	they	O
36193	were	O
36194	not	O
36195	started	O
36196	.	O
36197	on	O
36198	day	b-DATE
36199	six	i-DATE
36200	,	O
36201	an	b-TEST
36202	echocardiogram	i-TEST
36203	showed	b-EVIDENTIAL
36204	an	b-TEST
36205	ejection	i-TEST
36206	fraction	i-TEST
36207	of	O
36208	44%	O
36209	with	O
36210	anterior	b-PROBLEM
36211	akinesis	i-PROBLEM
36212	and	O
36213	septal	b-PROBLEM
36214	hypokinesis	i-PROBLEM
36215	.	O
36216	on	O
36217	day	b-DATE
36218	nine	i-DATE
36219	,	O
36220	he	O
36221	had	O
36222	a	b-TEST
36223	low	i-TEST
36224	level	i-TEST
36225	exercise	i-TEST
36226	tolerance	i-TEST
36227	test	i-TEST
36228	with	i-TEST
36229	thallium	i-TEST
36230	which	O
36231	was	O
36232	positive	O
36233	for	O
36234	2.5	b-PROBLEM
36235	mm	i-PROBLEM
36236	horizontal	i-PROBLEM
36237	depressions	i-PROBLEM
36238	in	i-PROBLEM
36239	ii	i-PROBLEM
36240	,	i-PROBLEM
36241	iii	i-PROBLEM
36242	,	i-PROBLEM
36243	and	i-PROBLEM
36244	avf	i-PROBLEM
36245	,	O
36246	and	O
36247	1.5	b-PROBLEM
36248	mm	i-PROBLEM
36249	downsloping	i-PROBLEM
36250	st	i-PROBLEM
36251	depressions	i-PROBLEM
36252	in	i-PROBLEM
36253	v5	i-PROBLEM
36254	and	i-PROBLEM
36255	v6	i-PROBLEM
36256	,	O
36257	as	O
36258	well	O
36259	as	O
36260	some	b-PROBLEM
36261	anteroseptal	i-PROBLEM
36262	redistribution	i-PROBLEM
36263	on	O
36264	thallium	b-TREATMENT
36265	.	O
36266	therefore	O
36267	,	O
36268	he	O
36269	went	O
36270	to	O
36271	repeat	b-TEST
36272	cardiac	i-TEST
36273	catheterization	i-TEST
36274	which	O
36275	revealed	b-EVIDENTIAL
36276	that	O
36277	the	b-PROBLEM
36278	left	i-PROBLEM
36279	anterior	i-PROBLEM
36280	descending	i-PROBLEM
36281	site	i-PROBLEM
36282	was	i-PROBLEM
36283	patent	i-PROBLEM
36284	and	O
36285	revealed	O
36286	a	b-PROBLEM
36287	distal	i-PROBLEM
36288	pda	i-PROBLEM
36289	lesion	i-PROBLEM
36290	and	O
36291	a	b-PROBLEM
36292	circumflex	i-PROBLEM
36293	lesion	i-PROBLEM
36294	after	O
36295	the	O
36296	om	O
36297	.	O
36298	the	O
36299	patient	O
36300	was	O
36301	discharged	b-OCCURRENCE
36302	to	O
36303	home	O
36304	and	O
36305	is	O
36306	supposed	O
36307	to	O
36308	follow	b-OCCURRENCE
36309	up	i-OCCURRENCE
36310	with	O
36311	doctor	O
36312	shuffburle	O
36313	of	O
36314	gastroenterology	O
36315	for	O
36316	work	b-TEST
36317	up	i-TEST
36318	of	O
36319	his	b-PROBLEM
36320	bright	i-PROBLEM
36321	red	i-PROBLEM
36322	blood	i-PROBLEM
36323	per	i-PROBLEM
36324	rectum	i-PROBLEM
36325	and	O
36326	is	O
36327	supposed	O
36328	to	O
36329	follow	b-OCCURRENCE
36330	up	i-OCCURRENCE
36331	with	O
36332	doctor	O
36333	amesin	O
36334	of	O
36335	cardiology	b-CLINICAL_DEPT
36336	and	O
36337	doctor	O
36338	shuffpasc	O
36339	of	O
36340	dingclearf	b-CLINICAL_DEPT
36341	alllirefaith	i-CLINICAL_DEPT
36342	memorial	i-CLINICAL_DEPT
36343	hospital	i-CLINICAL_DEPT
36344	.	O
36345	however	O
36346	,	O
36347	he	O
36348	did	O
36349	not	O
36350	keep	b-OCCURRENCE
36351	any	i-OCCURRENCE
36352	of	i-OCCURRENCE
36353	these	i-OCCURRENCE
36354	appointments	i-OCCURRENCE
36355	.	O
36356	he	O
36357	went	O
36358	home	O
36359	and	O
36360	did	O
36361	not	O
36362	take	O
36363	any	O
36364	of	O
36365	his	b-TREATMENT
36366	medications	i-TREATMENT
36367	and	O
36368	smoked	b-PROBLEM
36369	and	i-PROBLEM
36370	drank	i-PROBLEM
36371	heavily	i-PROBLEM
36372	throughout	O
36373	the	b-DURATION
36374	several	i-DURATION
36375	months	i-DURATION
36376	.	O
36377	on	O
36378	the	O
36379	a.m.	O
36380	of	O
36381	10-24-93	b-DATE
36382	,	O
36383	the	O
36384	patient	O
36385	developed	O
36386	crushing	b-PROBLEM
36387	substernal	i-PROBLEM
36388	chest	i-PROBLEM
36389	pain	i-PROBLEM
36390	and	O
36391	shortness	b-PROBLEM
36392	of	i-PROBLEM
36393	breath	i-PROBLEM
36394	.	O
36395	he	O
36396	came	O
36397	to	O
36398	the	b-CLINICAL_DEPT
36399	fairm	i-CLINICAL_DEPT
36400	of	i-CLINICAL_DEPT
36401	ijordcompmac	i-CLINICAL_DEPT
36402	hospital	i-CLINICAL_DEPT
36403	emergency	i-CLINICAL_DEPT
36404	ward	i-CLINICAL_DEPT
36405	where	O
36406	he	O
36407	was	O
36408	noted	O
36409	to	O
36410	be	O
36411	ashen	b-PROBLEM
36412	and	O
36413	diaphoretic	b-PROBLEM
36414	.	O
36415	he	O
36416	was	O
36417	treated	O
36418	with	O
36419	oxygen	b-TREATMENT
36420	,	O
36421	aspirin	b-TREATMENT
36422	,	O
36423	five	b-TREATMENT
36424	sublingual	i-TREATMENT
36425	nitroglycerins	i-TREATMENT
36426	,	O
36427	heparin	b-TREATMENT
36428	,	O
36429	and	O
36430	was	O
36431	eventually	O
36432	made	b-OCCURRENCE
36433	pain	i-OCCURRENCE
36434	free	i-OCCURRENCE
36435	with	O
36436	that	b-TREATMENT
36437	regimen	i-TREATMENT
36438	.	O
36439	cardiac	O
36440	risk	O
36441	factors	O
36442	:	O
36443	his	O
36444	cardiac	O
36445	risk	O
36446	factors	O
36447	included	O
36448	hypertension	b-PROBLEM
36449	,	O
36450	diabetes	b-PROBLEM
36451	mellitus	i-PROBLEM
36452	,	O
36453	hypercholesterolemia	b-PROBLEM
36454	,	O
36455	cigarette	b-PROBLEM
36456	smoking	i-PROBLEM
36457	,	O
36458	and	O
36459	a	b-PROBLEM
36460	positive	i-PROBLEM
36461	family	i-PROBLEM
36462	history	i-PROBLEM
36463	.	O
36464	hospital	O
36465	course	O
36466	:	O
36467	the	O
36468	patient	O
36469	was	O
36470	admitted	b-OCCURRENCE
36471	to	O
36472	the	b-CLINICAL_DEPT
36473	step	i-CLINICAL_DEPT
36474	down	i-CLINICAL_DEPT
36475	unit	i-CLINICAL_DEPT
36476	for	O
36477	a	O
36478	rule	O
36479	out	O
36480	mi	b-TREATMENT
36481	protocol	i-TREATMENT
36482	.	O
36483	he	O
36484	was	O
36485	treated	O
36486	with	O
36487	aspirin	b-TREATMENT
36488	,	O
36489	heparin	b-TREATMENT
36490	,	O
36491	and	O
36492	intravenous	b-TREATMENT
36493	nitroglycerin	i-TREATMENT
36494	.	O
36495	no	O
36496	beta	b-TREATMENT
36497	blockers	i-TREATMENT
36498	was	O
36499	started	O
36500	because	O
36501	of	O
36502	his	O
36503	history	O
36504	of	O
36505	hypertension	b-PROBLEM
36506	with	O
36507	beta	O
36508	blockers	O
36509	and	O
36510	because	O
36511	his	b-TEST
36512	blood	i-TEST
36513	pressure	i-TEST
36514	of	O
36515	only	O
36516	110/70	O
36517	.	O
36518	the	O
36519	patient	O
36520	ruled	O
36521	in	O
36522	for	O
36523	myocardial	b-PROBLEM
36524	infarction	i-PROBLEM
36525	with	O
36526	a	b-TEST
36527	peak	i-TEST
36528	cpk	i-TEST
36529	of	O
36530	219	O
36531	and	O
36532	20.9%	b-TEST
36533	mb	i-TEST
36534	fraction	i-TEST
36535	.	O
36536	this	O
36537	was	O
36538	a	b-PROBLEM
36539	non-q	i-PROBLEM
36540	wave	i-PROBLEM
36541	myocardial	i-PROBLEM
36542	infarction	i-PROBLEM
36543	as	O
36544	there	O
36545	were	O
36546	no	O
36547	diagnostic	b-PROBLEM
36548	electrocardiogram	i-PROBLEM
36549	changes	i-PROBLEM
36550	.	O
36551	on	O
36552	10-27-93	b-DATE
36553	,	O
36554	the	O
36555	patient	O
36556	went	O
36557	to	O
36558	the	b-CLINICAL_DEPT
36559	cath	i-CLINICAL_DEPT
36560	lab	i-CLINICAL_DEPT
36561	which	O
36562	revealed	O
36563	a	b-PROBLEM
36564	small	i-PROBLEM
36565	nondominant	i-PROBLEM
36566	right	i-PROBLEM
36567	coronary	i-PROBLEM
36568	artery	i-PROBLEM
36569	without	i-PROBLEM
36570	any	i-PROBLEM
36571	lesions	i-PROBLEM
36572	,	O
36573	a	b-PROBLEM
36574	restenosis	i-PROBLEM
36575	of	i-PROBLEM
36576	the	i-PROBLEM
36577	proximal	i-PROBLEM
36578	left	i-PROBLEM
36579	anterior	i-PROBLEM
36580	descending	i-PROBLEM
36581	lesion	i-PROBLEM
36582	that	O
36583	had	O
36584	been	O
36585	ptca	b-TREATMENT
36586	&apos;d	i-TREATMENT
36587	,	O
36588	a	b-PROBLEM
36589	lesion	i-PROBLEM
36590	in	i-PROBLEM
36591	the	i-PROBLEM
36592	first	i-PROBLEM
36593	om	i-PROBLEM
36594	,	O
36595	and	O
36596	a	b-PROBLEM
36597	moderately	i-PROBLEM
36598	severe	i-PROBLEM
36599	left	i-PROBLEM
36600	circumflex	i-PROBLEM
36601	lesion	i-PROBLEM
36602	after	i-PROBLEM
36603	the	i-PROBLEM
36604	om3	i-PROBLEM
36605	.	O
36606	the	b-TEST
36607	left	i-TEST
36608	ventriculogram	i-TEST
36609	revealed	b-OCCURRENCE
36610	an	b-PROBLEM
36611	akinetic	i-PROBLEM
36612	anterolateral	i-PROBLEM
36613	and	i-PROBLEM
36614	apical	i-PROBLEM
36615	ventricle	i-PROBLEM
36616	.	O
36617	given	O
36618	the	O
36619	results	O
36620	of	O
36621	this	b-TEST
36622	cardiac	i-TEST
36623	catheterization	i-TEST
36624	,	O
36625	which	O
36626	were	O
36627	not	O
36628	significantly	O
36629	changed	O
36630	from	O
36631	his	b-TEST
36632	previous	i-TEST
36633	cardiac	i-TEST
36634	catheterization	i-TEST
36635	prior	O
36636	to	O
36637	the	b-TREATMENT
36638	ptca	i-TREATMENT
36639	,	O
36640	it	O
36641	was	O
36642	elected	O
36643	to	O
36644	attempt	O
36645	to	O
36646	medically	O
36647	manage	O
36648	the	O
36649	patient	O
36650	.	O
36651	he	O
36652	was	O
36653	ambulated	b-TREATMENT
36654	progressively	i-TREATMENT
36655	on	O
36656	the	b-CLINICAL_DEPT
36657	floor	i-CLINICAL_DEPT
36658	.	O
36659	a	b-TREATMENT
36660	beta	i-TREATMENT
36661	blocker	i-TREATMENT
36662	was	O
36663	started	O
36664	with	O
36665	metoprolol	b-OCCURRENCE
36666	initially	i-OCCURRENCE
36667	at	O
36668	25	O
36669	mg	O
36670	po	O
36671	bid	b-FREQUENCY
36672	and	O
36673	eventually	O
36674	increased	O
36675	to	O
36676	50	O
36677	mg	O
36678	po	O
36679	bid	b-FREQUENCY
36680	.	O
36681	the	O
36682	patient	O
36683	ambulated	b-OCCURRENCE
36684	extensively	i-OCCURRENCE
36685	on	O
36686	the	b-CLINICAL_DEPT
36687	fih	i-CLINICAL_DEPT
36688	20	i-CLINICAL_DEPT
36689	floor	i-CLINICAL_DEPT
36690	each	b-FREQUENCY
36691	day	i-FREQUENCY
36692	without	O
36693	any	O
36694	episodes	O
36695	of	O
36696	chest	b-PROBLEM
36697	pain	i-PROBLEM
36698	or	O
36699	shortness	b-PROBLEM
36700	of	i-PROBLEM
36701	breath	i-PROBLEM
36702	.	O
36703	on	O
36704	11-2-93	b-DATE
36705	,	O
36706	the	O
36707	patient	O
36708	underwent	O
36709	a	b-TEST
36710	low	i-TEST
36711	level	i-TEST
36712	treadmill	i-TEST
36713	exercise	i-TEST
36714	test	i-TEST
36715	with	O
36716	thallium	b-TEST
36717	imaging	i-TEST
36718	.	O
36719	this	b-TEST
36720	treadmill	i-TEST
36721	test	i-TEST
36722	was	O
36723	done	O
36724	on	O
36725	medications	b-TREATMENT
36726	,	O
36727	including	O
36728	beta	b-TREATMENT
36729	blockers	i-TREATMENT
36730	,	O
36731	in	O
36732	hopes	O
36733	to	O
36734	assess	O
36735	an	O
36736	amount	O
36737	of	O
36738	ischemia	b-PROBLEM
36739	on	O
36740	treatment	b-TREATMENT
36741	.	O
36742	the	O
36743	patient	O
36744	was	O
36745	able	O
36746	to	O
36747	exercise	b-OCCURRENCE
36748	for	O
36749	approximately	O
36750	nine	b-DURATION
36751	minutes	i-DURATION
36752	on	O
36753	a	b-TREATMENT
36754	modified	i-TREATMENT
36755	bruce	i-TREATMENT
36756	protocol	i-TREATMENT
36757	,	O
36758	however	O
36759	,	O
36760	he	O
36761	did	O
36762	not	O
36763	reach	O
36764	his	O
36765	predicted	O
36766	maximal	O
36767	heart	O
36768	rate	O
36769	while	O
36770	he	O
36771	was	O
36772	on	O
36773	the	b-TREATMENT
36774	beta	i-TREATMENT
36775	blockade	i-TREATMENT
36776	.	O
36777	there	O
36778	were	O
36779	no	O
36780	diagnostic	b-PROBLEM
36781	electrocardiogram	i-PROBLEM
36782	changes	i-PROBLEM
36783	during	O
36784	the	b-TEST
36785	treadmill	i-TEST
36786	exercise	i-TEST
36787	test	i-TEST
36788	,	O
36789	although	O
36790	he	O
36791	did	O
36792	have	O
36793	0.5	b-PROBLEM
36794	to	i-PROBLEM
36795	1	i-PROBLEM
36796	mm	i-PROBLEM
36797	st	i-PROBLEM
36798	depression	i-PROBLEM
36799	in	i-PROBLEM
36800	ii	i-PROBLEM
36801	,	i-PROBLEM
36802	iii	i-PROBLEM
36803	,	i-PROBLEM
36804	and	i-PROBLEM
36805	avf	i-PROBLEM
36806	.	O
36807	the	b-TEST
36808	study	i-TEST
36809	was	O
36810	halted	O
36811	for	O
36812	shortness	b-PROBLEM
36813	of	i-PROBLEM
36814	breath	i-PROBLEM
36815	and	O
36816	there	O
36817	was	O
36818	no	O
36819	chest	b-PROBLEM
36820	pain	i-PROBLEM
36821	.	O
36822	thallium	b-TEST
36823	images	i-TEST
36824	revealed	b-EVIDENTIAL
36825	a	b-PROBLEM
36826	moderate	i-PROBLEM
36827	sized	i-PROBLEM
36828	region	i-PROBLEM
36829	of	i-PROBLEM
36830	ischemic	i-PROBLEM
36831	but	i-PROBLEM
36832	viable	i-PROBLEM
36833	myocardium	i-PROBLEM
36834	involving	O
36835	the	O
36836	anteroseptal	O
36837	and	O
36838	lateral	O
36839	segments	O
36840	of	O
36841	the	O
36842	left	O
36843	ventricle	O
36844	.	O
36845	there	O
36846	was	O
36847	also	O
36848	some	O
36849	evidence	O
36850	of	O
36851	left	b-PROBLEM
36852	ventricular	i-PROBLEM
36853	dysfunction	i-PROBLEM
36854	during	O
36855	the	b-TEST
36856	test	i-TEST
36857	.	O
36858	these	b-TEST
36859	images	i-TEST
36860	were	O
36861	essentially	O
36862	unchanged	O
36863	compared	O
36864	with	O
36865	the	b-TEST
36866	previous	i-TEST
36867	thallium	i-TEST
36868	images	i-TEST
36869	in	O
36870	may	b-DATE
36871	1993	i-DATE
36872	.	O
36873	after	O
36874	extensive	O
36875	discussion	O
36876	between	O
36877	myself	O
36878	,	O
36879	doctor	O
36880	amesin	O
36881	,	O
36882	and	O
36883	doctor	O
36884	scgach	O
36885	,	O
36886	it	O
36887	was	O
36888	elected	O
36889	to	O
36890	discharge	b-OCCURRENCE
36891	the	O
36892	patient	O
36893	to	O
36894	home	O
36895	with	O
36896	medical	b-TREATMENT
36897	management	i-TREATMENT
36898	.	O
36899	the	O
36900	patient	O
36901	was	O
36902	extremely	O
36903	reluctant	O
36904	to	O
36905	undergo	O
36906	surgery	b-TREATMENT
36907	,	O
36908	although	O
36909	he	O
36910	understands	O
36911	that	O
36912	this	O
36913	may	O
36914	become	O
36915	necessary	O
36916	in	O
36917	the	O
36918	future	O
36919	.	O
36920	doctor	O
36921	amesin	O
36922	had	O
36923	a	O
36924	long	O
36925	discussion	O
36926	with	O
36927	the	O
36928	patient	O
36929	&apos;s	O
36930	daughters	O
36931	revolving	O
36932	primarily	O
36933	around	O
36934	issues	O
36935	of	O
36936	the	O
36937	patient	O
36938	&apos;s	O
36939	compliance	O
36940	.	O
36941	previously	O
36942	he	O
36943	had	O
36944	not	O
36945	taken	O
36946	any	O
36947	of	O
36948	his	b-TREATMENT
36949	medicines	i-TREATMENT
36950	and	O
36951	smoked	b-PROBLEM
36952	heavily	i-PROBLEM
36953	on	O
36954	the	O
36955	outside	O
36956	and	O
36957	not	O
36958	kept	b-OCCURRENCE
36959	any	i-OCCURRENCE
36960	of	i-OCCURRENCE
36961	his	i-OCCURRENCE
36962	appointments	i-OCCURRENCE
36963	.	O
36964	the	O
36965	importance	O
36966	of	O
36967	quitting	b-OCCURRENCE
36968	smoking	i-OCCURRENCE
36969	as	O
36970	well	O
36971	as	O
36972	continuing	O
36973	to	O
36974	follow	O
36975	his	b-TREATMENT
36976	medical	i-TREATMENT
36977	regimen	i-TREATMENT
36978	was	O
36979	emphasized	O
36980	to	O
36981	the	O
36982	daughter	O
36983	and	O
36984	to	O
36985	the	O
36986	patient	O
36987	.	O
36988	she	O
36989	will	O
36990	be	O
36991	actively	O
36992	involved	O
36993	in	O
36994	encouraging	O
36995	the	O
36996	patient	O
36997	to	O
36998	comply	O
36999	with	O
37000	this	b-TREATMENT
37001	medical	i-TREATMENT
37002	regimen	i-TREATMENT
37003	and	O
37004	also	O
37005	to	O
37006	follow	b-OCCURRENCE
37007	up	i-OCCURRENCE
37008	with	O
37009	doctor	O
37010	amesin	O
37011	as	O
37012	well	O
37013	as	O
37014	doctor	O
37015	lfsquarc	O
37016	on	O
37017	the	O
37018	outside	O
37019	.	O
37020	the	O
37021	patient	O
37022	remained	O
37023	guaiac	b-TEST
37024	negative	O
37025	throughout	O
37026	the	O
37027	entire	O
37028	hospitalization	b-OCCURRENCE
37029	.	O
37030	despite	O
37031	being	O
37032	on	O
37033	heparin	b-TREATMENT
37034	for	O
37035	a	O
37036	short	O
37037	time	O
37038	,	O
37039	his	b-TEST
37040	hematocrit	i-TEST
37041	remained	O
37042	very	O
37043	stable	O
37044	with	O
37045	only	O
37046	a	O
37047	small	O
37048	dip	O
37049	after	O
37050	the	b-TREATMENT
37051	catheterization	i-TREATMENT
37052	was	O
37053	done	O
37054	.	O
37055	he	O
37056	will	O
37057	need	O
37058	to	O
37059	be	O
37060	followed	b-OCCURRENCE
37061	up	i-OCCURRENCE
37062	as	O
37063	an	O
37064	out	O
37065	patient	O
37066	for	O
37067	guaiac	b-PROBLEM
37068	positive	i-PROBLEM
37069	stools	i-PROBLEM
37070	and	O
37071	possibly	O
37072	worked	b-TEST
37073	up	i-TEST
37074	for	O
37075	this	O
37076	in	O
37077	the	O
37078	future	O
37079	.	O
37080	caghala	O
37081	uinteele	O
37082	,	O
37083	md	O
37084	tr	O
37085	:	O
37086	yf	O
37087	/	O
37088	bmot	O
37089	dd	O
37090	:	O
37091	11-3-93	O
37092	td	O
37093	:	O
37094	11/04/93	O
37095	cc	O
37096	:	O
37097	doctor	O
37098	telshey	O
37099	swatlleebtik	O
37100	doctor	O
37101	eri	O
37102	lfsquarc	O
37103		O
37104	admission	b-OCCURRENCE
37105	date	O
37106	:	O
37107	12-3-93	b-DATE
37108	discharge	b-OCCURRENCE
37109	date	O
37110	:	O
37111	12-10-93	b-DATE
37112	history	O
37113	of	O
37114	present	O
37115	illness	O
37116	:	O
37117	the	O
37118	patient	O
37119	is	O
37120	a	O
37121	47	O
37122	year	O
37123	old	O
37124	white	O
37125	male	O
37126	with	O
37127	a	O
37128	history	O
37129	of	O
37130	emphysema	b-PROBLEM
37131	who	O
37132	presents	b-OCCURRENCE
37133	for	O
37134	admission	b-OCCURRENCE
37135	with	O
37136	a	O
37137	diagnosis	O
37138	of	O
37139	broncho-alveolar	b-PROBLEM
37140	carcinoma	i-PROBLEM
37141	and	O
37142	is	O
37143	scheduled	O
37144	for	O
37145	flexible	b-TEST
37146	bronchoscopy	i-TEST
37147	,	O
37148	mediastinoscopy	b-TEST
37149	and	O
37150	thoracotomy	b-TREATMENT
37151	with	O
37152	questionable	O
37153	pneumonectomy	b-TREATMENT
37154	by	O
37155	doctor	O
37156	an	O
37157	on	O
37158	12-4-93	b-DATE
37159	.	O
37160	the	O
37161	patient	O
37162	is	O
37163	a	O
37164	native	O
37165	of	O
37166	nahuter	O
37167	with	O
37168	a	O
37169	70+	O
37170	pack	O
37171	year	O
37172	smoking	b-PROBLEM
37173	history	i-PROBLEM
37174	(	O
37175	2	O
37176	1/2-3	O
37177	pack	O
37178	per	O
37179	day	O
37180	x	O
37181	35	O
37182	years	O
37183	)	O
37184	whose	O
37185	symptoms	b-PROBLEM
37186	began	O
37187	last	O
37188	12/92	b-DATE
37189	when	O
37190	he	O
37191	had	O
37192	a	b-PROBLEM
37193	persistent	i-PROBLEM
37194	cough	i-PROBLEM
37195	and	O
37196	fever	b-PROBLEM
37197	.	O
37198	in	O
37199	six	b-DURATION
37200	months	i-DURATION
37201	,	O
37202	he	O
37203	was	O
37204	hospitalized	b-OCCURRENCE
37205	for	O
37206	pneumonia	b-PROBLEM
37207	x	O
37208	four	b-FREQUENCY
37209	.	O
37210	he	O
37211	has	O
37212	had	O
37213	worsening	b-PROBLEM
37214	dyspnea	i-PROBLEM
37215	and	O
37216	paroxysmal	b-PROBLEM
37217	nocturnal	i-PROBLEM
37218	dyspnea	i-PROBLEM
37219	,	O
37220	though	O
37221	denies	O
37222	orthopnea	b-PROBLEM
37223	.	O
37224	no	O
37225	hemoptysis	b-PROBLEM
37226	,	O
37227	no	O
37228	fevers	b-PROBLEM
37229	,	O
37230	chills	b-PROBLEM
37231	,	O
37232	sweats	b-PROBLEM
37233	,	O
37234	when	O
37235	pneumonia	b-PROBLEM
37236	resolved	O
37237	.	O
37238	the	O
37239	patient	O
37240	also	O
37241	noticed	O
37242	a	b-PROBLEM
37243	loss	i-PROBLEM
37244	of	i-PROBLEM
37245	weight	i-PROBLEM
37246	of	O
37247	approximately	O
37248	25	O
37249	pounds	O
37250	over	O
37251	a	b-DURATION
37252	few	i-DURATION
37253	months	i-DURATION
37254	with	O
37255	increased	b-PROBLEM
37256	fatigue	i-PROBLEM
37257	and	O
37258	lower	b-PROBLEM
37259	extremity	i-PROBLEM
37260	weakness	i-PROBLEM
37261	.	O
37262	a	b-PROBLEM
37263	&quot;	i-PROBLEM
37264	spot	i-PROBLEM
37265	&quot;	i-PROBLEM
37266	in	i-PROBLEM
37267	the	i-PROBLEM
37268	left	i-PROBLEM
37269	lower	i-PROBLEM
37270	lobe	i-PROBLEM
37271	on	O
37272	chest	b-TEST
37273	x-ray	i-TEST
37274	was	O
37275	noted	O
37276	in	O
37277	october	b-DATE
37278	of	i-DATE
37279	1993	i-DATE
37280	,	O
37281	after	O
37282	his	b-PROBLEM
37283	pneumonia	i-PROBLEM
37284	cleared	O
37285	.	O
37286	a	b-TEST
37287	follow	i-TEST
37288	up	i-TEST
37289	chest	i-TEST
37290	computerized	i-TEST
37291	tomography	i-TEST
37292	scan	i-TEST
37293	led	O
37294	to	O
37295	a	b-TEST
37296	tissue	i-TEST
37297	biopsy	i-TEST
37298	via	O
37299	flexible	b-TEST
37300	bronchoscopy	i-TEST
37301	in	O
37302	11/93	b-DATE
37303	.	O
37304	tissue	O
37305	returned	O
37306	well	b-PROBLEM
37307	differentiated	i-PROBLEM
37308	adenocarcinoma	i-PROBLEM
37309	.	O
37310	the	O
37311	patient	O
37312	was	O
37313	told	O
37314	nothing	O
37315	could	O
37316	be	O
37317	done	O
37318	until	O
37319	he	O
37320	was	O
37321	referred	O
37322	to	O
37323	doctor	O
37324	an	O
37325	.	O
37326	his	O
37327	appetite	O
37328	has	O
37329	been	O
37330	good	O
37331	and	O
37332	he	O
37333	has	O
37334	only	O
37335	complained	b-EVIDENTIAL
37336	of	O
37337	occasional	b-PROBLEM
37338	sharp	i-PROBLEM
37339	pain	i-PROBLEM
37340	under	i-PROBLEM
37341	his	i-PROBLEM
37342	rib	i-PROBLEM
37343	cage	i-PROBLEM
37344	,	O
37345	right	O
37346	greater	O
37347	than	O
37348	left	O
37349	.	O
37350	allergies	O
37351	:	O
37352	the	O
37353	patient	O
37354	is	O
37355	allergic	b-PROBLEM
37356	to	O
37357	percodan	b-TREATMENT
37358	,	O
37359	which	O
37360	gives	O
37361	him	O
37362	itchiness	b-PROBLEM
37363	.	O
37364	medications	O
37365	on	O
37366	admission	O
37367	:	O
37368	triamcinolone	b-TREATMENT
37369	,	O
37370	one	O
37371	tablet	O
37372	po	O
37373	b.i.d.	b-FREQUENCY
37374	,	O
37375	dosage	O
37376	unknown	O
37377	,	O
37378	xanax	b-TREATMENT
37379	one	O
37380	tablet	O
37381	po	O
37382	t.i.d.	b-FREQUENCY
37383	,	O
37384	prn	O
37385	anxiety	b-PROBLEM
37386	,	O
37387	dosage	O
37388	unknown	O
37389	,	O
37390	ms	b-TREATMENT
37391	contin	i-TREATMENT
37392	prn	O
37393	.	O
37394	hospital	O
37395	course	O
37396	:	O
37397	a	b-TEST
37398	quantitative	i-TEST
37399	v	i-TEST
37400	/	i-TEST
37401	q	i-TEST
37402	scan	i-TEST
37403	was	O
37404	also	O
37405	done	O
37406	preoperatively	O
37407	and	O
37408	pulmonary	b-CLINICAL_DEPT
37409	consult	i-CLINICAL_DEPT
37410	was	O
37411	obtained	O
37412	preoperatively	O
37413	.	O
37414	pulmonary	b-CLINICAL_DEPT
37415	recommended	O
37416	that	O
37417	he	O
37418	just	O
37419	be	O
37420	started	O
37421	on	O
37422	albuterol	b-TREATMENT
37423	and	O
37424	atrovent	b-TREATMENT
37425	metered	i-TREATMENT
37426	dose	i-TREATMENT
37427	inhalers	i-TREATMENT
37428	,	O
37429	2	b-FREQUENCY
37430	puffs	i-FREQUENCY
37431	q6h	i-FREQUENCY
37432	,	O
37433	prior	O
37434	to	O
37435	surgery	b-TREATMENT
37436	.	O
37437	the	O
37438	patient	O
37439	underwent	O
37440	his	b-TREATMENT
37441	procedure	i-TREATMENT
37442	on	O
37443	12-4-93	b-DATE
37444	,	O
37445	without	O
37446	complications	b-PROBLEM
37447	.	O
37448	findings	O
37449	included	O
37450	thickened	b-PROBLEM
37451	pleura	i-PROBLEM
37452	with	O
37453	multiple	b-PROBLEM
37454	adhesions	i-PROBLEM
37455	and	O
37456	an	b-PROBLEM
37457	abscess	i-PROBLEM
37458	near	i-PROBLEM
37459	the	i-PROBLEM
37460	margin	i-PROBLEM
37461	major	i-PROBLEM
37462	fissure	i-PROBLEM
37463	.	O
37464	he	O
37465	had	O
37466	a	b-PROBLEM
37467	firm	i-PROBLEM
37468	nodule	i-PROBLEM
37469	in	i-PROBLEM
37470	the	i-PROBLEM
37471	left	i-PROBLEM
37472	lower	i-PROBLEM
37473	lobe	i-PROBLEM
37474	.	O
37475	the	O
37476	patient	O
37477	was	O
37478	transferred	b-OCCURRENCE
37479	to	O
37480	the	b-CLINICAL_DEPT
37481	respiratory	i-CLINICAL_DEPT
37482	intensive	i-CLINICAL_DEPT
37483	care	i-CLINICAL_DEPT
37484	unit	i-CLINICAL_DEPT
37485	in	O
37486	stable	O
37487	condition	O
37488	and	O
37489	had	O
37490	an	O
37491	uneventful	O
37492	stay	O
37493	there	O
37494	.	O
37495	he	O
37496	had	O
37497	oxygen	b-TEST
37498	saturations	i-TEST
37499	of	O
37500	99%	O
37501	with	O
37502	an	b-TEST
37503	fi02	i-TEST
37504	of	O
37505	40%	O
37506	and	O
37507	had	O
37508	no	O
37509	complaints	b-EVIDENTIAL
37510	.	O
37511	he	O
37512	was	O
37513	transferred	b-OCCURRENCE
37514	to	O
37515	the	b-CLINICAL_DEPT
37516	floor	i-CLINICAL_DEPT
37517	on	O
37518	postoperative	b-DATE
37519	day	i-DATE
37520	number	i-DATE
37521	one	i-DATE
37522	and	O
37523	tolerated	b-OCCURRENCE
37524	his	i-OCCURRENCE
37525	po&apos;s	i-OCCURRENCE
37526	well	i-OCCURRENCE
37527	.	O
37528	his	b-TEST
37529	left	i-TEST
37530	lower	i-TEST
37531	lobe	i-TEST
37532	micro	i-TEST
37533	results	O
37534	revealed	O
37535	alpha	b-PROBLEM
37536	hemolytic	i-PROBLEM
37537	streptococcus	i-PROBLEM
37538	on	O
37539	culture	b-TEST
37540	and	O
37541	he	O
37542	was	O
37543	then	O
37544	switched	O
37545	to	O
37546	penicillin	b-TREATMENT
37547	and	O
37548	gentamicin	b-TREATMENT
37549	after	O
37550	being	O
37551	started	O
37552	on	O
37553	triples	O
37554	of	O
37555	flagyl	b-TREATMENT
37556	,	O
37557	ampicillin	b-TREATMENT
37558	,	O
37559	and	O
37560	gentamicin	b-TREATMENT
37561	.	O
37562	he	O
37563	had	O
37564	low	b-PROBLEM
37565	grade	i-PROBLEM
37566	temperatures	i-PROBLEM
37567	,	O
37568	though	O
37569	did	O
37570	not	O
37571	spike	O
37572	a	b-PROBLEM
37573	high	i-PROBLEM
37574	temperature	i-PROBLEM
37575	during	O
37576	his	b-OCCURRENCE
37577	hospital	i-OCCURRENCE
37578	course	i-OCCURRENCE
37579	.	O
37580	his	b-OCCURRENCE
37581	hospital	i-OCCURRENCE
37582	course	i-OCCURRENCE
37583	was	O
37584	otherwise	O
37585	uneventful	O
37586	and	O
37587	the	O
37588	patient	O
37589	was	O
37590	discharged	b-OCCURRENCE
37591	in	O
37592	stable	O
37593	condition	O
37594	on	O
37595	postoperative	b-DATE
37596	day	i-DATE
37597	,	O
37598	afebrile	b-PROBLEM
37599	.	O
37600	the	b-TEST
37601	chest	i-TEST
37602	x-ray	i-TEST
37603	on	O
37604	the	b-DATE
37605	morning	i-DATE
37606	of	i-DATE
37607	discharge	i-DATE
37608	was	O
37609	unchanged	O
37610	from	O
37611	the	b-DATE
37612	previous	i-DATE
37613	day	i-DATE
37614	,	O
37615	with	O
37616	slight	b-PROBLEM
37617	increase	i-PROBLEM
37618	in	i-PROBLEM
37619	left	i-PROBLEM
37620	pleural	i-PROBLEM
37621	fluid	i-PROBLEM
37622	.	O
37623	he	O
37624	had	O
37625	completed	O
37626	six	b-DURATION
37627	days	i-DURATION
37628	of	O
37629	penicillin	b-TREATMENT
37630	and	O
37631	gentamicin	b-TREATMENT
37632	and	O
37633	was	O
37634	discharged	b-OCCURRENCE
37635	on	O
37636	ciprofloxacin	b-TREATMENT
37637	and	O
37638	flagyl	b-TREATMENT
37639	for	O
37640	the	O
37641	next	O
37642	seven	b-DURATION
37643	days	i-DURATION
37644	.	O
37645	he	O
37646	stayed	O
37647	at	O
37648	the	O
37649	local	O
37650	comfort	O
37651	inn	O
37652	before	O
37653	his	O
37654	return	O
37655	back	O
37656	to	O
37657	aujer	O
37658	cin	O
37659	.	O
37660		O
37661	admission	b-OCCURRENCE
37662	date	O
37663	:	O
37664	2012-05-13	b-ADMISSION
37665	discharge	b-OCCURRENCE
37666	date	O
37667	:	O
37668	2012-05-22	b-DISCHARGE
37669	service	O
37670	:	O
37671	neonatology	O
37672	history	O
37673	of	O
37674	present	O
37675	illness	O
37676	:	O
37677	fred	O
37678	grauman	O
37679	is	O
37680	the	O
37681	former	O
37682	2.252	O
37683	kg	O
37684	product	O
37685	of	O
37686	a	O
37687	35-1/7	b-DURATION
37688	week	i-DURATION
37689	gestation	b-OCCURRENCE
37690	pregnancy	i-OCCURRENCE
37691	born	b-OCCURRENCE
37692	to	O
37693	a	O
37694	37-year-old	O
37695	g4	O
37696	p3-5	O
37697	woman	O
37698	.	O
37699	prenatal	O
37700	screens	O
37701	:	O
37702	blood	b-TEST
37703	type	i-TEST
37704	o+	O
37705	,	O
37706	antibody	b-TEST
37707	negative	O
37708	,	O
37709	rubella	b-TEST
37710	immune	O
37711	,	O
37712	rpr	b-TEST
37713	nonreactive	O
37714	,	O
37715	hepatitis	b-TEST
37716	b	i-TEST
37717	surface	i-TEST
37718	antigen	i-TEST
37719	negative	O
37720	,	O
37721	group	b-PROBLEM
37722	beta	i-PROBLEM
37723	strep	i-PROBLEM
37724	positive	i-PROBLEM
37725	.	O
37726	the	b-OCCURRENCE
37727	pregnancy	i-OCCURRENCE
37728	was	O
37729	complicated	b-PROBLEM
37730	by	O
37731	anemia	b-PROBLEM
37732	.	O
37733	mother	O
37734	has	O
37735	a	O
37736	prior	O
37737	history	O
37738	of	O
37739	mitral	b-PROBLEM
37740	valve	i-PROBLEM
37741	prolapse	i-PROBLEM
37742	.	O
37743	she	O
37744	had	O
37745	a	b-TREATMENT
37746	prior	i-TREATMENT
37747	cesarean	i-TREATMENT
37748	section	i-TREATMENT
37749	done	O
37750	,	O
37751	two	O
37752	vaginal	b-OCCURRENCE
37753	births	i-OCCURRENCE
37754	after	O
37755	cesarean	b-TREATMENT
37756	section	i-TREATMENT
37757	.	O
37758	she	O
37759	presented	b-OCCURRENCE
37760	in	O
37761	labor	b-OCCURRENCE
37762	on	O
37763	the	b-DATE
37764	day	i-DATE
37765	of	O
37766	delivery	b-OCCURRENCE
37767	.	O
37768	these	O
37769	infants	O
37770	were	O
37771	delivered	b-OCCURRENCE
37772	by	O
37773	repeat	b-TREATMENT
37774	cesarean	i-TREATMENT
37775	section	i-TREATMENT
37776	,	O
37777	this	O
37778	twin	O
37779	emerged	b-OCCURRENCE
37780	with	O
37781	good	b-OCCURRENCE
37782	tone	i-OCCURRENCE
37783	,	i-OCCURRENCE
37784	color	i-OCCURRENCE
37785	,	i-OCCURRENCE
37786	and	i-OCCURRENCE
37787	cry	i-OCCURRENCE
37788	.	O
37789	apgars	b-TEST
37790	were	O
37791	eight	O
37792	at	O
37793	one	b-DURATION
37794	minute	i-DURATION
37795	and	O
37796	nine	O
37797	at	O
37798	five	b-DURATION
37799	minutes	i-DURATION
37800	.	O
37801	he	O
37802	was	O
37803	admitted	b-OCCURRENCE
37804	to	O
37805	the	b-CLINICAL_DEPT
37806	neonatal	i-CLINICAL_DEPT
37807	intensive	i-CLINICAL_DEPT
37808	care	i-CLINICAL_DEPT
37809	unit	i-CLINICAL_DEPT
37810	for	O
37811	treatment	b-TREATMENT
37812	of	O
37813	prematurity	b-PROBLEM
37814	.	O
37815	hospital	O
37816	course	O
37817	by	O
37818	systems	O
37819	including	O
37820	pertinent	O
37821	laboratory	O
37822	data:	O
37823	1.	O
37824	respiratory	O
37825	:	O
37826	raymond	O
37827	required	O
37828	some	O
37829	intermittent	O
37830	blow-by	b-TREATMENT
37831	oxygen	i-TREATMENT
37832	for	O
37833	the	b-DURATION
37834	first	i-DURATION
37835	two	i-DURATION
37836	hours	i-DURATION
37837	of	O
37838	birth	b-OCCURRENCE
37839	.	O
37840	he	O
37841	has	O
37842	remained	O
37843	in	O
37844	room	O
37845	air	O
37846	since	O
37847	that	b-DATE
37848	time	i-DATE
37849	.	O
37850	the	b-PROBLEM
37851	grunting	i-PROBLEM
37852	noted	O
37853	on	O
37854	admission	b-OCCURRENCE
37855	resolved	O
37856	within	O
37857	the	O
37858	first	O
37859	few	b-DURATION
37860	hours	i-DURATION
37861	after	O
37862	birth	b-OCCURRENCE
37863	.	O
37864	he	O
37865	did	O
37866	not	O
37867	have	O
37868	any	O
37869	episodes	O
37870	of	O
37871	spontaneous	b-PROBLEM
37872	apnea	i-PROBLEM
37873	or	O
37874	bradycardia	b-PROBLEM
37875	.	O
37876	2.	O
37877	cardiovascular	O
37878	:	O
37879	no	O
37880	murmurs	b-PROBLEM
37881	were	O
37882	noted	b-EVIDENTIAL
37883	,	O
37884	although	O
37885	normal	O
37886	heart	b-TEST
37887	rates	i-TEST
37888	and	O
37889	blood	b-TEST
37890	pressures	i-TEST
37891	.	O
37892	3.	O
37893	fluids	O
37894	,	O
37895	electrolytes	O
37896	,	O
37897	and	O
37898	nutrition	O
37899	:	O
37900	enteral	b-TREATMENT
37901	feeds	i-TREATMENT
37902	were	O
37903	started	O
37904	on	O
37905	the	b-DATE
37906	date	i-DATE
37907	of	O
37908	birth	b-OCCURRENCE
37909	and	O
37910	gradually	O
37911	advanced	b-TREATMENT
37912	to	O
37913	full	b-OCCURRENCE
37914	volume	i-OCCURRENCE
37915	.	O
37916	he	O
37917	required	O
37918	some	b-TREATMENT
37919	gavage	i-TREATMENT
37920	feeds	i-TREATMENT
37921	through	O
37922	day	b-DATE
37923	of	i-DATE
37924	life	i-DATE
37925	#4	i-DATE
37926	,	O
37927	and	O
37928	has	O
37929	been	O
37930	all	b-OCCURRENCE
37931	po	i-OCCURRENCE
37932	since	O
37933	day	b-DATE
37934	of	i-DATE
37935	life	i-DATE
37936	#5	i-DATE
37937	.	O
37938	at	O
37939	the	b-DATE
37940	time	i-DATE
37941	of	O
37942	discharge	b-OCCURRENCE
37943	,	O
37944	he	O
37945	is	O
37946	taking	O
37947	enfamil	b-TREATMENT
37948	20	i-TREATMENT
37949	calories	i-TREATMENT
37950	/	i-TREATMENT
37951	ounce	i-TREATMENT
37952	with	i-TREATMENT
37953	iron	i-TREATMENT
37954	.	O
37955	discharge	b-TEST
37956	weight	i-TEST
37957	is	O
37958	2.37	O
37959	kg	O
37960	,	O
37961	head	b-TEST
37962	circumference	i-TEST
37963	32	O
37964	cm	O
37965	,	O
37966	length	b-TEST
37967	47	O
37968	cm	O
37969	.	O
37970	4.	O
37971	infectious	O
37972	disease	O
37973	:	O
37974	due	O
37975	to	O
37976	the	b-PROBLEM
37977	unknown	i-PROBLEM
37978	group	i-PROBLEM
37979	b	i-PROBLEM
37980	strep	i-PROBLEM
37981	status	i-PROBLEM
37982	and	O
37983	prematurity	b-PROBLEM
37984	,	O
37985	raymond	O
37986	was	O
37987	evaluated	b-TEST
37988	for	O
37989	sepsis	b-PROBLEM
37990	.	O
37991	a	b-TEST
37992	complete	i-TEST
37993	blood	i-TEST
37994	count	i-TEST
37995	had	O
37996	a	b-TEST
37997	white	i-TEST
37998	blood	i-TEST
37999	cell	i-TEST
38000	count	i-TEST
38001	of	O
38002	13,800	O
38003	with	O
38004	17%	b-TEST
38005	polys	i-TEST
38006	,	O
38007	0%	b-TEST
38008	bands	i-TEST
38009	.	O
38010	a	O
38011	repeat	O
38012	on	O
38013	day	b-DATE
38014	of	i-DATE
38015	life	i-DATE
38016	two	i-DATE
38017	,	O
38018	had	O
38019	a	b-TEST
38020	white	i-TEST
38021	count	i-TEST
38022	of	O
38023	13,000	O
38024	with	O
38025	50%	b-TEST
38026	polys	i-TEST
38027	,	O
38028	0%	b-TEST
38029	bands	i-TEST
38030	.	O
38031	a	b-TEST
38032	blood	i-TEST
38033	culture	i-TEST
38034	obtained	O
38035	prior	O
38036	to	O
38037	starting	O
38038	antibiotics	b-TREATMENT
38039	was	O
38040	no	O
38041	growth	b-PROBLEM
38042	at	O
38043	48	b-DURATION
38044	hours	i-DURATION
38045	.	O
38046	5.	O
38047	gastrointestinal	O
38048	:	O
38049	peak	b-TEST
38050	serum	i-TEST
38051	bilirubin	i-TEST
38052	occurred	O
38053	on	O
38054	day	b-DATE
38055	of	i-DATE
38056	life	i-DATE
38057	#4	i-DATE
38058	,	O
38059	a	b-TEST
38060	total	i-TEST
38061	of	O
38062	10.0/0.3	O
38063	direct	b-TEST
38064	.	O
38065	a	b-TEST
38066	repeat	i-TEST
38067	bilirubin	i-TEST
38068	on	O
38069	2012-05-19	b-DATE
38070	was	O
38071	8.0/0.3	O
38072	direct	O
38073	.	O
38074	6.	O
38075	hematological	O
38076	:	O
38077	hematocrit	b-TEST
38078	at	O
38079	birth	b-OCCURRENCE
38080	was	O
38081	43.8%.	O
38082	raymond	O
38083	did	O
38084	not	O
38085	receive	O
38086	any	b-TREATMENT
38087	transfusions	i-TREATMENT
38088	of	i-TREATMENT
38089	blood	i-TREATMENT
38090	products	i-TREATMENT
38091	during	O
38092	admission	b-OCCURRENCE
38093	.	O
38094	7.	O
38095	neurology	O
38096	:	O
38097	raymond	O
38098	has	O
38099	maintained	O
38100	normal	O
38101	neurological	b-TEST
38102	examination	i-TEST
38103	throughout	O
38104	admission	b-OCCURRENCE
38105	and	O
38106	there	O
38107	were	O
38108	no	O
38109	concerns	b-PROBLEM
38110	at	O
38111	the	b-DATE
38112	time	i-DATE
38113	of	O
38114	discharge	b-OCCURRENCE
38115	.	O
38116	8.	O
38117	sensory	O
38118	:	O
38119	audiology	b-TEST
38120	hearing	i-TEST
38121	screening	i-TEST
38122	was	O
38123	performed	O
38124	with	O
38125	automated	b-TEST
38126	auditory	i-TEST
38127	brain	i-TEST
38128	stem	i-TEST
38129	responses	i-TEST
38130	.	O
38131	raymond	O
38132	passed	b-OCCURRENCE
38133	in	O
38134	both	O
38135	ears	O
38136	.	O
38137		O
38138	admission	b-OCCURRENCE
38139	date	O
38140	:	O
38141	02/01/2002	b-ADMISSION
38142	discharge	b-OCCURRENCE
38143	date	O
38144	:	O
38145	02/08/2002	b-DISCHARGE
38146	history	O
38147	of	O
38148	present	O
38149	illness	O
38150	:	O
38151	saujule	O
38152	study	O
38153	is	O
38154	a	O
38155	77-year-old	O
38156	woman	O
38157	with	O
38158	a	O
38159	history	O
38160	of	O
38161	obesity	b-PROBLEM
38162	and	O
38163	hypertension	b-PROBLEM
38164	who	O
38165	presents	b-OCCURRENCE
38166	with	O
38167	increased	b-PROBLEM
38168	shortness	i-PROBLEM
38169	of	i-PROBLEM
38170	breath	i-PROBLEM
38171	x	O
38172	5	b-DURATION
38173	days	i-DURATION
38174	.	O
38175	her	b-PROBLEM
38176	shortness	i-PROBLEM
38177	of	i-PROBLEM
38178	breath	i-PROBLEM
38179	has	O
38180	been	O
38181	progressive	O
38182	over	O
38183	the	O
38184	last	O
38185	2-3	b-DURATION
38186	years	i-DURATION
38187	.	O
38188	she	O
38189	has	O
38190	an	b-PROBLEM
38191	associated	i-PROBLEM
38192	dry	i-PROBLEM
38193	cough	i-PROBLEM
38194	but	O
38195	no	O
38196	fevers	b-PROBLEM
38197	,	O
38198	chills	b-PROBLEM
38199	,	O
38200	or	O
38201	leg	b-PROBLEM
38202	pain	i-PROBLEM
38203	.	O
38204	she	O
38205	has	O
38206	dyspnea	b-PROBLEM
38207	on	O
38208	exertion	O
38209	.	O
38210	she	O
38211	ambulates	b-OCCURRENCE
38212	with	O
38213	walker	b-TREATMENT
38214	and	O
38215	a	b-TREATMENT
38216	cane	i-TREATMENT
38217	secondary	O
38218	to	O
38219	osteoarthritis	b-PROBLEM
38220	.	O
38221	she	O
38222	becomes	O
38223	short	b-PROBLEM
38224	of	i-PROBLEM
38225	breath	i-PROBLEM
38226	just	O
38227	by	O
38228	getting	b-OCCURRENCE
38229	up	i-OCCURRENCE
38230	from	i-OCCURRENCE
38231	her	i-OCCURRENCE
38232	chair	i-OCCURRENCE
38233	and	O
38234	can	O
38235	only	O
38236	walk	O
38237	2-3	O
38238	steps	O
38239	on	O
38240	a	O
38241	flat	O
38242	surface	O
38243	.	O
38244	she	O
38245	feels	O
38246	light	b-PROBLEM
38247	headed	i-PROBLEM
38248	when	O
38249	getting	O
38250	up	O
38251	.	O
38252	her	b-PROBLEM
38253	shortness	i-PROBLEM
38254	of	i-PROBLEM
38255	breath	i-PROBLEM
38256	and	O
38257	dyspnea	b-PROBLEM
38258	on	O
38259	exertion	O
38260	has	O
38261	been	O
38262	progressive	O
38263	for	O
38264	the	O
38265	past	O
38266	several	b-DURATION
38267	years	i-DURATION
38268	.	O
38269	it	O
38270	has	O
38271	not	O
38272	been	O
38273	sudden	O
38274	or	O
38275	acute	O
38276	.	O
38277	she	O
38278	sleeps	b-OCCURRENCE
38279	in	i-OCCURRENCE
38280	a	i-OCCURRENCE
38281	chair	i-OCCURRENCE
38282	up	i-OCCURRENCE
38283	right	i-OCCURRENCE
38284	for	O
38285	the	O
38286	last	O
38287	2	b-DURATION
38288	1/2	i-DURATION
38289	years	i-DURATION
38290	secondary	O
38291	to	O
38292	osteoarthritis	b-PROBLEM
38293	.	O
38294	she	O
38295	has	O
38296	orthopnea	b-PROBLEM
38297	as	O
38298	well	O
38299	but	O
38300	noparoxysmal	b-PROBLEM
38301	nocturnal	i-PROBLEM
38302	dyspnea	i-PROBLEM
38303	.	O
38304	she	O
38305	occasionally	O
38306	feels	O
38307	chest	b-PROBLEM
38308	twinges	i-PROBLEM
38309	which	O
38310	are	O
38311	nonradiating	b-PROBLEM
38312	but	O
38313	are	O
38314	sharp	b-PROBLEM
38315	.	O
38316	they	O
38317	last	O
38318	a	b-DURATION
38319	few	i-DURATION
38320	seconds	i-DURATION
38321	on	O
38322	the	O
38323	left	O
38324	side	O
38325	and	O
38326	are	O
38327	not	O
38328	associated	O
38329	with	O
38330	sweating	b-PROBLEM
38331	,	O
38332	nausea	b-PROBLEM
38333	,	O
38334	vomiting	b-PROBLEM
38335	or	O
38336	syncope	b-PROBLEM
38337	.	O
38338	she	O
38339	has	O
38340	had	O
38341	lower	b-PROBLEM
38342	extremity	i-PROBLEM
38343	edema	i-PROBLEM
38344	for	O
38345	thelast	O
38346	several	b-DURATION
38347	years	i-DURATION
38348	with	O
38349	multiple	O
38350	episodes	O
38351	of	O
38352	cellulitis	b-PROBLEM
38353	.	O
38354	her	b-PROBLEM
38355	lower	i-PROBLEM
38356	extremity	i-PROBLEM
38357	edema	i-PROBLEM
38358	has	O
38359	increased	O
38360	for	O
38361	the	b-DURATION
38362	several	i-DURATION
38363	weeks	i-DURATION
38364	prior	O
38365	to	O
38366	admission	b-OCCURRENCE
38367	secondary	O
38368	to	O
38369	an	b-OCCURRENCE
38370	inability	i-OCCURRENCE
38371	to	i-OCCURRENCE
38372	elevate	i-OCCURRENCE
38373	her	i-OCCURRENCE
38374	legs	i-OCCURRENCE
38375	due	O
38376	to	O
38377	a	b-OCCURRENCE
38378	broken	i-OCCURRENCE
38379	chair	i-OCCURRENCE
38380	at	O
38381	home	O
38382	.	O
38383	she	O
38384	denies	b-EVIDENTIAL
38385	any	b-PROBLEM
38386	pleural	i-PROBLEM
38387	chest	i-PROBLEM
38388	pain	i-PROBLEM
38389	.	O
38390	review	O
38391	of	O
38392	systems	O
38393	:	O
38394	negative	O
38395	for	O
38396	headaches	b-PROBLEM
38397	,	O
38398	vision	b-PROBLEM
38399	changes	i-PROBLEM
38400	,	O
38401	numbness	b-PROBLEM
38402	,	O
38403	tingling	b-PROBLEM
38404	,	O
38405	dyspnea	b-PROBLEM
38406	,	O
38407	hematuria	b-PROBLEM
38408	,	O
38409	abdominal	b-PROBLEM
38410	pain	i-PROBLEM
38411	,	O
38412	diarrhea	b-PROBLEM
38413	,	O
38414	melena	b-PROBLEM
38415	or	O
38416	hematochezia	b-PROBLEM
38417	.	O
38418	hospital	O
38419	course	O
38420	:	O
38421	the	O
38422	patient	O
38423	was	O
38424	admitted	b-OCCURRENCE
38425	to	O
38426	the	b-CLINICAL_DEPT
38427	hospital	i-CLINICAL_DEPT
38428	for	O
38429	acute	b-PROBLEM
38430	and	i-PROBLEM
38431	chronic	i-PROBLEM
38432	shortness	i-PROBLEM
38433	of	i-PROBLEM
38434	breath	i-PROBLEM
38435	.	O
38436	1.	O
38437	cardiovascular	O
38438	:	O
38439	the	O
38440	patient	O
38441	was	O
38442	found	b-EVIDENTIAL
38443	to	O
38444	be	O
38445	in	O
38446	congestive	b-PROBLEM
38447	heart	i-PROBLEM
38448	failure	i-PROBLEM
38449	and	O
38450	thought	O
38451	likely	O
38452	secondary	O
38453	to	O
38454	diastolic	b-PROBLEM
38455	dysfunction	i-PROBLEM
38456	secondary	O
38457	to	O
38458	hypertension	b-PROBLEM
38459	.	O
38460	the	O
38461	patient	O
38462	was	O
38463	also	O
38464	found	b-EVIDENTIAL
38465	to	O
38466	have	O
38467	pulmonary	b-PROBLEM
38468	hypertension	i-PROBLEM
38469	.	O
38470	she	O
38471	ruled	b-OCCURRENCE
38472	out	i-OCCURRENCE
38473	for	O
38474	myocardial	b-PROBLEM
38475	infarction	i-PROBLEM
38476	with	O
38477	3	O
38478	negative	b-TEST
38479	enzymes	i-TEST
38480	.	O
38481	on	O
38482	admission	b-OCCURRENCE
38483	,	O
38484	she	O
38485	was	O
38486	diuresed	b-TREATMENT
38487	with	O
38488	lasix	b-TREATMENT
38489	and	O
38490	was	O
38491	negative	b-OCCURRENCE
38492	1-2	i-OCCURRENCE
38493	liters	i-OCCURRENCE
38494	per	i-OCCURRENCE
38495	day	i-OCCURRENCE
38496	for	O
38497	several	b-DURATION
38498	days	i-DURATION
38499	.	O
38500	the	b-TREATMENT
38501	diuresis	i-TREATMENT
38502	was	O
38503	backed	b-OCCURRENCE
38504	off	i-OCCURRENCE
38505	when	O
38506	her	b-TEST
38507	bicarbonate	i-TEST
38508	increased	O
38509	from	O
38510	36	O
38511	to	O
38512	39	O
38513	.	O
38514	she	O
38515	was	O
38516	restarted	b-OCCURRENCE
38517	on	O
38518	20	O
38519	mg	O
38520	p.o.	O
38521	q	b-FREQUENCY
38522	day	i-FREQUENCY
38523	prior	O
38524	to	O
38525	discharge	b-OCCURRENCE
38526	.	O
38527	her	b-TEST
38528	lipids	i-TEST
38529	were	O
38530	checked	O
38531	with	O
38532	a	b-TEST
38533	total	i-TEST
38534	cholesterol	i-TEST
38535	of	O
38536	110	O
38537	,	O
38538	triglycerides	b-TEST
38539	59	O
38540	,	O
38541	hdl32	b-TEST
38542	,	O
38543	ldl	b-TEST
38544	64	O
38545	.	O
38546	the	O
38547	patient	O
38548	had	O
38549	a	b-TEST
38550	d-dimer	i-TEST
38551	greater	O
38552	than	O
38553	1000	O
38554	with	O
38555	lower	b-TEST
38556	extremity	i-TEST
38557	non-invasive	i-TEST
38558	studies	i-TEST
38559	which	O
38560	were	O
38561	positive	O
38562	for	O
38563	a	b-PROBLEM
38564	small	i-PROBLEM
38565	right	i-PROBLEM
38566	common	i-PROBLEM
38567	femoral	i-PROBLEM
38568	clot	i-PROBLEM
38569	.	O
38570	it	O
38571	was	O
38572	unclear	O
38573	whether	O
38574	this	O
38575	was	O
38576	old	O
38577	or	O
38578	new	O
38579	.	O
38580	a	b-TEST
38581	tte	i-TEST
38582	showed	b-EVIDENTIAL
38583	an	b-TEST
38584	ejection	i-TEST
38585	fraction	i-TEST
38586	of	O
38587	60%	O
38588	,	O
38589	mild	b-PROBLEM
38590	mitral	i-PROBLEM
38591	regurgitation	i-PROBLEM
38592	,	O
38593	left	b-PROBLEM
38594	atrial	i-PROBLEM
38595	enlargement	i-PROBLEM
38596	,	O
38597	mild	b-PROBLEM
38598	tricuspid	i-PROBLEM
38599	regurgitation	i-PROBLEM
38600	,	O
38601	pulmonary	b-TEST
38602	artery	i-TEST
38603	pressures	i-TEST
38604	of	O
38605	44	b-TEST
38606	plus	i-TEST
38607	right	i-TEST
38608	atrial	i-TEST
38609	pressure	i-TEST
38610	.	O
38611	there	O
38612	was	O
38613	an	b-PROBLEM
38614	intra-atrial	i-PROBLEM
38615	shunt	i-PROBLEM
38616	from	O
38617	the	O
38618	right	O
38619	to	O
38620	the	O
38621	left	O
38622	through	O
38623	a	b-PROBLEM
38624	patent	i-PROBLEM
38625	foramen	i-PROBLEM
38626	ovale	i-PROBLEM
38627	.	O
38628	chest	b-TEST
38629	ct	i-TEST
38630	was	O
38631	a	b-TEST
38632	poor	i-TEST
38633	study	i-TEST
38634	but	O
38635	did	O
38636	not	O
38637	show	O
38638	a	b-PROBLEM
38639	pulmonary	i-PROBLEM
38640	embolus	i-PROBLEM
38641	.	O
38642	the	O
38643	patient	O
38644	had	O
38645	subsequent	b-TEST
38646	dobutamine	i-TEST
38647	mibi	i-TEST
38648	which	O
38649	was	O
38650	positive	O
38651	for	O
38652	inducible	b-PROBLEM
38653	ischemia	i-PROBLEM
38654	in	O
38655	the	O
38656	distribution	O
38657	of	O
38658	posterior	O
38659	descending	O
38660	coronary	O
38661	artery	O
38662	and	O
38663	posterolateral	O
38664	coronary	O
38665	artery	O
38666	with	O
38667	a	b-PROBLEM
38668	small	i-PROBLEM
38669	to	i-PROBLEM
38670	medium	i-PROBLEM
38671	perfusion	i-PROBLEM
38672	defect	i-PROBLEM
38673	in	O
38674	the	O
38675	inferolateral	O
38676	wall	O
38677	and	O
38678	basal	O
38679	inferior	O
38680	wall	O
38681	which	O
38682	was	O
38683	partially	O
38684	reversible	O
38685	.	O
38686	the	b-OCCURRENCE
38687	cardiology	i-OCCURRENCE
38688	service	i-OCCURRENCE
38689	saw	i-OCCURRENCE
38690	the	i-OCCURRENCE
38691	patient	i-OCCURRENCE
38692	and	O
38693	recommended	O
38694	medical	b-TREATMENT
38695	management	i-TREATMENT
38696	only	O
38697	without	O
38698	catheterization	b-TEST
38699	.	O
38700	her	b-TEST
38701	blood	i-TEST
38702	pressure	i-TEST
38703	was	O
38704	high	b-PROBLEM
38705	so	O
38706	captopril	b-TREATMENT
38707	was	O
38708	titrated	b-OCCURRENCE
38709	up	i-OCCURRENCE
38710	to	O
38711	50	O
38712	mg	O
38713	p.o.	O
38714	t.i.d.	b-FREQUENCY
38715	.	O
38716	she	O
38717	will	O
38718	be	O
38719	discharged	b-OCCURRENCE
38720	on	O
38721	lisinopril	b-TREATMENT
38722	with	O
38723	further	b-OCCURRENCE
38724	titration	i-OCCURRENCE
38725	as	O
38726	an	O
38727	outpatient	O
38728	.	O
38729	she	O
38730	is	O
38731	on	O
38732	hydrochlorothiazide	b-TREATMENT
38733	50	O
38734	mg	O
38735	p.o.	O
38736	q	b-FREQUENCY
38737	day	i-FREQUENCY
38738	.	O
38739	her	b-TREATMENT
38740	atenolol	i-TREATMENT
38741	was	O
38742	stopped	b-OCCURRENCE
38743	due	O
38744	to	O
38745	bradycardia	b-PROBLEM
38746	on	O
38747	admission	b-OCCURRENCE
38748	but	O
38749	this	O
38750	may	O
38751	be	O
38752	restarted	b-OCCURRENCE
38753	as	O
38754	an	O
38755	outpatient	O
38756	in	O
38757	gentle	b-TREATMENT
38758	doses	i-TREATMENT
38759	with	O
38760	careful	b-TEST
38761	monitoring	i-TEST
38762	of	O
38763	heart	b-TEST
38764	rate	i-TEST
38765	.	O
38766	she	O
38767	is	O
38768	on	O
38769	an	b-TREATMENT
38770	aspirin	i-TREATMENT
38771	.	O
38772	she	O
38773	will	O
38774	be	O
38775	discharged	b-OCCURRENCE
38776	on	O
38777	lasix	b-TREATMENT
38778	20	O
38779	mg	O
38780	for	O
38781	continued	O
38782	control	O
38783	of	O
38784	her	b-PROBLEM
38785	edema	i-PROBLEM
38786	.	O
38787	2.	O
38788	pulmonary	O
38789	;	O
38790	pulmonary	b-PROBLEM
38791	hypertension	i-PROBLEM
38792	as	O
38793	seen	O
38794	on	O
38795	echocardiogram	b-TEST
38796	.	O
38797	unclear	O
38798	whether	O
38799	there	O
38800	are	O
38801	chronic	b-PROBLEM
38802	pulmonary	i-PROBLEM
38803	embolus	i-PROBLEM
38804	but	O
38805	did	O
38806	have	O
38807	positive	O
38808	test	O
38809	for	O
38810	deep	b-PROBLEM
38811	venous	i-PROBLEM
38812	thrombosis	i-PROBLEM
38813	and	O
38814	will	O
38815	be	O
38816	treated	O
38817	with	O
38818	coumadin	b-TREATMENT
38819	.	O
38820	an	b-TEST
38821	abg	i-TEST
38822	was	O
38823	done	O
38824	which	O
38825	showed	b-EVIDENTIAL
38826	ph	b-TEST
38827	7.34	O
38828	,	O
38829	pco2	b-TEST
38830	78	O
38831	,	O
38832	po2	b-TEST
38833	92	O
38834	on	O
38835	2	O
38836	liters	O
38837	.	O
38838	her	b-TEST
38839	bicarbonate	i-TEST
38840	peaked	O
38841	at	O
38842	39	O
38843	and	O
38844	generally	O
38845	is	O
38846	in	O
38847	the	O
38848	36-38	O
38849	range	O
38850	.	O
38851	she	O
38852	has	O
38853	severe	b-PROBLEM
38854	sleep	i-PROBLEM
38855	apnea	i-PROBLEM
38856	and	O
38857	falls	b-PROBLEM
38858	asleep	i-PROBLEM
38859	midsentence	i-PROBLEM
38860	.	O
38861	she	O
38862	has	O
38863	episodes	O
38864	of	O
38865	not	b-PROBLEM
38866	breathing	i-PROBLEM
38867	.	O
38868	bipap	b-TREATMENT
38869	was	O
38870	attempted	O
38871	for	O
38872	3	b-DURATION
38873	nights	i-DURATION
38874	in	O
38875	a	O
38876	row	O
38877	and	O
38878	the	O
38879	patient	O
38880	did	O
38881	not	O
38882	tolerate	b-OCCURRENCE
38883	this	O
38884	.	O
38885	she	O
38886	will	O
38887	need	O
38888	pulmonary	b-TEST
38889	function	i-TEST
38890	studies	i-TEST
38891	as	O
38892	an	O
38893	outpatient	O
38894	as	O
38895	these	O
38896	were	O
38897	not	O
38898	done	O
38899	in	O
38900	the	b-CLINICAL_DEPT
38901	hospital	i-CLINICAL_DEPT
38902	.	O
38903	the	b-OCCURRENCE
38904	pulmonary	i-OCCURRENCE
38905	team	i-OCCURRENCE
38906	saw	i-OCCURRENCE
38907	the	i-OCCURRENCE
38908	patient	i-OCCURRENCE
38909	and	O
38910	only	O
38911	recommended	O
38912	the	b-TEST
38913	above	i-TEST
38914	testing	i-TEST
38915	.	O
38916	she	O
38917	needs	O
38918	home	b-TREATMENT
38919	oxygen	i-TREATMENT
38920	and	O
38921	is	O
38922	currently	O
38923	at	O
38924	2	b-TREATMENT
38925	liters	i-TREATMENT
38926	nasal	i-TREATMENT
38927	cannula	i-TREATMENT
38928	oxygen	i-TREATMENT
38929	.	O
38930	3.	O
38931	infectious	b-PROBLEM
38932	disease	i-PROBLEM
38933	:	O
38934	evidence	O
38935	for	O
38936	cellulitis	b-PROBLEM
38937	on	i-PROBLEM
38938	her	i-PROBLEM
38939	legs	i-PROBLEM
38940	,	O
38941	likely	O
38942	due	O
38943	to	O
38944	distention	b-PROBLEM
38945	from	O
38946	edema	b-PROBLEM
38947	and	O
38948	poor	b-PROBLEM
38949	perfusion	i-PROBLEM
38950	.	O
38951	she	O
38952	was	O
38953	originally	O
38954	started	O
38955	on	O
38956	cefazolin	b-TREATMENT
38957	which	O
38958	was	O
38959	then	O
38960	changed	O
38961	to	O
38962	keflex	b-TREATMENT
38963	with	O
38964	good	O
38965	improvement	b-OCCURRENCE
38966	.	O
38967	she	O
38968	will	O
38969	need	O
38970	to	O
38971	continue	O
38972	for	O
38973	at	O
38974	least	O
38975	10	b-DURATION
38976	more	i-DURATION
38977	days	i-DURATION
38978	or	O
38979	as	O
38980	clinically	O
38981	indicated	O
38982	by	O
38983	the	O
38984	course	O
38985	of	O
38986	her	b-PROBLEM
38987	cellulitis	i-PROBLEM
38988	.	O
38989	4.	O
38990	hematology	O
38991	:	O
38992	d-dimer	b-TEST
38993	in	O
38994	the	b-CLINICAL_DEPT
38995	emergency	i-CLINICAL_DEPT
38996	room	i-CLINICAL_DEPT
38997	was	O
38998	greater	O
38999	than	O
39000	1000	O
39001	and	O
39002	a	b-PROBLEM
39003	right	i-PROBLEM
39004	common	i-PROBLEM
39005	femoral	i-PROBLEM
39006	clot	i-PROBLEM
39007	was	O
39008	seen	b-EVIDENTIAL
39009	.	O
39010	this	b-PROBLEM
39011	clot	i-PROBLEM
39012	was	O
39013	small	O
39014	and	O
39015	it	O
39016	was	O
39017	questionable	O
39018	as	O
39019	to	O
39020	whether	O
39021	it	O
39022	was	O
39023	old	O
39024	or	O
39025	new	O
39026	.	O
39027	she	O
39028	was	O
39029	started	O
39030	on	O
39031	anticoagulation	b-TREATMENT
39032	given	O
39033	the	b-PROBLEM
39034	positive	i-PROBLEM
39035	d-dimer	i-PROBLEM
39036	.	O
39037	chest	b-TEST
39038	ct	i-TEST
39039	was	O
39040	nondiagnostic	O
39041	but	O
39042	did	O
39043	not	O
39044	show	O
39045	pulmonary	b-PROBLEM
39046	embolus	i-PROBLEM
39047	.	O
39048	it	O
39049	was	O
39050	a	b-TEST
39051	poor	i-TEST
39052	study	i-TEST
39053	.	O
39054	heparin	b-TREATMENT
39055	was	O
39056	maintained	O
39057	during	O
39058	her	b-OCCURRENCE
39059	hospital	i-OCCURRENCE
39060	course	i-OCCURRENCE
39061	and	O
39062	then	O
39063	lovenox	b-TREATMENT
39064	was	O
39065	started	O
39066	.	O
39067	her	b-TREATMENT
39068	dose	i-TREATMENT
39069	was	O
39070	increased	b-OCCURRENCE
39071	to	O
39072	7.5	O
39073	mg	O
39074	q	b-FREQUENCY
39075	day	i-FREQUENCY
39076	the	b-DATE
39077	day	i-DATE
39078	prior	i-DATE
39079	to	i-DATE
39080	discharge	i-DATE
39081	.	O
39082	she	O
39083	will	O
39084	be	O
39085	discharged	b-OCCURRENCE
39086	on	O
39087	this	O
39088	dose	O
39089	in	O
39090	addition	O
39091	to	O
39092	1	b-DURATION
39093	day	i-DURATION
39094	of	O
39095	lovenox	b-TREATMENT
39096	.	O
39097	discharge	b-TEST
39098	inr	i-TEST
39099	1.8	O
39100	.	O
39101	goal	b-TEST
39102	inr	i-TEST
39103	is	O
39104	2.0-3.0	O
39105	.	O
39106	5.	O
39107	fluids	O
39108	/	O
39109	electrolytes	O
39110	/	O
39111	nutrition	O
39112	:	O
39113	low	b-TREATMENT
39114	salt	i-TREATMENT
39115	diet	i-TREATMENT
39116	.	O
39117	low	b-TREATMENT
39118	cholesterol	i-TREATMENT
39119	,	i-TREATMENT
39120	low	i-TREATMENT
39121	fat	i-TREATMENT
39122	diet	i-TREATMENT
39123	.	O
39124		O
39125	admission	b-OCCURRENCE
39126	date	O
39127	:	O
39128	2017-05-08	b-ADMISSION
39129	discharge	b-OCCURRENCE
39130	date	O
39131	:	O
39132	2017-05-16	b-DISCHARGE
39133	service	O
39134	:	O
39135	cardiothoracic	O
39136	history	O
39137	of	O
39138	present	O
39139	illness	O
39140	:	O
39141	mr.	O
39142	williams	O
39143	is	O
39144	an	O
39145	85	O
39146	yo	O
39147	gentleman	O
39148	who	O
39149	has	O
39150	a	b-PROBLEM
39151	known	i-PROBLEM
39152	cardiac	i-PROBLEM
39153	history	i-PROBLEM
39154	and	O
39155	has	O
39156	had	O
39157	a	O
39158	h/o	O
39159	worsening	b-PROBLEM
39160	chest	i-PROBLEM
39161	pain	i-PROBLEM
39162	and	O
39163	shortness	b-PROBLEM
39164	of	i-PROBLEM
39165	breath	i-PROBLEM
39166	.	O
39167	he	O
39168	had	O
39169	an	b-TEST
39170	echocardiogram	i-TEST
39171	which	O
39172	showed	b-EVIDENTIAL
39173	an	b-TEST
39174	ef	i-TEST
39175	40-45%	O
39176	and	O
39177	severe	b-PROBLEM
39178	aortic	i-PROBLEM
39179	stenosis	i-PROBLEM
39180	.	O
39181	he	O
39182	underwent	O
39183	cardiac	b-TEST
39184	catheterization	i-TEST
39185	which	O
39186	showed	b-EVIDENTIAL
39187	an	b-PROBLEM
39188	80%	i-PROBLEM
39189	lad	i-PROBLEM
39190	lesion	i-PROBLEM
39191	,	O
39192	chronically	b-PROBLEM
39193	occluded	i-PROBLEM
39194	rca	i-PROBLEM
39195	,	O
39196	anneurysmal	b-PROBLEM
39197	mid	i-PROBLEM
39198	lcx	i-PROBLEM
39199	w/50%	b-PROBLEM
39200	lesion	i-PROBLEM
39201	.	O
39202	he	O
39203	was	O
39204	refered	O
39205	to	O
39206	doctor	O
39207	barber	O
39208	for	O
39209	surgical	b-TREATMENT
39210	treatment	i-TREATMENT
39211	.	O
39212	brief	O
39213	hospital	O
39214	course	O
39215	:	O
39216	mr.	O
39217	williams	O
39218	was	O
39219	admitted	b-OCCURRENCE
39220	to	O
39221	hallmark	b-CLINICAL_DEPT
39222	health	i-CLINICAL_DEPT
39223	system	i-CLINICAL_DEPT
39224	on	O
39225	05-08	b-DATE
39226	and	O
39227	taken	O
39228	to	O
39229	the	b-CLINICAL_DEPT
39230	operating	i-CLINICAL_DEPT
39231	room	i-CLINICAL_DEPT
39232	with	O
39233	doctor	O
39234	barber	O
39235	for	O
39236	a	b-TREATMENT
39237	cabgx2	i-TREATMENT
39238	and	O
39239	avr	b-TREATMENT
39240	w/	O
39241	25	b-TREATMENT
39242	mm	i-TREATMENT
39243	pericardial	i-TREATMENT
39244	valve	i-TREATMENT
39245	.	O
39246	please	O
39247	see	O
39248	operative	O
39249	note	O
39250	for	O
39251	full	O
39252	details	O
39253	.	O
39254	he	O
39255	was	O
39256	transfered	b-OCCURRENCE
39257	to	O
39258	the	b-CLINICAL_DEPT
39259	icu	i-CLINICAL_DEPT
39260	in	O
39261	stable	b-OCCURRENCE
39262	condition	i-OCCURRENCE
39263	.	O
39264	he	O
39265	was	O
39266	weaned	b-TREATMENT
39267	and	O
39268	extubated	b-TREATMENT
39269	from	O
39270	mechanical	b-TREATMENT
39271	ventillation	i-TREATMENT
39272	on	O
39273	pod#1	b-DATE
39274	without	O
39275	difficulty	b-PROBLEM
39276	.	O
39277	he	O
39278	was	O
39279	transfered	b-OCCURRENCE
39280	to	O
39281	the	b-CLINICAL_DEPT
39282	regular	i-CLINICAL_DEPT
39283	part	i-CLINICAL_DEPT
39284	of	i-CLINICAL_DEPT
39285	the	i-CLINICAL_DEPT
39286	hospital	i-CLINICAL_DEPT
39287	on	O
39288	pod#2	b-DATE
39289	,	O
39290	where	O
39291	he	O
39292	began	O
39293	working	O
39294	with	O
39295	physical	b-CLINICAL_DEPT
39296	therapy	i-CLINICAL_DEPT
39297	.	O
39298	he	O
39299	developed	O
39300	atrial	b-PROBLEM
39301	fibrillation	i-PROBLEM
39302	on	O
39303	pod#2	b-DATE
39304	with	O
39305	well	b-OCCURRENCE
39306	controlled	i-OCCURRENCE
39307	rate	i-OCCURRENCE
39308	and	O
39309	hemodynamically	b-OCCURRENCE
39310	stable	i-OCCURRENCE
39311	.	O
39312	he	O
39313	was	O
39314	started	O
39315	on	O
39316	heparin	b-TREATMENT
39317	and	O
39318	coumadin	b-TREATMENT
39319	for	O
39320	anticoagulation	b-TREATMENT
39321	on	O
39322	pod#5	b-DATE
39323	.	O
39324	on	O
39325	pod#7	b-DATE
39326	he	O
39327	was	O
39328	cleared	b-OCCURRENCE
39329	for	O
39330	discharge	b-OCCURRENCE
39331	to	O
39332	home	O
39333	by	O
39334	physical	O
39335	therapy	O
39336	and	O
39337	on	O
39338	pod#8	b-DATE
39339	he	O
39340	was	O
39341	discharged	b-OCCURRENCE
39342	.	O
39343		O
39344	admission	b-OCCURRENCE
39345	date	O
39346	:	O
39347	01/11/1996	b-ADMISSION
39348	discharge	b-OCCURRENCE
39349	date	O
39350	:	O
39351	01/19/1996	b-DISCHARGE
39352	history	O
39353	of	O
39354	present	O
39355	illness	O
39356	:	O
39357	ms.	O
39358	less	O
39359	is	O
39360	a	O
39361	79	O
39362	year	O
39363	old	O
39364	white	O
39365	female	O
39366	with	O
39367	history	O
39368	of	O
39369	non	b-PROBLEM
39370	small	i-PROBLEM
39371	cell	i-PROBLEM
39372	lung	i-PROBLEM
39373	cancer	i-PROBLEM
39374	diagnosed	O
39375	in	O
39376	02/95	b-DATE
39377	.	O
39378	she	O
39379	underwent	O
39380	a	b-TREATMENT
39381	resection	i-TREATMENT
39382	for	O
39383	stage	b-PROBLEM
39384	i	i-PROBLEM
39385	in	O
39386	10/95	b-DATE
39387	and	O
39388	treated	O
39389	with	O
39390	xrt	b-TREATMENT
39391	.	O
39392	she	O
39393	presented	b-OCCURRENCE
39394	to	O
39395	the	b-CLINICAL_DEPT
39396	hospital	i-CLINICAL_DEPT
39397	with	O
39398	a	b-PROBLEM
39399	numb	i-PROBLEM
39400	right	i-PROBLEM
39401	leg	i-PROBLEM
39402	this	b-DATE
39403	morning	i-DATE
39404	and	O
39405	underwent	O
39406	an	b-TREATMENT
39407	emergent	i-TREATMENT
39408	embolectomy	i-TREATMENT
39409	.	O
39410		O
39411	admission	b-OCCURRENCE
39412	date	O
39413	:	O
39414	2013-10-21	b-ADMISSION
39415	discharge	b-OCCURRENCE
39416	date	O
39417	:	O
39418	2013-10-31	b-DISCHARGE
39419	service	O
39420	:	O
39421	cardiothoracic	O
39422	history	O
39423	of	O
39424	present	O
39425	illness	O
39426	:	O
39427	this	O
39428	is	O
39429	an	O
39430	85	O
39431	year	O
39432	old	O
39433	female	O
39434	with	O
39435	prior	O
39436	history	O
39437	of	O
39438	non-hodgkins	b-PROBLEM
39439	lymphoma	i-PROBLEM
39440	,	O
39441	s/p	O
39442	cytoxan	b-TREATMENT
39443	in	O
39444	2003	b-DATE
39445	a	O
39446	with	O
39447	recurrence	b-PROBLEM
39448	in	O
39449	2009	b-DATE
39450	.	O
39451	follow	b-TEST
39452	up	i-TEST
39453	examinations	i-TEST
39454	have	O
39455	found	b-EVIDENTIAL
39456	a	b-PROBLEM
39457	suspicious	i-PROBLEM
39458	left	i-PROBLEM
39459	lower	i-PROBLEM
39460	lobe	i-PROBLEM
39461	finding	i-PROBLEM
39462	.	O
39463	cardiac	b-TEST
39464	workup	i-TEST
39465	prior	O
39466	to	O
39467	left	b-TREATMENT
39468	lower	i-TREATMENT
39469	lobe	i-TREATMENT
39470	resection	i-TREATMENT
39471	led	O
39472	to	O
39473	cardiac	b-TEST
39474	catheterization	i-TEST
39475	which	O
39476	found	b-EVIDENTIAL
39477	severe	b-PROBLEM
39478	three	i-PROBLEM
39479	vessel	i-PROBLEM
39480	disease	i-PROBLEM
39481	with	O
39482	04-05+	b-PROBLEM
39483	mitral	i-PROBLEM
39484	regurgitation	i-PROBLEM
39485	.	O
39486	she	O
39487	now	O
39488	present	b-OCCURRENCE
39489	for	O
39490	surgical	b-TREATMENT
39491	intervention	i-TREATMENT
39492	.	O
39493	brief	O
39494	hospital	O
39495	course	O
39496	:	O
39497	mrs.	O
39498	mandelbaum	O
39499	was	O
39500	admitted	b-OCCURRENCE
39501	and	O
39502	underwent	O
39503	three	b-TREATMENT
39504	vessel	i-TREATMENT
39505	coronary	i-TREATMENT
39506	artery	i-TREATMENT
39507	bypass	i-TREATMENT
39508	grafting	i-TREATMENT
39509	by	O
39510	doctor	O
39511	larry	O
39512	mckinney	O
39513	.	O
39514	of	O
39515	note	O
39516	,	O
39517	intraoperative	b-TEST
39518	transesophageal	i-TEST
39519	echocardiogram	i-TEST
39520	evaluation	i-TEST
39521	showed	b-EVIDENTIAL
39522	only	O
39523	mild	O
39524	mitral	b-PROBLEM
39525	regurgitation	i-PROBLEM
39526	,	O
39527	so	O
39528	no	O
39529	repair/replacement	b-TREATMENT
39530	was	O
39531	indicated	O
39532	.	O
39533	following	O
39534	the	b-TREATMENT
39535	operation	i-TREATMENT
39536	,	O
39537	she	O
39538	was	O
39539	brought	O
39540	to	O
39541	the	b-CLINICAL_DEPT
39542	csru	i-CLINICAL_DEPT
39543	.	O
39544	on	O
39545	postoperative	b-DATE
39546	day	i-DATE
39547	one	i-DATE
39548	,	O
39549	she	O
39550	was	O
39551	noted	b-EVIDENTIAL
39552	to	O
39553	be	O
39554	largely	b-PROBLEM
39555	unresponsive	i-PROBLEM
39556	with	O
39557	left	b-PROBLEM
39558	hemiparesis	i-PROBLEM
39559	.	O
39560	restlessness	b-PROBLEM
39561	with	O
39562	body	b-PROBLEM
39563	tremors	i-PROBLEM
39564	were	O
39565	also	O
39566	noted	O
39567	.	O
39568	a	b-TEST
39569	stat	i-TEST
39570	mri	i-TEST
39571	was	O
39572	notable	b-EVIDENTIAL
39573	for	O
39574	multiple	b-PROBLEM
39575	abnormal	i-PROBLEM
39576	foci	i-PROBLEM
39577	consistent	O
39578	with	O
39579	systemic	b-PROBLEM
39580	emboli	i-PROBLEM
39581	.	O
39582	these	O
39583	were	O
39584	found	O
39585	in	O
39586	the	O
39587	right	O
39588	cerebellar	O
39589	,	O
39590	occipital	O
39591	and	O
39592	anterior	O
39593	parietal	O
39594	lobes	O
39595	.	O
39596	the	b-CLINICAL_DEPT
39597	neurology	i-CLINICAL_DEPT
39598	service	i-CLINICAL_DEPT
39599	was	O
39600	consulted	O
39601	and	O
39602	attributed	O
39603	these	O
39604	findings	O
39605	to	O
39606	cholesterol	b-PROBLEM
39607	emboli	i-PROBLEM
39608	.	O
39609	due	O
39610	to	O
39611	seizure	b-PROBLEM
39612	activity	i-PROBLEM
39613	,	O
39614	dilantin	b-TREATMENT
39615	was	O
39616	started	O
39617	.	O
39618	anticoagulation	b-TREATMENT
39619	was	O
39620	not	O
39621	recommended	O
39622	.	O
39623	over	O
39624	the	b-DURATION
39625	next	i-DURATION
39626	several	i-DURATION
39627	days	i-DURATION
39628	,	O
39629	her	O
39630	neurological	O
39631	status	O
39632	slowly	b-OCCURRENCE
39633	improved	i-OCCURRENCE
39634	.	O
39635	she	O
39636	was	O
39637	eventually	O
39638	extubated	b-TREATMENT
39639	without	O
39640	incident	b-PROBLEM
39641	.	O
39642	she	O
39643	went	O
39644	on	O
39645	to	O
39646	experience	O
39647	paroxysmal	b-PROBLEM
39648	atrial	i-PROBLEM
39649	fibrillation	i-PROBLEM
39650	which	O
39651	was	O
39652	initially	O
39653	treated	O
39654	with	O
39655	intravenous	b-TREATMENT
39656	amiodarone	i-TREATMENT
39657	.	O
39658	she	O
39659	concomitantly	O
39660	had	O
39661	loose	b-PROBLEM
39662	stools	i-PROBLEM
39663	which	O
39664	were	O
39665	c.	b-TEST
39666	diff	i-TEST
39667	negative	O
39668	.	O
39669	her	O
39670	clinical	O
39671	status	O
39672	stablized	b-OCCURRENCE
39673	and	O
39674	she	O
39675	transferred	b-OCCURRENCE
39676	to	O
39677	the	b-CLINICAL_DEPT
39678	step	i-CLINICAL_DEPT
39679	down	i-CLINICAL_DEPT
39680	unit	i-CLINICAL_DEPT
39681	on	O
39682	postoperative	b-DATE
39683	day	i-DATE
39684	six	i-DATE
39685	.	O
39686	she	O
39687	remained	O
39688	mostly	O
39689	in	O
39690	a	b-OCCURRENCE
39691	normal	i-OCCURRENCE
39692	sinus	i-OCCURRENCE
39693	rhythm	i-OCCURRENCE
39694	and	O
39695	transitioned	O
39696	to	O
39697	oral	b-TREATMENT
39698	amiodarone	i-TREATMENT
39699	which	O
39700	will	O
39701	need	O
39702	to	O
39703	continue	O
39704	for	O
39705	three	b-DURATION
39706	months	i-DURATION
39707	postop	O
39708	.	O
39709	she	O
39710	tolerated	O
39711	beta	b-TREATMENT
39712	blockade	i-TREATMENT
39713	which	O
39714	was	O
39715	slowly	O
39716	advanced	b-OCCURRENCE
39717	as	i-OCCURRENCE
39718	tolerated	i-OCCURRENCE
39719	.	O
39720	she	O
39721	worked	O
39722	daily	b-FREQUENCY
39723	with	O
39724	physical	b-TREATMENT
39725	and	i-TREATMENT
39726	occupational	i-TREATMENT
39727	therapy	i-TREATMENT
39728	.	O
39729	her	b-OCCURRENCE
39730	neurological	i-OCCURRENCE
39731	status	i-OCCURRENCE
39732	continued	O
39733	to	O
39734	improve	b-OCCURRENCE
39735	.	O
39736	acyclovir	b-TREATMENT
39737	was	O
39738	eventually	O
39739	increased	b-TREATMENT
39740	from	O
39741	her	b-TREATMENT
39742	maintenance	i-TREATMENT
39743	dose	i-TREATMENT
39744	for	O
39745	a	b-PROBLEM
39746	herpes	i-PROBLEM
39747	zoster	i-PROBLEM
39748	breakout	i-PROBLEM
39749	on	i-PROBLEM
39750	her	i-PROBLEM
39751	right	i-PROBLEM
39752	upper	i-PROBLEM
39753	back	i-PROBLEM
39754	.	O
39755	in	O
39756	addition	O
39757	,	O
39758	she	O
39759	was	O
39760	empirically	O
39761	started	O
39762	on	O
39763	flagyl	b-TREATMENT
39764	for	O
39765	persistent	b-PROBLEM
39766	diarrhea	i-PROBLEM
39767	(	O
39768	despite	O
39769	negative	O
39770	c.	b-TEST
39771	diff	i-TEST
39772	cultures	i-TEST
39773	)	O
39774	,	O
39775	however	O
39776	she	O
39777	developed	O
39778	an	b-PROBLEM
39779	additional	i-PROBLEM
39780	rash	i-PROBLEM
39781	on	i-PROBLEM
39782	her	i-PROBLEM
39783	buttocks	i-PROBLEM
39784	after	O
39785	the	O
39786	first	O
39787	dose	O
39788	of	O
39789	flagyl	b-TREATMENT
39790	,	O
39791	so	O
39792	the	b-TREATMENT
39793	flagyl	i-TREATMENT
39794	was	O
39795	discontinued	O
39796	.	O
39797	she	O
39798	developed	O
39799	a	b-PROBLEM
39800	urinary	i-PROBLEM
39801	tract	i-PROBLEM
39802	infection	i-PROBLEM
39803	for	O
39804	which	O
39805	she	O
39806	was	O
39807	started	O
39808	on	O
39809	bactrim	b-TREATMENT
39810	.	O
39811	a	b-TREATMENT
39812	foley	i-TREATMENT
39813	catheter	i-TREATMENT
39814	was	O
39815	inserted	O
39816	given	O
39817	her	O
39818	mutiple	O
39819	episodes	O
39820	of	O
39821	incontinence	b-PROBLEM
39822	that	O
39823	were	O
39824	adding	O
39825	to	O
39826	skin	b-PROBLEM
39827	irritation	i-PROBLEM
39828	.	O
39829	on	O
39830	insertion	b-TREATMENT
39831	she	O
39832	was	O
39833	found	O
39834	to	O
39835	be	O
39836	retaining	b-PROBLEM
39837	1400	O
39838	cc	O
39839	of	O
39840	urine	b-OCCURRENCE
39841	,	O
39842	so	O
39843	the	b-TREATMENT
39844	foley	i-TREATMENT
39845	catheter	i-TREATMENT
39846	was	O
39847	left	O
39848	in	O
39849	.	O
39850	she	O
39851	continued	O
39852	to	O
39853	make	O
39854	clinical	b-OCCURRENCE
39855	improvements	i-OCCURRENCE
39856	and	O
39857	was	O
39858	cleared	O
39859	for	O
39860	discharge	b-OCCURRENCE
39861	to	O
39862	rehab	O
39863	on	O
39864	postoperative	b-DATE
39865	day	i-DATE
39866	10	i-DATE
39867	.	O
39868		O
39869	admission	b-OCCURRENCE
39870	date	O
39871	:	O
39872	06/29/92	b-ADMISSION
39873	discharge	b-OCCURRENCE
39874	date	O
39875	:	O
39876	07/27/92	b-DISCHARGE
39877	history	O
39878	of	O
39879	present	O
39880	illness	O
39881	:	O
39882	mr.	O
39883	villesatelkscurb	O
39884	is	O
39885	a	O
39886	fifty	O
39887	year	O
39888	old	O
39889	black	O
39890	gentleman	O
39891	with	O
39892	a	O
39893	long	O
39894	history	O
39895	of	O
39896	hepatitis	b-PROBLEM
39897	c	i-PROBLEM
39898	,	O
39899	believed	O
39900	to	O
39901	be	O
39902	contracted	O
39903	during	O
39904	transfusions	b-TREATMENT
39905	in	O
39906	a	b-PROBLEM
39907	previous	i-PROBLEM
39908	trauma	i-PROBLEM
39909	.	O
39910	the	O
39911	patient	O
39912	had	O
39913	recently	O
39914	prior	O
39915	to	O
39916	this	b-OCCURRENCE
39917	admission	i-OCCURRENCE
39918	,	O
39919	had	O
39920	a	b-PROBLEM
39921	rise	i-PROBLEM
39922	in	i-PROBLEM
39923	his	i-PROBLEM
39924	alpha	i-PROBLEM
39925	feta	i-PROBLEM
39926	protein	i-PROBLEM
39927	and	O
39928	a	b-TEST
39929	biopsy	i-TEST
39930	of	i-TEST
39931	his	i-TEST
39932	liver	i-TEST
39933	had	O
39934	shown	O
39935	hepatocellular	b-PROBLEM
39936	carcinoma	i-PROBLEM
39937	.	O
39938	the	O
39939	patient	O
39940	was	O
39941	admitted	b-OCCURRENCE
39942	for	O
39943	liver	b-TEST
39944	transplant	i-TEST
39945	workup	i-TEST
39946	and	O
39947	to	O
39948	await	O
39949	liver	b-TREATMENT
39950	transplant	i-TREATMENT
39951	.	O
39952	past	O
39953	medical	O
39954	and	O
39955	surgical	O
39956	history	O
39957	:	O
39958	significant	O
39959	for	O
39960	motor	b-OCCURRENCE
39961	vehicle	i-OCCURRENCE
39962	accident	i-OCCURRENCE
39963	in	O
39964	1966	b-DATE
39965	,	O
39966	requiring	O
39967	exploratory	b-TEST
39968	laparotomy	i-TEST
39969	and	O
39970	splenectomy	b-TREATMENT
39971	,	O
39972	tonsillectomy	b-TREATMENT
39973	as	O
39974	a	O
39975	child	O
39976	,	O
39977	pneumonia	b-PROBLEM
39978	in	O
39979	the	O
39980	past	O
39981	,	O
39982	hepatitis	b-PROBLEM
39983	c	i-PROBLEM
39984	and	O
39985	recent	O
39986	diagnosis	O
39987	of	O
39988	hepatocellular	b-PROBLEM
39989	carcinoma	i-PROBLEM
39990	.	O
39991	adverse	O
39992	drug	O
39993	reactions	O
39994	:	O
39995	no	O
39996	known	b-PROBLEM
39997	drug	i-PROBLEM
39998	allergies	i-PROBLEM
39999	.	O
40000	medications	O
40001	on	O
40002	admission	O
40003	:	O
40004	on	O
40005	admission	b-OCCURRENCE
40006	medications	b-TREATMENT
40007	included	O
40008	lasix	b-TREATMENT
40009	and	O
40010	iron	b-TREATMENT
40011	.	O
40012	hospital	O
40013	course	O
40014	:	O
40015	preoperatively	O
40016	,	O
40017	the	O
40018	patient	O
40019	underwent	O
40020	chemo-embolization	b-TREATMENT
40021	for	O
40022	his	b-PROBLEM
40023	hepatocellular	i-PROBLEM
40024	carcinoma	i-PROBLEM
40025	.	O
40026	the	O
40027	remainder	O
40028	of	O
40029	his	O
40030	preoperative	O
40031	course	O
40032	was	O
40033	benign	O
40034	.	O
40035	on	O
40036	july	b-DATE
40037	15	i-DATE
40038	,	i-DATE
40039	1992	i-DATE
40040	,	O
40041	a	O
40042	liver	O
40043	became	O
40044	available	O
40045	,	O
40046	and	O
40047	the	O
40048	patient	O
40049	underwent	O
40050	hepatectomy	b-TREATMENT
40051	and	O
40052	orthotopic	b-TREATMENT
40053	liver	i-TREATMENT
40054	transplant	i-TREATMENT
40055	.	O
40056	his	b-TREATMENT
40057	operation	i-TREATMENT
40058	was	O
40059	complicated	O
40060	by	O
40061	severe	b-PROBLEM
40062	coagulopathy	i-PROBLEM
40063	requiring	O
40064	fifty-nine	O
40065	units	O
40066	of	O
40067	packed	b-TREATMENT
40068	red	i-TREATMENT
40069	blood	i-TREATMENT
40070	cells	i-TREATMENT
40071	,	O
40072	64	O
40073	units	O
40074	of	O
40075	ffp	b-TREATMENT
40076	and	O
40077	34	O
40078	units	O
40079	of	O
40080	platelets	b-TREATMENT
40081	.	O
40082	postoperatively	O
40083	,	O
40084	the	O
40085	patient	O
40086	continued	O
40087	to	O
40088	have	O
40089	a	b-PROBLEM
40090	coagulopathy	i-PROBLEM
40091	requiring	O
40092	re-exploration	b-TEST
40093	on	O
40094	postoperatively	b-DATE
40095	day	i-DATE
40096	2	i-DATE
40097	,	O
40098	with	O
40099	findings	O
40100	only	O
40101	of	O
40102	hematoma	b-PROBLEM
40103	and	O
40104	no	O
40105	active	b-PROBLEM
40106	bleeding	i-PROBLEM
40107	.	O
40108	initially	O
40109	,	O
40110	the	O
40111	patient	O
40112	did	O
40113	well	O
40114	in	O
40115	the	b-CLINICAL_DEPT
40116	intensive	i-CLINICAL_DEPT
40117	care	i-CLINICAL_DEPT
40118	unit	i-CLINICAL_DEPT
40119	,	O
40120	mentally	b-OCCURRENCE
40121	alert	i-OCCURRENCE
40122	,	i-OCCURRENCE
40123	and	i-OCCURRENCE
40124	oriented	i-OCCURRENCE
40125	,	O
40126	however	O
40127	,	O
40128	he	O
40129	continued	O
40130	to	O
40131	be	O
40132	coagulopathic	b-PROBLEM
40133	and	O
40134	was	O
40135	requiring	O
40136	large	b-TREATMENT
40137	amounts	i-TREATMENT
40138	of	i-TREATMENT
40139	blood	i-TREATMENT
40140	and	O
40141	ffp	b-TREATMENT
40142	transfusions	i-TREATMENT
40143	,	O
40144	with	O
40145	a	b-PROBLEM
40146	resultant	i-PROBLEM
40147	pulmonary	i-PROBLEM
40148	edema	i-PROBLEM
40149	.	O
40150	he	O
40151	developed	O
40152	renal	b-PROBLEM
40153	failure	i-PROBLEM
40154	felt	O
40155	to	O
40156	be	O
40157	atn	b-PROBLEM
40158	secondary	O
40159	to	O
40160	ischemia	b-PROBLEM
40161	of	i-PROBLEM
40162	his	i-PROBLEM
40163	kidneys	i-PROBLEM
40164	.	O
40165	the	O
40166	patient	O
40167	remained	O
40168	intubated	b-TREATMENT
40169	in	O
40170	the	b-CLINICAL_DEPT
40171	intensive	i-CLINICAL_DEPT
40172	care	i-CLINICAL_DEPT
40173	unit	i-CLINICAL_DEPT
40174	for	O
40175	twelve	b-DURATION
40176	days	i-DURATION
40177	prior	O
40178	to	O
40179	his	b-OCCURRENCE
40180	death	i-OCCURRENCE
40181	.	O
40182	he	O
40183	had	O
40184	daily	b-TREATMENT
40185	transfusions	i-TREATMENT
40186	of	O
40187	ffp	b-TREATMENT
40188	and	O
40189	blood	b-TREATMENT
40190	,	O
40191	and	O
40192	continued	O
40193	coagulopathy	b-PROBLEM
40194	.	O
40195	he	O
40196	also	O
40197	developed	O
40198	thrombocytopenia	b-PROBLEM
40199	,	O
40200	requiring	O
40201	persistent	b-TREATMENT
40202	platelet	i-TREATMENT
40203	transfusions	i-TREATMENT
40204	on	O
40205	a	b-FREQUENCY
40206	daily	i-FREQUENCY
40207	basis	O
40208	.	O
40209	his	b-TREATMENT
40210	immunosuppression	i-TREATMENT
40211	was	O
40212	okt3	b-TREATMENT
40213	and	O
40214	solu	b-TREATMENT
40215	medrol	i-TREATMENT
40216	,	O
40217	and	O
40218	he	O
40219	underwent	O
40220	hemodialysis	b-TREATMENT
40221	and	O
40222	ultra	b-TREATMENT
40223	filtration	i-TREATMENT
40224	to	O
40225	remove	O
40226	fluid	O
40227	.	O
40228	while	O
40229	in	O
40230	the	b-CLINICAL_DEPT
40231	icu	i-CLINICAL_DEPT
40232	he	O
40233	developed	O
40234	seizures	b-PROBLEM
40235	,	O
40236	requiring	O
40237	large	b-TREATMENT
40238	amounts	i-TREATMENT
40239	of	i-TREATMENT
40240	intravenous	i-TREATMENT
40241	valium	i-TREATMENT
40242	to	O
40243	break	O
40244	his	b-PROBLEM
40245	seizures	i-PROBLEM
40246	,	O
40247	and	O
40248	he	O
40249	was	O
40250	maintained	O
40251	on	O
40252	tegretol	b-TREATMENT
40253	and	O
40254	dilantin	b-TREATMENT
40255	.	O
40256	however	O
40257	,	O
40258	he	O
40259	became	O
40260	progressively	O
40261	more	O
40262	mentally	b-PROBLEM
40263	obtunded	i-PROBLEM
40264	.	O
40265	during	O
40266	the	b-PROBLEM
40267	seizure	i-PROBLEM
40268	,	O
40269	he	O
40270	bit	b-PROBLEM
40271	his	i-PROBLEM
40272	tongue	i-PROBLEM
40273	,	O
40274	resulting	O
40275	in	O
40276	a	b-PROBLEM
40277	large	i-PROBLEM
40278	bleed	i-PROBLEM
40279	from	i-PROBLEM
40280	his	i-PROBLEM
40281	tongue	i-PROBLEM
40282	,	O
40283	which	O
40284	was	O
40285	sutured	b-TREATMENT
40286	by	O
40287	the	b-CLINICAL_DEPT
40288	ent	i-CLINICAL_DEPT
40289	service	i-CLINICAL_DEPT
40290	,	O
40291	however	O
40292	,	O
40293	his	b-PROBLEM
40294	continued	i-PROBLEM
40295	coagulopathy	i-PROBLEM
40296	resulted	O
40297	in	O
40298	bleeding	b-PROBLEM
40299	from	i-PROBLEM
40300	his	i-PROBLEM
40301	nasopharynx	i-PROBLEM
40302	,	O
40303	which	O
40304	could	O
40305	never	O
40306	be	O
40307	identified	O
40308	,	O
40309	and	O
40310	also	O
40311	upper	b-PROBLEM
40312	gastrointestinal	i-PROBLEM
40313	bleeding	i-PROBLEM
40314	.	O
40315	endoscopy	b-TEST
40316	never	O
40317	revealed	O
40318	specific	O
40319	sources	O
40320	of	O
40321	bleeding	b-PROBLEM
40322	,	O
40323	although	O
40324	he	O
40325	appeared	O
40326	to	O
40327	have	O
40328	a	b-PROBLEM
40329	diffuse	i-PROBLEM
40330	duodenitis	i-PROBLEM
40331	.	O
40332	he	O
40333	was	O
40334	started	O
40335	on	O
40336	pitressin	b-TREATMENT
40337	to	O
40338	try	O
40339	to	O
40340	control	O
40341	the	b-PROBLEM
40342	gastrointestinal	i-PROBLEM
40343	bleeding	i-PROBLEM
40344	,	O
40345	but	O
40346	he	O
40347	continued	O
40348	to	O
40349	have	O
40350	severe	b-PROBLEM
40351	bleeding	i-PROBLEM
40352	,	O
40353	and	O
40354	became	O
40355	progressively	b-PROBLEM
40356	hypotensive	i-PROBLEM
40357	,	O
40358	with	O
40359	eventual	b-PROBLEM
40360	bradycardia	i-PROBLEM
40361	and	O
40362	cardiac	b-PROBLEM
40363	arrest	i-PROBLEM
40364	.	O
40365	he	O
40366	was	O
40367	pronounced	O
40368	dead	b-OCCURRENCE
40369	at	O
40370	3:49	b-TIME
40371	pm	i-TIME
40372	on	O
40373	july	b-DATE
40374	27	i-DATE
40375	,	i-DATE
40376	1992	i-DATE
40377	.	O
40378		O
40379	admission	b-OCCURRENCE
40380	date	O
40381	:	O
40382	05/08/95	b-ADMISSION
40383	discharge	b-OCCURRENCE
40384	date	O
40385	:	O
40386	05/14/95	b-DISCHARGE
40387	history	O
40388	of	O
40389	present	O
40390	illness	O
40391	:	O
40392	the	O
40393	patient	O
40394	is	O
40395	a	O
40396	72-year-old	O
40397	right-handed	O
40398	gentleman	O
40399	with	O
40400	a	O
40401	history	O
40402	of	O
40403	coronary	b-PROBLEM
40404	artery	i-PROBLEM
40405	disease	i-PROBLEM
40406	status	O
40407	post	O
40408	myocardial	b-PROBLEM
40409	infarction	i-PROBLEM
40410	in	O
40411	1984	b-DATE
40412	.	O
40413	also	O
40414	with	O
40415	a	O
40416	history	O
40417	of	O
40418	noninsulin	b-PROBLEM
40419	dependent	i-PROBLEM
40420	diabetes	i-PROBLEM
40421	mellitus	i-PROBLEM
40422	,	O
40423	now	O
40424	presenting	b-OCCURRENCE
40425	with	O
40426	acute	b-PROBLEM
40427	blurry	i-PROBLEM
40428	vision	i-PROBLEM
40429	on	i-PROBLEM
40430	the	i-PROBLEM
40431	left	i-PROBLEM
40432	side	i-PROBLEM
40433	,	O
40434	which	O
40435	is	O
40436	homonymous	O
40437	.	O
40438	the	O
40439	patient	O
40440	woke	O
40441	up	O
40442	as	O
40443	usual	O
40444	on	O
40445	may	b-DATE
40446	8	i-DATE
40447	,	i-DATE
40448	1995	i-DATE
40449	.	O
40450	at	O
40451	8	b-TIME
40452	a.m.	i-TIME
40453	the	O
40454	patient	O
40455	was	O
40456	looking	O
40457	at	O
40458	his	O
40459	wife	O
40460	with	O
40461	the	O
40462	background	O
40463	outside	O
40464	a	O
40465	large	O
40466	window	O
40467	.	O
40468	the	O
40469	patient	O
40470	had	O
40471	sudden	O
40472	onset	O
40473	of	O
40474	blurred	b-PROBLEM
40475	vision	i-PROBLEM
40476	,	O
40477	where	O
40478	the	O
40479	right	O
40480	side	O
40481	of	O
40482	his	O
40483	wife	O
40484	&apos;s	O
40485	face	O
40486	looked	O
40487	blurred	O
40488	.	O
40489	the	O
40490	patient	O
40491	did	O
40492	not	O
40493	notice	O
40494	change	b-PROBLEM
40495	of	i-PROBLEM
40496	vision	i-PROBLEM
40497	in	O
40498	the	O
40499	background	O
40500	.	O
40501	the	b-PROBLEM
40502	blurred	i-PROBLEM
40503	vision	i-PROBLEM
40504	was	O
40505	homonymous	O
40506	,	O
40507	which	O
40508	he	O
40509	had	O
40510	blurred	b-PROBLEM
40511	in	i-PROBLEM
40512	each	i-PROBLEM
40513	eye	i-PROBLEM
40514	in	O
40515	the	O
40516	left	O
40517	visual	O
40518	field	O
40519	.	O
40520	the	b-PROBLEM
40521	same	i-PROBLEM
40522	blurred	i-PROBLEM
40523	vision	i-PROBLEM
40524	was	O
40525	also	O
40526	noticed	O
40527	later	b-TIME
40528	when	O
40529	the	O
40530	patient	O
40531	was	O
40532	watching	O
40533	television	O
40534	and	O
40535	also	O
40536	when	O
40537	he	O
40538	was	O
40539	reading	O
40540	.	O
40541	the	O
40542	patient	O
40543	was	O
40544	seen	O
40545	at	O
40546	the	b-CLINICAL_DEPT
40547	ochtuheihugh	i-CLINICAL_DEPT
40548	put	i-CLINICAL_DEPT
40549	university	i-CLINICAL_DEPT
40550	medical	i-CLINICAL_DEPT
40551	center	i-CLINICAL_DEPT
40552	and	O
40553	then	O
40554	he	O
40555	was	O
40556	referred	b-OCCURRENCE
40557	to	O
40558	the	b-CLINICAL_DEPT
40559	purckecation	i-CLINICAL_DEPT
40560	balpoingdelt	i-CLINICAL_DEPT
40561	pabarnes-	i-CLINICAL_DEPT
40562	campa	i-CLINICAL_DEPT
40563	memorial	i-CLINICAL_DEPT
40564	hospital	i-CLINICAL_DEPT
40565	.	O
40566	at	O
40567	8	b-TIME
40568	p.m.	i-TIME
40569	the	O
40570	patient	O
40571	seen	O
40572	at	O
40573	the	b-CLINICAL_DEPT
40574	purckecation	i-CLINICAL_DEPT
40575	balpoingdelt	i-CLINICAL_DEPT
40576	pabarnes-	i-CLINICAL_DEPT
40577	campa	i-CLINICAL_DEPT
40578	memorial	i-CLINICAL_DEPT
40579	hospital	i-CLINICAL_DEPT
40580	and	O
40581	was	O
40582	examined	b-OCCURRENCE
40583	and	i-OCCURRENCE
40584	assessed	i-OCCURRENCE
40585	.	O
40586	the	O
40587	patient	O
40588	was	O
40589	referred	b-OCCURRENCE
40590	to	O
40591	ph	b-CLINICAL_DEPT
40592	university	i-CLINICAL_DEPT
40593	of	i-CLINICAL_DEPT
40594	medical	i-CLINICAL_DEPT
40595	center	i-CLINICAL_DEPT
40596	for	O
40597	rule	b-TEST
40598	out	i-TEST
40599	transient	b-PROBLEM
40600	ischemic	i-PROBLEM
40601	attack	i-PROBLEM
40602	and	O
40603	rule	b-TEST
40604	out	i-TEST
40605	stroke	b-PROBLEM
40606	.	O
40607	the	O
40608	patient	O
40609	denies	b-EVIDENTIAL
40610	any	b-PROBLEM
40611	nausea	i-PROBLEM
40612	,	O
40613	vomiting	b-PROBLEM
40614	,	O
40615	ataxia	b-PROBLEM
40616	,	O
40617	motor	b-PROBLEM
40618	deficits	i-PROBLEM
40619	,	O
40620	speech	b-PROBLEM
40621	deficits	i-PROBLEM
40622	or	O
40623	sensory	b-PROBLEM
40624	deficits	i-PROBLEM
40625	.	O
40626	the	O
40627	patient	O
40628	lightly	O
40629	bumped	b-PROBLEM
40630	his	O
40631	head	O
40632	on	O
40633	the	O
40634	top	O
40635	three	b-FREQUENCY
40636	times	i-FREQUENCY
40637	on	O
40638	the	b-DATE
40639	previous	i-DATE
40640	night	i-DATE
40641	and	O
40642	the	O
40643	patient	O
40644	had	O
40645	frontal	b-PROBLEM
40646	headaches	i-PROBLEM
40647	and	O
40648	a	b-PROBLEM
40649	tight	i-PROBLEM
40650	neck	i-PROBLEM
40651	.	O
40652	one	b-DURATION
40653	hour	i-DURATION
40654	after	O
40655	he	O
40656	had	O
40657	physical	b-OCCURRENCE
40658	activity	i-OCCURRENCE
40659	on	O
40660	the	b-DATE
40661	previously	i-DATE
40662	night	i-DATE
40663	as	O
40664	well	O
40665	.	O
40666	allergies	O
40667	:	O
40668	the	O
40669	patient	O
40670	denies	b-EVIDENTIAL
40671	any	b-PROBLEM
40672	drug	i-PROBLEM
40673	allergies	i-PROBLEM
40674	.	O
40675	hospital	O
40676	course	O
40677	:	O
40678	the	O
40679	patient	O
40680	was	O
40681	admitted	b-OCCURRENCE
40682	with	O
40683	a	b-PROBLEM
40684	right	i-PROBLEM
40685	occipital	i-PROBLEM
40686	cerebral	i-PROBLEM
40687	infarction	i-PROBLEM
40688	.	O
40689	the	O
40690	patient	O
40691	was	O
40692	started	O
40693	on	O
40694	intravenous	b-TREATMENT
40695	heparin	i-TREATMENT
40696	and	O
40697	had	O
40698	the	b-TEST
40699	studies	i-TEST
40700	as	O
40701	described	O
40702	above	O
40703	for	O
40704	rule	b-TEST
40705	out	i-TEST
40706	source	O
40707	of	O
40708	embolic	b-PROBLEM
40709	strokes	i-PROBLEM
40710	including	O
40711	carotid	b-TEST
40712	noninvasives	i-TEST
40713	,	O
40714	transcranial	b-TEST
40715	dopplers	i-TEST
40716	,	O
40717	holter	b-TEST
40718	electrocardiogram	i-TEST
40719	and	O
40720	echocardiogram	b-TEST
40721	.	O
40722	the	O
40723	patient	O
40724	also	O
40725	had	O
40726	serial	b-TEST
40727	electrocardiogram	i-TEST
40728	,	O
40729	which	O
40730	showed	b-EVIDENTIAL
40731	no	O
40732	change	b-PROBLEM
40733	.	O
40734	the	O
40735	patient	O
40736	also	O
40737	had	O
40738	serial	b-TEST
40739	creatinine	i-TEST
40740	kinase	i-TEST
40741	with	i-TEST
40742	mb	i-TEST
40743	fractions	i-TEST
40744	studied	O
40745	,	O
40746	which	O
40747	revealed	b-EVIDENTIAL
40748	mb	O
40749	fraction	O
40750	too	b-PROBLEM
40751	low	i-PROBLEM
40752	to	O
40753	be	O
40754	tested	O
40755	.	O
40756	the	O
40757	patient	O
40758	also	O
40759	experienced	O
40760	a	b-PROBLEM
40761	feeling	i-PROBLEM
40762	of	i-PROBLEM
40763	moving	i-PROBLEM
40764	back	i-PROBLEM
40765	and	i-PROBLEM
40766	forth	i-PROBLEM
40767	when	i-PROBLEM
40768	lying	i-PROBLEM
40769	down	i-PROBLEM
40770	with	O
40771	neck	O
40772	extended	O
40773	during	O
40774	the	b-TEST
40775	magnetic	i-TEST
40776	resonance	i-TEST
40777	imaging	i-TEST
40778	study	i-TEST
40779	and	O
40780	also	O
40781	in	O
40782	bed	O
40783	.	O
40784	this	b-PROBLEM
40785	moving	i-PROBLEM
40786	sense	i-PROBLEM
40787	,	O
40788	with	O
40789	normal	O
40790	electroencephalogram	b-TEST
40791	,	O
40792	was	O
40793	thought	O
40794	to	O
40795	be	O
40796	a	O
40797	mild	O
40798	vestibular	b-PROBLEM
40799	dysfunction	i-PROBLEM
40800	or	O
40801	from	O
40802	the	O
40803	acute	O
40804	episode	O
40805	of	O
40806	the	b-PROBLEM
40807	stroke	i-PROBLEM
40808	.	O
40809	the	O
40810	patient	O
40811	will	O
40812	have	O
40813	these	b-PROBLEM
40814	symptoms	i-PROBLEM
40815	only	O
40816	when	O
40817	the	O
40818	eyes	O
40819	are	O
40820	closed	O
40821	.	O
40822	our	O
40823	opinion	O
40824	was	O
40825	not	O
40826	to	O
40827	intervene	O
40828	or	O
40829	have	O
40830	any	b-TEST
40831	further	i-TEST
40832	studies	i-TEST
40833	for	O
40834	acute	O
40835	period	O
40836	and	O
40837	to	O
40838	continued	b-TREATMENT
40839	to	i-TREATMENT
40840	observe	i-TREATMENT
40841	.	O
40842	the	O
40843	patient	O
40844	did	O
40845	have	O
40846	a	b-PROBLEM
40847	hypotensive	i-PROBLEM
40848	episode	i-PROBLEM
40849	and	O
40850	the	b-TEST
40851	systolic	i-TEST
40852	blood	i-TEST
40853	pressure	i-TEST
40854	was	O
40855	80	O
40856	,	O
40857	after	O
40858	the	O
40859	patient	O
40860	received	O
40861	his	b-TREATMENT
40862	regular	i-TREATMENT
40863	cardiac	i-TREATMENT
40864	medications	i-TREATMENT
40865	.	O
40866	the	O
40867	patient	O
40868	had	O
40869	been	O
40870	off	O
40871	his	b-TREATMENT
40872	regular	i-TREATMENT
40873	medications	i-TREATMENT
40874	since	O
40875	during	O
40876	the	b-OCCURRENCE
40877	admission	i-OCCURRENCE
40878	and	O
40879	will	O
40880	be	O
40881	discharged	b-OCCURRENCE
40882	off	O
40883	his	b-TREATMENT
40884	medications	i-TREATMENT
40885	.	O
40886	otherwise	O
40887	,	O
40888	there	O
40889	were	O
40890	no	O
40891	further	O
40892	episodes	O
40893	of	O
40894	blurred	b-PROBLEM
40895	vision	i-PROBLEM
40896	.	O
40897	the	O
40898	patient	O
40899	was	O
40900	stable	b-OCCURRENCE
40901	with	O
40902	an	O
40903	unchanged	O
40904	neurological	b-TEST
40905	and	i-TEST
40906	physical	i-TEST
40907	examination	i-TEST
40908	and	O
40909	was	O
40910	discharged	b-OCCURRENCE
40911	on	O
40912	aspirin	b-TREATMENT
40913	325	O
40914	mg	O
40915	po	O
40916	qd	O
40917	,	O
40918	on	O
40919	may	b-DATE
40920	14	i-DATE
40921	,	i-DATE
40922	1995	i-DATE
40923	.	O
40924	the	O
40925	patient	O
40926	will	O
40927	be	O
40928	randomized	O
40929	on	O
40930	the	O
40931	wars	O
40932	study	O
40933	early	O
40934	next	O
40935	week	O
40936	by	O
40937	the	O
40938	stroke	O
40939	service	O
40940	at	O
40941	ph	O
40942	university	O
40943	of	O
40944	medical	O
40945	center	O
40946	.	O
40947		O
40948	admission	b-OCCURRENCE
40949	date	O
40950	:	O
40951	2012-05-21	b-ADMISSION
40952	discharge	b-OCCURRENCE
40953	date	O
40954	:	O
40955	2012-05-25	b-DISCHARGE
40956	service	O
40957	:	O
40958	cmed	O
40959	ccu	O
40960	history	O
40961	of	O
40962	present	O
40963	illness	O
40964	:	O
40965	this	O
40966	is	O
40967	a	O
40968	55-year-old	O
40969	female	O
40970	with	O
40971	multiple	b-FREQUENCY
40972	prior	O
40973	admissions	b-OCCURRENCE
40974	for	O
40975	pneumonia	b-PROBLEM
40976	,	O
40977	copd	b-PROBLEM
40978	,	O
40979	asthma	b-PROBLEM
40980	exacerbation	i-PROBLEM
40981	,	O
40982	over	O
40983	3	b-DURATION
40984	weeks	i-DURATION
40985	of	O
40986	upper	b-PROBLEM
40987	respiratory	i-PROBLEM
40988	like	i-PROBLEM
40989	infection	i-PROBLEM
40990	unremitting	O
40991	with	O
40992	increased	b-TREATMENT
40993	nebulizer	i-TREATMENT
40994	treatments	i-TREATMENT
40995	at	O
40996	home	O
40997	.	O
40998	the	O
40999	patient	O
41000	saw	O
41001	her	b-OCCURRENCE
41002	pcp	i-OCCURRENCE
41003	and	O
41004	was	O
41005	known	O
41006	to	O
41007	have	O
41008	an	b-TEST
41009	oxygen	i-TEST
41010	saturation	i-TEST
41011	of	O
41012	82	O
41013	to	O
41014	85	O
41015	percent	O
41016	on	O
41017	room	O
41018	air	O
41019	.	O
41020	she	O
41021	was	O
41022	referred	O
41023	to	O
41024	the	b-CLINICAL_DEPT
41025	emergency	i-CLINICAL_DEPT
41026	department	i-CLINICAL_DEPT
41027	.	O
41028	in	O
41029	the	b-CLINICAL_DEPT
41030	emergency	i-CLINICAL_DEPT
41031	department	i-CLINICAL_DEPT
41032	,	O
41033	the	O
41034	patient	O
41035	received	O
41036	zithromax	b-TREATMENT
41037	,	O
41038	ceftriaxone	b-TREATMENT
41039	,	O
41040	and	O
41041	flagyl	b-TREATMENT
41042	.	O
41043	chest	b-TEST
41044	x-ray	i-TEST
41045	was	O
41046	remarkable	O
41047	for	O
41048	a	O
41049	questionable	O
41050	left	b-PROBLEM
41051	lower	i-PROBLEM
41052	lobe	i-PROBLEM
41053	infiltrate	i-PROBLEM
41054	.	O
41055	the	O
41056	patient	O
41057	received	O
41058	nebulizer	b-TREATMENT
41059	treatment	i-TREATMENT
41060	with	O
41061	oxygen	b-TEST
41062	saturations	i-TEST
41063	increasing	O
41064	up	O
41065	to	O
41066	98	O
41067	percent	O
41068	on	O
41069	room	O
41070	air	O
41071	.	O
41072	hospital	O
41073	course	O
41074	:	O
41075	shortness	b-PROBLEM
41076	of	i-PROBLEM
41077	breath	i-PROBLEM
41078	.	O
41079	the	O
41080	patient	O
41081	was	O
41082	maintained	O
41083	on	O
41084	albuterol	b-TREATMENT
41085	nebulizer	i-TREATMENT
41086	treatments	i-TREATMENT
41087	and	O
41088	ipratropium	b-TREATMENT
41089	nebulizer	i-TREATMENT
41090	treatments	i-TREATMENT
41091	,	O
41092	as	O
41093	this	O
41094	was	O
41095	apparently	O
41096	thought	O
41097	to	O
41098	be	O
41099	related	O
41100	to	O
41101	her	b-PROBLEM
41102	chronic	i-PROBLEM
41103	obstructive	i-PROBLEM
41104	pulmonary	i-PROBLEM
41105	disease	i-PROBLEM
41106	.	O
41107	given	O
41108	the	O
41109	presence	O
41110	of	O
41111	consolidation	b-PROBLEM
41112	on	O
41113	chest	b-TEST
41114	x-ray	i-TEST
41115	,	O
41116	however	O
41117	,	O
41118	and	O
41119	previous	O
41120	history	O
41121	of	O
41122	pneumonia	b-PROBLEM
41123	,	O
41124	the	O
41125	patient	O
41126	was	O
41127	maintained	O
41128	on	O
41129	antibiotics	b-TREATMENT
41130	of	O
41131	zithromax	b-TREATMENT
41132	500	O
41133	mg	O
41134	daily	b-FREQUENCY
41135	and	O
41136	ceftriaxone	b-TREATMENT
41137	.	O
41138	the	O
41139	patient	O
41140	was	O
41141	also	O
41142	started	O
41143	on	O
41144	solu-medrol	b-TREATMENT
41145	iv	i-TREATMENT
41146	for	O
41147	active	b-PROBLEM
41148	airway	i-PROBLEM
41149	disease	i-PROBLEM
41150	component	i-PROBLEM
41151	of	O
41152	her	b-PROBLEM
41153	shortness	i-PROBLEM
41154	of	i-PROBLEM
41155	breath	i-PROBLEM
41156	.	O
41157	the	O
41158	patient	O
41159	was	O
41160	maintained	O
41161	on	O
41162	supplemental	b-TREATMENT
41163	oxygen	i-TREATMENT
41164	and	O
41165	sputum	b-OCCURRENCE
41166	production	i-OCCURRENCE
41167	was	O
41168	maximized	O
41169	with	O
41170	the	O
41171	help	O
41172	of	O
41173	an	b-TREATMENT
41174	acapella	i-TREATMENT
41175	device	i-TREATMENT
41176	and	O
41177	respiratory	b-TREATMENT
41178	therapy	i-TREATMENT
41179	.	O
41180	mucomyst	b-TREATMENT
41181	was	O
41182	also	O
41183	considered	O
41184	as	O
41185	a	b-TREATMENT
41186	mucolytic	i-TREATMENT
41187	component	i-TREATMENT
41188	towards	O
41189	secretions	b-PROBLEM
41190	.	O
41191	adrenal	b-PROBLEM
41192	insufficiency	i-PROBLEM
41193	.	O
41194	the	O
41195	patient	O
41196	was	O
41197	maintained	O
41198	on	O
41199	iv	b-TREATMENT
41200	solu	i-TREATMENT
41201	-	i-TREATMENT
41202	medrol	i-TREATMENT
41203	60	O
41204	mg	O
41205	q.	b-FREQUENCY
41206	8	i-FREQUENCY
41207	h.	i-FREQUENCY
41208	chest	b-PROBLEM
41209	soreness	i-PROBLEM
41210	.	O
41211	the	O
41212	patient	O
41213	describes	b-EVIDENTIAL
41214	chest	b-PROBLEM
41215	discomfort	i-PROBLEM
41216	without	O
41217	any	b-PROBLEM
41218	significant	i-PROBLEM
41219	ekg	i-PROBLEM
41220	changes	i-PROBLEM
41221	.	O
41222	the	O
41223	patient	O
41224	was	O
41225	maintained	O
41226	on	O
41227	percocet	b-TREATMENT
41228	p.r.n.	O
41229	for	O
41230	pain	b-TREATMENT
41231	relief	i-TREATMENT
41232	.	O
41233	this	O
41234	was	O
41235	thought	O
41236	to	O
41237	be	O
41238	related	O
41239	to	O
41240	musculoskeletal	b-OCCURRENCE
41241	.	O
41242	there	O
41243	was	O
41244	no	O
41245	evidence	O
41246	of	O
41247	acute	b-PROBLEM
41248	rib	i-PROBLEM
41249	factors	i-PROBLEM
41250	on	O
41251	her	b-TEST
41252	chest	i-TEST
41253	x-ray	i-TEST
41254	.	O
41255	gi	O
41256	.	O
41257	the	O
41258	patient	O
41259	was	O
41260	maintained	O
41261	on	O
41262	ppi	b-TREATMENT
41263	for	O
41264	reflux	b-PROBLEM
41265	disease	i-PROBLEM
41266	and	O
41267	known	b-PROBLEM
41268	gastritis	i-PROBLEM
41269	.	O
41270	cmed	O
41271	.	O
41272	the	O
41273	patient	O
41274	has	O
41275	a	O
41276	history	O
41277	of	O
41278	neurogenic	b-PROBLEM
41279	bladder	i-PROBLEM
41280	and	O
41281	,	O
41282	therefore	O
41283	,	O
41284	she	O
41285	required	O
41286	a	b-TREATMENT
41287	foley	i-TREATMENT
41288	catheterization	i-TREATMENT
41289	.	O
41290	endocrine	O
41291	.	O
41292	the	O
41293	patient	O
41294	was	O
41295	on	O
41296	levoxyl	b-TREATMENT
41297	at	O
41298	home	O
41299	as	O
41300	her	O
41301	home	O
41302	dose	O
41303	for	O
41304	hyperthyroidism	b-PROBLEM
41305	.	O
41306	cmed	b-CLINICAL_DEPT
41307	csru	i-CLINICAL_DEPT
41308	transfer	b-OCCURRENCE
41309	.	O
41310	the	O
41311	patient	O
41312	was	O
41313	transferred	b-OCCURRENCE
41314	on	O
41315	the	O
41316	evening	O
41317	of	O
41318	2012-05-22	b-DATE
41319	to	O
41320	the	b-CLINICAL_DEPT
41321	icu	i-CLINICAL_DEPT
41322	given	O
41323	persistent	b-PROBLEM
41324	carbon	i-PROBLEM
41325	dioxide	i-PROBLEM
41326	retention	i-PROBLEM
41327	and	O
41328	respiratory	b-PROBLEM
41329	acidosis	i-PROBLEM
41330	and	O
41331	the	b-PROBLEM
41332	intermittent	i-PROBLEM
41333	mental	i-PROBLEM
41334	status	i-PROBLEM
41335	changes	i-PROBLEM
41336	.	O
41337	the	O
41338	patient	O
41339	had	O
41340	had	O
41341	abg	b-TEST
41342	on	O
41343	the	b-CLINICAL_DEPT
41344	floor	i-CLINICAL_DEPT
41345	,	O
41346	which	O
41347	prompted	O
41348	her	O
41349	to	O
41350	transfer	b-OCCURRENCE
41351	to	O
41352	the	b-CLINICAL_DEPT
41353	icu	i-CLINICAL_DEPT
41354	.	O
41355	her	b-TEST
41356	ph	i-TEST
41357	was	O
41358	7.23	O
41359	,	O
41360	pco2	b-TEST
41361	73	O
41362	,	O
41363	po2	b-TEST
41364	146	O
41365	on	O
41366	a	b-TREATMENT
41367	nonrebreather	i-TREATMENT
41368	.	O
41369	the	O
41370	patient	O
41371	had	O
41372	bipap	b-TREATMENT
41373	initiated	O
41374	once	O
41375	she	O
41376	reached	O
41377	the	b-CLINICAL_DEPT
41378	unit	i-CLINICAL_DEPT
41379	,	O
41380	but	O
41381	did	O
41382	not	O
41383	tolerate	O
41384	it	O
41385	,	O
41386	becoming	O
41387	apneic	b-PROBLEM
41388	and	O
41389	obstructing	b-PROBLEM
41390	.	O
41391	the	O
41392	patient	O
41393	was	O
41394	switched	O
41395	to	O
41396	2	b-TREATMENT
41397	liters	i-TREATMENT
41398	nasal	i-TREATMENT
41399	cannula	i-TREATMENT
41400	and	O
41401	oxygen	O
41402	saturating	b-OCCURRENCE
41403	at	O
41404	98	O
41405	to	O
41406	100	O
41407	percent	O
41408	.	O
41409	after	O
41410	bipap	b-TREATMENT
41411	was	O
41412	initiated	O
41413	,	O
41414	the	O
41415	patient	O
41416	became	O
41417	hypotensive	b-PROBLEM
41418	down	O
41419	to	O
41420	75/28	O
41421	and	O
41422	bradycardiac	b-PROBLEM
41423	,	O
41424	responding	O
41425	to	O
41426	3	b-TREATMENT
41427	fluid	i-TREATMENT
41428	boluses	i-TREATMENT
41429	over	O
41430	the	b-DURATION
41431	course	i-DURATION
41432	of	i-DURATION
41433	the	i-DURATION
41434	night	i-DURATION
41435	.	O
41436	the	O
41437	patient	O
41438	was	O
41439	started	O
41440	on	O
41441	florinef	b-TREATMENT
41442	for	O
41443	concern	O
41444	of	O
41445	adrenal	b-PROBLEM
41446	insufficiency	i-PROBLEM
41447	;	O
41448	however	O
41449	,	O
41450	she	O
41451	was	O
41452	hemodynamically	b-OCCURRENCE
41453	stable	i-OCCURRENCE
41454	that	b-DATE
41455	morning	i-DATE
41456	and	O
41457	was	O
41458	transferred	b-OCCURRENCE
41459	back	O
41460	out	O
41461	to	O
41462	the	b-CLINICAL_DEPT
41463	floor	i-CLINICAL_DEPT
41464	.	O
41465	it	O
41466	was	O
41467	thought	O
41468	that	O
41469	the	O
41470	patient	O
41471	may	O
41472	have	O
41473	been	O
41474	mucous	b-PROBLEM
41475	plugging	i-PROBLEM
41476	during	O
41477	her	O
41478	stay	O
41479	in	O
41480	the	b-CLINICAL_DEPT
41481	icu	i-CLINICAL_DEPT
41482	.	O
41483	hematologic	O
41484	.	O
41485	the	O
41486	patient	O
41487	has	O
41488	a	O
41489	history	O
41490	of	O
41491	high	b-PROBLEM
41492	mcv	i-PROBLEM
41493	and	O
41494	megaloblastic	b-PROBLEM
41495	cells	i-PROBLEM
41496	on	O
41497	smear	b-TEST
41498	in	O
41499	the	O
41500	setting	O
41501	of	O
41502	anemia	b-PROBLEM
41503	;	O
41504	question	O
41505	b12	b-PROBLEM
41506	deficiency	i-PROBLEM
41507	,	O
41508	the	O
41509	patient	O
41510	also	O
41511	has	O
41512	a	O
41513	history	O
41514	of	O
41515	borderline	b-PROBLEM
41516	low	i-PROBLEM
41517	b12	i-PROBLEM
41518	levels	i-PROBLEM
41519	.	O
41520	the	O
41521	patient	O
41522	was	O
41523	diagnosed	O
41524	for	O
41525	b12	b-PROBLEM
41526	deficiency	i-PROBLEM
41527	due	O
41528	to	O
41529	her	O
41530	long	O
41531	history	O
41532	of	O
41533	poor	b-PROBLEM
41534	p.o.	i-PROBLEM
41535	intake	i-PROBLEM
41536	.	O
41537	methylmalonic	b-TEST
41538	acid	i-TEST
41539	levels	i-TEST
41540	were	O
41541	sent	O
41542	,	O
41543	the	O
41544	results	O
41545	are	O
41546	pending	O
41547	at	O
41548	the	O
41549	time	O
41550	of	O
41551	discharge	b-OCCURRENCE
41552	.	O
41553		O
41554	admission	b-OCCURRENCE
41555	date	O
41556	:	O
41557	2016-12-15	b-ADMISSION
41558	discharge	b-OCCURRENCE
41559	date	O
41560	:	O
41561	2016-12-21	b-DISCHARGE
41562	service	O
41563	:	O
41564	obstetrics	O
41565	/	O
41566	gynecology	O
41567	history	O
41568	of	O
41569	present	O
41570	illness	O
41571	:	O
41572	36	O
41573	yo	O
41574	g3p2	O
41575	at	O
41576	38+5	O
41577	weeks	O
41578	ga	O
41579	presented	b-OCCURRENCE
41580	to	O
41581	l&d	b-CLINICAL_DEPT
41582	for	O
41583	elective	b-TREATMENT
41584	induction	i-TREATMENT
41585	of	i-TREATMENT
41586	labor	i-TREATMENT
41587	.	O
41588	antenatal	b-OCCURRENCE
41589	course	i-OCCURRENCE
41590	benign	O
41591	.	O
41592	brief	O
41593	hospital	O
41594	course	O
41595	:	O
41596	after	O
41597	admission	b-OCCURRENCE
41598	to	O
41599	l&d	b-CLINICAL_DEPT
41600	,	O
41601	the	O
41602	patient	O
41603	was	O
41604	administered	b-TREATMENT
41605	pitocin	b-TREATMENT
41606	for	O
41607	elective	b-TREATMENT
41608	induction	i-TREATMENT
41609	of	i-TREATMENT
41610	labor	i-TREATMENT
41611	and	O
41612	progressed	b-OCCURRENCE
41613	uneventfully	i-OCCURRENCE
41614	and	O
41615	went	O
41616	on	O
41617	to	O
41618	deliver	b-OCCURRENCE
41619	a	O
41620	viable	O
41621	female	O
41622	infant	O
41623	,	O
41624	weight	b-TEST
41625	3595	O
41626	g	O
41627	,	O
41628	apgars	b-TEST
41629	11-11	O
41630	.	O
41631	ebl	b-TEST
41632	during	O
41633	delivery	b-OCCURRENCE
41634	was	O
41635	300	O
41636	cc	O
41637	.	O
41638	patient	O
41639	was	O
41640	transferred	b-OCCURRENCE
41641	to	O
41642	the	b-CLINICAL_DEPT
41643	pp	i-CLINICAL_DEPT
41644	floor	i-CLINICAL_DEPT
41645	in	O
41646	stable	b-OCCURRENCE
41647	condition	i-OCCURRENCE
41648	.	O
41649	soon	O
41650	after	O
41651	transfer	b-OCCURRENCE
41652	,	O
41653	patient	O
41654	had	O
41655	a	b-PROBLEM
41656	large	i-PROBLEM
41657	post	i-PROBLEM
41658	partum	i-PROBLEM
41659	hemorrhage	i-PROBLEM
41660	.	O
41661	this	O
41662	was	O
41663	treated	b-OCCURRENCE
41664	with	O
41665	transfer	b-OCCURRENCE
41666	back	O
41667	to	O
41668	l&d	b-CLINICAL_DEPT
41669	,	O
41670	bimanual	b-TREATMENT
41671	massage	i-TREATMENT
41672	,	O
41673	administration	O
41674	of	O
41675	various	b-TREATMENT
41676	uterotonics	i-TREATMENT
41677	,	O
41678	namely	O
41679	pitocin	b-TREATMENT
41680	100	O
41681	u	O
41682	,	O
41683	methergine	b-TREATMENT
41684	x	b-FREQUENCY
41685	1	i-FREQUENCY
41686	,	O
41687	hemabate	b-TREATMENT
41688	x	b-FREQUENCY
41689	1	i-FREQUENCY
41690	,	O
41691	and	O
41692	cytotec	b-TREATMENT
41693	1000	O
41694	mcgs	O
41695	with	O
41696	minimal	O
41697	response	b-OCCURRENCE
41698	.	O
41699	patient	O
41700	underwent	O
41701	suction	b-TREATMENT
41702	curettage	i-TREATMENT
41703	and	O
41704	finally	O
41705	a	b-TREATMENT
41706	supercervical	i-TREATMENT
41707	hysterectomy	i-TREATMENT
41708	.	O
41709	ebl	b-TEST
41710	4000	O
41711	cc	O
41712	;	O
41713	ivf	b-TREATMENT
41714	6000	O
41715	cc	O
41716	crystalloid	b-TREATMENT
41717	;	O
41718	u/o	b-TEST
41719	3500	O
41720	cc	O
41721	.	O
41722	products	O
41723	:	O
41724	8	b-TREATMENT
41725	units	i-TREATMENT
41726	rbc	i-TREATMENT
41727	,	O
41728	6ffp	b-TREATMENT
41729	,	O
41730	1	b-TREATMENT
41731	cryo	i-TREATMENT
41732	,	O
41733	1	b-TREATMENT
41734	pack	i-TREATMENT
41735	plt	i-TREATMENT
41736	.	O
41737	after	O
41738	this	b-TREATMENT
41739	procedure	i-TREATMENT
41740	,	O
41741	the	O
41742	patient	O
41743	again	O
41744	hemorrhaged	b-PROBLEM
41745	in	O
41746	the	b-CLINICAL_DEPT
41747	icu	i-CLINICAL_DEPT
41748	and	O
41749	was	O
41750	taken	O
41751	back	O
41752	to	O
41753	the	b-CLINICAL_DEPT
41754	or	i-CLINICAL_DEPT
41755	for	O
41756	reexploration	b-TEST
41757	and	O
41758	ligation	b-TREATMENT
41759	of	O
41760	a	b-PROBLEM
41761	bleeding	i-PROBLEM
41762	vaginal	i-PROBLEM
41763	artery	i-PROBLEM
41764	.	O
41765	ebl	b-TEST
41766	3500	O
41767	;	O
41768	ivf	b-TREATMENT
41769	4000	O
41770	;	O
41771	uo	b-TEST
41772	45	O
41773	;	O
41774	rbc	b-TREATMENT
41775	9u	O
41776	;	O
41777	plt	b-TREATMENT
41778	12	O
41779	pack	O
41780	;	O
41781	1u	b-TREATMENT
41782	cryo	i-TREATMENT
41783	;	O
41784	6u	b-TREATMENT
41785	ffp	i-TREATMENT
41786	.	O
41787	for	O
41788	details	O
41789	of	O
41790	these	b-TREATMENT
41791	procedures	i-TREATMENT
41792	,	O
41793	please	O
41794	see	O
41795	op	O
41796	notes	O
41797	dictated	O
41798	by	O
41799	doctor	O
41800	day	O
41801	on	O
41802	2016-12-16	O
41803	.	O
41804	overall	O
41805	,	O
41806	the	O
41807	pt	O
41808	maintained	O
41809	good	O
41810	bp	b-TEST
41811	throughout	O
41812	and	O
41813	was	O
41814	on	O
41815	pressors	b-TREATMENT
41816	only	O
41817	briefly	O
41818	.	O
41819	hct	b-TEST
41820	was	O
41821	maintained	O
41822	in	O
41823	stable	b-OCCURRENCE
41824	range	i-OCCURRENCE
41825	with	O
41826	product	b-TREATMENT
41827	transfusions	i-TREATMENT
41828	.	O
41829	patient	O
41830	did	O
41831	well	b-EVIDENTIAL
41832	and	O
41833	was	O
41834	extubated	b-TREATMENT
41835	uneventfully	O
41836	on	O
41837	12-17	b-DATE
41838	.	O
41839	she	O
41840	was	O
41841	transferred	b-OCCURRENCE
41842	from	O
41843	the	b-CLINICAL_DEPT
41844	icu	i-CLINICAL_DEPT
41845	back	O
41846	to	O
41847	the	b-CLINICAL_DEPT
41848	pp	i-CLINICAL_DEPT
41849	floor	i-CLINICAL_DEPT
41850	on	O
41851	12-19	b-DATE
41852	.	O
41853	there	O
41854	,	O
41855	she	O
41856	made	O
41857	great	O
41858	progress	b-OCCURRENCE
41859	.	O
41860	her	b-TEST
41861	vital	i-TEST
41862	signs	i-TEST
41863	were	O
41864	stable	b-EVIDENTIAL
41865	,	O
41866	she	O
41867	remained	O
41868	afebrile	b-PROBLEM
41869	off	O
41870	antibiotics	b-TREATMENT
41871	.	O
41872	her	b-PROBLEM
41873	pain	i-PROBLEM
41874	was	O
41875	controlled	b-OCCURRENCE
41876	with	O
41877	percocet	b-TREATMENT
41878	and	O
41879	motrin	b-TREATMENT
41880	.	O
41881	her	b-TREATMENT
41882	foley	i-TREATMENT
41883	was	O
41884	removed	b-OCCURRENCE
41885	and	O
41886	she	O
41887	voided	b-OCCURRENCE
41888	without	O
41889	problems	b-PROBLEM
41890	.	O
41891	she	O
41892	john	O
41893	,	O
41894	tolerated	b-OCCURRENCE
41895	a	b-OCCURRENCE
41896	regular	i-OCCURRENCE
41897	diet	i-OCCURRENCE
41898	,	O
41899	and	O
41900	was	O
41901	discharged	b-OCCURRENCE
41902	home	i-OCCURRENCE
41903	in	O
41904	good	b-OCCURRENCE
41905	condition	i-OCCURRENCE
41906	on	O
41907	12-21	b-DATE
41908	.	O
41909		O
41910	admission	b-OCCURRENCE
41911	date	O
41912	:	O
41913	10-01-94	b-ADMISSION
41914	discharge	b-OCCURRENCE
41915	date	O
41916	:	O
41917	10-10-94	b-DISCHARGE
41918	history	O
41919	of	O
41920	present	O
41921	illness	O
41922	:	O
41923	the	O
41924	patient	O
41925	is	O
41926	a	O
41927	60	O
41928	year	O
41929	old	O
41930	diabetic	b-PROBLEM
41931	who	O
41932	underwent	O
41933	an	b-TREATMENT
41934	apr	i-TREATMENT
41935	in	O
41936	1989	b-DATE
41937	for	O
41938	rectal	b-PROBLEM
41939	carcinoma	i-PROBLEM
41940	and	O
41941	has	O
41942	been	O
41943	doing	O
41944	following	O
41945	radiation	b-TREATMENT
41946	therapy	i-TREATMENT
41947	and	O
41948	5fu	b-TREATMENT
41949	.	O
41950	he	O
41951	recently	O
41952	developed	O
41953	fatigue	b-PROBLEM
41954	and	O
41955	dyspnea	b-PROBLEM
41956	and	O
41957	workup	b-TEST
41958	disclosed	O
41959	a	b-PROBLEM
41960	large	i-PROBLEM
41961	liver	i-PROBLEM
41962	mass	i-PROBLEM
41963	which	O
41964	was	O
41965	biopsied	b-TEST
41966	and	O
41967	revealed	b-EVIDENTIAL
41968	to	O
41969	be	O
41970	poorly	b-PROBLEM
41971	differentiated	i-PROBLEM
41972	neoplasm	i-PROBLEM
41973	most	O
41974	consistent	O
41975	with	O
41976	metastatic	b-PROBLEM
41977	rectal	i-PROBLEM
41978	discontinued	i-PROBLEM
41979	.	O
41980	hospital	O
41981	course	O
41982	:	O
41983	the	O
41984	patient	O
41985	was	O
41986	admitted	b-OCCURRENCE
41987	and	O
41988	underwent	O
41989	celiac	b-TEST
41990	and	i-TEST
41991	superior	i-TEST
41992	mesenteric	i-TEST
41993	artery	i-TEST
41994	angiography	i-TEST
41995	which	O
41996	demonstrated	O
41997	a	O
41998	patent	O
41999	celiac	O
42000	and	O
42001	superior	O
42002	mesenteric	O
42003	artery	O
42004	with	O
42005	normal	O
42006	branching	O
42007	pattern	O
42008	.	O
42009	his	b-TEST
42010	preoperative	i-TEST
42011	workup	i-TEST
42012	was	O
42013	completed	O
42014	and	O
42015	included	O
42016	a	b-TEST
42017	normal	i-TEST
42018	white	i-TEST
42019	count	i-TEST
42020	,	O
42021	hematocrit	b-TEST
42022	42	O
42023	.	O
42024	normal	b-TEST
42025	electrolytes	i-TEST
42026	,	O
42027	normal	b-TEST
42028	coags	i-TEST
42029	and	O
42030	normal	b-OCCURRENCE
42031	renal	i-OCCURRENCE
42032	function	i-OCCURRENCE
42033	.	O
42034	on	O
42035	10-02-94	b-DATE
42036	the	O
42037	patient	O
42038	was	O
42039	brought	O
42040	to	O
42041	the	b-CLINICAL_DEPT
42042	operating	i-CLINICAL_DEPT
42043	room	i-CLINICAL_DEPT
42044	where	O
42045	he	O
42046	underwent	O
42047	exploratory	b-TEST
42048	laparotomy	i-TEST
42049	and	O
42050	left	b-TREATMENT
42051	hepatectomy	i-TREATMENT
42052	and	O
42053	cholecystectomy	b-TREATMENT
42054	by	O
42055	doctor	O
42056	duhenile	O
42057	.	O
42058	the	O
42059	patient	O
42060	tolerated	b-OCCURRENCE
42061	the	b-TREATMENT
42062	procedure	i-TREATMENT
42063	well	O
42064	with	O
42065	a	O
42066	2000	O
42067	cc.	O
42068	blood	b-PROBLEM
42069	loss	i-PROBLEM
42070	and	O
42071	was	O
42072	autotransfused	b-TREATMENT
42073	two	O
42074	units	O
42075	of	O
42076	blood	b-TREATMENT
42077	.	O
42078	in	O
42079	the	b-OCCURRENCE
42080	postoperative	i-OCCURRENCE
42081	course	i-OCCURRENCE
42082	mr.	O
42083	fyfe	O
42084	did	O
42085	surprisingly	O
42086	well	b-EVIDENTIAL
42087	given	O
42088	his	b-PROBLEM
42089	underlying	i-PROBLEM
42090	medical	i-PROBLEM
42091	condition	i-PROBLEM
42092	.	O
42093	,	O
42094	he	O
42095	did	O
42096	require	O
42097	two	O
42098	units	O
42099	of	O
42100	transfused	b-TREATMENT
42101	blood	i-TREATMENT
42102	but	O
42103	otherwise	O
42104	did	O
42105	quite	O
42106	well	O
42107	and	O
42108	was	O
42109	extubated	b-TREATMENT
42110	on	O
42111	the	b-TIME
42112	night	i-TIME
42113	of	O
42114	surgery	b-TREATMENT
42115	.	O
42116	he	O
42117	remained	O
42118	in	O
42119	the	b-CLINICAL_DEPT
42120	intensive	i-CLINICAL_DEPT
42121	care	i-CLINICAL_DEPT
42122	unit	i-CLINICAL_DEPT
42123	for	O
42124	two	b-DURATION
42125	days	i-DURATION
42126	but	O
42127	was	O
42128	hemodynamically	b-OCCURRENCE
42129	stable	i-OCCURRENCE
42130	throughout	O
42131	.	O
42132	he	O
42133	continued	O
42134	to	O
42135	manifest	O
42136	occasional	b-PROBLEM
42137	premature	i-PROBLEM
42138	ventricular	i-PROBLEM
42139	contractions	i-PROBLEM
42140	,	O
42141	but	O
42142	these	O
42143	were	O
42144	unchanged	O
42145	from	O
42146	preoperatively	O
42147	and	O
42148	the	O
42149	patient	O
42150	otherwise	O
42151	did	b-OCCURRENCE
42152	well	i-OCCURRENCE
42153	.	O
42154	his	b-TREATMENT
42155	nasogastric	i-TREATMENT
42156	tube	i-TREATMENT
42157	was	O
42158	discontinued	O
42159	and	O
42160	he	O
42161	was	O
42162	begun	O
42163	on	O
42164	clear	b-TREATMENT
42165	liquids	i-TREATMENT
42166	and	O
42167	subsequently	O
42168	advanced	O
42169	to	O
42170	a	b-OCCURRENCE
42171	regular	i-OCCURRENCE
42172	diet	i-OCCURRENCE
42173	without	O
42174	difficulty	O
42175	.	O
42176	both	O
42177	of	O
42178	his	b-TREATMENT
42179	jackson-pratt	i-TREATMENT
42180	drains	i-TREATMENT
42181	were	O
42182	removed	O
42183	without	O
42184	incident	b-PROBLEM
42185	.	O
42186	by	O
42187	postoperative	b-DATE
42188	day	i-DATE
42189	#	i-DATE
42190	7	i-DATE
42191	,	O
42192	mr.	O
42193	fyfe	O
42194	was	O
42195	tolerating	O
42196	a	b-TREATMENT
42197	regular	i-TREATMENT
42198	ada	i-TREATMENT
42199	1800	i-TREATMENT
42200	kilocalorie	i-TREATMENT
42201	diet	i-TREATMENT
42202	without	O
42203	difficulty	b-OCCURRENCE
42204	with	O
42205	all	O
42206	of	O
42207	his	b-TREATMENT
42208	tubes	i-TREATMENT
42209	and	O
42210	drains	b-TREATMENT
42211	removed	O
42212	.	O
42213	his	b-PROBLEM
42214	wound	i-PROBLEM
42215	was	O
42216	noted	O
42217	to	O
42218	be	O
42219	healing	b-OCCURRENCE
42220	well	i-OCCURRENCE
42221	and	O
42222	his	b-TREATMENT
42223	colostomy	i-TREATMENT
42224	functioning	b-OCCURRENCE
42225	appropriately	i-OCCURRENCE
42226	without	O
42227	significant	b-OCCURRENCE
42228	difficulty	i-OCCURRENCE
42229	.	O
42230	he	O
42231	is	O
42232	being	O
42233	transferred	b-OCCURRENCE
42234	back	O
42235	to	O
42236	the	b-CLINICAL_DEPT
42237	per	i-CLINICAL_DEPT
42238	naplesspecrycet	i-CLINICAL_DEPT
42239	hospital	i-CLINICAL_DEPT
42240	in	O
42241	stable	b-OCCURRENCE
42242	condition	i-OCCURRENCE
42243	on	O
42244	the	b-TREATMENT
42245	same	i-TREATMENT
42246	medications	i-TREATMENT
42247	which	O
42248	he	O
42249	was	O
42250	on	O
42251	preoperatively	O
42252	.	O
42253	these	O
42254	include	O
42255	diabeta	b-TREATMENT
42256	10	O
42257	mg.	O
42258	po.	O
42259	bid	b-FREQUENCY
42260	.	i-FREQUENCY
42261	serax	b-TREATMENT
42262	20	O
42263	mg.	O
42264	po.	O
42265	qhs	b-FREQUENCY
42266	.	O
42267	sudafed	b-TREATMENT
42268	30	O
42269	po.	O
42270	bid	b-FREQUENCY
42271	.	O
42272	theo-dur	b-TREATMENT
42273	300	O
42274	mg.	O
42275	po.	O
42276	bid	b-FREQUENCY
42277	.	O
42278	betoptic	b-TREATMENT
42279	0.5%	O
42280	one	O
42281	drop	O
42282	ou	O
42283	bid	b-FREQUENCY
42284	,	O
42285	propene	b-TREATMENT
42286	0.1%	O
42287	one	O
42288	drop	O
42289	ou	O
42290	bid	b-FREQUENCY
42291	.	O
42292	pred-forte	b-TREATMENT
42293	1%	O
42294	one	O
42295	drop	O
42296	os	O
42297	bid	b-FREQUENCY
42298	.	O
42299	percocet	b-TREATMENT
42300	two	O
42301	tabs	O
42302	po.	O
42303	q4h	b-FREQUENCY
42304	prn	O
42305	.	O
42306	proventil	b-TREATMENT
42307	2	O
42308	puffs	O
42309	q6hours	b-FREQUENCY
42310	prn	O
42311	..	O
42312	the	O
42313	patient	O
42314	will	O
42315	followup	b-OCCURRENCE
42316	with	O
42317	doctor	O
42318	fede	O
42319	duhenile	O
42320	in	O
42321	two	b-DURATION
42322	weeks	i-DURATION
42323	in	O
42324	doctor	O
42325	duhenile	O
42326	&apos;s	O
42327	office	O
42328	.	O
42329	lenni	O
42330	breutzoln	O
42331	,	O
42332	md	O
42333		O
42334	admission	b-OCCURRENCE
42335	date	O
42336	:	O
42337	2013-08-24	b-ADMISSION
42338	discharge	b-OCCURRENCE
42339	date	O
42340	:	O
42341	2013-08-27	b-DISCHARGE
42342	service	O
42343	:	O
42344	trauma	O
42345	surgery	O
42346	history	O
42347	of	O
42348	present	O
42349	illness	O
42350	:	O
42351	this	O
42352	is	O
42353	a	O
42354	25	O
42355	-	O
42356	year-old	O
42357	gentleman	O
42358	who	O
42359	is	O
42360	status	O
42361	post	O
42362	a	b-OCCURRENCE
42363	motor	i-OCCURRENCE
42364	vehicle	i-OCCURRENCE
42365	accident	i-OCCURRENCE
42366	in	O
42367	which	O
42368	he	O
42369	was	O
42370	the	O
42371	unrestrained	O
42372	driver	O
42373	and	O
42374	struck	b-OCCURRENCE
42375	a	i-OCCURRENCE
42376	telephone	i-OCCURRENCE
42377	pole	i-OCCURRENCE
42378	.	O
42379	he	O
42380	was	O
42381	ejected	b-OCCURRENCE
42382	from	i-OCCURRENCE
42383	the	i-OCCURRENCE
42384	car	i-OCCURRENCE
42385	and	O
42386	landed	b-OCCURRENCE
42387	on	i-OCCURRENCE
42388	his	i-OCCURRENCE
42389	face	i-OCCURRENCE
42390	.	O
42391	extreme	O
42392	damage	O
42393	was	O
42394	reported	O
42395	to	O
42396	the	O
42397	vehicle	O
42398	by	O
42399	first	O
42400	responders	O
42401	.	O
42402	it	O
42403	was	O
42404	presumed	O
42405	high-speed	b-OCCURRENCE
42406	motor	i-OCCURRENCE
42407	vehicle	i-OCCURRENCE
42408	collision	i-OCCURRENCE
42409	.	O
42410	the	O
42411	patient	O
42412	was	O
42413	cmed-flighted	b-OCCURRENCE
42414	to	O
42415	quincy	b-CLINICAL_DEPT
42416	medical	i-CLINICAL_DEPT
42417	center	i-CLINICAL_DEPT
42418	,	O
42419	and	O
42420	he	O
42421	was	O
42422	intubated	b-TREATMENT
42423	upon	O
42424	arrival	b-OCCURRENCE
42425	in	O
42426	the	b-CLINICAL_DEPT
42427	emergency	i-CLINICAL_DEPT
42428	department	i-CLINICAL_DEPT
42429	.	O
42430	after	O
42431	initial	b-TEST
42432	trauma	i-TEST
42433	assessment	i-TEST
42434	and	O
42435	initiation	O
42436	of	O
42437	resuscitation	b-TREATMENT
42438	,	O
42439	a	b-TEST
42440	ct	i-TEST
42441	scan	i-TEST
42442	was	O
42443	performed	O
42444	.	O
42445	images	b-TEST
42446	of	i-TEST
42447	his	i-TEST
42448	head	i-TEST
42449	,	i-TEST
42450	abdomen	i-TEST
42451	,	i-TEST
42452	and	i-TEST
42453	thorax	i-TEST
42454	were	O
42455	obtained	O
42456	.	O
42457	his	b-PROBLEM
42458	injuries	i-PROBLEM
42459	included	O
42460	bilateral	b-PROBLEM
42461	zygomal	i-PROBLEM
42462	and	i-PROBLEM
42463	orbital	i-PROBLEM
42464	rim	i-PROBLEM
42465	fractures	i-PROBLEM
42466	,	O
42467	a	b-PROBLEM
42468	right	i-PROBLEM
42469	temporal	i-PROBLEM
42470	fracture	i-PROBLEM
42471	,	O
42472	bilateral	b-PROBLEM
42473	frontal	i-PROBLEM
42474	contusions	i-PROBLEM
42475	,	O
42476	and	O
42477	a	b-PROBLEM
42478	right	i-PROBLEM
42479	temporal	i-PROBLEM
42480	epidural	i-PROBLEM
42481	versus	O
42482	subdural	b-PROBLEM
42483	hematoma	i-PROBLEM
42484	.	O
42485	the	O
42486	anterior	O
42487	and	O
42488	posterior	O
42489	of	O
42490	the	O
42491	frontal	O
42492	sinus	O
42493	was	O
42494	fractured	b-PROBLEM
42495	with	O
42496	communication	b-PROBLEM
42497	with	i-PROBLEM
42498	the	i-PROBLEM
42499	ethmoid	i-PROBLEM
42500	air	i-PROBLEM
42501	cells	i-PROBLEM
42502	,	O
42503	presumably	O
42504	caused	O
42505	air	b-PROBLEM
42506	in	i-PROBLEM
42507	the	i-PROBLEM
42508	orbit	i-PROBLEM
42509	.	O
42510	hospital	O
42511	course	O
42512	by	O
42513	system	O
42514	:	O
42515	1.	O
42516	neurology	O
42517	:	O
42518	mr.	O
42519	roach	O
42520	was	O
42521	transported	O
42522	to	O
42523	intensive	b-CLINICAL_DEPT
42524	care	i-CLINICAL_DEPT
42525	unit	i-CLINICAL_DEPT
42526	from	O
42527	the	b-CLINICAL_DEPT
42528	trauma	i-CLINICAL_DEPT
42529	bay	i-CLINICAL_DEPT
42530	.	O
42531	upon	O
42532	arrival	b-OCCURRENCE
42533	,	O
42534	neurosurgery	b-CLINICAL_DEPT
42535	promptly	O
42536	placed	O
42537	v.	b-TREATMENT
42538	holtzen	i-TREATMENT
42539	bolt	i-TREATMENT
42540	.	O
42541	this	O
42542	allowed	O
42543	continuous	b-TEST
42544	monitoring	i-TEST
42545	of	i-TEST
42546	intracranial	i-TEST
42547	pressure	i-TEST
42548	.	O
42549	notably	O
42550	,	O
42551	intracranial	b-TEST
42552	pressure	i-TEST
42553	was	O
42554	17	O
42555	when	O
42556	the	b-TREATMENT
42557	bolt	i-TREATMENT
42558	was	O
42559	placed	O
42560	.	O
42561	during	O
42562	his	b-OCCURRENCE
42563	hospitalization	i-OCCURRENCE
42564	,	O
42565	his	b-TEST
42566	intracranial	i-TEST
42567	pressure	i-TEST
42568	was	O
42569	monitored	b-TREATMENT
42570	very	i-TREATMENT
42571	closely	i-TREATMENT
42572	and	O
42573	maintained	b-TREATMENT
42574	to	O
42575	a	O
42576	level	O
42577	of	O
42578	less	O
42579	than	O
42580	20	O
42581	.	O
42582	to	O
42583	do	O
42584	this	O
42585	,	O
42586	mannitol	b-TREATMENT
42587	25	O
42588	mg	O
42589	q.	b-FREQUENCY
42590	6h.	i-FREQUENCY
42591	was	O
42592	used	O
42593	.	O
42594	while	O
42595	using	O
42596	mannitol	b-TREATMENT
42597	,	O
42598	his	b-TEST
42599	serum	i-TEST
42600	osmolalities	i-TEST
42601	were	O
42602	followed	O
42603	closely	O
42604	.	O
42605	in	O
42606	addition	O
42607	,	O
42608	to	O
42609	monitoring	O
42610	his	b-TEST
42611	intracranial	i-TEST
42612	pressure	i-TEST
42613	,	O
42614	his	b-TEST
42615	systemic	i-TEST
42616	blood	i-TEST
42617	pressures	i-TEST
42618	were	O
42619	maintained	b-TREATMENT
42620	in	O
42621	such	O
42622	a	O
42623	manner	O
42624	that	O
42625	his	b-TEST
42626	cerebral	i-TEST
42627	perfusion	i-TEST
42628	pressure	i-TEST
42629	was	O
42630	maintained	b-TREATMENT
42631	at	O
42632	70	O
42633	mmhg	O
42634	.	O
42635	a	b-TEST
42636	parameter	i-TEST
42637	monitor	i-TEST
42638	for	O
42639	his	O
42640	neurologic	O
42641	status	O
42642	paco2	b-TEST
42643	which	O
42644	was	O
42645	maintained	b-TREATMENT
42646	between	O
42647	35	O
42648	and	O
42649	40	O
42650	during	O
42651	his	b-OCCURRENCE
42652	hospitalization	i-OCCURRENCE
42653	.	O
42654	mr.	O
42655	roach	O
42656	was	O
42657	kept	O
42658	sedated	b-TREATMENT
42659	with	O
42660	propofol	b-TREATMENT
42661	and	O
42662	was	O
42663	given	O
42664	fentanyl	b-TREATMENT
42665	and	O
42666	/	O
42667	or	O
42668	morphine	b-TREATMENT
42669	boluses	i-TREATMENT
42670	for	O
42671	pain	b-PROBLEM
42672	.	O
42673	neurologic	b-TEST
42674	checks	i-TEST
42675	were	O
42676	followed	O
42677	initially	O
42678	every	b-FREQUENCY
42679	one	i-FREQUENCY
42680	hour	i-FREQUENCY
42681	and	O
42682	then	O
42683	every	b-FREQUENCY
42684	two	i-FREQUENCY
42685	hours	i-FREQUENCY
42686	to	O
42687	monitor	O
42688	for	O
42689	change	b-PROBLEM
42690	in	i-PROBLEM
42691	neurologic	i-PROBLEM
42692	examination	i-PROBLEM
42693	.	O
42694	during	O
42695	his	b-OCCURRENCE
42696	hospitalization	i-OCCURRENCE
42697	,	O
42698	two	b-FREQUENCY
42699	subsequent	O
42700	cat	b-TEST
42701	scans	i-TEST
42702	were	O
42703	obtained	O
42704	;	O
42705	one	b-TEST
42706	on	O
42707	hospital	b-DATE
42708	day	i-DATE
42709	two	i-DATE
42710	.	O
42711	this	b-TEST
42712	cat	i-TEST
42713	scan	i-TEST
42714	revealed	b-EVIDENTIAL
42715	possible	O
42716	worsening	b-PROBLEM
42717	and	O
42718	was	O
42719	read	O
42720	as	O
42721	epidural	b-PROBLEM
42722	versus	O
42723	subdural	b-PROBLEM
42724	bleed	i-PROBLEM
42725	.	O
42726	after	O
42727	a	O
42728	discussion	O
42729	with	O
42730	both	O
42731	radiology	b-CLINICAL_DEPT
42732	and	O
42733	neurosurgery	b-CLINICAL_DEPT
42734	,	O
42735	the	b-OCCURRENCE
42736	decision	i-OCCURRENCE
42737	was	i-OCCURRENCE
42738	made	i-OCCURRENCE
42739	that	O
42740	the	b-PROBLEM
42741	worsening	i-PROBLEM
42742	did	O
42743	not	O
42744	appear	O
42745	significant	O
42746	,	O
42747	and	O
42748	this	b-PROBLEM
42749	was	O
42750	not	O
42751	accompanied	O
42752	by	O
42753	a	b-PROBLEM
42754	change	i-PROBLEM
42755	in	i-PROBLEM
42756	his	i-PROBLEM
42757	clinical	i-PROBLEM
42758	condition	i-PROBLEM
42759	.	O
42760	his	b-TEST
42761	intracranial	i-TEST
42762	pressure	i-TEST
42763	remained	O
42764	stable	b-OCCURRENCE
42765	,	O
42766	and	O
42767	his	b-TEST
42768	clinical	i-TEST
42769	examination	i-TEST
42770	was	O
42771	unchanged	b-OCCURRENCE
42772	.	O
42773	an	b-TEST
42774	additional	i-TEST
42775	ct	i-TEST
42776	scan	i-TEST
42777	was	O
42778	obtained	O
42779	on	O
42780	hospital	b-DATE
42781	day	i-DATE
42782	three	i-DATE
42783	.	O
42784	this	b-TEST
42785	examination	i-TEST
42786	was	O
42787	unchanged	b-OCCURRENCE
42788	from	O
42789	the	b-TEST
42790	previous	i-TEST
42791	examination	i-TEST
42792	.	O
42793	again	O
42794	,	O
42795	his	b-TEST
42796	intracranial	i-TEST
42797	pressure	i-TEST
42798	and	O
42799	neurologic	b-TEST
42800	examination	i-TEST
42801	remained	O
42802	the	b-OCCURRENCE
42803	same	i-OCCURRENCE
42804	,	O
42805	and	O
42806	conservative	b-TREATMENT
42807	treatment	i-TREATMENT
42808	was	O
42809	opted	O
42810	for	O
42811	.	O
42812	2.	O
42813	cardiovascular	O
42814	:	O
42815	as	O
42816	described	O
42817	in	O
42818	previous	O
42819	section	O
42820	,	O
42821	neo-synephrine	b-TREATMENT
42822	and	O
42823	eventually	O
42824	levophed	b-TREATMENT
42825	were	O
42826	used	O
42827	to	O
42828	maintain	b-OCCURRENCE
42829	a	b-TEST
42830	coronary	i-TEST
42831	perfusion	i-TEST
42832	pressure	i-TEST
42833	of	O
42834	greater	O
42835	than	O
42836	70	O
42837	.	O
42838	a	b-TREATMENT
42839	pulmonary	i-TREATMENT
42840	artery	i-TREATMENT
42841	catheter	i-TREATMENT
42842	was	O
42843	placed	O
42844	on	O
42845	hospital	b-DATE
42846	day	i-DATE
42847	four	i-DATE
42848	.	O
42849	this	b-TREATMENT
42850	catheter	i-TREATMENT
42851	was	O
42852	placed	O
42853	when	O
42854	the	O
42855	patient	O
42856	started	O
42857	to	O
42858	demonstrate	O
42859	septic	b-PROBLEM
42860	physiology	i-PROBLEM
42861	and	O
42862	for	O
42863	increasing	O
42864	pressor	b-TREATMENT
42865	support	i-TREATMENT
42866	.	O
42867	please	O
42868	see	O
42869	infectious	O
42870	disease	O
42871	section	O
42872	for	O
42873	more	O
42874	details	O
42875	.	O
42876	3.	O
42877	gastrointestinal	O
42878	:	O
42879	mr.	O
42880	roach	O
42881	was	O
42882	n.p.o.	b-TREATMENT
42883	from	O
42884	the	b-DATE
42885	time	i-DATE
42886	of	i-DATE
42887	his	i-DATE
42888	admission	i-DATE
42889	.	O
42890	a	b-TREATMENT
42891	orogastric	i-TREATMENT
42892	tube	i-TREATMENT
42893	was	O
42894	passed	O
42895	.	O
42896	initially	O
42897	during	O
42898	admission	b-OCCURRENCE
42899	,	O
42900	carafate	b-TREATMENT
42901	was	O
42902	given	O
42903	down	O
42904	the	b-TREATMENT
42905	orogastric	i-TREATMENT
42906	tube	i-TREATMENT
42907	.	O
42908	however	O
42909	,	O
42910	on	O
42911	a	b-TEST
42912	routine	i-TEST
42913	chest	i-TEST
42914	x-ray	i-TEST
42915	shot	O
42916	on	O
42917	hospital	b-DATE
42918	day	i-DATE
42919	three	i-DATE
42920	,	O
42921	a	b-PROBLEM
42922	mediastinum	i-PROBLEM
42923	was	O
42924	noted	O
42925	.	O
42926	this	b-PROBLEM
42927	raised	O
42928	the	O
42929	question	O
42930	of	O
42931	potential	O
42932	esophageal	b-PROBLEM
42933	rupture	i-PROBLEM
42934	.	O
42935	gastroenterology	b-CLINICAL_DEPT
42936	was	O
42937	consulted	O
42938	for	O
42939	this	b-PROBLEM
42940	.	O
42941	gastroenterology	b-CLINICAL_DEPT
42942	was	O
42943	consulted	O
42944	to	O
42945	assist	O
42946	in	O
42947	creating	O
42948	the	O
42949	most	O
42950	appropriate	O
42951	diagnostic	O
42952	rhythm	O
42953	given	O
42954	his	b-TREATMENT
42955	intubated	i-TREATMENT
42956	and	O
42957	sedated	b-TREATMENT
42958	status	O
42959	.	O
42960	at	O
42961	this	b-DATE
42962	point	i-DATE
42963	,	O
42964	his	b-TREATMENT
42965	carafate	i-TREATMENT
42966	was	O
42967	switched	O
42968	to	O
42969	intravenous	b-TREATMENT
42970	protonix	i-TREATMENT
42971	and	O
42972	he	O
42973	was	O
42974	strictly	b-TREATMENT
42975	n.p.o.	i-TREATMENT
42976	4.	O
42977	hematology	O
42978	:	O
42979	throughout	O
42980	mr.	O
42981	richard	O
42982	admission	b-OCCURRENCE
42983	,	O
42984	his	b-TEST
42985	hematocrit	i-TEST
42986	remained	O
42987	stable	b-OCCURRENCE
42988	in	O
42989	the	O
42990	low	O
42991	30s	O
42992	.	O
42993	as	O
42994	will	O
42995	be	O
42996	discussed	O
42997	in	O
42998	the	O
42999	infectious	O
43000	disease	O
43001	section	O
43002	,	O
43003	he	O
43004	developed	O
43005	an	O
43006	episode	O
43007	of	O
43008	what	O
43009	appeared	O
43010	to	O
43011	be	O
43012	sepsis	b-PROBLEM
43013	,	O
43014	and	O
43015	his	b-TEST
43016	white	i-TEST
43017	blood	i-TEST
43018	cell	i-TEST
43019	count	i-TEST
43020	peaked	O
43021	at	O
43022	23	O
43023	.	O
43024	mr.	O
43025	roach	O
43026	was	O
43027	on	O
43028	pneumo	b-TREATMENT
43029	boots	i-TREATMENT
43030	spontaneous	i-TREATMENT
43031	compression	i-TREATMENT
43032	devices	i-TREATMENT
43033	for	O
43034	deep	b-TREATMENT
43035	venous	i-TREATMENT
43036	thrombosis	i-TREATMENT
43037	prophylaxis	i-TREATMENT
43038	.	O
43039	he	O
43040	was	O
43041	not	O
43042	a	O
43043	candidate	O
43044	for	O
43045	subcutaneous	b-TREATMENT
43046	heparin	i-TREATMENT
43047	as	O
43048	we	O
43049	were	O
43050	concerned	O
43051	of	O
43052	an	b-PROBLEM
43053	intracranial	i-PROBLEM
43054	hemorrhage	i-PROBLEM
43055	.	O
43056	an	b-TREATMENT
43057	inferior	i-TREATMENT
43058	vena	i-TREATMENT
43059	cava	i-TREATMENT
43060	filter	i-TREATMENT
43061	was	O
43062	considered	O
43063	but	O
43064	was	O
43065	deferred	O
43066	,	O
43067	as	O
43068	it	O
43069	was	O
43070	felt	O
43071	that	O
43072	mr.	O
43073	roach	O
43074	was	O
43075	too	b-PROBLEM
43076	unstable	i-PROBLEM
43077	to	O
43078	undergo	O
43079	the	b-TREATMENT
43080	procedure	i-TREATMENT
43081	.	O
43082	5.	O
43083	endocrine	O
43084	:	O
43085	mr.	O
43086	marian	O
43087	blood	b-TEST
43088	sugar	i-TEST
43089	was	O
43090	maintained	b-TREATMENT
43091	under	O
43092	tight	O
43093	control	O
43094	from	O
43095	100	O
43096	to	O
43097	130	O
43098	using	O
43099	a	b-TREATMENT
43100	regular	i-TREATMENT
43101	insulin	i-TREATMENT
43102	sliding-scale	i-TREATMENT
43103	.	O
43104	6.	O
43105	infectious	O
43106	disease	O
43107	:	O
43108	mr.	O
43109	roach	O
43110	had	O
43111	a	b-PROBLEM
43112	spike	i-PROBLEM
43113	in	i-PROBLEM
43114	white	i-PROBLEM
43115	blood	i-PROBLEM
43116	cell	i-PROBLEM
43117	count	i-PROBLEM
43118	and	O
43119	developed	O
43120	fevers	b-PROBLEM
43121	.	O
43122	his	b-TEST
43123	blood	i-TEST
43124	urine	i-TEST
43125	and	O
43126	sputum	b-TEST
43127	were	O
43128	all	O
43129	cultured	b-TEST
43130	.	O
43131	blood	b-TEST
43132	cultures	i-TEST
43133	were	O
43134	pertinent	O
43135	for	O
43136	one	O
43137	bottle	O
43138	of	O
43139	gram	b-PROBLEM
43140	-	i-PROBLEM
43141	positive	i-PROBLEM
43142	coagulase	i-PROBLEM
43143	-	i-PROBLEM
43144	negative	i-PROBLEM
43145	staphylococcus	i-PROBLEM
43146	which	O
43147	grew	O
43148	from	O
43149	08-25	b-DATE
43150	.	O
43151	his	b-TEST
43152	preliminary	i-TEST
43153	cultures	i-TEST
43154	including	O
43155	sputum	O
43156	from	O
43157	08-25	b-DATE
43158	grew	O
43159	escherichia	b-PROBLEM
43160	coli	i-PROBLEM
43161	.	O
43162	sputum	b-TEST
43163	from	O
43164	08-27	b-DATE
43165	grew	O
43166	gram-negative	b-PROBLEM
43167	rods	i-PROBLEM
43168	,	O
43169	not	O
43170	yet	O
43171	speciated	O
43172	,	O
43173	and	O
43174	from	O
43175	08-27	b-DATE
43176	a	b-TEST
43177	bronchoalveolar	i-TEST
43178	lavage	i-TEST
43179	grew	O
43180	1+	b-PROBLEM
43181	gram-negative	i-PROBLEM
43182	rods	i-PROBLEM
43183	and	O
43184	4+	b-PROBLEM
43185	polymorphonuclear	i-PROBLEM
43186	lymphocytes	i-PROBLEM
43187	.	O
43188	throughout	O
43189	this	b-DURATION
43190	time	i-DURATION
43191	,	O
43192	mr.	O
43193	richard	O
43194	temperature	b-TEST
43195	continued	O
43196	to	O
43197	increase	O
43198	and	O
43199	was	O
43200	such	O
43201	that	O
43202	on	O
43203	hospital	b-DATE
43204	day	i-DATE
43205	four	i-DATE
43206	,	O
43207	his	b-TEST
43208	temperature	i-TEST
43209	maximum	i-TEST
43210	was	O
43211	42.2	O
43212	degrees	O
43213	centigrade	O
43214	.	O
43215	during	O
43216	his	b-OCCURRENCE
43217	hospitalization	i-OCCURRENCE
43218	,	O
43219	his	O
43220	was	O
43221	treated	O
43222	with	O
43223	vancomycin	b-TREATMENT
43224	for	O
43225	his	b-PROBLEM
43226	gram-negative	i-PROBLEM
43227	rods	i-PROBLEM
43228	,	O
43229	imipenem	b-TREATMENT
43230	,	O
43231	and	O
43232	flagyl	b-TREATMENT
43233	.	O
43234	initially	O
43235	,	O
43236	he	O
43237	had	O
43238	been	O
43239	placed	O
43240	on	O
43241	clindamycin	b-TREATMENT
43242	to	O
43243	cover	O
43244	his	b-TREATMENT
43245	drain	i-TREATMENT
43246	,	O
43247	but	O
43248	his	b-TEST
43249	cultures	i-TEST
43250	became	O
43251	positive	b-PROBLEM
43252	,	O
43253	and	O
43254	his	b-TEST
43255	white	i-TEST
43256	blood	i-TEST
43257	cell	i-TEST
43258	count	i-TEST
43259	increased	O
43260	.	O
43261	he	O
43262	was	O
43263	switched	O
43264	from	O
43265	clindamycin	b-TREATMENT
43266	to	O
43267	the	b-TREATMENT
43268	imipenem	i-TREATMENT
43269	and	O
43270	flagyl	b-TREATMENT
43271	.	O
43272	vancomycin	b-TREATMENT
43273	was	O
43274	added	O
43275	when	O
43276	we	O
43277	had	O
43278	the	b-PROBLEM
43279	positive	i-PROBLEM
43280	blood	i-PROBLEM
43281	culture	i-PROBLEM
43282	.	O
43283	with	O
43284	a	b-PROBLEM
43285	fever	i-PROBLEM
43286	of	O
43287	102	O
43288	,	O
43289	up	O
43290	to	O
43291	42	O
43292	degrees	O
43293	centigrade	O
43294	,	O
43295	aggressive	b-TREATMENT
43296	measures	i-TREATMENT
43297	including	O
43298	cooling	b-TREATMENT
43299	blankets	i-TREATMENT
43300	,	O
43301	alcohol	b-TREATMENT
43302	swabs	i-TREATMENT
43303	,	O
43304	and	O
43305	fans	b-TREATMENT
43306	were	O
43307	used	O
43308	in	O
43309	an	O
43310	attempt	O
43311	to	O
43312	bring	O
43313	his	b-TEST
43314	body	i-TEST
43315	temperature	i-TEST
43316	down	O
43317	.	O
43318	hypercarbia	b-PROBLEM
43319	would	O
43320	result	O
43321	and	O
43322	increase	b-PROBLEM
43323	in	i-PROBLEM
43324	cerebral	i-PROBLEM
43325	perfusion	i-PROBLEM
43326	,	O
43327	paralysis	b-TREATMENT
43328	was	O
43329	initiated	O
43330	to	O
43331	decrease	b-TREATMENT
43332	genesis	i-TREATMENT
43333	of	i-TREATMENT
43334	carbon	i-TREATMENT
43335	dioxide	i-TREATMENT
43336	secreted	i-TREATMENT
43337	during	O
43338	shivering	b-PROBLEM
43339	.	O
43340	7.	O
43341	pulmonary	O
43342	:	O
43343	as	O
43344	discussed	O
43345	in	O
43346	the	O
43347	infectious	O
43348	disease	O
43349	section	O
43350	,	O
43351	mr.	O
43352	roach	O
43353	developed	O
43354	a	b-PROBLEM
43355	pneumonia	i-PROBLEM
43356	likely	O
43357	from	O
43358	gram-negative	b-PROBLEM
43359	organisms	i-PROBLEM
43360	,	O
43361	but	O
43362	most	O
43363	likely	O
43364	from	O
43365	escherichia	b-PROBLEM
43366	coli	i-PROBLEM
43367	.	O
43368	for	O
43369	this	b-PROBLEM
43370	pneumonia	i-PROBLEM
43371	,	O
43372	he	O
43373	was	O
43374	placed	O
43375	empirically	O
43376	on	O
43377	imipenem	b-TREATMENT
43378	,	O
43379	vancomycin	b-TREATMENT
43380	,	O
43381	and	O
43382	flagyl	b-TREATMENT
43383	.	O
43384	on	O
43385	hospital	b-DATE
43386	day	i-DATE
43387	three	i-DATE
43388	,	O
43389	mr.	O
43390	roach	O
43391	had	O
43392	developed	O
43393	an	O
43394	episode	O
43395	of	O
43396	tachycardia	b-PROBLEM
43397	and	O
43398	tachypnea	b-PROBLEM
43399	.	O
43400	for	O
43401	this	b-TEST
43402	,	O
43403	a	b-TEST
43404	ct	i-TEST
43405	angiogram	i-TEST
43406	was	O
43407	obtained	O
43408	which	O
43409	demonstrated	b-EVIDENTIAL
43410	no	O
43411	pulmonary	b-PROBLEM
43412	embolism	i-PROBLEM
43413	.	O
43414	on	O
43415	hospital	b-DATE
43416	day	i-DATE
43417	four	i-DATE
43418	,	O
43419	a	b-TEST
43420	routine	i-TEST
43421	chest	i-TEST
43422	x-ray	i-TEST
43423	revealed	b-EVIDENTIAL
43424	a	b-PROBLEM
43425	left-sided	i-PROBLEM
43426	pneumothorax	i-PROBLEM
43427	.	O
43428	for	O
43429	this	b-PROBLEM
43430	,	O
43431	a	b-TREATMENT
43432	left	i-TREATMENT
43433	#34	i-TREATMENT
43434	caucasian	i-TREATMENT
43435	chest	i-TREATMENT
43436	tube	i-TREATMENT
43437	was	O
43438	placed	O
43439	.	O
43440	on	O
43441	the	b-DATE
43442	evening	i-DATE
43443	of	i-DATE
43444	hospital	i-DATE
43445	day	i-DATE
43446	four	i-DATE
43447	,	O
43448	mr.	O
43449	roach	O
43450	had	O
43451	an	b-PROBLEM
43452	acute	i-PROBLEM
43453	episode	i-PROBLEM
43454	whereby	O
43455	his	b-TEST
43456	central	i-TEST
43457	venous	i-TEST
43458	pressure	i-TEST
43459	rose	b-OCCURRENCE
43460	sharply	i-OCCURRENCE
43461	and	O
43462	immediately	O
43463	followed	O
43464	by	O
43465	a	O
43466	period	O
43467	of	O
43468	asystole	b-PROBLEM
43469	.	O
43470	urgent	b-TREATMENT
43471	resuscitation	i-TREATMENT
43472	measures	i-TREATMENT
43473	were	O
43474	initiated	O
43475	.	O
43476	the	b-TREATMENT
43477	measures	i-TREATMENT
43478	included	O
43479	attempts	O
43480	at	O
43481	pacing	b-TREATMENT
43482	.	O
43483	epinephrine	b-TREATMENT
43484	and	O
43485	atropine	b-TREATMENT
43486	were	O
43487	administered	O
43488	as	O
43489	were	O
43490	bicarbonate	b-TREATMENT
43491	and	O
43492	calcium	b-TREATMENT
43493	.	O
43494	he	O
43495	had	O
43496	a	O
43497	differential	O
43498	diagnosis	O
43499	of	O
43500	asystole	b-PROBLEM
43501	preceded	O
43502	by	O
43503	an	b-PROBLEM
43504	acute	i-PROBLEM
43505	rise	i-PROBLEM
43506	in	i-PROBLEM
43507	central	i-PROBLEM
43508	venous	i-PROBLEM
43509	pressure	i-PROBLEM
43510	included	O
43511	attention	b-PROBLEM
43512	pneumothorax	i-PROBLEM
43513	,	O
43514	cardiac	b-PROBLEM
43515	tamponade	i-PROBLEM
43516	,	O
43517	and	O
43518	pulmonary	b-PROBLEM
43519	embolism	i-PROBLEM
43520	.	O
43521	during	O
43522	the	b-TREATMENT
43523	resuscitation	i-TREATMENT
43524	afterwards	O
43525	,	O
43526	it	O
43527	was	O
43528	noted	O
43529	that	O
43530	a	b-TREATMENT
43531	patent	i-TREATMENT
43532	left	i-TREATMENT
43533	chest	i-TREATMENT
43534	tube	i-TREATMENT
43535	was	O
43536	present	O
43537	in	O
43538	the	O
43539	left	O
43540	chest	O
43541	,	O
43542	so	O
43543	initially	O
43544	neo-decompression	b-TREATMENT
43545	was	O
43546	attempted	O
43547	in	O
43548	the	O
43549	right	O
43550	chest	O
43551	.	O
43552	there	O
43553	was	O
43554	no	O
43555	sign	O
43556	of	O
43557	attention	b-PROBLEM
43558	pneumothorax	i-PROBLEM
43559	with	O
43560	decompression	b-PROBLEM
43561	,	O
43562	and	O
43563	a	b-TREATMENT
43564	right	i-TREATMENT
43565	chest	i-TREATMENT
43566	tube	i-TREATMENT
43567	was	O
43568	placed	O
43569	.	O
43570	during	O
43571	this	b-DATE
43572	time	i-DATE
43573	,	O
43574	a	b-TEST
43575	needle	i-TEST
43576	aspiration	i-TEST
43577	of	O
43578	what	O
43579	was	O
43580	felt	O
43581	to	O
43582	be	O
43583	the	O
43584	pericardium	O
43585	was	O
43586	performed	O
43587	revealing	b-EVIDENTIAL
43588	bloody	b-PROBLEM
43589	fluid	i-PROBLEM
43590	coming	O
43591	back	O
43592	.	O
43593	a	b-TREATMENT
43594	left	i-TREATMENT
43595	anterior	i-TREATMENT
43596	thoracotomy	i-TREATMENT
43597	was	O
43598	made	O
43599	by	O
43600	the	b-CLINICAL_DEPT
43601	cardiac	i-CLINICAL_DEPT
43602	surgery	i-CLINICAL_DEPT
43603	fellow	i-CLINICAL_DEPT
43604	who	O
43605	was	O
43606	present	O
43607	.	O
43608	after	O
43609	30	b-DURATION
43610	minutes	i-DURATION
43611	of	O
43612	active	b-TREATMENT
43613	resuscitation	i-TREATMENT
43614	including	O
43615	internal	b-TREATMENT
43616	cardiac	i-TREATMENT
43617	massage	i-TREATMENT
43618	,	O
43619	there	O
43620	was	O
43621	no	O
43622	evidence	O
43623	of	O
43624	return	O
43625	of	O
43626	vital	b-TEST
43627	signs	i-TEST
43628	or	O
43629	electric	b-TEST
43630	activity	i-TEST
43631	to	i-TEST
43632	the	i-TEST
43633	heart	i-TEST
43634	as	O
43635	noted	O
43636	on	O
43637	electrocardiogram	b-TEST
43638	monitors	i-TEST
43639	.	O
43640	resuscitation	b-TREATMENT
43641	was	O
43642	terminated	O
43643	at	O
43644	1914	b-TIME
43645	on	i-TIME
43646	08-27	i-TIME
43647	.	O
43648	after	O
43649	the	O
43650	termination	O
43651	of	O
43652	resuscitation	b-TREATMENT
43653	,	O
43654	both	O
43655	the	O
43656	anesthesia	O
43657	intensive	b-CLINICAL_DEPT
43658	care	i-CLINICAL_DEPT
43659	unit	i-CLINICAL_DEPT
43660	attending	O
43661	and	O
43662	the	b-CLINICAL_DEPT
43663	surgical	i-CLINICAL_DEPT
43664	attending	O
43665	were	O
43666	present	O
43667	to	O
43668	discuss	O
43669	the	O
43670	proceedings	O
43671	events	O
43672	with	O
43673	the	O
43674	patient	O
43675	's	O
43676	family	O
43677	members	O
43678	including	O
43679	his	O
43680	next	O
43681	of	O
43682	kin	O
43683	,	O
43684	his	O
43685	mother	O
43686	.	O
43687	permission	O
43688	for	O
43689	a	b-TEST
43690	postmortem	i-TEST
43691	examination	i-TEST
43692	was	O
43693	granted	O
43694	.	O
43695	matthew	O
43696	m.	O
43697	barnett	O
43698	,	O
43699	md	O
43700	78-102	O
43701	dictated	O
43702	by	O
43703	:	O
43704	mark	O
43705	d.	O
43706	eng	O
43707	,	O
43708	md	O
43709	medquist36	O
43710	d	O
43711	:	O
43712	2013-08-28	O
43713	00:21	O
43714	t	O
43715	:	O
43716	2013-09-03	O
43717	11:11	O
43718	job	O
43719	#	O
43720	:	O
43721	24887	O
43722	signed	O
43723	electronically	O
43724	by	O
43725	:	O
43726	doctor	O
43727	katherin	O
43728	toth	O
43729	on	O
43730	:	O
43731	mon	O
43732	2013-10-14	O
43733	3:05	O
43734	pm	O
43735	(	O
43736	end	O
43737	of	O
43738	report	O
43739	)	O
43740		O
43741	admission	b-OCCURRENCE
43742	date	O
43743	:	O
43744		O
43745	04/21/1994	b-ADMISSION
43746		O
43747	discharge	b-OCCURRENCE
43748	date	O
43749	:	O
43750		O
43751	04/29/1994	b-DISCHARGE
43752		O
43753	history	O
43754	of	O
43755	present	O
43756	illness	O
43757	:	O
43758		O
43759	patient	O
43760	is	O
43761	an	O
43762	88	O
43763	year	O
43764	old	O
43765	female	O
43766	with	O
43767	fatigue	b-PROBLEM
43768	and	O
43769	decreased	b-PROBLEM
43770	short	i-PROBLEM
43771	term	i-PROBLEM
43772	memory	i-PROBLEM
43773	for	O
43774	the	O
43775	past	O
43776	six	b-DURATION
43777	months	i-DURATION
43778	.	O
43779		O
43780	the	O
43781	past	O
43782	six	b-DURATION
43783	weeks	i-DURATION
43784	,	O
43785	she	O
43786	has	O
43787	also	O
43788	been	O
43789	complaining	b-EVIDENTIAL
43790	of	O
43791	hot	b-PROBLEM
43792	sensation	i-PROBLEM
43793	and	O
43794	tingling	b-PROBLEM
43795	sensation	i-PROBLEM
43796	in	i-PROBLEM
43797	the	i-PROBLEM
43798	hands	i-PROBLEM
43799	bilaterally	i-PROBLEM
43800	.	O
43801		O
43802	for	O
43803	the	O
43804	past	O
43805	five	b-DURATION
43806	weeks	i-DURATION
43807	,	O
43808	the	O
43809	patient	O
43810	has	O
43811	experienced	O
43812	dragging	b-PROBLEM
43813	of	i-PROBLEM
43814	the	i-PROBLEM
43815	right	i-PROBLEM
43816	leg	i-PROBLEM
43817	with	O
43818	weakness	b-PROBLEM
43819	throughout	O
43820	that	O
43821	side	O
43822	.	O
43823		O
43824	head	b-TEST
43825	ct	i-TEST
43826	was	O
43827	done	O
43828	which	O
43829	patient	O
43830	reported	b-EVIDENTIAL
43831	demonstrated	b-EVIDENTIAL
43832	three	b-PROBLEM
43833	lesions	i-PROBLEM
43834	in	i-PROBLEM
43835	the	i-PROBLEM
43836	left	i-PROBLEM
43837	parietal	i-PROBLEM
43838	region	i-PROBLEM
43839	of	O
43840	the	O
43841	brain	O
43842	.	O
43843		O
43844	bone	b-TEST
43845	scan	i-TEST
43846	,	O
43847	ct	b-TEST
43848	of	i-TEST
43849	the	i-TEST
43850	abdomen	i-TEST
43851	,	O
43852	chest	b-TEST
43853	x-ray	i-TEST
43854	,	O
43855	and	O
43856	mammogram	b-TEST
43857	were	O
43858	all	O
43859	negative	b-EVIDENTIAL
43860	.	O
43861		O
43862	patient	O
43863	noted	b-EVIDENTIAL
43864	the	b-PROBLEM
43865	foot	i-PROBLEM
43866	dragging	i-PROBLEM
43867	to	O
43868	have	O
43869	worsened	b-OCCURRENCE
43870	over	O
43871	the	O
43872	past	O
43873	few	b-DURATION
43874	weeks	i-DURATION
43875	but	O
43876	improved	b-OCCURRENCE
43877	since	O
43878	on	O
43879	decadron	b-TREATMENT
43880	the	b-DURATION
43881	past	i-DURATION
43882	week	i-DURATION
43883	before	O
43884	admission	b-OCCURRENCE
43885	.	O
43886		O
43887	patient	O
43888	is	O
43889	now	O
43890	admitted	b-OCCURRENCE
43891	for	O
43892	elective	b-TEST
43893	left	i-TEST
43894	parietal	i-TEST
43895	stereotactic	i-TEST
43896	biopsy	i-TEST
43897	of	O
43898	the	b-PROBLEM
43899	tumor	i-PROBLEM
43900	.	O
43901		O
43902	past	O
43903	medical	O
43904	/	O
43905	surgical	O
43906	history	O
43907	:	O
43908		O
43909	significant	O
43910	for	O
43911	a	O
43912	history	O
43913	of	O
43914	hypertension	b-PROBLEM
43915	,	O
43916	basal	b-PROBLEM
43917	cell	i-PROBLEM
43918	carcinoma	i-PROBLEM
43919	of	i-PROBLEM
43920	the	i-PROBLEM
43921	nose	i-PROBLEM
43922	six	O
43923	years	O
43924	ago	O
43925	,	O
43926	cataracts	b-PROBLEM
43927	,	O
43928	and	O
43929	a	b-TREATMENT
43930	hysterectomy	i-TREATMENT
43931	.	O
43932		O
43933	allergies	O
43934	:	O
43935		O
43936	no	O
43937	known	b-PROBLEM
43938	drug	i-PROBLEM
43939	allergies	i-PROBLEM
43940	.	O
43941		O
43942	current	O
43943	medications	O
43944	:	O
43945		O
43946	hydrochlorothiazide	b-TREATMENT
43947	25	O
43948	mg	O
43949	q.d.	b-FREQUENCY
43950	and	O
43951	decadron	b-TREATMENT
43952	25	O
43953	mg	O
43954	b.i.d.	b-FREQUENCY
43955		O
43956	hospital	O
43957	course	O
43958	:	O
43959		O
43960	patient	O
43961	was	O
43962	taken	O
43963	to	O
43964	the	b-CLINICAL_DEPT
43965	operating	i-CLINICAL_DEPT
43966	room	i-CLINICAL_DEPT
43967	on	O
43968	april	b-DATE
43969	21	i-DATE
43970	where	O
43971	patient	O
43972	underwent	O
43973	a	b-TEST
43974	left	i-TEST
43975	parietal	i-TEST
43976	stereotactic	i-TEST
43977	guided	i-TEST
43978	brain	i-TEST
43979	biopsy	i-TEST
43980	.	O
43981		O
43982	patient	O
43983	tolerated	b-OCCURRENCE
43984	the	b-TEST
43985	procedure	i-TEST
43986	well	O
43987	without	O
43988	any	b-PROBLEM
43989	complications	i-PROBLEM
43990	and	O
43991	was	O
43992	taken	O
43993	to	O
43994	the	b-CLINICAL_DEPT
43995	recovery	i-CLINICAL_DEPT
43996	room	i-CLINICAL_DEPT
43997	awake	b-OCCURRENCE
43998	and	i-OCCURRENCE
43999	stable	i-OCCURRENCE
44000	then	O
44001	subsequently	O
44002	transferred	b-OCCURRENCE
44003	to	O
44004	the	b-CLINICAL_DEPT
44005	floor	i-CLINICAL_DEPT
44006	.	O
44007		O
44008	patient	O
44009	did	O
44010	well	b-OCCURRENCE
44011	post-operatively	O
44012	,	O
44013	continued	O
44014	to	O
44015	have	O
44016	a	b-PROBLEM
44017	right	i-PROBLEM
44018	sided	i-PROBLEM
44019	deficit	i-PROBLEM
44020	,	O
44021	and	O
44022	physical	b-CLINICAL_DEPT
44023	therapy	i-CLINICAL_DEPT
44024	and	O
44025	occupational	b-CLINICAL_DEPT
44026	therapy	i-CLINICAL_DEPT
44027	visited	O
44028	the	O
44029	patient	O
44030	,	O
44031	worked	b-TREATMENT
44032	with	O
44033	the	O
44034	patient	O
44035	,	O
44036	and	O
44037	determined	b-OCCURRENCE
44038	that	O
44039	patient	O
44040	needed	O
44041	rehabilitation	b-TREATMENT
44042	with	O
44043	physical	b-CLINICAL_DEPT
44044	therapy	i-CLINICAL_DEPT
44045	.	i-CLINICAL_DEPT
44046		O
44047	the	O
44048	patient	O
44049	was	O
44050	evaluated	b-TEST
44051	by	O
44052	doing	O
44053	and	O
44054	was	O
44055	subsequently	O
44056	accepted	b-OCCURRENCE
44057	into	i-OCCURRENCE
44058	that	i-OCCURRENCE
44059	program	i-OCCURRENCE
44060	.	O
44061		O
44062	patient	O
44063	is	O
44064	now	O
44065	discharged	b-OCCURRENCE
44066	to	O
44067	harl	b-CLINICAL_DEPT
44068	wa	i-CLINICAL_DEPT
44069	healthcare	i-CLINICAL_DEPT
44070	network	i-CLINICAL_DEPT
44071	on	O
44072	april	b-DATE
44073	29	i-DATE
44074	,	i-DATE
44075	1994	i-DATE
44076	in	O
44077	stable	b-OCCURRENCE
44078	condition	i-OCCURRENCE
44079	.	O
44080		O
44081		O
44082	admission	b-OCCURRENCE
44083	date	O
44084	:	O
44085	08/05/98	b-ADMISSION
44086	discharge	b-OCCURRENCE
44087	date	O
44088	:	O
44089	08/07/98	b-DISCHARGE
44090	history	O
44091	of	O
44092	present	O
44093	illness	O
44094	:	O
44095	miss	O
44096	siehjesc	O
44097	is	O
44098	an	O
44099	85-year-old	O
44100	woman	O
44101	with	O
44102	a	O
44103	past	O
44104	medical	O
44105	history	O
44106	significant	O
44107	for	O
44108	parkinson	b-PROBLEM
44109	's	i-PROBLEM
44110	disease	i-PROBLEM
44111	of	O
44112	ten	b-DURATION
44113	years	i-DURATION
44114	duration	O
44115	,	O
44116	supraventricular	b-PROBLEM
44117	tachycardia	i-PROBLEM
44118	,	O
44119	and	O
44120	a	O
44121	history	O
44122	of	O
44123	colon	b-PROBLEM
44124	carcinoma	i-PROBLEM
44125	,	O
44126	who	O
44127	was	O
44128	in	O
44129	her	b-EVIDENTIAL
44130	usual	i-EVIDENTIAL
44131	state	i-EVIDENTIAL
44132	of	i-EVIDENTIAL
44133	health	i-EVIDENTIAL
44134	until	O
44135	11:30	b-TIME
44136	on	i-TIME
44137	the	i-TIME
44138	morning	i-TIME
44139	of	O
44140	admission	O
44141	when	O
44142	she	O
44143	felt	O
44144	the	O
44145	acute	O
44146	on	O
44147	set	O
44148	of	O
44149	5	O
44150	out	O
44151	of	O
44152	10	O
44153	right	b-PROBLEM
44154	sided	i-PROBLEM
44155	chest	i-PROBLEM
44156	pain	i-PROBLEM
44157	with	O
44158	radiation	b-PROBLEM
44159	to	i-PROBLEM
44160	her	i-PROBLEM
44161	sternum	i-PROBLEM
44162	but	O
44163	not	O
44164	to	O
44165	her	O
44166	neck	O
44167	or	O
44168	arms	O
44169	or	O
44170	back	O
44171	.	O
44172	it	O
44173	was	O
44174	not	O
44175	relieved	O
44176	by	O
44177	2	b-TREATMENT
44178	sublingual	i-TREATMENT
44179	nitroglycerins	i-TREATMENT
44180	.	O
44181	she	O
44182	did	O
44183	state	b-EVIDENTIAL
44184	that	O
44185	she	O
44186	experienced	O
44187	some	b-PROBLEM
44188	shortness	i-PROBLEM
44189	of	i-PROBLEM
44190	breath	i-PROBLEM
44191	(	O
44192	her	O
44193	usual	O
44194	anginal	O
44195	equivalent	O
44196	)	O
44197	and	O
44198	believes	O
44199	she	O
44200	did	O
44201	experience	O
44202	some	b-PROBLEM
44203	lightheadedness	i-PROBLEM
44204	as	O
44205	well	O
44206	,	O
44207	but	O
44208	denies	O
44209	blacking	b-PROBLEM
44210	out	i-PROBLEM
44211	or	O
44212	falling	b-PROBLEM
44213	.	O
44214	while	O
44215	the	b-PROBLEM
44216	pain	i-PROBLEM
44217	was	O
44218	initially	O
44219	intermittent	O
44220	,	O
44221	it	O
44222	became	O
44223	steady	b-OCCURRENCE
44224	at	O
44225	about	O
44226	1:00	b-TIME
44227	p.m.	i-TIME
44228	at	O
44229	which	b-TIME
44230	time	i-TIME
44231	she	O
44232	presented	b-OCCURRENCE
44233	to	O
44234	the	b-CLINICAL_DEPT
44235	tecal	i-CLINICAL_DEPT
44236	galecounxopt	i-CLINICAL_DEPT
44237	community	i-CLINICAL_DEPT
44238	hospital	i-CLINICAL_DEPT
44239	emergency	i-CLINICAL_DEPT
44240	room	i-CLINICAL_DEPT
44241	and	O
44242	following	O
44243	this	O
44244	experience	O
44245	a	O
44246	spontaneous	O
44247	remission	O
44248	of	O
44249	her	b-PROBLEM
44250	right	i-PROBLEM
44251	sided	i-PROBLEM
44252	pain	i-PROBLEM
44253	.	O
44254	since	O
44255	that	b-TIME
44256	time	i-TIME
44257	she	O
44258	has	O
44259	experience	O
44260	occasional	b-PROBLEM
44261	episodes	i-PROBLEM
44262	of	O
44263	the	b-PROBLEM
44264	same	i-PROBLEM
44265	focal	i-PROBLEM
44266	chest	i-PROBLEM
44267	pain	i-PROBLEM
44268	but	O
44269	finds	O
44270	that	O
44271	it	O
44272	spontaneously	O
44273	remits	O
44274	.	O
44275	it	O
44276	is	O
44277	made	O
44278	better	O
44279	by	O
44280	direct	b-TREATMENT
44281	pressure	i-TREATMENT
44282	to	i-TREATMENT
44283	the	i-TREATMENT
44284	point	i-TREATMENT
44285	and	O
44286	she	O
44287	recalls	O
44288	no	O
44289	factors	b-OCCURRENCE
44290	which	O
44291	worsened	O
44292	it	O
44293	.	O
44294	she	O
44295	is	O
44296	admitted	b-OCCURRENCE
44297	to	O
44298	rule	O
44299	out	O
44300	myocardial	b-PROBLEM
44301	infarction	i-PROBLEM
44302	.	O
44303	hospital	O
44304	course	O
44305	and	O
44306	treatment	O
44307	:	O
44308	the	O
44309	patient	O
44310	proceeded	O
44311	to	O
44312	rule	O
44313	out	O
44314	formyocardial	b-PROBLEM
44315	infarction	i-PROBLEM
44316	by	O
44317	enzymes	b-TEST
44318	.	O
44319	additionally	O
44320	,	O
44321	the	O
44322	patient	O
44323	underwent	O
44324	a	b-TEST
44325	exercise	i-TEST
44326	stress	i-TEST
44327	test	i-TEST
44328	on	O
44329	8/6/98	b-DATE
44330	with	O
44331	a	b-TEST
44332	heart	i-TEST
44333	rate	i-TEST
44334	proceeding	O
44335	from	O
44336	76	O
44337	to	O
44338	93	O
44339	beats	O
44340	per	O
44341	minute	O
44342	.	O
44343	there	O
44344	were	O
44345	no	O
44346	electrocardiogram	b-PROBLEM
44347	changes	i-PROBLEM
44348	noted	O
44349	and	O
44350	there	O
44351	were	O
44352	no	O
44353	arrhythmias	b-PROBLEM
44354	noted	O
44355	as	O
44356	well	O
44357	.	O
44358	during	O
44359	the	b-TEST
44360	test	i-TEST
44361	the	O
44362	patient	O
44363	experienced	O
44364	no	O
44365	chest	b-PROBLEM
44366	pressure	i-PROBLEM
44367	or	O
44368	pain	b-PROBLEM
44369	or	O
44370	dyspnea	b-PROBLEM
44371	and	O
44372	nuclear	b-TEST
44373	medical	i-TEST
44374	imaging	i-TEST
44375	was	O
44376	without	O
44377	evidence	O
44378	of	O
44379	ischemia	b-PROBLEM
44380	.	O
44381	the	O
44382	patient	O
44383	was	O
44384	in	O
44385	this	O
44386	fashion	O
44387	discharged	b-OCCURRENCE
44388	from	O
44389	the	b-CLINICAL_DEPT
44390	service	i-CLINICAL_DEPT
44391	to	O
44392	continue	O
44393	on	O
44394	her	b-TREATMENT
44395	current	i-TREATMENT
44396	medications	i-TREATMENT
44397	and	O
44398	to	O
44399	call	O
44400	in	O
44401	oneweek	b-DATE
44402	to	O
44403	follow	b-OCCURRENCE
44404	up	O
44405	with	O
44406	doctor	O
44407	sterpbreutzsterp	O
44408	and	O
44409	cardiology	b-CLINICAL_DEPT
44410	.	O
44411	the	O
44412	patient	O
44413	already	O
44414	had	O
44415	a	b-OCCURRENCE
44416	follow	i-OCCURRENCE
44417	up	i-OCCURRENCE
44418	appointment	i-OCCURRENCE
44419	with	O
44420	doctor	O
44421	sterpbreutzsterp	O
44422	in	O
44423	three	b-DATE
44424	weeks	i-DATE
44425	,	O
44426	and	O
44427	was	O
44428	instructed	O
44429	to	O
44430	keep	O
44431	that	O
44432	appointment	O
44433	.	O
44434		O
44435	admission	b-OCCURRENCE
44436	date	O
44437	:	O
44438	05/12/2000	b-ADMISSION
44439	discharge	b-OCCURRENCE
44440	date	O
44441	:	O
44442	05/20/2000	b-DISCHARGE
44443	history	O
44444	of	O
44445	present	O
44446	illness	O
44447	:	O
44448	provided	O
44449	in	O
44450	the	O
44451	house	O
44452	staff	O
44453	note	O
44454	from	O
44455	the	b-DATE
44456	admission	i-DATE
44457	date	i-DATE
44458	.	O
44459	briefly	O
44460	this	O
44461	is	O
44462	a	O
44463	hispanic	O
44464	patient	O
44465	with	O
44466	history	O
44467	of	O
44468	advanced	b-PROBLEM
44469	lung	i-PROBLEM
44470	cancer	i-PROBLEM
44471	,	O
44472	small	b-PROBLEM
44473	cell	i-PROBLEM
44474	in	O
44475	histology	O
44476	.	O
44477	the	O
44478	patient	O
44479	presented	b-OCCURRENCE
44480	with	O
44481	almost	b-PROBLEM
44482	a	i-PROBLEM
44483	stridor	i-PROBLEM
44484	and	O
44485	a	b-PROBLEM
44486	large	i-PROBLEM
44487	mediastinal	i-PROBLEM
44488	mass	i-PROBLEM
44489	with	O
44490	shortness	b-PROBLEM
44491	of	i-PROBLEM
44492	breath	i-PROBLEM
44493	.	O
44494	he	O
44495	was	O
44496	transferred	b-OCCURRENCE
44497	to	O
44498	the	b-CLINICAL_DEPT
44499	oncology	i-CLINICAL_DEPT
44500	service	i-CLINICAL_DEPT
44501	after	O
44502	discussions	O
44503	about	O
44504	the	O
44505	utility	O
44506	of	O
44507	chemotherapy	b-TREATMENT
44508	.	O
44509	hospital	O
44510	course	O
44511	:	O
44512	in	O
44513	the	b-CLINICAL_DEPT
44514	oncology	i-CLINICAL_DEPT
44515	floor	i-CLINICAL_DEPT
44516	he	O
44517	received	O
44518	carboplatin	b-TREATMENT
44519	and	O
44520	etoposide	b-TREATMENT
44521	to	O
44522	which	O
44523	he	O
44524	reacted	O
44525	well	O
44526	.	O
44527	there	O
44528	were	O
44529	no	O
44530	major	b-PROBLEM
44531	issues	i-PROBLEM
44532	and	O
44533	he	O
44534	was	O
44535	discharged	b-OCCURRENCE
44536	home	O
44537	on	O
44538	5/20/00	b-DATE
44539	.	O
44540	________________________	O
44541	maren	O
44542	tlandflent	O
44543	,	O
44544	md	O
44545	electronically	O
44546	signed	O
44547	maren	O
44548	stea	O
44549	tlandflent	O
44550	,	O
44551	md	O
44552	07/15/2000	O
44553	21:36	O
44554	tr	O
44555	:	O
44556	se	O
44557	dd	O
44558	:	O
44559	07/06/2000	O
44560	td	O
44561	:	O
44562	07/11/2000	O
44563	12:44	O
44564	p	O
44565	cc	O
44566	:	O
44567	maren	O
44568	stea	O
44569	tlandflent	O
44570	,	O
44571	md	O
44572		O
44573	admission	b-OCCURRENCE
44574	date	O
44575	:	O
44576	2017-04-26	b-ADMISSION
44577	discharge	b-OCCURRENCE
44578	date	O
44579	:	O
44580	2017-05-01	b-DISCHARGE
44581	service	O
44582	:	O
44583	card	O
44584	cmed	O
44585	history	O
44586	of	O
44587	present	O
44588	illness	O
44589	:	O
44590	this	O
44591	is	O
44592	a	O
44593	62	O
44594	year	O
44595	old	O
44596	gentleman	O
44597	who	O
44598	underwent	O
44599	an	b-TEST
44600	exercise	i-TEST
44601	treadmill	i-TEST
44602	test	i-TEST
44603	for	O
44604	screening	O
44605	through	O
44606	the	b-CLINICAL_DEPT
44607	beth	i-CLINICAL_DEPT
44608	israel	i-CLINICAL_DEPT
44609	deaconess	i-CLINICAL_DEPT
44610	hospital-needham	i-CLINICAL_DEPT
44611	clinic	i-CLINICAL_DEPT
44612	.	O
44613	the	b-TEST
44614	test	i-TEST
44615	was	O
44616	positive	O
44617	for	O
44618	ekg	b-PROBLEM
44619	changes	i-PROBLEM
44620	and	O
44621	shortness	b-PROBLEM
44622	of	i-PROBLEM
44623	breath	i-PROBLEM
44624	.	O
44625	the	O
44626	patient	O
44627	has	O
44628	no	O
44629	history	O
44630	of	O
44631	chest	b-PROBLEM
44632	pain;	i-PROBLEM
44633	no	O
44634	history	O
44635	of	O
44636	myocardial	b-PROBLEM
44637	infarction	i-PROBLEM
44638	.	O
44639	the	O
44640	patient	O
44641	was	O
44642	referred	O
44643	to	O
44644	cambridge	b-CLINICAL_DEPT
44645	health	i-CLINICAL_DEPT
44646	alliance	i-CLINICAL_DEPT
44647	for	O
44648	cardiac	b-TEST
44649	catheterization	i-TEST
44650	.	O
44651	cardiac	b-TEST
44652	catheterization	i-TEST
44653	showed	b-EVIDENTIAL
44654	an	b-TEST
44655	ejection	i-TEST
44656	fraction	i-TEST
44657	of	O
44658	50%	O
44659	,	O
44660	left	b-TEST
44661	ventricular	i-TEST
44662	end	i-TEST
44663	diastolic	i-TEST
44664	pressure	i-TEST
44665	of	O
44666	20	O
44667	,	O
44668	90%	b-PROBLEM
44669	left	i-PROBLEM
44670	anterior	i-PROBLEM
44671	descending	i-PROBLEM
44672	lesion	i-PROBLEM
44673	,	O
44674	80%	b-PROBLEM
44675	left	i-PROBLEM
44676	circumflex	i-PROBLEM
44677	lesion	i-PROBLEM
44678	,	O
44679	80%	b-PROBLEM
44680	mid	i-PROBLEM
44681	right	i-PROBLEM
44682	coronary	i-PROBLEM
44683	artery	i-PROBLEM
44684	lesion	i-PROBLEM
44685	and	O
44686	80%	b-PROBLEM
44687	distal	i-PROBLEM
44688	right	i-PROBLEM
44689	coronary	i-PROBLEM
44690	artery	i-PROBLEM
44691	lesion	i-PROBLEM
44692	.	O
44693	the	O
44694	patient	O
44695	was	O
44696	referred	O
44697	to	O
44698	doctor	O
44699	rota	O
44700	for	O
44701	coronary	b-TREATMENT
44702	artery	i-TREATMENT
44703	bypass	i-TREATMENT
44704	grafting	i-TREATMENT
44705	.	O
44706	hospital	O
44707	course	O
44708	:	O
44709	the	O
44710	patient	O
44711	was	O
44712	admitted	b-OCCURRENCE
44713	to	O
44714	saint	b-CLINICAL_DEPT
44715	vincent	i-CLINICAL_DEPT
44716	hospital	i-CLINICAL_DEPT
44717	on	O
44718	2017-04-26	b-DATE
44719	and	O
44720	underwent	O
44721	a	b-TREATMENT
44722	coronary	i-TREATMENT
44723	artery	i-TREATMENT
44724	bypass	i-TREATMENT
44725	graft	i-TREATMENT
44726	times	b-FREQUENCY
44727	four	i-FREQUENCY
44728	with	O
44729	left	b-TREATMENT
44730	internal	i-TREATMENT
44731	mammary	i-TREATMENT
44732	artery	i-TREATMENT
44733	to	i-TREATMENT
44734	left	i-TREATMENT
44735	anterior	i-TREATMENT
44736	descending	i-TREATMENT
44737	,	O
44738	saphenous	b-TREATMENT
44739	vein	i-TREATMENT
44740	graft	i-TREATMENT
44741	to	i-TREATMENT
44742	right	i-TREATMENT
44743	coronary	i-TREATMENT
44744	artery	i-TREATMENT
44745	,	O
44746	saphenous	b-TREATMENT
44747	vein	i-TREATMENT
44748	graft	i-TREATMENT
44749	to	i-TREATMENT
44750	pda	i-TREATMENT
44751	and	O
44752	saphenous	b-TREATMENT
44753	vein	i-TREATMENT
44754	graft	i-TREATMENT
44755	to	i-TREATMENT
44756	obtuse	i-TREATMENT
44757	marginal	i-TREATMENT
44758	with	O
44759	doctor	O
44760	rota	O
44761	.	O
44762	please	O
44763	see	O
44764	the	O
44765	operative	O
44766	note	O
44767	for	O
44768	further	O
44769	details	O
44770	.	O
44771	the	O
44772	patient	O
44773	was	O
44774	transferred	b-OCCURRENCE
44775	to	O
44776	the	b-CLINICAL_DEPT
44777	intensive	i-CLINICAL_DEPT
44778	care	i-CLINICAL_DEPT
44779	unit	i-CLINICAL_DEPT
44780	in	O
44781	stable	b-OCCURRENCE
44782	condition	i-OCCURRENCE
44783	on	O
44784	neo-synephrine	b-TREATMENT
44785	infusion	i-TREATMENT
44786	.	O
44787	the	O
44788	patient	O
44789	was	O
44790	weaned	b-OCCURRENCE
44791	the	b-DATE
44792	next	i-DATE
44793	day	i-DATE
44794	from	O
44795	mechanical	b-TREATMENT
44796	ventilation	i-TREATMENT
44797	on	O
44798	his	b-DATE
44799	first	i-DATE
44800	postoperative	i-DATE
44801	night	i-DATE
44802	.	O
44803	postoperative	b-DURATION
44804	days	i-DURATION
44805	one	i-DURATION
44806	and	i-DURATION
44807	two	i-DURATION
44808	,	O
44809	the	O
44810	patient	O
44811	continued	O
44812	to	O
44813	require	O
44814	neo-synephrine	b-TREATMENT
44815	to	O
44816	maintain	O
44817	systolic	b-TEST
44818	blood	i-TEST
44819	pressures	i-TEST
44820	greater	O
44821	than	O
44822	100	O
44823	.	O
44824	on	O
44825	postoperative	b-DATE
44826	day	i-DATE
44827	two	i-DATE
44828	,	O
44829	the	b-TEST
44830	patient	i-TEST
44831	's	i-TEST
44832	hematocrit	i-TEST
44833	was	O
44834	noted	O
44835	to	O
44836	be	O
44837	23.1	O
44838	;	O
44839	he	O
44840	was	O
44841	transfused	b-TREATMENT
44842	one	O
44843	unit	O
44844	of	O
44845	packed	b-TREATMENT
44846	red	i-TREATMENT
44847	blood	i-TREATMENT
44848	cells	i-TREATMENT
44849	as	O
44850	well	O
44851	as	O
44852	given	O
44853	a	O
44854	dose	O
44855	of	O
44856	lasix	b-TREATMENT
44857	.	O
44858	the	b-TREATMENT
44859	neo-synephrine	i-TREATMENT
44860	was	O
44861	weaned	b-OCCURRENCE
44862	off	O
44863	by	O
44864	postoperative	b-DATE
44865	day	i-DATE
44866	number	i-DATE
44867	three	i-DATE
44868	.	O
44869	the	b-TREATMENT
44870	patient	i-TREATMENT
44871	's	i-TREATMENT
44872	chest	i-TREATMENT
44873	tubes	i-TREATMENT
44874	were	O
44875	removed	O
44876	on	O
44877	postoperative	b-DATE
44878	day	i-DATE
44879	three	i-DATE
44880	without	O
44881	incident	b-PROBLEM
44882	.	O
44883	the	O
44884	patient	O
44885	was	O
44886	started	O
44887	on	O
44888	low	b-TREATMENT
44889	dose	i-TREATMENT
44890	lasix	i-TREATMENT
44891	and	O
44892	lopressor	b-TREATMENT
44893	which	O
44894	he	O
44895	tolerated	O
44896	well	O
44897	.	O
44898	on	O
44899	postoperative	b-DATE
44900	day	i-DATE
44901	number	i-DATE
44902	four	i-DATE
44903	,	O
44904	the	O
44905	patient	O
44906	was	O
44907	transferred	b-OCCURRENCE
44908	from	O
44909	the	b-CLINICAL_DEPT
44910	intensive	i-CLINICAL_DEPT
44911	care	i-CLINICAL_DEPT
44912	unit	i-CLINICAL_DEPT
44913	to	O
44914	the	b-CLINICAL_DEPT
44915	regular	i-CLINICAL_DEPT
44916	part	i-CLINICAL_DEPT
44917	of	i-CLINICAL_DEPT
44918	the	i-CLINICAL_DEPT
44919	hospital	i-CLINICAL_DEPT
44920	where	O
44921	he	O
44922	began	O
44923	working	O
44924	with	O
44925	physical	b-CLINICAL_DEPT
44926	therapy	i-CLINICAL_DEPT
44927	and	O
44928	on	O
44929	his	b-TREATMENT
44930	first	i-TREATMENT
44931	session	i-TREATMENT
44932	he	O
44933	was	O
44934	able	O
44935	to	O
44936	ambulate	b-OCCURRENCE
44937	500	O
44938	feet	O
44939	and	O
44940	climb	b-OCCURRENCE
44941	one	i-OCCURRENCE
44942	flight	i-OCCURRENCE
44943	of	i-OCCURRENCE
44944	stairs	i-OCCURRENCE
44945	while	O
44946	remaining	O
44947	hemodynamically	b-OCCURRENCE
44948	stable	i-OCCURRENCE
44949	without	O
44950	requiring	O
44951	any	b-TREATMENT
44952	oxygen	i-TREATMENT
44953	.	O
44954	on	O
44955	postoperative	b-DATE
44956	day	i-DATE
44957	number	i-DATE
44958	five	i-DATE
44959	,	O
44960	the	O
44961	patient	O
44962	continued	O
44963	to	O
44964	remain	O
44965	hemodynamically	b-OCCURRENCE
44966	stable	i-OCCURRENCE
44967	.	O
44968	the	b-TREATMENT
44969	patient	i-TREATMENT
44970	's	i-TREATMENT
44971	epicardial	i-TREATMENT
44972	pacing	i-TREATMENT
44973	wires	i-TREATMENT
44974	were	O
44975	removed	b-OCCURRENCE
44976	without	O
44977	incident	b-PROBLEM
44978	and	O
44979	the	O
44980	patient	O
44981	was	O
44982	cleared	O
44983	for	O
44984	discharge	b-OCCURRENCE
44985	to	i-OCCURRENCE
44986	home	i-OCCURRENCE
44987	.	O
44988		O
44989	admission	b-OCCURRENCE
44990	date	O
44991	:	O
44992	2-5-94	b-DATE
44993	discharge	b-OCCURRENCE
44994	date	O
44995	:	O
44996	4-2-94	b-DATE
44997	history	O
44998	of	O
44999	present	O
45000	illness	O
45001	:	O
45002	the	O
45003	patient	O
45004	was	O
45005	a	O
45006	71	O
45007	year	O
45008	old	O
45009	white	O
45010	female	O
45011	with	O
45012	a	O
45013	history	O
45014	of	O
45015	carcinoid	b-PROBLEM
45016	lung	i-PROBLEM
45017	cancer	i-PROBLEM
45018	who	O
45019	presented	b-OCCURRENCE
45020	for	O
45021	evaluation	b-TEST
45022	of	O
45023	a	b-PROBLEM
45024	tracheoesophageal	i-PROBLEM
45025	fistula	i-PROBLEM
45026	.	O
45027	the	O
45028	patient	O
45029	was	O
45030	initially	O
45031	diagnosed	O
45032	in	O
45033	1978	b-DATE
45034	with	O
45035	atypical	b-PROBLEM
45036	small	i-PROBLEM
45037	cell	i-PROBLEM
45038	carcinoma	i-PROBLEM
45039	of	i-PROBLEM
45040	the	i-PROBLEM
45041	lung	i-PROBLEM
45042	and	O
45043	treated	O
45044	with	O
45045	chemotherapy	b-TREATMENT
45046	and	O
45047	radiation	b-TREATMENT
45048	therapy	i-TREATMENT
45049	until	O
45050	1980	b-DATE
45051	.	O
45052	she	O
45053	did	b-OCCURRENCE
45054	well	i-OCCURRENCE
45055	for	O
45056	approximately	O
45057	twelve	b-DURATION
45058	years	i-DURATION
45059	until	O
45060	she	O
45061	was	O
45062	diagnosed	b-OCCURRENCE
45063	with	O
45064	carcinoid	b-PROBLEM
45065	cancer	i-PROBLEM
45066	of	i-PROBLEM
45067	the	i-PROBLEM
45068	same	i-PROBLEM
45069	right	i-PROBLEM
45070	upper	i-PROBLEM
45071	lobe	i-PROBLEM
45072	.	O
45073	this	O
45074	may	O
45075	have	O
45076	been	O
45077	the	b-PROBLEM
45078	initial	i-PROBLEM
45079	primary	i-PROBLEM
45080	cancer	i-PROBLEM
45081	although	O
45082	it	O
45083	is	O
45084	unclear	O
45085	at	O
45086	present	b-DATE
45087	.	O
45088	bronchoscopy	b-TEST
45089	at	O
45090	that	b-DATE
45091	time	i-DATE
45092	showed	b-EVIDENTIAL
45093	an	b-PROBLEM
45094	endobronchial	i-PROBLEM
45095	tumor	i-PROBLEM
45096	of	i-PROBLEM
45097	the	i-PROBLEM
45098	right	i-PROBLEM
45099	upper	i-PROBLEM
45100	lobe	i-PROBLEM
45101	bronchus	i-PROBLEM
45102	and	O
45103	it	O
45104	was	O
45105	felt	O
45106	to	O
45107	be	O
45108	unresectable	O
45109	.	O
45110	she	O
45111	underwent	O
45112	four	b-TREATMENT
45113	treatments	i-TREATMENT
45114	of	O
45115	brachytherapy	b-TREATMENT
45116	in	O
45117	march	b-DURATION
45118	through	i-DURATION
45119	may	i-DURATION
45120	of	i-DURATION
45121	1993	i-DURATION
45122	.	O
45123	she	O
45124	had	O
45125	been	O
45126	doing	b-OCCURRENCE
45127	reasonably	i-OCCURRENCE
45128	well	i-OCCURRENCE
45129	until	O
45130	december	b-DATE
45131	of	i-DATE
45132	1993	i-DATE
45133	when	O
45134	she	O
45135	presented	b-OCCURRENCE
45136	with	O
45137	persistent	b-PROBLEM
45138	and	i-PROBLEM
45139	worsening	i-PROBLEM
45140	cough	i-PROBLEM
45141	and	O
45142	near	b-PROBLEM
45143	strangulation	i-PROBLEM
45144	on	O
45145	attempts	O
45146	at	O
45147	eating	O
45148	solids	O
45149	or	O
45150	drinking	O
45151	liquids	O
45152	.	O
45153	a	b-TEST
45154	bronchoscopy	i-TEST
45155	showed	b-OCCURRENCE
45156	a	b-PROBLEM
45157	tracheoesophageal	i-PROBLEM
45158	fistula	i-PROBLEM
45159	with	O
45160	an	O
45161	opening	O
45162	into	O
45163	the	O
45164	trachea	O
45165	above	O
45166	the	O
45167	carina	O
45168	and	O
45169	no	O
45170	tumor	b-PROBLEM
45171	in	i-PROBLEM
45172	the	i-PROBLEM
45173	right	i-PROBLEM
45174	upper	i-PROBLEM
45175	lobe	i-PROBLEM
45176	.	O
45177	she	O
45178	has	O
45179	been	O
45180	on	O
45181	total	b-TREATMENT
45182	parenteral	i-TREATMENT
45183	nutrition	i-TREATMENT
45184	and	O
45185	has	O
45186	been	O
45187	nothing	b-TREATMENT
45188	by	i-TREATMENT
45189	mouth	i-TREATMENT
45190	since	O
45191	then	b-DURATION
45192	.	O
45193	a	b-TEST
45194	barium	i-TEST
45195	swallow	i-TEST
45196	prior	O
45197	to	O
45198	admission	b-OCCURRENCE
45199	showed	b-EVIDENTIAL
45200	the	O
45201	presence	O
45202	of	O
45203	a	b-PROBLEM
45204	tracheoesophageal	i-PROBLEM
45205	fistula	i-PROBLEM
45206	with	O
45207	entrance	O
45208	into	O
45209	the	O
45210	right	O
45211	mainstem	O
45212	bronchus	O
45213	below	O
45214	the	O
45215	carina	O
45216	.	O
45217	hospital	O
45218	course	O
45219	:	O
45220	the	O
45221	patient	O
45222	was	O
45223	admitted	b-OCCURRENCE
45224	on	O
45225	february	b-DATE
45226	5	i-DATE
45227	,	i-DATE
45228	1994	i-DATE
45229	and	O
45230	had	O
45231	a	b-TREATMENT
45232	central	i-TREATMENT
45233	venous	i-TREATMENT
45234	line	i-TREATMENT
45235	placed	O
45236	in	O
45237	her	O
45238	right	O
45239	subclavian	O
45240	.	O
45241	the	O
45242	patient	O
45243	was	O
45244	brought	O
45245	to	O
45246	the	b-CLINICAL_DEPT
45247	operating	i-CLINICAL_DEPT
45248	room	i-CLINICAL_DEPT
45249	on	O
45250	february	b-DATE
45251	6	i-DATE
45252	,	i-DATE
45253	1994	i-DATE
45254	where	O
45255	she	O
45256	underwent	O
45257	rigid	b-TEST
45258	and	i-TEST
45259	flexible	i-TEST
45260	bronchoscopy	i-TEST
45261	and	O
45262	upper	b-TEST
45263	gastrointestinal	i-TEST
45264	endoscopy	i-TEST
45265	.	O
45266	findings	O
45267	included	O
45268	necrotic	b-PROBLEM
45269	debris	i-PROBLEM
45270	in	i-PROBLEM
45271	the	i-PROBLEM
45272	distal	i-PROBLEM
45273	trachea	i-PROBLEM
45274	at	O
45275	the	O
45276	carina	O
45277	and	O
45278	right	O
45279	mainstem	O
45280	bronchus	O
45281	.	O
45282	esophageal	O
45283	mucosa	O
45284	was	O
45285	visible	O
45286	through	O
45287	the	O
45288	trachea	O
45289	.	O
45290	her	b-TREATMENT
45291	steroids	i-TREATMENT
45292	were	O
45293	weaned	O
45294	and	O
45295	the	O
45296	patient	O
45297	was	O
45298	brought	O
45299	to	O
45300	the	b-CLINICAL_DEPT
45301	operating	i-CLINICAL_DEPT
45302	room	i-CLINICAL_DEPT
45303	on	O
45304	february	b-DATE
45305	10	i-DATE
45306	,	i-DATE
45307	1994	i-DATE
45308	where	O
45309	she	O
45310	underwent	O
45311	once	O
45312	again	O
45313	flexible	b-TEST
45314	bronchoscopy	i-TEST
45315	and	O
45316	flexible	b-TEST
45317	esophagoscopy	i-TEST
45318	,	O
45319	as	O
45320	well	O
45321	as	O
45322	rigid	b-TEST
45323	bronchoscopy	i-TEST
45324	.	O
45325	she	O
45326	then	O
45327	had	O
45328	a	b-TREATMENT
45329	transhiatal	i-TREATMENT
45330	esophagectomy	i-TREATMENT
45331	which	O
45332	was	O
45333	partial	O
45334	,	O
45335	and	O
45336	a	b-TREATMENT
45337	substernal	i-TREATMENT
45338	gastric	i-TREATMENT
45339	interposition	i-TREATMENT
45340	as	O
45341	well	O
45342	as	O
45343	a	b-TREATMENT
45344	jejunostomy	i-TREATMENT
45345	.	O
45346	the	b-TEST
45347	pathology	i-TEST
45348	report	i-TEST
45349	suggested	b-EVIDENTIAL
45350	that	O
45351	the	O
45352	area	O
45353	was	O
45354	involved	O
45355	with	O
45356	radiation	b-PROBLEM
45357	esophagitis	i-PROBLEM
45358	and	O
45359	focal	b-PROBLEM
45360	ulceration	i-PROBLEM
45361	.	O
45362	she	O
45363	remained	O
45364	ventilator	b-PROBLEM
45365	dependent	i-PROBLEM
45366	postoperatively	O
45367	and	O
45368	was	O
45369	taken	O
45370	to	O
45371	the	b-CLINICAL_DEPT
45372	respiratory	i-CLINICAL_DEPT
45373	intensive	i-CLINICAL_DEPT
45374	care	i-CLINICAL_DEPT
45375	unit	i-CLINICAL_DEPT
45376	.	O
45377	the	O
45378	patient	O
45379	was	O
45380	maintained	O
45381	on	O
45382	triple	b-TREATMENT
45383	antibiotics	i-TREATMENT
45384	which	O
45385	included	O
45386	vancomycin	b-TREATMENT
45387	,	O
45388	ceftazidime	b-TREATMENT
45389	and	O
45390	gentamicin	b-TREATMENT
45391	.	O
45392	on	O
45393	postoperative	b-DATE
45394	day	i-DATE
45395	two	i-DATE
45396	,	O
45397	she	O
45398	had	O
45399	an	b-TEST
45400	electroencephalogram	i-TEST
45401	which	O
45402	showed	b-EVIDENTIAL
45403	no	O
45404	evidence	O
45405	of	O
45406	seizure	b-PROBLEM
45407	activity	i-PROBLEM
45408	but	O
45409	some	b-PROBLEM
45410	generalized	i-PROBLEM
45411	slowing	i-PROBLEM
45412	.	O
45413	the	O
45414	patient	O
45415	was	O
45416	seen	O
45417	in	O
45418	consultation	O
45419	by	O
45420	the	b-CLINICAL_DEPT
45421	neurology	i-CLINICAL_DEPT
45422	service	i-CLINICAL_DEPT
45423	for	O
45424	her	b-PROBLEM
45425	apparent	i-PROBLEM
45426	postoperative	i-PROBLEM
45427	encephalopathy	i-PROBLEM
45428	and	O
45429	episodes	O
45430	of	O
45431	shaking	b-PROBLEM
45432	.	O
45433	an	b-TEST
45434	endoscopy	i-TEST
45435	was	O
45436	also	O
45437	performed	O
45438	on	O
45439	postoperative	b-DATE
45440	day	i-DATE
45441	two	i-DATE
45442	which	O
45443	showed	b-EVIDENTIAL
45444	clean	O
45445	anastomosis	b-TREATMENT
45446	.	O
45447	she	O
45448	received	O
45449	multiple	b-TEST
45450	bronchoscopies	i-TEST
45451	for	O
45452	pulmonary	b-TREATMENT
45453	toilet	i-TREATMENT
45454	.	O
45455	the	O
45456	patient	O
45457	was	O
45458	maintained	O
45459	on	O
45460	tube	b-TREATMENT
45461	feedings	i-TREATMENT
45462	and	O
45463	the	b-TREATMENT
45464	ventilator	i-TREATMENT
45465	.	O
45466	a	b-TEST
45467	repeat	i-TEST
45468	echocardiogram	i-TEST
45469	on	O
45470	february	b-DATE
45471	18	i-DATE
45472	showed	b-EVIDENTIAL
45473	no	O
45474	significant	b-PROBLEM
45475	change	i-PROBLEM
45476	of	O
45477	her	b-TEST
45478	previous	i-TEST
45479	echocardiogram	i-TEST
45480	on	O
45481	february	b-DATE
45482	11	i-DATE
45483	,	O
45484	which	O
45485	showed	b-EVIDENTIAL
45486	only	O
45487	a	b-PROBLEM
45488	small	i-PROBLEM
45489	pericardial	i-PROBLEM
45490	effusion	i-PROBLEM
45491	.	O
45492	a	b-TEST
45493	pelvic	i-TEST
45494	and	i-TEST
45495	abdominal	i-TEST
45496	computerized	i-TEST
45497	tomography	i-TEST
45498	scan	i-TEST
45499	on	O
45500	february	b-DATE
45501	18	i-DATE
45502	also	O
45503	showed	b-EVIDENTIAL
45504	no	O
45505	evidence	O
45506	of	O
45507	a	b-PROBLEM
45508	focal	i-PROBLEM
45509	collection	i-PROBLEM
45510	or	O
45511	abscess	b-PROBLEM
45512	.	O
45513	she	O
45514	remained	O
45515	intermittently	b-PROBLEM
45516	febrile	i-PROBLEM
45517	despite	O
45518	numerous	b-TREATMENT
45519	antibiotics	i-TREATMENT
45520	.	O
45521	her	b-TEST
45522	chest	i-TEST
45523	x-ray	i-TEST
45524	showed	b-EVIDENTIAL
45525	bilateral	b-PROBLEM
45526	air	i-PROBLEM
45527	space	i-PROBLEM
45528	disease	i-PROBLEM
45529	,	O
45530	consistent	O
45531	with	O
45532	pneumonia	b-PROBLEM
45533	or	O
45534	adult	b-PROBLEM
45535	respiratory	i-PROBLEM
45536	distress	i-PROBLEM
45537	syndrome	i-PROBLEM
45538	.	O
45539	she	O
45540	suffered	O
45541	an	O
45542	episode	O
45543	of	O
45544	renal	b-PROBLEM
45545	failure	i-PROBLEM
45546	which	O
45547	was	O
45548	felt	O
45549	attributable	O
45550	to	O
45551	aminoglycoside	b-PROBLEM
45552	toxicity	i-PROBLEM
45553	.	O
45554	her	b-TREATMENT
45555	steroids	i-TREATMENT
45556	were	O
45557	weaned	b-OCCURRENCE
45558	.	O
45559	because	O
45560	of	O
45561	her	b-TREATMENT
45562	prolonged	i-TREATMENT
45563	intubation	i-TREATMENT
45564	and	O
45565	inability	b-PROBLEM
45566	to	i-PROBLEM
45567	wean	i-PROBLEM
45568	,	O
45569	on	O
45570	february	b-DATE
45571	24	i-DATE
45572	,	i-DATE
45573	1994	i-DATE
45574	,	O
45575	she	O
45576	had	O
45577	a	b-TREATMENT
45578	tracheostomy	i-TREATMENT
45579	placed	O
45580	.	O
45581	she	O
45582	remained	O
45583	in	O
45584	a	b-PROBLEM
45585	coma	i-PROBLEM
45586	.	O
45587	the	b-TEST
45588	blood	i-TEST
45589	cultures	i-TEST
45590	on	O
45591	february	b-DATE
45592	26	i-DATE
45593	,	i-DATE
45594	1994	i-DATE
45595	grew	O
45596	out	O
45597	staphylococcus	b-PROBLEM
45598	and	O
45599	she	O
45600	was	O
45601	treated	O
45602	for	O
45603	septicemia	b-PROBLEM
45604	.	O
45605	her	b-TEST
45606	sputum	i-TEST
45607	grew	O
45608	out	O
45609	pseudomonas	b-PROBLEM
45610	aeruginosa	i-PROBLEM
45611	as	O
45612	well	O
45613	.	O
45614	the	b-TEST
45615	urine	i-TEST
45616	contained	O
45617	yeast	b-PROBLEM
45618	and	O
45619	she	O
45620	was	O
45621	treated	O
45622	with	O
45623	amphotericin	b-TREATMENT
45624	.	O
45625	on	O
45626	march	b-DATE
45627	3	i-DATE
45628	,	i-DATE
45629	1994	i-DATE
45630	,	O
45631	a	b-TEST
45632	repeat	i-TEST
45633	chest	i-TEST
45634	and	i-TEST
45635	abdominal	i-TEST
45636	and	i-TEST
45637	pelvis	i-TEST
45638	computerized	i-TEST
45639	tomography	i-TEST
45640	scan	i-TEST
45641	showed	b-EVIDENTIAL
45642	no	O
45643	evidence	O
45644	of	O
45645	fluid	b-PROBLEM
45646	collections	i-PROBLEM
45647	.	O
45648	there	O
45649	was	O
45650	a	b-PROBLEM
45651	large	i-PROBLEM
45652	left	i-PROBLEM
45653	pleural	i-PROBLEM
45654	effusion	i-PROBLEM
45655	however	O
45656	.	O
45657	this	O
45658	was	O
45659	drained	O
45660	with	O
45661	a	b-TREATMENT
45662	left	i-TREATMENT
45663	chest	i-TREATMENT
45664	tube	i-TREATMENT
45665	.	O
45666	her	b-TEST
45667	sputum	i-TEST
45668	then	O
45669	grew	O
45670	out	O
45671	klebsiella	b-PROBLEM
45672	and	O
45673	she	O
45674	was	O
45675	treated	O
45676	with	O
45677	amikacin	b-TREATMENT
45678	and	O
45679	imipenem	b-TREATMENT
45680	.	O
45681	she	O
45682	developed	O
45683	a	b-PROBLEM
45684	right	i-PROBLEM
45685	pleural	i-PROBLEM
45686	effusion	i-PROBLEM
45687	and	O
45688	had	O
45689	a	b-TREATMENT
45690	right	i-TREATMENT
45691	chest	i-TREATMENT
45692	tube	i-TREATMENT
45693	placed	O
45694	.	O
45695	on	O
45696	march	b-DATE
45697	13	i-DATE
45698	,	i-DATE
45699	1994	i-DATE
45700	,	O
45701	she	O
45702	regained	O
45703	some	b-OCCURRENCE
45704	level	i-OCCURRENCE
45705	of	i-OCCURRENCE
45706	consciousness	i-OCCURRENCE
45707	.	O
45708	she	O
45709	was	O
45710	able	O
45711	to	O
45712	fix	O
45713	and	O
45714	follow	O
45715	with	O
45716	her	O
45717	eyes	O
45718	,	O
45719	respond	O
45720	to	O
45721	commands	O
45722	.	O
45723	on	O
45724	march	b-DATE
45725	14	i-DATE
45726	,	i-DATE
45727	1994	i-DATE
45728	,	O
45729	her	O
45730	right	O
45731	lung	O
45732	was	O
45733	pleurodesed	b-TREATMENT
45734	.	O
45735	attempts	O
45736	were	O
45737	made	O
45738	to	O
45739	facilitate	O
45740	her	b-TREATMENT
45741	wean	i-TREATMENT
45742	by	O
45743	resting	O
45744	her	b-DURATION
45745	overnight	i-DURATION
45746	with	O
45747	a	O
45748	combination	O
45749	of	O
45750	propafol	b-TREATMENT
45751	and	O
45752	fentanyl	b-TREATMENT
45753	.	O
45754	this	O
45755	was	O
45756	tried	O
45757	for	O
45758	approximately	O
45759	seven	b-DURATION
45760	days	i-DURATION
45761	with	O
45762	no	O
45763	real	b-OCCURRENCE
45764	progress	i-OCCURRENCE
45765	made	O
45766	toward	O
45767	facilitating	O
45768	her	b-TREATMENT
45769	vent	i-TREATMENT
45770	wean	i-TREATMENT
45771	.	O
45772	she	O
45773	continued	O
45774	to	O
45775	require	O
45776	pressor	b-TREATMENT
45777	support	i-TREATMENT
45778	in	O
45779	the	O
45780	high	O
45781	30	O
45782	&apos;s	O
45783	.	O
45784	she	O
45785	also	O
45786	fell	O
45787	into	O
45788	a	b-PROBLEM
45789	coma	i-PROBLEM
45790	once	O
45791	again	O
45792	.	O
45793	on	O
45794	march	b-DATE
45795	31	i-DATE
45796	,	i-DATE
45797	1994	i-DATE
45798	,	O
45799	her	b-PROBLEM
45800	pressor	i-PROBLEM
45801	support	i-PROBLEM
45802	requirement	i-PROBLEM
45803	increased	O
45804	and	O
45805	she	O
45806	continued	O
45807	to	O
45808	have	O
45809	tachypneic	b-PROBLEM
45810	episodes	i-PROBLEM
45811	.	O
45812	on	O
45813	april	b-DATE
45814	2	i-DATE
45815	,	i-DATE
45816	1994	i-DATE
45817	,	O
45818	she	O
45819	had	O
45820	several	O
45821	episodes	O
45822	of	O
45823	bradycardia	b-PROBLEM
45824	and	O
45825	asystole	b-PROBLEM
45826	,	O
45827	which	O
45828	responded	O
45829	only	O
45830	to	O
45831	manual	b-TREATMENT
45832	ventilation	i-TREATMENT
45833	.	O
45834	discussions	O
45835	were	O
45836	held	O
45837	with	O
45838	the	O
45839	patient	O
45840	&apos;s	O
45841	family	O
45842	with	O
45843	regard	O
45844	to	O
45845	her	O
45846	previously	O
45847	expressed	O
45848	wishes	O
45849	not	O
45850	to	O
45851	be	O
45852	maintained	O
45853	on	O
45854	artificial	b-TREATMENT
45855	life	i-TREATMENT
45856	support	i-TREATMENT
45857	for	O
45858	extended	O
45859	period	O
45860	of	O
45861	time	O
45862	with	O
45863	little	O
45864	or	O
45865	no	O
45866	hope	O
45867	for	O
45868	recovery	O
45869	.	O
45870	she	O
45871	had	O
45872	expressed	O
45873	these	O
45874	wishes	O
45875	in	O
45876	writing	O
45877	on	O
45878	several	O
45879	legal	O
45880	forms	O
45881	from	O
45882	the	O
45883	state	O
45884	of	O
45885	jose	O
45886	pineston	O
45887	,	O
45888	as	O
45889	well	O
45890	as	O
45891	in	O
45892	discussions	O
45893	with	O
45894	her	O
45895	loved	O
45896	ones	O
45897	.	O
45898	decision	O
45899	was	O
45900	made	O
45901	in	O
45902	conjunction	O
45903	with	O
45904	the	O
45905	family	O
45906	and	O
45907	doctor	O
45908	caslighlourdes	O
45909	to	O
45910	terminate	O
45911	artificial	b-TREATMENT
45912	respiratory	i-TREATMENT
45913	support	i-TREATMENT
45914	.	O
45915	the	O
45916	patient	O
45917	was	O
45918	removed	O
45919	from	O
45920	the	b-TREATMENT
45921	ventilator	i-TREATMENT
45922	and	O
45923	placed	O
45924	on	O
45925	a	b-TREATMENT
45926	t-piece	i-TREATMENT
45927	in	i-TREATMENT
45928	her	i-TREATMENT
45929	trachea	i-TREATMENT
45930	only	O
45931	and	O
45932	was	O
45933	made	O
45934	comfortable	O
45935	with	O
45936	narcotics	b-TREATMENT
45937	.	O
45938	her	b-TEST
45939	respirations	i-TEST
45940	ceased	O
45941	and	O
45942	she	O
45943	died	b-OCCURRENCE
45944	at	O
45945	10:15	b-TIME
45946	a.m.	i-TIME
45947	on	i-TIME
45948	april	i-TIME
45949	2	i-TIME
45950	,	i-TIME
45951	1994	i-TIME
45952	.	O
45953		O
45954	admission	b-OCCURRENCE
45955	date	O
45956	:	O
45957	02/08/1990	b-ADMISSION
45958	discharge	b-OCCURRENCE
45959	date	O
45960	:	O
45961	02/13/1990	b-DISCHARGE
45962	history	O
45963	of	O
45964	present	O
45965	illness	O
45966	:	O
45967	the	O
45968	patient	O
45969	is	O
45970	a	O
45971	43-year-old	O
45972	gravida	b-OCCURRENCE
45973	ii	i-OCCURRENCE
45974	para	i-OCCURRENCE
45975	ii	i-OCCURRENCE
45976	white	O
45977	female	O
45978	referred	b-OCCURRENCE
45979	by	O
45980	doctor	O
45981	ca	O
45982	shuff	O
45983	for	O
45984	evaluation	b-TEST
45985	.	O
45986	she	O
45987	was	O
45988	in	O
45989	her	b-OCCURRENCE
45990	usual	i-OCCURRENCE
45991	state	i-OCCURRENCE
45992	of	i-OCCURRENCE
45993	good	i-OCCURRENCE
45994	health	i-OCCURRENCE
45995	until	O
45996	december	b-DATE
45997	when	O
45998	she	O
45999	was	O
46000	seen	b-OCCURRENCE
46001	emergently	i-OCCURRENCE
46002	for	O
46003	treatment	b-TREATMENT
46004	of	O
46005	a	b-PROBLEM
46006	perforated	i-PROBLEM
46007	colon	i-PROBLEM
46008	cancer	i-PROBLEM
46009	.	O
46010	that	O
46011	area	O
46012	was	O
46013	resected	b-TREATMENT
46014	with	O
46015	no	O
46016	evidence	b-EVIDENTIAL
46017	of	O
46018	metastatic	b-PROBLEM
46019	disease	i-PROBLEM
46020	.	O
46021	she	O
46022	has	O
46023	had	O
46024	subsequent	b-TEST
46025	cea&apos;s	i-TEST
46026	and	O
46027	scans	b-TEST
46028	which	O
46029	were	O
46030	negative	b-EVIDENTIAL
46031	.	O
46032	a	b-PROBLEM
46033	tumor	i-PROBLEM
46034	was	O
46035	noted	b-EVIDENTIAL
46036	on	O
46037	her	O
46038	vulva	O
46039	which	O
46040	was	O
46041	biopsied	b-TEST
46042	and	O
46043	revealed	b-EVIDENTIAL
46044	squamous	b-PROBLEM
46045	cell	i-PROBLEM
46046	carcinoma	i-PROBLEM
46047	in	i-PROBLEM
46048	situ	i-PROBLEM
46049	.	O
46050	allergies	O
46051	:	O
46052	no	O
46053	known	b-PROBLEM
46054	drug	i-PROBLEM
46055	allergies	i-PROBLEM
46056	.	O
46057	medications	O
46058	:	O
46059	none	O
46060	.	O
46061	past	O
46062	surgical	O
46063	history	O
46064	:	O
46065	as	O
46066	above	O
46067	with	O
46068	colostomy	b-TREATMENT
46069	.	O
46070	hospital	O
46071	course	O
46072	:	O
46073	the	O
46074	plan	O
46075	was	O
46076	for	O
46077	right	b-TREATMENT
46078	radical	i-TREATMENT
46079	vulvectomy	i-TREATMENT
46080	.	O
46081	1.	O
46082	vulvectomy	b-TREATMENT
46083	:	O
46084	the	O
46085	patient	O
46086	on	O
46087	2/8/90	b-DATE
46088	underwent	O
46089	a	b-TREATMENT
46090	right	i-TREATMENT
46091	radical	i-TREATMENT
46092	vulvectomy	i-TREATMENT
46093	with	O
46094	excellent	b-OCCURRENCE
46095	results	i-OCCURRENCE
46096	and	O
46097	negative	b-OCCURRENCE
46098	margins	i-OCCURRENCE
46099	on	O
46100	frozen	b-TEST
46101	section	i-TEST
46102	.	O
46103	her	b-OCCURRENCE
46104	postoperative	i-OCCURRENCE
46105	course	i-OCCURRENCE
46106	was	O
46107	unremarkble	b-OCCURRENCE
46108	.	O
46109	she	O
46110	was	O
46111	kept	O
46112	on	O
46113	bedrest	b-TREATMENT
46114	for	O
46115	two	b-DURATION
46116	days	i-DURATION
46117	and	O
46118	then	O
46119	was	O
46120	ambulating	b-OCCURRENCE
46121	and	O
46122	voiding	b-OCCURRENCE
46123	well	i-OCCURRENCE
46124	without	O
46125	trouble	b-PROBLEM
46126	on	O
46127	postoperative	b-DATE
46128	day	i-DATE
46129	number	i-DATE
46130	three	i-DATE
46131	when	O
46132	the	b-TREATMENT
46133	foley	i-TREATMENT
46134	catheter	i-TREATMENT
46135	was	O
46136	discontinued	b-OCCURRENCE
46137	.	O
46138	she	O
46139	has	O
46140	been	O
46141	doing	O
46142	betadine	b-TREATMENT
46143	paint	i-TREATMENT
46144	and	O
46145	blow	b-TREATMENT
46146	drying	i-TREATMENT
46147	the	O
46148	area	O
46149	several	b-FREQUENCY
46150	times	i-FREQUENCY
46151	a	i-FREQUENCY
46152	day	i-FREQUENCY
46153	and	O
46154	after	O
46155	each	O
46156	bowel	b-OCCURRENCE
46157	movement	i-OCCURRENCE
46158	and	O
46159	urine	b-OCCURRENCE
46160	without	O
46161	incident	b-PROBLEM
46162	.	O
46163		O
46164	admission	b-OCCURRENCE
46165	date	O
46166	:	O
46167	5-3-93	b-DATE
46168	discharge	b-OCCURRENCE
46169	date	O
46170	:	O
46171	5-12-93	b-DATE
46172	history	O
46173	of	O
46174	present	O
46175	illness	O
46176	:	O
46177	mr.	O
46178	stain	O
46179	was	O
46180	transferred	b-OCCURRENCE
46181	from	O
46182	the	b-CLINICAL_DEPT
46183	oreiewlefell	i-CLINICAL_DEPT
46184	merkane	i-CLINICAL_DEPT
46185	i	i-CLINICAL_DEPT
46186	penaltbridgesgreat	i-CLINICAL_DEPT
46187	university	i-CLINICAL_DEPT
46188	medical	i-CLINICAL_DEPT
46189	center	i-CLINICAL_DEPT
46190	for	O
46191	progressive	b-PROBLEM
46192	respiratory	i-PROBLEM
46193	failure	i-PROBLEM
46194	and	O
46195	adult	b-PROBLEM
46196	respiratory	i-PROBLEM
46197	distress	i-PROBLEM
46198	syndrome	i-PROBLEM
46199	superimposed	O
46200	on	O
46201	a	O
46202	history	O
46203	of	O
46204	chronic	b-PROBLEM
46205	obstructive	i-PROBLEM
46206	pulmonary	i-PROBLEM
46207	disease	i-PROBLEM
46208	,	O
46209	perhaps	O
46210	asthma	b-PROBLEM
46211	,	O
46212	and	O
46213	ulcerative	b-PROBLEM
46214	colitis	i-PROBLEM
46215	.	O
46216	his	O
46217	only	O
46218	positive	O
46219	result	O
46220	was	O
46221	a	b-TEST
46222	sputum	i-TEST
46223	culture	i-TEST
46224	for	O
46225	pseudomonas	b-PROBLEM
46226	and	O
46227	this	O
46228	came	O
46229	after	O
46230	he	O
46231	had	O
46232	already	O
46233	been	O
46234	on	O
46235	antibiotics	b-TREATMENT
46236	.	O
46237	hospital	O
46238	course	O
46239	:	O
46240	the	O
46241	patient	O
46242	was	O
46243	seen	O
46244	in	O
46245	consultation	b-OCCURRENCE
46246	by	O
46247	doctor	O
46248	wire	O
46249	who	O
46250	felt	O
46251	that	O
46252	manipulation	b-TREATMENT
46253	of	i-TREATMENT
46254	the	i-TREATMENT
46255	tracheal	i-TREATMENT
46256	tube	i-TREATMENT
46257	was	O
46258	the	O
46259	best	O
46260	approach	O
46261	to	O
46262	the	b-PROBLEM
46263	air	i-PROBLEM
46264	leak	i-PROBLEM
46265	since	O
46266	it	O
46267	was	O
46268	a	b-TREATMENT
46269	new	i-TREATMENT
46270	trach	i-TREATMENT
46271	and	O
46272	he	O
46273	was	O
46274	requiring	O
46275	such	O
46276	high	b-TREATMENT
46277	ventilator	i-TREATMENT
46278	support	i-TREATMENT
46279	that	O
46280	it	O
46281	was	O
46282	risky	O
46283	to	O
46284	change	O
46285	it	O
46286	.	O
46287	he	O
46288	also	O
46289	felt	O
46290	that	O
46291	lung	b-TEST
46292	biopsy	i-TEST
46293	at	O
46294	this	b-DATE
46295	time	i-DATE
46296	was	O
46297	rather	O
46298	risky	O
46299	.	O
46300	the	O
46301	patient	O
46302	was	O
46303	therefore	O
46304	completely	b-TEST
46305	cultured	i-TEST
46306	again	O
46307	and	O
46308	begun	O
46309	on	O
46310	antibiotic	b-TREATMENT
46311	coverage	i-TREATMENT
46312	which	O
46313	would	O
46314	take	O
46315	care	O
46316	of	O
46317	the	b-PROBLEM
46318	pseudomonas	i-PROBLEM
46319	he	O
46320	was	O
46321	known	O
46322	to	O
46323	have	O
46324	.	O
46325	the	b-TREATMENT
46326	steroids	i-TREATMENT
46327	were	O
46328	tapered	O
46329	.	O
46330	he	O
46331	was	O
46332	also	O
46333	begun	O
46334	on	O
46335	anti-candida	b-TREATMENT
46336	regimen	i-TREATMENT
46337	for	O
46338	his	b-PROBLEM
46339	urinary	i-PROBLEM
46340	tract	i-PROBLEM
46341	infection	i-PROBLEM
46342	with	O
46343	yeast	b-PROBLEM
46344	being	O
46345	seen	O
46346	.	O
46347	because	O
46348	of	O
46349	the	O
46350	story	O
46351	of	O
46352	hemoptysis	b-PROBLEM
46353	,	O
46354	he	O
46355	also	O
46356	underwent	O
46357	an	b-TEST
46358	exotic	i-TEST
46359	bleeding	i-TEST
46360	work	i-TEST
46361	up	i-TEST
46362	for	O
46363	such	O
46364	things	O
46365	as	O
46366	wegner	b-PROBLEM
46367	&apos;s	i-PROBLEM
46368	and	O
46369	goodpasture	b-PROBLEM
46370	&apos;s	i-PROBLEM
46371	.	O
46372	these	O
46373	results	O
46374	were	O
46375	all	O
46376	negative	O
46377	.	O
46378	he	O
46379	continued	O
46380	to	O
46381	require	O
46382	very	b-TREATMENT
46383	high	i-TREATMENT
46384	fio2	i-TREATMENT
46385	.	O
46386	he	O
46387	was	O
46388	found	O
46389	to	O
46390	have	O
46391	a	b-PROBLEM
46392	dvt	i-PROBLEM
46393	by	O
46394	ultrasound	b-TEST
46395	.	O
46396	he	O
46397	underwent	O
46398	a	b-TREATMENT
46399	trial	i-TREATMENT
46400	of	i-TREATMENT
46401	tpa	i-TREATMENT
46402	followed	O
46403	by	O
46404	heparin	b-TREATMENT
46405	.	O
46406	this	O
46407	produced	O
46408	substantially	b-PROBLEM
46409	further	i-PROBLEM
46410	hemoptysis	i-PROBLEM
46411	and	O
46412	the	O
46413	need	O
46414	for	O
46415	transfusion	b-TREATMENT
46416	.	O
46417	he	O
46418	stabilized	O
46419	from	O
46420	this	O
46421	,	O
46422	but	O
46423	on	O
46424	the	b-DATE
46425	fifth	i-DATE
46426	while	O
46427	continuing	O
46428	to	O
46429	have	O
46430	extremely	b-PROBLEM
46431	ventilator	i-PROBLEM
46432	requirement	i-PROBLEM
46433	.	O
46434	in	O
46435	consultation	O
46436	with	O
46437	his	O
46438	family	O
46439	,	O
46440	it	O
46441	was	O
46442	decided	O
46443	that	O
46444	enough	O
46445	support	O
46446	had	O
46447	been	O
46448	done	O
46449	.	O
46450	at	O
46451	that	O
46452	time	O
46453	,	O
46454	therefore	O
46455	,	O
46456	ventilator	b-TREATMENT
46457	support	i-TREATMENT
46458	was	O
46459	withdrawn	b-OCCURRENCE
46460	under	O
46461	the	b-TREATMENT
46462	comfort	i-TREATMENT
46463	measures	i-TREATMENT
46464	of	O
46465	morphine	b-TREATMENT
46466	.	O
46467	stain	O
46468	j.	O
46469	a	O
46470	,	O
46471	md	O
46472	tr	O
46473	:	O
46474	sj	O
46475	/	O
46476	bmot	O
46477	dd	O
46478	:	O
46479	6-4-93	O
46480	td	O
46481	:	O
46482	06/05/93	O
46483	cc	O
46484	:	O
46485		O
46486	admission	b-OCCURRENCE
46487	date	O
46488	:	O
46489	2017-09-13	b-ADMISSION
46490	discharge	b-OCCURRENCE
46491	date	O
46492	:	O
46493	2017-09-15	b-DISCHARGE
46494	service	O
46495	:	O
46496	nsu	O
46497	history	O
46498	of	O
46499	present	O
46500	illness	O
46501	:	O
46502	the	O
46503	patient	O
46504	is	O
46505	a	O
46506	45	O
46507	-	O
46508	year-old	O
46509	female	O
46510	here	O
46511	for	O
46512	a	b-TEST
46513	diagnostic	i-TEST
46514	cerebral	i-TEST
46515	angiogram	i-TEST
46516	with	O
46517	coiling	b-TREATMENT
46518	.	O
46519	hospital	O
46520	course	O
46521	:	O
46522	on	O
46523	admission	b-OCCURRENCE
46524	,	O
46525	the	b-TEST
46526	patient	i-TEST
46527	's	i-TEST
46528	vital	i-TEST
46529	signs	i-TEST
46530	were	O
46531	stable	O
46532	.	O
46533	her	b-TEST
46534	blood	i-TEST
46535	pressure	i-TEST
46536	was	O
46537	102/82	O
46538	.	O
46539	her	b-TEST
46540	heart	i-TEST
46541	rate	i-TEST
46542	was	O
46543	71	O
46544	.	O
46545	her	b-TEST
46546	spo2	i-TEST
46547	was	O
46548	98	O
46549	percent	O
46550	on	O
46551	room	O
46552	air	O
46553	.	O
46554	medications	O
46555	on	O
46556	admission	O
46557	:	O
46558	1.	O
46559	plavix	b-TREATMENT
46560	75	O
46561	mg	O
46562	times	b-FREQUENCY
46563	6	i-FREQUENCY
46564	doses	O
46565	.	O
46566	2.	O
46567	xanax	b-TREATMENT
46568	q.d.	b-FREQUENCY
46569	3.	O
46570	prozac	b-TREATMENT
46571	20	O
46572	mg	O
46573	q.d.	b-FREQUENCY
46574	4.	O
46575	cyclobenzaprine	b-TREATMENT
46576	10	O
46577	mg	O
46578	q.d.	b-FREQUENCY
46579	5.	O
46580	aspirin	b-TREATMENT
46581	325	O
46582	mg	O
46583	times	b-FREQUENCY
46584	3	i-FREQUENCY
46585	doses	O
46586	.	O
46587	6.	O
46588	vitamin	b-TREATMENT
46589	e	i-TREATMENT
46590	.	O
46591	past	O
46592	surgical	O
46593	history	O
46594	:	O
46595	tubal	b-TREATMENT
46596	ligation	i-TREATMENT
46597	,	O
46598	1986	b-DATE
46599	.	O
46600	cystectomy	b-TREATMENT
46601	,	O
46602	1992	b-DATE
46603	and	O
46604	1998	b-DATE
46605	.	O
46606	breast	b-TREATMENT
46607	lesion	i-TREATMENT
46608	excision	i-TREATMENT
46609	,	O
46610	1989	b-DATE
46611	.	O
46612	allergies	O
46613	:	O
46614	tetracycline	b-TREATMENT
46615	.	O
46616	social	O
46617	history	O
46618	:	O
46619	the	O
46620	patient	O
46621	uses	O
46622	alcohol	O
46623	socially	O
46624	;	O
46625	was	O
46626	a	b-PROBLEM
46627	smoker	i-PROBLEM
46628	,	O
46629	used	O
46630	tobacco	b-PROBLEM
46631	,	O
46632	she	O
46633	quit	O
46634	4	b-DATE
46635	years	i-DATE
46636	ago	i-DATE
46637	;	O
46638	denies	O
46639	using	O
46640	recreational	b-PROBLEM
46641	drug	i-PROBLEM
46642	.	O
46643	hospital	O
46644	course	O
46645	:	O
46646	on	O
46647	2017-09-13	b-DATE
46648	,	O
46649	the	O
46650	patient	O
46651	was	O
46652	brought	O
46653	to	O
46654	the	b-CLINICAL_DEPT
46655	operating	i-CLINICAL_DEPT
46656	room	i-CLINICAL_DEPT
46657	and	O
46658	underwent	O
46659	a	b-TREATMENT
46660	coiling	i-TREATMENT
46661	with	O
46662	stent	b-TREATMENT
46663	placement	i-TREATMENT
46664	of	O
46665	the	b-PROBLEM
46666	left	i-PROBLEM
46667	carotid	i-PROBLEM
46668	ophthalmic	i-PROBLEM
46669	aneurysm	i-PROBLEM
46670	.	O
46671	the	O
46672	patient	O
46673	underwent	O
46674	coiling	b-TREATMENT
46675	and	O
46676	stent	b-TREATMENT
46677	placement	i-TREATMENT
46678	without	O
46679	complications	b-PROBLEM
46680	.	O
46681	she	O
46682	was	O
46683	discharged	b-OCCURRENCE
46684	to	O
46685	the	b-CLINICAL_DEPT
46686	pacu	i-CLINICAL_DEPT
46687	in	O
46688	stable	b-OCCURRENCE
46689	condition	i-OCCURRENCE
46690	.	O
46691	postoperative	b-TEST
46692	check	i-TEST
46693	,	O
46694	the	b-TEST
46695	patient	i-TEST
46696	's	i-TEST
46697	vital	i-TEST
46698	signs	i-TEST
46699	were	O
46700	stable	b-OCCURRENCE
46701	.	O
46702	her	b-TEST
46703	temperature	i-TEST
46704	was	O
46705	96.3	O
46706	degrees	O
46707	,	O
46708	blood	b-TEST
46709	pressure	i-TEST
46710	was	O
46711	128/63	O
46712	.	O
46713	her	b-TEST
46714	pulse	i-TEST
46715	was	O
46716	61	O
46717	,	O
46718	respirations	b-TEST
46719	12	O
46720	,	O
46721	and	O
46722	her	b-TEST
46723	o2	i-TEST
46724	saturation	i-TEST
46725	was	O
46726	98	O
46727	percent	O
46728	on	O
46729	room	O
46730	air	O
46731	.	O
46732	her	b-TEST
46733	labs	i-TEST
46734	showed	b-EVIDENTIAL
46735	a	b-TEST
46736	white	i-TEST
46737	blood	i-TEST
46738	count	i-TEST
46739	of	O
46740	7.7	O
46741	,	O
46742	hematocrit	b-TEST
46743	of	O
46744	33.3	O
46745	,	O
46746	and	O
46747	platelets	b-TEST
46748	were	O
46749	305	O
46750	.	O
46751	her	b-TEST
46752	coags	i-TEST
46753	,	O
46754	her	b-TEST
46755	pt	i-TEST
46756	was	O
46757	14.5	O
46758	,	O
46759	ptt	b-TEST
46760	was	O
46761	143.4	O
46762	,	O
46763	and	O
46764	her	b-TEST
46765	inr	i-TEST
46766	was	O
46767	1.3	O
46768	.	O
46769	her	b-TEST
46770	electrolytes	i-TEST
46771	were	O
46772	all	O
46773	within	O
46774	normal	O
46775	limits	O
46776	.	O
46777	on	O
46778	physical	b-TEST
46779	exam	i-TEST
46780	,	O
46781	the	O
46782	patient	O
46783	was	O
46784	awake	O
46785	,	O
46786	alert	O
46787	,	O
46788	and	O
46789	oriented	O
46790	times	O
46791	3	O
46792	.	O
46793	she	O
46794	had	O
46795	a	O
46796	symmetric	O
46797	smile	O
46798	.	O
46799	her	O
46800	extraocular	O
46801	movements	O
46802	were	O
46803	full	O
46804	.	O
46805	her	O
46806	pupils	O
46807	were	O
46808	3	O
46809	to	O
46810	2	O
46811	bilaterally	O
46812	,	O
46813	briskly	O
46814	reactive	O
46815	.	O
46816	the	O
46817	visual	O
46818	fields	O
46819	were	O
46820	intact	O
46821	.	O
46822	her	O
46823	strength	O
46824	was	O
46825	05-31	O
46826	throughout	O
46827	except	O
46828	for	O
46829	right	O
46830	was	O
46831	not	O
46832	tested	O
46833	due	O
46834	to	O
46835	the	b-PROBLEM
46836	angiocele	i-PROBLEM
46837	in	i-PROBLEM
46838	her	i-PROBLEM
46839	groin	i-PROBLEM
46840	.	O
46841	angiocele	b-PROBLEM
46842	was	O
46843	intact	O
46844	without	O
46845	hematoma	b-PROBLEM
46846	,	O
46847	and	O
46848	she	O
46849	exhibited	O
46850	strong	O
46851	pedal	O
46852	pulses	O
46853	on	O
46854	the	O
46855	right	O
46856	side	O
46857	.	O
46858	the	b-TEST
46859	assessment	i-TEST
46860	at	O
46861	that	b-DATE
46862	time	i-DATE
46863	was	O
46864	she	O
46865	was	O
46866	neurologically	b-OCCURRENCE
46867	stable	i-OCCURRENCE
46868	.	O
46869	the	O
46870	plan	O
46871	was	O
46872	q.	b-FREQUENCY
46873	1-hour	i-FREQUENCY
46874	neuro	b-TEST
46875	checks	i-TEST
46876	.	O
46877	she	O
46878	was	O
46879	started	O
46880	on	O
46881	a	b-TREATMENT
46882	heparin	i-TREATMENT
46883	drip	i-TREATMENT
46884	at	O
46885	800	O
46886	per	O
46887	hour	O
46888	.	O
46889	her	b-TEST
46890	ptt	i-TEST
46891	goes	O
46892	50	O
46893	to	O
46894	60	O
46895	at	O
46896	that	O
46897	time	O
46898	.	O
46899	she	O
46900	was	O
46901	cleared	O
46902	to	O
46903	take	O
46904	sips	O
46905	of	O
46906	clear	O
46907	fluids	O
46908	and	O
46909	was	O
46910	to	O
46911	remain	b-OCCURRENCE
46912	flat	i-OCCURRENCE
46913	for	O
46914	4	b-DURATION
46915	hours	i-DURATION
46916	.	O
46917	on	O
46918	postoperative	b-DATE
46919	day	i-DATE
46920	1	i-DATE
46921	,	O
46922	the	O
46923	patient	O
46924	was	O
46925	alert	b-OCCURRENCE
46926	and	O
46927	oriented	O
46928	times	O
46929	3	O
46930	.	O
46931	she	O
46932	exhibited	O
46933	no	O
46934	drift	b-PROBLEM
46935	.	O
46936	her	b-TEST
46937	ips	i-TEST
46938	were	O
46939	full	O
46940	at	O
46941	5/5	O
46942	.	O
46943	she	O
46944	had	O
46945	no	O
46946	hematoma	b-PROBLEM
46947	in	i-PROBLEM
46948	her	i-PROBLEM
46949	groin	i-PROBLEM
46950	site	i-PROBLEM
46951	.	O
46952	visual	O
46953	fields	O
46954	were	O
46955	full	O
46956	,	O
46957	her	O
46958	pupils	O
46959	were	O
46960	round	O
46961	and	O
46962	reactive	O
46963	bilaterally	O
46964	.	O
46965	her	b-TEST
46966	vital	i-TEST
46967	signs	i-TEST
46968	were	O
46969	stable	b-OCCURRENCE
46970	with	O
46971	a	b-TEST
46972	temperature	i-TEST
46973	of	O
46974	97.8	O
46975	degrees	O
46976	,	O
46977	blood	b-TEST
46978	pressure	i-TEST
46979	was	O
46980	104	O
46981	to	O
46982	121	O
46983	over	O
46984	50s	O
46985	.	O
46986	pulse	b-TEST
46987	was	O
46988	60	O
46989	to	O
46990	70	O
46991	.	O
46992	respirations	b-TEST
46993	were	O
46994	15	O
46995	,	O
46996	and	O
46997	she	O
46998	was	O
46999	saturating	b-TEST
47000	at	O
47001	96	O
47002	percent	O
47003	on	O
47004	room	O
47005	air	O
47006	.	O
47007	her	b-TEST
47008	ptt	i-TEST
47009	at	O
47010	that	b-DATE
47011	time	i-DATE
47012	was	O
47013	67.8	O
47014	.	O
47015	she	O
47016	was	O
47017	started	O
47018	on	O
47019	aspirin	b-TREATMENT
47020	325	O
47021	mg	O
47022	q.d.	b-FREQUENCY
47023	and	O
47024	plavix	b-TREATMENT
47025	75	O
47026	mg	O
47027	q.d.	b-FREQUENCY
47028	on	O
47029	2017-09-14	b-DATE
47030	,	O
47031	she	O
47032	was	O
47033	transferred	b-OCCURRENCE
47034	to	O
47035	the	b-CLINICAL_DEPT
47036	regular	i-CLINICAL_DEPT
47037	floor	i-CLINICAL_DEPT
47038	at	O
47039	far	O
47040	5	O
47041	.	O
47042	postoperative	b-DATE
47043	day	i-DATE
47044	2	i-DATE
47045	,	O
47046	the	O
47047	patient	O
47048	was	O
47049	stable	b-OCCURRENCE
47050	without	O
47051	events	b-OCCURRENCE
47052	,	O
47053	all	b-TEST
47054	vital	i-TEST
47055	signs	i-TEST
47056	were	O
47057	stable	b-OCCURRENCE
47058	.	O
47059	she	O
47060	was	O
47061	moving	O
47062	all	O
47063	extremities	O
47064	and	O
47065	exhibiting	O
47066	good	O
47067	strength	O
47068	.	O
47069	her	b-PROBLEM
47070	visual	i-PROBLEM
47071	fields	i-PROBLEM
47072	were	O
47073	intact	b-OCCURRENCE
47074	.	O
47075	her	b-PROBLEM
47076	extraocular	i-PROBLEM
47077	movements	i-PROBLEM
47078	were	O
47079	full	b-OCCURRENCE
47080	.	O
47081	angio	b-PROBLEM
47082	site	i-PROBLEM
47083	was	O
47084	clean	b-OCCURRENCE
47085	,	i-OCCURRENCE
47086	dry	i-OCCURRENCE
47087	,	O
47088	and	O
47089	intact	b-OCCURRENCE
47090	without	i-OCCURRENCE
47091	bleeding	i-OCCURRENCE
47092	or	i-OCCURRENCE
47093	drainage	i-OCCURRENCE
47094	.	O
47095	she	O
47096	was	O
47097	to	O
47098	be	O
47099	discharged	b-OCCURRENCE
47100	today	b-DATE
47101	and	O
47102	encouraged	O
47103	to	O
47104	ambulate	O
47105	on	O
47106	her	O
47107	own	O
47108	.	O
47109	discharge	b-TEST
47110	condition	i-TEST
47111	for	O
47112	this	O
47113	patient	O
47114	was	O
47115	good	b-OCCURRENCE
47116	.	O
47117	she	O
47118	was	O
47119	ambulating	b-OCCURRENCE
47120	on	i-OCCURRENCE
47121	her	i-OCCURRENCE
47122	own	i-OCCURRENCE
47123	and	O
47124	tolerating	b-OCCURRENCE
47125	a	i-OCCURRENCE
47126	p.o.	i-OCCURRENCE
47127	diet	i-OCCURRENCE
47128	.	O
47129	she	O
47130	was	O
47131	discharged	b-OCCURRENCE
47132	to	i-OCCURRENCE
47133	home	i-OCCURRENCE
47134	in	O
47135	stable	b-OCCURRENCE
47136	condition	i-OCCURRENCE
47137	.	O
47138		O
47139	admission	b-OCCURRENCE
47140	date	O
47141	:	O
47142	8-15-93	b-ADMISSION
47143	discharge	b-OCCURRENCE
47144	date	O
47145	:	O
47146	08-22-93	b-DISCHARGE
47147	history	O
47148	of	O
47149	present	O
47150	illness	O
47151	:	O
47152	the	O
47153	patient	O
47154	is	O
47155	a	O
47156	58	O
47157	year	O
47158	old	O
47159	female	O
47160	with	O
47161	a	O
47162	history	O
47163	of	O
47164	parkinson	b-PROBLEM
47165	&apos;s	i-PROBLEM
47166	disease	i-PROBLEM
47167	for	O
47168	more	O
47169	than	O
47170	twenty	b-DURATION
47171	years	i-DURATION
47172	who	O
47173	presented	b-OCCURRENCE
47174	to	O
47175	the	b-CLINICAL_DEPT
47176	gemenadentoolpai	i-CLINICAL_DEPT
47177	medical	i-CLINICAL_DEPT
47178	center	i-CLINICAL_DEPT
47179	with	O
47180	a	b-PROBLEM
47181	revolving	i-PROBLEM
47182	anterolateral	i-PROBLEM
47183	wall	i-PROBLEM
47184	myocardial	i-PROBLEM
47185	infarction	i-PROBLEM
47186	on	O
47187	08-01-93	b-DATE
47188	.	O
47189	she	O
47190	has	O
47191	been	O
47192	under	O
47193	the	b-TREATMENT
47194	care	i-TREATMENT
47195	of	O
47196	doctor	O
47197	aalv	O
47198	manual	O
47199	and	O
47200	was	O
47201	referred	b-OCCURRENCE
47202	here	b-CLINICAL_DEPT
47203	for	O
47204	further	b-TREATMENT
47205	therapy	i-TREATMENT
47206	.	O
47207	she	O
47208	had	O
47209	no	O
47210	prior	b-OCCURRENCE
47211	significant	i-OCCURRENCE
47212	cardiac	i-OCCURRENCE
47213	history	i-OCCURRENCE
47214	and	O
47215	presented	b-OCCURRENCE
47216	to	O
47217	her	b-CLINICAL_DEPT
47218	local	i-CLINICAL_DEPT
47219	medical	i-CLINICAL_DEPT
47220	doctor	i-CLINICAL_DEPT
47221	&apos;s	i-CLINICAL_DEPT
47222	office	i-CLINICAL_DEPT
47223	with	O
47224	an	O
47225	episode	O
47226	of	O
47227	severe	b-PROBLEM
47228	retrosternal	i-PROBLEM
47229	chest	i-PROBLEM
47230	pain	i-PROBLEM
47231	.	O
47232	her	b-TEST
47233	electrocardiogram	i-TEST
47234	showed	b-EVIDENTIAL
47235	a	b-PROBLEM
47236	new	i-PROBLEM
47237	right	i-PROBLEM
47238	bundle	i-PROBLEM
47239	branch	i-PROBLEM
47240	block	i-PROBLEM
47241	and	O
47242	left	b-PROBLEM
47243	anterior	i-PROBLEM
47244	hemiblock	i-PROBLEM
47245	.	O
47246	the	O
47247	patient	O
47248	was	O
47249	transferred	b-OCCURRENCE
47250	to	O
47251	the	b-CLINICAL_DEPT
47252	gemenadentoolpai	i-CLINICAL_DEPT
47253	medical	i-CLINICAL_DEPT
47254	center	i-CLINICAL_DEPT
47255	and	O
47256	was	O
47257	admitted	b-OCCURRENCE
47258	.	O
47259	her	b-OCCURRENCE
47260	hospital	i-OCCURRENCE
47261	course	i-OCCURRENCE
47262	was	O
47263	remarkable	O
47264	for	O
47265	ruling	O
47266	in	O
47267	for	O
47268	a	b-PROBLEM
47269	myocardial	i-PROBLEM
47270	infarction	i-PROBLEM
47271	with	O
47272	a	b-TEST
47273	peak	i-TEST
47274	cpk	i-TEST
47275	of	O
47276	9,379	O
47277	units	O
47278	with	O
47279	a	O
47280	5.9%	O
47281	mb	b-TEST
47282	fraction	i-TEST
47283	.	O
47284	in	O
47285	addition	O
47286	,	O
47287	on	O
47288	telemetry	b-TEST
47289	she	O
47290	developed	b-OCCURRENCE
47291	complete	b-PROBLEM
47292	heart	i-PROBLEM
47293	block	i-PROBLEM
47294	and	O
47295	hypotension	b-PROBLEM
47296	requiring	O
47297	temporary	b-TREATMENT
47298	pacing	i-TREATMENT
47299	wire	i-TREATMENT
47300	and	O
47301	then	O
47302	a	b-TREATMENT
47303	permanent	i-TREATMENT
47304	pacemaker	i-TREATMENT
47305	implantation	i-TREATMENT
47306	on	O
47307	08-03-93	b-DATE
47308	.	O
47309	she	O
47310	developed	O
47311	congestive	b-PROBLEM
47312	heart	i-PROBLEM
47313	failure	i-PROBLEM
47314	and	O
47315	required	O
47316	pressor	b-TREATMENT
47317	support	i-TREATMENT
47318	.	O
47319	she	O
47320	underwent	O
47321	cardiac	b-TEST
47322	catheterization	i-TEST
47323	on	O
47324	8-15-93	b-DATE
47325	and	O
47326	was	O
47327	found	b-OCCURRENCE
47328	to	O
47329	have	O
47330	a	b-TEST
47331	left	i-TEST
47332	ventricular	i-TEST
47333	end	i-TEST
47334	diastolic	i-TEST
47335	pressure	i-TEST
47336	of	O
47337	28	O
47338	millimeters	O
47339	of	O
47340	mercury	O
47341	.	O
47342	she	O
47343	had	O
47344	a	b-PROBLEM
47345	dominant	i-PROBLEM
47346	right	i-PROBLEM
47347	coronary	i-PROBLEM
47348	artery	i-PROBLEM
47349	with	O
47350	minor	b-PROBLEM
47351	disease	i-PROBLEM
47352	.	O
47353	the	O
47354	main	O
47355	left	O
47356	coronary	O
47357	artery	O
47358	had	O
47359	a	b-PROBLEM
47360	20%	i-PROBLEM
47361	stenosis	i-PROBLEM
47362	.	O
47363	the	O
47364	left	O
47365	anterior	O
47366	descending	O
47367	had	O
47368	a	b-PROBLEM
47369	severe	i-PROBLEM
47370	80%	i-PROBLEM
47371	proximal	i-PROBLEM
47372	stenosis	i-PROBLEM
47373	with	O
47374	a	b-PROBLEM
47375	filling	i-PROBLEM
47376	defect	i-PROBLEM
47377	consistent	O
47378	with	O
47379	intraluminal	b-PROBLEM
47380	thrombus	i-PROBLEM
47381	.	O
47382	the	O
47383	circumflex	O
47384	artery	O
47385	had	O
47386	a	b-PROBLEM
47387	minor	i-PROBLEM
47388	40%	i-PROBLEM
47389	stenosis	i-PROBLEM
47390	.	O
47391	cine	b-TEST
47392	left	i-TEST
47393	ventriculogram	i-TEST
47394	revealed	b-EVIDENTIAL
47395	a	b-PROBLEM
47396	dilated	i-PROBLEM
47397	left	i-PROBLEM
47398	ventricle	i-PROBLEM
47399	with	O
47400	an	b-PROBLEM
47401	area	i-PROBLEM
47402	of	i-PROBLEM
47403	anterolateral	i-PROBLEM
47404	,	i-PROBLEM
47405	apical	i-PROBLEM
47406	,	i-PROBLEM
47407	and	i-PROBLEM
47408	septal	i-PROBLEM
47409	akinesis	i-PROBLEM
47410	.	O
47411	the	b-TEST
47412	left	i-TEST
47413	ventricular	i-TEST
47414	ejection	i-TEST
47415	fraction	i-TEST
47416	was	O
47417	estimated	b-EVIDENTIAL
47418	to	O
47419	38%	O
47420	.	O
47421	the	O
47422	patient	O
47423	was	O
47424	transferred	b-OCCURRENCE
47425	to	O
47426	the	b-CLINICAL_DEPT
47427	heaonboburg	i-CLINICAL_DEPT
47428	linpack	i-CLINICAL_DEPT
47429	grant	i-CLINICAL_DEPT
47430	medical	i-CLINICAL_DEPT
47431	center	i-CLINICAL_DEPT
47432	for	O
47433	consideration	O
47434	of	O
47435	coronary	b-TREATMENT
47436	angioplasty	i-TREATMENT
47437	.	O
47438	cardiac	O
47439	risk	O
47440	factors	O
47441	:	O
47442	her	b-PROBLEM
47443	risk	i-PROBLEM
47444	factors	i-PROBLEM
47445	for	O
47446	coronary	b-PROBLEM
47447	artery	i-PROBLEM
47448	disease	i-PROBLEM
47449	included	O
47450	a	b-PROBLEM
47451	positive	i-PROBLEM
47452	family	i-PROBLEM
47453	history	i-PROBLEM
47454	and	O
47455	an	b-PROBLEM
47456	elevated	i-PROBLEM
47457	cholesterol	i-PROBLEM
47458	level	i-PROBLEM
47459	.	O
47460	hospital	O
47461	course	O
47462	:	O
47463	the	O
47464	patient	O
47465	was	O
47466	admitted	b-OCCURRENCE
47467	to	O
47468	the	b-CLINICAL_DEPT
47469	medical	i-CLINICAL_DEPT
47470	service	i-CLINICAL_DEPT
47471	.	O
47472	the	O
47473	patient	O
47474	was	O
47475	seen	b-OCCURRENCE
47476	in	i-OCCURRENCE
47477	consultation	i-OCCURRENCE
47478	by	O
47479	the	b-CLINICAL_DEPT
47480	neurology	i-CLINICAL_DEPT
47481	department	i-CLINICAL_DEPT
47482	because	O
47483	of	O
47484	the	O
47485	history	O
47486	of	O
47487	parkinson	b-PROBLEM
47488	&apos;s	i-PROBLEM
47489	disease	i-PROBLEM
47490	.	O
47491	the	O
47492	patient	O
47493	was	O
47494	maintained	O
47495	on	O
47496	intravenous	b-TREATMENT
47497	heparin	i-TREATMENT
47498	.	O
47499	on	O
47500	8-17-93	b-DATE
47501	,	O
47502	she	O
47503	was	O
47504	taken	O
47505	to	O
47506	the	b-CLINICAL_DEPT
47507	cardiac	i-CLINICAL_DEPT
47508	catheterization	i-CLINICAL_DEPT
47509	laboratory	i-CLINICAL_DEPT
47510	where	O
47511	she	O
47512	underwent	O
47513	percutaneous	b-TREATMENT
47514	transluminal	i-TREATMENT
47515	coronary	i-TREATMENT
47516	angioplasty	i-TREATMENT
47517	of	i-TREATMENT
47518	the	i-TREATMENT
47519	proximal	i-TREATMENT
47520	left	i-TREATMENT
47521	anterior	i-TREATMENT
47522	descending	i-TREATMENT
47523	.	O
47524	following	O
47525	balloon	b-TREATMENT
47526	angioplasty	i-TREATMENT
47527	,	O
47528	there	O
47529	was	O
47530	a	b-TREATMENT
47531	local	i-TREATMENT
47532	dissection	i-TREATMENT
47533	with	O
47534	evidence	O
47535	of	O
47536	intraluminal	b-PROBLEM
47537	thrombus	i-PROBLEM
47538	,	O
47539	with	O
47540	a	b-PROBLEM
47541	greater	i-PROBLEM
47542	than	i-PROBLEM
47543	10%	i-PROBLEM
47544	loss	i-PROBLEM
47545	in	i-PROBLEM
47546	the	i-PROBLEM
47547	initial	i-PROBLEM
47548	gain	i-PROBLEM
47549	following	O
47550	coronary	b-TREATMENT
47551	angioplasty	i-TREATMENT
47552	.	O
47553	therefore	O
47554	,	O
47555	directional	b-TREATMENT
47556	coronary	i-TREATMENT
47557	atherectomy	i-TREATMENT
47558	was	O
47559	performed	O
47560	with	O
47561	an	b-OCCURRENCE
47562	excellent	i-OCCURRENCE
47563	angiographic	i-OCCURRENCE
47564	outcome	i-OCCURRENCE
47565	,	O
47566	and	O
47567	a	b-PROBLEM
47568	less	i-PROBLEM
47569	than	i-PROBLEM
47570	10%	i-PROBLEM
47571	residual	i-PROBLEM
47572	narrowing	i-PROBLEM
47573	.	O
47574	the	O
47575	patient	O
47576	tolerated	b-OCCURRENCE
47577	the	b-TREATMENT
47578	procedure	i-TREATMENT
47579	well	b-OCCURRENCE
47580	.	O
47581	she	O
47582	was	O
47583	maintained	O
47584	on	O
47585	intravenous	b-TREATMENT
47586	heparin	i-TREATMENT
47587	and	O
47588	was	O
47589	brought	O
47590	back	O
47591	to	O
47592	the	b-CLINICAL_DEPT
47593	cardiac	i-CLINICAL_DEPT
47594	catheterization	i-CLINICAL_DEPT
47595	laboratory	i-CLINICAL_DEPT
47596	on	O
47597	08-18-93	b-DATE
47598	for	O
47599	a	b-TEST
47600	relook	i-TEST
47601	coronary	i-TEST
47602	angiography	i-TEST
47603	.	O
47604	coronary	b-TEST
47605	angiography	i-TEST
47606	demonstrated	b-EVIDENTIAL
47607	ongoing	b-OCCURRENCE
47608	benefit	i-OCCURRENCE
47609	of	O
47610	the	b-TREATMENT
47611	initial	i-TREATMENT
47612	coronary	i-TREATMENT
47613	atherectomy	i-TREATMENT
47614	.	O
47615	specifically	O
47616	,	O
47617	there	O
47618	was	O
47619	no	O
47620	decrease	b-PROBLEM
47621	in	O
47622	the	b-OCCURRENCE
47623	initial	i-OCCURRENCE
47624	gain	i-OCCURRENCE
47625	that	O
47626	she	O
47627	achieved	O
47628	after	O
47629	directional	b-TREATMENT
47630	atherectomy	i-TREATMENT
47631	.	O
47632	the	O
47633	patient	O
47634	remained	b-OCCURRENCE
47635	stable	i-OCCURRENCE
47636	during	O
47637	the	b-OCCURRENCE
47638	rest	i-OCCURRENCE
47639	of	i-OCCURRENCE
47640	the	i-OCCURRENCE
47641	hospitalization	i-OCCURRENCE
47642	.	O
47643	she	O
47644	was	O
47645	transferred	b-OCCURRENCE
47646	in	O
47647	stable	b-OCCURRENCE
47648	condition	i-OCCURRENCE
47649	to	O
47650	the	b-CLINICAL_DEPT
47651	pasi	i-CLINICAL_DEPT
47652	for	O
47653	further	b-TREATMENT
47654	rehabilitation	i-TREATMENT
47655	therapy	i-TREATMENT
47656	.	O
47657	renlan	O
47658	fyfezeis	O
47659	,	O
47660	md	O
47661	doctor	O
47662	aalv	O
47663	lorjes	O
47664	salv	O
47665	manual	O
47666	pasi	O
47667	tr	O
47668	:	O
47669	jb	O
47670	/	O
47671	bmot	O
47672	dd	O
47673	:	O
47674	9-17-93	O
47675	td	O
47676	:	O
47677	09/19/93	O
47678	cc	O
47679	:	O
47680		O
47681	admission	b-OCCURRENCE
47682	date	O
47683	:	O
47684	2017-07-12	b-ADMISSION
47685	discharge	b-OCCURRENCE
47686	date	O
47687	:	O
47688	2017-07-17	b-DISCHARGE
47689	service	O
47690	:	O
47691	medicine	O
47692	history	O
47693	of	O
47694	present	O
47695	illness	O
47696	:	O
47697	57	O
47698	y/o	O
47699	f	O
47700	with	O
47701	multiple	b-PROBLEM
47702	medical	i-PROBLEM
47703	problems	i-PROBLEM
47704	including	O
47705	polyendocrine	b-PROBLEM
47706	deficiency	i-PROBLEM
47707	comprised	O
47708	of	O
47709	adrenal	b-PROBLEM
47710	insufficiency	i-PROBLEM
47711	,	O
47712	dm	b-PROBLEM
47713	,	O
47714	premature	b-PROBLEM
47715	ovarian	i-PROBLEM
47716	failure	i-PROBLEM
47717	,	O
47718	hypoparathyroidism	b-PROBLEM
47719	,	O
47720	addison	b-PROBLEM
47721	's	i-PROBLEM
47722	disease	i-PROBLEM
47723	and	O
47724	also	O
47725	breast	b-PROBLEM
47726	ca	i-PROBLEM
47727	and	O
47728	depression	b-PROBLEM
47729	with	O
47730	multiple	O
47731	suicide	b-PROBLEM
47732	attempts	i-PROBLEM
47733	in	O
47734	the	O
47735	past	O
47736	who	O
47737	originally	O
47738	presented	b-OCCURRENCE
47739	s/p	O
47740	tylenol	b-PROBLEM
47741	with	i-PROBLEM
47742	codeine	i-PROBLEM
47743	overdose	i-PROBLEM
47744	and	O
47745	hypotension	b-PROBLEM
47746	,	O
47747	was	O
47748	intubated	b-TREATMENT
47749	and	O
47750	admitted	b-OCCURRENCE
47751	to	O
47752	the	b-CLINICAL_DEPT
47753	ficu	i-CLINICAL_DEPT
47754	.	O
47755	she	O
47756	was	O
47757	eventually	O
47758	stabilized	b-OCCURRENCE
47759	and	O
47760	transfered	b-OCCURRENCE
47761	out	O
47762	of	O
47763	the	b-CLINICAL_DEPT
47764	icu	i-CLINICAL_DEPT
47765	to	O
47766	the	b-CLINICAL_DEPT
47767	medical	i-CLINICAL_DEPT
47768	mary	i-CLINICAL_DEPT
47769	lane	i-CLINICAL_DEPT
47770	hospital	i-CLINICAL_DEPT
47771	.	O
47772	subsequently	O
47773	,	O
47774	she	O
47775	was	O
47776	transfered	b-OCCURRENCE
47777	to	O
47778	the	b-CLINICAL_DEPT
47779	psychiatric	i-CLINICAL_DEPT
47780	mary	i-CLINICAL_DEPT
47781	lane	i-CLINICAL_DEPT
47782	hospital	i-CLINICAL_DEPT
47783	in	i-CLINICAL_DEPT
47784	boston	i-CLINICAL_DEPT
47785	medical	i-CLINICAL_DEPT
47786	center	i-CLINICAL_DEPT
47787	4	i-CLINICAL_DEPT
47788	for	O
47789	further	b-TEST
47790	psychiatric	i-TEST
47791	w/u	i-TEST
47792	.	O
47793	this	b-DATE
47794	morning	i-DATE
47795	,	i-DATE
47796	2017-07-12	i-DATE
47797	,	O
47798	ms.	O
47799	gallegos	O
47800	king	O
47801	feeling	O
47802	weaker	b-PROBLEM
47803	than	i-PROBLEM
47804	usual	i-PROBLEM
47805	.	O
47806	she	O
47807	noted	b-EVIDENTIAL
47808	that	O
47809	she	O
47810	had	O
47811	increased	b-PROBLEM
47812	pain	i-PROBLEM
47813	in	i-PROBLEM
47814	her	i-PROBLEM
47815	lower	i-PROBLEM
47816	back	i-PROBLEM
47817	,	O
47818	which	O
47819	she	O
47820	attributed	O
47821	to	O
47822	her	b-PROBLEM
47823	arthritis	i-PROBLEM
47824	.	O
47825	she	O
47826	ate	O
47827	a	O
47828	normal	O
47829	breakfast	O
47830	of	O
47831	cereal	O
47832	and	O
47833	milk	O
47834	.	O
47835	later	O
47836	that	O
47837	am	b-DATE
47838	,	O
47839	she	O
47840	stood	b-OCCURRENCE
47841	from	i-OCCURRENCE
47842	her	i-OCCURRENCE
47843	wheelchair	i-OCCURRENCE
47844	,	O
47845	had	O
47846	a	b-PROBLEM
47847	prodrome	i-PROBLEM
47848	of	i-PROBLEM
47849	lh	i-PROBLEM
47850	and	O
47851	then	O
47852	reports	b-EVIDENTIAL
47853	loc	b-PROBLEM
47854	and	O
47855	fall	b-PROBLEM
47856	.	O
47857	she	O
47858	denies	O
47859	any	b-PROBLEM
47860	tunnel	i-PROBLEM
47861	vision	i-PROBLEM
47862	,	O
47863	darkened	b-PROBLEM
47864	vision	i-PROBLEM
47865	,	O
47866	or	O
47867	focal	b-PROBLEM
47868	weakness	i-PROBLEM
47869	this	b-DATE
47870	morning	i-DATE
47871	.	O
47872	no	O
47873	bowel	b-PROBLEM
47874	/	i-PROBLEM
47875	bladder	i-PROBLEM
47876	incont	i-PROBLEM
47877	,	O
47878	no	O
47879	aura	b-PROBLEM
47880	,	O
47881	no	O
47882	postictal	b-PROBLEM
47883	state	i-PROBLEM
47884	.	O
47885	she	O
47886	does	O
47887	not	O
47888	recall	b-PROBLEM
47889	falling	i-PROBLEM
47890	,	O
47891	but	O
47892	does	O
47893	recall	O
47894	waking	O
47895	up	O
47896	with	O
47897	people	O
47898	surrounding	O
47899	her	O
47900	.	O
47901	during	O
47902	the	O
47903	fall	O
47904	she	O
47905	hit	b-PROBLEM
47906	her	i-PROBLEM
47907	nose	i-PROBLEM
47908	and	i-PROBLEM
47909	her	i-PROBLEM
47910	r	i-PROBLEM
47911	knee	i-PROBLEM
47912	.	O
47913	she	O
47914	does	O
47915	not	O
47916	recall	b-PROBLEM
47917	hitting	i-PROBLEM
47918	her	i-PROBLEM
47919	head	i-PROBLEM
47920	.	O
47921	she	O
47922	does	O
47923	not	O
47924	describe	O
47925	decreased	b-PROBLEM
47926	po	i-PROBLEM
47927	intake	i-PROBLEM
47928	from	O
47929	her	O
47930	norm	O
47931	this	b-DATE
47932	morning	i-DATE
47933	,	O
47934	but	O
47935	did	O
47936	feel	O
47937	dehydrated	b-PROBLEM
47938	at	O
47939	the	b-DATE
47940	time	i-DATE
47941	of	i-DATE
47942	her	i-DATE
47943	fall	i-DATE
47944	.	O
47945	loc	b-PROBLEM
47946	was	O
47947	unwitnessed	O
47948	.	O
47949	early	b-DATE
47950	this	i-DATE
47951	morning	i-DATE
47952	before	O
47953	breakfast	O
47954	her	b-TEST
47955	bs	i-TEST
47956	was	O
47957	reportedly	O
47958	145	O
47959	,	O
47960	and	O
47961	after	O
47962	loc	b-PROBLEM
47963	,	O
47964	her	b-TEST
47965	bs	i-TEST
47966	was	O
47967	reportedly	O
47968	207	O
47969	.	O
47970	she	O
47971	reports	b-EVIDENTIAL
47972	that	O
47973	her	b-TEST
47974	bp	i-TEST
47975	was	O
47976	read	O
47977	at	O
47978	60/48	O
47979	after	O
47980	her	b-PROBLEM
47981	fall	i-PROBLEM
47982	.	O
47983	her	b-TEST
47984	systolic	i-TEST
47985	bp	i-TEST
47986	measurements	i-TEST
47987	have	O
47988	been	O
47989	running	O
47990	around	O
47991	100-110	O
47992	over	O
47993	the	b-DURATION
47994	past	i-DURATION
47995	few	i-DURATION
47996	weeks	i-DURATION
47997	.	O
47998	ms.	O
47999	cassata	O
48000	has	O
48001	a	O
48002	history	O
48003	of	O
48004	""""	O
48005	passing	b-PROBLEM
48006	out	i-PROBLEM
48007	""""	O
48008	in	O
48009	august	b-DATE
48010	of	i-DATE
48011	2004	i-DATE
48012	,	O
48013	(	O
48014	?	O
48015	7	b-DURATION
48016	hours	i-DURATION
48017	)	O
48018	,	O
48019	and	O
48020	reports	O
48021	that	O
48022	this	b-PROBLEM
48023	episode	i-PROBLEM
48024	did	O
48025	not	O
48026	feel	O
48027	similar	O
48028	.	O
48029	ros	O
48030	:	O
48031	she	O
48032	denies	O
48033	any	b-PROBLEM
48034	recent	i-PROBLEM
48035	nausea	i-PROBLEM
48036	,	O
48037	but	O
48038	had	O
48039	an	O
48040	episode	O
48041	of	O
48042	vomiting	b-PROBLEM
48043	last	b-DURATION
48044	week	i-DURATION
48045	.	O
48046	she	O
48047	denies	O
48048	any	b-PROBLEM
48049	pain	i-PROBLEM
48050	with	i-PROBLEM
48051	urination	i-PROBLEM
48052	or	O
48053	incontinence	b-PROBLEM
48054	.	O
48055	she	O
48056	also	O
48057	denies	O
48058	any	b-PROBLEM
48059	recent	i-PROBLEM
48060	cough	i-PROBLEM
48061	,	O
48062	chest	b-PROBLEM
48063	pain	i-PROBLEM
48064	,	O
48065	chest	b-PROBLEM
48066	palpitations	i-PROBLEM
48067	,	O
48068	heart	b-PROBLEM
48069	racing	i-PROBLEM
48070	.	O
48071	she	O
48072	reports	O
48073	2	b-DURATION
48074	nights	i-DURATION
48075	with	O
48076	soaking	b-PROBLEM
48077	ns	i-PROBLEM
48078	.	O
48079	denies	O
48080	subj	b-PROBLEM
48081	/	i-PROBLEM
48082	obj	i-PROBLEM
48083	fevers	i-PROBLEM
48084	or	O
48085	chills	b-PROBLEM
48086	.	O
48087	she	O
48088	describes	b-EVIDENTIAL
48089	her	O
48090	mood	O
48091	as	O
48092	depressed	b-PROBLEM
48093	,	O
48094	however	O
48095	she	O
48096	denies	O
48097	suicidal	b-PROBLEM
48098	ideation	i-PROBLEM
48099	at	O
48100	this	b-DATE
48101	time	i-DATE
48102	.	O
48103	she	O
48104	reports	b-EVIDENTIAL
48105	that	O
48106	she	O
48107	took	O
48108	all	b-TREATMENT
48109	her	i-TREATMENT
48110	medications	i-TREATMENT
48111	as	O
48112	usual	O
48113	this	b-DATE
48114	morning	i-DATE
48115	,	O
48116	with	O
48117	no	O
48118	changes	O
48119	.	O
48120	brief	O
48121	hospital	O
48122	course	O
48123	:	O
48124	brief	O
48125	overview	O
48126	:	O
48127	57	O
48128	yo	O
48129	f	O
48130	with	O
48131	h/o	O
48132	polyglandular	b-PROBLEM
48133	autoimmune	i-PROBLEM
48134	syndrome	i-PROBLEM
48135	initially	O
48136	admitted	b-OCCURRENCE
48137	in	O
48138	may	b-DATE
48139	to	O
48140	ficu	b-CLINICAL_DEPT
48141	for	O
48142	suicide	b-PROBLEM
48143	overdose	i-PROBLEM
48144	then	O
48145	transferred	b-OCCURRENCE
48146	to	O
48147	whittier	b-CLINICAL_DEPT
48148	rehab	i-CLINICAL_DEPT
48149	hospital	i-CLINICAL_DEPT
48150	4	i-CLINICAL_DEPT
48151	for	O
48152	depression	b-PROBLEM
48153	,	O
48154	who	O
48155	was	O
48156	transferred	b-OCCURRENCE
48157	to	O
48158	the	b-CLINICAL_DEPT
48159	medical	i-CLINICAL_DEPT
48160	floor	i-CLINICAL_DEPT
48161	for	O
48162	a	b-PROBLEM
48163	syncopal	i-PROBLEM
48164	episode	i-PROBLEM
48165	and	O
48166	hypotension	b-PROBLEM
48167	to	O
48168	60	O
48169	systolic	O
48170	that	O
48171	returned	O
48172	to	O
48173	baseline	O
48174	with	O
48175	2.5l	O
48176	ivf	b-TREATMENT
48177	who	O
48178	was	O
48179	subsequently	O
48180	transferred	b-OCCURRENCE
48181	to	O
48182	the	b-CLINICAL_DEPT
48183	cmed	i-CLINICAL_DEPT
48184	csru	i-CLINICAL_DEPT
48185	for	O
48186	a	O
48187	recurrent	O
48188	episode	O
48189	of	O
48190	hypotension	b-PROBLEM
48191	,	O
48192	fevers	b-PROBLEM
48193	and	O
48194	concern	O
48195	for	O
48196	sepsis	b-PROBLEM
48197	.	O
48198	initially	O
48199	when	O
48200	she	O
48201	arrived	b-OCCURRENCE
48202	to	O
48203	the	b-CLINICAL_DEPT
48204	floor	i-CLINICAL_DEPT
48205	she	O
48206	was	O
48207	afebrile	b-PROBLEM
48208	,	O
48209	normotensive	O
48210	without	O
48211	signs	O
48212	of	O
48213	orthostasis	b-PROBLEM
48214	,	O
48215	had	O
48216	a	b-TEST
48217	negative	i-TEST
48218	ua	i-TEST
48219	,	O
48220	a	b-TEST
48221	clear	i-TEST
48222	chest	i-TEST
48223	xray	i-TEST
48224	and	O
48225	no	O
48226	signs	O
48227	/	O
48228	symptoms	O
48229	of	O
48230	a	b-PROBLEM
48231	fever	i-PROBLEM
48232	.	O
48233	she	O
48234	was	O
48235	slightly	b-PROBLEM
48236	tachycardic	i-PROBLEM
48237	.	O
48238	she	O
48239	was	O
48240	initially	O
48241	not	O
48242	started	O
48243	on	O
48244	antibiotics	b-TREATMENT
48245	.	O
48246	she	O
48247	was	O
48248	given	O
48249	a	b-TREATMENT
48250	standing	i-TREATMENT
48251	ivf	i-TREATMENT
48252	order	i-TREATMENT
48253	.	O
48254	overnight	b-DURATION
48255	she	O
48256	became	O
48257	febrile	b-PROBLEM
48258	to	O
48259	102.3	O
48260	,	O
48261	increasingly	b-PROBLEM
48262	tachycardic	i-PROBLEM
48263	to	O
48264	125	O
48265	,	O
48266	and	O
48267	hypotensive	b-PROBLEM
48268	to	O
48269	80	O
48270	systolic	O
48271	.	O
48272	she	O
48273	was	O
48274	started	O
48275	on	O
48276	stress	b-TREATMENT
48277	dose	i-TREATMENT
48278	steroids	i-TREATMENT
48279	and	O
48280	levo	b-TREATMENT
48281	,	O
48282	flagyl	b-TREATMENT
48283	,	O
48284	and	O
48285	vanco	b-TREATMENT
48286	.	O
48287	she	O
48288	was	O
48289	given	O
48290	4l	O
48291	of	O
48292	fluid	b-TREATMENT
48293	boluses	i-TREATMENT
48294	and	O
48295	transfered	b-OCCURRENCE
48296	to	O
48297	the	b-CLINICAL_DEPT
48298	cmed	i-CLINICAL_DEPT
48299	csru	i-CLINICAL_DEPT
48300	.	O
48301	in	O
48302	the	b-CLINICAL_DEPT
48303	cmed	i-CLINICAL_DEPT
48304	csru	i-CLINICAL_DEPT
48305	,	O
48306	repeated	O
48307	attempts	O
48308	to	O
48309	place	O
48310	lines	b-TREATMENT
48311	were	O
48312	unsuccessful	O
48313	.	O
48314	the	b-TREATMENT
48315	above	i-TREATMENT
48316	treatments	i-TREATMENT
48317	were	O
48318	continued	O
48319	.	O
48320	urine	b-TEST
48321	cultures	i-TEST
48322	returned	O
48323	with	O
48324	10-100,000	O
48325	organisms	O
48326	coag	b-PROBLEM
48327	negative	i-PROBLEM
48328	staph	i-PROBLEM
48329	.	O
48330	blood	b-TEST
48331	cultures	i-TEST
48332	remained	O
48333	negative	O
48334	.	O
48335	vital	b-TEST
48336	signs	i-TEST
48337	stabilized	O
48338	and	O
48339	she	O
48340	was	O
48341	transfered	b-OCCURRENCE
48342	back	O
48343	to	O
48344	the	b-CLINICAL_DEPT
48345	medical	i-CLINICAL_DEPT
48346	floor	i-CLINICAL_DEPT
48347	after	O
48348	2	b-DURATION
48349	days	i-DURATION
48350	in	O
48351	the	b-CLINICAL_DEPT
48352	icu	i-CLINICAL_DEPT
48353	.	O
48354	stress	b-TREATMENT
48355	dose	i-TREATMENT
48356	steroids	i-TREATMENT
48357	were	O
48358	planned	O
48359	for	O
48360	a	O
48361	7	b-DURATION
48362	day	i-DURATION
48363	course	i-DURATION
48364	,	O
48365	antibiotics	b-TREATMENT
48366	were	O
48367	peeled	O
48368	back	O
48369	to	O
48370	levofloxacin	b-TREATMENT
48371	alone	O
48372	,	O
48373	and	O
48374	a	b-TEST
48375	r	i-TEST
48376	hip	i-TEST
48377	film	i-TEST
48378	revealed	O
48379	no	O
48380	loosening	b-PROBLEM
48381	nor	O
48382	inflammation	b-PROBLEM
48383	.	O
48384	echo	b-TEST
48385	showed	O
48386	normal	O
48387	function	O
48388	,	O
48389	trace	b-PROBLEM
48390	ar	i-PROBLEM
48391	,	O
48392	and	O
48393	no	O
48394	mr	b-PROBLEM
48395	.	O
48396	she	O
48397	had	O
48398	a	O
48399	normal	O
48400	ruq	O
48401	us	O
48402	,	O
48403	as	O
48404	well	O
48405	.	O
48406	on	O
48407	the	b-CLINICAL_DEPT
48408	floor	i-CLINICAL_DEPT
48409	the	O
48410	patient	O
48411	remained	O
48412	stable	O
48413	hemodynamically	O
48414	without	O
48415	recurrent	b-PROBLEM
48416	fever	i-PROBLEM
48417	and	O
48418	was	O
48419	stable	O
48420	for	O
48421	transfer	b-OCCURRENCE
48422	back	O
48423	to	O
48424	franciscan	b-CLINICAL_DEPT
48425	children	i-CLINICAL_DEPT
48426	's	i-CLINICAL_DEPT
48427	hospital	i-CLINICAL_DEPT
48428	&	i-CLINICAL_DEPT
48429	rehab	i-CLINICAL_DEPT
48430	center	i-CLINICAL_DEPT
48431	4	i-CLINICAL_DEPT
48432	.	O
48433	at	O
48434	the	b-DATE
48435	time	i-DATE
48436	of	i-DATE
48437	discharge	i-DATE
48438	,	O
48439	her	b-TEST
48440	potassium	i-TEST
48441	had	O
48442	been	O
48443	low	O
48444	despite	O
48445	repletion	b-TREATMENT
48446	,	O
48447	na	b-TEST
48448	was	O
48449	elevated	O
48450	,	O
48451	as	O
48452	was	O
48453	blood	b-TEST
48454	pressure	i-TEST
48455	.	O
48456	on	O
48457	recommendation	O
48458	from	O
48459	endocrine	b-CLINICAL_DEPT
48460	,	O
48461	her	b-TREATMENT
48462	fludrocortisone	i-TREATMENT
48463	was	O
48464	decreased	O
48465	from	O
48466	0.2	O
48467	to	O
48468	0.1	O
48469	(	O
48470	higher	O
48471	than	O
48472	required	O
48473	doses	O
48474	of	O
48475	fludrocort	b-TREATMENT
48476	can	O
48477	cause	O
48478	these	b-PROBLEM
48479	symptoms	i-PROBLEM
48480	.	O
48481	)	O
48482	.	O
48483	1.	O
48484	hypotension	b-PROBLEM
48485	:	O
48486	patient	O
48487	presented	b-OCCURRENCE
48488	after	O
48489	episode	O
48490	of	O
48491	hypotension	b-PROBLEM
48492	and	O
48493	syncope	b-PROBLEM
48494	on	O
48495	mass.	b-CLINICAL_DEPT
48496	mental	i-CLINICAL_DEPT
48497	health	i-CLINICAL_DEPT
48498	center	i-CLINICAL_DEPT
48499	5	i-CLINICAL_DEPT
48500	.	O
48501	initially	O
48502	it	O
48503	was	O
48504	felt	O
48505	that	O
48506	this	O
48507	was	O
48508	a	O
48509	result	O
48510	of	O
48511	poor	b-PROBLEM
48512	po	i-PROBLEM
48513	intake	i-PROBLEM
48514	.	O
48515	she	O
48516	was	O
48517	afebrile	b-PROBLEM
48518	without	O
48519	orthostatic	b-PROBLEM
48520	vital	i-PROBLEM
48521	signs	i-PROBLEM
48522	nor	O
48523	hypotension	b-PROBLEM
48524	.	O
48525	she	O
48526	had	O
48527	no	O
48528	symptoms	O
48529	of	O
48530	infectious	b-PROBLEM
48531	source	i-PROBLEM
48532	,	O
48533	normal	O
48534	ua	b-TEST
48535	,	O
48536	normal	O
48537	chest	b-TEST
48538	xray	i-TEST
48539	,	O
48540	and	O
48541	no	O
48542	symptoms	O
48543	nor	O
48544	signs	O
48545	of	O
48546	injury	b-PROBLEM
48547	after	O
48548	her	b-OCCURRENCE
48549	fall	i-OCCURRENCE
48550	with	O
48551	syncope	b-PROBLEM
48552	.	O
48553	neuro	b-TEST
48554	exam	i-TEST
48555	was	O
48556	normal	O
48557	.	O
48558	subsequently	O
48559	overnight	b-DURATION
48560	,	O
48561	she	O
48562	developed	O
48563	a	b-PROBLEM
48564	fever	i-PROBLEM
48565	to	O
48566	102.3	O
48567	and	O
48568	recurrent	b-PROBLEM
48569	hypotension	i-PROBLEM
48570	in	O
48571	the	O
48572	setting	O
48573	of	O
48574	fevers	b-PROBLEM
48575	and	O
48576	tachycardia	b-PROBLEM
48577	that	O
48578	was	O
48579	concerning	O
48580	for	O
48581	an	b-PROBLEM
48582	infectious	i-PROBLEM
48583	source	i-PROBLEM
48584	.	O
48585	she	O
48586	still	O
48587	had	O
48588	no	O
48589	localizing	b-EVIDENTIAL
48590	signs	i-EVIDENTIAL
48591	of	O
48592	infection	b-PROBLEM
48593	and	O
48594	culture	b-TEST
48595	data	i-TEST
48596	was	O
48597	negative	O
48598	to	O
48599	be	O
48600	negative	O
48601	.	O
48602	ruq	b-TEST
48603	us	i-TEST
48604	was	O
48605	ordered	O
48606	and	O
48607	returned	O
48608	without	O
48609	signs	O
48610	of	O
48611	infection	b-PROBLEM
48612	later	O
48613	.	O
48614	she	O
48615	was	O
48616	started	O
48617	on	O
48618	stress	b-TREATMENT
48619	dose	i-TREATMENT
48620	steroids	i-TREATMENT
48621	.	O
48622	she	O
48623	had	O
48624	cultures	b-TEST
48625	drawn	O
48626	,	O
48627	was	O
48628	given	O
48629	tylenol	b-TREATMENT
48630	(	O
48631	tylenol	b-TEST
48632	screen	i-TEST
48633	prior	O
48634	to	O
48635	this	b-TREATMENT
48636	dose	i-TREATMENT
48637	was	O
48638	negative	O
48639	,	O
48640	as	O
48641	was	O
48642	a	b-TEST
48643	urine	i-TEST
48644	tox	i-TEST
48645	)	O
48646	,	O
48647	was	O
48648	started	O
48649	on	O
48650	levofloxacin	b-TREATMENT
48651	,	O
48652	metronidazole	b-TREATMENT
48653	,	O
48654	and	O
48655	vancomycin	b-TREATMENT
48656	to	O
48657	cover	O
48658	emperically	O
48659	for	O
48660	hospital	b-PROBLEM
48661	aquired	i-PROBLEM
48662	pneumonia	i-PROBLEM
48663	,	O
48664	gi	b-PROBLEM
48665	sources	i-PROBLEM
48666	,	O
48667	and	O
48668	a	O
48669	potential	O
48670	hip	b-PROBLEM
48671	infection	i-PROBLEM
48672	.	O
48673	her	b-TEST
48674	transaminases	i-TEST
48675	were	O
48676	slightly	O
48677	elevated	O
48678	,	O
48679	which	O
48680	was	O
48681	later	O
48682	attributed	O
48683	to	O
48684	shock	b-PROBLEM
48685	liver	i-PROBLEM
48686	as	O
48687	a	O
48688	result	O
48689	of	O
48690	her	O
48691	period	O
48692	of	O
48693	hypotension	b-PROBLEM
48694	.	O
48695	lipase	b-TEST
48696	and	O
48697	amylase	b-TEST
48698	remained	O
48699	normal	O
48700	.	O
48701	in	O
48702	the	b-CLINICAL_DEPT
48703	icu	i-CLINICAL_DEPT
48704	she	O
48705	also	O
48706	received	O
48707	an	b-TEST
48708	echo	i-TEST
48709	that	O
48710	revealed	O
48711	normal	O
48712	function	O
48713	and	O
48714	little	b-PROBLEM
48715	valvular	i-PROBLEM
48716	disease	i-PROBLEM
48717	(	O
48718	she	O
48719	has	O
48720	two	b-PROBLEM
48721	loud	i-PROBLEM
48722	systolic	i-PROBLEM
48723	murmurs	i-PROBLEM
48724	on	O
48725	exam	b-TEST
48726	)	O
48727	,	O
48728	and	O
48729	a	b-TEST
48730	hip	i-TEST
48731	film	i-TEST
48732	revealing	O
48733	no	O
48734	inflammation	b-PROBLEM
48735	nor	O
48736	loosening	b-PROBLEM
48737	.	O
48738	urine	b-TEST
48739	culture	i-TEST
48740	twice	O
48741	grew	O
48742	10-100,000	O
48743	coag	b-PROBLEM
48744	negative	i-PROBLEM
48745	staph	i-PROBLEM
48746	.	O
48747	a	b-TREATMENT
48748	line	i-TREATMENT
48749	could	O
48750	not	O
48751	be	O
48752	placed	b-OCCURRENCE
48753	for	O
48754	technical	O
48755	reasons	O
48756	,	O
48757	however	O
48758	after	O
48759	4l	O
48760	ns	b-TREATMENT
48761	on	O
48762	the	b-CLINICAL_DEPT
48763	floor	i-CLINICAL_DEPT
48764	and	O
48765	01-30	O
48766	more	O
48767	in	O
48768	the	b-CLINICAL_DEPT
48769	icu	i-CLINICAL_DEPT
48770	via	O
48771	peripheral	b-TREATMENT
48772	iv	i-TREATMENT
48773	's	O
48774	she	O
48775	was	O
48776	stable	O
48777	.	O
48778	she	O
48779	remained	b-OCCURRENCE
48780	hemodynamically	i-OCCURRENCE
48781	stable	i-OCCURRENCE
48782	with	i-OCCURRENCE
48783	good	i-OCCURRENCE
48784	uop	i-OCCURRENCE
48785	in	O
48786	the	O
48787	setting	O
48788	of	O
48789	being	O
48790	started	O
48791	on	O
48792	abx	b-TREATMENT
48793	and	O
48794	stress	b-TREATMENT
48795	dose	i-TREATMENT
48796	steroids	i-TREATMENT
48797	.	O
48798	the	b-TREATMENT
48799	steroids	i-TREATMENT
48800	were	O
48801	thought	O
48802	to	O
48803	have	O
48804	helped	O
48805	significantly	O
48806	in	O
48807	in	O
48808	the	O
48809	setting	O
48810	of	O
48811	addison	b-PROBLEM
48812	's	i-PROBLEM
48813	with	O
48814	possibely	O
48815	superimposed	b-PROBLEM
48816	infection	i-PROBLEM
48817	.	O
48818	the	O
48819	patient	O
48820	was	O
48821	planned	O
48822	for	O
48823	a	O
48824	7	b-DURATION
48825	day	i-DURATION
48826	course	i-DURATION
48827	of	O
48828	stress	b-TREATMENT
48829	dose	i-TREATMENT
48830	steroids	i-TREATMENT
48831	followed	O
48832	by	O
48833	a	O
48834	return	O
48835	to	O
48836	her	b-TREATMENT
48837	basal	i-TREATMENT
48838	predinisone	i-TREATMENT
48839	/	O
48840	fludrocortisone	b-TREATMENT
48841	dose	i-TREATMENT
48842	.	O
48843	2.	O
48844	elevated	b-PROBLEM
48845	lfts	i-PROBLEM
48846	:	O
48847	lfts	b-TEST
48848	wre	O
48849	elevated	b-PROBLEM
48850	at	O
48851	presentation	b-OCCURRENCE
48852	.	O
48853	initially	O
48854	the	O
48855	differential	O
48856	was	O
48857	thought	O
48858	to	O
48859	include	O
48860	shock	b-PROBLEM
48861	liver	i-PROBLEM
48862	from	O
48863	hypotension	b-PROBLEM
48864	,	O
48865	hepatitis	b-PROBLEM
48866	,	O
48867	cholangitis	b-PROBLEM
48868	or	O
48869	choledocholithiasis	b-PROBLEM
48870	.	O
48871	hepatitis	b-TEST
48872	serologies	i-TEST
48873	were	O
48874	negative	O
48875	and	O
48876	the	O
48877	pt	O
48878	was	O
48879	eventually	O
48880	felt	O
48881	to	O
48882	have	O
48883	had	O
48884	shock	b-PROBLEM
48885	liver	i-PROBLEM
48886	from	O
48887	her	b-PROBLEM
48888	hypotensive	i-PROBLEM
48889	episode	i-PROBLEM
48890	as	O
48891	the	b-PROBLEM
48892	transaminitis	i-PROBLEM
48893	resolved	O
48894	over	O
48895	time	O
48896	.	O
48897	3.	O
48898	hypoparathyroidism	b-PROBLEM
48899	:	O
48900	this	O
48901	is	O
48902	a	b-PROBLEM
48903	chronic	i-PROBLEM
48904	problem	i-PROBLEM
48905	.	O
48906	calcium	b-TEST
48907	levels	i-TEST
48908	were	O
48909	followed	O
48910	with	O
48911	a	O
48912	goal	O
48913	to	O
48914	keep	O
48915	them	O
48916	around	O
48917	8.0	O
48918	by	O
48919	continuing	O
48920	calcium	b-TREATMENT
48921	carbonate	i-TREATMENT
48922	,	O
48923	calcitriol	b-TREATMENT
48924	.	O
48925	the	O
48926	pt	O
48927	required	O
48928	calcium	b-TREATMENT
48929	gluconate	i-TREATMENT
48930	x1	O
48931	the	b-DATE
48932	day	i-DATE
48933	prior	i-DATE
48934	to	i-DATE
48935	discharge	i-DATE
48936	.	O
48937	per	O
48938	endocrine	b-CLINICAL_DEPT
48939	at	O
48940	the	b-DATE
48941	time	i-DATE
48942	of	i-DATE
48943	discharge	i-DATE
48944	,	O
48945	the	O
48946	pt	O
48947	may	O
48948	need	O
48949	an	O
48950	increase	O
48951	in	O
48952	calcium	b-TREATMENT
48953	po	i-TREATMENT
48954	,	O
48955	but	O
48956	at	O
48957	this	b-DATE
48958	time	i-DATE
48959	they	O
48960	recommended	O
48961	no	O
48962	change	O
48963	.	O
48964	it	O
48965	will	O
48966	need	O
48967	to	O
48968	be	O
48969	monitored	O
48970	over	O
48971	time	O
48972	.	O
48973	4.	O
48974	addison	b-PROBLEM
48975	's-	i-PROBLEM
48976	the	O
48977	patient	O
48978	is	O
48979	on	O
48980	basal	b-TREATMENT
48981	prednisone	i-TREATMENT
48982	/	O
48983	fludrocortisone	b-TREATMENT
48984	.	O
48985	these	O
48986	were	O
48987	initially	O
48988	continued	O
48989	as	O
48990	above	O
48991	and	O
48992	later	O
48993	,	O
48994	when	O
48995	she	O
48996	became	O
48997	hypotensive	b-PROBLEM
48998	and	O
48999	febrile	b-PROBLEM
49000	,	O
49001	stress	b-TREATMENT
49002	dose	i-TREATMENT
49003	steroids	i-TREATMENT
49004	were	O
49005	started	O
49006	and	O
49007	planned	O
49008	for	O
49009	a	O
49010	7	b-DURATION
49011	day	i-DURATION
49012	course	i-DURATION
49013	followed	O
49014	by	O
49015	a	O
49016	return	O
49017	to	O
49018	her	O
49019	prior	O
49020	dose	O
49021	of	O
49022	prednisone	b-TREATMENT
49023	.	O
49024	at	O
49025	the	b-DATE
49026	time	i-DATE
49027	of	i-DATE
49028	discharge	i-DATE
49029	,	O
49030	her	b-TEST
49031	potassium	i-TEST
49032	had	O
49033	been	O
49034	low	O
49035	despite	O
49036	repletion	b-TREATMENT
49037	,	O
49038	na	b-TEST
49039	was	O
49040	elevated	O
49041	,	O
49042	as	O
49043	was	O
49044	blood	b-TEST
49045	pressure	i-TEST
49046	.	O
49047	on	O
49048	recommendation	O
49049	from	O
49050	endocrine	b-CLINICAL_DEPT
49051	,	O
49052	her	b-TREATMENT
49053	fludrocortisone	i-TREATMENT
49054	was	O
49055	decreased	O
49056	from	O
49057	0.2	O
49058	to	O
49059	0.1	O
49060	(	O
49061	higher	O
49062	than	O
49063	required	O
49064	doses	O
49065	of	O
49066	fludrocort	O
49067	can	O
49068	cause	O
49069	these	b-PROBLEM
49070	symptoms.	i-PROBLEM
49071	)	O
49072	.	O
49073	5.	O
49074	dm	b-PROBLEM
49075	:	O
49076	light	O
49077	followed	O
49078	the	O
49079	patient	O
49080	.	O
49081	she	O
49082	was	O
49083	continued	O
49084	on	O
49085	her	O
49086	prior	O
49087	dose	O
49088	of	O
49089	steroids	b-TREATMENT
49090	with	O
49091	sliding	b-TREATMENT
49092	scale	i-TREATMENT
49093	per	O
49094	patient	O
49095	using	O
49096	a	b-TREATMENT
49097	1:15	i-TREATMENT
49098	carb	i-TREATMENT
49099	counting	i-TREATMENT
49100	scheme	i-TREATMENT
49101	with	O
49102	a	b-TREATMENT
49103	1:30	i-TREATMENT
49104	correction	i-TREATMENT
49105	factor	i-TREATMENT
49106	.	O
49107	on	O
49108	the	b-DATE
49109	day	i-DATE
49110	of	i-DATE
49111	discharge	i-DATE
49112	her	b-TREATMENT
49113	glargine	i-TREATMENT
49114	was	O
49115	decreased	O
49116	by	O
49117	one	O
49118	unit	O
49119	because	O
49120	her	b-TEST
49121	glucose	i-TEST
49122	remained	O
49123	somewhat	O
49124	low	O
49125	in	O
49126	the	b-DATE
49127	mornings	i-DATE
49128	.	O
49129	6.	O
49130	r	b-PROBLEM
49131	hip	i-PROBLEM
49132	pain	i-PROBLEM
49133	:	O
49134	later	O
49135	in	O
49136	her	b-OCCURRENCE
49137	hospital	i-OCCURRENCE
49138	course	i-OCCURRENCE
49139	,	O
49140	the	O
49141	pt	O
49142	complained	O
49143	of	O
49144	hip	b-PROBLEM
49145	pain	i-PROBLEM
49146	.	O
49147	a	b-TEST
49148	r	i-TEST
49149	hip	i-TEST
49150	film	i-TEST
49151	was	O
49152	negative	O
49153	for	O
49154	pathology	b-PROBLEM
49155	or	O
49156	failure	b-PROBLEM
49157	of	O
49158	her	b-TREATMENT
49159	hip	i-TREATMENT
49160	replacement	i-TREATMENT
49161	.	O
49162	pain	b-PROBLEM
49163	was	O
49164	controlled	O
49165	with	O
49166	tylenol	b-TREATMENT
49167	and	O
49168	the	O
49169	pt	O
49170	was	O
49171	reassured	O
49172	.	O
49173	pt	O
49174	was	O
49175	consulted	O
49176	.	O
49177	the	O
49178	pt	O
49179	uses	O
49180	a	O
49181	wheelchair	O
49182	often	O
49183	at	O
49184	baseline	O
49185	due	O
49186	to	O
49187	pain	b-PROBLEM
49188	from	O
49189	arthritis	b-PROBLEM
49190	.	O
49191	7.	O
49192	depression	b-PROBLEM
49193	:	O
49194	the	O
49195	pt	O
49196	was	O
49197	being	O
49198	treated	O
49199	at	O
49200	mediplex	b-CLINICAL_DEPT
49201	rehab	i-CLINICAL_DEPT
49202	hospital	i-CLINICAL_DEPT
49203	4	i-CLINICAL_DEPT
49204	for	O
49205	suicidal	b-PROBLEM
49206	ideation	i-PROBLEM
49207	and	O
49208	a	b-PROBLEM
49209	suicide	i-PROBLEM
49210	attempt	i-PROBLEM
49211	on	O
49212	original	O
49213	admission	b-OCCURRENCE
49214	with	O
49215	tylenol	b-TREATMENT
49216	and	O
49217	oxycodone	b-TREATMENT
49218	.	O
49219	she	O
49220	had	O
49221	planned	O
49222	this	b-OCCURRENCE
49223	attempt	i-OCCURRENCE
49224	carefully	O
49225	without	O
49226	the	O
49227	knowledge	O
49228	of	O
49229	those	O
49230	close	O
49231	to	O
49232	her	O
49233	and	O
49234	very	O
49235	much	O
49236	expected	O
49237	her	b-OCCURRENCE
49238	attempt	i-OCCURRENCE
49239	to	O
49240	work	O
49241	.	O
49242	she	O
49243	had	O
49244	been	O
49245	depressed	b-PROBLEM
49246	for	O
49247	some	O
49248	time	O
49249	but	O
49250	her	O
49251	loved	O
49252	ones	O
49253	were	O
49254	very	O
49255	surprised	O
49256	at	O
49257	her	b-OCCURRENCE
49258	attempt	i-OCCURRENCE
49259	.	O
49260	she	O
49261	remained	O
49262	very	b-PROBLEM
49263	depressed	i-PROBLEM
49264	at	O
49265	her	O
49266	inpatient	O
49267	admission	b-OCCURRENCE
49268	and	O
49269	refractory	b-PROBLEM
49270	to	O
49271	treatment	b-TREATMENT
49272	.	O
49273	one	b-DATE
49274	day	i-DATE
49275	prior	i-DATE
49276	to	i-DATE
49277	her	i-DATE
49278	transfer	i-DATE
49279	to	O
49280	the	b-CLINICAL_DEPT
49281	medical	i-CLINICAL_DEPT
49282	floor	i-CLINICAL_DEPT
49283	she	O
49284	was	O
49285	sectioned	O
49286	to	O
49287	initiate	O
49288	ect	b-TREATMENT
49289	,	O
49290	which	O
49291	she	O
49292	had	O
49293	previously	O
49294	refused	O
49295	.	O
49296	as	O
49297	a	O
49298	result	O
49299	,	O
49300	she	O
49301	was	O
49302	maintained	O
49303	on	O
49304	her	b-TREATMENT
49305	ativan	i-TREATMENT
49306	,	O
49307	mirtazapine	b-TREATMENT
49308	,	O
49309	risperidone	b-TREATMENT
49310	,	O
49311	duloxetine	b-TREATMENT
49312	.	O
49313	she	O
49314	did	O
49315	not	O
49316	exhibit	O
49317	psychotic	b-PROBLEM
49318	symptoms	i-PROBLEM
49319	.	O
49320	she	O
49321	had	O
49322	a	O
49323	1:1	O
49324	sitter	O
49325	at	O
49326	all	O
49327	times	O
49328	.	O
49329	she	O
49330	denied	O
49331	any	b-PROBLEM
49332	suicidality	i-PROBLEM
49333	but	O
49334	did	O
49335	endorse	O
49336	depression	b-PROBLEM
49337	.	O
49338	she	O
49339	denied	O
49340	hi	b-PROBLEM
49341	,	O
49342	si	b-PROBLEM
49343	,	O
49344	and	O
49345	illusions	b-PROBLEM
49346	/	O
49347	hallucinations	b-PROBLEM
49348	.	O
49349	her	O
49350	mood	O
49351	appeared	O
49352	stable	b-OCCURRENCE
49353	throughout	O
49354	her	b-OCCURRENCE
49355	hospitalization	i-OCCURRENCE
49356	.	O
49357	she	O
49358	was	O
49359	followed	O
49360	by	O
49361	psychiatry	b-CLINICAL_DEPT
49362	in	O
49363	consultation	O
49364	while	O
49365	she	O
49366	was	O
49367	on	O
49368	the	b-CLINICAL_DEPT
49369	medical	i-CLINICAL_DEPT
49370	floor	i-CLINICAL_DEPT
49371	.	O
49372	the	O
49373	patient	O
49374	did	O
49375	have	O
49376	heparin	b-TREATMENT
49377	subcutaneously	i-TREATMENT
49378	while	O
49379	on	O
49380	the	b-CLINICAL_DEPT
49381	medical	i-CLINICAL_DEPT
49382	floor	i-CLINICAL_DEPT
49383	and	O
49384	in	O
49385	the	b-CLINICAL_DEPT
49386	icu	i-CLINICAL_DEPT
49387	.	O
49388	she	O
49389	remained	O
49390	full	b-TREATMENT
49391	code	i-TREATMENT
49392	throughout	O
49393	the	b-OCCURRENCE
49394	hospitalization	i-OCCURRENCE
49395	.	O
49396	as	O
49397	on	O
49398	prior	O
49399	hospitalization	O
49400	,	O
49401	her	O
49402	hcp	O
49403	was	O
49404	shared	O
49405	by	O
49406	dianne	O
49407	white	O
49408	.	O
49409		O
49410	admission	b-OCCURRENCE
49411	date	O
49412	:	O
49413	06/02/2005	b-ADMISSION
49414	discharge	b-OCCURRENCE
49415	date	O
49416	:	O
49417	06/05/2005	b-DISCHARGE
49418	history	O
49419	of	O
49420	present	O
49421	illness	O
49422	:	O
49423	the	O
49424	patient	O
49425	is	O
49426	a	O
49427	63-year-old	O
49428	female	O
49429	with	O
49430	a	O
49431	three-year	b-DURATION
49432	history	O
49433	of	O
49434	bilateral	b-PROBLEM
49435	hand	i-PROBLEM
49436	numbness	i-PROBLEM
49437	and	O
49438	occasional	b-PROBLEM
49439	weakness	i-PROBLEM
49440	.	O
49441	within	O
49442	the	O
49443	past	O
49444	year	b-DURATION
49445	,	O
49446	these	b-PROBLEM
49447	symptoms	i-PROBLEM
49448	have	O
49449	progressively	b-OCCURRENCE
49450	gotten	i-OCCURRENCE
49451	worse	i-OCCURRENCE
49452	,	O
49453	to	O
49454	encompass	O
49455	also	O
49456	her	O
49457	feet	O
49458	.	O
49459	she	O
49460	had	O
49461	a	b-TEST
49462	workup	i-TEST
49463	by	O
49464	her	O
49465	neurologist	O
49466	and	O
49467	an	b-TEST
49468	mri	i-TEST
49469	revealed	b-EVIDENTIAL
49470	a	b-PROBLEM
49471	c5-6	i-PROBLEM
49472	disc	i-PROBLEM
49473	herniation	i-PROBLEM
49474	with	O
49475	cord	b-PROBLEM
49476	compression	i-PROBLEM
49477	and	O
49478	a	b-PROBLEM
49479	t2	i-PROBLEM
49480	signal	i-PROBLEM
49481	change	i-PROBLEM
49482	at	O
49483	that	O
49484	level	O
49485	.	O
49486	hospital	O
49487	course	O
49488	:	O
49489	the	O
49490	patient	O
49491	tolerated	b-OCCURRENCE
49492	a	b-TREATMENT
49493	c5-6	i-TREATMENT
49494	acdf	i-TREATMENT
49495	by	O
49496	doctor	O
49497	miezetri	O
49498	gach	O
49499	quite	O
49500	well	b-OCCURRENCE
49501	.	O
49502	she	O
49503	had	O
49504	a	b-TEST
49505	postoperative	i-TEST
49506	ct	i-TEST
49507	scan	i-TEST
49508	that	O
49509	revealed	b-EVIDENTIAL
49510	partial	b-PROBLEM
49511	decompression	i-PROBLEM
49512	of	i-PROBLEM
49513	the	i-PROBLEM
49514	spinal	i-PROBLEM
49515	canal	i-PROBLEM
49516	and	O
49517	good	b-OCCURRENCE
49518	placement	i-OCCURRENCE
49519	of	O
49520	her	b-TREATMENT
49521	hardware	i-TREATMENT
49522	.	O
49523	immediately	O
49524	postop	O
49525	,	O
49526	her	b-TEST
49527	exam	i-TEST
49528	only	O
49529	improved	b-OCCURRENCE
49530	slightly	O
49531	in	O
49532	her	b-PROBLEM
49533	hyperreflexia	i-PROBLEM
49534	.	O
49535	she	O
49536	was	O
49537	ambulating	b-OCCURRENCE
49538	by	O
49539	postoperative	b-DATE
49540	day	i-DATE
49541	number	i-DATE
49542	two	i-DATE
49543	.	O
49544	she	O
49545	tolerated	O
49546	a	b-OCCURRENCE
49547	regular	i-OCCURRENCE
49548	diet	i-OCCURRENCE
49549	.	O
49550	her	b-PROBLEM
49551	pain	i-PROBLEM
49552	was	O
49553	under	O
49554	good	b-OCCURRENCE
49555	control	i-OCCURRENCE
49556	with	O
49557	po	b-TREATMENT
49558	pain	i-TREATMENT
49559	medications	i-TREATMENT
49560	and	O
49561	she	O
49562	was	O
49563	deemed	O
49564	suitable	O
49565	for	O
49566	discharge	b-OCCURRENCE
49567	.	O
49568		O
49569	admission	b-OCCURRENCE
49570	date	O
49571	:	O
49572	10/14/2004	b-ADMISSION
49573	discharge	b-OCCURRENCE
49574	date	O
49575	:	O
49576	10/17/2004	b-DISCHARGE
49577	history	O
49578	of	O
49579	present	O
49580	illness	O
49581	:	O
49582	this	O
49583	is	O
49584	a	O
49585	56-year-old	O
49586	menopausal	O
49587	female	O
49588	g3	b-OCCURRENCE
49589	,	i-OCCURRENCE
49590	p3	i-OCCURRENCE
49591	who	O
49592	presented	b-EVIDENTIAL
49593	initially	O
49594	for	O
49595	evaluation	b-TEST
49596	of	O
49597	a	b-PROBLEM
49598	pelvic	i-PROBLEM
49599	mass	i-PROBLEM
49600	while	O
49601	recently	O
49602	vacationing	b-OCCURRENCE
49603	in	O
49604	an	O
49605	saintcafield	O
49606	terland	O
49607	.	O
49608	she	O
49609	had	O
49610	a	b-TEST
49611	physical	i-TEST
49612	over	O
49613	there	O
49614	,	O
49615	and	O
49616	the	b-TEST
49617	evaluation	i-TEST
49618	included	O
49619	an	b-TEST
49620	ultrasound	i-TEST
49621	which	O
49622	showed	b-EVIDENTIAL
49623	an	b-PROBLEM
49624	ovarian	i-PROBLEM
49625	mass	i-PROBLEM
49626	.	O
49627	she	O
49628	was	O
49629	seen	O
49630	in	O
49631	the	b-CLINICAL_DEPT
49632	emergency	i-CLINICAL_DEPT
49633	room	i-CLINICAL_DEPT
49634	here	O
49635	on	O
49636	08/31/04	b-DATE
49637	where	O
49638	they	O
49639	performed	O
49640	an	b-TEST
49641	abdominal	i-TEST
49642	ct	i-TEST
49643	that	O
49644	showed	b-EVIDENTIAL
49645	a	b-PROBLEM
49646	14	i-PROBLEM
49647	x	i-PROBLEM
49648	14	i-PROBLEM
49649	x	i-PROBLEM
49650	10	i-PROBLEM
49651	cm	i-PROBLEM
49652	pelvic	i-PROBLEM
49653	mass	i-PROBLEM
49654	with	O
49655	multiple	b-PROBLEM
49656	enlarged	i-PROBLEM
49657	lymph	i-PROBLEM
49658	nodes	i-PROBLEM
49659	.	O
49660	the	O
49661	patient	O
49662	was	O
49663	thus	O
49664	sent	b-OCCURRENCE
49665	to	i-OCCURRENCE
49666	gyn	i-OCCURRENCE
49667	for	O
49668	further	b-TEST
49669	workup	i-TEST
49670	and	O
49671	is	O
49672	now	O
49673	here	O
49674	for	O
49675	surgical	b-TREATMENT
49676	management	i-TREATMENT
49677	of	O
49678	pelvic	b-PROBLEM
49679	mass	i-PROBLEM
49680	.	O
49681	her	b-TEST
49682	ca-125	i-TEST
49683	is	O
49684	9	O
49685	.	O
49686	hospital	O
49687	course	O
49688	:	O
49689	the	O
49690	patient	O
49691	was	O
49692	taken	O
49693	to	O
49694	the	b-CLINICAL_DEPT
49695	operating	i-CLINICAL_DEPT
49696	room	i-CLINICAL_DEPT
49697	on	O
49698	hospital	b-DATE
49699	day	i-DATE
49700	#	i-DATE
49701	1	i-DATE
49702	where	O
49703	she	O
49704	underwent	O
49705	an	b-TREATMENT
49706	uncomplicated	i-TREATMENT
49707	total	i-TREATMENT
49708	abdominal	i-TREATMENT
49709	hysterectomy	i-TREATMENT
49710	,	O
49711	bilateral	b-TREATMENT
49712	salpingo-oophorectomy	i-TREATMENT
49713	,	O
49714	right	b-TREATMENT
49715	lymph	i-TREATMENT
49716	node	i-TREATMENT
49717	dissection	i-TREATMENT
49718	,	O
49719	appendectomy	b-TREATMENT
49720	,	O
49721	omental	b-TEST
49722	biopsy	i-TEST
49723	,	O
49724	pelvic	b-TREATMENT
49725	washings	i-TREATMENT
49726	,	O
49727	and	O
49728	pap	b-TREATMENT
49729	of	i-TREATMENT
49730	the	i-TREATMENT
49731	diaphragm	i-TREATMENT
49732	.	O
49733	an	b-PROBLEM
49734	estimated	i-PROBLEM
49735	blood	i-PROBLEM
49736	loss	i-PROBLEM
49737	was	O
49738	100	O
49739	cc	O
49740	.	O
49741	at	O
49742	the	O
49743	time	O
49744	of	O
49745	surgery	b-TREATMENT
49746	,	O
49747	frozen	b-TEST
49748	section	i-TEST
49749	revealed	b-EVIDENTIAL
49750	benign	b-PROBLEM
49751	mucinous	i-PROBLEM
49752	cystadenoma	i-PROBLEM
49753	.	O
49754	by	O
49755	postoperative	b-DATE
49756	day	i-DATE
49757	#3	i-DATE
49758	,	O
49759	the	O
49760	patient	O
49761	was	O
49762	tolerating	b-OCCURRENCE
49763	p.o.&apos;	i-OCCURRENCE
49764	s	i-OCCURRENCE
49765	,	O
49766	tolerating	O
49767	oral	b-TREATMENT
49768	pain	i-TREATMENT
49769	medications	i-TREATMENT
49770	,	O
49771	ambulating	b-OCCURRENCE
49772	,	O
49773	passing	b-OCCURRENCE
49774	flatus	i-OCCURRENCE
49775	,	O
49776	and	O
49777	having	b-OCCURRENCE
49778	a	i-OCCURRENCE
49779	bowel	i-OCCURRENCE
49780	movement	i-OCCURRENCE
49781	.	O
49782	she	O
49783	was	O
49784	voiding	b-OCCURRENCE
49785	without	O
49786	difficulty	b-PROBLEM
49787	.	O
49788	her	b-TEST
49789	hematocrit	i-TEST
49790	preoperatively	O
49791	was	O
49792	36	O
49793	and	O
49794	postoperatively	O
49795	was	O
49796	33	O
49797	and	O
49798	then	O
49799	32	O
49800	.	O
49801	the	O
49802	patient	O
49803	did	O
49804	have	O
49805	some	b-PROBLEM
49806	tachycardia	b-PROBLEM
49807	postoperatively	i-PROBLEM
49808	;	O
49809	however	O
49810	,	O
49811	her	b-TEST
49812	hematocrit	i-TEST
49813	remained	O
49814	stable	b-OCCURRENCE
49815	.	O
49816	she	O
49817	was	O
49818	asymptomatic	b-PROBLEM
49819	,	O
49820	and	O
49821	her	b-TEST
49822	ekg	i-TEST
49823	was	O
49824	within	O
49825	normal	O
49826	limits	O
49827	.	O
49828	her	b-PROBLEM
49829	tachycardia	i-PROBLEM
49830	improved	b-OCCURRENCE
49831	.	O
49832	throughout	O
49833	this	O
49834	time	O
49835	,	O
49836	she	O
49837	had	O
49838	normal	b-TEST
49839	vital	i-TEST
49840	signs	i-TEST
49841	with	O
49842	a	b-TEST
49843	normal	i-TEST
49844	o2	i-TEST
49845	saturation	i-TEST
49846	.	O
49847		O
49848	admission	b-OCCURRENCE
49849	date	O
49850	:	O
49851	2020-01-20	b-ADMISSION
49852	discharge	b-OCCURRENCE
49853	date	O
49854	:	O
49855	2020-01-21	b-DISCHARGE
49856	service	O
49857	:	O
49858	medicine	O
49859	history	O
49860	of	O
49861	present	O
49862	illness	O
49863	:	O
49864	42	O
49865	yom	O
49866	with	O
49867	pmh	O
49868	of	O
49869	htn	b-PROBLEM
49870	,	O
49871	hyperchol	b-PROBLEM
49872	admitted	b-OCCURRENCE
49873	to	O
49874	osh	b-CLINICAL_DEPT
49875	1	b-DATE
49876	day	i-DATE
49877	ago	i-DATE
49878	with	O
49879	black	b-PROBLEM
49880	tarry	i-PROBLEM
49881	stools	i-PROBLEM
49882	x	O
49883	2	b-DURATION
49884	days	i-DURATION
49885	.	O
49886	patient	O
49887	states	b-EVIDENTIAL
49888	that	O
49889	he	O
49890	had	O
49891	chronically	O
49892	had	O
49893	loose	b-PROBLEM
49894	stools	i-PROBLEM
49895	but	O
49896	over	O
49897	2	b-DURATION
49898	preeceeding	i-DURATION
49899	days	i-DURATION
49900	noticed	O
49901	the	b-OCCURRENCE
49902	stool	i-OCCURRENCE
49903	to	O
49904	be	O
49905	dark	b-PROBLEM
49906	and	O
49907	tarry	b-PROBLEM
49908	.	O
49909	+	O
49910	epigastric	b-PROBLEM
49911	discomfort	i-PROBLEM
49912	,	O
49913	gurgling	b-PROBLEM
49914	gas-like	i-PROBLEM
49915	pain	i-PROBLEM
49916	,	O
49917	no	O
49918	association	b-OCCURRENCE
49919	with	i-OCCURRENCE
49920	food	i-OCCURRENCE
49921	.	O
49922	+	O
49923	lightheadedness	b-PROBLEM
49924	when	O
49925	he	O
49926	stood	O
49927	up	O
49928	prompting	O
49929	him	O
49930	to	O
49931	go	O
49932	to	O
49933	osh	b-CLINICAL_DEPT
49934	nellie	i-CLINICAL_DEPT
49935	.	O
49936	he	O
49937	states	b-EVIDENTIAL
49938	that	O
49939	he	O
49940	takes	O
49941	asa	b-TREATMENT
49942	daily	b-FREQUENCY
49943	and	O
49944	takes	O
49945	motrin	b-TREATMENT
49946	800	O
49947	mg	O
49948	tid	b-FREQUENCY
49949	sometimes	O
49950	for	O
49951	pain	b-PROBLEM
49952	,	O
49953	last	O
49954	use	O
49955	2	b-DATE
49956	wks	i-DATE
49957	pta	i-DATE
49958	.	O
49959	denies	b-EVIDENTIAL
49960	brbpr	b-PROBLEM
49961	,	O
49962	n/v/d	b-PROBLEM
49963	.	O
49964	denies	b-EVIDENTIAL
49965	recent	b-PROBLEM
49966	fevers	i-PROBLEM
49967	,	O
49968	chills	b-PROBLEM
49969	.	O
49970	denies	b-EVIDENTIAL
49971	any	b-PROBLEM
49972	hemetemesis	i-PROBLEM
49973	.	O
49974	at	O
49975	osh	b-CLINICAL_DEPT
49976	initial	b-TEST
49977	hct	i-TEST
49978	=	O
49979	26	O
49980	,	O
49981	and	O
49982	22	O
49983	upon	O
49984	repeat	O
49985	.	O
49986	he	O
49987	was	O
49988	also	O
49989	orthostatic	b-PROBLEM
49990	given	O
49991	3	O
49992	units	O
49993	prbc	b-TREATMENT
49994	and	O
49995	ivf	b-TREATMENT
49996	.	O
49997	egd	b-TEST
49998	attempted	O
49999	but	O
50000	pt	O
50001	unable	b-PROBLEM
50002	to	i-PROBLEM
50003	tolerate	i-PROBLEM
50004	.	O
50005	he	O
50006	is	O
50007	now	O
50008	transferred	b-OCCURRENCE
50009	to	O
50010	mediplex	b-CLINICAL_DEPT
50011	rehab	i-CLINICAL_DEPT
50012	hospital	i-CLINICAL_DEPT
50013	for	O
50014	futher	b-TEST
50015	workup	i-TEST
50016	and	O
50017	rx	b-TREATMENT
50018	.	O
50019	on	O
50020	transfer	b-OCCURRENCE
50021	pt	O
50022	denies	b-EVIDENTIAL
50023	any	O
50024	complaints	b-PROBLEM
50025	.	O
50026	states	b-EVIDENTIAL
50027	that	O
50028	lightheadedness	b-PROBLEM
50029	is	O
50030	resolved	O
50031	.	O
50032	brief	O
50033	hospital	O
50034	course	O
50035	:	O
50036	assessment	O
50037	and	O
50038	plan	O
50039	:	O
50040	42	O
50041	yom	O
50042	with	O
50043	h/o	O
50044	nsaid	b-TREATMENT
50045	use	O
50046	transferred	b-OCCURRENCE
50047	from	O
50048	osh	b-CLINICAL_DEPT
50049	with	O
50050	black	b-PROBLEM
50051	tarry	i-PROBLEM
50052	stools	i-PROBLEM
50053	at	O
50054	home	O
50055	.	O
50056	patient	O
50057	was	O
50058	admitted	b-OCCURRENCE
50059	to	O
50060	cmed	b-CLINICAL_DEPT
50061	ccu	i-CLINICAL_DEPT
50062	with	O
50063	tid	b-FREQUENCY
50064	hct	b-TEST
50065	check	i-TEST
50066	.	O
50067	gi	O
50068	was	O
50069	consulted	O
50070	and	O
50071	performed	O
50072	endoscopy	b-TEST
50073	under	O
50074	general	b-TREATMENT
50075	anesthesia	i-TREATMENT
50076	which	O
50077	revealed	b-EVIDENTIAL
50078	a	b-PROBLEM
50079	non	i-PROBLEM
50080	bleeding	i-PROBLEM
50081	ulcer	i-PROBLEM
50082	and	O
50083	gastritis	b-PROBLEM
50084	.	O
50085	patient	O
50086	was	O
50087	continued	O
50088	on	O
50089	bid	b-FREQUENCY
50090	ppi	b-TREATMENT
50091	,	O
50092	h	b-TREATMENT
50093	.	O
50094	pylori	b-TEST
50095	serology	i-TEST
50096	checked	O
50097	(	O
50098	pending	O
50099	at	O
50100	time	O
50101	of	O
50102	discharge	b-OCCURRENCE
50103	)	O
50104	.	O
50105	his	b-TREATMENT
50106	antihypertensives	i-TREATMENT
50107	were	O
50108	held	b-OCCURRENCE
50109	given	O
50110	concern	O
50111	for	O
50112	gi	b-PROBLEM
50113	bleed	i-PROBLEM
50114	and	O
50115	should	O
50116	be	O
50117	restarted	b-TREATMENT
50118	at	O
50119	follow	b-OCCURRENCE
50120	up	i-OCCURRENCE
50121	appointment	i-OCCURRENCE
50122	with	O
50123	pcp	O
50124	.	O
50125	marie	O
50126	was	O
50127	discharged	b-OCCURRENCE
50128	with	O
50129	goal	b-TREATMENT
50130	ppi	i-TREATMENT
50131	twice	b-FREQUENCY
50132	day	i-FREQUENCY
50133	for	O
50134	1	b-DURATION
50135	month	i-DURATION
50136	followed	O
50137	by	O
50138	once	b-FREQUENCY
50139	a	i-FREQUENCY
50140	day	i-FREQUENCY
50141	.	O
50142	he	O
50143	is	O
50144	scheduled	O
50145	to	O
50146	follow	b-OCCURRENCE
50147	up	i-OCCURRENCE
50148	with	O
50149	daughter	O
50150	in	O
50151	2	b-DATE
50152	days	i-DATE
50153	.	O
50154		O
50155	admission	b-OCCURRENCE
50156	date	O
50157	:	O
50158	2019-06-14	b-ADMISSION
50159	discharge	b-OCCURRENCE
50160	date	O
50161	:	O
50162	2019-06-19	b-DISCHARGE
50163	service	O
50164	:	O
50165	medicine	O
50166	history	O
50167	of	O
50168	present	O
50169	illness	O
50170	:	O
50171	mr.	O
50172	mcelveen	O
50173	is	O
50174	a	O
50175	51	O
50176	year-old	O
50177	male	O
50178	with	O
50179	metastatic	b-PROBLEM
50180	rcc	i-PROBLEM
50181	status	O
50182	post	O
50183	left	b-TREATMENT
50184	radical	i-TREATMENT
50185	nephrectomy	i-TREATMENT
50186	in	O
50187	2018-03-21	b-DATE
50188	,	O
50189	status	O
50190	post	O
50191	avastin	b-TREATMENT
50192	and	O
50193	sorafenib	b-TREATMENT
50194	,	O
50195	most	O
50196	recently	O
50197	on	O
50198	sutent	b-TREATMENT
50199	monotherapy	i-TREATMENT
50200	since	O
50201	2018-12-21	b-DATE
50202	,	O
50203	with	O
50204	mild	b-PROBLEM
50205	renal	i-PROBLEM
50206	insufficiency	i-PROBLEM
50207	,	O
50208	who	O
50209	presented	b-OCCURRENCE
50210	from	O
50211	home	O
50212	on	O
50213	2019-06-14	b-DATE
50214	with	O
50215	shortness	b-PROBLEM
50216	of	i-PROBLEM
50217	breath	i-PROBLEM
50218	and	O
50219	fever	b-PROBLEM
50220	.	O
50221	of	O
50222	note	O
50223	,	O
50224	he	O
50225	was	O
50226	hospitalized	b-OCCURRENCE
50227	at	O
50228	dana-farber	b-CLINICAL_DEPT
50229	cancer	i-CLINICAL_DEPT
50230	institute	i-CLINICAL_DEPT
50231	from	O
50232	9/25-10/6	b-DURATION
50233	with	O
50234	chest	b-PROBLEM
50235	pain	i-PROBLEM
50236	,	O
50237	at	O
50238	which	O
50239	time	O
50240	he	O
50241	reportedly	O
50242	had	O
50243	cardiac	b-TEST
50244	enzymes	i-TEST
50245	,	O
50246	an	b-TEST
50247	echocardiogram	i-TEST
50248	and	O
50249	a	b-TEST
50250	pharmacological	i-TEST
50251	stress	i-TEST
50252	test	i-TEST
50253	performed	O
50254	.	O
50255	it	O
50256	is	O
50257	unclear	O
50258	from	O
50259	history	O
50260	what	O
50261	these	b-TEST
50262	studies	i-TEST
50263	revealed	O
50264	.	O
50265	he	O
50266	reports	b-EVIDENTIAL
50267	that	O
50268	he	O
50269	felt	O
50270	fatigued	b-PROBLEM
50271	during	O
50272	the	b-DURATION
50273	week	i-DURATION
50274	prior	O
50275	to	O
50276	the	b-OCCURRENCE
50277	current	i-OCCURRENCE
50278	admission	i-OCCURRENCE
50279	.	O
50280	on	O
50281	the	b-DATE
50282	day	i-DATE
50283	of	O
50284	admission	b-OCCURRENCE
50285	,	O
50286	he	O
50287	felt	O
50288	""""	O
50289	congested	b-PROBLEM
50290	""""	O
50291	in	O
50292	his	O
50293	chest	O
50294	,	O
50295	and	O
50296	had	O
50297	a	b-PROBLEM
50298	new	i-PROBLEM
50299	fever	i-PROBLEM
50300	.	O
50301	he	O
50302	was	O
50303	taken	O
50304	to	O
50305	the	b-CLINICAL_DEPT
50306	deanna	i-CLINICAL_DEPT
50307	by	O
50308	his	O
50309	wife	O
50310	.	O
50311	patrick	O
50312	reports	O
50313	a	b-PROBLEM
50314	mild	i-PROBLEM
50315	cough	i-PROBLEM
50316	for	O
50317	2	b-DURATION
50318	days	i-DURATION
50319	pta	O
50320	,	O
50321	non-productive	b-PROBLEM
50322	.	O
50323	he	O
50324	denies	b-EVIDENTIAL
50325	a	O
50326	history	O
50327	of	O
50328	aspiration	b-PROBLEM
50329	events	i-PROBLEM
50330	or	O
50331	choking	b-PROBLEM
50332	with	O
50333	food	b-OCCURRENCE
50334	intake	i-OCCURRENCE
50335	.	O
50336	he	O
50337	describes	b-EVIDENTIAL
50338	mild	b-PROBLEM
50339	reflux	i-PROBLEM
50340	symptoms	i-PROBLEM
50341	at	O
50342	night	O
50343	.	O
50344	further	b-TEST
50345	ros	i-TEST
50346	reveals	O
50347	mild	b-PROBLEM
50348	sob	i-PROBLEM
50349	in	O
50350	the	b-DURATION
50351	days	i-DURATION
50352	preceding	O
50353	admission	b-OCCURRENCE
50354	,	O
50355	but	O
50356	he	O
50357	tells	b-EVIDENTIAL
50358	me	O
50359	that	O
50360	he	O
50361	was	O
50362	surprised	O
50363	to	O
50364	find	O
50365	out	O
50366	about	O
50367	his	b-PROBLEM
50368	low	i-PROBLEM
50369	oxygen	i-PROBLEM
50370	saturation	i-PROBLEM
50371	because	O
50372	he	O
50373	did	O
50374	not	O
50375	feel	O
50376	that	O
50377	bad	O
50378	.	O
50379	he	O
50380	denies	b-EVIDENTIAL
50381	chills	b-PROBLEM
50382	,	O
50383	no	O
50384	chest	b-PROBLEM
50385	pain	i-PROBLEM
50386	,	O
50387	no	O
50388	le	b-PROBLEM
50389	swelling	i-PROBLEM
50390	.	O
50391	in	O
50392	the	b-CLINICAL_DEPT
50393	deanna	i-CLINICAL_DEPT
50394	,	O
50395	tmax	b-TEST
50396	102.8	O
50397	,	O
50398	bp	b-TEST
50399	100	O
50400	-	O
50401	140/60	O
50402	s,	O
50403	hr	b-TEST
50404	80	O
50405	s,	O
50406	rr	b-TEST
50407	20	O
50408	s,	O
50409	sat	b-TEST
50410	75%	O
50411	on	O
50412	ra	b-TREATMENT
50413	in	O
50414	triage	O
50415	,	O
50416	up	O
50417	to	O
50418	100%	O
50419	on	O
50420	nrb	b-TREATMENT
50421	.	O
50422	cxr	b-TEST
50423	with	O
50424	bibasilar	b-PROBLEM
50425	consolidations	i-PROBLEM
50426	.	O
50427	he	O
50428	was	O
50429	given	O
50430	levo	b-TREATMENT
50431	750	O
50432	mg	O
50433	po	O
50434	x1	O
50435	,	O
50436	and	O
50437	flagyl	b-TREATMENT
50438	500	O
50439	mg	O
50440	po	O
50441	x1	O
50442	.	O
50443	his	b-TEST
50444	bp	i-TEST
50445	decreased	O
50446	to	O
50447	100	O
50448	systolic	O
50449	despite	O
50450	hydration	b-TREATMENT
50451	with	O
50452	2l	O
50453	of	O
50454	ns	b-TREATMENT
50455	.	O
50456	he	O
50457	was	O
50458	subsquently	O
50459	admitted	b-OCCURRENCE
50460	to	O
50461	the	b-CLINICAL_DEPT
50462	icu	i-CLINICAL_DEPT
50463	for	O
50464	further	b-TREATMENT
50465	care	i-TREATMENT
50466	.	O
50467	he	O
50468	was	O
50469	placed	O
50470	on	O
50471	levo	b-TREATMENT
50472	and	O
50473	ceftriaxone	b-TREATMENT
50474	.	O
50475	a	b-TEST
50476	cosyntropin	i-TEST
50477	stimulation	i-TEST
50478	test	i-TEST
50479	revealed	O
50480	cortisol	b-TEST
50481	32.1	O
50482	-->	O
50483	36.4	O
50484	.	O
50485	his	b-PROBLEM
50486	oxygen	i-PROBLEM
50487	requirement	i-PROBLEM
50488	decreased	O
50489	,	O
50490	and	O
50491	his	b-OCCURRENCE
50492	overall	i-OCCURRENCE
50493	status	i-OCCURRENCE
50494	improved	O
50495	quickly	O
50496	.	O
50497	he	O
50498	is	O
50499	being	O
50500	transferred	b-OCCURRENCE
50501	to	O
50502	the	b-CLINICAL_DEPT
50503	floor	i-CLINICAL_DEPT
50504	for	O
50505	ongoing	b-TREATMENT
50506	care	i-TREATMENT
50507	.	O
50508	brief	O
50509	hospital	O
50510	course	O
50511	:	O
50512	mr.	O
50513	mcelveen	O
50514	51	O
50515	year-old	O
50516	male	O
50517	with	O
50518	metastatic	b-PROBLEM
50519	rcc	i-PROBLEM
50520	on	O
50521	sutent	b-TREATMENT
50522	since	O
50523	2018-12-21	b-DATE
50524	,	O
50525	admitted	b-OCCURRENCE
50526	with	O
50527	fever	b-PROBLEM
50528	,	O
50529	hypoxemia	b-PROBLEM
50530	,	O
50531	and	O
50532	bibasilar	b-PROBLEM
50533	pneumonia	i-PROBLEM
50534	.	O
50535	1)	O
50536	bibasilar	b-PROBLEM
50537	pneumonia	i-PROBLEM
50538	:	O
50539	patient	O
50540	was	O
50541	treated	O
50542	for	O
50543	community-acquired	b-PROBLEM
50544	pneumonia	i-PROBLEM
50545	.	O
50546	he	O
50547	was	O
50548	initially	O
50549	placed	O
50550	on	O
50551	ceftriaxone	b-TREATMENT
50552	,	O
50553	levaquin	b-TREATMENT
50554	,	O
50555	and	O
50556	flagyl	b-TREATMENT
50557	in	O
50558	the	b-CLINICAL_DEPT
50559	icu	i-CLINICAL_DEPT
50560	but	O
50561	then	O
50562	changed	O
50563	to	O
50564		O
50565	azithromycin	b-TREATMENT
50566	&	O
50567	ctx	b-TREATMENT
50568	at	O
50569	time	O
50570	of	O
50571	transfer	b-OCCURRENCE
50572	to	O
50573	the	b-CLINICAL_DEPT
50574	oncology	i-CLINICAL_DEPT
50575	service	i-CLINICAL_DEPT
50576	.	O
50577	he	O
50578	continued	O
50579	to	O
50580	have	O
50581	an	b-PROBLEM
50582	oxygen	i-PROBLEM
50583	requirement	i-PROBLEM
50584	and	O
50585	ct	b-TEST
50586	scan	i-TEST
50587	suggested	b-EVIDENTIAL
50588	ground	b-PROBLEM
50589	glass	i-PROBLEM
50590	opacities	i-PROBLEM
50591	,	O
50592	suggestive	O
50593	of	O
50594	an	b-PROBLEM
50595	underlying	i-PROBLEM
50596	infectious	i-PROBLEM
50597	process	i-PROBLEM
50598	.	O
50599	echo	b-TEST
50600	was	O
50601	done	O
50602	and	O
50603	confirmed	b-EVIDENTIAL
50604	normal	b-TEST
50605	ejection	i-TEST
50606	fraction	i-TEST
50607	.	O
50608	his	b-TEST
50609	respiratory	i-TEST
50610	status	i-TEST
50611	improved	O
50612	slowly	O
50613	,	O
50614	oxygen	b-TREATMENT
50615	was	O
50616	weaned	b-OCCURRENCE
50617	off	i-OCCURRENCE
50618	,	O
50619	and	O
50620	he	O
50621	was	O
50622	discharged	b-OCCURRENCE
50623	on	O
50624	course	O
50625	of	O
50626	levaquin	b-TREATMENT
50627	.	O
50628	2)	O
50629	metastatic	b-PROBLEM
50630	rcc	i-PROBLEM
50631	:	O
50632	sutent	b-TREATMENT
50633	was	O
50634	held	O
50635	on	O
50636	admission	b-OCCURRENCE
50637	in	O
50638	light	O
50639	of	O
50640	acute	b-PROBLEM
50641	infection	i-PROBLEM
50642	.	O
50643	he	O
50644	underwent	O
50645	a	b-TEST
50646	staging	i-TEST
50647	ct	i-TEST
50648	scan	i-TEST
50649	torso	i-TEST
50650	which	O
50651	suggested	b-EVIDENTIAL
50652	no	O
50653	significant	b-PROBLEM
50654	increase	i-PROBLEM
50655	in	i-PROBLEM
50656	tumor	i-PROBLEM
50657	burden	i-PROBLEM
50658	.	O
50659	patient	O
50660	was	O
50661	also	O
50662	found	b-EVIDENTIAL
50663	to	O
50664	have	O
50665	abnormal	b-PROBLEM
50666	tfts	i-PROBLEM
50667	on	O
50668	sutent	b-TREATMENT
50669	and	O
50670	was	O
50671	started	O
50672	on	O
50673	replacement	b-TREATMENT
50674	therapy	i-TREATMENT
50675	.	O
50676	he	O
50677	will	O
50678	need	O
50679	follow-up	b-TEST
50680	bloodwork	i-TEST
50681	as	O
50682	an	O
50683	outpatient	O
50684	.	O
50685	recent	b-TEST
50686	ct	i-TEST
50687	scan	i-TEST
50688	showed	b-EVIDENTIAL
50689	destruction	b-PROBLEM
50690	of	i-PROBLEM
50691	l	i-PROBLEM
50692	femoral	i-PROBLEM
50693	neck	i-PROBLEM
50694	.	O
50695	he	O
50696	underwent	O
50697	an	b-TEST
50698	xray	i-TEST
50699	of	i-TEST
50700	the	i-TEST
50701	l	i-TEST
50702	femur	i-TEST
50703	which	O
50704	did	O
50705	not	O
50706	suggest	b-EVIDENTIAL
50707	an	b-PROBLEM
50708	acute	i-PROBLEM
50709	fracture	i-PROBLEM
50710	.	O
50711	no	O
50712	limitations	b-TREATMENT
50713	were	O
50714	placed	O
50715	in	O
50716	regards	O
50717	to	O
50718	weightbearing	b-OCCURRENCE
50719	status	i-OCCURRENCE
50720	.	O
50721	patient	O
50722	was	O
50723	instructed	O
50724	to	O
50725	restart	O
50726	sutent	b-TREATMENT
50727	next	b-DATE
50728	monday	i-DATE
50729	.	O
50730	3)	O
50731	renal	b-PROBLEM
50732	insufficiency	i-PROBLEM
50733	:	O
50734	creatinine	b-TEST
50735	improved	O
50736	from	O
50737	2.1	O
50738	to	O
50739	1.3	O
50740	at	O
50741	time	O
50742	of	O
50743	discharge	b-OCCURRENCE
50744	.	O
50745	likely	O
50746	related	O
50747	to	O
50748	underlying	b-PROBLEM
50749	malignancy	i-PROBLEM
50750	as	O
50751	well	O
50752	as	O
50753	prerenal	b-PROBLEM
50754	component	i-PROBLEM
50755	given	O
50756	improvement	b-OCCURRENCE
50757	with	O
50758	gentle	b-TREATMENT
50759	hydration	i-TREATMENT
50760	.	O
50761		O
50762	admission	b-OCCURRENCE
50763	date	O
50764	:	O
50765	2012-07-17	b-ADMISSION
50766	discharge	b-OCCURRENCE
50767	date	O
50768	:	O
50769	2012-07-22	b-DISCHARGE
50770	service	O
50771	:	O
50772	surgery	O
50773	history	O
50774	of	O
50775	present	O
50776	illness	O
50777	:	O
50778	58	O
50779	year-old	O
50780	female	O
50781	s/p	O
50782	gastric	b-TREATMENT
50783	bypass	i-TREATMENT
50784	03-01	b-DATE
50785	without	O
50786	complications	b-PROBLEM
50787	post-operatively	O
50788	,	O
50789	now	O
50790	presents	b-OCCURRENCE
50791	with	O
50792	abomenal	b-PROBLEM
50793	and	i-PROBLEM
50794	and	i-PROBLEM
50795	ascociated	i-PROBLEM
50796	nausea	i-PROBLEM
50797	since	O
50798	the	b-DATE
50799	night	i-DATE
50800	before	i-DATE
50801	admission	i-DATE
50802	.	O
50803	pain	b-PROBLEM
50804	is	O
50805	diffused	O
50806	,	O
50807	06-05	O
50808	out	O
50809	of	O
50810	10	O
50811	in	O
50812	intensity	O
50813	,	O
50814	and	O
50815	has	O
50816	not	O
50817	improved	O
50818	overnight	b-DURATION
50819	.	O
50820	no	O
50821	flatus	b-PROBLEM
50822	x	O
50823	1	b-DURATION
50824	day	i-DURATION
50825	.	O
50826	brief	O
50827	hospital	O
50828	course	O
50829	:	O
50830	upon	O
50831	presentation	b-OCCURRENCE
50832	to	O
50833	the	b-CLINICAL_DEPT
50834	hospital	i-CLINICAL_DEPT
50835	and	O
50836	intial	b-TEST
50837	work-up	i-TEST
50838	,	O
50839	the	O
50840	patient	O
50841	was	O
50842	immediately	O
50843	taken	O
50844	to	O
50845	the	b-CLINICAL_DEPT
50846	operating	i-CLINICAL_DEPT
50847	room	i-CLINICAL_DEPT
50848	for	O
50849	an	b-TEST
50850	exploratory	i-TEST
50851	laporatomy	i-TEST
50852	.	O
50853	intraoperatively	O
50854	,	O
50855	the	O
50856	patient	O
50857	was	O
50858	found	O
50859	to	O
50860	have	O
50861	small	b-PROBLEM
50862	bowel	i-PROBLEM
50863	obstruction	i-PROBLEM
50864	with	O
50865	ischemic	b-PROBLEM
50866	small	i-PROBLEM
50867	bowel	i-PROBLEM
50868	.	O
50869	portions	O
50870	of	O
50871	the	O
50872	small	O
50873	bowel	O
50874	were	O
50875	resected	b-TREATMENT
50876	.	O
50877	she	O
50878	tolerated	O
50879	the	b-TREATMENT
50880	procedure	i-TREATMENT
50881	and	O
50882	was	O
50883	admitted	b-OCCURRENCE
50884	to	O
50885	the	b-CLINICAL_DEPT
50886	intensive	i-CLINICAL_DEPT
50887	care	i-CLINICAL_DEPT
50888	unit	i-CLINICAL_DEPT
50889	.	O
50890	she	O
50891	did	O
50892	well	O
50893	in	O
50894	the	b-CLINICAL_DEPT
50895	icu	i-CLINICAL_DEPT
50896	and	O
50897	was	O
50898	subsequently	O
50899	transfered	b-OCCURRENCE
50900	to	O
50901	the	b-CLINICAL_DEPT
50902	floor	i-CLINICAL_DEPT
50903	.	O
50904	she	O
50905	has	O
50906	been	O
50907	afebrile	b-PROBLEM
50908	post-operatively	O
50909	,	O
50910	making	b-EVIDENTIAL
50911	good	i-EVIDENTIAL
50912	urine	i-EVIDENTIAL
50913	,	O
50914	ambulating	b-OCCURRENCE
50915	,	O
50916	eating	b-OCCURRENCE
50917	a	i-OCCURRENCE
50918	regular	i-OCCURRENCE
50919	diet	i-OCCURRENCE
50920	without	O
50921	any	b-PROBLEM
50922	complications	i-PROBLEM
50923	.	O
50924		O
50925	admission	b-OCCURRENCE
50926	date	O
50927	:	O
50928	02/04/1990	b-ADMISSION
50929	discharge	b-OCCURRENCE
50930	date	O
50931	:	O
50932	02/12/1990	b-DISCHARGE
50933	history	O
50934	of	O
50935	present	O
50936	illness	O
50937	:	O
50938	the	O
50939	patient	O
50940	is	O
50941	a	O
50942	52-year-old	O
50943	right	O
50944	handed	O
50945	male	O
50946	with	O
50947	a	b-DURATION
50948	many	i-DURATION
50949	year	i-DURATION
50950	history	O
50951	of	O
50952	bilateral	b-PROBLEM
50953	shoulder	i-PROBLEM
50954	pain	i-PROBLEM
50955	,	O
50956	right	O
50957	greater	O
50958	than	O
50959	left	O
50960	.	O
50961	he	O
50962	has	O
50963	steroid	b-TREATMENT
50964	injections	i-TREATMENT
50965	in	O
50966	the	O
50967	right	O
50968	and	O
50969	in	O
50970	the	O
50971	left	O
50972	four	b-FREQUENCY
50973	times	O
50974	.	O
50975	arthrogram	b-TEST
50976	in	O
50977	the	b-DATE
50978	distant	i-DATE
50979	past	i-DATE
50980	showed	b-EVIDENTIAL
50981	a	b-PROBLEM
50982	right	i-PROBLEM
50983	rotator	i-PROBLEM
50984	cuff	i-PROBLEM
50985	tear	i-PROBLEM
50986	and	O
50987	he	O
50988	now	b-DATE
50989	has	O
50990	increased	b-PROBLEM
50991	pain	i-PROBLEM
50992	in	i-PROBLEM
50993	his	i-PROBLEM
50994	left	i-PROBLEM
50995	shoulder	i-PROBLEM
50996	.	O
50997	mri	b-TEST
50998	by	O
50999	report	O
51000	showed	b-EVIDENTIAL
51001	bilateral	b-TREATMENT
51002	rotator	i-TREATMENT
51003	cuff	i-TREATMENT
51004	repairs	i-TREATMENT
51005	and	O
51006	he	O
51007	was	O
51008	admitted	b-OCCURRENCE
51009	for	O
51010	repair	b-TREATMENT
51011	of	i-TREATMENT
51012	the	i-TREATMENT
51013	left	i-TREATMENT
51014	rotator	i-TREATMENT
51015	cuff	i-TREATMENT
51016	.	O
51017	hospital	O
51018	course	O
51019	:	O
51020	the	O
51021	patient	O
51022	was	O
51023	admitted	b-OCCURRENCE
51024	with	O
51025	the	b-TEST
51026	assessment	i-TEST
51027	of	O
51028	left	b-TREATMENT
51029	rotator	i-TREATMENT
51030	cuff	i-TREATMENT
51031	repair	i-TREATMENT
51032	and	O
51033	he	O
51034	was	O
51035	taken	O
51036	to	O
51037	the	b-CLINICAL_DEPT
51038	operating	i-CLINICAL_DEPT
51039	room	i-CLINICAL_DEPT
51040	on	O
51041	the	b-DATE
51042	day	i-DATE
51043	of	O
51044	admission	O
51045	where	O
51046	he	O
51047	underwent	O
51048	left	b-TREATMENT
51049	rotator	i-TREATMENT
51050	cuff	i-TREATMENT
51051	repair	i-TREATMENT
51052	under	O
51053	general	b-TREATMENT
51054	endotracheal	i-TREATMENT
51055	tube	i-TREATMENT
51056	anesthesia	i-TREATMENT
51057	.	O
51058	there	O
51059	were	O
51060	no	O
51061	intraoperative	b-PROBLEM
51062	complications	i-PROBLEM
51063	.	O
51064	his	b-OCCURRENCE
51065	postoperative	i-OCCURRENCE
51066	course	i-OCCURRENCE
51067	was	O
51068	generally	O
51069	unremarkable	O
51070	except	O
51071	for	O
51072	a	b-PROBLEM
51073	prolonged	i-PROBLEM
51074	course	i-PROBLEM
51075	of	i-PROBLEM
51076	advancement	i-PROBLEM
51077	with	i-PROBLEM
51078	range	i-PROBLEM
51079	of	i-PROBLEM
51080	motion	i-PROBLEM
51081	of	O
51082	his	O
51083	left	O
51084	shoulder	O
51085	.	O
51086	occupational	b-CLINICAL_DEPT
51087	therapy	i-CLINICAL_DEPT
51088	became	O
51089	involved	O
51090	initially	O
51091	and	O
51092	he	O
51093	remained	O
51094	on	O
51095	patient	b-TREATMENT
51096	controlled	i-TREATMENT
51097	analgesia	i-TREATMENT
51098	secondary	O
51099	to	O
51100	problems	O
51101	with	O
51102	left	b-PROBLEM
51103	shoulder	i-PROBLEM
51104	pain	i-PROBLEM
51105	.	O
51106	he	O
51107	was	O
51108	kept	O
51109	in	O
51110	the	b-CLINICAL_DEPT
51111	hospital	i-CLINICAL_DEPT
51112	for	O
51113	an	b-DURATION
51114	extended	i-DURATION
51115	period	i-DURATION
51116	to	O
51117	improve	O
51118	his	b-PROBLEM
51119	postoperative	i-PROBLEM
51120	range	i-PROBLEM
51121	of	i-PROBLEM
51122	motion	i-PROBLEM
51123	.	O
51124	however	O
51125	,	O
51126	he	O
51127	was	O
51128	eventually	O
51129	able	O
51130	to	O
51131	achieve	O
51132	forward	b-TEST
51133	flexion	i-TEST
51134	of	O
51135	135	O
51136	degrees	O
51137	and	O
51138	external	b-TEST
51139	rotation	i-TEST
51140	of	O
51141	30	O
51142	degrees	O
51143	by	O
51144	postoperative	b-DATE
51145	day	i-DATE
51146	number	i-DATE
51147	eight	i-DATE
51148	.	O
51149	his	b-PROBLEM
51150	wound	i-PROBLEM
51151	remained	O
51152	clean	O
51153	and	O
51154	dry	O
51155	and	O
51156	showed	O
51157	no	O
51158	signs	b-PROBLEM
51159	of	i-PROBLEM
51160	infection	i-PROBLEM
51161	and	O
51162	healed	b-OCCURRENCE
51163	well	i-OCCURRENCE
51164	.	O
51165	however	O
51166	,	O
51167	his	b-OCCURRENCE
51168	course	i-OCCURRENCE
51169	was	O
51170	otherwise	O
51171	complicated	O
51172	by	O
51173	discovery	O
51174	of	O
51175	persistently	b-PROBLEM
51176	elevated	i-PROBLEM
51177	blood	i-PROBLEM
51178	sugars	i-PROBLEM
51179	and	O
51180	endocrinology	b-CLINICAL_DEPT
51181	was	O
51182	consulted	O
51183	to	O
51184	rule	O
51185	out	O
51186	possible	O
51187	newly	b-PROBLEM
51188	diagnosed	i-PROBLEM
51189	diabetes	i-PROBLEM
51190	.	O
51191	his	b-TEST
51192	hemoglobin	i-TEST
51193	a1c	i-TEST
51194	levels	i-TEST
51195	actually	O
51196	came	O
51197	back	O
51198	within	O
51199	normal	O
51200	limits	O
51201	,	O
51202	however	O
51203	,	O
51204	the	b-PROBLEM
51205	wide	i-PROBLEM
51206	excursions	i-PROBLEM
51207	of	O
51208	his	b-TEST
51209	sugars	i-TEST
51210	were	O
51211	consistent	O
51212	with	O
51213	possible	O
51214	diabetes	b-PROBLEM
51215	.	O
51216	he	O
51217	was	O
51218	placed	O
51219	on	O
51220	a	b-TREATMENT
51221	diabetic	i-TREATMENT
51222	diet	i-TREATMENT
51223	and	O
51224	his	b-TEST
51225	sugars	i-TEST
51226	did	O
51227	show	O
51228	some	b-OCCURRENCE
51229	improvement	i-OCCURRENCE
51230	.	O
51231	it	O
51232	was	O
51233	not	O
51234	necessary	O
51235	to	O
51236	start	O
51237	him	O
51238	on	O
51239	oral	b-TREATMENT
51240	hypoglycemics	i-TREATMENT
51241	or	O
51242	insulin	b-TREATMENT
51243	.	O
51244	he	O
51245	also	O
51246	complained	b-EVIDENTIAL
51247	of	O
51248	occasional	b-PROBLEM
51249	spells	i-PROBLEM
51250	and	O
51251	jitteriness	b-PROBLEM
51252	and	O
51253	some	b-PROBLEM
51254	orthostatic	i-PROBLEM
51255	dizziness	i-PROBLEM
51256	and	O
51257	thus	O
51258	neurology	b-CLINICAL_DEPT
51259	was	O
51260	consulted	O
51261	and	O
51262	emg	b-TEST
51263	&apos;s	i-TEST
51264	were	O
51265	performed	O
51266	which	O
51267	were	O
51268	normal	b-EVIDENTIAL
51269	.	O
51270	his	b-CLINICAL_DEPT
51271	neurologist	i-CLINICAL_DEPT
51272	was	O
51273	contacted	O
51274	,	O
51275	doctor	O
51276	cap	O
51277	,	O
51278	and	O
51279	the	O
51280	exact	O
51281	of	O
51282	his	b-PROBLEM
51283	problems	i-PROBLEM
51284	was	O
51285	not	O
51286	demonstrated	b-EVIDENTIAL
51287	during	O
51288	this	b-OCCURRENCE
51289	hospitalization	i-OCCURRENCE
51290	,	O
51291	however	O
51292	,	O
51293	they	O
51294	felt	O
51295	that	O
51296	this	O
51297	could	O
51298	possibly	O
51299	be	O
51300	an	b-PROBLEM
51301	autonomic	i-PROBLEM
51302	type	i-PROBLEM
51303	neuropathy	i-PROBLEM
51304	maybe	O
51305	secondary	O
51306	to	O
51307	some	b-PROBLEM
51308	underlying	i-PROBLEM
51309	diabetic	i-PROBLEM
51310	process	i-PROBLEM
51311	.	O
51312	further	b-TEST
51313	work-up	i-TEST
51314	of	O
51315	his	b-PROBLEM
51316	neurologic	i-PROBLEM
51317	conditions	i-PROBLEM
51318	were	O
51319	planned	O
51320	as	O
51321	an	O
51322	outpatient	O
51323	.	O
51324	thus	O
51325	,	O
51326	he	O
51327	was	O
51328	discharged	b-OCCURRENCE
51329	on	O
51330	postoperative	b-DATE
51331	day	i-DATE
51332	number	i-DATE
51333	eight	i-DATE
51334	in	O
51335	good	b-EVIDENTIAL
51336	condition	i-EVIDENTIAL
51337	with	O
51338	a	b-PROBLEM
51339	well	i-PROBLEM
51340	healed	i-PROBLEM
51341	left	i-PROBLEM
51342	shoulder	i-PROBLEM
51343	wound	i-PROBLEM
51344	and	O
51345	doing	b-EVIDENTIAL
51346	well	i-EVIDENTIAL
51347	with	O
51348	occupational	b-TREATMENT
51349	therapy	i-TREATMENT
51350	with	O
51351	plans	O
51352	for	O
51353	him	O
51354	to	O
51355	follow-up	b-OCCURRENCE
51356	with	O
51357	doctor	O
51358	necessary	O
51359	.	O
51360		O
51361	admission	b-OCCURRENCE
51362	date	O
51363	:	O
51364	2018-12-29	b-ADMISSION
51365	discharge	b-OCCURRENCE
51366	date	O
51367	:	O
51368	2019-01-04	b-DISCHARGE
51369	service	O
51370	:	O
51371	neonatology	O
51372	history	O
51373	of	O
51374	present	O
51375	illness	O
51376	:	O
51377	baby	O
51378	davis	O
51379	is	O
51380	the	O
51381	3.160	O
51382	kilogram	O
51383	product	O
51384	of	O
51385	a	b-PROBLEM
51386	term	i-PROBLEM
51387	pregnancy	i-PROBLEM
51388	.	O
51389	he	O
51390	was	O
51391	born	b-OCCURRENCE
51392	to	O
51393	a	O
51394	38	O
51395	-	O
51396	year-old	O
51397	gravida	O
51398	i	O
51399	,	O
51400	para	O
51401	0	O
51402	(	O
51403	now	O
51404	1	O
51405	)	O
51406	mother	O
51407	at	O
51408	37	O
51409	and	O
51410	1/7	O
51411	weeks	O
51412	.	O
51413	the	b-OCCURRENCE
51414	pregnancy	i-OCCURRENCE
51415	was	O
51416	benign	b-EVIDENTIAL
51417	with	O
51418	an	b-OCCURRENCE
51419	edc	i-OCCURRENCE
51420	of	O
51421	2019-01-18	b-DATE
51422	.	O
51423	prenatal	b-TEST
51424	screens	i-TEST
51425	were	O
51426	o	O
51427	positive	O
51428	,	O
51429	antibody	b-TEST
51430	negative	O
51431	,	O
51432	hepatitis	b-TEST
51433	surface	i-TEST
51434	antigen	i-TEST
51435	negative	O
51436	,	O
51437	rapid	b-TEST
51438	plasma	i-TEST
51439	reagent	i-TEST
51440	nonreactive	O
51441	,	O
51442	rubella	b-TEST
51443	immune	O
51444	,	O
51445	group	b-TEST
51446	b	i-TEST
51447	strep	i-TEST
51448	negative	O
51449	.	O
51450	the	O
51451	infant	O
51452	delivered	b-OCCURRENCE
51453	by	O
51454	spontaneous	b-OCCURRENCE
51455	vaginal	i-OCCURRENCE
51456	delivery	i-OCCURRENCE
51457	with	O
51458	apgar	b-TEST
51459	scores	i-TEST
51460	of	O
51461	8	O
51462	at	O
51463	one	O
51464	minute	O
51465	and	O
51466	8	O
51467	at	O
51468	five	O
51469	minutes	O
51470	.	O
51471	hospital	O
51472	course	O
51473	:	O
51474	1.	O
51475	respiratory	O
51476	.	O
51477	without	O
51478	issues	b-PROBLEM
51479	on	O
51480	this	b-OCCURRENCE
51481	admission	i-OCCURRENCE
51482	.	O
51483	breath	b-TEST
51484	sounds	i-TEST
51485	are	O
51486	clear	O
51487	and	O
51488	equal	O
51489	.	O
51490	2.	O
51491	cardiovascular	O
51492	.	O
51493	without	O
51494	issues	b-PROBLEM
51495	on	O
51496	this	b-OCCURRENCE
51497	admission	i-OCCURRENCE
51498	.	O
51499	he	O
51500	had	O
51501	a	O
51502	regular	O
51503	heart	b-TEST
51504	rate	i-TEST
51505	and	i-TEST
51506	rhythm	i-TEST
51507	,	O
51508	no	O
51509	murmur	b-PROBLEM
51510	,	O
51511	pulses	b-TEST
51512	were	O
51513	2+	O
51514	and	O
51515	symmetric	O
51516	.	O
51517	3.	O
51518	fluids	O
51519	,	O
51520	electrolytes	O
51521	and	O
51522	nutrition	O
51523	.	O
51524	the	b-TEST
51525	baby	i-TEST
51526	's	i-TEST
51527	weight	i-TEST
51528	was	O
51529	3.160	O
51530	kilograms	O
51531	(	O
51532	7	O
51533	pounds	O
51534	3	O
51535	ounces	O
51536	).	O
51537	he	O
51538	is	O
51539	breast	b-TREATMENT
51540	and	i-TREATMENT
51541	bottle	i-TREATMENT
51542	feeding	i-TREATMENT
51543	every	O
51544	3	b-FREQUENCY
51545	hours	i-FREQUENCY
51546	with	O
51547	expressed	O
51548	breast	b-TREATMENT
51549	milk	i-TREATMENT
51550	and	O
51551	/	O
51552	or	O
51553	enfamil	b-TREATMENT
51554	.	O
51555	he	O
51556	is	O
51557	feeding	b-OCCURRENCE
51558	well	i-OCCURRENCE
51559	.	O
51560	his	b-TEST
51561	discharge	i-TEST
51562	weight	i-TEST
51563	is	O
51564	3025	O
51565	gm	O
51566	,	O
51567	and	O
51568	has	O
51569	been	O
51570	stable	b-EVIDENTIAL
51571	for	O
51572	past	b-DURATION
51573	2	i-DURATION
51574	days	i-DURATION
51575	.	O
51576	4.	O
51577	gastrointestinal	O
51578	.	O
51579	the	b-TEST
51580	baby	i-TEST
51581	's	i-TEST
51582	bilirubin	i-TEST
51583	on	O
51584	2018-12-31	b-DATE
51585	,	O
51586	was	O
51587	15.5	O
51588	/	O
51589	0.5	O
51590	at	O
51591	which	O
51592	time	O
51593	double	b-TREATMENT
51594	phototherapy	i-TREATMENT
51595	was	O
51596	started	O
51597	.	O
51598	on	O
51599	01-01	b-DATE
51600	,	O
51601	his	b-TEST
51602	bilirubin	i-TEST
51603	was	O
51604	17.3	O
51605	/	O
51606	0.4	O
51607	at	O
51608	which	O
51609	time	O
51610	triple	b-TREATMENT
51611	phototherapy	i-TREATMENT
51612	was	O
51613	started	O
51614	and	O
51615	then	O
51616	his	b-OCCURRENCE
51617	subsequent	i-OCCURRENCE
51618	bilirubins	i-OCCURRENCE
51619	are	O
51620	16.5	O
51621	/	O
51622	0.4	O
51623	on	O
51624	2019-01-01	b-DATE
51625	,	O
51626	and	O
51627	16.2	O
51628	/	O
51629	0.5	O
51630	on	O
51631	2019-01-02	b-DATE
51632	.	O
51633	phototherapy	b-TREATMENT
51634	was	O
51635	discontinued	O
51636	on	O
51637	2019-01-04	b-DATE
51638	for	O
51639	a	b-TEST
51640	bilirubin	i-TEST
51641	of	O
51642	12.1	O
51643	,	O
51644	and	O
51645	a	b-TEST
51646	rebound	i-TEST
51647	bilirubin	i-TEST
51648	will	O
51649	be	O
51650	checked	O
51651	on	O
51652	01-05	b-DATE
51653	.	O
51654	5.	O
51655	hematology	O
51656	.	O
51657	the	b-TEST
51658	hematocrit	i-TEST
51659	on	O
51660	01-02	b-DATE
51661	,	O
51662	was	O
51663	61	O
51664	with	O
51665	a	b-TEST
51666	reticulocyte	i-TEST
51667	of	O
51668	2.6%	O
51669	.	O
51670	his	b-TEST
51671	blood	i-TEST
51672	type	i-TEST
51673	is	O
51674	a+	O
51675	,	O
51676	coombs	b-TEST
51677	negative	O
51678	.	O
51679	6.	O
51680	infectious	O
51681	disease	O
51682	.	O
51683	no	O
51684	issues	b-PROBLEM
51685	on	O
51686	this	b-OCCURRENCE
51687	admission	i-OCCURRENCE
51688	.	O
51689	7.	O
51690	neurological	O
51691	.	O
51692	the	O
51693	baby	O
51694	has	O
51695	been	O
51696	appropriate	O
51697	for	O
51698	gestational	O
51699	age	O
51700	with	O
51701	normal	b-EVIDENTIAL
51702	newborn	i-EVIDENTIAL
51703	reflexes	i-EVIDENTIAL
51704	.	O
51705	8.	O
51706	sensory	O
51707	.	O
51708	auditory	b-TEST
51709	hearing	i-TEST
51710	screening	i-TEST
51711	was	O
51712	performed	O
51713	with	O
51714	automated	b-OCCURRENCE
51715	brainstem	i-OCCURRENCE
51716	responses	i-OCCURRENCE
51717	.	O
51718	the	O
51719	infant	O
51720	passed	b-TEST
51721	both	i-TEST
51722	ears	i-TEST
51723	on	O
51724	2018-12-30	b-DATE
51725	.	O
51726	9.	O
51727	psychosocial	O
51728	.	O
51729	the	O
51730	family	O
51731	is	O
51732	invested	b-OCCURRENCE
51733	and	i-OCCURRENCE
51734	involved	i-OCCURRENCE
51735	.	O
51736		O
51737	admission	b-OCCURRENCE
51738	date	O
51739	:	O
51740	06-22-93	b-DATE
51741	discharge	b-OCCURRENCE
51742	date	O
51743	:	O
51744	06-27-93	b-DATE
51745	history	O
51746	of	O
51747	present	O
51748	illness	O
51749	:	O
51750	mrs.	O
51751	cast	O
51752	is	O
51753	a	O
51754	50	O
51755	year	O
51756	old	O
51757	white	O
51758	female	O
51759	with	O
51760	a	O
51761	history	O
51762	of	O
51763	chronic	b-PROBLEM
51764	obstructive	i-PROBLEM
51765	pulmonary	i-PROBLEM
51766	disease	i-PROBLEM
51767	and	O
51768	evidence	O
51769	of	O
51770	severe	b-PROBLEM
51771	lobular	i-PROBLEM
51772	emphysema	i-PROBLEM
51773	,	O
51774	who	O
51775	has	O
51776	progressive	b-PROBLEM
51777	shortness	i-PROBLEM
51778	of	i-PROBLEM
51779	breath	i-PROBLEM
51780	and	O
51781	inability	b-PROBLEM
51782	to	i-PROBLEM
51783	carry	i-PROBLEM
51784	on	i-PROBLEM
51785	with	i-PROBLEM
51786	activities	i-PROBLEM
51787	of	i-PROBLEM
51788	daily	i-PROBLEM
51789	living	i-PROBLEM
51790	without	O
51791	assistance	b-TREATMENT
51792	.	O
51793	she	O
51794	was	O
51795	admitted	b-OCCURRENCE
51796	to	O
51797	the	b-CLINICAL_DEPT
51798	hospital	i-CLINICAL_DEPT
51799	for	O
51800	a	b-TEST
51801	pre	i-TEST
51802	lung	i-TEST
51803	transplant	i-TEST
51804	evaluation	i-TEST
51805	.	O
51806	the	O
51807	patient	O
51808	has	O
51809	been	O
51810	steroid	b-PROBLEM
51811	dependent	i-PROBLEM
51812	for	O
51813	two	b-DURATION
51814	years	i-DURATION
51815	and	O
51816	has	O
51817	been	O
51818	intubated	b-TREATMENT
51819	in	O
51820	the	O
51821	past	O
51822	only	O
51823	once	b-FREQUENCY
51824	for	O
51825	a	b-TREATMENT
51826	surgical	i-TREATMENT
51827	repair	i-TREATMENT
51828	of	i-TREATMENT
51829	trigeminal	i-TREATMENT
51830	neuralgia	i-TREATMENT
51831	.	O
51832	her	O
51833	previous	O
51834	occupation	O
51835	was	O
51836	an	O
51837	executive	O
51838	secretary	O
51839	,	O
51840	home	O
51841	trainer	O
51842	/	O
51843	nurse	O
51844	,	O
51845	rental	O
51846	aide	O
51847	.	O
51848	she	O
51849	has	O
51850	no	O
51851	history	O
51852	of	O
51853	asbestos	b-PROBLEM
51854	exposure	i-PROBLEM
51855	or	O
51856	tuberculosis	b-PROBLEM
51857	exposure	i-PROBLEM
51858	.	O
51859	hospital	O
51860	course	O
51861	:	O
51862	the	O
51863	patient	O
51864	was	O
51865	seen	b-OCCURRENCE
51866	in	i-OCCURRENCE
51867	consultation	i-OCCURRENCE
51868	by	O
51869	a	O
51870	variety	O
51871	of	O
51872	consultants	O
51873	including	O
51874	infectious	b-CLINICAL_DEPT
51875	disease	i-CLINICAL_DEPT
51876	,	O
51877	cardiology	b-CLINICAL_DEPT
51878	,	O
51879	endocrine	b-CLINICAL_DEPT
51880	,	O
51881	psychiatry	b-CLINICAL_DEPT
51882	,	O
51883	ent	b-CLINICAL_DEPT
51884	,	O
51885	and	O
51886	neuro-ophthalmology	b-CLINICAL_DEPT
51887	.	O
51888	she	O
51889	was	O
51890	noted	b-EVIDENTIAL
51891	to	O
51892	have	O
51893	mild	b-PROBLEM
51894	cataracts	i-PROBLEM
51895	,	O
51896	possibly	O
51897	due	O
51898	to	O
51899	chronic	b-TREATMENT
51900	steroids	i-TREATMENT
51901	,	O
51902	as	O
51903	well	O
51904	as	O
51905	a	b-PROBLEM
51906	subtle	i-PROBLEM
51907	temporal	i-PROBLEM
51908	disc	i-PROBLEM
51909	pallor	i-PROBLEM
51910	od	i-PROBLEM
51911	,	O
51912	possibly	O
51913	due	O
51914	to	O
51915	previous	O
51916	episode	O
51917	of	O
51918	optic	b-PROBLEM
51919	neuritis	i-PROBLEM
51920	.	O
51921	no	O
51922	acute	b-PROBLEM
51923	pathology	i-PROBLEM
51924	was	O
51925	noted	b-EVIDENTIAL
51926	and	O
51927	no	O
51928	treatment	b-TREATMENT
51929	was	O
51930	necessary	O
51931	at	O
51932	this	b-DATE
51933	time	i-DATE
51934	.	O
51935	doctor	O
51936	koteelks	O
51937	indicated	b-EVIDENTIAL
51938	that	O
51939	the	O
51940	patient	O
51941	did	O
51942	not	O
51943	have	O
51944	sinus	b-PROBLEM
51945	problems	i-PROBLEM
51946	currently	O
51947	but	O
51948	thought	O
51949	that	O
51950	the	b-PROBLEM
51951	trigeminal	i-PROBLEM
51952	pain	i-PROBLEM
51953	might	O
51954	be	O
51955	investigated	b-TREATMENT
51956	further	i-TREATMENT
51957	and	O
51958	that	O
51959	the	b-PROBLEM
51960	sphenoid	i-PROBLEM
51961	might	O
51962	account	O
51963	for	O
51964	some	O
51965	of	O
51966	the	b-PROBLEM
51967	patient	i-PROBLEM
51968	&apos;s	i-PROBLEM
51969	discomfort	i-PROBLEM
51970	.	O
51971	if	O
51972	so	O
51973	,	O
51974	he	O
51975	considers	O
51976	the	O
51977	possibility	O
51978	that	O
51979	this	O
51980	could	O
51981	be	O
51982	opened	O
51983	.	O
51984	this	O
51985	is	O
51986	left	O
51987	for	O
51988	further	O
51989	follow	O
51990	up	O
51991	as	O
51992	an	O
51993	outpatient	O
51994	.	O
51995	doctor	O
51996	tikkerth	O
51997	felt	O
51998	that	O
51999	the	O
52000	patient	O
52001	had	O
52002	mild	b-PROBLEM
52003	adjustment	i-PROBLEM
52004	related	i-PROBLEM
52005	anxiety	i-PROBLEM
52006	under	O
52007	good	b-TREATMENT
52008	control	i-TREATMENT
52009	with	O
52010	a	O
52011	history	O
52012	of	O
52013	tobacco	b-PROBLEM
52014	abuse	i-PROBLEM
52015	in	O
52016	the	O
52017	past	O
52018	.	O
52019	the	O
52020	patient	O
52021	completed	O
52022	the	b-TEST
52023	studies	i-TEST
52024	and	O
52025	to	O
52026	be	O
52027	informed	O
52028	of	O
52029	the	O
52030	results	O
52031	as	O
52032	an	O
52033	outpatient	O
52034	.	O
52035	she	O
52036	knows	O
52037	to	O
52038	return	O
52039	to	O
52040	her	b-CLINICAL_DEPT
52041	local	i-CLINICAL_DEPT
52042	physician	i-CLINICAL_DEPT
52043	for	O
52044	her	b-TREATMENT
52045	routine	i-TREATMENT
52046	care	i-TREATMENT
52047	with	O
52048	her	b-PROBLEM
52049	condition	i-PROBLEM
52050	unchanged	O
52051	at	O
52052	the	b-DATE
52053	time	i-DATE
52054	of	O
52055	discharge	O
52056	.	O
52057	i	O
52058	l.	O
52059	sterpskolk	O
52060	,	O
52061	md	O
52062	tr	O
52063	:	O
52064	bg	O
52065	/	O
52066	bmot	O
52067	dd	O
52068	:	O
52069	09-08-93	O
52070	td	O
52071	:	O
52072	09/09/93	O
52073	cc	O
52074	:	O
52075		O
52076	admission	b-OCCURRENCE
52077	date	O
52078	:	O
52079	2012-04-27	b-ADMISSION
52080	discharge	b-OCCURRENCE
52081	date	O
52082	:	O
52083	2012-04-30	b-DISCHARGE
52084	service	O
52085	:	O
52086	neurosurgery	O
52087	history	O
52088	of	O
52089	present	O
52090	illness	O
52091	:	O
52092	patient	O
52093	is	O
52094	a	O
52095	79	O
52096	-	O
52097	year-old	O
52098	female	O
52099	with	O
52100	a	O
52101	history	O
52102	of	O
52103	cataracts	b-PROBLEM
52104	,	O
52105	glaucoma	b-PROBLEM
52106	,	O
52107	and	O
52108	diabetes	b-PROBLEM
52109	,	O
52110	who	O
52111	fell	b-OCCURRENCE
52112	and	i-OCCURRENCE
52113	tripped	i-OCCURRENCE
52114	over	O
52115	a	O
52116	wheelchair	O
52117	of	O
52118	a	O
52119	friend	O
52120	with	O
52121	no	O
52122	loss	b-PROBLEM
52123	of	i-PROBLEM
52124	consciousness	i-PROBLEM
52125	,	O
52126	no	O
52127	dizziness	b-PROBLEM
52128	,	O
52129	no	O
52130	chest	b-PROBLEM
52131	pain	i-PROBLEM
52132	,	O
52133	and	O
52134	no	O
52135	shortness	b-PROBLEM
52136	of	i-PROBLEM
52137	breath	i-PROBLEM
52138	.	O
52139	physical	O
52140	exam	O
52141	:	O
52142	she	O
52143	was	O
52144	afebrile	b-PROBLEM
52145	.	O
52146	heart	b-TEST
52147	rate	i-TEST
52148	was	O
52149	77	O
52150	.	O
52151	blood	b-TEST
52152	pressure	i-TEST
52153	132/48	O
52154	.	O
52155	respiratory	b-TEST
52156	rate	i-TEST
52157	was	O
52158	17	O
52159	.	O
52160	sats	b-TEST
52161	96%	O
52162	on	O
52163	room	O
52164	air	O
52165	.	O
52166	her	b-TEST
52167	temperature	i-TEST
52168	was	O
52169	97.6	O
52170	.	O
52171	she	O
52172	neurologically	O
52173	,	O
52174	she	O
52175	had	O
52176	a	O
52177	nonfocal	O
52178	neurologic	b-TEST
52179	examination	i-TEST
52180	.	O
52181	her	O
52182	cardiovascular	O
52183	was	O
52184	regular	O
52185	rate	O
52186	and	O
52187	rhythm	O
52188	.	O
52189	her	O
52190	pulmonary	O
52191	:	O
52192	chest	O
52193	was	O
52194	clear	O
52195	to	O
52196	auscultation	b-TEST
52197	bilaterally	O
52198	.	O
52199	extremities	O
52200	:	O
52201	no	O
52202	cyanosis	b-PROBLEM
52203	,	O
52204	clubbing	b-PROBLEM
52205	,	O
52206	or	O
52207	edema	b-PROBLEM
52208	.	O
52209	head	b-TEST
52210	ct	i-TEST
52211	showed	b-EVIDENTIAL
52212	a	b-PROBLEM
52213	front	i-PROBLEM
52214	focal	i-PROBLEM
52215	hemorrhage	i-PROBLEM
52216	in	i-PROBLEM
52217	the	i-PROBLEM
52218	left	i-PROBLEM
52219	occipital	i-PROBLEM
52220	lobe	i-PROBLEM
52221	adjacent	O
52222	to	O
52223	the	O
52224	falx	O
52225	with	O
52226	intraparenchymal	b-PROBLEM
52227	hemorrhage	i-PROBLEM
52228	or	O
52229	epidural	b-PROBLEM
52230	or	i-PROBLEM
52231	subdural	i-PROBLEM
52232	hemorrhage	i-PROBLEM
52233	near	i-PROBLEM
52234	the	i-PROBLEM
52235	falx	i-PROBLEM
52236	with	O
52237	no	O
52238	shift	b-PROBLEM
52239	.	O
52240	ct	b-TEST
52241	of	i-TEST
52242	the	i-TEST
52243	c	i-TEST
52244	spine	i-TEST
52245	was	O
52246	negative	O
52247	and	O
52248	her	O
52249	cervical	O
52250	spine	O
52251	was	O
52252	cleared	O
52253	.	O
52254	hospital	O
52255	course	O
52256	:	O
52257	she	O
52258	was	O
52259	admitted	b-OCCURRENCE
52260	to	O
52261	the	b-CLINICAL_DEPT
52262	icu	i-CLINICAL_DEPT
52263	for	O
52264	close	b-TEST
52265	neurosurgical	i-TEST
52266	and	i-TEST
52267	neurological	i-TEST
52268	observation	i-TEST
52269	.	O
52270	she	O
52271	remained	b-OCCURRENCE
52272	neurologically	i-OCCURRENCE
52273	stable	i-OCCURRENCE
52274	.	O
52275	repeat	b-TEST
52276	head	i-TEST
52277	ct	i-TEST
52278	showed	b-EVIDENTIAL
52279	stable	b-PROBLEM
52280	bleed	i-PROBLEM
52281	.	O
52282	the	O
52283	patient	O
52284	was	O
52285	transferred	b-OCCURRENCE
52286	to	O
52287	the	b-CLINICAL_DEPT
52288	regular	i-CLINICAL_DEPT
52289	floor	i-CLINICAL_DEPT
52290	.	O
52291	she	O
52292	was	O
52293	out	O
52294	of	O
52295	bed	O
52296	ambulating	b-OCCURRENCE
52297	,	O
52298	tolerating	b-OCCURRENCE
52299	a	i-OCCURRENCE
52300	regular	i-OCCURRENCE
52301	diet	i-OCCURRENCE
52302	,	O
52303	voiding	b-OCCURRENCE
52304	spontaneously	i-OCCURRENCE
52305	.	O
52306	she	O
52307	will	O
52308	be	O
52309	discharged	b-OCCURRENCE
52310	to	O
52311	home	O
52312	with	O
52313	followup	b-OCCURRENCE
52314	with	O
52315	doctor	O
52316	wilson	O
52317	in	O
52318	two	b-DATE
52319	weeks	i-DATE
52320	with	O
52321	a	b-TEST
52322	repeat	i-TEST
52323	head	i-TEST
52324	ct	i-TEST
52325	.	O
52326	medications	O
52327	on	O
52328	discharge	O
52329	:	O
52330	1.	O
52331	levofloxacin	b-TREATMENT
52332	250	O
52333	mg	O
52334	p.o.	O
52335	q.24h.	b-FREQUENCY
52336	x3	i-FREQUENCY
52337	days	i-FREQUENCY
52338	.	O
52339	2.	O
52340	dilantin	b-TREATMENT
52341	100	O
52342	mg	O
52343	p.o.	O
52344	t.i.d.	b-FREQUENCY
52345	3.	O
52346	colace	b-TREATMENT
52347	100	O
52348	mg	O
52349	p.o.	O
52350	b.i.d.	b-FREQUENCY
52351	4.	O
52352	timoptic	b-TREATMENT
52353	0.25	O
52354	one	O
52355	drop	O
52356	o.u.	O
52357	b.i.d.	b-FREQUENCY
52358	5.	O
52359	lantoprost	b-TREATMENT
52360	0.005	O
52361	ophthalmic	O
52362	solution	O
52363	one	O
52364	drop	O
52365	o.u.	O
52366	q.h.s.	b-FREQUENCY
52367	6.	O
52368	zantac	b-TREATMENT
52369	150	O
52370	mg	O
52371	p.o.	O
52372	b.i.d.	b-FREQUENCY
52373	7.	O
52374	insulin-sliding	b-TREATMENT
52375	scale	i-TREATMENT
52376	as	O
52377	well	O
52378	as	O
52379	40	O
52380	units	O
52381	of	O
52382	humalog	b-TREATMENT
52383	in	O
52384	the	b-FREQUENCY
52385	a.m.	i-FREQUENCY
52386	and	O
52387	20	O
52388	at	O
52389	night	b-FREQUENCY
52390	.	O
52391	condition	O
52392	on	O
52393	discharge	O
52394	:	O
52395	stable	b-OCCURRENCE
52396	.	O
52397	follow-up	O
52398	instructions	O
52399	:	O
52400	she	O
52401	will	O
52402	follow	b-OCCURRENCE
52403	up	i-OCCURRENCE
52404	with	O
52405	doctor	O
52406	perez	O
52407	in	O
52408	two	b-DATE
52409	weeks	i-DATE
52410	with	O
52411	repeat	b-TEST
52412	head	i-TEST
52413	ct	i-TEST
52414	.	O
52415	danvers	O
52416	t	O
52417	sharp	O
52418	,	O
52419	md	O
52420	16-530	O
52421	dictated	O
52422	by	O
52423	:	O
52424	david	O
52425	ga	O
52426	crane	O
52427	,	O
52428	md	O
52429	medquist36	O
52430	d	O
52431	:	O
52432	2012-04-30	O
52433	11:30	O
52434	t	O
52435	:	O
52436	2012-05-01	O
52437	08:13	O
52438	job	O
52439	#:	O
52440	10027	O
52441	signed	O
52442	electronically	O
52443	by	O
52444	:	O
52445	doctor	O
52446	margarita	O
52447	martin	O
52448	on	O
52449	:	O
52450	tue	O
52451	2012-06-05	O
52452	8:08	O
52453	am	O
52454	(	O
52455	end	O
52456	of	O
52457	report	O
52458	)	O
52459		O
52460	admission	b-OCCURRENCE
52461	date	O
52462	:	O
52463	01/17/1993	b-ADMISSION
52464	discharge	b-OCCURRENCE
52465	date	O
52466	:	O
52467	01/21/1993	b-DISCHARGE
52468	history	O
52469	of	O
52470	present	O
52471	illness	O
52472	:	O
52473	the	O
52474	patient	O
52475	is	O
52476	a	O
52477	42	O
52478	year	O
52479	old	O
52480	gentleman	O
52481	who	O
52482	suffered	O
52483	lower	b-PROBLEM
52484	back	i-PROBLEM
52485	pain	i-PROBLEM
52486	during	O
52487	an	b-PROBLEM
52488	accident	i-PROBLEM
52489	at	i-PROBLEM
52490	work	i-PROBLEM
52491	in	O
52492	1990	b-DATE
52493	.	O
52494	this	b-PROBLEM
52495	gradually	O
52496	increased	b-PROBLEM
52497	until	O
52498	june	b-DATE
52499	1992	i-DATE
52500	where	O
52501	he	O
52502	had	O
52503	recurrent	O
52504	severe	O
52505	right	b-PROBLEM
52506	sided	i-PROBLEM
52507	sciatica	i-PROBLEM
52508	.	O
52509	in	O
52510	september	b-DATE
52511	1992	i-DATE
52512	ct	b-TEST
52513	myelogram	i-TEST
52514	showed	b-EVIDENTIAL
52515	a	b-PROBLEM
52516	lateral	i-PROBLEM
52517	l-1	i-PROBLEM
52518	s-1	i-PROBLEM
52519	disc	i-PROBLEM
52520	bulge	i-PROBLEM
52521	and	O
52522	small	b-PROBLEM
52523	l-4-4	i-PROBLEM
52524	bulge	i-PROBLEM
52525	.	O
52526	he	O
52527	has	O
52528	had	O
52529	no	O
52530	change	b-OCCURRENCE
52531	in	O
52532	pain	b-PROBLEM
52533	in	O
52534	the	O
52535	last	O
52536	few	b-DURATION
52537	months	i-DURATION
52538	.	O
52539	hospital	O
52540	course	O
52541	:	O
52542	he	O
52543	was	O
52544	admitted	b-OCCURRENCE
52545	,	O
52546	taken	O
52547	to	O
52548	the	b-CLINICAL_DEPT
52549	operating	i-CLINICAL_DEPT
52550	room	i-CLINICAL_DEPT
52551	where	O
52552	he	O
52553	underwent	O
52554	l5-s1	b-TREATMENT
52555	right	i-TREATMENT
52556	hemilaminectomy	i-TREATMENT
52557	and	O
52558	discectomy	b-TREATMENT
52559	.	O
52560	he	O
52561	tolerated	O
52562	the	b-TREATMENT
52563	procedure	i-TREATMENT
52564	well	b-OCCURRENCE
52565	,	O
52566	was	O
52567	taken	O
52568	to	O
52569	the	b-CLINICAL_DEPT
52570	floor	i-CLINICAL_DEPT
52571	in	O
52572	stable	b-OCCURRENCE
52573	condition	i-OCCURRENCE
52574	.	i-OCCURRENCE
52575	over	O
52576	the	O
52577	next	O
52578	three	b-DURATION
52579	days	i-DURATION
52580	he	O
52581	increased	b-TREATMENT
52582	his	i-TREATMENT
52583	activity	i-TREATMENT
52584	gradually	O
52585	,	O
52586	was	O
52587	able	O
52588	to	O
52589	do	O
52590	stairs	O
52591	with	O
52592	physical	b-TREATMENT
52593	therapy	i-TREATMENT
52594	and	O
52595	had	O
52596	pain	b-PROBLEM
52597	which	O
52598	could	O
52599	be	O
52600	controlled	O
52601	with	O
52602	oral	b-TREATMENT
52603	analgesics	i-TREATMENT
52604	.	O
52605		O
52606	admission	b-OCCURRENCE
52607	date	O
52608	:	O
52609	2018-05-12	b-ADMISSION
52610	discharge	b-OCCURRENCE
52611	date	O
52612	:	O
52613	2018-05-14	b-DISCHARGE
52614	service	O
52615	:	O
52616	neonatology	O
52617	history	O
52618	of	O
52619	present	O
52620	illness	O
52621	:	O
52622	melba	O
52623	barnett	O
52624	is	O
52625	the	O
52626	3.710	O
52627	-	O
52628	kg	O
52629	(	O
52630	8	O
52631	-	O
52632	pound	O
52633	3	O
52634	-	O
52635	ounce	O
52636	)	O
52637	product	O
52638	of	O
52639	a	O
52640	term	O
52641	gestation	O
52642	.	O
52643	he	O
52644	was	O
52645	born	b-OCCURRENCE
52646	to	O
52647	a	O
52648	35	O
52649	-	O
52650	year-old	O
52651	gravida	O
52652	2	O
52653	,	O
52654	para	O
52655	1	O
52656	(	O
52657	now	O
52658	2	O
52659	)	O
52660	mother	O
52661	.	O
52662	readmitted	b-OCCURRENCE
52663	for	O
52664	hyperbilirubinemia	b-PROBLEM
52665	on	O
52666	day	b-DATE
52667	of	i-DATE
52668	life	i-DATE
52669	#5	i-DATE
52670	.	O
52671	the	O
52672	pregnancy	O
52673	was	O
52674	benign	O
52675	with	O
52676	an	b-OCCURRENCE
52677	edc	i-OCCURRENCE
52678	of	O
52679	2018-05-07	b-DATE
52680	.	O
52681	prenatal	b-TEST
52682	screens	i-TEST
52683	were	O
52684	o+	O
52685	,	O
52686	antibody	b-TEST
52687	negative	O
52688	,	O
52689	hepatitis	b-TEST
52690	surface	i-TEST
52691	antigen	i-TEST
52692	negative	O
52693	,	O
52694	rapid	b-TEST
52695	plasma	i-TEST
52696	reagin	i-TEST
52697	nonreactive	O
52698	,	O
52699	rubella	b-TEST
52700	immune	O
52701	,	O
52702	group	b-TEST
52703	b	i-TEST
52704	strep	i-TEST
52705	positive	O
52706	.	O
52707	the	O
52708	infant	O
52709	delivered	b-OCCURRENCE
52710	vaginally	i-OCCURRENCE
52711	with	O
52712	apgar	b-TEST
52713	scores	i-TEST
52714	of	O
52715	9	O
52716	at	O
52717	one	O
52718	minute	O
52719	and	O
52720	9	O
52721	at	O
52722	five	O
52723	minutes	O
52724	.	O
52725	alleyne	O
52726	blood	b-TEST
52727	type	i-TEST
52728	is	O
52729	o+	O
52730	/	O
52731	coombs	b-TEST
52732	negative	O
52733	.	O
52734	he	O
52735	was	O
52736	readmitted	b-OCCURRENCE
52737	for	O
52738	phototherapy	b-TREATMENT
52739	on	O
52740	day	b-DATE
52741	of	i-DATE
52742	life	i-DATE
52743	#5	i-DATE
52744	for	O
52745	a	b-TEST
52746	bilirubin	i-TEST
52747	of	O
52748	23.3	O
52749	.	O
52750	summary	O
52751	of	O
52752	hospital	O
52753	course	O
52754	:	O
52755	respiratory	O
52756	:	O
52757	without	O
52758	issues	b-PROBLEM
52759	on	O
52760	this	b-OCCURRENCE
52761	admission	i-OCCURRENCE
52762	.	O
52763	breath	b-TEST
52764	sounds	i-TEST
52765	are	O
52766	clear	O
52767	and	O
52768	equal	O
52769	.	O
52770	cardiovascular	O
52771	:	O
52772	without	O
52773	issues	b-PROBLEM
52774	on	O
52775	this	b-OCCURRENCE
52776	admission	i-OCCURRENCE
52777	.	O
52778	he	O
52779	had	O
52780	a	O
52781	regular	O
52782	heart	b-TEST
52783	rate	i-TEST
52784	and	O
52785	rhythm	b-TEST
52786	,	O
52787	no	O
52788	murmur	b-PROBLEM
52789	,	O
52790	and	O
52791	pulses	b-TEST
52792	were	O
52793	2+	O
52794	and	O
52795	symmetric	O
52796	.	O
52797	fluids	O
52798	,	O
52799	electrolytes	O
52800	and	O
52801	nutrition	O
52802	:	O
52803	alleyne	O
52804	birth	b-TEST
52805	weight	i-TEST
52806	was	O
52807	3.710	O
52808	kg	O
52809	(	O
52810	8	O
52811	pounds	O
52812	/	O
52813	3	O
52814	ounces	O
52815	).	O
52816	his	b-TEST
52817	weight	i-TEST
52818	on	O
52819	this	b-OCCURRENCE
52820	admission	i-OCCURRENCE
52821	was	O
52822	3.505	O
52823	kg	O
52824	(	O
52825	7	O
52826	pounds	O
52827	/	O
52828	12	O
52829	ounces	O
52830	).	O
52831	linda	O
52832	is	O
52833	breast	b-OCCURRENCE
52834	feeding	i-OCCURRENCE
52835	every	O
52836	3	b-FREQUENCY
52837	hours	i-FREQUENCY
52838	and	O
52839	supplementing	O
52840	with	O
52841	expressed	O
52842	breast	O
52843	milk	O
52844	.	O
52845	he	O
52846	is	O
52847	feeding	b-OCCURRENCE
52848	well	i-OCCURRENCE
52849	.	O
52850	his	b-TEST
52851	discharge	i-TEST
52852	weight	i-TEST
52853	is	O
52854	3585	O
52855	grams	O
52856	(	O
52857	7	O
52858	pounds	O
52859	13	O
52860	ounces	O
52861	)	O
52862	.	O
52863	gastrointestinal	O
52864	:	O
52865	alleyne	O
52866	bilirubin	b-TEST
52867	on	O
52868	2018-05-09	b-DATE
52869	was	O
52870	10.4	O
52871	;	O
52872	at	O
52873	which	b-DATE
52874	time	i-DATE
52875	he	O
52876	was	O
52877	discharged	b-OCCURRENCE
52878	to	O
52879	home	O
52880	.	O
52881	at	O
52882	the	b-CLINICAL_DEPT
52883	primary	i-CLINICAL_DEPT
52884	pediatrician	i-CLINICAL_DEPT
52885	's	i-CLINICAL_DEPT
52886	office	i-CLINICAL_DEPT
52887	on	O
52888	2018-05-12	b-DATE
52889	his	b-TEST
52890	bilirubin	i-TEST
52891	had	O
52892	been	O
52893	23	O
52894	,	O
52895	at	O
52896	which	b-DATE
52897	time	i-DATE
52898	he	O
52899	was	O
52900	readmitted	b-OCCURRENCE
52901	to	O
52902	the	b-CLINICAL_DEPT
52903	healthsouth	i-CLINICAL_DEPT
52904	rehab	i-CLINICAL_DEPT
52905	hospital	i-CLINICAL_DEPT
52906	of	i-CLINICAL_DEPT
52907	western	i-CLINICAL_DEPT
52908	mass.	i-CLINICAL_DEPT
52909	and	O
52910	double	b-TREATMENT
52911	phototherapy	i-TREATMENT
52912	was	O
52913	started	O
52914	.	O
52915	his	b-TEST
52916	bilirubin	i-TEST
52917	on	O
52918	05-13	b-DATE
52919	was	O
52920	18.4	O
52921	;	O
52922	and	O
52923	on	O
52924	05-14	b-DATE
52925	it	O
52926	was	O
52927	14.7	O
52928	.	O
52929	phototherapy	b-TREATMENT
52930	was	O
52931	discontinued	O
52932	on	O
52933	2018-05-14	b-DATE
52934	,	O
52935	and	O
52936	a	b-TEST
52937	rebound	i-TEST
52938	bilirubin	i-TEST
52939	will	O
52940	be	O
52941	checked	O
52942	in	O
52943	the	b-CLINICAL_DEPT
52944	pediatrician	i-CLINICAL_DEPT
52945	's	i-CLINICAL_DEPT
52946	office	i-CLINICAL_DEPT
52947	.	O
52948	hematology	O
52949	:	O
52950	the	b-TEST
52951	hematocrit	i-TEST
52952	on	O
52953	05-12	b-DATE
52954	was	O
52955	48.7	O
52956	with	O
52957	a	b-TEST
52958	reticulocyte	i-TEST
52959	count	i-TEST
52960	of	O
52961	1.9	O
52962	,	O
52963	and	O
52964	his	b-TEST
52965	blood	i-TEST
52966	type	i-TEST
52967	is	O
52968	o+	O
52969	/	O
52970	coombs	b-TEST
52971	negative	O
52972	.	O
52973	infectious	O
52974	disease	O
52975	:	O
52976	no	O
52977	issues	b-PROBLEM
52978	on	O
52979	this	b-OCCURRENCE
52980	admission	i-OCCURRENCE
52981	.	O
52982	neurological	O
52983	:	O
52984	the	O
52985	infant	O
52986	has	O
52987	been	O
52988	appropriate	O
52989	for	O
52990	gestational	O
52991	age	O
52992	.	O
52993	sensory	O
52994	:	O
52995	auditory	b-TEST
52996	hearing	i-TEST
52997	screening	i-TEST
52998	was	O
52999	performed	O
53000	with	O
53001	automated	b-OCCURRENCE
53002	auditory	i-OCCURRENCE
53003	brain	i-OCCURRENCE
53004	stem	i-OCCURRENCE
53005	responses	i-OCCURRENCE
53006	,	O
53007	and	O
53008	the	O
53009	infant	O
53010	passed	b-OCCURRENCE
53011	both	i-OCCURRENCE
53012	ears	i-OCCURRENCE
53013	on	O
53014	his	b-OCCURRENCE
53015	previous	i-OCCURRENCE
53016	admission	i-OCCURRENCE
53017	.	O
53018	hearing	b-TEST
53019	screens	i-TEST
53020	were	O
53021	repeated	O
53022	on	O
53023	2018-05-13	b-DATE
53024	and	O
53025	he	O
53026	passed	b-OCCURRENCE
53027	both	i-OCCURRENCE
53028	ears	i-OCCURRENCE
53029	.	O
53030	psychosocial	O
53031	:	O
53032	family	O
53033	is	O
53034	invested	O
53035	and	O
53036	involved	O
53037	.	O
53038		O
53039	admission	b-OCCURRENCE
53040	date	O
53041	:	O
53042	03/03/1999	b-ADMISSION
53043	discharge	b-OCCURRENCE
53044	date	O
53045	:	O
53046	03/08/1999	b-DISCHARGE
53047	history	O
53048	of	O
53049	present	O
53050	illness	O
53051	:	O
53052	mr.	O
53053	prehekote	O
53054	is	O
53055	an	O
53056	88-year-old	O
53057	portuguese	O
53058	speaking	O
53059	only	O
53060	male	O
53061	who	O
53062	was	O
53063	diagnosed	b-OCCURRENCE
53064	with	O
53065	adenocarcinoma	b-PROBLEM
53066	of	i-PROBLEM
53067	the	i-PROBLEM
53068	prostate	i-PROBLEM
53069	in	O
53070	1998	b-DATE
53071	.	O
53072	he	O
53073	received	O
53074	transurethral	b-TREATMENT
53075	resection	i-TREATMENT
53076	of	i-TREATMENT
53077	the	i-TREATMENT
53078	prostate	i-TREATMENT
53079	one	b-DATE
53080	year	i-DATE
53081	ago	i-DATE
53082	because	O
53083	of	O
53084	persistent	b-PROBLEM
53085	urinary	i-PROBLEM
53086	retention	i-PROBLEM
53087	.	O
53088	after	O
53089	that	O
53090	,	O
53091	he	O
53092	was	O
53093	on	O
53094	lupron	b-TREATMENT
53095	and	O
53096	nilandron	b-TREATMENT
53097	hormone	i-TREATMENT
53098	therapy	i-TREATMENT
53099	.	O
53100	the	O
53101	patient	O
53102	was	O
53103	admitted	b-OCCURRENCE
53104	on	O
53105	february	b-DATE
53106	23	i-DATE
53107	,	i-DATE
53108	1999	i-DATE
53109	to	O
53110	eifro	b-CLINICAL_DEPT
53111	medical	i-CLINICAL_DEPT
53112	center	i-CLINICAL_DEPT
53113	because	O
53114	of	O
53115	failure	b-PROBLEM
53116	to	i-PROBLEM
53117	thrive	i-PROBLEM
53118	and	O
53119	decreased	b-PROBLEM
53120	hematocrit	i-PROBLEM
53121	.	O
53122	he	O
53123	was	O
53124	noted	O
53125	to	O
53126	have	O
53127	elevated	b-PROBLEM
53128	bun	i-PROBLEM
53129	and	O
53130	creatinine	b-TEST
53131	.	O
53132	bun	b-TEST
53133	was	O
53134	34	O
53135	and	O
53136	creatinine	b-TEST
53137	was	O
53138	2.6	O
53139	,	O
53140	up	O
53141	from	O
53142	his	O
53143	baseline	O
53144	of	O
53145	1.0	O
53146	.	O
53147	prostate	b-TEST
53148	specific	i-TEST
53149	antigen	i-TEST
53150	increased	O
53151	from	O
53152	77.9	O
53153	to	O
53154	88	O
53155	,	O
53156	and	O
53157	the	O
53158	patient	O
53159	also	O
53160	had	O
53161	urinary	b-PROBLEM
53162	incontinence	i-PROBLEM
53163	and	O
53164	body	b-PROBLEM
53165	weight	i-PROBLEM
53166	loss	i-PROBLEM
53167	.	O
53168	further	b-TEST
53169	evaluation	i-TEST
53170	of	O
53171	his	b-PROBLEM
53172	renal	i-PROBLEM
53173	failure	i-PROBLEM
53174	showed	O
53175	that	O
53176	the	O
53177	patient	O
53178	has	O
53179	bilateral	b-PROBLEM
53180	hydronephrosis	i-PROBLEM
53181	,	O
53182	most	O
53183	likely	O
53184	obstructive	b-PROBLEM
53185	uropathy	i-PROBLEM
53186	due	O
53187	to	O
53188	prostate	b-PROBLEM
53189	ca	i-PROBLEM
53190	in	i-PROBLEM
53191	the	i-PROBLEM
53192	pelvic	i-PROBLEM
53193	area	i-PROBLEM
53194	.	O
53195	because	O
53196	of	O
53197	the	b-PROBLEM
53198	increasing	i-PROBLEM
53199	creatinine	i-PROBLEM
53200	to	O
53201	8.0	O
53202	on	O
53203	february	b-DATE
53204	28	i-DATE
53205	,	i-DATE
53206	1999	i-DATE
53207	,	O
53208	a	b-TREATMENT
53209	left	i-TREATMENT
53210	nephrostomy	i-TREATMENT
53211	tube	i-TREATMENT
53212	was	O
53213	placed	O
53214	.	O
53215	however	O
53216	after	O
53217	the	b-TREATMENT
53218	procedure	i-TREATMENT
53219	,	O
53220	the	b-PROBLEM
53221	patient	i-PROBLEM
53222	&apos;s	i-PROBLEM
53223	hematocrit	i-PROBLEM
53224	dropped	O
53225	to	O
53226	24	O
53227	and	O
53228	he	O
53229	was	O
53230	transfused	b-OCCURRENCE
53231	two	O
53232	units	O
53233	of	O
53234	packed	O
53235	red	O
53236	blood	O
53237	cells	O
53238	.	O
53239	his	b-TEST
53240	hematocrit	i-TEST
53241	increased	O
53242	to	O
53243	about	O
53244	30	O
53245	,	O
53246	but	O
53247	he	O
53248	continued	O
53249	to	O
53250	have	O
53251	hematuria	b-PROBLEM
53252	and	O
53253	his	b-PROBLEM
53254	renal	i-PROBLEM
53255	function	i-PROBLEM
53256	only	O
53257	improved	b-OCCURRENCE
53258	very	O
53259	slowly	O
53260	.	O
53261	he	O
53262	also	O
53263	received	O
53264	kayexalate	b-TREATMENT
53265	for	O
53266	hyperkalemia	b-PROBLEM
53267	.	O
53268	due	O
53269	to	O
53270	the	b-PROBLEM
53271	persistent	i-PROBLEM
53272	blood	i-PROBLEM
53273	in	i-PROBLEM
53274	the	i-PROBLEM
53275	urine	i-PROBLEM
53276	,	O
53277	he	O
53278	was	O
53279	transferred	b-OCCURRENCE
53280	from	O
53281	eifro	b-CLINICAL_DEPT
53282	medical	i-CLINICAL_DEPT
53283	center	i-CLINICAL_DEPT
53284	to	O
53285	the	b-CLINICAL_DEPT
53286	retelk	i-CLINICAL_DEPT
53287	county	i-CLINICAL_DEPT
53288	medical	i-CLINICAL_DEPT
53289	center	i-CLINICAL_DEPT
53290	for	O
53291	angiographic	b-TEST
53292	studies	i-TEST
53293	to	O
53294	rule	O
53295	out	O
53296	any	O
53297	vascular	b-PROBLEM
53298	injuries	i-PROBLEM
53299	.	O
53300	the	O
53301	patient	O
53302	was	O
53303	transferred	b-OCCURRENCE
53304	to	O
53305	genearocktemp	b-CLINICAL_DEPT
53306	ry	i-CLINICAL_DEPT
53307	health	i-CLINICAL_DEPT
53308	on	O
53309	march	b-DATE
53310	3	i-DATE
53311	,	i-DATE
53312	1999	i-DATE
53313	.	O
53314	review	O
53315	of	O
53316	systems	O
53317	:	O
53318	the	O
53319	patient	O
53320	had	O
53321	constipation	b-PROBLEM
53322	with	O
53323	dysuria	b-PROBLEM
53324	,	O
53325	but	O
53326	no	O
53327	fever	b-PROBLEM
53328	or	O
53329	chills	b-PROBLEM
53330	.	O
53331	no	O
53332	cough	b-PROBLEM
53333	.	O
53334	no	O
53335	chest	b-PROBLEM
53336	pain	i-PROBLEM
53337	.	O
53338	no	O
53339	palpitations	b-PROBLEM
53340	,	O
53341	history	O
53342	of	O
53343	epigastric	b-PROBLEM
53344	pain	i-PROBLEM
53345	and	O
53346	body	b-PROBLEM
53347	weight	i-PROBLEM
53348	loss	i-PROBLEM
53349	.	O
53350	no	O
53351	headache	b-PROBLEM
53352	.	O
53353	no	O
53354	bone	b-PROBLEM
53355	pain	i-PROBLEM
53356	.	O
53357	hospital	O
53358	course	O
53359	:	O
53360	after	O
53361	admission	b-OCCURRENCE
53362	,	O
53363	urology	O
53364	,	O
53365	nephrology	O
53366	as	O
53367	well	O
53368	as	O
53369	interventional	O
53370	radiology	O
53371	was	O
53372	consulted	b-OCCURRENCE
53373	about	O
53374	the	b-TREATMENT
53375	management	i-TREATMENT
53376	of	O
53377	this	O
53378	patient	O
53379	.	O
53380	the	O
53381	specialist	O
53382	concluded	b-OCCURRENCE
53383	that	O
53384	because	O
53385	the	b-PROBLEM
53386	patient	i-PROBLEM
53387	&apos;s	i-PROBLEM
53388	hematuria	i-PROBLEM
53389	seemed	O
53390	to	O
53391	be	O
53392	stable	O
53393	and	O
53394	hematocrit	b-TEST
53395	to	O
53396	maintain	O
53397	at	O
53398	about	O
53399	29-30	O
53400	,	O
53401	there	O
53402	is	O
53403	no	O
53404	urgent	O
53405	need	O
53406	to	O
53407	do	O
53408	an	b-TEST
53409	arteriogram	i-TEST
53410	which	O
53411	may	O
53412	cause	O
53413	further	b-PROBLEM
53414	damage	i-PROBLEM
53415	to	i-PROBLEM
53416	the	i-PROBLEM
53417	patient	i-PROBLEM
53418	&apos;s	i-PROBLEM
53419	kidney	i-PROBLEM
53420	.	O
53421	urology	b-TEST
53422	consultation	i-TEST
53423	thinks	O
53424	that	O
53425	cystoscopy	b-TREATMENT
53426	would	O
53427	not	O
53428	add	O
53429	any	O
53430	benefit	O
53431	to	O
53432	the	b-TREATMENT
53433	management	i-TREATMENT
53434	and	O
53435	only	O
53436	would	O
53437	consider	O
53438	a	b-TREATMENT
53439	right	i-TREATMENT
53440	nephrostomy	i-TREATMENT
53441	if	O
53442	renal	b-PROBLEM
53443	function	i-PROBLEM
53444	failed	O
53445	to	O
53446	improve	b-OCCURRENCE
53447	.	O
53448	after	O
53449	admission	b-OCCURRENCE
53450	,	O
53451	the	O
53452	patient	O
53453	was	O
53454	treated	b-TREATMENT
53455	conservatively	i-TREATMENT
53456	to	O
53457	correct	O
53458	his	b-PROBLEM
53459	electrolyte	i-PROBLEM
53460	and	i-PROBLEM
53461	metabolic	i-PROBLEM
53462	acidosis	i-PROBLEM
53463	.	O
53464	he	O
53465	was	O
53466	given	O
53467	blood	b-TREATMENT
53468	transfusion	i-TREATMENT
53469	,	O
53470	two	O
53471	units	O
53472	when	O
53473	his	b-TEST
53474	hematocrit	i-TEST
53475	dropped	O
53476	to	O
53477	29.4	O
53478	.	O
53479	after	O
53480	transfusion	b-TREATMENT
53481	,	O
53482	the	b-TEST
53483	patient	i-TEST
53484	&apos;s	i-TEST
53485	hematocrit	i-TEST
53486	rose	O
53487	to	O
53488	37.7	O
53489	on	O
53490	the	b-DATE
53491	day	i-DATE
53492	of	i-DATE
53493	discharge	i-DATE
53494	.	O
53495	the	O
53496	patient	O
53497	was	O
53498	also	O
53499	given	O
53500	sodium	b-TREATMENT
53501	bicarbonate	i-TREATMENT
53502	to	O
53503	correct	O
53504	his	b-PROBLEM
53505	metabolic	i-PROBLEM
53506	acidosis	i-PROBLEM
53507	.	O
53508	he	O
53509	continued	O
53510	to	O
53511	pass	O
53512	about	O
53513	1500-2000	O
53514	cc	O
53515	of	O
53516	urine	b-OCCURRENCE
53517	a	O
53518	day	O
53519	and	O
53520	his	b-TEST
53521	renal	i-TEST
53522	function	i-TEST
53523	improved	b-OCCURRENCE
53524	slowly	O
53525	with	O
53526	creatinine	b-TEST
53527	decreased	O
53528	to	O
53529	4.2	O
53530	on	O
53531	the	b-DATE
53532	day	i-DATE
53533	of	i-DATE
53534	discharge	i-DATE
53535	.	O
53536	during	O
53537	this	b-OCCURRENCE
53538	admission	i-OCCURRENCE
53539	,	O
53540	the	O
53541	patient	O
53542	also	O
53543	developed	O
53544	atrial	b-PROBLEM
53545	fibrillation	i-PROBLEM
53546	with	O
53547	ventricular	b-TEST
53548	rate	i-TEST
53549	of	O
53550	about	O
53551	70-80	O
53552	.	O
53553	cpk	b-TEST
53554	was	O
53555	tracked	O
53556	,	O
53557	but	O
53558	was	O
53559	totally	O
53560	normal	b-OCCURRENCE
53561	.	O
53562	no	O
53563	beta	b-TREATMENT
53564	blockers	i-TREATMENT
53565	were	O
53566	given	O
53567	.	O
53568	a	b-OCCURRENCE
53569	long	i-OCCURRENCE
53570	discussion	i-OCCURRENCE
53571	amongst	O
53572	the	O
53573	specialist	O
53574	,	O
53575	nephrology	O
53576	,	O
53577	urology	O
53578	,	O
53579	interventional	O
53580	radiology	O
53581	,	O
53582	primary	O
53583	oncology	O
53584	as	O
53585	well	O
53586	with	O
53587	the	O
53588	family	O
53589	lead	O
53590	to	O
53591	the	b-OCCURRENCE
53592	conclusion	i-OCCURRENCE
53593	that	O
53594	conservative	b-TREATMENT
53595	management	i-TREATMENT
53596	may	O
53597	give	O
53598	the	O
53599	patient	O
53600	more	O
53601	comfort	O
53602	than	O
53603	crisis	b-TREATMENT
53604	treatment	i-TREATMENT
53605	in	O
53606	this	b-PROBLEM
53607	well	i-PROBLEM
53608	advanced	i-PROBLEM
53609	prostate	i-PROBLEM
53610	ca	i-PROBLEM
53611	.	O
53612	doctor	O
53613	lucreamull	O
53614	discussed	b-OCCURRENCE
53615	the	O
53616	patient	O
53617	&apos;s	O
53618	clinical	O
53619	status	b-OCCURRENCE
53620	and	O
53621	overall	O
53622	situation	O
53623	with	O
53624	the	O
53625	patient	O
53626	&apos;s	O
53627	family	O
53628	and	O
53629	the	O
53630	family	O
53631	decided	b-OCCURRENCE
53632	that	O
53633	mr.	O
53634	prehekote	O
53635	could	O
53636	return	b-OCCURRENCE
53637	home	i-OCCURRENCE
53638	with	O
53639	hospice	b-TREATMENT
53640	.	O
53641	the	O
53642	patient	O
53643	&apos;s	O
53644	primary	O
53645	care	O
53646	physician	O
53647	,	O
53648	doctor	O
53649	tomedankell	O
53650	flowayles	O
53651	will	O
53652	manage	O
53653	the	b-TREATMENT
53654	hospice	i-TREATMENT
53655	issues	i-TREATMENT
53656	.	O
53657	the	O
53658	patient	O
53659	was	O
53660	discharged	b-OCCURRENCE
53661	to	O
53662	home	b-OCCURRENCE
53663	for	O
53664	hospice	b-TREATMENT
53665	on	O
53666	march	b-DATE
53667	8	i-DATE
53668	,	i-DATE
53669	1999	i-DATE
53670	.	O
53671		O
53672	admission	b-OCCURRENCE
53673	date	O
53674	:	O
53675	05/09/1998	b-ADMISSION
53676	discharge	b-OCCURRENCE
53677	date	O
53678	:	O
53679	05/25/1998	b-DISCHARGE
53680	history	O
53681	of	O
53682	present	O
53683	illness	O
53684	:	O
53685	the	O
53686	patient	O
53687	is	O
53688	a	O
53689	74-year-old	O
53690	woman	O
53691	,	O
53692	well	O
53693	known	O
53694	to	O
53695	the	b-CLINICAL_DEPT
53696	cardiac	i-CLINICAL_DEPT
53697	surgery	i-CLINICAL_DEPT
53698	service	i-CLINICAL_DEPT
53699	,	O
53700	readmitted	b-OCCURRENCE
53701	from	O
53702	glasmif/putdi	b-CLINICAL_DEPT
53703	health	i-CLINICAL_DEPT
53704	network	i-CLINICAL_DEPT
53705	with	O
53706	sternal	b-PROBLEM
53707	wound	i-PROBLEM
53708	infection	i-PROBLEM
53709	.	O
53710	she	O
53711	has	O
53712	been	O
53713	previously	O
53714	hospitalized	b-OCCURRENCE
53715	on	O
53716	12	b-DATE
53717	april	i-DATE
53718	1998	i-DATE
53719	for	O
53720	the	b-PROBLEM
53721	same	i-PROBLEM
53722	diagnosis	i-PROBLEM
53723	.	O
53724	she	O
53725	is	O
53726	now	O
53727	coming	b-OCCURRENCE
53728	for	O
53729	surgical	b-TREATMENT
53730	treatment	i-TREATMENT
53731	,	O
53732	wound	b-TREATMENT
53733	debridement	i-TREATMENT
53734	,	O
53735	and	O
53736	possible	O
53737	wound	b-TREATMENT
53738	closure	i-TREATMENT
53739	with	i-TREATMENT
53740	bilateral	i-TREATMENT
53741	pectoralis	i-TREATMENT
53742	flap	i-TREATMENT
53743	.	O
53744	she	O
53745	underwent	O
53746	coronary	b-TREATMENT
53747	artery	i-TREATMENT
53748	bypass	i-TREATMENT
53749	graft	i-TREATMENT
53750	times	O
53751	two	O
53752	with	O
53753	saphenous	b-TREATMENT
53754	vein	i-TREATMENT
53755	graft	i-TREATMENT
53756	on	O
53757	29	b-DATE
53758	march	i-DATE
53759	1998	i-DATE
53760	.	O
53761	of	O
53762	note	O
53763	,	O
53764	the	O
53765	patient	O
53766	is	O
53767	status	O
53768	post	O
53769	lymphoma	b-PROBLEM
53770	with	O
53771	treatment	O
53772	of	O
53773	chemotherapy	b-TREATMENT
53774	and	O
53775	radiation	b-TREATMENT
53776	six	b-DATE
53777	years	i-DATE
53778	ago	i-DATE
53779	,	O
53780	and	O
53781	is	O
53782	an	b-PROBLEM
53783	insulin-dependent	i-PROBLEM
53784	diabetic	i-PROBLEM
53785	.	O
53786	hospital	O
53787	course	O
53788	:	O
53789	the	O
53790	patient	O
53791	was	O
53792	placed	O
53793	on	O
53794	iv	b-TREATMENT
53795	antibiotics	i-TREATMENT
53796	,	O
53797	ancef	b-TREATMENT
53798	1	O
53799	gm	O
53800	q.8h.	b-FREQUENCY
53801	on	O
53802	10	b-DATE
53803	may	i-DATE
53804	1998	i-DATE
53805	,	O
53806	she	O
53807	underwent	O
53808	sternal	b-TREATMENT
53809	wound	i-TREATMENT
53810	debridement	i-TREATMENT
53811	and	O
53812	closure	b-TREATMENT
53813	,	O
53814	performed	O
53815	by	O
53816	doctor	O
53817	falccouette	O
53818	and	O
53819	doctor	O
53820	shuffzeln	O
53821	.	O
53822	the	O
53823	patient	O
53824	was	O
53825	switched	b-OCCURRENCE
53826	to	O
53827	ampicillin	b-TREATMENT
53828	,	O
53829	gentamicin	b-TREATMENT
53830	,	O
53831	and	O
53832	clindamycin	b-TREATMENT
53833	,	O
53834	according	O
53835	to	O
53836	the	b-TEST
53837	culture	i-TEST
53838	,	O
53839	enterococci	b-PROBLEM
53840	and	O
53841	staphylococcus	b-PROBLEM
53842	in	O
53843	the	b-PROBLEM
53844	wound	i-PROBLEM
53845	.	O
53846	due	O
53847	to	O
53848	the	b-PROBLEM
53849	persistent	i-PROBLEM
53850	fevers	i-PROBLEM
53851	,	O
53852	the	O
53853	patient	O
53854	underwent	O
53855	vancomycin	b-TREATMENT
53856	desensitization	i-TREATMENT
53857	in	O
53858	the	b-CLINICAL_DEPT
53859	surgical	i-CLINICAL_DEPT
53860	intensive	i-CLINICAL_DEPT
53861	care	i-CLINICAL_DEPT
53862	unit	i-CLINICAL_DEPT
53863	followed	O
53864	by	O
53865	a	b-TREATMENT
53866	change	i-TREATMENT
53867	of	i-TREATMENT
53868	antibiotics	i-TREATMENT
53869	to	O
53870	vancomycin	b-TREATMENT
53871	and	O
53872	levofloxacin	b-TREATMENT
53873	.	O
53874	further	b-TEST
53875	cultures	i-TEST
53876	from	i-TEST
53877	sputum	i-TEST
53878	and	i-TEST
53879	urine	i-TEST
53880	revealed	b-EVIDENTIAL
53881	yeast	b-PROBLEM
53882	sensitive	O
53883	to	O
53884	diflucan	b-TREATMENT
53885	,	O
53886	which	O
53887	was	O
53888	administered	O
53889	shortly	O
53890	after	O
53891	.	O
53892	because	O
53893	of	O
53894	expected	b-TREATMENT
53895	long	i-TREATMENT
53896	term	i-TREATMENT
53897	antibiotic	i-TREATMENT
53898	administration	i-TREATMENT
53899	,	O
53900	a	b-TREATMENT
53901	picc	i-TREATMENT
53902	line	i-TREATMENT
53903	was	O
53904	placed	O
53905	and	O
53906	the	O
53907	patient	O
53908	was	O
53909	prepared	b-OCCURRENCE
53910	for	O
53911	transfer	b-OCCURRENCE
53912	back	O
53913	to	O
53914	fo	b-CLINICAL_DEPT
53915	hospital	i-CLINICAL_DEPT
53916	.	O
53917	as	O
53918	a	b-PROBLEM
53919	small	i-PROBLEM
53920	complication	i-PROBLEM
53921	,	O
53922	the	O
53923	patient	O
53924	opened	b-PROBLEM
53925	a	b-PROBLEM
53926	left	i-PROBLEM
53927	ankle	i-PROBLEM
53928	wound	i-PROBLEM
53929	post	O
53930	saphenous	b-TREATMENT
53931	vein	i-TREATMENT
53932	harvest	i-TREATMENT
53933	,	O
53934	which	O
53935	persists	b-OCCURRENCE
53936	up	O
53937	until	O
53938	now	b-DATE
53939	and	O
53940	is	O
53941	of	O
53942	a	O
53943	size	O
53944	2	O
53945	x	O
53946	1	O
53947	cm	O
53948	.	O
53949	due	O
53950	to	O
53951	difficult	b-PROBLEM
53952	ambulation	i-PROBLEM
53953	,	O
53954	the	O
53955	patient	O
53956	developed	O
53957	a	b-PROBLEM
53958	small	i-PROBLEM
53959	ulcer	i-PROBLEM
53960	in	i-PROBLEM
53961	the	i-PROBLEM
53962	sacral	i-PROBLEM
53963	area	i-PROBLEM
53964	,	O
53965	which	O
53966	was	O
53967	treated	O
53968	with	O
53969	duoderm	b-TREATMENT
53970	dressing	i-TREATMENT
53971	.	O
53972	during	O
53973	the	b-OCCURRENCE
53974	course	i-OCCURRENCE
53975	of	i-OCCURRENCE
53976	hospitalization	i-OCCURRENCE
53977	,	O
53978	the	O
53979	patient	O
53980	was	O
53981	followed	O
53982	by	O
53983	cardiac	b-CLINICAL_DEPT
53984	surgery	i-CLINICAL_DEPT
53985	,	O
53986	cardiology	b-CLINICAL_DEPT
53987	,	O
53988	infectious	b-CLINICAL_DEPT
53989	disease	i-CLINICAL_DEPT
53990	,	O
53991	allergy	b-CLINICAL_DEPT
53992	,	O
53993	and	O
53994	medicine	b-CLINICAL_DEPT
53995	,	O
53996	including	O
53997	gi	b-CLINICAL_DEPT
53998	teams	i-CLINICAL_DEPT
53999	.	O
54000		O
54001	admission	b-OCCURRENCE
54002	date	O
54003	:	O
54004	11/24/1994	b-ADMISSION
54005	discharge	b-OCCURRENCE
54006	date	O
54007	:	O
54008	principal	O
54009	diagnosis	O
54010	:	O
54011	history	O
54012	of	O
54013	present	O
54014	illness	O
54015	:	O
54016	this	O
54017	is	O
54018	a	O
54019	59-year-old	O
54020	white	O
54021	male	O
54022	.	O
54023	the	O
54024	patient	O
54025	has	O
54026	had	O
54027	multiple	b-PROBLEM
54028	myeloma	i-PROBLEM
54029	since	O
54030	1990	b-DATE
54031	.	O
54032	he	O
54033	underwent	O
54034	an	b-TREATMENT
54035	autologous	i-TREATMENT
54036	bone	i-TREATMENT
54037	marrow	i-TREATMENT
54038	transplant	i-TREATMENT
54039	in	O
54040	10/92	b-DATE
54041	at	O
54042	petersly	b-CLINICAL_DEPT
54043	hospital	i-CLINICAL_DEPT
54044	and	i-CLINICAL_DEPT
54045	medical	i-CLINICAL_DEPT
54046	center	i-CLINICAL_DEPT
54047	.	O
54048	at	O
54049	that	b-DATE
54050	time	i-DATE
54051	he	O
54052	received	O
54053	total	b-TREATMENT
54054	body	i-TREATMENT
54055	irradiation	i-TREATMENT
54056	of	O
54057	1400	O
54058	cgy	O
54059	.	O
54060	this	b-TREATMENT
54061	bone	i-TREATMENT
54062	marrow	i-TREATMENT
54063	transplant	i-TREATMENT
54064	did	O
54065	not	O
54066	produce	O
54067	remission	b-OCCURRENCE
54068	and	O
54069	then	O
54070	he	O
54071	was	O
54072	treated	O
54073	with	O
54074	three	O
54075	cycles	O
54076	of	O
54077	vad	b-TREATMENT
54078	subsequently	O
54079	.	O
54080	in	O
54081	08/94	b-DATE
54082	,	O
54083	the	O
54084	patient	O
54085	developed	O
54086	lower	b-PROBLEM
54087	back	i-PROBLEM
54088	pain	i-PROBLEM
54089	.	O
54090	a	b-TEST
54091	workup	i-TEST
54092	done	O
54093	in	O
54094	de	O
54095	is	O
54096	not	O
54097	available	O
54098	at	O
54099	the	O
54100	time	O
54101	of	O
54102	this	O
54103	dictation	O
54104	.	O
54105	according	O
54106	to	O
54107	her	O
54108	scanty	O
54109	records	O
54110	,	O
54111	an	b-TEST
54112	mri	i-TEST
54113	of	i-TEST
54114	the	i-TEST
54115	spine	i-TEST
54116	showed	b-EVIDENTIAL
54117	diffuse	b-PROBLEM
54118	spinal	i-PROBLEM
54119	column	i-PROBLEM
54120	involvement	i-PROBLEM
54121	with	O
54122	lesions	b-PROBLEM
54123	in	i-PROBLEM
54124	t4	i-PROBLEM
54125	and	i-PROBLEM
54126	t8	i-PROBLEM
54127	with	O
54128	no	O
54129	cord	b-PROBLEM
54130	compression	i-PROBLEM
54131	at	O
54132	that	O
54133	time	O
54134	.	O
54135	he	O
54136	was	O
54137	then	O
54138	treated	O
54139	with	O
54140	radiation	b-TREATMENT
54141	therapy	i-TREATMENT
54142	from	O
54143	t3	O
54144	to	O
54145	t9	O
54146	receiving	O
54147	2500	O
54148	cgy	O
54149	from	O
54150	08/94	b-DATE
54151	to	O
54152	09/94	b-DATE
54153	.	O
54154	he	O
54155	has	O
54156	been	O
54157	on	O
54158	decadron	b-TREATMENT
54159	since	O
54160	08/94	b-DATE
54161	.	O
54162	about	O
54163	two	b-DATE
54164	weeks	i-DATE
54165	prior	O
54166	to	O
54167	admission	b-OCCURRENCE
54168	the	O
54169	patient	O
54170	developed	O
54171	mid	b-PROBLEM
54172	back	i-PROBLEM
54173	pain	i-PROBLEM
54174	,	O
54175	burning	O
54176	in	O
54177	nature	O
54178	with	O
54179	radiation	O
54180	around	O
54181	the	O
54182	right	O
54183	lower	O
54184	ribs	O
54185	.	O
54186	he	O
54187	also	O
54188	began	O
54189	to	O
54190	develop	O
54191	noticeably	b-PROBLEM
54192	increasing	i-PROBLEM
54193	bilateral	i-PROBLEM
54194	lower	i-PROBLEM
54195	extremity	i-PROBLEM
54196	weakness	i-PROBLEM
54197	and	O
54198	possibly	O
54199	numbness	b-PROBLEM
54200	in	i-PROBLEM
54201	the	i-PROBLEM
54202	lower	i-PROBLEM
54203	extremities	i-PROBLEM
54204	.	O
54205	he	O
54206	stated	b-EVIDENTIAL
54207	that	O
54208	he	O
54209	had	O
54210	difficulty	b-PROBLEM
54211	rising	i-PROBLEM
54212	from	i-PROBLEM
54213	a	i-PROBLEM
54214	chair	i-PROBLEM
54215	.	O
54216	an	b-TEST
54217	mri	i-TEST
54218	without	i-TEST
54219	gadolinium	i-TEST
54220	done	O
54221	on	O
54222	11/20/94	b-DATE
54223	of	O
54224	the	O
54225	spine	O
54226	showed	b-EVIDENTIAL
54227	a	b-PROBLEM
54228	right	i-PROBLEM
54229	posterior	i-PROBLEM
54230	lateral	i-PROBLEM
54231	epidural	i-PROBLEM
54232	mass	i-PROBLEM
54233	extending	O
54234	from	O
54235	t9	O
54236	to	O
54237	t12	O
54238	.	O
54239	there	O
54240	was	O
54241	evidence	b-OCCURRENCE
54242	of	O
54243	cord	b-PROBLEM
54244	compression	i-PROBLEM
54245	.	O
54246	the	O
54247	patient	O
54248	&apos;s	O
54249	decadron	b-TREATMENT
54250	dose	O
54251	was	O
54252	increased	b-OCCURRENCE
54253	to	O
54254	12	O
54255	mg	O
54256	q	b-FREQUENCY
54257	day	i-FREQUENCY
54258	and	O
54259	he	O
54260	was	O
54261	also	O
54262	started	O
54263	on	O
54264	ms	b-TREATMENT
54265	contin	i-TREATMENT
54266	and	O
54267	radiation	b-TREATMENT
54268	therapy	i-TREATMENT
54269	was	O
54270	being	O
54271	planned	O
54272	and	O
54273	arranged	O
54274	at	O
54275	the	b-CLINICAL_DEPT
54276	petersly	i-CLINICAL_DEPT
54277	hospital	i-CLINICAL_DEPT
54278	and	i-CLINICAL_DEPT
54279	medical	i-CLINICAL_DEPT
54280	center	i-CLINICAL_DEPT
54281	.	O
54282	however	O
54283	,	O
54284	one	b-DURATION
54285	day	i-DURATION
54286	prior	O
54287	to	O
54288	admission	b-OCCURRENCE
54289	the	O
54290	patient	O
54291	developed	O
54292	right	b-PROBLEM
54293	lower	i-PROBLEM
54294	extremity	i-PROBLEM
54295	pain	i-PROBLEM
54296	and	O
54297	could	b-PROBLEM
54298	not	i-PROBLEM
54299	walk	i-PROBLEM
54300	secondary	O
54301	to	O
54302	the	b-PROBLEM
54303	pain	i-PROBLEM
54304	.	O
54305	over	O
54306	the	O
54307	next	O
54308	12	b-DURATION
54309	hours	i-DURATION
54310	while	O
54311	in	O
54312	transit	b-OCCURRENCE
54313	to	O
54314	the	b-OCCURRENCE
54315	hospital	i-OCCURRENCE
54316	,	O
54317	the	O
54318	patient	O
54319	&apos;s	O
54320	right	O
54321	lower	O
54322	extremity	O
54323	became	O
54324	red	b-PROBLEM
54325	,	O
54326	swollen	b-PROBLEM
54327	,	O
54328	and	O
54329	increasingly	b-PROBLEM
54330	painful	i-PROBLEM
54331	.	O
54332	he	O
54333	has	O
54334	had	O
54335	chronic	b-PROBLEM
54336	bilateral	i-PROBLEM
54337	lower	i-PROBLEM
54338	extremity	i-PROBLEM
54339	swelling	i-PROBLEM
54340	since	O
54341	his	b-TREATMENT
54342	transplant	i-TREATMENT
54343	but	O
54344	the	b-PROBLEM
54345	right	i-PROBLEM
54346	lower	i-PROBLEM
54347	extremity	i-PROBLEM
54348	swelling	i-PROBLEM
54349	was	O
54350	noticeably	O
54351	increased	O
54352	.	O
54353	he	O
54354	also	O
54355	complained	b-EVIDENTIAL
54356	of	O
54357	some	b-PROBLEM
54358	fecal	i-PROBLEM
54359	incontinence	i-PROBLEM
54360	the	b-DATE
54361	day	i-DATE
54362	prior	i-DATE
54363	to	i-DATE
54364	admission	i-DATE
54365	without	O
54366	urinary	b-PROBLEM
54367	incontinence	i-PROBLEM
54368	.	O
54369	at	O
54370	the	O
54371	time	O
54372	of	O
54373	presentation	b-OCCURRENCE
54374	the	O
54375	patient	O
54376	denied	b-EVIDENTIAL
54377	headache	b-PROBLEM
54378	,	O
54379	arm	b-PROBLEM
54380	weakness	i-PROBLEM
54381	,	O
54382	changes	b-PROBLEM
54383	in	i-PROBLEM
54384	vision	i-PROBLEM
54385	,	O
54386	dysarthria	b-PROBLEM
54387	,	O
54388	abdominal	b-PROBLEM
54389	pain	i-PROBLEM
54390	,	O
54391	nausea	b-PROBLEM
54392	or	O
54393	vomiting	b-PROBLEM
54394	,	O
54395	chest	b-PROBLEM
54396	pain	i-PROBLEM
54397	or	O
54398	shortness	b-PROBLEM
54399	of	i-PROBLEM
54400	breath	i-PROBLEM
54401	.	O
54402	he	O
54403	was	O
54404	taken	O
54405	to	O
54406	huyychestleme	b-CLINICAL_DEPT
54407	health	i-CLINICAL_DEPT
54408	of	O
54409	in	O
54410	scoo	O
54411	,	O
54412	utah	O
54413	where	O
54414	he	O
54415	had	O
54416	a	b-TEST
54417	temperature	i-TEST
54418	of	O
54419	99.9	O
54420	,	O
54421	blood	b-TEST
54422	pressure	i-TEST
54423	90/50	O
54424	,	O
54425	heart	b-TEST
54426	rate	i-TEST
54427	128	O
54428	,	O
54429	and	O
54430	o2	b-TEST
54431	sat	i-TEST
54432	of	O
54433	91%	O
54434	on	O
54435	room	O
54436	air	O
54437	.	O
54438	blood	b-TEST
54439	cultures	i-TEST
54440	,	O
54441	urine	b-TEST
54442	culture	i-TEST
54443	,	O
54444	and	O
54445	ua	b-TEST
54446	were	O
54447	all	O
54448	done	O
54449	.	O
54450	blood	b-TEST
54451	cultures	i-TEST
54452	drawn	O
54453	on	O
54454	admission	b-OCCURRENCE
54455	subsequently	O
54456	grew	O
54457	pseudomonas	b-PROBLEM
54458	aeruginosa	i-PROBLEM
54459	.	O
54460	he	O
54461	was	O
54462	treated	O
54463	with	O
54464	ceftazidime	b-TREATMENT
54465	,	O
54466	gentamicin	b-TREATMENT
54467	,	O
54468	and	O
54469	vancomycin	b-TREATMENT
54470	and	O
54471	also	O
54472	was	O
54473	started	O
54474	on	O
54475	a	b-TREATMENT
54476	dopamine	i-TREATMENT
54477	drip	i-TREATMENT
54478	for	O
54479	treatment	O
54480	of	O
54481	his	b-PROBLEM
54482	sepsis	i-PROBLEM
54483	.	O
54484	a	b-TEST
54485	swan	i-TEST
54486	was	O
54487	placed	O
54488	and	O
54489	initial	O
54490	readings	O
54491	were	O
54492	cvp	b-TEST
54493	of	O
54494	6	O
54495	,	O
54496	wedge	b-TEST
54497	pressure	i-TEST
54498	of	O
54499	10	O
54500	to	O
54501	12	O
54502	,	O
54503	cardiac	b-TEST
54504	index	i-TEST
54505	of	O
54506	4.7	O
54507	,	O
54508	and	O
54509	svr	b-TEST
54510	of	O
54511	438	O
54512	all	O
54513	consistent	O
54514	with	O
54515	a	b-PROBLEM
54516	pseudomonas	i-PROBLEM
54517	sepsis	i-PROBLEM
54518	picture	i-PROBLEM
54519	.	O
54520	he	O
54521	was	O
54522	given	O
54523	stress	b-TREATMENT
54524	steroids	i-TREATMENT
54525	and	O
54526	was	O
54527	subsequently	O
54528	transferred	b-OCCURRENCE
54529	to	O
54530	lorough	b-CLINICAL_DEPT
54531	medical	i-CLINICAL_DEPT
54532	center	i-CLINICAL_DEPT
54533	&apos;s	i-CLINICAL_DEPT
54534	intensive	i-CLINICAL_DEPT
54535	care	i-CLINICAL_DEPT
54536	unit	i-CLINICAL_DEPT
54537	for	O
54538	further	b-TREATMENT
54539	management	i-TREATMENT
54540	.	O
54541	hospital	O
54542	course	O
54543	:	O
54544	by	O
54545	problems	O
54546	-	O
54547	1)	O
54548	infectious	O
54549	disease	O
54550	/	O
54551	cellulitis	O
54552	:	O
54553	the	O
54554	patient	O
54555	&apos;s	O
54556	clinical	b-OCCURRENCE
54557	situation	i-OCCURRENCE
54558	was	O
54559	most	O
54560	consistent	O
54561	with	O
54562	a	b-PROBLEM
54563	pseudomonas	i-PROBLEM
54564	cellulitis	i-PROBLEM
54565	and	O
54566	subsequent	O
54567	sepsis	b-PROBLEM
54568	.	O
54569	blood	b-TEST
54570	cultures	i-TEST
54571	drawn	O
54572	at	O
54573	the	b-CLINICAL_DEPT
54574	outside	i-CLINICAL_DEPT
54575	hospital	i-CLINICAL_DEPT
54576	grew	O
54577	out	O
54578	pseudomonas	b-PROBLEM
54579	that	O
54580	was	O
54581	sensitive	b-TEST
54582	to	O
54583	imipenem	b-TREATMENT
54584	and	O
54585	tobramycin	b-TREATMENT
54586	.	O
54587	there	O
54588	were	O
54589	cultures	b-TEST
54590	obtained	O
54591	seeping	O
54592	from	O
54593	the	b-PROBLEM
54594	wound	i-PROBLEM
54595	at	O
54596	retelk	b-CLINICAL_DEPT
54597	county	i-CLINICAL_DEPT
54598	medical	i-CLINICAL_DEPT
54599	center	i-CLINICAL_DEPT
54600	and	O
54601	those	O
54602	also	O
54603	grew	O
54604	out	O
54605	pseudomonas	b-PROBLEM
54606	aeruginosa	i-PROBLEM
54607	.	O
54608	the	b-PROBLEM
54609	organism	i-PROBLEM
54610	grown	O
54611	at	O
54612	this	b-CLINICAL_DEPT
54613	institution	i-CLINICAL_DEPT
54614	was	O
54615	sensitive	b-TEST
54616	to	O
54617	imipenem	b-TREATMENT
54618	,	O
54619	ceftazidime	b-TREATMENT
54620	,	O
54621	amikacin	b-TREATMENT
54622	,	O
54623	gentamicin	b-TREATMENT
54624	,	O
54625	ciprofloxacin	b-TREATMENT
54626	,	O
54627	tobramycin	b-TREATMENT
54628	but	O
54629	was	O
54630	resistant	b-TEST
54631	to	O
54632	cefotetan	b-TREATMENT
54633	,	O
54634	ceftriaxone	b-TREATMENT
54635	,	O
54636	mezlocillin	b-TREATMENT
54637	,	O
54638	bactrim	b-TREATMENT
54639	,	O
54640	ampicillin	b-TREATMENT
54641	,	O
54642	chloramphenicol	b-TREATMENT
54643	,	O
54644	and	O
54645	sulbactam	b-TREATMENT
54646	.	O
54647	he	O
54648	was	O
54649	treated	O
54650	initially	O
54651	with	O
54652	ceftazidime	b-TREATMENT
54653	and	O
54654	gentamicin	b-TREATMENT
54655	but	O
54656	there	O
54657	was	O
54658	a	O
54659	question	O
54660	about	O
54661	the	b-PROBLEM
54662	organism	i-PROBLEM
54663	&apos;s	i-PROBLEM
54664	susceptibility	i-PROBLEM
54665	from	O
54666	lab	b-TEST
54667	studies	i-TEST
54668	done	O
54669	at	O
54670	the	b-CLINICAL_DEPT
54671	outside	i-CLINICAL_DEPT
54672	hospital	i-CLINICAL_DEPT
54673	.	O
54674	he	O
54675	was	O
54676	subsequently	O
54677	switched	O
54678	to	O
54679	imipenem	b-TREATMENT
54680	and	O
54681	tobramycin	b-TREATMENT
54682	and	O
54683	was	O
54684	maintained	O
54685	on	O
54686	those	b-TREATMENT
54687	medications	i-TREATMENT
54688	throughout	O
54689	the	b-OCCURRENCE
54690	hospital	i-OCCURRENCE
54691	course	i-OCCURRENCE
54692	.	O
54693	the	b-TREATMENT
54694	tobramycin	i-TREATMENT
54695	and	O
54696	imipenem	b-TREATMENT
54697	were	O
54698	started	O
54699	on	O
54700	11/25/94	b-DATE
54701	.	O
54702	in	O
54703	addition	O
54704	,	O
54705	the	O
54706	patient	O
54707	received	O
54708	a	O
54709	five	b-DURATION
54710	day	i-DURATION
54711	course	O
54712	of	O
54713	intravenous	b-TREATMENT
54714	igg	i-TREATMENT
54715	to	O
54716	improve	O
54717	infection	b-TREATMENT
54718	control	i-TREATMENT
54719	.	O
54720	vancomycin	b-TREATMENT
54721	was	O
54722	also	O
54723	added	O
54724	to	O
54725	his	b-TREATMENT
54726	regimen	i-TREATMENT
54727	on	O
54728	11/28/94	b-DATE
54729	and	O
54730	this	O
54731	was	O
54732	primarily	O
54733	to	O
54734	provide	O
54735	improved	b-TREATMENT
54736	mrsa	i-TREATMENT
54737	coverage	i-TREATMENT
54738	as	O
54739	he	O
54740	continued	O
54741	to	O
54742	have	O
54743	erythema	b-PROBLEM
54744	along	i-PROBLEM
54745	the	i-PROBLEM
54746	lateral	i-PROBLEM
54747	right	i-PROBLEM
54748	lower	i-PROBLEM
54749	extremity	i-PROBLEM
54750	.	O
54751	he	O
54752	was	O
54753	evaluated	b-OCCURRENCE
54754	by	O
54755	the	b-OCCURRENCE
54756	surgery	i-OCCURRENCE
54757	department	i-OCCURRENCE
54758	and	O
54759	it	O
54760	is	O
54761	there	O
54762	feeling	O
54763	that	O
54764	there	O
54765	is	O
54766	no	O
54767	indication	b-OCCURRENCE
54768	for	O
54769	surgical	b-TREATMENT
54770	intervention	i-TREATMENT
54771	/	O
54772	amputation	b-TREATMENT
54773	at	O
54774	this	O
54775	time	O
54776	.	O
54777	he	O
54778	is	O
54779	being	O
54780	maintained	O
54781	with	O
54782	twice	b-FREQUENCY
54783	daily	i-FREQUENCY
54784	xeroform	b-TREATMENT
54785	with	O
54786	betadine	b-TREATMENT
54787	changes	O
54788	.	O
54789	these	b-TREATMENT
54790	dressing	i-TREATMENT
54791	changes	i-TREATMENT
54792	are	O
54793	applied	O
54794	by	O
54795	applying	O
54796	the	b-TREATMENT
54797	xeroform	i-TREATMENT
54798	on	O
54799	betadine	b-TREATMENT
54800	initially	O
54801	and	O
54802	then	O
54803	changing	O
54804	it	O
54805	with	O
54806	sterile	b-TREATMENT
54807	dry	i-TREATMENT
54808	bandages	i-TREATMENT
54809	.	O
54810	of	O
54811	note	O
54812	,	O
54813	the	O
54814	patient	O
54815	has	O
54816	extreme	b-PROBLEM
54817	pain	i-PROBLEM
54818	with	O
54819	these	b-TREATMENT
54820	dressing	i-TREATMENT
54821	changes	i-TREATMENT
54822	and	O
54823	requires	O
54824	parenteral	b-TREATMENT
54825	morphine	i-TREATMENT
54826	sulfate	i-TREATMENT
54827	for	O
54828	pain	b-OCCURRENCE
54829	control	i-OCCURRENCE
54830	during	O
54831	dressing	b-TREATMENT
54832	changes	i-TREATMENT
54833	.	O
54834	the	O
54835	plan	O
54836	is	O
54837	to	O
54838	complete	O
54839	a	O
54840	full	O
54841	course	O
54842	of	O
54843	imipenem	b-TREATMENT
54844	and	O
54845	tobramycin	b-TREATMENT
54846	for	O
54847	his	b-PROBLEM
54848	pseudomonas	i-PROBLEM
54849	cellulitis	i-PROBLEM
54850	.	O
54851	as	O
54852	mentioned	O
54853	earlier	O
54854	he	O
54855	continues	O
54856	to	O
54857	have	O
54858	erythema	b-PROBLEM
54859	tracking	O
54860	up	O
54861	his	O
54862	leg	O
54863	and	O
54864	up	O
54865	to	O
54866	his	O
54867	lateral	O
54868	thigh	O
54869	.	O
54870	the	O
54871	cause	O
54872	of	O
54873	this	b-PROBLEM
54874	erythema	i-PROBLEM
54875	is	O
54876	not	O
54877	know	O
54878	at	O
54879	this	O
54880	time	O
54881	but	O
54882	has	O
54883	not	O
54884	shown	O
54885	extensive	b-OCCURRENCE
54886	progression	i-OCCURRENCE
54887	.	O
54888	2)	O
54889	cardiovascular	O
54890	:	O
54891	the	O
54892	patient	O
54893	was	O
54894	initially	O
54895	treated	O
54896	with	O
54897	dopamine	b-TREATMENT
54898	which	O
54899	was	O
54900	subsequently	O
54901	weaned	O
54902	off	O
54903	after	O
54904	his	b-PROBLEM
54905	sepsis	i-PROBLEM
54906	improved	b-OCCURRENCE
54907	.	O
54908	he	O
54909	was	O
54910	noted	b-EVIDENTIAL
54911	to	O
54912	be	O
54913	in	O
54914	rapid	b-PROBLEM
54915	af	i-PROBLEM
54916	on	O
54917	several	O
54918	episodes	O
54919	receiving	O
54920	5	O
54921	mg	O
54922	iv	b-TREATMENT
54923	lopressor	i-TREATMENT
54924	each	O
54925	time	O
54926	with	O
54927	improvement	b-OCCURRENCE
54928	.	O
54929	he	O
54930	has	O
54931	been	O
54932	in	O
54933	and	O
54934	out	O
54935	of	O
54936	atrial	b-PROBLEM
54937	fibrillation	i-PROBLEM
54938	and	O
54939	normal	b-OCCURRENCE
54940	sinus	i-OCCURRENCE
54941	rhythm	i-OCCURRENCE
54942	.	O
54943	an	b-TEST
54944	echocardiogram	i-TEST
54945	performed	O
54946	at	O
54947	the	b-CLINICAL_DEPT
54948	outside	i-CLINICAL_DEPT
54949	hospital	i-CLINICAL_DEPT
54950	while	O
54951	he	O
54952	was	O
54953	septic	b-PROBLEM
54954	showed	b-EVIDENTIAL
54955	decreased	b-PROBLEM
54956	global	i-PROBLEM
54957	ef	i-PROBLEM
54958	.	O
54959	the	O
54960	patient	O
54961	is	O
54962	being	O
54963	maintained	O
54964	on	O
54965	digoxin	b-TREATMENT
54966	for	O
54967	his	b-PROBLEM
54968	paroxysmal	i-PROBLEM
54969	atrial	i-PROBLEM
54970	fibrillation	i-PROBLEM
54971	.	O
54972	he	O
54973	has	O
54974	had	O
54975	no	O
54976	significant	O
54977	episode	O
54978	of	O
54979	tachycardia	b-PROBLEM
54980	or	O
54981	blood	b-PROBLEM
54982	pressure	i-PROBLEM
54983	alteration	i-PROBLEM
54984	during	O
54985	the	b-DURATION
54986	final	i-DURATION
54987	days	i-DURATION
54988	of	O
54989	hospitalization	b-OCCURRENCE
54990	.	O
54991	the	O
54992	plan	O
54993	is	O
54994	to	O
54995	continue	O
54996	the	b-TREATMENT
54997	digoxin	i-TREATMENT
54998	and	O
54999	to	O
55000	recheck	O
55001	an	b-TEST
55002	echocardiogram	i-TEST
55003	to	O
55004	assess	O
55005	his	b-TEST
55006	ejection	i-TEST
55007	fraction	i-TEST
55008	when	O
55009	he	O
55010	is	O
55011	clinically	b-OCCURRENCE
55012	better	i-OCCURRENCE
55013	.	O
55014	3)	O
55015	oncology	O
55016	:	O
55017	the	O
55018	patient	O
55019	has	O
55020	a	b-PROBLEM
55021	plasmacytoma	i-PROBLEM
55022	affecting	O
55023	the	O
55024	spine	O
55025	.	O
55026	he	O
55027	has	O
55028	been	O
55029	receiving	O
55030	radiation	b-TREATMENT
55031	therapy	i-TREATMENT
55032	to	O
55033	that	O
55034	area	O
55035	during	O
55036	the	b-OCCURRENCE
55037	hospital	i-OCCURRENCE
55038	stay	i-OCCURRENCE
55039	.	O
55040	the	O
55041	plan	O
55042	is	O
55043	to	O
55044	complete	O
55045	a	O
55046	full	O
55047	course	O
55048	of	O
55049	xrt	b-TREATMENT
55050	to	i-TREATMENT
55051	the	i-TREATMENT
55052	spinal	i-TREATMENT
55053	region	i-TREATMENT
55054	for	O
55055	the	b-PROBLEM
55056	plasmacytoma	i-PROBLEM
55057	.	O
55058	the	b-PROBLEM
55059	patient	i-PROBLEM
55060	&apos;s	i-PROBLEM
55061	lesion	i-PROBLEM
55062	compressing	O
55063	his	O
55064	thoracic	O
55065	spine	O
55066	was	O
55067	never	O
55068	biopsied	b-TEST
55069	,	O
55070	however	O
55071	,	O
55072	the	b-TEST
55073	mri	i-TEST
55074	appearance	O
55075	does	O
55076	not	O
55077	seem	O
55078	to	O
55079	be	O
55080	infectious	b-PROBLEM
55081	and	O
55082	is	O
55083	most	O
55084	consistent	O
55085	with	O
55086	plasmacytoma	b-PROBLEM
55087	for	O
55088	which	O
55089	he	O
55090	is	O
55091	receiving	O
55092	the	b-TREATMENT
55093	radiation	i-TREATMENT
55094	therapy	i-TREATMENT
55095	.	O
55096	4)	O
55097	neurologic	O
55098	:	O
55099	as	O
55100	mentioned	O
55101	above	O
55102	he	O
55103	has	O
55104	a	b-PROBLEM
55105	cord	i-PROBLEM
55106	compression	i-PROBLEM
55107	and	O
55108	is	O
55109	on	O
55110	steroids	b-TREATMENT
55111	.	O
55112	he	O
55113	was	O
55114	initially	O
55115	treated	O
55116	with	O
55117	iv	b-TREATMENT
55118	decadron	i-TREATMENT
55119	10	O
55120	mg	O
55121	up	O
55122	front	O
55123	and	O
55124	then	O
55125	6	O
55126	mg	O
55127	q6h.	b-FREQUENCY
55128	his	b-TEST
55129	neurological	i-TEST
55130	exam	i-TEST
55131	remained	O
55132	stable	b-OCCURRENCE
55133	with	O
55134	no	O
55135	evidence	b-EVIDENTIAL
55136	of	O
55137	increasing	b-PROBLEM
55138	lower	i-PROBLEM
55139	extremity	i-PROBLEM
55140	edema	i-PROBLEM
55141	.	O
55142	his	b-TREATMENT
55143	decadron	i-TREATMENT
55144	dose	O
55145	was	O
55146	titrated	b-OCCURRENCE
55147	down	i-OCCURRENCE
55148	to	O
55149	5	O
55150	mg	O
55151	iv	O
55152	q6h	b-FREQUENCY
55153	on	O
55154	12/3/94	b-DATE
55155	.	O
55156	his	b-TREATMENT
55157	decadron	i-TREATMENT
55158	dose	O
55159	will	O
55160	be	O
55161	slowly	O
55162	titrated	b-OCCURRENCE
55163	down	i-OCCURRENCE
55164	over	O
55165	time	O
55166	following	O
55167	his	b-TEST
55168	neurological	i-TEST
55169	exam	i-TEST
55170	closely	O
55171	.	O
55172	5)	O
55173	blood	O
55174	sugars	O
55175	:	O
55176	the	O
55177	patient	O
55178	has	O
55179	steroid	b-PROBLEM
55180	induced	i-PROBLEM
55181	diabetes	i-PROBLEM
55182	mellitus	i-PROBLEM
55183	.	O
55184	he	O
55185	has	O
55186	been	O
55187	on	O
55188	increasing	b-TREATMENT
55189	doses	i-TREATMENT
55190	of	i-TREATMENT
55191	insulin	i-TREATMENT
55192	receiving	O
55193	nph	b-TREATMENT
55194	in	O
55195	the	O
55196	morning	O
55197	and	O
55198	night	O
55199	in	O
55200	addition	O
55201	to	O
55202	a	b-TREATMENT
55203	czi	i-TREATMENT
55204	sliding	i-TREATMENT
55205	scale	i-TREATMENT
55206	on	O
55207	a	O
55208	q6h	b-FREQUENCY
55209	basis	O
55210	.	O
55211	the	O
55212	plan	O
55213	is	O
55214	to	O
55215	continue	O
55216	the	b-TREATMENT
55217	supplemental	i-TREATMENT
55218	insulin	i-TREATMENT
55219	while	O
55220	he	O
55221	is	O
55222	on	O
55223	steroids	b-TREATMENT
55224	and	O
55225	while	O
55226	his	b-TEST
55227	sugars	i-TEST
55228	remain	O
55229	high	b-PROBLEM
55230	.	O
55231	6)	O
55232	respiratory	O
55233	:	O
55234	he	O
55235	initially	O
55236	required	O
55237	a	b-TREATMENT
55238	face	i-TREATMENT
55239	mask	i-TREATMENT
55240	to	O
55241	keep	O
55242	his	b-TEST
55243	saturation	i-TEST
55244	above	O
55245	90%	O
55246	.	O
55247	however	O
55248	,	O
55249	with	O
55250	increasing	O
55251	diuresis	b-TREATMENT
55252	and	O
55253	improving	b-PROBLEM
55254	septic	i-PROBLEM
55255	pictures	i-PROBLEM
55256	his	b-TEST
55257	o2	i-TEST
55258	saturations	i-TEST
55259	have	O
55260	improved	b-OCCURRENCE
55261	and	O
55262	he	O
55263	is	O
55264	now	O
55265	on	O
55266	nasal	b-TREATMENT
55267	cannula	i-TREATMENT
55268	and	O
55269	will	O
55270	be	O
55271	maintained	O
55272	on	O
55273	nasal	b-TREATMENT
55274	cannula	i-TREATMENT
55275	to	O
55276	keep	O
55277	his	b-TEST
55278	sat	i-TEST
55279	above	O
55280	93%	O
55281	.	O
55282	he	O
55283	can	O
55284	be	O
55285	given	O
55286	intravenous	b-TREATMENT
55287	lasix	i-TREATMENT
55288	as	O
55289	needed	O
55290	for	O
55291	any	O
55292	evidence	O
55293	of	O
55294	respiratory	b-PROBLEM
55295	compromise	i-PROBLEM
55296	or	O
55297	increasing	b-PROBLEM
55298	pulmonary	i-PROBLEM
55299	edema	i-PROBLEM
55300	.	O
55301	7)	O
55302	nutrition	O
55303	:	O
55304	the	O
55305	patient	O
55306	has	O
55307	a	b-PROBLEM
55308	poor	i-PROBLEM
55309	nutritional	i-PROBLEM
55310	status	i-PROBLEM
55311	with	O
55312	hypoalbuminemia	b-PROBLEM
55313	.	O
55314	he	O
55315	has	O
55316	been	O
55317	maintained	O
55318	on	O
55319	tube	O
55320	feeds	O
55321	and	O
55322	that	O
55323	should	O
55324	be	O
55325	continued	O
55326	.	O
55327	he	O
55328	should	O
55329	also	O
55330	be	O
55331	encouraged	b-OCCURRENCE
55332	to	i-OCCURRENCE
55333	eat	i-OCCURRENCE
55334	as	O
55335	much	O
55336	as	O
55337	possible	O
55338	orally	O
55339	in	O
55340	addition	O
55341	to	O
55342	this	b-TREATMENT
55343	tube	i-TREATMENT
55344	feeds	i-TREATMENT
55345	and	O
55346	aspiration	b-TREATMENT
55347	precaution	i-TREATMENT
55348	should	O
55349	be	O
55350	maintained	O
55351	.	O
55352	8)	O
55353	elevated	b-PROBLEM
55354	pt	i-PROBLEM
55355	and	i-PROBLEM
55356	ptt	i-PROBLEM
55357	:	O
55358	both	O
55359	of	O
55360	these	O
55361	responded	O
55362	to	O
55363	three	b-DURATION
55364	day	i-DURATION
55365	course	O
55366	of	O
55367	vitamin	b-TREATMENT
55368	k	i-TREATMENT
55369	10	O
55370	mg	O
55371	each	b-FREQUENCY
55372	day	i-FREQUENCY
55373	.	O
55374	his	b-TEST
55375	pt	i-TEST
55376	and	O
55377	ptt	b-TEST
55378	are	O
55379	now	O
55380	normal	b-OCCURRENCE
55381	,	O
55382	however	O
55383	,	O
55384	he	O
55385	continues	O
55386	to	O
55387	run	O
55388	a	b-PROBLEM
55389	low	i-PROBLEM
55390	platelet	i-PROBLEM
55391	count	i-PROBLEM
55392	.	O
55393	this	O
55394	has	O
55395	been	O
55396	evident	O
55397	since	O
55398	the	O
55399	time	O
55400	of	O
55401	his	b-TREATMENT
55402	bone	i-TREATMENT
55403	marrow	i-TREATMENT
55404	transplant	i-TREATMENT
55405	.	O
55406	we	O
55407	have	O
55408	been	O
55409	transfusing	O
55410	him	O
55411	with	O
55412	platelets	b-TREATMENT
55413	to	O
55414	keep	O
55415	his	b-TEST
55416	counts	i-TEST
55417	above	O
55418	20,000	O
55419	to	O
55420	reduce	O
55421	his	b-PROBLEM
55422	bleeding	i-PROBLEM
55423	risk	i-PROBLEM
55424	.	O
55425	he	O
55426	also	O
55427	received	O
55428	several	b-TREATMENT
55429	blood	i-TREATMENT
55430	transfusions	i-TREATMENT
55431	while	O
55432	here	O
55433	to	O
55434	maintain	O
55435	his	b-TEST
55436	hct	i-TEST
55437	around	O
55438	30	O
55439	.	O
55440	thrombocytopenic	b-TREATMENT
55441	inducing	i-TREATMENT
55442	drugs	i-TREATMENT
55443	should	O
55444	be	O
55445	avoided	b-OCCURRENCE
55446	if	O
55447	possible	O
55448	on	O
55449	this	O
55450	patient	O
55451	.	O
55452		O
55453	admission	b-OCCURRENCE
55454	date	O
55455	:	O
55456	06-06-93	b-DATE
55457	discharge	b-OCCURRENCE
55458	date	O
55459	:	O
55460	06-07-93	b-DATE
55461	history	O
55462	of	O
55463	present	O
55464	illness	O
55465	:	O
55466	the	O
55467	patient	O
55468	is	O
55469	a	O
55470	68	O
55471	year	O
55472	old	O
55473	male	O
55474	status	O
55475	post	O
55476	three	O
55477	and	O
55478	a	O
55479	half	O
55480	cycles	O
55481	of	O
55482	adjuvant	b-TREATMENT
55483	eap	i-TREATMENT
55484	chemotherapy	i-TREATMENT
55485	.	O
55486	he	O
55487	had	O
55488	a	b-OCCURRENCE
55489	good	i-OCCURRENCE
55490	response	i-OCCURRENCE
55491	to	O
55492	preoperative	b-TREATMENT
55493	therapy	i-TREATMENT
55494	and	O
55495	negative	b-OCCURRENCE
55496	nodes	i-OCCURRENCE
55497	,	O
55498	and	O
55499	is	O
55500	admitted	b-OCCURRENCE
55501	for	O
55502	the	O
55503	final	O
55504	portion	O
55505	of	O
55506	his	b-TREATMENT
55507	postoperative	i-TREATMENT
55508	cycles	i-TREATMENT
55509	.	O
55510	his	b-TREATMENT
55511	chemotherapy	i-TREATMENT
55512	the	b-DURATION
55513	week	i-DURATION
55514	before	i-DURATION
55515	was	O
55516	decreased	b-OCCURRENCE
55517	because	O
55518	the	b-TEST
55519	white	i-TEST
55520	blood	i-TEST
55521	count	i-TEST
55522	dropped	b-OCCURRENCE
55523	to	O
55524	2.8	O
55525	.	O
55526	in	O
55527	the	O
55528	interim	O
55529	,	O
55530	the	b-TEST
55531	white	i-TEST
55532	blood	i-TEST
55533	count	i-TEST
55534	rose	b-OCCURRENCE
55535	again	O
55536	to	O
55537	4.2	O
55538	with	O
55539	a	b-TEST
55540	hematocrit	i-TEST
55541	of	O
55542	30.5	O
55543	,	O
55544	platelet	b-TEST
55545	count	i-TEST
55546	of	O
55547	196	O
55548	thousand	O
55549	.	O
55550	hospital	O
55551	course	O
55552	:	O
55553	the	O
55554	patient	O
55555	was	O
55556	treated	O
55557	with	O
55558	adriamycin	b-TREATMENT
55559	25	O
55560	mg	O
55561	,	O
55562	cis-platinum	b-TREATMENT
55563	40	O
55564	mg	O
55565	,	O
55566	preceded	O
55567	by	O
55568	mannitol	b-TREATMENT
55569	12.5	O
55570	grams	O
55571	intravenous	O
55572	bolus	O
55573	,	O
55574	and	O
55575	zofran	b-TREATMENT
55576	11	O
55577	mg	O
55578	on	O
55579	two	b-FREQUENCY
55580	occasions	i-FREQUENCY
55581	given	O
55582	as	O
55583	an	b-TREATMENT
55584	antiemetic	i-TREATMENT
55585	.	O
55586	the	b-TREATMENT
55587	chemotherapy	i-TREATMENT
55588	was	O
55589	well	b-OCCURRENCE
55590	tolerated	i-OCCURRENCE
55591	.	O
55592		O
55593	admission	b-OCCURRENCE
55594	date	O
55595	:	O
55596	2017-06-16	b-ADMISSION
55597	discharge	b-OCCURRENCE
55598	date	O
55599	:	O
55600	2017-07-27	b-DISCHARGE
55601	service	O
55602	:	O
55603	medicine	O
55604	history	O
55605	of	O
55606	present	O
55607	illness	O
55608	:	O
55609	patient	O
55610	is	O
55611	a	O
55612	58	O
55613	year	O
55614	old	O
55615	male	O
55616	with	O
55617	a	O
55618	recent	O
55619	admission	b-OCCURRENCE
55620	for	O
55621	abdominal	b-PROBLEM
55622	pain	i-PROBLEM
55623	s/p	O
55624	negative	O
55625	exploratory	b-TEST
55626	laparotomy	i-TEST
55627	for	O
55628	suspected	O
55629	intussuception	b-PROBLEM
55630	now	O
55631	returns	b-OCCURRENCE
55632	on	O
55633	day	b-DATE
55634	of	i-DATE
55635	discharge	i-DATE
55636	with	O
55637	fever	b-PROBLEM
55638	and	O
55639	tachycardia	b-PROBLEM
55640	.	O
55641	patient	O
55642	has	O
55643	a	O
55644	history	O
55645	for	O
55646	terrible	b-PROBLEM
55647	vasculopathy	i-PROBLEM
55648	s/p	O
55649	recent	b-TREATMENT
55650	right	i-TREATMENT
55651	bka	i-TREATMENT
55652	with	O
55653	dry	b-PROBLEM
55654	gangrene	i-PROBLEM
55655	of	i-PROBLEM
55656	the	i-PROBLEM
55657	distal	i-PROBLEM
55658	stump	i-PROBLEM
55659	.	O
55660	patient	O
55661	's	O
55662	last	O
55663	admission	b-OCCURRENCE
55664	was	O
55665	significant	O
55666	for	O
55667	a	O
55668	negative	O
55669	ex-lap	b-TEST
55670	.	O
55671	post-operatively	O
55672	,	O
55673	his	O
55674	course	O
55675	was	O
55676	complicated	O
55677	by	O
55678	respiratory	b-PROBLEM
55679	distress	i-PROBLEM
55680	necessitating	O
55681	an	b-OCCURRENCE
55682	urgent	i-OCCURRENCE
55683	return	i-OCCURRENCE
55684	to	O
55685	the	b-CLINICAL_DEPT
55686	icu	i-CLINICAL_DEPT
55687	and	O
55688	was	O
55689	intubated	b-TREATMENT
55690	.	O
55691	after	O
55692	multuple	O
55693	failed	O
55694	attempts	O
55695	at	O
55696	extubation	b-TREATMENT
55697	,	O
55698	the	O
55699	patient	O
55700	was	O
55701	trached	b-TREATMENT
55702	.	O
55703	patient	O
55704	then	O
55705	did	b-OCCURRENCE
55706	well	i-OCCURRENCE
55707	on	O
55708	a	b-TREATMENT
55709	trach	i-TREATMENT
55710	mask	i-TREATMENT
55711	and	O
55712	was	O
55713	transferred	b-OCCURRENCE
55714	to	O
55715	rehab	b-CLINICAL_DEPT
55716	on	O
55717	the	b-DATE
55718	day	i-DATE
55719	of	i-DATE
55720	admission	i-DATE
55721	but	O
55722	now	b-DATE
55723	returns	b-OCCURRENCE
55724	with	O
55725	tachycardia	b-PROBLEM
55726	to	O
55727	the	O
55728	120	O
55729	's	O
55730	,	O
55731	and	O
55732	fever	b-PROBLEM
55733	to	O
55734	102	O
55735	degrees	O
55736	f	O
55737	.	O
55738	brief	O
55739	hospital	O
55740	course	O
55741	:	O
55742	the	O
55743	patient	O
55744	was	O
55745	re-admitted	b-OCCURRENCE
55746	to	O
55747	the	b-CLINICAL_DEPT
55748	surgical	i-CLINICAL_DEPT
55749	service	i-CLINICAL_DEPT
55750	and	O
55751	taken	O
55752	to	O
55753	the	b-CLINICAL_DEPT
55754	cmed	i-CLINICAL_DEPT
55755	.	O
55756	a	b-TEST
55757	chest	i-TEST
55758	x-ray	i-TEST
55759	on	O
55760	admission	b-OCCURRENCE
55761	showed	b-EVIDENTIAL
55762	effusions	b-PROBLEM
55763	consistent	O
55764	with	O
55765	chf	b-PROBLEM
55766	along	O
55767	with	O
55768	overlying	b-PROBLEM
55769	pnumonia	i-PROBLEM
55770	.	O
55771	urine	b-TEST
55772	cultures	i-TEST
55773	were	O
55774	significant	O
55775	for	O
55776	klebsiella	b-PROBLEM
55777	uti	i-PROBLEM
55778	and	O
55779	sputum	b-TEST
55780	cultures	i-TEST
55781	were	O
55782	significant	O
55783	for	O
55784	mrsa	b-PROBLEM
55785	.	O
55786	he	O
55787	was	O
55788	placed	O
55789	on	O
55790	vancomycin	b-TREATMENT
55791	,	O
55792	levofloxacin	b-TREATMENT
55793	and	O
55794	fluconazole	b-TREATMENT
55795	.	O
55796	he	O
55797	underwent	O
55798	picc	b-TREATMENT
55799	line	i-TREATMENT
55800	placement	i-TREATMENT
55801	on	O
55802	06-18	b-DATE
55803	.	O
55804	a	b-TREATMENT
55805	trach	i-TREATMENT
55806	collar	i-TREATMENT
55807	was	O
55808	placed	O
55809	on	O
55810	06-19	b-DATE
55811	.	O
55812	gi	b-CLINICAL_DEPT
55813	was	O
55814	consulted	O
55815	for	O
55816	colonoscopy	b-TEST
55817	.	O
55818	patient	O
55819	was	O
55820	transferred	b-OCCURRENCE
55821	to	O
55822	the	b-CLINICAL_DEPT
55823	floor	i-CLINICAL_DEPT
55824	on	O
55825	06-20	b-DATE
55826	.	O
55827	he	O
55828	was	O
55829	seen	O
55830	by	O
55831	respiratory	b-CLINICAL_DEPT
55832	therapy	i-CLINICAL_DEPT
55833	and	O
55834	suctioned	b-TREATMENT
55835	continually	i-TREATMENT
55836	throughout	O
55837	his	b-OCCURRENCE
55838	hospital	i-OCCURRENCE
55839	course	i-OCCURRENCE
55840	.	O
55841	his	b-OCCURRENCE
55842	respiratory	i-OCCURRENCE
55843	status	i-OCCURRENCE
55844	improved	O
55845	.	O
55846	he	O
55847	tolerated	O
55848	his	b-TREATMENT
55849	trach	i-TREATMENT
55850	collar	i-TREATMENT
55851	,	O
55852	and	O
55853	tube	b-TREATMENT
55854	feeds	i-TREATMENT
55855	at	O
55856	goal	O
55857	.	O
55858	the	b-TREATMENT
55859	fluconazole	i-TREATMENT
55860	was	O
55861	discontinued	O
55862	.	O
55863	on	O
55864	06-21	b-DATE
55865	the	O
55866	patient	O
55867	was	O
55868	seen	O
55869	by	O
55870	physical	b-CLINICAL_DEPT
55871	therapy	i-CLINICAL_DEPT
55872	.	O
55873	a	b-CLINICAL_DEPT
55874	nutrition	i-CLINICAL_DEPT
55875	consult	i-CLINICAL_DEPT
55876	was	O
55877	obtained	O
55878	on	O
55879	06-22	b-DATE
55880	.	O
55881	he	O
55882	underwent	O
55883	a	b-PROBLEM
55884	failed	i-PROBLEM
55885	bedside	i-PROBLEM
55886	swallow	i-PROBLEM
55887	study	i-PROBLEM
55888	.	O
55889	based	O
55890	on	O
55891	a	b-TEST
55892	chest	i-TEST
55893	x-ray	i-TEST
55894	that	O
55895	showed	b-EVIDENTIAL
55896	a	b-PROBLEM
55897	small	i-PROBLEM
55898	hydro-pneumothorax	i-PROBLEM
55899	on	O
55900	the	O
55901	left	O
55902	lower	O
55903	lobe	O
55904	of	O
55905	the	O
55906	lung	O
55907	,	O
55908	a	b-CLINICAL_DEPT
55909	thoracic	i-CLINICAL_DEPT
55910	surgery	i-CLINICAL_DEPT
55911	consult	O
55912	was	O
55913	obtained	O
55914	,	O
55915	though	O
55916	no	O
55917	specific	b-TREATMENT
55918	interventions	i-TREATMENT
55919	were	O
55920	warranted	O
55921	at	O
55922	the	O
55923	time	O
55924	.	O
55925	on	O
55926	06-23	b-DATE
55927	the	b-TREATMENT
55928	patient	i-TREATMENT
55929	's	i-TREATMENT
55930	tube	i-TREATMENT
55931	feed	i-TREATMENT
55932	were	O
55933	changed	O
55934	from	O
55935	respalor	b-TREATMENT
55936	to	O
55937	deliver	b-TREATMENT
55938	2.0	i-TREATMENT
55939	to	O
55940	give	O
55941	increased	O
55942	calories	O
55943	.	O
55944	on	O
55945	06-25	b-DATE
55946	,	O
55947	urine	b-TEST
55948	cultures	i-TEST
55949	grew	O
55950	out	O
55951	vre	b-PROBLEM
55952	,	O
55953	and	O
55954	a	b-TEST
55955	c	i-TEST
55956	diff	i-TEST
55957	was	O
55958	negative	O
55959	.	O
55960	he	O
55961	experienced	O
55962	low	b-PROBLEM
55963	grade	i-PROBLEM
55964	fevers	i-PROBLEM
55965	.	O
55966	he	O
55967	was	O
55968	pan-cultured	b-TEST
55969	on	O
55970	06-26	b-DATE
55971	for	O
55972	continued	b-PROBLEM
55973	fevers	i-PROBLEM
55974	.	O
55975	on	O
55976	06-27	b-DATE
55977	,	O
55978	his	b-TREATMENT
55979	nutrition	i-TREATMENT
55980	regimen	i-TREATMENT
55981	was	O
55982	changed	O
55983	to	O
55984	deliver	b-TREATMENT
55985	2.0	i-TREATMENT
55986	at	O
55987	70	O
55988	cc	O
55989	/	O
55990	hr	O
55991	with	O
55992	15	O
55993	g	O
55994	promod	b-TREATMENT
55995	.	O
55996	on	O
55997	06-28	b-DATE
55998	,	O
55999	the	O
56000	patient	O
56001	experienced	O
56002	pvc	b-PROBLEM
56003	's	O
56004	.	O
56005	an	b-TEST
56006	ekg	i-TEST
56007	showed	b-EVIDENTIAL
56008	st	b-PROBLEM
56009	segment	i-PROBLEM
56010	depression	i-PROBLEM
56011	along	O
56012	the	O
56013	lateral	O
56014	pre-cordial	O
56015	leads	O
56016	.	O
56017	serial	b-TEST
56018	enzymes	i-TEST
56019	showed	b-EVIDENTIAL
56020	mild	b-PROBLEM
56021	elevation	i-PROBLEM
56022	of	O
56023	troponins	b-TEST
56024	.	O
56025	a	b-CLINICAL_DEPT
56026	cardiology	i-CLINICAL_DEPT
56027	consult	O
56028	was	O
56029	obtained	O
56030	.	O
56031	the	b-CLINICAL_DEPT
56032	cardiology	i-CLINICAL_DEPT
56033	service	i-CLINICAL_DEPT
56034	simply	O
56035	recommended	O
56036	increasing	O
56037	the	b-TREATMENT
56038	beta-blockade	i-TREATMENT
56039	and	O
56040	maximizing	O
56041	the	O
56042	patient	O
56043	's	O
56044	electrolyte	O
56045	status	O
56046	.	O
56047	on	O
56048	06-29	b-DATE
56049	,	O
56050	the	O
56051	patient	O
56052	was	O
56053	transferred	b-OCCURRENCE
56054	to	O
56055	the	b-CLINICAL_DEPT
56056	medical	i-CLINICAL_DEPT
56057	service	i-CLINICAL_DEPT
56058	.	O
56059	pt	b-TREATMENT
56060	's	i-TREATMENT
56061	vancomycin	i-TREATMENT
56062	was	O
56063	stopped	O
56064	after	O
56065	14	b-DURATION
56066	days	i-DURATION
56067	of	O
56068	treatment	b-TREATMENT
56069	.	O
56070	hiv	b-TEST
56071	test	i-TEST
56072	was	O
56073	found	O
56074	to	O
56075	be	O
56076	negative	O
56077	.	O
56078	mri	b-TEST
56079	head	i-TEST
56080	was	O
56081	obtained	O
56082	to	O
56083	further	O
56084	w/u	O
56085	patient	b-PROBLEM
56086	's	i-PROBLEM
56087	apparent	i-PROBLEM
56088	cognitive	i-PROBLEM
56089	decline	i-PROBLEM
56090	.	O
56091	mri	b-TEST
56092	showed	b-EVIDENTIAL
56093	prominent	b-PROBLEM
56094	sulci	i-PROBLEM
56095	and	O
56096	enlarged	b-PROBLEM
56097	ventricles	i-PROBLEM
56098	abnormal	O
56099	for	O
56100	the	O
56101	patient	O
56102	's	O
56103	age	O
56104	.	O
56105	due	O
56106	to	O
56107	concerns	O
56108	for	O
56109	dementia	b-PROBLEM
56110	,	O
56111	neurology	b-CLINICAL_DEPT
56112	consult	O
56113	was	O
56114	obtained	O
56115	.	O
56116	neurology	b-CLINICAL_DEPT
56117	felt	O
56118	that	O
56119	the	b-PROBLEM
56120	patient	i-PROBLEM
56121	's	i-PROBLEM
56122	cognitive	i-PROBLEM
56123	symptoms	i-PROBLEM
56124	were	O
56125	consistent	O
56126	w/	O
56127	metabolic	b-PROBLEM
56128	encephalopathy	i-PROBLEM
56129	due	O
56130	to	O
56131	his	b-PROBLEM
56132	multiple	i-PROBLEM
56133	medical	i-PROBLEM
56134	problems	i-PROBLEM
56135	.	O
56136	they	O
56137	felt	O
56138	that	O
56139	his	b-OCCURRENCE
56140	mental	i-OCCURRENCE
56141	status	i-OCCURRENCE
56142	would	i-OCCURRENCE
56143	improve	i-OCCURRENCE
56144	as	O
56145	his	b-OCCURRENCE
56146	health	i-OCCURRENCE
56147	improved	i-OCCURRENCE
56148	.	O
56149	underlying	b-PROBLEM
56150	dementia	i-PROBLEM
56151	was	O
56152	possible	O
56153	but	O
56154	difficult	O
56155	to	O
56156	assess	O
56157	with	O
56158	an	b-PROBLEM
56159	overlying	i-PROBLEM
56160	delerium	i-PROBLEM
56161	.	O
56162	the	O
56163	patient	O
56164	continued	O
56165	to	O
56166	pull	O
56167	out	O
56168	his	b-TREATMENT
56169	doboff	i-TREATMENT
56170	tube	i-TREATMENT
56171	.	O
56172	pt	O
56173	had	O
56174	egd	b-TEST
56175	performed	O
56176	to	O
56177	evaluate	b-EVIDENTIAL
56178	his	b-PROBLEM
56179	poor	i-PROBLEM
56180	nutritional	i-PROBLEM
56181	status	i-PROBLEM
56182	.	O
56183	he	O
56184	was	O
56185	found	b-EVIDENTIAL
56186	to	O
56187	have	O
56188	a	b-PROBLEM
56189	large	i-PROBLEM
56190	gastric	i-PROBLEM
56191	ulcer	i-PROBLEM
56192	and	O
56193	high	b-TREATMENT
56194	dose	i-TREATMENT
56195	ppi	i-TREATMENT
56196	was	O
56197	started	O
56198	.	O
56199	the	b-TEST
56200	gastric	i-TEST
56201	biopsy	i-TEST
56202	and	O
56203	the	b-TEST
56204	serology	i-TEST
56205	were	O
56206	both	O
56207	negative	O
56208	for	O
56209	h.	b-PROBLEM
56210	pylori	i-PROBLEM
56211	.	O
56212	peg	b-TREATMENT
56213	placement	i-TREATMENT
56214	was	O
56215	unsuccessful	O
56216	by	O
56217	gi	b-CLINICAL_DEPT
56218	due	O
56219	to	O
56220	the	O
56221	patient	O
56222	's	O
56223	anantomy	O
56224	.	O
56225	07-05	b-DATE
56226	the	O
56227	patient	O
56228	had	O
56229	a	b-TREATMENT
56230	j	i-TREATMENT
56231	tube	i-TREATMENT
56232	placed	O
56233	in	O
56234	interventional	b-CLINICAL_DEPT
56235	radiology	i-CLINICAL_DEPT
56236	for	O
56237	nutritional	b-TREATMENT
56238	support	i-TREATMENT
56239	.	O
56240	he	O
56241	was	O
56242	re-started	O
56243	on	O
56244	tube	b-TREATMENT
56245	feeds	i-TREATMENT
56246	.	O
56247	07-06	b-DATE
56248	patient	O
56249	failed	O
56250	a	b-TEST
56251	repeat	i-TEST
56252	swallow	i-TEST
56253	evaluation	i-TEST
56254	due	O
56255	to	O
56256	discoordinated	b-PROBLEM
56257	swallow	i-PROBLEM
56258	.	O
56259	07-07	b-DATE
56260	the	O
56261	patient	O
56262	was	O
56263	taken	O
56264	for	O
56265	colonoscopy	b-TEST
56266	and	O
56267	found	O
56268	to	O
56269	have	O
56270	a	O
56271	normal	O
56272	colon	O
56273	to	O
56274	cecum	O
56275	.	O
56276	07-12	b-DATE
56277	the	O
56278	patient	O
56279	was	O
56280	found	O
56281	to	O
56282	be	O
56283	c	b-PROBLEM
56284	diff	i-PROBLEM
56285	positive	i-PROBLEM
56286	and	O
56287	was	O
56288	started	O
56289	on	O
56290	14	b-DURATION
56291	day	i-DURATION
56292	course	O
56293	of	O
56294	flagyl	b-TREATMENT
56295	.	O
56296	on	O
56297	07-18	b-DATE
56298	,	O
56299	as	O
56300	his	O
56301	mental	O
56302	status	O
56303	improved	O
56304	,	O
56305	he	O
56306	did	O
56307	well	O
56308	at	O
56309	the	b-TEST
56310	bed	i-TEST
56311	side	i-TEST
56312	swall	i-TEST
56313	evaluation	i-TEST
56314	.	O
56315	on	O
56316	07-19	b-DATE
56317	,	O
56318	he	O
56319	underwent	O
56320	video	b-TEST
56321	swallow	i-TEST
56322	evaluation	i-TEST
56323	and	O
56324	was	O
56325	able	O
56326	to	O
56327	tolerate	O
56328	ground	b-TREATMENT
56329	consistent	i-TREATMENT
56330	food	i-TREATMENT
56331	and	O
56332	thin	b-TREATMENT
56333	liquids	i-TREATMENT
56334	.	O
56335	his	b-TREATMENT
56336	meds	i-TREATMENT
56337	should	O
56338	be	O
56339	crushed	O
56340	and	O
56341	mixed	O
56342	with	O
56343	puree	b-TREATMENT
56344	thick	i-TREATMENT
56345	liquid	i-TREATMENT
56346	.	O
56347	he	O
56348	has	O
56349	gained	O
56350	30	b-PROBLEM
56351	lb	i-PROBLEM
56352	since	O
56353	the	b-TREATMENT
56354	tubefeed	i-TREATMENT
56355	was	O
56356	initiated	O
56357	(	O
56358	70	O
56359	lb	O
56360	to	O
56361	100	O
56362	lb	O
56363	)	O
56364	during	O
56365	this	b-OCCURRENCE
56366	admission	i-OCCURRENCE
56367	.	O
56368	he	O
56369	will	O
56370	still	O
56371	need	O
56372	to	O
56373	be	O
56374	on	O
56375	tubefeed	b-TREATMENT
56376	to	O
56377	support	O
56378	his	O
56379	nutrition	O
56380	until	O
56381	he	O
56382	is	O
56383	cleared	b-OCCURRENCE
56384	by	O
56385	a	O
56386	nutritionist	O
56387	.	O
56388	in	O
56389	terms	O
56390	of	O
56391	his	O
56392	mental	O
56393	status	O
56394	,	O
56395	he	O
56396	continued	b-EVIDENTIAL
56397	to	i-EVIDENTIAL
56398	improve	i-EVIDENTIAL
56399	steadily	i-EVIDENTIAL
56400	over	O
56401	the	b-DURATION
56402	last	i-DURATION
56403	few	i-DURATION
56404	weeks	i-DURATION
56405	of	O
56406	his	b-OCCURRENCE
56407	hospital	i-OCCURRENCE
56408	stay	i-OCCURRENCE
56409	.	O
56410	he	O
56411	was	O
56412	more	b-EVIDENTIAL
56413	alert	i-EVIDENTIAL
56414	and	O
56415	engaged	b-OCCURRENCE
56416	with	i-OCCURRENCE
56417	activity	i-OCCURRENCE
56418	.	O
56419	he	O
56420	did	O
56421	much	O
56422	better	O
56423	with	O
56424	pt	b-TREATMENT
56425	and	O
56426	ot	b-TREATMENT
56427	at	O
56428	the	O
56429	end	O
56430	after	O
56431	his	b-EVIDENTIAL
56432	mental	i-EVIDENTIAL
56433	status	i-EVIDENTIAL
56434	improved	i-EVIDENTIAL
56435	.	O
56436	as	O
56437	noted	O
56438	above	O
56439	,	O
56440	his	b-PROBLEM
56441	mental	i-PROBLEM
56442	status	i-PROBLEM
56443	change	i-PROBLEM
56444	was	O
56445	likely	O
56446	toxic-metabolic	b-PROBLEM
56447	from	O
56448	acute	b-PROBLEM
56449	infection	i-PROBLEM
56450	.	O
56451	he	O
56452	started	O
56453	to	O
56454	develop	O
56455	more	b-PROBLEM
56456	pain	i-PROBLEM
56457	around	i-PROBLEM
56458	the	i-PROBLEM
56459	right	i-PROBLEM
56460	stump	i-PROBLEM
56461	since	O
56462	07-17	b-DATE
56463	.	O
56464	he	O
56465	was	O
56466	seen	O
56467	by	O
56468	the	b-CLINICAL_DEPT
56469	vascular	i-CLINICAL_DEPT
56470	surgery	i-CLINICAL_DEPT
56471	who	O
56472	felt	O
56473	that	O
56474	he	O
56475	is	O
56476	too	O
56477	medically	b-PROBLEM
56478	sick	i-PROBLEM
56479	and	O
56480	malnourished	b-PROBLEM
56481	to	O
56482	have	O
56483	surgery	b-TREATMENT
56484	at	O
56485	this	b-DATE
56486	time	i-DATE
56487	.	O
56488	he	O
56489	will	O
56490	follow	b-OCCURRENCE
56491	up	i-OCCURRENCE
56492	with	O
56493	doctor	O
56494	javier	O
56495	as	O
56496	outpatient	O
56497	.	O
56498	initially	O
56499	,	O
56500	his	b-PROBLEM
56501	pain	i-PROBLEM
56502	was	O
56503	controlled	O
56504	with	O
56505	titrating	O
56506	up	O
56507	the	b-TREATMENT
56508	oxycontin	i-TREATMENT
56509	.	O
56510	however	O
56511	,	O
56512	it	O
56513	was	O
56514	titrated	b-OCCURRENCE
56515	too	i-OCCURRENCE
56516	quickly	i-OCCURRENCE
56517	from	O
56518	10	O
56519	mg	O
56520	bid	b-FREQUENCY
56521	to	O
56522	30	O
56523	mg	O
56524	bid	b-FREQUENCY
56525	.	O
56526	he	O
56527	then	O
56528	developed	O
56529	urinary	b-PROBLEM
56530	retention	i-PROBLEM
56531	requiring	O
56532	foley	b-TREATMENT
56533	placement	i-TREATMENT
56534	.	O
56535	after	O
56536	he	O
56537	passed	O
56538	the	b-TEST
56539	video	i-TEST
56540	swallowing	i-TEST
56541	,	O
56542	he	O
56543	was	O
56544	tolerating	O
56545	ground	b-TREATMENT
56546	consistent	i-TREATMENT
56547	solids	i-TREATMENT
56548	.	O
56549	on	O
56550	07-24	b-DATE
56551	,	O
56552	he	O
56553	had	O
56554	an	b-PROBLEM
56555	emesis	i-PROBLEM
56556	x	O
56557	1	O
56558	,	O
56559	and	O
56560	had	O
56561	aspiration	b-PROBLEM
56562	pneumonia	i-PROBLEM
56563	(	O
56564	+	O
56565	interstital	b-PROBLEM
56566	markings	i-PROBLEM
56567	on	O
56568	the	O
56569	left	O
56570	on	O
56571	cxr	b-TEST
56572	,	O
56573	fever	b-PROBLEM
56574	,	O
56575	leukocytosis	b-PROBLEM
56576	)	O
56577	.	O
56578	his	b-TREATMENT
56579	flagyl	i-TREATMENT
56580	course	i-TREATMENT
56581	was	O
56582	extended	O
56583	,	O
56584	and	O
56585	vanc	b-TREATMENT
56586	/	O
56587	levo	b-TREATMENT
56588	were	O
56589	added	O
56590	.	O
56591	his	b-TEST
56592	sputum	i-TEST
56593	showed	b-EVIDENTIAL
56594	many	b-PROBLEM
56595	gpc	i-PROBLEM
56596	which	O
56597	later	O
56598	grew	O
56599	staph	b-PROBLEM
56600	aureus	i-PROBLEM
56601	.	O
56602	given	O
56603	his	b-PROBLEM
56604	recent	i-PROBLEM
56605	mrsa	i-PROBLEM
56606	pneumonia	i-PROBLEM
56607	,	O
56608	he	O
56609	will	O
56610	be	O
56611	treated	O
56612	with	O
56613	2	b-DURATION
56614	week	i-DURATION
56615	course	O
56616	of	O
56617	vanc	b-TREATMENT
56618	/	O
56619	levo	b-TREATMENT
56620	/	O
56621	flagyl	b-TREATMENT
56622	.	O
56623	he	O
56624	was	O
56625	seen	O
56626	by	O
56627	the	b-CLINICAL_DEPT
56628	pain	i-CLINICAL_DEPT
56629	service	i-CLINICAL_DEPT
56630	who	O
56631	recommended	O
56632	to	O
56633	discontinue	O
56634	oxycontin	b-TREATMENT
56635	,	O
56636	and	O
56637	start	O
56638	neurontin	b-TREATMENT
56639	,	O
56640	msir	b-TREATMENT
56641	,	O
56642	and	O
56643	lidocaine	b-TREATMENT
56644	patch	i-TREATMENT
56645	in	O
56646	addition	O
56647	to	O
56648	the	b-TREATMENT
56649	standing	i-TREATMENT
56650	tylenol	i-TREATMENT
56651	.	O
56652	on	O
56653	07-25	b-DATE
56654	,	O
56655	his	b-TREATMENT
56656	j-tube	i-TREATMENT
56657	was	O
56658	noted	O
56659	to	O
56660	be	O
56661	obstructed	b-PROBLEM
56662	but	O
56663	was	O
56664	able	O
56665	to	O
56666	be	O
56667	flushed	b-TREATMENT
56668	by	O
56669	ir	b-CLINICAL_DEPT
56670	on	O
56671	07-26	b-DATE
56672	.	O
56673	tubefeed	b-TREATMENT
56674	was	O
56675	resumed	O
56676	without	O
56677	any	b-PROBLEM
56678	difficulty	i-PROBLEM
56679	since	O
56680	.	O
56681	since	O
56682	oxycontin	b-TREATMENT
56683	was	O
56684	discontinued	O
56685	,	O
56686	the	b-TREATMENT
56687	foley	i-TREATMENT
56688	was	O
56689	removed	O
56690	on	O
56691	07-27	b-DATE
56692	and	O
56693	was	O
56694	able	O
56695	to	O
56696	void	O
56697	without	O
56698	any	b-EVIDENTIAL
56699	difficulty	i-EVIDENTIAL
56700	.	O
56701		O
56702	admission	b-OCCURRENCE
56703	date	O
56704	:	O
56705		O
56706	12/25/96	b-DATE
56707		O
56708	discharge	b-OCCURRENCE
56709	date	O
56710	:	O
56711		O
56712	12/29/96	b-DATE
56713		b-DISCHARGE
56714	history	O
56715	of	O
56716	present	O
56717	illness	O
56718	:	O
56719		O
56720	ms.	O
56721	lenkpruskihkooglekih	O
56722	is	O
56723	a	O
56724	63-year-old	O
56725	lady	O
56726	with	O
56727	a	O
56728	history	O
56729	of	O
56730	frequent	b-PROBLEM
56731	premature	i-PROBLEM
56732	ventricular	i-PROBLEM
56733	contractions	i-PROBLEM
56734	and	O
56735	infrequent	b-PROBLEM
56736	short	i-PROBLEM
56737	runs	i-PROBLEM
56738	of	i-PROBLEM
56739	non-sustained	i-PROBLEM
56740	ventricular	i-PROBLEM
56741	tachycardia	i-PROBLEM
56742	(	O
56743	one	b-FREQUENCY
56744	four-beat	O
56745	run	O
56746	)	O
56747	in	O
56748	1991	b-DATE
56749	,	O
56750	for	O
56751	which	O
56752	several	b-FREQUENCY
56753	antiarrhythmic	b-TREATMENT
56754	agents	i-TREATMENT
56755	including	O
56756	propranolol	b-TREATMENT
56757	,	O
56758	quinidine	b-TREATMENT
56759	,	O
56760	procainamide	b-TREATMENT
56761	,	O
56762	tenormin	b-TREATMENT
56763	,	O
56764	norpace	b-TREATMENT
56765	,	O
56766	corgard	b-TREATMENT
56767	,	O
56768	and	O
56769	flecainide	b-TREATMENT
56770	were	O
56771	used	O
56772	,	O
56773	but	O
56774	were	O
56775	stopped	b-OCCURRENCE
56776	because	O
56777	of	O
56778	intolerance	b-PROBLEM
56779	.	O
56780		O
56781	at	O
56782	that	O
56783	time	O
56784	,	O
56785	she	O
56786	had	O
56787	clear	O
56788	coronary	O
56789	arteries	O
56790	on	O
56791	coronary	b-TEST
56792	angiography	i-TEST
56793	and	O
56794	an	b-TEST
56795	ejection	i-TEST
56796	fraction	i-TEST
56797	greater	O
56798	than	O
56799	50%	O
56800	.	O
56801		O
56802	she	O
56803	did	b-OCCURRENCE
56804	well	i-OCCURRENCE
56805	off	O
56806	antiarrhythmic	b-TREATMENT
56807	agents	i-TREATMENT
56808	until	O
56809	october	b-DATE
56810	of	i-DATE
56811	this	i-DATE
56812	year	i-DATE
56813	when	O
56814	she	O
56815	was	O
56816	noted	b-EVIDENTIAL
56817	to	O
56818	have	O
56819	atrial	b-PROBLEM
56820	fibrillation	i-PROBLEM
56821	with	O
56822	a	b-PROBLEM
56823	rapid	i-PROBLEM
56824	ventricular	i-PROBLEM
56825	rate	i-PROBLEM
56826	after	O
56827	several	b-DURATION
56828	days	i-DURATION
56829	of	O
56830	decreased	b-PROBLEM
56831	exercise	i-PROBLEM
56832	tolerance	i-PROBLEM
56833	.	O
56834		O
56835	she	O
56836	was	O
56837	started	O
56838	on	O
56839	coumadin	b-TREATMENT
56840	and	O
56841	had	O
56842	a	b-PROBLEM
56843	failed	i-PROBLEM
56844	attempt	i-PROBLEM
56845	at	O
56846	dc	b-TREATMENT
56847	electrical	i-TREATMENT
56848	cardioversion	i-TREATMENT
56849	on	O
56850	11/16/96	b-DATE
56851	.	O
56852		O
56853	she	O
56854	has	O
56855	been	O
56856	on	O
56857	coumadin	b-TREATMENT
56858	since	O
56859	and	O
56860	has	O
56861	continued	O
56862	to	O
56863	have	O
56864	occasional	b-PROBLEM
56865	palpitations	i-PROBLEM
56866	and	O
56867	mild	b-PROBLEM
56868	shortness	i-PROBLEM
56869	of	i-PROBLEM
56870	breath	i-PROBLEM
56871	.	O
56872		O
56873	hospital	O
56874	course	O
56875	and	O
56876	treatment	O
56877	:	O
56878		O
56879	the	O
56880	patient	O
56881	was	O
56882	started	O
56883	on	O
56884	propafenone	b-TREATMENT
56885	300	O
56886	mg	O
56887	three	b-FREQUENCY
56888	times	i-FREQUENCY
56889	a	i-FREQUENCY
56890	day	i-FREQUENCY
56891	and	O
56892	underwent	O
56893	an	O
56894	attempt	O
56895	at	O
56896	electrical	b-TREATMENT
56897	cardioversion	i-TREATMENT
56898	after	O
56899	seven	b-FREQUENCY
56900	doses	O
56901	of	O
56902	this	O
56903	.	O
56904		O
56905	this	b-PROBLEM
56906	failed	i-PROBLEM
56907	,	O
56908	despite	O
56909	one	b-FREQUENCY
56910	shock	b-TREATMENT
56911	at	O
56912	300	O
56913	joules	O
56914	and	O
56915	two	b-FREQUENCY
56916	shocks	b-TREATMENT
56917	at	O
56918	360	O
56919	joules	O
56920	.	O
56921		O
56922	the	b-TREATMENT
56923	propafenone	i-TREATMENT
56924	was	O
56925	stopped	O
56926	,	O
56927	and	O
56928	the	O
56929	patient	O
56930	was	O
56931	changed	O
56932	to	O
56933	amiodarone	b-TREATMENT
56934	400	O
56935	mg	O
56936	t.i.d.	b-FREQUENCY
56937	,	O
56938	which	O
56939	was	O
56940	continued	O
56941	for	O
56942	two	b-DURATION
56943	days	i-DURATION
56944	.	O
56945		O
56946	the	O
56947	patient	O
56948	was	O
56949	discharged	b-OCCURRENCE
56950	to	O
56951	home	O
56952	on	O
56953	amiodarone	b-TREATMENT
56954	200	O
56955	mg	O
56956	daily	b-FREQUENCY
56957	on	O
56958	12/29/96	b-DATE
56959	.	O
56960		O
56961	an	b-TEST
56962	electrocardiogram	i-TEST
56963	showed	b-EVIDENTIAL
56964	no	O
56965	evidence	O
56966	of	O
56967	qt	b-PROBLEM
56968	prolongation	i-PROBLEM
56969	prior	O
56970	to	O
56971	discharge	b-OCCURRENCE
56972	,	O
56973	and	O
56974	pulmonary	b-TEST
56975	function	i-TEST
56976	tests	i-TEST
56977	will	O
56978	be	O
56979	performed	O
56980	before	O
56981	the	O
56982	patient	O
56983	goes	b-OCCURRENCE
56984	home	i-OCCURRENCE
56985	today	b-DATE
56986	.	O
56987		O
56988	the	O
56989	patient	O
56990	will	O
56991	follow	O
56992	up	O
56993	with	O
56994	doctor	O
56995	ther	O
56996	ludzjesc	O
56997	at	O
56998	shiekeu	O
56999	hospital	O
57000	medical	O
57001	centers	O
57002	in	O
57003	connecticut	O
57004	.	O
57005		O
57006	in	O
57007	addition	O
57008	,	O
57009	she	O
57010	will	O
57011	return	O
57012	to	O
57013	this	O
57014	hospital	O
57015	in	O
57016	early	O
57017	february	O
57018	for	O
57019	repeat	O
57020	attempt	O
57021	at	O
57022	electrical	O
57023	cardioversion	O
57024	on	O
57025	amiodarone	O
57026	.	O
57027		O
57028	she	O
57029	will	O
57030	continue	O
57031	her	O
57032	coumadin	O
57033	until	O
57034	then	O
57035	and	O
57036	arrangements	O
57037	for	O
57038	her	O
57039	readmission	O
57040	can	O
57041	be	O
57042	made	O
57043	through	O
57044	doctor	O
57045	iceca	O
57046	rhaltkaaispehbreun	O
57047	's	O
57048	office	O
57049	here	O
57050	.	O
57051		O
57052	medications	O
57053	:	O
57054		O
57055	other	O
57056	than	O
57057	the	O
57058	addition	O
57059	of	O
57060	amiodarone	b-TREATMENT
57061	200	O
57062	mg	O
57063	daily	b-FREQUENCY
57064	,	O
57065	will	O
57066	be	O
57067	the	O
57068	same	O
57069	as	O
57070	her	b-TREATMENT
57071	admission	i-TREATMENT
57072	medications	i-TREATMENT
57073	.	O
57074		O
57075	sta	O
57076	bodejove	O
57077	,	O
57078	md	O
57079		O
57080		O
57081	admission	b-OCCURRENCE
57082	date	O
57083	:	O
57084	09/09/2003	b-ADMISSION
57085	discharge	b-OCCURRENCE
57086	date	O
57087	:	O
57088	09/12/2003	b-DISCHARGE
57089	history	O
57090	of	O
57091	present	O
57092	illness	O
57093	:	O
57094	the	O
57095	patient	O
57096	is	O
57097	an	O
57098	84	O
57099	year	O
57100	old	O
57101	male	O
57102	,	O
57103	with	O
57104	a	O
57105	history	O
57106	of	O
57107	hypertension	b-PROBLEM
57108	,	O
57109	who	O
57110	was	O
57111	discovered	b-EVIDENTIAL
57112	to	O
57113	have	O
57114	an	b-PROBLEM
57115	asymptomatic	i-PROBLEM
57116	7	i-PROBLEM
57117	cm	i-PROBLEM
57118	abdominal	i-PROBLEM
57119	aortic	i-PROBLEM
57120	aneurysm	i-PROBLEM
57121	on	O
57122	ct	b-TEST
57123	scan	i-TEST
57124	obtained	O
57125	in	O
57126	the	b-CLINICAL_DEPT
57127	emergency	i-CLINICAL_DEPT
57128	room	i-CLINICAL_DEPT
57129	back	O
57130	in	O
57131	may	b-DATE
57132	.	O
57133	at	O
57134	that	b-DATE
57135	time	i-DATE
57136	he	O
57137	had	O
57138	presented	b-EVIDENTIAL
57139	with	O
57140	abdominal	b-PROBLEM
57141	pain	i-PROBLEM
57142	,	O
57143	and	O
57144	was	O
57145	found	O
57146	to	O
57147	have	O
57148	acute	b-PROBLEM
57149	cholecystectomy	i-PROBLEM
57150	.	O
57151	he	O
57152	underwent	O
57153	an	b-TREATMENT
57154	uncomplicated	i-TREATMENT
57155	laparoscopic	i-TREATMENT
57156	cholecystectomy	i-TREATMENT
57157	.	O
57158	he	O
57159	presents	b-EVIDENTIAL
57160	at	O
57161	this	b-DATE
57162	time	i-DATE
57163	for	O
57164	endovascular	b-TREATMENT
57165	repair	i-TREATMENT
57166	of	O
57167	this	b-PROBLEM
57168	abdominal	i-PROBLEM
57169	aortic	i-PROBLEM
57170	aneurysm	i-PROBLEM
57171	.	O
57172	hospital	O
57173	course	O
57174	:	O
57175	the	O
57176	patient	O
57177	was	O
57178	admitted	b-OCCURRENCE
57179	to	O
57180	vascular	b-CLINICAL_DEPT
57181	surgery	i-CLINICAL_DEPT
57182	service	i-CLINICAL_DEPT
57183	as	O
57184	a	b-DATE
57185	same	i-DATE
57186	day	i-DATE
57187	admission	b-OCCURRENCE
57188	,	O
57189	and	O
57190	taken	O
57191	to	O
57192	the	b-CLINICAL_DEPT
57193	operating	i-CLINICAL_DEPT
57194	room	i-CLINICAL_DEPT
57195	for	O
57196	an	b-TREATMENT
57197	uncomplicated	i-TREATMENT
57198	endovascular	i-TREATMENT
57199	repair	i-TREATMENT
57200	of	O
57201	his	b-PROBLEM
57202	abdominal	i-PROBLEM
57203	aortic	i-PROBLEM
57204	aneurysm	i-PROBLEM
57205	,	O
57206	and	O
57207	anurx	b-TREATMENT
57208	modular	i-TREATMENT
57209	bifurcated	i-TREATMENT
57210	graft	i-TREATMENT
57211	was	O
57212	placed	O
57213	,	O
57214	and	O
57215	both	O
57216	common	b-PROBLEM
57217	femoral	i-PROBLEM
57218	arteries	i-PROBLEM
57219	were	O
57220	repaired	b-TREATMENT
57221	in	O
57222	the	O
57223	usual	O
57224	fashion	O
57225	.	O
57226	he	O
57227	had	O
57228	pulsatile	b-TEST
57229	pulse	i-TEST
57230	volume	i-TEST
57231	recordings	i-TEST
57232	,	O
57233	in	O
57234	both	O
57235	lower	O
57236	extremities	O
57237	,	O
57238	and	O
57239	both	O
57240	renal	O
57241	arteries	O
57242	were	O
57243	noted	O
57244	to	O
57245	be	O
57246	patent	O
57247	,	O
57248	as	O
57249	were	O
57250	both	O
57251	internal	O
57252	iliac	O
57253	arteries	O
57254	.	O
57255	his	b-TEST
57256	angiogram	i-TEST
57257	in	O
57258	the	b-CLINICAL_DEPT
57259	operating	i-CLINICAL_DEPT
57260	room	i-CLINICAL_DEPT
57261	,	O
57262	revealed	b-EVIDENTIAL
57263	no	O
57264	evidence	O
57265	of	O
57266	an	b-PROBLEM
57267	endo	i-PROBLEM
57268	leak	i-PROBLEM
57269	.	O
57270	postoperatively	O
57271	,	O
57272	his	O
57273	course	O
57274	was	O
57275	relatively	O
57276	uncomplicated	O
57277	.	O
57278	he	O
57279	did	O
57280	have	O
57281	an	O
57282	episode	O
57283	of	O
57284	a	b-PROBLEM
57285	prolonged	i-PROBLEM
57286	sinus	i-PROBLEM
57287	pause	i-PROBLEM
57288	in	O
57289	the	b-CLINICAL_DEPT
57290	recovery	i-CLINICAL_DEPT
57291	room	i-CLINICAL_DEPT
57292	,	O
57293	which	O
57294	resulted	O
57295	in	O
57296	transient	b-PROBLEM
57297	loss	i-PROBLEM
57298	of	i-PROBLEM
57299	consciousness	i-PROBLEM
57300	.	O
57301	he	O
57302	responded	O
57303	to	O
57304	a	b-TREATMENT
57305	neo-synephrine	i-TREATMENT
57306	bolus	i-TREATMENT
57307	,	O
57308	and	O
57309	had	O
57310	no	O
57311	further	b-PROBLEM
57312	complications	i-PROBLEM
57313	from	O
57314	this	O
57315	standpoint	O
57316	.	O
57317	doctor	O
57318	rosean	O
57319	fletcher	O
57320	,	O
57321	of	O
57322	the	b-CLINICAL_DEPT
57323	cardiology	i-CLINICAL_DEPT
57324	department	i-CLINICAL_DEPT
57325	was	O
57326	consulted	b-OCCURRENCE
57327	,	O
57328	and	O
57329	it	O
57330	was	O
57331	his	O
57332	opinion	O
57333	that	O
57334	the	b-PROBLEM
57335	sinus	i-PROBLEM
57336	pause	i-PROBLEM
57337	was	O
57338	related	O
57339	to	O
57340	increased	b-PROBLEM
57341	vagal	i-PROBLEM
57342	tone	i-PROBLEM
57343	postoperatively	O
57344	,	O
57345	perhaps	O
57346	secondary	O
57347	to	O
57348	the	b-TREATMENT
57349	epidural	i-TREATMENT
57350	,	O
57351	as	O
57352	well	O
57353	as	O
57354	the	b-TREATMENT
57355	patient	i-TREATMENT
57356	&apos;s	i-TREATMENT
57357	atenolol	i-TREATMENT
57358	use	i-TREATMENT
57359	.	O
57360	his	b-TREATMENT
57361	atenolol	i-TREATMENT
57362	was	O
57363	held	O
57364	,	O
57365	and	O
57366	he	O
57367	had	O
57368	no	O
57369	further	b-PROBLEM
57370	pauses	i-PROBLEM
57371	during	O
57372	his	b-OCCURRENCE
57373	stay	i-OCCURRENCE
57374	.	O
57375	his	b-TEST
57376	postoperative	i-TEST
57377	ct	i-TEST
57378	scan	i-TEST
57379	showed	b-EVIDENTIAL
57380	no	O
57381	evidence	O
57382	of	O
57383	endo	b-PROBLEM
57384	leak	i-PROBLEM
57385	,	O
57386	or	O
57387	graft	b-PROBLEM
57388	kinking	i-PROBLEM
57389	.	O
57390	he	O
57391	maintained	O
57392	good	O
57393	peripheral	O
57394	pulses	O
57395	and	O
57396	warm	O
57397	feet	O
57398	postoperatively	O
57399	.	O
57400	however	O
57401	,	O
57402	he	O
57403	did	O
57404	develop	O
57405	significant	b-PROBLEM
57406	ecchymosis	i-PROBLEM
57407	in	i-PROBLEM
57408	both	i-PROBLEM
57409	groins	i-PROBLEM
57410	,	O
57411	extending	O
57412	down	O
57413	into	O
57414	his	O
57415	scrotum	O
57416	.	O
57417	there	O
57418	was	O
57419	no	O
57420	evidence	O
57421	of	O
57422	significant	b-PROBLEM
57423	groin	i-PROBLEM
57424	hematomas	i-PROBLEM
57425	.	O
57426	he	O
57427	tolerated	O
57428	a	O
57429	regular	O
57430	diet	O
57431	.	O
57432	his	b-PROBLEM
57433	pain	i-PROBLEM
57434	was	O
57435	adequately	O
57436	controlled	O
57437	with	O
57438	oral	b-TREATMENT
57439	medications	i-TREATMENT
57440	.	O
57441	accordingly	O
57442	,	O
57443	the	O
57444	patient	O
57445	was	O
57446	discharged	b-OCCURRENCE
57447	to	O
57448	home	O
57449	on	O
57450	postoperative	b-DATE
57451	day	i-DATE
57452	2	i-DATE
57453	.	O
57454	he	O
57455	will	O
57456	be	O
57457	visited	O
57458	by	O
57459	ldamc	O
57460	for	O
57461	blood	O
57462	pressure	O
57463	and	O
57464	incision	O
57465	checks	O
57466	.	O
57467	he	O
57468	will	O
57469	follow	O
57470	up	O
57471	with	O
57472	doctor	O
57473	dye	O
57474	in	O
57475	the	O
57476	clinic	O
57477	.	O
57478		O
57479	admission	b-OCCURRENCE
57480	date	O
57481	:	O
57482	2020-05-23	b-ADMISSION
57483	discharge	b-OCCURRENCE
57484	date	O
57485	:	O
57486	2020-05-29	b-DISCHARGE
57487	service	O
57488	:	O
57489	medicine	O
57490	history	O
57491	of	O
57492	present	O
57493	illness	O
57494	:	O
57495	64	O
57496	f	O
57497	with	O
57498	breast	b-PROBLEM
57499	ca	i-PROBLEM
57500	s/p	O
57501	mastectomy	b-TREATMENT
57502	17	b-DATE
57503	y	i-DATE
57504	ago	i-DATE
57505	with	O
57506	local	b-PROBLEM
57507	recurrence	i-PROBLEM
57508	leading	O
57509	to	O
57510	paralysis	b-PROBLEM
57511	of	i-PROBLEM
57512	l	i-PROBLEM
57513	arm	i-PROBLEM
57514	~	O
57515	5-6	b-DATE
57516	y	i-DATE
57517	ago	i-DATE
57518	.	O
57519	now	O
57520	declining	b-OCCURRENCE
57521	gradually	O
57522	since	O
57523	january	b-DATE
57524	(	O
57525	30	b-PROBLEM
57526	lbs	i-PROBLEM
57527	weight	i-PROBLEM
57528	loss	i-PROBLEM
57529	,	O
57530	becoming	O
57531	more	b-PROBLEM
57532	confused	i-PROBLEM
57533	,	O
57534	decreased	b-PROBLEM
57535	appetite	i-PROBLEM
57536	).	O
57537	patient	O
57538	declined	O
57539	workup	b-TEST
57540	/	O
57541	imaging	b-TEST
57542	for	O
57543	mets	b-PROBLEM
57544	as	O
57545	outpatient	O
57546	.	O
57547	moving	O
57548	toward	O
57549	home	b-TREATMENT
57550	hospice	i-TREATMENT
57551	.	O
57552	over	O
57553	the	b-DURATION
57554	last	i-DURATION
57555	2	i-DURATION
57556	weeks	i-DURATION
57557	,	O
57558	husband	O
57559	reports	b-EVIDENTIAL
57560	patient	O
57561	becoming	O
57562	increasingly	b-PROBLEM
57563	weak	i-PROBLEM
57564	,	O
57565	unable	b-PROBLEM
57566	to	i-PROBLEM
57567	leave	i-PROBLEM
57568	bed	i-PROBLEM
57569	,	O
57570	confused	b-PROBLEM
57571	,	O
57572	unable	b-PROBLEM
57573	to	i-PROBLEM
57574	feed	i-PROBLEM
57575	herself	i-PROBLEM
57576	.	O
57577	seen	O
57578	by	O
57579	vna	b-CLINICAL_DEPT
57580	and	O
57581	noted	b-EVIDENTIAL
57582	to	O
57583	be	O
57584	tachycardic	b-PROBLEM
57585	and	O
57586	sent	b-OCCURRENCE
57587	to	O
57588	middleborough	b-CLINICAL_DEPT
57589	or	O
57590	evaluation	b-TEST
57591	.	O
57592	now	b-DATE
57593	sent	b-OCCURRENCE
57594	in	i-OCCURRENCE
57595	to	O
57596	amesbury	b-CLINICAL_DEPT
57597	by	O
57598	vna	b-CLINICAL_DEPT
57599	because	O
57600	of	O
57601	asymptomatic	b-PROBLEM
57602	sinus	i-PROBLEM
57603	tachycardia	i-PROBLEM
57604	.	O
57605	transferred	b-OCCURRENCE
57606	here	O
57607	for	O
57608	workup	b-TEST
57609	for	O
57610	cns	b-PROBLEM
57611	mets	i-PROBLEM
57612	and	O
57613	admission	b-OCCURRENCE
57614	.	O
57615	in	O
57616	john	b-CLINICAL_DEPT
57617	,	O
57618	vs	b-TEST
57619	-	O
57620	99.6	O
57621	,	O
57622	135	O
57623	,	O
57624	122/65	O
57625	,	O
57626	20	O
57627	.	O
57628	neurology	b-CLINICAL_DEPT
57629	evaluated	O
57630	pt	O
57631	and	O
57632	felt	O
57633	to	O
57634	have	O
57635	intact	b-PROBLEM
57636	brainstem	i-PROBLEM
57637	reflexes	i-PROBLEM
57638	but	O
57639	poor	b-PROBLEM
57640	prognosis	i-PROBLEM
57641	.	O
57642	neurosurg	b-CLINICAL_DEPT
57643	evaluated	O
57644	pt	O
57645	and	O
57646	felt	O
57647	to	O
57648	not	O
57649	be	O
57650	surgical	b-TREATMENT
57651	candidate	i-TREATMENT
57652	;	O
57653	recommended	O
57654	dilantin	b-TREATMENT
57655	load	i-TREATMENT
57656	and	O
57657	decadron	b-TREATMENT
57658	.	O
57659	received	O
57660	lorazepam	b-TREATMENT
57661	prior	O
57662	to	O
57663	ct	b-TEST
57664	scan	i-TEST
57665	.	O
57666	intubated	b-TREATMENT
57667	for	O
57668	ms	b-PROBLEM
57669	changes	i-PROBLEM
57670	and	O
57671	lethargy	b-PROBLEM
57672	and	O
57673	concern	O
57674	for	O
57675	airway	b-TREATMENT
57676	protection	i-TREATMENT
57677	.	O
57678	post	O
57679	intubation	b-TREATMENT
57680	,	O
57681	hypotensive	b-PROBLEM
57682	and	O
57683	started	O
57684	on	O
57685	dopamine	b-TREATMENT
57686	and	O
57687	transitioned	O
57688	to	O
57689	levophed	b-TREATMENT
57690	.	O
57691	received	O
57692	vancomycin	b-TREATMENT
57693	/	O
57694	levafloxacin	b-TREATMENT
57695	at	O
57696	osh	b-CLINICAL_DEPT
57697	.	O
57698	received	O
57699	metronidazole	b-TREATMENT
57700	at	O
57701	ricky	b-CLINICAL_DEPT
57702	in	O
57703	mediplex	b-CLINICAL_DEPT
57704	rehab	i-CLINICAL_DEPT
57705	hospital	i-CLINICAL_DEPT
57706	.	O
57707	in	O
57708	cmed	b-CLINICAL_DEPT
57709	ccu	i-CLINICAL_DEPT
57710	,	O
57711	pt.	O
57712	responsive	O
57713	to	O
57714	noxious	b-TEST
57715	stimuli	i-TEST
57716	only	O
57717	.	O
57718	history	O
57719	obtained	O
57720	from	O
57721	husband	O
57722	as	O
57723	above	O
57724	.	O
57725	brief	O
57726	hospital	O
57727	course	O
57728	:	O
57729	metastatic	b-PROBLEM
57730	breast	i-PROBLEM
57731	ca	i-PROBLEM
57732	-	O
57733	large	b-PROBLEM
57734	brain	i-PROBLEM
57735	mets	i-PROBLEM
57736	with	O
57737	midline	b-PROBLEM
57738	shift	i-PROBLEM
57739	.	O
57740	intubated	b-TREATMENT
57741	for	O
57742	airway	b-TREATMENT
57743	protection	i-TREATMENT
57744	.	O
57745	treated	O
57746	with	O
57747	iv	b-TREATMENT
57748	dilantin	i-TREATMENT
57749	and	O
57750	decadron	b-TREATMENT
57751	.	O
57752	patient	O
57753	mental	b-OCCURRENCE
57754	status	i-OCCURRENCE
57755	improved	i-OCCURRENCE
57756	slightly	O
57757	.	O
57758	after	O
57759	discussion	b-OCCURRENCE
57760	with	O
57761	primary	b-CLINICAL_DEPT
57762	oncologist	i-CLINICAL_DEPT
57763	goals	O
57764	of	O
57765	care	O
57766	where	O
57767	change	O
57768	to	O
57769	comfort	b-TREATMENT
57770	.	O
57771	dilantin	b-TREATMENT
57772	was	O
57773	stopped	O
57774	.	O
57775	will	O
57776	go	O
57777	home	O
57778	with	O
57779	prn	O
57780	morphine	b-TREATMENT
57781	,	O
57782	ativan	b-TREATMENT
57783	,	O
57784	and	O
57785	pr	b-TREATMENT
57786	decadron	i-TREATMENT
57787	.	O
57788	pnuemonia	b-PROBLEM
57789	-	O
57790	possible	O
57791	aspiration	b-PROBLEM
57792	.	O
57793	completed	O
57794	a	O
57795	7	b-DURATION
57796	day	i-DURATION
57797	course	O
57798	of	O
57799	vancomycin	b-TREATMENT
57800	and	O
57801	levofloxacin	b-TREATMENT
57802	.	O
57803		O
57804	admission	b-OCCURRENCE
57805	date	O
57806	:	O
57807	11/03/1993	b-ADMISSION
57808	discharge	b-OCCURRENCE
57809	date	O
57810	:	O
57811	11/07/1993	b-DISCHARGE
57812	history	O
57813	of	O
57814	present	O
57815	illness	O
57816	:	O
57817	the	O
57818	patient	O
57819	is	O
57820	a	O
57821	69-year-old	O
57822	male	O
57823	with	O
57824	multiple	b-PROBLEM
57825	medical	i-PROBLEM
57826	problems	i-PROBLEM
57827	and	O
57828	known	b-PROBLEM
57829	transfusion	i-PROBLEM
57830	dependent	i-PROBLEM
57831	secondary	O
57832	to	O
57833	myelodysplastic	b-PROBLEM
57834	syndrome	i-PROBLEM
57835	admitted	b-OCCURRENCE
57836	with	O
57837	decreased	b-PROBLEM
57838	hematocrit	i-PROBLEM
57839	.	O
57840	the	O
57841	patient	O
57842	has	O
57843	had	O
57844	multiple	b-FREQUENCY
57845	previous	O
57846	admissions	b-OCCURRENCE
57847	for	O
57848	cardiac	b-PROBLEM
57849	and	i-PROBLEM
57850	pulmonary	i-PROBLEM
57851	disease	i-PROBLEM
57852	.	O
57853	he	O
57854	has	O
57855	had	O
57856	chronic	b-PROBLEM
57857	anemia	i-PROBLEM
57858	since	O
57859	1990	b-DATE
57860	,	O
57861	but	O
57862	a	b-TEST
57863	bone	i-TEST
57864	marrow	i-TEST
57865	biopsy	i-TEST
57866	in	O
57867	07-92	b-DATE
57868	,	O
57869	was	O
57870	consistent	O
57871	with	O
57872	myelodysplastic	b-PROBLEM
57873	syndrome	i-PROBLEM
57874	.	O
57875	over	O
57876	the	b-DURATION
57877	past	i-DURATION
57878	several	i-DURATION
57879	months	i-DURATION
57880	,	O
57881	the	O
57882	patient	O
57883	has	O
57884	had	O
57885	increasing	b-PROBLEM
57886	transfusing	i-PROBLEM
57887	requirements	i-PROBLEM
57888	.	O
57889	his	b-TREATMENT
57890	transfusions	i-TREATMENT
57891	have	O
57892	been	O
57893	complicated	O
57894	by	O
57895	fluid	b-PROBLEM
57896	overload	i-PROBLEM
57897	and	O
57898	congestive	b-PROBLEM
57899	heart	i-PROBLEM
57900	failure	i-PROBLEM
57901	,	O
57902	secondary	O
57903	to	O
57904	ischemia	b-PROBLEM
57905	cardiomyopathy	i-PROBLEM
57906	.	O
57907	his	O
57908	last	O
57909	admission	b-OCCURRENCE
57910	was	O
57911	9-14-93	b-DATE
57912	,	O
57913	for	O
57914	a	b-TREATMENT
57915	transfusion	i-TREATMENT
57916	without	O
57917	complications	b-PROBLEM
57918	,	O
57919	and	O
57920	prior	O
57921	to	O
57922	admission	b-OCCURRENCE
57923	the	O
57924	patient	O
57925	reports	b-EVIDENTIAL
57926	having	O
57927	several	b-DURATION
57928	days	i-DURATION
57929	of	O
57930	increasing	b-PROBLEM
57931	weakness	i-PROBLEM
57932	,	O
57933	dizziness	b-PROBLEM
57934	and	O
57935	fatigue	b-PROBLEM
57936	.	O
57937	his	O
57938	wife	O
57939	says	b-EVIDENTIAL
57940	his	b-PROBLEM
57941	hands	i-PROBLEM
57942	and	i-PROBLEM
57943	lips	i-PROBLEM
57944	have	i-PROBLEM
57945	been	i-PROBLEM
57946	blue	i-PROBLEM
57947	.	O
57948	apparently	O
57949	,	O
57950	he	O
57951	had	O
57952	had	O
57953	a	b-PROBLEM
57954	low	i-PROBLEM
57955	hematocrit	i-PROBLEM
57956	as	O
57957	an	O
57958	outpatient	O
57959	and	O
57960	was	O
57961	checked	b-TEST
57962	two	b-DATE
57963	weeks	i-DATE
57964	prior	O
57965	to	O
57966	admission	b-OCCURRENCE
57967	but	O
57968	was	O
57969	not	O
57970	given	O
57971	transfusion	b-TREATMENT
57972	because	O
57973	the	O
57974	patient	O
57975	did	O
57976	not	O
57977	want	b-OCCURRENCE
57978	to	i-OCCURRENCE
57979	come	i-OCCURRENCE
57980	in	O
57981	at	O
57982	that	b-DATE
57983	time	i-DATE
57984	.	O
57985	aside	O
57986	from	O
57987	the	O
57988	above	O
57989	,	O
57990	the	O
57991	patient	O
57992	had	O
57993	felt	O
57994	that	O
57995	baseline	O
57996	without	O
57997	fever	b-PROBLEM
57998	and	O
57999	chills	b-PROBLEM
58000	or	O
58001	change	b-PROBLEM
58002	in	i-PROBLEM
58003	chronic	i-PROBLEM
58004	cough	i-PROBLEM
58005	.	O
58006	he	O
58007	had	O
58008	no	O
58009	increase	b-PROBLEM
58010	in	O
58011	his	b-PROBLEM
58012	congestive	i-PROBLEM
58013	heart	i-PROBLEM
58014	failure	i-PROBLEM
58015	symptoms	i-PROBLEM
58016	,	O
58017	no	O
58018	chest	b-PROBLEM
58019	pain	i-PROBLEM
58020	,	O
58021	and	O
58022	no	O
58023	hemoptysis	b-PROBLEM
58024	or	O
58025	changed	O
58026	in	O
58027	arthritis	b-PROBLEM
58028	.	O
58029	the	O
58030	patient	O
58031	did	O
58032	report	b-EVIDENTIAL
58033	taking	O
58034	a	b-TREATMENT
58035	po	i-TREATMENT
58036	antibiotic	i-TREATMENT
58037	(	i-TREATMENT
58038	ciprofloxacin	i-TREATMENT
58039	)	i-TREATMENT
58040	for	O
58041	right	b-PROBLEM
58042	great	i-PROBLEM
58043	toe	i-PROBLEM
58044	infection	i-PROBLEM
58045	(	O
58046	question	O
58047	of	O
58048	cellulitis	b-PROBLEM
58049	vs.	O
58050	paronychia	b-PROBLEM
58051	)	O
58052	.	O
58053	hospital	O
58054	course	O
58055	:	O
58056	the	O
58057	patient	O
58058	was	O
58059	admitted	b-OCCURRENCE
58060	and	O
58061	placed	O
58062	in	O
58063	isolation	b-TREATMENT
58064	on	O
58065	neutropenic	b-TREATMENT
58066	precautions	i-TREATMENT
58067	.	O
58068	he	O
58069	was	O
58070	transfused	b-TREATMENT
58071	with	O
58072	1/2	b-TREATMENT
58073	units	i-TREATMENT
58074	of	i-TREATMENT
58075	packed	i-TREATMENT
58076	red	i-TREATMENT
58077	blood	i-TREATMENT
58078	cells	i-TREATMENT
58079	and	O
58080	given	O
58081	lasix	b-TREATMENT
58082	periodically	O
58083	to	O
58084	prevent	O
58085	him	O
58086	from	O
58087	going	O
58088	into	O
58089	congestive	b-PROBLEM
58090	heart	i-PROBLEM
58091	failure	i-PROBLEM
58092	has	O
58093	he	O
58094	had	O
58095	on	O
58096	his	b-TREATMENT
58097	prior	i-TREATMENT
58098	transfusion	i-TREATMENT
58099	.	O
58100	because	O
58101	his	O
58102	need	O
58103	for	O
58104	multiple	b-TREATMENT
58105	transfusionsm	i-TREATMENT
58106	he	O
58107	was	O
58108	transfused	b-TREATMENT
58109	with	O
58110	radiated	b-TREATMENT
58111	leuco	i-TREATMENT
58112	four	O
58113	units	O
58114	.	O
58115	the	O
58116	patient	O
58117	had	O
58118	a	b-OCCURRENCE
58119	good	i-OCCURRENCE
58120	bump	i-OCCURRENCE
58121	in	O
58122	his	b-TEST
58123	hematocrit	i-TEST
58124	,	O
58125	more	O
58126	than	O
58127	expected	O
58128	from	O
58129	22	O
58130	to	O
58131	high	O
58132	20	O
58133	&apos;s	O
58134	range	O
58135	next	b-DATE
58136	day	i-DATE
58137	after	O
58138	3	O
58139	1/2	O
58140	units	O
58141	,	O
58142	but	O
58143	later	O
58144	that	b-DATE
58145	evening	i-DATE
58146	had	O
58147	a	b-PROBLEM
58148	drop	i-PROBLEM
58149	in	O
58150	his	b-TEST
58151	hematocrit	i-TEST
58152	so	O
58153	was	O
58154	given	O
58155	4	O
58156	more	O
58157	1/2	O
58158	units	O
58159	at	O
58160	this	O
58161	point	O
58162	for	O
58163	a	O
58164	total	O
58165	of	O
58166	4	b-TREATMENT
58167	units	i-TREATMENT
58168	packed	i-TREATMENT
58169	red	i-TREATMENT
58170	blood	i-TREATMENT
58171	cells	i-TREATMENT
58172	.	O
58173	he	O
58174	again	O
58175	did	O
58176	not	O
58177	bump	O
58178	his	b-TEST
58179	hematocrit	i-TEST
58180	sufficiently	O
58181	and	O
58182	remained	O
58183	in	O
58184	the	O
58185	high	O
58186	20	O
58187	&apos;s	O
58188	after	O
58189	a	O
58190	total	O
58191	of	O
58192	4	O
58193	units	O
58194	,	O
58195	so	O
58196	he	O
58197	was	O
58198	given	O
58199	2	O
58200	more	O
58201	total	O
58202	units	O
58203	in	O
58204	1/2	O
58205	units	O
58206	segments	O
58207	the	b-DATE
58208	following	i-DATE
58209	day	i-DATE
58210	.	O
58211	his	b-TEST
58212	hematocrit	i-TEST
58213	subsequently	O
58214	bumped	b-OCCURRENCE
58215	to	O
58216	greater	O
58217	than	O
58218	30	O
58219	and	O
58220	was	O
58221	discharged	b-OCCURRENCE
58222	with	O
58223	hematocrit	b-TEST
58224	of	O
58225	32	O
58226	on	O
58227	11-7-93	b-DATE
58228	.	O
58229	the	O
58230	patient	O
58231	remained	O
58232	asymptomatic	O
58233	from	O
58234	a	O
58235	chf	O
58236	stand	O
58237	point	O
58238	and	O
58239	felt	b-OCCURRENCE
58240	much	i-OCCURRENCE
58241	better	i-OCCURRENCE
58242	after	O
58243	the	b-TREATMENT
58244	transfusions	i-TREATMENT
58245	.	O
58246	it	O
58247	is	O
58248	unclear	O
58249	why	O
58250	the	O
58251	patient	O
58252	did	O
58253	not	O
58254	bump	O
58255	his	b-TEST
58256	hematocrit	i-TEST
58257	more	O
58258	but	O
58259	he	O
58260	did	O
58261	not	O
58262	appear	O
58263	to	O
58264	be	O
58265	hemolyzing	b-OCCURRENCE
58266	from	O
58267	laboratory	b-TEST
58268	data	i-TEST
58269	,	O
58270	that	O
58271	is	O
58272	his	b-TEST
58273	ldh	i-TEST
58274	was	O
58275	within	O
58276	normal	O
58277	limits	O
58278	.	O
58279	in	O
58280	addition	O
58281	,	O
58282	multiple	O
58283	stools	O
58284	were	O
58285	guaiaced	b-TEST
58286	and	O
58287	were	O
58288	all	O
58289	guaiac	b-PROBLEM
58290	negative	O
58291	.	O
58292	the	O
58293	patient	O
58294	was	O
58295	discharged	b-OCCURRENCE
58296	with	O
58297	follow-up	b-OCCURRENCE
58298	with	O
58299	his	O
58300	hematologist	O
58301	,	O
58302	doctor	O
58303	eci	O
58304	area	O
58305	and	O
58306	rheumatologist	O
58307	,	O
58308	doctor	O
58309	taange	O
58310	peter	O
58311	,	O
58312	and	O
58313	cardiologist	O
58314	,	O
58315	doctor	O
58316	peter	O
58317	.	O
58318		O
58319	admission	b-OCCURRENCE
58320	date	O
58321	:	O
58322	2016-02-14	b-ADMISSION
58323	discharge	b-OCCURRENCE
58324	date	O
58325	:	O
58326	date	O
58327	of	O
58328	birth	O
58329	:	O
58330	service	O
58331	:	O
58332	admission	O
58333	diagnosis	O
58334	:	O
58335	history	O
58336	of	O
58337	present	O
58338	illness	O
58339	:	O
58340	the	O
58341	patient	O
58342	is	O
58343	a	O
58344	63	O
58345	year	O
58346	old	O
58347	gentleman	O
58348	who	O
58349	had	O
58350	initially	O
58351	presented	b-EVIDENTIAL
58352	with	O
58353	exertional	b-PROBLEM
58354	chest	i-PROBLEM
58355	pressure	i-PROBLEM
58356	several	b-DURATION
58357	weeks	i-DURATION
58358	prior	O
58359	to	O
58360	this	b-OCCURRENCE
58361	admission	i-OCCURRENCE
58362	that	O
58363	would	O
58364	resolve	b-OCCURRENCE
58365	with	O
58366	rest	b-OCCURRENCE
58367	.	O
58368	stress	b-TEST
58369	echocardiogram	i-TEST
58370	demonstrated	b-EVIDENTIAL
58371	an	b-TEST
58372	ejection	i-TEST
58373	fraction	i-TEST
58374	of	O
58375	40%	O
58376	,	O
58377	hypokinesis	b-PROBLEM
58378	of	i-PROBLEM
58379	distal	i-PROBLEM
58380	anterior	i-PROBLEM
58381	wall	i-PROBLEM
58382	,	O
58383	akinesis	b-PROBLEM
58384	of	i-PROBLEM
58385	distal	i-PROBLEM
58386	inferior	i-PROBLEM
58387	wall	i-PROBLEM
58388	and	i-PROBLEM
58389	apex	i-PROBLEM
58390	.	O
58391	the	O
58392	patient	O
58393	had	O
58394	a	b-TEST
58395	cardiac	i-TEST
58396	catheterization	i-TEST
58397	which	O
58398	revealed	b-EVIDENTIAL
58399	three	b-PROBLEM
58400	vessel	i-PROBLEM
58401	disease	i-PROBLEM
58402	and	O
58403	the	O
58404	patient	O
58405	now	O
58406	presents	b-EVIDENTIAL
58407	for	O
58408	elective	b-TREATMENT
58409	coronary	i-TREATMENT
58410	artery	i-TREATMENT
58411	bypass	i-TREATMENT
58412	grafting	i-TREATMENT
58413	.	O
58414	hospital	O
58415	course	O
58416	:	O
58417	the	O
58418	patient	O
58419	was	O
58420	initially	O
58421	admitted	b-OCCURRENCE
58422	to	O
58423	the	b-CLINICAL_DEPT
58424	medical	i-CLINICAL_DEPT
58425	service	i-CLINICAL_DEPT
58426	for	O
58427	optimization	b-TREATMENT
58428	prior	O
58429	to	O
58430	his	b-TREATMENT
58431	coronary	i-TREATMENT
58432	artery	i-TREATMENT
58433	bypass	i-TREATMENT
58434	graft	i-TREATMENT
58435	.	O
58436	the	O
58437	patient	O
58438	was	O
58439	given	O
58440	stress	b-TREATMENT
58441	dose	i-TREATMENT
58442	steroids	i-TREATMENT
58443	on	O
58444	the	b-DATE
58445	day	i-DATE
58446	prior	O
58447	to	O
58448	his	b-TREATMENT
58449	surgery	i-TREATMENT
58450	.	O
58451	he	O
58452	was	O
58453	closely	O
58454	followed	b-OCCURRENCE
58455	from	O
58456	his	b-OCCURRENCE
58457	admission	i-OCCURRENCE
58458	through	O
58459	to	O
58460	his	b-OCCURRENCE
58461	discharge	i-OCCURRENCE
58462	by	O
58463	the	O
58464	renal	O
58465	service	O
58466	for	O
58467	his	b-PROBLEM
58468	transplant	i-PROBLEM
58469	issues	i-PROBLEM
58470	.	O
58471	on	O
58472	2016-02-15	b-DATE
58473	,	O
58474	the	O
58475	patient	O
58476	was	O
58477	taken	b-OCCURRENCE
58478	to	O
58479	the	b-CLINICAL_DEPT
58480	operating	i-CLINICAL_DEPT
58481	room	i-CLINICAL_DEPT
58482	and	O
58483	had	O
58484	an	b-TREATMENT
58485	off	i-TREATMENT
58486	pump	i-TREATMENT
58487	coronary	i-TREATMENT
58488	artery	i-TREATMENT
58489	bypass	i-TREATMENT
58490	graft	i-TREATMENT
58491	performed	O
58492	with	O
58493	the	b-TREATMENT
58494	left	i-TREATMENT
58495	internal	i-TREATMENT
58496	mammary	i-TREATMENT
58497	artery	i-TREATMENT
58498	to	i-TREATMENT
58499	the	i-TREATMENT
58500	left	i-TREATMENT
58501	anterior	i-TREATMENT
58502	descending	i-TREATMENT
58503	,	O
58504	saphenous	b-TREATMENT
58505	vein	i-TREATMENT
58506	graft	i-TREATMENT
58507	to	i-TREATMENT
58508	obtuse	i-TREATMENT
58509	marginal	i-TREATMENT
58510	and	O
58511	posterior	O
58512	descending	O
58513	artery	O
58514	.	O
58515	for	O
58516	details	O
58517	of	O
58518	this	b-TREATMENT
58519	operation	i-TREATMENT
58520	,	O
58521	please	O
58522	see	O
58523	the	O
58524	previously	O
58525	dictated	b-EVIDENTIAL
58526	operative	O
58527	note	O
58528	.	O
58529	postoperatively	O
58530	,	O
58531	the	O
58532	patient	O
58533	was	O
58534	transferred	b-OCCURRENCE
58535	to	O
58536	the	b-CLINICAL_DEPT
58537	csru	i-CLINICAL_DEPT
58538	for	O
58539	close	b-TEST
58540	monitoring	i-TEST
58541	.	O
58542	on	O
58543	the	b-DATE
58544	evening	i-DATE
58545	of	i-DATE
58546	postoperative	i-DATE
58547	day	i-DATE
58548	number	i-DATE
58549	zero	i-DATE
58550	,	O
58551	the	O
58552	patient	O
58553	had	O
58554	decreased	b-PROBLEM
58555	urine	i-PROBLEM
58556	output	i-PROBLEM
58557	and	O
58558	was	O
58559	placed	O
58560	on	O
58561	a	b-TREATMENT
58562	lasix	i-TREATMENT
58563	drip	i-TREATMENT
58564	for	O
58565	diuresis	b-TREATMENT
58566	.	O
58567	the	O
58568	patient	O
58569	tolerated	b-EVIDENTIAL
58570	this	O
58571	well	b-EVIDENTIAL
58572	.	O
58573	the	O
58574	renal	O
58575	service	O
58576	continued	O
58577	to	O
58578	follow	O
58579	close	b-TREATMENT
58580	management	i-TREATMENT
58581	of	O
58582	his	b-TREATMENT
58583	immunosuppression	i-TREATMENT
58584	.	O
58585	on	O
58586	postoperative	b-DATE
58587	day	i-DATE
58588	number	i-DATE
58589	one	i-DATE
58590	,	O
58591	the	O
58592	patient	O
58593	was	O
58594	extubated	b-TREATMENT
58595	and	O
58596	awakened	b-OCCURRENCE
58597	from	O
58598	sedation	b-TREATMENT
58599	.	O
58600	he	O
58601	did	b-OCCURRENCE
58602	well	i-OCCURRENCE
58603	on	O
58604	this	O
58605	and	O
58606	his	b-TREATMENT
58607	levophed	i-TREATMENT
58608	drip	i-TREATMENT
58609	was	O
58610	weaned	b-OCCURRENCE
58611	to	i-OCCURRENCE
58612	off	i-OCCURRENCE
58613	as	O
58614	tolerated	O
58615	.	O
58616	over	O
58617	the	b-OCCURRENCE
58618	course	i-OCCURRENCE
58619	of	i-OCCURRENCE
58620	his	i-OCCURRENCE
58621	intensive	i-OCCURRENCE
58622	care	i-OCCURRENCE
58623	unit	i-OCCURRENCE
58624	stay	i-OCCURRENCE
58625	,	O
58626	the	O
58627	patient	O
58628	received	O
58629	six	O
58630	units	O
58631	of	O
58632	packed	b-TREATMENT
58633	red	i-TREATMENT
58634	blood	i-TREATMENT
58635	cells	i-TREATMENT
58636	for	O
58637	a	b-PROBLEM
58638	low	i-PROBLEM
58639	hematocrit	i-PROBLEM
58640	.	O
58641	he	O
58642	otherwise	O
58643	had	O
58644	a	O
58645	fairly	O
58646	uncomplicated	b-OCCURRENCE
58647	postoperative	b-OCCURRENCE
58648	course	i-OCCURRENCE
58649	.	O
58650	on	O
58651	postoperative	b-DATE
58652	day	i-DATE
58653	number	i-DATE
58654	three	i-DATE
58655	,	O
58656	the	O
58657	patient	O
58658	was	O
58659	transferred	b-OCCURRENCE
58660	to	O
58661	the	b-CLINICAL_DEPT
58662	floor	i-CLINICAL_DEPT
58663	.	O
58664	on	O
58665	postoperative	b-DATE
58666	day	i-DATE
58667	number	i-DATE
58668	four	i-DATE
58669	,	O
58670	the	O
58671	patient	O
58672	was	O
58673	noted	O
58674	to	O
58675	have	O
58676	a	b-PROBLEM
58677	low	i-PROBLEM
58678	platelet	i-PROBLEM
58679	level	i-PROBLEM
58680	of	O
58681	43,000	O
58682	.	O
58683	heparin	b-TEST
58684	induced	i-TEST
58685	thrombocytopenia	i-TEST
58686	antibody	i-TEST
58687	panel	i-TEST
58688	was	O
58689	sent	O
58690	.	O
58691	other	O
58692	than	O
58693	this	O
58694	,	O
58695	the	O
58696	patient	O
58697	did	O
58698	very	O
58699	well	b-EVIDENTIAL
58700	.	O
58701	chest	b-TREATMENT
58702	tubes	i-TREATMENT
58703	were	O
58704	removed	b-OCCURRENCE
58705	when	O
58706	output	b-TEST
58707	was	O
58708	low	b-OCCURRENCE
58709	.	O
58710	pacing	b-TREATMENT
58711	wires	i-TREATMENT
58712	were	O
58713	removed	b-OCCURRENCE
58714	.	O
58715	physical	b-TREATMENT
58716	therapy	i-TREATMENT
58717	saw	O
58718	the	O
58719	patient	O
58720	and	O
58721	cleared	b-OCCURRENCE
58722	the	O
58723	patient	O
58724	for	O
58725	discharge	b-OCCURRENCE
58726	.	O
58727	ultimately	O
58728	,	O
58729	the	O
58730	patient	O
58731	was	O
58732	discharged	b-OCCURRENCE
58733	on	O
58734	postoperative	b-DATE
58735	day	i-DATE
58736	number	i-DATE
58737	six	i-DATE
58738	tolerating	b-OCCURRENCE
58739	a	i-OCCURRENCE
58740	regular	i-OCCURRENCE
58741	diet	i-OCCURRENCE
58742	,	O
58743	adequate	O
58744	pain	b-TREATMENT
58745	control	i-TREATMENT
58746	on	O
58747	p.o.	b-TREATMENT
58748	pain	i-TREATMENT
58749	medications	i-TREATMENT
58750	,	O
58751	and	O
58752	ambulating	b-OCCURRENCE
58753	well	O
58754	with	O
58755	clearance	b-OCCURRENCE
58756	of	i-OCCURRENCE
58757	physical	i-OCCURRENCE
58758	therapy	i-OCCURRENCE
58759	.	O
58760		O
58761	admission	b-OCCURRENCE
58762	date	O
58763	:	O
58764	06/10/1999	b-ADMISSION
58765	discharge	b-OCCURRENCE
58766	date	O
58767	:	O
58768	06/26/1999	b-DISCHARGE
58769	history	O
58770	of	O
58771	the	O
58772	present	O
58773	illness	O
58774	:	O
58775	mr.	O
58776	vinktlandfreierm	O
58777	was	O
58778	admitted	b-OCCURRENCE
58779	from	O
58780	owaleharbo	b-CLINICAL_DEPT
58781	tanaminer	i-CLINICAL_DEPT
58782	hospital	i-CLINICAL_DEPT
58783	to	O
58784	which	O
58785	he	O
58786	had	O
58787	been	O
58788	discharged	b-OCCURRENCE
58789	approximately	O
58790	four	b-DATE
58791	days	i-DATE
58792	prior	i-DATE
58793	to	O
58794	admission	b-OCCURRENCE
58795	.	O
58796	he	O
58797	was	O
58798	noted	b-EVIDENTIAL
58799	to	O
58800	have	O
58801	dark	b-PROBLEM
58802	stools	i-PROBLEM
58803	per	i-PROBLEM
58804	rectum	i-PROBLEM
58805	and	O
58806	to	O
58807	be	O
58808	somewhat	b-PROBLEM
58809	fluid	i-PROBLEM
58810	overloaded	i-PROBLEM
58811	.	O
58812	hospital	O
58813	course	O
58814	:	O
58815	he	O
58816	was	O
58817	admitted	b-OCCURRENCE
58818	and	O
58819	found	O
58820	to	O
58821	have	O
58822	a	b-PROBLEM
58823	significant	i-PROBLEM
58824	hematocrit	i-PROBLEM
58825	drop	i-PROBLEM
58826	from	O
58827	33.8	O
58828	to	O
58829	24.3	O
58830	.	O
58831	he	O
58832	was	O
58833	found	O
58834	operation	O
58835	be	O
58836	short	b-PROBLEM
58837	of	i-PROBLEM
58838	breath	i-PROBLEM
58839	and	O
58840	was	O
58841	taken	O
58842	to	O
58843	dialysis	b-TREATMENT
58844	for	O
58845	apparent	b-PROBLEM
58846	fluid	i-PROBLEM
58847	overload	i-PROBLEM
58848	.	O
58849	his	b-PROBLEM
58850	gastrointestinal	i-PROBLEM
58851	bleeding	i-PROBLEM
58852	issues	i-PROBLEM
58853	were	O
58854	investigated	O
58855	with	O
58856	an	b-TEST
58857	upper	i-TEST
58858	endoscopy	i-TEST
58859	which	O
58860	revealed	b-EVIDENTIAL
58861	multiple	O
58862	superficial	O
58863	gastric	b-PROBLEM
58864	ulcerations	i-PROBLEM
58865	consistent	O
58866	with	O
58867	an	b-PROBLEM
58868	non-steroidal	i-PROBLEM
58869	anti-inflammatory	i-PROBLEM
58870	drugs	i-PROBLEM
58871	gastropathy	i-PROBLEM
58872	.	O
58873	he	O
58874	had	O
58875	been	O
58876	discharged	b-OCCURRENCE
58877	on	O
58878	one	b-TREATMENT
58879	aspirin	i-TREATMENT
58880	a	b-FREQUENCY
58881	day	i-FREQUENCY
58882	with	O
58883	20	O
58884	of	O
58885	prilosec	b-TREATMENT
58886	b.i.d.	b-FREQUENCY
58887	the	b-TREATMENT
58888	aspirin	i-TREATMENT
58889	was	O
58890	discontinued	b-OCCURRENCE
58891	and	O
58892	he	O
58893	had	O
58894	no	O
58895	further	b-PROBLEM
58896	problems	i-PROBLEM
58897	with	O
58898	gastrointestinal	b-PROBLEM
58899	bleeding	i-PROBLEM
58900	and	O
58901	a	b-PROBLEM
58902	stable	i-PROBLEM
58903	hematocrit	i-PROBLEM
58904	the	O
58905	rest	O
58906	of	O
58907	his	b-OCCURRENCE
58908	hospitalization	i-OCCURRENCE
58909	.	O
58910	during	O
58911	the	O
58912	course	O
58913	of	O
58914	his	b-OCCURRENCE
58915	hospitalization	i-OCCURRENCE
58916	,	O
58917	he	O
58918	became	O
58919	increasingly	b-PROBLEM
58920	lethargic	i-PROBLEM
58921	.	O
58922	an	b-TEST
58923	extensive	i-TEST
58924	work-up	i-TEST
58925	was	O
58926	done	O
58927	for	O
58928	any	b-PROBLEM
58929	metabolic	i-PROBLEM
58930	abnormalities	i-PROBLEM
58931	which	O
58932	was	O
58933	unrevealing	O
58934	.	O
58935	he	O
58936	responded	b-EVIDENTIAL
58937	somewhat	O
58938	to	O
58939	lactulose	b-TREATMENT
58940	for	O
58941	hepatic	b-PROBLEM
58942	encephalopathy	i-PROBLEM
58943	.	O
58944	he	O
58945	had	O
58946	one	b-TEST
58947	positive	i-TEST
58948	blood	i-TEST
58949	culture	i-TEST
58950	for	O
58951	vancomycin	b-PROBLEM
58952	resistant	i-PROBLEM
58953	enterococcus	i-PROBLEM
58954	.	O
58955	in	O
58956	the	b-DATE
58957	few	i-DATE
58958	days	i-DATE
58959	prior	i-DATE
58960	to	O
58961	his	b-OCCURRENCE
58962	demise	i-OCCURRENCE
58963	,	O
58964	he	O
58965	was	O
58966	intermittently	O
58967	somewhat	b-PROBLEM
58968	lethargic	i-PROBLEM
58969	buton	O
58970	the	O
58971	morning	O
58972	of	O
58973	june	b-DATE
58974	25	i-DATE
58975	,	i-DATE
58976	1999	i-DATE
58977	,	O
58978	his	b-TEST
58979	white	i-TEST
58980	count	i-TEST
58981	was	O
58982	noted	b-EVIDENTIAL
58983	to	O
58984	have	O
58985	increased	b-OCCURRENCE
58986	from	O
58987	8	O
58988	to	O
58989	13,000	O
58990	.	O
58991	that	b-DATE
58992	day	i-DATE
58993	,	O
58994	he	O
58995	was	O
58996	found	O
58997	to	O
58998	be	O
58999	acutely	b-PROBLEM
59000	short	i-PROBLEM
59001	of	i-PROBLEM
59002	breath	i-PROBLEM
59003	with	O
59004	a	b-TEST
59005	respiratory	i-TEST
59006	rate	i-TEST
59007	of	O
59008	40	O
59009	and	O
59010	oxygen	b-TEST
59011	saturations	i-TEST
59012	in	O
59013	the	O
59014	mid	O
59015	seventies	O
59016	.	O
59017	he	O
59018	was	O
59019	put	O
59020	on	O
59021	100%	b-TREATMENT
59022	nonrebreather	i-TREATMENT
59023	and	O
59024	his	b-TEST
59025	oxygen	i-TEST
59026	saturations	i-TEST
59027	improved	O
59028	to	O
59029	the	O
59030	low	O
59031	nineties	O
59032	.	O
59033	nasal	b-TREATMENT
59034	trumpet	i-TREATMENT
59035	suction	i-TREATMENT
59036	was	O
59037	done	O
59038	and	O
59039	he	O
59040	was	O
59041	found	O
59042	to	O
59043	have	O
59044	food	O
59045	like	O
59046	material	O
59047	that	O
59048	was	O
59049	easily	O
59050	suctioned	O
59051	out	O
59052	.	O
59053	he	O
59054	was	O
59055	also	O
59056	found	O
59057	to	O
59058	havesome	O
59059	pieces	O
59060	of	O
59061	toast	O
59062	in	O
59063	his	O
59064	mouth	O
59065	.	O
59066	blood	b-TEST
59067	gases	i-TEST
59068	were	O
59069	done	O
59070	and	O
59071	he	O
59072	was	O
59073	found	O
59074	to	O
59075	have	O
59076	a	b-TEST
59077	ph	i-TEST
59078	of	O
59079	7.2	O
59080	with	O
59081	a	b-TEST
59082	pco2	i-TEST
59083	of	O
59084	21	O
59085	.	O
59086	fingerstick	b-TEST
59087	glucose	i-TEST
59088	revealed	O
59089	a	b-TEST
59090	sugar	i-TEST
59091	of	O
59092	12	O
59093	.	O
59094	a	b-TEST
59095	stat	i-TEST
59096	panel	i-TEST
59097	7	i-TEST
59098	confirmed	O
59099	that	O
59100	the	b-TEST
59101	sugar	i-TEST
59102	was	O
59103	23	O
59104	and	O
59105	that	O
59106	he	O
59107	had	O
59108	a	b-TEST
59109	new	i-TEST
59110	anion	i-TEST
59111	gap	i-TEST
59112	of	O
59113	40	O
59114	.	O
59115	repeat	b-TEST
59116	blood	i-TEST
59117	gas	i-TEST
59118	was	O
59119	done	O
59120	which	O
59121	was	O
59122	almost	O
59123	identical	O
59124	to	O
59125	the	O
59126	first	O
59127	.	O
59128	the	O
59129	family	O
59130	was	O
59131	called	O
59132	and	O
59133	came	O
59134	in	O
59135	to	O
59136	see	O
59137	the	O
59138	patient	O
59139	.	O
59140	an	O
59141	extensive	O
59142	family	b-OCCURRENCE
59143	meeting	i-OCCURRENCE
59144	was	O
59145	held	O
59146	and	O
59147	the	O
59148	family	O
59149	agreed	O
59150	that	O
59151	it	O
59152	did	O
59153	not	O
59154	make	O
59155	sense	O
59156	to	O
59157	intubate	b-TREATMENT
59158	the	O
59159	patient	O
59160	and	O
59161	send	b-OCCURRENCE
59162	him	O
59163	to	O
59164	the	b-CLINICAL_DEPT
59165	intensive	i-CLINICAL_DEPT
59166	care	i-CLINICAL_DEPT
59167	unit	i-CLINICAL_DEPT
59168	.	O
59169	in	O
59170	the	O
59171	acute	O
59172	setting	O
59173	,	O
59174	he	O
59175	had	O
59176	been	O
59177	started	O
59178	on	O
59179	levofloxacin	b-TREATMENT
59180	,	O
59181	flagyl	b-TREATMENT
59182	,	O
59183	and	O
59184	vancomycin	b-TREATMENT
59185	.	O
59186	these	b-TREATMENT
59187	antibiotics	i-TREATMENT
59188	were	O
59189	continued	O
59190	but	O
59191	the	O
59192	family	O
59193	decided	O
59194	that	O
59195	they	O
59196	wanted	O
59197	us	O
59198	to	O
59199	emphasize	O
59200	the	b-TREATMENT
59201	comfort	i-TREATMENT
59202	of	O
59203	the	O
59204	patient	O
59205	and	O
59206	pursue	O
59207	no	O
59208	further	b-TREATMENT
59209	invasive	i-TREATMENT
59210	measures	i-TREATMENT
59211	.	O
59212	the	O
59213	patient	O
59214	was	O
59215	made	O
59216	do	O
59217	not	O
59218	resuscitate	b-TREATMENT
59219	/	O
59220	do	O
59221	not	O
59222	intubate	b-TREATMENT
59223	.	O
59224	at	O
59225	2:30	b-TIME
59226	on	i-TIME
59227	june	i-TIME
59228	26	i-TIME
59229	,	i-TIME
59230	1999	i-TIME
59231	,	O
59232	i	O
59233	was	O
59234	called	O
59235	to	O
59236	see	O
59237	the	O
59238	patient	O
59239	who	O
59240	had	O
59241	expired	b-OCCURRENCE
59242	.	O
59243	disposition	O
59244	:	O
59245	the	O
59246	family	O
59247	was	O
59248	notified	O
59249	and	O
59250	came	O
59251	in	O
59252	to	O
59253	see	O
59254	the	O
59255	patient	O
59256	.	O
59257	the	O
59258	family	O
59259	declined	b-EVIDENTIAL
59260	an	b-TEST
59261	autopsy	i-TEST
59262	saying	O
59263	that	O
59264	they	O
59265	felt	O
59266	that	O
59267	the	O
59268	patient	O
59269	had	O
59270	been	O
59271	through	O
59272	enough	O
59273	.	O
59274	the	O
59275	patient	O
59276	&apos;s	O
59277	attending	O
59278	physician	O
59279	,	O
59280	doctor	O
59281	erm	O
59282	neidwierst	O
59283	,	O
59284	was	O
59285	notified	O
59286	as	O
59287	well	O
59288	.	O
59289	dictated	O
59290	by	O
59291	:	O
59292	conrellie	O
59293	koterudes	O
59294	,	O
59295	md	O
59296	uk0	O
59297	attending	O
59298	:	O
59299	erm	O
59300	k.	O
59301	neidwierst	O
59302	,	O
59303	md	O
59304	qq62	O
59305	oc499/5391	O
59306	batch	O
59307	:	O
59308	15168	O
59309	index	O
59310	no.	O
59311	vkrpjq81j6	O
59312	d	O
59313	:	O
59314	06/26/99	O
59315	t	O
59316	:	O
59317	06/29/99	O
59318		O
59319	admission	b-OCCURRENCE
59320	date	O
59321	:	O
59322	2018-05-26	b-ADMISSION
59323	discharge	b-OCCURRENCE
59324	date	O
59325	:	O
59326	2018-06-13	b-DISCHARGE
59327	service	O
59328	:	O
59329	medicine	O
59330	history	O
59331	of	O
59332	present	O
59333	illness	O
59334	:	O
59335	52	O
59336	y.o.	O
59337	male	O
59338	with	O
59339	esld	b-PROBLEM
59340	due	O
59341	to	O
59342	hcv	b-PROBLEM
59343	/	O
59344	etoh	b-PROBLEM
59345	cirrhosis	i-PROBLEM
59346	now	O
59347	with	O
59348	delta	b-PROBLEM
59349	ms	i-PROBLEM
59350	.	O
59351	recently	O
59352	d/c	b-OCCURRENCE
59353	'd	i-OCCURRENCE
59354	on	O
59355	05-15	b-DATE
59356	after	O
59357	admission	b-OCCURRENCE
59358	for	O
59359	hepatic	b-PROBLEM
59360	encephalopathy	i-PROBLEM
59361	versus	O
59362	opiate	b-PROBLEM
59363	abuse	i-PROBLEM
59364	.	O
59365	brought	O
59366	in	O
59367	by	O
59368	family	O
59369	for	O
59370	ams	b-PROBLEM
59371	.	O
59372	no	O
59373	hx	O
59374	available	O
59375	at	O
59376	youville	b-CLINICAL_DEPT
59377	hospital	i-CLINICAL_DEPT
59378	katherine	i-CLINICAL_DEPT
59379	,	O
59380	except	O
59381	for	O
59382	abdominal	b-PROBLEM
59383	pain	i-PROBLEM
59384	.	O
59385	increasing	b-PROBLEM
59386	tachypnea	i-PROBLEM
59387	and	O
59388	tachycardia	b-PROBLEM
59389	in	O
59390	leola	b-CLINICAL_DEPT
59391	,	O
59392	cxr	b-TEST
59393	with	O
59394	likely	O
59395	aspiration	b-PROBLEM
59396	pna	i-PROBLEM
59397	versus	O
59398	chf	b-PROBLEM
59399	,	O
59400	intubated	b-TREATMENT
59401	.	O
59402	started	O
59403	on	O
59404	levo	b-TREATMENT
59405	/	O
59406	flagyl	b-TREATMENT
59407	/	O
59408	ceftriaxone	b-TREATMENT
59409	and	O
59410	lasix	b-TREATMENT
59411	for	O
59412	sbp	b-PROBLEM
59413	and	O
59414	questionable	O
59415	meningitis	b-PROBLEM
59416	.	O
59417	brief	O
59418	hospital	O
59419	course	O
59420	:	O
59421	sbp	b-PROBLEM
59422	:	O
59423	pt	O
59424	admitted	b-OCCURRENCE
59425	with	O
59426	e	b-PROBLEM
59427	coli	i-PROBLEM
59428	spb	i-PROBLEM
59429	and	O
59430	bacteremia	b-PROBLEM
59431	.	O
59432	was	O
59433	treated	O
59434	with	O
59435	ceftriaxone	b-TREATMENT
59436	2	O
59437	gm	O
59438	iv	O
59439	daily	b-FREQUENCY
59440	with	O
59441	multiple	b-TREATMENT
59442	repeat	i-TREATMENT
59443	paracenteses	i-TREATMENT
59444	.	O
59445	repeat	b-TEST
59446	taps	i-TEST
59447	did	O
59448	not	O
59449	revealed	b-EVIDENTIAL
59450	evidence	O
59451	of	O
59452	infection	b-PROBLEM
59453	.	O
59454	patient	O
59455	was	O
59456	treated	O
59457	with	O
59458	14	b-DURATION
59459	days	i-DURATION
59460	of	O
59461	levoflox	b-TREATMENT
59462	.	O
59463	resp	b-PROBLEM
59464	failure	i-PROBLEM
59465	:	O
59466	unclear	O
59467	etiology	O
59468	,	O
59469	but	O
59470	likely	O
59471	aspiration	b-PROBLEM
59472	event	i-PROBLEM
59473	in	O
59474	monica	b-CLINICAL_DEPT
59475	.	O
59476	treated	b-TREATMENT
59477	aspiration	b-PROBLEM
59478	pneumonia	i-PROBLEM
59479	.	O
59480	weaning	b-OCCURRENCE
59481	and	O
59482	potential	b-TREATMENT
59483	extubation	i-TREATMENT
59484	complicated	O
59485	by	O
59486	mechanical	b-PROBLEM
59487	disadvantage	i-PROBLEM
59488	from	O
59489	large	b-PROBLEM
59490	ascites	i-PROBLEM
59491	as	O
59492	well	O
59493	as	O
59494	continued	b-PROBLEM
59495	somnolence	i-PROBLEM
59496	(	O
59497	off	O
59498	sedation	b-TREATMENT
59499	).	O
59500	we	O
59501	performed	O
59502	frequent	b-TREATMENT
59503	large	i-TREATMENT
59504	vol	i-TREATMENT
59505	taps	i-TREATMENT
59506	and	O
59507	attempted	O
59508	to	O
59509	give	O
59510	diuretics	b-TREATMENT
59511	,	O
59512	but	O
59513	were	O
59514	limited	O
59515	by	O
59516	renal	b-PROBLEM
59517	failure	i-PROBLEM
59518	.	O
59519	the	b-PROBLEM
59520	ascites	i-PROBLEM
59521	quickly	O
59522	accumulated	O
59523	after	O
59524	each	b-TREATMENT
59525	tap	i-TREATMENT
59526	.	O
59527	patient	O
59528	was	O
59529	not	O
59530	a	b-TREATMENT
59531	tips	i-TREATMENT
59532	candidate	i-TREATMENT
59533	.	O
59534	cirrhosis	b-PROBLEM
59535	:	O
59536	end-stage	b-PROBLEM
59537	cirrhosis	i-PROBLEM
59538	with	O
59539	refractory	b-PROBLEM
59540	ascites	i-PROBLEM
59541	.	O
59542	each	O
59543	time	O
59544	we	O
59545	have	O
59546	initiated	O
59547	diuretics	b-TREATMENT
59548	,	O
59549	creatinine	b-TEST
59550	rose	O
59551	.	O
59552	patient	O
59553	was	O
59554	continued	O
59555	on	O
59556	nadolol	b-TREATMENT
59557	(	O
59558	as	O
59559	bp	b-TEST
59560	tolerated	O
59561	)	O
59562	and	O
59563	lactulose	b-TREATMENT
59564	)	O
59565	renal	b-PROBLEM
59566	failure	i-PROBLEM
59567	:	O
59568	creatinine	b-PROBLEM
59569	elevation	i-PROBLEM
59570	appears	O
59571	to	O
59572	be	O
59573	related	O
59574	to	O
59575	both	O
59576	elevated	b-PROBLEM
59577	abdominal	i-PROBLEM
59578	pressures	i-PROBLEM
59579	from	O
59580	ascites	b-PROBLEM
59581	as	O
59582	well	O
59583	as	O
59584	to	O
59585	attempts	O
59586	at	O
59587	diuresis	b-TREATMENT
59588	.	O
59589	ams	b-PROBLEM
59590	:	O
59591	likely	O
59592	hepatic	b-PROBLEM
59593	encepholopathy	i-PROBLEM
59594	initially	O
59595	,	O
59596	and	O
59597	later	O
59598	likely	O
59599	related	O
59600	to	O
59601	sedation	b-TREATMENT
59602	and	O
59603	delayed	b-PROBLEM
59604	clearance	i-PROBLEM
59605	from	O
59606	liver	b-PROBLEM
59607	disease	i-PROBLEM
59608	.	O
59609	patient	O
59610	became	O
59611	increasingly	O
59612	hypotensive	b-PROBLEM
59613	with	O
59614	a	b-PROBLEM
59615	rising	i-PROBLEM
59616	cr	i-PROBLEM
59617	,	O
59618	eventually	O
59619	becoming	O
59620	pressor	b-PROBLEM
59621	dependent	i-PROBLEM
59622	.	O
59623	family	O
59624	meeting	O
59625	was	O
59626	held	O
59627	to	O
59628	discuss	O
59629	grave	O
59630	prognosis	O
59631	,	O
59632	and	O
59633	patient	O
59634	was	O
59635	made	O
59636	cmo	b-TREATMENT
59637	.	O
59638	he	O
59639	passed	b-OCCURRENCE
59640	away	i-OCCURRENCE
59641	shortly	O
59642	thereafter	O
59643	.	O
59644		O
59645	admission	b-OCCURRENCE
59646	date	O
59647	:	O
59648	2012-05-24	b-ADMISSION
59649	discharge	b-OCCURRENCE
59650	date	O
59651	:	O
59652	2012-06-19	b-DISCHARGE
59653	service	O
59654	:	O
59655	neurosurgery	O
59656	history	O
59657	of	O
59658	present	O
59659	illness	O
59660	:	O
59661	57	O
59662	yo	O
59663	right	O
59664	handed	O
59665	male	O
59666	with	O
59667	seizure	b-PROBLEM
59668	history	i-PROBLEM
59669	since	O
59670	1988	b-DATE
59671	,	O
59672	s/p	O
59673	craniotomies	b-TREATMENT
59674	x	b-FREQUENCY
59675	3	i-FREQUENCY
59676	(	O
59677	most	O
59678	recently	O
59679	05-05	b-DATE
59680	)	O
59681	for	O
59682	oligodendroglioma	b-PROBLEM
59683	.	O
59684	the	O
59685	patient	O
59686	began	O
59687	having	O
59688	generalized	b-PROBLEM
59689	tonic	i-PROBLEM
59690	-	i-PROBLEM
59691	clonic	i-PROBLEM
59692	seizures	i-PROBLEM
59693	in	O
59694	1988	b-DATE
59695	,	O
59696	which	O
59697	at	O
59698	the	b-DATE
59699	time	i-DATE
59700	were	O
59701	thought	O
59702	to	O
59703	be	O
59704	related	O
59705	to	O
59706	asthma	b-TREATMENT
59707	medications	i-TREATMENT
59708	.	O
59709	at	O
59710	this	b-DATE
59711	time	i-DATE
59712	,	O
59713	his	b-TEST
59714	head	i-TEST
59715	ct	i-TEST
59716	was	O
59717	negative	O
59718	,	O
59719	and	O
59720	he	O
59721	was	O
59722	treated	O
59723	with	O
59724	dilantin	b-TREATMENT
59725	and	O
59726	phenobarbital	b-TREATMENT
59727	.	O
59728	however	O
59729	,	O
59730	he	O
59731	continued	O
59732	to	O
59733	have	O
59734	left	b-PROBLEM
59735	arm	i-PROBLEM
59736	focal	i-PROBLEM
59737	motor	i-PROBLEM
59738	seizures	i-PROBLEM
59739	and	O
59740	problems	b-PROBLEM
59741	thinking	i-PROBLEM
59742	.	O
59743	in	O
59744	2001-08-31	b-DATE
59745	he	O
59746	stopped	O
59747	his	b-TREATMENT
59748	medication	i-TREATMENT
59749	and	O
59750	had	O
59751	a	b-PROBLEM
59752	generalized	i-PROBLEM
59753	tonic	i-PROBLEM
59754	-	i-PROBLEM
59755	clonic	i-PROBLEM
59756	seizure	i-PROBLEM
59757	in	O
59758	12/94	b-DATE
59759	.	O
59760	he	O
59761	was	O
59762	diagnosed	O
59763	by	O
59764	biopsy	b-TEST
59765	with	O
59766	oligodendroglioma	b-PROBLEM
59767	,	O
59768	and	O
59769	gross	b-TREATMENT
59770	total	i-TREATMENT
59771	resection	i-TREATMENT
59772	by	O
59773	doctor	O
59774	redner	O
59775	in	O
59776	95	b-DATE
59777	revealed	O
59778	a	b-PROBLEM
59779	low-grade	i-PROBLEM
59780	oligodendroglioma	i-PROBLEM
59781	.	O
59782	he	O
59783	was	O
59784	followed	O
59785	by	O
59786	doctor	O
59787	gregory	O
59788	dumas	O
59789	,	O
59790	with	O
59791	serial	b-TEST
59792	mri	i-TEST
59793	's.	i-TEST
59794	in	O
59795	2011-05-02	b-DATE
59796	,	O
59797	he	O
59798	was	O
59799	requiring	O
59800	more	b-TREATMENT
59801	ativan	i-TREATMENT
59802	to	O
59803	control	O
59804	his	b-PROBLEM
59805	seizures	i-PROBLEM
59806	,	O
59807	and	O
59808	was	O
59809	increasingly	b-PROBLEM
59810	disoriented	i-PROBLEM
59811	and	O
59812	forgetful	b-PROBLEM
59813	with	O
59814	headaches	b-PROBLEM
59815	.	O
59816	he	O
59817	had	O
59818	a	b-TREATMENT
59819	repeat	i-TREATMENT
59820	total	i-TREATMENT
59821	resection	i-TREATMENT
59822	in	O
59823	4/04	b-DATE
59824	by	O
59825	doctor	O
59826	peter	O
59827	hoadley	O
59828	at	O
59829	hallmark	b-CLINICAL_DEPT
59830	health	i-CLINICAL_DEPT
59831	system	i-CLINICAL_DEPT
59832	which	b-TREATMENT
59833	revealed	b-EVIDENTIAL
59834	anaplastic	b-PROBLEM
59835	oligodendroglioma	i-PROBLEM
59836	grade	i-PROBLEM
59837	iii	i-PROBLEM
59838	.	O
59839	he	O
59840	had	O
59841	radiation	b-TREATMENT
59842	following	O
59843	the	b-TREATMENT
59844	resection	i-TREATMENT
59845	and	O
59846	was	O
59847	doing	b-EVIDENTIAL
59848	well	i-EVIDENTIAL
59849	on	O
59850	monthly	b-FREQUENCY
59851	temodar	i-TREATMENT
59852	until	O
59853	2012-04-23	b-DATE
59854	when	O
59855	he	O
59856	had	O
59857	a	b-PROBLEM
59858	marked	i-PROBLEM
59859	change	i-PROBLEM
59860	in	i-PROBLEM
59861	behavior	i-PROBLEM
59862	,	O
59863	his	b-PROBLEM
59864	balance	i-PROBLEM
59865	was	i-PROBLEM
59866	off	i-PROBLEM
59867	,	O
59868	speech	b-PROBLEM
59869	slurred	i-PROBLEM
59870	,	O
59871	and	O
59872	he	O
59873	had	O
59874	difficulty	b-PROBLEM
59875	using	i-PROBLEM
59876	the	i-PROBLEM
59877	computer	i-PROBLEM
59878	.	O
59879	a	b-TEST
59880	head	i-TEST
59881	mri	i-TEST
59882	on	O
59883	2012-04-24	b-DATE
59884	revealed	b-EVIDENTIAL
59885	increasing	b-PROBLEM
59886	tumor	i-PROBLEM
59887	infiltration	i-PROBLEM
59888	with	O
59889	increased	b-PROBLEM
59890	edema	i-PROBLEM
59891	and	O
59892	mass	b-PROBLEM
59893	effect	i-PROBLEM
59894	.	O
59895	he	O
59896	underwent	O
59897	a	b-TREATMENT
59898	right	i-TREATMENT
59899	craniotomy	i-TREATMENT
59900	with	O
59901	resection	b-TREATMENT
59902	and	O
59903	gliadel	b-TREATMENT
59904	wafers	i-TREATMENT
59905	on	O
59906	2012-05-02	b-DATE
59907	at	O
59908	hallmark	b-CLINICAL_DEPT
59909	health	i-CLINICAL_DEPT
59910	system	i-CLINICAL_DEPT
59911	by	O
59912	doctor	O
59913	ackley	O
59914	.	O
59915	came	O
59916	for	O
59917	neurosurgery	b-CLINICAL_DEPT
59918	follow	b-TREATMENT
59919	up	i-TREATMENT
59920	on	O
59921	05-21	b-DATE
59922	,	O
59923	and	O
59924	had	O
59925	been	O
59926	having	O
59927	clear	b-PROBLEM
59928	fluid	i-PROBLEM
59929	leaking	i-PROBLEM
59930	from	O
59931	his	b-PROBLEM
59932	incision	i-PROBLEM
59933	,	O
59934	as	O
59935	well	O
59936	as	O
59937	frontal	b-PROBLEM
59938	headache	i-PROBLEM
59939	,	O
59940	imbalance	b-PROBLEM
59941	,	O
59942	bumping	b-PROBLEM
59943	into	i-PROBLEM
59944	things	i-PROBLEM
59945	with	i-PROBLEM
59946	his	i-PROBLEM
59947	left	i-PROBLEM
59948	leg	i-PROBLEM
59949	and	O
59950	worsening	b-PROBLEM
59951	tremors	i-PROBLEM
59952	.	O
59953	he	O
59954	was	O
59955	admitted	b-OCCURRENCE
59956	for	O
59957	lumbar	b-TREATMENT
59958	drain	i-TREATMENT
59959	placement	i-TREATMENT
59960	brief	O
59961	hospital	O
59962	course	O
59963	:	O
59964	patient	O
59965	was	O
59966	admitted	b-OCCURRENCE
59967	on	O
59968	2012-05-24	b-DATE
59969	after	O
59970	having	O
59971	drainage	b-PROBLEM
59972	from	O
59973	his	b-PROBLEM
59974	incision	i-PROBLEM
59975	for	O
59976	the	b-DURATION
59977	last	i-DURATION
59978	couple	i-DURATION
59979	of	i-DURATION
59980	days	i-DURATION
59981	.	O
59982	he	O
59983	was	O
59984	seen	O
59985	in	O
59986	the	b-CLINICAL_DEPT
59987	brain	i-CLINICAL_DEPT
59988	tumor	i-CLINICAL_DEPT
59989	clinic	i-CLINICAL_DEPT
59990	on	O
59991	05-21	b-DATE
59992	and	O
59993	stitches	b-TREATMENT
59994	were	O
59995	placed	O
59996	in	O
59997	the	b-PROBLEM
59998	incision	i-PROBLEM
59999	,	O
60000	however	O
60001	it	b-PROBLEM
60002	continued	O
60003	to	O
60004	leak	b-PROBLEM
60005	.	O
60006	he	O
60007	had	O
60008	a	b-TREATMENT
60009	lumbar	i-TREATMENT
60010	drain	i-TREATMENT
60011	placed	O
60012	.	O
60013	he	O
60014	c/o	b-EVIDENTIAL
60015	of	O
60016	abd	b-PROBLEM
60017	pain	i-PROBLEM
60018	and	O
60019	distension	b-PROBLEM
60020	on	O
60021	05-25	b-DATE
60022	he	O
60023	had	O
60024	a	b-TEST
60025	kub	i-TEST
60026	done	O
60027	which	b-TEST
60028	was	O
60029	negative	O
60030	.	O
60031	on	O
60032	05-26	b-DATE
60033	he	O
60034	continued	O
60035	to	O
60036	c/o	b-EVIDENTIAL
60037	of	O
60038	epigastric	b-PROBLEM
60039	pain	i-PROBLEM
60040	had	O
60041	a	b-TEST
60042	chest	i-TEST
60043	x-ray	i-TEST
60044	done	O
60045	to	O
60046	due	O
60047	to	O
60048	decreased	b-PROBLEM
60049	lung	i-PROBLEM
60050	sounds	i-PROBLEM
60051	.	O
60052	the	b-TEST
60053	chest	i-TEST
60054	x-ray	i-TEST
60055	showed	b-EVIDENTIAL
60056	free	b-PROBLEM
60057	air	i-PROBLEM
60058	.	O
60059	general	b-CLINICAL_DEPT
60060	surgery	i-CLINICAL_DEPT
60061	was	O
60062	consulted	b-OCCURRENCE
60063	and	O
60064	the	O
60065	patient	O
60066	was	O
60067	taken	O
60068	to	O
60069	the	b-CLINICAL_DEPT
60070	or	i-CLINICAL_DEPT
60071	for	O
60072	exploratory	b-TEST
60073	laproratomy	i-TEST
60074	.	O
60075	he	O
60076	was	O
60077	found	b-EVIDENTIAL
60078	to	O
60079	have	O
60080	a	b-PROBLEM
60081	perforated	i-PROBLEM
60082	sigmoid	i-PROBLEM
60083	diverticulum	i-PROBLEM
60084	.	O
60085	he	O
60086	had	O
60087	a	b-TREATMENT
60088	colostomy	i-TREATMENT
60089	and	O
60090	partial	b-TREATMENT
60091	colectomy	i-TREATMENT
60092	.	O
60093	patient	O
60094	recovered	b-EVIDENTIAL
60095	well	i-EVIDENTIAL
60096	from	O
60097	colocetomy	b-TREATMENT
60098	.	O
60099	he	O
60100	was	O
60101	found	b-EVIDENTIAL
60102	to	O
60103	have	O
60104	an	b-PROBLEM
60105	abd	i-PROBLEM
60106	abcess	i-PROBLEM
60107	which	b-PROBLEM
60108	was	O
60109	drained	b-TREATMENT
60110	via	O
60111	ct	b-TEST
60112	guidance	i-TEST
60113	on	O
60114	06-01	b-DATE
60115	.	O
60116	on	O
60117	06-02	b-DATE
60118	his	b-TREATMENT
60119	lumbar	i-TREATMENT
60120	drain	i-TREATMENT
60121	pulled	b-TREATMENT
60122	out	i-TREATMENT
60123	.	O
60124	he	O
60125	had	O
60126	to	O
60127	have	O
60128	it	b-TREATMENT
60129	replaced	b-TREATMENT
60130	,	O
60131	however	O
60132	,	O
60133	because	O
60134	his	b-PROBLEM
60135	head	i-PROBLEM
60136	incision	i-PROBLEM
60137	began	O
60138	to	O
60139	leak	b-PROBLEM
60140	again	O
60141	.	O
60142	on	O
60143	06-03	b-DATE
60144	he	O
60145	was	O
60146	taken	O
60147	back	O
60148	to	O
60149	the	b-CLINICAL_DEPT
60150	or	i-CLINICAL_DEPT
60151	for	O
60152	debridement	b-TREATMENT
60153	of	O
60154	his	b-PROBLEM
60155	head	i-PROBLEM
60156	wound	i-PROBLEM
60157	with	O
60158	removal	b-TREATMENT
60159	of	O
60160	the	b-PROBLEM
60161	remaining	i-PROBLEM
60162	gliadel	i-PROBLEM
60163	waffers	i-PROBLEM
60164	.	O
60165	he	O
60166	tolerated	b-EVIDENTIAL
60167	the	b-TREATMENT
60168	procedure	i-TREATMENT
60169	well	O
60170	,	O
60171	postop	O
60172	however	O
60173	he	O
60174	had	O
60175	a	b-PROBLEM
60176	grand	i-PROBLEM
60177	mal	i-PROBLEM
60178	seizure	i-PROBLEM
60179	and	O
60180	was	O
60181	intubated	b-TREATMENT
60182	and	O
60183	sent	O
60184	to	O
60185	the	b-CLINICAL_DEPT
60186	icu	i-CLINICAL_DEPT
60187	.	O
60188	id	b-CLINICAL_DEPT
60189	was	O
60190	consulted	O
60191	for	O
60192	both	O
60193	the	b-PROBLEM
60194	abd	i-PROBLEM
60195	abcess	i-PROBLEM
60196	and	O
60197	possible	O
60198	meningitis	b-PROBLEM
60199	given	O
60200	the	b-PROBLEM
60201	large	i-PROBLEM
60202	amount	i-PROBLEM
60203	of	i-PROBLEM
60204	wbc	i-PROBLEM
60205	in	O
60206	the	b-TEST
60207	csf	i-TEST
60208	cultures	i-TEST
60209	.	O
60210	patient	O
60211	was	O
60212	placed	O
60213	on	O
60214	vancomycin	b-TREATMENT
60215	1	O
60216	gm	O
60217	iv	O
60218	q12	b-FREQUENCY
60219	and	O
60220	zosyn	b-TREATMENT
60221	.	O
60222	he	O
60223	was	O
60224	kept	O
60225	on	O
60226	antibiotics	b-TREATMENT
60227	until	O
60228	06-17	b-DATE
60229	.	O
60230	neurologically	O
60231	he	b-OCCURRENCE
60232	slowly	i-OCCURRENCE
60233	woke	i-OCCURRENCE
60234	up	i-OCCURRENCE
60235	after	O
60236	the	b-PROBLEM
60237	seizures	i-PROBLEM
60238	and	O
60239	was	O
60240	extubated	b-OCCURRENCE
60241	on	O
60242	06-03	b-DATE
60243	.	O
60244	he	O
60245	was	O
60246	transfered	b-OCCURRENCE
60247	to	O
60248	the	b-CLINICAL_DEPT
60249	step	i-CLINICAL_DEPT
60250	down	i-CLINICAL_DEPT
60251	unit	i-CLINICAL_DEPT
60252	and	O
60253	had	O
60254	his	b-TREATMENT
60255	lumbar	i-TREATMENT
60256	drain	i-TREATMENT
60257	slowly	O
60258	weaned	b-OCCURRENCE
60259	.	O
60260	the	b-TREATMENT
60261	lumbar	i-TREATMENT
60262	drain	i-TREATMENT
60263	was	O
60264	d/ced	b-OCCURRENCE
60265	on	O
60266	06-14	b-DATE
60267	.	O
60268	he	O
60269	had	O
60270	a	b-TEST
60271	head	i-TEST
60272	ct	i-TEST
60273	which	b-TEST
60274	remains	O
60275	stable	b-EVIDENTIAL
60276	and	O
60277	head	b-PROBLEM
60278	wound	i-PROBLEM
60279	remain	O
60280	dry	b-OCCURRENCE
60281	.	O
60282	neurologically	O
60283	he	O
60284	is	O
60285	awake	b-OCCURRENCE
60286	and	i-OCCURRENCE
60287	alert	i-OCCURRENCE
60288	and	i-OCCURRENCE
60289	oriented	i-OCCURRENCE
60290	x	i-OCCURRENCE
60291	3	i-OCCURRENCE
60292	he	O
60293	is	O
60294	07-05	O
60295	in	O
60296	all	O
60297	muscle	O
60298	group	O
60299	bilat	O
60300	.	O
60301	he	O
60302	follows	b-OCCURRENCE
60303	commands	i-OCCURRENCE
60304	,	O
60305	he	O
60306	is	O
60307	out	O
60308	of	O
60309	bed	O
60310	ambulating	b-OCCURRENCE
60311	with	O
60312	max	O
60313	assist	O
60314	.	O
60315	pt	b-CLINICAL_DEPT
60316	and	O
60317	ot	b-CLINICAL_DEPT
60318	are	O
60319	recommending	O
60320	rehab	b-TREATMENT
60321	.	O
60322	he	O
60323	will	O
60324	follow	b-TREATMENT
60325	up	i-TREATMENT
60326	with	O
60327	dr	O
60328	fisher	O
60329	the	b-CLINICAL_DEPT
60330	general	i-CLINICAL_DEPT
60331	surgeon	i-CLINICAL_DEPT
60332	in	O
60333	two	b-DATE
60334	weeks	i-DATE
60335	and	O
60336	follow	b-TREATMENT
60337	up	i-TREATMENT
60338	in	O
60339	the	b-CLINICAL_DEPT
60340	brain	i-CLINICAL_DEPT
60341	tumor	i-CLINICAL_DEPT
60342	clinic	i-CLINICAL_DEPT
60343	in	O
60344	two	b-DATE
60345	weeks	i-DATE
60346	for	O
60347	stitch	b-TREATMENT
60348	removal	i-TREATMENT
60349	.	O
60350	h	O
60351	ewas	O
60352	switched	O
60353	to	O
60354	oral	b-TREATMENT
60355	cipro	i-TREATMENT
60356	for	O
60357	the	b-PROBLEM
60358	pelvic	i-PROBLEM
60359	abcess	i-PROBLEM
60360	and	O
60361	will	O
60362	continue	O
60363	it	b-TREATMENT
60364	until	O
60365	he	O
60366	has	O
60367	his	b-OCCURRENCE
60368	followup	i-OCCURRENCE
60369	with	O
60370	infectious	b-CLINICAL_DEPT
60371	disease	i-CLINICAL_DEPT
60372	in	O
60373	2	b-DATE
60374	weeks	i-DATE
60375	.	O
60376		O
60377	admission	b-OCCURRENCE
60378	date	O
60379	:	O
60380	06/03/1993	b-ADMISSION
60381	discharge	b-OCCURRENCE
60382	date	O
60383	:	O
60384	06/06/1993	b-DISCHARGE
60385	history	O
60386	of	O
60387	present	O
60388	illness	O
60389	:	O
60390	this	O
60391	is	O
60392	a	O
60393	70	O
60394	year	O
60395	old	O
60396	gravida	O
60397	iv	O
60398	,	O
60399	para	O
60400	4	O
60401	who	O
60402	presented	b-OCCURRENCE
60403	for	O
60404	a	b-TREATMENT
60405	vaginal	i-TREATMENT
60406	hysterectomy	i-TREATMENT
60407	secondary	O
60408	to	O
60409	uterine	b-PROBLEM
60410	prolapse	i-PROBLEM
60411	and	O
60412	also	O
60413	presented	b-OCCURRENCE
60414	for	O
60415	evaluation	b-TEST
60416	of	O
60417	a	b-PROBLEM
60418	suspicious	i-PROBLEM
60419	lesion	i-PROBLEM
60420	seen	O
60421	on	O
60422	a	b-TEST
60423	mammogram	i-TEST
60424	.	O
60425	patient	b-PROBLEM
60426	&apos;s	i-PROBLEM
60427	problem	i-PROBLEM
60428	started	O
60429	four	b-DURATION
60430	years	i-DURATION
60431	ago	O
60432	when	O
60433	she	O
60434	first	O
60435	experienced	O
60436	a	b-PROBLEM
60437	pushing	i-PROBLEM
60438	forward	i-PROBLEM
60439	of	i-PROBLEM
60440	her	i-PROBLEM
60441	uterus	i-PROBLEM
60442	.	O
60443	the	O
60444	patient	O
60445	described	b-EVIDENTIAL
60446	this	O
60447	sensation	O
60448	as	O
60449	uncomfortable	b-PROBLEM
60450	and	O
60451	becoming	b-OCCURRENCE
60452	more	i-OCCURRENCE
60453	prominent	i-OCCURRENCE
60454	over	O
60455	the	O
60456	following	O
60457	three	b-DURATION
60458	years	i-DURATION
60459	with	O
60460	increasing	b-PROBLEM
60461	pressure	i-PROBLEM
60462	and	O
60463	pain	b-PROBLEM
60464	.	O
60465	two	b-DATE
60466	months	i-DATE
60467	ago	O
60468	,	O
60469	the	O
60470	patient	O
60471	slipped	O
60472	and	O
60473	fell	b-OCCURRENCE
60474	with	O
60475	valsalva	b-OCCURRENCE
60476	that	O
60477	precipitated	O
60478	an	b-OCCURRENCE
60479	exacerbation	i-OCCURRENCE
60480	of	O
60481	her	O
60482	prolapse	O
60483	.	O
60484	she	O
60485	subsequently	O
60486	could	O
60487	not	O
60488	urinate	b-OCCURRENCE
60489	and	O
60490	was	O
60491	in	O
60492	pain	b-PROBLEM
60493	secondary	O
60494	to	O
60495	her	b-PROBLEM
60496	problem	i-PROBLEM
60497	.	O
60498	at	O
60499	this	b-DATE
60500	time	i-DATE
60501	,	O
60502	she	O
60503	decided	O
60504	that	O
60505	she	O
60506	needed	O
60507	the	b-PROBLEM
60508	prolapse	i-PROBLEM
60509	fixed	b-TREATMENT
60510	and	O
60511	actually	O
60512	wrote	O
60513	to	O
60514	the	b-CLINICAL_DEPT
60515	norri	i-CLINICAL_DEPT
60516	hospital	i-CLINICAL_DEPT
60517	to	O
60518	try	O
60519	and	O
60520	find	O
60521	a	O
60522	gynecologist	O
60523	.	O
60524	her	O
60525	letter	O
60526	was	O
60527	referred	O
60528	to	O
60529	doctor	O
60530	earllamarg	O
60531	para	O
60532	who	O
60533	saw	O
60534	her	O
60535	in	O
60536	the	b-CLINICAL_DEPT
60537	office	i-CLINICAL_DEPT
60538	and	O
60539	recommended	O
60540	vaginal	b-TREATMENT
60541	hysterectomy	i-TREATMENT
60542	.	O
60543	patient	O
60544	has	O
60545	never	O
60546	had	O
60547	a	b-TREATMENT
60548	pessary	i-TREATMENT
60549	and	O
60550	refused	O
60551	one	O
60552	and	O
60553	denies	b-EVIDENTIAL
60554	nausea	b-PROBLEM
60555	,	O
60556	fever	b-PROBLEM
60557	,	O
60558	chills	b-PROBLEM
60559	,	O
60560	dysuria	b-PROBLEM
60561	,	O
60562	or	O
60563	stress	b-PROBLEM
60564	incontinence	i-PROBLEM
60565	on	O
60566	her	b-OCCURRENCE
60567	current	i-OCCURRENCE
60568	admission	i-OCCURRENCE
60569	.	O
60570	hospital	O
60571	course	O
60572	:	O
60573	cardiology	O
60574	was	O
60575	consulted	O
60576	to	O
60577	evaluate	b-TEST
60578	this	O
60579	and	O
60580	felt	O
60581	that	O
60582	the	b-PROBLEM
60583	changes	i-PROBLEM
60584	seen	O
60585	on	O
60586	the	b-TEST
60587	ekg	i-TEST
60588	were	O
60589	not	O
60590	significant	O
60591	.	O
60592	the	O
60593	patient	O
60594	was	O
60595	also	O
60596	seen	O
60597	by	O
60598	doctor	O
60599	nusc	O
60600	from	O
60601	general	O
60602	surgery	O
60603	for	O
60604	evaluation	b-TEST
60605	of	O
60606	micro	b-PROBLEM
60607	calcifications	i-PROBLEM
60608	in	i-PROBLEM
60609	the	i-PROBLEM
60610	right	i-PROBLEM
60611	breast	i-PROBLEM
60612	.	O
60613	the	O
60614	patient	O
60615	refused	O
60616	a	b-TEST
60617	biopsy	i-TEST
60618	for	O
60619	this	b-OCCURRENCE
60620	admission	i-OCCURRENCE
60621	and	O
60622	desires	O
60623	follow-up	b-TEST
60624	mammograms	i-TEST
60625	.	O
60626	she	O
60627	is	O
60628	to	O
60629	be	O
60630	followed	b-OCCURRENCE
60631	up	i-OCCURRENCE
60632	by	O
60633	general	O
60634	surgery	O
60635	.	O
60636	the	O
60637	patient	O
60638	underwent	O
60639	a	b-TREATMENT
60640	total	i-TREATMENT
60641	vaginal	i-TREATMENT
60642	hysterectomy	i-TREATMENT
60643	on	O
60644	june	b-DATE
60645	4	i-DATE
60646	,	i-DATE
60647	1993	i-DATE
60648	which	O
60649	she	O
60650	tolerated	b-OCCURRENCE
60651	without	O
60652	complications	b-PROBLEM
60653	.	O
60654	her	b-OCCURRENCE
60655	post-operative	i-OCCURRENCE
60656	course	i-OCCURRENCE
60657	has	O
60658	been	O
60659	uncomplicated	b-OCCURRENCE
60660	.	O
60661	she	O
60662	remained	O
60663	afebrile	b-PROBLEM
60664	throughout	O
60665	her	b-OCCURRENCE
60666	admission	i-OCCURRENCE
60667	tolerating	O
60668	a	b-OCCURRENCE
60669	regular	i-OCCURRENCE
60670	diet	i-OCCURRENCE
60671	by	O
60672	post-operative	b-DATE
60673	day	i-DATE
60674	two	i-DATE
60675	and	O
60676	was	O
60677	discharged	b-OCCURRENCE
60678	on	O
60679	june	b-DATE
60680	6	i-DATE
60681	,	i-DATE
60682	1993	i-DATE
60683	with	O
60684	percocet	b-TREATMENT
60685	for	O
60686	pain	b-PROBLEM
60687	.	O
60688	the	b-TREATMENT
60689	foley	i-TREATMENT
60690	was	O
60691	discontinued	O
60692	and	O
60693	the	O
60694	patient	O
60695	was	O
60696	urinating	b-OCCURRENCE
60697	on	O
60698	her	O
60699	own	O
60700	.	O
60701		O
60702	admission	b-OCCURRENCE
60703	date	O
60704	:	O
60705	report	O
60706	status	O
60707	:	O
60708	discharge	b-OCCURRENCE
60709	date	O
60710	:	O
60711	01/23/2003	b-DISCHARGE
60712	history	O
60713	of	O
60714	present	O
60715	illness	O
60716	:	O
60717	the	O
60718	patient	O
60719	is	O
60720	a	O
60721	50-year-old	O
60722	female	O
60723	with	O
60724	history	O
60725	of	O
60726	low	b-PROBLEM
60727	back	i-PROBLEM
60728	pain	i-PROBLEM
60729	radiating	i-PROBLEM
60730	to	i-PROBLEM
60731	both	i-PROBLEM
60732	legs	i-PROBLEM
60733	.	O
60734	she	O
60735	had	O
60736	increasing	b-PROBLEM
60737	symptoms	i-PROBLEM
60738	overtime	O
60739	,	O
60740	not	O
60741	controlled	O
60742	by	O
60743	conservative	b-TREATMENT
60744	management	i-TREATMENT
60745	.	O
60746	she	O
60747	therefore	O
60748	elected	b-OCCURRENCE
60749	to	O
60750	undergo	O
60751	surgical	b-TREATMENT
60752	treatment	i-TREATMENT
60753	.	O
60754	hospital	O
60755	course	O
60756	:	O
60757	she	O
60758	was	O
60759	taken	O
60760	to	O
60761	the	b-CLINICAL_DEPT
60762	operating	i-CLINICAL_DEPT
60763	room	i-CLINICAL_DEPT
60764	on	O
60765	01/16/2003	b-DATE
60766	for	O
60767	decompression	b-TREATMENT
60768	at	i-TREATMENT
60769	l2	i-TREATMENT
60770	,	i-TREATMENT
60771	l5	i-TREATMENT
60772	and	O
60773	laminectomy	b-TREATMENT
60774	with	O
60775	posterior	b-TREATMENT
60776	instrumented	i-TREATMENT
60777	fusion	i-TREATMENT
60778	at	i-TREATMENT
60779	l3	i-TREATMENT
60780	to	i-TREATMENT
60781	l5	i-TREATMENT
60782	.	O
60783	she	O
60784	tolerated	O
60785	the	b-TREATMENT
60786	surgery	i-TREATMENT
60787	well	O
60788	.	O
60789	she	O
60790	was	O
60791	transferred	b-OCCURRENCE
60792	to	O
60793	recovery	b-CLINICAL_DEPT
60794	room	i-CLINICAL_DEPT
60795	in	O
60796	stable	b-OCCURRENCE
60797	condition	i-OCCURRENCE
60798	.	O
60799	she	O
60800	received	O
60801	blood	b-TREATMENT
60802	transfusions	i-TREATMENT
60803	intraoperatively	O
60804	and	O
60805	postoperatively	O
60806	in	O
60807	addition	O
60808	to	O
60809	autologous	b-TREATMENT
60810	blood	i-TREATMENT
60811	.	O
60812	her	b-TEST
60813	hematocrit	i-TEST
60814	was	O
60815	stable	b-OCCURRENCE
60816	postoperatively	O
60817	.	O
60818	her	b-TEST
60819	neurologic	i-TEST
60820	exam	i-TEST
60821	was	O
60822	stable	b-OCCURRENCE
60823	postoperatively	O
60824	with	O
60825	5/5	O
60826	bilaterally	O
60827	,	O
60828	tibial	b-TEST
60829	,	O
60830	ehl	b-TEST
60831	,	O
60832	fhl	b-EVIDENTIAL
60833	,	O
60834	gastroc	b-TEST
60835	soleus	i-TEST
60836	,	O
60837	and	O
60838	intact	b-TEST
60839	quadriceps	i-TEST
60840	.	O
60841	she	O
60842	has	O
60843	intact	O
60844	sensation	b-TEST
60845	l3	i-TEST
60846	to	i-TEST
60847	s1	i-TEST
60848	and	i-TEST
60849	bilateral	i-TEST
60850	lower	i-TEST
60851	extremities	i-TEST
60852	.	O
60853	she	O
60854	was	O
60855	fitted	b-TEST
60856	for	O
60857	verholl	b-TREATMENT
60858	aet	i-TREATMENT
60859	over	i-TREATMENT
60860	leg	i-TREATMENT
60861	brace	i-TREATMENT
60862	and	O
60863	mobilized	b-TREATMENT
60864	out	O
60865	of	O
60866	the	O
60867	bed	O
60868	in	O
60869	the	b-TREATMENT
60870	brace	i-TREATMENT
60871	with	O
60872	physical	b-TREATMENT
60873	therapy	i-TREATMENT
60874	.	O
60875	her	b-PROBLEM
60876	wounds	i-PROBLEM
60877	were	O
60878	stable	b-OCCURRENCE
60879	without	O
60880	any	O
60881	erythema	b-PROBLEM
60882	or	O
60883	drainage	b-PROBLEM
60884	.	O
60885	she	O
60886	reported	b-EVIDENTIAL
60887	nausea	b-PROBLEM
60888	on	O
60889	pain	b-TREATMENT
60890	medications	i-TREATMENT
60891	.	O
60892	her	b-TREATMENT
60893	pain	i-TREATMENT
60894	medications	i-TREATMENT
60895	were	O
60896	changed	b-OCCURRENCE
60897	around	O
60898	until	O
60899	an	b-TREATMENT
60900	acceptable	i-TREATMENT
60901	regime	i-TREATMENT
60902	was	O
60903	accomplished	O
60904	.	O
60905	she	O
60906	is	O
60907	stable	b-OCCURRENCE
60908	for	O
60909	discharge	b-OCCURRENCE
60910	to	O
60911	rehab	O
60912	.	O
60913		O
60914	admission	b-OCCURRENCE
60915	date	O
60916	:	O
60917	2019-02-28	b-ADMISSION
60918	discharge	b-OCCURRENCE
60919	date	O
60920	:	O
60921	2019-03-26	b-DISCHARGE
60922	service	O
60923	:	O
60924	cardiothoracic	O
60925	history	O
60926	of	O
60927	present	O
60928	illness	O
60929	:	O
60930	mr.	O
60931	pizano	O
60932	is	O
60933	a	O
60934	75	O
60935	y/o	O
60936	man	O
60937	who	O
60938	has	O
60939	a	O
60940	pmhx	O
60941	significant	O
60942	for	O
60943	enterococcus	b-PROBLEM
60944	mitral	i-PROBLEM
60945	valve	i-PROBLEM
60946	endocarditis	i-PROBLEM
60947	which	O
60948	has	O
60949	been	O
60950	treated	b-TREATMENT
60951	since	O
60952	09-19	b-DATE
60953	.	O
60954	he	O
60955	has	O
60956	had	O
60957	2	b-FREQUENCY
60958	6	i-FREQUENCY
60959	week	i-FREQUENCY
60960	courses	O
60961	of	O
60962	antibiotics	b-TREATMENT
60963	with	O
60964	recurrent	b-PROBLEM
60965	bacteremia	i-PROBLEM
60966	.	O
60967	he	O
60968	had	O
60969	a	b-TEST
60970	tee	i-TEST
60971	on	O
60972	2019-01-22	b-DATE
60973	which	O
60974	revealed	b-EVIDENTIAL
60975	thickened	b-PROBLEM
60976	mitral	i-PROBLEM
60977	leaflets	i-PROBLEM
60978	with	O
60979	small	b-PROBLEM
60980	vegetations	i-PROBLEM
60981	on	i-PROBLEM
60982	both	i-PROBLEM
60983	anterior	i-PROBLEM
60984	and	i-PROBLEM
60985	posterior	i-PROBLEM
60986	leaflets	i-PROBLEM
60987	with	O
60988	moderate	b-PROBLEM
60989	to	i-PROBLEM
60990	severe	i-PROBLEM
60991	mitral	i-PROBLEM
60992	regurgitation	i-PROBLEM
60993	.	O
60994	he	O
60995	has	O
60996	preserved	b-OCCURRENCE
60997	lv	i-OCCURRENCE
60998	systolic	i-OCCURRENCE
60999	function	i-OCCURRENCE
61000	with	O
61001	mild	b-PROBLEM
61002	tr	i-PROBLEM
61003	and	O
61004	ar	b-PROBLEM
61005	and	O
61006	lae	b-PROBLEM
61007	without	O
61008	abscess	b-PROBLEM
61009	.	O
61010	he	O
61011	had	O
61012	a	b-TEST
61013	repeat	i-TEST
61014	tee	i-TEST
61015	on	O
61016	02-19	b-DATE
61017	which	O
61018	revealed	b-EVIDENTIAL
61019	4	b-PROBLEM
61020	+	i-PROBLEM
61021	mr	i-PROBLEM
61022	.	O
61023	thomasine	O
61024	was	O
61025	tranferred	b-OCCURRENCE
61026	from	O
61027	mwmc	b-CLINICAL_DEPT
61028	(	O
61029	where	O
61030	he	O
61031	was	O
61032	admitted	b-OCCURRENCE
61033	on	O
61034	02-15	b-DATE
61035	with	O
61036	fevers	b-PROBLEM
61037	and	O
61038	positive	b-PROBLEM
61039	blood	i-PROBLEM
61040	cultures	i-PROBLEM
61041	)	O
61042	to	O
61043	idmc	b-CLINICAL_DEPT
61044	for	O
61045	further	b-TREATMENT
61046	treatment	i-TREATMENT
61047	and	O
61048	possibly	O
61049	mvr	b-TREATMENT
61050	.	O
61051	brief	O
61052	hospital	O
61053	course	O
61054	:	O
61055	as	O
61056	mentioned	O
61057	in	O
61058	the	O
61059	hpi	O
61060	,	O
61061	mr.	O
61062	mcculley	O
61063	was	O
61064	transferred	b-OCCURRENCE
61065	from	O
61066	mwmc	b-CLINICAL_DEPT
61067	to	O
61068	nantucket	b-CLINICAL_DEPT
61069	cottage	i-CLINICAL_DEPT
61070	hospital	i-CLINICAL_DEPT
61071	for	O
61072	ongoing	O
61073	care	O
61074	(	O
61075	?	O
61076	mvr	b-TREATMENT
61077	).	O
61078	and	O
61079	infectious	b-OCCURRENCE
61080	disease	i-OCCURRENCE
61081	consult	i-OCCURRENCE
61082	was	O
61083	immediately	O
61084	made	O
61085	.	O
61086	iv	b-TREATMENT
61087	daptomycin	i-TREATMENT
61088	was	O
61089	continued	O
61090	via	O
61091	picc	b-TREATMENT
61092	line	i-TREATMENT
61093	which	O
61094	was	O
61095	inserted	O
61096	on	O
61097	02-20	b-DATE
61098	at	O
61099	mwmc	b-CLINICAL_DEPT
61100	.	O
61101	mr	O
61102	stutts	O
61103	had	O
61104	an	b-TEST
61105	extensive	i-TEST
61106	preop	i-TEST
61107	evaluation	i-TEST
61108	including	O
61109	cardiology	b-CLINICAL_DEPT
61110	,	O
61111	infectious	b-CLINICAL_DEPT
61112	diseases	i-CLINICAL_DEPT
61113	,	O
61114	orthopedics	b-CLINICAL_DEPT
61115	,	O
61116	psychiatry	b-CLINICAL_DEPT
61117	and	O
61118	ethics	b-CLINICAL_DEPT
61119	services	i-CLINICAL_DEPT
61120	.	O
61121	he	O
61122	ultimately	O
61123	was	O
61124	brought	O
61125	to	O
61126	the	b-CLINICAL_DEPT
61127	operating	i-CLINICAL_DEPT
61128	room	i-CLINICAL_DEPT
61129	on	O
61130	03-19	b-DATE
61131	.	O
61132	at	O
61133	that	b-DATE
61134	time	i-DATE
61135	he	O
61136	had	O
61137	a	b-TREATMENT
61138	mitral	i-TREATMENT
61139	valve	i-TREATMENT
61140	replacement	i-TREATMENT
61141	,	O
61142	aortoomy	b-TREATMENT
61143	,	O
61144	and	O
61145	left	b-TREATMENT
61146	atrial	i-TREATMENT
61147	appendage	i-TREATMENT
61148	resection	i-TREATMENT
61149	.	O
61150	his	b-TREATMENT
61151	bypass	i-TREATMENT
61152	time	O
61153	was	O
61154	103	b-DURATION
61155	minutes	i-DURATION
61156	/	O
61157	crossclamp	b-TREATMENT
61158	89	b-DURATION
61159	mins	i-DURATION
61160	.	O
61161	please	O
61162	see	O
61163	or	b-EVIDENTIAL
61164	report	i-EVIDENTIAL
61165	for	O
61166	full	O
61167	details	O
61168	.	O
61169	he	O
61170	tolerated	O
61171	the	b-TREATMENT
61172	surgery	i-TREATMENT
61173	well	O
61174	and	O
61175	was	O
61176	transferred	b-OCCURRENCE
61177	from	O
61178	the	b-CLINICAL_DEPT
61179	or	i-CLINICAL_DEPT
61180	to	O
61181	the	b-CLINICAL_DEPT
61182	csru	i-CLINICAL_DEPT
61183	on	O
61184	epinephrinne	b-TREATMENT
61185	and	O
61186	propofol	b-TREATMENT
61187	infusions	i-TREATMENT
61188	.	O
61189	he	O
61190	did	O
61191	well	O
61192	in	O
61193	immediate	O
61194	postoperative	O
61195	period	O
61196	.	O
61197	following	O
61198	surgery	b-TREATMENT
61199	his	b-TREATMENT
61200	anesthesia	i-TREATMENT
61201	was	O
61202	reversed	b-TREATMENT
61203	,	O
61204	he	O
61205	was	O
61206	weaned	b-OCCURRENCE
61207	from	O
61208	ventilator	b-TREATMENT
61209	and	O
61210	successfully	O
61211	extubated	b-TREATMENT
61212	.	O
61213	his	b-TREATMENT
61214	iv	i-TREATMENT
61215	medications	i-TREATMENT
61216	were	O
61217	also	O
61218	weaned	b-TREATMENT
61219	to	i-TREATMENT
61220	off	i-TREATMENT
61221	.	O
61222	on	O
61223	pod1	b-DATE
61224	his	b-TREATMENT
61225	pa	i-TREATMENT
61226	line	i-TREATMENT
61227	and	O
61228	chest	b-TREATMENT
61229	tubes	i-TREATMENT
61230	were	O
61231	removed	O
61232	,	O
61233	he	O
61234	was	O
61235	also	O
61236	started	O
61237	on	O
61238	beta	b-TREATMENT
61239	blockers	i-TREATMENT
61240	and	O
61241	diuretics	b-TREATMENT
61242	.	O
61243	on	O
61244	pod2	b-DATE
61245	the	O
61246	patient	O
61247	remained	O
61248	hemodynamically	b-OCCURRENCE
61249	stable	i-OCCURRENCE
61250	and	O
61251	was	O
61252	transferred	b-OCCURRENCE
61253	from	O
61254	the	b-CLINICAL_DEPT
61255	icu	i-CLINICAL_DEPT
61256	to	O
61257	f2	b-CLINICAL_DEPT
61258	for	O
61259	continued	O
61260	postop	b-TREATMENT
61261	care	i-TREATMENT
61262	.	O
61263	over	O
61264	the	O
61265	next	O
61266	several	b-DURATION
61267	days	i-DURATION
61268	with	O
61269	the	O
61270	assisstance	O
61271	of	O
61272	the	O
61273	nursing	O
61274	staff	O
61275	and	O
61276	physical	O
61277	therapy	O
61278	the	O
61279	patients	O
61280	activity	b-TREATMENT
61281	level	i-TREATMENT
61282	was	i-TREATMENT
61283	advanced	i-TREATMENT
61284	,	O
61285	he	O
61286	was	O
61287	transitioned	b-OCCURRENCE
61288	to	O
61289	all	b-TREATMENT
61290	oral	i-TREATMENT
61291	medications	i-TREATMENT
61292	with	O
61293	the	O
61294	exception	O
61295	of	O
61296	his	b-TREATMENT
61297	antibiotics	i-TREATMENT
61298	.	O
61299	on	O
61300	pod7	b-DATE
61301	it	O
61302	was	O
61303	decided	O
61304	that	O
61305	the	O
61306	pt	O
61307	was	O
61308	stable	O
61309	and	O
61310	ready	O
61311	for	O
61312	discharge	b-OCCURRENCE
61313	to	O
61314	rehabilitation	O
61315	.	O
61316	it	O
61317	should	O
61318	be	O
61319	noted	O
61320	that	O
61321	the	O
61322	patient	O
61323	did	O
61324	have	O
61325	episodes	O
61326	of	O
61327	postoperative	b-PROBLEM
61328	atrial	i-PROBLEM
61329	fibrillation	i-PROBLEM
61330	,	O
61331	he	O
61332	was	O
61333	seen	O
61334	by	O
61335	the	O
61336	electrophysiology	b-CLINICAL_DEPT
61337	service	i-CLINICAL_DEPT
61338	,	O
61339	started	O
61340	on	O
61341	procainamide	b-TREATMENT
61342	and	O
61343	coumadin	b-TREATMENT
61344	.	O
61345		O
61346	admission	b-OCCURRENCE
61347	date	O
61348	:	O
61349	2016-03-22	b-ADMISSION
61350	discharge	b-OCCURRENCE
61351	date	O
61352	:	O
61353	2016-04-04	b-DISCHARGE
61354	service	O
61355	:	O
61356	medicine	O
61357	history	O
61358	of	O
61359	present	O
61360	illness	O
61361	:	O
61362	75	O
61363	yo	O
61364	f	O
61365	with	O
61366	cad	b-PROBLEM
61367	s/p	O
61368	mi	b-PROBLEM
61369	x4	b-FREQUENCY
61370	(	O
61371	s/p	O
61372	lad	b-TREATMENT
61373	stent.	i-TREATMENT
61374	'09	b-DATE
61375	and	O
61376	rca	b-TREATMENT
61377	stent	i-TREATMENT
61378	x	b-FREQUENCY
61379	2	i-FREQUENCY
61380	in.	O
61381	'00	b-DATE
61382	and.	O
61383	'04	b-DATE
61384	)	O
61385	,	O
61386	chf	b-PROBLEM
61387	with	O
61388	ef	b-TEST
61389	55%	O
61390	,	O
61391	paf	b-PROBLEM
61392	,	O
61393	inducible	b-PROBLEM
61394	vtach	i-PROBLEM
61395	s/p	O
61396	aicd	b-TREATMENT
61397	placement	i-TREATMENT
61398	,	O
61399	sick	b-PROBLEM
61400	sinus	i-PROBLEM
61401	syndrome	i-PROBLEM
61402	s/p	O
61403	pacer	b-TREATMENT
61404	and	O
61405	copd	b-PROBLEM
61406	with	O
61407	restrictive	b-PROBLEM
61408	lung	i-PROBLEM
61409	disease	i-PROBLEM
61410	.	O
61411	per	O
61412	daughter	O
61413	,	O
61414	pt	O
61415	was	O
61416	in	O
61417	her	b-OCCURRENCE
61418	usoh	i-OCCURRENCE
61419	until	O
61420	two	b-DATE
61421	days	i-DATE
61422	prior	O
61423	to	O
61424	admission	b-OCCURRENCE
61425	when	O
61426	she	O
61427	was	O
61428	noted	O
61429	to	O
61430	have	O
61431	a	b-PROBLEM
61432	superficial	i-PROBLEM
61433	ulcerations	i-PROBLEM
61434	on	i-PROBLEM
61435	her	i-PROBLEM
61436	foot	i-PROBLEM
61437	with	O
61438	erythema	b-PROBLEM
61439	.	O
61440	pt	O
61441	was	O
61442	taken	O
61443	to	O
61444	bridgewater	b-CLINICAL_DEPT
61445	chelsea	i-CLINICAL_DEPT
61446	soldier	i-CLINICAL_DEPT
61447	's	i-CLINICAL_DEPT
61448	home	i-CLINICAL_DEPT
61449	hospital	i-CLINICAL_DEPT
61450	and	O
61451	started	O
61452	on	O
61453	unasyn	b-TREATMENT
61454	iv	i-TREATMENT
61455	.	O
61456	pt	O
61457	awoke	O
61458	later	O
61459	that	b-DATE
61460	night	i-DATE
61461	and	O
61462	felt	O
61463	unsteady	b-PROBLEM
61464	on	i-PROBLEM
61465	her	i-PROBLEM
61466	feet	i-PROBLEM
61467	and	O
61468	sustained	O
61469	a	O
61470	mechanical	O
61471	fall	b-OCCURRENCE
61472	.	O
61473	per	O
61474	daughter	O
61475	,	O
61476	pt	O
61477	did	O
61478	not	O
61479	note	O
61480	chest	b-PROBLEM
61481	pain	i-PROBLEM
61482	,	O
61483	tachycardia	b-PROBLEM
61484	,	O
61485	had	O
61486	a	b-OCCURRENCE
61487	good	i-OCCURRENCE
61488	po	i-OCCURRENCE
61489	intake	i-OCCURRENCE
61490	and	O
61491	no	O
61492	noted	b-PROBLEM
61493	seizure	i-PROBLEM
61494	activity	i-PROBLEM
61495	.	O
61496	pt	O
61497	was	O
61498	in	O
61499	severe	O
61500	""""	O
61501	back	b-PROBLEM
61502	pain	i-PROBLEM
61503	""""	O
61504	as	O
61505	per	O
61506	daughter	O
61507	which	O
61508	was	O
61509	treated	O
61510	with	O
61511	dilaudid	b-TREATMENT
61512	.	O
61513	ct	b-TEST
61514	of	i-TEST
61515	the	i-TEST
61516	neck	i-TEST
61517	revealed	b-EVIDENTIAL
61518	a	O
61519	possible	O
61520	c1	b-PROBLEM
61521	fracture	i-PROBLEM
61522	and	O
61523	the	b-TEST
61524	x-ray	i-TEST
61525	at	O
61526	the	b-CLINICAL_DEPT
61527	osh	i-CLINICAL_DEPT
61528	revealed	b-EVIDENTIAL
61529	intratrochanteric	b-PROBLEM
61530	fracture	i-PROBLEM
61531	of	O
61532	the	O
61533	right	O
61534	femur	O
61535	.	O
61536	pt	O
61537	was	O
61538	subsequently	O
61539	transferred	b-OCCURRENCE
61540	to	O
61541	hallmark	b-CLINICAL_DEPT
61542	health	i-CLINICAL_DEPT
61543	system	i-CLINICAL_DEPT
61544	for	O
61545	orthopaedic	b-TEST
61546	evaluation	i-TEST
61547	.	O
61548	in	O
61549	monica	b-CLINICAL_DEPT
61550	at	i-CLINICAL_DEPT
61551	hallmark	i-CLINICAL_DEPT
61552	health	i-CLINICAL_DEPT
61553	system	i-CLINICAL_DEPT
61554	,	O
61555	pt	O
61556	was	O
61557	seen	O
61558	by	O
61559	the	O
61560	trauma	O
61561	service	O
61562	where	O
61563	a	b-TEST
61564	ct	i-TEST
61565	of	O
61566	the	O
61567	neck	O
61568	revealed	b-EVIDENTIAL
61569	no	O
61570	fracture	b-PROBLEM
61571	(	O
61572	however	O
61573	,	O
61574	the	b-TREATMENT
61575	c-collar	i-TREATMENT
61576	was	O
61577	maintained	O
61578	secondary	O
61579	to	O
61580	pain	b-PROBLEM
61581	)	O
61582	.	O
61583	the	O
61584	orthopaedic	O
61585	service	O
61586	recommended	O
61587	emergent	b-TREATMENT
61588	repair	b-TREATMENT
61589	of	i-TREATMENT
61590	the	b-PROBLEM
61591	intratrochanteric	i-PROBLEM
61592	fracture	i-PROBLEM
61593	secondary	O
61594	to	O
61595	instability	b-PROBLEM
61596	.	O
61597	the	b-OCCURRENCE
61598	monica	i-OCCURRENCE
61599	stay	i-OCCURRENCE
61600	was	O
61601	complicated	O
61602	by	O
61603	runs	O
61604	of	O
61605	afib	b-PROBLEM
61606	to	O
61607	133	O
61608	requiring	O
61609	iv	b-TREATMENT
61610	lopressor	i-TREATMENT
61611	.	O
61612	ros	O
61613	:	O
61614	pt	O
61615	is	O
61616	very	O
61617	sob	b-PROBLEM
61618	at	O
61619	baseline	O
61620	,	O
61621	not	O
61622	on	O
61623	home	b-TREATMENT
61624	ox	i-TREATMENT
61625	,	O
61626	no	O
61627	cp	b-PROBLEM
61628	at	O
61629	rest	b-OCCURRENCE
61630	,	O
61631	no	O
61632	le	b-PROBLEM
61633	edema	i-PROBLEM
61634	,	O
61635	no	O
61636	pnd	b-PROBLEM
61637	,	O
61638	stable	O
61639	orthopnea	b-PROBLEM
61640	(	O
61641	2	b-TREATMENT
61642	pillows	i-TREATMENT
61643	)	O
61644	.	O
61645	pt	O
61646	ambulates	b-OCCURRENCE
61647	10	i-OCCURRENCE
61648	feet	i-OCCURRENCE
61649	with	O
61650	significant	O
61651	fatigue	b-PROBLEM
61652	as	O
61653	per	O
61654	daughter	O
61655	.	O
61656	(	O
61657	?	O
61658	dec	b-PROBLEM
61659	in	i-PROBLEM
61660	exercise	i-PROBLEM
61661	tolerance	i-PROBLEM
61662	)	O
61663	.	O
61664	cmed	b-CLINICAL_DEPT
61665	ccu	i-CLINICAL_DEPT
61666	change	O
61667	include	O
61668	discontinuation	O
61669	of	O
61670	coumadin	b-TREATMENT
61671	secondary	O
61672	to	O
61673	inc	O
61674	risk	O
61675	of	O
61676	upper	b-PROBLEM
61677	gi	i-PROBLEM
61678	bleed	i-PROBLEM
61679	.	O
61680	digoxin	b-TREATMENT
61681	,	O
61682	norvasc	b-TREATMENT
61683	and	O
61684	imdur	b-TREATMENT
61685	was	O
61686	also	O
61687	discontinued	O
61688	.	O
61689	hpi	O
61690	:	O
61691	75	O
61692	yo	O
61693	f	O
61694	with	O
61695	cad	b-PROBLEM
61696	s/p	O
61697	stenting	b-TREATMENT
61698	,	O
61699	vt	b-PROBLEM
61700	,	O
61701	sss	b-PROBLEM
61702	s/p	O
61703	pacer	b-TREATMENT
61704	,	O
61705	copd	b-PROBLEM
61706	,	O
61707	presented	b-EVIDENTIAL
61708	to	O
61709	osh	b-CLINICAL_DEPT
61710	2016-03-21	b-DATE
61711	with	O
61712	foot	b-PROBLEM
61713	ulceration	i-PROBLEM
61714	.	O
61715	started	O
61716	on	O
61717	unasyn	b-TREATMENT
61718	,	O
61719	in	O
61720	hospital	b-CLINICAL_DEPT
61721	suffered	O
61722	mech.	b-PROBLEM
61723	fall	i-PROBLEM
61724	with	O
61725	hip	b-PROBLEM
61726	fx	i-PROBLEM
61727	.	O
61728	transferred	b-OCCURRENCE
61729	to	O
61730	hallmark	b-CLINICAL_DEPT
61731	health	i-CLINICAL_DEPT
61732	system	i-CLINICAL_DEPT
61733	03-22	b-DATE
61734	.	O
61735	medically	b-TEST
61736	eval	i-TEST
61737	not	O
61738	high	b-PROBLEM
61739	risk	i-PROBLEM
61740	surgery	i-PROBLEM
61741	,	O
61742	preop	O
61743	beta	b-TREATMENT
61744	blocker	i-TREATMENT
61745	given	O
61746	.	O
61747	orif	b-TREATMENT
61748	with	O
61749	repair	b-TREATMENT
61750	of	O
61751	neck	b-PROBLEM
61752	fracture	i-PROBLEM
61753	2016-03-23	b-DATE
61754	.	O
61755	expected	O
61756	prolonged	b-PROBLEM
61757	extubation	i-PROBLEM
61758	course	i-PROBLEM
61759	given	O
61760	copd	b-PROBLEM
61761	history	O
61762	,	O
61763	as	O
61764	with	O
61765	colon	b-PROBLEM
61766	ca	i-PROBLEM
61767	resection	b-TREATMENT
61768	surgery	i-TREATMENT
61769	.	O
61770	in	O
61771	pm	b-DATE
61772	extubated	b-TREATMENT
61773	,	O
61774	transferred	b-OCCURRENCE
61775	to	O
61776	floor	b-CLINICAL_DEPT
61777	2016-03-23	b-DATE
61778	.	O
61779	late	O
61780	03-23	b-DATE
61781	found	O
61782	with	O
61783	afib	b-PROBLEM
61784	and	O
61785	rvr	b-PROBLEM
61786	,	O
61787	given	O
61788	beta	b-TREATMENT
61789	blocker	i-TREATMENT
61790	with	O
61791	min.	O
61792	response	b-OCCURRENCE
61793	,	O
61794	started	O
61795	dilt.	b-TREATMENT
61796	drip	i-TREATMENT
61797	.	O
61798	received	O
61799	2	O
61800	mg	O
61801	dilaudid	b-TREATMENT
61802	for	O
61803	pain	b-PROBLEM
61804	o/n	b-DURATION
61805	.	O
61806	this	b-DATE
61807	am	i-DATE
61808	with	O
61809	respiratory	b-PROBLEM
61810	failure	i-PROBLEM
61811	,	O
61812	continued	O
61813	tachycardia	b-PROBLEM
61814	on	O
61815	dilt.	b-TREATMENT
61816	gtt	i-TREATMENT
61817	.	O
61818	transferred	b-OCCURRENCE
61819	to	O
61820	unit	b-CLINICAL_DEPT
61821	and	O
61822	urgently	O
61823	intubated	b-TREATMENT
61824	(	O
61825	labs	b-TEST
61826	below.	O
61827	)	O
61828	of	O
61829	note	O
61830	,	O
61831	a	b-TREATMENT
61832	ngt	i-TREATMENT
61833	by	O
61834	xray	b-TEST
61835	was	O
61836	not	b-PROBLEM
61837	in	i-PROBLEM
61838	correct	i-PROBLEM
61839	position	i-PROBLEM
61840	?	O
61841	lungs	O
61842	->	O
61843	possibly	O
61844	used	O
61845	for	O
61846	medication	b-TREATMENT
61847	administration	i-TREATMENT
61848	this	b-DATE
61849	am	i-DATE
61850	.	O
61851	brief	O
61852	hospital	O
61853	course	O
61854	:	O
61855	a/p	O
61856	:	O
61857	75	O
61858	y	O
61859	f	O
61860	s/p	O
61861	mi	b-PROBLEM
61862	x4	b-FREQUENCY
61863	,	O
61864	numerous	O
61865	cath	b-TREATMENT
61866	,	O
61867	paf	b-PROBLEM
61868	,	O
61869	inducible	b-PROBLEM
61870	vtach	i-PROBLEM
61871	s/p	O
61872	aicd	b-TREATMENT
61873	and	O
61874	pacer	b-TREATMENT
61875	with	O
61876	severe	O
61877	copd	b-PROBLEM
61878	/	O
61879	restrictive	b-PROBLEM
61880	lung	i-PROBLEM
61881	disease	i-PROBLEM
61882	s/p	O
61883	fall	b-PROBLEM
61884	with	O
61885	intertrochanteric	b-PROBLEM
61886	fracture	i-PROBLEM
61887	.	O
61888	as	O
61889	per	O
61890	cmed	b-CLINICAL_DEPT
61891	ccu	i-CLINICAL_DEPT
61892	,	O
61893	pt	O
61894	requires	O
61895	emergent	b-TREATMENT
61896	repair	i-TREATMENT
61897	of	O
61898	intertrochanteric	b-PROBLEM
61899	fracture	i-PROBLEM
61900	to	O
61901	preserve	b-TREATMENT
61902	neurovascular	i-TREATMENT
61903	function	i-TREATMENT
61904	.	O
61905	pt	O
61906	is	O
61907	a	b-PROBLEM
61908	moderate	i-PROBLEM
61909	risk	i-PROBLEM
61910	for	O
61911	a	O
61912	needed	O
61913	emergent	b-TREATMENT
61914	non-cardiac	i-TREATMENT
61915	procedure	i-TREATMENT
61916	.	O
61917	pt	O
61918	is	O
61919	medically	O
61920	cleared	O
61921	for	O
61922	procedure.	b-TREATMENT
61923	,	O
61924	likely	O
61925	has	O
61926	some	O
61927	mile	O
61928	rate	b-PROBLEM
61929	related	i-PROBLEM
61930	ischemia	i-PROBLEM
61931	.	O
61932	1.	O
61933	cards	O
61934	:	O
61935	---	O
61936	pre-op	O
61937	b-blocker	b-TREATMENT
61938	with	O
61939	goal	O
61940	hr	O
61941	<	O
61942	70	O
61943	---	O
61944	no	O
61945	real	O
61946	utility	O
61947	in	O
61948	mibi	b-TEST
61949	/	i-TEST
61950	cath	i-TEST
61951	prior	O
61952	to	O
61953	procedure	b-TREATMENT
61954	gien	O
61955	previous	O
61956	caths	b-TREATMENT
61957	with	O
61958	no	O
61959	significant	O
61960	lesions	b-PROBLEM
61961	to	O
61962	be	O
61963	intervened	b-TREATMENT
61964	on	O
61965	.	O
61966	---	O
61967	v-tach	b-PROBLEM
61968	:	O
61969	pt	O
61970	has	O
61971	aicd	b-TREATMENT
61972	in	O
61973	place	O
61974	,	O
61975	however	O
61976	b-blocker	b-TREATMENT
61977	should	O
61978	contorl	O
61979	vtach	b-PROBLEM
61980	for	O
61981	now	O
61982	.	O
61983	---	O
61984	b-blocker	b-TREATMENT
61985	iv	i-TREATMENT
61986	,	O
61987	dilt	b-TREATMENT
61988	prn	O
61989	for	O
61990	paf	b-PROBLEM
61991	---	O
61992	hold	O
61993	coumadin	b-TREATMENT
61994	for	O
61995	afib	b-PROBLEM
61996	given	O
61997	hx	O
61998	of	O
61999	upper	b-PROBLEM
62000	gib	i-PROBLEM
62001	and	O
62002	surgery	b-TREATMENT
62003	in	i-TREATMENT
62004	am	b-DATE
62005	---	O
62006	continue	O
62007	asa	b-TREATMENT
62008	,	O
62009	plavix	b-TREATMENT
62010	---	O
62011	romi	b-TEST
62012	,	O
62013	check	O
62014	am	b-DATE
62015	ecg	b-TEST
62016	2.	O
62017	copd	b-PROBLEM
62018	/	O
62019	restrictive	b-PROBLEM
62020	lung	i-PROBLEM
62021	disease	i-PROBLEM
62022	:	O
62023	---	O
62024	nebs	b-TREATMENT
62025	/	i-TREATMENT
62026	mdi	b-TREATMENT
62027	prn	O
62028	---	O
62029	no	O
62030	need	O
62031	for	O
62032	steroids	b-TREATMENT
62033	now	O
62034	---	O
62035	expect	O
62036	prolonged	b-PROBLEM
62037	wean	i-PROBLEM
62038	given	O
62039	previous	O
62040	history	O
62041	of	O
62042	prolonged	b-PROBLEM
62043	wean	i-PROBLEM
62044	s/p	O
62045	colonic	b-TREATMENT
62046	resection	i-TREATMENT
62047	---	O
62048	incentive	b-TREATMENT
62049	spirometry	i-TREATMENT
62050	for	O
62051	atelectasis	b-PROBLEM
62052	3.	O
62053	hip	b-PROBLEM
62054	fracture	i-PROBLEM
62055	:	O
62056	---	O
62057	pain	b-TREATMENT
62058	control	i-TREATMENT
62059	with	O
62060	diluadid	b-TREATMENT
62061	,	O
62062	tylenol	b-TREATMENT
62063	---	O
62064	lovenox	b-TREATMENT
62065	tonight	b-DATE
62066	x1	b-FREQUENCY
62067	,	O
62068	hold	O
62069	am	b-DATE
62070	dose	b-TREATMENT
62071	per	O
62072	cmed	b-CLINICAL_DEPT
62073	ccu	i-CLINICAL_DEPT
62074	---	O
62075	pt	O
62076	to	O
62077	or	b-CLINICAL_DEPT
62078	in	O
62079	early	b-DATE
62080	am	i-DATE
62081	4.	O
62082	anemia	b-PROBLEM
62083	:	O
62084	---	O
62085	iron	b-TEST
62086	studies	i-TEST
62087	---	O
62088	tsh	b-TEST
62089	---no	O
62090	need	O
62091	for	O
62092	transfusion	b-TREATMENT
62093	currently	O
62094	,	O
62095	keep	O
62096	hct	O
62097	>	O
62098	30	O
62099	5.	O
62100	hypokalemia	b-PROBLEM
62101	:	O
62102	---	O
62103	60iv	O
62104	k	b-TREATMENT
62105	now	O
62106	---	O
62107	continue	O
62108	po	b-TREATMENT
62109	k	i-TREATMENT
62110	---	O
62111	check	O
62112	lytes	b-TEST
62113	in	O
62114	pm	b-DATE
62115	6.	O
62116	cellulitis	b-PROBLEM
62117	:	O
62118	---	O
62119	continue	O
62120	unasyn	b-TREATMENT
62121	---	O
62122	hold	O
62123	off	O
62124	on	O
62125	x-rays	b-TEST
62126	for	O
62127	now	O
62128	7.	O
62129	dm	b-PROBLEM
62130	:	O
62131	---	O
62132	riss	b-TREATMENT
62133	-	O
62134	tight	b-TREATMENT
62135	glucose	i-TREATMENT
62136	control	i-TREATMENT
62137	pre-op	O
62138	8.	O
62139	ppx	b-TREATMENT
62140	:	O
62141	---	O
62142	protonix	b-TREATMENT
62143	,	O
62144	lovenox	b-TREATMENT
62145	,	O
62146	r	b-TREATMENT
62147	boot	i-TREATMENT
62148	as	O
62149	per	O
62150	cmed	b-CLINICAL_DEPT
62151	ccu	i-CLINICAL_DEPT
62152	9.	O
62153	diet	O
62154	:	O
62155	npo	b-TREATMENT
62156	10.	O
62157	code	O
62158	:	O
62159	full	O
62160	-->	O
62161	dnr	O
62162	/	O
62163	dni	O
62164	cmed	O
62165	course	O
62166	:	O
62167	orif	b-TREATMENT
62168	with	O
62169	repair	b-TREATMENT
62170	of	O
62171	neck	b-PROBLEM
62172	fracture	i-PROBLEM
62173	2016-03-23	b-DATE
62174	.	O
62175	had	O
62176	expected	O
62177	prolonged	b-PROBLEM
62178	post-op	i-PROBLEM
62179	extubation	b-TREATMENT
62180	in	O
62181	pacu	b-CLINICAL_DEPT
62182	given	O
62183	copd	b-PROBLEM
62184	history	O
62185	,	O
62186	as	O
62187	with	O
62188	colon	b-PROBLEM
62189	ca	i-PROBLEM
62190	resection	b-TREATMENT
62191	surgery	i-TREATMENT
62192	.	O
62193	in	O
62194	pm	b-DATE
62195	extubated	b-TREATMENT
62196	,	O
62197	transferred	b-OCCURRENCE
62198	to	O
62199	floor	b-CLINICAL_DEPT
62200	2016-03-23	b-DATE
62201	.	O
62202	late	O
62203	03-23	b-DATE
62204	found	O
62205	with	O
62206	afib	b-PROBLEM
62207	and	O
62208	rvr	b-PROBLEM
62209	,	O
62210	given	O
62211	beta	b-TREATMENT
62212	blocker	i-TREATMENT
62213	with	O
62214	min.	O
62215	response	b-OCCURRENCE
62216	,	O
62217	started	O
62218	dilt.	b-TREATMENT
62219	drip	i-TREATMENT
62220	.	O
62221	received	O
62222	2	O
62223	mg	O
62224	dilaudid	b-TREATMENT
62225	for	O
62226	pain	b-PROBLEM
62227	o/n	b-DURATION
62228	.	O
62229	on	O
62230	03-24	b-DATE
62231	am	i-DATE
62232	p/w	b-EVIDENTIAL
62233	with	O
62234	respiratory	b-PROBLEM
62235	failure	i-PROBLEM
62236	,	O
62237	continued	O
62238	tachycardia	b-PROBLEM
62239	on	O
62240	dilt.	b-TREATMENT
62241	gtt.	i-TREATMENT
62242	transferred	b-OCCURRENCE
62243	to	O
62244	unit	b-CLINICAL_DEPT
62245	and	O
62246	urgently	O
62247	intubated	b-TREATMENT
62248	.	O
62249	of	O
62250	note	O
62251	,	O
62252	there	O
62253	was	O
62254	a	O
62255	question	O
62256	of	O
62257	misplaced	b-PROBLEM
62258	ngt	i-PROBLEM
62259	.	O
62260	when	O
62261	ngt	b-TREATMENT
62262	tube	i-TREATMENT
62263	was	O
62264	pulled	O
62265	out	O
62266	,	O
62267	it	O
62268	was	O
62269	noted	O
62270	to	O
62271	have	O
62272	respiratory-like	b-PROBLEM
62273	secretions	i-PROBLEM
62274	.	O
62275	concern	O
62276	for	O
62277	aspiration	b-PROBLEM
62278	of	O
62279	mediations	b-PROBLEM
62280	to	i-PROBLEM
62281	lungs	i-PROBLEM
62282	.	O
62283	however	O
62284	,	O
62285	evaluation	O
62286	of	O
62287	cxr	b-TEST
62288	revealed	b-EVIDENTIAL
62289	ngt	b-TREATMENT
62290	coiled	b-PROBLEM
62291	in	i-PROBLEM
62292	esophagus	i-PROBLEM
62293	.	O
62294	pt	O
62295	's	O
62296	respiratory	b-PROBLEM
62297	distress	i-PROBLEM
62298	is	O
62299	most	O
62300	likely	O
62301	on	O
62302	setting	O
62303	of	O
62304	aspiration	b-PROBLEM
62305	pneumonia	i-PROBLEM
62306	vs.	O
62307	pneumonitis	b-PROBLEM
62308	in	O
62309	the	O
62310	setting	O
62311	of	O
62312	depressed	b-PROBLEM
62313	mental	i-PROBLEM
62314	status	i-PROBLEM
62315	secondary	O
62316	to	O
62317	post-operative	O
62318	narcotics	b-TREATMENT
62319	.	O
62320	pt	O
62321	was	O
62322	pan-cultured	b-TEST
62323	and	O
62324	switched	O
62325	from	O
62326	unasyn	b-TREATMENT
62327	(	O
62328	started	O
62329	at	O
62330	osh	b-CLINICAL_DEPT
62331	for	O
62332	foot	b-PROBLEM
62333	ulcer	i-PROBLEM
62334	)	O
62335	to	O
62336	zosyn	b-TREATMENT
62337	.	O
62338	vanco	b-TREATMENT
62339	was	O
62340	added	O
62341	for	O
62342	possible	O
62343	nosocomial	b-PROBLEM
62344	infection	i-PROBLEM
62345	.	O
62346	cta	b-TEST
62347	was	O
62348	performed	O
62349	which	O
62350	was	O
62351	negative	O
62352	for	O
62353	pe	b-PROBLEM
62354	,	O
62355	but	O
62356	revealed	b-EVIDENTIAL
62357	bilateral	b-PROBLEM
62358	patchy	i-PROBLEM
62359	ground	i-PROBLEM
62360	glass	i-PROBLEM
62361	opacities	i-PROBLEM
62362	c/w	O
62363	aspiration	b-PROBLEM
62364	vs.	O
62365	pneumonia	b-PROBLEM
62366	vs.	O
62367	edema	b-PROBLEM
62368	.	O
62369	pt	O
62370	was	O
62371	weaned	b-TREATMENT
62372	down	i-TREATMENT
62373	on	O
62374	ventilator	b-TREATMENT
62375	,	O
62376	minimal	O
62377	secretions	b-OCCURRENCE
62378	noted	O
62379	.	O
62380	on	O
62381	03-27	b-DATE
62382	,	O
62383	pt	O
62384	was	O
62385	noted	O
62386	to	O
62387	have	O
62388	depressed	b-PROBLEM
62389	mental	i-PROBLEM
62390	status	i-PROBLEM
62391	off	O
62392	all	O
62393	sedating	b-TREATMENT
62394	medications	i-TREATMENT
62395	;	O
62396	mental	b-OCCURRENCE
62397	status	i-OCCURRENCE
62398	improved	i-OCCURRENCE
62399	over	O
62400	the	b-DURATION
62401	course	i-DURATION
62402	of	i-DURATION
62403	the	i-DURATION
62404	day	i-DURATION
62405	.	O
62406	pt	O
62407	was	O
62408	diuresed	b-TREATMENT
62409	.	O
62410	atrial	b-PROBLEM
62411	fibrillation	i-PROBLEM
62412	was	O
62413	rate-controlled	b-TREATMENT
62414	on	O
62415	dilt	b-TREATMENT
62416	drip	i-TREATMENT
62417	.	O
62418	dilt	b-TREATMENT
62419	drip	i-TREATMENT
62420	was	O
62421	discontinued	O
62422	and	O
62423	metoprolol	b-TREATMENT
62424	titrated	b-TREATMENT
62425	up	i-TREATMENT
62426	.	O
62427	cardiac	b-TEST
62428	enzymes	i-TEST
62429	were	O
62430	cycled	O
62431	in	O
62432	setting	O
62433	of	O
62434	rapid	b-PROBLEM
62435	af	i-PROBLEM
62436	and	O
62437	were	O
62438	flat	O
62439	.	O
62440	initially	O
62441	,	O
62442	pt	O
62443	was	O
62444	noted	O
62445	to	O
62446	be	O
62447	dry	b-PROBLEM
62448	with	O
62449	low	b-PROBLEM
62450	fena	i-PROBLEM
62451	and	O
62452	given	O
62453	ivf	b-TREATMENT
62454	.	O
62455	then	O
62456	,	O
62457	noted	O
62458	to	O
62459	be	O
62460	volume	b-PROBLEM
62461	overloaded	i-PROBLEM
62462	and	O
62463	diuresed	b-TREATMENT
62464	with	O
62465	lasix	b-TREATMENT
62466	.	O
62467	pt	O
62468	had	O
62469	depressed	b-PROBLEM
62470	mental	i-PROBLEM
62471	status	i-PROBLEM
62472	on	O
62473	transfer	b-OCCURRENCE
62474	to	O
62475	cmed	b-CLINICAL_DEPT
62476	in	O
62477	setting	O
62478	of	O
62479	narcotics	b-TREATMENT
62480	.	O
62481	she	O
62482	was	O
62483	then	O
62484	started	O
62485	on	O
62486	propofol	b-TREATMENT
62487	while	O
62488	intubated	b-TREATMENT
62489	.	O
62490	head	b-TEST
62491	ct	i-TEST
62492	was	O
62493	negative	O
62494	for	O
62495	acute	b-PROBLEM
62496	bleed	i-PROBLEM
62497	,	O
62498	mass	b-PROBLEM
62499	effect	i-PROBLEM
62500	,	O
62501	or	O
62502	stroke	b-PROBLEM
62503	.	O
62504	mental	b-OCCURRENCE
62505	status	i-OCCURRENCE
62506	improved	i-OCCURRENCE
62507	during	O
62508	times	O
62509	when	O
62510	propofol	b-TREATMENT
62511	was	O
62512	held	O
62513	.	O
62514	on	O
62515	03-27	b-DATE
62516	,	O
62517	pt	O
62518	was	O
62519	noted	O
62520	to	O
62521	have	O
62522	significantly	O
62523	depressed	b-PROBLEM
62524	m.s.	i-PROBLEM
62525	off	O
62526	propol	b-TREATMENT
62527	improved	b-OCCURRENCE
62528	off	O
62529	sedation	b-TREATMENT
62530	.	O
62531	all	O
62532	sedating	b-TREATMENT
62533	medications	i-TREATMENT
62534	including	O
62535	prn	O
62536	narcotics	b-TREATMENT
62537	were	O
62538	held	O
62539	and	O
62540	mental	b-OCCURRENCE
62541	status	i-OCCURRENCE
62542	cleared	i-OCCURRENCE
62543	somewhat	O
62544	.	O
62545	s/p	O
62546	hip	b-TREATMENT
62547	fx	i-TREATMENT
62548	repair	i-TREATMENT
62549	:	O
62550	started	O
62551	on	O
62552	lovenox	b-TREATMENT
62553	for	O
62554	anti-coagulation	b-TREATMENT
62555	.	O
62556	given	O
62557	standing	O
62558	nsaid	b-TREATMENT
62559	,	O
62560	tylenol	b-TREATMENT
62561	for	O
62562	pain	b-TREATMENT
62563	control	i-TREATMENT
62564	.	O
62565	opiates	b-TREATMENT
62566	used	O
62567	very	O
62568	sparingly	O
62569	in	O
62570	setting	O
62571	of	O
62572	ms	b-PROBLEM
62573	change	i-PROBLEM
62574	on	O
62575	transfer	b-OCCURRENCE
62576	to	O
62577	floor	b-CLINICAL_DEPT
62578	team	O
62579	from	O
62580	cmed	b-CLINICAL_DEPT
62581	active	O
62582	issues	O
62583	and	O
62584	plan	O
62585	included	O
62586	:	O
62587	resp	b-PROBLEM
62588	failure	i-PROBLEM
62589	/	O
62590	copd	b-PROBLEM
62591	:	O
62592	initially	O
62593	got	O
62594	steroids	b-TREATMENT
62595	upon	O
62596	intubation	b-TREATMENT
62597	.	O
62598	off	O
62599	for	O
62600	days	b-DURATION
62601	now	O
62602	.	O
62603	extubated	b-TREATMENT
62604	on	O
62605	03-31	b-DATE
62606	.	O
62607	still	O
62608	tachypneic	b-PROBLEM
62609	and	O
62610	hypoxic	b-PROBLEM
62611	on	O
62612	room	O
62613	air	O
62614	.	O
62615	lung	b-TEST
62616	sounds	i-TEST
62617	fairly	O
62618	clear	b-OCCURRENCE
62619	.	O
62620	?	O
62621	copd	b-PROBLEM
62622	vs	O
62623	atelectasis	b-PROBLEM
62624	as	O
62625	cause	O
62626	of	O
62627	hypoxia	b-PROBLEM
62628	.	O
62629	on	O
62630	blake	O
62631	,	O
62632	nancy	O
62633	pe	O
62634	less	O
62635	likely	O
62636	-	O
62637	atrovent	b-TREATMENT
62638	standing	O
62639	.	O
62640	prn	O
62641	albuterol	b-TREATMENT
62642	only	O
62643	given	O
62644	a	b-PROBLEM
62645	fib	i-PROBLEM
62646	with	O
62647	rvr	b-PROBLEM
62648	-	O
62649	inhaled	b-TREATMENT
62650	steroids	i-TREATMENT
62651	-	O
62652	obtaining	O
62653	pcp	O
62654	set	O
62655	of	O
62656	reginald	O
62657	fever	b-PROBLEM
62658	:	O
62659	in	O
62660	the	b-CLINICAL_DEPT
62661	icu	i-CLINICAL_DEPT
62662	.	O
62663	had	O
62664	received	O
62665	unasyn	b-TREATMENT
62666	,	O
62667	vanc	b-TREATMENT
62668	,	O
62669	zosyn	b-TREATMENT
62670	during	O
62671	hospital	b-OCCURRENCE
62672	course	i-OCCURRENCE
62673	for	O
62674	cellulitis	b-PROBLEM
62675	and	O
62676	other	O
62677	unclear	O
62678	reasons	O
62679	,	O
62680	including	O
62681	possible	O
62682	vent	b-PROBLEM
62683	associated	i-PROBLEM
62684	pna	i-PROBLEM
62685	.	O
62686	no	O
62687	true	O
62688	source	O
62689	found	O
62690	.	O
62691	afebrile	b-OCCURRENCE
62692	>	O
62693	24	b-DURATION
62694	hours	i-DURATION
62695	off	O
62696	abx	b-TREATMENT
62697	.	O
62698	-	O
62699	culture	b-TEST
62700	if	O
62701	spikes	b-PROBLEM
62702	.	O
62703	no	O
62704	abx	b-TREATMENT
62705	unless	O
62706	source	O
62707	found	O
62708	a.fib	b-PROBLEM
62709	with	O
62710	rvr	b-PROBLEM
62711	-	O
62712	has	O
62713	ppm	b-TREATMENT
62714	,	O
62715	so	O
62716	can	O
62717	have	O
62718	lot	O
62719	of	O
62720	nodal	b-TREATMENT
62721	agents	i-TREATMENT
62722	.	O
62723	now	O
62724	rate	b-TREATMENT
62725	controlled	i-TREATMENT
62726	on	O
62727	metop	b-TREATMENT
62728	125	O
62729	tid	b-FREQUENCY
62730	and	O
62731	dilt	b-TREATMENT
62732	.	O
62733	30	O
62734	qid	b-FREQUENCY
62735	.	O
62736	titrate	b-TREATMENT
62737	prn	O
62738	.	O
62739	-	O
62740	continue	O
62741	nodal	b-TREATMENT
62742	agents	i-TREATMENT
62743	-	O
62744	consider	O
62745	anti	b-TREATMENT
62746	coag	i-TREATMENT
62747	for	O
62748	cva	b-TREATMENT
62749	prevention	i-TREATMENT
62750	,	O
62751	but	O
62752	wait	O
62753	until	O
62754	ambulating	b-OCCURRENCE
62755	better	i-OCCURRENCE
62756	cad	b-PROBLEM
62757	:	O
62758	on	O
62759	asa	b-TREATMENT
62760	,	O
62761	b	b-TREATMENT
62762	blocker	i-TREATMENT
62763	,	O
62764	ace	b-TREATMENT
62765	.	O
62766	no	O
62767	statin	b-TREATMENT
62768	.	O
62769	need	O
62770	to	O
62771	clear	O
62772	with	O
62773	family	O
62774	heme	O
62775	-	O
62776	anemic	b-PROBLEM
62777	.	O
62778	unclear	O
62779	baseline	O
62780	.	O
62781	possible	O
62782	anemia	b-PROBLEM
62783	03-02	O
62784	operative	b-PROBLEM
62785	blood	i-PROBLEM
62786	loss	i-PROBLEM
62787	.	O
62788	follow	O
62789	hct	b-TEST
62790	daily	b-FREQUENCY
62791	goal	O
62792	>	O
62793	28	O
62794	neck	O
62795	:	O
62796	never	O
62797	had	O
62798	c	b-TEST
62799	spine	i-TEST
62800	cleared	i-TEST
62801	by	O
62802	neurosurg	O
62803	.	O
62804	had	O
62805	fall	b-PROBLEM
62806	pta	O
62807	with	O
62808	?	O
62809	fx	b-PROBLEM
62810	on	O
62811	initial	O
62812	ct	b-TEST
62813	,	O
62814	neg	O
62815	fx	b-PROBLEM
62816	on	O
62817	f/u	O
62818	ct	b-TEST
62819	.	O
62820	-	O
62821	flex	b-TEST
62822	/	i-TEST
62823	ext	i-TEST
62824	films	i-TEST
62825	done	O
62826	-	O
62827	will	O
62828	clear	b-OCCURRENCE
62829	with	O
62830	neursurg	O
62831	prior	O
62832	to	O
62833	removing	O
62834	hard	b-TREATMENT
62835	collar	i-TREATMENT
62836	overnight	O
62837	on	O
62838	pt	O
62839	's	O
62840	first	b-DATE
62841	evening	i-DATE
62842	on	O
62843	the	b-CLINICAL_DEPT
62844	floor	i-CLINICAL_DEPT
62845	,	O
62846	she	O
62847	had	O
62848	episode	O
62849	of	O
62850	desaturation	b-PROBLEM
62851	with	O
62852	inc	b-PROBLEM
62853	o2	i-PROBLEM
62854	requirement	i-PROBLEM
62855	(	O
62856	4l	O
62857	->	O
62858	6l	O
62859	->	O
62860	sating	b-TEST
62861	91%	O
62862	on	O
62863	nrb	O
62864	)	O
62865	-	O
62866	cxr	b-TEST
62867	with	O
62868	worsening	O
62869	-	O
62870	non	O
62871	responsive	O
62872	to	O
62873	lasix	b-TREATMENT
62874	.	O
62875	family	b-OCCURRENCE
62876	meeting	i-OCCURRENCE
62877	held	i-OCCURRENCE
62878	and	O
62879	pt	O
62880	made	O
62881	clear	O
62882	wishes	O
62883	after	O
62884	extubation	b-TREATMENT
62885	that	O
62886	she	O
62887	does	O
62888	not	O
62889	want	O
62890	to	O
62891	be	O
62892	intubated	b-TREATMENT
62893	again	O
62894	and	O
62895	made	O
62896	dnr	b-TREATMENT
62897	/	i-TREATMENT
62898	dni	i-TREATMENT
62899	.	O
62900	no	O
62901	bipap	b-TREATMENT
62902	.	O
62903	now	O
62904	pt	O
62905	lethargic	b-PROBLEM
62906	and	O
62907	min	b-PROBLEM
62908	responsive	i-PROBLEM
62909	.	O
62910	all	O
62911	four	O
62912	children	O
62913	in	O
62914	pts	O
62915	room	O
62916	and	O
62917	agree	O
62918	on	O
62919	cmo	b-TREATMENT
62920	-	O
62921	want	O
62922	to	O
62923	d/c	O
62924	c-collar	b-TREATMENT
62925	and	O
62926	start	O
62927	morphine	b-TREATMENT
62928	ggt	i-TREATMENT
62929	.	O
62930	discussed	O
62931	with	O
62932	night	O
62933	float	O
62934	cover	O
62935	doctor	O
62936	dennis	O
62937	commander	O
62938	and	O
62939	doctor	O
62940	mike	O
62941	french	O
62942	.	O
62943	although	O
62944	doctor	O
62945	ray	O
62946	will	O
62947	be	O
62948	covering	O
62949	pt	O
62950	today	b-DATE
62951	,	O
62952	doctor	O
62953	stephanie	O
62954	wilson	O
62955	spoke	b-OCCURRENCE
62956	with	i-OCCURRENCE
62957	family	i-OCCURRENCE
62958	this	b-DATE
62959	morning	i-DATE
62960	and	O
62961	has	O
62962	noted	b-EVIDENTIAL
62963	that	O
62964	pt	O
62965	is	O
62966	cmo	b-TREATMENT
62967	.	O
62968	ep	O
62969	was	O
62970	called	O
62971	to	O
62972	deactivate	b-TREATMENT
62973	pt	i-TREATMENT
62974	dual	i-TREATMENT
62975	chamber	i-TREATMENT
62976	icd	i-TREATMENT
62977	as	O
62978	per	O
62979	family	O
62980	wishes	O
62981	.	O
62982	on	O
62983	exam	b-TEST
62984	,	O
62985	pt	O
62986	lethargic	b-TREATMENT
62987	,	O
62988	responsive	b-OCCURRENCE
62989	to	i-OCCURRENCE
62990	pain	i-OCCURRENCE
62991	but	O
62992	not	O
62993	voice	O
62994	,	O
62995	with	O
62996	nrb	b-TREATMENT
62997	in	O
62998	place	O
62999	;	O
63000	obvious	O
63001	inc	b-PROBLEM
63002	wob	i-PROBLEM
63003	.	O
63004	iv	b-TREATMENT
63005	in	O
63006	r	O
63007	foot	O
63008	for	O
63009	access	O
63010	.	O
63011	family	O
63012	at	O
63013	bedside	O
63014	.	O
63015	afebrile	b-OCCURRENCE
63016	;	O
63017	bp	b-TEST
63018	:	O
63019	159-161-139-98	O
63020	(	O
63021	after	O
63022	morphine	b-TREATMENT
63023	)/	O
63024	69	O
63025	hr	b-TEST
63026	:	O
63027	148	O
63028	-->	O
63029	88	O
63030	;	O
63031	rr	b-TEST
63032	:	O
63033	28-40	O
63034	o2	O
63035	:	O
63036	94%	O
63037	nrb	O
63038	as	O
63039	above	O
63040	,	O
63041	made	O
63042	cmo	b-TREATMENT
63043	after	O
63044	meeting	b-OCCURRENCE
63045	with	i-OCCURRENCE
63046	nf	i-OCCURRENCE
63047	team	i-OCCURRENCE
63048	and	i-OCCURRENCE
63049	family	i-OCCURRENCE
63050	and	O
63051	reconfirmed	b-OCCURRENCE
63052	with	O
63053	primary	O
63054	medical	O
63055	team	O
63056	on	O
63057	04-02	b-DATE
63058	.	O
63059	start	O
63060	morphine	b-TREATMENT
63061	ggt	i-TREATMENT
63062	and	O
63063	titrate	b-TREATMENT
63064	to	i-TREATMENT
63065	comfort	i-TREATMENT
63066	.	O
63067	d/c	O
63068	'ed	O
63069	all	O
63070	lab	b-TEST
63071	draws	i-TEST
63072	/	O
63073	vitals	b-TEST
63074	.	O
63075	prn	O
63076	nebs	b-TREATMENT
63077	for	O
63078	comfort	O
63079	.	O
63080	family	O
63081	at	O
63082	bedside	O
63083	and	O
63084	aware	O
63085	and	O
63086	in	O
63087	agreement	O
63088	of	O
63089	plan	O
63090	.	O
63091	morhpine	b-TREATMENT
63092	ggt	i-TREATMENT
63093	titrated	b-TREATMENT
63094	up	i-TREATMENT
63095	to	O
63096	18	O
63097	mg	O
63098	/	O
63099	hr	O
63100	by	O
63101	monday	b-DATE
63102	morning	i-DATE
63103	and	O
63104	pt	O
63105	expired	b-PROBLEM
63106	04-04	b-TIME
63107	at	i-TIME
63108	7:40	i-TIME
63109	am	i-TIME
63110	.	O
63111		O
63112	admission	b-OCCURRENCE
63113	date	O
63114	:	O
63115	01/25/97	b-ADMISSION
63116	discharge	b-OCCURRENCE
63117	date	O
63118	:	O
63119	01/30/97	b-DISCHARGE
63120	history	O
63121	of	O
63122	present	O
63123	illness	O
63124	:	O
63125	the	O
63126	patient	O
63127	is	O
63128	a	O
63129	70-year-old	O
63130	female	O
63131	with	O
63132	cryptogenic	b-PROBLEM
63133	cirrhosis	i-PROBLEM
63134	.	O
63135	she	O
63136	has	O
63137	a	O
63138	history	O
63139	of	O
63140	esophageal	b-PROBLEM
63141	varices	i-PROBLEM
63142	and	O
63143	a	O
63144	history	O
63145	of	O
63146	an	b-PROBLEM
63147	upper	i-PROBLEM
63148	gi	i-PROBLEM
63149	bleed	i-PROBLEM
63150	.	O
63151	she	O
63152	has	O
63153	had	O
63154	one	O
63155	pervious	O
63156	episode	O
63157	of	O
63158	variceal	b-PROBLEM
63159	bleeding	i-PROBLEM
63160	with	O
63161	an	O
63162	unclear	O
63163	date	O
63164	.	O
63165	however	O
63166	she	O
63167	is	O
63168	followed	b-OCCURRENCE
63169	by	O
63170	a	O
63171	doctor	O
63172	joasscchird	O
63173	at	O
63174	vaila	b-CLINICAL_DEPT
63175	medical	i-CLINICAL_DEPT
63176	center	i-CLINICAL_DEPT
63177	.	O
63178	she	O
63179	was	O
63180	in	O
63181	her	b-OCCURRENCE
63182	usual	i-OCCURRENCE
63183	state	i-OCCURRENCE
63184	of	i-OCCURRENCE
63185	health	i-OCCURRENCE
63186	until	O
63187	one	b-DATE
63188	day	i-DATE
63189	prior	O
63190	to	O
63191	admission	O
63192	when	O
63193	she	O
63194	felt	O
63195	increasing	b-PROBLEM
63196	fatigue	i-PROBLEM
63197	,	O
63198	nausea	b-PROBLEM
63199	and	O
63200	vomiting	b-PROBLEM
63201	productive	O
63202	of	O
63203	bright	b-PROBLEM
63204	red	i-PROBLEM
63205	blood	i-PROBLEM
63206	and	O
63207	coffee	b-PROBLEM
63208	ground	i-PROBLEM
63209	emesis	i-PROBLEM
63210	.	O
63211	she	O
63212	also	O
63213	had	O
63214	some	b-PROBLEM
63215	black	i-PROBLEM
63216	,	i-PROBLEM
63217	tarry	i-PROBLEM
63218	stool	i-PROBLEM
63219	in	O
63220	her	b-TREATMENT
63221	colostomy	i-TREATMENT
63222	bag	i-TREATMENT
63223	.	O
63224	at	O
63225	vaila	b-CLINICAL_DEPT
63226	medical	i-CLINICAL_DEPT
63227	center	i-CLINICAL_DEPT
63228	,	O
63229	she	O
63230	had	O
63231	a	b-TEST
63232	hematocrit	i-TEST
63233	of	O
63234	25	O
63235	and	O
63236	was	O
63237	transfused	b-TREATMENT
63238	2	O
63239	units	O
63240	of	O
63241	packed	b-TREATMENT
63242	red	i-TREATMENT
63243	blood	i-TREATMENT
63244	cells	i-TREATMENT
63245	.	O
63246	she	O
63247	had	O
63248	an	b-TEST
63249	upper	i-TEST
63250	endoscopy	i-TEST
63251	at	O
63252	va	b-CLINICAL_DEPT
63253	sit	i-CLINICAL_DEPT
63254	namar	i-CLINICAL_DEPT
63255	healthcare	i-CLINICAL_DEPT
63256	showing	b-EVIDENTIAL
63257	an	b-OCCURRENCE
63258	esophagus	i-OCCURRENCE
63259	filled	i-OCCURRENCE
63260	with	i-OCCURRENCE
63261	clots	i-OCCURRENCE
63262	and	O
63263	small	O
63264	amount	O
63265	of	O
63266	bleeding	b-PROBLEM
63267	varices	i-PROBLEM
63268	,	O
63269	clot	b-PROBLEM
63270	in	i-PROBLEM
63271	the	i-PROBLEM
63272	stomach	i-PROBLEM
63273	with	O
63274	antral	b-PROBLEM
63275	gastritis	i-PROBLEM
63276	,	O
63277	and	O
63278	a	b-OCCURRENCE
63279	normal	i-OCCURRENCE
63280	duodenum	i-OCCURRENCE
63281	.	O
63282	she	O
63283	was	O
63284	started	O
63285	on	O
63286	pitressin	b-TREATMENT
63287	,	O
63288	a	b-TREATMENT
63289	blakemore	i-TREATMENT
63290	tube	i-TREATMENT
63291	was	O
63292	inserted	O
63293	.	O
63294	she	O
63295	was	O
63296	transferred	b-OCCURRENCE
63297	to	O
63298	the	b-CLINICAL_DEPT
63299	ph	i-CLINICAL_DEPT
63300	university	i-CLINICAL_DEPT
63301	of	i-CLINICAL_DEPT
63302	medical	i-CLINICAL_DEPT
63303	center	i-CLINICAL_DEPT
63304	intensive	i-CLINICAL_DEPT
63305	care	i-CLINICAL_DEPT
63306	unit	i-CLINICAL_DEPT
63307	where	O
63308	on	O
63309	january	b-DATE
63310	25	i-DATE
63311	in	O
63312	the	O
63313	morning	O
63314	her	b-TEST
63315	hematocrit	i-TEST
63316	was	O
63317	found	O
63318	to	O
63319	be	O
63320	27.4	O
63321	.	O
63322	she	O
63323	was	O
63324	transfused	b-TREATMENT
63325	another	O
63326	2	O
63327	units	O
63328	of	O
63329	packed	b-TREATMENT
63330	red	i-TREATMENT
63331	blood	i-TREATMENT
63332	cells	i-TREATMENT
63333	over	O
63334	the	b-DURATION
63335	course	i-DURATION
63336	of	i-DURATION
63337	the	i-DURATION
63338	day	i-DURATION
63339	and	O
63340	her	b-TEST
63341	hematocrit	i-TEST
63342	improved	O
63343	to	O
63344	29.4	O
63345	and	O
63346	then	O
63347	31.2	O
63348	.	O
63349	the	O
63350	gi	O
63351	service	O
63352	was	O
63353	consulted	b-OCCURRENCE
63354	and	O
63355	an	b-TEST
63356	upper	i-TEST
63357	endoscopy	i-TEST
63358	study	i-TEST
63359	showed	b-EVIDENTIAL
63360	grade	b-PROBLEM
63361	iii	i-PROBLEM
63362	varices	i-PROBLEM
63363	with	O
63364	no	O
63365	active	b-PROBLEM
63366	bleeding	i-PROBLEM
63367	and	O
63368	a	b-PROBLEM
63369	clean	i-PROBLEM
63370	base	i-PROBLEM
63371	gastric	i-PROBLEM
63372	ulcer	i-PROBLEM
63373	possibly	O
63374	secondary	O
63375	to	O
63376	the	b-TREATMENT
63377	blakemore	i-TREATMENT
63378	tube	i-TREATMENT
63379	.	O
63380	her	b-PROBLEM
63381	varices	i-PROBLEM
63382	had	O
63383	stigmata	b-PROBLEM
63384	of	O
63385	recent	b-PROBLEM
63386	bleeding	i-PROBLEM
63387	,	O
63388	were	O
63389	banded	b-TREATMENT
63390	successfully	O
63391	.	O
63392	after	O
63393	the	b-TREATMENT
63394	procedure	i-TREATMENT
63395	and	O
63396	2	O
63397	more	O
63398	units	O
63399	of	O
63400	packed	b-TREATMENT
63401	red	i-TREATMENT
63402	blood	i-TREATMENT
63403	cells	i-TREATMENT
63404	,	O
63405	the	O
63406	patient	O
63407	was	O
63408	hemodynamically	b-OCCURRENCE
63409	stable	i-OCCURRENCE
63410	and	O
63411	hematocrit	b-TEST
63412	was	O
63413	stable	b-EVIDENTIAL
63414	at	O
63415	31.2	O
63416	.	O
63417	at	O
63418	that	O
63419	time	O
63420	she	O
63421	was	O
63422	transferred	b-OCCURRENCE
63423	from	O
63424	the	b-CLINICAL_DEPT
63425	intensive	i-CLINICAL_DEPT
63426	care	i-CLINICAL_DEPT
63427	unit	i-CLINICAL_DEPT
63428	to	O
63429	coden	O
63430	2	O
63431	for	O
63432	the	b-CLINICAL_DEPT
63433	lemgarson	i-CLINICAL_DEPT
63434	hospital	i-CLINICAL_DEPT
63435	service	i-CLINICAL_DEPT
63436	.	O
63437	hospital	O
63438	course	O
63439	and	O
63440	treatment	O
63441	:	O
63442	as	O
63443	described	O
63444	above	O
63445	the	O
63446	patient	O
63447	was	O
63448	transfused	b-TREATMENT
63449	an	b-TREATMENT
63450	additional	i-TREATMENT
63451	2	i-TREATMENT
63452	units	i-TREATMENT
63453	in	O
63454	the	b-CLINICAL_DEPT
63455	intensive	i-CLINICAL_DEPT
63456	care	i-CLINICAL_DEPT
63457	unit	i-CLINICAL_DEPT
63458	and	O
63459	the	O
63460	patient	O
63461	also	O
63462	received	O
63463	an	b-TEST
63464	upper	i-TEST
63465	endoscopy	i-TEST
63466	study	i-TEST
63467	and	O
63468	her	b-PROBLEM
63469	varices	i-PROBLEM
63470	were	O
63471	banded	b-TREATMENT
63472	.	O
63473	on	O
63474	transfer	b-OCCURRENCE
63475	to	O
63476	the	b-CLINICAL_DEPT
63477	lemgarson	i-CLINICAL_DEPT
63478	hospital	i-CLINICAL_DEPT
63479	service	i-CLINICAL_DEPT
63480	,	O
63481	her	b-TEST
63482	hematocrit	i-TEST
63483	was	O
63484	31.2	O
63485	,	O
63486	white	b-TEST
63487	count	i-TEST
63488	11.1	O
63489	and	O
63490	a	b-TEST
63491	platelet	i-TEST
63492	count	i-TEST
63493	80	O
63494	.	O
63495	her	b-TEST
63496	pt	i-TEST
63497	was	O
63498	13.1	O
63499	,	O
63500	ptt	b-TEST
63501	26.7	O
63502	.	O
63503	the	O
63504	rest	O
63505	of	O
63506	her	b-TEST
63507	labs	i-TEST
63508	were	O
63509	unremarkable	b-EVIDENTIAL
63510	.	O
63511	she	O
63512	was	O
63513	watched	b-TEST
63514	very	i-TEST
63515	closely	i-TEST
63516	while	O
63517	on	O
63518	the	b-CLINICAL_DEPT
63519	floor	i-CLINICAL_DEPT
63520	.	O
63521	she	O
63522	was	O
63523	on	O
63524	gi	b-TREATMENT
63525	bleed	i-TREATMENT
63526	precautions	i-TREATMENT
63527	at	O
63528	all	O
63529	times	O
63530	,	O
63531	was	O
63532	too	O
63533	large	O
63534	for	O
63535	iv	b-TREATMENT
63536	.	O
63537	she	O
63538	had	O
63539	a	b-PROBLEM
63540	clot	i-PROBLEM
63541	at	O
63542	the	O
63543	blood	O
63544	bank	O
63545	and	O
63546	she	O
63547	had	O
63548	bid	b-FREQUENCY
63549	hematocrits	i-TEST
63550	checked	O
63551	.	O
63552	she	O
63553	was	O
63554	kept	O
63555	npo	b-TREATMENT
63556	until	O
63557	january	b-DATE
63558	26	i-DATE
63559	when	O
63560	she	O
63561	began	O
63562	to	O
63563	feel	b-EVIDENTIAL
63564	hungry	i-EVIDENTIAL
63565	.	O
63566	at	O
63567	that	O
63568	time	O
63569	clear	b-TREATMENT
63570	liquids	i-TREATMENT
63571	were	O
63572	started	O
63573	.	O
63574	all	O
63575	of	O
63576	her	b-PROBLEM
63577	stools	i-PROBLEM
63578	were	O
63579	guaiaced	b-TEST
63580	.	O
63581	she	O
63582	also	O
63583	began	O
63584	nadolol	b-TREATMENT
63585	40	O
63586	mg	O
63587	qd	b-FREQUENCY
63588	to	O
63589	reduce	O
63590	her	b-PROBLEM
63591	portal	i-PROBLEM
63592	hypertension	i-PROBLEM
63593	.	O
63594	the	O
63595	gi	O
63596	consult	O
63597	team	O
63598	continued	b-OCCURRENCE
63599	to	O
63600	follow	b-OCCURRENCE
63601	her	O
63602	.	O
63603	we	O
63604	also	O
63605	tried	O
63606	to	O
63607	contact	b-OCCURRENCE
63608	her	i-OCCURRENCE
63609	physician	i-OCCURRENCE
63610	at	O
63611	va	b-CLINICAL_DEPT
63612	sit	i-CLINICAL_DEPT
63613	namar	i-CLINICAL_DEPT
63614	healthcare	i-CLINICAL_DEPT
63615	and	O
63616	was	O
63617	unsuccessful	O
63618	.	O
63619	therefore	O
63620	we	O
63621	decided	O
63622	to	O
63623	work	b-TEST
63624	up	i-TEST
63625	her	b-PROBLEM
63626	cirrhosis	i-PROBLEM
63627	.	O
63628	she	O
63629	was	O
63630	described	b-EVIDENTIAL
63631	as	O
63632	having	O
63633	_______	O
63634	cirrhosis	b-PROBLEM
63635	and	O
63636	we	O
63637	decided	O
63638	that	O
63639	we	O
63640	wanted	O
63641	to	O
63642	try	O
63643	to	O
63644	figure	O
63645	out	O
63646	the	O
63647	etiology	O
63648	.	O
63649	her	b-TEST
63650	ferritin	i-TEST
63651	and	O
63652	iron	b-TEST
63653	studies	i-TEST
63654	did	O
63655	not	O
63656	reveal	b-EVIDENTIAL
63657	any	O
63658	evidence	O
63659	of	O
63660	hemochromatosis	b-PROBLEM
63661	and	O
63662	her	b-TEST
63663	hep	i-TEST
63664	serologies	i-TEST
63665	were	O
63666	all	O
63667	negative	O
63668	.	O
63669	she	O
63670	also	O
63671	had	O
63672	negative	b-TEST
63673	antimitochondrial	i-TEST
63674	antibody	i-TEST
63675	and	O
63676	she	O
63677	also	O
63678	had	O
63679	no	O
63680	evidence	O
63681	of	O
63682	ceruloplasmin	b-PROBLEM
63683	.	O
63684	over	O
63685	the	b-OCCURRENCE
63686	course	i-OCCURRENCE
63687	of	i-OCCURRENCE
63688	her	i-OCCURRENCE
63689	admission	i-OCCURRENCE
63690	were	O
63691	also	O
63692	sent	O
63693	an	b-TEST
63694	alpha-1-antitrypsin	i-TEST
63695	,	O
63696	which	O
63697	was	O
63698	negative	O
63699	.	O
63700	she	O
63701	did	O
63702	very	O
63703	well	b-EVIDENTIAL
63704	over	O
63705	the	b-OCCURRENCE
63706	course	i-OCCURRENCE
63707	of	i-OCCURRENCE
63708	her	i-OCCURRENCE
63709	admission	i-OCCURRENCE
63710	with	O
63711	no	O
63712	evidence	O
63713	of	O
63714	further	b-PROBLEM
63715	bleeding	i-PROBLEM
63716	.	O
63717	her	b-TEST
63718	hematocrit	i-TEST
63719	stayed	O
63720	stable	b-EVIDENTIAL
63721	at	O
63722	approximately	O
63723	32	O
63724	.	O
63725	we	O
63726	also	O
63727	did	O
63728	an	b-TEST
63729	ultrasound	i-TEST
63730	guided	i-TEST
63731	paracentesis	i-TEST
63732	.	O
63733	the	b-TEST
63734	peritoneal	i-TEST
63735	fluid	i-TEST
63736	showed	b-EVIDENTIAL
63737	a	b-TEST
63738	glucose	i-TEST
63739	of	O
63740	244	O
63741	,	O
63742	total	b-TEST
63743	protein	i-TEST
63744	0.8	O
63745	and	O
63746	a	b-TEST
63747	albumin	i-TEST
63748	of	O
63749	0.5	O
63750	,	O
63751	globulin	b-TEST
63752	0.3	O
63753	,	O
63754	amylase	b-TEST
63755	16	O
63756	,	O
63757	ldh	b-TEST
63758	of	O
63759	51	O
63760	.	O
63761	the	b-TEST
63762	serum	i-TEST
63763	albumin	i-TEST
63764	gradient	i-TEST
63765	was	O
63766	1.8	O
63767	consistent	O
63768	with	O
63769	portal	b-PROBLEM
63770	hypertension	i-PROBLEM
63771	.	O
63772	the	b-TEST
63773	cell	i-TEST
63774	count	i-TEST
63775	showed	b-EVIDENTIAL
63776	a	b-TEST
63777	white	i-TEST
63778	blood	i-TEST
63779	cell	i-TEST
63780	count	i-TEST
63781	of	O
63782	160	O
63783	with	O
63784	16%	O
63785	polys	O
63786	.	O
63787	she	O
63788	therefore	O
63789	_________	O
63790	criteria	O
63791	for	O
63792	a	b-PROBLEM
63793	spontaneous	i-PROBLEM
63794	bacterial	i-PROBLEM
63795	peritonitis	i-PROBLEM
63796	.	O
63797	her	b-TEST
63798	platelet	i-TEST
63799	count	i-TEST
63800	stayed	O
63801	persistently	b-EVIDENTIAL
63802	low	i-EVIDENTIAL
63803	and	O
63804	we	O
63805	decided	b-EVIDENTIAL
63806	that	O
63807	it	O
63808	might	O
63809	be	O
63810	due	O
63811	to	O
63812	cimetidine	b-TREATMENT
63813	.	O
63814	therefore	O
63815	we	O
63816	switched	O
63817	her	b-TREATMENT
63818	cimetidine	i-TREATMENT
63819	to	O
63820	prilosec	b-TREATMENT
63821	.	O
63822	by	O
63823	the	b-DATE
63824	2th	i-DATE
63825	the	O
63826	patient	O
63827	was	O
63828	feeling	O
63829	very	O
63830	well	b-EVIDENTIAL
63831	and	O
63832	desired	O
63833	to	O
63834	transfer	O
63835	or	O
63836	discharge	O
63837	to	O
63838	home	O
63839	.	O
63840	she	O
63841	wanted	O
63842	to	O
63843	be	O
63844	closer	O
63845	to	O
63846	north	O
63847	dakota	O
63848	.	O
63849	after	O
63850	discussion	b-OCCURRENCE
63851	with	O
63852	her	O
63853	private	O
63854	physician	O
63855	,	O
63856	doctor	O
63857	joasscchird	O
63858	,	O
63859	tel.	O
63860	090-249-6079	O
63861	,	O
63862	at	O
63863	va	b-CLINICAL_DEPT
63864	sit	i-CLINICAL_DEPT
63865	namar	i-CLINICAL_DEPT
63866	healthcare	i-CLINICAL_DEPT
63867	and	O
63868	doctor	O
63869	acrookesjo	O
63870	at	O
63871	do	b-CLINICAL_DEPT
63872	of	i-CLINICAL_DEPT
63873	hospital	i-CLINICAL_DEPT
63874	,	O
63875	the	O
63876	patient	O
63877	was	O
63878	judged	O
63879	to	O
63880	be	O
63881	fit	O
63882	for	O
63883	discharge	b-OCCURRENCE
63884	and	O
63885	she	O
63886	was	O
63887	sent	b-OCCURRENCE
63888	home	i-OCCURRENCE
63889	with	O
63890	ah	b-TREATMENT
63891	and	O
63892	physical	b-TREATMENT
63893	therapy	i-TREATMENT
63894	.	O
63895	she	O
63896	was	O
63897	quite	b-OCCURRENCE
63898	able	i-OCCURRENCE
63899	to	i-OCCURRENCE
63900	climb	i-OCCURRENCE
63901	stairs	i-OCCURRENCE
63902	on	O
63903	her	O
63904	own	O
63905	in	O
63906	the	b-OCCURRENCE
63907	hospital	i-OCCURRENCE
63908	.	O
63909	she	O
63910	is	O
63911	to	O
63912	follow	b-OCCURRENCE
63913	up	i-OCCURRENCE
63914	with	O
63915	doctor	O
63916	acrookesjo	O
63917	in	O
63918	one	b-DURATION
63919	week	i-DURATION
63920	and	O
63921	doctor	O
63922	work	O
63923	the	O
63924	gastrointestinal	O
63925	fellow	O
63926	here	O
63927	at	O
63928	puomc	b-CLINICAL_DEPT
63929	in	O
63930	2	b-DURATION
63931	weeks	i-DURATION
63932	.	O
63933	she	O
63934	may	O
63935	require	O
63936	a	b-TEST
63937	repeat	i-TEST
63938	upper	i-TEST
63939	endoscopy	i-TEST
63940	study	i-TEST
63941	to	O
63942	see	O
63943	if	O
63944	she	O
63945	needs	O
63946	any	b-TREATMENT
63947	rebanding	i-TREATMENT
63948	.	O
63949	the	O
63950	patient	O
63951	however	O
63952	complained	b-EVIDENTIAL
63953	of	O
63954	a	b-PROBLEM
63955	persistent	i-PROBLEM
63956	wheeze	i-PROBLEM
63957	with	O
63958	beta	b-TREATMENT
63959	blocker	i-TREATMENT
63960	,	O
63961	therefore	O
63962	it	O
63963	was	O
63964	agreed	O
63965	that	O
63966	we	O
63967	would	O
63968	stop	O
63969	the	b-TREATMENT
63970	beta	i-TREATMENT
63971	blocker	i-TREATMENT
63972	until	O
63973	the	O
63974	patient	O
63975	was	O
63976	followed	b-OCCURRENCE
63977	up	i-OCCURRENCE
63978	as	O
63979	an	O
63980	outpatient	O
63981	.	O
63982		O
63983	admission	b-OCCURRENCE
63984	date	O
63985	:	O
63986	2011-10-17	b-ADMISSION
63987	discharge	b-OCCURRENCE
63988	date	O
63989	:	O
63990	2011-10-31	b-DISCHARGE
63991	service	O
63992	:	O
63993	cardiothor	O
63994	history	O
63995	of	O
63996	present	O
63997	illness	O
63998	:	O
63999	this	O
64000	is	O
64001	a	O
64002	56	O
64003	year-old	O
64004	gentleman	O
64005	with	O
64006	severe	b-PROBLEM
64007	aortic	i-PROBLEM
64008	stenosis	i-PROBLEM
64009	,	O
64010	reports	b-EVIDENTIAL
64011	having	O
64012	been	O
64013	told	O
64014	he	O
64015	had	O
64016	a	b-PROBLEM
64017	heart	i-PROBLEM
64018	murmur	i-PROBLEM
64019	many	b-DATE
64020	years	i-DATE
64021	ago	i-DATE
64022	but	O
64023	just	O
64024	recently	O
64025	diagnosed	b-OCCURRENCE
64026	with	O
64027	aortic	b-PROBLEM
64028	stenosis	i-PROBLEM
64029	.	O
64030	he	O
64031	has	O
64032	had	O
64033	mild	b-PROBLEM
64034	dyspnea	i-PROBLEM
64035	on	O
64036	exertion	O
64037	increasing	b-OCCURRENCE
64038	over	O
64039	the	O
64040	past	O
64041	couple	b-DURATION
64042	of	i-DURATION
64043	months	i-DURATION
64044	prior	O
64045	to	O
64046	admission	b-OCCURRENCE
64047	.	O
64048	an	b-TEST
64049	echocardiogram	i-TEST
64050	in	O
64051	2011-09-05	b-DATE
64052	revealed	b-EVIDENTIAL
64053	a	b-PROBLEM
64054	left	i-PROBLEM
64055	ventricular	i-PROBLEM
64056	ejection	i-PROBLEM
64057	fraction	i-PROBLEM
64058	of	O
64059	20	O
64060	to	O
64061	25%	O
64062	.	O
64063		O
64064	admission	b-OCCURRENCE
64065	date	O
64066	:	O
64067	09/26/2001	b-ADMISSION
64068	discharge	b-OCCURRENCE
64069	date	O
64070	:	O
64071	10/06/2001	b-DISCHARGE
64072	history	O
64073	of	O
64074	present	O
64075	illness	O
64076	:	O
64077	the	O
64078	patient	O
64079	is	O
64080	a	O
64081	60-year-old	O
64082	male	O
64083	with	O
64084	a	O
64085	past	O
64086	medical	O
64087	history	O
64088	notable	O
64089	for	O
64090	coronary	b-PROBLEM
64091	artery	i-PROBLEM
64092	disease	i-PROBLEM
64093	and	O
64094	cabg	b-TREATMENT
64095	x2	b-FREQUENCY
64096	in	O
64097	2001	b-DATE
64098	.	O
64099	the	O
64100	patient	O
64101	has	O
64102	felt	O
64103	unwell	b-PROBLEM
64104	since	O
64105	7/21	b-DATE
64106	after	O
64107	his	b-PROBLEM
64108	non-q	i-PROBLEM
64109	wave	i-PROBLEM
64110	mi	i-PROBLEM
64111	.	O
64112	the	O
64113	patient	O
64114	,	O
64115	at	O
64116	this	O
64117	time	O
64118	,	O
64119	was	O
64120	started	O
64121	on	O
64122	statin	b-TREATMENT
64123	and	O
64124	developed	O
64125	in	O
64126	arthritis	b-PROBLEM
64127	approximately	O
64128	one	b-DURATION
64129	month	i-DURATION
64130	later	O
64131	with	O
64132	joint	b-PROBLEM
64133	pain	i-PROBLEM
64134	,	O
64135	myalgia	b-PROBLEM
64136	and	O
64137	fatigue	b-PROBLEM
64138	.	O
64139	no	O
64140	clear	b-OCCURRENCE
64141	diagnosis	i-OCCURRENCE
64142	was	O
64143	made	O
64144	.	O
64145	the	O
64146	patient	O
64147	was	O
64148	presumed	O
64149	to	O
64150	have	O
64151	a	b-PROBLEM
64152	rheumatoid	i-PROBLEM
64153	factor	i-PROBLEM
64154	negative	i-PROBLEM
64155	,	i-PROBLEM
64156	rheumatoid	i-PROBLEM
64157	arthritis	i-PROBLEM
64158	and	O
64159	he	O
64160	was	O
64161	prescribed	O
64162	naprosyn	b-TREATMENT
64163	,	O
64164	prednisone	b-TREATMENT
64165	and	O
64166	sulfasalazine	b-TREATMENT
64167	.	O
64168	he	O
64169	had	O
64170	a	b-TEST
64171	cabg	i-TEST
64172	review	i-TEST
64173	in	O
64174	2/21	b-DATE
64175	.	O
64176	his	b-TREATMENT
64177	first	i-TREATMENT
64178	cabg	i-TREATMENT
64179	was	O
64180	in	O
64181	02/89	b-DATE
64182	.	O
64183	since	O
64184	2/21	b-DATE
64185	,	O
64186	he	O
64187	has	O
64188	had	O
64189	increasing	b-PROBLEM
64190	weight	i-PROBLEM
64191	loss	i-PROBLEM
64192	of	O
64193	30-49	O
64194	pounds	O
64195	,	O
64196	night	b-PROBLEM
64197	sweats	i-PROBLEM
64198	which	O
64199	he	O
64200	attributed	O
64201	to	O
64202	the	b-TREATMENT
64203	prednisone	i-TREATMENT
64204	and	O
64205	increased	b-PROBLEM
64206	fatigue	i-PROBLEM
64207	and	O
64208	myalgias	b-PROBLEM
64209	.	O
64210	the	O
64211	patient	O
64212	has	O
64213	gradually	O
64214	taken	b-PROBLEM
64215	to	i-PROBLEM
64216	bed	i-PROBLEM
64217	with	O
64218	decreasing	b-PROBLEM
64219	activity	i-PROBLEM
64220	.	O
64221	in	O
64222	late	O
64223	7/22	b-DATE
64224	,	O
64225	sulfasalazine	b-TREATMENT
64226	was	O
64227	started	O
64228	at	O
64229	one	O
64230	tab	O
64231	three	b-FREQUENCY
64232	times	i-FREQUENCY
64233	a	i-FREQUENCY
64234	day	i-FREQUENCY
64235	.	O
64236	the	O
64237	patient	O
64238	subsequently	O
64239	developed	O
64240	diffuse	b-PROBLEM
64241	abdominal	i-PROBLEM
64242	pain	i-PROBLEM
64243	,	O
64244	nausea	b-PROBLEM
64245	,	O
64246	vomiting	b-PROBLEM
64247	,	O
64248	and	O
64249	decreased	b-PROBLEM
64250	p.o.	i-PROBLEM
64251	intake	i-PROBLEM
64252	.	O
64253	a	b-PROBLEM
64254	guaiac	i-PROBLEM
64255	positive	i-PROBLEM
64256	stool	i-PROBLEM
64257	was	O
64258	also	O
64259	noted	O
64260	in	O
64261	the	O
64262	month	O
64263	of	O
64264	july	b-DATE
64265	.	O
64266	10	b-DURATION
64267	days	i-DURATION
64268	prior	O
64269	to	O
64270	admission	b-OCCURRENCE
64271	,	O
64272	the	O
64273	patient	O
64274	&apos;s	O
64275	primary	O
64276	care	O
64277	physician	O
64278	increased	b-OCCURRENCE
64279	his	b-TREATMENT
64280	sulfasalazine	i-TREATMENT
64281	dose	i-TREATMENT
64282	to	O
64283	two	O
64284	tabs	O
64285	three	b-FREQUENCY
64286	times	i-FREQUENCY
64287	a	i-FREQUENCY
64288	day	i-FREQUENCY
64289	.	O
64290	the	b-TREATMENT
64291	patient	i-TREATMENT
64292	&apos;s	i-TREATMENT
64293	prednisone	i-TREATMENT
64294	was	O
64295	increased	b-OCCURRENCE
64296	to	O
64297	60	O
64298	mg	O
64299	q.d.	b-FREQUENCY
64300	as	O
64301	the	O
64302	patient	O
64303	was	O
64304	diagnosed	O
64305	with	O
64306	an	b-PROBLEM
64307	arthritis	i-PROBLEM
64308	flare	i-PROBLEM
64309	.	O
64310	the	b-TREATMENT
64311	prednisone	i-TREATMENT
64312	dose	i-TREATMENT
64313	was	O
64314	gradually	b-OCCURRENCE
64315	tapered	i-OCCURRENCE
64316	to	O
64317	20	O
64318	mg	O
64319	q.d.	b-FREQUENCY
64320	the	b-DATE
64321	day	i-DATE
64322	before	O
64323	admission	b-OCCURRENCE
64324	,	O
64325	the	O
64326	patient	O
64327	developed	O
64328	a	b-PROBLEM
64329	fever	i-PROBLEM
64330	to	O
64331	102	O
64332	degrees	O
64333	and	O
64334	increasing	b-PROBLEM
64335	abdominal	i-PROBLEM
64336	pain	i-PROBLEM
64337	.	O
64338	he	O
64339	presented	b-EVIDENTIAL
64340	to	O
64341	an	b-CLINICAL_DEPT
64342	outside	i-CLINICAL_DEPT
64343	hops	i-CLINICAL_DEPT
64344	where	O
64345	he	O
64346	was	O
64347	noted	O
64348	to	O
64349	be	O
64350	leukopenic	b-PROBLEM
64351	with	O
64352	a	b-TEST
64353	white	i-TEST
64354	blood	i-TEST
64355	cell	i-TEST
64356	count	i-TEST
64357	of	O
64358	0.6	O
64359	,	O
64360	0	O
64361	neutrophils	b-TEST
64362	,	O
64363	a	b-TEST
64364	hematocrit	i-TEST
64365	of	O
64366	32	O
64367	,	O
64368	platelets	b-TEST
64369	of	O
64370	326	O
64371	,	O
64372	a	b-TEST
64373	mcv	i-TEST
64374	of	O
64375	79	O
64376	,	O
64377	and	O
64378	rdw	b-TEST
64379	of	O
64380	22	O
64381	.	O
64382	the	O
64383	patient	O
64384	was	O
64385	given	O
64386	iv	b-TREATMENT
64387	fluids	i-TREATMENT
64388	and	O
64389	treated	O
64390	with	O
64391	imipenem	b-TREATMENT
64392	,	O
64393	transferred	b-OCCURRENCE
64394	to	O
64395	ca	b-CLINICAL_DEPT
64396	valley	i-CLINICAL_DEPT
64397	hospital	i-CLINICAL_DEPT
64398	ed	i-CLINICAL_DEPT
64399	,	O
64400	where	O
64401	it	O
64402	was	O
64403	noted	O
64404	that	O
64405	the	O
64406	patient	O
64407	had	O
64408	face	b-PROBLEM
64409	and	i-PROBLEM
64410	neck	i-PROBLEM
64411	swelling	i-PROBLEM
64412	,	O
64413	as	O
64414	well	O
64415	as	O
64416	erythema	b-PROBLEM
64417	and	O
64418	cervical	b-PROBLEM
64419	lymphadenopathy	i-PROBLEM
64420	.	O
64421	the	O
64422	patient	O
64423	states	b-EVIDENTIAL
64424	that	O
64425	his	b-PROBLEM
64426	swelling	i-PROBLEM
64427	of	i-PROBLEM
64428	his	i-PROBLEM
64429	face	i-PROBLEM
64430	began	O
64431	two	b-DATE
64432	days	i-DATE
64433	prior	O
64434	to	O
64435	admission	b-OCCURRENCE
64436	and	O
64437	has	O
64438	doubled	O
64439	since	O
64440	then	O
64441	.	O
64442	in	O
64443	the	b-CLINICAL_DEPT
64444	emergency	i-CLINICAL_DEPT
64445	department	i-CLINICAL_DEPT
64446	,	O
64447	ct	b-TEST
64448	of	i-TEST
64449	head	i-TEST
64450	,	i-TEST
64451	neck	i-TEST
64452	and	i-TEST
64453	abdomen	i-TEST
64454	were	O
64455	performed	O
64456	.	O
64457	the	b-TEST
64458	ct	i-TEST
64459	of	i-TEST
64460	the	i-TEST
64461	abdomen	i-TEST
64462	was	O
64463	without	O
64464	lymphadenopathy	b-PROBLEM
64465	,	O
64466	revealed	b-EVIDENTIAL
64467	a	b-PROBLEM
64468	right	i-PROBLEM
64469	renal	i-PROBLEM
64470	cyst	i-PROBLEM
64471	,	O
64472	otherwise	O
64473	unremarkable	O
64474	.	O
64475	the	b-TEST
64476	ct	i-TEST
64477	of	i-TEST
64478	head	i-TEST
64479	and	i-TEST
64480	neck	i-TEST
64481	was	O
64482	likewise	O
64483	unremarkable	O
64484	showing	b-EVIDENTIAL
64485	no	O
64486	evidence	O
64487	of	O
64488	fasciitis	b-PROBLEM
64489	or	O
64490	deep	b-PROBLEM
64491	tissue	i-PROBLEM
64492	thread	i-PROBLEM
64493	.	O
64494	no	O
64495	abscesses	b-PROBLEM
64496	were	O
64497	noted	O
64498	.	O
64499	review	O
64500	of	O
64501	systems	O
64502	:	O
64503	the	O
64504	patient	O
64505	denies	b-EVIDENTIAL
64506	shortness	b-PROBLEM
64507	of	i-PROBLEM
64508	breath	i-PROBLEM
64509	,	O
64510	chest	b-PROBLEM
64511	pain	i-PROBLEM
64512	,	O
64513	orthopnea	b-PROBLEM
64514	,	O
64515	no	O
64516	dysuria	b-PROBLEM
64517	,	O
64518	hematuria	b-PROBLEM
64519	,	O
64520	no	O
64521	visual	b-PROBLEM
64522	changes	i-PROBLEM
64523	,	O
64524	no	O
64525	rashes	b-PROBLEM
64526	,	O
64527	no	O
64528	blurry	b-PROBLEM
64529	vision	i-PROBLEM
64530	.	O
64531	hospital	O
64532	course	O
64533	:	O
64534	the	O
64535	patient	O
64536	was	O
64537	started	O
64538	on	O
64539	ceftazidime	b-TREATMENT
64540	,	O
64541	nafcillin	b-TREATMENT
64542	and	O
64543	flagyl	b-TREATMENT
64544	for	O
64545	concern	O
64546	of	O
64547	a	b-PROBLEM
64548	soft	i-PROBLEM
64549	tissue	i-PROBLEM
64550	infection	i-PROBLEM
64551	.	O
64552	neutropenic	b-TREATMENT
64553	precautions	i-TREATMENT
64554	were	O
64555	taken	O
64556	.	O
64557	the	O
64558	patient	O
64559	had	O
64560	a	b-TEST
64561	bone	i-TEST
64562	marrow	i-TEST
64563	biopsy	i-TEST
64564	which	O
64565	showed	b-EVIDENTIAL
64566	myeloid	b-PROBLEM
64567	arrest	i-PROBLEM
64568	and	O
64569	probable	O
64570	neutropenia	b-PROBLEM
64571	from	O
64572	a	b-OCCURRENCE
64573	drug-related	i-OCCURRENCE
64574	cause	i-OCCURRENCE
64575	presumed	O
64576	to	O
64577	be	O
64578	the	b-TREATMENT
64579	sulfasalazine	i-TREATMENT
64580	.	O
64581	over	O
64582	the	O
64583	course	O
64584	of	O
64585	the	b-OCCURRENCE
64586	hospitalization	i-OCCURRENCE
64587	,	O
64588	the	b-TEST
64589	patient	i-TEST
64590	&apos;s	i-TEST
64591	white	i-TEST
64592	blood	i-TEST
64593	cell	i-TEST
64594	count	i-TEST
64595	rose	b-OCCURRENCE
64596	from	O
64597	0.4	O
64598	to	O
64599	6.3	O
64600	after	O
64601	he	O
64602	was	O
64603	given	O
64604	g-csf	b-TREATMENT
64605	,	O
64606	a	O
64607	course	O
64608	lasting	O
64609	from	O
64610	9/28/01	b-DATE
64611	until	O
64612	9/30/01	b-DATE
64613	.	O
64614	after	O
64615	the	b-TREATMENT
64616	g-csf	i-TREATMENT
64617	,	O
64618	the	b-TEST
64619	absolute	i-TEST
64620	neutrophil	i-TEST
64621	count	i-TEST
64622	was	O
64623	greater	O
64624	than	O
64625	8000	O
64626	.	O
64627	on	O
64628	10/3/01	b-DATE
64629	,	O
64630	the	O
64631	patient	O
64632	had	O
64633	a	b-TEST
64634	repeat	i-TEST
64635	head	i-TEST
64636	and	i-TEST
64637	neck	i-TEST
64638	ct	i-TEST
64639	,	O
64640	which	O
64641	showed	b-EVIDENTIAL
64642	a	b-PROBLEM
64643	right	i-PROBLEM
64644	parotitis	i-PROBLEM
64645	and	O
64646	left	b-PROBLEM
64647	submandibular	i-PROBLEM
64648	lymphadenopathy	i-PROBLEM
64649	with	O
64650	some	b-PROBLEM
64651	necrosis	i-PROBLEM
64652	.	O
64653	no	O
64654	frank	b-PROBLEM
64655	abscesses	i-PROBLEM
64656	.	O
64657	the	b-TREATMENT
64658	patient	i-TREATMENT
64659	&apos;s	i-TREATMENT
64660	antibiotics	i-TREATMENT
64661	were	O
64662	changed	O
64663	to	O
64664	clindamycin	b-TREATMENT
64665	300	O
64666	mg	O
64667	q.i.d.	b-FREQUENCY
64668	and	O
64669	patient	O
64670	was	O
64671	also	O
64672	put	O
64673	on	O
64674	sialagogue	b-TREATMENT
64675	.	O
64676	over	O
64677	the	O
64678	course	O
64679	of	O
64680	the	b-OCCURRENCE
64681	hospitalization	i-OCCURRENCE
64682	,	O
64683	the	b-PROBLEM
64684	swelling	i-PROBLEM
64685	and	O
64686	tenderness	b-PROBLEM
64687	and	O
64688	erythema	b-PROBLEM
64689	have	O
64690	steadily	b-OCCURRENCE
64691	decreased	i-OCCURRENCE
64692	.	O
64693	recommendations	O
64694	on	O
64695	antibiotics	b-TREATMENT
64696	were	O
64697	made	O
64698	by	O
64699	infectious	O
64700	disease	O
64701	team	O
64702	,	O
64703	who	O
64704	was	O
64705	consulted	b-OCCURRENCE
64706	.	O
64707	rheumatology	O
64708	was	O
64709	also	O
64710	consulted	b-OCCURRENCE
64711	for	O
64712	patient	O
64713	and	O
64714	after	O
64715	workup	b-TEST
64716	,	O
64717	it	O
64718	was	O
64719	believed	O
64720	that	O
64721	arthritis	b-PROBLEM
64722	may	O
64723	be	O
64724	a	b-PROBLEM
64725	rheumatoid	i-PROBLEM
64726	factor	i-PROBLEM
64727	negative	i-PROBLEM
64728	,	i-PROBLEM
64729	rheumatoid	i-PROBLEM
64730	polyarthritis	i-PROBLEM
64731	.	O
64732	rheumatology	O
64733	recommended	O
64734	a	b-TREATMENT
64735	taper	i-TREATMENT
64736	of	i-TREATMENT
64737	his	i-TREATMENT
64738	prednisone	i-TREATMENT
64739	to	O
64740	20	O
64741	mg	O
64742	q.d.	b-FREQUENCY
64743	and	O
64744	the	O
64745	patient	O
64746	will	O
64747	be	O
64748	followed	b-OCCURRENCE
64749	by	O
64750	the	O
64751	rheumatology	O
64752	service	O
64753	.	O
64754	the	O
64755	oncology	O
64756	service	O
64757	was	O
64758	also	O
64759	consulted	b-OCCURRENCE
64760	for	O
64761	patient	O
64762	and	O
64763	performed	O
64764	a	b-TEST
64765	bone	i-TEST
64766	marrow	i-TEST
64767	biopsy	i-TEST
64768	.	O
64769	throughout	O
64770	his	O
64771	course	O
64772	during	O
64773	this	b-OCCURRENCE
64774	hospitalization	i-OCCURRENCE
64775	,	O
64776	the	O
64777	patient	O
64778	was	O
64779	also	O
64780	followed	b-OCCURRENCE
64781	by	i-OCCURRENCE
64782	the	i-OCCURRENCE
64783	ent	i-OCCURRENCE
64784	service	i-OCCURRENCE
64785	.	O
64786	the	O
64787	ent	O
64788	physicians	O
64789	did	O
64790	not	O
64791	recommend	O
64792	any	b-TREATMENT
64793	procedures	i-TREATMENT
64794	,	O
64795	incision	b-TREATMENT
64796	and	O
64797	drainage	b-TREATMENT
64798	for	O
64799	his	b-PROBLEM
64800	right	i-PROBLEM
64801	parotitis	i-PROBLEM
64802	or	O
64803	left	b-PROBLEM
64804	submandibular	i-PROBLEM
64805	cervical	i-PROBLEM
64806	lymph	i-PROBLEM
64807	node	i-PROBLEM
64808	necrosis	i-PROBLEM
64809	.	O
64810	the	O
64811	ent	O
64812	team	O
64813	recommended	O
64814	watching	b-TEST
64815	patient	i-TEST
64816	in-house	i-TEST
64817	for	O
64818	two	b-DURATION
64819	days	i-DURATION
64820	after	O
64821	his	b-TEST
64822	repeat	i-TEST
64823	imaging	i-TEST
64824	on	O
64825	10/3/01	b-DATE
64826	,	O
64827	and	O
64828	to	O
64829	continue	O
64830	antibiotic	b-TREATMENT
64831	coverage	i-TREATMENT
64832	with	O
64833	clindamycin	b-TREATMENT
64834	.	O
64835	the	O
64836	patient	O
64837	had	O
64838	no	O
64839	positive	b-PROBLEM
64840	blood	i-PROBLEM
64841	cultures	i-PROBLEM
64842	during	O
64843	his	b-OCCURRENCE
64844	hospitalization	i-OCCURRENCE
64845	and	O
64846	remained	O
64847	afebrile	b-PROBLEM
64848	after	O
64849	the	b-DATE
64850	second	i-DATE
64851	day	i-DATE
64852	of	O
64853	admission	b-OCCURRENCE
64854	.	O
64855		O
64856	admission	b-OCCURRENCE
64857	date	O
64858	:	O
64859	2012-03-01	b-ADMISSION
64860	discharge	b-OCCURRENCE
64861	date	O
64862	:	O
64863	2012-03-13	b-DISCHARGE
64864	service	O
64865	:	O
64866	cmed	O
64867	ccu	O
64868	history	O
64869	of	O
64870	present	O
64871	illness	O
64872	:	O
64873	patient	O
64874	is	O
64875	a	O
64876	26	O
64877	-	O
64878	year-old	O
64879	female	O
64880	with	O
64881	a	O
64882	past	O
64883	medical	O
64884	history	O
64885	significant	O
64886	for	O
64887	nonischemic	b-PROBLEM
64888	dilated	i-PROBLEM
64889	cardiomyopathy	i-PROBLEM
64890	with	O
64891	an	b-TEST
64892	ejection	i-TEST
64893	fraction	i-TEST
64894	of	O
64895	15-20%	O
64896	,	O
64897	who	O
64898	presents	b-OCCURRENCE
64899	with	O
64900	a	b-DURATION
64901	one-week	i-DURATION
64902	history	O
64903	of	O
64904	progressive	b-PROBLEM
64905	shortness	i-PROBLEM
64906	of	i-PROBLEM
64907	breath	i-PROBLEM
64908	.	O
64909	she	O
64910	reports	b-EVIDENTIAL
64911	orthopnea	b-PROBLEM
64912	with	O
64913	an	b-PROBLEM
64914	increasing	i-PROBLEM
64915	pillow	i-PROBLEM
64916	requirement	i-PROBLEM
64917	of	O
64918	2-4	O
64919	with	O
64920	paroxysmal	b-PROBLEM
64921	nocturnal	i-PROBLEM
64922	dyspnea	i-PROBLEM
64923	.	O
64924	patient	O
64925	also	O
64926	reports	b-EVIDENTIAL
64927	a	b-PROBLEM
64928	6-pound	i-PROBLEM
64929	weight	i-PROBLEM
64930	gain	i-PROBLEM
64931	over	O
64932	the	O
64933	last	O
64934	four	b-DURATION
64935	days	i-DURATION
64936	with	O
64937	associated	O
64938	lower	b-PROBLEM
64939	extremity	i-PROBLEM
64940	edema	i-PROBLEM
64941	.	O
64942	she	O
64943	also	O
64944	reports	b-EVIDENTIAL
64945	positional	b-PROBLEM
64946	chest	i-PROBLEM
64947	pain	i-PROBLEM
64948	,	O
64949	which	O
64950	is	O
64951	worse	O
64952	with	O
64953	lying	O
64954	down	O
64955	and	O
64956	relieved	O
64957	with	O
64958	sitting	O
64959	up	O
64960	.	O
64961	she	O
64962	denies	b-EVIDENTIAL
64963	any	b-PROBLEM
64964	pain	i-PROBLEM
64965	with	O
64966	activity	O
64967	.	O
64968	she	O
64969	also	O
64970	reports	b-EVIDENTIAL
64971	a	b-PROBLEM
64972	cough	i-PROBLEM
64973	productive	O
64974	of	O
64975	green	b-PROBLEM
64976	sputum	i-PROBLEM
64977	for	O
64978	approximately	O
64979	one	b-DURATION
64980	week	i-DURATION
64981	.	O
64982	she	O
64983	does	O
64984	report	b-EVIDENTIAL
64985	chills	b-PROBLEM
64986	,	O
64987	but	O
64988	no	O
64989	fevers	b-PROBLEM
64990	.	O
64991	in	O
64992	the	b-CLINICAL_DEPT
64993	emergency	i-CLINICAL_DEPT
64994	department	i-CLINICAL_DEPT
64995	,	O
64996	she	O
64997	was	O
64998	started	O
64999	on	O
65000	a	b-TREATMENT
65001	nesiritide	i-TREATMENT
65002	drip	i-TREATMENT
65003	and	O
65004	responded	b-OCCURRENCE
65005	well	i-OCCURRENCE
65006	with	O
65007	2000	O
65008	cc	O
65009	urine	O
65010	output	O
65011	.	O
65012	hospital	O
65013	course	O
65014	:	O
65015	1.	O
65016	congestive	b-PROBLEM
65017	heart	i-PROBLEM
65018	failure	i-PROBLEM
65019	:	O
65020	patient	O
65021	was	O
65022	diuresed	b-TREATMENT
65023	effectively	O
65024	with	O
65025	nesiritide	b-TREATMENT
65026	and	O
65027	lasix	b-TREATMENT
65028	.	O
65029	patient	b-TEST
65030	's	i-TEST
65031	weight	i-TEST
65032	on	O
65033	admission	b-OCCURRENCE
65034	was	O
65035	250	O
65036	pounds	O
65037	,	O
65038	and	O
65039	on	O
65040	the	b-DATE
65041	day	i-DATE
65042	of	i-DATE
65043	discharge	i-DATE
65044	was	O
65045	244	O
65046	pounds	O
65047	which	O
65048	was	O
65049	back	O
65050	to	O
65051	her	b-TEST
65052	dry	i-TEST
65053	weight	i-TEST
65054	.	O
65055	she	O
65056	had	O
65057	lost	b-OCCURRENCE
65058	the	i-OCCURRENCE
65059	6	i-OCCURRENCE
65060	pounds	i-OCCURRENCE
65061	that	O
65062	she	O
65063	reported	b-EVIDENTIAL
65064	gaining	b-PROBLEM
65065	in	O
65066	the	b-DURATION
65067	four	i-DURATION
65068	days	i-DURATION
65069	prior	O
65070	to	O
65071	her	b-OCCURRENCE
65072	hospitalization	i-OCCURRENCE
65073	.	O
65074	patient	O
65075	was	O
65076	continued	O
65077	on	O
65078	her	b-TREATMENT
65079	toprol	i-TREATMENT
65080	,	O
65081	her	b-TREATMENT
65082	lisinopril	i-TREATMENT
65083	,	O
65084	and	O
65085	her	b-TREATMENT
65086	digoxin	i-TREATMENT
65087	.	O
65088	patient	b-TREATMENT
65089	's	i-TREATMENT
65090	coumadin	i-TREATMENT
65091	was	O
65092	held	O
65093	for	O
65094	right	b-TEST
65095	heart	i-TEST
65096	catheterization	i-TEST
65097	and	O
65098	biopsy	b-TEST
65099	,	O
65100	and	O
65101	then	O
65102	ep	b-TEST
65103	study	i-TEST
65104	with	O
65105	icd	b-TREATMENT
65106	placement	i-TREATMENT
65107	.	O
65108	patient	O
65109	did	O
65110	have	O
65111	woodrow	b-TEST
65112	betty	i-TEST
65113	,	O
65114	spep	b-TEST
65115	,	O
65116	and	O
65117	anticardiolipin	b-TEST
65118	antibody	i-TEST
65119	sent	O
65120	for	O
65121	further	b-TEST
65122	workup	i-TEST
65123	of	O
65124	the	O
65125	etiology	O
65126	of	O
65127	her	b-PROBLEM
65128	cardiomyopathy	i-PROBLEM
65129	.	O
65130	the	b-TEST
65131	courtney	i-TEST
65132	,	O
65133	spep	b-TEST
65134	,	O
65135	and	O
65136	anticardiolipin	b-TEST
65137	antibody	i-TEST
65138	were	O
65139	all	O
65140	negative	O
65141	.	O
65142	her	b-TEST
65143	cks	i-TEST
65144	did	O
65145	trend	b-OCCURRENCE
65146	down	i-OCCURRENCE
65147	over	O
65148	the	O
65149	course	O
65150	of	O
65151	her	b-OCCURRENCE
65152	hospital	i-OCCURRENCE
65153	stay	i-OCCURRENCE
65154	,	O
65155	and	O
65156	in	O
65157	the	O
65158	setting	O
65159	of	O
65160	her	O
65161	known	O
65162	clean	O
65163	coronaries	O
65164	on	O
65165	cardiac	b-TEST
65166	catheterization	i-TEST
65167	in	O
65168	2011-11-19	b-DATE
65169	,	O
65170	it	O
65171	was	O
65172	believed	O
65173	that	O
65174	a	b-PROBLEM
65175	myocarditis	i-PROBLEM
65176	might	O
65177	be	O
65178	the	O
65179	cause	O
65180	of	O
65181	her	b-PROBLEM
65182	elevated	i-PROBLEM
65183	cardiac	i-PROBLEM
65184	enzymes	i-PROBLEM
65185	and	O
65186	also	O
65187	could	O
65188	have	O
65189	exacerbated	O
65190	her	b-PROBLEM
65191	congestive	i-PROBLEM
65192	heart	i-PROBLEM
65193	failure	i-PROBLEM
65194	.	O
65195	patient	O
65196	did	O
65197	receive	O
65198	a	b-TEST
65199	right	i-TEST
65200	heart	i-TEST
65201	catheterization	i-TEST
65202	,	O
65203	which	b-TEST
65204	showed	b-EVIDENTIAL
65205	elevated	b-PROBLEM
65206	wedge	i-PROBLEM
65207	pressures	i-PROBLEM
65208	and	O
65209	biopsy	b-TEST
65210	specimens	i-TEST
65211	were	O
65212	obtained	O
65213	of	O
65214	the	O
65215	right	O
65216	ventricle	O
65217	.	O
65218	the	b-TEST
65219	results	i-TEST
65220	of	O
65221	these	b-TEST
65222	biopsies	i-TEST
65223	are	O
65224	still	O
65225	pending	O
65226	in	O
65227	pathology	O
65228	.	O
65229	post	O
65230	right	b-TEST
65231	heart	i-TEST
65232	catheterization	i-TEST
65233	and	O
65234	right	b-TEST
65235	ventricular	i-TEST
65236	biopsy	i-TEST
65237	,	O
65238	the	O
65239	patient	O
65240	was	O
65241	sent	O
65242	to	O
65243	the	b-CLINICAL_DEPT
65244	ccu	i-CLINICAL_DEPT
65245	for	O
65246	a	b-TREATMENT
65247	swan	i-TREATMENT
65248	-	i-TREATMENT
65249	guided	i-TREATMENT
65250	therapy	i-TREATMENT
65251	in	O
65252	the	O
65253	setting	O
65254	of	O
65255	her	b-PROBLEM
65256	elevated	i-PROBLEM
65257	wedge	i-PROBLEM
65258	pressures	i-PROBLEM
65259	and	O
65260	low	b-PROBLEM
65261	cardiac	i-PROBLEM
65262	output	i-PROBLEM
65263	.	O
65264	in	O
65265	the	b-CLINICAL_DEPT
65266	ccu	i-CLINICAL_DEPT
65267	,	O
65268	she	O
65269	was	O
65270	put	O
65271	on	O
65272	milrinone	b-TREATMENT
65273	with	O
65274	good	b-OCCURRENCE
65275	results	i-OCCURRENCE
65276	.	O
65277	patient	O
65278	was	O
65279	also	O
65280	seen	O
65281	by	O
65282	the	b-CLINICAL_DEPT
65283	pulmonary	i-CLINICAL_DEPT
65284	service	i-CLINICAL_DEPT
65285	here	b-CLINICAL_DEPT
65286	and	O
65287	had	O
65288	pulmonary	b-TEST
65289	function	i-TEST
65290	tests	i-TEST
65291	done	O
65292	as	O
65293	part	O
65294	of	O
65295	a	b-TEST
65296	pretransplant	i-TEST
65297	workup	i-TEST
65298	.	O
65299	there	O
65300	is	O
65301	no	O
65302	pulmonary	b-PROBLEM
65303	process	i-PROBLEM
65304	to	O
65305	exclude	O
65306	her	O
65307	from	O
65308	the	O
65309	transplant	O
65310	list	O
65311	as	O
65312	noted	b-EVIDENTIAL
65313	by	O
65314	the	b-CLINICAL_DEPT
65315	pulmonary	i-CLINICAL_DEPT
65316	service	i-CLINICAL_DEPT
65317	.	O
65318	patient	O
65319	did	O
65320	receive	O
65321	an	b-TREATMENT
65322	icd	i-TREATMENT
65323	during	O
65324	this	b-OCCURRENCE
65325	hospital	i-OCCURRENCE
65326	admission	i-OCCURRENCE
65327	without	O
65328	complication	b-PROBLEM
65329	.	O
65330	patient	O
65331	was	O
65332	in	O
65333	bigeminy	b-PROBLEM
65334	during	O
65335	the	O
65336	course	O
65337	of	O
65338	her	b-OCCURRENCE
65339	hospital	i-OCCURRENCE
65340	stay	i-OCCURRENCE
65341	,	O
65342	and	O
65343	did	O
65344	have	O
65345	frequent	O
65346	runs	O
65347	of	O
65348	ectopy	b-PROBLEM
65349	as	O
65350	noted	b-EVIDENTIAL
65351	on	O
65352	telemetry	b-TEST
65353	.	O
65354	2.	O
65355	her	b-PROBLEM
65356	right	i-PROBLEM
65357	lower	i-PROBLEM
65358	lobe	i-PROBLEM
65359	infiltrate	i-PROBLEM
65360	:	O
65361	patient	O
65362	did	O
65363	report	b-EVIDENTIAL
65364	a	b-PROBLEM
65365	cough	i-PROBLEM
65366	productive	O
65367	of	O
65368	green	b-PROBLEM
65369	sputum	i-PROBLEM
65370	on	O
65371	admission	b-OCCURRENCE
65372	.	O
65373	she	O
65374	received	O
65375	a	O
65376	full	O
65377	course	O
65378	of	O
65379	azithromycin	b-TREATMENT
65380	for	O
65381	this	b-PROBLEM
65382	with	O
65383	resolution	O
65384	of	O
65385	her	b-PROBLEM
65386	cough	i-PROBLEM
65387	and	O
65388	sputum	b-PROBLEM
65389	production	i-PROBLEM
65390	.	O
65391	on	O
65392	discharge	b-OCCURRENCE
65393	,	O
65394	the	O
65395	patient	O
65396	was	O
65397	restarted	O
65398	on	O
65399	her	b-TREATMENT
65400	coumadin	i-TREATMENT
65401	,	O
65402	which	b-TREATMENT
65403	was	O
65404	held	O
65405	for	O
65406	her	b-TEST
65407	right	i-TEST
65408	heart	i-TEST
65409	catheterization	i-TEST
65410	,	O
65411	and	O
65412	her	b-TEST
65413	biopsy	i-TEST
65414	,	O
65415	and	O
65416	her	b-TREATMENT
65417	icd	i-TREATMENT
65418	placement	i-TREATMENT
65419	.	O
65420	she	O
65421	was	O
65422	also	O
65423	continued	O
65424	on	O
65425	all	b-TREATMENT
65426	her	i-TREATMENT
65427	heart	i-TREATMENT
65428	failure	i-TREATMENT
65429	medications	i-TREATMENT
65430	including	O
65431	her	b-TREATMENT
65432	toprol	i-TREATMENT
65433	,	O
65434	her	b-TREATMENT
65435	lisinopril	i-TREATMENT
65436	,	O
65437	her	b-TREATMENT
65438	digoxin	i-TREATMENT
65439	,	O
65440	and	O
65441	her	b-TREATMENT
65442	lasix	i-TREATMENT
65443	.	O
65444		O
65445	admission	b-OCCURRENCE
65446	date	O
65447	:	O
65448	04/30/2005	b-ADMISSION
65449	discharge	b-OCCURRENCE
65450	date	O
65451	:	O
65452	5/14/05	O
65453	05/14/2005	b-DATE
65454	history	O
65455	of	O
65456	present	O
65457	illness	O
65458	:	O
65459	the	O
65460	patient	O
65461	is	O
65462	a	O
65463	pleasant	O
65464	83-year-old	O
65465	retired	O
65466	psychiatrist	O
65467	who	O
65468	presents	O
65469	with	O
65470	a	O
65471	chief	O
65472	complaint	O
65473	of	O
65474	gait	b-PROBLEM
65475	difficulty	i-PROBLEM
65476	for	O
65477	the	O
65478	last	O
65479	five	b-DATE
65480	to	i-DATE
65481	six	i-DATE
65482	months	i-DATE
65483	.	O
65484	the	O
65485	patient	O
65486	has	O
65487	a	O
65488	history	O
65489	of	O
65490	laryngeal	b-PROBLEM
65491	cancer	i-PROBLEM
65492	in	O
65493	2000	b-DATE
65494	and	O
65495	2001	b-DATE
65496	,	O
65497	cva	b-PROBLEM
65498	in	O
65499	2001	b-DATE
65500	to	O
65501	2002	b-DATE
65502	and	O
65503	hypertension	b-PROBLEM
65504	,	O
65505	who	O
65506	has	O
65507	a	b-DURATION
65508	six	i-DURATION
65509	month	i-DURATION
65510	history	O
65511	of	O
65512	progressive	b-PROBLEM
65513	difficulty	i-PROBLEM
65514	in	i-PROBLEM
65515	ambulation	i-PROBLEM
65516	.	O
65517	the	O
65518	patient	O
65519	was	O
65520	in	O
65521	previously	O
65522	good	b-OCCURRENCE
65523	health	i-OCCURRENCE
65524	when	O
65525	he	O
65526	reports	b-EVIDENTIAL
65527	starting	O
65528	to	O
65529	notice	O
65530	problems	b-PROBLEM
65531	ambulating	i-PROBLEM
65532	about	O
65533	six	b-DATE
65534	months	i-DATE
65535	ago	i-DATE
65536	.	O
65537	his	O
65538	partner	O
65539	also	O
65540	reports	b-EVIDENTIAL
65541	that	O
65542	he	O
65543	has	O
65544	been	O
65545	having	O
65546	more	b-PROBLEM
65547	difficulty	i-PROBLEM
65548	with	i-PROBLEM
65549	adls	i-PROBLEM
65550	.	O
65551	he	O
65552	reported	b-EVIDENTIAL
65553	that	O
65554	he	O
65555	began	O
65556	with	O
65557	difficulty	b-PROBLEM
65558	buttoning	i-PROBLEM
65559	his	i-PROBLEM
65560	shirt	i-PROBLEM
65561	for	O
65562	many	b-DURATION
65563	years	i-DURATION
65564	since	O
65565	after	O
65566	a	b-PROBLEM
65567	stroke	i-PROBLEM
65568	but	O
65569	now	O
65570	reports	b-EVIDENTIAL
65571	that	O
65572	on	O
65573	occasion	O
65574	she	O
65575	would	O
65576	ask	O
65577	him	O
65578	why	O
65579	he	O
65580	was	O
65581	doing	O
65582	certain	O
65583	things	O
65584	and	O
65585	he	O
65586	could	O
65587	not	O
65588	give	b-PROBLEM
65589	a	i-PROBLEM
65590	concrete	i-PROBLEM
65591	example	i-PROBLEM
65592	.	O
65593	the	O
65594	patient	O
65595	was	O
65596	having	O
65597	a	b-PROBLEM
65598	hard	i-PROBLEM
65599	time	i-PROBLEM
65600	walking	i-PROBLEM
65601	and	O
65602	reports	b-EVIDENTIAL
65603	that	O
65604	he	O
65605	has	O
65606	felt	b-PROBLEM
65607	weaker	i-PROBLEM
65608	.	O
65609	he	O
65610	has	O
65611	had	O
65612	uncoordination	b-PROBLEM
65613	of	i-PROBLEM
65614	his	i-PROBLEM
65615	feet	i-PROBLEM
65616	and	O
65617	began	O
65618	having	O
65619	a	b-TREATMENT
65620	cane	i-TREATMENT
65621	four	b-DATE
65622	to	i-DATE
65623	five	i-DATE
65624	months	i-DATE
65625	ago	i-DATE
65626	with	O
65627	the	b-PROBLEM
65628	increasing	i-PROBLEM
65629	weakness	i-PROBLEM
65630	.	O
65631	this	O
65632	was	O
65633	especially	b-OCCURRENCE
65634	bad	i-OCCURRENCE
65635	when	O
65636	trying	b-OCCURRENCE
65637	to	i-OCCURRENCE
65638	arise	i-OCCURRENCE
65639	.	O
65640	the	O
65641	patient	O
65642	has	O
65643	seen	b-CLINICAL_DEPT
65644	his	i-CLINICAL_DEPT
65645	primary	i-CLINICAL_DEPT
65646	care	i-CLINICAL_DEPT
65647	physician	i-CLINICAL_DEPT
65648	who	O
65649	referred	b-OCCURRENCE
65650	him	O
65651	to	O
65652	physical	b-CLINICAL_DEPT
65653	therapy	i-CLINICAL_DEPT
65654	for	O
65655	his	b-PROBLEM
65656	gait	i-PROBLEM
65657	weakness	i-PROBLEM
65658	but	O
65659	his	b-PROBLEM
65660	symptoms	i-PROBLEM
65661	failed	b-OCCURRENCE
65662	to	i-OCCURRENCE
65663	improve	i-OCCURRENCE
65664	.	O
65665	he	O
65666	continued	b-OCCURRENCE
65667	to	i-OCCURRENCE
65668	progress	i-OCCURRENCE
65669	until	O
65670	two	b-DURATION
65671	weeks	i-DURATION
65672	prior	O
65673	to	O
65674	admission	b-OCCURRENCE
65675	when	O
65676	he	O
65677	was	O
65678	found	b-OCCURRENCE
65679	in	i-OCCURRENCE
65680	the	i-OCCURRENCE
65681	bathtub	i-OCCURRENCE
65682	,	O
65683	unsteady	b-PROBLEM
65684	and	O
65685	fell	b-PROBLEM
65686	trying	i-PROBLEM
65687	to	i-PROBLEM
65688	steady	i-PROBLEM
65689	himself	i-PROBLEM
65690	.	O
65691	the	O
65692	patient	O
65693	could	b-PROBLEM
65694	not	i-PROBLEM
65695	be	i-PROBLEM
65696	moved	i-PROBLEM
65697	and	O
65698	had	O
65699	to	O
65700	have	O
65701	911	O
65702	called	O
65703	for	O
65704	help	O
65705	.	O
65706	since	O
65707	that	O
65708	time	O
65709	he	O
65710	had	O
65711	been	O
65712	ambulating	b-OCCURRENCE
65713	with	O
65714	a	b-TREATMENT
65715	walker	i-TREATMENT
65716	and	O
65717	has	O
65718	had	O
65719	increasing	b-PROBLEM
65720	difficulty	i-PROBLEM
65721	with	i-PROBLEM
65722	falls	i-PROBLEM
65723	in	O
65724	the	O
65725	last	O
65726	two	b-DATE
65727	weeks	i-DATE
65728	.	O
65729	the	O
65730	patient	O
65731	was	O
65732	again	O
65733	seen	b-CLINICAL_DEPT
65734	by	i-CLINICAL_DEPT
65735	his	i-CLINICAL_DEPT
65736	primary	i-CLINICAL_DEPT
65737	care	i-CLINICAL_DEPT
65738	physician	i-CLINICAL_DEPT
65739	and	O
65740	a	b-TEST
65741	cg	i-TEST
65742	scan	i-TEST
65743	revealed	O
65744	a	b-PROBLEM
65745	mass	i-PROBLEM
65746	in	i-PROBLEM
65747	the	i-PROBLEM
65748	right	i-PROBLEM
65749	parietal	i-PROBLEM
65750	lobe	i-PROBLEM
65751	.	O
65752	the	O
65753	patient	O
65754	was	O
65755	referred	b-OCCURRENCE
65756	to	O
65757	the	b-CLINICAL_DEPT
65758	neurology	i-CLINICAL_DEPT
65759	service	i-CLINICAL_DEPT
65760	for	O
65761	further	b-TEST
65762	workup	i-TEST
65763	of	O
65764	the	b-PROBLEM
65765	mass	i-PROBLEM
65766	.	O
65767	the	O
65768	patient	O
65769	denied	b-EVIDENTIAL
65770	blurry	b-PROBLEM
65771	vision	i-PROBLEM
65772	,	O
65773	headache	b-PROBLEM
65774	,	O
65775	nausea	b-PROBLEM
65776	,	O
65777	vomiting	b-PROBLEM
65778	,	O
65779	paresthesias	b-PROBLEM
65780	,	O
65781	pain	b-PROBLEM
65782	in	i-PROBLEM
65783	mental	i-PROBLEM
65784	status	i-PROBLEM
65785	,	O
65786	confusion	b-PROBLEM
65787	or	O
65788	seizures	b-PROBLEM
65789	.	O
65790	the	O
65791	patient	O
65792	is	O
65793	status	O
65794	post	O
65795	radiation	b-TREATMENT
65796	therapy	i-TREATMENT
65797	and	O
65798	resection	b-TREATMENT
65799	and	O
65800	reconstruction	b-TREATMENT
65801	for	O
65802	his	b-PROBLEM
65803	laryngeal	i-PROBLEM
65804	cancer	i-PROBLEM
65805	.	O
65806	review	O
65807	of	O
65808	systems	O
65809	:	O
65810	positive	b-PROBLEM
65811	weakness	i-PROBLEM
65812	,	O
65813	otherwise	O
65814	negative	b-EVIDENTIAL
65815	.	O
65816		O
65817	admission	b-OCCURRENCE
65818	date	O
65819	:	O
65820	09/10/1999	b-ADMISSION
65821	discharge	b-OCCURRENCE
65822	date	O
65823	:	O
65824	09/14/1999	b-DISCHARGE
65825	history	O
65826	of	O
65827	present	O
65828	illness	O
65829	:	O
65830	ms.	O
65831	sterpkoteneish	O
65832	is	O
65833	a	O
65834	69-year-old	O
65835	woman	O
65836	,	O
65837	who	O
65838	over	O
65839	the	b-DURATION
65840	past	i-DURATION
65841	six	i-DURATION
65842	months	i-DURATION
65843	has	O
65844	noted	b-EVIDENTIAL
65845	increasing	b-PROBLEM
65846	pain	i-PROBLEM
65847	in	i-PROBLEM
65848	her	i-PROBLEM
65849	left	i-PROBLEM
65850	upper	i-PROBLEM
65851	quadrant	i-PROBLEM
65852	radiating	O
65853	to	O
65854	the	O
65855	back	O
65856	.	O
65857	she	O
65858	described	b-EVIDENTIAL
65859	the	b-PROBLEM
65860	pain	i-PROBLEM
65861	as	O
65862	being	O
65863	exacerbated	b-PROBLEM
65864	by	O
65865	eating	b-OCCURRENCE
65866	and	O
65867	described	b-EVIDENTIAL
65868	an	b-PROBLEM
65869	associated	i-PROBLEM
65870	weight	i-PROBLEM
65871	loss	i-PROBLEM
65872	.	O
65873	she	O
65874	presented	b-EVIDENTIAL
65875	to	O
65876	her	O
65877	primary	O
65878	care	O
65879	physician	O
65880	,	O
65881	doctor	O
65882	tlandtaze	O
65883	,	O
65884	in	O
65885	aersing	b-CLINICAL_DEPT
65886	rocuch	i-CLINICAL_DEPT
65887	sun	i-CLINICAL_DEPT
65888	,	O
65889	who	O
65890	obtained	b-OCCURRENCE
65891	a	b-TEST
65892	ct	i-TEST
65893	scan	i-TEST
65894	,	O
65895	which	b-TEST
65896	demonstrated	b-EVIDENTIAL
65897	a	b-PROBLEM
65898	mass	i-PROBLEM
65899	in	O
65900	the	O
65901	tail	O
65902	of	O
65903	the	O
65904	pancreas	O
65905	.	O
65906	she	O
65907	was	O
65908	then	O
65909	referred	b-OCCURRENCE
65910	to	O
65911	the	b-CLINICAL_DEPT
65912	fairm	i-CLINICAL_DEPT
65913	of	i-CLINICAL_DEPT
65914	ijordcompmac	i-CLINICAL_DEPT
65915	hospital	i-CLINICAL_DEPT
65916	under	O
65917	the	b-CLINICAL_DEPT
65918	el	i-CLINICAL_DEPT
65919	memorial	i-CLINICAL_DEPT
65920	and	O
65921	was	O
65922	seen	O
65923	by	O
65924	doctor	O
65925	blinjesc	O
65926	,	O
65927	who	O
65928	scheduled	b-OCCURRENCE
65929	her	O
65930	for	O
65931	an	b-TEST
65932	exploratory	i-TEST
65933	laparoscopy	i-TEST
65934	.	O
65935	hospital	O
65936	course	O
65937	and	O
65938	treatment	O
65939	:	O
65940	the	O
65941	patient	O
65942	was	O
65943	admitted	b-OCCURRENCE
65944	through	O
65945	same	b-DATE
65946	day	i-DATE
65947	surgery	i-CLINICAL_DEPT
65948	and	O
65949	taken	O
65950	to	O
65951	the	b-CLINICAL_DEPT
65952	operating	i-CLINICAL_DEPT
65953	room	i-CLINICAL_DEPT
65954	where	O
65955	doctor	O
65956	blinjesc	O
65957	,	O
65958	assisted	O
65959	by	O
65960	doctor	O
65961	zockbeathe	O
65962	,	O
65963	performed	b-OCCURRENCE
65964	a	b-TEST
65965	diagnostic	i-TEST
65966	laparoscopy	i-TEST
65967	with	O
65968	peritoneal	b-TEST
65969	washings	i-TEST
65970	.	O
65971	findings	O
65972	included	O
65973	no	b-PROBLEM
65974	gross	i-PROBLEM
65975	evidence	i-PROBLEM
65976	seating	i-PROBLEM
65977	in	i-PROBLEM
65978	the	i-PROBLEM
65979	abdominal	i-PROBLEM
65980	wall	i-PROBLEM
65981	;	O
65982	one	b-PROBLEM
65983	nodule	i-PROBLEM
65984	on	O
65985	the	O
65986	posterior	O
65987	surface	O
65988	of	O
65989	the	O
65990	right	O
65991	lobe	O
65992	of	O
65993	the	O
65994	liver	O
65995	;	O
65996	one	b-PROBLEM
65997	nodule	i-PROBLEM
65998	in	O
65999	the	O
66000	inferior	O
66001	edge	O
66002	of	O
66003	the	O
66004	falciform	O
66005	ligament	O
66006	.	O
66007	specimens	b-TEST
66008	sent	O
66009	to	O
66010	pathology	O
66011	included	O
66012	peritoneal	b-TEST
66013	washings	i-TEST
66014	and	O
66015	permanent	b-TEST
66016	specimens	i-TEST
66017	from	i-TEST
66018	the	i-TEST
66019	liver	i-TEST
66020	and	O
66021	falciform	b-PROBLEM
66022	nodules	i-PROBLEM
66023	.	O
66024	there	O
66025	were	O
66026	no	O
66027	complications	b-PROBLEM
66028	,	O
66029	and	O
66030	the	O
66031	patient	O
66032	tolerated	b-EVIDENTIAL
66033	the	b-TEST
66034	procedure	i-TEST
66035	well	O
66036	.	O
66037	postoperatively	O
66038	,	O
66039	the	O
66040	patient	O
66041	had	O
66042	some	b-PROBLEM
66043	abdominal	i-PROBLEM
66044	bloating	i-PROBLEM
66045	with	O
66046	evidence	b-EVIDENTIAL
66047	of	O
66048	subcutaneous	b-PROBLEM
66049	emphysema	i-PROBLEM
66050	over	i-PROBLEM
66051	the	i-PROBLEM
66052	abdomen	i-PROBLEM
66053	.	O
66054	she	O
66055	was	O
66056	uncomfortable	b-PROBLEM
66057	and	O
66058	slow	b-PROBLEM
66059	to	i-PROBLEM
66060	have	i-PROBLEM
66061	bowel	i-PROBLEM
66062	movements	i-PROBLEM
66063	,	O
66064	although	O
66065	she	O
66066	did	O
66067	have	O
66068	flatus	b-OCCURRENCE
66069	.	O
66070	she	O
66071	tolerated	b-EVIDENTIAL
66072	a	O
66073	full	O
66074	diet	b-TREATMENT
66075	well	O
66076	,	O
66077	but	O
66078	continued	b-EVIDENTIAL
66079	to	O
66080	have	O
66081	abdominal	b-PROBLEM
66082	cramping	i-PROBLEM
66083	and	O
66084	a	b-PROBLEM
66085	mild	i-PROBLEM
66086	ileus	i-PROBLEM
66087	for	O
66088	the	b-DURATION
66089	following	i-DURATION
66090	three	i-DURATION
66091	days	i-DURATION
66092	.	O
66093	she	O
66094	was	O
66095	treated	b-OCCURRENCE
66096	with	O
66097	repeated	b-TREATMENT
66098	fleet	i-TREATMENT
66099	&apos;s	i-TREATMENT
66100	enemas	i-TREATMENT
66101	,	O
66102	and	O
66103	on	O
66104	postoperative	b-DATE
66105	day	i-DATE
66106	three	i-DATE
66107	,	O
66108	she	O
66109	had	O
66110	a	b-OCCURRENCE
66111	number	i-OCCURRENCE
66112	of	i-OCCURRENCE
66113	bowel	i-OCCURRENCE
66114	movements	i-OCCURRENCE
66115	,	O
66116	was	O
66117	considerably	O
66118	more	O
66119	comfortable	b-EVIDENTIAL
66120	,	O
66121	and	O
66122	deemed	O
66123	ready	b-EVIDENTIAL
66124	for	O
66125	discharge	b-OCCURRENCE
66126	.	O
66127		O
66128	admission	b-OCCURRENCE
66129	date	O
66130	:	O
66131	2015-09-30	b-ADMISSION
66132	discharge	b-OCCURRENCE
66133	date	O
66134	:	O
66135	2015-10-02	b-DISCHARGE
66136	service	O
66137	:	O
66138	medical	O
66139	icu	O
66140	history	O
66141	of	O
66142	present	O
66143	illness	O
66144	:	O
66145	this	O
66146	is	O
66147	a	O
66148	57-year-old	O
66149	nursing	O
66150	home	O
66151	resident	O
66152	female	O
66153	,	O
66154	who	O
66155	had	O
66156	been	O
66157	in	O
66158	her	b-OCCURRENCE
66159	usual	i-OCCURRENCE
66160	state	i-OCCURRENCE
66161	of	i-OCCURRENCE
66162	health	i-OCCURRENCE
66163	until	O
66164	about	O
66165	three	b-DATE
66166	weeks	i-DATE
66167	ago	i-DATE
66168	when	O
66169	the	O
66170	daughter	O
66171	noted	O
66172	she	O
66173	was	O
66174	sleeping	b-PROBLEM
66175	more	i-PROBLEM
66176	.	O
66177	per	O
66178	record	O
66179	,	O
66180	she	O
66181	has	O
66182	had	O
66183	multiple	b-FREQUENCY
66184	episodes	i-FREQUENCY
66185	in	O
66186	the	b-DURATION
66187	last	i-DURATION
66188	week	i-DURATION
66189	of	O
66190	changes	b-PROBLEM
66191	in	i-PROBLEM
66192	mental	i-PROBLEM
66193	status	i-PROBLEM
66194	.	O
66195	emts	b-TREATMENT
66196	called	O
66197	many	b-FREQUENCY
66198	times	i-FREQUENCY
66199	.	O
66200	the	O
66201	patient	O
66202	would	O
66203	awake	b-OCCURRENCE
66204	prior	O
66205	to	O
66206	arrival	b-OCCURRENCE
66207	and	O
66208	not	O
66209	need	O
66210	transfer	b-OCCURRENCE
66211	.	O
66212	the	O
66213	patient	O
66214	was	O
66215	seen	O
66216	at	O
66217	the	b-CLINICAL_DEPT
66218	leonard	i-CLINICAL_DEPT
66219	morse/metrowest	i-CLINICAL_DEPT
66220	medical	i-CLINICAL_DEPT
66221	center	i-CLINICAL_DEPT
66222	on	O
66223	09-28	b-DATE
66224	.	O
66225	no	O
66226	localizing	b-OCCURRENCE
66227	etiology	i-OCCURRENCE
66228	of	O
66229	delta	b-PROBLEM
66230	ms	i-PROBLEM
66231	.	O
66232	that	b-DATE
66233	evening	i-DATE
66234	she	O
66235	was	O
66236	unresponsive	b-PROBLEM
66237	and	O
66238	the	O
66239	patient	O
66240	was	O
66241	brought	O
66242	to	O
66243	amesbury	b-CLINICAL_DEPT
66244	hospital	i-CLINICAL_DEPT
66245	hospital	i-CLINICAL_DEPT
66246	.	O
66247	there	O
66248	her	b-TREATMENT
66249	oxygen	i-TREATMENT
66250	she	O
66251	was	O
66252	sating	O
66253	65%	O
66254	on	O
66255	room	O
66256	air	O
66257	,	O
66258	increased	b-TREATMENT
66259	to	O
66260	98%	O
66261	with	O
66262	a	b-TREATMENT
66263	nonrebreather	i-TREATMENT
66264	mask	i-TREATMENT
66265	.	O
66266	there	O
66267	an	b-TEST
66268	abg	i-TEST
66269	was	O
66270	done	O
66271	which	O
66272	showed	b-EVIDENTIAL
66273	an	b-TEST
66274	abg	i-TEST
66275	of	O
66276	7.42	O
66277	,	O
66278	62	O
66279	,	O
66280	and	O
66281	55	O
66282	.	O
66283	she	O
66284	had	O
66285	a	b-TEST
66286	head	i-TEST
66287	ct	i-TEST
66288	that	O
66289	was	O
66290	negative	O
66291	.	O
66292	chest	b-TEST
66293	x-ray	i-TEST
66294	that	O
66295	was	O
66296	questionable	O
66297	left	b-PROBLEM
66298	lower	i-PROBLEM
66299	lobe	i-PROBLEM
66300	infiltrate	i-PROBLEM
66301	.	O
66302	lumbar	b-TEST
66303	puncture	i-TEST
66304	was	O
66305	performed	O
66306	and	O
66307	the	b-TEST
66308	micro	i-TEST
66309	cultures	i-TEST
66310	are	O
66311	still	O
66312	pending	O
66313	.	O
66314	she	O
66315	was	O
66316	seen	O
66317	by	O
66318	psychiatry	b-CLINICAL_DEPT
66319	at	O
66320	the	b-CLINICAL_DEPT
66321	outside	i-CLINICAL_DEPT
66322	hospital	i-CLINICAL_DEPT
66323	,	O
66324	but	O
66325	noted	O
66326	there	O
66327	was	O
66328	no	O
66329	psychoses	b-PROBLEM
66330	,	O
66331	but	O
66332	delirium	b-PROBLEM
66333	.	O
66334	the	b-TEST
66335	patient	i-TEST
66336	's	i-TEST
66337	mental	i-TEST
66338	status	i-TEST
66339	waxed	b-OCCURRENCE
66340	and	i-OCCURRENCE
66341	waned	i-OCCURRENCE
66342	there	O
66343	.	O
66344	she	O
66345	also	O
66346	had	O
66347	a	b-TEST
66348	k	i-TEST
66349	of	O
66350	6.0	O
66351	and	O
66352	given	O
66353	30	O
66354	of	O
66355	kayexalate	b-TREATMENT
66356	,	O
66357	5	O
66358	of	O
66359	haldol	b-TREATMENT
66360	,	O
66361	2	O
66362	mg	O
66363	of	O
66364	ativan	b-TREATMENT
66365	given	O
66366	for	O
66367	agitation	b-PROBLEM
66368	,	O
66369	and	O
66370	2	O
66371	mg	O
66372	of	O
66373	ceftriaxone	b-TREATMENT
66374	was	O
66375	given	O
66376	for	O
66377	a	b-TEST
66378	temperature	i-TEST
66379	of	O
66380	101.3	O
66381	with	O
66382	a	O
66383	concern	O
66384	for	O
66385	meningitis	b-PROBLEM
66386	as	O
66387	a	b-TEST
66388	lp	i-TEST
66389	was	O
66390	done	O
66391	prior	O
66392	.	O
66393	patient	O
66394	was	O
66395	transferred	b-OCCURRENCE
66396	to	O
66397	the	b-CLINICAL_DEPT
66398	kindred	i-CLINICAL_DEPT
66399	hospital	i-CLINICAL_DEPT
66400	melendez	i-CLINICAL_DEPT
66401	the	O
66402	patient	O
66403	's	O
66404	primary	b-CLINICAL_DEPT
66405	care	i-CLINICAL_DEPT
66406	provider	i-CLINICAL_DEPT
66407	was	O
66408	here	O
66409	.	O
66410	she	O
66411	is	O
66412	currently	O
66413	being	O
66414	seen	O
66415	by	O
66416	addison	b-CLINICAL_DEPT
66417	gilbert	i-CLINICAL_DEPT
66418	hospital	i-CLINICAL_DEPT
66419	group	i-CLINICAL_DEPT
66420	.	O
66421	on	O
66422	arrival	O
66423	to	O
66424	mass.	b-CLINICAL_DEPT
66425	eye	i-CLINICAL_DEPT
66426	&	i-CLINICAL_DEPT
66427	ear	i-CLINICAL_DEPT
66428	infirmary	i-CLINICAL_DEPT
66429	,	O
66430	she	O
66431	was	O
66432	unresponsive	b-PROBLEM
66433	with	O
66434	an	b-TEST
66435	oxygen	i-TEST
66436	saturation	i-TEST
66437	of	O
66438	72%	O
66439	on	O
66440	6	O
66441	liters	O
66442	.	O
66443	she	O
66444	was	O
66445	placed	O
66446	on	O
66447	50%	b-TREATMENT
66448	vent	i-TREATMENT
66449	mask	i-TREATMENT
66450	,	O
66451	which	O
66452	improved	O
66453	her	b-TEST
66454	oxygenation	i-TEST
66455	to	O
66456	97%	O
66457	.	O
66458	patient	O
66459	was	O
66460	placed	O
66461	on	O
66462	bipap	b-TREATMENT
66463	.	O
66464	original	b-TEST
66465	abg	i-TEST
66466	here	O
66467	before	O
66468	bipap	b-TREATMENT
66469	was	O
66470	7.19	O
66471	,	O
66472	102	O
66473	,	O
66474	and	O
66475	92	O
66476	.	O
66477	after	O
66478	being	O
66479	placed	O
66480	on	O
66481	bipap	b-TREATMENT
66482	,	O
66483	her	b-TEST
66484	blood	i-TEST
66485	pressure	i-TEST
66486	decreased	O
66487	to	O
66488	the	O
66489	80s	O
66490	.	O
66491	she	O
66492	responded	b-OCCURRENCE
66493	to	O
66494	1	O
66495	liter	O
66496	of	O
66497	iv	b-TREATMENT
66498	fluids	i-TREATMENT
66499	,	O
66500	normal	b-TREATMENT
66501	saline	i-TREATMENT
66502	and	O
66503	blood	b-TEST
66504	pressure	i-TEST
66505	remained	b-OCCURRENCE
66506	stable	i-OCCURRENCE
66507	.	O
66508	patient	O
66509	had	O
66510	peripheral	b-TREATMENT
66511	iv	i-TREATMENT
66512	x1	b-FREQUENCY
66513	placed	O
66514	and	O
66515	right	b-TREATMENT
66516	femoral	i-TREATMENT
66517	line	i-TREATMENT
66518	placed	O
66519	in	O
66520	the	b-CLINICAL_DEPT
66521	matthew	i-CLINICAL_DEPT
66522	.	O
66523	when	O
66524	laying	b-OCCURRENCE
66525	flat	i-OCCURRENCE
66526	,	O
66527	her	b-TEST
66528	sats	i-TEST
66529	decreased	O
66530	to	O
66531	50%	O
66532	on	O
66533	30%	O
66534	fio2	b-TREATMENT
66535	,	O
66536	peep	b-TREATMENT
66537	of	O
66538	10	O
66539	,	O
66540	and	O
66541	pressure	b-TREATMENT
66542	support	i-TREATMENT
66543	of	O
66544	5	O
66545	.	O
66546	her	b-TEST
66547	abg	i-TEST
66548	at	O
66549	the	b-DATE
66550	time	i-DATE
66551	was	O
66552	7.24	O
66553	,	O
66554	91	O
66555	,	O
66556	and	O
66557	38	O
66558	.	O
66559	once	O
66560	the	O
66561	patient	O
66562	sat	b-OCCURRENCE
66563	up	i-OCCURRENCE
66564	,	O
66565	her	b-TEST
66566	sats	i-TEST
66567	improved	b-OCCURRENCE
66568	and	O
66569	her	O
66570	airway	O
66571	was	O
66572	no	O
66573	longer	O
66574	obstructed	b-OCCURRENCE
66575	.	O
66576	after	O
66577	a	O
66578	history	O
66579	on	O
66580	bipap	b-TREATMENT
66581	about	O
66582	a	b-DURATION
66583	half	i-DURATION
66584	an	i-DURATION
66585	hour	i-DURATION
66586	,	O
66587	her	b-TEST
66588	abg	i-TEST
66589	was	O
66590	7.29	O
66591	,	O
66592	79	O
66593	,	O
66594	and	O
66595	106	O
66596	on	O
66597	30%	O
66598	pressure	b-TREATMENT
66599	support	i-TREATMENT
66600	of	O
66601	5	O
66602	and	O
66603	peep	b-TREATMENT
66604	of	O
66605	10	O
66606	.	O
66607	patient	O
66608	was	O
66609	intermittently	b-OCCURRENCE
66610	awaking	i-OCCURRENCE
66611	.	O
66612	she	O
66613	denied	b-EVIDENTIAL
66614	any	O
66615	pain	b-PROBLEM
66616	and	O
66617	was	O
66618	not	O
66619	answering	b-OCCURRENCE
66620	questions	i-OCCURRENCE
66621	at	O
66622	the	b-DATE
66623	time	i-DATE
66624	.	O
66625	hospital	O
66626	course	O
66627	:	O
66628	1.	O
66629	hypercarbic	O
66630	respiratory	O
66631	failure	O
66632	issues	O
66633	:	O
66634	the	O
66635	patient	O
66636	presented	O
66637	with	O
66638	changes	b-PROBLEM
66639	in	i-PROBLEM
66640	mental	i-PROBLEM
66641	status	i-PROBLEM
66642	,	O
66643	pco2	b-TEST
66644	of	O
66645	100	O
66646	,	O
66647	ph	b-TEST
66648	of	O
66649	7.19	O
66650	,	O
66651	decreasing	b-PROBLEM
66652	sats	i-PROBLEM
66653	on	O
66654	arrival	O
66655	likely	O
66656	element	O
66657	of	O
66658	obstructive-sleep	b-PROBLEM
66659	apnea	i-PROBLEM
66660	.	O
66661	she	O
66662	was	O
66663	monitored	b-TREATMENT
66664	overnight	b-DURATION
66665	.	O
66666	she	O
66667	had	O
66668	admitted	O
66669	to	O
66670	the	b-CLINICAL_DEPT
66671	cmed	i-CLINICAL_DEPT
66672	and	O
66673	had	O
66674	multiple	b-FREQUENCY
66675	episodes	i-FREQUENCY
66676	of	O
66677	apnea	b-PROBLEM
66678	throughout	O
66679	the	b-DURATION
66680	night	i-DURATION
66681	.	O
66682	she	O
66683	was	O
66684	placed	O
66685	on	O
66686	pressure	b-TREATMENT
66687	support	i-TREATMENT
66688	,	O
66689	which	O
66690	improved	b-OCCURRENCE
66691	her	b-TEST
66692	saturations	i-TEST
66693	and	O
66694	decreased	b-OCCURRENCE
66695	her	b-PROBLEM
66696	hypercarbia	i-PROBLEM
66697	.	O
66698	patient	O
66699	improved	b-OCCURRENCE
66700	that	O
66701	her	b-TEST
66702	mental	i-TEST
66703	status	i-TEST
66704	with	O
66705	improvement	b-OCCURRENCE
66706	of	O
66707	her	b-TEST
66708	oxygenation	i-TEST
66709	and	i-TEST
66710	ventilation	i-TEST
66711	as	O
66712	well	O
66713	as	O
66714	for	O
66715	correction	b-TREATMENT
66716	of	O
66717	her	b-PROBLEM
66718	respiratory	i-PROBLEM
66719	acidosis	i-PROBLEM
66720	.	O
66721	patient	O
66722	was	O
66723	eventually	O
66724	placed	O
66725	on	O
66726	bipap	b-TREATMENT
66727	on	O
66728	hospital	b-DATE
66729	day	i-DATE
66730	three	i-DATE
66731	,	O
66732	on	O
66733	the	b-DATE
66734	date	i-DATE
66735	prior	O
66736	to	O
66737	discharge	O
66738	of	O
66739	bipap	b-TREATMENT
66740	settings	O
66741	of	O
66742	12/8/5	O
66743	liters	O
66744	of	O
66745	oxygen	O
66746	with	O
66747	saturations	b-TEST
66748	of	O
66749	96%	O
66750	with	O
66751	a	b-TEST
66752	gas	i-TEST
66753	of	O
66754	7.38	O
66755	,	O
66756	67	O
66757	,	O
66758	and	O
66759	91	O
66760	with	O
66761	an	O
66762	aim	O
66763	of	O
66764	a	O
66765	goal	O
66766	pco2	b-TEST
66767	of	O
66768	67	O
66769	.	O
66770	she	O
66771	only	O
66772	had	O
66773	one	b-FREQUENCY
66774	episode	O
66775	of	O
66776	apnea	b-PROBLEM
66777	on	O
66778	the	b-DATE
66779	day	i-DATE
66780	prior	O
66781	to	O
66782	discharge	O
66783	.	O
66784	2.	O
66785	delta	O
66786	ms/mental	O
66787	status	O
66788	issues	O
66789	:	O
66790	most	O
66791	likely	O
66792	her	b-PROBLEM
66793	waxing	i-PROBLEM
66794	and	i-PROBLEM
66795	waning	i-PROBLEM
66796	mental	i-PROBLEM
66797	status	i-PROBLEM
66798	and	O
66799	hypercarbia/hypoxia	b-PROBLEM
66800	compounded	O
66801	by	O
66802	infection	b-PROBLEM
66803	of	i-PROBLEM
66804	pneumonia	i-PROBLEM
66805	and	O
66806	uti	b-PROBLEM
66807	.	O
66808	with	O
66809	improvements	b-OCCURRENCE
66810	of	O
66811	her	b-TEST
66812	ventilation	i-TEST
66813	and	O
66814	oxygenation	b-TEST
66815	and	O
66816	treatment	O
66817	with	O
66818	levofloxacin	b-TREATMENT
66819	of	O
66820	her	b-PROBLEM
66821	uti	i-PROBLEM
66822	and	O
66823	pneumonia	b-PROBLEM
66824	,	O
66825	her	b-TEST
66826	mental	i-TEST
66827	status	i-TEST
66828	greatly	b-OCCURRENCE
66829	improved	i-OCCURRENCE
66830	on	O
66831	hospital	b-DATE
66832	day	i-DATE
66833	two	i-DATE
66834	without	O
66835	further	O
66836	waxing	O
66837	and	O
66838	waning	O
66839	.	O
66840	her	O
66841	daughters	O
66842	came	O
66843	by	O
66844	and	O
66845	visited	O
66846	her	O
66847	,	O
66848	and	O
66849	reported	b-EVIDENTIAL
66850	that	O
66851	she	O
66852	was	O
66853	at	O
66854	her	b-OCCURRENCE
66855	baseline	i-OCCURRENCE
66856	mental	i-OCCURRENCE
66857	status	i-OCCURRENCE
66858	on	O
66859	the	b-DATE
66860	day	i-DATE
66861	prior	O
66862	to	O
66863	discharge	O
66864	.	O
66865	b12	b-TEST
66866	,	O
66867	folate	b-TEST
66868	,	O
66869	rpr	b-TEST
66870	were	O
66871	all	O
66872	sent	O
66873	that	O
66874	were	O
66875	unremarkable	O
66876	as	O
66877	causes	O
66878	for	O
66879	delta	b-PROBLEM
66880	ms	i-PROBLEM
66881	.	O
66882	we	O
66883	are	O
66884	awaiting	O
66885	results	O
66886	of	O
66887	the	b-TEST
66888	lumbar	i-TEST
66889	puncture	i-TEST
66890	from	O
66891	the	b-CLINICAL_DEPT
66892	outside	i-CLINICAL_DEPT
66893	hospital	i-CLINICAL_DEPT
66894	,	O
66895	but	O
66896	on	O
66897	hospital	b-DATE
66898	day	i-DATE
66899	two	i-DATE
66900	.	O
66901	those	b-TEST
66902	cultures	i-TEST
66903	are	O
66904	still	O
66905	pending	b-OCCURRENCE
66906	at	O
66907	the	b-DATE
66908	time	i-DATE
66909	.	O
66910	patient	O
66911	was	O
66912	also	O
66913	given	O
66914	multivites	b-TREATMENT
66915	.	O
66916	3.	O
66917	fever	O
66918	issues	O
66919	:	O
66920	the	O
66921	patient	O
66922	initially	O
66923	presented	b-OCCURRENCE
66924	with	O
66925	t	b-TEST
66926	max	i-TEST
66927	of	O
66928	101.3	O
66929	at	O
66930	outside	b-CLINICAL_DEPT
66931	hospital	i-CLINICAL_DEPT
66932	with	O
66933	increasing	b-PROBLEM
66934	white	i-PROBLEM
66935	blood	i-PROBLEM
66936	cell	i-PROBLEM
66937	counts	i-PROBLEM
66938	and	O
66939	a	b-PROBLEM
66940	positive	i-PROBLEM
66941	urinalysis	i-PROBLEM
66942	.	O
66943	a	b-TEST
66944	chest	i-TEST
66945	x-ray	i-TEST
66946	with	O
66947	bilateral	b-PROBLEM
66948	patchy	i-PROBLEM
66949	infiltrates	i-PROBLEM
66950	likely	O
66951	pneumonia	b-PROBLEM
66952	and	O
66953	uti	b-PROBLEM
66954	.	O
66955	upon	O
66956	calling	O
66957	the	b-CLINICAL_DEPT
66958	outside	i-CLINICAL_DEPT
66959	hospital	i-CLINICAL_DEPT
66960	,	O
66961	the	O
66962	urine	O
66963	was	O
66964	growing	O
66965	out	O
66966	klebsiella	b-PROBLEM
66967	,	O
66968	and	O
66969	patient	O
66970	was	O
66971	given	O
66972	a	b-DURATION
66973	10	i-DURATION
66974	day	i-DURATION
66975	course	O
66976	of	O
66977	levofloxacin	b-TREATMENT
66978	to	O
66979	cover	O
66980	both	O
66981	the	b-PROBLEM
66982	pneumonia	i-PROBLEM
66983	and	O
66984	uti	b-PROBLEM
66985	.	O
66986	blood	b-TEST
66987	cultures	i-TEST
66988	and	O
66989	urine	b-TEST
66990	cultures	i-TEST
66991	are	O
66992	still	O
66993	pending	b-OCCURRENCE
66994	at	O
66995	this	b-OCCURRENCE
66996	hospital	i-OCCURRENCE
66997	visit	i-OCCURRENCE
66998	and	O
66999	the	b-TEST
67000	csf	i-TEST
67001	fluid	i-TEST
67002	from	O
67003	whitter	b-CLINICAL_DEPT
67004	rehabilitation	i-CLINICAL_DEPT
67005	hospital	i-CLINICAL_DEPT
67006	needs	O
67007	to	O
67008	be	O
67009	further	b-OCCURRENCE
67010	evaluated	i-OCCURRENCE
67011	.	O
67012	patient	O
67013	on	O
67014	the	b-DATE
67015	day	i-DATE
67016	of	O
67017	discharge	O
67018	was	O
67019	afebrile	b-PROBLEM
67020	with	O
67021	a	b-TEST
67022	decreasing	i-TEST
67023	white	i-TEST
67024	count	i-TEST
67025	x48	b-DURATION
67026	hours	i-DURATION
67027	.	O
67028	4.	O
67029	acute	O
67030	renal	O
67031	failure	O
67032	issues	O
67033	:	O
67034	creatinine	b-TEST
67035	initially	O
67036	presented	b-OCCURRENCE
67037	at	O
67038	1.3	O
67039	.	O
67040	patient	O
67041	is	O
67042	known	O
67043	to	O
67044	have	O
67045	a	b-TEST
67046	baseline	i-TEST
67047	of	O
67048	1.0	O
67049	,	O
67050	most	O
67051	likely	O
67052	hypovolemia	b-PROBLEM
67053	and	O
67054	prerenal	b-PROBLEM
67055	.	O
67056	a	b-TEST
67057	fena	i-TEST
67058	was	O
67059	sent	O
67060	,	O
67061	was	O
67062	0.3%	O
67063	.	O
67064	patient	O
67065	was	O
67066	gently	b-TREATMENT
67067	hydrated	i-TREATMENT
67068	and	O
67069	iv	b-TREATMENT
67070	fluids	i-TREATMENT
67071	started	O
67072	up	O
67073	on	O
67074	a	b-TREATMENT
67075	p.o.	i-TREATMENT
67076	diet	i-TREATMENT
67077	regimen	i-TREATMENT
67078	.	O
67079	on	O
67080	hospital	b-DATE
67081	day	i-DATE
67082	two	i-DATE
67083	,	O
67084	her	b-TEST
67085	creatinine	i-TEST
67086	returned	O
67087	to	O
67088	0.8	O
67089	,	O
67090	and	O
67091	she	O
67092	remained	O
67093	with	O
67094	a	b-TEST
67095	creatinine	i-TEST
67096	of	O
67097	0.8	O
67098	for	O
67099	the	O
67100	remainder	O
67101	of	O
67102	her	b-OCCURRENCE
67103	hospital	i-OCCURRENCE
67104	stay	i-OCCURRENCE
67105	.	O
67106	patient's	O
67107	k	b-TEST
67108	was	O
67109	followed	b-OCCURRENCE
67110	,	O
67111	and	O
67112	trended	O
67113	back	O
67114	down	O
67115	to	O
67116	normal	b-OCCURRENCE
67117	on	O
67118	the	b-DATE
67119	day	i-DATE
67120	of	O
67121	discharge	O
67122	at	O
67123	3.9	O
67124	.	O
67125	5.	O
67126	elevated	O
67127	transaminases	O
67128	:	O
67129	patient	O
67130	had	O
67131	no	O
67132	right	b-PROBLEM
67133	upper	i-PROBLEM
67134	quadrant	i-PROBLEM
67135	pain	i-PROBLEM
67136	.	O
67137	stewart	b-TEST
67138	sign	i-TEST
67139	was	O
67140	negative	O
67141	.	O
67142	a	b-TEST
67143	right	i-TEST
67144	upper	i-TEST
67145	quadrant	i-TEST
67146	ultrasound	i-TEST
67147	was	O
67148	performed	O
67149	that	O
67150	showed	b-EVIDENTIAL
67151	no	O
67152	hepatic	b-PROBLEM
67153	or	i-PROBLEM
67154	biliary	i-PROBLEM
67155	pathology	i-PROBLEM
67156	likely	O
67157	due	O
67158	to	O
67159	acute	b-PROBLEM
67160	phase	i-PROBLEM
67161	stress	i-PROBLEM
67162	changes	i-PROBLEM
67163	given	O
67164	the	O
67165	fact	O
67166	that	O
67167	she	O
67168	had	O
67169	no	O
67170	clinical	b-PROBLEM
67171	symptoms	i-PROBLEM
67172	.	O
67173	there	O
67174	is	O
67175	no	O
67176	need	O
67177	to	O
67178	followup	b-OCCURRENCE
67179	these	b-TEST
67180	transaminases	i-TEST
67181	.	O
67182	6.	O
67183	congestive	O
67184	heart	O
67185	failure	O
67186	history	O
67187	:	O
67188	patient	O
67189	was	O
67190	stable	b-OCCURRENCE
67191	without	O
67192	evidence	O
67193	of	O
67194	chf	b-PROBLEM
67195	on	O
67196	chest	b-TEST
67197	x-ray	i-TEST
67198	.	O
67199	followed	O
67200	her	b-TEST
67201	sats	i-TEST
67202	likely	O
67203	due	O
67204	to	O
67205	obstructive-sleep	b-PROBLEM
67206	apnea	i-PROBLEM
67207	and	O
67208	hypoventilation	b-PROBLEM
67209	.	O
67210	patient	O
67211	was	O
67212	restarted	O
67213	on	O
67214	her	b-TREATMENT
67215	beta	i-TREATMENT
67216	blocker	i-TREATMENT
67217	and	O
67218	.......-	O
67219	receptor	b-TREATMENT
67220	blocker	i-TREATMENT
67221	on	O
67222	hospital	b-DATE
67223	day	i-DATE
67224	two	i-DATE
67225	given	O
67226	that	O
67227	her	b-TEST
67228	creatinine	i-TEST
67229	had	O
67230	stabilized	b-OCCURRENCE
67231	.	O
67232	patient	O
67233	had	O
67234	no	O
67235	further	b-PROBLEM
67236	cardiac	i-PROBLEM
67237	issues	i-PROBLEM
67238	at	O
67239	this	b-DATE
67240	time	i-DATE
67241	.	O
67242	she	O
67243	was	O
67244	on	O
67245	telemetry	b-TEST
67246	without	O
67247	any	O
67248	episodes	O
67249	of	O
67250	any	b-PROBLEM
67251	rhythm	i-PROBLEM
67252	abnormalities	i-PROBLEM
67253	.	O
67254	7.	O
67255	cmed	O
67256	ccu	O
67257	:	O
67258	the	O
67259	patient	O
67260	had	O
67261	some	b-PROBLEM
67262	vaginal	i-PROBLEM
67263	bleeding	i-PROBLEM
67264	x2	b-DURATION
67265	days	i-DURATION
67266	.	O
67267	patient	O
67268	had	O
67269	a	O
67270	history	O
67271	of	O
67272	fibroids	b-PROBLEM
67273	during	O
67274	this	b-OCCURRENCE
67275	hospitalization	i-OCCURRENCE
67276	.	O
67277	followed	O
67278	her	O
67279	examination	O
67280	.	O
67281	her	b-TEST
67282	hematocrit	i-TEST
67283	remained	O
67284	stable	b-OCCURRENCE
67285	throughout	O
67286	this	b-OCCURRENCE
67287	course	i-OCCURRENCE
67288	.	O
67289	patient	O
67290	is	O
67291	strongly	O
67292	encouraged	O
67293	to	O
67294	followup	O
67295	with	O
67296	her	b-CLINICAL_DEPT
67297	outside	i-CLINICAL_DEPT
67298	primary	i-CLINICAL_DEPT
67299	care	i-CLINICAL_DEPT
67300	provider	i-CLINICAL_DEPT
67301	to	O
67302	followup	b-OCCURRENCE
67303	for	O
67304	the	b-PROBLEM
67305	vaginal	i-PROBLEM
67306	bleeding	i-PROBLEM
67307	given	O
67308	her	O
67309	history	O
67310	of	O
67311	fibroids	b-PROBLEM
67312	and	O
67313	question	O
67314	metaplasia	b-PROBLEM
67315	of	i-PROBLEM
67316	the	i-PROBLEM
67317	endometrium	i-PROBLEM
67318	.	O
67319	8.	O
67320	heme	O
67321	:	O
67322	her	b-TEST
67323	hematocrit	i-TEST
67324	remained	O
67325	stable	b-OCCURRENCE
67326	.	O
67327	she	O
67328	had	O
67329	a	O
67330	history	O
67331	of	O
67332	nucleated	b-PROBLEM
67333	rbcs	i-PROBLEM
67334	likely	O
67335	secondary	O
67336	to	O
67337	stress	b-PROBLEM
67338	and	O
67339	hypoxia	b-PROBLEM
67340	during	O
67341	this	b-OCCURRENCE
67342	admission	i-OCCURRENCE
67343	.	O
67344	hemolysis	b-TEST
67345	laboratories	i-TEST
67346	were	O
67347	negative	O
67348	.	O
67349	patient	O
67350	was	O
67351	restarted	O
67352	on	O
67353	her	b-TREATMENT
67354	iron	i-TREATMENT
67355	supplementation	i-TREATMENT
67356	.	O
67357	reticulocyte	b-TEST
67358	count	i-TEST
67359	was	O
67360	performed	O
67361	that	O
67362	was	O
67363	negative	O
67364	.	O
67365	9.	O
67366	fen	O
67367	:	O
67368	she	O
67369	was	O
67370	npo	b-TREATMENT
67371	with	O
67372	a	b-PROBLEM
67373	decrease	i-PROBLEM
67374	in	i-PROBLEM
67375	her	i-PROBLEM
67376	mental	i-PROBLEM
67377	status	i-PROBLEM
67378	.	O
67379	we	O
67380	slowly	O
67381	advanced	b-OCCURRENCE
67382	her	i-OCCURRENCE
67383	diet	i-OCCURRENCE
67384	as	O
67385	her	b-OCCURRENCE
67386	mental	i-OCCURRENCE
67387	status	i-OCCURRENCE
67388	improved	O
67389	and	O
67390	repleted	b-TREATMENT
67391	her	i-TREATMENT
67392	electrolytes	i-TREATMENT
67393	,	O
67394	and	O
67395	started	O
67396	on	O
67397	her	b-TREATMENT
67398	p.o.	i-TREATMENT
67399	medications	i-TREATMENT
67400	on	O
67401	hospital	b-DATE
67402	day	i-DATE
67403	two	i-DATE
67404	.	O
67405	10.	O
67406	diabetes	O
67407	:	O
67408	patient	O
67409	had	O
67410	q.i.d.	b-FREQUENCY
67411	fingersticks	b-TEST
67412	with	O
67413	a	b-TREATMENT
67414	humalog	i-TREATMENT
67415	sliding	i-TREATMENT
67416	scale	i-TREATMENT
67417	and	O
67418	nph	b-TREATMENT
67419	doses	i-TREATMENT
67420	were	O
67421	cut	O
67422	in	O
67423	half	O
67424	while	O
67425	she	O
67426	was	O
67427	npo	b-TREATMENT
67428	,	O
67429	and	O
67430	they	O
67431	were	O
67432	brought	O
67433	back	O
67434	to	O
67435	her	b-TREATMENT
67436	normal	i-TREATMENT
67437	doses	i-TREATMENT
67438	on	O
67439	the	b-DATE
67440	day	i-DATE
67441	of	O
67442	discharge	O
67443	with	O
67444	a	b-OCCURRENCE
67445	full	i-OCCURRENCE
67446	diet	i-OCCURRENCE
67447	.	O
67448	11.	O
67449	code	O
67450	status	O
67451	:	O
67452	full	O
67453	.	O
67454	two	O
67455	daughters	O
67456	came	O
67457	by	O
67458	and	O
67459	requested	O
67460	to	O
67461	be	O
67462	health	O
67463	care	O
67464	proxies	O
67465	as	O
67466	patient	O
67467	approved	O
67468	.	O
67469	documentation	O
67470	is	O
67471	in	O
67472	her	O
67473	medical	O
67474	chart	O
67475	.	O
67476	12.	O
67477	prophylaxis	O
67478	:	O
67479	the	O
67480	patient	O
67481	was	O
67482	on	O
67483	subq	b-TREATMENT
67484	heparin	i-TREATMENT
67485	for	O
67486	dvt	b-PROBLEM
67487	and	O
67488	ranitidine	b-TREATMENT
67489	for	O
67490	gi	b-TREATMENT
67491	prophylaxis	i-TREATMENT
67492	.	O
67493	disposition:	O
67494	the	O
67495	patient	O
67496	is	O
67497	to	O
67498	be	O
67499	discharged	b-OCCURRENCE
67500	today	b-DATE
67501	to	O
67502	lahey	b-CLINICAL_DEPT
67503	clinic	i-CLINICAL_DEPT
67504	-	i-CLINICAL_DEPT
67505	north	i-CLINICAL_DEPT
67506	shore	i-CLINICAL_DEPT
67507	hospital	i-CLINICAL_DEPT
67508	for	O
67509	long-term	b-TREATMENT
67510	pulmonary	i-TREATMENT
67511	........	i-TREATMENT
67512	therapy	i-TREATMENT
67513	and	O
67514	further	O
67515	evaluation	b-TEST
67516	of	O
67517	her	b-PROBLEM
67518	obstructive-sleep	i-PROBLEM
67519	apnea	i-PROBLEM
67520	.	i-PROBLEM
67521		O
67522	admission	b-OCCURRENCE
67523	date	O
67524	:	O
67525	2013-09-06	b-ADMISSION
67526	discharge	b-OCCURRENCE
67527	date	O
67528	:	O
67529	2013-09-18	b-DISCHARGE
67530	service	O
67531	:	O
67532	neurologic	O
67533	medicine	O
67534	history	O
67535	of	O
67536	present	O
67537	illness	O
67538	:	O
67539	this	O
67540	is	O
67541	an	O
67542	86	O
67543	year	O
67544	old	O
67545	woman	O
67546	who	O
67547	has	O
67548	a	O
67549	history	O
67550	of	O
67551	atrial	b-PROBLEM
67552	fibrillation	i-PROBLEM
67553	,	O
67554	peripheral	b-PROBLEM
67555	vascular	i-PROBLEM
67556	disease	i-PROBLEM
67557	,	O
67558	and	O
67559	a	O
67560	history	O
67561	of	O
67562	atrial	b-PROBLEM
67563	emboli	i-PROBLEM
67564	who	O
67565	was	O
67566	admitted	b-OCCURRENCE
67567	on	O
67568	2013-09-06	b-DATE
67569	,	O
67570	to	O
67571	the	b-CLINICAL_DEPT
67572	neurologic	i-CLINICAL_DEPT
67573	intensive	i-CLINICAL_DEPT
67574	care	i-CLINICAL_DEPT
67575	unit	i-CLINICAL_DEPT
67576	service	O
67577	after	O
67578	collapsing	b-OCCURRENCE
67579	at	O
67580	home	O
67581	at	O
67582	8:30	b-TIME
67583	p.m	i-TIME
67584	.	O
67585	she	O
67586	was	O
67587	found	O
67588	to	O
67589	have	O
67590	right	b-PROBLEM
67591	sided	i-PROBLEM
67592	weakness	i-PROBLEM
67593	and	O
67594	was	O
67595	noted	O
67596	by	O
67597	her	O
67598	husband	O
67599	to	O
67600	have	O
67601	vomited	b-PROBLEM
67602	.	O
67603	she	O
67604	was	O
67605	found	O
67606	comatose	b-PROBLEM
67607	at	O
67608	home	O
67609	by	O
67610	ems	b-CLINICAL_DEPT
67611	and	O
67612	was	O
67613	brought	O
67614	to	O
67615	the	b-CLINICAL_DEPT
67616	emergency	i-CLINICAL_DEPT
67617	department	i-CLINICAL_DEPT
67618	.	O
67619	on	O
67620	arrival	b-OCCURRENCE
67621	to	O
67622	the	b-CLINICAL_DEPT
67623	emergency	i-CLINICAL_DEPT
67624	department	i-CLINICAL_DEPT
67625	,	O
67626	she	O
67627	was	O
67628	noted	O
67629	to	O
67630	have	O
67631	a	b-TEST
67632	temperature	i-TEST
67633	of	O
67634	98.2	O
67635	,	O
67636	blood	b-TEST
67637	pressure	i-TEST
67638	164/110	O
67639	,	O
67640	respiratory	b-TEST
67641	rate	i-TEST
67642	28	O
67643	,	O
67644	and	O
67645	heart	b-TEST
67646	rate	i-TEST
67647	of	O
67648	74	O
67649	.	O
67650	she	O
67651	was	O
67652	found	O
67653	to	O
67654	be	O
67655	responsive	b-PROBLEM
67656	only	i-PROBLEM
67657	to	i-PROBLEM
67658	painful	i-PROBLEM
67659	stimuli	i-PROBLEM
67660	at	O
67661	this	b-DATE
67662	time	i-DATE
67663	.	O
67664	she	O
67665	was	O
67666	intubated	b-TREATMENT
67667	for	O
67668	airway	b-TREATMENT
67669	protection	i-TREATMENT
67670	and	O
67671	received	O
67672	multiple	b-TREATMENT
67673	medications	i-TREATMENT
67674	prior	O
67675	to	O
67676	her	b-TEST
67677	initial	i-TEST
67678	neurologic	i-TEST
67679	examination	i-TEST
67680	.	O
67681	she	O
67682	was	O
67683	also	O
67684	noted	O
67685	to	O
67686	have	O
67687	a	b-PROBLEM
67688	cold	i-PROBLEM
67689	distal	i-PROBLEM
67690	left	i-PROBLEM
67691	upper	i-PROBLEM
67692	extremity	i-PROBLEM
67693	which	O
67694	was	O
67695	operated	b-TREATMENT
67696	on	O
67697	and	O
67698	she	O
67699	is	O
67700	now	O
67701	status	O
67702	post	O
67703	left	b-TREATMENT
67704	brachial	i-TREATMENT
67705	artery	i-TREATMENT
67706	embolectomy	i-TREATMENT
67707	.	O
67708	throughout	O
67709	her	O
67710	course	O
67711	on	O
67712	the	b-CLINICAL_DEPT
67713	intensive	i-CLINICAL_DEPT
67714	care	i-CLINICAL_DEPT
67715	unit	i-CLINICAL_DEPT
67716	service	O
67717	,	O
67718	she	O
67719	has	O
67720	remained	O
67721	unresponsive	b-PROBLEM
67722	with	O
67723	imaging	b-TEST
67724	studies	i-TEST
67725	consistent	O
67726	with	O
67727	a	O
67728	large	O
67729	left	O
67730	middle	O
67731	cerebral	O
67732	artery	O
67733	and	O
67734	posterior	b-PROBLEM
67735	cerebral	i-PROBLEM
67736	artery	i-PROBLEM
67737	distribution	i-PROBLEM
67738	cerebral	i-PROBLEM
67739	infarction	i-PROBLEM
67740	with	O
67741	mass	b-PROBLEM
67742	effect	i-PROBLEM
67743	and	O
67744	midline	b-PROBLEM
67745	shift	i-PROBLEM
67746	.	O
67747	there	O
67748	is	O
67749	evidence	O
67750	of	O
67751	bilateral	b-PROBLEM
67752	occipital	i-PROBLEM
67753	and	i-PROBLEM
67754	cerebellar	i-PROBLEM
67755	infarctions	i-PROBLEM
67756	as	O
67757	well	O
67758	.	O
67759	discussion	O
67760	with	O
67761	the	O
67762	patient	O
67763	's	O
67764	family	O
67765	by	O
67766	the	b-CLINICAL_DEPT
67767	intensive	i-CLINICAL_DEPT
67768	care	i-CLINICAL_DEPT
67769	unit	i-CLINICAL_DEPT
67770	service	O
67771	has	O
67772	resulted	O
67773	in	O
67774	focusing	O
67775	on	O
67776	her	b-TREATMENT
67777	comfort	i-TREATMENT
67778	care	i-TREATMENT
67779	.	O
67780	this	O
67781	decision	O
67782	was	O
67783	made	O
67784	after	O
67785	an	O
67786	extensive	O
67787	discussion	O
67788	with	O
67789	her	O
67790	husband	O
67791	and	O
67792	family	O
67793	as	O
67794	the	O
67795	likelihood	O
67796	of	O
67797	significant	O
67798	meaningful	O
67799	recovery	O
67800	is	O
67801	extremely	O
67802	low	O
67803	.	O
67804	based	O
67805	on	O
67806	this	O
67807	,	O
67808	she	O
67809	is	O
67810	transferred	b-OCCURRENCE
67811	to	O
67812	the	b-CLINICAL_DEPT
67813	neurology	i-CLINICAL_DEPT
67814	service	O
67815	for	O
67816	focus	O
67817	on	O
67818	comfort	b-TREATMENT
67819	care	i-TREATMENT
67820	.	O
67821	hospital	O
67822	course	O
67823	:	O
67824	the	O
67825	patient	O
67826	's	O
67827	course	O
67828	up	O
67829	to	O
67830	the	O
67831	date	O
67832	of	O
67833	transfer	b-OCCURRENCE
67834	to	O
67835	neurology	b-CLINICAL_DEPT
67836	has	O
67837	been	O
67838	outlined	O
67839	above	O
67840	.	O
67841	briefly	O
67842	,	O
67843	she	O
67844	is	O
67845	an	O
67846	86	O
67847	year	O
67848	old	O
67849	woman	O
67850	who	O
67851	has	O
67852	suffered	O
67853	multiple	b-PROBLEM
67854	cardioembolic	i-PROBLEM
67855	cerebral	i-PROBLEM
67856	infarctions	i-PROBLEM
67857	in	i-PROBLEM
67858	multiple	i-PROBLEM
67859	arterial	i-PROBLEM
67860	territories	i-PROBLEM
67861	.	O
67862	she	O
67863	has	O
67864	remained	O
67865	unresponsive	b-PROBLEM
67866	throughout	O
67867	the	b-OCCURRENCE
67868	hospitalization	i-OCCURRENCE
67869	and	O
67870	currently	O
67871	only	O
67872	withdraws	O
67873	to	O
67874	pain	b-PROBLEM
67875	.	O
67876	after	O
67877	extensive	O
67878	discussion	O
67879	with	O
67880	her	O
67881	family	O
67882	,	O
67883	her	O
67884	care	O
67885	was	O
67886	focused	O
67887	on	O
67888	comfort	b-TREATMENT
67889	.	O
67890	a	b-TREATMENT
67891	low	i-TREATMENT
67892	dose	i-TREATMENT
67893	morphine	i-TREATMENT
67894	drip	i-TREATMENT
67895	was	O
67896	initiated	O
67897	after	O
67898	further	O
67899	serious	O
67900	discussion	O
67901	with	O
67902	her	O
67903	husband	O
67904	and	O
67905	nieces	O
67906	and	O
67907	nephews	O
67908	.	O
67909	the	O
67910	patient	O
67911	passed	b-OCCURRENCE
67912	away	i-OCCURRENCE
67913	peacefully	O
67914	on	O
67915	2013-09-18	b-DATE
67916	.	O
67917	the	O
67918	family	O
67919	did	O
67920	not	O
67921	want	O
67922	postmortem	b-TEST
67923	examination	i-TEST
67924	.	O
67925	michael	O
67926	p	O
67927	galuszka	O
67928	,	O
67929	md	O
67930	46-348	O
67931	dictated	O
67932	by	O
67933	:	O
67934	melissa	O
67935	u	O
67936	sangi	O
67937	,	O
67938	md	O
67939	medquist36	O
67940	d	O
67941	:	O
67942	2013-11-11	O
67943	18:47	O
67944	t	O
67945	:	O
67946	2013-11-11	O
67947	19:46	O
67948	job	O
67949	#:	O
67950	93375	O
67951	signed	O
67952	electronically	O
67953	by	O
67954	:	O
67955	doctor	O
67956	ryann	O
67957	w.	O
67958	u.	O
67959	galuszka	O
67960	on	O
67961	:	O
67962	tue	O
67963	2013-11-19	O
67964	12:45	O
67965	pm	O
67966	(	O
67967	end	O
67968	of	O
67969	report	O
67970	)	O
67971		O
67972	admission	b-OCCURRENCE
67973	date	O
67974	:	O
67975	2013-09-05	b-ADMISSION
67976	discharge	b-OCCURRENCE
67977	date	O
67978	:	O
67979	2013-09-12	b-DISCHARGE
67980	service	O
67981	:	O
67982	medicine	O
67983	history	O
67984	of	O
67985	present	O
67986	illness	O
67987	:	O
67988	hpi	O
67989	:	O
67990	this	O
67991	is	O
67992	a	O
67993	79	O
67994	y/o	O
67995	m	O
67996	with	O
67997	h/o	O
67998	of	O
67999	htn	b-PROBLEM
68000	,	O
68001	dm	b-PROBLEM
68002	,	O
68003	recent	b-PROBLEM
68004	cva	i-PROBLEM
68005	theresa	O
68006	,	O
68007	chronic	b-PROBLEM
68008	respiratory	i-PROBLEM
68009	failure	i-PROBLEM
68010	on	O
68011	vent	b-TREATMENT
68012	,	O
68013	trached	b-TREATMENT
68014	,	O
68015	esrd	b-PROBLEM
68016	on	O
68017	hd	b-TREATMENT
68018	who	O
68019	was	O
68020	sent	O
68021	from	O
68022	rehab	b-CLINICAL_DEPT
68023	facility	i-CLINICAL_DEPT
68024	for	O
68025	worsening	b-PROBLEM
68026	mental	i-PROBLEM
68027	status	i-PROBLEM
68028	.	O
68029	per	O
68030	refferal	O
68031	notes	O
68032	,	O
68033	he	O
68034	went	O
68035	to	O
68036	hemodyalisis	b-TREATMENT
68037	today	b-DATE
68038	in	i-DATE
68039	the	i-DATE
68040	morning	i-DATE
68041	.	O
68042	1	O
68043	l	O
68044	was	O
68045	removed	b-TREATMENT
68046	.	O
68047	at	O
68048	about	O
68049	2:30	b-TIME
68050	pm	i-TIME
68051	,	O
68052	he	O
68053	was	O
68054	found	O
68055	to	O
68056	have	O
68057	worsening	b-PROBLEM
68058	mental	i-PROBLEM
68059	status	i-PROBLEM
68060	.	O
68061	in	O
68062	that	O
68063	setting	O
68064	he	O
68065	was	O
68066	hypotensive	b-PROBLEM
68067	down	O
68068	to	O
68069	the	O
68070	92/45	O
68071	,	O
68072	and	O
68073	was	O
68074	given	O
68075	1	b-TREATMENT
68076	l	i-TREATMENT
68077	ns	i-TREATMENT
68078	.	O
68079	fs	b-TEST
68080	was	O
68081	also	O
68082	checked	O
68083	179	O
68084	.	O
68085	at	O
68086	that	O
68087	time	O
68088	,	O
68089	it	O
68090	seems	O
68091	that	O
68092	he	O
68093	had	O
68094	been	O
68095	on	O
68096	t	b-TREATMENT
68097	peace	i-TREATMENT
68098	since	O
68099	4	b-TIME
68100	am	i-TIME
68101	today	i-TIME
68102	.	O
68103	at	O
68104	2:30	b-TIME
68105	he	O
68106	was	O
68107	also	O
68108	found	O
68109	with	O
68110	sats	b-TEST
68111	in	O
68112	the	O
68113	90%	O
68114	.	O
68115	abg	b-TEST
68116	done	O
68117	7.1	O
68118	,	O
68119	89/72	O
68120	-	O
68121	he	O
68122	was	O
68123	placed	O
68124	on	O
68125	ac	b-TREATMENT
68126	600	O
68127	/	O
68128	0.4	O
68129	and	O
68130	6	O
68131	peep	b-TREATMENT
68132	-	O
68133	sats	b-TEST
68134	up	O
68135	to	O
68136	94%	O
68137	.	O
68138	given	O
68139	persistent	b-PROBLEM
68140	lethargy	i-PROBLEM
68141	,	O
68142	patient	O
68143	was	O
68144	sent	O
68145	to	O
68146	falkener	b-CLINICAL_DEPT
68147	amanda	i-CLINICAL_DEPT
68148	.	O
68149	of	O
68150	note	O
68151	,	O
68152	after	O
68153	interview	b-OCCURRENCE
68154	with	i-OCCURRENCE
68155	hcp	i-OCCURRENCE
68156	,	O
68157	at	O
68158	around	O
68159	07-23	b-DATE
68160	,	O
68161	patient	O
68162	started	O
68163	having	O
68164	episodes	O
68165	of	O
68166	dizziness	b-PROBLEM
68167	,	O
68168	and	O
68169	had	O
68170	unstable	b-PROBLEM
68171	gait	i-PROBLEM
68172	.	O
68173	he	O
68174	was	O
68175	taken	O
68176	to	O
68177	williams	b-CLINICAL_DEPT
68178	icu	i-CLINICAL_DEPT
68179	until	O
68180	08-09	b-DATE
68181	when	O
68182	he	O
68183	was	O
68184	discharged	b-OCCURRENCE
68185	to	O
68186	waltham/weston	b-CLINICAL_DEPT
68187	hospital	i-CLINICAL_DEPT
68188	rehab	i-CLINICAL_DEPT
68189	.	O
68190	he	O
68191	had	O
68192	a	b-TREATMENT
68193	peg	i-TREATMENT
68194	tube	i-TREATMENT
68195	and	O
68196	tracheostomy	b-TREATMENT
68197	prior	O
68198	to	O
68199	d/c	b-OCCURRENCE
68200	.	O
68201	he	O
68202	had	O
68203	been	O
68204	chronicallyl	b-PROBLEM
68205	vent	i-PROBLEM
68206	dependent	i-PROBLEM
68207	.	O
68208	his	O
68209	companion	O
68210	states	b-EVIDENTIAL
68211	that	O
68212	they	O
68213	have	O
68214	been	O
68215	trying	O
68216	to	O
68217	wean	b-TREATMENT
68218	him	i-TREATMENT
68219	down	i-TREATMENT
68220	at	O
68221	rehab	b-CLINICAL_DEPT
68222	.	O
68223	his	b-OCCURRENCE
68224	basline	i-OCCURRENCE
68225	mental	i-OCCURRENCE
68226	staus	i-OCCURRENCE
68227	apparently	O
68228	responds	O
68229	with	O
68230	his	b-OCCURRENCE
68231	head	i-OCCURRENCE
68232	shaking	i-OCCURRENCE
68233	,	O
68234	and	O
68235	also	O
68236	try	b-OCCURRENCE
68237	to	i-OCCURRENCE
68238	write	i-OCCURRENCE
68239	sentences	i-OCCURRENCE
68240	.	O
68241	in	O
68242	the	b-CLINICAL_DEPT
68243	amanda	i-CLINICAL_DEPT
68244	:	O
68245	vs	b-TEST
68246	t	b-TEST
68247	103	O
68248	rectal	O
68249	bp90/44	b-TEST
68250	hr	b-TEST
68251	:	O
68252	84	O
68253	rr	b-TEST
68254	16	O
68255	sats	b-TEST
68256	:	O
68257	98	O
68258	+	b-PROBLEM
68259	guiac	i-PROBLEM
68260	stool	i-PROBLEM
68261	.	O
68262	he	O
68263	received	O
68264	tylenol	b-TREATMENT
68265	,	O
68266	levofloxacin	b-TREATMENT
68267	500	O
68268	mg	O
68269	iv	O
68270	,	O
68271	flagyl	b-TREATMENT
68272	500	O
68273	mg	O
68274	and	O
68275	vancomycin	b-TREATMENT
68276	and	O
68277	i	O
68278	l	O
68279	ns	b-TREATMENT
68280	.	O
68281	ros	b-TEST
68282	:	O
68283	difficult	O
68284	to	O
68285	obtain	O
68286	2x2	O
68287	to	O
68288	patient	b-OCCURRENCE
68289	mental	i-OCCURRENCE
68290	status	i-OCCURRENCE
68291	baselin	i-OCCURRENCE
68292	brief	O
68293	hospital	O
68294	course	O
68295	:	O
68296	assessment	O
68297	and	O
68298	plan	O
68299	:	O
68300	this	O
68301	is	O
68302	a	O
68303	79	O
68304	y/o	O
68305	m	O
68306	with	O
68307	h/o	O
68308	htn	b-PROBLEM
68309	,	O
68310	dm	b-PROBLEM
68311	,	O
68312	recent	b-PROBLEM
68313	cva	i-PROBLEM
68314	,	O
68315	chronic	b-PROBLEM
68316	ventilatory	i-PROBLEM
68317	failure	i-PROBLEM
68318	,	O
68319	cri	b-PROBLEM
68320	on	O
68321	hd	b-TREATMENT
68322	who	O
68323	presents	b-EVIDENTIAL
68324	with	O
68325	change	b-PROBLEM
68326	in	i-PROBLEM
68327	ms	i-PROBLEM
68328	and	O
68329	febrile	b-PROBLEM
68330	in	O
68331	the	b-CLINICAL_DEPT
68332	amanda	i-CLINICAL_DEPT
68333	,	O
68334	admitted	b-OCCURRENCE
68335	to	O
68336	cmed	b-CLINICAL_DEPT
68337	.	O
68338	#	O
68339	altered	b-PROBLEM
68340	mental	i-PROBLEM
68341	status	i-PROBLEM
68342	:	O
68343	ct	b-TEST
68344	scan	i-TEST
68345	with	O
68346	no	O
68347	evidence	O
68348	of	O
68349	new	b-PROBLEM
68350	intracraneal	i-PROBLEM
68351	bleeding	i-PROBLEM
68352	.	O
68353	patient	O
68354	febrile	b-PROBLEM
68355	in	O
68356	the	b-CLINICAL_DEPT
68357	amanda	i-CLINICAL_DEPT
68358	.	O
68359	high	b-PROBLEM
68360	wbc	i-PROBLEM
68361	.	O
68362	it	O
68363	was	O
68364	thought	O
68365	that	O
68366	it	O
68367	could	O
68368	have	O
68369	been	O
68370	a	O
68371	combination	O
68372	of	O
68373	hypotension	b-PROBLEM
68374	,	O
68375	hypercapnia	b-PROBLEM
68376	and	O
68377	infection	b-PROBLEM
68378	.	O
68379	he	O
68380	was	O
68381	initially	O
68382	started	O
68383	on	O
68384	broad	b-TREATMENT
68385	spectrum	i-TREATMENT
68386	antibiotics	i-TREATMENT
68387	.	O
68388	despite	O
68389	having	O
68390	a	b-PROBLEM
68391	profund	i-PROBLEM
68392	limitation	i-PROBLEM
68393	communicating	i-PROBLEM
68394	given	O
68395	his	b-PROBLEM
68396	neurological	i-PROBLEM
68397	status	i-PROBLEM
68398	,	O
68399	his	b-PROBLEM
68400	mental	i-PROBLEM
68401	changes	i-PROBLEM
68402	seemed	O
68403	to	O
68404	improved	b-OCCURRENCE
68405	initially	i-OCCURRENCE
68406	.	O
68407	however	O
68408	later	O
68409	on	O
68410	during	O
68411	his	b-OCCURRENCE
68412	course	i-OCCURRENCE
68413	,	O
68414	his	b-PROBLEM
68415	mental	i-PROBLEM
68416	status	i-PROBLEM
68417	deteriorated	i-PROBLEM
68418	,	O
68419	being	O
68420	even	O
68421	less	b-PROBLEM
68422	responsive	i-PROBLEM
68423	.	O
68424	#	O
68425	id	O
68426	:	O
68427	patient	O
68428	febrile	b-PROBLEM
68429	and	O
68430	with	O
68431	a	b-PROBLEM
68432	high	i-PROBLEM
68433	wbc	i-PROBLEM
68434	on	O
68435	admission	b-OCCURRENCE
68436	.	O
68437	after	O
68438	starting	O
68439	broad	b-TREATMENT
68440	spectrum	i-TREATMENT
68441	antibiotics	i-TREATMENT
68442	-	O
68443	cefepime	b-TREATMENT
68444	-	O
68445	vancomycin	b-TREATMENT
68446	and	O
68447	flagyl	b-TREATMENT
68448	(	O
68449	for	O
68450	initial	O
68451	concern	O
68452	of	O
68453	aspiration	b-PROBLEM
68454	pneumonia	i-PROBLEM
68455	),	O
68456	he	O
68457	responded	b-OCCURRENCE
68458	clinically	O
68459	.	O
68460	urine	b-TEST
68461	cx	i-TEST
68462	from	O
68463	rehab	b-CLINICAL_DEPT
68464	showed	b-EVIDENTIAL
68465	gram	b-PROBLEM
68466	negative	i-PROBLEM
68467	rods	i-PROBLEM
68468	>	b-PROBLEM
68469	100	i-PROBLEM
68470	k	i-PROBLEM
68471	enterobacter	i-PROBLEM
68472	cloacae	i-PROBLEM
68473	.	O
68474	urine	b-TEST
68475	cx	i-TEST
68476	in	b-CLINICAL_DEPT
68477	house	i-CLINICAL_DEPT
68478	grew	O
68479	citrobacter	b-PROBLEM
68480	freundi	i-PROBLEM
68481	and	O
68482	his	b-TEST
68483	sputum	i-TEST
68484	grew	O
68485	acinetobacter	b-PROBLEM
68486	baummani	i-PROBLEM
68487	.	O
68488	since	O
68489	there	O
68490	was	O
68491	no	O
68492	more	O
68493	evidence	O
68494	of	O
68495	gram	b-PROBLEM
68496	positive	i-PROBLEM
68497	infections	i-PROBLEM
68498	,	O
68499	vancomycin	b-TREATMENT
68500	was	O
68501	discontinued	O
68502	and	O
68503	cefepime	b-TREATMENT
68504	was	O
68505	kept	O
68506	.	O
68507	#	O
68508	fevers	b-PROBLEM
68509	:	O
68510	in	O
68511	the	b-CLINICAL_DEPT
68512	amanda	i-CLINICAL_DEPT
68513	,	O
68514	high	b-PROBLEM
68515	wbc	i-PROBLEM
68516	,	O
68517	possible	O
68518	pneumonia	b-PROBLEM
68519	.	O
68520	also	O
68521	possible	O
68522	source	O
68523	sinus	b-PROBLEM
68524	infections	i-PROBLEM
68525	given	O
68526	findings	b-EVIDENTIAL
68527	on	O
68528	intial	b-TEST
68529	ct	i-TEST
68530	(	O
68531	see	O
68532	summary	O
68533	in	O
68534	significant	O
68535	studies	O
68536	).	O
68537	he	O
68538	did	O
68539	not	O
68540	spike	O
68541	any	O
68542	fevers	b-PROBLEM
68543	after	O
68544	being	O
68545	transfer	b-OCCURRENCE
68546	to	O
68547	the	b-CLINICAL_DEPT
68548	cmed	i-CLINICAL_DEPT
68549	from	O
68550	the	b-CLINICAL_DEPT
68551	amanda	i-CLINICAL_DEPT
68552	.	O
68553	#	O
68554	resp	O
68555	:	O
68556	patient	O
68557	was	O
68558	intermitentely	O
68559	switched	O
68560	from	O
68561	ac	b-TREATMENT
68562	to	O
68563	pressure	b-TREATMENT
68564	support	i-TREATMENT
68565	trials	i-TREATMENT
68566	.	O
68567	however	O
68568	,	O
68569	after	O
68570	patient	b-OCCURRENCE
68571	did	i-OCCURRENCE
68572	well	i-OCCURRENCE
68573	.	O
68574	then	O
68575	trach	b-TREATMENT
68576	mask	i-TREATMENT
68577	trials	i-TREATMENT
68578	were	O
68579	done	O
68580	.	O
68581	he	O
68582	tolerated	b-OCCURRENCE
68583	this	i-OCCURRENCE
68584	well	i-OCCURRENCE
68585	,	O
68586	although	O
68587	he	O
68588	required	O
68589	ps	b-TREATMENT
68590	overnight	b-DURATION
68591	.	O
68592	#	O
68593	esrd	b-PROBLEM
68594	on	O
68595	hemodyalisis	b-TREATMENT
68596	:	O
68597	renal	O
68598	service	O
68599	was	O
68600	consulted	b-OCCURRENCE
68601	and	O
68602	hd	b-TREATMENT
68603	was	O
68604	continued	O
68605	.	O
68606	#	O
68607	cv	O
68608	:	O
68609	rhythm	b-TEST
68610	:	O
68611	nsr	b-OCCURRENCE
68612	,	O
68613	not	O
68614	tachycardic	b-PROBLEM
68615	.	O
68616	pump	O
68617	:	O
68618	with	O
68619	trace	O
68620	of	O
68621	lower	b-PROBLEM
68622	extremity	i-PROBLEM
68623	edema	i-PROBLEM
68624	.	O
68625	x	b-TEST
68626	ray	i-TEST
68627	suggested	O
68628	some	b-PROBLEM
68629	pulmonary	i-PROBLEM
68630	edema	i-PROBLEM
68631	on	O
68632	admission	b-OCCURRENCE
68633	.	O
68634	despite	O
68635	this	O
68636	findings	O
68637	,	O
68638	he	O
68639	was	O
68640	supported	O
68641	with	O
68642	40%	b-TREATMENT
68643	fio2	i-TREATMENT
68644	most	O
68645	of	O
68646	the	O
68647	time	O
68648	.	O
68649	cad	b-PROBLEM
68650	:	O
68651	on	O
68652	admission	b-OCCURRENCE
68653	ck	b-TEST
68654	low	O
68655	normal	O
68656	,	O
68657	mb	b-TEST
68658	not	O
68659	done	O
68660	.	O
68661	troponin	b-TEST
68662	0.44.	O
68663		O
68664	it	O
68665	was	O
68666	more	O
68667	likely	O
68668	due	O
68669	to	O
68670	cri	b-PROBLEM
68671	.	O
68672	second	b-FREQUENCY
68673	set	b-TEST
68674	12	b-DURATION
68675	hours	i-DURATION
68676	apart	O
68677	,	O
68678	showed	b-EVIDENTIAL
68679	no	O
68680	changes	b-PROBLEM
68681	.	O
68682	s/p	O
68683	stroke	b-PROBLEM
68684	:	O
68685	continue	O
68686	aspirin	b-TREATMENT
68687	,	O
68688	statin	b-TREATMENT
68689	,	O
68690	plavix	b-TREATMENT
68691	#	O
68692	hypotension	b-PROBLEM
68693	:	O
68694	per	O
68695	referral	O
68696	form	O
68697	.	O
68698	intially	O
68699	concern	O
68700	for	O
68701	sepsis	b-PROBLEM
68702	in	O
68703	the	O
68704	setting	O
68705	of	O
68706	fevers	b-PROBLEM
68707	and	O
68708	high	b-PROBLEM
68709	blood	i-PROBLEM
68710	count	i-PROBLEM
68711	.	O
68712	his	b-TREATMENT
68713	bp	i-TREATMENT
68714	medications	i-TREATMENT
68715	were	O
68716	held	O
68717	on	O
68718	admission	b-OCCURRENCE
68719	.	O
68720	patient	O
68721	did	O
68722	not	O
68723	require	O
68724	pressors	b-TREATMENT
68725	.	O
68726	his	b-TEST
68727	blood	i-TEST
68728	pressure	i-TEST
68729	remained	b-OCCURRENCE
68730	stable	i-OCCURRENCE
68731	and	O
68732	bp	b-TREATMENT
68733	meds	i-TREATMENT
68734	were	O
68735	restarted	O
68736	.	O
68737	#	O
68738	fen	O
68739	:	O
68740	tube	b-TREATMENT
68741	feedings	i-TREATMENT
68742	were	O
68743	started	O
68744	thorugh	O
68745	peg	b-TREATMENT
68746	tube	i-TREATMENT
68747	.	O
68748	on	O
68749	2013-09-08	b-DATE
68750	,	O
68751	patient	O
68752	pulled	b-PROBLEM
68753	out	i-PROBLEM
68754	peg	b-TREATMENT
68755	tube	i-TREATMENT
68756	.	O
68757	temporary	b-TREATMENT
68758	foley	i-TREATMENT
68759	was	O
68760	placed	O
68761	and	O
68762	on	O
68763	2013-09-11	b-DATE
68764	,	O
68765	on	O
68766	2013-09-12	b-DATE
68767	after	O
68768	deterioration	b-PROBLEM
68769	of	i-PROBLEM
68770	his	i-PROBLEM
68771	mental	i-PROBLEM
68772	status	i-PROBLEM
68773	and	i-PROBLEM
68774	also	i-PROBLEM
68775	of	i-PROBLEM
68776	his	i-PROBLEM
68777	blood	i-PROBLEM
68778	pressure	i-PROBLEM
68779	,	O
68780	goals	O
68781	of	O
68782	care	O
68783	were	O
68784	discussed	b-OCCURRENCE
68785	with	O
68786	his	O
68787	hcp	O
68788	.	O
68789	it	O
68790	was	O
68791	decided	O
68792	to	O
68793	direct	O
68794	goals	O
68795	of	O
68796	care	O
68797	towards	O
68798	confort	b-TREATMENT
68799	care	i-TREATMENT
68800	.	O
68801	patient	O
68802	passed	b-PROBLEM
68803	away	i-PROBLEM
68804	accompanied	O
68805	by	O
68806	his	O
68807	significant	O
68808	other	O
68809	.	O
68810		O
68811	admission	b-OCCURRENCE
68812	date	O
68813	:	O
68814	06-30-93	b-ADMISSION
68815	discharge	b-OCCURRENCE
68816	date	O
68817	:	O
68818	07-06-93	b-DISCHARGE
68819	history	O
68820	of	O
68821	present	O
68822	illness	O
68823	:	O
68824	the	O
68825	patient	O
68826	is	O
68827	a	O
68828	67	O
68829	year	O
68830	old	O
68831	white	O
68832	male	O
68833	with	O
68834	a	O
68835	recent	O
68836	history	O
68837	of	O
68838	urinary	b-PROBLEM
68839	frequency	i-PROBLEM
68840	q2-3h	b-FREQUENCY
68841	,	O
68842	stranguria	b-PROBLEM
68843	,	O
68844	nocturia	b-PROBLEM
68845	x	b-FREQUENCY
68846	3-4	i-FREQUENCY
68847	per	i-FREQUENCY
68848	night	i-FREQUENCY
68849	.	O
68850	he	O
68851	was	O
68852	found	O
68853	on	O
68854	physical	b-TEST
68855	exam	i-TEST
68856	to	O
68857	have	O
68858	an	b-PROBLEM
68859	asymmetric	i-PROBLEM
68860	prostate	i-PROBLEM
68861	with	O
68862	prominence	b-PROBLEM
68863	on	i-PROBLEM
68864	the	i-PROBLEM
68865	left	i-PROBLEM
68866	and	O
68867	a	O
68868	question	O
68869	of	O
68870	a	b-PROBLEM
68871	nodule	i-PROBLEM
68872	.	O
68873	repeat	b-TEST
68874	exam	i-TEST
68875	one	b-DURATION
68876	month	i-DURATION
68877	later	O
68878	showed	b-EVIDENTIAL
68879	a	b-PROBLEM
68880	firm	i-PROBLEM
68881	left-sided	i-PROBLEM
68882	lobe	i-PROBLEM
68883	.	O
68884	transrectal	b-TEST
68885	ultrasound	i-TEST
68886	showed	b-EVIDENTIAL
68887	a	b-PROBLEM
68888	hypoechoic	i-PROBLEM
68889	left-sided	i-PROBLEM
68890	mass	i-PROBLEM
68891	in	i-PROBLEM
68892	the	i-PROBLEM
68893	peripheral	i-PROBLEM
68894	zone	i-PROBLEM
68895	.	O
68896	a	b-TEST
68897	biopsy	i-TEST
68898	showed	b-EVIDENTIAL
68899	moderately	b-PROBLEM
68900	to	i-PROBLEM
68901	poorly	i-PROBLEM
68902	differentiated	i-PROBLEM
68903	grade	i-PROBLEM
68904	iii-iv	i-PROBLEM
68905	adenocarcinoma	i-PROBLEM
68906	on	i-PROBLEM
68907	the	i-PROBLEM
68908	left	i-PROBLEM
68909	.	O
68910	the	O
68911	right	O
68912	lobe	O
68913	was	O
68914	within	O
68915	normal	b-OCCURRENCE
68916	limits	i-OCCURRENCE
68917	.	O
68918	this	O
68919	was	O
68920	done	O
68921	on	O
68922	05/05/93	b-DATE
68923	at	O
68924	fih	b-CLINICAL_DEPT
68925	.	O
68926	he	O
68927	also	O
68928	had	O
68929	a	O
68930	3-4	b-DURATION
68931	year	i-DURATION
68932	history	O
68933	of	O
68934	impotence	b-PROBLEM
68935	.	O
68936	hospital	O
68937	course	O
68938	:	O
68939	the	O
68940	patient	O
68941	was	O
68942	brought	O
68943	to	O
68944	the	b-CLINICAL_DEPT
68945	operating	i-CLINICAL_DEPT
68946	room	i-CLINICAL_DEPT
68947	on	O
68948	06/30/93	b-DATE
68949	after	O
68950	informed	b-OCCURRENCE
68951	consent	i-OCCURRENCE
68952	was	i-OCCURRENCE
68953	obtained	i-OCCURRENCE
68954	.	O
68955	a	b-TREATMENT
68956	radical	i-TREATMENT
68957	retropubic	i-TREATMENT
68958	prostatectomy	i-TREATMENT
68959	with	O
68960	bilateral	b-TREATMENT
68961	lymph	i-TREATMENT
68962	node	i-TREATMENT
68963	dissection	i-TREATMENT
68964	was	O
68965	done	O
68966	.	O
68967	he	O
68968	was	O
68969	afebrile	b-PROBLEM
68970	postoperatively	O
68971	with	O
68972	vital	b-TEST
68973	signs	i-TEST
68974	stable	b-OCCURRENCE
68975	.	O
68976	his	b-TEST
68977	potassium	i-TEST
68978	was	O
68979	3.7	O
68980	and	O
68981	his	b-TEST
68982	hematocrit	i-TEST
68983	33	O
68984	.	O
68985	his	b-OCCURRENCE
68986	postoperative	i-OCCURRENCE
68987	course	i-OCCURRENCE
68988	was	O
68989	remarkable	O
68990	for	O
68991	a	b-PROBLEM
68992	low	i-PROBLEM
68993	grade	i-PROBLEM
68994	temperature	i-PROBLEM
68995	to	O
68996	101.7	O
68997	.	O
68998	his	b-TEST
68999	blood	i-TEST
69000	cultures	i-TEST
69001	and	O
69002	chest	b-TEST
69003	x-ray	i-TEST
69004	were	O
69005	negative	O
69006	.	O
69007	he	O
69008	had	O
69009	flatus	b-OCCURRENCE
69010	on	O
69011	postoperative	b-DATE
69012	day	i-DATE
69013	#	i-DATE
69014	3	i-DATE
69015	.	O
69016	his	b-TREATMENT
69017	jackson-pratt	i-TREATMENT
69018	drained	O
69019	about	O
69020	35-40	O
69021	cc	O
69022	per	O
69023	day	O
69024	and	O
69025	was	O
69026	discontinued	O
69027	on	O
69028	postoperative	b-DATE
69029	day	i-DATE
69030	#	i-DATE
69031	3	i-DATE
69032	.	O
69033	his	b-TEST
69034	hematocrit	i-TEST
69035	on	O
69036	07/03	b-DATE
69037	was	O
69038	28.1	O
69039	.	O
69040	on	O
69041	that	b-DATE
69042	day	i-DATE
69043	he	O
69044	was	O
69045	slightly	b-PROBLEM
69046	diaphoretic	i-PROBLEM
69047	with	O
69048	some	b-PROBLEM
69049	tachycardia	i-PROBLEM
69050	to	O
69051	100	O
69052	.	O
69053	the	O
69054	remaining	O
69055	unit	O
69056	of	O
69057	autologous	b-TREATMENT
69058	packed	i-TREATMENT
69059	red	i-TREATMENT
69060	blood	i-TREATMENT
69061	cells	i-TREATMENT
69062	was	O
69063	transfused	O
69064	.	O
69065	a	b-OCCURRENCE
69066	cardiology	i-OCCURRENCE
69067	consult	i-OCCURRENCE
69068	was	O
69069	obtained	O
69070	for	O
69071	this	O
69072	episode	O
69073	of	O
69074	diaphoresis	b-PROBLEM
69075	with	O
69076	tachycardia	b-PROBLEM
69077	,	O
69078	as	O
69079	well	O
69080	as	O
69081	for	O
69082	an	b-TEST
69083	ekg	i-TEST
69084	being	O
69085	read	O
69086	as	O
69087	having	O
69088	anterolateral	b-PROBLEM
69089	changes	i-PROBLEM
69090	.	O
69091	he	O
69092	had	O
69093	no	O
69094	symptoms	b-PROBLEM
69095	of	O
69096	chest	b-PROBLEM
69097	pain	i-PROBLEM
69098	or	O
69099	myocardial	b-PROBLEM
69100	ischemia	i-PROBLEM
69101	.	O
69102	a	b-TEST
69103	repeat	i-TEST
69104	ekg	i-TEST
69105	showed	b-EVIDENTIAL
69106	no	O
69107	changes	b-PROBLEM
69108	.	O
69109	he	O
69110	subsequently	O
69111	did	b-OCCURRENCE
69112	well	i-OCCURRENCE
69113	,	O
69114	with	O
69115	a	b-TEST
69116	repeat	i-TEST
69117	hematocrit	i-TEST
69118	of	O
69119	34.3	O
69120	after	O
69121	the	b-TREATMENT
69122	transfusion	i-TREATMENT
69123	.	O
69124	his	b-TEST
69125	creatinine	i-TEST
69126	was	O
69127	1.2	O
69128	on	O
69129	postoperative	b-DATE
69130	day	i-DATE
69131	#	i-DATE
69132	5	i-DATE
69133	.	O
69134	on	O
69135	postoperative	b-DATE
69136	day	i-DATE
69137	#	i-DATE
69138	6	i-DATE
69139	his	b-PROBLEM
69140	low	i-PROBLEM
69141	grade	i-PROBLEM
69142	temperature	i-PROBLEM
69143	resolved	O
69144	.	O
69145	his	b-TEST
69146	vital	i-TEST
69147	signs	i-TEST
69148	were	O
69149	stable	b-OCCURRENCE
69150	.	O
69151	he	O
69152	was	O
69153	discharged	b-OCCURRENCE
69154	home	O
69155	on	O
69156	percocet	b-TREATMENT
69157	and	O
69158	keflex	b-TREATMENT
69159	.	O
69160	he	O
69161	was	O
69162	discharged	b-OCCURRENCE
69163	in	O
69164	good	b-OCCURRENCE
69165	condition	i-OCCURRENCE
69166	.	O
69167	he	O
69168	will	O
69169	follow	b-OCCURRENCE
69170	up	i-OCCURRENCE
69171	with	O
69172	doctor	O
69173	iechalette	O
69174	cancer	O
69175	in	O
69176	his	O
69177	office	O
69178	.	O
69179	sie	O
69180	room	O
69181	,	O
69182	md	O
69183		O
69184	admission	b-OCCURRENCE
69185	date	O
69186	:	O
69187	12/12/1996	b-ADMISSION
69188	discharge	b-OCCURRENCE
69189	date	O
69190	:	O
69191	12/16/1996	b-DISCHARGE
69192	history	O
69193	/	O
69194	reason	O
69195	for	O
69196	hospitalization	O
69197	:	O
69198	the	O
69199	patient	O
69200	is	O
69201	a	O
69202	42	O
69203	year	O
69204	old	O
69205	gravida	O
69206	ii	O
69207	,	O
69208	para	O
69209	i	O
69210	female	O
69211	with	O
69212	a	O
69213	long	O
69214	history	O
69215	of	O
69216	menorrhagia	b-PROBLEM
69217	and	O
69218	pelvic	b-PROBLEM
69219	pain	i-PROBLEM
69220	.	O
69221	she	O
69222	also	O
69223	has	O
69224	a	O
69225	history	O
69226	of	O
69227	endometriosis	b-PROBLEM
69228	that	O
69229	is	O
69230	symptomatic	b-PROBLEM
69231	.	O
69232	she	O
69233	used	O
69234	danocrine	b-TREATMENT
69235	for	O
69236	approximately	O
69237	nine	b-DURATION
69238	months	i-DURATION
69239	and	O
69240	was	O
69241	pain	b-PROBLEM
69242	free	O
69243	,	O
69244	but	O
69245	was	O
69246	unable	O
69247	to	O
69248	tolerate	O
69249	the	b-PROBLEM
69250	side	i-PROBLEM
69251	effects	i-PROBLEM
69252	.	O
69253	she	O
69254	is	O
69255	status	O
69256	post	O
69257	several	b-TEST
69258	laparoscopies	i-TEST
69259	in	O
69260	the	O
69261	past	O
69262	with	O
69263	which	O
69264	she	O
69265	was	O
69266	diagnosed	O
69267	with	O
69268	endometriosis	b-PROBLEM
69269	.	O
69270	she	O
69271	has	O
69272	recently	O
69273	been	O
69274	on	O
69275	depo-provera	b-TREATMENT
69276	and	O
69277	has	O
69278	had	O
69279	episodes	O
69280	of	O
69281	break-through	b-PROBLEM
69282	bleeding	i-PROBLEM
69283	for	O
69284	six	b-DURATION
69285	weeks	i-DURATION
69286	at	O
69287	a	O
69288	time	O
69289	.	O
69290	she	O
69291	desired	O
69292	surgical	b-TREATMENT
69293	therapy	i-TREATMENT
69294	.	O
69295	hospital	O
69296	course	O
69297	:	O
69298	on	O
69299	12/12/96	b-DATE
69300	she	O
69301	had	O
69302	an	b-TREATMENT
69303	uncomplicated	i-TREATMENT
69304	total	i-TREATMENT
69305	abdominal	i-TREATMENT
69306	hysterectomy	i-TREATMENT
69307	and	O
69308	bilateral	b-TREATMENT
69309	salpingo-oophorectomy	i-TREATMENT
69310	.	O
69311	estimated	b-TEST
69312	blood	i-TEST
69313	loss	i-TEST
69314	was	O
69315	100	O
69316	cc	O
69317	and	O
69318	she	O
69319	tolerated	O
69320	the	b-TREATMENT
69321	procedure	i-TREATMENT
69322	well	O
69323	.	O
69324	on	O
69325	postop	b-DATE
69326	day	i-DATE
69327	number	i-DATE
69328	one	i-DATE
69329	she	O
69330	was	O
69331	afebrile	b-PROBLEM
69332	and	O
69333	doing	O
69334	well	b-OCCURRENCE
69335	with	O
69336	a	b-TREATMENT
69337	pca	i-TREATMENT
69338	for	O
69339	pain	b-TREATMENT
69340	control	i-TREATMENT
69341	.	O
69342	on	O
69343	postop	b-DATE
69344	day	i-DATE
69345	number	i-DATE
69346	two	i-DATE
69347	she	O
69348	was	O
69349	also	O
69350	afebrile	b-PROBLEM
69351	and	O
69352	had	O
69353	not	O
69354	passed	b-OCCURRENCE
69355	any	i-OCCURRENCE
69356	flatus	i-OCCURRENCE
69357	yet	O
69358	.	O
69359	she	O
69360	was	O
69361	ambulating	b-OCCURRENCE
69362	frequently	i-OCCURRENCE
69363	.	i-OCCURRENCE
69364	her	b-TEST
69365	hematocrit	i-TEST
69366	was	O
69367	34.2	O
69368	and	O
69369	stable	b-OCCURRENCE
69370	from	O
69371	her	b-TEST
69372	preoperative	i-TEST
69373	value	i-TEST
69374	.	O
69375	on	O
69376	postop	b-DATE
69377	day	i-DATE
69378	number	i-DATE
69379	three	i-DATE
69380	her	O
69381	abdomen	O
69382	was	O
69383	noted	O
69384	to	O
69385	be	O
69386	distended	b-PROBLEM
69387	with	O
69388	a	O
69389	few	O
69390	bowel	b-OCCURRENCE
69391	sounds	i-OCCURRENCE
69392	and	O
69393	she	O
69394	still	O
69395	had	O
69396	not	O
69397	passed	b-OCCURRENCE
69398	gas	i-OCCURRENCE
69399	.	O
69400	the	O
69401	patient	O
69402	decreased	b-OCCURRENCE
69403	the	O
69404	amount	O
69405	of	O
69406	demerol	b-TREATMENT
69407	she	O
69408	was	O
69409	using	O
69410	and	O
69411	supplemented	O
69412	with	O
69413	tylenol	b-TREATMENT
69414	and	O
69415	continued	O
69416	her	b-OCCURRENCE
69417	frequent	i-OCCURRENCE
69418	ambulation	i-OCCURRENCE
69419	.	O
69420	on	O
69421	postop	b-DATE
69422	day	i-DATE
69423	number	i-DATE
69424	four	i-DATE
69425	she	O
69426	had	O
69427	passed	O
69428	flatus	b-PROBLEM
69429	and	O
69430	was	O
69431	feeling	b-OCCURRENCE
69432	much	i-OCCURRENCE
69433	better	i-OCCURRENCE
69434	.	O
69435	she	O
69436	was	O
69437	discharged	b-OCCURRENCE
69438	to	O
69439	home	O
69440	in	O
69441	good	b-OCCURRENCE
69442	condition	i-OCCURRENCE
69443	on	O
69444	the	b-TREATMENT
69445	following	i-TREATMENT
69446	medications	i-TREATMENT
69447	.	O
69448	discharge	O
69449	medications	O
69450	:	O
69451	demerol	b-TREATMENT
69452	for	O
69453	pain	b-PROBLEM
69454	.	O
69455	motrin	b-TREATMENT
69456	for	O
69457	pain	b-PROBLEM
69458	.	O
69459	colace	b-TREATMENT
69460	stool	i-TREATMENT
69461	softener	i-TREATMENT
69462	.	O
69463	disposition	O
69464	:	O
69465	the	O
69466	patient	O
69467	should	O
69468	follow-up	O
69469	with	O
69470	doctor	O
69471	side	O
69472	in	O
69473	two	O
69474	weeks	O
69475	.	O
69476	dictated	O
69477	by	O
69478	:	O
69479	iedearc	O
69480	side	O
69481	,	O
69482	md	O
69483	lb28	O
69484	attending	O
69485	:	O
69486	mitery	O
69487	d.	O
69488	loss	O
69489	,	O
69490	md	O
69491	cb51	O
69492	ii795/2112	O
69493	batch	O
69494	:	O
69495	42100	O
69496	index	O
69497	no.	O
69498	zmfx3o4g1	O
69499	d	O
69500	:	O
69501	01/04/97	O
69502	t	O
69503	:	O
69504	01/06/97	O
69505	cc	O
69506	:	O
69507	1.	O
69508	mitery	O
69509	d.	O
69510	loss	O
69511	,	O
69512	md	O
69513	nt11	O
69514	[	O
69515	report	O
69516	_	O
69517	end	O
69518	]	O
69519		O
69520	admission	b-OCCURRENCE
69521	date	O
69522	:	O
69523	5-28-93	b-DATE
69524	discharge	b-OCCURRENCE
69525	date	O
69526	:	O
69527	6-4-93	b-DATE
69528	history	O
69529	of	O
69530	present	O
69531	illness	O
69532	:	O
69533	the	O
69534	patient	O
69535	is	O
69536	a	O
69537	58	O
69538	year	O
69539	old	O
69540	right	O
69541	hand	O
69542	dominant	O
69543	white	O
69544	male	O
69545	with	O
69546	a	O
69547	long	O
69548	history	O
69549	of	O
69550	hypertension	b-PROBLEM
69551	,	O
69552	changed	O
69553	his	b-TREATMENT
69554	medications	i-TREATMENT
69555	from	O
69556	aldomet	b-TREATMENT
69557	to	O
69558	clonidine	b-TREATMENT
69559	six	b-DATE
69560	weeks	i-DATE
69561	ago	i-DATE
69562	.	O
69563	the	O
69564	patient	O
69565	has	O
69566	a	O
69567	history	O
69568	of	O
69569	adult	b-PROBLEM
69570	onset	i-PROBLEM
69571	diabetes	i-PROBLEM
69572	mellitus	i-PROBLEM
69573	,	O
69574	ankylosing	b-PROBLEM
69575	spondylitis	i-PROBLEM
69576	,	O
69577	status	O
69578	post	O
69579	myocardial	b-PROBLEM
69580	infarction	i-PROBLEM
69581	in	O
69582	&apos;96	b-DATE
69583	(	O
69584	?	O
69585	)	O
69586	now	O
69587	with	O
69588	acute	O
69589	onset	O
69590	of	O
69591	left	O
69592	face	O
69593	and	O
69594	arm	O
69595	greater	O
69596	than	O
69597	leg	O
69598	hemiplegia	b-PROBLEM
69599	and	O
69600	primary	b-PROBLEM
69601	hemisensory	i-PROBLEM
69602	loss	i-PROBLEM
69603	on	i-PROBLEM
69604	the	i-PROBLEM
69605	left	i-PROBLEM
69606	.	O
69607	briefly	O
69608	,	O
69609	he	O
69610	was	O
69611	talking	O
69612	to	O
69613	a	O
69614	friend	O
69615	at	O
69616	5:30	b-TIME
69617	p.m.	i-TIME
69618	the	O
69619	day	O
69620	prior	O
69621	to	O
69622	admission	O
69623	,	O
69624	when	O
69625	he	O
69626	had	O
69627	to	O
69628	grab	O
69629	his	O
69630	locker	O
69631	and	O
69632	sit	O
69633	down	O
69634	.	O
69635	his	O
69636	voice	O
69637	became	O
69638	slurred	b-PROBLEM
69639	and	O
69640	he	O
69641	had	O
69642	a	b-PROBLEM
69643	mild	i-PROBLEM
69644	central	i-PROBLEM
69645	dull	i-PROBLEM
69646	headache	i-PROBLEM
69647	.	O
69648	he	O
69649	was	O
69650	unable	b-PROBLEM
69651	to	i-PROBLEM
69652	move	i-PROBLEM
69653	the	i-PROBLEM
69654	left	i-PROBLEM
69655	side	i-PROBLEM
69656	of	i-PROBLEM
69657	his	i-PROBLEM
69658	body	i-PROBLEM
69659	and	O
69660	felt	O
69661	numb	b-PROBLEM
69662	on	i-PROBLEM
69663	that	i-PROBLEM
69664	side	i-PROBLEM
69665	.	O
69666	he	O
69667	was	O
69668	taken	O
69669	to	O
69670	wayskemedcalltown	b-CLINICAL_DEPT
69671	talmi	i-CLINICAL_DEPT
69672	and	O
69673	transferred	b-OCCURRENCE
69674	to	O
69675	heaonboburg	b-CLINICAL_DEPT
69676	linpack	i-CLINICAL_DEPT
69677	grant	i-CLINICAL_DEPT
69678	medical	i-CLINICAL_DEPT
69679	center	i-CLINICAL_DEPT
69680	with	O
69681	a	b-TEST
69682	computerized	i-TEST
69683	tomography	i-TEST
69684	scan	i-TEST
69685	showing	b-OCCURRENCE
69686	a	b-PROBLEM
69687	1x2	i-PROBLEM
69688	thalamic	i-PROBLEM
69689	capsular	i-PROBLEM
69690	hemorrhage	i-PROBLEM
69691	without	O
69692	superficial	b-PROBLEM
69693	mass	i-PROBLEM
69694	effect	i-PROBLEM
69695	.	O
69696	his	b-TEST
69697	blood	i-TEST
69698	pressure	i-TEST
69699	was	O
69700	220/110	O
69701	there	O
69702	.	O
69703	he	O
69704	denies	b-EVIDENTIAL
69705	any	O
69706	visual	b-PROBLEM
69707	symptoms	i-PROBLEM
69708	or	O
69709	cortical-type	b-PROBLEM
69710	symptoms	i-PROBLEM
69711	.	O
69712	he	O
69713	is	O
69714	a	b-PROBLEM
69715	heavy	i-PROBLEM
69716	smoker	i-PROBLEM
69717	and	O
69718	drinks	b-PROBLEM
69719	2-3	b-FREQUENCY
69720	shots	i-FREQUENCY
69721	per	i-FREQUENCY
69722	day	i-FREQUENCY
69723	at	O
69724	times	O
69725	.	O
69726	medications	O
69727	on	O
69728	admission	O
69729	:	O
69730	vasotec	b-TREATMENT
69731	40	O
69732	mg	O
69733	q.day	b-FREQUENCY
69734	,	O
69735	soma	b-TREATMENT
69736	1	O
69737	tablet	O
69738	q.day	b-FREQUENCY
69739	,	O
69740	demerolprn	b-TREATMENT
69741	,	O
69742	clonidine	b-TREATMENT
69743	.	O
69744	allergies	O
69745	:	O
69746	the	O
69747	patient	O
69748	has	O
69749	no	O
69750	known	b-PROBLEM
69751	drug	i-PROBLEM
69752	allergies	i-PROBLEM
69753	.	O
69754	hospital	O
69755	course	O
69756	:	O
69757	the	O
69758	patient	O
69759	was	O
69760	admitted	b-OCCURRENCE
69761	to	O
69762	the	b-CLINICAL_DEPT
69763	floor	i-CLINICAL_DEPT
69764	for	O
69765	observation	O
69766	.	O
69767	the	b-TEST
69768	neurological	i-TEST
69769	examination	i-TEST
69770	on	O
69771	discharge	b-OCCURRENCE
69772	was	O
69773	no	O
69774	movement	b-PROBLEM
69775	in	i-PROBLEM
69776	the	i-PROBLEM
69777	hand	i-PROBLEM
69778	on	O
69779	the	O
69780	left	O
69781	or	O
69782	arm	O
69783	.	O
69784	slight	O
69785	abductive	b-PROBLEM
69786	and	i-PROBLEM
69787	adductive	i-PROBLEM
69788	movement	i-PROBLEM
69789	on	O
69790	the	O
69791	left	O
69792	only	O
69793	in	O
69794	the	O
69795	upper	O
69796	extremity	O
69797	.	O
69798	on	O
69799	the	O
69800	lower	O
69801	extremity	O
69802	,	O
69803	could	O
69804	wiggle	b-TEST
69805	toes	i-TEST
69806	,	O
69807	flexor	b-TEST
69808	and	O
69809	plantar	b-TEST
69810	,	O
69811	3+/5	O
69812	,	O
69813	quadriceps	O
69814	4/5	O
69815	on	O
69816	the	O
69817	left	O
69818	.	O
69819	2.	O
69820	hypertension	O
69821	.	O
69822	the	O
69823	patient	O
69824	was	O
69825	managed	O
69826	with	O
69827	vasotec	b-TREATMENT
69828	,	O
69829	nifedipine	b-TREATMENT
69830	and	O
69831	clonidine	b-TREATMENT
69832	with	O
69833	blood	b-TEST
69834	pressure	i-TEST
69835	under	O
69836	good	O
69837	control	O
69838	at	O
69839	the	b-DATE
69840	time	i-DATE
69841	of	O
69842	discharge	O
69843	,	O
69844	average	O
69845	125	O
69846	systolic	b-TEST
69847	,	O
69848	70	O
69849	diastolic	b-TEST
69850	,	O
69851	heart	b-TEST
69852	rate	i-TEST
69853	of	O
69854	72	O
69855	.	O
69856	also	O
69857	managed	O
69858	with	O
69859	valium	b-TREATMENT
69860	5	O
69861	mg	O
69862	po	O
69863	t.i.d.	b-FREQUENCY
69864	muscle	b-PROBLEM
69865	spasms	i-PROBLEM
69866	were	O
69867	managed	O
69868	with	O
69869	flexeril	b-TREATMENT
69870	10	O
69871	po	O
69872	t.i.d.	b-FREQUENCY
69873	3.	O
69874	diabetes	O
69875	mellitus	O
69876	.	O
69877	the	O
69878	patient	O
69879	was	O
69880	started	O
69881	on	O
69882	2.5	O
69883	of	O
69884	micronase	b-TREATMENT
69885	with	O
69886	resulting	b-TEST
69887	sugars	i-TEST
69888	as	O
69889	low	O
69890	as	O
69891	63	O
69892	,	O
69893	decreased	O
69894	to	O
69895	1.25	O
69896	mg	O
69897	q.day	b-FREQUENCY
69898	.	O
69899	the	O
69900	patient	O
69901	is	O
69902	discharged	b-OCCURRENCE
69903	in	O
69904	fair	O
69905	condition	O
69906	with	O
69907	medical	O
69908	approval	O
69909	to	O
69910	the	O
69911	pasi	O
69912	.	O
69913		O
69914	admission	b-OCCURRENCE
69915	date	O
69916	:	O
69917	2009-06-23	b-ADMISSION
69918	discharge	b-OCCURRENCE
69919	date	O
69920	:	O
69921	2009-07-12	b-DISCHARGE
69922	service	O
69923	:	O
69924	cmi	O
69925	;	O
69926	then	O
69927	to	O
69928	medcine	O
69929	;	O
69930	then	O
69931	transferred	O
69932	to	O
69933	ccu	O
69934	history	O
69935	of	O
69936	present	O
69937	illness	O
69938	:	O
69939	the	O
69940	patient	O
69941	is	O
69942	an	O
69943	83-year-old	O
69944	male	O
69945	with	O
69946	a	O
69947	history	O
69948	of	O
69949	diabetes	b-PROBLEM
69950	mellitus	i-PROBLEM
69951	,	O
69952	steroid-treated	b-PROBLEM
69953	polymyalgia	i-PROBLEM
69954	rheumatica	i-PROBLEM
69955	,	O
69956	hypertension	b-PROBLEM
69957	,	O
69958	benign	b-PROBLEM
69959	prostatic	i-PROBLEM
69960	hypertrophy	i-PROBLEM
69961	,	O
69962	and	O
69963	high	b-PROBLEM
69964	cholesterol	i-PROBLEM
69965	who	O
69966	presented	b-OCCURRENCE
69967	for	O
69968	a	b-TEST
69969	lower	i-TEST
69970	extremity	i-TEST
69971	peripheral	i-TEST
69972	angiography	i-TEST
69973	for	O
69974	bilateral	b-PROBLEM
69975	foot	i-PROBLEM
69976	ulcers	i-PROBLEM
69977	,	O
69978	and	O
69979	he	O
69980	was	O
69981	found	O
69982	to	O
69983	an	b-PROBLEM
69984	evaluated	i-PROBLEM
69985	blood	i-PROBLEM
69986	urea	i-PROBLEM
69987	nitrogen	i-PROBLEM
69988	,	i-PROBLEM
69989	and	i-PROBLEM
69990	creatinine	i-PROBLEM
69991	,	i-PROBLEM
69992	and	i-PROBLEM
69993	potassium	i-PROBLEM
69994	.	O
69995	the	O
69996	patient	O
69997	notes	b-EVIDENTIAL
69998	he	O
69999	developed	O
70000	worsening	b-PROBLEM
70001	foot	i-PROBLEM
70002	pain	i-PROBLEM
70003	and	O
70004	ulcers	b-PROBLEM
70005	four	b-DATE
70006	months	i-DATE
70007	ago	i-DATE
70008	.	O
70009	due	O
70010	to	O
70011	his	b-PROBLEM
70012	worsening	i-PROBLEM
70013	blood	i-PROBLEM
70014	glucose	i-PROBLEM
70015	,	O
70016	he	O
70017	was	O
70018	started	O
70019	on	O
70020	insulin	b-TREATMENT
70021	.	O
70022	his	b-PROBLEM
70023	foot	i-PROBLEM
70024	ulcers	i-PROBLEM
70025	continued	O
70026	to	O
70027	develop	O
70028	,	O
70029	and	O
70030	the	O
70031	patient	O
70032	complained	b-EVIDENTIAL
70033	of	O
70034	pain	b-PROBLEM
70035	in	i-PROBLEM
70036	his	i-PROBLEM
70037	feet	i-PROBLEM
70038	;	O
70039	primarily	O
70040	at	O
70041	night	O
70042	.	O
70043	the	O
70044	patient	O
70045	was	O
70046	referred	b-OCCURRENCE
70047	to	O
70048	for	O
70049	vascular	b-TEST
70050	consultation	i-TEST
70051	because	O
70052	of	O
70053	the	b-PROBLEM
70054	ulcerations	i-PROBLEM
70055	and	O
70056	pain	b-PROBLEM
70057	and	O
70058	scheduled	O
70059	for	O
70060	a	O
70061	lower	b-TEST
70062	extremity	i-TEST
70063	angiography	i-TEST
70064	on	O
70065	the	b-DATE
70066	day	i-DATE
70067	of	O
70068	admission	O
70069	,	O
70070	but	O
70071	due	O
70072	to	O
70073	his	b-PROBLEM
70074	renal	i-PROBLEM
70075	failure	i-PROBLEM
70076	the	b-TEST
70077	procedure	i-TEST
70078	was	O
70079	cancelled	O
70080	.	O
70081	the	O
70082	patient	O
70083	showed	b-EVIDENTIAL
70084	peaked	b-PROBLEM
70085	t	i-PROBLEM
70086	waves	i-PROBLEM
70087	on	O
70088	electrocardiogram	b-TEST
70089	,	O
70090	and	O
70091	he	O
70092	was	O
70093	transferred	b-OCCURRENCE
70094	to	O
70095	medicine	b-CLINICAL_DEPT
70096	.	O
70097	the	O
70098	patient	O
70099	denied	b-EVIDENTIAL
70100	any	O
70101	oliguria	b-PROBLEM
70102	,	O
70103	hematuria	b-PROBLEM
70104	,	O
70105	dysuria	b-PROBLEM
70106	,	O
70107	foamy	b-PROBLEM
70108	urine	i-PROBLEM
70109	,	O
70110	flank	b-PROBLEM
70111	pain	i-PROBLEM
70112	,	O
70113	abdominal	b-PROBLEM
70114	pain	i-PROBLEM
70115	,	O
70116	or	O
70117	urinary	b-PROBLEM
70118	hesitancy	i-PROBLEM
70119	.	O
70120	he	O
70121	has	O
70122	complained	b-EVIDENTIAL
70123	of	O
70124	fatigue	b-PROBLEM
70125	,	O
70126	anorexia	b-PROBLEM
70127	,	O
70128	and	O
70129	a	b-PROBLEM
70130	10-pound	i-PROBLEM
70131	weight	i-PROBLEM
70132	loss	i-PROBLEM
70133	in	O
70134	the	b-DURATION
70135	last	i-DURATION
70136	four	i-DURATION
70137	months	i-DURATION
70138	.	O
70139	he	O
70140	gets	O
70141	short	b-PROBLEM
70142	of	i-PROBLEM
70143	breath	i-PROBLEM
70144	with	O
70145	one	O
70146	flight	O
70147	of	O
70148	stairs	O
70149	.	O
70150	he	O
70151	denies	b-EVIDENTIAL
70152	any	b-PROBLEM
70153	fevers	i-PROBLEM
70154	,	O
70155	chills	b-PROBLEM
70156	,	O
70157	recent	b-PROBLEM
70158	infections	i-PROBLEM
70159	,	O
70160	chest	b-PROBLEM
70161	pain	i-PROBLEM
70162	,	O
70163	orthopnea	b-PROBLEM
70164	,	O
70165	nausea	b-PROBLEM
70166	,	O
70167	vomiting	b-PROBLEM
70168	,	O
70169	diarrhea	b-PROBLEM
70170	,	O
70171	hematemesis	b-PROBLEM
70172	,	O
70173	melena	b-PROBLEM
70174	,	O
70175	or	O
70176	hematochezia	b-PROBLEM
70177	.	O
70178	the	O
70179	patient	O
70180	also	O
70181	notes	b-EVIDENTIAL
70182	he	O
70183	has	O
70184	had	O
70185	hoarseness	b-PROBLEM
70186	for	O
70187	the	b-DURATION
70188	last	i-DURATION
70189	two	i-DURATION
70190	to	i-DURATION
70191	three	i-DURATION
70192	weeks	i-DURATION
70193	.	O
70194	hospital	O
70195	course	O
70196	:	O
70197	the	O
70198	patient	O
70199	is	O
70200	an	O
70201	83	O
70202	-	O
70203	year-old	O
70204	male	O
70205	with	O
70206	a	O
70207	history	O
70208	of	O
70209	diabetes	b-PROBLEM
70210	,	O
70211	steroid-treated	b-PROBLEM
70212	polymyalgia	i-PROBLEM
70213	rheumatica	i-PROBLEM
70214	,	O
70215	hypertension	b-PROBLEM
70216	,	O
70217	benign	b-PROBLEM
70218	prostatic	i-PROBLEM
70219	hypertrophy	i-PROBLEM
70220	,	O
70221	and	O
70222	high	b-PROBLEM
70223	cholesterol	i-PROBLEM
70224	without	O
70225	presented	b-OCCURRENCE
70226	to	O
70227	the	b-CLINICAL_DEPT
70228	hospital	i-CLINICAL_DEPT
70229	for	O
70230	lower	b-TEST
70231	extremity	i-TEST
70232	angiograph	i-TEST
70233	;	O
70234	however	O
70235	,	O
70236	that	b-TEST
70237	was	O
70238	deferred	b-OCCURRENCE
70239	due	O
70240	to	O
70241	new	b-PROBLEM
70242	onset	i-PROBLEM
70243	renal	i-PROBLEM
70244	failure	i-PROBLEM
70245	.	O
70246	1.	O
70247	renal	O
70248	failure	O
70249	:	O
70250	the	O
70251	patient	O
70252	was	O
70253	initially	O
70254	thought	O
70255	to	O
70256	be	O
70257	prerenal	b-PROBLEM
70258	,	O
70259	and	O
70260	his	b-PROBLEM
70261	renal	i-PROBLEM
70262	status	i-PROBLEM
70263	improved	b-OCCURRENCE
70264	after	O
70265	hydration	b-TREATMENT
70266	and	O
70267	increased	b-TREATMENT
70268	oral	i-TREATMENT
70269	intake	i-TREATMENT
70270	.	O
70271	he	O
70272	did	O
70273	have	O
70274	a	b-TEST
70275	magnetic	i-TEST
70276	resonance	i-TEST
70277	angiography	i-TEST
70278	of	i-TEST
70279	his	i-TEST
70280	kidneys	i-TEST
70281	which	O
70282	showed	b-EVIDENTIAL
70283	mild	b-PROBLEM
70284	right-sided	i-PROBLEM
70285	renal	i-PROBLEM
70286	artery	i-PROBLEM
70287	stenosis	i-PROBLEM
70288	.	O
70289	his	b-TEST
70290	renal	i-TEST
70291	function	i-TEST
70292	fluctuated	b-OCCURRENCE
70293	throughout	O
70294	his	b-OCCURRENCE
70295	hospital	i-OCCURRENCE
70296	stay	i-OCCURRENCE
70297	,	O
70298	and	O
70299	when	O
70300	he	O
70301	was	O
70302	in	O
70303	the	b-CLINICAL_DEPT
70304	medical	i-CLINICAL_DEPT
70305	intensive	i-CLINICAL_DEPT
70306	care	i-CLINICAL_DEPT
70307	unit	i-CLINICAL_DEPT
70308	he	O
70309	did	O
70310	have	O
70311	decreased	b-PROBLEM
70312	urine	i-PROBLEM
70313	output	i-PROBLEM
70314	in	O
70315	the	O
70316	setting	O
70317	of	O
70318	cardiogenic	b-PROBLEM
70319	shock	i-PROBLEM
70320	.	O
70321	2.	O
70322	cardiovascular	O
70323	:	O
70324	the	O
70325	patient	O
70326	with	O
70327	severe	b-PROBLEM
70328	peripheral	i-PROBLEM
70329	vascular	i-PROBLEM
70330	disease	i-PROBLEM
70331	.	O
70332	during	O
70333	his	b-OCCURRENCE
70334	hospital	i-OCCURRENCE
70335	stay	i-OCCURRENCE
70336	,	O
70337	he	O
70338	developed	O
70339	some	b-PROBLEM
70340	nonsustained	i-PROBLEM
70341	ventricular	i-PROBLEM
70342	tachycardia	i-PROBLEM
70343	.	O
70344	he	O
70345	also	O
70346	became	O
70347	hypotensive	b-PROBLEM
70348	on	O
70349	07-02	b-DATE
70350	in	O
70351	the	O
70352	setting	O
70353	of	O
70354	infection	b-PROBLEM
70355	.	O
70356	the	O
70357	patient	O
70358	had	O
70359	a	b-TREATMENT
70360	central	i-TREATMENT
70361	line	i-TREATMENT
70362	placed	O
70363	and	O
70364	went	O
70365	into	O
70366	sustained	b-PROBLEM
70367	ventricular	i-PROBLEM
70368	tachycardia	i-PROBLEM
70369	that	O
70370	was	O
70371	treated	O
70372	with	O
70373	lidocaine	b-TREATMENT
70374	.	O
70375	after	O
70376	being	O
70377	treated	O
70378	with	O
70379	lidocaine	b-TREATMENT
70380	,	O
70381	the	O
70382	patient	O
70383	became	O
70384	apneic	b-PROBLEM
70385	requiring	O
70386	intubation	b-TREATMENT
70387	and	O
70388	transfer	b-OCCURRENCE
70389	to	O
70390	the	b-CLINICAL_DEPT
70391	coronary	i-CLINICAL_DEPT
70392	care	i-CLINICAL_DEPT
70393	unit	i-CLINICAL_DEPT
70394	.	O
70395	his	b-PROBLEM
70396	nonsustained	i-PROBLEM
70397	ventricular	i-PROBLEM
70398	tachycardia	i-PROBLEM
70399	was	O
70400	treated	O
70401	with	O
70402	a	b-TREATMENT
70403	lidocaine	i-TREATMENT
70404	drip	i-TREATMENT
70405	.	O
70406	it	O
70407	was	O
70408	found	O
70409	that	O
70410	he	O
70411	had	O
70412	elevated	b-PROBLEM
70413	troponins	i-PROBLEM
70414	and	O
70415	likely	O
70416	an	b-PROBLEM
70417	ischemic	i-PROBLEM
70418	event	i-PROBLEM
70419	on	O
70420	the	b-DATE
70421	07-02	i-DATE
70422	.	O
70423	a	b-TEST
70424	repeat	i-TEST
70425	echocardiogram	i-TEST
70426	showed	b-EVIDENTIAL
70427	a	b-PROBLEM
70428	decreased	i-PROBLEM
70429	ejection	i-PROBLEM
70430	fraction	i-PROBLEM
70431	from	O
70432	prior	b-TEST
70433	.	O
70434	he	O
70435	had	O
70436	a	b-TEST
70437	cardiac	i-TEST
70438	catheterization	i-TEST
70439	which	O
70440	revealed	b-EVIDENTIAL
70441	3-vessel	b-PROBLEM
70442	disease	i-PROBLEM
70443	.	O
70444	cardiothoracic	b-CLINICAL_DEPT
70445	surgery	i-CLINICAL_DEPT
70446	was	O
70447	consulted	O
70448	,	O
70449	and	O
70450	due	O
70451	to	O
70452	the	b-PROBLEM
70453	patient	i-PROBLEM
70454	's	i-PROBLEM
70455	acute	i-PROBLEM
70456	illness	i-PROBLEM
70457	,	O
70458	they	O
70459	wanted	O
70460	to	O
70461	re-evaluate	b-TEST
70462	after	O
70463	the	O
70464	patient	O
70465	was	O
70466	extubated	b-OCCURRENCE
70467	.	O
70468	the	O
70469	patient	O
70470	continued	O
70471	to	O
70472	have	O
70473	intermittent	O
70474	episodes	O
70475	of	O
70476	ventricular	b-PROBLEM
70477	tachycardia	i-PROBLEM
70478	.	O
70479	he	O
70480	was	O
70481	continued	O
70482	on	O
70483	lidocaine	b-TREATMENT
70484	and	O
70485	eventually	O
70486	changed	O
70487	over	O
70488	to	O
70489	amiodarone	b-TREATMENT
70490	.	O
70491	he	O
70492	was	O
70493	noted	b-OCCURRENCE
70494	to	O
70495	be	O
70496	cardiogenic	b-PROBLEM
70497	shock	i-PROBLEM
70498	requiring	O
70499	pressors	b-TREATMENT
70500	.	O
70501	of	O
70502	note	O
70503	,	O
70504	he	O
70505	likely	O
70506	suffered	O
70507	a	b-PROBLEM
70508	second	i-PROBLEM
70509	ischemic	i-PROBLEM
70510	event	i-PROBLEM
70511	during	O
70512	his	b-CLINICAL_DEPT
70513	coronary	i-CLINICAL_DEPT
70514	care	i-CLINICAL_DEPT
70515	unit	i-CLINICAL_DEPT
70516	stay	O
70517	.	O
70518	the	O
70519	patient	O
70520	did	O
70521	have	O
70522	a	b-TEST
70523	swan-ganz	i-TEST
70524	catheter	i-TEST
70525	in	O
70526	place	O
70527	and	O
70528	had	O
70529	a	b-PROBLEM
70530	low	i-PROBLEM
70531	cardiac	i-PROBLEM
70532	output	i-PROBLEM
70533	.	O
70534	the	O
70535	patient	O
70536	's	O
70537	family	O
70538	eventually	O
70539	decided	O
70540	to	O
70541	withdraw	b-OCCURRENCE
70542	care	i-OCCURRENCE
70543	,	O
70544	and	O
70545	the	O
70546	patient	O
70547	was	O
70548	extubated	b-OCCURRENCE
70549	and	O
70550	passed	b-OCCURRENCE
70551	away	i-OCCURRENCE
70552	on	O
70553	2009-07-12	b-DATE
70554	.	O
70555	2.	O
70556	infectious	O
70557	disease	O
70558	:	O
70559	the	O
70560	patient	O
70561	was	O
70562	initially	O
70563	treated	O
70564	with	O
70565	levofloxacin	b-TREATMENT
70566	for	O
70567	a	b-PROBLEM
70568	left	i-PROBLEM
70569	lower	i-PROBLEM
70570	lobe	i-PROBLEM
70571	infiltrate	i-PROBLEM
70572	and	O
70573	a	b-PROBLEM
70574	urinary	i-PROBLEM
70575	tract	i-PROBLEM
70576	infection	i-PROBLEM
70577	.	O
70578	he	O
70579	then	O
70580	developed	O
70581	positive	b-PROBLEM
70582	blood	i-PROBLEM
70583	cultures	i-PROBLEM
70584	with	O
70585	staphylococcus	b-PROBLEM
70586	aureus	i-PROBLEM
70587	sensitive	O
70588	to	O
70589	levofloxacin	b-TREATMENT
70590	,	O
70591	and	O
70592	that	b-TREATMENT
70593	was	O
70594	continued	O
70595	.	O
70596	when	O
70597	the	O
70598	patient	O
70599	became	O
70600	hypotensive	b-PROBLEM
70601	and	O
70602	required	O
70603	intubation	b-TREATMENT
70604	and	O
70605	pressors	b-TREATMENT
70606	,	O
70607	his	b-TREATMENT
70608	antibiotics	i-TREATMENT
70609	were	O
70610	broadened	O
70611	,	O
70612	and	O
70613	he	O
70614	was	O
70615	put	O
70616	on	O
70617	stress-dose	b-TREATMENT
70618	steroids	i-TREATMENT
70619	.	O
70620	he	O
70621	was	O
70622	found	O
70623	to	O
70624	have	O
70625	bilateral	b-PROBLEM
70626	staphylococcus	i-PROBLEM
70627	pneumonia	i-PROBLEM
70628	.	O
70629	3.	O
70630	pulmonary	O
70631	:	O
70632	the	O
70633	patient	O
70634	required	O
70635	intubation	b-TREATMENT
70636	in	O
70637	the	O
70638	setting	O
70639	of	O
70640	hypotension	b-PROBLEM
70641	and	O
70642	ventricular	b-PROBLEM
70643	tachycardia	i-PROBLEM
70644	.	O
70645	he	O
70646	was	O
70647	actually	O
70648	extubated	b-OCCURRENCE
70649	on	O
70650	07-09	b-DATE
70651	,	O
70652	but	O
70653	then	O
70654	reintubated	b-TREATMENT
70655	one	b-DURATION
70656	hour	i-DURATION
70657	later	O
70658	due	O
70659	to	O
70660	hypoxia	b-PROBLEM
70661	.	O
70662	he	O
70663	was	O
70664	also	O
70665	found	O
70666	to	O
70667	have	O
70668	a	b-PROBLEM
70669	bilateral	i-PROBLEM
70670	staphylococcus	i-PROBLEM
70671	pneumonia	i-PROBLEM
70672	.	O
70673		O
70674	admission	b-OCCURRENCE
70675	date	O
70676	:	O
70677	2013-08-05	b-ADMISSION
70678	discharge	b-OCCURRENCE
70679	date	O
70680	:	O
70681	2013-08-15	b-DISCHARGE
70682	service	O
70683	:	O
70684	history	O
70685	of	O
70686	present	O
70687	illness	O
70688	:	O
70689	history	O
70690	of	O
70691	present	O
70692	illness	O
70693	:	O
70694	in	O
70695	brief	O
70696	,	O
70697	the	O
70698	patient	O
70699	is	O
70700	a	O
70701	64	O
70702	-	O
70703	year-old	O
70704	male	O
70705	with	O
70706	a	O
70707	significant	O
70708	history	O
70709	for	O
70710	coronary	b-PROBLEM
70711	artery	i-PROBLEM
70712	disease	i-PROBLEM
70713	,	O
70714	status	O
70715	post	O
70716	three	b-PROBLEM
70717	myocardial	i-PROBLEM
70718	infarctions	i-PROBLEM
70719	and	O
70720	also	O
70721	status	O
70722	post	O
70723	five	b-TREATMENT
70724	vessel	i-TREATMENT
70725	coronary	i-TREATMENT
70726	artery	i-TREATMENT
70727	bypass	i-TREATMENT
70728	graft	i-TREATMENT
70729	in	O
70730	'	b-DATE
70731	89	i-DATE
70732	and	O
70733	status	O
70734	post	O
70735	multiple	b-TREATMENT
70736	percutaneous	i-TREATMENT
70737	transluminal	i-TREATMENT
70738	coronary	i-TREATMENT
70739	angioplasties	i-TREATMENT
70740	who	O
70741	recently	O
70742	had	O
70743	a	b-TEST
70744	catheterization	i-TEST
70745	done	O
70746	in	O
70747	mississippi	b-CLINICAL_DEPT
70748	and	O
70749	stent	b-TREATMENT
70750	placed	O
70751	in	O
70752	2013-03-24	b-DATE
70753	.	O
70754	the	O
70755	patient	O
70756	did	b-EVIDENTIAL
70757	well	i-EVIDENTIAL
70758	until	O
70759	approximately	O
70760	three	b-DATE
70761	to	i-DATE
70762	four	i-DATE
70763	weeks	i-DATE
70764	prior	O
70765	to	O
70766	presentation	O
70767	when	O
70768	he	O
70769	began	O
70770	to	O
70771	experience	O
70772	increased	b-PROBLEM
70773	dyspnea	i-PROBLEM
70774	on	O
70775	exertion	O
70776	.	O
70777	one	b-DATE
70778	week	i-DATE
70779	prior	O
70780	to	O
70781	presentation	O
70782	,	O
70783	he	O
70784	had	O
70785	chest	b-PROBLEM
70786	pain	i-PROBLEM
70787	leading	O
70788	to	O
70789	a	b-TEST
70790	repeat	i-TEST
70791	catheterization	i-TEST
70792	at	O
70793	springfield	b-CLINICAL_DEPT
70794	on	O
70795	07-30	b-DATE
70796	which	O
70797	showed	b-EVIDENTIAL
70798	narrowing	O
70799	of	O
70800	the	b-PROBLEM
70801	stent	i-PROBLEM
70802	and	O
70803	an	b-PROBLEM
70804	ejection	i-PROBLEM
70805	fraction	i-PROBLEM
70806	of	O
70807	approximately	O
70808	20%	O
70809	.	O
70810	no	O
70811	intervention	b-TREATMENT
70812	was	O
70813	done	O
70814	at	O
70815	that	b-DATE
70816	point	i-DATE
70817	.	O
70818	on	O
70819	the	b-DATE
70820	evening	i-DATE
70821	prior	i-DATE
70822	to	O
70823	admission	O
70824	,	O
70825	the	O
70826	patient	O
70827	was	O
70828	awoken	O
70829	with	O
70830	chest	b-PROBLEM
70831	pressure	i-PROBLEM
70832	radiating	O
70833	to	O
70834	the	O
70835	neck	O
70836	anginal	O
70837	equivalent	O
70838	which	O
70839	was	O
70840	relieved	O
70841	by	O
70842	sublingual	b-TREATMENT
70843	nitroglycerin	i-TREATMENT
70844	.	O
70845	this	b-PROBLEM
70846	episode	i-PROBLEM
70847	happened	O
70848	three	b-FREQUENCY
70849	times	i-FREQUENCY
70850	that	b-DATE
70851	night	i-DATE
70852	and	O
70853	finally	O
70854	on	O
70855	the	b-OCCURRENCE
70856	fourth	i-OCCURRENCE
70857	re-awakening	i-OCCURRENCE
70858	,	O
70859	the	O
70860	patient	O
70861	presented	b-OCCURRENCE
70862	to	O
70863	the	b-CLINICAL_DEPT
70864	emergency	i-CLINICAL_DEPT
70865	department	i-CLINICAL_DEPT
70866	at	i-CLINICAL_DEPT
70867	springfield	i-CLINICAL_DEPT
70868	and	O
70869	was	O
70870	transferred	b-OCCURRENCE
70871	to	O
70872	the	b-CLINICAL_DEPT
70873	faulkner	i-CLINICAL_DEPT
70874	hospital	i-CLINICAL_DEPT
70875	for	O
70876	coronary	b-TREATMENT
70877	revascularization	i-TREATMENT
70878	.	O
70879	hospital	O
70880	course	O
70881	:	O
70882	the	O
70883	patient	O
70884	was	O
70885	medically	b-TREATMENT
70886	managed	i-TREATMENT
70887	initially	O
70888	and	O
70889	then	O
70890	underwent	O
70891	on	O
70892	2013-08-09	b-DATE
70893	,	O
70894	coronary	b-TREATMENT
70895	artery	i-TREATMENT
70896	bypass	i-TREATMENT
70897	grafting	i-TREATMENT
70898	x2	b-FREQUENCY
70899	and	O
70900	a	b-TREATMENT
70901	mitral	i-TREATMENT
70902	valve	i-TREATMENT
70903	annuloplasty	i-TREATMENT
70904	with	O
70905	placement	b-TREATMENT
70906	of	i-TREATMENT
70907	intra-aortic	i-TREATMENT
70908	balloon	i-TREATMENT
70909	pump	i-TREATMENT
70910	.	O
70911	he	O
70912	was	O
70913	transferred	b-OCCURRENCE
70914	to	O
70915	the	b-CLINICAL_DEPT
70916	intensive	i-CLINICAL_DEPT
70917	care	i-CLINICAL_DEPT
70918	unit	i-CLINICAL_DEPT
70919	in	O
70920	relatively	b-EVIDENTIAL
70921	stable	i-EVIDENTIAL
70922	condition	i-EVIDENTIAL
70923	.	O
70924	on	O
70925	postoperative	b-DATE
70926	day	i-DATE
70927	#1	i-DATE
70928	,	O
70929	his	b-TREATMENT
70930	balloon	i-TREATMENT
70931	pump	i-TREATMENT
70932	was	O
70933	weaned	O
70934	and	O
70935	the	O
70936	patient	O
70937	was	O
70938	transferred	O
70939	at	O
70940	2	b-TREATMENT
70941	units	i-TREATMENT
70942	of	i-TREATMENT
70943	packed	i-TREATMENT
70944	red	i-TREATMENT
70945	blood	i-TREATMENT
70946	cells	i-TREATMENT
70947	.	O
70948	he	O
70949	also	O
70950	began	O
70951	to	O
70952	wean	b-OCCURRENCE
70953	off	O
70954	the	b-TREATMENT
70955	ventilator	i-TREATMENT
70956	.	O
70957	on	O
70958	postoperative	b-DATE
70959	day	i-DATE
70960	#1	i-DATE
70961	in	i-DATE
70962	the	i-DATE
70963	evening	i-DATE
70964	,	O
70965	the	O
70966	patient	O
70967	was	O
70968	noted	O
70969	to	O
70970	go	O
70971	into	O
70972	atrial	b-PROBLEM
70973	fibrillation	i-PROBLEM
70974	,	O
70975	for	O
70976	which	O
70977	he	O
70978	was	O
70979	controlled	O
70980	and	O
70981	started	O
70982	on	O
70983	amiodarone	b-TREATMENT
70984	,	O
70985	after	O
70986	which	O
70987	he	O
70988	converted	O
70989	again	O
70990	to	O
70991	normal	b-OCCURRENCE
70992	sinus	i-OCCURRENCE
70993	rhythm	i-OCCURRENCE
70994	.	O
70995	he	O
70996	was	O
70997	extubated	b-TREATMENT
70998	during	O
70999	postoperative	b-DATE
71000	day	i-DATE
71001	#1	i-DATE
71002	.	O
71003	on	O
71004	postoperative	b-DATE
71005	day	i-DATE
71006	#2	i-DATE
71007	,	O
71008	the	O
71009	patient	O
71010	was	O
71011	noted	O
71012	to	O
71013	be	O
71014	relatively	b-EVIDENTIAL
71015	stable	i-EVIDENTIAL
71016	.	O
71017	his	b-TREATMENT
71018	balloon	i-TREATMENT
71019	pump	i-TREATMENT
71020	had	O
71021	already	O
71022	been	O
71023	removed	O
71024	and	O
71025	on	O
71026	postoperative	b-DATE
71027	day	i-DATE
71028	#3	i-DATE
71029	,	O
71030	he	O
71031	was	O
71032	transferred	b-OCCURRENCE
71033	to	O
71034	the	b-CLINICAL_DEPT
71035	floor	i-CLINICAL_DEPT
71036	on	O
71037	lopressor	b-TREATMENT
71038	and	O
71039	amiodarone	b-TREATMENT
71040	in	O
71041	normal	b-OCCURRENCE
71042	sinus	i-OCCURRENCE
71043	rhythm	i-OCCURRENCE
71044	.	O
71045	on	O
71046	the	b-CLINICAL_DEPT
71047	floor	i-CLINICAL_DEPT
71048	,	O
71049	the	O
71050	patient	O
71051	was	O
71052	noted	O
71053	to	O
71054	do	b-OCCURRENCE
71055	extremely	i-OCCURRENCE
71056	well	i-OCCURRENCE
71057	.	O
71058	physical	b-CLINICAL_DEPT
71059	therapy	i-CLINICAL_DEPT
71060	was	O
71061	consulted	O
71062	and	O
71063	the	O
71064	patient	O
71065	was	O
71066	ambulating	b-OCCURRENCE
71067	extremely	i-OCCURRENCE
71068	well	i-OCCURRENCE
71069	with	O
71070	minimal	O
71071	assistance	O
71072	.	O
71073	on	O
71074	postoperative	b-DATE
71075	day	i-DATE
71076	#4	i-DATE
71077	,	O
71078	he	O
71079	remained	O
71080	afebrile	b-PROBLEM
71081	with	O
71082	stable	b-EVIDENTIAL
71083	vital	i-EVIDENTIAL
71084	signs	i-EVIDENTIAL
71085	on	O
71086	lopressor	b-TREATMENT
71087	at	O
71088	25	O
71089	mg	O
71090	po	O
71091	bid	b-FREQUENCY
71092	and	O
71093	an	b-TREATMENT
71094	amiodarone	i-TREATMENT
71095	dose	i-TREATMENT
71096	.	O
71097	his	b-TREATMENT
71098	left	i-TREATMENT
71099	chest	i-TREATMENT
71100	tube	i-TREATMENT
71101	was	O
71102	discontinued	O
71103	at	O
71104	this	b-DATE
71105	time	i-DATE
71106	and	O
71107	his	b-TREATMENT
71108	right	i-TREATMENT
71109	chest	i-TREATMENT
71110	tube	i-TREATMENT
71111	was	O
71112	removed	O
71113	the	b-DATE
71114	following	i-DATE
71115	day	i-DATE
71116	on	O
71117	postoperative	b-DATE
71118	day	i-DATE
71119	#5	i-DATE
71120	.	O
71121	currently	O
71122	,	O
71123	the	O
71124	patient	O
71125	is	O
71126	postoperative	b-DATE
71127	day	i-DATE
71128	#6	i-DATE
71129	.	O
71130	he	O
71131	remains	O
71132	afebrile	b-PROBLEM
71133	with	O
71134	stable	b-OCCURRENCE
71135	vital	i-OCCURRENCE
71136	signs	i-OCCURRENCE
71137	and	O
71138	the	O
71139	patient	O
71140	is	O
71141	ambulating	b-OCCURRENCE
71142	to	O
71143	a	O
71144	level	O
71145	5	O
71146	with	O
71147	physical	b-TREATMENT
71148	therapy	i-TREATMENT
71149	and	O
71150	wishes	O
71151	to	O
71152	be	O
71153	discharged	b-OCCURRENCE
71154	home	O
71155	today	b-DATE
71156	.	O
71157		O
71158	admission	b-OCCURRENCE
71159	date	O
71160	:	O
71161	2015-11-22	b-ADMISSION
71162	discharge	b-OCCURRENCE
71163	date	O
71164	:	O
71165	2015-11-27	b-DISCHARGE
71166	service	O
71167	:	O
71168	cmed	O
71169	ccu-green	O
71170	history	O
71171	of	O
71172	present	O
71173	illness	O
71174	:	O
71175	the	O
71176	patient	O
71177	is	O
71178	a	O
71179	73	O
71180	year	O
71181	old	O
71182	male	O
71183	with	O
71184	a	O
71185	recent	O
71186	history	O
71187	of	O
71188	paroxysmal	b-PROBLEM
71189	atrial	i-PROBLEM
71190	fibrillation	i-PROBLEM
71191	and	O
71192	hypercholesterolemia	b-PROBLEM
71193	who	O
71194	presented	b-OCCURRENCE
71195	to	O
71196	the	b-CLINICAL_DEPT
71197	emergency	i-CLINICAL_DEPT
71198	department	i-CLINICAL_DEPT
71199	with	O
71200	the	O
71201	chief	O
71202	complaint	O
71203	of	O
71204	syncope	b-PROBLEM
71205	.	O
71206	the	O
71207	patient	O
71208	was	O
71209	discharged	b-OCCURRENCE
71210	from	O
71211	the	b-CLINICAL_DEPT
71212	hospital	i-CLINICAL_DEPT
71213	for	i-CLINICAL_DEPT
71214	orthopedics	i-CLINICAL_DEPT
71215	with	O
71216	the	O
71217	diagnosis	O
71218	of	O
71219	pulmonary	b-PROBLEM
71220	embolism	i-PROBLEM
71221	about	O
71222	six	b-DATE
71223	months	i-DATE
71224	prior	i-DATE
71225	to	O
71226	the	b-OCCURRENCE
71227	current	i-OCCURRENCE
71228	admission	i-OCCURRENCE
71229	and	O
71230	was	O
71231	started	O
71232	on	O
71233	warfarin	b-TREATMENT
71234	.	O
71235	one	b-DATE
71236	month	i-DATE
71237	prior	i-DATE
71238	to	O
71239	this	O
71240	admission	O
71241	,	O
71242	the	O
71243	patient	O
71244	reports	b-EVIDENTIAL
71245	not	O
71246	feeling	O
71247	well	O
71248	with	O
71249	worsening	b-PROBLEM
71250	gastric	i-PROBLEM
71251	distress	i-PROBLEM
71252	.	O
71253	a	b-DATE
71254	few	i-DATE
71255	weeks	i-DATE
71256	prior	i-DATE
71257	to	O
71258	admission	O
71259	,	O
71260	he	O
71261	fell	b-PROBLEM
71262	down	i-PROBLEM
71263	on	i-PROBLEM
71264	his	i-PROBLEM
71265	back	i-PROBLEM
71266	and	O
71267	started	O
71268	taking	O
71269	ibuprofen	b-TREATMENT
71270	1000	O
71271	mg	O
71272	once	b-FREQUENCY
71273	a	i-FREQUENCY
71274	day	i-FREQUENCY
71275	for	O
71276	pain	b-PROBLEM
71277	and	O
71278	vioxx	b-TREATMENT
71279	in	O
71280	addition	O
71281	to	O
71282	his	b-TREATMENT
71283	aspirin	i-TREATMENT
71284	and	O
71285	coumadin	b-TREATMENT
71286	regimen	i-TREATMENT
71287	.	O
71288	the	b-DATE
71289	night	i-DATE
71290	prior	i-DATE
71291	to	O
71292	admission	O
71293	,	O
71294	he	O
71295	was	O
71296	found	O
71297	by	O
71298	his	O
71299	wife	O
71300	on	O
71301	the	b-PROBLEM
71302	bathroom	i-PROBLEM
71303	floor	i-PROBLEM
71304	in	i-PROBLEM
71305	a	i-PROBLEM
71306	pool	i-PROBLEM
71307	of	i-PROBLEM
71308	urine	i-PROBLEM
71309	,	O
71310	unresponsive	b-PROBLEM
71311	without	O
71312	any	O
71313	body	b-OCCURRENCE
71314	movements	i-OCCURRENCE
71315	,	O
71316	post-ictal	b-PROBLEM
71317	state	i-PROBLEM
71318	.	O
71319	ems	b-CLINICAL_DEPT
71320	was	O
71321	activated	O
71322	,	O
71323	however	O
71324	,	O
71325	the	O
71326	patient	O
71327	refused	O
71328	to	O
71329	go	O
71330	to	O
71331	the	O
71332	hospital	O
71333	.	O
71334	a	b-OCCURRENCE
71335	similar	i-OCCURRENCE
71336	episode	i-OCCURRENCE
71337	happened	O
71338	at	O
71339	2	b-TIME
71340	a.m.	i-TIME
71341	the	i-TIME
71342	same	i-TIME
71343	night	i-TIME
71344	and	O
71345	at	O
71346	07:45	b-TIME
71347	on	O
71348	the	O
71349	day	O
71350	of	O
71351	admission	O
71352	,	O
71353	the	O
71354	patient	O
71355	lost	b-PROBLEM
71356	consciousness	i-PROBLEM
71357	once	O
71358	again	O
71359	when	O
71360	he	O
71361	was	O
71362	trying	O
71363	to	O
71364	sit	O
71365	up	O
71366	.	O
71367	he	O
71368	was	O
71369	then	O
71370	transferred	b-OCCURRENCE
71371	to	O
71372	the	b-CLINICAL_DEPT
71373	hospital	i-CLINICAL_DEPT
71374	for	i-CLINICAL_DEPT
71375	orthopedics	i-CLINICAL_DEPT
71376	.	O
71377	the	O
71378	patient	O
71379	reports	b-EVIDENTIAL
71380	some	b-PROBLEM
71381	nausea	i-PROBLEM
71382	and	O
71383	epigastric	b-PROBLEM
71384	pressure	i-PROBLEM
71385	which	O
71386	is	O
71387	post-prandial	b-PROBLEM
71388	.	O
71389	he	O
71390	denies	b-EVIDENTIAL
71391	any	O
71392	emesis	b-PROBLEM
71393	,	O
71394	melena	b-PROBLEM
71395	,	O
71396	diarrhea	b-PROBLEM
71397	or	O
71398	constipation	b-PROBLEM
71399	.	O
71400	he	O
71401	describes	b-EVIDENTIAL
71402	the	b-PROBLEM
71403	room	i-PROBLEM
71404	spinning	i-PROBLEM
71405	with	O
71406	attempts	O
71407	to	O
71408	sit	O
71409	upright	O
71410	.	O
71411	no	O
71412	history	O
71413	of	O
71414	previous	O
71415	episodes	O
71416	was	O
71417	noted	O
71418	.	O
71419	denies	b-EVIDENTIAL
71420	incontinence	b-PROBLEM
71421	.	O
71422	he	O
71423	does	O
71424	have	O
71425	diaphoresis	b-PROBLEM
71426	and	O
71427	weakness	b-PROBLEM
71428	with	O
71429	orthostatic	O
71430	changes	O
71431	.	O
71432	in	O
71433	the	b-CLINICAL_DEPT
71434	emergency	i-CLINICAL_DEPT
71435	department	i-CLINICAL_DEPT
71436	,	O
71437	stool	b-TEST
71438	guaiac	i-TEST
71439	was	O
71440	trace	O
71441	positive	O
71442	.	O
71443	hematocrit	b-TEST
71444	was	O
71445	24.8	O
71446	,	O
71447	with	O
71448	a	O
71449	baseline	O
71450	of	O
71451	46	O
71452	.	O
71453	gastric	b-TREATMENT
71454	lavage	i-TREATMENT
71455	was	O
71456	grossly	O
71457	positive	O
71458	for	O
71459	coffee	b-PROBLEM
71460	ground	i-PROBLEM
71461	material	i-PROBLEM
71462	.	O
71463	his	b-TEST
71464	inr	i-TEST
71465	was	O
71466	found	O
71467	to	O
71468	be	O
71469	4.4	O
71470	.	O
71471	he	O
71472	was	O
71473	given	O
71474	vitamin	b-TREATMENT
71475	k	i-TREATMENT
71476	10	O
71477	mg	O
71478	subcutaneously	O
71479	,	O
71480	2.5	O
71481	liters	O
71482	of	O
71483	normal	b-TREATMENT
71484	saline	i-TREATMENT
71485	,	O
71486	two	O
71487	units	O
71488	of	O
71489	packed	b-TREATMENT
71490	red	i-TREATMENT
71491	blood	i-TREATMENT
71492	cells	i-TREATMENT
71493	and	O
71494	two	O
71495	units	O
71496	of	O
71497	fresh	b-TREATMENT
71498	frozen	i-TREATMENT
71499	plasma	i-TREATMENT
71500	and	O
71501	transferred	b-OCCURRENCE
71502	to	O
71503	the	b-CLINICAL_DEPT
71504	medical	i-CLINICAL_DEPT
71505	intensive	i-CLINICAL_DEPT
71506	care	i-CLINICAL_DEPT
71507	unit	i-CLINICAL_DEPT
71508	for	O
71509	further	O
71510	management	O
71511	.	O
71512	hospital	O
71513	course	O
71514	:	O
71515	the	O
71516	patient	O
71517	was	O
71518	transferred	b-OCCURRENCE
71519	to	O
71520	medical	b-CLINICAL_DEPT
71521	intensive	i-CLINICAL_DEPT
71522	care	i-CLINICAL_DEPT
71523	unit	i-CLINICAL_DEPT
71524	for	O
71525	further	O
71526	management	O
71527	for	O
71528	acute	b-PROBLEM
71529	gi	i-PROBLEM
71530	bleed	i-PROBLEM
71531	.	O
71532	1.	O
71533	gastrointestinal	O
71534	bleed	O
71535	:	O
71536	the	O
71537	patient	O
71538	continued	O
71539	to	O
71540	receive	O
71541	blood	b-TREATMENT
71542	transfusions	i-TREATMENT
71543	on	O
71544	the	b-CLINICAL_DEPT
71545	floor	i-CLINICAL_DEPT
71546	and	O
71547	serial	b-TEST
71548	hematocrits	i-TEST
71549	with	O
71550	serial	b-TEST
71551	inr	i-TEST
71552	checks	i-TEST
71553	were	O
71554	drawn	O
71555	.	O
71556	as	O
71557	he	O
71558	was	O
71559	receiving	O
71560	his	O
71561	third	O
71562	unit	O
71563	of	O
71564	packed	b-TREATMENT
71565	red	i-TREATMENT
71566	blood	i-TREATMENT
71567	cells	i-TREATMENT
71568	,	O
71569	the	O
71570	patient	O
71571	became	O
71572	tachycardic	b-PROBLEM
71573	and	O
71574	short	b-PROBLEM
71575	of	i-PROBLEM
71576	breath	i-PROBLEM
71577	.	O
71578	his	b-TEST
71579	temperature	i-TEST
71580	raised	O
71581	from	O
71582	98.6	O
71583	f.	O
71584	,	O
71585	to	O
71586	101.0	O
71587	f.	O
71588	he	O
71589	was	O
71590	shown	b-EVIDENTIAL
71591	to	O
71592	have	O
71593	rigors	b-PROBLEM
71594	.	O
71595	the	b-TREATMENT
71596	transfusion	i-TREATMENT
71597	was	O
71598	stopped	O
71599	and	O
71600	the	O
71601	patient	O
71602	was	O
71603	given	O
71604	tylenol	b-TREATMENT
71605	1	O
71606	mg	O
71607	with	O
71608	epinephrine	b-TREATMENT
71609	,	O
71610	100	O
71611	mg	O
71612	of	O
71613	hydrocortisone	b-TREATMENT
71614	,	O
71615	25	O
71616	mg	O
71617	of	O
71618	benadryl	b-TREATMENT
71619	and	O
71620	demerol	b-TREATMENT
71621	15	i-TREATMENT
71622	as	O
71623	well	O
71624	as	O
71625	pepcid	b-TREATMENT
71626	.	O
71627	he	O
71628	had	O
71629	emesis	b-PROBLEM
71630	times	O
71631	three	O
71632	of	O
71633	75	O
71634	cc	O
71635	of	O
71636	coffee	b-PROBLEM
71637	ground	i-PROBLEM
71638	material	i-PROBLEM
71639	.	O
71640	the	O
71641	patient	O
71642	also	O
71643	desaturated	b-PROBLEM
71644	to	O
71645	the	O
71646	low	O
71647	80	O
71648	s	O
71649	and	O
71650	was	O
71651	started	O
71652	on	O
71653	a	b-TREATMENT
71654	non-rebreather	i-TREATMENT
71655	mask	i-TREATMENT
71656	.	O
71657	his	b-TEST
71658	saturations	i-TEST
71659	improved	O
71660	quickly	O
71661	on	O
71662	100%	b-TREATMENT
71663	non-rebreather	i-TREATMENT
71664	mask	i-TREATMENT
71665	within	O
71666	15	b-DURATION
71667	to	i-DURATION
71668	20	i-DURATION
71669	minutes	i-DURATION
71670	.	O
71671	shortly	O
71672	after	O
71673	his	b-OCCURRENCE
71674	mental	i-OCCURRENCE
71675	status	i-OCCURRENCE
71676	changed	i-OCCURRENCE
71677	;	O
71678	he	O
71679	became	O
71680	disoriented	b-PROBLEM
71681	and	O
71682	euphoric	b-PROBLEM
71683	and	O
71684	continued	O
71685	to	O
71686	be	O
71687	in	O
71688	this	O
71689	state	O
71690	for	O
71691	two	b-DURATION
71692	more	i-DURATION
71693	hours	i-DURATION
71694	.	O
71695	after	O
71696	that	O
71697	period	O
71698	of	O
71699	time	O
71700	,	O
71701	his	b-OCCURRENCE
71702	mental	i-OCCURRENCE
71703	status	i-OCCURRENCE
71704	gradually	i-OCCURRENCE
71705	improved	i-OCCURRENCE
71706	and	O
71707	he	O
71708	continued	O
71709	to	O
71710	receive	O
71711	his	b-TREATMENT
71712	blood	i-TREATMENT
71713	transfusions	i-TREATMENT
71714	requiring	O
71715	a	O
71716	total	O
71717	of	O
71718	ten	O
71719	units	O
71720	of	O
71721	packed	b-TREATMENT
71722	red	i-TREATMENT
71723	blood	i-TREATMENT
71724	cells	i-TREATMENT
71725	and	O
71726	four	O
71727	units	O
71728	of	O
71729	fresh	b-TREATMENT
71730	frozen	i-TREATMENT
71731	plasma	i-TREATMENT
71732	to	O
71733	reach	O
71734	a	b-TEST
71735	hematocrit	i-TEST
71736	of	O
71737	30.0	O
71738	,	O
71739	which	O
71740	remained	b-OCCURRENCE
71741	stable	i-OCCURRENCE
71742	for	O
71743	the	O
71744	duration	O
71745	of	O
71746	his	b-OCCURRENCE
71747	stay	i-OCCURRENCE
71748	.	O
71749	on	O
71750	admission	b-OCCURRENCE
71751	,	O
71752	the	O
71753	patient	O
71754	was	O
71755	started	O
71756	on	O
71757	high	b-TREATMENT
71758	dose	i-TREATMENT
71759	proton	i-TREATMENT
71760	pump	i-TREATMENT
71761	inhibitors	i-TREATMENT
71762	for	O
71763	prophylaxis	b-TREATMENT
71764	.	O
71765	on	O
71766	wednesday	b-DATE
71767	,	i-DATE
71768	11-25	i-DATE
71769	,	O
71770	an	b-TEST
71771	esophagogastroduodenoscopy	i-TEST
71772	was	O
71773	performed	O
71774	and	O
71775	was	O
71776	significant	O
71777	for	O
71778	the	O
71779	following	O
71780	findings	O
71781	:	O
71782	medium	b-PROBLEM
71783	hiatal	i-PROBLEM
71784	hernia	i-PROBLEM
71785	,	O
71786	barrett's	b-PROBLEM
71787	esophagus	i-PROBLEM
71788	,	O
71789	erosion	b-PROBLEM
71790	of	i-PROBLEM
71791	the	i-PROBLEM
71792	gastroesophageal	i-PROBLEM
71793	junction	i-PROBLEM
71794	,	O
71795	granularity	b-PROBLEM
71796	,	O
71797	erythema	b-PROBLEM
71798	and	O
71799	congestion	b-PROBLEM
71800	of	i-PROBLEM
71801	the	i-PROBLEM
71802	antrum	i-PROBLEM
71803	in	O
71804	the	O
71805	pre-pyloric	O
71806	region	O
71807	compatible	O
71808	with	O
71809	gastritis	b-PROBLEM
71810	.	O
71811	erosions	b-PROBLEM
71812	in	i-PROBLEM
71813	the	i-PROBLEM
71814	antrum	i-PROBLEM
71815	and	i-PROBLEM
71816	pre-pyloric	i-PROBLEM
71817	region	i-PROBLEM
71818	,	O
71819	granularity	b-PROBLEM
71820	,	O
71821	erythema	b-PROBLEM
71822	and	O
71823	congestion	b-PROBLEM
71824	of	i-PROBLEM
71825	the	i-PROBLEM
71826	anterior	i-PROBLEM
71827	bulb	i-PROBLEM
71828	and	i-PROBLEM
71829	posterior	i-PROBLEM
71830	bulb	i-PROBLEM
71831	compatible	O
71832	with	O
71833	duodenitis	b-PROBLEM
71834	.	O
71835	it	O
71836	was	O
71837	recommended	O
71838	by	O
71839	gastroenterology	b-OCCURRENCE
71840	that	O
71841	the	O
71842	patient	O
71843	is	O
71844	to	O
71845	stay	O
71846	off	O
71847	aspirin	b-TREATMENT
71848	for	O
71849	at	O
71850	least	O
71851	four	b-DURATION
71852	to	i-DURATION
71853	six	i-DURATION
71854	weeks	i-DURATION
71855	at	O
71856	discharge	b-OCCURRENCE
71857	to	O
71858	prevent	O
71859	further	b-PROBLEM
71860	bleeding	i-PROBLEM
71861	.	O
71862	2.	O
71863	cardiovascular	O
71864	:	O
71865	during	O
71866	transfusion	b-PROBLEM
71867	reaction	i-PROBLEM
71868	episode	i-PROBLEM
71869	,	O
71870	the	O
71871	patient	O
71872	had	O
71873	an	O
71874	episode	O
71875	of	O
71876	tachycardia	b-PROBLEM
71877	ranging	O
71878	from	O
71879	134	O
71880	to	O
71881	158	O
71882	,	O
71883	for	O
71884	one	b-DURATION
71885	to	i-DURATION
71886	two	i-DURATION
71887	hours	i-DURATION
71888	.	O
71889	ekg	b-TEST
71890	during	O
71891	this	b-PROBLEM
71892	episode	i-PROBLEM
71893	was	O
71894	taken	O
71895	and	O
71896	showed	b-EVIDENTIAL
71897	sinus	b-PROBLEM
71898	tachycardia	i-PROBLEM
71899	;	O
71900	however	O
71901	,	O
71902	serial	b-TEST
71903	enzymes	i-TEST
71904	were	O
71905	significant	O
71906	for	O
71907	ck	b-TEST
71908	peaking	O
71909	at	O
71910	1075	O
71911	,	O
71912	mb	b-TEST
71913	peaking	O
71914	at	O
71915	114	O
71916	and	O
71917	mb	b-TEST
71918	index	i-TEST
71919	peaking	O
71920	at	O
71921	10.8	O
71922	,	O
71923	consistent	O
71924	with	O
71925	myocardial	b-PROBLEM
71926	damage	i-PROBLEM
71927	.	O
71928	the	b-DATE
71929	day	i-DATE
71930	following	i-DATE
71931	this	i-DATE
71932	episode	i-DATE
71933	,	O
71934	ekg	b-TEST
71935	showed	b-EVIDENTIAL
71936	loss	b-PROBLEM
71937	of	i-PROBLEM
71938	r	i-PROBLEM
71939	wave	i-PROBLEM
71940	progression	i-PROBLEM
71941	in	O
71942	anterior	O
71943	leads	O
71944	and	O
71945	q	b-PROBLEM
71946	waves	i-PROBLEM
71947	in	i-PROBLEM
71948	leads	i-PROBLEM
71949	iii	i-PROBLEM
71950	and	O
71951	avf	b-PROBLEM
71952	consistent	O
71953	with	O
71954	anteroseptal	b-PROBLEM
71955	myocardial	i-PROBLEM
71956	infarction	i-PROBLEM
71957	.	O
71958	the	b-TEST
71959	patient	i-TEST
71960	's	i-TEST
71961	blood	i-TEST
71962	pressures	i-TEST
71963	remained	O
71964	stable	O
71965	during	O
71966	his	b-OCCURRENCE
71967	stay	i-OCCURRENCE
71968	.	O
71969	he	O
71970	had	O
71971	no	O
71972	episodes	O
71973	of	O
71974	arrhythmia	b-PROBLEM
71975	on	O
71976	telemetry	b-TEST
71977	.	O
71978	cardiology	b-CLINICAL_DEPT
71979	consultation	b-OCCURRENCE
71980	was	O
71981	obtained	O
71982	.	O
71983	the	b-PROBLEM
71984	myocardial	i-PROBLEM
71985	infarction	i-PROBLEM
71986	was	O
71987	attributed	b-OCCURRENCE
71988	to	O
71989	demand	b-PROBLEM
71990	ischemia	i-PROBLEM
71991	secondary	O
71992	to	O
71993	acute	b-PROBLEM
71994	hematocrit	i-PROBLEM
71995	drop	i-PROBLEM
71996	exacerbated	O
71997	by	O
71998	tachycardia	b-PROBLEM
71999	secondary	O
72000	to	O
72001	blood	b-PROBLEM
72002	transfusion	i-PROBLEM
72003	reaction	i-PROBLEM
72004	.	O
72005	further	b-TEST
72006	cardiologic	i-TEST
72007	work-up	i-TEST
72008	was	O
72009	suggested	O
72010	as	O
72011	an	O
72012	outpatient	O
72013	at	O
72014	four	b-DATE
72015	to	i-DATE
72016	six	i-DATE
72017	weeks	i-DATE
72018	post	i-DATE
72019	discharge	O
72020	.	O
72021	the	O
72022	patient	O
72023	was	O
72024	started	O
72025	on	O
72026	lopressor	b-TREATMENT
72027	,	O
72028	lipitor	b-TREATMENT
72029	and	O
72030	lisinopril	b-TREATMENT
72031	.	O
72032	3.	O
72033	after	O
72034	ten	O
72035	units	O
72036	of	O
72037	packed	b-TREATMENT
72038	red	i-TREATMENT
72039	blood	i-TREATMENT
72040	cells	i-TREATMENT
72041	and	O
72042	four	O
72043	units	O
72044	of	O
72045	fresh	b-TREATMENT
72046	frozen	i-TREATMENT
72047	plasma	i-TREATMENT
72048	transfusions	i-TREATMENT
72049	,	O
72050	the	b-TEST
72051	patient	i-TEST
72052	's	i-TEST
72053	hematocrit	i-TEST
72054	remained	O
72055	stable	O
72056	at	O
72057	above	O
72058	30	O
72059	.	O
72060	his	b-TEST
72061	inr	i-TEST
72062	decreased	O
72063	to	O
72064	1.3	O
72065	at	O
72066	the	b-DATE
72067	time	i-DATE
72068	of	O
72069	discharge	O
72070	.	O
72071	he	O
72072	required	O
72073	no	O
72074	blood	b-TREATMENT
72075	transfusions	i-TREATMENT
72076	for	O
72077	four	b-DURATION
72078	days	i-DURATION
72079	prior	O
72080	to	O
72081	discharge	b-OCCURRENCE
72082	.	O
72083	4.	O
72084	history	O
72085	of	O
72086	pulmonary	b-PROBLEM
72087	embolism	i-PROBLEM
72088	likely	O
72089	secondary	O
72090	to	O
72091	frequent	b-OCCURRENCE
72092	flying	i-OCCURRENCE
72093	.	O
72094	the	O
72095	need	O
72096	for	O
72097	further	b-TREATMENT
72098	anti-coagulation	i-TREATMENT
72099	was	O
72100	discussed	O
72101	with	O
72102	the	O
72103	patient	O
72104	's	O
72105	attending	O
72106	,	O
72107	doctor	O
72108	coleman	O
72109	,	O
72110	and	O
72111	it	O
72112	was	O
72113	decided	O
72114	not	O
72115	to	O
72116	continue	O
72117	anti-coagulation	b-OCCURRENCE
72118	due	O
72119	to	O
72120	increased	O
72121	risk	b-PROBLEM
72122	of	i-PROBLEM
72123	gastrointestinal	i-PROBLEM
72124	bleeding	i-PROBLEM
72125	.	O
72126	the	O
72127	patient	O
72128	remained	O
72129	symptom	b-OCCURRENCE
72130	free	i-OCCURRENCE
72131	during	O
72132	his	b-OCCURRENCE
72133	stay	i-OCCURRENCE
72134	in	i-OCCURRENCE
72135	the	i-OCCURRENCE
72136	hospital	i-OCCURRENCE
72137	,	O
72138	saturating	b-OCCURRENCE
72139	well	i-OCCURRENCE
72140	in	O
72141	room	O
72142	air	O
72143	.	O
72144	5.	O
72145	endocrine	O
72146	:	O
72147	the	O
72148	patient	O
72149	was	O
72150	restarted	O
72151	on	O
72152	levothyroxine	b-TREATMENT
72153	soon	O
72154	after	O
72155	admission	b-OCCURRENCE
72156	.	O
72157	his	b-TEST
72158	hemoglobin	i-TEST
72159	a1c	i-TEST
72160	was	O
72161	sent	O
72162	and	O
72163	it	O
72164	was	O
72165	pending	b-OCCURRENCE
72166	at	O
72167	the	b-DATE
72168	time	i-DATE
72169	of	O
72170	discharge	O
72171	.	O
72172	6.	O
72173	single	b-PROBLEM
72174	mental	i-PROBLEM
72175	status	i-PROBLEM
72176	change	i-PROBLEM
72177	times	O
72178	two	b-DURATION
72179	hours	i-DURATION
72180	during	O
72181	episode	O
72182	of	O
72183	blood	b-PROBLEM
72184	transfusion	i-PROBLEM
72185	reaction	i-PROBLEM
72186	.	O
72187	was	O
72188	most	O
72189	likely	O
72190	due	O
72191	to	O
72192	multiple	b-TREATMENT
72193	drugs	i-TREATMENT
72194	administered	O
72195	during	O
72196	the	b-PROBLEM
72197	episode	i-PROBLEM
72198	including	O
72199	demerol	b-TREATMENT
72200	.	O
72201	after	O
72202	this	b-OCCURRENCE
72203	episode	i-OCCURRENCE
72204	,	O
72205	the	b-PROBLEM
72206	patient	i-PROBLEM
72207	's	i-PROBLEM
72208	mental	i-PROBLEM
72209	status	i-PROBLEM
72210	remained	O
72211	clear	O
72212	for	O
72213	the	b-OCCURRENCE
72214	rest	i-OCCURRENCE
72215	of	i-OCCURRENCE
72216	the	i-OCCURRENCE
72217	duration	i-OCCURRENCE
72218	of	i-OCCURRENCE
72219	his	i-OCCURRENCE
72220	stay	i-OCCURRENCE
72221	.	O
72222	7.	O
72223	prophylaxis	O
72224	:	O
72225	the	O
72226	patient	O
72227	was	O
72228	sent	b-OCCURRENCE
72229	home	i-OCCURRENCE
72230	on	O
72231	proton	b-TREATMENT
72232	pump	i-TREATMENT
72233	inhibitors	i-TREATMENT
72234	.	O
72235	his	b-TEST
72236	helicobacter	i-TEST
72237	pylori	i-TEST
72238	serology	i-TEST
72239	was	O
72240	sent	O
72241	and	O
72242	was	O
72243	pending	b-OCCURRENCE
72244	at	O
72245	the	b-DATE
72246	time	i-DATE
72247	of	O
72248	discharge	O
72249	.	O
72250		O
72251	admission	b-OCCURRENCE
72252	date	O
72253	:	O
72254	06/07/2000	b-ADMISSION
72255	discharge	b-OCCURRENCE
72256	date	O
72257	:	O
72258	07/02/2000	b-DISCHARGE
72259	history	O
72260	of	O
72261	present	O
72262	illness	O
72263	:	O
72264	mr.	O
72265	larsen	O
72266	was	O
72267	a	O
72268	50-year-old	O
72269	salesman	O
72270	who	O
72271	in	O
72272	12/26	b-DATE
72273	was	O
72274	noted	O
72275	to	O
72276	have	O
72277	an	b-PROBLEM
72278	elevated	i-PROBLEM
72279	platelet	i-PROBLEM
72280	count	i-PROBLEM
72281	of	O
72282	778,000	O
72283	.	O
72284	he	O
72285	was	O
72286	found	O
72287	to	O
72288	have	O
72289	cml	b-PROBLEM
72290	.	O
72291	he	O
72292	was	O
72293	admitted	b-OCCURRENCE
72294	on	O
72295	06/07/00	b-DATE
72296	for	O
72297	a	b-TREATMENT
72298	matched	i-TREATMENT
72299	,	i-TREATMENT
72300	unrelated	i-TREATMENT
72301	donor	i-TREATMENT
72302	bone	i-TREATMENT
72303	marrow	i-TREATMENT
72304	transplant	i-TREATMENT
72305	.	O
72306	hospital	O
72307	course	O
72308	:	O
72309	the	O
72310	patient	O
72311	received	O
72312	his	b-TREATMENT
72313	bone	i-TREATMENT
72314	marrow	i-TREATMENT
72315	transplant	i-TREATMENT
72316	on	O
72317	06/12/00	b-DATE
72318	.	O
72319	his	O
72320	course	O
72321	was	O
72322	then	O
72323	complicated	O
72324	by	O
72325	fevers	b-PROBLEM
72326	and	O
72327	neutropenia	b-PROBLEM
72328	which	O
72329	were	O
72330	treated	O
72331	with	O
72332	antibiotics	b-TREATMENT
72333	and	O
72334	a	b-PROBLEM
72335	diffuse	i-PROBLEM
72336	erythroderm	i-PROBLEM
72337	felt	O
72338	to	O
72339	be	O
72340	a	b-PROBLEM
72341	drug	i-PROBLEM
72342	reaction	i-PROBLEM
72343	.	O
72344	on	O
72345	06/24/00	b-DATE
72346	the	O
72347	patient	O
72348	was	O
72349	found	O
72350	to	O
72351	have	O
72352	pulmonary	b-PROBLEM
72353	infiltrates	i-PROBLEM
72354	and	O
72355	some	b-PROBLEM
72356	hemoptysis	i-PROBLEM
72357	.	O
72358	a	b-TEST
72359	bronchoscopy	i-TEST
72360	was	O
72361	done	O
72362	and	O
72363	there	O
72364	was	O
72365	blood	b-PROBLEM
72366	found	O
72367	in	O
72368	the	O
72369	upper	O
72370	airways	O
72371	but	O
72372	no	O
72373	evidence	O
72374	of	O
72375	blood	b-PROBLEM
72376	in	i-PROBLEM
72377	alveoli	i-PROBLEM
72378	so	O
72379	it	O
72380	was	O
72381	not	O
72382	felt	O
72383	to	O
72384	be	O
72385	dah	b-PROBLEM
72386	.	O
72387	on	O
72388	06/26/00	b-DATE
72389	due	O
72390	to	O
72391	agitation	b-PROBLEM
72392	,	O
72393	change	b-PROBLEM
72394	in	i-PROBLEM
72395	mental	i-PROBLEM
72396	status	i-PROBLEM
72397	and	O
72398	increased	b-PROBLEM
72399	respiratory	i-PROBLEM
72400	distress	i-PROBLEM
72401	,	O
72402	the	O
72403	patient	O
72404	was	O
72405	intubated	b-TREATMENT
72406	.	O
72407	it	O
72408	was	O
72409	felt	O
72410	at	O
72411	that	O
72412	time	O
72413	that	O
72414	the	b-PROBLEM
72415	changing	i-PROBLEM
72416	mental	i-PROBLEM
72417	status	i-PROBLEM
72418	and	O
72419	respiratory	b-PROBLEM
72420	distress	i-PROBLEM
72421	might	O
72422	be	O
72423	due	O
72424	to	O
72425	a	O
72426	combination	O
72427	of	O
72428	medication	b-TREATMENT
72429	and	O
72430	worsening	b-PROBLEM
72431	mucositis	i-PROBLEM
72432	.	O
72433	although	O
72434	the	b-TREATMENT
72435	patient	i-TREATMENT
72436	&apos;s	i-TREATMENT
72437	pain	i-TREATMENT
72438	and	i-TREATMENT
72439	sedation	i-TREATMENT
72440	meds	i-TREATMENT
72441	were	O
72442	adjusted	O
72443	he	O
72444	continued	O
72445	to	O
72446	be	O
72447	agitated	b-PROBLEM
72448	and	O
72449	there	O
72450	was	O
72451	difficulty	O
72452	weaning	O
72453	him	O
72454	off	O
72455	the	b-TREATMENT
72456	vent	i-TREATMENT
72457	.	O
72458	because	O
72459	of	O
72460	this	b-PROBLEM
72461	continued	i-PROBLEM
72462	agitation	i-PROBLEM
72463	,	O
72464	a	b-TEST
72465	head	i-TEST
72466	ct	i-TEST
72467	was	O
72468	performed	O
72469	on	O
72470	07/01/00	b-DATE
72471	and	O
72472	it	O
72473	revealed	O
72474	an	b-PROBLEM
72475	intraparenchymal	i-PROBLEM
72476	hemorrhage	i-PROBLEM
72477	.	O
72478	neurosurgery	b-CLINICAL_DEPT
72479	was	O
72480	consulted	b-OCCURRENCE
72481	but	O
72482	due	O
72483	to	O
72484	the	O
72485	severity	O
72486	of	O
72487	the	b-TREATMENT
72488	bleed	i-TREATMENT
72489	surgery	i-TREATMENT
72490	was	O
72491	not	O
72492	considered	O
72493	an	O
72494	option	O
72495	.	O
72496	the	O
72497	patient	O
72498	gradually	O
72499	lost	O
72500	brain	b-PROBLEM
72501	systolic	i-PROBLEM
72502	ejection	i-PROBLEM
72503	murmur	i-PROBLEM
72504	function	i-PROBLEM
72505	and	O
72506	was	O
72507	pronounced	O
72508	dead	b-OCCURRENCE
72509	on	O
72510	07/02/00	b-DATE
72511	.	O
72512	dictated	O
72513	by	O
72514	:	O
72515	laymie	O
72516	larsen	O
72517	,	O
72518	md	O
72519	em08	O
72520	attending	O
72521	:	O
72522	ana	O
72523	v.	O
72524	a	O
72525	,	O
72526	md	O
72527	zm0	O
72528	lb414/6537	O
72529	batch	O
72530	:	O
72531	67043	O
72532	index	O
72533	no.	O
72534	ezcdq560n8	O
72535	d	O
72536	:	O
72537	07/19/00	O
72538	t	O
72539	:	O
72540	07/20/00	O
72541		O
72542	admission	b-OCCURRENCE
72543	date	O
72544	:	O
72545	10/19/93	b-ADMISSION
72546	discharge	b-OCCURRENCE
72547	date	O
72548	:	O
72549	10/25/93	b-DISCHARGE
72550	history	O
72551	of	O
72552	present	O
72553	illness	O
72554	:	O
72555	mrs.	O
72556	dua	O
72557	is	O
72558	a	O
72559	34	O
72560	year	O
72561	old	O
72562	white	O
72563	female	O
72564	with	O
72565	an	O
72566	unclear	O
72567	history	O
72568	of	O
72569	hypertension	b-PROBLEM
72570	for	O
72571	at	O
72572	least	O
72573	five	b-DURATION
72574	years	i-DURATION
72575	.	O
72576	she	O
72577	was	O
72578	in	O
72579	her	b-OCCURRENCE
72580	usual	i-OCCURRENCE
72581	state	i-OCCURRENCE
72582	of	i-OCCURRENCE
72583	health	i-OCCURRENCE
72584	until	O
72585	around	O
72586	12:40	b-TIME
72587	on	i-TIME
72588	october	i-TIME
72589	19	i-TIME
72590	,	O
72591	when	O
72592	while	O
72593	on	O
72594	the	O
72595	phone	O
72596	,	O
72597	started	O
72598	to	O
72599	have	O
72600	difficulty	b-PROBLEM
72601	in	i-PROBLEM
72602	talking	i-PROBLEM
72603	.	O
72604	her	O
72605	speech	O
72606	became	O
72607	slurred	b-PROBLEM
72608	,	O
72609	this	O
72610	was	O
72611	followed	O
72612	a	b-DURATION
72613	few	i-DURATION
72614	seconds	i-DURATION
72615	after	O
72616	by	O
72617	weakness	b-PROBLEM
72618	and	i-PROBLEM
72619	numbness	i-PROBLEM
72620	of	i-PROBLEM
72621	her	i-PROBLEM
72622	arm	i-PROBLEM
72623	and	i-PROBLEM
72624	leg	i-PROBLEM
72625	.	O
72626	she	O
72627	did	O
72628	not	O
72629	complain	O
72630	of	O
72631	headache	b-PROBLEM
72632	,	O
72633	diplopia	b-PROBLEM
72634	,	O
72635	or	O
72636	any	b-PROBLEM
72637	other	i-PROBLEM
72638	neurological	i-PROBLEM
72639	symptoms	i-PROBLEM
72640	.	O
72641	she	O
72642	was	O
72643	seen	O
72644	at	O
72645	a	b-CLINICAL_DEPT
72646	memorial	i-CLINICAL_DEPT
72647	hospital	i-CLINICAL_DEPT
72648	where	O
72649	her	b-TEST
72650	blood	i-TEST
72651	pressure	i-TEST
72652	was	O
72653	measured	O
72654	at	O
72655	240/120	O
72656	and	O
72657	was	O
72658	found	O
72659	to	O
72660	have	O
72661	a	b-PROBLEM
72662	mild	i-PROBLEM
72663	left	i-PROBLEM
72664	hemiparesis	i-PROBLEM
72665	.	O
72666	she	O
72667	was	O
72668	then	O
72669	transferred	b-OCCURRENCE
72670	to	O
72671	ro	b-CLINICAL_DEPT
72672	woodma	i-CLINICAL_DEPT
72673	healthcare	i-CLINICAL_DEPT
72674	for	O
72675	further	b-TREATMENT
72676	management	i-TREATMENT
72677	.	O
72678	hospital	O
72679	course	O
72680	:	O
72681	given	O
72682	the	O
72683	localization	O
72684	of	O
72685	the	b-PROBLEM
72686	hematoma	i-PROBLEM
72687	and	O
72688	the	O
72689	history	O
72690	of	O
72691	hypertension	b-PROBLEM
72692	,	O
72693	the	O
72694	most	O
72695	likely	O
72696	cause	O
72697	for	O
72698	mrs.	O
72699	dua	O
72700	&apos;s	O
72701	cerebellar	b-PROBLEM
72702	hemorrhage	i-PROBLEM
72703	is	O
72704	hypertension	b-PROBLEM
72705	.	O
72706	a	b-TEST
72707	magnetic	i-TEST
72708	resonance	i-TEST
72709	imaging	i-TEST
72710	study	i-TEST
72711	will	O
72712	be	O
72713	scheduled	O
72714	as	O
72715	an	O
72716	outpatient	O
72717	in	O
72718	three	b-DATE
72719	months	i-DATE
72720	to	O
72721	rule	O
72722	out	O
72723	a	b-PROBLEM
72724	small	i-PROBLEM
72725	vascular	i-PROBLEM
72726	malformation	i-PROBLEM
72727	if	O
72728	responsible	O
72729	for	O
72730	the	b-PROBLEM
72731	hemorrhage	i-PROBLEM
72732	.	O
72733	at	O
72734	the	b-DATE
72735	time	i-DATE
72736	of	O
72737	discharge	O
72738	,	O
72739	mrs.	O
72740	dua	O
72741	has	O
72742	had	O
72743	a	b-OCCURRENCE
72744	remarkable	i-OCCURRENCE
72745	recovery	i-OCCURRENCE
72746	.	O
72747	she	O
72748	is	O
72749	now	O
72750	able	b-OCCURRENCE
72751	to	i-OCCURRENCE
72752	walk	i-OCCURRENCE
72753	fitfully	i-OCCURRENCE
72754	and	O
72755	use	b-OCCURRENCE
72756	her	i-OCCURRENCE
72757	left	i-OCCURRENCE
72758	hand	i-OCCURRENCE
72759	with	O
72760	no	O
72761	problem	b-PROBLEM
72762	.	O
72763	the	b-TEST
72764	exam	i-TEST
72765	is	O
72766	remarkable	O
72767	for	O
72768	a	b-PROBLEM
72769	mild	i-PROBLEM
72770	leftsided	i-PROBLEM
72771	face	i-PROBLEM
72772	,	O
72773	arm	b-PROBLEM
72774	and	i-PROBLEM
72775	leg	i-PROBLEM
72776	weakness	i-PROBLEM
72777	and	O
72778	sensory	b-PROBLEM
72779	deficit	i-PROBLEM
72780	that	O
72781	should	O
72782	further	O
72783	improve	O
72784	with	O
72785	physical	b-TREATMENT
72786	therapy	i-TREATMENT
72787	and	O
72788	occupational	b-TREATMENT
72789	therapy	i-TREATMENT
72790	help	O
72791	.	O
72792	she	O
72793	will	O
72794	be	O
72795	followed	O
72796	by	O
72797	the	b-CLINICAL_DEPT
72798	ot	i-CLINICAL_DEPT
72799	/	i-CLINICAL_DEPT
72800	pt	i-CLINICAL_DEPT
72801	dept.	O
72802	for	O
72803	that	O
72804	.	O
72805	her	b-PROBLEM
72806	hypertension	i-PROBLEM
72807	was	O
72808	difficult	O
72809	to	O
72810	manage	O
72811	initially	O
72812	and	O
72813	required	O
72814	three	b-DURATION
72815	days	i-DURATION
72816	of	O
72817	intensive	b-CLINICAL_DEPT
72818	care	i-CLINICAL_DEPT
72819	unit	i-CLINICAL_DEPT
72820	with	O
72821	a-line	b-TREATMENT
72822	and	O
72823	nipride	b-TREATMENT
72824	intravenously	i-TREATMENT
72825	.	O
72826	it	O
72827	was	O
72828	finally	O
72829	under	O
72830	control	O
72831	with	O
72832	high	O
72833	doses	O
72834	of	O
72835	captopril	b-TREATMENT
72836	,	O
72837	nifedipine	b-TREATMENT
72838	,	O
72839	and	O
72840	hydrochlorothiazide	b-TREATMENT
72841	.	O
72842	the	b-TEST
72843	workup	i-TEST
72844	to	O
72845	rule	O
72846	out	O
72847	secondary	b-PROBLEM
72848	cause	i-PROBLEM
72849	of	O
72850	hypertension	b-PROBLEM
72851	given	O
72852	the	O
72853	patient	O
72854	&apos;s	O
72855	young	O
72856	age	O
72857	and	O
72858	the	b-OCCURRENCE
72859	difficulty	i-OCCURRENCE
72860	controlling	i-OCCURRENCE
72861	the	i-OCCURRENCE
72862	blood	i-OCCURRENCE
72863	pressure	i-OCCURRENCE
72864	was	O
72865	started	O
72866	as	O
72867	an	O
72868	inpatient	O
72869	and	O
72870	will	O
72871	be	O
72872	completed	O
72873	by	O
72874	doctor	O
72875	______________as	O
72876	an	O
72877	outpatient	O
72878	.	O
72879	so	O
72880	far	O
72881	no	O
72882	secondary	b-PROBLEM
72883	causes	i-PROBLEM
72884	of	O
72885	hypertension	b-PROBLEM
72886	were	O
72887	identified	O
72888	but	O
72889	causes	O
72890	like	O
72891	lymphocytic	b-PROBLEM
72892	?	i-PROBLEM
72893	chromocytoma	i-PROBLEM
72894	or	O
72895	renal	b-PROBLEM
72896	artery	i-PROBLEM
72897	stenosis	i-PROBLEM
72898	have	O
72899	not	O
72900	been	O
72901	ruled	O
72902	out	O
72903	yet	O
72904	.	O
72905		O
72906	admission	b-OCCURRENCE
72907	date	O
72908	:	O
72909	02/22/92	b-ADMISSION
72910	discharge	b-OCCURRENCE
72911	date	O
72912	:	O
72913	03/08/92	b-DISCHARGE
72914	history	O
72915	of	O
72916	present	O
72917	illness	O
72918	:	O
72919	patient	O
72920	is	O
72921	a	O
72922	72	O
72923	year	O
72924	old	O
72925	female	O
72926	with	O
72927	known	b-PROBLEM
72928	carotid	i-PROBLEM
72929	stenosis	i-PROBLEM
72930	,	O
72931	and	O
72932	recent	b-TEST
72933	carotid	i-TEST
72934	noninvasives	i-TEST
72935	at	O
72936	an	b-CLINICAL_DEPT
72937	outside	i-CLINICAL_DEPT
72938	hospital	i-CLINICAL_DEPT
72939	,	O
72940	which	O
72941	showed	b-EVIDENTIAL
72942	90%	b-PROBLEM
72943	left	i-PROBLEM
72944	sided	i-PROBLEM
72945	stenosis	i-PROBLEM
72946	.	O
72947	she	O
72948	has	O
72949	not	O
72950	had	O
72951	a	b-PROBLEM
72952	stroke	i-PROBLEM
72953	,	O
72954	or	O
72955	transient	b-PROBLEM
72956	ischemic	i-PROBLEM
72957	attack	i-PROBLEM
72958	.	O
72959	she	O
72960	was	O
72961	recently	O
72962	discharged	b-OCCURRENCE
72963	from	O
72964	the	b-CLINICAL_DEPT
72965	per	i-CLINICAL_DEPT
72966	naplesspecrycet	i-CLINICAL_DEPT
72967	hospital	i-CLINICAL_DEPT
72968	after	O
72969	an	b-OCCURRENCE
72970	admission	i-OCCURRENCE
72971	for	O
72972	congestive	b-PROBLEM
72973	heart	i-PROBLEM
72974	failure	i-PROBLEM
72975	.	O
72976	hospital	O
72977	course	O
72978	:	O
72979	the	O
72980	patient	O
72981	was	O
72982	admitted	b-OCCURRENCE
72983	to	O
72984	the	b-CLINICAL_DEPT
72985	tau	i-CLINICAL_DEPT
72986	memorial	i-CLINICAL_DEPT
72987	hospital	i-CLINICAL_DEPT
72988	.	O
72989	she	O
72990	was	O
72991	seen	O
72992	by	O
72993	doctor	O
72994	freiermthalskush	O
72995	of	O
72996	the	b-OCCURRENCE
72997	renal	i-OCCURRENCE
72998	service	i-OCCURRENCE
72999	for	O
73000	management	b-TREATMENT
73001	of	O
73002	her	b-PROBLEM
73003	chronic	i-PROBLEM
73004	renal	i-PROBLEM
73005	insufficiency	i-PROBLEM
73006	.	O
73007	on	O
73008	02/22	b-DATE
73009	,	O
73010	she	O
73011	underwent	O
73012	angiography	b-TEST
73013	,	O
73014	which	O
73015	revealed	b-EVIDENTIAL
73016	minimal	b-PROBLEM
73017	right	i-PROBLEM
73018	internal	i-PROBLEM
73019	carotid	i-PROBLEM
73020	artery	i-PROBLEM
73021	disease	i-PROBLEM
73022	,	O
73023	and	O
73024	proximal	b-PROBLEM
73025	left	i-PROBLEM
73026	internal	i-PROBLEM
73027	carotid	i-PROBLEM
73028	artery	i-PROBLEM
73029	stenosis	i-PROBLEM
73030	,	O
73031	2	O
73032	cm	O
73033	in	O
73034	length	O
73035	for	O
73036	the	O
73037	1	O
73038	mm	O
73039	residual	O
73040	lumen	O
73041	.	O
73042	the	O
73043	left	O
73044	anterior	O
73045	communicating	O
73046	artery	O
73047	fell	O
73048	from	O
73049	the	O
73050	right	O
73051	.	O
73052	she	O
73053	was	O
73054	also	O
73055	seen	O
73056	by	O
73057	cardiology	b-OCCURRENCE
73058	,	O
73059	and	O
73060	she	O
73061	underwent	O
73062	cardiac	b-TEST
73063	catheterization	i-TEST
73064	,	O
73065	as	O
73066	part	O
73067	of	O
73068	her	b-TEST
73069	preop	i-TEST
73070	evaluation	i-TEST
73071	,	O
73072	which	O
73073	revealed	b-EVIDENTIAL
73074	normal	O
73075	resting	b-OCCURRENCE
73076	hemodynamics	i-OCCURRENCE
73077	,	O
73078	and	O
73079	a	b-PROBLEM
73080	moderate	i-PROBLEM
73081	posterior	i-PROBLEM
73082	descending	i-PROBLEM
73083	artery	i-PROBLEM
73084	,	O
73085	and	O
73086	obtuse	b-PROBLEM
73087	marginal	i-PROBLEM
73088	stenoses	i-PROBLEM
73089	.	O
73090	she	O
73091	was	O
73092	,	O
73093	therefore	O
73094	,	O
73095	cleared	b-OCCURRENCE
73096	for	O
73097	the	b-CLINICAL_DEPT
73098	operating	i-CLINICAL_DEPT
73099	room	i-CLINICAL_DEPT
73100	,	O
73101	and	O
73102	on	O
73103	3/3/92	b-DATE
73104	,	O
73105	she	O
73106	underwent	O
73107	a	b-TREATMENT
73108	left	i-TREATMENT
73109	carotid	i-TREATMENT
73110	endarterectomy	i-TREATMENT
73111	,	O
73112	with	O
73113	continuous	b-TEST
73114	electroencephalogram	i-TEST
73115	monitoring	i-TEST
73116	and	O
73117	vein	b-TREATMENT
73118	patch	i-TREATMENT
73119	angioplasty	i-TREATMENT
73120	,	O
73121	which	O
73122	was	O
73123	uneventful	b-OCCURRENCE
73124	.	O
73125	her	b-OCCURRENCE
73126	postoperative	i-OCCURRENCE
73127	course	i-OCCURRENCE
73128	was	O
73129	marked	O
73130	only	O
73131	by	O
73132	prolonged	b-PROBLEM
73133	ileus	i-PROBLEM
73134	,	O
73135	perhaps	O
73136	secondary	O
73137	to	O
73138	constipation	b-PROBLEM
73139	,	O
73140	with	O
73141	persistent	b-PROBLEM
73142	vomiting	i-PROBLEM
73143	,	O
73144	requiring	O
73145	intravenous	b-TREATMENT
73146	fluids	i-TREATMENT
73147	,	O
73148	however	O
73149	,	O
73150	on	O
73151	03/07/92	b-DATE
73152	,	O
73153	she	O
73154	had	O
73155	a	b-OCCURRENCE
73156	large	i-OCCURRENCE
73157	bowel	i-OCCURRENCE
73158	movement	i-OCCURRENCE
73159	,	O
73160	after	O
73161	aggressive	b-TREATMENT
73162	bowel	i-TREATMENT
73163	regime	i-TREATMENT
73164	,	O
73165	felt	O
73166	significantly	O
73167	better	O
73168	,	O
73169	was	O
73170	able	O
73171	to	O
73172	tolerate	b-OCCURRENCE
73173	po	i-OCCURRENCE
73174	&apos;s	i-OCCURRENCE
73175	.	O
73176	she	O
73177	is	O
73178	now	O
73179	able	O
73180	to	O
73181	be	O
73182	discharged	b-OCCURRENCE
73183	home	O
73184	on	O
73185	her	b-TREATMENT
73186	admission	i-TREATMENT
73187	medications	i-TREATMENT
73188	,	O
73189	with	O
73190	the	O
73191	exception	O
73192	of	O
73193	the	O
73194	fact	O
73195	that	O
73196	vasotec	b-TREATMENT
73197	was	O
73198	increased	b-OCCURRENCE
73199	to	O
73200	10	O
73201	mg	O
73202	po	O
73203	bid	b-FREQUENCY
73204	.	O
73205	shermene	O
73206	jescselc	O
73207	,	O
73208	md	O
73209		O
73210	admission	b-OCCURRENCE
73211	date	O
73212	:	O
73213	2011-06-10	b-ADMISSION
73214	discharge	b-OCCURRENCE
73215	date	O
73216	:	O
73217	2011-06-13	b-DISCHARGE
73218	service	O
73219	:	O
73220	cmed	O
73221	csru	O
73222	history	O
73223	of	O
73224	present	O
73225	illness	O
73226	:	O
73227	this	O
73228	is	O
73229	a	O
73230	35-year-old	O
73231	gentleman	O
73232	with	O
73233	hiv	b-PROBLEM
73234	on	O
73235	haart	b-TREATMENT
73236	with	O
73237	last	b-TEST
73238	cd4	i-TEST
73239	count	i-TEST
73240	of	O
73241	268	O
73242	and	O
73243	undetectable	O
73244	viral	b-TEST
73245	load	i-TEST
73246	who	O
73247	was	O
73248	referred	b-OCCURRENCE
73249	to	O
73250	the	b-CLINICAL_DEPT
73251	emergency	i-CLINICAL_DEPT
73252	room	i-CLINICAL_DEPT
73253	via	O
73254	his	b-CLINICAL_DEPT
73255	pcp	i-CLINICAL_DEPT
73256	for	O
73257	progressive	b-PROBLEM
73258	throat	i-PROBLEM
73259	pain	i-PROBLEM
73260	and	O
73261	edema	b-PROBLEM
73262	.	O
73263	his	b-PROBLEM
73264	throat	i-PROBLEM
73265	pain	i-PROBLEM
73266	began	O
73267	2	b-DURATION
73268	to	i-DURATION
73269	3	i-DURATION
73270	days	i-DURATION
73271	prior	O
73272	to	O
73273	admission	b-OCCURRENCE
73274	,	O
73275	initially	O
73276	treated	b-OCCURRENCE
73277	with	O
73278	ibuprofen	b-TREATMENT
73279	,	O
73280	seen	b-OCCURRENCE
73281	in	i-OCCURRENCE
73282	an	i-OCCURRENCE
73283	outside	i-OCCURRENCE
73284	hospital	i-OCCURRENCE
73285	emergency	i-OCCURRENCE
73286	room	i-OCCURRENCE
73287	day	b-DATE
73288	prior	O
73289	to	O
73290	admission	O
73291	where	O
73292	he	O
73293	received	b-OCCURRENCE
73294	iv	b-TREATMENT
73295	penicillin	i-TREATMENT
73296	and	O
73297	was	O
73298	sent	b-OCCURRENCE
73299	home	i-OCCURRENCE
73300	.	O
73301	in	O
73302	clinic	O
73303	today	b-DATE
73304	,	O
73305	the	O
73306	patient	O
73307	desaturated	b-PROBLEM
73308	to	O
73309	low	O
73310	90	O
73311	s	O
73312	with	O
73313	ambulation	b-OCCURRENCE
73314	and	O
73315	also	O
73316	had	O
73317	complaints	b-EVIDENTIAL
73318	of	O
73319	progressive	b-PROBLEM
73320	swelling	i-PROBLEM
73321	""""	O
73322	like	O
73323	my	O
73324	throat	O
73325	is	O
73326	going	O
73327	to	O
73328	close	O
73329	up	O
73330	""""	O
73331	with	O
73332	increasing	b-PROBLEM
73333	drooling	i-PROBLEM
73334	,	O
73335	unable	O
73336	to	O
73337	swallow	b-OCCURRENCE
73338	the	b-TREATMENT
73339	hiv	i-TREATMENT
73340	medications	i-TREATMENT
73341	.	O
73342	also	O
73343	noted	b-EVIDENTIAL
73344	to	O
73345	have	O
73346	low-grade	b-PROBLEM
73347	temperature	i-PROBLEM
73348	of	O
73349	99	O
73350	to	O
73351	100	O
73352	degrees	O
73353	with	O
73354	productive	b-PROBLEM
73355	cough	i-PROBLEM
73356	and	O
73357	yellow	b-PROBLEM
73358	sputum	i-PROBLEM
73359	times	b-FREQUENCY
73360	1	i-FREQUENCY
73361	day	i-FREQUENCY
73362	with	O
73363	right	b-PROBLEM
73364	ear	i-PROBLEM
73365	pain	i-PROBLEM
73366	.	O
73367	no	O
73368	subjective	b-PROBLEM
73369	shortness	i-PROBLEM
73370	of	i-PROBLEM
73371	breath	i-PROBLEM
73372	.	O
73373	the	O
73374	patient	O
73375	describes	O
73376	whole	b-PROBLEM
73377	body	i-PROBLEM
73378	numbness	i-PROBLEM
73379	.	O
73380	he	O
73381	currently	O
73382	notes	b-EVIDENTIAL
73383	improvement	b-EVIDENTIAL
73384	in	O
73385	his	b-PROBLEM
73386	throat	i-PROBLEM
73387	pain	i-PROBLEM
73388	after	O
73389	some	b-TREATMENT
73390	decadron	i-TREATMENT
73391	and	O
73392	clindamycin	b-TREATMENT
73393	.	O
73394	he	O
73395	was	O
73396	seen	b-OCCURRENCE
73397	by	O
73398	cmed	b-CLINICAL_DEPT
73399	csru	i-CLINICAL_DEPT
73400	in	O
73401	the	b-CLINICAL_DEPT
73402	emergency	i-CLINICAL_DEPT
73403	room	i-CLINICAL_DEPT
73404	and	O
73405	the	b-TEST
73406	exam	i-TEST
73407	was	O
73408	consistent	O
73409	with	O
73410	supraglottitis	b-PROBLEM
73411	.	O
73412	review	O
73413	of	O
73414	systems	O
73415	:	O
73416	review	b-TEST
73417	of	i-TEST
73418	systems	i-TEST
73419	was	O
73420	negative	O
73421	for	O
73422	history	O
73423	of	O
73424	opportunistic	b-PROBLEM
73425	infections	i-PROBLEM
73426	or	O
73427	prior	b-OCCURRENCE
73428	hospitalizations	i-OCCURRENCE
73429	.	O
73430	of	O
73431	note	b-EVIDENTIAL
73432	,	O
73433	his	b-TEST
73434	cd4	i-TEST
73435	count	i-TEST
73436	was	O
73437	less	O
73438	than	O
73439	200	O
73440	last	b-DATE
73441	winter	i-DATE
73442	.	O
73443	he	O
73444	believes	O
73445	he	O
73446	is	O
73447	up-to-date	O
73448	on	O
73449	all	O
73450	his	b-TREATMENT
73451	vaccines	i-TREATMENT
73452	.	O
73453	hospital	O
73454	course	O
73455	:	O
73456	this	O
73457	is	O
73458	a	O
73459	35-year-old	O
73460	gentleman	O
73461	with	O
73462	hiv	b-PROBLEM
73463	on	O
73464	haart	b-TREATMENT
73465	,	O
73466	last	b-TEST
73467	cd4	i-TEST
73468	count	i-TEST
73469	268	O
73470	with	O
73471	undetectable	O
73472	viral	b-TEST
73473	load	i-TEST
73474	who	O
73475	was	O
73476	initially	O
73477	admitted	b-OCCURRENCE
73478	to	O
73479	the	b-CLINICAL_DEPT
73480	cmed	i-CLINICAL_DEPT
73481	csru	i-CLINICAL_DEPT
73482	for	O
73483	supraglottitis	b-PROBLEM
73484	with	O
73485	significant	b-PROBLEM
73486	edema	i-PROBLEM
73487	.	O
73488	problem	O
73489	list	O
73490	:	O
73491	1.	O
73492	epiglottitis	b-PROBLEM
73493	/	O
73494	supraglottitis	b-PROBLEM
73495	.	O
73496	the	O
73497	patient	O
73498	was	O
73499	observed	b-TEST
73500	in	O
73501	the	b-CLINICAL_DEPT
73502	cmed	i-CLINICAL_DEPT
73503	csru	i-CLINICAL_DEPT
73504	for	O
73505	48	b-DURATION
73506	hours	i-DURATION
73507	and	O
73508	noted	b-EVIDENTIAL
73509	to	O
73510	have	O
73511	decrease	b-OCCURRENCE
73512	in	O
73513	swelling	b-PROBLEM
73514	on	O
73515	serial	b-TEST
73516	exams	i-TEST
73517	.	O
73518	he	O
73519	was	O
73520	followed	b-OCCURRENCE
73521	by	O
73522	the	b-CLINICAL_DEPT
73523	cmed	i-CLINICAL_DEPT
73524	csru	i-CLINICAL_DEPT
73525	service	i-CLINICAL_DEPT
73526	and	O
73527	was	O
73528	started	b-OCCURRENCE
73529	on	O
73530	iv	b-TREATMENT
73531	decadron	i-TREATMENT
73532	initially	O
73533	in	O
73534	addition	O
73535	to	O
73536	iv	b-TREATMENT
73537	unasyn	i-TREATMENT
73538	,	O
73539	which	O
73540	he	O
73541	tolerated	b-OCCURRENCE
73542	well	i-OCCURRENCE
73543	.	O
73544	his	b-PROBLEM
73545	edema	i-PROBLEM
73546	was	O
73547	improving	b-EVIDENTIAL
73548	and	O
73549	was	O
73550	starting	b-OCCURRENCE
73551	to	i-OCCURRENCE
73552	tolerate	i-OCCURRENCE
73553	p.o.	i-OCCURRENCE
73554	his	O
73555	airway	O
73556	and	O
73557	symptoms	b-PROBLEM
73558	continued	O
73559	to	O
73560	improve	b-EVIDENTIAL
73561	and	O
73562	remained	b-OCCURRENCE
73563	stable	i-OCCURRENCE
73564	.	O
73565	the	O
73566	patient	O
73567	was	O
73568	stable	b-EVIDENTIAL
73569	for	O
73570	transfer	b-OCCURRENCE
73571	to	O
73572	the	b-CLINICAL_DEPT
73573	floor	i-CLINICAL_DEPT
73574	,	O
73575	was	O
73576	treated	b-OCCURRENCE
73577	with	O
73578	over	O
73579	72	b-DATE
73580	hours	i-DATE
73581	of	O
73582	iv	b-TREATMENT
73583	unasyn	i-TREATMENT
73584	,	O
73585	and	O
73586	then	O
73587	transitioned	b-OCCURRENCE
73588	to	O
73589	oral	O
73590	regimen	O
73591	of	O
73592	augmentin	b-TREATMENT
73593	to	O
73594	be	O
73595	continued	b-OCCURRENCE
73596	as	O
73597	an	O
73598	outpatient	O
73599	.	O
73600	eventually	O
73601	,	O
73602	his	b-TREATMENT
73603	iv	i-TREATMENT
73604	steroids	i-TREATMENT
73605	were	O
73606	transitioned	b-OCCURRENCE
73607	to	O
73608	a	b-TREATMENT
73609	p.o.	i-TREATMENT
73610	steroid	i-TREATMENT
73611	taper	i-TREATMENT
73612	,	O
73613	which	O
73614	he	O
73615	tolerated	b-OCCURRENCE
73616	well	i-OCCURRENCE
73617	,	O
73618	and	O
73619	was	O
73620	discharged	b-OCCURRENCE
73621	on	O
73622	a	b-TREATMENT
73623	steroid	i-TREATMENT
73624	taper	i-TREATMENT
73625	also	O
73626	with	O
73627	cmed	b-CLINICAL_DEPT
73628	csru	i-CLINICAL_DEPT
73629	follow-up	b-OCCURRENCE
73630	as	O
73631	an	O
73632	outpatient	O
73633	.	O
73634	his	O
73635	oxygenation	O
73636	and	O
73637	symptoms	b-PROBLEM
73638	remained	b-OCCURRENCE
73639	stable	i-OCCURRENCE
73640	and	O
73641	again	O
73642	tolerated	b-OCCURRENCE
73643	p.o.	i-OCCURRENCE
73644	without	O
73645	difficulty	b-OCCURRENCE
73646	.	O
73647	eventually	O
73648	,	O
73649	as	O
73650	the	O
73651	patient	O
73652	remained	b-OCCURRENCE
73653	hemodynamically	i-OCCURRENCE
73654	stable	i-OCCURRENCE
73655	,	O
73656	his	b-OCCURRENCE
73657	airway	i-OCCURRENCE
73658	remained	i-OCCURRENCE
73659	stable	i-OCCURRENCE
73660	,	O
73661	and	O
73662	he	O
73663	was	O
73664	tolerating	b-OCCURRENCE
73665	po	i-OCCURRENCE
73666	s,	O
73667	he	O
73668	was	O
73669	transitioned	b-OCCURRENCE
73670	to	O
73671	the	b-CLINICAL_DEPT
73672	floor	i-CLINICAL_DEPT
73673	where	O
73674	he	O
73675	remained	O
73676	otherwise	O
73677	stable	b-EVIDENTIAL
73678	and	O
73679	asymptomatic	b-PROBLEM
73680	.	O
73681	his	b-PROBLEM
73682	voice	i-PROBLEM
73683	improved	i-PROBLEM
73684	during	O
73685	the	b-OCCURRENCE
73686	course	i-OCCURRENCE
73687	of	i-OCCURRENCE
73688	his	i-OCCURRENCE
73689	stay	i-OCCURRENCE
73690	and	O
73691	was	O
73692	talking	b-OCCURRENCE
73693	clearly	i-OCCURRENCE
73694	by	O
73695	the	b-DATE
73696	time	i-DATE
73697	of	i-DATE
73698	discharge	i-DATE
73699	.	O
73700	he	O
73701	remained	O
73702	afebrile	b-PROBLEM
73703	during	O
73704	the	b-OCCURRENCE
73705	course	i-OCCURRENCE
73706	of	i-OCCURRENCE
73707	his	i-OCCURRENCE
73708	stay	i-OCCURRENCE
73709	after	O
73710	transfer	b-OCCURRENCE
73711	to	O
73712	the	b-CLINICAL_DEPT
73713	floor	i-CLINICAL_DEPT
73714	and	O
73715	per	O
73716	cmed	b-CLINICAL_DEPT
73717	csru	i-CLINICAL_DEPT
73718	was	O
73719	to	O
73720	be	O
73721	discharged	b-OCCURRENCE
73722	on	O
73723	a	b-DURATION
73724	2-week	i-DURATION
73725	course	O
73726	of	O
73727	augmentin	b-TREATMENT
73728	with	O
73729	follow-up	b-OCCURRENCE
73730	with	O
73731	doctor	O
73732	thibodeau	O
73733	in	O
73734	2	b-DURATION
73735	weeks	i-DURATION
73736	'	O
73737	time	O
73738	in	O
73739	addition	O
73740	to	O
73741	a	b-TREATMENT
73742	medrol	i-TREATMENT
73743	dosepak	i-TREATMENT
73744	.	O
73745	1.	O
73746	hiv	b-PROBLEM
73747	.	O
73748	once	O
73749	,	O
73750	the	O
73751	patient	O
73752	was	O
73753	tolerating	b-EVIDENTIAL
73754	p.o.	i-EVIDENTIAL
73755	,	O
73756	the	O
73757	patient	O
73758	was	O
73759	restarted	b-OCCURRENCE
73760	on	O
73761	his	b-TREATMENT
73762	haart	i-TREATMENT
73763	regimen	i-TREATMENT
73764	and	O
73765	remained	b-OCCURRENCE
73766	stable	i-OCCURRENCE
73767	from	O
73768	that	O
73769	perspective	O
73770	.	O
73771		O
73772	admission	b-OCCURRENCE
73773	date	O
73774	:	O
73775	11/3/92	b-ADMISSION
73776	discharge	b-OCCURRENCE
73777	date	O
73778	:	O
73779	12/6/92	b-DISCHARGE
73780	history	O
73781	of	O
73782	present	O
73783	illness	O
73784	:	O
73785	the	O
73786	patient	O
73787	is	O
73788	a	O
73789	68	O
73790	year	O
73791	old	O
73792	,	O
73793	right	O
73794	handed	O
73795	caucasian	O
73796	female	O
73797	,	O
73798	former	O
73799	r.n.	O
73800	who	O
73801	complained	b-EVIDENTIAL
73802	of	O
73803	several	b-DURATION
73804	days	i-DURATION
73805	of	O
73806	vertigo	b-PROBLEM
73807	,	O
73808	one	b-DURATION
73809	day	i-DURATION
73810	of	O
73811	double	b-PROBLEM
73812	vision	i-PROBLEM
73813	,	O
73814	dysarthria	b-PROBLEM
73815	and	O
73816	worsening	b-PROBLEM
73817	of	i-PROBLEM
73818	vertigo	i-PROBLEM
73819	.	O
73820	she	O
73821	was	O
73822	seen	O
73823	at	O
73824	the	b-CLINICAL_DEPT
73825	outside	i-CLINICAL_DEPT
73826	hospital	i-CLINICAL_DEPT
73827	and	O
73828	put	O
73829	on	O
73830	aspirin	b-TREATMENT
73831	for	O
73832	two	b-DURATION
73833	days	i-DURATION
73834	.	O
73835	an	b-TEST
73836	magnetic	i-TEST
73837	resonance	i-TEST
73838	imaging	i-TEST
73839	study	i-TEST
73840	showed	b-EVIDENTIAL
73841	basilar	b-PROBLEM
73842	artery	i-PROBLEM
73843	disease	i-PROBLEM
73844	,	O
73845	questionable	O
73846	aneurysm	b-PROBLEM
73847	.	O
73848	the	O
73849	patient	O
73850	was	O
73851	transferred	b-OCCURRENCE
73852	to	O
73853	the	b-CLINICAL_DEPT
73854	fairm	i-CLINICAL_DEPT
73855	of	i-CLINICAL_DEPT
73856	ijordcompmac	i-CLINICAL_DEPT
73857	hospital	i-CLINICAL_DEPT
73858	.	O
73859	an	b-TEST
73860	angiogram	i-TEST
73861	on	O
73862	11/3	b-DATE
73863	was	O
73864	consistent	O
73865	with	O
73866	thrombosis	b-PROBLEM
73867	at	i-PROBLEM
73868	the	i-PROBLEM
73869	mid	i-PROBLEM
73870	basilar	i-PROBLEM
73871	artery	i-PROBLEM
73872	.	O
73873	the	O
73874	patient	O
73875	was	O
73876	put	O
73877	on	O
73878	heparin	b-TREATMENT
73879	and	O
73880	was	O
73881	stable	b-OCCURRENCE
73882	since	O
73883	.	O
73884	hospital	O
73885	course	O
73886	:	O
73887	the	O
73888	patient	O
73889	was	O
73890	taken	O
73891	to	O
73892	the	b-CLINICAL_DEPT
73893	intensive	i-CLINICAL_DEPT
73894	care	i-CLINICAL_DEPT
73895	unit	i-CLINICAL_DEPT
73896	after	O
73897	her	b-TEST
73898	angiogram	i-TEST
73899	.	O
73900	she	O
73901	was	O
73902	aggressively	O
73903	anticoagulated	b-TREATMENT
73904	with	O
73905	heparin	b-TREATMENT
73906	.	O
73907	a	b-PROBLEM
73908	small	i-PROBLEM
73909	intimal	i-PROBLEM
73910	tear	i-PROBLEM
73911	in	O
73912	the	O
73913	arch	O
73914	of	O
73915	the	O
73916	aorta	O
73917	during	O
73918	the	b-TEST
73919	angiogram	i-TEST
73920	,	O
73921	was	O
73922	without	O
73923	sequelae	b-PROBLEM
73924	.	O
73925	she	O
73926	was	O
73927	doing	O
73928	well	b-OCCURRENCE
73929	with	O
73930	at	O
73931	least	O
73932	4+	O
73933	strength	O
73934	in	O
73935	all	O
73936	of	O
73937	her	O
73938	extremities	O
73939	,	O
73940	when	O
73941	on	O
73942	11/13	b-DATE
73943	,	O
73944	she	O
73945	had	O
73946	an	b-PROBLEM
73947	acute	i-PROBLEM
73948	drop	i-PROBLEM
73949	in	O
73950	her	b-TEST
73951	systolic	i-TEST
73952	blood	i-TEST
73953	pressure	i-TEST
73954	to	O
73955	70	O
73956	for	O
73957	unclear	O
73958	reasons	O
73959	and	O
73960	without	O
73961	evidence	O
73962	of	O
73963	acute	b-PROBLEM
73964	sepsis	i-PROBLEM
73965	.	O
73966	this	b-PROBLEM
73967	was	O
73968	accompanied	O
73969	by	O
73970	substantial	b-PROBLEM
73971	decrement	i-PROBLEM
73972	in	i-PROBLEM
73973	neurologic	i-PROBLEM
73974	function	i-PROBLEM
73975	.	O
73976	for	O
73977	a	b-DURATION
73978	short	i-DURATION
73979	time	i-DURATION
73980	,	O
73981	she	O
73982	seemed	O
73983	&quot;	O
73984	locked	b-PROBLEM
73985	in	i-PROBLEM
73986	&quot;	O
73987	.	O
73988	she	O
73989	has	O
73990	made	b-OCCURRENCE
73991	slow	i-OCCURRENCE
73992	progress	i-OCCURRENCE
73993	since	O
73994	then	b-DATE
73995	and	O
73996	at	O
73997	the	b-DATE
73998	time	i-DATE
73999	of	O
74000	discharge	b-OCCURRENCE
74001	has	O
74002	4-strength	O
74003	at	O
74004	the	O
74005	left	O
74006	elbow	O
74007	and	O
74008	4+	O
74009	in	O
74010	the	O
74011	left	O
74012	wrist	O
74013	and	O
74014	hand	O
74015	.	O
74016	trace	O
74017	movement	O
74018	of	O
74019	the	O
74020	right	O
74021	elbow	O
74022	and	O
74023	4-strength	O
74024	of	O
74025	the	O
74026	right	O
74027	wrist	O
74028	and	O
74029	hand	O
74030	.	O
74031	4-to	O
74032	4+	O
74033	strength	O
74034	at	O
74035	the	O
74036	left	O
74037	ankle	O
74038	,	O
74039	4+	O
74040	strength	O
74041	at	O
74042	the	O
74043	right	O
74044	knee	O
74045	and	O
74046	right	O
74047	ankle	O
74048	.	O
74049	she	O
74050	is	O
74051	unable	b-PROBLEM
74052	to	O
74053	lift	b-OCCURRENCE
74054	either	O
74055	foot	O
74056	off	O
74057	the	O
74058	bed	O
74059	.	O
74060	the	b-TEST
74061	extra	i-TEST
74062	ocular	i-TEST
74063	movements	i-TEST
74064	are	O
74065	full	O
74066	.	O
74067	tongue	b-PROBLEM
74068	protrudes	i-PROBLEM
74069	4	O
74070	cm	O
74071	.	O
74072	she	O
74073	is	O
74074	drowsy	b-PROBLEM
74075	at	O
74076	times	O
74077	,	O
74078	but	O
74079	generally	O
74080	alert	b-OCCURRENCE
74081	,	O
74082	responsive	b-OCCURRENCE
74083	,	O
74084	interactive	b-OCCURRENCE
74085	,	O
74086	able	b-OCCURRENCE
74087	to	O
74088	talk	b-OCCURRENCE
74089	in	O
74090	two	O
74091	to	O
74092	three	O
74093	word	O
74094	sentences	O
74095	when	O
74096	she	O
74097	wants	O
74098	to	O
74099	.	O
74100	she	O
74101	has	O
74102	severe	O
74103	memory	b-OCCURRENCE
74104	deficits	i-OCCURRENCE
74105	,	O
74106	but	O
74107	nevertheless	O
74108	,	O
74109	is	O
74110	able	b-OCCURRENCE
74111	to	O
74112	engage	b-OCCURRENCE
74113	in	i-OCCURRENCE
74114	conversation	i-OCCURRENCE
74115	,	O
74116	answers	b-OCCURRENCE
74117	questions	i-OCCURRENCE
74118	,	O
74119	names	b-OCCURRENCE
74120	things	i-OCCURRENCE
74121	well	i-OCCURRENCE
74122	,	O
74123	does	b-OCCURRENCE
74124	calculations	i-OCCURRENCE
74125	and	O
74126	recognizes	b-OCCURRENCE
74127	family	i-OCCURRENCE
74128	members	i-OCCURRENCE
74129	and	O
74130	states	b-OCCURRENCE
74131	preferences	i-OCCURRENCE
74132	.	O
74133	she	O
74134	has	O
74135	been	O
74136	working	O
74137	with	O
74138	speech	b-CLINICAL_DEPT
74139	therapy	i-CLINICAL_DEPT
74140	,	O
74141	occupational	b-CLINICAL_DEPT
74142	therapy	i-CLINICAL_DEPT
74143	and	O
74144	physical	b-CLINICAL_DEPT
74145	therapy	i-CLINICAL_DEPT
74146	closely	O
74147	and	O
74148	should	O
74149	continue	O
74150	to	O
74151	show	b-OCCURRENCE
74152	improvement	i-OCCURRENCE
74153	.	O
74154	she	O
74155	is	O
74156	anticoagulated	b-TREATMENT
74157	on	O
74158	coumadin	b-TREATMENT
74159	and	O
74160	this	O
74161	has	O
74162	been	O
74163	stable	b-OCCURRENCE
74164	.	O
74165	she	O
74166	is	O
74167	do	O
74168	not	O
74169	resuscitate	b-TREATMENT
74170	in	O
74171	agreement	O
74172	with	O
74173	the	O
74174	wishes	O
74175	of	O
74176	her	O
74177	multiple	O
74178	family	O
74179	members	O
74180	.	O
74181	follow	O
74182	up	O
74183	computerized	b-TEST
74184	tomography	i-TEST
74185	scans	i-TEST
74186	and	O
74187	magnetic	b-TEST
74188	resonance	i-TEST
74189	imaging	i-TEST
74190	studies	i-TEST
74191	have	O
74192	shown	b-EVIDENTIAL
74193	infarction	b-PROBLEM
74194	in	O
74195	bilateral	O
74196	basis	O
74197	pontis	O
74198	,	O
74199	mid	O
74200	brain	O
74201	,	O
74202	the	O
74203	superior	O
74204	cerebellar	O
74205	areas	O
74206	,	O
74207	left	O
74208	thalamus	O
74209	,	O
74210	bilateral	O
74211	temporal	O
74212	lobes	O
74213	medially	O
74214	and	O
74215	inferiorly	O
74216	and	O
74217	left	O
74218	posterior	O
74219	communicating	O
74220	artery	O
74221	.	O
74222	the	O
74223	patient	O
74224	had	O
74225	fevers	b-PROBLEM
74226	sporadically	O
74227	during	O
74228	this	b-OCCURRENCE
74229	hospitalization	i-OCCURRENCE
74230	with	O
74231	rising	b-PROBLEM
74232	white	i-PROBLEM
74233	blood	i-PROBLEM
74234	counts	i-PROBLEM
74235	.	O
74236	a	b-TEST
74237	chest	i-TEST
74238	x-ray	i-TEST
74239	documented	b-EVIDENTIAL
74240	a	b-PROBLEM
74241	progressing	i-PROBLEM
74242	left	i-PROBLEM
74243	lower	i-PROBLEM
74244	lobe	i-PROBLEM
74245	infiltrate	i-PROBLEM
74246	.	O
74247	initially	O
74248	this	b-PROBLEM
74249	improved	O
74250	on	O
74251	clindamycin	b-TREATMENT
74252	and	O
74253	cefotetan	b-TREATMENT
74254	,	O
74255	but	O
74256	fevers	b-PROBLEM
74257	recurred	O
74258	on	O
74259	this	b-TREATMENT
74260	antibiotic	i-TREATMENT
74261	regimen	i-TREATMENT
74262	.	O
74263	sputum	b-TEST
74264	grew	O
74265	out	O
74266	klebsiella	b-PROBLEM
74267	pneumoniae	i-PROBLEM
74268	,	O
74269	and	O
74270	she	O
74271	was	O
74272	treated	O
74273	with	O
74274	gentamicin	b-TREATMENT
74275	and	O
74276	ancef	b-TREATMENT
74277	for	O
74278	14	b-DURATION
74279	days	i-DURATION
74280	intravenous	O
74281	(	O
74282	bug	b-PROBLEM
74283	being	O
74284	sensitive	O
74285	to	O
74286	these	b-TREATMENT
74287	two	i-TREATMENT
74288	drugs	i-TREATMENT
74289	)	O
74290	.	O
74291	a	b-PROBLEM
74292	left	i-PROBLEM
74293	pleural	i-PROBLEM
74294	effusion	i-PROBLEM
74295	developed	O
74296	and	O
74297	this	O
74298	was	O
74299	tapped	b-TREATMENT
74300	with	O
74301	ultrasound	b-TEST
74302	guidance	i-TEST
74303	,	O
74304	and	O
74305	found	O
74306	to	O
74307	be	O
74308	sterile	O
74309	,	O
74310	and	O
74311	without	O
74312	evidence	O
74313	of	O
74314	empyema	O
74315	.	O
74316	the	O
74317	patient	O
74318	is	O
74319	on	O
74320	ciprofloxacin	b-TREATMENT
74321	.	O
74322	the	b-DATE
74323	day	i-DATE
74324	of	O
74325	discharge	b-OCCURRENCE
74326	is	O
74327	day	b-DATE
74328	#3	i-DATE
74329	of	O
74330	7	b-DURATION
74331	,	O
74332	after	O
74333	which	O
74334	antibiotics	b-TREATMENT
74335	should	O
74336	be	O
74337	totally	O
74338	discontinued	O
74339	.	O
74340	she	O
74341	has	O
74342	developed	O
74343	bad	b-PROBLEM
74344	thrush	i-PROBLEM
74345	in	O
74346	this	O
74347	setting	O
74348	,	O
74349	she	O
74350	is	O
74351	not	O
74352	yet	O
74353	able	b-PROBLEM
74354	to	O
74355	swallow	b-OCCURRENCE
74356	and	O
74357	so	O
74358	she	O
74359	is	O
74360	on	O
74361	nystatin	b-TREATMENT
74362	swish	i-TREATMENT
74363	and	i-TREATMENT
74364	spit	i-TREATMENT
74365	five	b-FREQUENCY
74366	times	i-FREQUENCY
74367	a	i-FREQUENCY
74368	day	i-FREQUENCY
74369	.	O
74370	she	O
74371	also	O
74372	gets	O
74373	peridex	b-TREATMENT
74374	to	O
74375	clean	O
74376	out	O
74377	her	O
74378	mouth	O
74379	.	O
74380	once	O
74381	her	b-TEST
74382	liver	i-TEST
74383	enzymes	i-TEST
74384	are	O
74385	completely	O
74386	normal	b-OCCURRENCE
74387	,	O
74388	a	b-DURATION
74389	seven	i-DURATION
74390	day	i-DURATION
74391	course	O
74392	of	O
74393	fluconazol	b-TREATMENT
74394	may	O
74395	be	O
74396	helpful	O
74397	if	O
74398	the	b-PROBLEM
74399	thrush	i-PROBLEM
74400	is	O
74401	not	O
74402	spontaneously	O
74403	resolving	b-OCCURRENCE
74404	off	O
74405	of	O
74406	antibiotics	b-TREATMENT
74407	.	O
74408	she	O
74409	has	O
74410	been	O
74411	afebrile	b-PROBLEM
74412	for	O
74413	greater	O
74414	than	O
74415	10	b-DURATION
74416	days	i-DURATION
74417	,	O
74418	including	O
74419	several	b-DURATION
74420	days	i-DURATION
74421	on	O
74422	oral	b-TREATMENT
74423	antibiotics	i-TREATMENT
74424	.	O
74425	the	b-TEST
74426	patient	i-TEST
74427	&apos;s	i-TEST
74428	liver	i-TEST
74429	enzymes	i-TEST
74430	were	O
74431	noted	b-EVIDENTIAL
74432	to	O
74433	be	O
74434	elevated	b-PROBLEM
74435	mid	b-DATE
74436	way	i-DATE
74437	through	O
74438	her	b-OCCURRENCE
74439	hospital	i-OCCURRENCE
74440	course	i-OCCURRENCE
74441	,	O
74442	to	O
74443	about	O
74444	three	O
74445	times	O
74446	normal	O
74447	,	O
74448	especially	O
74449	the	b-TEST
74450	sgot	i-TEST
74451	and	O
74452	sgpt	b-TEST
74453	.	O
74454	these	O
74455	have	O
74456	spontaneously	O
74457	reversed	b-OCCURRENCE
74458	,	O
74459	and	O
74460	are	O
74461	nearly	O
74462	normal	b-OCCURRENCE
74463	at	O
74464	the	b-DATE
74465	time	i-DATE
74466	of	O
74467	discharge	b-OCCURRENCE
74468	.	O
74469	a	b-TEST
74470	right	i-TEST
74471	upper	i-TEST
74472	quadrant	i-TEST
74473	ultrasound	i-TEST
74474	documented	b-EVIDENTIAL
74475	gallstones	b-PROBLEM
74476	,	O
74477	without	O
74478	evidence	O
74479	of	O
74480	common	b-PROBLEM
74481	bile	i-PROBLEM
74482	duct	i-PROBLEM
74483	dilatation	i-PROBLEM
74484	or	O
74485	active	b-PROBLEM
74486	cholecystitis	i-PROBLEM
74487	.	O
74488	the	O
74489	exact	O
74490	cause	O
74491	of	O
74492	her	b-TEST
74493	liver	i-TEST
74494	enzyme	i-TEST
74495	elevation	b-PROBLEM
74496	is	O
74497	unclear	O
74498	,	O
74499	but	O
74500	we	O
74501	are	O
74502	being	O
74503	careful	O
74504	about	O
74505	administering	O
74506	drugs	b-TREATMENT
74507	,	O
74508	which	O
74509	might	O
74510	irritate	b-PROBLEM
74511	the	O
74512	liver	O
74513	.	O
74514	the	O
74515	patient	O
74516	had	O
74517	a	O
74518	steady	O
74519	decline	b-PROBLEM
74520	in	O
74521	her	b-TEST
74522	hematocrit	i-TEST
74523	during	O
74524	this	b-OCCURRENCE
74525	hospitalization	i-OCCURRENCE
74526	.	O
74527	iron	b-TEST
74528	studies	i-TEST
74529	are	O
74530	all	O
74531	entirely	O
74532	normal	O
74533	,	O
74534	her	b-PROBLEM
74535	anemia	i-PROBLEM
74536	is	O
74537	attributed	O
74538	to	O
74539	anemia	O
74540	or	O
74541	chronic	O
74542	disease	O
74543	with	O
74544	hypoproliferation	b-PROBLEM
74545	as	O
74546	well	O
74547	as	O
74548	multiple	b-TEST
74549	phlebotomies	i-TEST
74550	.	O
74551	the	O
74552	plan	O
74553	is	O
74554	to	O
74555	give	O
74556	her	b-TREATMENT
74557	folic	i-TREATMENT
74558	acid	i-TREATMENT
74559	,	O
74560	but	O
74561	not	O
74562	iron	b-TREATMENT
74563	.	O
74564	the	b-TEST
74565	patient	i-TEST
74566	&apos;s	i-TEST
74567	potassiums	i-TEST
74568	have	O
74569	been	O
74570	repeatedly	b-PROBLEM
74571	low	i-PROBLEM
74572	and	O
74573	require	O
74574	daily	b-FREQUENCY
74575	checks	b-TEST
74576	and	O
74577	repletion	b-TREATMENT
74578	.	O
74579	this	b-PROBLEM
74580	is	O
74581	thought	O
74582	due	O
74583	to	O
74584	the	O
74585	extensive	O
74586	course	O
74587	of	O
74588	gentamicin	b-TREATMENT
74589	which	O
74590	she	O
74591	received	O
74592	.	O
74593	this	b-PROBLEM
74594	must	O
74595	be	O
74596	carefully	O
74597	checked	O
74598	despite	O
74599	the	O
74600	standing	O
74601	order	O
74602	for	O
74603	potassium	b-TREATMENT
74604	.	O
74605	the	O
74606	patient	O
74607	has	O
74608	had	O
74609	low	b-PROBLEM
74610	sodiums	i-PROBLEM
74611	during	O
74612	this	b-OCCURRENCE
74613	hospitalization	i-OCCURRENCE
74614	.	O
74615	this	b-PROBLEM
74616	may	O
74617	due	O
74618	to	O
74619	her	b-PROBLEM
74620	central	i-PROBLEM
74621	nervous	i-PROBLEM
74622	system	i-PROBLEM
74623	process	i-PROBLEM
74624	or	O
74625	her	b-PROBLEM
74626	pulmonary	i-PROBLEM
74627	process	i-PROBLEM
74628	,	O
74629	with	O
74630	fluids	b-TREATMENT
74631	administered	i-TREATMENT
74632	as	O
74633	described	O
74634	,	O
74635	she	O
74636	should	O
74637	not	O
74638	have	O
74639	any	b-PROBLEM
74640	problems	i-PROBLEM
74641	from	O
74642	this	b-PROBLEM
74643	.	O
74644	her	b-TEST
74645	sodiums	i-TEST
74646	were	O
74647	never	O
74648	below	O
74649	130	O
74650	.	O
74651	she	O
74652	does	O
74653	well	b-OCCURRENCE
74654	with	O
74655	tube	b-TREATMENT
74656	feeds	i-TREATMENT
74657	.	O
74658	her	b-TREATMENT
74659	tube	i-TREATMENT
74660	feeds	i-TREATMENT
74661	orders	O
74662	are	O
74663	as	O
74664	follow	O
74665	:	O
74666	full	O
74667	strength	O
74668	replete	b-TREATMENT
74669	with	O
74670	fiber	b-TREATMENT
74671	at	O
74672	70	O
74673	cc.	O
74674	per	b-FREQUENCY
74675	hour	i-FREQUENCY
74676	.	O
74677	in	O
74678	addition	O
74679	,	O
74680	the	O
74681	patient	O
74682	gets	O
74683	250	O
74684	cc.	O
74685	of	O
74686	juice	b-TREATMENT
74687	(	O
74688	not	O
74689	water	O
74690	)	O
74691	three	b-FREQUENCY
74692	times	i-FREQUENCY
74693	a	i-FREQUENCY
74694	day	i-FREQUENCY
74695	.	O
74696	she	O
74697	also	O
74698	gets	O
74699	lactinex	b-TREATMENT
74700	granules	i-TREATMENT
74701	three	O
74702	packages	O
74703	in	O
74704	each	O
74705	bottle	O
74706	of	O
74707	tube	b-TREATMENT
74708	feeds	i-TREATMENT
74709	.	O
74710	she	O
74711	also	O
74712	gets	O
74713	metamucil	b-TREATMENT
74714	one	O
74715	teaspoon	O
74716	with	O
74717	the	O
74718	first	O
74719	bolus	O
74720	of	O
74721	juice	b-TREATMENT
74722	each	b-FREQUENCY
74723	day	i-FREQUENCY
74724	.	O
74725	please	O
74726	note	O
74727	that	O
74728	evaluation	b-TEST
74729	by	O
74730	the	O
74731	swallowing	O
74732	therapist	O
74733	,	O
74734	showed	b-EVIDENTIAL
74735	that	O
74736	the	O
74737	patient	O
74738	is	O
74739	aspirating	b-PROBLEM
74740	at	O
74741	this	b-DATE
74742	time	i-DATE
74743	,	O
74744	but	O
74745	there	O
74746	is	O
74747	great	O
74748	hope	O
74749	from	O
74750	the	O
74751	nature	O
74752	of	O
74753	her	b-PROBLEM
74754	deficit	i-PROBLEM
74755	and	O
74756	the	O
74757	good	O
74758	movements	O
74759	of	O
74760	her	O
74761	tongue	O
74762	that	O
74763	normal	b-OCCURRENCE
74764	swallowing	i-OCCURRENCE
74765	should	O
74766	return	b-OCCURRENCE
74767	soon	O
74768	.	O
74769	it	O
74770	is	O
74771	for	O
74772	this	O
74773	reason	O
74774	that	O
74775	she	O
74776	is	O
74777	discharged	b-OCCURRENCE
74778	with	O
74779	an	b-TREATMENT
74780	nasogastric	i-TREATMENT
74781	tube	i-TREATMENT
74782	and	O
74783	that	O
74784	no	O
74785	plans	O
74786	for	O
74787	g	b-TREATMENT
74788	tube	i-TREATMENT
74789	placement	i-TREATMENT
74790	are	O
74791	made	O
74792	at	O
74793	this	b-DATE
74794	time	i-DATE
74795	.	O
74796	she	O
74797	has	O
74798	a	O
74799	history	O
74800	of	O
74801	of	O
74802	angina	b-PROBLEM
74803	without	O
74804	myocardial	b-PROBLEM
74805	infarction	i-PROBLEM
74806	that	O
74807	has	O
74808	not	O
74809	been	O
74810	worked	b-TEST
74811	up	i-TEST
74812	.	O
74813	she	O
74814	did	O
74815	have	O
74816	brief	b-PROBLEM
74817	chest	i-PROBLEM
74818	pain	i-PROBLEM
74819	twice	b-FREQUENCY
74820	during	O
74821	this	b-OCCURRENCE
74822	admission	i-OCCURRENCE
74823	that	O
74824	did	O
74825	not	O
74826	correlate	O
74827	with	O
74828	electrocardiogram	b-PROBLEM
74829	changes	i-PROBLEM
74830	.	O
74831	in	O
74832	the	b-DATE
74833	first	i-DATE
74834	week	i-DATE
74835	of	i-DATE
74836	november	i-DATE
74837	,	O
74838	her	b-TEST
74839	electrocardiogram	i-TEST
74840	showed	b-EVIDENTIAL
74841	t	b-PROBLEM
74842	wave	i-PROBLEM
74843	inversions	i-PROBLEM
74844	in	i-PROBLEM
74845	the	i-PROBLEM
74846	lateral	i-PROBLEM
74847	leads	i-PROBLEM
74848	,	O
74849	correlating	O
74850	with	O
74851	an	b-PROBLEM
74852	increase	i-PROBLEM
74853	in	O
74854	the	b-TEST
74855	ldh	i-TEST
74856	,	O
74857	but	O
74858	not	O
74859	ck	b-TEST
74860	.	O
74861	this	b-PROBLEM
74862	did	O
74863	not	O
74864	normalize	b-OCCURRENCE
74865	with	O
74866	administration	O
74867	of	O
74868	isordil	b-TREATMENT
74869	and	O
74870	the	O
74871	patient	O
74872	denied	b-EVIDENTIAL
74873	chest	b-PROBLEM
74874	pain	i-PROBLEM
74875	at	O
74876	this	b-DATE
74877	time	i-DATE
74878	.	O
74879	as	O
74880	of	O
74881	4/7	b-DATE
74882	,	O
74883	her	b-TEST
74884	electrocardiogram	i-TEST
74885	had	O
74886	reverted	b-OCCURRENCE
74887	back	i-OCCURRENCE
74888	to	i-OCCURRENCE
74889	normal	i-OCCURRENCE
74890	and	O
74891	there	O
74892	is	O
74893	no	O
74894	evidence	O
74895	of	O
74896	congestive	b-PROBLEM
74897	heart	i-PROBLEM
74898	failure	i-PROBLEM
74899	or	O
74900	continued	b-PROBLEM
74901	electrocardiogram	i-PROBLEM
74902	changes	i-PROBLEM
74903	,	O
74904	and	O
74905	chest	b-PROBLEM
74906	pain	i-PROBLEM
74907	is	O
74908	absent	O
74909	.	O
74910	her	b-TEST
74911	cholesterol	i-TEST
74912	was	O
74913	350	O
74914	here	O
74915	.	O
74916	she	O
74917	has	O
74918	been	O
74919	off	O
74920	of	O
74921	her	b-TREATMENT
74922	hypercholesterol	i-TREATMENT
74923	medicines	i-TREATMENT
74924	.	O
74925	these	b-TREATMENT
74926	can	O
74927	be	O
74928	restarted	O
74929	when	O
74930	it	O
74931	is	O
74932	deemed	O
74933	reasonable	O
74934	,	O
74935	in	O
74936	view	O
74937	of	O
74938	her	b-PROBLEM
74939	acute	i-PROBLEM
74940	disease	i-PROBLEM
74941	and	O
74942	recently	O
74943	elevated	b-PROBLEM
74944	liver	i-PROBLEM
74945	enzymes	i-PROBLEM
74946	.	O
74947	note	O
74948	that	O
74949	the	b-TEST
74950	liver	i-TEST
74951	enzymes	i-TEST
74952	were	O
74953	normal	b-OCCURRENCE
74954	on	O
74955	admission	b-OCCURRENCE
74956	,	O
74957	at	O
74958	which	b-DATE
74959	time	i-DATE
74960	she	O
74961	was	O
74962	taking	O
74963	all	O
74964	of	O
74965	the	b-TREATMENT
74966	above	i-TREATMENT
74967	cholesterol	i-TREATMENT
74968	medicines	i-TREATMENT
74969	.	O
74970		O
74971	admission	b-OCCURRENCE
74972	date	O
74973	:	O
74974	2014-08-07	b-ADMISSION
74975	discharge	b-OCCURRENCE
74976	date	O
74977	:	O
74978	2014-08-09	b-DISCHARGE
74979	service	O
74980	:	O
74981	neurosurg	O
74982	history	O
74983	of	O
74984	present	O
74985	illness	O
74986	:	O
74987	this	O
74988	is	O
74989	a	O
74990	56	O
74991	-	O
74992	year-old	O
74993	man	O
74994	without	O
74995	any	O
74996	significant	b-PROBLEM
74997	past	i-PROBLEM
74998	medical	i-PROBLEM
74999	history	i-PROBLEM
75000	who	O
75001	presented	b-OCCURRENCE
75002	to	O
75003	the	b-CLINICAL_DEPT
75004	emergency	i-CLINICAL_DEPT
75005	room	i-CLINICAL_DEPT
75006	after	O
75007	the	O
75008	sudden	O
75009	onset	O
75010	of	O
75011	headache	b-PROBLEM
75012	while	O
75013	he	O
75014	was	O
75015	riding	b-OCCURRENCE
75016	a	i-OCCURRENCE
75017	bicycle	i-OCCURRENCE
75018	.	O
75019	he	O
75020	characterized	b-EVIDENTIAL
75021	this	b-PROBLEM
75022	headache	i-PROBLEM
75023	as	O
75024	the	b-PROBLEM
75025	worst	i-PROBLEM
75026	headache	i-PROBLEM
75027	of	O
75028	his	O
75029	life	O
75030	and	O
75031	had	O
75032	associated	O
75033	nausea	b-PROBLEM
75034	and	O
75035	vomiting	b-PROBLEM
75036	times	b-FREQUENCY
75037	one	i-FREQUENCY
75038	.	O
75039	he	O
75040	also	O
75041	complained	b-EVIDENTIAL
75042	of	O
75043	dizziness	b-PROBLEM
75044	at	O
75045	the	O
75046	time	O
75047	of	O
75048	headache	b-PROBLEM
75049	onset	O
75050	.	O
75051	he	O
75052	presented	b-OCCURRENCE
75053	to	O
75054	the	b-CLINICAL_DEPT
75055	edith	i-CLINICAL_DEPT
75056	nourse	i-CLINICAL_DEPT
75057	rogers	i-CLINICAL_DEPT
75058	memorial	i-CLINICAL_DEPT
75059	va	i-CLINICAL_DEPT
75060	hospital	i-CLINICAL_DEPT
75061	emergency	i-CLINICAL_DEPT
75062	room	i-CLINICAL_DEPT
75063	,	O
75064	where	O
75065	an	b-TEST
75066	initial	i-TEST
75067	head	i-TEST
75068	ct	i-TEST
75069	scan	i-TEST
75070	was	O
75071	read	O
75072	as	O
75073	negative	b-OCCURRENCE
75074	.	O
75075	however	O
75076	,	O
75077	a	b-TEST
75078	lumbar	i-TEST
75079	puncture	i-TEST
75080	was	O
75081	done	O
75082	,	O
75083	in	O
75084	which	O
75085	tube	O
75086	1	O
75087	showed	O
75088	4800	b-TEST
75089	red	i-TEST
75090	blood	i-TEST
75091	cells	i-TEST
75092	and	O
75093	tube	O
75094	4	O
75095	showed	O
75096	4000	b-TEST
75097	red	i-TEST
75098	blood	i-TEST
75099	cells	i-TEST
75100	.	O
75101	the	O
75102	patient	O
75103	was	O
75104	sent	O
75105	for	O
75106	an	b-TEST
75107	mri	i-TEST
75108	of	i-TEST
75109	the	i-TEST
75110	head	i-TEST
75111	,	O
75112	which	O
75113	raised	O
75114	the	O
75115	question	O
75116	of	O
75117	a	b-PROBLEM
75118	right	i-PROBLEM
75119	posterior	i-PROBLEM
75120	cerebral	i-PROBLEM
75121	artery	i-PROBLEM
75122	aneurysm	i-PROBLEM
75123	.	O
75124	the	b-TEST
75125	ct	i-TEST
75126	scan	i-TEST
75127	was	O
75128	revealed	O
75129	and	O
75130	,	O
75131	on	O
75132	second	O
75133	analysis	O
75134	,	O
75135	it	O
75136	was	O
75137	thought	O
75138	that	O
75139	it	O
75140	was	O
75141	suspicious	O
75142	for	O
75143	a	b-PROBLEM
75144	subarachnoid	i-PROBLEM
75145	hemorrhage	i-PROBLEM
75146	in	i-PROBLEM
75147	the	i-PROBLEM
75148	suprasellar	i-PROBLEM
75149	cistern	i-PROBLEM
75150	.	O
75151	the	O
75152	patient	O
75153	was	O
75154	then	O
75155	admitted	b-OCCURRENCE
75156	for	O
75157	further	b-TEST
75158	evaluation	i-TEST
75159	.	O
75160	hospital	O
75161	course	O
75162	:	O
75163	the	O
75164	patient	O
75165	was	O
75166	admitted	b-OCCURRENCE
75167	to	O
75168	the	b-CLINICAL_DEPT
75169	surgical	i-CLINICAL_DEPT
75170	intensive	i-CLINICAL_DEPT
75171	care	i-CLINICAL_DEPT
75172	unit	i-CLINICAL_DEPT
75173	,	O
75174	where	O
75175	a	b-TEST
75176	continued	i-TEST
75177	cerebral	i-TEST
75178	angiogram	i-TEST
75179	was	O
75180	done	O
75181	that	O
75182	was	O
75183	essentially	b-OCCURRENCE
75184	normal	i-OCCURRENCE
75185	,	O
75186	without	O
75187	evidence	O
75188	of	O
75189	any	b-PROBLEM
75190	obvious	i-PROBLEM
75191	aneurysm	i-PROBLEM
75192	.	O
75193	the	O
75194	patient	O
75195	was	O
75196	observed	b-TEST
75197	for	O
75198	two	b-DURATION
75199	days	i-DURATION
75200	with	O
75201	a	b-TEST
75202	repeat	i-TEST
75203	ct	i-TEST
75204	scan	i-TEST
75205	showing	b-EVIDENTIAL
75206	no	O
75207	changes	b-PROBLEM
75208	from	O
75209	the	b-TEST
75210	previous	i-TEST
75211	examination	i-TEST
75212	.	O
75213	the	b-PROBLEM
75214	headache	i-PROBLEM
75215	stabilized	b-OCCURRENCE
75216	after	O
75217	the	O
75218	patient	O
75219	was	O
75220	transferred	b-OCCURRENCE
75221	to	O
75222	the	b-CLINICAL_DEPT
75223	floor	i-CLINICAL_DEPT
75224	.	O
75225	the	O
75226	patient	O
75227	continued	O
75228	to	O
75229	do	b-EVIDENTIAL
75230	well	i-EVIDENTIAL
75231	and	O
75232	the	O
75233	decision	O
75234	was	O
75235	made	O
75236	to	O
75237	discharge	b-OCCURRENCE
75238	him	O
75239	.	O
75240		O
75241	admission	b-OCCURRENCE
75242	date	O
75243	:	O
75244	2014-04-17	b-ADMISSION
75245	discharge	b-OCCURRENCE
75246	date	O
75247	:	O
75248	2014-04-25	b-DISCHARGE
75249	service	O
75250	:	O
75251	cardiothoracic	O
75252	history	O
75253	of	O
75254	present	O
75255	illness	O
75256	:	O
75257	this	O
75258	is	O
75259	a	O
75260	60	O
75261	year	O
75262	old	O
75263	male	O
75264	with	O
75265	new	b-PROBLEM
75266	onset	i-PROBLEM
75267	chest	i-PROBLEM
75268	pain	i-PROBLEM
75269	.	O
75270	nuclear	b-TEST
75271	myocardial	i-TEST
75272	perfusion	i-TEST
75273	study	i-TEST
75274	was	O
75275	notable	O
75276	for	O
75277	a	b-PROBLEM
75278	moderate	i-PROBLEM
75279	fixed	i-PROBLEM
75280	defect	i-PROBLEM
75281	within	O
75282	the	O
75283	inferior	O
75284	wall	O
75285	and	O
75286	cardiac	O
75287	apex	O
75288	.	O
75289	his	b-TEST
75290	ejection	i-TEST
75291	fraction	i-TEST
75292	however	O
75293	appeared	O
75294	preserved	O
75295	at	O
75296	73%	O
75297	with	O
75298	mild	b-PROBLEM
75299	inferior	i-PROBLEM
75300	wall	i-PROBLEM
75301	hypokinesis	i-PROBLEM
75302	.	O
75303	subsequent	b-TEST
75304	cardiac	i-TEST
75305	catheterization	i-TEST
75306	at	O
75307	nantucket	b-CLINICAL_DEPT
75308	cottage	i-CLINICAL_DEPT
75309	hospital	i-CLINICAL_DEPT
75310	hospital	i-CLINICAL_DEPT
75311	on	O
75312	2014-04-16	b-DATE
75313	was	O
75314	significant	O
75315	for	O
75316	severe	b-PROBLEM
75317	two	i-PROBLEM
75318	vessel	i-PROBLEM
75319	coronary	i-PROBLEM
75320	artery	i-PROBLEM
75321	disease	i-PROBLEM
75322	.	O
75323	angiography	b-TEST
75324	revealed	b-EVIDENTIAL
75325	a	b-PROBLEM
75326	right	i-PROBLEM
75327	dominant	i-PROBLEM
75328	system	i-PROBLEM
75329	with	O
75330	a	b-PROBLEM
75331	40%	i-PROBLEM
75332	lesion	i-PROBLEM
75333	in	O
75334	the	O
75335	distal	O
75336	left	O
75337	main,	O
75338	several	b-PROBLEM
75339	tight	i-PROBLEM
75340	lesions	i-PROBLEM
75341	in	O
75342	the	O
75343	proximal	O
75344	and	O
75345	mid	O
75346	left	O
75347	anterior	O
75348	descending	O
75349	artery	O
75350	,	O
75351	and	O
75352	a	b-PROBLEM
75353	90%	i-PROBLEM
75354	stenosis	i-PROBLEM
75355	in	O
75356	the	O
75357	proximal	O
75358	circumflex	O
75359	.	O
75360	the	O
75361	right	O
75362	coronary	O
75363	artery	O
75364	had	O
75365	mild	b-PROBLEM
75366	diffuse	i-PROBLEM
75367	plaquing	i-PROBLEM
75368	but	O
75369	no	O
75370	evidence	O
75371	of	O
75372	focal	b-PROBLEM
75373	stenosis	i-PROBLEM
75374	.	O
75375	based	O
75376	upon	O
75377	the	O
75378	above	O
75379	results	O
75380	,	O
75381	he	O
75382	was	O
75383	transferred	b-OCCURRENCE
75384	to	O
75385	the	b-CLINICAL_DEPT
75386	mediplex	i-CLINICAL_DEPT
75387	rehab	i-CLINICAL_DEPT
75388	hospital	i-CLINICAL_DEPT
75389	for	O
75390	surgical	b-TREATMENT
75391	revascularization	i-TREATMENT
75392	.	O
75393	brief	O
75394	hospital	O
75395	course	O
75396	:	O
75397	mr.	O
75398	chester	O
75399	was	O
75400	admitted	b-OCCURRENCE
75401	to	O
75402	the	b-CLINICAL_DEPT
75403	cardiac	i-CLINICAL_DEPT
75404	surgical	i-CLINICAL_DEPT
75405	service	i-CLINICAL_DEPT
75406	and	O
75407	underwent	O
75408	routine	b-TEST
75409	preoperative	i-TEST
75410	evaluation	i-TEST
75411	.	O
75412	he	O
75413	remained	O
75414	pain	b-PROBLEM
75415	free	O
75416	on	O
75417	medical	b-TREATMENT
75418	therapy	i-TREATMENT
75419	.	O
75420	workup	b-TEST
75421	was	O
75422	unremarkable	O
75423	and	O
75424	he	O
75425	was	O
75426	cleared	O
75427	for	O
75428	surgery	b-TREATMENT
75429	.	O
75430	on	O
75431	04-18	b-DATE
75432	,	O
75433	doctor	O
75434	oneill	O
75435	performed	O
75436	off	b-TREATMENT
75437	pump	i-TREATMENT
75438	coronary	i-TREATMENT
75439	artery	i-TREATMENT
75440	bypass	i-TREATMENT
75441	grafting	i-TREATMENT
75442	.	O
75443	for	O
75444	surgical	O
75445	details	O
75446	,	O
75447	please	O
75448	see	O
75449	seperate	O
75450	dictated	O
75451	operative	O
75452	note	O
75453	.	O
75454	following	O
75455	the	b-TREATMENT
75456	operation	i-TREATMENT
75457	,	O
75458	he	O
75459	was	O
75460	brought	b-OCCURRENCE
75461	to	O
75462	the	b-CLINICAL_DEPT
75463	csru	i-CLINICAL_DEPT
75464	for	O
75465	invasive	b-TEST
75466	monitoring	i-TEST
75467	.	O
75468	within	O
75469	24	b-DURATION
75470	hours	i-DURATION
75471	,	O
75472	he	O
75473	awoke	b-OCCURRENCE
75474	neurologically	O
75475	intact	O
75476	and	O
75477	was	O
75478	extubated	b-TREATMENT
75479	without	O
75480	incident	b-PROBLEM
75481	.	O
75482	given	O
75483	hypotension	b-PROBLEM
75484	and	O
75485	bradycardia	b-PROBLEM
75486	,	O
75487	he	O
75488	was	O
75489	slow	b-PROBLEM
75490	to	i-PROBLEM
75491	wean	i-PROBLEM
75492	from	O
75493	neosynephrine	b-TREATMENT
75494	.	O
75495	low	b-TREATMENT
75496	dose	i-TREATMENT
75497	beta	i-TREATMENT
75498	blockade	i-TREATMENT
75499	was	O
75500	eventually	O
75501	resumed	O
75502	.	O
75503	chest	b-TREATMENT
75504	tubes	i-TREATMENT
75505	and	O
75506	pacing	b-TREATMENT
75507	wires	i-TREATMENT
75508	were	O
75509	removed	O
75510	without	O
75511	complication	b-PROBLEM
75512	.	O
75513	on	O
75514	postoperative	b-DATE
75515	day	i-DATE
75516	three	i-DATE
75517	,	O
75518	he	O
75519	transferred	b-OCCURRENCE
75520	to	O
75521	the	b-CLINICAL_DEPT
75522	sdu	i-CLINICAL_DEPT
75523	.	O
75524	he	O
75525	maintained	O
75526	a	b-OCCURRENCE
75527	normal	i-OCCURRENCE
75528	sinus	i-OCCURRENCE
75529	rhythm	i-OCCURRENCE
75530	without	O
75531	atrial	b-PROBLEM
75532	or	i-PROBLEM
75533	ventricular	i-PROBLEM
75534	arrhythmias	i-PROBLEM
75535	.	O
75536	he	O
75537	remained	O
75538	in	O
75539	sinus	b-PROBLEM
75540	bradycardia	i-PROBLEM
75541	(	O
75542	rate	O
75543	50-60	O
75544	)	O
75545	and	O
75546	tolerated	b-OCCURRENCE
75547	low	b-TREATMENT
75548	dose	i-TREATMENT
75549	beta	i-TREATMENT
75550	blockade	i-TREATMENT
75551	.	O
75552	on	O
75553	pod	b-DATE
75554	#6	i-DATE
75555	his	b-TEST
75556	creatinine	i-TEST
75557	became	O
75558	slightly	b-PROBLEM
75559	elevated	i-PROBLEM
75560	at	O
75561	1.4	O
75562	,	O
75563	his	b-TREATMENT
75564	lasix	i-TREATMENT
75565	was	O
75566	discontinued	O
75567	and	O
75568	the	b-DATE
75569	following	i-DATE
75570	day	i-DATE
75571	his	b-TEST
75572	creatinine	i-TEST
75573	was	O
75574	stable	b-OCCURRENCE
75575	at	O
75576	1.4	O
75577	.	O
75578	he	O
75579	continued	O
75580	to	O
75581	progress	b-OCCURRENCE
75582	and	O
75583	was	O
75584	eventually	O
75585	cleared	O
75586	for	O
75587	discharge	b-OCCURRENCE
75588	to	O
75589	home	O
75590	on	O
75591	postoperative	b-DATE
75592	day	i-DATE
75593	7	i-DATE
75594	.	O
75595	his	b-TEST
75596	discharge	i-TEST
75597	chest	i-TEST
75598	x-ray	i-TEST
75599	showed	b-EVIDENTIAL
75600	persistent	b-PROBLEM
75601	bibasilar	i-PROBLEM
75602	atelectasis	i-PROBLEM
75603	with	O
75604	only	O
75605	tiny	b-PROBLEM
75606	pleural	i-PROBLEM
75607	effusions	i-PROBLEM
75608	.	O
75609	of	O
75610	note	O
75611	,	O
75612	he	O
75613	will	O
75614	need	O
75615	to	O
75616	remain	O
75617	on	O
75618	plavix	b-TREATMENT
75619	for	O
75620	three	b-DURATION
75621	months	i-DURATION
75622	postop	O
75623	given	O
75624	the	b-TREATMENT
75625	off	i-TREATMENT
75626	pump	i-TREATMENT
75627	procedure	i-TREATMENT
75628	.	O
75629	in	O
75630	addition	O
75631	,	O
75632	he	O
75633	will	O
75634	need	O
75635	to	O
75636	remain	O
75637	on	O
75638	imdur	b-TREATMENT
75639	given	O
75640	use	O
75641	of	O
75642	his	O
75643	right	O
75644	internal	O
75645	mammary	O
75646	artery	O
75647	as	O
75648	a	O
75649	""""	O
75650	free	O
75651	""""	O
75652	arterial	O
75653	graft	O
75654	in	O
75655	preventing	O
75656		O
75657	vasospasm	b-PROBLEM
75658	.	O
75659		O
75660	admission	b-OCCURRENCE
75661	date	O
75662	:	O
75663	06/25/1990	b-ADMISSION
75664	discharge	b-OCCURRENCE
75665	date	O
75666	:	O
75667	07/05/1990	b-DISCHARGE
75668	history	O
75669	of	O
75670	present	O
75671	illness	O
75672	:	O
75673	the	O
75674	patient	O
75675	is	O
75676	a	O
75677	78-year-old	O
75678	female	O
75679	who	O
75680	has	O
75681	had	O
75682	osteoarthritis	b-PROBLEM
75683	and	O
75684	noted	b-EVIDENTIAL
75685	the	O
75686	sudden	O
75687	onset	O
75688	of	O
75689	left	b-PROBLEM
75690	knee	i-PROBLEM
75691	pain	i-PROBLEM
75692	in	O
75693	09/89	b-DATE
75694	.	O
75695	since	O
75696	that	b-DATE
75697	time	i-DATE
75698	,	O
75699	she	O
75700	has	O
75701	used	O
75702	a	b-TREATMENT
75703	cane	i-TREATMENT
75704	and	O
75705	she	O
75706	was	O
75707	referred	O
75708	to	O
75709	doctor	O
75710	koors	O
75711	.	O
75712	mri	b-TEST
75713	demonstrated	b-EVIDENTIAL
75714	a	b-PROBLEM
75715	left	i-PROBLEM
75716	femoral	i-PROBLEM
75717	condyle	i-PROBLEM
75718	osteonecrotic	i-PROBLEM
75719	defect	i-PROBLEM
75720	and	O
75721	degenerative	b-PROBLEM
75722	meniscus	i-PROBLEM
75723	.	O
75724	she	O
75725	climbs	b-PROBLEM
75726	stairs	i-PROBLEM
75727	one	i-PROBLEM
75728	at	i-PROBLEM
75729	a	i-PROBLEM
75730	time	i-PROBLEM
75731	and	O
75732	denied	b-EVIDENTIAL
75733	rest	b-PROBLEM
75734	pain	i-PROBLEM
75735	.	O
75736	she	O
75737	can	O
75738	one	O
75739	walk	b-OCCURRENCE
75740	without	O
75741	difficulties	b-PROBLEM
75742	.	O
75743	she	O
75744	presented	b-EVIDENTIAL
75745	for	O
75746	an	b-TREATMENT
75747	elective	i-TREATMENT
75748	left	i-TREATMENT
75749	total	i-TREATMENT
75750	knee	i-TREATMENT
75751	arthroplasty	i-TREATMENT
75752	.	O
75753	hospital	O
75754	course	O
75755	:	O
75756	the	O
75757	patient	O
75758	was	O
75759	cleared	b-OCCURRENCE
75760	for	O
75761	surgery	b-TREATMENT
75762	by	O
75763	doctor	O
75764	lupevickette	O
75765	ca	O
75766	.	O
75767	her	b-TEST
75768	ekg	i-TEST
75769	was	O
75770	normal	b-OCCURRENCE
75771	.	O
75772	she	O
75773	was	O
75774	therefore	O
75775	taken	O
75776	to	O
75777	the	b-CLINICAL_DEPT
75778	operating	i-CLINICAL_DEPT
75779	room	i-CLINICAL_DEPT
75780	on	O
75781	6/26	b-DATE
75782	and	O
75783	underwent	O
75784	a	b-TREATMENT
75785	left	i-TREATMENT
75786	total	i-TREATMENT
75787	knee	i-TREATMENT
75788	arthroplasty	i-TREATMENT
75789	losing	b-PROBLEM
75790	200	O
75791	cc	O
75792	of	O
75793	blood	b-OCCURRENCE
75794	in	O
75795	the	b-TREATMENT
75796	procedure	i-TREATMENT
75797	with	O
75798	two	b-TREATMENT
75799	drains	i-TREATMENT
75800	left	O
75801	in	O
75802	which	O
75803	were	O
75804	removed	b-OCCURRENCE
75805	on	O
75806	the	b-DATE
75807	first	i-DATE
75808	postoperative	i-DATE
75809	day	i-DATE
75810	.	O
75811	she	O
75812	was	O
75813	slightly	O
75814	agitated	b-PROBLEM
75815	on	O
75816	the	b-DATE
75817	first	i-DATE
75818	postoperative	i-DATE
75819	day	i-DATE
75820	but	O
75821	this	O
75822	resolved	O
75823	by	O
75824	the	b-DATE
75825	second	i-DATE
75826	postoperative	i-DATE
75827	day	i-DATE
75828	.	O
75829	her	b-TREATMENT
75830	epidural	i-TREATMENT
75831	catheter	i-TREATMENT
75832	was	O
75833	removed	O
75834	on	O
75835	6/29	b-DATE
75836	.	O
75837	the	b-TREATMENT
75838	foley	i-TREATMENT
75839	catheter	i-TREATMENT
75840	was	O
75841	removed	O
75842	on	O
75843	6/29	b-DATE
75844	and	O
75845	she	O
75846	had	O
75847	no	O
75848	difficulties	b-PROBLEM
75849	voiding	i-PROBLEM
75850	.	O
75851	psychiatry	b-CLINICAL_DEPT
75852	service	i-CLINICAL_DEPT
75853	saw	O
75854	her	O
75855	on	O
75856	6/28	b-DATE
75857	and	O
75858	recommended	b-OCCURRENCE
75859	avoiding	O
75860	benzodiazepines	b-TREATMENT
75861	and	O
75862	haldol	b-TREATMENT
75863	for	O
75864	agitation	b-PROBLEM
75865	.	O
75866	she	O
75867	was	O
75868	prophylaxed	O
75869	with	O
75870	kefzol	b-TREATMENT
75871	perioperatively	O
75872	and	O
75873	with	O
75874	coumadin	b-TREATMENT
75875	postoperatively	O
75876	.	O
75877	she	O
75878	was	O
75879	also	O
75880	given	O
75881	whiskey	b-TREATMENT
75882	spirits	i-TREATMENT
75883	because	O
75884	of	O
75885	the	O
75886	fact	O
75887	that	O
75888	she	O
75889	drank	O
75890	one	O
75891	to	O
75892	two	O
75893	drinks	O
75894	of	O
75895	scotch	b-OCCURRENCE
75896	per	O
75897	day	O
75898	.	O
75899	her	b-TEST
75900	hematocrit	i-TEST
75901	was	O
75902	31.4	O
75903	on	O
75904	6/29	b-DATE
75905	with	O
75906	a	b-TEST
75907	pt	i-TEST
75908	of	O
75909	18.2	O
75910	her	b-TEST
75911	pt	i-TEST
75912	drifted	b-OCCURRENCE
75913	down	i-OCCURRENCE
75914	to	O
75915	a	O
75916	level	O
75917	of	O
75918	12.9	O
75919	by	O
75920	7/3	b-DATE
75921	and	O
75922	therefore	O
75923	she	O
75924	will	O
75925	be	O
75926	discharged	b-OCCURRENCE
75927	with	O
75928	4	O
75929	mg	O
75930	of	O
75931	coumadin	b-TREATMENT
75932	per	b-FREQUENCY
75933	day	i-FREQUENCY
75934	to	O
75935	be	O
75936	followed	b-OCCURRENCE
75937	by	O
75938	the	b-CLINICAL_DEPT
75939	coumadin	i-CLINICAL_DEPT
75940	clinic	i-CLINICAL_DEPT
75941	at	O
75942	cowerin	b-CLINICAL_DEPT
75943	tonli	i-CLINICAL_DEPT
75944	medical	i-CLINICAL_DEPT
75945	center	i-CLINICAL_DEPT
75946	.	O
75947	she	O
75948	was	O
75949	discharged	b-OCCURRENCE
75950	with	O
75951	a	O
75952	prescription	O
75953	for	O
75954	tylenol	b-TREATMENT
75955	#3	i-TREATMENT
75956	with	O
75957	physical	b-TREATMENT
75958	therapy	i-TREATMENT
75959	.	O
75960	she	O
75961	did	O
75962	quite	b-OCCURRENCE
75963	well	i-OCCURRENCE
75964	with	O
75965	physical	b-TREATMENT
75966	therapy	i-TREATMENT
75967	and	O
75968	was	O
75969	ambulating	b-OCCURRENCE
75970	with	O
75971	a	b-TREATMENT
75972	walker	i-TREATMENT
75973	and	O
75974	crutches	b-TREATMENT
75975	by	O
75976	7/3/90	b-DATE
75977	.	O
75978	she	O
75979	was	O
75980	able	O
75981	to	O
75982	flex	b-OCCURRENCE
75983	her	i-OCCURRENCE
75984	knees	i-OCCURRENCE
75985	to	O
75986	90	O
75987	degrees	O
75988	by	O
75989	that	b-DATE
75990	time	i-DATE
75991	.	O
75992	she	O
75993	developed	O
75994	no	O
75995	problems	b-PROBLEM
75996	with	O
75997	edema	b-PROBLEM
75998	or	O
75999	with	O
76000	her	b-PROBLEM
76001	wound	i-PROBLEM
76002	during	O
76003	her	b-OCCURRENCE
76004	hospital	i-OCCURRENCE
76005	stay	i-OCCURRENCE
76006	.	O
76007	she	O
76008	will	O
76009	follow-up	b-OCCURRENCE
76010	with	O
76011	doctor	O
76012	koors	O
76013	in	O
76014	approximately	O
76015	five	b-DATE
76016	weeks	i-DATE
76017	.	O
76018	________________________________	O
76019	ia605/6041	O
76020	de	O
76021	koors	O
76022	,	O
76023	md	O
76024	cu2	O
76025	d	O
76026	:	O
76027	07/03/90	O
76028	batch	O
76029	:	O
76030	1726	O
76031	report	O
76032	:	O
76033	j0929x49	O
76034	t	O
76035	:	O
76036	07/04/90	O
76037	dicatated	O
76038	by	O
76039	:	O
76040	lentny	O
76041	farstnappsshee	O
76042	,	O
76043	md	O
76044		O
76045	admission	b-OCCURRENCE
76046	date	O
76047	:	O
76048	10/10/97	b-ADMISSION
76049	discharge	b-OCCURRENCE
76050	date	O
76051	:	O
76052	10/23/97	b-DISCHARGE
76053	history	O
76054	of	O
76055	present	O
76056	illness	O
76057	:	O
76058	the	O
76059	patient	O
76060	is	O
76061	a	O
76062	65-year-old	O
76063	male	O
76064	with	O
76065	a	O
76066	past	O
76067	medical	O
76068	history	O
76069	of	O
76070	diabetes	b-PROBLEM
76071	mellitus	i-PROBLEM
76072	,	O
76073	three-vessel	b-TREATMENT
76074	coronary	i-TREATMENT
76075	artery	i-TREATMENT
76076	bypassgraft	i-TREATMENT
76077	,	O
76078	congestive	b-PROBLEM
76079	heart	i-PROBLEM
76080	failure	i-PROBLEM
76081	,	O
76082	who	O
76083	presents	b-EVIDENTIAL
76084	with	O
76085	a	b-PROBLEM
76086	humeral	i-PROBLEM
76087	fracture	i-PROBLEM
76088	.	O
76089	the	O
76090	patient	O
76091	is	O
76092	admitted	b-OCCURRENCE
76093	for	O
76094	preoperative	b-TEST
76095	and	i-TEST
76096	orthopedic	i-TEST
76097	evaluations	i-TEST
76098	.	O
76099	the	O
76100	patient	O
76101	presented	b-EVIDENTIAL
76102	with	O
76103	a	b-PROBLEM
76104	comminuted	i-PROBLEM
76105	fracture	i-PROBLEM
76106	of	i-PROBLEM
76107	the	i-PROBLEM
76108	proximal	i-PROBLEM
76109	left	i-PROBLEM
76110	humerus	i-PROBLEM
76111	when	O
76112	he	O
76113	slipped	b-OCCURRENCE
76114	over	O
76115	the	O
76116	stairs	O
76117	,	O
76118	about	O
76119	to	O
76120	board	O
76121	an	O
76122	airplane	O
76123	back	O
76124	to	O
76125	jeglas	O
76126	blvd.	O
76127	,	O
76128	jolouisrowarlihis	O
76129	,	O
76130	alabama	O
76131	86071	O
76132	.	O
76133	the	b-PROBLEM
76134	fracture	i-PROBLEM
76135	was	O
76136	seen	O
76137	by	O
76138	orthopedics	O
76139	and	O
76140	was	O
76141	reduced	b-TREATMENT
76142	.	O
76143	during	O
76144	conscious	b-TREATMENT
76145	sedation	i-TREATMENT
76146	,	O
76147	the	O
76148	patient	O
76149	developed	O
76150	bigeminy	b-PROBLEM
76151	(	O
76152	the	O
76153	patient	O
76154	was	O
76155	sedated	b-TREATMENT
76156	,	O
76157	did	O
76158	not	O
76159	feel	O
76160	chest	b-PROBLEM
76161	pain	i-PROBLEM
76162	or	O
76163	shortness	b-PROBLEM
76164	of	i-PROBLEM
76165	breath	i-PROBLEM
76166	)	O
76167	.	O
76168	the	O
76169	patient	O
76170	presented	b-EVIDENTIAL
76171	to	O
76172	bri	b-CLINICAL_DEPT
76173	health	i-CLINICAL_DEPT
76174	in	O
76175	order	O
76176	to	O
76177	be	O
76178	evaluated	b-TEST
76179	for	O
76180	preoperative	b-TEST
76181	clearance	i-TEST
76182	.	O
76183	he	O
76184	was	O
76185	reported	b-EVIDENTIAL
76186	to	O
76187	have	O
76188	had	O
76189	a	b-PROBLEM
76190	myocardial	i-PROBLEM
76191	infarction	i-PROBLEM
76192	in	O
76193	the	O
76194	past	O
76195	(	O
76196	ekg	b-TEST
76197	positive	O
76198	for	O
76199	ischemia	b-PROBLEM
76200	,	O
76201	exercise	b-TEST
76202	tolerance	i-TEST
76203	test	i-TEST
76204	positive	O
76205	,	O
76206	cardiac	b-TEST
76207	catheterization	i-TEST
76208	positive	O
76209	,	O
76210	the	O
76211	patient	O
76212	is	O
76213	now	O
76214	status	O
76215	posta	O
76216	three-vessel	b-TREATMENT
76217	coronary	i-TREATMENT
76218	artery	i-TREATMENT
76219	bypass	i-TREATMENT
76220	graft	i-TREATMENT
76221	in	O
76222	1987	b-DATE
76223	)	O
76224	.	O
76225	the	O
76226	patient	O
76227	also	O
76228	hada	O
76229	history	O
76230	of	O
76231	arrhythmia	b-PROBLEM
76232	,	O
76233	found	O
76234	approximately	O
76235	ten	b-DURATION
76236	years	i-DURATION
76237	ago	O
76238	,	O
76239	unknown	O
76240	what	O
76241	type	O
76242	.	O
76243	the	O
76244	patient	O
76245	was	O
76246	on	O
76247	coumadin	b-TREATMENT
76248	recently	O
76249	,	O
76250	?	O
76251	whether	O
76252	for	O
76253	the	b-PROBLEM
76254	arrhythmia	i-PROBLEM
76255	.	O
76256	coumadin	b-TREATMENT
76257	was	O
76258	reportedly	O
76259	discontinued	O
76260	approximately	O
76261	six	b-DURATION
76262	months	i-DURATION
76263	ago	O
76264	secondary	O
76265	to	O
76266	planned	O
76267	surgery	b-TREATMENT
76268	for	O
76269	diabetic	b-PROBLEM
76270	retinopathy	i-PROBLEM
76271	and	O
76272	glaucoma	b-PROBLEM
76273	.	O
76274	the	O
76275	patient	O
76276	did	O
76277	not	O
76278	have	O
76279	chest	b-PROBLEM
76280	pain	i-PROBLEM
76281	until	O
76282	approximately	O
76283	1-1/2	b-DURATION
76284	years	i-DURATION
76285	ago	O
76286	,	O
76287	when	O
76288	he	O
76289	began	O
76290	to	O
76291	have	O
76292	chest	b-PROBLEM
76293	tightness	i-PROBLEM
76294	(	i-PROBLEM
76295	pressure	i-PROBLEM
76296	)	i-PROBLEM
76297	approximately	O
76298	every	b-FREQUENCY
76299	three	i-FREQUENCY
76300	months	i-FREQUENCY
76301	with	O
76302	stress	b-PROBLEM
76303	.	O
76304	the	O
76305	patient	O
76306	has	O
76307	no	O
76308	chest	b-PROBLEM
76309	pain	i-PROBLEM
76310	when	O
76311	walking	b-OCCURRENCE
76312	slowly	i-OCCURRENCE
76313	and	O
76314	can	O
76315	walk	O
76316	approximately	O
76317	1.5	O
76318	miles	O
76319	.	O
76320	he	O
76321	can	O
76322	climb	b-OCCURRENCE
76323	approximately	O
76324	three	O
76325	flights	O
76326	of	O
76327	stairs	O
76328	before	O
76329	becoming	O
76330	short	b-PROBLEM
76331	of	i-PROBLEM
76332	breath	i-PROBLEM
76333	.	O
76334	he	O
76335	does	O
76336	become	O
76337	slightly	b-PROBLEM
76338	short	i-PROBLEM
76339	of	i-PROBLEM
76340	breath	i-PROBLEM
76341	when	O
76342	lifting	b-OCCURRENCE
76343	furniture	i-OCCURRENCE
76344	.	O
76345	on	O
76346	the	b-DATE
76347	day	i-DATE
76348	of	O
76349	admission	b-OCCURRENCE
76350	,	O
76351	when	O
76352	he	b-OCCURRENCE
76353	fell	i-OCCURRENCE
76354	,	O
76355	the	O
76356	patient	O
76357	was	O
76358	experiencing	O
76359	no	O
76360	chest	b-PROBLEM
76361	pain	i-PROBLEM
76362	,	O
76363	no	O
76364	shortness	b-PROBLEM
76365	of	i-PROBLEM
76366	breath	i-PROBLEM
76367	,	O
76368	and	O
76369	had	O
76370	no	O
76371	loss	b-PROBLEM
76372	of	i-PROBLEM
76373	consciousness	i-PROBLEM
76374	,	O
76375	no	O
76376	head	b-PROBLEM
76377	trauma	i-PROBLEM
76378	with	i-PROBLEM
76379	fall	i-PROBLEM
76380	.	O
76381	review	O
76382	of	O
76383	systems	O
76384	:	O
76385	no	O
76386	fevers	b-PROBLEM
76387	or	O
76388	chills	b-PROBLEM
76389	,	O
76390	no	O
76391	chest	b-PROBLEM
76392	pain	i-PROBLEM
76393	,	O
76394	no	O
76395	shortness	b-PROBLEM
76396	of	i-PROBLEM
76397	breath	i-PROBLEM
76398	.	O
76399	the	O
76400	patient	O
76401	has	O
76402	stable	b-PROBLEM
76403	three-pillow	i-PROBLEM
76404	orthopnea	i-PROBLEM
76405	and	O
76406	occasional	b-PROBLEM
76407	paroxysmal	i-PROBLEM
76408	nocturnal	i-PROBLEM
76409	dyspnea	i-PROBLEM
76410	.	O
76411	he	O
76412	has	O
76413	a	b-PROBLEM
76414	chronic	i-PROBLEM
76415	cough	i-PROBLEM
76416	with	O
76417	clear	b-PROBLEM
76418	sputum	i-PROBLEM
76419	.	O
76420	no	O
76421	hemoptysis	b-PROBLEM
76422	,	O
76423	hematemesis	b-PROBLEM
76424	,	O
76425	abdominal	b-PROBLEM
76426	pain	i-PROBLEM
76427	,	O
76428	black	b-PROBLEM
76429	or	i-PROBLEM
76430	tarry	i-PROBLEM
76431	stools	i-PROBLEM
76432	,	O
76433	dysuria	b-PROBLEM
76434	/	O
76435	frequency/urgency	b-PROBLEM
76436	.	O
76437	hospital	O
76438	course	O
76439	and	O
76440	treatment	O
76441	:	O
76442	1.	O
76443	orthopedics	O
76444	:	O
76445	the	O
76446	patient	O
76447	has	O
76448	a	b-PROBLEM
76449	severely	i-PROBLEM
76450	comminuted	i-PROBLEM
76451	fracture	i-PROBLEM
76452	of	i-PROBLEM
76453	the	i-PROBLEM
76454	proximal	i-PROBLEM
76455	left	i-PROBLEM
76456	humerus	i-PROBLEM
76457	.	O
76458	he	O
76459	is	O
76460	status	O
76461	post	O
76462	a	b-TREATMENT
76463	hemiarthroplasty	i-TREATMENT
76464	on	O
76465	10/17/97	b-DATE
76466	.	O
76467	he	O
76468	received	O
76469	ancef	b-TREATMENT
76470	preoperatively	O
76471	.	O
76472	physical	O
76473	therapy	O
76474	has	O
76475	been	O
76476	seeing	O
76477	the	O
76478	patient	O
76479	and	O
76480	putting	O
76481	him	O
76482	through	O
76483	passive	b-TREATMENT
76484	external	i-TREATMENT
76485	rotation	i-TREATMENT
76486	to	O
76487	the	O
76488	neutral	O
76489	position	O
76490	of	O
76491	the	O
76492	left	O
76493	shoulder	O
76494	and	O
76495	forward	O
76496	flexion	O
76497	with	O
76498	physical	b-TREATMENT
76499	therapy	i-TREATMENT
76500	assistance	i-TREATMENT
76501	.	O
76502	brittle	b-PROBLEM
76503	bones	i-PROBLEM
76504	were	O
76505	noted	O
76506	during	O
76507	the	b-TREATMENT
76508	operation	i-TREATMENT
76509	.	O
76510	a	b-TEST
76511	bone	i-TEST
76512	density	i-TEST
76513	scan	i-TEST
76514	would	O
76515	be	O
76516	recommended	O
76517	as	O
76518	an	O
76519	outpatient	O
76520	,	O
76521	in	O
76522	order	O
76523	to	O
76524	evaluate	b-TEST
76525	this	O
76526	.	O
76527	2.	O
76528	neurological	O
76529	:	O
76530	the	O
76531	patient	O
76532	has	O
76533	right	b-PROBLEM
76534	facial	i-PROBLEM
76535	droop	i-PROBLEM
76536	,	O
76537	right	b-PROBLEM
76538	ptosis	i-PROBLEM
76539	,	O
76540	stable	b-OCCURRENCE
76541	and	O
76542	present	O
76543	for	O
76544	greater	b-DURATION
76545	than	i-DURATION
76546	one	i-DURATION
76547	year	i-DURATION
76548	.	O
76549	3.	O
76550	cardiovascular	O
76551	:	O
76552	no	O
76553	chest	b-PROBLEM
76554	pain	i-PROBLEM
76555	,	O
76556	no	O
76557	shortness	b-PROBLEM
76558	of	i-PROBLEM
76559	breath	i-PROBLEM
76560	,	O
76561	1+	b-PROBLEM
76562	ankle	i-PROBLEM
76563	edema	i-PROBLEM
76564	.	O
76565	the	O
76566	patient	O
76567	was	O
76568	ruled	b-TEST
76569	out	i-TEST
76570	for	O
76571	a	b-PROBLEM
76572	myocardial	i-PROBLEM
76573	infarction	i-PROBLEM
76574	,	O
76575	given	O
76576	his	b-OCCURRENCE
76577	fall	i-OCCURRENCE
76578	at	O
76579	the	O
76580	airport	O
76581	and	O
76582	bigeminy	b-PROBLEM
76583	seen	O
76584	on	O
76585	electrocardiogram	b-TEST
76586	that	O
76587	he	O
76588	developed	O
76589	during	O
76590	conscious	b-TREATMENT
76591	sedation	i-TREATMENT
76592	during	O
76593	reduction	b-TREATMENT
76594	of	i-TREATMENT
76595	the	i-TREATMENT
76596	fracture	i-TREATMENT
76597	.	O
76598	cardiology	O
76599	was	O
76600	consulted	b-OCCURRENCE
76601	and	O
76602	aspirin	b-TREATMENT
76603	and	O
76604	beta	b-TREATMENT
76605	blocker	i-TREATMENT
76606	added	O
76607	to	O
76608	his	b-TREATMENT
76609	regimen	i-TREATMENT
76610	,	O
76611	as	O
76612	well	O
76613	as	O
76614	chest	b-TREATMENT
76615	wall	i-TREATMENT
76616	nitroglycerin	i-TREATMENT
76617	around	O
76618	the	O
76619	time	O
76620	of	O
76621	surgery	b-TREATMENT
76622	,	O
76623	which	O
76624	was	O
76625	subsequently	O
76626	discontinued	O
76627	.	O
76628	an	b-TEST
76629	adenosine	i-TEST
76630	sestamibi	i-TEST
76631	was	O
76632	performed	O
76633	on	O
76634	10/12/97	b-DATE
76635	,	O
76636	which	O
76637	showed	b-OCCURRENCE
76638	a	O
76639	negative	O
76640	electrocardiogram	b-TEST
76641	for	O
76642	ischemia	b-PROBLEM
76643	and	O
76644	cardiac	b-TEST
76645	perfusion	i-TEST
76646	scans	i-TEST
76647	,	O
76648	with	O
76649	a	b-PROBLEM
76650	moderate-sized	i-PROBLEM
76651	,	i-PROBLEM
76652	dense	i-PROBLEM
76653	,	i-PROBLEM
76654	fixed	i-PROBLEM
76655	inferior	i-PROBLEM
76656	defect	i-PROBLEM
76657	indicative	O
76658	of	O
76659	scar	b-PROBLEM
76660	.	O
76661	a	b-PROBLEM
76662	small	i-PROBLEM
76663	/	i-PROBLEM
76664	moderate-sized	i-PROBLEM
76665	,	i-PROBLEM
76666	mild-intensity	i-PROBLEM
76667	,	i-PROBLEM
76668	reversible	i-PROBLEM
76669	posterior	i-PROBLEM
76670	lateral	i-PROBLEM
76671	defect	i-PROBLEM
76672	was	O
76673	also	O
76674	seen	O
76675	,	O
76676	indicative	O
76677	of	O
76678	mild	b-PROBLEM
76679	/	i-PROBLEM
76680	moderate	i-PROBLEM
76681	ischemia	i-PROBLEM
76682	.	O
76683	an	b-TEST
76684	echocardiogram	i-TEST
76685	was	O
76686	performed	O
76687	on	O
76688	columbus	b-DATE
76689	day	i-DATE
76690	which	O
76691	showed	b-EVIDENTIAL
76692	an	b-TEST
76693	ejection	i-TEST
76694	fraction	i-TEST
76695	of	O
76696	50%	O
76697	,	O
76698	left	b-PROBLEM
76699	atrial	i-PROBLEM
76700	enlargement	i-PROBLEM
76701	,	O
76702	thickening	b-PROBLEM
76703	of	i-PROBLEM
76704	the	i-PROBLEM
76705	aortic	i-PROBLEM
76706	wall	i-PROBLEM
76707	consistent	O
76708	with	O
76709	atherosclerotic	b-PROBLEM
76710	changes	i-PROBLEM
76711	,	O
76712	left	b-TEST
76713	ventricle	i-TEST
76714	size	i-TEST
76715	,	O
76716	and	O
76717	systolic	b-TEST
76718	function	i-TEST
76719	within	O
76720	normal	O
76721	limits	O
76722	.	O
76723	cardiac	b-TEST
76724	monitor	i-TEST
76725	was	O
76726	placed	O
76727	on	O
76728	the	O
76729	patient	O
76730	,	O
76731	given	O
76732	the	b-PROBLEM
76733	bigeminy	i-PROBLEM
76734	,	O
76735	and	O
76736	he	O
76737	did	O
76738	rule	b-TEST
76739	out	i-TEST
76740	for	O
76741	myocardial	b-PROBLEM
76742	infarction	i-PROBLEM
76743	.	O
76744	cardiology	O
76745	recommended	b-OCCURRENCE
76746	that	O
76747	in	O
76748	addition	O
76749	to	O
76750	the	b-TREATMENT
76751	medications	i-TREATMENT
76752	already	O
76753	stated	O
76754	above	O
76755	,	O
76756	his	b-TEST
76757	hematocrit	i-TEST
76758	be	O
76759	kept	O
76760	greater	O
76761	than	O
76762	30	O
76763	.	O
76764	after	O
76765	his	b-TREATMENT
76766	procedure	i-TREATMENT
76767	on	O
76768	10/17/97	b-DATE
76769	,	O
76770	elevated	b-PROBLEM
76771	cpks	i-PROBLEM
76772	were	O
76773	noted	O
76774	on	O
76775	10/19/97	b-DATE
76776	to	O
76777	10/20/97	b-DATE
76778	,	O
76779	and	O
76780	the	O
76781	first	O
76782	level	O
76783	was	O
76784	744	O
76785	,	O
76786	cpk	b-TEST
76787	#	O
76788	2	O
76789	635	O
76790	,	O
76791	and	O
76792	cpk	b-TEST
76793	#	O
76794	3	O
76795	461	O
76796	.	O
76797	mb	b-PROBLEM
76798	fractionations	i-PROBLEM
76799	of	O
76800	the	b-TEST
76801	cpks	i-TEST
76802	were	O
76803	all	O
76804	negative	O
76805	and	O
76806	were	O
76807	thought	O
76808	to	O
76809	be	O
76810	secondary	O
76811	to	O
76812	the	O
76813	patient	O
76814	&apos;s	O
76815	beginning	O
76816	physical	b-TREATMENT
76817	therapy	i-TREATMENT
76818	on	O
76819	10/19/97	b-DATE
76820	,	O
76821	and	O
76822	all	O
76823	muscular	O
76824	in	O
76825	origin	O
76826	.	O
76827	4.	O
76828	gastroenterology	O
76829	:	O
76830	gi	O
76831	was	O
76832	consulted	b-OCCURRENCE
76833	on	O
76834	10/15/97	b-DATE
76835	for	O
76836	melena	b-PROBLEM
76837	,	O
76838	decreased	b-PROBLEM
76839	hematocrit	i-PROBLEM
76840	prior	O
76841	to	O
76842	his	b-TREATMENT
76843	humeral	i-TREATMENT
76844	fixation	i-TREATMENT
76845	surgery	i-TREATMENT
76846	.	O
76847	upper	b-TEST
76848	endoscopy	i-TEST
76849	x	b-DURATION
76850	2	i-DURATION
76851	were	O
76852	done	O
76853	.	O
76854	the	O
76855	first	O
76856	was	O
76857	on	O
76858	10/15/97	b-DATE
76859	,	O
76860	which	O
76861	showed	b-EVIDENTIAL
76862	clotted	b-PROBLEM
76863	blood	i-PROBLEM
76864	in	i-PROBLEM
76865	the	i-PROBLEM
76866	esophagus	i-PROBLEM
76867	.	O
76868	the	O
76869	stomach	O
76870	had	O
76871	evidence	O
76872	of	O
76873	prior	b-TREATMENT
76874	surgery	i-TREATMENT
76875	and	O
76876	old	b-PROBLEM
76877	blood	i-PROBLEM
76878	in	i-PROBLEM
76879	the	i-PROBLEM
76880	stomach	i-PROBLEM
76881	.	O
76882	it	O
76883	was	O
76884	thought	O
76885	that	O
76886	the	b-PROBLEM
76887	blood	i-PROBLEM
76888	in	i-PROBLEM
76889	the	i-PROBLEM
76890	esophagus	i-PROBLEM
76891	was	O
76892	secondary	O
76893	to	O
76894	a	O
76895	possible	O
76896	mallory-weiss	b-PROBLEM
76897	tear	i-PROBLEM
76898	.	O
76899	a	b-TEST
76900	second	i-TEST
76901	endoscopy	i-TEST
76902	was	O
76903	also	O
76904	performed	O
76905	several	b-DURATION
76906	days	i-DURATION
76907	later	O
76908	,	O
76909	in	O
76910	order	O
76911	to	O
76912	rule	b-TEST
76913	out	i-TEST
76914	a	b-PROBLEM
76915	gastric	i-PROBLEM
76916	ulcer	i-PROBLEM
76917	,	O
76918	and	O
76919	also	O
76920	because	O
76921	the	O
76922	patient	O
76923	had	O
76924	had	O
76925	another	O
76926	episode	O
76927	of	O
76928	melena	b-PROBLEM
76929	.	O
76930	a	b-PROBLEM
76931	gastric	i-PROBLEM
76932	ulcer	i-PROBLEM
76933	was	O
76934	found	O
76935	and	O
76936	this	O
76937	was	O
76938	biopsied	b-TEST
76939	and	O
76940	pathology	b-TEST
76941	is	O
76942	pending	O
76943	at	O
76944	this	O
76945	time	O
76946	.	O
76947	this	O
76948	report	O
76949	needs	O
76950	to	O
76951	be	O
76952	followed	b-OCCURRENCE
76953	up	i-OCCURRENCE
76954	,	O
76955	and	O
76956	will	O
76957	be	O
76958	available	O
76959	at	O
76960	bri	O
76961	health	O
76962	in	O
76963	the	O
76964	pathology	O
76965	department	O
76966	some	O
76967	time	O
76968	within	O
76969	the	b-DURATION
76970	next	i-DURATION
76971	three	i-DURATION
76972	to	i-DURATION
76973	seven	i-DURATION
76974	days	i-DURATION
76975	.	O
76976	the	O
76977	patient	O
76978	also	O
76979	needs	O
76980	a	b-TEST
76981	repeat	i-TEST
76982	endoscopy	i-TEST
76983	and	O
76984	a	b-TEST
76985	gi	i-TEST
76986	follow-up	i-TEST
76987	appointment	O
76988	inapproximately	O
76989	two	b-DURATION
76990	months	i-DURATION
76991	.	O
76992	i	O
76993	have	O
76994	spoken	O
76995	with	O
76996	the	O
76997	patient	O
76998	in	O
76999	detail	O
77000	,	O
77001	and	O
77002	he	O
77003	will	O
77004	be	O
77005	getting	O
77006	in	O
77007	touch	O
77008	with	O
77009	his	O
77010	primary-care	O
77011	physician	O
77012	,	O
77013	doctor	O
77014	fordwoodall	O
77015	stick	O
77016	,	O
77017	in	O
77018	ranegei	O
77019	pkwy	O
77020	,	O
77021	verertliet	O
77022	,	O
77023	south	O
77024	carolina	O
77025	62156	O
77026	.	O
77027	the	O
77028	patient	O
77029	is	O
77030	to	O
77031	arrange	b-OCCURRENCE
77032	follow	i-OCCURRENCE
77033	up	i-OCCURRENCE
77034	with	O
77035	a	O
77036	gi	O
77037	doctor	O
77038	in	O
77039	jotar	O
77040	boulevard	O
77041	,	O
77042	cunahtampfordama	O
77043	,	O
77044	south	O
77045	dakota	O
77046	62848	O
77047	through	O
77048	his	O
77049	primary-care	O
77050	physician	O
77051	.	O
77052	the	O
77053	patient	O
77054	was	O
77055	initially	O
77056	on	O
77057	cimetidine	b-TREATMENT
77058	and	O
77059	carafate	b-TREATMENT
77060	here	O
77061	at	O
77062	bri	b-CLINICAL_DEPT
77063	health	i-CLINICAL_DEPT
77064	,	O
77065	and	O
77066	then	O
77067	switched	O
77068	to	O
77069	prilosec	b-TREATMENT
77070	20	O
77071	mg	O
77072	bid	b-FREQUENCY
77073	.	O
77074	5.	O
77075	pulmonary	O
77076	:	O
77077	the	b-TEST
77078	patient	i-TEST
77079	&apos;s	i-TEST
77080	admitting	i-TEST
77081	chest	i-TEST
77082	x-ray	i-TEST
77083	showed	b-EVIDENTIAL
77084	an	b-PROBLEM
77085	elevated	i-PROBLEM
77086	left	i-PROBLEM
77087	hemidiaphragm	i-PROBLEM
77088	consistent	O
77089	with	O
77090	atelectasis	b-PROBLEM
77091	versus	O
77092	splinting	b-PROBLEM
77093	on	i-PROBLEM
77094	that	i-PROBLEM
77095	side	i-PROBLEM
77096	.	O
77097	incentive	b-TREATMENT
77098	spirometry	i-TREATMENT
77099	was	O
77100	started	O
77101	.	O
77102	albuterol	b-TREATMENT
77103	and	i-TREATMENT
77104	atrovent	i-TREATMENT
77105	nebulizers	i-TREATMENT
77106	were	O
77107	done	O
77108	.	O
77109	the	O
77110	patient	O
77111	received	O
77112	chest	b-TREATMENT
77113	physical	i-TREATMENT
77114	therapy	i-TREATMENT
77115	bid	b-FREQUENCY
77116	.	O
77117	6.	O
77118	endocrine	O
77119	:	O
77120	the	O
77121	patient	O
77122	needs	O
77123	still	O
77124	better	O
77125	diabetes	b-TREATMENT
77126	control	i-TREATMENT
77127	.	O
77128	he	O
77129	has	O
77130	been	O
77131	somewhat	O
77132	noncompliant	b-PROBLEM
77133	with	O
77134	his	b-TREATMENT
77135	diet	i-TREATMENT
77136	(	O
77137	eating	b-OCCURRENCE
77138	pringle	i-OCCURRENCE
77139	&apos;s	i-OCCURRENCE
77140	in	O
77141	the	O
77142	room	O
77143	)	O
77144	.	O
77145	his	b-TREATMENT
77146	nph	i-TREATMENT
77147	was	O
77148	recently	O
77149	increased	b-OCCURRENCE
77150	today	O
77151	(	O
77152	10/23/97	b-DATE
77153	)	O
77154	to	O
77155	24	O
77156	units	O
77157	in	O
77158	the	O
77159	a.m.	O
77160	and	O
77161	14	O
77162	units	O
77163	in	O
77164	the	O
77165	p.m.	O
77166	with	O
77167	czi	b-TREATMENT
77168	sliding-scale	i-TREATMENT
77169	coverage	i-TREATMENT
77170	.	O
77171	7.	O
77172	infectious	O
77173	disease	O
77174	:	O
77175	the	b-TEST
77176	patient	i-TEST
77177	urinalysis	i-TEST
77178	on	O
77179	10/19/97	b-DATE
77180	showed	b-EVIDENTIAL
77181	moderate	b-PROBLEM
77182	occult	i-PROBLEM
77183	blood	i-PROBLEM
77184	,	O
77185	ph	b-TEST
77186	5	O
77187	,	O
77188	albumin	b-TEST
77189	1+	O
77190	,	O
77191	white	b-TEST
77192	blood	i-TEST
77193	cells	i-TEST
77194	present	O
77195	,	O
77196	2-50	O
77197	red	b-TEST
77198	blood	i-TEST
77199	cell	i-TEST
77200	,	O
77201	10-20	O
77202	white	b-TEST
77203	blood	i-TEST
77204	cells	i-TEST
77205	,	O
77206	few	b-PROBLEM
77207	bacteria	i-PROBLEM
77208	,	O
77209	and	O
77210	moderate	b-PROBLEM
77211	bladder	i-PROBLEM
77212	epithelial	i-PROBLEM
77213	cells	i-PROBLEM
77214	.	O
77215	floxin	b-TREATMENT
77216	200	O
77217	mg	O
77218	po	O
77219	bid	b-FREQUENCY
77220	was	O
77221	begun	O
77222	.	O
77223	however	O
77224	,	O
77225	his	b-TEST
77226	urine	i-TEST
77227	culture	i-TEST
77228	from	O
77229	the	b-DATE
77230	same	i-DATE
77231	day	i-DATE
77232	remained	O
77233	negative	O
77234	,	O
77235	and	O
77236	this	O
77237	was	O
77238	discontinued	O
77239	two	b-DURATION
77240	days	i-DURATION
77241	later	O
77242	.	O
77243	a	b-TEST
77244	repeat	i-TEST
77245	urinalysis	i-TEST
77246	on	O
77247	10/22/97	b-DATE
77248	was	O
77249	negative	O
77250	.	O
77251	8.	O
77252	renal	O
77253	:	O
77254	after	O
77255	the	b-TREATMENT
77256	patient	i-TREATMENT
77257	&apos;s	i-TREATMENT
77258	procedure	i-TREATMENT
77259	,	O
77260	he	O
77261	was	O
77262	felt	O
77263	to	O
77264	be	O
77265	volume	b-PROBLEM
77266	overloaded	i-PROBLEM
77267	.	O
77268	he	O
77269	was	O
77270	given	O
77271	lasix	b-TREATMENT
77272	40	O
77273	mg	O
77274	iv	O
77275	x	O
77276	1	O
77277	and	O
77278	also	O
77279	had	O
77280	nitro	b-TREATMENT
77281	paste	i-TREATMENT
77282	around	O
77283	the	O
77284	time	O
77285	of	O
77286	his	b-TREATMENT
77287	surgery	i-TREATMENT
77288	and	O
77289	beta	b-TREATMENT
77290	blocker	i-TREATMENT
77291	.	O
77292	the	O
77293	patient	O
77294	became	O
77295	slightly	b-PROBLEM
77296	hypotensive	i-PROBLEM
77297	on	O
77298	the	b-DATE
77299	night	i-DATE
77300	of	i-DATE
77301	10/18/97	i-DATE
77302	with	O
77303	systolic	b-TEST
77304	blood	i-TEST
77305	pressures	i-TEST
77306	in	O
77307	the	O
77308	80s	O
77309	to	O
77310	90s.	O
77311	his	b-TEST
77312	bun/	i-TEST
77313	creatinine	i-TEST
77314	rose	O
77315	from	O
77316	16/1.2	O
77317	on	O
77318	10/18/97	b-DATE
77319	to	O
77320	25/1.9	O
77321	on	O
77322	10/18/97	b-DATE
77323	to	O
77324	22/9.1	O
77325	to	O
77326	today	b-DATE
77327	&apos;s	O
77328	labs	b-TEST
77329	,	O
77330	which	O
77331	are	O
77332	15/0.7	O
77333	on	O
77334	10/23/97	b-DATE
77335	.	O
77336	9.	O
77337	hematology	O
77338	:	O
77339	the	O
77340	patient	O
77341	transfused	b-TREATMENT
77342	2	i-TREATMENT
77343	units	i-TREATMENT
77344	on	O
77345	10/15/97	b-DATE
77346	for	O
77347	a	b-TEST
77348	hematocrit	i-TEST
77349	of	O
77350	27.6	O
77351	.	O
77352	the	O
77353	patient	O
77354	transfused	b-TREATMENT
77355	2	i-TREATMENT
77356	units	i-TREATMENT
77357	of	O
77358	10/16/97	b-DATE
77359	for	O
77360	a	b-TEST
77361	hematocrit	i-TEST
77362	of	O
77363	30.03	O
77364	.	O
77365	the	O
77366	patient	O
77367	transfused	b-TREATMENT
77368	1	i-TREATMENT
77369	unit	i-TREATMENT
77370	on	O
77371	10/18/97	b-DATE
77372	for	O
77373	a	b-TEST
77374	hematocrit	i-TEST
77375	of	O
77376	29.4	O
77377	.	O
77378	the	O
77379	patient	O
77380	transfused	b-TREATMENT
77381	1	i-TREATMENT
77382	unit	i-TREATMENT
77383	on	O
77384	10/19/97	b-DATE
77385	for	O
77386	a	b-TEST
77387	hematocrit	i-TEST
77388	of	O
77389	27.9	O
77390	.	O
77391	the	O
77392	patient	O
77393	transfused	b-TREATMENT
77394	2	i-TREATMENT
77395	units	i-TREATMENT
77396	on	O
77397	10/20/97	b-DATE
77398	for	O
77399	a	b-TEST
77400	hematocrit	i-TEST
77401	of	O
77402	28.2.10	O
77403	.	O
77404	fen	O
77405	:	O
77406	repleting	O
77407	potassium	b-TREATMENT
77408	,	O
77409	magnesium	b-TREATMENT
77410	,	O
77411	phosphorus	b-TREATMENT
77412	as	O
77413	needed	O
77414	.	O
77415	the	O
77416	patient	O
77417	was	O
77418	noted	O
77419	to	O
77420	be	O
77421	slightly	b-PROBLEM
77422	hyponatremic	i-PROBLEM
77423	over	O
77424	the	O
77425	past	O
77426	few	b-DURATION
77427	days	i-DURATION
77428	,	O
77429	with	O
77430	sodiums	b-TEST
77431	in	O
77432	the	O
77433	128-132	O
77434	range	O
77435	,	O
77436	but	O
77437	this	O
77438	was	O
77439	secondary	O
77440	to	O
77441	elevated	b-PROBLEM
77442	glucose	i-PROBLEM
77443	fingerstick	i-PROBLEM
77444	blood	i-PROBLEM
77445	sugars	i-PROBLEM
77446	.	O
77447		O
77448	admission	b-OCCURRENCE
77449	date	O
77450	:	O
77451	01/16/1996	b-ADMISSION
77452	discharge	b-OCCURRENCE
77453	date	O
77454	:	O
77455	01/20/1996	b-DISCHARGE
77456	history	O
77457	of	O
77458	present	O
77459	illness	O
77460	:	O
77461	the	O
77462	patient	O
77463	has	O
77464	a	O
77465	history	O
77466	four	b-DATE
77467	years	i-DATE
77468	ago	i-DATE
77469	of	O
77470	being	O
77471	admitted	b-OCCURRENCE
77472	to	O
77473	the	b-CLINICAL_DEPT
77474	etearal	i-CLINICAL_DEPT
77475	etsystems/	i-CLINICAL_DEPT
77476	hospital	i-CLINICAL_DEPT
77477	after	O
77478	suffering	O
77479	an	b-PROBLEM
77480	acute	i-PROBLEM
77481	anterior	i-PROBLEM
77482	myocardial	i-PROBLEM
77483	infarction	i-PROBLEM
77484	.	O
77485	the	O
77486	course	O
77487	had	O
77488	multiple	b-PROBLEM
77489	complications	i-PROBLEM
77490	requiring	O
77491	pressors	b-TREATMENT
77492	.	O
77493	he	O
77494	had	O
77495	a	b-TEST
77496	cardiac	i-TEST
77497	catheterization	i-TEST
77498	performed	O
77499	which	O
77500	revealed	b-EVIDENTIAL
77501	a	b-PROBLEM
77502	three	i-PROBLEM
77503	vessel	i-PROBLEM
77504	coronary	i-PROBLEM
77505	artery	i-PROBLEM
77506	disease	i-PROBLEM
77507	with	O
77508	an	b-PROBLEM
77509	occluded	i-PROBLEM
77510	rca	i-PROBLEM
77511	,	O
77512	70%-80%	b-PROBLEM
77513	proximal	i-PROBLEM
77514	lad	i-PROBLEM
77515	,	O
77516	and	O
77517	a	b-PROBLEM
77518	high	i-PROBLEM
77519	grade	i-PROBLEM
77520	left	i-PROBLEM
77521	circumflex	i-PROBLEM
77522	lesion	i-PROBLEM
77523	after	i-PROBLEM
77524	the	i-PROBLEM
77525	om	i-PROBLEM
77526	with	O
77527	distal	b-PROBLEM
77528	left	i-PROBLEM
77529	circumflex	i-PROBLEM
77530	occlusion	i-PROBLEM
77531	.	O
77532	the	O
77533	patient	O
77534	was	O
77535	subsequently	O
77536	medically	b-TREATMENT
77537	management	i-TREATMENT
77538	after	O
77539	this	b-OCCURRENCE
77540	hospitalization	i-OCCURRENCE
77541	and	O
77542	has	O
77543	done	O
77544	very	b-OCCURRENCE
77545	well	i-OCCURRENCE
77546	.	O
77547	his	O
77548	most	O
77549	recent	O
77550	echocardiogram	b-TEST
77551	in	O
77552	april	b-DATE
77553	of	i-DATE
77554	1995	i-DATE
77555	showed	b-EVIDENTIAL
77556	an	b-TEST
77557	ejection	i-TEST
77558	fraction	i-TEST
77559	of	O
77560	20%	O
77561	with	O
77562	a	b-PROBLEM
77563	thin	i-PROBLEM
77564	fibrotic	i-PROBLEM
77565	septum	i-PROBLEM
77566	with	O
77567	akinesis	b-PROBLEM
77568	and	O
77569	moderately	b-PROBLEM
77570	severe	i-PROBLEM
77571	hypokinesis	i-PROBLEM
77572	in	O
77573	all	O
77574	other	O
77575	regions	O
77576	except	O
77577	for	O
77578	the	O
77579	lateral	O
77580	wall	O
77581	.	O
77582	the	O
77583	patient	O
77584	also	O
77585	had	O
77586	an	b-TEST
77587	electrocardiogram	i-TEST
77588	in	O
77589	april	b-DATE
77590	of	i-DATE
77591	1995	i-DATE
77592	which	O
77593	was	O
77594	negative	O
77595	following	O
77596	,	O
77597	however	O
77598	was	O
77599	at	O
77600	a	b-OCCURRENCE
77601	low	i-OCCURRENCE
77602	workload	i-OCCURRENCE
77603	.	O
77604	the	O
77605	patient	O
77606	&apos;s	O
77607	was	O
77608	most	O
77609	recently	O
77610	admitted	b-OCCURRENCE
77611	to	O
77612	centdick	b-CLINICAL_DEPT
77613	naco	i-CLINICAL_DEPT
77614	hospital	i-CLINICAL_DEPT
77615	medical	i-CLINICAL_DEPT
77616	center	i-CLINICAL_DEPT
77617	on	O
77618	martin	b-DATE
77619	luther	i-DATE
77620	king	i-DATE
77621	day	i-DATE
77622	after	O
77623	becoming	O
77624	acutely	b-PROBLEM
77625	short	i-PROBLEM
77626	of	i-PROBLEM
77627	breath	i-PROBLEM
77628	after	O
77629	a	b-DURATION
77630	five	i-DURATION
77631	minute	i-DURATION
77632	walk	b-OCCURRENCE
77633	.	O
77634	he	O
77635	had	O
77636	no	O
77637	chest	b-PROBLEM
77638	pain	i-PROBLEM
77639	,	O
77640	palpitations	b-PROBLEM
77641	,	O
77642	diaphoresis	b-PROBLEM
77643	,	O
77644	or	O
77645	nausea	b-PROBLEM
77646	.	O
77647	he	O
77648	called	b-OCCURRENCE
77649	the	i-OCCURRENCE
77650	emt	i-OCCURRENCE
77651	&apos;s	i-OCCURRENCE
77652	and	O
77653	was	O
77654	found	b-EVIDENTIAL
77655	to	O
77656	be	O
77657	in	O
77658	pulmonary	b-PROBLEM
77659	edema	i-PROBLEM
77660	by	O
77661	chest	b-TEST
77662	x-ray	i-TEST
77663	at	O
77664	centdick	b-CLINICAL_DEPT
77665	naco	i-CLINICAL_DEPT
77666	hospital	i-CLINICAL_DEPT
77667	medical	i-CLINICAL_DEPT
77668	center	i-CLINICAL_DEPT
77669	.	O
77670	he	O
77671	was	O
77672	diuresed	b-TREATMENT
77673	and	O
77674	ruled	O
77675	out	O
77676	for	O
77677	myocardial	b-PROBLEM
77678	infarction	i-PROBLEM
77679	.	O
77680	his	b-TEST
77681	ecg	i-TEST
77682	showed	b-EVIDENTIAL
77683	no	O
77684	ischemic	b-PROBLEM
77685	changes	i-PROBLEM
77686	.	O
77687	he	O
77688	was	O
77689	then	O
77690	transferred	b-OCCURRENCE
77691	to	O
77692	the	b-CLINICAL_DEPT
77693	retelk	i-CLINICAL_DEPT
77694	county	i-CLINICAL_DEPT
77695	medical	i-CLINICAL_DEPT
77696	center	i-CLINICAL_DEPT
77697	for	O
77698	further	b-TREATMENT
77699	management	i-TREATMENT
77700	.	O
77701	hospital	O
77702	course	O
77703	:	O
77704	the	O
77705	patient	O
77706	was	O
77707	admitted	b-OCCURRENCE
77708	for	O
77709	further	b-TREATMENT
77710	management	i-TREATMENT
77711	of	O
77712	his	b-PROBLEM
77713	pulmonary	i-PROBLEM
77714	edema	i-PROBLEM
77715	.	O
77716	it	O
77717	was	O
77718	felt	O
77719	that	O
77720	the	O
77721	patient	O
77722	possibly	O
77723	had	O
77724	a	O
77725	worsening	O
77726	of	O
77727	his	b-PROBLEM
77728	coronary	i-PROBLEM
77729	artery	i-PROBLEM
77730	disease	i-PROBLEM
77731	and	O
77732	therefore	O
77733	underwent	O
77734	cardiac	b-TEST
77735	catheterization	i-TEST
77736	on	O
77737	01/17/96	b-DATE
77738	.	O
77739	at	O
77740	cardiac	b-TEST
77741	catheterization	i-TEST
77742	he	O
77743	had	O
77744	an	b-TEST
77745	ra	i-TEST
77746	pressure	i-TEST
77747	of	O
77748	8	O
77749	,	O
77750	an	b-TEST
77751	rv	i-TEST
77752	pressure	i-TEST
77753	of	O
77754	52/10	O
77755	,	O
77756	pa	b-TEST
77757	pressure	i-TEST
77758	of	O
77759	60/25	O
77760	,	O
77761	and	O
77762	wedge	b-TEST
77763	of	O
77764	26	O
77765	.	O
77766	his	O
77767	coronary	O
77768	arteries	O
77769	revealed	b-EVIDENTIAL
77770	an	b-PROBLEM
77771	80%	i-PROBLEM
77772	stenosis	i-PROBLEM
77773	and	O
77774	a	b-PROBLEM
77775	large	i-PROBLEM
77776	om	i-PROBLEM
77777	.	O
77778	the	O
77779	dominant	O
77780	left	O
77781	circumflex	O
77782	was	O
77783	occluded	b-PROBLEM
77784	with	O
77785	left-to-left	b-PROBLEM
77786	filling	i-PROBLEM
77787	.	O
77788	he	O
77789	also	O
77790	had	O
77791	a	b-PROBLEM
77792	50%	i-PROBLEM
77793	lad	i-PROBLEM
77794	stenosis	i-PROBLEM
77795	,	O
77796	a	b-PROBLEM
77797	100%	i-PROBLEM
77798	large	i-PROBLEM
77799	dt	i-PROBLEM
77800	stenosis	i-PROBLEM
77801	and	O
77802	a	O
77803	nondominant	O
77804	rca	O
77805	with	O
77806	left	O
77807	rca	O
77808	collaterals	O
77809	.	O
77810	it	O
77811	was	O
77812	felt	O
77813	that	O
77814	this	b-TEST
77815	cardiac	i-TEST
77816	catheterization	i-TEST
77817	was	O
77818	not	O
77819	significantly	O
77820	changed	O
77821	from	O
77822	his	b-TEST
77823	previous	i-TEST
77824	catheterization	i-TEST
77825	.	O
77826	given	O
77827	his	b-PROBLEM
77828	high	i-PROBLEM
77829	right-sided	i-PROBLEM
77830	filling	i-PROBLEM
77831	pressure	i-PROBLEM
77832	,	O
77833	he	O
77834	was	O
77835	started	O
77836	on	O
77837	lasix	b-TREATMENT
77838	for	O
77839	diuresis	b-TREATMENT
77840	and	O
77841	his	b-TREATMENT
77842	captopril	i-TREATMENT
77843	was	O
77844	increased	O
77845	for	O
77846	greater	b-TREATMENT
77847	afterload	i-TREATMENT
77848	reduction	i-TREATMENT
77849	.	O
77850	it	O
77851	was	O
77852	felt	O
77853	that	O
77854	the	O
77855	patient	O
77856	should	O
77857	have	O
77858	an	b-TREATMENT
77859	augmented	i-TREATMENT
77860	medical	i-TREATMENT
77861	regimen	i-TREATMENT
77862	and	O
77863	as	O
77864	an	O
77865	outpatient	O
77866	undergo	O
77867	an	b-TEST
77868	exercise	i-TEST
77869	tolerance	i-TEST
77870	test	i-TEST
77871	with	O
77872	viability	b-TEST
77873	evaluation	i-TEST
77874	to	O
77875	determine	O
77876	whether	O
77877	he	O
77878	would	O
77879	benefit	O
77880	from	O
77881	revascularization	b-TREATMENT
77882	.	O
77883	he	O
77884	was	O
77885	restarted	O
77886	on	O
77887	coumadin	b-TREATMENT
77888	for	O
77889	his	b-PROBLEM
77890	low	i-PROBLEM
77891	ejection	i-PROBLEM
77892	fraction	i-PROBLEM
77893	and	O
77894	started	O
77895	on	O
77896	diuresis	b-TREATMENT
77897	with	O
77898	iv	b-TREATMENT
77899	lasix	i-TREATMENT
77900	for	O
77901	two	b-DURATION
77902	days	i-DURATION
77903	and	O
77904	then	O
77905	switched	O
77906	to	O
77907	an	b-TREATMENT
77908	oral	i-TREATMENT
77909	lasix	i-TREATMENT
77910	regimen	i-TREATMENT
77911	.	O
77912		O
77913	admission	b-OCCURRENCE
77914	date	O
77915	:	O
77916	2013-03-27	b-ADMISSION
77917	discharge	b-OCCURRENCE
77918	date	O
77919	:	O
77920	2013-04-01	b-DISCHARGE
77921	service	O
77922	:	O
77923	neurosurgery	O
77924	allergies	O
77925	:	O
77926	history	O
77927	of	O
77928	present	O
77929	illness	O
77930	:	O
77931	58	O
77932	yo	O
77933	female	O
77934	s/p	O
77935	high	b-OCCURRENCE
77936	speed	i-OCCURRENCE
77937	mvc	i-OCCURRENCE
77938	.	O
77939	she	O
77940	lost	b-OCCURRENCE
77941	contaol	i-OCCURRENCE
77942	of	i-OCCURRENCE
77943	her	i-OCCURRENCE
77944	car	i-OCCURRENCE
77945	,	O
77946	she	O
77947	hit	b-OCCURRENCE
77948	the	i-OCCURRENCE
77949	barnes	i-OCCURRENCE
77950	rails	i-OCCURRENCE
77951	then	O
77952	the	b-OCCURRENCE
77953	car	i-OCCURRENCE
77954	stopped	i-OCCURRENCE
77955	.	O
77956	another	O
77957	car	O
77958	was	O
77959	coming	O
77960	behind	O
77961	her	O
77962	did	O
77963	not	O
77964	see	O
77965	her	O
77966	car	O
77967	,	O
77968	hit	O
77969	again	O
77970	,	O
77971	the	O
77972	person	O
77973	checked	O
77974	the	O
77975	car	O
77976	,	O
77977	she	O
77978	was	O
77979	not	O
77980	inside	O
77981	.	O
77982	+loc	b-PROBLEM
77983	,	O
77984	gcs:14	b-TEST
77985	.	O
77986	she	O
77987	ejected	b-OCCURRENCE
77988	.	O
77989	she	O
77990	brought	O
77991	by	O
77992	ems	b-TREATMENT
77993	to	O
77994	nantucket	b-CLINICAL_DEPT
77995	cottage	i-CLINICAL_DEPT
77996	hospital	i-CLINICAL_DEPT
77997	for	O
77998	furher	b-TEST
77999	evaluation	i-TEST
78000	.	O
78001	brief	O
78002	hospital	O
78003	course	O
78004	:	O
78005	the	O
78006	patient	O
78007	was	O
78008	admitted	b-OCCURRENCE
78009	to	O
78010	nantucket	b-CLINICAL_DEPT
78011	cottage	i-CLINICAL_DEPT
78012	hospital	i-CLINICAL_DEPT
78013	on	O
78014	2013-03-27	b-DATE
78015	following	O
78016	a	b-OCCURRENCE
78017	motor	i-OCCURRENCE
78018	vehicle	i-OCCURRENCE
78019	crash	i-OCCURRENCE
78020	as	O
78021	described	O
78022	previously	O
78023	.	O
78024	chest	b-TEST
78025	and	i-TEST
78026	pelvis	i-TEST
78027	x-rays	i-TEST
78028	were	O
78029	negative	O
78030	for	O
78031	fractures	b-PROBLEM
78032	.	O
78033	a	b-TEST
78034	ct	i-TEST
78035	of	i-TEST
78036	her	i-TEST
78037	head	i-TEST
78038	demonstrated	b-EVIDENTIAL
78039	intraparenchymal	b-PROBLEM
78040	and	i-PROBLEM
78041	extraaxial	i-PROBLEM
78042	blood	i-PROBLEM
78043	(	i-PROBLEM
78044	mostly	i-PROBLEM
78045	subarachnoid	i-PROBLEM
78046	)	i-PROBLEM
78047	in	i-PROBLEM
78048	bilateral	i-PROBLEM
78049	cerebral	i-PROBLEM
78050	hemispheres	i-PROBLEM
78051	,	O
78052	right	O
78053	greater	O
78054	than	O
78055	left	O
78056	,	O
78057	in	O
78058	a	O
78059	pattern	O
78060	indicating	O
78061	contrecoup	b-PROBLEM
78062	injury	i-PROBLEM
78063	.	O
78064	a	b-TEST
78065	ct	i-TEST
78066	of	i-TEST
78067	her	i-TEST
78068	c-spine	i-TEST
78069	revealed	b-EVIDENTIAL
78070	a	O
78071	possible	O
78072	fracture	b-PROBLEM
78073	of	i-PROBLEM
78074	right	i-PROBLEM
78075	c7	i-PROBLEM
78076	pedicle	i-PROBLEM
78077	.	O
78078	a	b-TEST
78079	ct	i-TEST
78080	of	i-TEST
78081	her	i-TEST
78082	chest	i-TEST
78083	revealed	b-EVIDENTIAL
78084	bliateral	b-PROBLEM
78085	lung	i-PROBLEM
78086	nodules	i-PROBLEM
78087	and	O
78088	a	b-PROBLEM
78089	right	i-PROBLEM
78090	thyroid	i-PROBLEM
78091	nodule	i-PROBLEM
78092	.	O
78093	a	b-TEST
78094	ct	i-TEST
78095	of	i-TEST
78096	her	i-TEST
78097	sinues	i-TEST
78098	revealed	b-EVIDENTIAL
78099	no	O
78100	fractures	b-PROBLEM
78101	.	O
78102	x-rays	b-TEST
78103	of	i-TEST
78104	her	i-TEST
78105	right	i-TEST
78106	lower	i-TEST
78107	extremity	i-TEST
78108	were	O
78109	negative	O
78110	for	O
78111	any	b-PROBLEM
78112	acute	i-PROBLEM
78113	injury	i-PROBLEM
78114	.	O
78115	a	b-CLINICAL_DEPT
78116	neurosurgery	i-CLINICAL_DEPT
78117	consult	O
78118	was	O
78119	obtained	O
78120	.	O
78121	our	O
78122	recommendations	O
78123	were	O
78124	to	O
78125	load	O
78126	her	O
78127	with	O
78128	dilantin	b-TREATMENT
78129	and	O
78130	then	O
78131	continue	O
78132	at	O
78133	100	O
78134	mg	O
78135	po	O
78136	tid	b-FREQUENCY
78137	.	O
78138	the	b-CLINICAL_DEPT
78139	orthopedics	i-CLINICAL_DEPT
78140	spine	i-CLINICAL_DEPT
78141	service	i-CLINICAL_DEPT
78142	saw	O
78143	her	O
78144	and	O
78145	put	O
78146	her	O
78147	in	O
78148	a	b-TREATMENT
78149	c-collar	i-TREATMENT
78150	.	O
78151	she	O
78152	was	O
78153	admitted	b-OCCURRENCE
78154	to	O
78155	the	b-CLINICAL_DEPT
78156	trauma	i-CLINICAL_DEPT
78157	icu	i-CLINICAL_DEPT
78158	.	O
78159	a	b-TEST
78160	repeat	i-TEST
78161	head	i-TEST
78162	ct	i-TEST
78163	12	b-TIME
78164	hours	i-TIME
78165	after	i-TIME
78166	the	b-TEST
78167	first	i-TEST
78168	was	O
78169	largely	b-OCCURRENCE
78170	unchanged	i-OCCURRENCE
78171	.	O
78172	she	O
78173	was	O
78174	transferred	b-OCCURRENCE
78175	to	O
78176	step	b-CLINICAL_DEPT
78177	down	i-CLINICAL_DEPT
78178	.	O
78179	she	O
78180	was	O
78181	having	O
78182	some	b-PROBLEM
78183	pain	i-PROBLEM
78184	issues	i-PROBLEM
78185	and	O
78186	morphine	b-TREATMENT
78187	was	O
78188	making	O
78189	her	O
78190	""""	O
78191	jittery	b-PROBLEM
78192	"."""	O
78193	on	O
78194	hd	b-DATE
78195	2	i-DATE
78196	she	O
78197	was	O
78198	switched	O
78199	to	O
78200	fioricet	b-TREATMENT
78201	,	O
78202	which	O
78203	helped	b-EVIDENTIAL
78204	with	O
78205	her	b-PROBLEM
78206	headaches	i-PROBLEM
78207	.	O
78208	a	b-TEST
78209	repeact	i-TEST
78210	head	i-TEST
78211	ct	i-TEST
78212	was	O
78213	unchanged	b-OCCURRENCE
78214	.	O
78215	an	b-TEST
78216	mri	i-TEST
78217	of	i-TEST
78218	her	i-TEST
78219	c-spine	i-TEST
78220	was	O
78221	done	O
78222	to	O
78223	evaluate	O
78224	for	O
78225	ligamentous	b-PROBLEM
78226	injury	i-PROBLEM
78227	,	O
78228	but	O
78229	this	O
78230	was	O
78231	extremely	b-TEST
78232	limited	i-TEST
78233	examination	i-TEST
78234	due	O
78235	to	O
78236	patient	O
78237	motion	O
78238	and	O
78239	the	O
78240	signal	O
78241	in	O
78242	the	O
78243	spinal	O
78244	cord	O
78245	could	O
78246	not	O
78247	be	O
78248	adequately	O
78249	assessed	O
78250	for	O
78251	edema	b-PROBLEM
78252	.	O
78253	as	O
78254	per	O
78255	cmed	b-CLINICAL_DEPT
78256	csru	i-CLINICAL_DEPT
78257	spine	i-CLINICAL_DEPT
78258	,	O
78259	the	O
78260	patient	O
78261	was	O
78262	instructed	O
78263	to	O
78264	follow-up	b-TREATMENT
78265	in	O
78266	2	b-DATE
78267	weeks	i-DATE
78268	for	O
78269	repeat	b-TEST
78270	x-rays	i-TEST
78271	.	O
78272	on	O
78273	discharge	b-OCCURRENCE
78274	she	O
78275	was	O
78276	awake	b-OCCURRENCE
78277	,	i-OCCURRENCE
78278	alert	i-OCCURRENCE
78279	and	i-OCCURRENCE
78280	orientated	i-OCCURRENCE
78281	x3	i-OCCURRENCE
78282	with	O
78283	c/o	O
78284	mild	b-PROBLEM
78285	headache	i-PROBLEM
78286	.	O
78287	she	O
78288	had	O
78289	full	b-TEST
78290	strength	i-TEST
78291	motor	i-TEST
78292	exam	i-TEST
78293	,	O
78294	no	O
78295	pronator	b-PROBLEM
78296	drift	i-PROBLEM
78297	and	O
78298	perrla	b-OCCURRENCE
78299	with	O
78300	full	b-OCCURRENCE
78301	eom	i-OCCURRENCE
78302	s.	i-OCCURRENCE
78303	she	O
78304	was	O
78305	ambulating	b-OCCURRENCE
78306	without	O
78307	difficulties	b-PROBLEM
78308	.	O
78309	on	O
78310	04-01	b-DATE
78311	she	O
78312	was	O
78313	seen	b-OCCURRENCE
78314	by	i-OCCURRENCE
78315	physical	i-OCCURRENCE
78316	therapy	i-OCCURRENCE
78317	was	O
78318	thought	O
78319	to	O
78320	benefit	O
78321	from	O
78322	acute	b-TREATMENT
78323	rehabilitation	i-TREATMENT
78324	.	O
78325	she	O
78326	had	O
78327	a	b-TEST
78328	head	i-TEST
78329	ct	i-TEST
78330	prior	O
78331	to	O
78332	discharge	b-OCCURRENCE
78333	that	O
78334	showed	b-EVIDENTIAL
78335	resolution	O
78336	of	O
78337	the	b-PROBLEM
78338	subarachnoid	i-PROBLEM
78339	hemorrhage	i-PROBLEM
78340	.	O
78341	follow-up	b-TEST
78342	in	O
78343	1	b-DATE
78344	month	i-DATE
78345	with	O
78346	neurosurgery	b-CLINICAL_DEPT
78347	for	O
78348	a	b-TEST
78349	repeat	i-TEST
78350	head	i-TEST
78351	ct	i-TEST
78352	was	O
78353	arranged	O
78354	.	O
78355	she	O
78356	was	O
78357	discharged	b-OCCURRENCE
78358	on	O
78359	fioricet	b-TREATMENT
78360	and	O
78361	dilantin	b-TREATMENT
78362	.	O
78363	she	O
78364	was	O
78365	counseled	O
78366	to	O
78367	follow-up	b-TEST
78368	with	O
78369	her	b-CLINICAL_DEPT
78370	pcp	i-CLINICAL_DEPT
78371	f	O
78372	6-12	b-DATE
78373	months	i-DATE
78374	regading	O
78375	the	b-PROBLEM
78376	right	i-PROBLEM
78377	thyroid	i-PROBLEM
78378	nodule	i-PROBLEM
78379	and	O
78380	the	b-PROBLEM
78381	bilateral	i-PROBLEM
78382	small	i-PROBLEM
78383	lung	i-PROBLEM
78384	nodules	i-PROBLEM
78385	seen	O
78386	on	O
78387	her	b-TEST
78388	chest	i-TEST
78389	ct	i-TEST
78390	.	O
78391		O
78392	admission	b-OCCURRENCE
78393	date	O
78394	:	O
78395	4/16/93	b-ADMISSION
78396	discharge	b-OCCURRENCE
78397	date	O
78398	:	O
78399	4/23/93	b-DISCHARGE
78400	history	O
78401	of	O
78402	present	O
78403	illness	O
78404	:	O
78405	the	O
78406	patient	O
78407	is	O
78408	a	b-OCCURRENCE
78409	generally	i-OCCURRENCE
78410	healthy	i-OCCURRENCE
78411	85	O
78412	year	O
78413	old	O
78414	female	O
78415	,	O
78416	who	O
78417	has	O
78418	had	O
78419	a	O
78420	five	b-DURATION
78421	year	i-DURATION
78422	history	O
78423	of	O
78424	right	b-PROBLEM
78425	hip	i-PROBLEM
78426	pain	i-PROBLEM
78427	,	O
78428	worsening	b-PROBLEM
78429	over	O
78430	the	b-DURATION
78431	past	i-DURATION
78432	several	i-DURATION
78433	months	i-DURATION
78434	.	O
78435	her	b-PROBLEM
78436	pain	i-PROBLEM
78437	is	O
78438	located	O
78439	in	O
78440	the	O
78441	groin	O
78442	and	O
78443	thigh	O
78444	.	O
78445	it	O
78446	is	O
78447	aggravated	b-PROBLEM
78448	by	O
78449	activity	b-OCCURRENCE
78450	and	O
78451	improved	b-OCCURRENCE
78452	by	O
78453	sitting	b-OCCURRENCE
78454	or	i-OCCURRENCE
78455	lying	i-OCCURRENCE
78456	down	i-OCCURRENCE
78457	.	O
78458	it	O
78459	is	O
78460	associated	O
78461	with	O
78462	rest	b-PROBLEM
78463	pain	i-PROBLEM
78464	as	O
78465	well	O
78466	.	O
78467	she	O
78468	uses	O
78469	a	b-TREATMENT
78470	cane	i-TREATMENT
78471	or	O
78472	walker	b-TREATMENT
78473	for	O
78474	ambulation	b-OCCURRENCE
78475	,	O
78476	and	O
78477	is	O
78478	limited	O
78479	to	O
78480	one	O
78481	to	O
78482	two	O
78483	blocks	O
78484	.	O
78485	she	O
78486	does	O
78487	stairs	b-OCCURRENCE
78488	one	O
78489	at	O
78490	a	O
78491	time	O
78492	and	O
78493	only	O
78494	with	O
78495	help	b-OCCURRENCE
78496	.	O
78497	she	O
78498	has	O
78499	difficulty	b-PROBLEM
78500	with	i-PROBLEM
78501	shoes	i-PROBLEM
78502	and	i-PROBLEM
78503	socks	i-PROBLEM
78504	and	i-PROBLEM
78505	foot	i-PROBLEM
78506	care	i-PROBLEM
78507	.	O
78508	the	b-PROBLEM
78509	patient	i-PROBLEM
78510	&apos;s	i-PROBLEM
78511	pain	i-PROBLEM
78512	has	O
78513	not	O
78514	been	O
78515	relieved	O
78516	by	O
78517	darvocet	b-TREATMENT
78518	and	O
78519	advil	b-TREATMENT
78520	.	O
78521	radiographs	b-TEST
78522	demonstrate	b-EVIDENTIAL
78523	right	b-PROBLEM
78524	hip	i-PROBLEM
78525	osteoarthritis	i-PROBLEM
78526	.	O
78527	having	O
78528	failed	O
78529	conservative	b-TREATMENT
78530	management	i-TREATMENT
78531	,	O
78532	the	O
78533	patient	O
78534	presented	b-EVIDENTIAL
78535	for	O
78536	elective	b-TREATMENT
78537	right	i-TREATMENT
78538	total	i-TREATMENT
78539	hip	i-TREATMENT
78540	replacement	i-TREATMENT
78541	.	O
78542	hospital	O
78543	course	O
78544	:	O
78545	the	O
78546	patient	O
78547	was	O
78548	admitted	b-OCCURRENCE
78549	to	O
78550	the	O
78551	orthopedic	O
78552	service	O
78553	on	O
78554	4/16/93	b-DATE
78555	.	O
78556	on	O
78557	that	b-DATE
78558	day	i-DATE
78559	she	O
78560	underwent	O
78561	clearance	b-TEST
78562	from	O
78563	the	O
78564	cardiology	O
78565	service	O
78566	,	O
78567	doctor	O
78568	shuff	O
78569	.	O
78570	it	O
78571	was	O
78572	his	O
78573	impression	O
78574	that	O
78575	the	b-PROBLEM
78576	patient	i-PROBLEM
78577	&apos;s	i-PROBLEM
78578	hypertension	i-PROBLEM
78579	was	O
78580	controlled	O
78581	on	O
78582	hydrochlorothiazide	b-TREATMENT
78583	.	O
78584	given	O
78585	the	b-PROBLEM
78586	patient	i-PROBLEM
78587	&apos;s	i-PROBLEM
78588	low	i-PROBLEM
78589	potassium	i-PROBLEM
78590	level	i-PROBLEM
78591	of	O
78592	2.4	O
78593	on	O
78594	the	b-DATE
78595	day	i-DATE
78596	of	O
78597	admission	b-OCCURRENCE
78598	,	O
78599	he	O
78600	suggested	O
78601	supplementation	O
78602	with	O
78603	potassium	b-TREATMENT
78604	.	O
78605	the	O
78606	patient	O
78607	was	O
78608	cleared	b-OCCURRENCE
78609	from	O
78610	surgery	O
78611	from	O
78612	a	O
78613	cardiology	O
78614	standpoint	O
78615	.	O
78616	on	O
78617	the	O
78618	following	O
78619	morning	b-DATE
78620	4/17/93	i-DATE
78621	,	O
78622	the	O
78623	patient	O
78624	was	O
78625	taken	O
78626	to	O
78627	the	b-CLINICAL_DEPT
78628	operating	i-CLINICAL_DEPT
78629	room	i-CLINICAL_DEPT
78630	where	O
78631	she	O
78632	underwent	O
78633	a	b-TREATMENT
78634	right	i-TREATMENT
78635	total	i-TREATMENT
78636	hip	i-TREATMENT
78637	replacement	i-TREATMENT
78638	,	O
78639	using	O
78640	a	b-TREATMENT
78641	hybrid	i-TREATMENT
78642	s-rom	i-TREATMENT
78643	system	i-TREATMENT
78644	.	O
78645	postoperatively	O
78646	,	O
78647	the	O
78648	patient	O
78649	did	b-OCCURRENCE
78650	extremely	i-OCCURRENCE
78651	well	i-OCCURRENCE
78652	.	O
78653	the	O
78654	patient	O
78655	was	O
78656	seen	O
78657	in	O
78658	consultation	b-OCCURRENCE
78659	with	O
78660	the	O
78661	physical	O
78662	therapy	O
78663	service	O
78664	initially	O
78665	for	O
78666	routine	b-TREATMENT
78667	rehabilitation	i-TREATMENT
78668	after	O
78669	a	b-TREATMENT
78670	total	i-TREATMENT
78671	hip	i-TREATMENT
78672	replacement	i-TREATMENT
78673	.	O
78674	her	b-TREATMENT
78675	hemovac	i-TREATMENT
78676	drains	i-TREATMENT
78677	were	O
78678	removed	O
78679	on	O
78680	postoperative	b-DATE
78681	day	i-DATE
78682	#	i-DATE
78683	2	i-DATE
78684	as	O
78685	was	O
78686	her	b-TREATMENT
78687	foley	i-TREATMENT
78688	catheter	i-TREATMENT
78689	.	O
78690	her	b-TEST
78691	hematocrit	i-TEST
78692	remained	O
78693	stable	b-OCCURRENCE
78694	in	O
78695	the	O
78696	low	O
78697	to	O
78698	mid	O
78699	30	O
78700	&apos;s	O
78701	and	O
78702	she	O
78703	did	O
78704	not	O
78705	require	O
78706	a	b-TREATMENT
78707	transfusion	i-TREATMENT
78708	.	O
78709	the	O
78710	patient	O
78711	did	O
78712	have	O
78713	postoperatively	b-PROBLEM
78714	hypokalemia	i-PROBLEM
78715	to	O
78716	a	O
78717	level	O
78718	of	O
78719	2.7	O
78720	and	O
78721	subsequently	O
78722	was	O
78723	corrected	O
78724	with	O
78725	oral	b-TREATMENT
78726	and	i-TREATMENT
78727	intravenous	i-TREATMENT
78728	potassium	i-TREATMENT
78729	on	O
78730	4/22/93	b-DATE
78731	,	O
78732	the	O
78733	patient	O
78734	underwent	O
78735	a	b-TEST
78736	duplex	i-TEST
78737	ultrasound	i-TEST
78738	examination	i-TEST
78739	,	O
78740	which	O
78741	showed	b-EVIDENTIAL
78742	no	O
78743	evidence	O
78744	of	O
78745	of	O
78746	deep	b-PROBLEM
78747	venous	i-PROBLEM
78748	thrombosis	i-PROBLEM
78749	.	O
78750	the	b-TREATMENT
78751	patient	i-TREATMENT
78752	&apos;s	i-TREATMENT
78753	coumadin	i-TREATMENT
78754	was	O
78755	thus	O
78756	stopped	O
78757	and	O
78758	she	O
78759	was	O
78760	switched	O
78761	to	O
78762	bufferin	b-TREATMENT
78763	.	O
78764	the	O
78765	patient	O
78766	&apos;s	O
78767	hospitalization	b-OCCURRENCE
78768	was	O
78769	uncomplicated	b-OCCURRENCE
78770	.	O
78771	she	O
78772	was	O
78773	discharged	b-OCCURRENCE
78774	to	O
78775	the	b-CLINICAL_DEPT
78776	encharlea	i-CLINICAL_DEPT
78777	il	i-CLINICAL_DEPT
78778	medical	i-CLINICAL_DEPT
78779	center	i-CLINICAL_DEPT
78780	in	O
78781	new	O
78782	hampshire	O
78783	.	O
78784		O
78785	admission	b-OCCURRENCE
78786	date	O
78787	:	O
78788	2015-08-10	b-ADMISSION
78789	discharge	b-OCCURRENCE
78790	date	O
78791	:	O
78792	2015-08-15	b-DISCHARGE
78793	service	O
78794	:	O
78795	ct	O
78796	cmed	O
78797	csru	O
78798	history	O
78799	of	O
78800	present	O
78801	illness	O
78802	:	O
78803	mr.	O
78804	bruno	O
78805	is	O
78806	a	O
78807	60	O
78808	year	O
78809	old	O
78810	gentleman	O
78811	who	O
78812	initially	O
78813	presented	b-OCCURRENCE
78814	with	O
78815	hematemesis	b-PROBLEM
78816	,	O
78817	hemoptysis	b-PROBLEM
78818	and	O
78819	on	O
78820	work-up	b-TEST
78821	was	O
78822	found	O
78823	to	O
78824	have	O
78825	a	b-PROBLEM
78826	left	i-PROBLEM
78827	lower	i-PROBLEM
78828	lobe	i-PROBLEM
78829	mass	i-PROBLEM
78830	.	O
78831	he	O
78832	previously	O
78833	underwent	O
78834	bronchoscopy	b-TEST
78835	with	i-TEST
78836	washings	i-TEST
78837	which	O
78838	showed	b-EVIDENTIAL
78839	to	O
78840	be	O
78841	negative	O
78842	for	O
78843	malignant	b-PROBLEM
78844	cells	i-PROBLEM
78845	and	O
78846	showed	b-EVIDENTIAL
78847	atypical	b-PROBLEM
78848	bronchial	i-PROBLEM
78849	epithelial	i-PROBLEM
78850	cells	i-PROBLEM
78851	,	O
78852	likely	O
78853	to	O
78854	be	O
78855	reactive	b-TEST
78856	.	O
78857	hospital	O
78858	course	O
78859	:	O
78860	the	O
78861	patient	O
78862	was	O
78863	taken	O
78864	to	O
78865	the	b-CLINICAL_DEPT
78866	operating	i-CLINICAL_DEPT
78867	room	i-CLINICAL_DEPT
78868	the	b-DATE
78869	day	i-DATE
78870	of	O
78871	admission	b-OCCURRENCE
78872	.	O
78873	he	O
78874	underwent	O
78875	a	b-TEST
78876	left	i-TEST
78877	bronchoscopy	i-TEST
78878	and	O
78879	lower	b-TREATMENT
78880	lobectomy	i-TREATMENT
78881	of	i-TREATMENT
78882	the	i-TREATMENT
78883	left	i-TREATMENT
78884	side	i-TREATMENT
78885	.	O
78886	the	b-TREATMENT
78887	operation	i-TREATMENT
78888	was	O
78889	subsequently	O
78890	complicated	O
78891	by	O
78892	a	b-PROBLEM
78893	postoperative	i-PROBLEM
78894	bleeding	i-PROBLEM
78895	.	O
78896	the	O
78897	patient	O
78898	had	O
78899	to	O
78900	be	O
78901	taken	b-OCCURRENCE
78902	back	i-OCCURRENCE
78903	to	O
78904	the	b-CLINICAL_DEPT
78905	operating	i-CLINICAL_DEPT
78906	room	i-CLINICAL_DEPT
78907	where	O
78908	a	b-TREATMENT
78909	repair	i-TREATMENT
78910	of	i-TREATMENT
78911	the	i-TREATMENT
78912	left	i-TREATMENT
78913	pulmonary	i-TREATMENT
78914	artery	i-TREATMENT
78915	was	O
78916	performed	O
78917	.	O
78918	the	O
78919	patient	O
78920	was	O
78921	then	O
78922	transferred	b-OCCURRENCE
78923	to	O
78924	the	b-CLINICAL_DEPT
78925	csru	i-CLINICAL_DEPT
78926	,	O
78927	intubated	b-TREATMENT
78928	,	O
78929	in	O
78930	stable	O
78931	condition	O
78932	.	O
78933	vascular	b-CLINICAL_DEPT
78934	surgery	i-CLINICAL_DEPT
78935	service	i-CLINICAL_DEPT
78936	was	O
78937	also	O
78938	consulted	O
78939	.	O
78940	during	O
78941	the	b-TREATMENT
78942	operation	i-TREATMENT
78943	,	O
78944	the	O
78945	patient	O
78946	received	O
78947	13	O
78948	units	O
78949	of	O
78950	packed	b-TREATMENT
78951	red	i-TREATMENT
78952	blood	i-TREATMENT
78953	cells	i-TREATMENT
78954	,	O
78955	four	O
78956	units	O
78957	of	O
78958	fresh	b-TREATMENT
78959	frozen	i-TREATMENT
78960	plasma	i-TREATMENT
78961	and	O
78962	one	O
78963	unit	O
78964	of	O
78965	platelets	b-TREATMENT
78966	with	O
78967	an	b-PROBLEM
78968	estimated	i-PROBLEM
78969	blood	i-PROBLEM
78970	loss	i-PROBLEM
78971	of	O
78972	1500	O
78973	cc	O
78974	.	O
78975	the	O
78976	patient	O
78977	remained	O
78978	to	O
78979	be	O
78980	stable	O
78981	on	O
78982	the	b-CLINICAL_DEPT
78983	floor	i-CLINICAL_DEPT
78984	with	O
78985	subsequent	O
78986	monitoring	O
78987	of	O
78988	hematocrit	b-TEST
78989	within	O
78990	a	O
78991	normal	O
78992	stable	O
78993	range	O
78994	.	O
78995	he	O
78996	is	O
78997	successfully	O
78998	extubated	b-TREATMENT
78999	on	O
79000	08-12	b-DATE
79001	and	O
79002	hypertension	b-PROBLEM
79003	transferred	b-OCCURRENCE
79004	to	O
79005	the	b-CLINICAL_DEPT
79006	floor	i-CLINICAL_DEPT
79007	in	O
79008	stable	O
79009	condition	O
79010	where	O
79011	the	b-CLINICAL_DEPT
79012	pain	i-CLINICAL_DEPT
79013	service	i-CLINICAL_DEPT
79014	is	O
79015	managing	O
79016	his	b-TREATMENT
79017	epidural	i-TREATMENT
79018	with	O
79019	very	O
79020	good	O
79021	effect	O
79022	and	O
79023	he	O
79024	is	O
79025	tolerating	O
79026	a	O
79027	regular	O
79028	p.o.	O
79029	diet	O
79030	and	O
79031	is	O
79032	making	O
79033	adequate	O
79034	amount	O
79035	of	O
79036	urine	O
79037	.	O
79038	his	O
79039	recovery	O
79040	was	O
79041	essentially	O
79042	unremarkable	O
79043	.	O
79044	his	b-TREATMENT
79045	epidural	i-TREATMENT
79046	was	O
79047	successfully	O
79048	discontinued	O
79049	and	O
79050	he	O
79051	is	O
79052	discharged	b-OCCURRENCE
79053	to	O
79054	home	O
79055	on	O
79056	08-15	b-DATE
79057	with	O
79058	instructions	O
79059	to	O
79060	follow-up	b-OCCURRENCE
79061	with	O
79062	doctor	O
79063	cordova	O
79064	in	O
79065	the	O
79066	office	O
79067	within	O
79068	the	b-DATE
79069	next	i-DATE
79070	one	i-DATE
79071	to	i-DATE
79072	two	i-DATE
79073	weeks	i-DATE
79074	.	O
79075	he	O
79076	is	O
79077	discharged	b-OCCURRENCE
79078	to	O
79079	home	O
79080	with	O
79081	pain	b-TREATMENT
79082	medication	i-TREATMENT
79083	which	O
79084	is	O
79085	percocet	b-TREATMENT
79086	.	O
79087		O
79088	admission	b-OCCURRENCE
79089	date	O
79090	:	O
79091	2016-02-15	b-ADMISSION
79092	discharge	b-OCCURRENCE
79093	date	O
79094	:	O
79095	2016-02-21	b-DISCHARGE
79096	service	O
79097	:	O
79098	neonatology	O
79099	history	O
79100	of	O
79101	present	O
79102	illness	O
79103	:	O
79104	the	O
79105	infant	O
79106	is	O
79107	a	O
79108	32	b-DURATION
79109	and	i-DURATION
79110	03-05	i-DURATION
79111	week	i-DURATION
79112	male	O
79113	,	O
79114	twin	O
79115	a	O
79116	,	O
79117	who	O
79118	was	O
79119	admitted	b-OCCURRENCE
79120	to	O
79121	the	b-CLINICAL_DEPT
79122	neonatal	i-CLINICAL_DEPT
79123	intensive	i-CLINICAL_DEPT
79124	care	i-CLINICAL_DEPT
79125	unit	i-CLINICAL_DEPT
79126	for	O
79127	management	b-TREATMENT
79128	of	O
79129	prematurity	b-PROBLEM
79130	.	O
79131	the	O
79132	infant	O
79133	was	O
79134	born	b-OCCURRENCE
79135	to	O
79136	a	O
79137	38	O
79138	year	O
79139	old	O
79140	,	O
79141	gravida	b-OCCURRENCE
79142	v	i-OCCURRENCE
79143	,	i-OCCURRENCE
79144	para	i-OCCURRENCE
79145	iii	i-OCCURRENCE
79146	,	O
79147	woman	O
79148	.	O
79149	serologies	b-TEST
79150	:	O
79151	a	b-TEST
79152	positive	i-TEST
79153	,	O
79154	antibody	b-TEST
79155	negative	O
79156	,	O
79157	hepatitis	b-TEST
79158	b	i-TEST
79159	surface	i-TEST
79160	antigen	i-TEST
79161	negative	O
79162	,	O
79163	rpr	b-TEST
79164	nonreactive	O
79165	,	O
79166	rubella	b-TEST
79167	immune	O
79168	,	O
79169	gbs	b-TEST
79170	unknown	O
79171	.	O
79172	pregnancy	b-PROBLEM
79173	notable	O
79174	for:	O
79175	1.	O
79176	gestational	b-OCCURRENCE
79177	carrier	i-OCCURRENCE
79178	for	O
79179	brother	O
79180	and	O
79181	his	O
79182	wife	O
79183	(	O
79184	donor	O
79185	eggs	O
79186	).	O
79187	2.	O
79188	ivf	b-TREATMENT
79189	with	O
79190	diamniotic	b-OCCURRENCE
79191	,	O
79192	dichorionic	b-OCCURRENCE
79193	twins	O
79194	.	O
79195	3.	O
79196	at	O
79197	29-30	b-DURATION
79198	week	i-DURATION
79199	gestation	b-OCCURRENCE
79200	concern	O
79201	for	O
79202	fetal	b-PROBLEM
79203	decelerations	i-PROBLEM
79204	of	O
79205	twin	O
79206	a	O
79207	,	O
79208	admitted	b-OCCURRENCE
79209	to	O
79210	cambridge	b-CLINICAL_DEPT
79211	health	i-CLINICAL_DEPT
79212	alliance	i-CLINICAL_DEPT
79213	,	O
79214	completed	O
79215	a	O
79216	course	O
79217	of	O
79218	betamethasone	b-TREATMENT
79219	,	O
79220	discharged	b-OCCURRENCE
79221	to	O
79222	home	O
79223	.	O
79224	4.	O
79225	elevated	b-PROBLEM
79226	one	i-PROBLEM
79227	hour	i-PROBLEM
79228	glucose	i-PROBLEM
79229	tolerance	i-PROBLEM
79230	test	i-PROBLEM
79231	,	O
79232	normal	O
79233	three	b-TEST
79234	hour	i-TEST
79235	glucose	i-TEST
79236	tolerance	i-TEST
79237	test	i-TEST
79238	.	O
79239	5.	O
79240	declined	O
79241	triple	b-TEST
79242	screen	i-TEST
79243	and	O
79244	amniocentesis	b-TEST
79245	.	O
79246	gestational	b-OCCURRENCE
79247	carrier	i-OCCURRENCE
79248	for	O
79249	brother	O
79250	and	O
79251	sister-in-law	O
79252	as	O
79253	noted	O
79254	above	O
79255	.	O
79256	presented	b-OCCURRENCE
79257	with	O
79258	spontaneous	b-PROBLEM
79259	,	i-PROBLEM
79260	premature	i-PROBLEM
79261	rupture	i-PROBLEM
79262	of	i-PROBLEM
79263	membranes	i-PROBLEM
79264	.	O
79265	no	O
79266	maternal	b-PROBLEM
79267	fever	i-PROBLEM
79268	.	O
79269	clear	b-OCCURRENCE
79270	fluid	i-OCCURRENCE
79271	.	O
79272	delivery	b-TREATMENT
79273	by	i-TREATMENT
79274	cesarean	i-TREATMENT
79275	section	i-TREATMENT
79276	secondary	O
79277	to	O
79278	twin	b-PROBLEM
79279	b	i-PROBLEM
79280	breech	i-PROBLEM
79281	presentation	i-PROBLEM
79282	.	O
79283	apgars	b-TEST
79284	eight	O
79285	at	O
79286	one	b-DURATION
79287	minute	i-DURATION
79288	and	O
79289	eight	O
79290	at	O
79291	five	b-DURATION
79292	minutes	i-DURATION
79293	.	O
79294	hospital	O
79295	course	O
79296	:	O
79297	1.	O
79298	respiratory	O
79299	-	O
79300	the	O
79301	infant	O
79302	has	O
79303	remained	O
79304	in	O
79305	room	b-OCCURRENCE
79306	air	i-OCCURRENCE
79307	throughout	O
79308	this	b-OCCURRENCE
79309	hospitalization	i-OCCURRENCE
79310	with	O
79311	respiratory	b-TEST
79312	rates	i-TEST
79313	40	O
79314	s	O
79315	to	O
79316	50	O
79317	s,	O
79318	oxygen	b-TEST
79319	saturation	i-TEST
79320	greater	O
79321	than	O
79322	94%	O
79323	.	O
79324	one	b-PROBLEM
79325	apnea	i-PROBLEM
79326	and	i-PROBLEM
79327	bradycardia	i-PROBLEM
79328	event	i-PROBLEM
79329	which	O
79330	was	O
79331	self	O
79332	resolved	O
79333	on	O
79334	day	b-DATE
79335	of	i-DATE
79336	life	i-DATE
79337	four	i-DATE
79338	.	O
79339	2.	O
79340	cardiovascular	O
79341	-	O
79342	the	O
79343	infant	O
79344	was	O
79345	noted	O
79346	on	O
79347	cr-monitor	b-TEST
79348	to	O
79349	have	O
79350	premature	b-PROBLEM
79351	ventricular	i-PROBLEM
79352	contractions	i-PROBLEM
79353	which	O
79354	resolved	O
79355	spontaneously	O
79356	.	O
79357	a	b-TEST
79358	twelve	i-TEST
79359	lead	i-TEST
79360	electrocardiogram	i-TEST
79361	was	O
79362	recommended	O
79363	if	O
79364	this	O
79365	persists	O
79366	.	O
79367	no	O
79368	murmur	b-PROBLEM
79369	.	O
79370	heart	b-TEST
79371	rates	i-TEST
79372	140	O
79373	s	O
79374	to	O
79375	150	O
79376	s.	O
79377	mean	b-TEST
79378	blood	i-TEST
79379	pressure	i-TEST
79380	has	O
79381	been	O
79382	46	O
79383	to	O
79384	54	O
79385	.	O
79386	3.	O
79387	fluid	O
79388	,	O
79389	electrolytes	O
79390	and	O
79391	nutrition	O
79392	-	O
79393	the	O
79394	infant	O
79395	was	O
79396	started	O
79397	on	O
79398	enteral	b-TREATMENT
79399	feedings	i-TREATMENT
79400	on	O
79401	day	b-DATE
79402	of	i-DATE
79403	life	i-DATE
79404	one	i-DATE
79405	and	O
79406	advanced	b-OCCURRENCE
79407	to	O
79408	full	b-TREATMENT
79409	volume	i-TREATMENT
79410	feedings	i-TREATMENT
79411	by	O
79412	day	b-DATE
79413	of	i-DATE
79414	life	i-DATE
79415	four	i-DATE
79416	.	O
79417	the	O
79418	infant	O
79419	was	O
79420	initially	O
79421	started	O
79422	on	O
79423	80	O
79424	cc	O
79425	/	O
79426	kg	O
79427	/	O
79428	day	O
79429	of	O
79430	intravenous	b-TREATMENT
79431	fluid	i-TREATMENT
79432	d10w	i-TREATMENT
79433	and	O
79434	advanced	b-OCCURRENCE
79435	to	O
79436	150	O
79437	cc	O
79438	/	O
79439	kg	O
79440	/	O
79441	day	O
79442	by	O
79443	day	b-DATE
79444	of	i-DATE
79445	life	i-DATE
79446	four	i-DATE
79447	.	O
79448	the	O
79449	infant	O
79450	tolerated	b-OCCURRENCE
79451	feeding	b-OCCURRENCE
79452	advancement	i-OCCURRENCE
79453	without	O
79454	difficulty	b-PROBLEM
79455	.	O
79456	the	O
79457	infant	O
79458	did	O
79459	not	O
79460	receive	O
79461	parenteral	b-TREATMENT
79462	nutrition	i-TREATMENT
79463	.	O
79464	the	b-TEST
79465	most	i-TEST
79466	recent	i-TEST
79467	electrolytes	i-TEST
79468	on	O
79469	day	b-DATE
79470	of	i-DATE
79471	life	i-DATE
79472	two	i-DATE
79473	showed	b-EVIDENTIAL
79474	a	b-TEST
79475	sodium	i-TEST
79476	of	O
79477	145	O
79478	,	O
79479	chloride	b-TEST
79480	111	O
79481	,	O
79482	potassium	b-TEST
79483	3.8	O
79484	,	O
79485	bicarbonate	b-TEST
79486	21	O
79487	.	O
79488	the	O
79489	infant	O
79490	is	O
79491	currently	O
79492	receiving	O
79493	breast	b-OCCURRENCE
79494	milk	i-OCCURRENCE
79495	22	i-OCCURRENCE
79496	calories	i-OCCURRENCE
79497	per	O
79498	ounce	O
79499	or	O
79500	premature	b-TREATMENT
79501	enfamil	i-TREATMENT
79502	22	i-TREATMENT
79503	calories	i-TREATMENT
79504	per	O
79505	ounce	O
79506	,	O
79507	150	O
79508	cc	O
79509	/	O
79510	kg	O
79511	/	O
79512	day	O
79513	p.o.	O
79514	and	O
79515	gavage	b-TREATMENT
79516	.	O
79517	the	b-TEST
79518	most	i-TEST
79519	recent	i-TEST
79520	weight	i-TEST
79521	today	b-DATE
79522	is	O
79523	1810	O
79524	grams	O
79525	which	O
79526	was	O
79527	no	O
79528	change	O
79529	from	O
79530	the	b-DATE
79531	previous	i-DATE
79532	day	i-DATE
79533	.	O
79534	4.	O
79535	gastrointestinal	O
79536	-	O
79537	the	O
79538	infant	O
79539	was	O
79540	started	O
79541	on	O
79542	single	b-TREATMENT
79543	phototherapy	i-TREATMENT
79544	on	O
79545	day	b-DATE
79546	of	i-DATE
79547	life	i-DATE
79548	two	i-DATE
79549	for	O
79550	a	b-TEST
79551	maximum	i-TEST
79552	bilirubin	i-TEST
79553	level	i-TEST
79554	of	O
79555	9.1	O
79556	with	O
79557	a	b-TEST
79558	direct	i-TEST
79559	of	O
79560	0.3	O
79561	.	O
79562	phototherapy	b-TREATMENT
79563	was	O
79564	discontinued	O
79565	on	O
79566	day	b-DATE
79567	of	i-DATE
79568	life	i-DATE
79569	five	i-DATE
79570	and	O
79571	the	b-TEST
79572	rebound	i-TEST
79573	bilirubin	i-TEST
79574	level	i-TEST
79575	on	O
79576	day	b-DATE
79577	of	i-DATE
79578	life	i-DATE
79579	six	i-DATE
79580	is	O
79581	7.7	O
79582	with	O
79583	a	b-TEST
79584	direct	i-TEST
79585	of	O
79586	0.2	O
79587	.	O
79588	5.	O
79589	hematology	O
79590	-	O
79591	the	b-TEST
79592	most	i-TEST
79593	recent	i-TEST
79594	hematocrit	i-TEST
79595	on	O
79596	day	b-DATE
79597	of	i-DATE
79598	life	i-DATE
79599	two	i-DATE
79600	was	O
79601	45.8%	O
79602	.	O
79603	hematocrit	b-TEST
79604	on	O
79605	admission	b-OCCURRENCE
79606	was	O
79607	54.0%	O
79608	.	O
79609	the	O
79610	infant	O
79611	has	O
79612	not	O
79613	received	O
79614	any	b-TREATMENT
79615	blood	i-TREATMENT
79616	transfusions	i-TREATMENT
79617	this	b-OCCURRENCE
79618	hospitalization	i-OCCURRENCE
79619	.	O
79620	6.	O
79621	infectious	O
79622	disease	O
79623	-	O
79624	the	O
79625	infant	O
79626	received	O
79627	48	b-DURATION
79628	hours	i-DURATION
79629	of	O
79630	ampicillin	b-TREATMENT
79631	and	O
79632	gentamicin	b-TREATMENT
79633	for	O
79634	rule	b-TEST
79635	out	i-TEST
79636	sepsis	b-PROBLEM
79637	.	O
79638	the	b-TEST
79639	complete	i-TEST
79640	blood	i-TEST
79641	count	i-TEST
79642	on	O
79643	admission	b-OCCURRENCE
79644	showed	b-EVIDENTIAL
79645	a	b-TEST
79646	white	i-TEST
79647	blood	i-TEST
79648	cell	i-TEST
79649	count	i-TEST
79650	of	O
79651	8.0	O
79652	,	O
79653	hematocrit	b-TEST
79654	54.0%	O
79655	,	O
79656	platelet	b-TEST
79657	count	i-TEST
79658	190,000	O
79659	,	O
79660	11	O
79661	neutrophils	b-TEST
79662	,	O
79663	0	O
79664	bands	b-TEST
79665	.	O
79666	a	b-TEST
79667	repeat	i-TEST
79668	complete	i-TEST
79669	blood	i-TEST
79670	count	i-TEST
79671	on	O
79672	day	b-DATE
79673	of	i-DATE
79674	life	i-DATE
79675	two	i-DATE
79676	showed	b-EVIDENTIAL
79677	a	b-TEST
79678	white	i-TEST
79679	blood	i-TEST
79680	cell	i-TEST
79681	count	i-TEST
79682	of	O
79683	6.3	O
79684	,	O
79685	hematocrit	b-TEST
79686	45.8%	O
79687	,	O
79688	platelet	b-TEST
79689	count	i-TEST
79690	199,000	O
79691	,	O
79692	37	O
79693	neutrophils	b-TEST
79694	,	O
79695	0	O
79696	bands	b-TEST
79697	,	O
79698	53	O
79699	lymphocytes	b-TEST
79700	.	O
79701	blood	b-TEST
79702	cultures	i-TEST
79703	remained	O
79704	negative	O
79705	to	O
79706	date	O
79707	.	O
79708	7.	O
79709	neurology	O
79710	-	O
79711	normal	b-TEST
79712	neurologic	b-TEST
79713	examination	i-TEST
79714	.	O
79715	the	O
79716	infant	O
79717	does	O
79718	not	O
79719	meet	O
79720	criteria	O
79721	for	O
79722	head	b-TEST
79723	ultrasound	i-TEST
79724	.	O
79725	8.	O
79726	sensory	O
79727	-	O
79728	hearing	b-TEST
79729	screening	i-TEST
79730	is	O
79731	recommended	O
79732	prior	O
79733	to	O
79734	discharge	b-OCCURRENCE
79735	.	O
79736	9.	O
79737	psychosocial	O
79738	-	O
79739	as	O
79740	noted	O
79741	above	O
79742	,	O
79743	paternal	O
79744	aunt	O
79745	was	O
79746	the	b-OCCURRENCE
79747	gestational	i-OCCURRENCE
79748	carrier	i-OCCURRENCE
79749	.	O
79750	the	O
79751	infants	O
79752	are	O
79753	legally	O
79754	under	O
79755	the	O
79756	parents	O
79757	'	O
79758	names	O
79759	and	O
79760	they	O
79761	are	O
79762	involved	O
79763	with	O
79764	the	O
79765	infant	O
79766	's	O
79767	care	O
79768	.	O
79769	the	b-OCCURRENCE
79770	gestational	i-OCCURRENCE
79771	carrier	i-OCCURRENCE
79772	is	O
79773	not	O
79774	involved	O
79775	.	O
79776	noted	O
79777	in	O
79778	the	O
79779	chart	O
79780	are	O
79781	legal	O
79782	documents	O
79783	.	O
79784	the	O
79785	contact	O
79786	social	O
79787	worker	O
79788	can	O
79789	be	O
79790	reached	O
79791	at	O
79792	(	O
79793	756	O
79794	)	O
79795	599-4849	O
79796	.	O
79797		O
79798	admission	b-OCCURRENCE
79799	date	O
79800	:	O
79801	06/16/1997	b-ADMISSION
79802	discharge	b-OCCURRENCE
79803	date	O
79804	:	O
79805	06/18/1997	b-DISCHARGE
79806	history	O
79807	of	O
79808	present	O
79809	illness	O
79810	:	O
79811	this	O
79812	is	O
79813	a	O
79814	70	O
79815	year	O
79816	old	O
79817	gentleman	O
79818	with	O
79819	metastatic	b-PROBLEM
79820	rectal	i-PROBLEM
79821	cancer	i-PROBLEM
79822	who	O
79823	presented	b-OCCURRENCE
79824	with	O
79825	biliary	b-PROBLEM
79826	obstruction	i-PROBLEM
79827	.	O
79828	in	O
79829	the	O
79830	past	O
79831	,	O
79832	he	O
79833	had	O
79834	biliary	b-TREATMENT
79835	stents	i-TREATMENT
79836	placed	O
79837	which	O
79838	clotted	b-PROBLEM
79839	off	i-PROBLEM
79840	.	O
79841	the	O
79842	patient	O
79843	was	O
79844	admitted	b-OCCURRENCE
79845	to	O
79846	the	b-CLINICAL_DEPT
79847	short	i-CLINICAL_DEPT
79848	stay	i-CLINICAL_DEPT
79849	unit	i-CLINICAL_DEPT
79850	for	O
79851	further	b-TEST
79852	evaluation	i-TEST
79853	.	O
79854	the	b-DATE
79855	day	i-DATE
79856	prior	i-DATE
79857	,	O
79858	the	O
79859	patient	O
79860	had	O
79861	endoscopic	b-TEST
79862	retrograde	i-TEST
79863	cholangiopancreatography	i-TEST
79864	done	O
79865	with	O
79866	dilated	b-PROBLEM
79867	ducts	i-PROBLEM
79868	times	O
79869	two	b-FREQUENCY
79870	and	O
79871	eventually	O
79872	had	O
79873	interventional	O
79874	radiology	O
79875	attempt	O
79876	to	O
79877	place	O
79878	percutaneous	b-TREATMENT
79879	drains	i-TREATMENT
79880	to	O
79881	decompress	b-TREATMENT
79882	his	i-TREATMENT
79883	biliary	i-TREATMENT
79884	tree	i-TREATMENT
79885	.	O
79886	the	O
79887	patient	O
79888	had	O
79889	two	b-TREATMENT
79890	drains	i-TREATMENT
79891	placed	O
79892	after	O
79893	a	b-TREATMENT
79894	prolonged	i-TREATMENT
79895	course	i-TREATMENT
79896	and	O
79897	difficult	b-TREATMENT
79898	procedure	i-TREATMENT
79899	.	O
79900	after	O
79901	being	O
79902	transferred	b-OCCURRENCE
79903	from	O
79904	the	O
79905	interventional	O
79906	radiology	O
79907	table	O
79908	to	O
79909	the	O
79910	stretcher	O
79911	,	O
79912	one	O
79913	of	O
79914	his	b-TREATMENT
79915	lateral	i-TREATMENT
79916	percutaneous	i-TREATMENT
79917	drains	i-TREATMENT
79918	had	O
79919	been	O
79920	pulled	b-PROBLEM
79921	out	i-PROBLEM
79922	inadvertently	O
79923	.	O
79924	he	O
79925	was	O
79926	admitted	b-OCCURRENCE
79927	to	O
79928	the	b-CLINICAL_DEPT
79929	short	i-CLINICAL_DEPT
79930	stay	i-CLINICAL_DEPT
79931	unit	i-CLINICAL_DEPT
79932	,	O
79933	given	O
79934	ancef	b-TREATMENT
79935	and	O
79936	gentamicin	b-TREATMENT
79937	per	O
79938	the	O
79939	team	O
79940	for	O
79941	antibiotic	b-TREATMENT
79942	prophylaxis	i-TREATMENT
79943	and	O
79944	observed	b-TEST
79945	overnight	b-DURATION
79946	.	O
79947	hospital	O
79948	course	O
79949	:	O
79950	the	O
79951	patient	O
79952	was	O
79953	admitted	b-OCCURRENCE
79954	to	O
79955	the	b-CLINICAL_DEPT
79956	short	i-CLINICAL_DEPT
79957	stay	i-CLINICAL_DEPT
79958	unit	i-CLINICAL_DEPT
79959	and	O
79960	continued	O
79961	to	O
79962	receive	O
79963	antibiotics	b-TREATMENT
79964	overnight	b-DURATION
79965	.	O
79966	the	b-DATE
79967	next	i-DATE
79968	morning	i-DATE
79969	,	O
79970	he	O
79971	was	O
79972	doing	b-OCCURRENCE
79973	well	i-OCCURRENCE
79974	with	O
79975	the	b-TREATMENT
79976	intact	i-TREATMENT
79977	drain	i-TREATMENT
79978	draining	b-OCCURRENCE
79979	bilious	i-OCCURRENCE
79980	material	i-OCCURRENCE
79981	without	O
79982	any	O
79983	difficulty	b-PROBLEM
79984	.	O
79985	the	O
79986	patient	O
79987	was	O
79988	doing	b-OCCURRENCE
79989	well	i-OCCURRENCE
79990	with	O
79991	minimal	O
79992	to	O
79993	no	O
79994	belly	b-PROBLEM
79995	pain	i-PROBLEM
79996	and	O
79997	no	O
79998	nausea	b-PROBLEM
79999	or	O
80000	vomiting	b-PROBLEM
80001	.	O
80002	the	O
80003	patient	O
80004	was	O
80005	taken	O
80006	back	O
80007	to	O
80008	surgery	b-CLINICAL_DEPT
80009	by	O
80010	the	O
80011	interventional	O
80012	radiology	O
80013	team	O
80014	and	O
80015	had	O
80016	a	b-TREATMENT
80017	second	i-TREATMENT
80018	drain	i-TREATMENT
80019	placed	O
80020	without	O
80021	any	O
80022	difficulty	b-PROBLEM
80023	and	O
80024	was	O
80025	transferred	b-OCCURRENCE
80026	back	O
80027	to	O
80028	the	b-CLINICAL_DEPT
80029	short	i-CLINICAL_DEPT
80030	stay	i-CLINICAL_DEPT
80031	unit	i-CLINICAL_DEPT
80032	.	O
80033	the	O
80034	patient	O
80035	was	O
80036	observed	b-TEST
80037	overnight	b-DURATION
80038	without	O
80039	any	b-PROBLEM
80040	problems	i-PROBLEM
80041	.	O
80042	he	O
80043	was	O
80044	tolerating	b-OCCURRENCE
80045	p.o.	i-OCCURRENCE
80046	and	O
80047	feeling	O
80048	back	O
80049	to	O
80050	his	b-OCCURRENCE
80051	baseline	i-OCCURRENCE
80052	.	O
80053	he	O
80054	was	O
80055	discharged	b-OCCURRENCE
80056	in	O
80057	stable	b-OCCURRENCE
80058	condition	i-OCCURRENCE
80059	.	O
80060		O
80061	admission	b-OCCURRENCE
80062	date	O
80063	:	O
80064	09/15/2000	b-ADMISSION
80065	discharge	b-OCCURRENCE
80066	date	O
80067	:	O
80068	the	O
80069	patient	O
80070	was	O
80071	admitted	b-OCCURRENCE
80072	to	O
80073	the	b-CLINICAL_DEPT
80074	hospital	i-CLINICAL_DEPT
80075	on	O
80076	july	b-DATE
80077	12th	i-DATE
80078	for	O
80079	a	b-TREATMENT
80080	chole	i-TREATMENT
80081	with	O
80082	a	O
80083	principle	O
80084	diagnosis	O
80085	of	O
80086	recurrent	b-PROBLEM
80087	biliary	i-PROBLEM
80088	colic	i-PROBLEM
80089	.	O
80090	history	O
80091	of	O
80092	present	O
80093	illness	O
80094	:	O
80095	the	O
80096	patient	O
80097	is	O
80098	a	O
80099	42	O
80100	year	O
80101	old	O
80102	with	O
80103	recurrent	b-PROBLEM
80104	biliary	i-PROBLEM
80105	colic	i-PROBLEM
80106	.	O
80107	she	O
80108	has	O
80109	had	O
80110	ultrasound	b-PROBLEM
80111	proven	i-PROBLEM
80112	gallstones	i-PROBLEM
80113	for	O
80114	ten	b-DURATION
80115	years	i-DURATION
80116	,	O
80117	seen	O
80118	on	O
80119	an	b-TEST
80120	earlier	i-TEST
80121	obstetric	i-TEST
80122	ultrasound	i-TEST
80123	.	O
80124	the	O
80125	patient	O
80126	has	O
80127	had	O
80128	no	O
80129	symptoms	b-PROBLEM
80130	until	O
80131	approximately	O
80132	two	b-DATE
80133	years	i-DATE
80134	ago	i-DATE
80135	when	O
80136	she	O
80137	began	O
80138	having	O
80139	classic	b-PROBLEM
80140	biliary	i-PROBLEM
80141	colic	i-PROBLEM
80142	pain	i-PROBLEM
80143	with	O
80144	right	b-PROBLEM
80145	upper	i-PROBLEM
80146	quadrant	i-PROBLEM
80147	epigastric	i-PROBLEM
80148	pain	i-PROBLEM
80149	radiating	O
80150	to	O
80151	midback	O
80152	with	O
80153	nausea	b-PROBLEM
80154	,	O
80155	but	O
80156	without	O
80157	vomiting	b-PROBLEM
80158	.	O
80159	onset	O
80160	was	O
80161	an	b-DURATION
80162	hour	i-DURATION
80163	to	i-DURATION
80164	1	i-DURATION
80165	hour	i-DURATION
80166	after	O
80167	meals	b-OCCURRENCE
80168	,	O
80169	worse	O
80170	with	O
80171	greasy	O
80172	meals	O
80173	,	O
80174	lasting	O
80175	five	b-DURATION
80176	minutes	i-DURATION
80177	to	i-DURATION
80178	two	i-DURATION
80179	hours	i-DURATION
80180	.	O
80181	episodes	b-PROBLEM
80182	have	O
80183	been	O
80184	increasing	b-OCCURRENCE
80185	in	O
80186	frequency	O
80187	over	O
80188	the	b-DURATION
80189	last	i-DURATION
80190	few	i-DURATION
80191	months	i-DURATION
80192	.	O
80193	she	O
80194	has	O
80195	had	O
80196	no	O
80197	fevers	b-PROBLEM
80198	,	O
80199	chills	b-PROBLEM
80200	,	O
80201	respiratory	b-PROBLEM
80202	symptoms	i-PROBLEM
80203	,	O
80204	diarrhea	b-PROBLEM
80205	,	O
80206	bright	b-PROBLEM
80207	red	i-PROBLEM
80208	blood	i-PROBLEM
80209	per	i-PROBLEM
80210	rectum	i-PROBLEM
80211	or	O
80212	melena	b-PROBLEM
80213	.	O
80214	she	O
80215	has	O
80216	not	O
80217	found	O
80218	any	b-OCCURRENCE
80219	relieve	i-OCCURRENCE
80220	with	O
80221	any	O
80222	over	O
80223	the	b-TREATMENT
80224	counter	i-TREATMENT
80225	medications	i-TREATMENT
80226	.	O
80227	she	O
80228	has	O
80229	no	O
80230	family	O
80231	history	O
80232	of	O
80233	gallbladder	b-PROBLEM
80234	or	O
80235	pancreatic	b-PROBLEM
80236	disease	i-PROBLEM
80237	.	O
80238	she	O
80239	has	O
80240	had	O
80241	no	O
80242	significant	O
80243	weight	b-PROBLEM
80244	loss	i-PROBLEM
80245	.	O
80246	no	O
80247	anorexia	b-PROBLEM
80248	.	O
80249	an	b-TEST
80250	ultrasound	i-TEST
80251	on	O
80252	1/25/00	b-DATE
80253	showed	b-EVIDENTIAL
80254	six	b-PROBLEM
80255	gallstones	i-PROBLEM
80256	without	O
80257	cholecystitis	b-PROBLEM
80258	.	O
80259	she	O
80260	has	O
80261	no	O
80262	history	O
80263	of	O
80264	liver	b-PROBLEM
80265	disease	i-PROBLEM
80266	,	O
80267	hepatitis	b-PROBLEM
80268	.	O
80269	the	O
80270	patient	O
80271	is	O
80272	from	O
80273	45	O
80274	sidewonly	O
80275	blvd	O
80276	,	O
80277	fresa	O
80278	loharanleah	O
80279	,	O
80280	maryland	O
80281	.	O
80282	has	O
80283	lived	O
80284	in	O
80285	896	O
80286	lokatspur	O
80287	pkwy	O
80288	,	O
80289	ingrich	O
80290	vepobuffh	O
80291	,	O
80292	indiana	O
80293	for	O
80294	25	b-DURATION
80295	years	i-DURATION
80296	and	O
80297	works	O
80298	as	O
80299	a	O
80300	teaching	O
80301	assistant	O
80302	in	O
80303	a	O
80304	second	O
80305	grade	O
80306	in	O
80307	satlnonew	O
80308	rollglend	O
80309	pabridrham	O
80310	.	O
80311	hospital	O
80312	course	O
80313	:	O
80314	the	O
80315	patient	O
80316	was	O
80317	admitted	b-OCCURRENCE
80318	for	O
80319	the	b-TREATMENT
80320	lap	i-TREATMENT
80321	coli	i-TREATMENT
80322	with	O
80323	an	b-TEST
80324	intraoperative	i-TEST
80325	cholangiogram	i-TEST
80326	by	O
80327	doctor	O
80328	sterp	O
80329	under	O
80330	general	b-TREATMENT
80331	anesthesia	i-TREATMENT
80332	.	O
80333	a	O
80334	separate	O
80335	operative	O
80336	note	O
80337	has	O
80338	been	O
80339	dictated	O
80340	.	O
80341	operative	O
80342	course	O
80343	and	O
80344	recovery	O
80345	were	O
80346	without	O
80347	complication	b-PROBLEM
80348	.	O
80349	the	O
80350	patient	O
80351	was	O
80352	admitted	b-OCCURRENCE
80353	to	O
80354	floor	b-CLINICAL_DEPT
80355	.	O
80356	the	O
80357	patient	O
80358	was	O
80359	afebrile	b-PROBLEM
80360	,	O
80361	vital	b-TEST
80362	signs	i-TEST
80363	were	O
80364	stable	O
80365	.	O
80366	she	O
80367	is	O
80368	taking	O
80369	po	O
80370	&apos;s	O
80371	.	O
80372	she	O
80373	is	O
80374	ambulatory	O
80375	.	O
80376	the	O
80377	patient	O
80378	will	O
80379	be	O
80380	discharged	b-OCCURRENCE
80381	to	O
80382	home	O
80383	in	O
80384	stable	b-OCCURRENCE
80385	condition	i-OCCURRENCE
80386	with	O
80387	a	b-OCCURRENCE
80388	follow	i-OCCURRENCE
80389	up	i-OCCURRENCE
80390	appointment	i-OCCURRENCE
80391	with	O
80392	doctor	O
80393	sterp	O
80394	.	O
80395		O
80396	admission	b-OCCURRENCE
80397	date	O
80398	:	O
80399	02/19/1991	b-ADMISSION
80400	discharge	b-OCCURRENCE
80401	date	O
80402	:	O
80403	02/25/1991	b-DISCHARGE
80404	history	O
80405	of	O
80406	present	O
80407	illness	O
80408	:	O
80409	this	O
80410	is	O
80411	an	O
80412	81-year-old	O
80413	who	O
80414	presented	b-OCCURRENCE
80415	with	O
80416	postmenopausal	b-PROBLEM
80417	spotting	i-PROBLEM
80418	and	O
80419	had	O
80420	an	b-TEST
80421	endometrial	i-TEST
80422	biopsy	i-TEST
80423	which	O
80424	was	O
80425	read	b-EVIDENTIAL
80426	at	O
80427	the	b-CLINICAL_DEPT
80428	etearal	i-CLINICAL_DEPT
80429	etsystems/	i-CLINICAL_DEPT
80430	hospital	i-CLINICAL_DEPT
80431	as	O
80432	showing	b-EVIDENTIAL
80433	grade	b-PROBLEM
80434	i	i-PROBLEM
80435	adenocarcinoma	i-PROBLEM
80436	.	O
80437	accordingly	O
80438	she	O
80439	presents	b-OCCURRENCE
80440	for	O
80441	operative	b-TREATMENT
80442	therapy	i-TREATMENT
80443	at	O
80444	this	b-DATE
80445	time	i-DATE
80446	.	O
80447	hospital	O
80448	course	O
80449	:	O
80450	the	O
80451	patient	O
80452	was	O
80453	brought	O
80454	to	O
80455	the	b-CLINICAL_DEPT
80456	operating	i-CLINICAL_DEPT
80457	room	i-CLINICAL_DEPT
80458	on	O
80459	2-19-91	b-DATE
80460	where	O
80461	she	O
80462	had	O
80463	an	b-TEST
80464	exploratory	i-TEST
80465	laparotomy	i-TEST
80466	,	O
80467	tah	b-TREATMENT
80468	/	i-TREATMENT
80469	bso	i-TREATMENT
80470	,	O
80471	and	O
80472	omental	b-TEST
80473	biopsy	i-TEST
80474	.	O
80475	she	O
80476	had	O
80477	a	b-TEST
80478	normal	i-TEST
80479	abdominal	b-TEST
80480	exploration	i-TEST
80481	of	O
80482	a	O
80483	small	O
80484	uterus	O
80485	with	O
80486	superficial	b-TEST
80487	invasion	i-TEST
80488	on	O
80489	gross	b-TEST
80490	examination	i-TEST
80491	,	O
80492	normal	O
80493	ovaries	O
80494	.	O
80495	washings	b-TEST
80496	were	O
80497	sent	b-OCCURRENCE
80498	.	O
80499	a	b-TREATMENT
80500	subfascial	i-TREATMENT
80501	j-p	i-TREATMENT
80502	was	O
80503	left	O
80504	.	O
80505	the	O
80506	patient	O
80507	did	O
80508	well	b-OCCURRENCE
80509	postoperatively	O
80510	and	O
80511	had	O
80512	a	b-OCCURRENCE
80513	regular	i-OCCURRENCE
80514	diet	i-OCCURRENCE
80515	by	O
80516	the	b-DATE
80517	third	i-DATE
80518	postoperative	i-DATE
80519	day	i-DATE
80520	.	O
80521	subfascia	b-TREATMENT
80522	drain	i-TREATMENT
80523	was	O
80524	discontinued	O
80525	.	O
80526	the	O
80527	patient	O
80528	&apos;s	O
80529	postoperative	O
80530	hct	b-TEST
80531	was	O
80532	34	O
80533	.	O
80534		O
80535	admission	b-OCCURRENCE
80536	date	O
80537	:	O
80538	2010-08-26	b-ADMISSION
80539	discharge	b-OCCURRENCE
80540	date	O
80541	:	O
80542	2010-09-02	b-DISCHARGE
80543	service	O
80544	:	O
80545	history	O
80546	of	O
80547	present	O
80548	illness	O
80549	:	O
80550	history	O
80551	of	O
80552	present	O
80553	illness	O
80554	:	O
80555	mr.	O
80556	robert	O
80557	mackey	O
80558	is	O
80559	a	O
80560	49	O
80561	year	O
80562	old	O
80563	gentleman	O
80564	with	O
80565	a	b-DURATION
80566	22	i-DURATION
80567	year	i-DURATION
80568	history	O
80569	of	O
80570	diabetes	b-PROBLEM
80571	mellitus	i-PROBLEM
80572	.	O
80573	he	O
80574	has	O
80575	a	O
80576	history	O
80577	of	O
80578	peripheral	b-PROBLEM
80579	neuropathy	i-PROBLEM
80580	,	O
80581	kidney	b-TREATMENT
80582	transplantation	i-TREATMENT
80583	in	O
80584	2003	b-DATE
80585	secondary	O
80586	to	O
80587	diabetic	b-PROBLEM
80588	nephropathy	i-PROBLEM
80589	,	O
80590	as	O
80591	well	O
80592	as	O
80593	throat	b-PROBLEM
80594	cancer	i-PROBLEM
80595	in	O
80596	2004	b-DATE
80597	treated	O
80598	with	O
80599	local	b-TREATMENT
80600	resection	i-TREATMENT
80601	and	O
80602	radical	b-TREATMENT
80603	neck	i-TREATMENT
80604	dissection	i-TREATMENT
80605	on	i-TREATMENT
80606	the	i-TREATMENT
80607	left	i-TREATMENT
80608	as	O
80609	well	O
80610	as	O
80611	postoperative	b-TREATMENT
80612	radiation	i-TREATMENT
80613	.	O
80614	mr..	O
80615	mackey	O
80616	also	O
80617	had	O
80618	signs	b-PROBLEM
80619	and	i-PROBLEM
80620	symptoms	i-PROBLEM
80621	consistent	O
80622	with	O
80623	cervical	b-PROBLEM
80624	myelopathy	i-PROBLEM
80625	;	O
80626	a	b-TEST
80627	cervical	i-TEST
80628	mri	i-TEST
80629	scan	i-TEST
80630	showed	b-EVIDENTIAL
80631	very	O
80632	impressive	b-PROBLEM
80633	disc	i-PROBLEM
80634	herniations	i-PROBLEM
80635	at	i-PROBLEM
80636	c5-c6	i-PROBLEM
80637	,	O
80638	less	O
80639	so	O
80640	at	O
80641	c4-c5	O
80642	,	O
80643	with	O
80644	clear	b-PROBLEM
80645	cut	i-PROBLEM
80646	cord	i-PROBLEM
80647	compression	i-PROBLEM
80648	,	O
80649	particularly	O
80650	on	O
80651	the	O
80652	right	O
80653	side	O
80654	c5-c6	O
80655	.	O
80656	therefore	O
80657	,	O
80658	he	O
80659	was	O
80660	admitted	b-OCCURRENCE
80661	for	O
80662	c4-c5	b-TREATMENT
80663	and	i-TREATMENT
80664	c5-c6	i-TREATMENT
80665	anterior	i-TREATMENT
80666	diskectomy	i-TREATMENT
80667	with	O
80668	autologous	b-TREATMENT
80669	bone	i-TREATMENT
80670	graft	i-TREATMENT
80671	and	O
80672	instrumented	b-TREATMENT
80673	fusion	i-TREATMENT
80674	.	O
80675	hospital	O
80676	course	O
80677	:	O
80678	while	O
80679	in	O
80680	the	b-CLINICAL_DEPT
80681	pacu	i-CLINICAL_DEPT
80682	,	O
80683	anesthesia	O
80684	was	O
80685	called	O
80686	because	O
80687	the	O
80688	patient	O
80689	became	O
80690	dyspneic	b-PROBLEM
80691	and	O
80692	tachypneic	b-PROBLEM
80693	and	O
80694	his	b-TEST
80695	sao2	i-TEST
80696	dropped	b-PROBLEM
80697	to	O
80698	89%	O
80699	.	O
80700	his	b-TEST
80701	respiratory	i-TEST
80702	rate	i-TEST
80703	was	O
80704	30	O
80705	on	O
80706	face	b-TREATMENT
80707	mask	i-TREATMENT
80708	.	O
80709	interoperatively	b-OCCURRENCE
80710	,	O
80711	he	O
80712	was	O
80713	positive	O
80714	two	O
80715	liters	O
80716	with	O
80717	a	b-OCCURRENCE
80718	stable	i-OCCURRENCE
80719	blood	b-TEST
80720	pressure	i-TEST
80721	and	O
80722	heart	b-TEST
80723	rate	i-TEST
80724	,	O
80725	although	O
80726	requiring	O
80727	some	b-TREATMENT
80728	neo-synephrine	i-TREATMENT
80729	interoperatively	b-OCCURRENCE
80730	.	O
80731	he	O
80732	responded	O
80733	to	O
80734	intravenous	b-TREATMENT
80735	lasix	i-TREATMENT
80736	with	O
80737	3.2	O
80738	liters	O
80739	of	O
80740	urine	b-TEST
80741	output	i-TEST
80742	as	O
80743	well	O
80744	as	O
80745	marked	O
80746	clinical	O
80747	improvement	b-OCCURRENCE
80748	.	O
80749	the	O
80750	etiology	O
80751	for	O
80752	his	b-PROBLEM
80753	congestive	i-PROBLEM
80754	heart	i-PROBLEM
80755	failure	i-PROBLEM
80756	was	O
80757	determined	O
80758	likely	O
80759	to	O
80760	be	O
80761	diastolic	b-PROBLEM
80762	dysfunction	i-PROBLEM
80763	from	O
80764	increased	b-PROBLEM
80765	heart	i-PROBLEM
80766	rate	i-PROBLEM
80767	as	O
80768	well	O
80769	as	O
80770	excess	b-PROBLEM
80771	volume	i-PROBLEM
80772	.	O
80773	no	O
80774	definite	O
80775	evidence	O
80776	for	O
80777	significant	b-PROBLEM
80778	myocardial	i-PROBLEM
80779	ischemia	i-PROBLEM
80780	,	O
80781	although	O
80782	cardiac	b-TEST
80783	enzymes	i-TEST
80784	were	O
80785	sent	O
80786	and	O
80787	he	O
80788	ruled	b-OCCURRENCE
80789	out	i-OCCURRENCE
80790	for	O
80791	myocardial	b-PROBLEM
80792	infarction	i-PROBLEM
80793	.	O
80794	he	O
80795	was	O
80796	admitted	b-OCCURRENCE
80797	to	O
80798	the	b-CLINICAL_DEPT
80799	surgical	i-CLINICAL_DEPT
80800	intensive	i-CLINICAL_DEPT
80801	care	i-CLINICAL_DEPT
80802	unit	i-CLINICAL_DEPT
80803	where	O
80804	his	b-OCCURRENCE
80805	respiratory	i-OCCURRENCE
80806	and	i-OCCURRENCE
80807	cardiac	i-OCCURRENCE
80808	status	i-OCCURRENCE
80809	was	O
80810	monitored	b-TEST
80811	carefully	O
80812	.	O
80813	he	O
80814	was	O
80815	given	O
80816	lasix	b-TREATMENT
80817	to	O
80818	continue	O
80819	to	O
80820	diurese	b-TREATMENT
80821	the	b-PROBLEM
80822	excess	i-PROBLEM
80823	volume	i-PROBLEM
80824	.	O
80825	he	O
80826	was	O
80827	also	O
80828	put	O
80829	on	O
80830	lopressor	b-TREATMENT
80831	150	O
80832	mg	O
80833	twice	b-FREQUENCY
80834	a	i-FREQUENCY
80835	day	i-FREQUENCY
80836	.	O
80837	also	O
80838	in	O
80839	the	b-CLINICAL_DEPT
80840	intensive	i-CLINICAL_DEPT
80841	care	i-CLINICAL_DEPT
80842	unit	i-CLINICAL_DEPT
80843	,	O
80844	o2	b-TEST
80845	saturation	i-TEST
80846	was	O
80847	closely	O
80848	monitored	b-TEST
80849	.	O
80850	the	O
80851	patient	O
80852	became	O
80853	agitated	b-PROBLEM
80854	with	O
80855	both	O
80856	tent	b-TREATMENT
80857	and	O
80858	bi-pap	b-TREATMENT
80859	machine	i-TREATMENT
80860	,	O
80861	although	O
80862	continued	O
80863	to	O
80864	saturate	b-OCCURRENCE
80865	well	i-OCCURRENCE
80866	.	O
80867	he	O
80868	was	O
80869	transferred	b-OCCURRENCE
80870	to	O
80871	medicine	b-CLINICAL_DEPT
80872	the	b-DATE
80873	morning	i-DATE
80874	of	i-DATE
80875	2010-08-30	i-DATE
80876	,	O
80877	for	O
80878	continued	b-TREATMENT
80879	medical	i-TREATMENT
80880	management	i-TREATMENT
80881	post	O
80882	surgery	b-TREATMENT
80883	.	O
80884	on	O
80885	the	b-DATE
80886	day	i-DATE
80887	of	i-DATE
80888	transfer	i-DATE
80889	,	O
80890	the	O
80891	patient	O
80892	was	O
80893	noted	b-EVIDENTIAL
80894	to	O
80895	be	O
80896	confused	b-PROBLEM
80897	with	O
80898	waxing	b-PROBLEM
80899	and	i-PROBLEM
80900	waning	i-PROBLEM
80901	sensorium	i-PROBLEM
80902	;	O
80903	thus	O
80904	,	O
80905	a	b-TEST
80906	delirium	i-TEST
80907	work-up	i-TEST
80908	was	O
80909	initiated	O
80910	looking	O
80911	for	O
80912	precipitants	b-PROBLEM
80913	.	O
80914	1.	O
80915	when	O
80916	his	b-TEST
80917	o2	i-TEST
80918	saturation	i-TEST
80919	was	O
80920	monitored	O
80921	,	O
80922	his	b-TEST
80923	pulse	i-TEST
80924	oximetry	i-TEST
80925	remained	O
80926	in	O
80927	the	O
80928	90s	O
80929	during	O
80930	his	b-OCCURRENCE
80931	stay	i-OCCURRENCE
80932	.	O
80933	2.	O
80934	his	b-TREATMENT
80935	non-essential	i-TREATMENT
80936	medications	i-TREATMENT
80937	that	O
80938	may	O
80939	have	O
80940	been	O
80941	contributing	b-OCCURRENCE
80942	to	O
80943	his	b-PROBLEM
80944	change	i-PROBLEM
80945	in	i-PROBLEM
80946	mental	i-PROBLEM
80947	status	i-PROBLEM
80948	were	O
80949	discontinued	O
80950	;	O
80951	those	O
80952	included	O
80953	temocillin	b-TREATMENT
80954	,	O
80955	nortriptyline	b-TREATMENT
80956	,	O
80957	haldol	b-TREATMENT
80958	,	O
80959	lorazepam	b-TREATMENT
80960	,	O
80961	venlafaxine	b-TREATMENT
80962	,	O
80963	bupropion	b-TREATMENT
80964	,	O
80965	and	O
80966	gabapentin	b-TREATMENT
80967	.	O
80968	in	O
80969	addition	O
80970	,	O
80971	his	b-TEST
80972	cyclosporin	i-TEST
80973	levels	i-TEST
80974	were	O
80975	checked	b-TEST
80976	.	O
80977	3.	O
80978	hypo	b-PROBLEM
80979	or	i-PROBLEM
80980	hyperglycemia	i-PROBLEM
80981	:	O
80982	mahoney	O
80983	had	O
80984	been	O
80985	following	O
80986	with	O
80987	their	O
80988	appreciated	O
80989	recommendations	O
80990	on	O
80991	glucose	b-TREATMENT
80992	control	i-TREATMENT
80993	.	O
80994	finger	b-TEST
80995	sticks	i-TEST
80996	were	O
80997	in	O
80998	the	O
80999	150	O
81000	s	O
81001	when	O
81002	acutely	b-PROBLEM
81003	agitated	i-PROBLEM
81004	,	O
81005	therefore	O
81006	,	O
81007	it	O
81008	was	O
81009	not	O
81010	determined	b-EVIDENTIAL
81011	that	O
81012	glucose	b-TEST
81013	levels	i-TEST
81014	were	O
81015	contributory	O
81016	.	O
81017	4.	O
81018	infectious	b-PROBLEM
81019	causes	i-PROBLEM
81020	were	O
81021	evaluated	b-TEST
81022	.	O
81023	he	O
81024	was	O
81025	febrile	b-PROBLEM
81026	in	O
81027	the	b-CLINICAL_DEPT
81028	intensive	i-CLINICAL_DEPT
81029	care	i-CLINICAL_DEPT
81030	unit	i-CLINICAL_DEPT
81031	to	O
81032	101.0	O
81033	f.	O
81034	;	O
81035	yet	O
81036	,	O
81037	chest	b-TEST
81038	x-ray	i-TEST
81039	,	O
81040	blood	b-TEST
81041	cultures	i-TEST
81042	,	O
81043	urinalysis	b-TEST
81044	and	O
81045	urine	b-TEST
81046	cultures	i-TEST
81047	were	O
81048	all	O
81049	negative	O
81050	for	O
81051	sources	b-PROBLEM
81052	.	O
81053	a	b-TEST
81054	lumbar	i-TEST
81055	puncture	i-TEST
81056	was	O
81057	considered	O
81058	,	O
81059	although	O
81060	not	O
81061	performed	O
81062	due	O
81063	to	O
81064	the	O
81065	fact	O
81066	that	O
81067	the	b-OCCURRENCE
81068	cerebrospinal	i-OCCURRENCE
81069	fluid	i-OCCURRENCE
81070	was	O
81071	not	O
81072	breached	b-OCCURRENCE
81073	during	O
81074	the	b-TREATMENT
81075	procedure	i-TREATMENT
81076	.	O
81077	5.	O
81078	mass	b-PROBLEM
81079	effect	i-PROBLEM
81080	was	O
81081	considered	O
81082	,	O
81083	although	O
81084	no	O
81085	focal	b-PROBLEM
81086	deficits	i-PROBLEM
81087	were	O
81088	ever	O
81089	noted	b-EVIDENTIAL
81090	on	O
81091	examination	b-TEST
81092	and	O
81093	due	O
81094	to	O
81095	the	b-PROBLEM
81096	fluctuating	i-PROBLEM
81097	sensorium	i-PROBLEM
81098	,	O
81099	it	O
81100	was	O
81101	determined	O
81102	that	O
81103	there	O
81104	was	O
81105	no	O
81106	severe	b-PROBLEM
81107	underlying	i-PROBLEM
81108	structural	i-PROBLEM
81109	abnormality	i-PROBLEM
81110	.	O
81111	a	b-TEST
81112	head	i-TEST
81113	and	i-TEST
81114	neck	i-TEST
81115	ct	i-TEST
81116	scan	i-TEST
81117	,	i-TEST
81118	non-contrast	i-TEST
81119	,	O
81120	were	O
81121	ordered	O
81122	though	O
81123	to	O
81124	evaluate	b-OCCURRENCE
81125	for	O
81126	such	b-PROBLEM
81127	processes	i-PROBLEM
81128	.	O
81129	no	O
81130	acute	b-PROBLEM
81131	intracranial	i-PROBLEM
81132	hemorrhages	i-PROBLEM
81133	or	O
81134	midline	b-PROBLEM
81135	shifts	i-PROBLEM
81136	were	O
81137	noted	b-EVIDENTIAL
81138	,	O
81139	although	O
81140	a	b-PROBLEM
81141	soft	i-PROBLEM
81142	tissue	i-PROBLEM
81143	mass	i-PROBLEM
81144	was	O
81145	noted	b-EVIDENTIAL
81146	at	O
81147	the	O
81148	level	O
81149	of	O
81150	c2	O
81151	.	O
81152	this	O
81153	was	O
81154	determined	O
81155	to	O
81156	be	O
81157	within	O
81158	the	b-OCCURRENCE
81159	normal	i-OCCURRENCE
81160	expected	O
81161	changes	b-OCCURRENCE
81162	post	O
81163	surgery	b-TREATMENT
81164	.	O
81165	6.	O
81166	trauma	b-PROBLEM
81167	was	O
81168	also	O
81169	considered	O
81170	.	O
81171	the	O
81172	patient	O
81173	was	O
81174	found	b-OCCURRENCE
81175	out	O
81176	of	O
81177	bed	O
81178	but	O
81179	no	O
81180	signs	O
81181	of	O
81182	head	b-PROBLEM
81183	trauma	i-PROBLEM
81184	,	O
81185	no	O
81186	loss	b-PROBLEM
81187	of	i-PROBLEM
81188	consciousness	i-PROBLEM
81189	.	O
81190	throughout	O
81191	his	b-OCCURRENCE
81192	stay	i-OCCURRENCE
81193	,	O
81194	chem-10	b-TEST
81195	was	O
81196	monitored	b-OCCURRENCE
81197	.	O
81198	there	O
81199	were	O
81200	no	O
81201	electrolytes	b-PROBLEM
81202	or	i-PROBLEM
81203	mineral	i-PROBLEM
81204	abnormalities	i-PROBLEM
81205	that	O
81206	could	O
81207	explain	O
81208	his	b-PROBLEM
81209	delirium	i-PROBLEM
81210	.	O
81211	liver	b-TEST
81212	function	i-TEST
81213	tests	i-TEST
81214	were	O
81215	checked	O
81216	,	O
81217	only	O
81218	total	b-TEST
81219	bilirubin	i-TEST
81220	was	O
81221	slightly	b-PROBLEM
81222	elevated	i-PROBLEM
81223	at	O
81224	1.6	O
81225	.	O
81226	tsh	b-TEST
81227	was	O
81228	within	O
81229	normal	O
81230	limits	O
81231	as	O
81232	was	O
81233	b12	b-TEST
81234	and	O
81235	folate	b-TEST
81236	.	O
81237	rpr	b-TEST
81238	evaluating	i-TEST
81239	for	O
81240	possible	O
81241	neurologic	b-PROBLEM
81242	syphilis	i-PROBLEM
81243	was	O
81244	also	O
81245	checked	O
81246	.	O
81247	the	b-TEST
81248	assay	i-TEST
81249	was	O
81250	nonreactive	b-OCCURRENCE
81251	.	O
81252	an	b-TEST
81253	eeg	i-TEST
81254	was	O
81255	also	O
81256	considered	O
81257	to	O
81258	rule	b-EVIDENTIAL
81259	out	i-EVIDENTIAL
81260	non-convulsive	b-PROBLEM
81261	status	i-PROBLEM
81262	epilepticus	i-PROBLEM
81263	,	O
81264	although	O
81265	again	O
81266	this	O
81267	did	O
81268	not	O
81269	seem	O
81270	to	O
81271	be	O
81272	a	O
81273	likely	O
81274	cause	O
81275	.	O
81276	on	O
81277	the	b-DATE
81278	evening	i-DATE
81279	of	i-DATE
81280	the	i-DATE
81281	22nd	i-DATE
81282	,	O
81283	the	O
81284	patient	O
81285	became	O
81286	acutely	b-PROBLEM
81287	agitated	i-PROBLEM
81288	,	O
81289	threatening	b-OCCURRENCE
81290	to	i-OCCURRENCE
81291	leave	i-OCCURRENCE
81292	,	O
81293	and	O
81294	also	O
81295	threatening	b-OCCURRENCE
81296	to	i-OCCURRENCE
81297	harm	i-OCCURRENCE
81298	those	i-OCCURRENCE
81299	nurses	i-OCCURRENCE
81300	and	i-OCCURRENCE
81301	physicians	i-OCCURRENCE
81302	that	O
81303	were	O
81304	attempting	O
81305	to	O
81306	prevent	O
81307	him	O
81308	from	O
81309	leaving	O
81310	.	O
81311	security	O
81312	was	O
81313	notified	O
81314	who	O
81315	then	O
81316	arrived	O
81317	to	O
81318	the	O
81319	room	O
81320	and	O
81321	helped	O
81322	to	O
81323	place	O
81324	the	O
81325	patient	O
81326	in	O
81327	four-point	b-TREATMENT
81328	restraints	i-TREATMENT
81329	,	O
81330	for	O
81331	the	b-OCCURRENCE
81332	safety	i-OCCURRENCE
81333	of	O
81334	both	O
81335	the	O
81336	patient	O
81337	and	O
81338	the	O
81339	staff	O
81340	of	O
81341	the	O
81342	hospital	O
81343	.	O
81344	the	b-TREATMENT
81345	restraints	i-TREATMENT
81346	were	O
81347	weaned	b-OCCURRENCE
81348	off	i-OCCURRENCE
81349	overnight	b-DURATION
81350	although	O
81351	he	O
81352	became	O
81353	acutely	b-PROBLEM
81354	agitated	i-PROBLEM
81355	and	O
81356	they	O
81357	were	O
81358	replaced	O
81359	early	b-DATE
81360	on	i-DATE
81361	08-31	i-DATE
81362	.	O
81363	later	O
81364	in	O
81365	the	b-DATE
81366	morning	i-DATE
81367	on	i-DATE
81368	08-31	i-DATE
81369	,	O
81370	the	O
81371	patient	O
81372	was	O
81373	more	b-OCCURRENCE
81374	oriented	i-OCCURRENCE
81375	and	O
81376	alert	b-OCCURRENCE
81377	,	O
81378	and	O
81379	asked	O
81380	to	O
81381	have	O
81382	the	b-TREATMENT
81383	restraints	i-TREATMENT
81384	removed	O
81385	.	O
81386	they	O
81387	were	O
81388	taken	O
81389	off	O
81390	two	O
81391	at	O
81392	a	O
81393	time	O
81394	.	O
81395	the	O
81396	patient	O
81397	continued	O
81398	to	O
81399	do	O
81400	well	b-OCCURRENCE
81401	and	O
81402	did	O
81403	not	O
81404	require	O
81405	restraints	b-TREATMENT
81406	after	O
81407	that	b-PROBLEM
81408	event	i-PROBLEM
81409	.	O
81410	intramuscular	b-TREATMENT
81411	as	i-TREATMENT
81412	well	i-TREATMENT
81413	as	i-TREATMENT
81414	intravenous	i-TREATMENT
81415	haldol	i-TREATMENT
81416	were	O
81417	ordered	O
81418	p.r.n.	O
81419	for	O
81420	emergency	O
81421	use	O
81422	should	O
81423	he	O
81424	become	O
81425	acutely	b-PROBLEM
81426	agitated	i-PROBLEM
81427	.	O
81428	haldol	b-TREATMENT
81429	as	O
81430	well	O
81431	as	O
81432	the	b-TREATMENT
81433	restraints	i-TREATMENT
81434	were	O
81435	not	O
81436	required	O
81437	after	O
81438	the	b-DATE
81439	morning	i-DATE
81440	of	i-DATE
81441	the	i-DATE
81442	23rd	i-DATE
81443	.	O
81444	each	b-DATE
81445	progressive	i-DATE
81446	day	i-DATE
81447	,	O
81448	mr.	O
81449	donald	O
81450	delirium	b-PROBLEM
81451	abated	O
81452	with	O
81453	return	O
81454	to	O
81455	baseline	b-EVIDENTIAL
81456	mental	i-EVIDENTIAL
81457	status	i-EVIDENTIAL
81458	early	b-DATE
81459	on	i-DATE
81460	09-01	i-DATE
81461	.	O
81462	the	O
81463	likely	O
81464	cause	O
81465	of	O
81466	the	b-PROBLEM
81467	delirium	i-PROBLEM
81468	was	O
81469	a	O
81470	combination	O
81471	of	O
81472	surgery	b-TREATMENT
81473	and	O
81474	intensive	b-CLINICAL_DEPT
81475	care	i-CLINICAL_DEPT
81476	unit	i-CLINICAL_DEPT
81477	stay	O
81478	in	O
81479	addition	O
81480	to	O
81481	poly-pharmacy	b-TREATMENT
81482	.	O
81483	other	O
81484	concerns	b-OCCURRENCE
81485	during	O
81486	his	b-OCCURRENCE
81487	stay	i-OCCURRENCE
81488	was	O
81489	his	b-PROBLEM
81490	kidney	i-PROBLEM
81491	function	i-PROBLEM
81492	,	O
81493	due	O
81494	to	O
81495	his	b-TREATMENT
81496	renal	i-TREATMENT
81497	transplant	i-TREATMENT
81498	in	O
81499	2003	b-DATE
81500	.	O
81501	his	b-TREATMENT
81502	immunosuppressive	i-TREATMENT
81503	therapy	i-TREATMENT
81504	was	O
81505	continued	O
81506	throughout	O
81507	his	b-OCCURRENCE
81508	stay	i-OCCURRENCE
81509	;	O
81510	his	b-TEST
81511	creatinine	i-TEST
81512	remained	O
81513	approximately	O
81514	2.3	O
81515	to	O
81516	2.4	O
81517	;	O
81518	he	O
81519	has	O
81520	a	b-PROBLEM
81521	baseline	i-PROBLEM
81522	renal	i-PROBLEM
81523	insufficiency	i-PROBLEM
81524	.	O
81525	with	O
81526	this	O
81527	in	O
81528	mind	O
81529	,	O
81530	when	O
81531	obtaining	O
81532	a	b-TEST
81533	ct	i-TEST
81534	scan	i-TEST
81535	it	O
81536	was	O
81537	determined	O
81538	that	O
81539	contrast	b-TREATMENT
81540	would	O
81541	not	O
81542	be	O
81543	the	O
81544	best	O
81545	option	O
81546	.	O
81547	while	O
81548	the	O
81549	patient	O
81550	was	O
81551	in	O
81552	restraints	b-TREATMENT
81553	,	O
81554	gentle	b-TREATMENT
81555	hydration	i-TREATMENT
81556	was	O
81557	initiated	O
81558	since	O
81559	p.o.	b-TEST
81560	intake	i-TEST
81561	was	O
81562	not	O
81563	adequate	b-OCCURRENCE
81564	.	O
81565	as	O
81566	for	O
81567	his	b-PROBLEM
81568	diabetes	i-PROBLEM
81569	mellitus	i-PROBLEM
81570	,	O
81571	the	b-OCCURRENCE
81572	mahoney	i-OCCURRENCE
81573	team	i-OCCURRENCE
81574	provided	O
81575	updated	O
81576	recommendations	b-OCCURRENCE
81577	each	b-FREQUENCY
81578	day	i-FREQUENCY
81579	,	O
81580	adjusting	O
81581	for	O
81582	the	O
81583	changing	O
81584	p.o.	b-OCCURRENCE
81585	intake	i-OCCURRENCE
81586	.	O
81587	the	O
81588	only	O
81589	other	b-PROBLEM
81590	complaints	i-PROBLEM
81591	from	O
81592	mr.	O
81593	mackey	O
81594	during	O
81595	his	b-OCCURRENCE
81596	stay	i-OCCURRENCE
81597	were	O
81598	:	O
81599	soreness	b-PROBLEM
81600	at	O
81601	his	b-PROBLEM
81602	operative	i-PROBLEM
81603	sites	i-PROBLEM
81604	,	O
81605	for	O
81606	which	O
81607	he	O
81608	was	O
81609	given	O
81610	p.r.n.	O
81611	tylenol	b-TREATMENT
81612	once	O
81613	his	b-PROBLEM
81614	delirium	i-PROBLEM
81615	had	O
81616	resolved	O
81617	.	O
81618	in	O
81619	addition	O
81620	,	O
81621	he	O
81622	also	O
81623	complained	O
81624	of	O
81625	difficulty	b-PROBLEM
81626	with	i-PROBLEM
81627	swallowing	i-PROBLEM
81628	,	O
81629	necessitating	O
81630	only	O
81631	soft	b-TREATMENT
81632	and	i-TREATMENT
81633	liquid	i-TREATMENT
81634	diet	i-TREATMENT
81635	.	O
81636	this	O
81637	was	O
81638	attributed	O
81639	to	O
81640	postoperative	b-PROBLEM
81641	swelling	i-PROBLEM
81642	and	O
81643	changes	b-PROBLEM
81644	from	O
81645	his	b-TREATMENT
81646	diskectomy	i-TREATMENT
81647	performed	O
81648	2010-08-27	b-DATE
81649	.	O
81650		O
81651	admission	b-OCCURRENCE
81652	date	O
81653	:	O
81654	03/24/97	b-ADMISSION
81655	discharge	b-OCCURRENCE
81656	date	O
81657	:	O
81658	03/28/97	b-DISCHARGE
81659	history	O
81660	of	O
81661	present	O
81662	illness	O
81663	:	O
81664	the	O
81665	patient	O
81666	is	O
81667	a	O
81668	31-year-old	O
81669	right-handed	O
81670	female	O
81671	with	O
81672	right-sided	b-PROBLEM
81673	greater	i-PROBLEM
81674	than	i-PROBLEM
81675	left-sided	i-PROBLEM
81676	weakness	i-PROBLEM
81677	and	O
81678	difficulty	b-PROBLEM
81679	walking	i-PROBLEM
81680	for	O
81681	several	b-DURATION
81682	days	i-DURATION
81683	.	O
81684	she	O
81685	was	O
81686	in	O
81687	her	b-OCCURRENCE
81688	usual	i-OCCURRENCE
81689	state	i-OCCURRENCE
81690	of	i-OCCURRENCE
81691	health	i-OCCURRENCE
81692	until	O
81693	3/20/97	b-DATE
81694	when	O
81695	she	O
81696	experienced	O
81697	the	O
81698	fairly	O
81699	sudden	O
81700	onset	O
81701	of	O
81702	predominantly	O
81703	right-sided	b-PROBLEM
81704	arm	i-PROBLEM
81705	and	i-PROBLEM
81706	leg	i-PROBLEM
81707	weakness	i-PROBLEM
81708	and	O
81709	ataxia	b-PROBLEM
81710	.	O
81711	she	O
81712	was	O
81713	standing	b-OCCURRENCE
81714	and	i-OCCURRENCE
81715	walking	i-OCCURRENCE
81716	with	i-OCCURRENCE
81717	her	i-OCCURRENCE
81718	friend	i-OCCURRENCE
81719	,	O
81720	who	O
81721	&quot;	O
81722	had	O
81723	to	O
81724	catch	O
81725	her	O
81726	from	O
81727	falling	O
81728	down	O
81729	&quot;	O
81730	as	O
81731	she	O
81732	toppled	b-OCCURRENCE
81733	towards	i-OCCURRENCE
81734	the	i-OCCURRENCE
81735	right	i-OCCURRENCE
81736	.	O
81737	she	O
81738	evidently	O
81739	recovered	b-OCCURRENCE
81740	from	O
81741	the	b-PROBLEM
81742	episode	i-PROBLEM
81743	after	O
81744	a	b-DURATION
81745	number	i-DURATION
81746	of	i-DURATION
81747	minutes	i-DURATION
81748	.	O
81749	the	b-DATE
81750	following	i-DATE
81751	day	i-DATE
81752	,	O
81753	she	O
81754	remained	b-OCCURRENCE
81755	in	i-OCCURRENCE
81756	bed	i-OCCURRENCE
81757	through	O
81758	essentially	b-DURATION
81759	all	i-DURATION
81760	of	i-DURATION
81761	the	i-DURATION
81762	day	i-DURATION
81763	due	O
81764	to	O
81765	malaise	b-PROBLEM
81766	with	O
81767	no	O
81768	specific	b-PROBLEM
81769	deficits	i-PROBLEM
81770	being	O
81771	noted	O
81772	.	O
81773	in	O
81774	the	b-DURATION
81775	subsequent	i-DURATION
81776	two	i-DURATION
81777	days	i-DURATION
81778	,	O
81779	she	O
81780	had	O
81781	several	O
81782	small	b-PROBLEM
81783	spells	i-PROBLEM
81784	of	i-PROBLEM
81785	&quot;	i-PROBLEM
81786	imbalance	i-PROBLEM
81787	&quot;	O
81788	,	O
81789	particularly	O
81790	towards	O
81791	the	O
81792	right	O
81793	,	O
81794	and	O
81795	other	b-PROBLEM
81796	symptoms	i-PROBLEM
81797	included	O
81798	diffuse	b-PROBLEM
81799	and	i-PROBLEM
81800	mainly	i-PROBLEM
81801	frontal	i-PROBLEM
81802	headaches	i-PROBLEM
81803	and	O
81804	mild	b-PROBLEM
81805	neck	i-PROBLEM
81806	soreness	i-PROBLEM
81807	.	O
81808	there	O
81809	was	O
81810	no	O
81811	diplopia	b-PROBLEM
81812	,	O
81813	visual	b-PROBLEM
81814	loss	i-PROBLEM
81815	,	O
81816	speech	b-PROBLEM
81817	abnormality	i-PROBLEM
81818	or	O
81819	sensory	b-PROBLEM
81820	change	i-PROBLEM
81821	in	O
81822	her	O
81823	history	O
81824	.	O
81825	she	O
81826	was	O
81827	initially	O
81828	evaluated	O
81829	at	O
81830	an	b-CLINICAL_DEPT
81831	outside	i-CLINICAL_DEPT
81832	hospital	i-CLINICAL_DEPT
81833	emergency	i-CLINICAL_DEPT
81834	room	i-CLINICAL_DEPT
81835	,	O
81836	and	O
81837	then	O
81838	transferred	b-OCCURRENCE
81839	to	O
81840	well	b-CLINICAL_DEPT
81841	general	i-CLINICAL_DEPT
81842	hospital	i-CLINICAL_DEPT
81843	.	O
81844	hospital	O
81845	course	O
81846	and	O
81847	treatment	O
81848	:	O
81849	the	O
81850	patient	O
81851	was	O
81852	admitted	b-OCCURRENCE
81853	for	O
81854	her	b-PROBLEM
81855	gait	i-PROBLEM
81856	disorder	i-PROBLEM
81857	with	O
81858	other	O
81859	notable	b-PROBLEM
81860	findings	i-PROBLEM
81861	on	O
81862	examination	b-TEST
81863	including	O
81864	anisocoria	b-PROBLEM
81865	,	O
81866	which	O
81867	,	O
81868	by	O
81869	the	O
81870	patient	O
81871	&apos;s	O
81872	report	O
81873	,	O
81874	had	O
81875	been	O
81876	noted	O
81877	several	b-DATE
81878	months	i-DATE
81879	earlier	i-DATE
81880	.	O
81881	a	b-TEST
81882	magnetic	i-TEST
81883	resonance	i-TEST
81884	imaging	i-TEST
81885	and	O
81886	magnetic	b-TEST
81887	resonance	i-TEST
81888	angiogram	i-TEST
81889	study	i-TEST
81890	was	O
81891	obtained	O
81892	,	O
81893	which	O
81894	showed	b-EVIDENTIAL
81895	no	O
81896	clear	O
81897	evidence	O
81898	of	O
81899	arterial	b-PROBLEM
81900	dissections	i-PROBLEM
81901	or	O
81902	infarction	b-PROBLEM
81903	or	O
81904	other	b-PROBLEM
81905	pathologic	i-PROBLEM
81906	processes	i-PROBLEM
81907	.	O
81908	she	O
81909	had	O
81910	been	O
81911	placed	O
81912	on	O
81913	heparin	b-TREATMENT
81914	initially	O
81915	,	O
81916	but	O
81917	this	O
81918	was	O
81919	discontinued	b-OCCURRENCE
81920	after	O
81921	the	b-TEST
81922	magnetic	i-TEST
81923	resonance	i-TEST
81924	imaging	i-TEST
81925	results	O
81926	were	O
81927	obtained	O
81928	.	O
81929	posterior	b-TEST
81930	transcranial	i-TEST
81931	doppler	i-TEST
81932	studies	i-TEST
81933	showed	b-EVIDENTIAL
81934	normal	b-OCCURRENCE
81935	studies	i-OCCURRENCE
81936	of	O
81937	both	O
81938	vertebral	O
81939	arteries	O
81940	,	O
81941	and	O
81942	carotid	b-TEST
81943	non-invasive	i-TEST
81944	studies	i-TEST
81945	showed	b-EVIDENTIAL
81946	normal	b-OCCURRENCE
81947	right	i-OCCURRENCE
81948	and	i-OCCURRENCE
81949	left	i-OCCURRENCE
81950	carotid	i-OCCURRENCE
81951	bifurcations	i-OCCURRENCE
81952	.	O
81953	on	O
81954	the	b-DATE
81955	second	i-DATE
81956	hospital	i-DATE
81957	day	i-DATE
81958	,	O
81959	her	b-PROBLEM
81960	gait	i-PROBLEM
81961	continued	O
81962	to	O
81963	be	O
81964	markedly	b-PROBLEM
81965	unstable	i-PROBLEM
81966	,	O
81967	although	O
81968	with	O
81969	no	O
81970	consistent	b-OCCURRENCE
81971	pattern	i-OCCURRENCE
81972	in	O
81973	terms	O
81974	of	O
81975	weakness	b-PROBLEM
81976	or	O
81977	directionality	O
81978	of	O
81979	falling	b-PROBLEM
81980	,	O
81981	and	O
81982	she	O
81983	continued	O
81984	to	O
81985	have	O
81986	no	O
81987	reproducible	b-PROBLEM
81988	upper	i-PROBLEM
81989	extremity	i-PROBLEM
81990	or	i-PROBLEM
81991	lower	i-PROBLEM
81992	extremity	i-PROBLEM
81993	ataxia	i-PROBLEM
81994	or	O
81995	dysmetria	b-PROBLEM
81996	.	O
81997	she	O
81998	was	O
81999	seen	b-OCCURRENCE
82000	by	O
82001	the	b-OCCURRENCE
82002	psychiatry	i-OCCURRENCE
82003	service	i-OCCURRENCE
82004	.	O
82005	she	O
82006	was	O
82007	not	O
82008	felt	O
82009	to	O
82010	be	O
82011	acutely	b-PROBLEM
82012	suicidal	i-PROBLEM
82013	or	O
82014	otherwise	O
82015	in	O
82016	need	O
82017	of	O
82018	acute	b-TREATMENT
82019	psychiatric	i-TREATMENT
82020	treatment	i-TREATMENT
82021	.	O
82022	the	b-CLINICAL_DEPT
82023	psychiatrist	i-CLINICAL_DEPT
82024	also	O
82025	noted	b-OCCURRENCE
82026	the	b-OCCURRENCE
82027	indifference	i-OCCURRENCE
82028	the	O
82029	patient	O
82030	evinced	O
82031	regarding	O
82032	her	b-EVIDENTIAL
82033	own	i-EVIDENTIAL
82034	symptomatology	i-EVIDENTIAL
82035	.	O
82036	the	O
82037	patient	O
82038	was	O
82039	evaluated	b-TEST
82040	in	O
82041	one	O
82042	of	O
82043	the	b-CLINICAL_DEPT
82044	neurology	i-CLINICAL_DEPT
82045	conferences	i-CLINICAL_DEPT
82046	for	O
82047	several	b-DURATION
82048	hours	i-DURATION
82049	,	O
82050	and	O
82051	during	O
82052	this	O
82053	time	O
82054	,	O
82055	showed	b-OCCURRENCE
82056	significant	i-OCCURRENCE
82057	improvement	i-OCCURRENCE
82058	while	O
82059	receiving	O
82060	gait	b-TREATMENT
82061	training	i-TREATMENT
82062	as	O
82063	well	O
82064	as	O
82065	evaluation	b-TEST
82066	;	O
82067	in	O
82068	particular	O
82069	,	O
82070	she	O
82071	became	O
82072	more	b-OCCURRENCE
82073	stable	i-OCCURRENCE
82074	with	O
82075	counter-balancing	b-TREATMENT
82076	methods	i-TREATMENT
82077	.	O
82078	this	b-OCCURRENCE
82079	trend	i-OCCURRENCE
82080	of	i-OCCURRENCE
82081	improvement	i-OCCURRENCE
82082	continued	i-OCCURRENCE
82083	,	O
82084	and	O
82085	she	O
82086	was	O
82087	discharged	b-OCCURRENCE
82088	in	O
82089	stable	b-OCCURRENCE
82090	condition	i-OCCURRENCE
82091	.	O
82092	she	O
82093	will	b-TREATMENT
82094	follow	i-TREATMENT
82095	up	i-TREATMENT
82096	with	O
82097	her	b-CLINICAL_DEPT
82098	psychiatrist	i-CLINICAL_DEPT
82099	,	O
82100	doctor	O
82101	freiermchird	O
82102	(	O
82103	sone	b-CLINICAL_DEPT
82104	memorial	i-CLINICAL_DEPT
82105	hospital	i-CLINICAL_DEPT
82106	)	O
82107	on	O
82108	a	b-FREQUENCY
82109	regular	i-FREQUENCY
82110	basis	i-FREQUENCY
82111	,	O
82112	and	O
82113	she	O
82114	can	O
82115	follow	b-TREATMENT
82116	up	i-TREATMENT
82117	with	O
82118	the	b-CLINICAL_DEPT
82119	neurology	i-CLINICAL_DEPT
82120	service	i-CLINICAL_DEPT
82121	on	O
82122	a	b-FREQUENCY
82123	p.r.n.	i-FREQUENCY
82124	basis	i-FREQUENCY
82125	if	O
82126	needed	O
82127	.	O
82128	she	O
82129	will	O
82130	continue	O
82131	on	O
82132	her	b-TREATMENT
82133	previous	i-TREATMENT
82134	outpatient	i-TREATMENT
82135	medical	i-TREATMENT
82136	regimen	i-TREATMENT
82137	.	O
82138	nirege	O
82139	memory	O
82140	,	O
82141	md	O
82142	tr	O
82143	:	O
82144	bzo	O
82145	dd	O
82146	:	O
82147	03/29/97	O
82148	td	O
82149	:	O
82150	03/31/97	O
82151	12:36	O
82152	p	O
82153	cc	O
82154	:	O
82155	nyri	O
82156	a	O
82157	memory	O
82158	,	O
82159	md	O
82160	ashellriette	O
82161	nessasu	O
82162	threatsvot	O
82163	,	O
82164	md	O
82165	ejean	O
82166	nadarc	O
82167	freiermchird	O
82168	,	O
82169	md	O
82170		O
82171	admission	b-OCCURRENCE
82172	date	O
82173	:	O
82174	2013-04-25	b-ADMISSION
82175	discharge	b-OCCURRENCE
82176	date	O
82177	:	O
82178	2013-05-11	b-DISCHARGE
82179	service	O
82180	:	O
82181	cmed	O
82182	csru	O
82183	history	O
82184	of	O
82185	present	O
82186	illness	O
82187	:	O
82188	the	O
82189	patient	O
82190	is	O
82191	a	O
82192	49	O
82193	year	O
82194	old	O
82195	man	O
82196	who	O
82197	was	O
82198	admitted	b-OCCURRENCE
82199	to	O
82200	the	b-CLINICAL_DEPT
82201	medical	i-CLINICAL_DEPT
82202	intensive	i-CLINICAL_DEPT
82203	care	i-CLINICAL_DEPT
82204	unit	i-CLINICAL_DEPT
82205	status	O
82206	post	O
82207	cardiac	b-PROBLEM
82208	arrest	i-PROBLEM
82209	.	O
82210	history	O
82211	was	O
82212	obtained	O
82213	per	O
82214	the	O
82215	emergency	O
82216	department	O
82217	report	O
82218	as	O
82219	well	O
82220	as	O
82221	from	O
82222	the	O
82223	patient	O
82224	's	O
82225	family	O
82226	.	O
82227	information	O
82228	was	O
82229	very	O
82230	limited	O
82231	regarding	O
82232	the	O
82233	circumstances	O
82234	of	O
82235	his	b-PROBLEM
82236	cardiac	i-PROBLEM
82237	arrest	i-PROBLEM
82238	.	O
82239	reportedly	O
82240	,	O
82241	the	O
82242	patient	O
82243	was	O
82244	at	O
82245	a	O
82246	local	O
82247	restaurant	O
82248	where	O
82249	he	O
82250	was	O
82251	noted	O
82252	to	O
82253	be	O
82254	unresponsive	b-PROBLEM
82255	.	O
82256	ems	O
82257	was	O
82258	called	b-OCCURRENCE
82259	and	O
82260	reported	O
82261	to	O
82262	arrive	b-OCCURRENCE
82263	on	O
82264	scene	O
82265	within	O
82266	three	b-DURATION
82267	minutes	i-DURATION
82268	.	O
82269	the	O
82270	patient	O
82271	was	O
82272	asystolic	b-PROBLEM
82273	but	O
82274	regained	O
82275	a	b-OCCURRENCE
82276	perfusing	i-OCCURRENCE
82277	rhythm	i-OCCURRENCE
82278	after	O
82279	2	O
82280	mg	O
82281	of	O
82282	epinephrine	b-TREATMENT
82283	and	O
82284	2	O
82285	mg	O
82286	of	O
82287	atropine	b-TREATMENT
82288	.	O
82289	he	O
82290	was	O
82291	intubated	b-TREATMENT
82292	in	O
82293	the	O
82294	field	O
82295	and	O
82296	brought	O
82297	to	O
82298	the	b-CLINICAL_DEPT
82299	emergency	i-CLINICAL_DEPT
82300	department	i-CLINICAL_DEPT
82301	.	O
82302	he	O
82303	remained	O
82304	unresponsive	b-PROBLEM
82305	despite	O
82306	the	O
82307	administration	O
82308	of	O
82309	narcan	b-TREATMENT
82310	.	O
82311	ct	b-TEST
82312	examinations	i-TEST
82313	of	i-TEST
82314	the	i-TEST
82315	head	i-TEST
82316	,	i-TEST
82317	chest	i-TEST
82318	,	i-TEST
82319	abdomen	i-TEST
82320	and	i-TEST
82321	pelvis	i-TEST
82322	were	O
82323	all	O
82324	unremarkable	O
82325	.	O
82326	initial	b-TEST
82327	chest	i-TEST
82328	x-ray	i-TEST
82329	showed	b-EVIDENTIAL
82330	a	b-PROBLEM
82331	left	i-PROBLEM
82332	retrocardiac	i-PROBLEM
82333	opacity	i-PROBLEM
82334	and	O
82335	prominent	b-PROBLEM
82336	interstitium	i-PROBLEM
82337	though	O
82338	his	b-TEST
82339	lung	i-TEST
82340	volumes	i-TEST
82341	were	O
82342	low	b-PROBLEM
82343	.	O
82344	subsequent	b-TEST
82345	chest	i-TEST
82346	x-ray	i-TEST
82347	showed	b-EVIDENTIAL
82348	right	b-TREATMENT
82349	main	i-TREATMENT
82350	stem	i-TREATMENT
82351	intubation	i-TREATMENT
82352	with	O
82353	left	b-PROBLEM
82354	lung	i-PROBLEM
82355	collapse	i-PROBLEM
82356	which	O
82357	had	O
82358	corrected	O
82359	with	O
82360	withdrawal	b-TREATMENT
82361	of	i-TREATMENT
82362	the	i-TREATMENT
82363	endotracheal	i-TREATMENT
82364	tube	i-TREATMENT
82365	.	O
82366	the	O
82367	patient	O
82368	was	O
82369	then	O
82370	transferred	b-OCCURRENCE
82371	to	O
82372	the	b-CLINICAL_DEPT
82373	medical	i-CLINICAL_DEPT
82374	intensive	i-CLINICAL_DEPT
82375	care	i-CLINICAL_DEPT
82376	unit	i-CLINICAL_DEPT
82377	for	O
82378	induced	b-TREATMENT
82379	hypothermia	i-TREATMENT
82380	given	O
82381	his	b-OCCURRENCE
82382	hemodynamic	i-OCCURRENCE
82383	stability	i-OCCURRENCE
82384	,	O
82385	ongoing	b-PROBLEM
82386	unresponsiveness	i-PROBLEM
82387	and	O
82388	recent	b-PROBLEM
82389	out	i-PROBLEM
82390	of	i-PROBLEM
82391	hospital	i-PROBLEM
82392	cardiac	i-PROBLEM
82393	arrest	i-PROBLEM
82394	.	O
82395	hospital	O
82396	course	O
82397	:	O
82398	cardiac	b-PROBLEM
82399	arrest	i-PROBLEM
82400	-	O
82401	his	b-PROBLEM
82402	arrest	i-PROBLEM
82403	was	O
82404	of	O
82405	unknown	O
82406	etiology	O
82407	at	O
82408	the	O
82409	time	O
82410	of	O
82411	admission	b-OCCURRENCE
82412	.	O
82413	no	O
82414	further	O
82415	history	O
82416	was	O
82417	ever	O
82418	gained	O
82419	about	O
82420	his	b-PROBLEM
82421	cardiac	i-PROBLEM
82422	arrest	i-PROBLEM
82423	throughout	O
82424	his	b-OCCURRENCE
82425	hospitalization	i-OCCURRENCE
82426	.	O
82427	ct	b-TEST
82428	angiogram	i-TEST
82429	had	O
82430	been	O
82431	negative	O
82432	for	O
82433	pulmonary	b-PROBLEM
82434	embolism	i-PROBLEM
82435	.	O
82436	the	O
82437	patient	O
82438	had	O
82439	an	b-TEST
82440	echocardiogram	i-TEST
82441	on	O
82442	2013-04-26	b-DATE
82443	,	O
82444	which	O
82445	showed	b-EVIDENTIAL
82446	a	O
82447	normal	O
82448	ejection	b-TEST
82449	fraction	i-TEST
82450	and	O
82451	trivial	b-PROBLEM
82452	mitral	i-PROBLEM
82453	regurgitation	i-PROBLEM
82454	;	O
82455	otherwise	O
82456	no	O
82457	obvious	b-PROBLEM
82458	abnormalities	i-PROBLEM
82459	were	O
82460	seen	O
82461	.	O
82462	given	O
82463	the	O
82464	patient	O
82465	had	O
82466	an	b-PROBLEM
82467	out	i-PROBLEM
82468	of	i-PROBLEM
82469	hospital	i-PROBLEM
82470	arrest	i-PROBLEM
82471	,	O
82472	remained	O
82473	unresponsive	b-PROBLEM
82474	despite	O
82475	hemodynamic	b-OCCURRENCE
82476	stability	i-OCCURRENCE
82477	,	O
82478	he	O
82479	was	O
82480	treated	O
82481	with	O
82482	induced	b-TREATMENT
82483	hypothermia	i-TREATMENT
82484	and	O
82485	with	O
82486	cold	b-TREATMENT
82487	packs	i-TREATMENT
82488	and	O
82489	a	b-TREATMENT
82490	cooling	i-TREATMENT
82491	blanket	i-TREATMENT
82492	were	O
82493	placed	O
82494	with	O
82495	goals	O
82496	of	O
82497	reducing	O
82498	his	b-TEST
82499	core	i-TEST
82500	body	i-TEST
82501	temperature	i-TEST
82502	to	O
82503	32	O
82504	degrees	O
82505	celsius	O
82506	for	O
82507	a	O
82508	period	O
82509	of	O
82510	twelve	b-DURATION
82511	hours	i-DURATION
82512	at	O
82513	which	O
82514	point	O
82515	he	O
82516	would	O
82517	be	O
82518	rewarmed	b-TREATMENT
82519	over	O
82520	the	O
82521	subsequent	O
82522	six	b-DURATION
82523	hours	i-DURATION
82524	.	O
82525	this	O
82526	was	O
82527	done	O
82528	,	O
82529	however	O
82530	,	O
82531	as	O
82532	in	O
82533	problem	O
82534	number	O
82535	two	O
82536	below	O
82537	,	O
82538	we	O
82539	were	O
82540	not	O
82541	successful	O
82542	in	O
82543	any	O
82544	neurologic	b-OCCURRENCE
82545	recovery	i-OCCURRENCE
82546	.	O
82547	neurology	O
82548	-	O
82549	the	O
82550	patient	O
82551	remained	O
82552	unresponsive	b-PROBLEM
82553	after	O
82554	the	b-TREATMENT
82555	induced	i-TREATMENT
82556	hypothermia	i-TREATMENT
82557	,	O
82558	the	O
82559	patient	O
82560	was	O
82561	noticed	O
82562	to	O
82563	develop	O
82564	myoclonic	b-PROBLEM
82565	jerks	i-PROBLEM
82566	and	O
82567	occasional	O
82568	fluttering	b-PROBLEM
82569	of	i-PROBLEM
82570	his	i-PROBLEM
82571	eyelids	i-PROBLEM
82572	.	O
82573	electroencephalogram	b-TEST
82574	revealed	b-EVIDENTIAL
82575	the	O
82576	patient	O
82577	was	O
82578	experiencing	O
82579	persistent	b-PROBLEM
82580	seizure	i-PROBLEM
82581	activity	i-PROBLEM
82582	.	O
82583	neurology	O
82584	was	O
82585	consulted	b-OCCURRENCE
82586	and	O
82587	the	O
82588	patient	O
82589	was	O
82590	treated	O
82591	very	O
82592	aggressively	O
82593	,	O
82594	loaded	O
82595	with	O
82596	multiple	b-TREATMENT
82597	drugs	i-TREATMENT
82598	,	O
82599	including	O
82600	ativan	b-TREATMENT
82601	and	O
82602	propofol	b-TREATMENT
82603	drips	i-TREATMENT
82604	.	O
82605	the	O
82606	patient	O
82607	continued	O
82608	to	O
82609	demonstrate	O
82610	seizure	b-PROBLEM
82611	activity	i-PROBLEM
82612	despite	O
82613	this	O
82614	.	O
82615	he	O
82616	was	O
82617	loaded	O
82618	with	O
82619	dilantin	b-TREATMENT
82620	and	O
82621	ultimately	O
82622	was	O
82623	treated	O
82624	with	O
82625	a	b-TREATMENT
82626	pentobarb	i-TREATMENT
82627	coma	i-TREATMENT
82628	.	O
82629	after	O
82630	multiple	O
82631	attempts	O
82632	of	O
82633	weaning	b-TREATMENT
82634	the	b-TREATMENT
82635	pentobarb	i-TREATMENT
82636	,	O
82637	the	O
82638	patient	O
82639	was	O
82640	continually	O
82641	reverting	O
82642	to	O
82643	status	b-PROBLEM
82644	epilepticus	i-PROBLEM
82645	which	O
82646	was	O
82647	never	O
82648	able	O
82649	to	O
82650	be	O
82651	suppressed	O
82652	.	O
82653	infectious	O
82654	disease	O
82655	-	O
82656	over	O
82657	the	b-OCCURRENCE
82658	course	i-OCCURRENCE
82659	of	i-OCCURRENCE
82660	his	i-OCCURRENCE
82661	hospital	i-OCCURRENCE
82662	stay	i-OCCURRENCE
82663	,	O
82664	the	b-TEST
82665	patient	i-TEST
82666	's	i-TEST
82667	white	i-TEST
82668	blood	i-TEST
82669	cell	i-TEST
82670	count	i-TEST
82671	rose	O
82672	to	O
82673	a	O
82674	peak	O
82675	of	O
82676	17	O
82677	.	O
82678	multiple	b-TEST
82679	cultures	i-TEST
82680	were	O
82681	done	O
82682	and	O
82683	the	O
82684	patient	O
82685	was	O
82686	ultimately	O
82687	found	O
82688	to	O
82689	have	O
82690	methicillin	b-PROBLEM
82691	resistant	i-PROBLEM
82692	staphylococcus	i-PROBLEM
82693	aureus	i-PROBLEM
82694	bacteremia	i-PROBLEM
82695	,	O
82696	pneumonia	b-PROBLEM
82697	,	O
82698	and	O
82699	urinary	b-PROBLEM
82700	tract	i-PROBLEM
82701	infection	i-PROBLEM
82702	.	O
82703	for	O
82704	all	O
82705	these	b-PROBLEM
82706	infections	i-PROBLEM
82707	,	O
82708	the	O
82709	patient	O
82710	was	O
82711	treated	O
82712	with	O
82713	vancomycin	b-TREATMENT
82714	and	O
82715	he	O
82716	was	O
82717	also	O
82718	on	O
82719	levofloxacin	b-TREATMENT
82720	and	O
82721	flagyl	b-TREATMENT
82722	for	O
82723	presumed	O
82724	aspiration	b-PROBLEM
82725	pneumonia	i-PROBLEM
82726	at	O
82727	the	O
82728	time	O
82729	of	O
82730	his	b-OCCURRENCE
82731	admission	i-OCCURRENCE
82732	.	O
82733	blood	b-TEST
82734	cultures	i-TEST
82735	cleared	b-OCCURRENCE
82736	by	O
82737	2013-05-03	b-DATE
82738	.	O
82739	sputum	b-TEST
82740	culture	i-TEST
82741	as	O
82742	late	O
82743	as	O
82744	2013-05-10	b-DATE
82745	,	O
82746	however	O
82747	was	O
82748	still	O
82749	positive	O
82750	for	O
82751	coagulase	b-PROBLEM
82752	positive	i-PROBLEM
82753	staphylococcus	i-PROBLEM
82754	which	O
82755	was	O
82756	methicillin	b-PROBLEM
82757	resistant	i-PROBLEM
82758	staphylococcus	i-PROBLEM
82759	aureus	i-PROBLEM
82760	.	O
82761	the	O
82762	patient	O
82763	remained	O
82764	gravely	b-PROBLEM
82765	ill	i-PROBLEM
82766	throughout	O
82767	his	b-OCCURRENCE
82768	hospital	i-OCCURRENCE
82769	stay	i-OCCURRENCE
82770	and	O
82771	had	O
82772	multiple	b-OCCURRENCE
82773	meetings	i-OCCURRENCE
82774	were	O
82775	held	O
82776	with	O
82777	his	O
82778	family	O
82779	with	O
82780	his	O
82781	son	O
82782	being	O
82783	his	O
82784	next	O
82785	of	O
82786	kin	O
82787	.	O
82788	ultimately	O
82789	it	O
82790	was	O
82791	decided	b-OCCURRENCE
82792	that	O
82793	the	O
82794	patient	O
82795	's	O
82796	wishes	O
82797	would	O
82798	be	O
82799	to	O
82800	not	O
82801	be	O
82802	maintained	O
82803	in	O
82804	a	O
82805	vegetative	O
82806	state	O
82807	and	O
82808	given	O
82809	his	b-OCCURRENCE
82810	poor	i-OCCURRENCE
82811	prognosis	i-OCCURRENCE
82812	ultimately	O
82813	the	O
82814	decision	O
82815	was	O
82816	made	O
82817	to	O
82818	pursue	O
82819	comfort	b-TREATMENT
82820	measures	i-TREATMENT
82821	only	O
82822	.	O
82823	with	O
82824	these	O
82825	goals	O
82826	of	O
82827	care	O
82828	,	O
82829	the	O
82830	patient	O
82831	expired	b-OCCURRENCE
82832	on	O
82833	2013-05-11	b-DATE
82834	.	O
82835	the	O
82836	family	O
82837	did	O
82838	consent	O
82839	to	O
82840	a	b-TEST
82841	postmortem	i-TEST
82842	examination	i-TEST
82843	.	O
82844		O
82845	admission	b-OCCURRENCE
82846	date	O
82847	:	O
82848	2009-11-10	b-ADMISSION
82849	discharge	b-OCCURRENCE
82850	date	O
82851	:	O
82852	2009-11-12	b-DISCHARGE
82853	service	O
82854	:	O
82855	ccu	O
82856	history	O
82857	of	O
82858	present	O
82859	illness	O
82860	:	O
82861	the	O
82862	patient	O
82863	is	O
82864	a	O
82865	61	O
82866	-	O
82867	year-old	O
82868	white	O
82869	male	O
82870	with	O
82871	a	O
82872	history	O
82873	of	O
82874	coronary	b-PROBLEM
82875	artery	i-PROBLEM
82876	disease	i-PROBLEM
82877	,	O
82878	status	O
82879	post	O
82880	5-vessel	b-TREATMENT
82881	coronary	i-TREATMENT
82882	artery	i-TREATMENT
82883	bypass	i-TREATMENT
82884	graft	i-TREATMENT
82885	on	O
82886	2009-09-11	b-DATE
82887	,	O
82888	who	O
82889	presents	b-OCCURRENCE
82890	for	O
82891	elective	b-TEST
82892	right	i-TEST
82893	heart	i-TEST
82894	catheterization	i-TEST
82895	and	O
82896	pericardiocentesis	b-TREATMENT
82897	.	O
82898	the	O
82899	patient	O
82900	did	b-OCCURRENCE
82901	well	i-OCCURRENCE
82902	after	O
82903	his	b-TREATMENT
82904	coronary	i-TREATMENT
82905	artery	i-TREATMENT
82906	bypass	i-TREATMENT
82907	graft	i-TREATMENT
82908	.	O
82909	on	O
82910	10-14	b-DATE
82911	,	O
82912	the	O
82913	patient	O
82914	had	O
82915	a	b-TEST
82916	transthoracic	i-TEST
82917	echocardiogram	i-TEST
82918	which	O
82919	revealed	O
82920	a	b-PROBLEM
82921	new	i-PROBLEM
82922	,	i-PROBLEM
82923	moderate-to-large	i-PROBLEM
82924	sized	i-PROBLEM
82925	pericardial	i-PROBLEM
82926	effusion	i-PROBLEM
82927	.	O
82928	the	O
82929	patient	O
82930	was	O
82931	asymptomatic	b-PROBLEM
82932	at	O
82933	this	b-DATE
82934	time	i-DATE
82935	,	O
82936	and	O
82937	the	O
82938	decision	O
82939	was	O
82940	made	O
82941	to	O
82942	monitor	b-TEST
82943	him	i-TEST
82944	and	O
82945	to	O
82946	start	O
82947	him	O
82948	on	O
82949	lasix	b-TREATMENT
82950	.	O
82951	the	O
82952	patient	O
82953	had	O
82954	follow-up	b-TEST
82955	transthoracic	i-TEST
82956	echocardiogram	i-TEST
82957	on	O
82958	11-04	b-DATE
82959	which	O
82960	revealed	O
82961	a	b-PROBLEM
82962	slightly	i-PROBLEM
82963	large	i-PROBLEM
82964	effusion	i-PROBLEM
82965	.	O
82966	a	b-DATE
82967	few	i-DATE
82968	days	i-DATE
82969	later	i-DATE
82970	,	i-DATE
82971	on	i-DATE
82972	11-07	i-DATE
82973	,	O
82974	the	O
82975	patient	O
82976	began	O
82977	to	O
82978	develop	O
82979	dyspnea	b-PROBLEM
82980	on	O
82981	exertion	O
82982	with	O
82983	normal	O
82984	activity	O
82985	.	O
82986	he	O
82987	also	O
82988	noted	O
82989	a	b-PROBLEM
82990	new	i-PROBLEM
82991	two	i-PROBLEM
82992	to	i-PROBLEM
82993	three-pillow	i-PROBLEM
82994	orthopnea	i-PROBLEM
82995	and	O
82996	paroxysmal	b-PROBLEM
82997	nocturnal	i-PROBLEM
82998	dyspnea	i-PROBLEM
82999	.	O
83000	on	O
83001	11-08	b-DATE
83002	,	O
83003	he	O
83004	had	O
83005	an	O
83006	episode	O
83007	of	O
83008	acute	b-PROBLEM
83009	shortness	i-PROBLEM
83010	of	i-PROBLEM
83011	breath	i-PROBLEM
83012	with	O
83013	chest	b-PROBLEM
83014	pressure	i-PROBLEM
83015	which	O
83016	he	O
83017	describes	O
83018	as	O
83019	different	O
83020	from	O
83021	his	b-PROBLEM
83022	typical	i-PROBLEM
83023	angina	i-PROBLEM
83024	with	O
83025	minimal	O
83026	exertion	O
83027	.	O
83028	the	O
83029	patient	O
83030	spoke	O
83031	with	O
83032	his	b-CLINICAL_DEPT
83033	cardiologist	i-CLINICAL_DEPT
83034	who	O
83035	referred	O
83036	him	O
83037	for	O
83038	pericardiocentesis	b-TREATMENT
83039	for	O
83040	persistent	b-PROBLEM
83041	and	i-PROBLEM
83042	symptomatic	i-PROBLEM
83043	pericardial	i-PROBLEM
83044	effusion	i-PROBLEM
83045	.	O
83046	on	O
83047	right	b-TEST
83048	heart	i-TEST
83049	catheterization	i-TEST
83050	,	O
83051	the	O
83052	patient	O
83053	was	O
83054	noted	O
83055	to	O
83056	have	O
83057	elevated	b-PROBLEM
83058	right-sided	i-PROBLEM
83059	and	i-PROBLEM
83060	left-sided	i-PROBLEM
83061	filling	i-PROBLEM
83062	pressures	i-PROBLEM
83063	with	O
83064	a	b-TEST
83065	pulmonary	i-TEST
83066	capillary	i-TEST
83067	wedge	i-TEST
83068	pressure	i-TEST
83069	of	O
83070	19	O
83071	and	O
83072	a	b-TEST
83073	right	i-TEST
83074	atrial	i-TEST
83075	pressure	i-TEST
83076	of	O
83077	16	O
83078	.	O
83079	after	O
83080	600	O
83081	cc	O
83082	of	O
83083	serosanguineous	b-TREATMENT
83084	pericardial	i-TREATMENT
83085	fluid	i-TREATMENT
83086	was	i-TREATMENT
83087	removed	i-TREATMENT
83088	,	O
83089	the	O
83090	patient	O
83091	was	O
83092	noted	O
83093	to	O
83094	have	O
83095	a	b-TEST
83096	pulmonary	i-TEST
83097	capillary	i-TEST
83098	wedge	i-TEST
83099	pressure	i-TEST
83100	of	O
83101	9	O
83102	and	O
83103	a	b-TEST
83104	right	i-TEST
83105	atrial	i-TEST
83106	pressure	i-TEST
83107	of	O
83108	2	O
83109	;	O
83110	indicating	O
83111	resolution	O
83112	of	O
83113	tamponade	b-PROBLEM
83114	physiology	i-PROBLEM
83115	.	O
83116	hospital	O
83117	course	O
83118	:	O
83119	the	O
83120	patient	O
83121	was	O
83122	transferred	b-OCCURRENCE
83123	to	O
83124	the	b-CLINICAL_DEPT
83125	coronary	i-CLINICAL_DEPT
83126	care	i-CLINICAL_DEPT
83127	unit	i-CLINICAL_DEPT
83128	after	O
83129	his	b-TREATMENT
83130	therapeutic	i-TREATMENT
83131	pericardiocentesis	i-TREATMENT
83132	.	O
83133	he	O
83134	was	O
83135	hemodynamically	b-OCCURRENCE
83136	stable	i-OCCURRENCE
83137	and	O
83138	without	O
83139	any	b-OCCURRENCE
83140	complaints	i-OCCURRENCE
83141	.	O
83142	he	O
83143	was	O
83144	continued	O
83145	on	O
83146	his	b-TREATMENT
83147	home	i-TREATMENT
83148	cardiac	i-TREATMENT
83149	regimen	i-TREATMENT
83150	,	O
83151	but	O
83152	was	O
83153	started	O
83154	on	O
83155	indomethacin	b-TREATMENT
83156	for	O
83157	post	b-PROBLEM
83158	pericardiotomy	i-PROBLEM
83159	syndrome	i-PROBLEM
83160	.	O
83161	over	O
83162	the	b-DURATION
83163	course	i-DURATION
83164	of	i-DURATION
83165	the	i-DURATION
83166	night	i-DURATION
83167	the	O
83168	patient	O
83169	drained	b-TREATMENT
83170	an	O
83171	additional	O
83172	400	O
83173	cc	O
83174	of	O
83175	serosanguineous	b-PROBLEM
83176	fluid	i-PROBLEM
83177	from	O
83178	his	O
83179	pericardial	O
83180	drain	O
83181	pouch	O
83182	.	O
83183	by	O
83184	the	b-DATE
83185	next	i-DATE
83186	morning	i-DATE
83187	,	O
83188	the	O
83189	degree	O
83190	of	O
83191	drainage	b-TREATMENT
83192	had	O
83193	decreased	b-OCCURRENCE
83194	considerably	O
83195	with	O
83196	only	O
83197	60	O
83198	cc	O
83199	drained	O
83200	over	O
83201	six	b-DURATION
83202	hours	i-DURATION
83203	.	O
83204	the	O
83205	patient	O
83206	had	O
83207	a	b-TEST
83208	repeat	i-TEST
83209	transthoracic	i-TEST
83210	echocardiogram	i-TEST
83211	prior	O
83212	to	O
83213	drain	b-TREATMENT
83214	removal	i-TREATMENT
83215	which	O
83216	revealed	b-EVIDENTIAL
83217	the	O
83218	following	O
83219	:	O
83220	a	b-PROBLEM
83221	trivial	i-PROBLEM
83222	/	i-PROBLEM
83223	physiologic	i-PROBLEM
83224	pericardial	i-PROBLEM
83225	effusion	i-PROBLEM
83226	one	b-DATE
83227	day	i-DATE
83228	post	i-DATE
83229	pericardiocentesis	b-TREATMENT
83230	with	O
83231	no	O
83232	change	O
83233	from	O
83234	the	b-TEST
83235	study	i-TEST
83236	immediately	O
83237	post	O
83238	pericardiocentesis	O
83239	.	O
83240	the	b-TREATMENT
83241	pericardial	i-TREATMENT
83242	drain	i-TREATMENT
83243	was	O
83244	removed	b-TREATMENT
83245	without	O
83246	any	b-PROBLEM
83247	difficulty	i-PROBLEM
83248	.	O
83249	the	b-TREATMENT
83250	pericardial	i-TREATMENT
83251	fluid	i-TREATMENT
83252	bag	i-TREATMENT
83253	was	O
83254	removed	b-TREATMENT
83255	without	O
83256	any	b-OCCURRENCE
83257	difficulty	i-OCCURRENCE
83258	with	O
83259	the	O
83260	decision	O
83261	to	O
83262	monitor	b-TEST
83263	the	O
83264	patient	O
83265	overnight	b-DURATION
83266	and	O
83267	repeat	O
83268	the	b-TEST
83269	echocardiogram	i-TEST
83270	prior	O
83271	to	O
83272	discharge	b-OCCURRENCE
83273	.	O
83274	the	O
83275	patient	O
83276	had	O
83277	an	b-PROBLEM
83278	enlarged	i-PROBLEM
83279	left	i-PROBLEM
83280	pleural	i-PROBLEM
83281	effusion	i-PROBLEM
83282	which	O
83283	was	O
83284	noted	O
83285	to	O
83286	layer	O
83287	on	O
83288	a	b-TEST
83289	lateral	i-TEST
83290	decubitus	i-TEST
83291	film	i-TEST
83292	.	O
83293	we	O
83294	decided	O
83295	to	O
83296	perform	O
83297	a	b-TREATMENT
83298	therapeutic	i-TREATMENT
83299	thoracentesis	i-TREATMENT
83300	.	O
83301	the	O
83302	patient	O
83303	was	O
83304	prepped	b-TREATMENT
83305	and	i-TREATMENT
83306	draped	i-TREATMENT
83307	in	O
83308	a	O
83309	sterile	O
83310	fashion	O
83311	,	O
83312	and	O
83313	1150	O
83314	cc	O
83315	of	O
83316	fluid	b-PROBLEM
83317	were	O
83318	drained	b-TREATMENT
83319	.	O
83320	a	b-TEST
83321	chest	i-TEST
83322	x-ray	i-TEST
83323	was	O
83324	obtained	O
83325	post	O
83326	thoracentesis	b-TREATMENT
83327	which	O
83328	revealed	b-EVIDENTIAL
83329	a	O
83330	significant	O
83331	decrease	O
83332	in	O
83333	the	O
83334	size	O
83335	of	O
83336	the	b-PROBLEM
83337	left	i-PROBLEM
83338	pleural	i-PROBLEM
83339	effusion	i-PROBLEM
83340	.	O
83341	no	O
83342	evidence	O
83343	of	O
83344	pneumothorax	b-PROBLEM
83345	.	O
83346	on	O
83347	the	b-DATE
83348	morning	i-DATE
83349	of	i-DATE
83350	admission	i-DATE
83351	the	O
83352	patient	O
83353	had	O
83354	a	b-TEST
83355	markedly	i-TEST
83356	improved	i-TEST
83357	lung	i-TEST
83358	examination	i-TEST
83359	with	O
83360	increased	b-OCCURRENCE
83361	air	i-OCCURRENCE
83362	movement	i-OCCURRENCE
83363	in	i-OCCURRENCE
83364	the	i-OCCURRENCE
83365	left	i-OCCURRENCE
83366	base	i-OCCURRENCE
83367	.	O
83368	he	O
83369	denied	O
83370	any	b-PROBLEM
83371	shortness	i-PROBLEM
83372	of	i-PROBLEM
83373	breath	i-PROBLEM
83374	and	O
83375	had	O
83376	oxygen	b-TEST
83377	saturations	i-TEST
83378	in	O
83379	the	O
83380	90	O
83381	s	O
83382	on	O
83383	room	O
83384	air	O
83385	.	O
83386	he	O
83387	had	O
83388	a	b-TEST
83389	repeat	i-TEST
83390	echocardiogram	i-TEST
83391	which	O
83392	revealed	b-EVIDENTIAL
83393	a	b-PROBLEM
83394	trivial	i-PROBLEM
83395	/	i-PROBLEM
83396	physiologic	i-PROBLEM
83397	pericardial	i-PROBLEM
83398	effusion	i-PROBLEM
83399	.	O
83400	the	O
83401	patient	O
83402	was	O
83403	without	O
83404	any	O
83405	complaints	b-EVIDENTIAL
83406	and	O
83407	remained	b-OCCURRENCE
83408	stable	i-OCCURRENCE
83409	.	O
83410		O
83411	admission	b-OCCURRENCE
83412	date	O
83413	:	O
83414	2015-04-16	b-ADMISSION
83415	discharge	b-OCCURRENCE
83416	date	O
83417	:	O
83418	2015-04-24	b-DISCHARGE
83419	service	O
83420	:	O
83421	surgery	O
83422	history	O
83423	of	O
83424	present	O
83425	illness	O
83426	:	O
83427	this	O
83428	78	O
83429	year	O
83430	old	O
83431	mexican	O
83432	speaking	O
83433	female	O
83434	presented	b-EVIDENTIAL
83435	to	O
83436	the	b-CLINICAL_DEPT
83437	emergency	i-CLINICAL_DEPT
83438	department	i-CLINICAL_DEPT
83439	on	O
83440	2015-04-16	b-DATE
83441	.	O
83442	her	O
83443	family	O
83444	memebers	O
83445	stated	b-EVIDENTIAL
83446	that	O
83447	she	O
83448	was	O
83449	found	O
83450	at	O
83451	home	O
83452	with	O
83453	altered	b-PROBLEM
83454	mental	i-PROBLEM
83455	status	i-PROBLEM
83456	and	O
83457	diaphoresis	b-PROBLEM
83458	.	O
83459	she	O
83460	is	O
83461	diabetic	b-PROBLEM
83462	.	O
83463	mental	b-PROBLEM
83464	status	i-PROBLEM
83465	improved	b-OCCURRENCE
83466	after	O
83467	binasal	b-TREATMENT
83468	cannula	i-TREATMENT
83469	oxygen	i-TREATMENT
83470	applied	O
83471	,	O
83472	at	O
83473	which	O
83474	time	O
83475	she	O
83476	localized	b-EVIDENTIAL
83477	right	b-PROBLEM
83478	upper	i-PROBLEM
83479	quadrant	i-PROBLEM
83480	pain	i-PROBLEM
83481	.	O
83482	she	O
83483	developed	O
83484	leukocytosis	b-PROBLEM
83485	and	O
83486	transaminasemia	b-PROBLEM
83487	.	O
83488	brief	O
83489	hospital	O
83490	course	O
83491	:	O
83492	ms	O
83493	malek	O
83494	was	O
83495	admitted	b-OCCURRENCE
83496	on	O
83497	2015-04-16	b-DATE
83498	due	O
83499	to	O
83500	altered	b-PROBLEM
83501	mental	i-PROBLEM
83502	status	i-PROBLEM
83503	and	O
83504	acute	b-PROBLEM
83505	right	i-PROBLEM
83506	upper	i-PROBLEM
83507	quadrant	i-PROBLEM
83508	abdominal	i-PROBLEM
83509	pain	i-PROBLEM
83510	.	O
83511	gallbladder	b-TEST
83512	ultra	i-TEST
83513	sound	i-TEST
83514	revealed	b-EVIDENTIAL
83515	a	O
83516	distended	O
83517	1.6	O
83518	cm_	O
83519	non	b-PROBLEM
83520	mobile	i-PROBLEM
83521	stone	i-PROBLEM
83522	in	O
83523	the	O
83524	neck	O
83525	.	O
83526	hd	b-DATE
83527	#	i-DATE
83528	01	i-DATE
83529	20	O
83530	she	O
83531	was	O
83532	monitored	b-TEST
83533	closely	O
83534	in	O
83535	the	b-CLINICAL_DEPT
83536	cmed	i-CLINICAL_DEPT
83537	.	O
83538	on	O
83539	2015-04-17	b-DATE
83540	she	O
83541	was	O
83542	taken	O
83543	to	O
83544	the	b-CLINICAL_DEPT
83545	or	i-CLINICAL_DEPT
83546	for	O
83547	lap	b-TREATMENT
83548	converted	O
83549	to	O
83550	open	b-TREATMENT
83551	cholecystectomy	i-TREATMENT
83552	.	O
83553	she	O
83554	tolerated	b-OCCURRENCE
83555	the	b-TREATMENT
83556	procedure	i-TREATMENT
83557	well	O
83558	,	O
83559	see	O
83560	op	O
83561	report	O
83562	for	O
83563	details	O
83564	.	O
83565	she	O
83566	was	O
83567	extubated	b-TREATMENT
83568	and	O
83569	recovered	b-OCCURRENCE
83570	well	i-OCCURRENCE
83571	in	O
83572	pacu	b-CLINICAL_DEPT
83573	.	O
83574	she	O
83575	remained	O
83576	npo	b-TREATMENT
83577	with	O
83578	iv	b-TREATMENT
83579	fluids	i-TREATMENT
83580	,	O
83581	foley	b-TREATMENT
83582	catheter	i-TREATMENT
83583	and	O
83584	dilaudid	b-TREATMENT
83585	iv	i-TREATMENT
83586	for	O
83587	pain	b-TREATMENT
83588	control	i-TREATMENT
83589	,	O
83590	unasyn	b-TREATMENT
83591	for	O
83592	antibiotic	b-TREATMENT
83593	coverage	i-TREATMENT
83594	.	O
83595	she	O
83596	returned	b-OCCURRENCE
83597	to	O
83598	cmed	b-CLINICAL_DEPT
83599	for	O
83600	further	b-TEST
83601	monitoring	i-TEST
83602	.	O
83603	she	O
83604	was	O
83605	noted	O
83606	to	O
83607	have	O
83608	low	b-PROBLEM
83609	urine	i-PROBLEM
83610	output	i-PROBLEM
83611	at	O
83612	times	O
83613	.	O
83614	she	O
83615	responded	b-OCCURRENCE
83616	well	i-OCCURRENCE
83617	to	O
83618	fluid	b-TREATMENT
83619	bolusing	i-TREATMENT
83620	.	O
83621	pod#1	b-DATE
83622	she	O
83623	was	O
83624	transferred	b-OCCURRENCE
83625	to	O
83626	cc6	b-CLINICAL_DEPT
83627	for	O
83628	further	b-OCCURRENCE
83629	recovery	i-OCCURRENCE
83630	.	O
83631	she	O
83632	remained	O
83633	afebrile	b-PROBLEM
83634	,	O
83635	she	O
83636	was	O
83637	given	O
83638	ice	b-OCCURRENCE
83639	chips	i-OCCURRENCE
83640	.	O
83641	physical	O
83642	therapy	O
83643	was	O
83644	consulted	b-OCCURRENCE
83645	for	O
83646	strength	O
83647	and	O
83648	mobility	O
83649	.	O
83650	pod#2	b-DATE
83651	her	b-PROBLEM
83652	pain	i-PROBLEM
83653	was	O
83654	somewhat	O
83655	uncontrolled	b-PROBLEM
83656	,	O
83657	she	O
83658	was	O
83659	placed	O
83660	on	O
83661	dilaudid	b-TREATMENT
83662	pca	i-TREATMENT
83663	with	O
83664	fair	b-OCCURRENCE
83665	effect	i-OCCURRENCE
83666	.	O
83667	urine	b-TEST
83668	output	i-TEST
83669	remained	O
83670	adequate	O
83671	.	O
83672	she	O
83673	was	O
83674	monitored	b-TEST
83675	on	O
83676	telemetry	b-TEST
83677	for	O
83678	mild	b-PROBLEM
83679	tachycardia	i-PROBLEM
83680	and	O
83681	recieved	O
83682	iv	b-TREATMENT
83683	beta	i-TREATMENT
83684	blockers	i-TREATMENT
83685	.	O
83686	she	O
83687	ambulated	b-OCCURRENCE
83688	with	O
83689	assistance	b-TREATMENT
83690	.	O
83691	pod#3	b-DATE
83692	she	O
83693	was	O
83694	advanced	O
83695	to	O
83696	sips	b-TREATMENT
83697	and	i-TREATMENT
83698	clears	i-TREATMENT
83699	,	O
83700	foley	b-TREATMENT
83701	catheter	i-TREATMENT
83702	was	O
83703	discontinued	O
83704	.	O
83705	pod#4	b-DATE
83706	,	O
83707	bilious	b-PROBLEM
83708	drainage	i-PROBLEM
83709	was	O
83710	noted	O
83711	in	O
83712	her	b-TREATMENT
83713	jp	i-TREATMENT
83714	.	O
83715	she	O
83716	had	O
83717	worsening	b-PROBLEM
83718	abdominal	i-PROBLEM
83719	pain	i-PROBLEM
83720	on	O
83721	exam	b-TEST
83722	.	O
83723	she	O
83724	was	O
83725	held	O
83726	npo	b-TREATMENT
83727	.	O
83728	she	O
83729	was	O
83730	taken	O
83731	to	O
83732	ercp	b-TEST
83733	where	O
83734	sphincterotomy	b-TREATMENT
83735	was	O
83736	performed	O
83737	and	O
83738	biliary	b-TREATMENT
83739	stent	i-TREATMENT
83740	was	O
83741	placed	O
83742	.	O
83743	she	O
83744	tolerated	b-OCCURRENCE
83745	the	b-TREATMENT
83746	procedure	i-TREATMENT
83747	well	O
83748	and	O
83749	returned	O
83750	to	O
83751	cc6	b-CLINICAL_DEPT
83752	post-procedure	O
83753	.	O
83754	jp	b-TREATMENT
83755	remained	O
83756	intact	O
83757	with	O
83758	serosainguinous	b-PROBLEM
83759	drainage	i-PROBLEM
83760	.	O
83761	pod#5	b-DATE
83762	she	O
83763	c/o	O
83764	difficulty	b-PROBLEM
83765	voiding	i-PROBLEM
83766	,	O
83767	pt	O
83768	was	O
83769	straight	b-TREATMENT
83770	cathed	i-TREATMENT
83771	after	O
83772	bladder	b-TEST
83773	scan	i-TEST
83774	was	O
83775	obtained	O
83776	and	O
83777	revealed	b-EVIDENTIAL
83778	>	O
83779	600	O
83780	ccs	O
83781	urine	O
83782	.	O
83783	pod#	b-DATE
83784	05	i-DATE
83785	25	O
83786	she	O
83787	continued	O
83788	with	O
83789	intermittent	O
83790	complaints	b-EVIDENTIAL
83791	of	O
83792	urinary	b-PROBLEM
83793	retention	i-PROBLEM
83794	.	O
83795	however	O
83796	she	O
83797	was	O
83798	able	b-OCCURRENCE
83799	to	i-OCCURRENCE
83800	void	i-OCCURRENCE
83801	.	O
83802	renal	b-TEST
83803	function	i-TEST
83804	remained	O
83805	normal	O
83806	.	O
83807	she	O
83808	did	O
83809	not	O
83810	require	O
83811	further	b-TREATMENT
83812	straight	i-TREATMENT
83813	catheterization	i-TREATMENT
83814	.	O
83815	she	O
83816	was	O
83817	advanced	O
83818	to	O
83819	clear	b-TREATMENT
83820	liquids	i-TREATMENT
83821	again	O
83822	without	O
83823	nausea	b-PROBLEM
83824	or	O
83825	vomiting	b-PROBLEM
83826	.	O
83827	her	b-PROBLEM
83828	pain	i-PROBLEM
83829	was	O
83830	well	b-TREATMENT
83831	controlled	i-TREATMENT
83832	by	O
83833	tylenol	b-TREATMENT
83834	.	O
83835	her	O
83836	home	O
83837	regimen	O
83838	of	O
83839	lantus	b-TREATMENT
83840	was	O
83841	resumed	O
83842	for	O
83843	elevated	b-PROBLEM
83844	blood	i-PROBLEM
83845	glucose	i-PROBLEM
83846	.	O
83847	pod#6	b-DATE
83848	,	O
83849	her	O
83850	diet	O
83851	was	O
83852	advanced	b-OCCURRENCE
83853	to	i-OCCURRENCE
83854	regular	i-OCCURRENCE
83855	.	O
83856	she	O
83857	required	O
83858	disimpaction	b-TREATMENT
83859	and	O
83860	had	O
83861	hard	b-PROBLEM
83862	stool	i-PROBLEM
83863	in	i-PROBLEM
83864	the	i-PROBLEM
83865	rectum	i-PROBLEM
83866	.	O
83867	she	O
83868	was	O
83869	initiated	O
83870	on	O
83871	a	b-TREATMENT
83872	bowel	i-TREATMENT
83873	regimen	i-TREATMENT
83874	and	O
83875	had	O
83876	no	O
83877	further	O
83878	incidents	O
83879	of	O
83880	diarrhea	b-PROBLEM
83881	or	O
83882	constipation	b-PROBLEM
83883	.	O
83884	pod#7	b-DATE
83885	she	O
83886	was	O
83887	discharged	b-OCCURRENCE
83888	to	O
83889	rehab	b-CLINICAL_DEPT
83890	in	O
83891	stable	b-OCCURRENCE
83892	condition	i-OCCURRENCE
83893	.	O
83894	appropriate	O
83895	follow	b-OCCURRENCE
83896	up	i-OCCURRENCE
83897	appointments	i-OCCURRENCE
83898	are	O
83899	recommended	O
83900	as	O
83901	well	O
83902	as	O
83903	prescriptions	b-TREATMENT
83904	.	O
83905	she	O
83906	should	O
83907	return	O
83908	in	O
83909	6	b-DURATION
83910	weeks	i-DURATION
83911	for	O
83912	removal	b-TREATMENT
83913	of	O
83914	biliary	b-TREATMENT
83915	stent	i-TREATMENT
83916	.	O
83917		O
83918	admission	b-OCCURRENCE
83919	date	O
83920	:	O
83921	11/12/2002	b-ADMISSION
83922	discharge	b-OCCURRENCE
83923	date	O
83924	:	O
83925	11/15/2002	b-DISCHARGE
83926	history	O
83927	of	O
83928	present	O
83929	illness	O
83930	:	O
83931	this	O
83932	is	O
83933	a	O
83934	44	O
83935	year-old	O
83936	right	O
83937	handed	O
83938	woman	O
83939	with	O
83940	down	b-PROBLEM
83941	&apos;s	i-PROBLEM
83942	syndrome	i-PROBLEM
83943	who	O
83944	presents	b-OCCURRENCE
83945	with	O
83946	increased	b-PROBLEM
83947	falling	i-PROBLEM
83948	and	O
83949	gait	b-PROBLEM
83950	unsteadiness	i-PROBLEM
83951	and	O
83952	an	b-PROBLEM
83953	increased	i-PROBLEM
83954	inability	i-PROBLEM
83955	to	O
83956	perform	O
83957	her	O
83958	activities	O
83959	of	O
83960	daily	O
83961	living	O
83962	over	O
83963	the	b-DURATION
83964	past	i-DURATION
83965	three	i-DURATION
83966	years	i-DURATION
83967	.	O
83968	the	O
83969	diagnosis	O
83970	of	O
83971	alzheimer	b-PROBLEM
83972	&apos;s	i-PROBLEM
83973	was	O
83974	made	O
83975	in	O
83976	1998	b-DATE
83977	.	O
83978	the	O
83979	patient	O
83980	had	O
83981	an	b-TEST
83982	mri	i-TEST
83983	at	O
83984	an	b-CLINICAL_DEPT
83985	outside	i-CLINICAL_DEPT
83986	hospital	i-CLINICAL_DEPT
83987	which	O
83988	showed	b-EVIDENTIAL
83989	enlarged	b-PROBLEM
83990	lateral	i-PROBLEM
83991	ventricles	i-PROBLEM
83992	and	O
83993	the	O
83994	possible	O
83995	diagnosis	O
83996	of	O
83997	normal	b-PROBLEM
83998	pressure	i-PROBLEM
83999	hydrocephalus	i-PROBLEM
84000	was	O
84001	entertained	O
84002	and	O
84003	the	O
84004	patient	O
84005	was	O
84006	admitted	b-OCCURRENCE
84007	for	O
84008	diagnostic	b-TEST
84009	lumbar	i-TEST
84010	puncture	i-TEST
84011	.	O
84012	hospital	O
84013	course	O
84014	:	O
84015	the	O
84016	patient	O
84017	was	O
84018	admitted	b-OCCURRENCE
84019	to	O
84020	the	b-CLINICAL_DEPT
84021	arkzie-	i-CLINICAL_DEPT
84022	memorial	i-CLINICAL_DEPT
84023	for	O
84024	lumbar	b-TEST
84025	puncture	i-TEST
84026	.	O
84027	on	O
84028	the	b-DATE
84029	night	i-DATE
84030	of	O
84031	admission	b-OCCURRENCE
84032	lumbar	b-TEST
84033	puncture	i-TEST
84034	was	O
84035	attempted	O
84036	on	O
84037	the	b-CLINICAL_DEPT
84038	floor	i-CLINICAL_DEPT
84039	,	O
84040	but	O
84041	we	O
84042	were	O
84043	unable	O
84044	to	O
84045	get	O
84046	cerebral	O
84047	spinal	O
84048	fluid	O
84049	due	O
84050	to	O
84051	difficulty	O
84052	with	O
84053	compliance	O
84054	with	O
84055	the	O
84056	patient	O
84057	who	O
84058	was	O
84059	severely	b-PROBLEM
84060	agitated	i-PROBLEM
84061	and	O
84062	would	O
84063	not	O
84064	comply	b-OCCURRENCE
84065	with	O
84066	the	b-TEST
84067	examination	i-TEST
84068	.	O
84069	on	O
84070	hospital	b-DATE
84071	day	i-DATE
84072	the	O
84073	patient	O
84074	underwent	O
84075	conscious	b-TREATMENT
84076	sedation	i-TREATMENT
84077	in	O
84078	the	b-CLINICAL_DEPT
84079	operating	i-CLINICAL_DEPT
84080	room	i-CLINICAL_DEPT
84081	where	O
84082	lumbar	b-TEST
84083	puncture	i-TEST
84084	was	O
84085	performed	O
84086	.	O
84087	opening	b-TEST
84088	pressure	i-TEST
84089	was	O
84090	17	O
84091	and	O
84092	approximately	O
84093	20-25	O
84094	cc	O
84095	of	O
84096	csf	O
84097	was	O
84098	removed	O
84099	.	O
84100	csf	O
84101	was	O
84102	notable	O
84103	for	O
84104	sugar	b-TEST
84105	level	i-TEST
84106	of	O
84107	65	O
84108	and	O
84109	total	b-TEST
84110	protein	i-TEST
84111	level	i-TEST
84112	of	O
84113	56	O
84114	.	O
84115	other	O
84116	laboratories	O
84117	that	O
84118	were	O
84119	notable	O
84120	:	O
84121	vitamin	b-TEST
84122	b12	i-TEST
84123	of	O
84124	855	O
84125	,	O
84126	folic	b-TEST
84127	acid	i-TEST
84128	of	O
84129	15.4	O
84130	.	O
84131	chem-7	b-TEST
84132	was	O
84133	within	O
84134	normal	O
84135	limits	O
84136	.	O
84137	tube	O
84138	and	O
84139	requisition	O
84140	of	O
84141	the	b-TEST
84142	csf	i-TEST
84143	labeled	i-TEST
84144	tube	i-TEST
84145	#	i-TEST
84146	1	i-TEST
84147	was	O
84148	notable	O
84149	for	O
84150	color	b-TEST
84151	pink	O
84152	,	O
84153	turbidity	b-TEST
84154	slight	O
84155	,	O
84156	xanthochromia	b-TEST
84157	yes	O
84158	,	O
84159	red	b-TEST
84160	blood	i-TEST
84161	cells	i-TEST
84162	3,800	O
84163	,	O
84164	white	b-TEST
84165	blood	i-TEST
84166	cells	i-TEST
84167	3	O
84168	,	O
84169	neutrophils	b-TEST
84170	58	O
84171	,	O
84172	bands	b-TEST
84173	4	O
84174	,	O
84175	lymphs	b-TEST
84176	29	O
84177	,	O
84178	monos	b-TEST
84179	6	O
84180	,	O
84181	eos	b-TEST
84182	2	O
84183	and	O
84184	basos	b-TEST
84185	1	O
84186	.	O
84187	csf	b-TEST
84188	tube	i-TEST
84189	labeled	i-TEST
84190	#	i-TEST
84191	4	i-TEST
84192	was	O
84193	notable	O
84194	for	O
84195	csf	b-TEST
84196	color	i-TEST
84197	pink	O
84198	,	O
84199	csf	b-TEST
84200	turbidity	i-TEST
84201	slight	O
84202	,	O
84203	csf	b-TEST
84204	xanthochromia	i-TEST
84205	yes	O
84206	,	O
84207	csf	b-TEST
84208	rbcs	i-TEST
84209	3,900	O
84210	,	O
84211	csf	b-TEST
84212	white	i-TEST
84213	blood	i-TEST
84214	cells	i-TEST
84215	3	O
84216	,	O
84217	csf	b-TEST
84218	neutrophils	i-TEST
84219	61	O
84220	,	O
84221	csf	b-TEST
84222	bands	i-TEST
84223	3	O
84224	,	O
84225	csf	b-TEST
84226	lymphs	i-TEST
84227	31	O
84228	,	O
84229	csf	b-TEST
84230	monos	i-TEST
84231	1	O
84232	,	O
84233	csf	b-TEST
84234	eos	i-TEST
84235	3	O
84236	,	O
84237	csf	b-TEST
84238	basos	i-TEST
84239	1	O
84240	.	O
84241	csf	b-TEST
84242	gram	i-TEST
84243	stain	i-TEST
84244	was	O
84245	notable	O
84246	for	O
84247	no	O
84248	polys	b-PROBLEM
84249	and	O
84250	no	O
84251	organisms	b-PROBLEM
84252	seen	O
84253	.	O
84254	the	b-TEST
84255	fluid	i-TEST
84256	culture	i-TEST
84257	was	O
84258	no	O
84259	growth	b-PROBLEM
84260	to	O
84261	date	O
84262	.	O
84263	one	b-DATE
84264	day	i-DATE
84265	prior	O
84266	to	O
84267	lumbar	b-TEST
84268	puncture	i-TEST
84269	,	O
84270	an	b-TEST
84271	aerobic	i-TEST
84272	culture	i-TEST
84273	was	O
84274	similarly	O
84275	pending	O
84276	.	O
84277	lyme	b-TEST
84278	capture	i-TEST
84279	was	O
84280	pending	O
84281	and	O
84282	at	O
84283	the	b-DATE
84284	time	i-DATE
84285	of	O
84286	discharge	b-OCCURRENCE
84287	.	O
84288	other	O
84289	notable	O
84290	tests	O
84291	:	O
84292	rpr	b-TEST
84293	card	i-TEST
84294	test	i-TEST
84295	was	O
84296	negative	O
84297	.	O
84298	because	O
84299	of	O
84300	poor	b-PROBLEM
84301	compliance	i-PROBLEM
84302	with	O
84303	the	b-TEST
84304	gait	i-TEST
84305	examination	i-TEST
84306	it	O
84307	was	O
84308	very	O
84309	difficult	O
84310	to	O
84311	assess	O
84312	changing	b-PROBLEM
84313	gait	i-PROBLEM
84314	post	O
84315	lumbar	b-TEST
84316	puncture	i-TEST
84317	.	O
84318	the	O
84319	patient	O
84320	&apos;s	O
84321	gait	O
84322	remained	O
84323	wide	b-PROBLEM
84324	based	i-PROBLEM
84325	and	O
84326	shuffling	b-PROBLEM
84327	and	O
84328	requiring	b-PROBLEM
84329	assist	i-PROBLEM
84330	.	O
84331	her	O
84332	mental	O
84333	status	O
84334	remained	O
84335	similarly	O
84336	to	O
84337	her	b-TEST
84338	admission	i-TEST
84339	examination	i-TEST
84340	.	O
84341	the	O
84342	patient	O
84343	was	O
84344	discharged	b-OCCURRENCE
84345	to	O
84346	home	O
84347	on	O
84348	11/15/02	b-DATE
84349	with	O
84350	instructions	O
84351	to	O
84352	the	O
84353	family	O
84354	to	O
84355	observe	b-OCCURRENCE
84356	her	i-OCCURRENCE
84357	gait	i-OCCURRENCE
84358	in	O
84359	her	O
84360	home	O
84361	environment	O
84362	and	O
84363	to	O
84364	observe	b-OCCURRENCE
84365	her	i-OCCURRENCE
84366	behavior	i-OCCURRENCE
84367	in	O
84368	her	O
84369	home	O
84370	environment	O
84371	over	O
84372	the	b-DURATION
84373	next	i-DURATION
84374	day	i-DURATION
84375	and	O
84376	to	O
84377	report	b-EVIDENTIAL
84378	back	i-EVIDENTIAL
84379	to	O
84380	the	O
84381	primary	O
84382	neurologist	O
84383	,	O
84384	doctor	O
84385	flythegach	O
84386	,	O
84387	as	O
84388	to	O
84389	changes	O
84390	.	O
84391		O
84392	admission	b-OCCURRENCE
84393	date	O
84394	:	O
84395	2012-09-26	b-ADMISSION
84396	discharge	b-OCCURRENCE
84397	date	O
84398	:	O
84399	2012-10-01	b-DISCHARGE
84400	service	O
84401	:	O
84402	neonatology	O
84403	history	O
84404	of	O
84405	present	O
84406	illness	O
84407	:	O
84408	this	O
84409	is	O
84410	a	O
84411	5235	O
84412	-	O
84413	gram	O
84414	full-term	O
84415	male	O
84416	infant	O
84417	of	O
84418	a	O
84419	diabetic	O
84420	mother	O
84421	born	O
84422	by	O
84423	repeat	b-TREATMENT
84424	cesarean	i-TREATMENT
84425	section	i-TREATMENT
84426	to	O
84427	a	O
84428	29-year-old	O
84429	gravida	O
84430	1	O
84431	,	O
84432	para	O
84433	2	O
84434	,	O
84435	woman	O
84436	.	O
84437	prenatal	b-TEST
84438	screens	i-TEST
84439	benign	O
84440	.	O
84441	group	b-TEST
84442	b	i-TEST
84443	strep	i-TEST
84444	status	i-TEST
84445	negative	O
84446	.	O
84447	pregnancy	O
84448	complicated	O
84449	by	O
84450	insulin-dependent	O
84451	gestational	O
84452	diabetes	O
84453	.	O
84454	apgar	b-TEST
84455	scores	i-TEST
84456	were	O
84457	8	O
84458	at	O
84459	1	O
84460	minute	O
84461	and	O
84462	9	O
84463	at	O
84464	5	O
84465	minutes	O
84466	.	O
84467	the	O
84468	infant	O
84469	admitted	b-OCCURRENCE
84470	to	O
84471	the	b-CLINICAL_DEPT
84472	neonatal	i-CLINICAL_DEPT
84473	intensive	i-CLINICAL_DEPT
84474	care	i-CLINICAL_DEPT
84475	unit	i-CLINICAL_DEPT
84476	for	O
84477	a	b-TEST
84478	dextrose	i-TEST
84479	stick	i-TEST
84480	of	O
84481	20	O
84482	in	O
84483	the	b-CLINICAL_DEPT
84484	delivery	i-CLINICAL_DEPT
84485	room	i-CLINICAL_DEPT
84486	.	O
84487	summary	O
84488	of	O
84489	hospital	O
84490	course	O
84491	by	O
84492	issues-system	O
84493	:	O
84494	respiratory	O
84495	:	O
84496	the	O
84497	infant	O
84498	has	O
84499	remained	O
84500	on	O
84501	room	b-TREATMENT
84502	air	i-TREATMENT
84503	throughout	O
84504	his	b-OCCURRENCE
84505	hospitalization	i-OCCURRENCE
84506	with	O
84507	oxygen	b-TEST
84508	saturations	i-TEST
84509	of	O
84510	greater	O
84511	than	O
84512	95	O
84513	percent	O
84514	.	O
84515	respiratory	b-TEST
84516	rates	i-TEST
84517	have	O
84518	been	O
84519	40	O
84520	s	O
84521	to	O
84522	60	O
84523	s.	O
84524	the	O
84525	infant	O
84526	has	O
84527	had	O
84528	two	b-PROBLEM
84529	spontaneous	i-PROBLEM
84530	desaturations	i-PROBLEM
84531	which	O
84532	quickly	O
84533	self-resolved	O
84534	on	O
84535	day	b-DATE
84536	of	i-DATE
84537	life	i-DATE
84538	one	i-DATE
84539	.	O
84540	no	O
84541	other	b-PROBLEM
84542	issues	i-PROBLEM
84543	.	O
84544	no	O
84545	apnea	b-PROBLEM
84546	or	O
84547	bradycardia	b-PROBLEM
84548	.	O
84549	cardiovascular	O
84550	:	O
84551	the	O
84552	infant	O
84553	has	O
84554	remained	O
84555	hemodynamically	b-OCCURRENCE
84556	stable	i-OCCURRENCE
84557	with	O
84558	heart	b-TEST
84559	rates	i-TEST
84560	in	O
84561	the	O
84562	120	O
84563	s	O
84564	to	O
84565	140	O
84566	s	O
84567	and	O
84568	mean	b-TEST
84569	blood	i-TEST
84570	pressures	i-TEST
84571	of	O
84572	57	O
84573	to	O
84574	60	O
84575	.	O
84576	fluids	O
84577	,	O
84578	electrolytes	O
84579	and	O
84580	nutrition	O
84581	:	O
84582	the	O
84583	infant	O
84584	was	O
84585	admitted	b-OCCURRENCE
84586	to	O
84587	the	b-CLINICAL_DEPT
84588	neonatal	i-CLINICAL_DEPT
84589	intensive	i-CLINICAL_DEPT
84590	care	i-CLINICAL_DEPT
84591	unit	i-CLINICAL_DEPT
84592	for	O
84593	treatment	b-TREATMENT
84594	of	O
84595	hypoglycemia	b-PROBLEM
84596	.	O
84597	the	O
84598	infant	O
84599	was	O
84600	started	O
84601	on	O
84602	enteral	b-TREATMENT
84603	feedings	i-TREATMENT
84604	of	O
84605	enfamil	b-TREATMENT
84606	20	O
84607	calories	O
84608	per	O
84609	ounce	O
84610	by	O
84611	mouth	O
84612	ad	b-FREQUENCY
84613	lib	i-FREQUENCY
84614	and	O
84615	maintained	O
84616	glucoses	b-TEST
84617	in	O
84618	the	O
84619	middle	O
84620	to	O
84621	high	O
84622	40	O
84623	s	O
84624	taking	O
84625	by	O
84626	mouth	b-TREATMENT
84627	feedings	i-TREATMENT
84628	every	b-FREQUENCY
84629	two	i-FREQUENCY
84630	to	i-FREQUENCY
84631	three	i-FREQUENCY
84632	hours	i-FREQUENCY
84633	by	O
84634	mouth	O
84635	ad	b-FREQUENCY
84636	lib	i-FREQUENCY
84637	.	O
84638	on	O
84639	day	b-DATE
84640	of	i-DATE
84641	life	i-DATE
84642	one	i-DATE
84643	,	O
84644	the	O
84645	infant	O
84646	had	O
84647	a	b-TEST
84648	dextrose	i-TEST
84649	stick	i-TEST
84650	of	O
84651	34	O
84652	.	O
84653	at	O
84654	that	b-DATE
84655	time	i-DATE
84656	,	O
84657	an	b-TREATMENT
84658	intravenous	i-TREATMENT
84659	of	O
84660	d-10-w	b-TREATMENT
84661	was	O
84662	started	O
84663	at	O
84664	80	O
84665	cc	O
84666	/	O
84667	kilogram	O
84668	per	O
84669	day	O
84670	.	O
84671	on	O
84672	day	b-DATE
84673	of	i-DATE
84674	life	i-DATE
84675	two	i-DATE
84676	,	O
84677	the	O
84678	infant	O
84679	began	O
84680	to	O
84681	wean	b-TREATMENT
84682	off	i-TREATMENT
84683	intravenous	b-TREATMENT
84684	fluids	i-TREATMENT
84685	,	O
84686	and	O
84687	this	O
84688	was	O
84689	completed	O
84690	by	O
84691	day	b-DATE
84692	of	i-DATE
84693	life	i-DATE
84694	four	i-DATE
84695	.	O
84696	calories	O
84697	were	O
84698	increased	O
84699	to	O
84700	similac	b-TREATMENT
84701	24	O
84702	calories	O
84703	per	O
84704	ounce	O
84705	.	O
84706	before	O
84707	discharge	b-OCCURRENCE
84708	to	O
84709	the	b-CLINICAL_DEPT
84710	newborn	i-CLINICAL_DEPT
84711	nursery	i-CLINICAL_DEPT
84712	,	O
84713	the	O
84714	infant	O
84715	was	O
84716	taking	O
84717	similac	b-TREATMENT
84718	22	O
84719	calories	O
84720	per	O
84721	ounce	O
84722	by	O
84723	mouth	O
84724	ad	b-FREQUENCY
84725	lib	i-FREQUENCY
84726	and	O
84727	maintaining	O
84728	dextrose	b-TEST
84729	sticks	i-TEST
84730	in	O
84731	the	O
84732	60	O
84733	s.	O
84734	weight	b-TEST
84735	on	O
84736	discharge	b-OCCURRENCE
84737	was	O
84738	5200	O
84739	grams	O
84740	.	O
84741	gastrointestinal	b-PROBLEM
84742	:	O
84743	no	O
84744	issues	b-PROBLEM
84745	.	O
84746	hematology	b-PROBLEM
84747	:	O
84748	no	O
84749	issues	b-PROBLEM
84750	.	O
84751	neurology	b-PROBLEM
84752	:	O
84753	normal	b-OCCURRENCE
84754	neurologic	i-OCCURRENCE
84755	examination	i-OCCURRENCE
84756	.	O
84757	screens	O
84758	:	O
84759	a	b-TEST
84760	hearing	i-TEST
84761	screen	i-TEST
84762	was	O
84763	performed	O
84764	with	O
84765	automated	b-TEST
84766	auditory	i-TEST
84767	brain	i-TEST
84768	stem	i-TEST
84769	responses	i-TEST
84770	and	O
84771	the	O
84772	infant	O
84773	passed	b-OCCURRENCE
84774	on	i-OCCURRENCE
84775	both	i-OCCURRENCE
84776	ears	i-OCCURRENCE
84777	.	O
84778	psychosocial	O
84779	:	O
84780	the	O
84781	parents	O
84782	are	O
84783	involved	O
84784	.	O
84785		O
84786	admission	b-OCCURRENCE
84787	date	O
84788	:	O
84789	10-03-94	b-ADMISSION
84790	discharge	b-OCCURRENCE
84791	date	O
84792	:	O
84793	10-06-94	b-DISCHARGE
84794	history	O
84795	of	O
84796	present	O
84797	illness	O
84798	:	O
84799	this	O
84800	85	O
84801	year	O
84802	old	O
84803	man	O
84804	was	O
84805	admitted	b-OCCURRENCE
84806	because	O
84807	of	O
84808	the	O
84809	new	O
84810	onset	O
84811	of	O
84812	focal	b-PROBLEM
84813	left-sided	i-PROBLEM
84814	seizure	i-PROBLEM
84815	and	O
84816	unresponsiveness	b-PROBLEM
84817	.	O
84818	he	O
84819	had	O
84820	a	O
84821	past	O
84822	history	O
84823	of	O
84824	ischemic	b-PROBLEM
84825	cardiomyopathy	i-PROBLEM
84826	with	O
84827	an	b-TEST
84828	ejection	i-TEST
84829	fraction	i-TEST
84830	of	O
84831	10	O
84832	,	O
84833	mild	b-PROBLEM
84834	aortic	i-PROBLEM
84835	stenosis	i-PROBLEM
84836	and	O
84837	a	b-PROBLEM
84838	right	i-PROBLEM
84839	middle	i-PROBLEM
84840	cerebral	i-PROBLEM
84841	artery	i-PROBLEM
84842	territory	i-PROBLEM
84843	stroke	i-PROBLEM
84844	in	O
84845	07/94	b-DATE
84846	.	O
84847	he	O
84848	was	O
84849	at	O
84850	orlak	b-CLINICAL_DEPT
84851	on	O
84852	the	b-DATE
84853	day	i-DATE
84854	of	O
84855	admission	b-OCCURRENCE
84856	and	O
84857	was	O
84858	found	O
84859	unresponsive	b-PROBLEM
84860	with	O
84861	left	b-PROBLEM
84862	tonic-clonic	i-PROBLEM
84863	movements	i-PROBLEM
84864	,	O
84865	greater	O
84866	in	O
84867	the	O
84868	arms	O
84869	than	O
84870	in	O
84871	the	O
84872	legs	O
84873	.	O
84874	he	O
84875	was	O
84876	transferred	b-OCCURRENCE
84877	to	O
84878	fairm	b-CLINICAL_DEPT
84879	of	i-CLINICAL_DEPT
84880	ijordcompmac	i-CLINICAL_DEPT
84881	hospital	i-CLINICAL_DEPT
84882	,	O
84883	where	O
84884	seizures	b-PROBLEM
84885	were	O
84886	stopped	O
84887	with	O
84888	2	O
84889	mg	O
84890	of	O
84891	ativan	b-TREATMENT
84892	.	O
84893	he	O
84894	was	O
84895	loaded	O
84896	with	O
84897	iv	b-TREATMENT
84898	dilantin	i-TREATMENT
84899	.	O
84900	he	O
84901	remained	O
84902	unresponsive	b-PROBLEM
84903	with	O
84904	poor	b-PROBLEM
84905	airway	i-PROBLEM
84906	protection	i-PROBLEM
84907	.	O
84908	hospital	O
84909	course	O
84910	:	O
84911	by	O
84912	the	O
84913	patient	O
84914	and	O
84915	his	O
84916	family	O
84917	&apos;s	O
84918	prior	O
84919	wishes	O
84920	,	O
84921	the	O
84922	patient	O
84923	was	O
84924	extubated	b-TREATMENT
84925	.	O
84926	an	b-TEST
84927	electroencephalogram	i-TEST
84928	revealed	b-EVIDENTIAL
84929	generalized	b-PROBLEM
84930	slowing	i-PROBLEM
84931	without	O
84932	ictal	b-PROBLEM
84933	events	i-PROBLEM
84934	.	O
84935	he	O
84936	had	O
84937	no	O
84938	carotid	b-PROBLEM
84939	bruits	i-PROBLEM
84940	.	O
84941	he	O
84942	had	O
84943	stertorous	b-PROBLEM
84944	breathing	i-PROBLEM
84945	,	O
84946	positional	b-PROBLEM
84947	tremors	i-PROBLEM
84948	of	i-PROBLEM
84949	the	i-PROBLEM
84950	left	i-PROBLEM
84951	upper	i-PROBLEM
84952	extremity	i-PROBLEM
84953	,	O
84954	a	b-PROBLEM
84955	spastic	i-PROBLEM
84956	left	i-PROBLEM
84957	hemiparesis	i-PROBLEM
84958	in	i-PROBLEM
84959	flexion	i-PROBLEM
84960	.	O
84961	he	O
84962	withdrew	b-OCCURRENCE
84963	both	i-OCCURRENCE
84964	legs	i-OCCURRENCE
84965	to	O
84966	painful	b-TEST
84967	stimuli	i-TEST
84968	.	O
84969	the	O
84970	right	O
84971	upper	O
84972	extremity	O
84973	was	O
84974	flaccid	b-PROBLEM
84975	and	O
84976	paresthetic	b-PROBLEM
84977	.	O
84978	again	O
84979	,	O
84980	comfort	b-TREATMENT
84981	measures	i-TREATMENT
84982	only	i-TREATMENT
84983	were	O
84984	undertaken	O
84985	as	O
84986	per	O
84987	the	O
84988	patient	O
84989	&apos;s	O
84990	previous	O
84991	wishes	O
84992	and	O
84993	the	O
84994	family	O
84995	&apos;s	O
84996	current	O
84997	insistence	O
84998	.	O
84999	at	O
85000	1:15	b-TIME
85001	pm	i-TIME
85002	on	i-TIME
85003	10/06/94	i-TIME
85004	,	O
85005	the	O
85006	patient	O
85007	was	O
85008	found	O
85009	unresponsive	b-PROBLEM
85010	with	O
85011	no	O
85012	heart	b-PROBLEM
85013	sounds	i-PROBLEM
85014	,	O
85015	carotid	b-PROBLEM
85016	pulse	i-PROBLEM
85017	,	O
85018	respiratory	b-PROBLEM
85019	excursions	i-PROBLEM
85020	,	O
85021	or	O
85022	pupillary	b-PROBLEM
85023	reactions	i-PROBLEM
85024	.	O
85025	his	O
85026	family	O
85027	was	O
85028	notified	b-OCCURRENCE
85029	.	O
85030	consent	O
85031	for	O
85032	autopsy	b-TEST
85033	was	O
85034	denied	O
85035	.	O
85036		O
85037	admission	b-OCCURRENCE
85038	date	O
85039	:	O
85040	2011-11-18	b-ADMISSION
85041	discharge	b-OCCURRENCE
85042	date	O
85043	:	O
85044	2011-11-22	b-DISCHARGE
85045	service	O
85046	:	O
85047	ccu	O
85048	history	O
85049	of	O
85050	present	O
85051	illness	O
85052	:	O
85053	the	O
85054	patient	O
85055	is	O
85056	a	O
85057	61	O
85058	-	O
85059	year-old	O
85060	caucasian-speaking	O
85061	woman	O
85062	with	O
85063	a	O
85064	history	O
85065	of	O
85066	hypercholesterolemia	b-PROBLEM
85067	and	O
85068	tobacco	b-PROBLEM
85069	use	i-PROBLEM
85070	who	O
85071	developed	O
85072	waxing	b-PROBLEM
85073	and	i-PROBLEM
85074	waning	i-PROBLEM
85075	left	i-PROBLEM
85076	substernal	i-PROBLEM
85077	chest	i-PROBLEM
85078	pain	i-PROBLEM
85079	with	O
85080	radiation	b-PROBLEM
85081	to	i-PROBLEM
85082	the	i-PROBLEM
85083	left	i-PROBLEM
85084	shoulder	i-PROBLEM
85085	on	O
85086	2011-11-17	b-DATE
85087	which	O
85088	lasted	O
85089	that	O
85090	entire	b-DURATION
85091	day	i-DURATION
85092	.	O
85093	upon	O
85094	waking	O
85095	on	O
85096	the	b-DATE
85097	morning	i-DATE
85098	of	O
85099	admission	b-OCCURRENCE
85100	,	O
85101	she	O
85102	had	O
85103	10/10	O
85104	chest	b-PROBLEM
85105	pain	i-PROBLEM
85106	associated	O
85107	with	O
85108	nausea	b-PROBLEM
85109	.	O
85110	she	O
85111	presented	b-OCCURRENCE
85112	to	O
85113	charlton	b-CLINICAL_DEPT
85114	memorial	i-CLINICAL_DEPT
85115	hospital	i-CLINICAL_DEPT
85116	hospital	i-CLINICAL_DEPT
85117	emergency	i-CLINICAL_DEPT
85118	department	i-CLINICAL_DEPT
85119	with	O
85120	inferior	b-PROBLEM
85121	st	i-PROBLEM
85122	elevations	i-PROBLEM
85123	;	O
85124	at	O
85125	which	O
85126	time	O
85127	she	O
85128	became	O
85129	acutely	b-PROBLEM
85130	hypotensive	i-PROBLEM
85131	to	O
85132	a	b-TEST
85133	systolic	i-TEST
85134	blood	i-TEST
85135	pressure	i-TEST
85136	of	O
85137	70	O
85138	to	O
85139	80	O
85140	after	O
85141	receiving	O
85142	one	O
85143	ublingual	b-TREATMENT
85144	nitroglycerin	i-TREATMENT
85145	.	O
85146	she	O
85147	then	O
85148	became	O
85149	bradycardic	b-PROBLEM
85150	which	O
85151	responded	O
85152	to	O
85153	atropine	b-TREATMENT
85154	and	O
85155	intravenous	b-TREATMENT
85156	fluids	i-TREATMENT
85157	.	O
85158	in	O
85159	addition	O
85160	,	O
85161	she	O
85162	was	O
85163	given	O
85164	aspirin	b-TREATMENT
85165	,	O
85166	plavix	b-TREATMENT
85167	,	O
85168	heparin	b-TREATMENT
85169	,	O
85170	and	O
85171	morphine	b-TREATMENT
85172	.	O
85173	immediately	O
85174	prior	O
85175	to	O
85176	transfer	b-OCCURRENCE
85177	to	O
85178	worcester	b-CLINICAL_DEPT
85179	state	i-CLINICAL_DEPT
85180	hospital	i-CLINICAL_DEPT
85181	,	O
85182	she	O
85183	went	O
85184	into	O
85185	ventricular	b-PROBLEM
85186	fibrillation	i-PROBLEM
85187	arrest	i-PROBLEM
85188	at	O
85189	12:30	b-TIME
85190	p.m.	i-TIME
85191	,	O
85192	at	O
85193	which	O
85194	time	O
85195	she	O
85196	was	O
85197	intubated	b-TREATMENT
85198	and	O
85199	defibrillated	b-TREATMENT
85200	back	O
85201	to	O
85202	sinus	b-OCCURRENCE
85203	rhythm	i-OCCURRENCE
85204	after	O
85205	five	b-TREATMENT
85206	shocks	i-TREATMENT
85207	.	O
85208	she	O
85209	received	O
85210	an	b-TREATMENT
85211	amiodarone	i-TREATMENT
85212	bolus	i-TREATMENT
85213	of	O
85214	150	O
85215	mg	O
85216	intravenously	O
85217	and	O
85218	was	O
85219	continued	O
85220	on	O
85221	an	b-TREATMENT
85222	amiodarone	i-TREATMENT
85223	drip	i-TREATMENT
85224	while	O
85225	cmed	b-OCCURRENCE
85226	csru-flighted	i-OCCURRENCE
85227	to	O
85228	boston	b-CLINICAL_DEPT
85229	regional	i-CLINICAL_DEPT
85230	medical	i-CLINICAL_DEPT
85231	center_	i-CLINICAL_DEPT
85232	where	O
85233	she	O
85234	underwent	O
85235	a	b-TEST
85236	catheterization	i-TEST
85237	.	O
85238	the	b-TEST
85239	cardiac	i-TEST
85240	catheterization	i-TEST
85241	revealed	b-EVIDENTIAL
85242	a	b-PROBLEM
85243	total	i-PROBLEM
85244	occlusion	i-PROBLEM
85245	of	i-PROBLEM
85246	the	i-PROBLEM
85247	proximal	i-PROBLEM
85248	right	i-PROBLEM
85249	coronary	i-PROBLEM
85250	artery	i-PROBLEM
85251	and	O
85252	diffuse	b-PROBLEM
85253	right	i-PROBLEM
85254	coronary	i-PROBLEM
85255	artery	i-PROBLEM
85256	disease	i-PROBLEM
85257	.	O
85258	she	O
85259	received	O
85260	three	b-TREATMENT
85261	stents	i-TREATMENT
85262	to	i-TREATMENT
85263	the	i-TREATMENT
85264	right	i-TREATMENT
85265	coronary	i-TREATMENT
85266	artery	i-TREATMENT
85267	which	O
85268	was	O
85269	complicated	O
85270	by	O
85271	a	b-PROBLEM
85272	proximal	i-PROBLEM
85273	dissection	i-PROBLEM
85274	.	O
85275	she	O
85276	had	O
85277	good	O
85278	post	b-TEST
85279	percutaneous	i-TEST
85280	coronary	i-TEST
85281	intervention	i-TEST
85282	angiographic	i-TEST
85283	results	i-TEST
85284	.	O
85285	incidentally	O
85286	,	O
85287	an	b-TEST
85288	aortogram	i-TEST
85289	during	O
85290	the	b-TEST
85291	catheterization	i-TEST
85292	revealed	b-EVIDENTIAL
85293	a	b-PROBLEM
85294	debakey	i-PROBLEM
85295	class	i-PROBLEM
85296	i	i-PROBLEM
85297	aortic	i-PROBLEM
85298	ascending	i-PROBLEM
85299	aneurysm	i-PROBLEM
85300	,	O
85301	and	O
85302	the	O
85303	patient	O
85304	had	O
85305	a	b-TEST
85306	pulmonary	i-TEST
85307	capillary	i-TEST
85308	wedge	i-TEST
85309	pressure	i-TEST
85310	of	O
85311	20	O
85312	at	O
85313	the	O
85314	time	O
85315	of	O
85316	catheterization	b-TEST
85317	.	O
85318	she	O
85319	was	O
85320	transferred	b-OCCURRENCE
85321	to	O
85322	the	b-CLINICAL_DEPT
85323	coronary	i-CLINICAL_DEPT
85324	care	i-CLINICAL_DEPT
85325	unit	i-CLINICAL_DEPT
85326	in	O
85327	stable	b-OCCURRENCE
85328	condition	i-OCCURRENCE
85329	and	O
85330	still	O
85331	intubated	b-TREATMENT
85332	.	O
85333	hospital	O
85334	course	O
85335	:	O
85336	1.	O
85337	cardiovascular	O
85338	system	O
85339	:	O
85340	on	O
85341	the	b-DATE
85342	night	i-DATE
85343	of	O
85344	admission	b-OCCURRENCE
85345	,	O
85346	the	O
85347	patient	O
85348	experienced	O
85349	post	b-PROBLEM
85350	catheterization	i-PROBLEM
85351	hypotension	i-PROBLEM
85352	which	O
85353	required	O
85354	intravenous	b-TREATMENT
85355	fluids	i-TREATMENT
85356	and	O
85357	dopamine	b-TREATMENT
85358	.	O
85359	electrocardiogram	b-TEST
85360	the	b-DATE
85361	following	i-DATE
85362	morning	i-DATE
85363	revealed	b-EVIDENTIAL
85364	normalization	b-OCCURRENCE
85365	of	i-OCCURRENCE
85366	her	i-OCCURRENCE
85367	st	i-OCCURRENCE
85368	segments	i-OCCURRENCE
85369	with	O
85370	evolution	b-PROBLEM
85371	of	i-PROBLEM
85372	q	i-PROBLEM
85373	waves	i-PROBLEM
85374	.	O
85375	her	b-TREATMENT
85376	dopamine	i-TREATMENT
85377	was	O
85378	weaned	O
85379	off	O
85380	the	b-DATE
85381	following	i-DATE
85382	day	i-DATE
85383	,	O
85384	and	O
85385	her	b-TREATMENT
85386	heparin	i-TREATMENT
85387	was	O
85388	discontinued	O
85389	secondary	O
85390	to	O
85391	a	b-PROBLEM
85392	right	i-PROBLEM
85393	groin	i-PROBLEM
85394	hematoma	i-PROBLEM
85395	which	O
85396	had	O
85397	developed	O
85398	after	O
85399	the	b-TREATMENT
85400	sheath	i-TREATMENT
85401	had	O
85402	been	O
85403	pulled	O
85404	out	O
85405	by	O
85406	the	O
85407	fellow	O
85408	.	O
85409	her	b-TEST
85410	creatine	i-TEST
85411	kinases	i-TEST
85412	climbed	b-PROBLEM
85413	;	O
85414	reaching	O
85415	a	O
85416	peak	O
85417	of	O
85418	3523	O
85419	,	O
85420	which	b-TEST
85421	was	O
85422	down	b-OCCURRENCE
85423	to	O
85424	1500	O
85425	at	O
85426	the	b-DATE
85427	time	i-DATE
85428	of	O
85429	discharge	b-OCCURRENCE
85430	.	O
85431	also	O
85432	noted	O
85433	on	O
85434	the	O
85435	day	O
85436	of	O
85437	11-20	b-DATE
85438	,	O
85439	the	O
85440	patient	O
85441	self-extubated	b-OCCURRENCE
85442	herself	O
85443	.	O
85444	for	O
85445	her	b-PROBLEM
85446	coronary	i-PROBLEM
85447	artery	i-PROBLEM
85448	disease	i-PROBLEM
85449	,	O
85450	status	O
85451	post	O
85452	catheterization	b-TEST
85453	,	O
85454	she	O
85455	was	O
85456	given	O
85457	integrilin	b-TREATMENT
85458	for	O
85459	18	b-DURATION
85460	hours	i-DURATION
85461	.	O
85462	she	O
85463	was	O
85464	continued	O
85465	on	O
85466	aspirin	b-TREATMENT
85467	,	O
85468	plavix	b-TREATMENT
85469	,	O
85470	and	O
85471	lipitor	b-TREATMENT
85472	.	O
85473	for	O
85474	her	O
85475	rhythm	O
85476	,	O
85477	amiodarone	b-TREATMENT
85478	was	O
85479	discontinued	O
85480	as	O
85481	she	O
85482	was	O
85483	maintained	O
85484	in	O
85485	sinus	b-OCCURRENCE
85486	rhythm	i-OCCURRENCE
85487	after	O
85488	moving	b-OCCURRENCE
85489	to	O
85490	the	b-CLINICAL_DEPT
85491	floor	i-CLINICAL_DEPT
85492	.	O
85493	for	O
85494	pump	O
85495	,	O
85496	once	O
85497	transferred	b-OCCURRENCE
85498	out	O
85499	of	O
85500	the	b-CLINICAL_DEPT
85501	coronary	i-CLINICAL_DEPT
85502	care	i-CLINICAL_DEPT
85503	unit	i-CLINICAL_DEPT
85504	on	O
85505	2011-11-20	b-DATE
85506	,	O
85507	a	b-TREATMENT
85508	beta	i-TREATMENT
85509	blocker	i-TREATMENT
85510	was	O
85511	begun	O
85512	at	O
85513	12.5	O
85514	mg	O
85515	of	O
85516	lopressor	b-TREATMENT
85517	p.o.	O
85518	b.i.d.	b-FREQUENCY
85519	which	O
85520	was	O
85521	titrated	b-OCCURRENCE
85522	to	O
85523	25	O
85524	mg	O
85525	at	O
85526	the	b-DATE
85527	time	i-DATE
85528	of	O
85529	discharge	b-OCCURRENCE
85530	.	O
85531	also	O
85532	,	O
85533	at	O
85534	the	b-DATE
85535	time	i-DATE
85536	of	O
85537	discharge	b-OCCURRENCE
85538	,	O
85539	for	O
85540	increased	b-TREATMENT
85541	afterload	i-TREATMENT
85542	reduction	i-TREATMENT
85543	,	O
85544	she	O
85545	was	O
85546	started	O
85547	on	O
85548	lisinopril	b-TREATMENT
85549	5	O
85550	mg	O
85551	p.o.	O
85552	q.d.	b-FREQUENCY
85553	on	O
85554	2011-11-21	b-DATE
85555	,	O
85556	the	O
85557	patient	O
85558	experienced	O
85559	atypical	b-PROBLEM
85560	chest	i-PROBLEM
85561	pain	i-PROBLEM
85562	which	O
85563	was	O
85564	made	O
85565	worse	b-PROBLEM
85566	with	O
85567	inspiration	b-OCCURRENCE
85568	and	O
85569	movement	b-OCCURRENCE
85570	.	O
85571	it	b-PROBLEM
85572	was	O
85573	not	O
85574	associated	O
85575	with	O
85576	any	b-PROBLEM
85577	nausea	i-PROBLEM
85578	or	O
85579	vomiting	b-PROBLEM
85580	.	O
85581	it	b-PROBLEM
85582	did	O
85583	not	O
85584	radiate	b-PROBLEM
85585	.	O
85586	it	b-PROBLEM
85587	was	O
85588	felt	O
85589	to	O
85590	be	O
85591	pain	b-PROBLEM
85592	secondary	O
85593	to	O
85594	her	b-PROBLEM
85595	self-extubation	i-PROBLEM
85596	and	O
85597	noncardiac	b-PROBLEM
85598	chest	i-PROBLEM
85599	pain	i-PROBLEM
85600	.	O
85601	an	b-TEST
85602	electrocardiogram	i-TEST
85603	was	O
85604	checked	O
85605	which	O
85606	revealed	b-EVIDENTIAL
85607	no	O
85608	st	b-PROBLEM
85609	changes	i-PROBLEM
85610	,	O
85611	and	O
85612	there	O
85613	was	O
85614	no	O
85615	increase	b-PROBLEM
85616	in	O
85617	her	O
85618	downward	O
85619	trending	O
85620	creatine	b-TEST
85621	phosphokinases	i-TEST
85622	.	O
85623	no	O
85624	further	b-TREATMENT
85625	intervention	i-TREATMENT
85626	was	O
85627	done	O
85628	.	O
85629	the	O
85630	patient	O
85631	was	O
85632	treated	O
85633	with	O
85634	tylenol	b-TREATMENT
85635	orally	i-TREATMENT
85636	as	O
85637	well	O
85638	as	O
85639	ativan	b-TREATMENT
85640	for	O
85641	anxiety	b-PROBLEM
85642	that	O
85643	she	O
85644	had	O
85645	about	O
85646	going	O
85647	home	O
85648	.	O
85649	she	O
85650	was	O
85651	pain	b-PROBLEM
85652	free	O
85653	on	O
85654	the	b-DATE
85655	day	i-DATE
85656	of	O
85657	discharge	b-OCCURRENCE
85658	.	O
85659	regarding	O
85660	her	b-PROBLEM
85661	aortic	i-PROBLEM
85662	ascending	i-PROBLEM
85663	aneurysm	i-PROBLEM
85664	,	O
85665	cardiothoracic	b-CLINICAL_DEPT
85666	surgery	i-CLINICAL_DEPT
85667	was	O
85668	consulted	O
85669	regarding	O
85670	further	b-TEST
85671	workup	i-TEST
85672	.	O
85673	at	O
85674	their	O
85675	request	O
85676	,	O
85677	a	b-TEST
85678	ct	i-TEST
85679	scan	i-TEST
85680	of	i-TEST
85681	the	i-TEST
85682	chest	i-TEST
85683	with	O
85684	contrast	b-TEST
85685	was	O
85686	performed	O
85687	on	O
85688	the	b-DATE
85689	day	i-DATE
85690	of	O
85691	discharge	b-OCCURRENCE
85692	.	O
85693	doctor	O
85694	streeter	O
85695	from	O
85696	cardiothoracic	b-CLINICAL_DEPT
85697	surgery	i-CLINICAL_DEPT
85698	will	O
85699	follow	b-OCCURRENCE
85700	up	i-OCCURRENCE
85701	with	O
85702	the	O
85703	patient	O
85704	for	O
85705	further	b-OCCURRENCE
85706	management	i-OCCURRENCE
85707	in	O
85708	approximately	b-DATE
85709	one	i-DATE
85710	month	i-DATE
85711	as	O
85712	an	O
85713	outpatient	O
85714	.	O
85715	his	O
85716	office	O
85717	will	O
85718	contact	O
85719	her	O
85720	to	O
85721	make	O
85722	that	O
85723	appointment	O
85724	.	O
85725	2.	O
85726	pulmonary	O
85727	system	O
85728	:	O
85729	as	O
85730	stated	O
85731	above	O
85732	,	O
85733	the	O
85734	patient	O
85735	self-extubated	b-OCCURRENCE
85736	herself	O
85737	.	O
85738	she	O
85739	complained	b-EVIDENTIAL
85740	of	O
85741	a	b-PROBLEM
85742	sore	i-PROBLEM
85743	throat	i-PROBLEM
85744	which	O
85745	was	O
85746	likely	O
85747	the	O
85748	etiology	O
85749	of	O
85750	her	b-PROBLEM
85751	atypical	i-PROBLEM
85752	chest	i-PROBLEM
85753	complaints	i-PROBLEM
85754	.	O
85755	this	b-PROBLEM
85756	resolved	O
85757	with	O
85758	tylenol	b-TREATMENT
85759	and	O
85760	as	O
85761	needed	b-FREQUENCY
85762	doses	O
85763	of	O
85764	oxycodone	b-TREATMENT
85765	.	O
85766	her	O
85767	lungs	O
85768	remained	O
85769	clear	b-OCCURRENCE
85770	to	O
85771	auscultation	b-TEST
85772	bilaterally	O
85773	throughout	O
85774	the	O
85775	remainder	O
85776	of	O
85777	her	b-OCCURRENCE
85778	hospital	i-OCCURRENCE
85779	course	i-OCCURRENCE
85780	.	O
85781	at	O
85782	the	b-DATE
85783	time	i-DATE
85784	of	O
85785	this	b-OCCURRENCE
85786	dictation	i-OCCURRENCE
85787	,	O
85788	the	b-TEST
85789	ct	i-TEST
85790	of	i-TEST
85791	her	i-TEST
85792	chest	i-TEST
85793	was	O
85794	still	O
85795	pending	O
85796	.	O
85797	the	b-OCCURRENCE
85798	official	i-OCCURRENCE
85799	result	i-OCCURRENCE
85800	was	O
85801	not	O
85802	yet	O
85803	in	O
85804	.	O
85805	3.	O
85806	fluids	O
85807	/	O
85808	electrolytes	O
85809	/	O
85810	nutrition	O
85811	:	O
85812	the	b-TEST
85813	patient	i-TEST
85814	's	i-TEST
85815	electrolytes	i-TEST
85816	sere	O
85817	managed	b-OCCURRENCE
85818	daily	b-FREQUENCY
85819	and	O
85820	repleted	b-TREATMENT
85821	on	O
85822	an	b-FREQUENCY
85823	as	i-FREQUENCY
85824	needed	i-FREQUENCY
85825	basis	i-FREQUENCY
85826	.	O
85827	she	O
85828	did	O
85829	receive	O
85830	intravenous	b-TREATMENT
85831	k-phos	i-TREATMENT
85832	for	O
85833	a	b-PROBLEM
85834	low	i-PROBLEM
85835	phosphorous	i-PROBLEM
85836	of	O
85837	1.5	O
85838	.	O
85839	her	b-TEST
85840	phosphorous	i-TEST
85841	rose	b-OCCURRENCE
85842	appropriately	O
85843	to	O
85844	3.6	O
85845	at	O
85846	the	b-DATE
85847	time	i-DATE
85848	of	O
85849	discharge	b-OCCURRENCE
85850	.	O
85851		O
85852	admission	b-OCCURRENCE
85853	date	O
85854	:	O
85855	06/26/2004	b-ADMISSION
85856	discharge	b-OCCURRENCE
85857	date	O
85858	:	O
85859	07/08/2004	b-DISCHARGE
85860	history	O
85861	of	O
85862	present	O
85863	illness	O
85864	:	O
85865	the	O
85866	patient	O
85867	is	O
85868	a	O
85869	38-year-old	O
85870	gentleman	O
85871	,	O
85872	spanish-speaking	O
85873	,	O
85874	from	O
85875	the	O
85876	taheimpromong	O
85877	,	O
85878	with	O
85879	no	O
85880	significant	O
85881	past	O
85882	medical	O
85883	history	O
85884	,	O
85885	who	O
85886	presents	b-OCCURRENCE
85887	with	O
85888	shortness	b-PROBLEM
85889	of	i-PROBLEM
85890	breath	i-PROBLEM
85891	x	O
85892	2	b-DURATION
85893	months	i-DURATION
85894	as	O
85895	well	O
85896	as	O
85897	a	b-PROBLEM
85898	dry	i-PROBLEM
85899	cough	i-PROBLEM
85900	x	O
85901	1	b-DURATION
85902	month	i-DURATION
85903	.	O
85904	the	O
85905	patient	O
85906	was	O
85907	in	O
85908	his	O
85909	usual	O
85910	state	O
85911	of	O
85912	health	O
85913	until	O
85914	two	b-DURATION
85915	months	i-DURATION
85916	prior	O
85917	to	O
85918	admission	b-OCCURRENCE
85919	when	O
85920	he	O
85921	began	O
85922	to	O
85923	notice	O
85924	shortness	b-PROBLEM
85925	of	i-PROBLEM
85926	breath	i-PROBLEM
85927	on	O
85928	climbing	O
85929	flights	O
85930	of	O
85931	stairs	O
85932	.	O
85933	he	O
85934	stated	b-EVIDENTIAL
85935	that	O
85936	this	O
85937	became	O
85938	worse	O
85939	over	O
85940	the	b-DURATION
85941	last	i-DURATION
85942	month	i-DURATION
85943	until	O
85944	he	O
85945	was	O
85946	noted	O
85947	to	O
85948	be	O
85949	short	b-PROBLEM
85950	of	i-PROBLEM
85951	breath	i-PROBLEM
85952	at	O
85953	rest	O
85954	.	O
85955	he	O
85956	also	O
85957	states	b-EVIDENTIAL
85958	that	O
85959	he	O
85960	has	O
85961	had	O
85962	a	b-PROBLEM
85963	dry	i-PROBLEM
85964	and	i-PROBLEM
85965	nonproductive	i-PROBLEM
85966	cough	i-PROBLEM
85967	for	O
85968	one	b-DURATION
85969	month	i-DURATION
85970	.	O
85971	he	O
85972	denied	b-EVIDENTIAL
85973	any	O
85974	fevers	b-PROBLEM
85975	,	O
85976	chills	b-PROBLEM
85977	,	O
85978	or	O
85979	night	b-PROBLEM
85980	sweats	i-PROBLEM
85981	.	O
85982	no	O
85983	nausea	b-PROBLEM
85984	,	O
85985	vomiting	b-PROBLEM
85986	,	O
85987	or	O
85988	diarrhea	b-PROBLEM
85989	.	O
85990	he	O
85991	did	O
85992	note	b-EVIDENTIAL
85993	some	b-PROBLEM
85994	weight	i-PROBLEM
85995	loss	i-PROBLEM
85996	over	O
85997	the	O
85998	past	O
85999	several	b-DURATION
86000	months	i-DURATION
86001	,	O
86002	though	O
86003	the	O
86004	amount	O
86005	was	O
86006	unknown	O
86007	.	O
86008	he	O
86009	denied	b-EVIDENTIAL
86010	any	O
86011	contact	b-OCCURRENCE
86012	with	O
86013	tb	b-PROBLEM
86014	positive	i-PROBLEM
86015	patients	i-PROBLEM
86016	.	O
86017	he	O
86018	describes	b-EVIDENTIAL
86019	a	O
86020	negative	O
86021	ppd	b-TEST
86022	one	b-DATE
86023	year	i-DATE
86024	prior	O
86025	to	O
86026	admission	b-OCCURRENCE
86027	when	O
86028	he	O
86029	was	O
86030	in	O
86031	prison	O
86032	for	O
86033	one	b-DURATION
86034	week	i-DURATION
86035	.	O
86036	he	O
86037	did	O
86038	travel	b-OCCURRENCE
86039	to	O
86040	the	O
86041	taheimpromong	O
86042	,	O
86043	last	O
86044	in	O
86045	01/2004	b-DATE
86046	for	O
86047	three	b-DURATION
86048	weeks	i-DURATION
86049	.	O
86050	he	O
86051	did	O
86052	note	b-EVIDENTIAL
86053	multiple	O
86054	female	O
86055	sexual	b-OCCURRENCE
86056	partners	i-OCCURRENCE
86057	,	O
86058	although	O
86059	described	b-EVIDENTIAL
86060	using	O
86061	condoms	b-OCCURRENCE
86062	except	O
86063	with	O
86064	his	O
86065	wife	O
86066	.	O
86067	he	O
86068	denies	b-EVIDENTIAL
86069	any	O
86070	iv	b-PROBLEM
86071	drug	i-PROBLEM
86072	use	i-PROBLEM
86073	,	O
86074	did	O
86075	describe	b-EVIDENTIAL
86076	cocaine	b-OCCURRENCE
86077	use	i-OCCURRENCE
86078	last	O
86079	two	b-DATE
86080	months	i-DATE
86081	ago	O
86082	.	O
86083	he	O
86084	did	O
86085	drink	b-OCCURRENCE
86086	alcohol	i-OCCURRENCE
86087	three	O
86088	drinks	O
86089	per	O
86090	day	O
86091	,	O
86092	no	O
86093	withdrawal	b-PROBLEM
86094	symptoms	i-PROBLEM
86095	.	O
86096	in	O
86097	emergency	b-CLINICAL_DEPT
86098	room	i-CLINICAL_DEPT
86099	,	O
86100	he	O
86101	was	O
86102	noted	b-EVIDENTIAL
86103	to	O
86104	be	O
86105	afebrile	b-PROBLEM
86106	with	O
86107	stable	b-OCCURRENCE
86108	vital	i-OCCURRENCE
86109	signs	i-OCCURRENCE
86110	,	O
86111	was	O
86112	treated	O
86113	with	O
86114	iv	b-TREATMENT
86115	fluids	i-TREATMENT
86116	,	O
86117	azithromycin	b-TREATMENT
86118	,	O
86119	and	O
86120	cefuroxime	b-TREATMENT
86121	.	O
86122	hospital	O
86123	course	O
86124	by	O
86125	system	O
86126	:	O
86127	1.	O
86128	pulmonary	O
86129	/	O
86130	infectious	O
86131	disease	O
86132	:	O
86133	the	O
86134	patient	O
86135	&apos;s	O
86136	differential	O
86137	diagnosis	O
86138	included	O
86139	initially	O
86140	a	O
86141	question	O
86142	of	O
86143	an	b-PROBLEM
86144	atypical	i-PROBLEM
86145	pneumonia	i-PROBLEM
86146	or	O
86147	pcp	b-PROBLEM
86148	.	O
86149	his	b-TEST
86150	ppd	i-TEST
86151	has	O
86152	been	O
86153	negative	O
86154	one	b-DATE
86155	year	i-DATE
86156	prior	O
86157	to	O
86158	admission	b-OCCURRENCE
86159	,	O
86160	ppd	b-TEST
86161	was	O
86162	rechecked	O
86163	during	O
86164	this	b-OCCURRENCE
86165	admission	i-OCCURRENCE
86166	and	O
86167	was	O
86168	negative	O
86169	.	O
86170	he	O
86171	was	O
86172	ruled	b-OCCURRENCE
86173	out	i-OCCURRENCE
86174	for	O
86175	tuberculosis	b-PROBLEM
86176	with	O
86177	an	b-TEST
86178	induced	i-TEST
86179	sputum	i-TEST
86180	x	O
86181	3	b-FREQUENCY
86182	,	O
86183	which	O
86184	showed	b-EVIDENTIAL
86185	no	O
86186	afb	b-PROBLEM
86187	.	O
86188	chest	b-TEST
86189	ct	i-TEST
86190	showed	b-EVIDENTIAL
86191	bibasilar	b-PROBLEM
86192	diffuse	i-PROBLEM
86193	infiltrates	i-PROBLEM
86194	,	O
86195	pcp	b-TEST
86196	was	O
86197	negative	O
86198	.	O
86199	thus	O
86200	initially	O
86201	he	O
86202	had	O
86203	been	O
86204	started	O
86205	on	O
86206	prednisone	b-TREATMENT
86207	and	O
86208	bactrim	b-TREATMENT
86209	,	O
86210	this	O
86211	was	O
86212	discontinued	O
86213	.	O
86214	he	O
86215	was	O
86216	continued	O
86217	on	O
86218	azithromycin	b-TREATMENT
86219	and	O
86220	cefuroxime	b-TREATMENT
86221	until	O
86222	bronchoscopy	b-TEST
86223	results	b-OCCURRENCE
86224	were	i-OCCURRENCE
86225	known	i-OCCURRENCE
86226	,	i-OCCURRENCE
86227	negative	i-OCCURRENCE
86228	.	O
86229	thus	O
86230	they	O
86231	were	O
86232	discontinued	O
86233	.	O
86234	he	O
86235	initially	O
86236	had	O
86237	refused	O
86238	hiv	b-TEST
86239	testing	i-TEST
86240	,	O
86241	however	O
86242	,	O
86243	was	O
86244	finally	O
86245	consented	O
86246	,	O
86247	hiv	b-PROBLEM
86248	was	O
86249	noted	b-EVIDENTIAL
86250	to	O
86251	be	O
86252	negative	O
86253	.	O
86254	pulmonary	b-OCCURRENCE
86255	consult	i-OCCURRENCE
86256	was	O
86257	invited	O
86258	,	O
86259	initially	O
86260	the	O
86261	patient	O
86262	refused	O
86263	bronchoscopy	b-TEST
86264	,	O
86265	however	O
86266	,	O
86267	did	O
86268	agree	O
86269	to	O
86270	it	O
86271	during	O
86272	his	b-OCCURRENCE
86273	hospital	i-OCCURRENCE
86274	stay	i-OCCURRENCE
86275	.	O
86276	the	O
86277	results	O
86278	were	O
86279	negative	O
86280	for	O
86281	micro	b-PROBLEM
86282	,	O
86283	most	O
86284	likely	O
86285	diagnosis	O
86286	as	O
86287	per	O
86288	review	b-TEST
86289	of	i-TEST
86290	pathology	i-TEST
86291	is	O
86292	organizing	b-PROBLEM
86293	pneumonia	i-PROBLEM
86294	with	O
86295	possible	O
86296	diagnosis	O
86297	of	O
86298	boop	b-PROBLEM
86299	and	O
86300	chronic	b-PROBLEM
86301	inhalational	i-PROBLEM
86302	injury	i-PROBLEM
86303	was	O
86304	a	O
86305	possibility	O
86306	.	O
86307	the	O
86308	patient	O
86309	required	O
86310	supplemental	b-TREATMENT
86311	oxygen	i-TREATMENT
86312	to	O
86313	keep	O
86314	his	b-TEST
86315	oxygen	i-TEST
86316	saturation	i-TEST
86317	greater	O
86318	than	O
86319	93%	O
86320	.	O
86321	ambulatory	b-TEST
86322	saturation	i-TEST
86323	was	O
86324	82%	O
86325	on	O
86326	room	O
86327	air	O
86328	.	O
86329	he	O
86330	was	O
86331	treated	O
86332	with	O
86333	supportive	b-TREATMENT
86334	medical	i-TREATMENT
86335	therapy	i-TREATMENT
86336	for	O
86337	his	b-PROBLEM
86338	cough	i-PROBLEM
86339	.	O
86340	he	O
86341	was	O
86342	to	O
86343	follow	b-OCCURRENCE
86344	up	i-OCCURRENCE
86345	with	O
86346	pulmonary	b-OCCURRENCE
86347	as	O
86348	an	b-OCCURRENCE
86349	outpatient	i-OCCURRENCE
86350	.	O
86351	2.	O
86352	cardiovascular	O
86353	:	O
86354	echocardiogram	b-TEST
86355	was	O
86356	checked	O
86357	to	O
86358	rule	O
86359	out	O
86360	chf	b-PROBLEM
86361	,	O
86362	showed	b-EVIDENTIAL
86363	lvh	b-PROBLEM
86364	and	O
86365	trace	b-PROBLEM
86366	tr	i-PROBLEM
86367	,	O
86368	ejection	b-TEST
86369	fraction	i-TEST
86370	of	O
86371	60%	O
86372	without	O
86373	any	O
86374	pulmonary	b-PROBLEM
86375	hypertension	i-PROBLEM
86376	.	O
86377	3.	O
86378	heme	O
86379	/id	O
86380	:	O
86381	hepatitis	b-TEST
86382	serologies	i-TEST
86383	were	O
86384	negative	O
86385	.	O
86386	4.	O
86387	fen	O
86388	:	O
86389	the	O
86390	patient	O
86391	was	O
86392	kept	O
86393	on	O
86394	a	O
86395	house	O
86396	diet	b-OCCURRENCE
86397	.	O
86398	his	b-TEST
86399	electrolytes	i-TEST
86400	were	O
86401	repeated	O
86402	p.r.n.	O
86403	5.	O
86404	prophylaxis	O
86405	:	O
86406	lovenox	b-TREATMENT
86407	.	O
86408	6.	O
86409	code	O
86410	status	O
86411	:	O
86412	full	O
86413	.	O
86414	7.	O
86415	disposition	O
86416	:	O
86417	the	O
86418	patient	O
86419	was	O
86420	discharged	b-OCCURRENCE
86421	to	O
86422	home	O
86423	in	O
86424	satisfactory	b-OCCURRENCE
86425	condition	i-OCCURRENCE
86426	with	O
86427	home	b-TREATMENT
86428	oxygen	i-TREATMENT
86429	.	O
86430	multiple	O
86431	conversations	O
86432	were	O
86433	had	O
86434	with	O
86435	the	O
86436	patient	O
86437	as	O
86438	well	O
86439	as	O
86440	an	O
86441	interpreter	O
86442	stating	O
86443	the	O
86444	importance	O
86445	of	O
86446	not	O
86447	smoking	O
86448	and	O
86449	keeping	O
86450	flames	O
86451	away	O
86452	from	O
86453	his	b-TREATMENT
86454	oxygen	i-TREATMENT
86455	tank	i-TREATMENT
86456	.	O
86457	he	O
86458	was	O
86459	sent	b-OCCURRENCE
86460	home	b-OCCURRENCE
86461	with	O
86462	ldamc	b-OCCURRENCE
86463	services	i-OCCURRENCE
86464	to	O
86465	help	O
86466	with	O
86467	his	b-TREATMENT
86468	medications	i-TREATMENT
86469	as	O
86470	well	O
86471	as	O
86472	oxygen	b-OCCURRENCE
86473	education	i-OCCURRENCE
86474	.	O
86475	he	O
86476	was	O
86477	told	O
86478	to	O
86479	call	O
86480	a	O
86481	doctor	O
86482	or	O
86483	come	O
86484	to	O
86485	the	b-CLINICAL_DEPT
86486	emergency	i-CLINICAL_DEPT
86487	room	i-CLINICAL_DEPT
86488	should	O
86489	he	O
86490	have	O
86491	any	b-OCCURRENCE
86492	further	i-OCCURRENCE
86493	troubles	i-OCCURRENCE
86494	,	i-OCCURRENCE
86495	breathing	i-OCCURRENCE
86496	,	O
86497	chest	b-PROBLEM
86498	pain	i-PROBLEM
86499	,	O
86500	or	O
86501	fevers	b-PROBLEM
86502	.	O
86503	he	O
86504	was	O
86505	to	O
86506	follow	b-OCCURRENCE
86507	up	i-OCCURRENCE
86508	with	O
86509	doctor	O
86510	malta	O
86511	at	O
86512	firmert	b-CLINICAL_DEPT
86513	hospital	i-CLINICAL_DEPT
86514	on	O
86515	07/23/04	b-DATE
86516	at	i-DATE
86517	3:00	i-DATE
86518	p.m.	i-DATE
86519	,	O
86520	as	O
86521	well	O
86522	as	O
86523	doctor	O
86524	shawn	O
86525	leick	O
86526	at	O
86527	the	b-CLINICAL_DEPT
86528	stonho	i-CLINICAL_DEPT
86529	health	i-CLINICAL_DEPT
86530	care	i-CLINICAL_DEPT
86531	pulmonary	i-CLINICAL_DEPT
86532	division	i-CLINICAL_DEPT
86533	as	O
86534	directed	O
86535	.	O
86536		O
86537	admission	b-OCCURRENCE
86538	date	O
86539	:	O
86540	08/07/1992	b-ADMISSION
86541	discharge	b-OCCURRENCE
86542	date	O
86543	:	O
86544	08/10/1992	b-DISCHARGE
86545	history	O
86546	of	O
86547	present	O
86548	illness	O
86549	:	O
86550	this	O
86551	is	O
86552	an	O
86553	81	O
86554	year	O
86555	old	O
86556	female	O
86557	with	O
86558	a	b-PROBLEM
86559	right	i-PROBLEM
86560	breast	i-PROBLEM
86561	mass	i-PROBLEM
86562	with	O
86563	a	b-PROBLEM
86564	discharge	i-PROBLEM
86565	.	O
86566	a	b-TEST
86567	mammogram	i-TEST
86568	of	i-TEST
86569	the	i-TEST
86570	right	i-TEST
86571	breast	i-TEST
86572	with	O
86573	shadow	b-TEST
86574	biopsy	i-TEST
86575	was	O
86576	negative	b-OCCURRENCE
86577	.	O
86578	in	O
86579	the	b-DATE
86580	fall	i-DATE
86581	of	i-DATE
86582	1991	i-DATE
86583	,	O
86584	nipple	b-PROBLEM
86585	changes	i-PROBLEM
86586	and	O
86587	discomfort	b-PROBLEM
86588	was	O
86589	again	O
86590	noted	b-OCCURRENCE
86591	.	O
86592	a	b-TEST
86593	mmamogram	i-TEST
86594	showed	b-EVIDENTIAL
86595	no	O
86596	change	b-OCCURRENCE
86597	on	i-OCCURRENCE
86598	right	i-OCCURRENCE
86599	,	O
86600	but	O
86601	new	b-TEST
86602	biopsy	i-TEST
86603	was	O
86604	positive	b-OCCURRENCE
86605	.	O
86606	on	O
86607	the	b-OCCURRENCE
86608	left	i-OCCURRENCE
86609	,	O
86610	there	O
86611	was	O
86612	a	b-PROBLEM
86613	new	i-PROBLEM
86614	shawdown	i-PROBLEM
86615	but	O
86616	the	b-TEST
86617	biopsy	i-TEST
86618	was	O
86619	negative	b-OCCURRENCE
86620	.	O
86621	the	O
86622	patient	O
86623	presents	b-OCCURRENCE
86624	now	b-DATE
86625	for	O
86626	right	b-TREATMENT
86627	modified	i-TREATMENT
86628	radical	i-TREATMENT
86629	mastectomy	i-TREATMENT
86630	with	O
86631	impant	b-TREATMENT
86632	.	O
86633	hospital	O
86634	course	O
86635	:	O
86636	the	O
86637	patient	O
86638	was	O
86639	taken	O
86640	to	O
86641	the	b-CLINICAL_DEPT
86642	operting	i-CLINICAL_DEPT
86643	room	i-CLINICAL_DEPT
86644	on	O
86645	8/7/92	b-DATE
86646	,	O
86647	where	O
86648	a	b-TREATMENT
86649	right	i-TREATMENT
86650	modified	i-TREATMENT
86651	radical	i-TREATMENT
86652	mastectomy	i-TREATMENT
86653	was	O
86654	performed	O
86655	.	O
86656	subsequently	O
86657	a	b-TREATMENT
86658	saline-filled	i-TREATMENT
86659	right	i-TREATMENT
86660	breast	i-TREATMENT
86661	implant	i-TREATMENT
86662	was	O
86663	performed	O
86664	.	O
86665	the	O
86666	patient	O
86667	tolerated	O
86668	the	b-TREATMENT
86669	procedure	i-TREATMENT
86670	extremely	b-OCCURRENCE
86671	well	i-OCCURRENCE
86672	.	O
86673	two	b-TREATMENT
86674	drains	i-TREATMENT
86675	were	O
86676	used	O
86677	.	O
86678	one	b-TREATMENT
86679	drain	i-TREATMENT
86680	was	O
86681	removed	O
86682	on	O
86683	postoperative	b-DATE
86684	day	i-DATE
86685	number	i-DATE
86686	two	i-DATE
86687	,	O
86688	and	O
86689	the	b-TREATMENT
86690	second	i-TREATMENT
86691	drain	i-TREATMENT
86692	she	O
86693	will	O
86694	be	O
86695	discharged	b-OCCURRENCE
86696	to	O
86697	home	O
86698	with	O
86699	.	O
86700		O
86701	admission	b-OCCURRENCE
86702	date	O
86703	:	O
86704	2013-10-27	b-ADMISSION
86705	discharge	b-OCCURRENCE
86706	date	O
86707	:	O
86708	2013-11-03	b-DISCHARGE
86709	service	O
86710	:	O
86711	medicine	O
86712	history	O
86713	of	O
86714	present	O
86715	illness	O
86716	:	O
86717	42	O
86718	year	O
86719	old	O
86720	female	O
86721	with	O
86722	h/o	O
86723	cholangiocarcinoma	b-PROBLEM
86724	dx	O
86725	in	O
86726	2009	b-DATE
86727	s/p	O
86728	resection	b-TREATMENT
86729	,	O
86730	with	O
86731	recent	b-TEST
86732	ct	i-TEST
86733	showing	b-EVIDENTIAL
86734	met	b-PROBLEM
86735	cholangiocarcinoma	i-PROBLEM
86736	in	O
86737	9/2004	b-DATE
86738	.	O
86739	pt	O
86740	was	O
86741	recently	O
86742	admitted	b-OCCURRENCE
86743	for	O
86744	fever	b-PROBLEM
86745	due	O
86746	to	O
86747	cholangitis	b-PROBLEM
86748	on	O
86749	10-18	b-DATE
86750	and	O
86751	had	O
86752	chemo	b-TREATMENT
86753	(	O
86754	cddp	b-TREATMENT
86755	and	O
86756	gemcitabine	b-TREATMENT
86757	)	O
86758	on	O
86759	monday	b-DATE
86760	,	i-DATE
86761	10-21	i-DATE
86762	.	O
86763	since	O
86764	chemo	b-TREATMENT
86765	pt	O
86766	has	O
86767	intermittent	b-PROBLEM
86768	nausea	i-PROBLEM
86769	adequately	O
86770	controlled	b-TREATMENT
86771	by	O
86772	zofran	b-TREATMENT
86773	and	O
86774	compazine	b-TREATMENT
86775	.	O
86776	pt	O
86777	was	O
86778	doing	b-OCCURRENCE
86779	well	i-OCCURRENCE
86780	till	O
86781	night	b-DATE
86782	of	O
86783	admission	b-OCCURRENCE
86784	when	O
86785	she	O
86786	developed	O
86787	nausea	b-PROBLEM
86788	/	O
86789	vomitting	b-PROBLEM
86790	and	O
86791	sizable	O
86792	amount	O
86793	of	O
86794	hemoptysis	b-PROBLEM
86795	and	O
86796	clots	b-PROBLEM
86797	.	O
86798	has	O
86799	low	b-PROBLEM
86800	grade	i-PROBLEM
86801	fever	i-PROBLEM
86802	since	O
86803	chemo	b-TREATMENT
86804	but	O
86805	otherwise	O
86806	ros	b-TEST
86807	was	O
86808	neg	O
86809	for	O
86810	shaking	b-PROBLEM
86811	chills	i-PROBLEM
86812	,	O
86813	chest	b-PROBLEM
86814	pain	i-PROBLEM
86815	,	O
86816	sob	b-PROBLEM
86817	,	O
86818	coughing	b-PROBLEM
86819	,	O
86820	constipation	b-PROBLEM
86821	,	O
86822	diarrhea	b-PROBLEM
86823	,	O
86824	tarry	b-PROBLEM
86825	stools	i-PROBLEM
86826	,	O
86827	abd	b-PROBLEM
86828	pain	i-PROBLEM
86829	.	O
86830	pt	O
86831	has	O
86832	reported	b-EVIDENTIAL
86833	gaining	b-PROBLEM
86834	30	i-PROBLEM
86835	lbs	i-PROBLEM
86836	since	O
86837	08-31	b-DATE
86838	due	O
86839	to	O
86840	ascites	b-PROBLEM
86841	.	O
86842	in	O
86843	monica	O
86844	:	O
86845	vitals	b-TEST
86846	:	O
86847	t	b-TEST
86848	98.8	O
86849	p	b-TEST
86850	98	O
86851	bp	b-TEST
86852	136/68	O
86853	r	b-TEST
86854	29	O
86855	sat	b-TEST
86856	98%	O
86857	rapt	O
86858	had	O
86859	ng	b-TREATMENT
86860	lavage	i-TREATMENT
86861	which	O
86862	evantually	O
86863	cleared	O
86864	up	O
86865	,	O
86866	also	O
86867	was	O
86868	transfused	O
86869	1u	b-TREATMENT
86870	prbc	i-TREATMENT
86871	,	O
86872	gi	b-OCCURRENCE
86873	consult	i-OCCURRENCE
86874	called	O
86875	,	O
86876	also	O
86877	got	O
86878	zofran	b-TREATMENT
86879	and	O
86880	iv	b-TREATMENT
86881	protonix	i-TREATMENT
86882	.	O
86883	brief	O
86884	hospital	O
86885	course	O
86886	:	O
86887	1)	O
86888	gi	O
86889	-	O
86890	in	O
86891	the	O
86892	monica	O
86893	pt	O
86894	had	O
86895	hct	b-TEST
86896	of	O
86897	20	O
86898	and	O
86899	bloody	b-PROBLEM
86900	ng	i-PROBLEM
86901	lavage	i-PROBLEM
86902	which	O
86903	did	O
86904	not	O
86905	clear	O
86906	.	O
86907	she	O
86908	was	O
86909	transfused	O
86910	1u	b-TREATMENT
86911	prbc	i-TREATMENT
86912	,	O
86913	gi	b-OCCURRENCE
86914	consult	i-OCCURRENCE
86915	called	O
86916	,	O
86917	also	O
86918	got	O
86919	zofran	b-TREATMENT
86920	and	O
86921	iv	b-TREATMENT
86922	protonix	i-TREATMENT
86923	and	O
86924	admitted	b-OCCURRENCE
86925	to	O
86926	the	b-CLINICAL_DEPT
86927	ficu	i-CLINICAL_DEPT
86928	.	O
86929	on	O
86930	arrival	O
86931	to	O
86932	unit	b-CLINICAL_DEPT
86933	pt	O
86934	had	O
86935	egd	b-TEST
86936	which	O
86937	revealed	b-EVIDENTIAL
86938	grade	b-PROBLEM
86939	iii	i-PROBLEM
86940	esophageal	i-PROBLEM
86941	varices	i-PROBLEM
86942	with	O
86943	signs	O
86944	of	O
86945	old	b-PROBLEM
86946	bleeding	i-PROBLEM
86947	.	O
86948	she	O
86949	was	O
86950	started	O
86951	on	O
86952	octreotide	b-TREATMENT
86953	and	O
86954	nadolol	b-TREATMENT
86955	to	O
86956	control	O
86957	portal	b-PROBLEM
86958	htn	i-PROBLEM
86959	.	O
86960	pt	O
86961	was	O
86962	stable	b-OCCURRENCE
86963	and	O
86964	had	O
86965	appropriate	O
86966	hct	b-PROBLEM
86967	bump	i-PROBLEM
86968	to	O
86969	25	O
86970	after	O
86971	2u	b-TREATMENT
86972	prbc	i-TREATMENT
86973	's.	i-TREATMENT
86974	she	O
86975	also	O
86976	had	O
86977	climbing	b-PROBLEM
86978	bilirubin	i-PROBLEM
86979	and	O
86980	low	b-PROBLEM
86981	grade	i-PROBLEM
86982	temp	i-PROBLEM
86983	and	O
86984	was	O
86985	started	O
86986	on	O
86987	zosyn	b-TREATMENT
86988	for	O
86989	suspected	O
86990	biliary	b-PROBLEM
86991	obstruction	i-PROBLEM
86992	and	O
86993	ascending	b-PROBLEM
86994	cholangitis	i-PROBLEM
86995	coverage	O
86996	.	O
86997	she	O
86998	was	O
86999	rescoped	b-TEST
87000	on	O
87001	10-28	b-DATE
87002	and	O
87003	varices	b-PROBLEM
87004	were	O
87005	sclerosed	b-TREATMENT
87006	(	O
87007	no	O
87008	banding	b-TREATMENT
87009	due	O
87010	to	O
87011	latex	b-PROBLEM
87012	allergy	i-PROBLEM
87013	)	O
87014	and	O
87015	diuretics	b-TREATMENT
87016	of	O
87017	lasix	b-TREATMENT
87018	and	O
87019	aldactone	b-TREATMENT
87020	were	O
87021	readded	O
87022	for	O
87023	ascites	b-PROBLEM
87024	since	O
87025	bp	b-TEST
87026	stable	b-OCCURRENCE
87027	.	O
87028	10-29	b-DATE
87029	she	O
87030	was	O
87031	transfused	O
87032	another	O
87033	3u	b-TREATMENT
87034	prbc	i-TREATMENT
87035	's	O
87036	with	O
87037	hct	b-PROBLEM
87038	bump	i-PROBLEM
87039	to	O
87040	31.9	O
87041	and	O
87042	antibiotic	b-TREATMENT
87043	coverage	i-TREATMENT
87044	broadend	O
87045	to	O
87046	unasyn	b-TREATMENT
87047	,	O
87048	ceftriaxone	b-TREATMENT
87049	,	O
87050	flagyl	b-TREATMENT
87051	because	O
87052	she	O
87053	continued	O
87054	to	O
87055	spike	O
87056	,	O
87057	and	O
87058	for	O
87059	sbp	b-TREATMENT
87060	prophylaxis	i-TREATMENT
87061	.	O
87062	preprocedure	b-TEST
87063	of	O
87064	ptc	b-TEST
87065	on	O
87066	10-30	b-DATE
87067	she	O
87068	was	O
87069	transfused	O
87070	1	b-TREATMENT
87071	unit	i-TREATMENT
87072	prbc	i-TREATMENT
87073	's,	i-TREATMENT
87074	2	b-TREATMENT
87075	platelets	i-TREATMENT
87076	and	O
87077	2u	b-TREATMENT
87078	ffp	i-TREATMENT
87079	and	O
87080	procedure	b-TREATMENT
87081	went	O
87082	without	O
87083	complication	b-PROBLEM
87084	.	O
87085	on	O
87086	transfer	b-OCCURRENCE
87087	to	O
87088	the	b-CLINICAL_DEPT
87089	floor	i-CLINICAL_DEPT
87090	she	O
87091	remained	O
87092	hemodynamically	b-OCCURRENCE
87093	stable	i-OCCURRENCE
87094	with	O
87095	stable	b-OCCURRENCE
87096	hct	i-OCCURRENCE
87097	and	O
87098	declining	b-OCCURRENCE
87099	bilirubin	i-OCCURRENCE
87100	.	O
87101	she	O
87102	remained	O
87103	afebrile	b-PROBLEM
87104	so	O
87105	on	O
87106	11-02	b-DATE
87107	antibiotic	b-TREATMENT
87108	regimen	i-TREATMENT
87109	was	O
87110	weaned	b-OCCURRENCE
87111	to	O
87112	only	O
87113	levofloxacin	b-TREATMENT
87114	.	O
87115	liver	b-OCCURRENCE
87116	teams	i-OCCURRENCE
87117	recommended	i-OCCURRENCE
87118	to	O
87119	repeat	b-TEST
87120	egd	i-TEST
87121	with	O
87122	non	b-TREATMENT
87123	latex	i-TREATMENT
87124	banding	i-TREATMENT
87125	in	O
87126	7-10	b-DURATION
87127	days	i-DURATION
87128	.	O
87129	she	O
87130	also	O
87131	went	O
87132	home	O
87133	on	O
87134	naldolol	b-TREATMENT
87135	20	O
87136	mg	O
87137	qd	b-FREQUENCY
87138	for	O
87139	portal	b-PROBLEM
87140	htn	i-PROBLEM
87141	,	O
87142	and	O
87143	her	b-TREATMENT
87144	home	i-TREATMENT
87145	doses	i-TREATMENT
87146	of	O
87147	diuretics	b-TREATMENT
87148	to	O
87149	control	O
87150	her	b-PROBLEM
87151	ascites	i-PROBLEM
87152	.	O
87153	2.	O
87154	us	b-TEST
87155	finding	O
87156	-	O
87157	pt	O
87158	was	O
87159	incidentally	O
87160	found	O
87161	to	O
87162	have	O
87163	r	b-PROBLEM
87164	hydronephrosis	i-PROBLEM
87165	and	O
87166	a	b-PROBLEM
87167	r	i-PROBLEM
87168	adenexal	i-PROBLEM
87169	mass	i-PROBLEM
87170	on	O
87171	her	b-TEST
87172	us	i-TEST
87173	.	O
87174	the	b-PROBLEM
87175	hydronephrosis	i-PROBLEM
87176	was	O
87177	likely	O
87178	caused	O
87179	by	O
87180	blockage	b-PROBLEM
87181	by	O
87182	her	b-PROBLEM
87183	tumor	i-PROBLEM
87184	.	O
87185	given	O
87186	her	b-PROBLEM
87187	disease	i-PROBLEM
87188	prognosis	i-PROBLEM
87189	and	O
87190	the	O
87191	fact	O
87192	that	O
87193	her	b-OCCURRENCE
87194	other	i-OCCURRENCE
87195	kidney	i-OCCURRENCE
87196	is	i-OCCURRENCE
87197	functioning	i-OCCURRENCE
87198	well	i-OCCURRENCE
87199	,	O
87200	no	O
87201	intervention	b-TREATMENT
87202	was	O
87203	done	O
87204	.	O
87205	also	O
87206	the	b-PROBLEM
87207	adenexal	i-PROBLEM
87208	mass	i-PROBLEM
87209	may	O
87210	represent	O
87211	a	b-PROBLEM
87212	second	i-PROBLEM
87213	primary	i-PROBLEM
87214	maligancy	i-PROBLEM
87215	.	O
87216	this	O
87217	was	O
87218	seen	O
87219	on	O
87220	a	b-TEST
87221	prior	i-TEST
87222	ct	i-TEST
87223	scan	i-TEST
87224	and	O
87225	her	O
87226	oncologist	O
87227	is	O
87228	aware	O
87229	.	O
87230	again	O
87231	given	O
87232	the	b-PROBLEM
87233	patient	i-PROBLEM
87234	's	i-PROBLEM
87235	poor	i-PROBLEM
87236	disease	i-PROBLEM
87237	prognosis	i-PROBLEM
87238	,	O
87239	there	O
87240	was	O
87241	no	O
87242	intervention	b-TREATMENT
87243	made	O
87244	at	O
87245	this	O
87246	time	O
87247	.	O
87248		O
87249	admission	b-OCCURRENCE
87250	date	O
87251	:	O
87252	08/16/1998	b-ADMISSION
87253	discharge	b-OCCURRENCE
87254	date	O
87255	:	O
87256	08/18/1998	b-DISCHARGE
87257	history	O
87258	of	O
87259	present	O
87260	illness	O
87261	:	O
87262	the	O
87263	patient	O
87264	is	O
87265	an	O
87266	88	O
87267	year-old	O
87268	woman	O
87269	undergoing	O
87270	treatment	b-TREATMENT
87271	for	O
87272	a	b-PROBLEM
87273	right	i-PROBLEM
87274	lower	i-PROBLEM
87275	extremity	i-PROBLEM
87276	cellulitis	i-PROBLEM
87277	who	O
87278	was	O
87279	transferred	b-OCCURRENCE
87280	from	O
87281	child	b-CLINICAL_DEPT
87282	for	O
87283	worsening	b-PROBLEM
87284	cellulitis	i-PROBLEM
87285	and	O
87286	new	b-PROBLEM
87287	confusion	i-PROBLEM
87288	.	O
87289	the	O
87290	patient	O
87291	has	O
87292	a	O
87293	history	O
87294	of	O
87295	severe	b-PROBLEM
87296	aortic	i-PROBLEM
87297	stenosis	i-PROBLEM
87298	and	O
87299	was	O
87300	recently	O
87301	admitted	b-OCCURRENCE
87302	to	O
87303	the	b-CLINICAL_DEPT
87304	retelk	i-CLINICAL_DEPT
87305	county	i-CLINICAL_DEPT
87306	medical	i-CLINICAL_DEPT
87307	center	i-CLINICAL_DEPT
87308	for	O
87309	a	b-PROBLEM
87310	nafcillin	i-PROBLEM
87311	sensitive	i-PROBLEM
87312	staphylococcus	i-PROBLEM
87313	aureus	i-PROBLEM
87314	cellulitis	i-PROBLEM
87315	of	i-PROBLEM
87316	the	i-PROBLEM
87317	right	i-PROBLEM
87318	leg	i-PROBLEM
87319	treated	O
87320	with	O
87321	a	b-TREATMENT
87322	course	i-TREATMENT
87323	of	i-TREATMENT
87324	nafcillin	i-TREATMENT
87325	and	O
87326	levofloxacin	b-TREATMENT
87327	.	O
87328	there	O
87329	was	O
87330	also	O
87331	a	b-PROBLEM
87332	right	i-PROBLEM
87333	leg	i-PROBLEM
87334	fluid	i-PROBLEM
87335	collection	i-PROBLEM
87336	that	O
87337	was	O
87338	incised	b-TREATMENT
87339	and	O
87340	drained	b-TREATMENT
87341	on	O
87342	august	b-DATE
87343	1	i-DATE
87344	,	i-DATE
87345	1998	i-DATE
87346	.	O
87347	the	O
87348	patient	O
87349	was	O
87350	sent	O
87351	to	O
87352	rehabilitation	b-TREATMENT
87353	on	O
87354	levofloxacin	b-TREATMENT
87355	orally	O
87356	.	O
87357	although	O
87358	details	O
87359	were	O
87360	not	O
87361	available	O
87362	at	O
87363	the	b-DATE
87364	time	i-DATE
87365	of	i-DATE
87366	admission	i-DATE
87367	,	O
87368	apparently	O
87369	,	O
87370	she	O
87371	had	O
87372	done	b-EVIDENTIAL
87373	well	i-EVIDENTIAL
87374	until	O
87375	the	b-DATE
87376	24	i-DATE
87377	hours	i-DATE
87378	proceeding	O
87379	admission	b-OCCURRENCE
87380	when	O
87381	the	b-PROBLEM
87382	cellulitis	i-PROBLEM
87383	was	O
87384	felt	O
87385	to	O
87386	be	O
87387	worsening	b-PROBLEM
87388	.	O
87389	she	O
87390	had	O
87391	also	O
87392	been	O
87393	noted	O
87394	to	O
87395	be	O
87396	confused	b-PROBLEM
87397	and	O
87398	combative	b-PROBLEM
87399	during	O
87400	that	O
87401	24	b-DURATION
87402	hour	i-DURATION
87403	period	O
87404	.	O
87405	as	O
87406	her	b-OCCURRENCE
87407	baseline	i-OCCURRENCE
87408	mental	i-OCCURRENCE
87409	status	i-OCCURRENCE
87410	is	O
87411	completely	b-OCCURRENCE
87412	alert	i-OCCURRENCE
87413	and	i-OCCURRENCE
87414	oriented	i-OCCURRENCE
87415	,	O
87416	this	O
87417	caused	O
87418	concern	O
87419	amongst	O
87420	the	O
87421	staff	O
87422	of	O
87423	the	b-CLINICAL_DEPT
87424	rehabilitation	i-CLINICAL_DEPT
87425	center	i-CLINICAL_DEPT
87426	and	O
87427	the	O
87428	patient	O
87429	was	O
87430	transferred	b-OCCURRENCE
87431	to	O
87432	the	b-CLINICAL_DEPT
87433	retelk	i-CLINICAL_DEPT
87434	county	i-CLINICAL_DEPT
87435	medical	i-CLINICAL_DEPT
87436	center	i-CLINICAL_DEPT
87437	.	O
87438	hospital	O
87439	course	O
87440	:	O
87441	1)	O
87442	mental	b-PROBLEM
87443	status	i-PROBLEM
87444	changes	i-PROBLEM
87445	:	O
87446	on	O
87447	admission	b-OCCURRENCE
87448	to	O
87449	the	b-CLINICAL_DEPT
87450	emergency	i-CLINICAL_DEPT
87451	room	i-CLINICAL_DEPT
87452	,	O
87453	the	O
87454	patient	O
87455	was	O
87456	somewhat	O
87457	argumentative	b-PROBLEM
87458	and	O
87459	confused	b-PROBLEM
87460	as	O
87461	well	O
87462	as	O
87463	uncooperative	b-PROBLEM
87464	with	i-PROBLEM
87465	procedures	i-PROBLEM
87466	.	O
87467	a	b-TEST
87468	neurologic	i-TEST
87469	work-up	i-TEST
87470	was	O
87471	undertaken	O
87472	which	O
87473	included	O
87474	a	b-TEST
87475	ct	i-TEST
87476	scan	i-TEST
87477	of	i-TEST
87478	the	i-TEST
87479	head	i-TEST
87480	which	O
87481	revealed	O
87482	no	O
87483	acute	b-PROBLEM
87484	bleed	i-PROBLEM
87485	and	O
87486	a	b-TEST
87487	lumbar	i-TEST
87488	puncture	i-TEST
87489	which	O
87490	revealed	O
87491	a	b-TEST
87492	glucose	i-TEST
87493	of	O
87494	72	O
87495	,	O
87496	protein	b-TEST
87497	65	O
87498	,	O
87499	white	b-TEST
87500	blood	i-TEST
87501	cell	i-TEST
87502	count	i-TEST
87503	19	O
87504	,	O
87505	red	b-TEST
87506	blood	i-TEST
87507	cell	i-TEST
87508	count	i-TEST
87509	11,500	O
87510	with	O
87511	no	O
87512	evidence	O
87513	of	O
87514	xanthrochromasia	b-PROBLEM
87515	.	O
87516	the	b-CLINICAL_DEPT
87517	neurology	i-CLINICAL_DEPT
87518	service	i-CLINICAL_DEPT
87519	evaluated	O
87520	the	O
87521	patient	O
87522	who	O
87523	felt	O
87524	that	O
87525	her	b-PROBLEM
87526	agitation	i-PROBLEM
87527	was	O
87528	most	O
87529	likely	O
87530	due	O
87531	to	O
87532	infection	b-PROBLEM
87533	,	O
87534	her	b-TREATMENT
87535	multiple	i-TREATMENT
87536	medications	i-TREATMENT
87537	,	O
87538	or	O
87539	her	b-PROBLEM
87540	metabolic	i-PROBLEM
87541	condition	i-PROBLEM
87542	.	O
87543	the	O
87544	patient	O
87545	&apos;s	O
87546	mental	b-PROBLEM
87547	status	i-PROBLEM
87548	slowly	b-OCCURRENCE
87549	began	i-OCCURRENCE
87550	to	i-OCCURRENCE
87551	recover	i-OCCURRENCE
87552	,	O
87553	however	O
87554	on	O
87555	the	b-DATE
87556	morning	i-DATE
87557	of	i-DATE
87558	the	i-DATE
87559	first	i-DATE
87560	day	i-DATE
87561	of	i-DATE
87562	admission	i-DATE
87563	,	i-DATE
87564	august	i-DATE
87565	16	i-DATE
87566	,	i-DATE
87567	1998	i-DATE
87568	,	O
87569	the	O
87570	patient	O
87571	was	O
87572	found	b-OCCURRENCE
87573	after	O
87574	having	O
87575	fallen	b-PROBLEM
87576	.	O
87577	a	b-TEST
87578	neurological	i-TEST
87579	examination	i-TEST
87580	was	O
87581	performed	O
87582	which	O
87583	revealed	O
87584	no	O
87585	abnormality	b-PROBLEM
87586	and	O
87587	imaging	b-TEST
87588	included	O
87589	a	b-TEST
87590	head	i-TEST
87591	scan	i-TEST
87592	which	O
87593	revealed	O
87594	no	O
87595	bleed	b-PROBLEM
87596	and	O
87597	a	b-TEST
87598	cervical	i-TEST
87599	spine	i-TEST
87600	series	i-TEST
87601	which	O
87602	revealed	O
87603	degenerative	b-PROBLEM
87604	joint	i-PROBLEM
87605	disease	i-PROBLEM
87606	but	O
87607	no	O
87608	obvious	b-PROBLEM
87609	fracture	i-PROBLEM
87610	.	O
87611	the	O
87612	patient	O
87613	decided	O
87614	not	O
87615	to	O
87616	pursue	O
87617	further	b-TEST
87618	testing	i-TEST
87619	with	O
87620	a	b-TEST
87621	neck	i-TEST
87622	ct	i-TEST
87623	scan	i-TEST
87624	.	O
87625	at	O
87626	the	b-DATE
87627	time	i-DATE
87628	of	O
87629	discharge	O
87630	,	O
87631	the	b-PROBLEM
87632	patient	i-PROBLEM
87633	&apos;s	i-PROBLEM
87634	mental	i-PROBLEM
87635	status	i-PROBLEM
87636	is	O
87637	back	b-OCCURRENCE
87638	to	i-OCCURRENCE
87639	its	i-OCCURRENCE
87640	baseline	i-OCCURRENCE
87641	.	O
87642	2)	O
87643	right	b-PROBLEM
87644	lower	i-PROBLEM
87645	extremity	i-PROBLEM
87646	cellulitis	i-PROBLEM
87647	:	O
87648	the	O
87649	patient	O
87650	was	O
87651	evaluated	O
87652	by	O
87653	the	b-CLINICAL_DEPT
87654	surgical	i-CLINICAL_DEPT
87655	service	i-CLINICAL_DEPT
87656	who	O
87657	felt	O
87658	that	O
87659	the	b-PROBLEM
87660	wound	i-PROBLEM
87661	was	O
87662	clean	O
87663	with	O
87664	some	b-PROBLEM
87665	erythema	i-PROBLEM
87666	but	O
87667	without	O
87668	evidence	O
87669	of	O
87670	true	b-PROBLEM
87671	cellulitis	i-PROBLEM
87672	.	O
87673	the	b-TREATMENT
87674	patient	i-TREATMENT
87675	&apos;s	i-TREATMENT
87676	antibiotics	i-TREATMENT
87677	were	O
87678	discontinued	O
87679	with	O
87680	the	O
87681	thought	O
87682	that	O
87683	prolonged	b-TREATMENT
87684	antibiotics	i-TREATMENT
87685	only	O
87686	put	O
87687	her	O
87688	at	O
87689	more	O
87690	risk	O
87691	for	O
87692	infection	b-PROBLEM
87693	.	O
87694	3)	O
87695	cardiac	O
87696	:	O
87697	the	O
87698	patient	O
87699	has	O
87700	a	O
87701	history	O
87702	of	O
87703	critical	b-PROBLEM
87704	aortic	i-PROBLEM
87705	stenosis	i-PROBLEM
87706	and	O
87707	mitral	b-PROBLEM
87708	regurgitation	i-PROBLEM
87709	.	O
87710	fortunately	O
87711	,	O
87712	these	b-PROBLEM
87713	issues	i-PROBLEM
87714	were	O
87715	not	O
87716	active	b-OCCURRENCE
87717	during	O
87718	the	b-OCCURRENCE
87719	present	i-OCCURRENCE
87720	admission	i-OCCURRENCE
87721	.	O
87722	4)	O
87723	status	O
87724	post	O
87725	fall	b-PROBLEM
87726	:	O
87727	the	O
87728	patient	O
87729	did	O
87730	fall	b-OCCURRENCE
87731	while	O
87732	inhouse	b-CLINICAL_DEPT
87733	.	O
87734	a	b-TEST
87735	head	i-TEST
87736	ct	i-TEST
87737	scan	i-TEST
87738	and	O
87739	cervical	b-TEST
87740	spine	i-TEST
87741	series	i-TEST
87742	were	O
87743	negative	b-OCCURRENCE
87744	.	O
87745	the	O
87746	patient	O
87747	appeared	O
87748	to	O
87749	have	O
87750	no	O
87751	deficits	b-PROBLEM
87752	at	O
87753	the	b-DATE
87754	time	i-DATE
87755	of	i-DATE
87756	discharge	i-DATE
87757	.	O
87758	5)	O
87759	atrial	b-PROBLEM
87760	fibrillation	i-PROBLEM
87761	:	O
87762	the	b-TREATMENT
87763	patient	i-TREATMENT
87764	&apos;s	i-TREATMENT
87765	coumadin	i-TREATMENT
87766	was	O
87767	continued	O
87768	.	O
87769	6)	O
87770	abnormal	O
87771	liver	O
87772	function	O
87773	tests	O
87774	:	O
87775	on	O
87776	admission	b-OCCURRENCE
87777	,	O
87778	the	O
87779	patient	O
87780	was	O
87781	noted	O
87782	to	O
87783	have	O
87784	elevated	b-TEST
87785	bilirubins	i-TEST
87786	in	O
87787	the	O
87788	3	O
87789	range	O
87790	and	O
87791	mildly	b-TEST
87792	elevated	i-TEST
87793	alkaline	i-TEST
87794	phosphatase	i-TEST
87795	consistent	O
87796	with	O
87797	a	b-OCCURRENCE
87798	cholestatic	i-OCCURRENCE
87799	picture	i-OCCURRENCE
87800	.	O
87801	these	b-TEST
87802	liver	i-TEST
87803	function	i-TEST
87804	tests	i-TEST
87805	will	O
87806	be	O
87807	followed	b-TREATMENT
87808	closely	i-TREATMENT
87809	as	O
87810	an	b-OCCURRENCE
87811	outpatient	i-OCCURRENCE
87812	.	O
87813		O
87814	admission	b-OCCURRENCE
87815	date	O
87816	:	O
87817	03/17/1998	b-ADMISSION
87818	discharge	b-OCCURRENCE
87819	date	O
87820	:	O
87821	04/12/1998	b-DISCHARGE
87822	history	O
87823	of	O
87824	present	O
87825	illness	O
87826	:	O
87827	the	O
87828	patient	O
87829	is	O
87830	a	O
87831	68	O
87832	year	O
87833	old	O
87834	with	O
87835	acute	b-PROBLEM
87836	leukemia	i-PROBLEM
87837	.	O
87838	the	O
87839	patient	O
87840	was	O
87841	in	O
87842	her	b-OCCURRENCE
87843	usual	i-OCCURRENCE
87844	state	i-OCCURRENCE
87845	of	i-OCCURRENCE
87846	health	i-OCCURRENCE
87847	until	O
87848	about	O
87849	three	b-DATE
87850	weeks	i-DATE
87851	prior	i-DATE
87852	to	O
87853	admission	b-OCCURRENCE
87854	when	O
87855	she	O
87856	began	O
87857	to	O
87858	notice	O
87859	increased	b-PROBLEM
87860	weakness	i-PROBLEM
87861	and	O
87862	bruising	b-PROBLEM
87863	.	O
87864	she	O
87865	presented	b-EVIDENTIAL
87866	to	O
87867	a	b-CLINICAL_DEPT
87868	wood	i-CLINICAL_DEPT
87869	emergency	i-CLINICAL_DEPT
87870	department	i-CLINICAL_DEPT
87871	six	b-DATE
87872	days	i-DATE
87873	prior	O
87874	to	O
87875	admission	b-OCCURRENCE
87876	.	O
87877	platelets	b-TEST
87878	were	O
87879	9,000	O
87880	,	O
87881	hemoglobin	b-TEST
87882	9.5	O
87883	,	O
87884	temperature	b-TEST
87885	was	O
87886	100.4	O
87887	.	O
87888	the	O
87889	patient	O
87890	had	O
87891	a	b-TEST
87892	smear	i-TEST
87893	there	O
87894	consistent	O
87895	with	O
87896	all	b-PROBLEM
87897	.	O
87898	the	O
87899	patient	O
87900	was	O
87901	transferred	b-OCCURRENCE
87902	to	O
87903	norri	b-CLINICAL_DEPT
87904	hospital	i-CLINICAL_DEPT
87905	.	O
87906	review	O
87907	of	O
87908	systems	O
87909	:	O
87910	no	O
87911	headache	b-PROBLEM
87912	,	O
87913	no	O
87914	nausea	b-PROBLEM
87915	,	O
87916	vomiting	b-PROBLEM
87917	or	O
87918	diarrhea	b-PROBLEM
87919	.	O
87920	some	O
87921	shortness	b-PROBLEM
87922	of	i-PROBLEM
87923	breath	i-PROBLEM
87924	with	O
87925	allergies	b-PROBLEM
87926	,	O
87927	particularly	O
87928	cats	O
87929	.	O
87930	no	O
87931	chest	b-PROBLEM
87932	pain	i-PROBLEM
87933	.	O
87934	the	O
87935	patient	O
87936	had	O
87937	been	O
87938	doing	O
87939	aerobics	b-OCCURRENCE
87940	three	b-FREQUENCY
87941	times	i-FREQUENCY
87942	a	i-FREQUENCY
87943	week	i-FREQUENCY
87944	until	O
87945	a	b-DATE
87946	couple	i-DATE
87947	of	i-DATE
87948	weeks	i-DATE
87949	before	i-DATE
87950	admission	i-DATE
87951	.	O
87952	hospital	O
87953	course	O
87954	:	O
87955	a	b-TREATMENT
87956	hickman	i-TREATMENT
87957	catheter	i-TREATMENT
87958	was	O
87959	placed	O
87960	and	O
87961	the	O
87962	patient	O
87963	was	O
87964	begun	O
87965	on	O
87966	chemotherapy	b-TREATMENT
87967	.	O
87968	the	b-TREATMENT
87969	regimen	i-TREATMENT
87970	included	O
87971	cyclophosphamide	b-TREATMENT
87972	,	O
87973	daunorubicin	b-TREATMENT
87974	,	O
87975	prednisone	b-TREATMENT
87976	,	O
87977	vincristine	b-TREATMENT
87978	and	O
87979	peg-asparaginase	b-TREATMENT
87980	.	O
87981	the	O
87982	patient	O
87983	tolerated	O
87984	the	b-TREATMENT
87985	chemotherapy	i-TREATMENT
87986	regimen	i-TREATMENT
87987	well	b-OCCURRENCE
87988	.	O
87989	the	O
87990	patient	O
87991	began	O
87992	neutropenic	b-PROBLEM
87993	on	O
87994	day	b-DATE
87995	five	i-DATE
87996	of	O
87997	induction	b-TREATMENT
87998	.	O
87999	the	b-TEST
88000	patient	i-TEST
88001	&apos;s	i-TEST
88002	liver	i-TEST
88003	function	i-TEST
88004	tests	i-TEST
88005	began	b-OCCURRENCE
88006	to	i-OCCURRENCE
88007	rise	i-OCCURRENCE
88008	and	O
88009	she	O
88010	began	O
88011	to	O
88012	experience	O
88013	pulmonary	b-PROBLEM
88014	symptoms	i-PROBLEM
88015	including	O
88016	increased	b-PROBLEM
88017	crackles	i-PROBLEM
88018	.	O
88019	the	O
88020	patient	O
88021	began	O
88022	to	O
88023	spike	b-PROBLEM
88024	and	O
88025	a	b-TEST
88026	blood	i-TEST
88027	culture	i-TEST
88028	grew	O
88029	out	O
88030	staphylococcusaureus	b-PROBLEM
88031	.	O
88032	the	O
88033	patient	O
88034	was	O
88035	begun	O
88036	on	O
88037	gentamicin	b-TREATMENT
88038	,	O
88039	vancomycin	b-TREATMENT
88040	and	O
88041	piperacillin	b-TREATMENT
88042	,	O
88043	which	O
88044	was	O
88045	changed	O
88046	to	O
88047	gentamicin	b-TREATMENT
88048	and	O
88049	ceftazidime	b-TREATMENT
88050	.	O
88051	the	O
88052	patient	O
88053	continued	O
88054	to	O
88055	spike	b-PROBLEM
88056	and	O
88057	was	O
88058	enrolled	O
88059	in	O
88060	a	b-TREATMENT
88061	randomized	i-TREATMENT
88062	trial	i-TREATMENT
88063	,	O
88064	the	O
88065	patient	O
88066	was	O
88067	randomized	O
88068	to	O
88069	ambisome	b-TREATMENT
88070	antifungal	i-TREATMENT
88071	treatment	i-TREATMENT
88072	.	O
88073	an	b-TEST
88074	abdominal	i-TEST
88075	mri	i-TEST
88076	was	O
88077	performed	O
88078	to	O
88079	assess	O
88080	continued	O
88081	elevated	b-PROBLEM
88082	liver	i-PROBLEM
88083	enzymes	i-PROBLEM
88084	;	O
88085	however	O
88086	,	O
88087	the	b-TEST
88088	mri	i-TEST
88089	was	O
88090	negative	b-OCCURRENCE
88091	.	O
88092	the	O
88093	patient	O
88094	was	O
88095	begun	O
88096	on	O
88097	nafcillin	b-TREATMENT
88098	due	O
88099	to	O
88100	continued	O
88101	spiking	b-PROBLEM
88102	.	O
88103	the	O
88104	patient	O
88105	began	O
88106	to	O
88107	experience	O
88108	urinary	b-PROBLEM
88109	retention	i-PROBLEM
88110	and	O
88111	was	O
88112	straight	b-TREATMENT
88113	catheterized	i-TREATMENT
88114	.	O
88115	thepatient	O
88116	developed	O
88117	a	O
88118	possible	O
88119	drug	b-PROBLEM
88120	rash	i-PROBLEM
88121	and	O
88122	nafcillin	b-TREATMENT
88123	was	O
88124	changed	O
88125	to	O
88126	ancef	b-TREATMENT
88127	.	O
88128	the	O
88129	patient	O
88130	became	O
88131	constipated	b-PROBLEM
88132	;	O
88133	this	O
88134	resolved	O
88135	with	O
88136	laxatives	b-TREATMENT
88137	.	O
88138	the	O
88139	patient	O
88140	improved	b-OCCURRENCE
88141	significantly	O
88142	and	O
88143	was	O
88144	thought	O
88145	to	O
88146	be	O
88147	ready	O
88148	for	O
88149	discharge	b-OCCURRENCE
88150	by	O
88151	the	b-DATE
88152	11th	i-DATE
88153	of	i-DATE
88154	april	i-DATE
88155	.	O
88156	she	O
88157	will	O
88158	follow	b-OCCURRENCE
88159	up	i-OCCURRENCE
88160	with	O
88161	her	O
88162	primary	O
88163	oncologists	O
88164	,	O
88165	dr	O
88166	a	O
88167	and	O
88168	dr	O
88169	dark	O
88170	,	O
88171	at	O
88172	ivmc	O
88173	,	O
88174	after	O
88175	her	b-OCCURRENCE
88176	discharge	i-OCCURRENCE
88177	.	O
88178		O
88179	admission	b-OCCURRENCE
88180	date	O
88181	:	O
88182	2015-10-05	b-ADMISSION
88183	discharge	b-OCCURRENCE
88184	date	O
88185	:	O
88186	2015-10-08	b-DISCHARGE
88187	service	O
88188	:	O
88189	medicine	O
88190	history	O
88191	of	O
88192	present	O
88193	illness:	O
88194	the	O
88195	patient	O
88196	is	O
88197	a	O
88198	91	O
88199	yo	O
88200	woman	O
88201	with	O
88202	h/o	O
88203	htn	b-PROBLEM
88204	who	O
88205	came	O
88206	from	O
88207	bridgewater	b-CLINICAL_DEPT
88208	state	i-CLINICAL_DEPT
88209	hospital	i-CLINICAL_DEPT
88210	rehab	i-CLINICAL_DEPT
88211	with	O
88212	substernal	b-PROBLEM
88213	chest	i-PROBLEM
88214	pain	i-PROBLEM
88215	after	O
88216	exercise	b-OCCURRENCE
88217	.	O
88218	pt	O
88219	had	O
88220	been	O
88221	in	O
88222	her	b-OCCURRENCE
88223	usual	i-OCCURRENCE
88224	state	i-OCCURRENCE
88225	of	i-OCCURRENCE
88226	health	i-OCCURRENCE
88227	and	O
88228	performed	b-OCCURRENCE
88229	here	i-OCCURRENCE
88230	regular	i-OCCURRENCE
88231	exercises	i-OCCURRENCE
88232	.	O
88233	after	O
88234	returning	O
88235	to	O
88236	her	O
88237	room	O
88238	she	O
88239	w	O
88240	noted	b-EVIDENTIAL
88241	sscp	b-PROBLEM
88242	without	O
88243	radiation	b-PROBLEM
88244	.	O
88245	no	O
88246	nausea	b-PROBLEM
88247	,	O
88248	vomiting	b-PROBLEM
88249	,	O
88250	diaphoresis	b-PROBLEM
88251	.	O
88252	they	O
88253	did	O
88254	an	b-TEST
88255	ecg	i-TEST
88256	at	O
88257	bridgewater	b-CLINICAL_DEPT
88258	state	i-CLINICAL_DEPT
88259	hospital	i-CLINICAL_DEPT
88260	rehab	i-CLINICAL_DEPT
88261	which	O
88262	demonstarted	b-EVIDENTIAL
88263	new	b-PROBLEM
88264	st	i-PROBLEM
88265	depressions	i-PROBLEM
88266	in	i-PROBLEM
88267	v1-v4	i-PROBLEM
88268	.	O
88269	she	O
88270	received	O
88271	asa	b-TREATMENT
88272	81	O
88273	mg	O
88274	x	b-FREQUENCY
88275	2	i-FREQUENCY
88276	and	O
88277	nitro	b-TREATMENT
88278	sl	i-TREATMENT
88279	x	b-FREQUENCY
88280	2	i-FREQUENCY
88281	with	O
88282	partial	b-OCCURRENCE
88283	relief	i-OCCURRENCE
88284	at	O
88285	nursing	b-CLINICAL_DEPT
88286	home	i-CLINICAL_DEPT
88287	.	O
88288	on	O
88289	presentation	b-OCCURRENCE
88290	to	O
88291	providence	b-CLINICAL_DEPT
88292	behavioral	i-CLINICAL_DEPT
88293	health	i-CLINICAL_DEPT
88294	hospital	i-CLINICAL_DEPT
88295	amanda	i-CLINICAL_DEPT
88296	,	O
88297	her	b-TEST
88298	vitals	i-TEST
88299	were	O
88300	hr	b-TEST
88301	68	O
88302	,	O
88303	bp	b-TEST
88304	142/68	O
88305	,	O
88306	rr	b-TEST
88307	28	O
88308	,	O
88309	o2	b-TEST
88310	sat	i-TEST
88311	100%	O
88312	ra	O
88313	.	O
88314	exam	b-TEST
88315	was	O
88316	notable	O
88317	for	O
88318	rrr	b-OCCURRENCE
88319	with	O
88320	no	O
88321	murmur	b-PROBLEM
88322	,	O
88323	bibasilar	b-PROBLEM
88324	crackles	i-PROBLEM
88325	,	O
88326	guaiac	b-TEST
88327	negative	O
88328	.	O
88329	ekg	b-TEST
88330	showed	b-EVIDENTIAL
88331	sinus	b-PROBLEM
88332	brady	i-PROBLEM
88333	,	O
88334	with	O
88335	old	b-PROBLEM
88336	lad	i-PROBLEM
88337	and	i-PROBLEM
88338	new	i-PROBLEM
88339	st	i-PROBLEM
88340	depressions	i-PROBLEM
88341	in	i-PROBLEM
88342	v1-v4	i-PROBLEM
88343	.	O
88344	troponin	b-TEST
88345	was	O
88346	0.07	O
88347	.	O
88348	she	O
88349	received	O
88350	asa	b-TREATMENT
88351	,	O
88352	nitro	b-TREATMENT
88353	sl	i-TREATMENT
88354	then	O
88355	gtt	b-TREATMENT
88356	,	O
88357	morphine	b-TREATMENT
88358	,	O
88359	metoprolol	b-TREATMENT
88360	,	O
88361	and	O
88362	heparin	b-TREATMENT
88363	gtt	i-TREATMENT
88364	.	O
88365	cardiology	b-CLINICAL_DEPT
88366	discussed	b-OCCURRENCE
88367	cath	b-TEST
88368	however	O
88369	,	O
88370	patient	b-OCCURRENCE
88371	's	i-OCCURRENCE
88372	family	i-OCCURRENCE
88373	turned	i-OCCURRENCE
88374	down	i-OCCURRENCE
88375	.	O
88376	transferred	b-OCCURRENCE
88377	to	O
88378	ccu	b-CLINICAL_DEPT
88379	for	O
88380	further	b-TREATMENT
88381	management	i-TREATMENT
88382	and	O
88383	observation	b-TEST
88384	.	O
88385	brief	O
88386	hospital	O
88387	course:	O
88388	initial	O
88389	impression	O
88390	:	O
88391	90	O
88392	year-old	O
88393	woman	O
88394	with	O
88395	h/o	O
88396	of	O
88397	htn	b-PROBLEM
88398	p/w	O
88399	substernal	b-PROBLEM
88400	chest	i-PROBLEM
88401	pain	i-PROBLEM
88402	shortly	O
88403	after	O
88404	exercise	b-OCCURRENCE
88405	at	O
88406	nursing	b-CLINICAL_DEPT
88407	home	i-CLINICAL_DEPT
88408	,	O
88409	with	O
88410	ekg	b-TEST
88411	showing	b-EVIDENTIAL
88412	st	b-PROBLEM
88413	depressions	i-PROBLEM
88414	in	i-PROBLEM
88415	v1-v4	i-PROBLEM
88416	and	O
88417	troponin	b-TEST
88418	0.07.	O
88419	likely	O
88420	nstemi	b-PROBLEM
88421	.	O
88422	.	O
88423	hospital	O
88424	course	O
88425	by	O
88426	system	O
88427	:	O
88428	.	O
88429	*	O
88430	cv	O
88431	:	O
88432	the	b-OCCURRENCE
88433	patient	i-OCCURRENCE
88434	's	i-OCCURRENCE
88435	family	i-OCCURRENCE
88436	refused	i-OCCURRENCE
88437	coronary	b-TREATMENT
88438	artery	i-TREATMENT
88439	catheterization	i-TREATMENT
88440	.	O
88441	the	O
88442	patient	O
88443	was	O
88444	given	O
88445	asa	b-TREATMENT
88446	,	O
88447	plavix	b-TREATMENT
88448	,	O
88449	heparin	b-TREATMENT
88450	drip	i-TREATMENT
88451	x	O
88452	24	b-DURATION
88453	hours	i-DURATION
88454	,	O
88455	nitro	b-TREATMENT
88456	drip	i-TREATMENT
88457	,	O
88458	atorvastatin	b-TREATMENT
88459	,	O
88460	metoprolol	b-TREATMENT
88461	,	O
88462	and	O
88463	lisinopril	b-TREATMENT
88464	.	O
88465	her	b-PROBLEM
88466	chest	i-PROBLEM
88467	pain	i-PROBLEM
88468	was	O
88469	controlled	O
88470	with	O
88471	morphine	b-TREATMENT
88472	.	O
88473	her	b-TEST
88474	sbp	i-TEST
88475	remained	O
88476	in	O
88477	the	O
88478	160s-170s	O
88479	on	O
88480	hospital	b-DATE
88481	day	i-DATE
88482	1	i-DATE
88483	and	O
88484	she	O
88485	was	O
88486	gently	b-TREATMENT
88487	diuresed	i-TREATMENT
88488	.	O
88489	on	O
88490	hospital	b-DATE
88491	day	i-DATE
88492	2	i-DATE
88493	she	O
88494	experienced	O
88495	atrial	b-PROBLEM
88496	fibrillation	i-PROBLEM
88497	with	O
88498	hr	b-TEST
88499	in	O
88500	the	O
88501	140s	O
88502	.	O
88503	her	b-TREATMENT
88504	metoprolol	i-TREATMENT
88505	dose	i-TREATMENT
88506	was	O
88507	increased	b-OCCURRENCE
88508	from	O
88509	25	O
88510	mg	O
88511	po	O
88512	bid	b-FREQUENCY
88513	to	O
88514	50	O
88515	mg	O
88516	po	O
88517	bid	b-FREQUENCY
88518	then	O
88519	75	O
88520	mg	O
88521	po	O
88522	tid	b-FREQUENCY
88523	.	O
88524	her	b-TEST
88525	hr	i-TEST
88526	decreased	b-OCCURRENCE
88527	to	O
88528	70s-80s	O
88529	.	O
88530	her	b-TEST
88531	bp	i-TEST
88532	remained	O
88533	stable	b-OCCURRENCE
88534	.	O
88535	an	b-TEST
88536	echo	i-TEST
88537	showed	b-EVIDENTIAL
88538	that	O
88539	she	O
88540	had	O
88541	preserved	b-OCCURRENCE
88542	ef	i-OCCURRENCE
88543	and	O
88544	no	O
88545	wall	b-PROBLEM
88546	motion	i-PROBLEM
88547	abnormalities	i-PROBLEM
88548	.	O
88549	we	O
88550	decided	O
88551	given	O
88552	her	O
88553	age	O
88554	that	O
88555	she	O
88556	would	O
88557	not	O
88558	be	O
88559	a	O
88560	good	O
88561	candidate	O
88562	for	O
88563	cardioversion	b-TREATMENT
88564	for	O
88565	her	b-PROBLEM
88566	afib	i-PROBLEM
88567	nor	O
88568	would	O
88569	she	O
88570	be	O
88571	a	O
88572	good	O
88573	candidate	O
88574	for	O
88575	coumadin	b-TREATMENT
88576	.	O
88577	therefore	O
88578	we	O
88579	will	O
88580	continue	O
88581	rate	b-TREATMENT
88582	control	i-TREATMENT
88583	with	O
88584	metoprolol	b-TREATMENT
88585	this	O
88586	can	O
88587	be	O
88588	titrated	O
88589	if	O
88590	needed	O
88591	,	O
88592	and	O
88593	aspirin	b-TREATMENT
88594	and	O
88595	plavix	b-TREATMENT
88596	for	O
88597	anti-coagulation	b-TREATMENT
88598	.	O
88599	she	O
88600	should	O
88601	also	O
88602	continue	O
88603	on	O
88604	lipitor	b-TREATMENT
88605	and	O
88606	lisinopril	b-TREATMENT
88607	.	O
88608	she	O
88609	should	O
88610	have	O
88611	her	b-TEST
88612	chem	i-TEST
88613	7	i-TEST
88614	checked	O
88615	next	b-DURATION
88616	week	i-DURATION
88617	given	O
88618	the	O
88619	start	O
88620	of	O
88621	her	b-TREATMENT
88622	new	i-TREATMENT
88623	meds	i-TREATMENT
88624	.	O
88625	will	O
88626	also	O
88627	need	O
88628	lft	b-TEST
88629	's	O
88630	checked	O
88631	in	O
88632	3-6	b-DATE
88633	months	i-DATE
88634	.	O
88635	.	O
88636	*	O
88637	pulmonary	O
88638	:	O
88639	bilateral	b-PROBLEM
88640	crackles	i-PROBLEM
88641	at	i-PROBLEM
88642	bases	i-PROBLEM
88643	and	i-PROBLEM
88644	midlungs	i-PROBLEM
88645	,	O
88646	elevated	b-PROBLEM
88647	jvp	i-PROBLEM
88648	,	O
88649	trace	b-PROBLEM
88650	bilateral	i-PROBLEM
88651	ankle	i-PROBLEM
88652	edema	i-PROBLEM
88653	,	O
88654	and	O
88655	cxr	b-TEST
88656	with	O
88657	diffuse	b-PROBLEM
88658	opacities	i-PROBLEM
88659	suggest	O
88660	possible	O
88661	pulmonary	b-PROBLEM
88662	edema	i-PROBLEM
88663	,	O
88664	likely	O
88665	secondary	O
88666	to	O
88667	acute	b-PROBLEM
88668	mi	i-PROBLEM
88669	.	O
88670	her	b-TEST
88671	o2	i-TEST
88672	sat	i-TEST
88673	was	O
88674	stable	b-OCCURRENCE
88675	at	O
88676	94-97%	O
88677	on	O
88678	2.5l	O
88679	of	O
88680	supplemental	b-TREATMENT
88681	o2	i-TREATMENT
88682	.	O
88683	she	O
88684	experienced	O
88685	no	O
88686	respiratory	b-PROBLEM
88687	difficulty	i-PROBLEM
88688	during	O
88689	the	b-OCCURRENCE
88690	hospital	i-OCCURRENCE
88691	stay	i-OCCURRENCE
88692	.	O
88693	she	O
88694	was	O
88695	diuresed	b-TREATMENT
88696	small	O
88697	amount	O
88698	.	O
88699	her	b-TEST
88700	cxr	i-TEST
88701	prior	O
88702	to	O
88703	discharge	b-OCCURRENCE
88704	showed	b-EVIDENTIAL
88705	mild	b-PROBLEM
88706	pulm	i-PROBLEM
88707	edema	i-PROBLEM
88708	and	O
88709	thus	O
88710	was	O
88711	given	O
88712	40	O
88713	of	O
88714	lasix	b-TREATMENT
88715	prior	O
88716	to	O
88717	going	b-OCCURRENCE
88718	to	i-OCCURRENCE
88719	rehab	i-OCCURRENCE
88720	.	O
88721	she	O
88722	can	O
88723	be	O
88724	given	O
88725	prn	O
88726	lasix	b-TREATMENT
88727	for	O
88728	weight	b-PROBLEM
88729	gain	i-PROBLEM
88730	or	O
88731	shortness	b-PROBLEM
88732	of	i-PROBLEM
88733	breath	i-PROBLEM
88734	.	O
88735	.	O
88736	*	O
88737	leukocytosis-	b-PROBLEM
88738	she	O
88739	developed	O
88740	mild	b-PROBLEM
88741	elevated	i-PROBLEM
88742	wbc	i-PROBLEM
88743	.	O
88744	ua	b-TEST
88745	had	O
88746	12-14	O
88747	wbc	b-PROBLEM
88748	's	O
88749	,	O
88750	few	b-PROBLEM
88751	bacteria	i-PROBLEM
88752	.	O
88753	she	O
88754	was	O
88755	initially	O
88756	started	O
88757	on	O
88758	bactrim	b-TREATMENT
88759	,	O
88760	but	O
88761	this	O
88762	was	O
88763	stopped	b-OCCURRENCE
88764	as	O
88765	she	O
88766	was	O
88767	afebrile	b-PROBLEM
88768	.	O
88769	she	O
88770	has	O
88771	a	b-TEST
88772	culture	i-TEST
88773	pending	O
88774	which	O
88775	needs	O
88776	to	O
88777	be	O
88778	followed	b-OCCURRENCE
88779	up	i-OCCURRENCE
88780	at	O
88781	the	b-CLINICAL_DEPT
88782	nursing	i-CLINICAL_DEPT
88783	home	i-CLINICAL_DEPT
88784	and	O
88785	treated	b-TREATMENT
88786	if	O
88787	positive	b-PROBLEM
88788	.	O
88789	.	O
88790	*	O
88791	code	O
88792	:	O
88793	dnr/dni	O
88794		O
88795	admission	b-OCCURRENCE
88796	date	O
88797	:	O
88798	12/26/96	b-ADMISSION
88799	discharge	b-OCCURRENCE
88800	date	O
88801	:	O
88802	01/01/97	b-DISCHARGE
88803	history	O
88804	of	O
88805	present	O
88806	illness	O
88807	:	O
88808	the	O
88809	patient	O
88810	is	O
88811	an	O
88812	83-year-old	O
88813	female	O
88814	who	O
88815	presents	b-OCCURRENCE
88816	for	O
88817	surgical	b-TEST
88818	evaluation	i-TEST
88819	for	O
88820	her	b-PROBLEM
88821	hyperparathyroidism	i-PROBLEM
88822	.	O
88823	this	O
88824	is	O
88825	an	O
88826	83-year-old	O
88827	female	O
88828	with	O
88829	a	O
88830	history	O
88831	of	O
88832	hypertrophic	b-PROBLEM
88833	obstructive	i-PROBLEM
88834	cardiomyopathy	i-PROBLEM
88835	,	O
88836	status	O
88837	post	O
88838	mitral	b-TREATMENT
88839	valve	i-TREATMENT
88840	replacement	i-TREATMENT
88841	in	O
88842	1988	b-DATE
88843	,	O
88844	chronic	b-PROBLEM
88845	atrial	i-PROBLEM
88846	fibrillation	i-PROBLEM
88847	,	O
88848	hypertension	b-PROBLEM
88849	,	O
88850	who	O
88851	presents	b-OCCURRENCE
88852	for	O
88853	parathyroidectomy	b-TREATMENT
88854	.	O
88855	in	O
88856	august	b-DATE
88857	of	i-DATE
88858	1996	i-DATE
88859	while	O
88860	the	O
88861	patient	O
88862	was	O
88863	at	O
88864	retelk	b-CLINICAL_DEPT
88865	county	i-CLINICAL_DEPT
88866	medical	i-CLINICAL_DEPT
88867	center	i-CLINICAL_DEPT
88868	for	O
88869	replacement	b-TREATMENT
88870	of	i-TREATMENT
88871	her	i-TREATMENT
88872	knees	i-TREATMENT
88873	bilaterally	i-TREATMENT
88874	,	O
88875	and	O
88876	on	O
88877	preoperative	b-TEST
88878	evaluation	i-TEST
88879	she	O
88880	was	O
88881	noted	b-EVIDENTIAL
88882	to	O
88883	have	O
88884	a	b-PROBLEM
88885	high	i-PROBLEM
88886	calcium	i-PROBLEM
88887	and	O
88888	therefore	O
88889	the	b-TREATMENT
88890	surgery	i-TREATMENT
88891	was	O
88892	canceled	b-OCCURRENCE
88893	.	O
88894	further	b-TEST
88895	testing	i-TEST
88896	revealed	b-EVIDENTIAL
88897	hyperparathyroidism	b-PROBLEM
88898	as	O
88899	evidenced	O
88900	by	O
88901	an	b-PROBLEM
88902	elevated	i-PROBLEM
88903	pth	i-PROBLEM
88904	.	O
88905	the	O
88906	patient	O
88907	reports	b-EVIDENTIAL
88908	no	O
88909	masses	b-PROBLEM
88910	in	i-PROBLEM
88911	her	i-PROBLEM
88912	neck	i-PROBLEM
88913	.	O
88914	she	O
88915	has	O
88916	noticed	O
88917	some	O
88918	generalized	b-PROBLEM
88919	hoarseness	i-PROBLEM
88920	in	i-PROBLEM
88921	her	i-PROBLEM
88922	voice	i-PROBLEM
88923	for	O
88924	the	b-DURATION
88925	past	i-DURATION
88926	5-6	i-DURATION
88927	months	i-DURATION
88928	.	O
88929	in	O
88930	addition	O
88931	,	O
88932	she	O
88933	has	O
88934	some	b-PROBLEM
88935	dysphagia	i-PROBLEM
88936	,	O
88937	particularly	O
88938	has	O
88939	had	O
88940	some	b-PROBLEM
88941	difficulties	i-PROBLEM
88942	with	i-PROBLEM
88943	swallowing	i-PROBLEM
88944	.	O
88945	she	O
88946	has	O
88947	been	O
88948	seen	b-OCCURRENCE
88949	by	O
88950	doctor	O
88951	tokbelb	O
88952	,	O
88953	her	b-CLINICAL_DEPT
88954	primary	i-CLINICAL_DEPT
88955	care	i-CLINICAL_DEPT
88956	physician	i-CLINICAL_DEPT
88957	in	O
88958	itgreenredan	b-CLINICAL_DEPT
88959	hospital	i-CLINICAL_DEPT
88960	,	O
88961	and	O
88962	also	O
88963	doctor	O
88964	kotefyfechird	O
88965	,	O
88966	her	b-CLINICAL_DEPT
88967	cardiologist	i-CLINICAL_DEPT
88968	,	O
88969	and	O
88970	also	O
88971	an	b-CLINICAL_DEPT
88972	endocrinologist	i-CLINICAL_DEPT
88973	at	O
88974	retelk	b-CLINICAL_DEPT
88975	county	i-CLINICAL_DEPT
88976	medical	i-CLINICAL_DEPT
88977	center	i-CLINICAL_DEPT
88978	.	O
88979	hospital	O
88980	course	O
88981	and	O
88982	treatment	O
88983	:	O
88984	on	O
88985	the	b-DATE
88986	day	i-DATE
88987	of	i-DATE
88988	admission	i-DATE
88989	,	O
88990	the	O
88991	patient	O
88992	was	O
88993	brought	O
88994	to	O
88995	the	b-CLINICAL_DEPT
88996	operating	i-CLINICAL_DEPT
88997	room	i-CLINICAL_DEPT
88998	for	O
88999	parathyroidectomy	b-TREATMENT
89000	.	O
89001	the	O
89002	right	O
89003	superior	O
89004	parathyroid	O
89005	gland	O
89006	was	O
89007	found	O
89008	to	O
89009	be	O
89010	markedly	b-PROBLEM
89011	enlarged	i-PROBLEM
89012	and	O
89013	consistent	O
89014	with	O
89015	an	b-PROBLEM
89016	adenoma	i-PROBLEM
89017	.	O
89018	her	b-OCCURRENCE
89019	right	i-OCCURRENCE
89020	superior	i-OCCURRENCE
89021	parathyroid	i-OCCURRENCE
89022	gland	i-OCCURRENCE
89023	was	i-OCCURRENCE
89024	removed	i-OCCURRENCE
89025	and	O
89026	the	b-OCCURRENCE
89027	rest	i-OCCURRENCE
89028	of	i-OCCURRENCE
89029	her	i-OCCURRENCE
89030	parathyroid	i-OCCURRENCE
89031	glands	i-OCCURRENCE
89032	were	i-OCCURRENCE
89033	left	i-OCCURRENCE
89034	in	i-OCCURRENCE
89035	place	i-OCCURRENCE
89036	.	O
89037	postoperatively	O
89038	,	O
89039	the	O
89040	patient	O
89041	did	O
89042	well	b-OCCURRENCE
89043	and	O
89044	was	O
89045	able	O
89046	to	O
89047	cough	b-OCCURRENCE
89048	and	O
89049	phonate	b-OCCURRENCE
89050	completely	i-OCCURRENCE
89051	with	O
89052	no	O
89053	changes	b-PROBLEM
89054	from	O
89055	preoperative	O
89056	.	O
89057	the	O
89058	plan	O
89059	was	O
89060	to	O
89061	start	O
89062	her	O
89063	on	O
89064	heparin	b-TREATMENT
89065	and	O
89066	coumadin	b-TREATMENT
89067	and	O
89068	discontinue	b-OCCURRENCE
89069	her	b-TREATMENT
89070	heparin	i-TREATMENT
89071	when	O
89072	her	b-OCCURRENCE
89073	coumadin	i-OCCURRENCE
89074	levels	i-OCCURRENCE
89075	became	i-OCCURRENCE
89076	therapeutic	i-OCCURRENCE
89077	as	O
89078	judged	O
89079	by	O
89080	the	b-TEST
89081	prothrombin	i-TEST
89082	time	i-TEST
89083	/	O
89084	inr	b-TEST
89085	.	O
89086	however	O
89087	,	O
89088	on	O
89089	postoperative	b-DATE
89090	day	i-DATE
89091	number	i-DATE
89092	two	i-DATE
89093	,	O
89094	the	O
89095	patient	O
89096	in	O
89097	the	b-TIME
89098	afternoon	i-TIME
89099	noticed	O
89100	some	b-PROBLEM
89101	tingling	i-PROBLEM
89102	in	i-PROBLEM
89103	her	i-PROBLEM
89104	hands	i-PROBLEM
89105	and	O
89106	also	O
89107	some	b-PROBLEM
89108	tingling	i-PROBLEM
89109	hear	i-PROBLEM
89110	her	i-PROBLEM
89111	perioral	i-PROBLEM
89112	region	i-PROBLEM
89113	.	O
89114	she	O
89115	had	O
89116	a	O
89117	negative	O
89118	chvostek	b-TEST
89119	&apos;s	i-TEST
89120	and	O
89121	negative	O
89122	trousseau	b-TEST
89123	&apos;s	i-TEST
89124	sign	i-TEST
89125	.	O
89126	she	O
89127	had	O
89128	no	O
89129	muscular	b-PROBLEM
89130	weakness	i-PROBLEM
89131	noted	O
89132	.	O
89133	an	b-TEST
89134	ionized	i-TEST
89135	calcium	i-TEST
89136	was	O
89137	drawn	O
89138	which	O
89139	was	O
89140	low	O
89141	at	O
89142	1.0	O
89143	.	O
89144	as	O
89145	a	O
89146	result	O
89147	,	O
89148	the	O
89149	patient	O
89150	was	O
89151	started	O
89152	on	O
89153	os-cal	b-TREATMENT
89154	250	O
89155	mg	O
89156	po	O
89157	q.i.d.	b-FREQUENCY
89158	on	O
89159	postoperative	b-DATE
89160	day	i-DATE
89161	number	i-DATE
89162	three	i-DATE
89163	,	O
89164	her	b-TEST
89165	ionized	i-TEST
89166	calcium	i-TEST
89167	was	O
89168	1.06	O
89169	and	O
89170	her	b-TREATMENT
89171	os-cal	i-TREATMENT
89172	was	O
89173	increased	b-OCCURRENCE
89174	to	O
89175	500	O
89176	q.i.d.	b-FREQUENCY
89177	however	O
89178	,	O
89179	her	b-PROBLEM
89180	ionized	i-PROBLEM
89181	calcium	i-PROBLEM
89182	decreased	i-PROBLEM
89183	to	O
89184	0.97	O
89185	and	O
89186	she	O
89187	was	O
89188	given	O
89189	one	O
89190	amp	O
89191	of	O
89192	calcium	b-TREATMENT
89193	gluconate	i-TREATMENT
89194	.	O
89195	on	O
89196	postoperative	b-DATE
89197	day	i-DATE
89198	number	i-DATE
89199	five	i-DATE
89200	,	O
89201	the	O
89202	patient	O
89203	felt	b-EVIDENTIAL
89204	fine	i-EVIDENTIAL
89205	and	O
89206	had	O
89207	an	b-TEST
89208	inr	i-TEST
89209	of	O
89210	1.9	O
89211	with	O
89212	a	b-TEST
89213	prothrombin	i-TEST
89214	time	i-TEST
89215	of	O
89216	16.6	O
89217	.	O
89218	her	b-TEST
89219	calcium	i-TEST
89220	was	O
89221	8.5	O
89222	,	O
89223	albumin	b-TEST
89224	3.6	O
89225	,	O
89226	and	O
89227	phosphate	b-TEST
89228	4.5	O
89229	.	O
89230	she	O
89231	had	O
89232	had	O
89233	no	O
89234	further	O
89235	episodes	O
89236	of	O
89237	tingling	b-PROBLEM
89238	in	i-PROBLEM
89239	her	i-PROBLEM
89240	fingers	i-PROBLEM
89241	after	O
89242	the	b-PROBLEM
89243	initial	i-PROBLEM
89244	episode	i-PROBLEM
89245	which	O
89246	had	O
89247	prompted	O
89248	us	O
89249	originally	O
89250	to	O
89251	draw	O
89252	the	b-TEST
89253	ionized	i-TEST
89254	calcium	i-TEST
89255	.	O
89256		O
89257	admission	b-OCCURRENCE
89258	date	O
89259	:	O
89260	10/23/1999	b-ADMISSION
89261	discharge	b-OCCURRENCE
89262	date	O
89263	:	O
89264	11/02/1999	b-DISCHARGE
89265	history	O
89266	of	O
89267	present	O
89268	illness	O
89269	:	O
89270	ms.	O
89271	breunlinke	O
89272	is	O
89273	a	O
89274	69	O
89275	year-old	O
89276	right	O
89277	handed	O
89278	woman	O
89279	,	O
89280	status	O
89281	post	O
89282	surgical	b-TREATMENT
89283	correction	i-TREATMENT
89284	of	i-TREATMENT
89285	a	i-TREATMENT
89286	c-1	i-TREATMENT
89287	to	i-TREATMENT
89288	c-2	i-TREATMENT
89289	dural	i-TREATMENT
89290	avm	i-TREATMENT
89291	in	O
89292	january	b-DATE
89293	,	i-DATE
89294	1998	i-DATE
89295	,	O
89296	now	O
89297	presenting	b-OCCURRENCE
89298	with	O
89299	a	O
89300	one	b-DURATION
89301	month	i-DURATION
89302	history	O
89303	of	O
89304	increasing	b-PROBLEM
89305	left	i-PROBLEM
89306	sided	i-PROBLEM
89307	weakness	i-PROBLEM
89308	and	O
89309	pain	b-PROBLEM
89310	with	O
89311	spasticity	b-PROBLEM
89312	,	O
89313	occasional	O
89314	difficulty	b-PROBLEM
89315	swallowing	i-PROBLEM
89316	and	O
89317	abdominal	b-PROBLEM
89318	pain	i-PROBLEM
89319	.	O
89320	she	O
89321	was	O
89322	originally	O
89323	admitted	b-OCCURRENCE
89324	to	O
89325	the	b-CLINICAL_DEPT
89326	verg	i-CLINICAL_DEPT
89327	medical	i-CLINICAL_DEPT
89328	center	i-CLINICAL_DEPT
89329	in	O
89330	january	b-DATE
89331	,	i-DATE
89332	1998	i-DATE
89333	,	O
89334	because	O
89335	of	O
89336	a	O
89337	one	b-DURATION
89338	year	i-DURATION
89339	history	O
89340	of	O
89341	left	b-PROBLEM
89342	sided	i-PROBLEM
89343	weakness	i-PROBLEM
89344	and	O
89345	spasticity	b-PROBLEM
89346	.	O
89347	she	O
89348	was	O
89349	found	O
89350	to	O
89351	have	O
89352	intermedullary	b-PROBLEM
89353	lesion	i-PROBLEM
89354	at	i-PROBLEM
89355	c1-2	i-PROBLEM
89356	level	i-PROBLEM
89357	which	O
89358	on	O
89359	biopsy	b-TEST
89360	showed	b-EVIDENTIAL
89361	abnormal	b-PROBLEM
89362	vasculature	i-PROBLEM
89363	,	O
89364	hemosiderin	b-PROBLEM
89365	deposit	i-PROBLEM
89366	,	O
89367	leading	O
89368	in	O
89369	turn	O
89370	to	O
89371	the	O
89372	discovery	O
89373	of	O
89374	a	b-PROBLEM
89375	dural	i-PROBLEM
89376	arteriovenous	i-PROBLEM
89377	malformation	i-PROBLEM
89378	at	O
89379	that	O
89380	level	O
89381	which	O
89382	was	O
89383	surgically	b-TREATMENT
89384	corrected	i-TREATMENT
89385	.	O
89386	the	b-OCCURRENCE
89387	postoperative	i-OCCURRENCE
89388	period	i-OCCURRENCE
89389	was	O
89390	complicated	O
89391	by	O
89392	transient	b-PROBLEM
89393	swallowing	i-PROBLEM
89394	difficulty	i-PROBLEM
89395	,	O
89396	increasing	b-PROBLEM
89397	left	i-PROBLEM
89398	sided	i-PROBLEM
89399	weakness	i-PROBLEM
89400	and	O
89401	urinary	b-PROBLEM
89402	retention	i-PROBLEM
89403	.	O
89404	she	O
89405	was	O
89406	discharged	b-OCCURRENCE
89407	to	O
89408	inpatient	b-CLINICAL_DEPT
89409	rehabilitation	i-CLINICAL_DEPT
89410	where	O
89411	she	O
89412	made	O
89413	significant	b-OCCURRENCE
89414	progress	i-OCCURRENCE
89415	toward	O
89416	recovery	O
89417	.	O
89418	as	O
89419	of	O
89420	the	O
89421	beginning	O
89422	of	O
89423	september	b-DATE
89424	,	i-DATE
89425	1999	i-DATE
89426	,	O
89427	she	O
89428	was	O
89429	able	O
89430	to	O
89431	swallow	b-OCCURRENCE
89432	without	O
89433	difficulty	b-OCCURRENCE
89434	,	O
89435	urinate	b-OCCURRENCE
89436	without	O
89437	difficulty	b-PROBLEM
89438	(	O
89439	although	O
89440	bowel	b-OCCURRENCE
89441	movements	i-OCCURRENCE
89442	have	O
89443	been	O
89444	problematic	b-EVIDENTIAL
89445	)	O
89446	.	O
89447	functionally	O
89448	,	O
89449	she	O
89450	was	O
89451	at	O
89452	the	O
89453	level	O
89454	of	O
89455	pre-gait	b-TREATMENT
89456	training	i-TREATMENT
89457	and	O
89458	able	b-OCCURRENCE
89459	to	i-OCCURRENCE
89460	stand	i-OCCURRENCE
89461	and	O
89462	take	b-OCCURRENCE
89463	several	i-OCCURRENCE
89464	steps	i-OCCURRENCE
89465	with	O
89466	upper	b-TREATMENT
89467	body	i-TREATMENT
89468	support	i-TREATMENT
89469	.	O
89470	over	O
89471	the	b-DURATION
89472	past	i-DURATION
89473	4-5	i-DURATION
89474	weeks	i-DURATION
89475	her	b-PROBLEM
89476	functional	i-PROBLEM
89477	level	i-PROBLEM
89478	has	O
89479	progressively	b-PROBLEM
89480	deteriorated	i-PROBLEM
89481	.	O
89482	she	O
89483	is	O
89484	now	O
89485	unable	b-PROBLEM
89486	to	i-PROBLEM
89487	stand	i-PROBLEM
89488	and	O
89489	needs	b-PROBLEM
89490	assistance	i-PROBLEM
89491	to	i-PROBLEM
89492	sit	i-PROBLEM
89493	up	i-PROBLEM
89494	.	O
89495	her	O
89496	left	O
89497	arm	O
89498	has	O
89499	developed	O
89500	a	b-PROBLEM
89501	flexure	i-PROBLEM
89502	contraction	i-PROBLEM
89503	and	O
89504	she	O
89505	reports	b-EVIDENTIAL
89506	intermitttent	b-PROBLEM
89507	pain	i-PROBLEM
89508	in	i-PROBLEM
89509	the	i-PROBLEM
89510	left	i-PROBLEM
89511	arm	i-PROBLEM
89512	and	i-PROBLEM
89513	leg	i-PROBLEM
89514	which	O
89515	occurs	O
89516	both	O
89517	spontaneously	b-OCCURRENCE
89518	and	O
89519	is	O
89520	also	O
89521	triggered	b-OCCURRENCE
89522	by	i-OCCURRENCE
89523	contact	i-OCCURRENCE
89524	.	O
89525	she	O
89526	has	O
89527	developed	O
89528	some	O
89529	new	b-PROBLEM
89530	swallowing	i-PROBLEM
89531	difficulty	i-PROBLEM
89532	and	O
89533	since	O
89534	her	b-OCCURRENCE
89535	transfer	i-OCCURRENCE
89536	to	O
89537	a	b-CLINICAL_DEPT
89538	long	i-CLINICAL_DEPT
89539	term	i-CLINICAL_DEPT
89540	inpatient	i-CLINICAL_DEPT
89541	care	i-CLINICAL_DEPT
89542	facility	i-CLINICAL_DEPT
89543	,	O
89544	she	O
89545	has	O
89546	lost	b-PROBLEM
89547	ten	i-PROBLEM
89548	pounds	i-PROBLEM
89549	.	O
89550	she	O
89551	denies	O
89552	dysuria	b-PROBLEM
89553	or	O
89554	excessive	b-PROBLEM
89555	urinary	i-PROBLEM
89556	frequency	i-PROBLEM
89557	.	O
89558	over	O
89559	the	O
89560	past	O
89561	several	b-DURATION
89562	weeks	i-DURATION
89563	she	O
89564	has	O
89565	also	O
89566	developed	O
89567	severe	b-PROBLEM
89568	intermittent	i-PROBLEM
89569	abdominal	i-PROBLEM
89570	pain	i-PROBLEM
89571	,	O
89572	localized	O
89573	to	O
89574	the	O
89575	suprapubic	O
89576	area	O
89577	,	O
89578	left	O
89579	greater	O
89580	than	O
89581	right	O
89582	,	O
89583	occurring	O
89584	intermittently	O
89585	.	O
89586	the	O
89587	patient	O
89588	feels	O
89589	this	O
89590	is	O
89591	secondary	O
89592	to	O
89593	her	b-PROBLEM
89594	hemorrhoids	i-PROBLEM
89595	,	O
89596	although	O
89597	it	O
89598	does	O
89599	not	O
89600	clearly	O
89601	localize	O
89602	to	O
89603	the	O
89604	rectum	O
89605	.	O
89606	this	b-PROBLEM
89607	pain	i-PROBLEM
89608	often	O
89609	follows	O
89610	bowel	b-OCCURRENCE
89611	movement	i-OCCURRENCE
89612	but	O
89613	does	O
89614	occur	O
89615	spontaneously	b-OCCURRENCE
89616	.	O
89617	hospital	O
89618	course	O
89619	:	O
89620	on	O
89621	admission	b-OCCURRENCE
89622	,	O
89623	a	b-TEST
89624	ct	i-TEST
89625	scan	i-TEST
89626	of	i-TEST
89627	the	i-TEST
89628	head	i-TEST
89629	with	O
89630	and	O
89631	without	O
89632	contrast	O
89633	was	O
89634	performed	O
89635	,	O
89636	showing	b-EVIDENTIAL
89637	a	b-PROBLEM
89638	missing	i-PROBLEM
89639	posterior	i-PROBLEM
89640	arch	i-PROBLEM
89641	at	i-PROBLEM
89642	c-1	i-PROBLEM
89643	and	O
89644	metallic	b-TREATMENT
89645	clips	i-TREATMENT
89646	at	i-TREATMENT
89647	the	i-TREATMENT
89648	craniocervical	i-TREATMENT
89649	junction	i-TREATMENT
89650	consistent	O
89651	with	O
89652	prior	b-TREATMENT
89653	surgical	i-TREATMENT
89654	intervention	i-TREATMENT
89655	.	O
89656	no	O
89657	arteriovenous	b-PROBLEM
89658	malformations	i-PROBLEM
89659	are	O
89660	identified	O
89661	;	O
89662	there	O
89663	is	O
89664	no	O
89665	evidence	O
89666	of	O
89667	recurrence	b-PROBLEM
89668	of	O
89669	her	b-PROBLEM
89670	former	i-PROBLEM
89671	vascular	i-PROBLEM
89672	malformation	i-PROBLEM
89673	.	O
89674	no	O
89675	intraspinal	b-PROBLEM
89676	lesions	i-PROBLEM
89677	are	O
89678	identified	O
89679	.	O
89680	upon	O
89681	further	b-OCCURRENCE
89682	review	i-OCCURRENCE
89683	of	O
89684	doctor	O
89685	laymie	O
89686	fields	O
89687	,	O
89688	department	b-CLINICAL_DEPT
89689	of	i-CLINICAL_DEPT
89690	neuroradiology	i-CLINICAL_DEPT
89691	,	O
89692	review	b-OCCURRENCE
89693	of	O
89694	the	O
89695	cervical	O
89696	spine	O
89697	on	O
89698	ct	b-TEST
89699	reveals	b-EVIDENTIAL
89700	no	O
89701	extrinsic	b-PROBLEM
89702	compressive	i-PROBLEM
89703	lesions	i-PROBLEM
89704	impacting	O
89705	the	O
89706	spinal	O
89707	cord	O
89708	and	O
89709	no	O
89710	enhancing	b-PROBLEM
89711	lesions	i-PROBLEM
89712	of	i-PROBLEM
89713	the	i-PROBLEM
89714	spinal	i-PROBLEM
89715	cord	i-PROBLEM
89716	with	O
89717	contrast	b-TEST
89718	.	O
89719	angiography	b-TEST
89720	performed	O
89721	on	O
89722	october	b-DATE
89723	31	i-DATE
89724	,	i-DATE
89725	1999	i-DATE
89726	,	O
89727	showed	b-EVIDENTIAL
89728	normal	b-PROBLEM
89729	vascular	i-PROBLEM
89730	distribution	i-PROBLEM
89731	of	i-PROBLEM
89732	the	i-PROBLEM
89733	head	i-PROBLEM
89734	and	i-PROBLEM
89735	neck	i-PROBLEM
89736	with	O
89737	no	O
89738	recurrence	b-PROBLEM
89739	of	i-PROBLEM
89740	arteriovenous	i-PROBLEM
89741	malformation	i-PROBLEM
89742	.	O
89743	during	O
89744	this	b-OCCURRENCE
89745	admission	i-OCCURRENCE
89746	,	O
89747	the	O
89748	patient	O
89749	was	O
89750	started	O
89751	on	O
89752	baclofen	b-TREATMENT
89753	10	O
89754	mg	O
89755	p.o.	O
89756	t.i.d.	b-FREQUENCY
89757	for	O
89758	spasticity	b-PROBLEM
89759	.	O
89760	coumadin	b-TREATMENT
89761	was	O
89762	discontinued	b-OCCURRENCE
89763	.	O
89764	the	O
89765	patient	O
89766	was	O
89767	given	O
89768	aspirin	b-TREATMENT
89769	325	O
89770	mg	O
89771	p.o.	O
89772	q.d.	b-FREQUENCY
89773	the	O
89774	patient	O
89775	was	O
89776	also	O
89777	given	O
89778	valium	b-TREATMENT
89779	5-10	O
89780	mg	O
89781	p.o.	O
89782	t.i.d.	b-FREQUENCY
89783	for	O
89784	muscle	b-PROBLEM
89785	spasm	i-PROBLEM
89786	.	O
89787	she	O
89788	was	O
89789	continued	O
89790	on	O
89791	demerol	b-TREATMENT
89792	50	O
89793	mg	O
89794	q	b-DATE
89795	6-8	i-DATE
89796	hours	i-DATE
89797	p.r.n.	i-DATE
89798	for	O
89799	left	b-PROBLEM
89800	arm	i-PROBLEM
89801	and	i-PROBLEM
89802	leg	i-PROBLEM
89803	pain	i-PROBLEM
89804	.	O
89805	upon	O
89806	further	O
89807	review	b-EVIDENTIAL
89808	of	O
89809	ct	b-TEST
89810	and	O
89811	angiography	b-TEST
89812	results	O
89813	with	O
89814	neuroradiology	b-CLINICAL_DEPT
89815	and	i-CLINICAL_DEPT
89816	neurology	i-CLINICAL_DEPT
89817	service	i-CLINICAL_DEPT
89818	,	O
89819	it	O
89820	was	O
89821	decided	O
89822	that	O
89823	ct	b-TEST
89824	myelography	i-TEST
89825	was	O
89826	not	O
89827	indicated	O
89828	at	O
89829	this	O
89830	time	O
89831	.	O
89832	note	O
89833	,	O
89834	the	O
89835	patient	O
89836	is	O
89837	not	O
89838	a	O
89839	candidate	O
89840	for	O
89841	magnetic	b-TEST
89842	resonance	i-TEST
89843	imaging	i-TEST
89844	secondary	O
89845	to	O
89846	ferromagnetic	b-TREATMENT
89847	intracardiac	i-TREATMENT
89848	pacing	i-TREATMENT
89849	device	i-TREATMENT
89850	.	O
89851		O
89852	admission	b-OCCURRENCE
89853	date	O
89854	:	O
89855	2018-03-04	b-ADMISSION
89856	discharge	b-OCCURRENCE
89857	date	O
89858	:	O
89859	2018-03-09	b-DISCHARGE
89860	service	O
89861	:	O
89862	urology	O
89863	history	O
89864	of	O
89865	present	O
89866	illness:	O
89867	justin	O
89868	searle	O
89869	a	O
89870	60-year-old	O
89871	man	O
89872	with	O
89873	a	O
89874	long	O
89875	history	O
89876	of	O
89877	chronic	b-PROBLEM
89878	prostatitis	i-PROBLEM
89879	status	O
89880	post	O
89881	two	O
89882	transurethral	b-TREATMENT
89883	resection	i-TREATMENT
89884	of	i-TREATMENT
89885	the	i-TREATMENT
89886	prostate	i-TREATMENT
89887	procedures	i-TREATMENT
89888	in	O
89889	2007	b-DATE
89890	and	O
89891	1998	b-DATE
89892	.	O
89893	he	O
89894	also	O
89895	has	O
89896	a	O
89897	diagnosis	O
89898	of	O
89899	interstitial	b-PROBLEM
89900	cystitis	i-PROBLEM
89901	and	O
89902	more	O
89903	significantly	O
89904	has	O
89905	a	O
89906	history	O
89907	of	O
89908	coronary	b-PROBLEM
89909	artery	i-PROBLEM
89910	disease	i-PROBLEM
89911	with	O
89912	a	b-TEST
89913	recent	i-TEST
89914	catheterization	i-TEST
89915	,	O
89916	supraventricular	b-PROBLEM
89917	tachycardia	i-PROBLEM
89918	,	O
89919	and	O
89920	a	b-PROBLEM
89921	progressive	i-PROBLEM
89922	mitochondrial	i-PROBLEM
89923	myopathy	i-PROBLEM
89924	.	O
89925	he	O
89926	has	O
89927	had	O
89928	symptoms	b-PROBLEM
89929	of	O
89930	dribbling	b-PROBLEM
89931	,	O
89932	stress	b-PROBLEM
89933	incontinence	i-PROBLEM
89934	,	O
89935	hematuria	b-PROBLEM
89936	,	O
89937	but	O
89938	has	O
89939	no	O
89940	dysuria	b-PROBLEM
89941	.	O
89942	he	O
89943	was	O
89944	preadmitted	b-OCCURRENCE
89945	for	O
89946	cardiac	b-TEST
89947	clearance	i-TEST
89948	by	O
89949	doctor	O
89950	lair	O
89951	,	O
89952	his	b-CLINICAL_DEPT
89953	cardiologist	i-CLINICAL_DEPT
89954	.	O
89955	brief	O
89956	hospital	O
89957	course:	O
89958	on	O
89959	hd2	b-DATE
89960	,	O
89961	cardiac	b-TEST
89962	clearance	i-TEST
89963	was	O
89964	obtained	O
89965	by	O
89966	doctor	O
89967	sanchez	O
89968	.	O
89969	patient	O
89970	tolerated	b-OCCURRENCE
89971	procedure	b-TREATMENT
89972	on	O
89973	2018-03-05	b-DATE
89974	and	O
89975	was	O
89976	transferred	b-OCCURRENCE
89977	to	O
89978	icu	b-CLINICAL_DEPT
89979	for	O
89980	24hr	b-DURATION
89981	post-op	O
89982	cardiac	b-TEST
89983	monitoring	i-TEST
89984	.	O
89985	stay	b-OCCURRENCE
89986	was	O
89987	uneventful	b-EVIDENTIAL
89988	.	O
89989	on	O
89990	pod1	b-DATE
89991	,	O
89992	patient	O
89993	was	O
89994	transferred	b-OCCURRENCE
89995	out	O
89996	of	O
89997	ficu	b-CLINICAL_DEPT
89998	to	O
89999	12r	b-CLINICAL_DEPT
90000	.	O
90001	catheter	b-TREATMENT
90002	was	O
90003	removed	O
90004	.	O
90005	he	O
90006	was	O
90007	started	O
90008	on	O
90009	pyridium	b-TREATMENT
90010	.	O
90011	on	O
90012	pod2	b-DATE
90013	,	O
90014	patient	O
90015	was	O
90016	deemed	O
90017	suitable	b-OCCURRENCE
90018	and	O
90019	stable	b-OCCURRENCE
90020	for	O
90021	discharge	b-OCCURRENCE
90022	.	O
90023	on	O
90024	pod4	b-DATE
90025	,	O
90026	patient	O
90027	was	O
90028	discharged	b-OCCURRENCE
90029	.	O
90030	discharge	O
90031	medications	O
90032	:	O
90033	1.	O
90034	hydroxyzine	b-TREATMENT
90035	hcl	i-TREATMENT
90036	10	O
90037	mg	O
90038	tablet	O
90039	sig	O
90040	:	O
90041	one	O
90042	(	O
90043	1	O
90044	)	O
90045	tablet	O
90046	po	O
90047	daily	b-DURATION
90048	(	i-DURATION
90049	daily	i-DURATION
90050	)	O
90051	.	O
90052	2.	O
90053	atorvastatin	b-TREATMENT
90054	calcium	i-TREATMENT
90055	20	O
90056	mg	O
90057	tablet	O
90058	sig	O
90059	:	O
90060	one	O
90061	(	O
90062	1	O
90063	)	O
90064	tablet	O
90065	po	O
90066	daily	b-DURATION
90067	(	i-DURATION
90068	daily	i-DURATION
90069	)	O
90070	.	O
90071	3.	O
90072	ezetimibe	b-TREATMENT
90073	10	O
90074	mg	O
90075	tablet	O
90076	sig	O
90077	:	O
90078	one	O
90079	(	O
90080	1	O
90081	)	O
90082	tablet	O
90083	po	O
90084	daily	b-DURATION
90085	(	i-DURATION
90086	daily	i-DURATION
90087	)	O
90088	.	O
90089	4.	O
90090	simethicone	b-TREATMENT
90091	80	O
90092	mg	O
90093	tablet	O
90094	,	O
90095	chewable	O
90096	sig	O
90097	:	O
90098	0.5-1	O
90099	tablet	O
90100	,	O
90101	chewable	O
90102	po	O
90103	qid	b-DURATION
90104	(	i-DURATION
90105	4	i-DURATION
90106	times	i-DURATION
90107	a	i-DURATION
90108	day	i-DURATION
90109	)	O
90110	as	O
90111	needed	O
90112	for	O
90113	indigestion/gas	b-PROBLEM
90114	pain	i-PROBLEM
90115	.	O
90116	5.	O
90117	aluminum-magnesium	b-TREATMENT
90118	hydroxide	i-TREATMENT
90119	225-200	O
90120	mg/5	O
90121	ml	O
90122	suspension	O
90123	sig	O
90124	:	O
90125	15-30	O
90126	mls	O
90127	po	O
90128	qid	b-DURATION
90129	(	i-DURATION
90130	4	i-DURATION
90131	times	i-DURATION
90132	a	i-DURATION
90133	day	i-DURATION
90134	)	O
90135	as	O
90136	needed	O
90137	for	O
90138	indigestion	b-PROBLEM
90139	.	O
90140	6.	O
90141	atenolol	b-TREATMENT
90142	100	O
90143	mg	O
90144	tablet	O
90145	sig	O
90146	:	O
90147	one	O
90148	(	O
90149	1	O
90150	)	O
90151	tablet	O
90152	po	O
90153	daily	b-DURATION
90154	(	i-DURATION
90155	daily	i-DURATION
90156	)	O
90157	.	O
90158	7.	O
90159	hyoscyamine	b-TREATMENT
90160	sulfate	i-TREATMENT
90161	0.125	O
90162	mg	O
90163	tablet	O
90164	sig	O
90165	:	O
90166	one	O
90167	(	O
90168	1	O
90169	)	O
90170	tablet	O
90171	po	O
90172	qid	b-DURATION
90173	(	i-DURATION
90174	4	i-DURATION
90175	times	i-DURATION
90176	a	i-DURATION
90177	day	i-DURATION
90178	)	O
90179	.	O
90180	8.	O
90181	phenazopyridine	b-TREATMENT
90182	hcl	i-TREATMENT
90183	100	O
90184	mg	O
90185	tablet	O
90186	sig	O
90187	:	O
90188	one	O
90189	(	O
90190	1	O
90191	)	O
90192	tablet	O
90193	po	O
90194	tid	b-DURATION
90195	(	i-DURATION
90196	3	i-DURATION
90197	times	i-DURATION
90198	a	i-DURATION
90199	day	i-DURATION
90200	)	i-DURATION
90201	for	i-DURATION
90202	3	i-DURATION
90203	days	i-DURATION
90204	.	O
90205	discharge	O
90206	disposition	O
90207	:	O
90208	home	O
90209	discharge	O
90210	diagnosis	O
90211	:	O
90212	chronic	b-PROBLEM
90213	prostatitis	i-PROBLEM
90214	interstitial	b-PROBLEM
90215	cystitis	i-PROBLEM
90216	discharge	O
90217	condition	O
90218	:	O
90219	good	b-OCCURRENCE
90220	discharge	O
90221	instructions	O
90222	:	O
90223	go	b-OCCURRENCE
90224	to	i-OCCURRENCE
90225	an	i-OCCURRENCE
90226	emergency	i-OCCURRENCE
90227	room	i-OCCURRENCE
90228	if	O
90229	you	O
90230	experience	O
90231	symptoms	b-PROBLEM
90232	including	O
90233	,	O
90234	but	O
90235	not	O
90236	necessarily	O
90237	limited	O
90238	to	O
90239	:	O
90240	new	b-PROBLEM
90241	and	i-PROBLEM
90242	continuing	i-PROBLEM
90243	nausea	i-PROBLEM
90244	,	O
90245	vomiting	b-PROBLEM
90246	,	O
90247	fevers	b-PROBLEM
90248	(	O
90249	>101.5	O
90250	f	O
90251	)	O
90252	,	O
90253	chills	b-PROBLEM
90254	,	O
90255	or	O
90256	shortness	b-PROBLEM
90257	of	i-PROBLEM
90258	breath	i-PROBLEM
90259	.	O
90260	proceed	b-OCCURRENCE
90261	to	i-OCCURRENCE
90262	the	i-OCCURRENCE
90263	er/ew/monica	i-OCCURRENCE
90264	if	O
90265	your	b-PROBLEM
90266	wound	i-PROBLEM
90267	becomes	O
90268	red	b-PROBLEM
90269	,	O
90270	swollen	b-PROBLEM
90271	,	O
90272	warm	b-PROBLEM
90273	,	O
90274	or	O
90275	produces	O
90276	pus	b-PROBLEM
90277	.	O
90278	you	O
90279	may	O
90280	remove	O
90281	your	b-TREATMENT
90282	dressings	i-TREATMENT
90283	2	b-DURATION
90284	days	i-DURATION
90285	after	O
90286	your	b-TREATMENT
90287	surgery	i-TREATMENT
90288	if	O
90289	they	O
90290	were	O
90291	not	O
90292	removed	O
90293	in	O
90294	the	b-CLINICAL_DEPT
90295	hospital	i-CLINICAL_DEPT
90296	.	O
90297	leave	O
90298	the	b-TREATMENT
90299	steri	i-TREATMENT
90300	strips	i-TREATMENT
90301	on	O
90302	until	O
90303	they	b-OCCURRENCE
90304	begin	i-OCCURRENCE
90305	to	i-OCCURRENCE
90306	peel	i-OCCURRENCE
90307	,	O
90308	then	O
90309	you	O
90310	may	O
90311	remove	b-OCCURRENCE
90312	them.	O
90313	staples	b-TREATMENT
90314	and	O
90315	stitches	b-TREATMENT
90316	will	O
90317	remain	O
90318	until	O
90319	your	O
90320	follow-up	b-OCCURRENCE
90321	appointment	i-OCCURRENCE
90322	.	O
90323	if	O
90324	you	O
90325	experience	O
90326	clear	b-PROBLEM
90327	drainage	i-PROBLEM
90328	from	O
90329	your	b-PROBLEM
90330	wounds	i-PROBLEM
90331	,	O
90332	cover	O
90333	them	O
90334	with	O
90335	a	b-TREATMENT
90336	clean	i-TREATMENT
90337	dressing	i-TREATMENT
90338	and	O
90339	stop	b-OCCURRENCE
90340	showering	i-OCCURRENCE
90341	until	O
90342	the	b-PROBLEM
90343	drainage	i-PROBLEM
90344	subsides	b-OCCURRENCE
90345	for	O
90346	at	O
90347	least	O
90348	2	b-DATE
90349	days	i-DATE
90350	.	O
90351	no	O
90352	heavy	b-OCCURRENCE
90353	lifting	i-OCCURRENCE
90354	or	O
90355	exertion	O
90356	for	O
90357	at	O
90358	least	O
90359	6	b-DATE
90360	weeks	i-DATE
90361	.	O
90362	no	O
90363	driving	b-OCCURRENCE
90364	while	O
90365	taking	O
90366	pain	b-TREATMENT
90367	medications	i-TREATMENT
90368	.	O
90369	narcotics	b-TREATMENT
90370	can	O
90371	cause	O
90372	constipation	b-PROBLEM
90373	.	O
90374	please	O
90375	take	O
90376	an	b-TREATMENT
90377	over	i-TREATMENT
90378	the	i-TREATMENT
90379	counter	i-TREATMENT
90380	stool	i-TREATMENT
90381	softener	i-TREATMENT
90382	such	O
90383	as	O
90384	colace	b-TREATMENT
90385	or	O
90386	a	b-TREATMENT
90387	gentle	i-TREATMENT
90388	laxative	i-TREATMENT
90389	such	O
90390	as	O
90391	milk	b-TREATMENT
90392	of	i-TREATMENT
90393	magnesia	i-TREATMENT
90394	if	O
90395	you	O
90396	experience	O
90397	constipation	b-PROBLEM
90398	.	O
90399	you	O
90400	may	O
90401	resume	b-OCCURRENCE
90402	your	i-OCCURRENCE
90403	regular	i-OCCURRENCE
90404	diet	i-OCCURRENCE
90405	as	O
90406	tolerated	b-OCCURRENCE
90407	.	O
90408	you	O
90409	may	O
90410	take	b-OCCURRENCE
90411	showers	i-OCCURRENCE
90412	(	O
90413	no	O
90414	baths	O
90415	)	O
90416	after	O
90417	your	b-TREATMENT
90418	dressings	i-TREATMENT
90419	have	O
90420	been	O
90421	removed	b-OCCURRENCE
90422	from	O
90423	your	b-PROBLEM
90424	wounds	i-PROBLEM
90425	.	O
90426	continue	O
90427	taking	O
90428	your	b-TREATMENT
90429	home	i-TREATMENT
90430	medications	i-TREATMENT
90431	unless	O
90432	otherwise	O
90433	contraindicated	b-OCCURRENCE
90434	and	O
90435	follow	b-OCCURRENCE
90436	up	i-OCCURRENCE
90437	with	O
90438	pcp	b-CLINICAL_DEPT
90439	.	O
90440	followup	O
90441	instructions	O
90442	:	O
90443	f/u	b-OCCURRENCE
90444	with	O
90445	rau	b-CLINICAL_DEPT
90446	.	O
90447	call	O
90448	for	O
90449	appointment	O
90450	f/u	b-OCCURRENCE
90451	with	O
90452	doctor	b-CLINICAL_DEPT
90453	ross	i-CLINICAL_DEPT
90454	in	O
90455	2-3	b-DURATION
90456	weeks	i-DURATION
90457	.	O
90458	michael	O
90459	morgan	O
90460	md	O
90461	43-508	O
90462	completed	O
90463	by	O
90464	:	O
90465	justin	O
90466	rao	O
90467	md	O
90468	71-039	O
90469	2018-03-09	O
90470	@	O
90471	0842	O
90472	signed	O
90473	electronically	O
90474	by	O
90475	:	O
90476	doctor	O
90477	freddy	O
90478	darr	O
90479	on	O
90480	:	O
90481	fri	O
90482	2018-03-23	O
90483	9:45	O
90484	am	O
90485	(	O
90486	end	O
90487	of	O
90488	report	O
90489	)	O
90490		O
90491	admission	b-OCCURRENCE
90492	date	O
90493	:	O
90494	02/08/1991	b-ADMISSION
90495	discharge	b-OCCURRENCE
90496	date	O
90497	:	O
90498	02/18/1991	b-DISCHARGE
90499	history	O
90500	of	O
90501	present	O
90502	illness	O
90503	:	O
90504	mr.	O
90505	breutzfarstxei	O
90506	is	O
90507	a	O
90508	30	O
90509	year	O
90510	old	O
90511	man	O
90512	with	O
90513	recently	O
90514	diagnosed	O
90515	acquired	b-PROBLEM
90516	immunodeficiency	i-PROBLEM
90517	syndrome	i-PROBLEM
90518	and	O
90519	pneumocystis	b-PROBLEM
90520	carinii	i-PROBLEM
90521	pneumonia	i-PROBLEM
90522	who	O
90523	presented	b-OCCURRENCE
90524	with	O
90525	pneumonia	b-PROBLEM
90526	,	O
90527	developed	O
90528	adult	b-PROBLEM
90529	respiratory	i-PROBLEM
90530	distress	i-PROBLEM
90531	syndrome	i-PROBLEM
90532	,	O
90533	and	O
90534	died	b-OCCURRENCE
90535	in	O
90536	the	b-CLINICAL_DEPT
90537	hospital	i-CLINICAL_DEPT
90538	after	O
90539	failed	O
90540	efforts	O
90541	of	O
90542	ventilatory	b-TREATMENT
90543	support	i-TREATMENT
90544	.	O
90545	mr.	O
90546	breutzfarstxei	O
90547	was	O
90548	recently	O
90549	diagnosed	O
90550	with	O
90551	acquired	b-PROBLEM
90552	immunodeficiency	i-PROBLEM
90553	syndrome	i-PROBLEM
90554	when	O
90555	he	O
90556	had	O
90557	pneumocystis	b-PROBLEM
90558	carinii	i-PROBLEM
90559	pneumonia	i-PROBLEM
90560	on	O
90561	01/17/91	b-DATE
90562	.	O
90563	he	O
90564	was	O
90565	admitted	b-OCCURRENCE
90566	to	O
90567	the	b-CLINICAL_DEPT
90568	retelk	i-CLINICAL_DEPT
90569	county	i-CLINICAL_DEPT
90570	medical	i-CLINICAL_DEPT
90571	center	i-CLINICAL_DEPT
90572	at	O
90573	that	b-DATE
90574	time	i-DATE
90575	and	O
90576	was	O
90577	treated	O
90578	with	O
90579	bactrim	b-TREATMENT
90580	and	O
90581	steroids	b-TREATMENT
90582	.	O
90583	he	O
90584	was	O
90585	actually	O
90586	intubated	b-TREATMENT
90587	and	O
90588	underwent	O
90589	bronchoscopy	b-TEST
90590	where	O
90591	the	O
90592	diagnosis	O
90593	was	O
90594	made	O
90595	with	O
90596	a	b-PROBLEM
90597	positive	i-PROBLEM
90598	toluidine	i-PROBLEM
90599	blue	i-PROBLEM
90600	study	i-PROBLEM
90601	.	O
90602	he	O
90603	initially	O
90604	did	O
90605	well	b-OCCURRENCE
90606	after	O
90607	extubation	b-TREATMENT
90608	and	O
90609	completed	O
90610	approximately	O
90611	two	b-DURATION
90612	weeks	i-DURATION
90613	of	O
90614	bactrim	b-TREATMENT
90615	and	O
90616	a	b-TREATMENT
90617	steroid	i-TREATMENT
90618	taper	i-TREATMENT
90619	.	O
90620	at	O
90621	discharge	b-OCCURRENCE
90622	after	O
90623	about	O
90624	two	b-DURATION
90625	weeks	i-DURATION
90626	post-extubation	O
90627	,	O
90628	he	O
90629	had	O
90630	an	b-TEST
90631	o2	i-TEST
90632	saturation	i-TEST
90633	of	O
90634	approximately	O
90635	95%	O
90636	on	O
90637	room	O
90638	air	O
90639	.	O
90640	he	O
90641	was	O
90642	seen	b-OCCURRENCE
90643	by	O
90644	doctor	b-CLINICAL_DEPT
90645	seen	i-CLINICAL_DEPT
90646	and	i-CLINICAL_DEPT
90647	doctor	i-CLINICAL_DEPT
90648	seen	i-CLINICAL_DEPT
90649	as	O
90650	an	O
90651	out-patient	O
90652	.	O
90653	on	O
90654	02/06/91	b-DATE
90655	,	O
90656	he	O
90657	was	O
90658	seen	b-OCCURRENCE
90659	in	O
90660	flfdmc	b-CLINICAL_DEPT
90661	and	O
90662	at	O
90663	that	O
90664	point	O
90665	,	O
90666	his	b-TEST
90667	temperature	i-TEST
90668	was	O
90669	noted	O
90670	to	O
90671	be	O
90672	101.4	O
90673	and	O
90674	he	O
90675	had	O
90676	malaise	b-PROBLEM
90677	and	O
90678	diarrhea	b-PROBLEM
90679	.	O
90680	he	O
90681	was	O
90682	evaluated	b-TEST
90683	in	O
90684	the	b-CLINICAL_DEPT
90685	emergency	i-CLINICAL_DEPT
90686	room	i-CLINICAL_DEPT
90687	.	O
90688	at	O
90689	that	b-DATE
90690	time	i-DATE
90691	,	O
90692	his	b-TEST
90693	oxygen	i-TEST
90694	saturation	i-TEST
90695	was	O
90696	only	O
90697	90%	O
90698	on	O
90699	room	O
90700	air	O
90701	and	O
90702	his	b-TEST
90703	chest	i-TEST
90704	x-ray	i-TEST
90705	showed	b-EVIDENTIAL
90706	no	O
90707	change	b-OCCURRENCE
90708	.	O
90709	cultures	b-TEST
90710	were	O
90711	taken	O
90712	and	O
90713	he	O
90714	was	O
90715	sent	b-OCCURRENCE
90716	out	i-OCCURRENCE
90717	.	O
90718	on	O
90719	02/08/91	b-DATE
90720	,	O
90721	the	O
90722	patient	O
90723	called	b-OCCURRENCE
90724	doctor	i-OCCURRENCE
90725	seen	i-OCCURRENCE
90726	because	O
90727	of	O
90728	increased	b-PROBLEM
90729	shortness	i-PROBLEM
90730	of	i-PROBLEM
90731	breath	i-PROBLEM
90732	and	O
90733	malaise	b-PROBLEM
90734	.	O
90735	he	O
90736	was	O
90737	seen	O
90738	in	O
90739	flfdmc	b-CLINICAL_DEPT
90740	where	O
90741	he	O
90742	was	O
90743	noted	b-EVIDENTIAL
90744	to	O
90745	have	O
90746	jaundice	b-PROBLEM
90747	and	O
90748	newly	b-PROBLEM
90749	palpable	i-PROBLEM
90750	liver	i-PROBLEM
90751	edge	i-PROBLEM
90752	.	O
90753	review	O
90754	of	O
90755	liver	b-TEST
90756	function	i-TEST
90757	tests	i-TEST
90758	revealed	b-EVIDENTIAL
90759	a	b-PROBLEM
90760	cholestatic	i-PROBLEM
90761	picture	i-PROBLEM
90762	which	O
90763	was	O
90764	not	O
90765	previously	O
90766	found	O
90767	and	O
90768	it	O
90769	was	O
90770	felt	O
90771	that	O
90772	this	O
90773	was	O
90774	secondary	O
90775	to	O
90776	the	b-TREATMENT
90777	bactrim	i-TREATMENT
90778	which	O
90779	had	O
90780	been	O
90781	recently	O
90782	stopped	O
90783	anyway	O
90784	.	O
90785	his	b-TEST
90786	oxygen	i-TEST
90787	saturation	i-TEST
90788	at	O
90789	that	b-DATE
90790	time	i-DATE
90791	was	O
90792	only	O
90793	86%	O
90794	on	O
90795	room	O
90796	air	O
90797	and	O
90798	he	O
90799	was	O
90800	admitted	b-OCCURRENCE
90801	.	O
90802	hospital	O
90803	course	O
90804	:	O
90805	the	O
90806	patient	O
90807	was	O
90808	admitted	b-OCCURRENCE
90809	for	O
90810	work-up	b-TEST
90811	of	O
90812	his	b-PROBLEM
90813	cholestatic	i-PROBLEM
90814	jaundice	i-PROBLEM
90815	picture	i-PROBLEM
90816	along	O
90817	with	O
90818	work-up	b-TEST
90819	for	O
90820	his	b-PROBLEM
90821	pulmonary	i-PROBLEM
90822	process	i-PROBLEM
90823	and	O
90824	treatment	b-TREATMENT
90825	of	O
90826	both	O
90827	.	O
90828	in	O
90829	terms	O
90830	of	O
90831	pulmonary	O
90832	function	O
90833	,	O
90834	it	O
90835	was	O
90836	felt	O
90837	that	O
90838	one	O
90839	possibility	O
90840	was	O
90841	that	O
90842	the	O
90843	patient	O
90844	was	O
90845	a	b-PROBLEM
90846	bactrim	i-PROBLEM
90847	failure	i-PROBLEM
90848	for	O
90849	pcp	b-PROBLEM
90850	although	O
90851	this	O
90852	was	O
90853	unusual	O
90854	.	O
90855	he	O
90856	was	O
90857	started	O
90858	on	O
90859	pentamidine	b-TREATMENT
90860	,	O
90861	especially	O
90862	in	O
90863	light	O
90864	of	O
90865	the	O
90866	fact	O
90867	that	O
90868	it	O
90869	was	O
90870	felt	O
90871	that	O
90872	his	b-TEST
90873	liver	i-TEST
90874	function	i-TEST
90875	tests	i-TEST
90876	were	O
90877	due	O
90878	possibly	O
90879	to	O
90880	bactrim	b-TREATMENT
90881	.	O
90882	the	O
90883	patient	O
90884	was	O
90885	also	O
90886	covered	O
90887	with	O
90888	erythromycin	b-TREATMENT
90889	and	O
90890	gentamicin	b-TREATMENT
90891	for	O
90892	coverage	O
90893	of	O
90894	community	b-PROBLEM
90895	acquired	i-PROBLEM
90896	pneumonias	i-PROBLEM
90897	and	O
90898	gram	b-PROBLEM
90899	negative	i-PROBLEM
90900	rods	i-PROBLEM
90901	.	O
90902	he	O
90903	was	O
90904	given	O
90905	supplemental	b-TREATMENT
90906	oxygen	i-TREATMENT
90907	.	O
90908	in	O
90909	terms	O
90910	of	O
90911	his	b-PROBLEM
90912	liver	i-PROBLEM
90913	abnormalities	i-PROBLEM
90914	,	O
90915	it	O
90916	was	O
90917	felt	O
90918	that	O
90919	viral	b-PROBLEM
90920	hepatitis	i-PROBLEM
90921	was	O
90922	in	O
90923	the	O
90924	differential	O
90925	as	O
90926	well	O
90927	as	O
90928	several	b-PROBLEM
90929	opportunistic	i-PROBLEM
90930	infections	i-PROBLEM
90931	of	i-PROBLEM
90932	the	i-PROBLEM
90933	liver	i-PROBLEM
90934	but	O
90935	also	O
90936	was	O
90937	felt	O
90938	that	O
90939	bactrim	b-TREATMENT
90940	could	O
90941	be	O
90942	a	O
90943	cause	O
90944	of	O
90945	these	b-PROBLEM
90946	abnormalities	i-PROBLEM
90947	.	O
90948	titers	b-TEST
90949	for	O
90950	cmv	b-PROBLEM
90951	and	O
90952	epstein-barr	b-PROBLEM
90953	virus	i-PROBLEM
90954	were	O
90955	sent	O
90956	and	O
90957	a	b-TEST
90958	titer	i-TEST
90959	for	O
90960	toxoplasma	b-PROBLEM
90961	was	O
90962	sent	O
90963	.	O
90964	stool	b-TEST
90965	was	O
90966	sent	O
90967	for	O
90968	ova	b-PROBLEM
90969	and	O
90970	parasites	b-PROBLEM
90971	.	O
90972	gastrointestinal	b-CLINICAL_DEPT
90973	was	O
90974	consulted	b-OCCURRENCE
90975	.	O
90976	initially	O
90977	,	O
90978	the	O
90979	patient	O
90980	did	O
90981	well	b-OCCURRENCE
90982	in	O
90983	terms	O
90984	of	O
90985	his	O
90986	pre-status	O
90987	and	O
90988	required	O
90989	less	O
90990	oxygen	b-TREATMENT
90991	.	O
90992	however	O
90993	,	O
90994	on	O
90995	02/10/91	b-DATE
90996	,	O
90997	his	b-TEST
90998	respiratory	i-TEST
90999	rate	i-TEST
91000	increased	b-OCCURRENCE
91001	and	O
91002	his	b-TEST
91003	oxygen	i-TEST
91004	saturation	i-TEST
91005	decreased	b-OCCURRENCE
91006	.	O
91007	actually	O
91008	in	O
91009	reviewing	O
91010	the	O
91011	records	O
91012	at	O
91013	this	O
91014	point	O
91015	,	O
91016	it	O
91017	appears	O
91018	that	O
91019	pentamidine	b-TREATMENT
91020	was	O
91021	not	O
91022	started	O
91023	initially	O
91024	so	O
91025	on	O
91026	the	b-TREATMENT
91027	antibiotics	i-TREATMENT
91028	of	O
91029	erythromycin	b-TREATMENT
91030	and	O
91031	gentamicin	b-TREATMENT
91032	,	O
91033	the	b-PROBLEM
91034	patient	i-PROBLEM
91035	&apos;s	i-PROBLEM
91036	respiratory	i-PROBLEM
91037	status	i-PROBLEM
91038	worsened	i-PROBLEM
91039	and	O
91040	his	b-TEST
91041	ldh	i-TEST
91042	climbed	b-PROBLEM
91043	so	O
91044	he	O
91045	began	O
91046	pentamidine	b-TREATMENT
91047	on	O
91048	02/10/91	b-DATE
91049	.	O
91050	on	O
91051	02/11/91	b-DATE
91052	,	O
91053	the	O
91054	patient	O
91055	again	O
91056	appeared	O
91057	more	b-OCCURRENCE
91058	comfortable	i-OCCURRENCE
91059	this	O
91060	time	O
91061	with	O
91062	50%	b-TREATMENT
91063	facemask	i-TREATMENT
91064	but	O
91065	then	O
91066	required	O
91067	more	O
91068	oxygen	b-TREATMENT
91069	,	O
91070	dropped	b-OCCURRENCE
91071	his	b-TEST
91072	o2	i-TEST
91073	saturations	i-TEST
91074	,	O
91075	and	O
91076	was	O
91077	intubated	b-TREATMENT
91078	on	O
91079	02/11/91	b-DATE
91080	.	O
91081	he	O
91082	was	O
91083	transferred	b-OCCURRENCE
91084	to	O
91085	the	b-CLINICAL_DEPT
91086	intensive	i-CLINICAL_DEPT
91087	care	i-CLINICAL_DEPT
91088	unit	i-CLINICAL_DEPT
91089	on	O
91090	12/12/90	b-DATE
91091	on	O
91092	gentamicin	b-TREATMENT
91093	,	O
91094	vancomycin	b-TREATMENT
91095	,	O
91096	pentamidine	b-TREATMENT
91097	,	O
91098	and	O
91099	prednisone	b-TREATMENT
91100	.	O
91101	also	O
91102	of	O
91103	note	O
91104	at	O
91105	that	O
91106	point	O
91107	,	O
91108	hepatitis	b-TEST
91109	c	i-TEST
91110	virus	i-TEST
91111	serologies	i-TEST
91112	had	O
91113	come	O
91114	back	O
91115	positive	b-PROBLEM
91116	.	O
91117	however	O
91118	,	O
91119	at	O
91120	this	O
91121	point	O
91122	,	O
91123	his	b-PROBLEM
91124	liver	i-PROBLEM
91125	function	i-PROBLEM
91126	test	i-PROBLEM
91127	abnormalities	i-PROBLEM
91128	appeared	O
91129	more	O
91130	consistent	O
91131	with	O
91132	a	b-PROBLEM
91133	cholestatic	i-PROBLEM
91134	picture	i-PROBLEM
91135	with	O
91136	his	b-TEST
91137	direct	i-TEST
91138	bilirubin	i-TEST
91139	being	O
91140	12.1	O
91141	and	O
91142	total	b-TEST
91143	being	O
91144	14.1	O
91145	.	O
91146	the	b-TEST
91147	patient	i-TEST
91148	&apos;s	i-TEST
91149	abdominal	i-TEST
91150	ct	i-TEST
91151	scan	i-TEST
91152	showed	b-EVIDENTIAL
91153	no	O
91154	liver	b-PROBLEM
91155	disease	i-PROBLEM
91156	and	O
91157	no	O
91158	obstruction	b-PROBLEM
91159	.	O
91160	the	b-TEST
91161	patient	i-TEST
91162	&apos;s	i-TEST
91163	liver	i-TEST
91164	function	i-TEST
91165	tests	i-TEST
91166	appeared	O
91167	to	O
91168	improve	b-OCCURRENCE
91169	.	O
91170	the	b-PROBLEM
91171	patient	i-PROBLEM
91172	&apos;s	i-PROBLEM
91173	penile	i-PROBLEM
91174	ulcer	i-PROBLEM
91175	was	O
91176	cultured	b-TEST
91177	and	O
91178	grew	O
91179	positive	b-PROBLEM
91180	herpes	i-PROBLEM
91181	simplex	i-PROBLEM
91182	virus	i-PROBLEM
91183	and	O
91184	the	O
91185	patient	O
91186	was	O
91187	started	O
91188	on	O
91189	acyclovir	b-TREATMENT
91190	.	O
91191	on	O
91192	02/13/91	b-DATE
91193	,	O
91194	the	O
91195	patient	O
91196	had	O
91197	a	b-TEST
91198	bronchoalveolar	i-TEST
91199	lavage	i-TEST
91200	performed	O
91201	which	O
91202	showed	b-EVIDENTIAL
91203	a	b-PROBLEM
91204	toluidine	i-PROBLEM
91205	blue	i-PROBLEM
91206	with	O
91207	many	b-PROBLEM
91208	pneumocysts	i-PROBLEM
91209	noted	O
91210	.	O
91211	no	O
91212	other	b-TEST
91213	cultures	i-TEST
91214	grew	O
91215	out	O
91216	and	O
91217	the	b-OCCURRENCE
91218	patient	i-OCCURRENCE
91219	&apos;s	i-OCCURRENCE
91220	clinical	i-OCCURRENCE
91221	status	i-OCCURRENCE
91222	deteriorated	i-OCCURRENCE
91223	.	O
91224	the	O
91225	patient	O
91226	required	O
91227	100%	b-TREATMENT
91228	oxygen	i-TREATMENT
91229	to	O
91230	maintain	O
91231	adequate	b-TREATMENT
91232	oxygen	i-TREATMENT
91233	saturations	i-TREATMENT
91234	on	O
91235	the	b-TREATMENT
91236	ventilator	i-TREATMENT
91237	.	O
91238	he	O
91239	required	O
91240	elevated	b-TREATMENT
91241	ventilatory	i-TREATMENT
91242	pressures	i-TREATMENT
91243	with	O
91244	pips	b-TEST
91245	often	O
91246	above	O
91247	60	O
91248	.	O
91249	fortunately	O
91250	,	O
91251	no	O
91252	evidence	O
91253	of	O
91254	baratroma	b-PROBLEM
91255	was	O
91256	ever	O
91257	discerned	O
91258	.	O
91259	however	O
91260	,	O
91261	the	O
91262	patient	O
91263	&apos;s	O
91264	respiratory	b-OCCURRENCE
91265	status	i-OCCURRENCE
91266	continued	b-PROBLEM
91267	to	i-PROBLEM
91268	decline	i-PROBLEM
91269	and	O
91270	we	O
91271	were	O
91272	unable	O
91273	to	O
91274	maintain	O
91275	oxygen	b-TEST
91276	saturations	i-TEST
91277	above	O
91278	80%	O
91279	even	O
91280	using	O
91281	reverse	b-TREATMENT
91282	i	i-TREATMENT
91283	to	i-TREATMENT
91284	e	i-TREATMENT
91285	ventilation	i-TREATMENT
91286	,	O
91287	paralysis	b-TREATMENT
91288	,	O
91289	sedation	b-TREATMENT
91290	,	O
91291	and	O
91292	other	b-TREATMENT
91293	modes	i-TREATMENT
91294	of	i-TREATMENT
91295	ventilation	i-TREATMENT
91296	.	O
91297	patient	O
91298	underwent	O
91299	liver	b-TEST
91300	biopsy	i-TEST
91301	on	O
91302	02/16/91	b-DATE
91303	and	O
91304	the	O
91305	results	O
91306	of	O
91307	this	O
91308	were	O
91309	pending	O
91310	when	O
91311	the	O
91312	patient	O
91313	died	b-OCCURRENCE
91314	.	O
91315	the	O
91316	patient	O
91317	actually	O
91318	developed	O
91319	decreasing	b-PROBLEM
91320	counts	i-PROBLEM
91321	with	O
91322	white	b-TEST
91323	count	i-TEST
91324	as	O
91325	low	O
91326	as	O
91327	1.75	O
91328	,	O
91329	hematocrit	b-TEST
91330	as	O
91331	low	O
91332	as	O
91333	26	O
91334	,	O
91335	and	O
91336	platelets	b-TEST
91337	as	O
91338	low	O
91339	as	O
91340	68	O
91341	noted	O
91342	on	O
91343	02/15/91	b-DATE
91344	.	O
91345	these	O
91346	were	O
91347	supported	O
91348	with	O
91349	blood	b-TREATMENT
91350	products	i-TREATMENT
91351	and	O
91352	hematology	b-CLINICAL_DEPT
91353	was	O
91354	consulted	b-OCCURRENCE
91355	.	O
91356	they	O
91357	felt	O
91358	that	O
91359	it	O
91360	was	O
91361	most	O
91362	likely	O
91363	secondary	O
91364	to	O
91365	bactrim	b-TREATMENT
91366	and	O
91367	these	O
91368	actually	O
91369	were	O
91370	getting	b-OCCURRENCE
91371	better	i-OCCURRENCE
91372	when	O
91373	the	O
91374	patient	O
91375	died	b-OCCURRENCE
91376	.	O
91377	bone	b-TEST
91378	marrow	i-TEST
91379	biopsy	i-TEST
91380	was	O
91381	not	O
91382	attempted	O
91383	.	O
91384	discussions	b-OCCURRENCE
91385	were	O
91386	begun	O
91387	with	O
91388	the	O
91389	family	O
91390	regarding	O
91391	limits	O
91392	of	O
91393	supportive	b-TREATMENT
91394	care	i-TREATMENT
91395	.	O
91396	due	O
91397	to	O
91398	continued	b-PROBLEM
91399	worsening	i-PROBLEM
91400	pulmonary	i-PROBLEM
91401	status	i-PROBLEM
91402	and	O
91403	an	O
91404	overall	O
91405	grim	O
91406	prognosis	O
91407	,	O
91408	the	b-OCCURRENCE
91409	family	i-OCCURRENCE
91410	decided	i-OCCURRENCE
91411	,	O
91412	in	O
91413	consultation	O
91414	with	O
91415	the	b-CLINICAL_DEPT
91416	medical	i-CLINICAL_DEPT
91417	team	i-CLINICAL_DEPT
91418	,	O
91419	to	O
91420	withdraw	b-OCCURRENCE
91421	ventilatory	b-TREATMENT
91422	support	i-TREATMENT
91423	.	O
91424	this	O
91425	was	O
91426	done	O
91427	on	O
91428	the	b-DATE
91429	evening	i-DATE
91430	of	i-DATE
91431	02/18/91	i-DATE
91432	.	O
91433	patient	O
91434	expired	b-OCCURRENCE
91435	after	O
91436	the	b-TREATMENT
91437	endotracheal	i-TREATMENT
91438	tube	i-TREATMENT
91439	was	O
91440	withdrawn	b-OCCURRENCE
91441	at	O
91442	6:40	b-TIME
91443	p.m.	i-TIME
91444		O
91445	admission	b-OCCURRENCE
91446	date	O
91447	:	O
91448	2018-05-24	b-ADMISSION
91449	discharge	b-OCCURRENCE
91450	date	O
91451	:	O
91452	2018-05-29	b-DISCHARGE
91453	service	O
91454	:	O
91455	cardiothoracic	O
91456	history	O
91457	of	O
91458	present	O
91459	illness	O
91460	:	O
91461	s/p	O
91462	avr	b-TREATMENT
91463	05-14	b-DATE
91464	.	O
91465	postop	b-OCCURRENCE
91466	course	i-OCCURRENCE
91467	c/b	O
91468	right	b-PROBLEM
91469	upper	i-PROBLEM
91470	extremity	i-PROBLEM
91471	dvt	i-PROBLEM
91472	and	O
91473	postop	b-PROBLEM
91474	afib	i-PROBLEM
91475	.	O
91476	discharged	b-OCCURRENCE
91477	home	O
91478	05-19	b-DATE
91479	with	O
91480	instructions	O
91481	to	O
91482	f/u	b-TREATMENT
91483	in	O
91484	vascular	b-CLINICAL_DEPT
91485	clinic	i-CLINICAL_DEPT
91486	.	O
91487	had	O
91488	vascular	b-CLINICAL_DEPT
91489	clinic	i-CLINICAL_DEPT
91490	f/u	b-TREATMENT
91491	on	O
91492	day	b-DATE
91493	of	O
91494	admission	O
91495	.	O
91496	at	O
91497	that	b-DATE
91498	time	i-DATE
91499	had	O
91500	ue	b-TEST
91501	duplex	i-TEST
91502	which	O
91503	revealed	b-EVIDENTIAL
91504	rue	b-PROBLEM
91505	dvt	i-PROBLEM
91506	involving	O
91507	ij	O
91508	,	O
91509	axillary	O
91510	,	O
91511	subclav	O
91512	,	O
91513	brachial	O
91514	,	O
91515	and	O
91516	basilic	O
91517	veins	O
91518	.	O
91519	then	O
91520	referred	b-OCCURRENCE
91521	to	O
91522	er	b-CLINICAL_DEPT
91523	for	O
91524	tx	b-TREATMENT
91525	brief	O
91526	hospital	O
91527	course	O
91528	:	O
91529	pt	O
91530	admitted	b-OCCURRENCE
91531	05-24	b-DATE
91532	from	O
91533	er	b-CLINICAL_DEPT
91534	after	O
91535	positive	b-PROBLEM
91536	rue	i-PROBLEM
91537	dvt	i-PROBLEM
91538	finding	O
91539	in	O
91540	vascular	b-CLINICAL_DEPT
91541	lab	i-CLINICAL_DEPT
91542	.	O
91543	during	O
91544	er	b-TEST
91545	evaluation	i-TEST
91546	pt	O
91547	was	O
91548	noted	b-EVIDENTIAL
91549	to	O
91550	have	O
91551	some	O
91552	degree	O
91553	of	O
91554	dyspnea	b-PROBLEM
91555	as	O
91556	well	O
91557	as	O
91558	mental	b-PROBLEM
91559	status	i-PROBLEM
91560	changes	i-PROBLEM
91561	,	O
91562	including	O
91563	loss	b-PROBLEM
91564	of	i-PROBLEM
91565	short	i-PROBLEM
91566	term	i-PROBLEM
91567	memory	i-PROBLEM
91568	and	O
91569	brief	b-PROBLEM
91570	unresponsive	i-PROBLEM
91571	period	i-PROBLEM
91572	after	O
91573	one	O
91574	dose	O
91575	of	O
91576	iv	b-TREATMENT
91577	benadry	i-TREATMENT
91578	and	O
91579	steroids	b-TREATMENT
91580	prior	O
91581	to	O
91582	ct	b-TEST
91583	scan	i-TEST
91584	.	O
91585	the	b-TEST
91586	ct	i-TEST
91587	was	O
91588	negative	O
91589	for	O
91590	cva	b-PROBLEM
91591	but	O
91592	positive	O
91593	for	O
91594	pulmonary	b-PROBLEM
91595	embolism	i-PROBLEM
91596	.	O
91597	he	O
91598	was	O
91599	transferred	b-OCCURRENCE
91600	to	O
91601	csru	b-CLINICAL_DEPT
91602	for	O
91603	evaluation	b-TEST
91604	.	O
91605	neurology	b-CLINICAL_DEPT
91606	was	O
91607	consulted	b-OCCURRENCE
91608	and	O
91609	the	O
91610	pt	O
91611	also	O
91612	had	O
91613	mri	b-TEST
91614	which	O
91615	was	O
91616	negative	O
91617	.	O
91618	the	O
91619	pt	O
91620	was	O
91621	begun	O
91622	on	O
91623	heparin	b-TREATMENT
91624	gtt	i-TREATMENT
91625	and	O
91626	was	O
91627	noted	b-EVIDENTIAL
91628	to	O
91629	have	O
91630	platelet	b-PROBLEM
91631	drop	i-PROBLEM
91632	>	O
91633	50%	O
91634	after	O
91635	infusion	b-TREATMENT
91636	began	O
91637	,	O
91638	hepain	b-TREATMENT
91639	was	O
91640	d/c	b-OCCURRENCE
91641	'd.	i-OCCURRENCE
91642	argatroban	b-TREATMENT
91643	was	O
91644	started	O
91645	abd	O
91646	a	b-TEST
91647	hit	i-TEST
91648	panel	i-TEST
91649	was	O
91650	sent	O
91651	,	O
91652	hit	b-TEST
91653	panel	i-TEST
91654	was	O
91655	positive	b-PROBLEM
91656	.	O
91657	hematology	b-CLINICAL_DEPT
91658	was	O
91659	consulted	b-OCCURRENCE
91660	.	O
91661	by	O
91662	the	b-DATE
91663	following	i-DATE
91664	mornig	i-DATE
91665	all	b-PROBLEM
91666	mental	i-PROBLEM
91667	status	i-PROBLEM
91668	changes	i-PROBLEM
91669	had	O
91670	cleared	O
91671	and	O
91672	the	O
91673	pt	O
91674	was	O
91675	transferred	b-OCCURRENCE
91676	to	O
91677	the	b-CLINICAL_DEPT
91678	floors	i-CLINICAL_DEPT
91679	for	O
91680	continued	b-TREATMENT
91681	care	i-TREATMENT
91682	.	O
91683	over	O
91684	the	b-DURATION
91685	next	i-DURATION
91686	several	i-DURATION
91687	days	i-DURATION
91688	the	O
91689	patient	O
91690	was	O
91691	maintained	O
91692	on	O
91693	argatroban	b-TREATMENT
91694	when	O
91695	coumadin	b-TREATMENT
91696	therapy	i-TREATMENT
91697	was	O
91698	initiated	O
91699	.	O
91700	on	O
91701	hd#6	b-DATE
91702	the	O
91703	pt	O
91704	had	O
91705	a	b-TEST
91706	therapeudic	i-TEST
91707	inr	i-TEST
91708	(	O
91709	4.4	O
91710	)	O
91711	off	O
91712	argatroban	b-TREATMENT
91713	and	O
91714	wad	O
91715	discharged	b-OCCURRENCE
91716	home	O
91717	.	O
91718	he	O
91719	was	O
91720	to	O
91721	have	O
91722	f/u	O
91723	inr	b-TEST
91724	check	i-TEST
91725	with	O
91726	dr	O
91727	lewis	O
91728	on	O
91729	05-31	b-DATE
91730	.	O
91731	additionally	O
91732	the	O
91733	pt	O
91734	should	O
91735	f/u	b-OCCURRENCE
91736	with	O
91737	the	b-CLINICAL_DEPT
91738	hematology	i-CLINICAL_DEPT
91739	clinic	i-CLINICAL_DEPT
91740	.	O
91741		O
91742	admission	b-OCCURRENCE
91743	date	O
91744	:	O
91745	05/16/2004	b-ADMISSION
91746	discharge	b-OCCURRENCE
91747	date	O
91748	:	O
91749	05/26/2004	b-DISCHARGE
91750	history	O
91751	of	O
91752	the	O
91753	present	O
91754	illness	O
91755	and	O
91756	reason	O
91757	for	O
91758	hospitalization	O
91759	:	O
91760	64-year-old	O
91761	g5p5	b-OCCURRENCE
91762	postmenopausal	b-OCCURRENCE
91763	for	O
91764	10	b-DURATION
91765	years	i-DURATION
91766	with	O
91767	a	O
91768	history	O
91769	of	O
91770	two	b-DURATION
91771	months	i-DURATION
91772	of	O
91773	progressive	b-PROBLEM
91774	abdominal	i-PROBLEM
91775	distention	i-PROBLEM
91776	,	O
91777	crampy	b-PROBLEM
91778	abdominal	i-PROBLEM
91779	pain	i-PROBLEM
91780	,	O
91781	urinary	b-PROBLEM
91782	frequency	i-PROBLEM
91783	and	O
91784	diarrhea	b-PROBLEM
91785	.	O
91786	the	O
91787	patient	O
91788	has	O
91789	not	O
91790	obtained	O
91791	gynecologic	b-TREATMENT
91792	care	i-TREATMENT
91793	for	O
91794	32	b-DURATION
91795	years	i-DURATION
91796	until	O
91797	april	b-DATE
91798	2004	i-DATE
91799	when	O
91800	an	O
91801	increase	O
91802	in	O
91803	abdominal	b-PROBLEM
91804	gerd	i-PROBLEM
91805	and	O
91806	urinary	b-PROBLEM
91807	symptoms	i-PROBLEM
91808	lead	O
91809	her	O
91810	to	O
91811	initial	O
91812	consultation	b-OCCURRENCE
91813	with	O
91814	doctor	b-CLINICAL_DEPT
91815	lentny	i-CLINICAL_DEPT
91816	farstnappsshee	i-CLINICAL_DEPT
91817	in	O
91818	gobrew	O
91819	street	O
91820	,	O
91821	denlandcobridclevena	O
91822	,	O
91823	west	O
91824	virginia	O
91825	28880	O
91826	.	O
91827	at	O
91828	that	b-DATE
91829	time	i-DATE
91830	a	b-TEST
91831	pelvic	i-TEST
91832	ultrasound	i-TEST
91833	was	O
91834	performed	O
91835	showing	b-EVIDENTIAL
91836	extensive	b-PROBLEM
91837	fluid	i-PROBLEM
91838	and	O
91839	clear	b-PROBLEM
91840	mass	i-PROBLEM
91841	within	O
91842	the	O
91843	pelvi-abdominal	O
91844	cavity	O
91845	.	O
91846	mri	b-TEST
91847	showed	b-EVIDENTIAL
91848	a	b-PROBLEM
91849	large	i-PROBLEM
91850	fluid	i-PROBLEM
91851	filled	i-PROBLEM
91852	abdomen	i-PROBLEM
91853	with	O
91854	a	b-PROBLEM
91855	relatively	i-PROBLEM
91856	small	i-PROBLEM
91857	mass	i-PROBLEM
91858	measuring	O
91859	about	O
91860	5	O
91861	to	O
91862	6	O
91863	cm	O
91864	in	O
91865	the	O
91866	right	O
91867	pelvis	O
91868	.	O
91869	at	O
91870	this	b-DATE
91871	point	i-DATE
91872	she	O
91873	had	O
91874	an	b-PROBLEM
91875	elevated	i-PROBLEM
91876	ca	i-PROBLEM
91877	125	O
91878	at	O
91879	440	O
91880	and	O
91881	came	O
91882	to	O
91883	doctor	b-CLINICAL_DEPT
91884	chabechird	i-CLINICAL_DEPT
91885	for	O
91886	further	b-OCCURRENCE
91887	consultation	i-OCCURRENCE
91888	.	O
91889	hospital	O
91890	course	O
91891	:	O
91892	the	O
91893	patient	O
91894	was	O
91895	admitted	b-OCCURRENCE
91896	on	O
91897	05/16/2004	b-DATE
91898	for	O
91899	bowel	b-TREATMENT
91900	preparation	i-TREATMENT
91901	before	O
91902	the	b-TREATMENT
91903	surgery	i-TREATMENT
91904	.	O
91905	on	O
91906	05/17/2004	b-DATE
91907	the	O
91908	patient	O
91909	underwent	O
91910	atotal	b-TREATMENT
91911	abdominal	i-TREATMENT
91912	hysterectomy	i-TREATMENT
91913	,	O
91914	bilateral	b-TREATMENT
91915	salpingooophorectomy	i-TREATMENT
91916	,	O
91917	bilateral	b-TREATMENT
91918	node	i-TREATMENT
91919	dissection	i-TREATMENT
91920	,	O
91921	omentectomy	b-TREATMENT
91922	,	O
91923	lysis	b-TREATMENT
91924	of	O
91925	adhesions	b-PROBLEM
91926	,	O
91927	removal	b-TREATMENT
91928	of	O
91929	mass	b-PROBLEM
91930	from	O
91931	surface	O
91932	of	O
91933	transverse	O
91934	colon	O
91935	.	O
91936	the	O
91937	report	b-EVIDENTIAL
91938	from	O
91939	the	b-TEST
91940	frozen	i-TEST
91941	section	i-TEST
91942	sent	O
91943	in	O
91944	the	b-TREATMENT
91945	surgery	i-TREATMENT
91946	came	O
91947	back	O
91948	with	O
91949	poorly	b-PROBLEM
91950	differentiated	i-PROBLEM
91951	adenocarcinoma	i-PROBLEM
91952	,	O
91953	possibly	O
91954	serous	b-PROBLEM
91955	carcinoma	i-PROBLEM
91956	of	i-PROBLEM
91957	the	i-PROBLEM
91958	ovary	i-PROBLEM
91959	.	O
91960	in	O
91961	the	b-CLINICAL_DEPT
91962	postoperative	i-CLINICAL_DEPT
91963	recovery	i-CLINICAL_DEPT
91964	room	i-CLINICAL_DEPT
91965	the	O
91966	patient	O
91967	had	O
91968	a	b-TEST
91969	hematocrit	i-TEST
91970	of	O
91971	29.2	O
91972	with	O
91973	low	b-PROBLEM
91974	urine	i-PROBLEM
91975	output	i-PROBLEM
91976	.	O
91977	she	O
91978	was	O
91979	given	O
91980	1	O
91981	unit	O
91982	of	O
91983	packed	b-TREATMENT
91984	red	i-TREATMENT
91985	blood	i-TREATMENT
91986	cell	i-TREATMENT
91987	.	O
91988	her	b-TEST
91989	urine	i-TEST
91990	output	i-TEST
91991	subsequently	O
91992	increased	b-OCCURRENCE
91993	.	O
91994	the	O
91995	patient	O
91996	was	O
91997	transferred	b-OCCURRENCE
91998	to	O
91999	the	b-CLINICAL_DEPT
92000	floor	i-CLINICAL_DEPT
92001	without	O
92002	any	b-PROBLEM
92003	complications	i-PROBLEM
92004	.	O
92005	she	O
92006	had	O
92007	an	b-OCCURRENCE
92008	uneventful	i-OCCURRENCE
92009	night	b-DATE
92010	.	O
92011	on	O
92012	postoperative	b-DATE
92013	day	i-DATE
92014	one	i-DATE
92015	,	O
92016	the	b-TEST
92017	patient	i-TEST
92018	&apos;s	i-TEST
92019	urine	i-TEST
92020	culture	i-TEST
92021	came	O
92022	back	O
92023	with	O
92024	moderate	b-PROBLEM
92025	e.	i-PROBLEM
92026	coli	i-PROBLEM
92027	.	O
92028	she	O
92029	was	O
92030	started	O
92031	on	O
92032	levofloxacin	b-TREATMENT
92033	500	O
92034	mg	O
92035	po	O
92036	daily	b-FREQUENCY
92037	.	O
92038	the	O
92039	patient	O
92040	was	O
92041	also	O
92042	started	O
92043	on	O
92044	a	b-TREATMENT
92045	clear	i-TREATMENT
92046	diet	i-TREATMENT
92047	.	O
92048	on	O
92049	postoperative	b-DATE
92050	day	i-DATE
92051	two	i-DATE
92052	,	O
92053	her	b-TREATMENT
92054	foley	i-TREATMENT
92055	was	O
92056	discontinued	O
92057	.	O
92058	the	O
92059	patient	O
92060	was	O
92061	out	b-OCCURRENCE
92062	of	i-OCCURRENCE
92063	bed	i-OCCURRENCE
92064	.	O
92065	she	O
92066	was	O
92067	tolerating	b-OCCURRENCE
92068	liquids	i-OCCURRENCE
92069	.	O
92070	on	O
92071	postoperative	b-DATE
92072	day	i-DATE
92073	three	i-DATE
92074	,	O
92075	the	O
92076	patient	O
92077	had	O
92078	a	b-TREATMENT
92079	port	i-TREATMENT
92080	placed	O
92081	.	O
92082	she	O
92083	also	O
92084	had	O
92085	one	b-FREQUENCY
92086	episode	i-FREQUENCY
92087	of	O
92088	shortness	b-PROBLEM
92089	of	i-PROBLEM
92090	breath	i-PROBLEM
92091	.	O
92092	achest	b-TEST
92093	x-ray	i-TEST
92094	done	O
92095	at	O
92096	that	b-DATE
92097	time	i-DATE
92098	showed	b-EVIDENTIAL
92099	left	b-PROBLEM
92100	pleural	i-PROBLEM
92101	effusion	i-PROBLEM
92102	and	O
92103	small	b-PROBLEM
92104	right	i-PROBLEM
92105	pleural	i-PROBLEM
92106	effusion	i-PROBLEM
92107	,	O
92108	not	O
92109	pulmonary	b-PROBLEM
92110	edema	i-PROBLEM
92111	and	O
92112	left	b-PROBLEM
92113	lower	i-PROBLEM
92114	lobe	i-PROBLEM
92115	consolidations	i-PROBLEM
92116	.	O
92117	the	O
92118	patient	O
92119	was	O
92120	afebrile	b-PROBLEM
92121	,	O
92122	her	b-TEST
92123	vital	i-TEST
92124	signs	i-TEST
92125	were	O
92126	stable	b-OCCURRENCE
92127	and	O
92128	she	O
92129	maintained	O
92130	a	O
92131	good	O
92132	urine	b-TEST
92133	output	i-TEST
92134	.	O
92135	she	O
92136	also	O
92137	had	O
92138	an	O
92139	episode	O
92140	of	O
92141	nausea	b-PROBLEM
92142	with	O
92143	some	b-PROBLEM
92144	emesis	i-PROBLEM
92145	,	O
92146	after	O
92147	being	O
92148	treated	O
92149	with	O
92150	zofran	b-TREATMENT
92151	with	O
92152	no	b-PROBLEM
92153	relief	i-PROBLEM
92154	,	O
92155	a	b-TREATMENT
92156	nasogastric	i-TREATMENT
92157	tube	i-TREATMENT
92158	was	O
92159	placed	O
92160	which	O
92161	drained	b-TREATMENT
92162	1200	O
92163	cc	O
92164	of	O
92165	bilious	b-PROBLEM
92166	fluid	i-PROBLEM
92167	.	O
92168	on	O
92169	postoperative	b-DATE
92170	day	i-DATE
92171	four	i-DATE
92172	,	O
92173	the	O
92174	patient	O
92175	continued	O
92176	to	O
92177	have	O
92178	nasogastric	b-TREATMENT
92179	tube	i-TREATMENT
92180	in	O
92181	place	O
92182	.	O
92183	a	b-TEST
92184	repeat	i-TEST
92185	chest	i-TEST
92186	x-ray	i-TEST
92187	done	O
92188	for	O
92189	dyspnea	b-PROBLEM
92190	showed	b-EVIDENTIAL
92191	persistent	b-PROBLEM
92192	pleural	i-PROBLEM
92193	effusion	i-PROBLEM
92194	with	O
92195	atelectasis	b-PROBLEM
92196	versus	O
92197	pneumonia	b-PROBLEM
92198	.	O
92199	her	b-TREATMENT
92200	levofloxacin	i-TREATMENT
92201	was	O
92202	continued	O
92203	.	O
92204	the	O
92205	patient	O
92206	tolerated	b-OCCURRENCE
92207	nasogastric	b-TEST
92208	tube	i-TEST
92209	clamping	i-TEST
92210	trials	i-TEST
92211	with	O
92212	high	b-PROBLEM
92213	residuals	i-PROBLEM
92214	in	O
92215	the	O
92216	600	O
92217	cc	O
92218	range	O
92219	.	O
92220	the	O
92221	patient	O
92222	did	O
92223	well	b-OCCURRENCE
92224	on	O
92225	postoperative	b-DATE
92226	day	i-DATE
92227	five	i-DATE
92228	and	O
92229	six	b-DATE
92230	.	O
92231	she	O
92232	was	O
92233	started	O
92234	on	O
92235	clear	b-TREATMENT
92236	fluids	i-TREATMENT
92237	with	O
92238	a	b-TREATMENT
92239	nasogastric	i-TREATMENT
92240	clamped	O
92241	.	O
92242	on	O
92243	postoperative	b-DATE
92244	day	i-DATE
92245	seven	i-DATE
92246	the	O
92247	patient	O
92248	diet	O
92249	was	O
92250	slowly	b-OCCURRENCE
92251	advanced	i-OCCURRENCE
92252	as	O
92253	tolerated	b-OCCURRENCE
92254	.	O
92255	she	O
92256	was	O
92257	also	O
92258	started	b-TREATMENT
92259	on	O
92260	decadron	b-TREATMENT
92261	in	O
92262	preparation	O
92263	for	O
92264	her	b-TREATMENT
92265	chemotherapy	i-TREATMENT
92266	.	O
92267	on	O
92268	postoperative	b-DATE
92269	day	i-DATE
92270	eight	i-DATE
92271	which	O
92272	is	O
92273	memorial	b-DATE
92274	day	i-DATE
92275	the	O
92276	patient	O
92277	was	O
92278	started	O
92279	on	O
92280	carboplatin-taxolchemo	b-TREATMENT
92281	therapy	i-TREATMENT
92282	,	O
92283	which	O
92284	she	O
92285	tolerated	b-OCCURRENCE
92286	without	O
92287	complication	b-PROBLEM
92288	.	O
92289	on	O
92290	postoperative	b-DATE
92291	nine	i-DATE
92292	,	O
92293	her	b-TREATMENT
92294	jp	i-TREATMENT
92295	drain	i-TREATMENT
92296	was	O
92297	discontinued	O
92298	.	O
92299	the	O
92300	patient	O
92301	was	O
92302	discharged	b-OCCURRENCE
92303	home	O
92304	that	b-DATE
92305	afternoon	i-DATE
92306	in	O
92307	stable	b-OCCURRENCE
92308	condition	i-OCCURRENCE
92309	in	O
92310	the	b-DATE
92311	afternoon	i-DATE
92312	.	O
92313		O
92314	admission	b-OCCURRENCE
92315	date	O
92316	:	O
92317	2018-10-25	b-ADMISSION
92318	discharge	b-OCCURRENCE
92319	date	O
92320	:	O
92321	2018-10-31	b-DISCHARGE
92322	service	O
92323	:	O
92324		O
92325	cardiothoracic	O
92326	history	O
92327	of	O
92328	present	O
92329	illness	O
92330	:	O
92331	67	O
92332	y/o	O
92333	male	O
92334	with	O
92335	worsening	b-PROBLEM
92336	shortness	i-PROBLEM
92337	of	i-PROBLEM
92338	breath.	i-PROBLEM
92339	had	O
92340	abnormal	b-PROBLEM
92341	ett	i-PROBLEM
92342	and	O
92343	referred	O
92344	for	O
92345	cath	b-TEST
92346	.	O
92347	cath	b-TEST
92348	revealed	b-EVIDENTIAL
92349	severe	b-PROBLEM
92350	3	i-PROBLEM
92351	vessel	i-PROBLEM
92352	disease	i-PROBLEM
92353	.	O
92354	then	O
92355	referred	O
92356	for	O
92357	surgical	b-TREATMENT
92358	intervention	i-TREATMENT
92359	.	O
92360	brief	O
92361	hospital	O
92362	course	O
92363	:	O
92364	mr.	O
92365	kammerer	O
92366	was	O
92367	a	b-OCCURRENCE
92368	same	i-OCCURRENCE
92369	day	i-OCCURRENCE
92370	admit	i-OCCURRENCE
92371	and	O
92372	on	O
92373	10-25	b-DATE
92374	was	O
92375	brought	O
92376	to	O
92377	the	b-CLINICAL_DEPT
92378	operating	i-CLINICAL_DEPT
92379	room	i-CLINICAL_DEPT
92380	where	O
92381	he	O
92382	underwent	O
92383	a	b-TREATMENT
92384	coronary	i-TREATMENT
92385	artery	i-TREATMENT
92386	bypass	i-TREATMENT
92387	graft	i-TREATMENT
92388	x	O
92389	3	O
92390	.	O
92391	please	O
92392	see	O
92393	operative	O
92394	report	O
92395	for	O
92396	surgical	O
92397	details	O
92398	.	O
92399	he	O
92400	tolerated	b-OCCURRENCE
92401	the	b-TREATMENT
92402	procedure	i-TREATMENT
92403	well	b-OCCURRENCE
92404	and	O
92405	was	O
92406	transferred	b-OCCURRENCE
92407	to	O
92408	the	b-CLINICAL_DEPT
92409	csru	i-CLINICAL_DEPT
92410	for	O
92411	invasive	b-TEST
92412	monitoring	i-TEST
92413	in	O
92414	stable	b-OCCURRENCE
92415	condition	i-OCCURRENCE
92416	.	O
92417	later	b-DATE
92418	on	i-DATE
92419	op	i-DATE
92420	day	i-DATE
92421	he	O
92422	was	O
92423	weaned	O
92424	from	O
92425	sedation	b-TREATMENT
92426	,	O
92427	awoke	b-OCCURRENCE
92428	neurologically	b-OCCURRENCE
92429	intact	i-OCCURRENCE
92430	,	O
92431	and	O
92432		O
92433	extubated	b-OCCURRENCE
92434	.	O
92435	beta	b-TREATMENT
92436	blockers	i-TREATMENT
92437	and	O
92438	diuretics	b-TREATMENT
92439	were	O
92440	initiated	O
92441	on	O
92442	post-op	b-DATE
92443	day	i-DATE
92444	one	i-DATE
92445	.	O
92446	he	O
92447	was	O
92448	diuresed	b-TREATMENT
92449	towards	O
92450	his	b-TEST
92451	pre-op	i-TEST
92452	weight	i-TEST
92453	.	O
92454	he	O
92455	appeared	O
92456	to	O
92457	be	O
92458	doing	O
92459	well	b-OCCURRENCE
92460	and	O
92461	was	O
92462	transferred	b-OCCURRENCE
92463	to	O
92464	the	b-CLINICAL_DEPT
92465	sdu	i-CLINICAL_DEPT
92466	on	O
92467	this	b-DATE
92468	day	i-DATE
92469	.	O
92470	he	O
92471	did	O
92472	have	O
92473	burst	b-PROBLEM
92474	of	i-PROBLEM
92475	atrial	i-PROBLEM
92476	fibrillation	i-PROBLEM
92477	and	O
92478	was	O
92479	started	O
92480	on	O
92481	a	b-TREATMENT
92482	amiodarone	i-TREATMENT
92483	gtt	i-TREATMENT
92484	.	O
92485	his	b-TREATMENT
92486	beta	i-TREATMENT
92487	blockers	i-TREATMENT
92488	were	O
92489	also	O
92490	titrated	O
92491	for	O
92492	maximal	b-TREATMENT
92493	bp	i-TREATMENT
92494	and	i-TREATMENT
92495	hr	i-TREATMENT
92496	control	i-TREATMENT
92497	.	O
92498	chest	b-TREATMENT
92499	tubes	i-TREATMENT
92500	were	O
92501	removed	O
92502	on	O
92503	post-op	b-DATE
92504	day	i-DATE
92505	two	i-DATE
92506	and	O
92507	epicardial	b-TREATMENT
92508	pacing	i-TREATMENT
92509	wires	i-TREATMENT
92510	on	O
92511	post-op	b-DATE
92512	day	i-DATE
92513	three	i-DATE
92514	.	O
92515	over	O
92516	the	b-DURATION
92517	next	i-DURATION
92518	several	i-DURATION
92519	days	i-DURATION
92520	he	O
92521	continued	O
92522	to	O
92523	improve	b-OCCURRENCE
92524	his	b-OCCURRENCE
92525	ambulation	i-OCCURRENCE
92526	and	O
92527	mobility	b-OCCURRENCE
92528	with	O
92529	physical	b-TREATMENT
92530	therapy	i-TREATMENT
92531	.	O
92532	he	O
92533	had	O
92534	no	O
92535	further	b-PROBLEM
92536	episodes	i-PROBLEM
92537	of	i-PROBLEM
92538	afib	i-PROBLEM
92539	while	O
92540	on	O
92541	po	b-TREATMENT
92542	amiodarone	i-TREATMENT
92543	.	O
92544	on	O
92545	post-op	b-DATE
92546	day	i-DATE
92547	five	i-DATE
92548	he	O
92549	appeared	O
92550	to	O
92551	have	O
92552	left	b-PROBLEM
92553	arm	i-PROBLEM
92554	phlebitis	i-PROBLEM
92555	and	O
92556	was	O
92557	started	O
92558	on	O
92559	antibiotics	b-TREATMENT
92560	.	O
92561	he	O
92562	was	O
92563	discharged	b-OCCURRENCE
92564	home	i-OCCURRENCE
92565	on	O
92566	post-op	b-DATE
92567	day	i-DATE
92568	six	i-DATE
92569	with	O
92570	antibiotics	b-TREATMENT
92571	and	O
92572	appropriate	b-TREATMENT
92573	meds	i-TREATMENT
92574	.	O
92575	he	O
92576	will	O
92577	have	O
92578	vna	b-TREATMENT
92579	services	i-TREATMENT
92580	and	O
92581	make	O
92582	the	O
92583	appropriate	O
92584	follow-up	b-OCCURRENCE
92585	appointments	i-OCCURRENCE
92586	.	O
92587		O
92588	admission	b-OCCURRENCE
92589	date	O
92590	:	O
92591	01/08/2001	b-ADMISSION
92592	discharge	b-OCCURRENCE
92593	date	O
92594	:	O
92595	01/30/2001	b-DISCHARGE
92596	history	O
92597	of	O
92598	present	O
92599	illness	O
92600	:	O
92601	this	O
92602	is	O
92603	a	O
92604	61	O
92605	year	O
92606	old	O
92607	male	O
92608	with	O
92609	a	O
92610	history	O
92611	of	O
92612	diabetes	b-PROBLEM
92613	,	O
92614	coronary	b-PROBLEM
92615	artery	i-PROBLEM
92616	disease	i-PROBLEM
92617	,	O
92618	hepatitis	b-PROBLEM
92619	c	i-PROBLEM
92620	,	O
92621	and	O
92622	asthma	b-PROBLEM
92623	who	O
92624	was	O
92625	diagnosed	O
92626	recently	O
92627	with	O
92628	pancreatic	b-PROBLEM
92629	cancer	i-PROBLEM
92630	after	O
92631	he	O
92632	presented	b-OCCURRENCE
92633	to	O
92634	seph&apos;sju	b-CLINICAL_DEPT
92635	memorial	i-CLINICAL_DEPT
92636	after	O
92637	a	b-OCCURRENCE
92638	motor	i-OCCURRENCE
92639	vehicle	i-OCCURRENCE
92640	accident	i-OCCURRENCE
92641	.	O
92642	chest	b-TEST
92643	ct	i-TEST
92644	revealed	b-EVIDENTIAL
92645	a	b-PROBLEM
92646	pulmonary	i-PROBLEM
92647	nodule	i-PROBLEM
92648	.	O
92649	abdominal	b-TEST
92650	ct	i-TEST
92651	revealed	b-EVIDENTIAL
92652	a	b-PROBLEM
92653	3.0	i-PROBLEM
92654	to	i-PROBLEM
92655	4.0	i-PROBLEM
92656	centimeter	i-PROBLEM
92657	lesion	i-PROBLEM
92658	in	i-PROBLEM
92659	the	i-PROBLEM
92660	pancreatic	i-PROBLEM
92661	head	i-PROBLEM
92662	.	O
92663	an	b-TEST
92664	ercp	i-TEST
92665	performed	O
92666	there	O
92667	showed	b-EVIDENTIAL
92668	a	b-PROBLEM
92669	long	i-PROBLEM
92670	segment	i-PROBLEM
92671	of	i-PROBLEM
92672	distal	i-PROBLEM
92673	narrowing	i-PROBLEM
92674	of	i-PROBLEM
92675	the	i-PROBLEM
92676	common	i-PROBLEM
92677	bileduct	i-PROBLEM
92678	and	O
92679	a	b-TREATMENT
92680	transhepatic	i-TREATMENT
92681	biliary	i-TREATMENT
92682	drain	i-TREATMENT
92683	was	O
92684	placed	O
92685	there	O
92686	on	O
92687	december	b-DATE
92688	29	i-DATE
92689	.	O
92690	on	O
92691	january	b-DATE
92692	1	i-DATE
92693	,	O
92694	a	b-TREATMENT
92695	chest	i-TREATMENT
92696	tube	i-TREATMENT
92697	was	O
92698	placed	O
92699	for	O
92700	a	b-PROBLEM
92701	loculated	i-PROBLEM
92702	pleural	i-PROBLEM
92703	effusion	i-PROBLEM
92704	.	O
92705	on	O
92706	january	b-DATE
92707	2	i-DATE
92708	,	O
92709	pleurodesis	b-TREATMENT
92710	was	O
92711	performed	O
92712	.	O
92713	on	O
92714	january	b-DATE
92715	4	i-DATE
92716	,	O
92717	he	O
92718	had	O
92719	a	b-PROBLEM
92720	desaturation	i-PROBLEM
92721	.	O
92722	vq	b-TEST
92723	was	O
92724	indeterminate	O
92725	.	O
92726	lenis	b-TEST
92727	were	O
92728	negative	O
92729	at	O
92730	that	b-DATE
92731	time	i-DATE
92732	.	O
92733	on	O
92734	january	b-DATE
92735	5	i-DATE
92736	,	O
92737	he	O
92738	had	O
92739	a	b-TEST
92740	chest	i-TEST
92741	xray	i-TEST
92742	with	O
92743	a	b-PROBLEM
92744	left	i-PROBLEM
92745	apicalpneumothorax	i-PROBLEM
92746	but	O
92747	was	O
92748	stable	b-OCCURRENCE
92749	on	O
92750	chest	b-TEST
92751	xray	i-TEST
92752	of	O
92753	january	b-DATE
92754	7	i-DATE
92755	.	O
92756	brain	b-TEST
92757	ct	i-TEST
92758	was	O
92759	negative	O
92760	,	O
92761	as	O
92762	was	O
92763	a	b-TEST
92764	bronchoscopy	i-TEST
92765	with	O
92766	lavage	b-TREATMENT
92767	.	O
92768	his	b-TEST
92769	ca99	i-TEST
92770	was	O
92771	normal	O
92772	.	O
92773	review	O
92774	of	O
92775	systems	O
92776	:	O
92777	the	O
92778	patient	O
92779	had	O
92780	reported	b-EVIDENTIAL
92781	an	O
92782	approximately	O
92783	30	O
92784	pound	O
92785	weight	b-PROBLEM
92786	loss	i-PROBLEM
92787	in	O
92788	six	b-DURATION
92789	weeks	i-DURATION
92790	.	O
92791	he	O
92792	had	O
92793	experienced	O
92794	some	b-PROBLEM
92795	constipation	i-PROBLEM
92796	for	O
92797	the	b-DURATION
92798	few	i-DURATION
92799	months	i-DURATION
92800	prior	O
92801	with	O
92802	lighter	b-PROBLEM
92803	colored	i-PROBLEM
92804	stools	i-PROBLEM
92805	,	O
92806	darkened	b-PROBLEM
92807	urine	i-PROBLEM
92808	and	O
92809	fatigue	b-PROBLEM
92810	for	O
92811	months	b-DURATION
92812	with	O
92813	increased	b-PROBLEM
92814	shortness	i-PROBLEM
92815	of	i-PROBLEM
92816	breath	i-PROBLEM
92817	,	O
92818	orthopnea	b-PROBLEM
92819	and	O
92820	dyspnea	b-PROBLEM
92821	on	O
92822	exertion	O
92823	.	O
92824	he	O
92825	denied	b-EVIDENTIAL
92826	any	O
92827	fevers	b-PROBLEM
92828	,	O
92829	chills	b-PROBLEM
92830	or	O
92831	night	b-PROBLEM
92832	sweats	i-PROBLEM
92833	.	O
92834	hospital	O
92835	course	O
92836	:	O
92837	1.	O
92838	gastrointestinal	O
92839	.	O
92840	the	O
92841	patient	O
92842	had	O
92843	an	b-PROBLEM
92844	elevated	i-PROBLEM
92845	bilirubin	i-PROBLEM
92846	on	O
92847	admission	b-OCCURRENCE
92848	with	O
92849	decreased	b-PROBLEM
92850	output	i-PROBLEM
92851	of	O
92852	biliary	b-TREATMENT
92853	drain	i-TREATMENT
92854	.	O
92855	the	b-TREATMENT
92856	drain	i-TREATMENT
92857	was	O
92858	replaced	b-TREATMENT
92859	over	i-TREATMENT
92860	the	i-TREATMENT
92861	wire	i-TREATMENT
92862	,	O
92863	8-10	O
92864	by	O
92865	ir	b-CLINICAL_DEPT
92866	,	O
92867	when	O
92868	it	O
92869	was	O
92870	accidentally	b-OCCURRENCE
92871	removed	i-OCCURRENCE
92872	.	O
92873	increased	b-OCCURRENCE
92874	flow	i-OCCURRENCE
92875	again	O
92876	.	O
92877	the	O
92878	patient	O
92879	had	O
92880	signs	b-PROBLEM
92881	and	O
92882	symptoms	b-PROBLEM
92883	develop	O
92884	of	O
92885	sbp	b-PROBLEM
92886	,	O
92887	also	O
92888	with	O
92889	an	b-PROBLEM
92890	elevated	i-PROBLEM
92891	white	i-PROBLEM
92892	count	i-PROBLEM
92893	.	O
92894	he	O
92895	was	O
92896	treated	O
92897	broadly	O
92898	with	O
92899	amp	b-TREATMENT
92900	,	O
92901	levo	b-TREATMENT
92902	and	O
92903	flagyl	b-TREATMENT
92904	.	O
92905	cultures	b-TEST
92906	were	O
92907	negative	O
92908	and	O
92909	onlyon	O
92910	one	b-TEST
92911	gram	i-TEST
92912	stain	i-TEST
92913	did	O
92914	it	O
92915	show	O
92916	rare	b-PROBLEM
92917	gram	i-PROBLEM
92918	negative	i-PROBLEM
92919	rods	i-PROBLEM
92920	.	O
92921	the	b-TEST
92922	patient	i-TEST
92923	&apos;s	i-TEST
92924	abdominal	i-TEST
92925	fluid	i-TEST
92926	cell	i-TEST
92927	counts	i-TEST
92928	showed	b-EVIDENTIAL
92929	2400	O
92930	white	b-TEST
92931	blood	i-TEST
92932	cells	i-TEST
92933	,	O
92934	500	O
92935	red	b-TEST
92936	cells	i-TEST
92937	with	O
92938	82	O
92939	polyps	b-TEST
92940	,	O
92941	11	O
92942	lymphs	b-TEST
92943	,	O
92944	7	O
92945	monos	b-TEST
92946	.	O
92947	clinically	O
92948	,	O
92949	this	O
92950	was	O
92951	consistent	O
92952	with	O
92953	sbp	b-PROBLEM
92954	,	O
92955	although	O
92956	unfortunately	O
92957	,	O
92958	fluid	O
92959	was	O
92960	never	O
92961	sent	O
92962	for	O
92963	cytology	b-TEST
92964	and	O
92965	a	O
92966	lot	O
92967	of	O
92968	those	b-PROBLEM
92969	white	i-PROBLEM
92970	cells	i-PROBLEM
92971	are	O
92972	most	O
92973	likely	O
92974	due	O
92975	to	O
92976	his	b-PROBLEM
92977	cancer	i-PROBLEM
92978	.	O
92979	he	O
92980	underwent	O
92981	abdominal	b-TREATMENT
92982	paracentesis	i-TREATMENT
92983	approximately	O
92984	two	b-FREQUENCY
92985	times	i-FREQUENCY
92986	a	i-FREQUENCY
92987	week	i-FREQUENCY
92988	for	O
92989	therapeutic	O
92990	.	O
92991	this	O
92992	had	O
92993	to	O
92994	be	O
92995	performed	O
92996	by	O
92997	ir	b-CLINICAL_DEPT
92998	because	O
92999	the	b-PROBLEM
93000	pocket	i-PROBLEM
93001	was	O
93002	too	b-OCCURRENCE
93003	deep	i-OCCURRENCE
93004	to	i-OCCURRENCE
93005	access	i-OCCURRENCE
93006	from	i-OCCURRENCE
93007	the	i-OCCURRENCE
93008	bedside	i-OCCURRENCE
93009	.	O
93010	he	O
93011	received	O
93012	a	O
93013	two	b-DURATION
93014	week	i-DURATION
93015	course	O
93016	of	O
93017	broad	b-TREATMENT
93018	spectrum	i-TREATMENT
93019	antibiotics	i-TREATMENT
93020	and	O
93021	will	O
93022	be	O
93023	maintained	O
93024	on	O
93025	levofloxacin	b-TREATMENT
93026	iv	i-TREATMENT
93027	for	O
93028	prophylaxis	b-TREATMENT
93029	against	O
93030	sbp	b-PROBLEM
93031	.	O
93032	2.	O
93033	pulmonary	O
93034	.	O
93035	from	O
93036	a	O
93037	pulmonary	O
93038	standpoint	O
93039	,	O
93040	he	O
93041	continued	O
93042	to	O
93043	complain	b-EVIDENTIAL
93044	of	O
93045	shortness	b-PROBLEM
93046	of	i-PROBLEM
93047	breath	i-PROBLEM
93048	.	O
93049	his	b-PROBLEM
93050	apical	i-PROBLEM
93051	pneumothorax	i-PROBLEM
93052	from	O
93053	the	b-CLINICAL_DEPT
93054	outside	i-CLINICAL_DEPT
93055	hospital	i-CLINICAL_DEPT
93056	had	O
93057	resolved	b-OCCURRENCE
93058	.	O
93059	chest	b-TEST
93060	xray	i-TEST
93061	was	O
93062	consistent	O
93063	with	O
93064	pleurodesis	b-TREATMENT
93065	.	O
93066	however	O
93067	,	O
93068	with	O
93069	persistent	b-PROBLEM
93070	abdomen	i-PROBLEM
93071	distention	i-PROBLEM
93072	,	O
93073	there	O
93074	is	O
93075	likely	O
93076	restrictive	b-PROBLEM
93077	deficit	i-PROBLEM
93078	and	O
93079	,	O
93080	in	O
93081	addition	O
93082	,	O
93083	after	O
93084	each	O
93085	tap	b-TEST
93086	,	O
93087	he	O
93088	at	O
93089	times	O
93090	became	O
93091	hypotensive	b-PROBLEM
93092	and	O
93093	with	O
93094	some	O
93095	mild	O
93096	fluid	b-TREATMENT
93097	resuscitation	i-TREATMENT
93098	decompensated	O
93099	with	O
93100	pulmonary	b-PROBLEM
93101	edema	i-PROBLEM
93102	,	O
93103	requiring	O
93104	both	O
93105	albumin	b-TREATMENT
93106	and	O
93107	lasix	b-TREATMENT
93108	to	O
93109	try	O
93110	to	O
93111	mobilize	O
93112	third	b-PROBLEM
93113	space	i-PROBLEM
93114	fluids	i-PROBLEM
93115	.	O
93116	on	O
93117	the	b-DATE
93118	day	i-DATE
93119	of	O
93120	discharge	O
93121	,	O
93122	he	O
93123	is	O
93124	stating	b-TEST
93125	approximately	O
93126	91	O
93127	to	O
93128	92%	O
93129	on	O
93130	three	O
93131	to	O
93132	four	O
93133	liters	O
93134	.	O
93135	chest	b-TEST
93136	xray	i-TEST
93137	is	O
93138	still	O
93139	consistent	O
93140	with	O
93141	volume	b-PROBLEM
93142	overload	i-PROBLEM
93143	.	O
93144	the	O
93145	plan	O
93146	will	O
93147	be	O
93148	to	O
93149	continue	O
93150	to	O
93151	try	O
93152	to	O
93153	alternate	O
93154	albumin	b-TREATMENT
93155	and	O
93156	lasix	b-TREATMENT
93157	to	O
93158	mobilize	O
93159	his	b-PROBLEM
93160	fluid	i-PROBLEM
93161	.	O
93162	3.	O
93163	cardiovascular	O
93164	.	O
93165	he	O
93166	had	O
93167	episodes	O
93168	of	O
93169	bradycardia	b-PROBLEM
93170	without	O
93171	subsequent	b-PROBLEM
93172	fall	i-PROBLEM
93173	in	i-PROBLEM
93174	blood	i-PROBLEM
93175	pressure	i-PROBLEM
93176	at	O
93177	the	O
93178	beginning	O
93179	of	O
93180	his	b-OCCURRENCE
93181	admission	i-OCCURRENCE
93182	.	O
93183	he	O
93184	was	O
93185	ruled	O
93186	out	O
93187	for	O
93188	a	b-PROBLEM
93189	myocardial	i-PROBLEM
93190	infarction	i-PROBLEM
93191	.	O
93192	echocardiogram	b-TEST
93193	showed	b-EVIDENTIAL
93194	50%	b-TEST
93195	ejection	i-TEST
93196	fraction	i-TEST
93197	with	O
93198	mild	b-PROBLEM
93199	mitral	i-PROBLEM
93200	regurgitation	i-PROBLEM
93201	.	O
93202	he	O
93203	did	O
93204	not	O
93205	show	O
93206	any	O
93207	episodes	O
93208	of	O
93209	bradycardia	b-PROBLEM
93210	throughout	O
93211	the	O
93212	remainder	O
93213	of	O
93214	his	b-OCCURRENCE
93215	hospital	i-OCCURRENCE
93216	course	i-OCCURRENCE
93217	.	O
93218	4.	O
93219	endocrine	O
93220	.	O
93221	diabetes	b-PROBLEM
93222	.	O
93223	his	b-TREATMENT
93224	avandia	i-TREATMENT
93225	was	O
93226	discontinued	O
93227	secondary	O
93228	to	O
93229	the	b-PROBLEM
93230	side	i-PROBLEM
93231	effect	i-PROBLEM
93232	profile	i-PROBLEM
93233	.	O
93234	he	O
93235	is	O
93236	being	O
93237	maintained	O
93238	on	O
93239	glipizide	b-TREATMENT
93240	and	O
93241	sliding	b-TREATMENT
93242	scale	i-TREATMENT
93243	insulin	i-TREATMENT
93244	.	O
93245	5.	O
93246	heme	O
93247	.	O
93248	from	O
93249	a	O
93250	heme	O
93251	standpoint	O
93252	,	O
93253	he	O
93254	presented	O
93255	anemic	b-PROBLEM
93256	and	O
93257	with	O
93258	an	b-PROBLEM
93259	elevated	i-PROBLEM
93260	pt	i-PROBLEM
93261	inr	i-PROBLEM
93262	.	O
93263	he	O
93264	required	O
93265	a	b-TREATMENT
93266	few	i-TREATMENT
93267	transfusions	i-TREATMENT
93268	during	O
93269	his	b-OCCURRENCE
93270	hospital	i-OCCURRENCE
93271	course	i-OCCURRENCE
93272	.	O
93273	he	O
93274	also	O
93275	required	O
93276	ffp	b-TREATMENT
93277	initially	O
93278	to	O
93279	reverse	O
93280	his	b-PROBLEM
93281	coagulopathy	i-PROBLEM
93282	.	O
93283	however	O
93284	,	O
93285	this	b-OCCURRENCE
93286	resolved	i-OCCURRENCE
93287	on	i-OCCURRENCE
93288	its	i-OCCURRENCE
93289	own	i-OCCURRENCE
93290	over	O
93291	the	b-OCCURRENCE
93292	hospital	i-OCCURRENCE
93293	course	i-OCCURRENCE
93294	.	O
93295	his	b-TEST
93296	inr	i-TEST
93297	normalized	b-OCCURRENCE
93298	,	O
93299	however	O
93300	,	O
93301	unfortunately	O
93302	,	O
93303	he	O
93304	developed	O
93305	bilateral	b-PROBLEM
93306	deep	i-PROBLEM
93307	venous	i-PROBLEM
93308	thromboses	i-PROBLEM
93309	during	O
93310	his	b-OCCURRENCE
93311	hospital	i-OCCURRENCE
93312	course	i-OCCURRENCE
93313	and	O
93314	will	O
93315	be	O
93316	maintained	O
93317	on	O
93318	lovenox	b-TREATMENT
93319	.	O
93320	6.	O
93321	renal	O
93322	.	O
93323	he	O
93324	had	O
93325	a	b-TEST
93326	creatinine	i-TEST
93327	of	O
93328	4.0	O
93329	on	O
93330	admission	b-OCCURRENCE
93331	and	O
93332	this	b-OCCURRENCE
93333	decreased	i-OCCURRENCE
93334	down	i-OCCURRENCE
93335	to	O
93336	the	O
93337	mid	O
93338	ones	O
93339	with	O
93340	fluid	b-TREATMENT
93341	,	O
93342	currently	O
93343	at	O
93344	1.7	O
93345	on	O
93346	discharge	b-OCCURRENCE
93347	.	O
93348	from	O
93349	his	b-TEST
93350	urinalysis	i-TEST
93351	,	O
93352	he	O
93353	has	O
93354	mostly	O
93355	a	b-PROBLEM
93356	prerenal	i-PROBLEM
93357	state	i-PROBLEM
93358	.	O
93359	however	O
93360	,	O
93361	he	O
93362	does	O
93363	require	O
93364	diuresis	b-TREATMENT
93365	to	O
93366	prevent	O
93367	increased	b-PROBLEM
93368	volume	i-PROBLEM
93369	overload	i-PROBLEM
93370	in	O
93371	his	O
93372	lungs	O
93373	from	O
93374	his	b-PROBLEM
93375	hypoalbunemic	i-PROBLEM
93376	state	i-PROBLEM
93377	.	O
93378	at	O
93379	the	O
93380	time	O
93381	,	O
93382	nutrition	b-CLINICAL_DEPT
93383	was	O
93384	following	b-TREATMENT
93385	,	O
93386	initially	O
93387	with	O
93388	a	b-TREATMENT
93389	low	i-TREATMENT
93390	fat	i-TREATMENT
93391	,	i-TREATMENT
93392	low	i-TREATMENT
93393	cholesterol	i-TREATMENT
93394	,	i-TREATMENT
93395	low	i-TREATMENT
93396	sugar	i-TREATMENT
93397	diet	i-TREATMENT
93398	.	O
93399	his	O
93400	appetite	O
93401	is	O
93402	decreasing	b-OCCURRENCE
93403	somewhat	O
93404	as	O
93405	his	b-PROBLEM
93406	disease	i-PROBLEM
93407	process	i-PROBLEM
93408	progresses	O
93409	,	O
93410	therefore	O
93411	,	O
93412	we	O
93413	have	O
93414	liberalized	b-TREATMENT
93415	his	i-TREATMENT
93416	diet	i-TREATMENT
93417	for	O
93418	him	O
93419	to	O
93420	take	O
93421	what	O
93422	he	O
93423	wishes	O
93424	.	O
93425	7.	O
93426	id	O
93427	.	O
93428	please	O
93429	see	O
93430	gi	O
93431	.	O
93432	he	O
93433	was	O
93434	treated	O
93435	with	O
93436	broad	b-TREATMENT
93437	spectrum	i-TREATMENT
93438	antibiotics	i-TREATMENT
93439	for	O
93440	a	O
93441	14	b-DURATION
93442	day	i-DURATION
93443	course	O
93444	for	O
93445	clinical	b-PROBLEM
93446	sbp	i-PROBLEM
93447	.	O
93448	he	O
93449	will	O
93450	be	O
93451	maintained	O
93452	on	O
93453	levofloxacin	b-TREATMENT
93454	for	O
93455	prophylaxis	b-TREATMENT
93456	against	O
93457	sbp	b-PROBLEM
93458	.	O
93459	given	O
93460	that	O
93461	he	O
93462	will	O
93463	need	O
93464	continued	b-TEST
93465	taps,	i-TEST
93466	8.	O
93467	oncology	O
93468	.	O
93469	the	O
93470	patient	O
93471	initially	O
93472	came	O
93473	for	O
93474	workup	b-TEST
93475	of	O
93476	pancreatic	b-PROBLEM
93477	cancer	i-PROBLEM
93478	with	O
93479	a	O
93480	questions	O
93481	of	O
93482	palliative	b-TREATMENT
93483	chemotherapy	i-TREATMENT
93484	.	O
93485	however	O
93486	,	O
93487	given	O
93488	his	b-PROBLEM
93489	rapid	i-PROBLEM
93490	clinical	i-PROBLEM
93491	decline	i-PROBLEM
93492	,	O
93493	this	O
93494	was	O
93495	deferred	O
93496	and	O
93497	i	O
93498	do	O
93499	not	O
93500	suspect	O
93501	that	O
93502	he	O
93503	will	O
93504	be	O
93505	a	O
93506	candidate	O
93507	for	O
93508	this	O
93509	,	O
93510	as	O
93511	the	O
93512	degree	O
93513	of	O
93514	his	b-PROBLEM
93515	decline	i-PROBLEM
93516	bodes	O
93517	a	O
93518	poor	O
93519	prognosis	O
93520	for	O
93521	him	O
93522	.	O
93523	his	b-PROBLEM
93524	pain	i-PROBLEM
93525	here	O
93526	has	O
93527	been	O
93528	controlled	b-TREATMENT
93529	,	O
93530	initially	O
93531	on	O
93532	oxycontin	b-TREATMENT
93533	with	O
93534	morphine	b-TREATMENT
93535	for	O
93536	breakthrough	b-PROBLEM
93537	pain	i-PROBLEM
93538	.	O
93539	as	O
93540	he	O
93541	becomes	O
93542	progressively	b-PROBLEM
93543	more	i-PROBLEM
93544	somnolent	i-PROBLEM
93545	,	O
93546	this	O
93547	will	O
93548	likely	O
93549	need	O
93550	to	O
93551	be	O
93552	switched	O
93553	to	O
93554	iv	b-TREATMENT
93555	pain	i-TREATMENT
93556	medications	i-TREATMENT
93557	only	O
93558	.	O
93559	discussion	O
93560	,	O
93561	at	O
93562	that	O
93563	point	O
93564	in	O
93565	time	O
93566	,	O
93567	should	O
93568	occur	O
93569	with	O
93570	the	O
93571	family	O
93572	about	O
93573	comfort	b-TREATMENT
93574	measures	i-TREATMENT
93575	and	O
93576	about	O
93577	weaning	b-OCCURRENCE
93578	him	i-OCCURRENCE
93579	from	O
93580	his	b-TREATMENT
93581	medications	i-TREATMENT
93582	to	O
93583	make	O
93584	him	O
93585	more	b-OCCURRENCE
93586	comfortable	i-OCCURRENCE
93587	.	O
93588	code	O
93589	status	O
93590	-	O
93591	the	O
93592	patient	O
93593	is	O
93594	a	O
93595	dnr	O
93596	/	O
93597	dni	O
93598	.	O
93599	this	O
93600	is	O
93601	an	O
93602	unfortunate	O
93603	case	O
93604	but	O
93605	mr.	O
93606	po	O
93607	does	O
93608	have	O
93609	an	O
93610	incredibly	O
93611	supportive	O
93612	family	O
93613	who	O
93614	have	O
93615	been	O
93616	here	O
93617	consistently	O
93618	to	O
93619	visit	O
93620	him	O
93621	and	O
93622	that	O
93623	offers	O
93624	him	O
93625	an	O
93626	important	O
93627	source	O
93628	of	O
93629	comfort	O
93630	.	O
93631		O
93632	admission	b-OCCURRENCE
93633	date	O
93634	:	O
93635	2012-11-06	b-ADMISSION
93636	discharge	b-OCCURRENCE
93637	date	O
93638	:	O
93639	2012-11-11	b-DISCHARGE
93640	service	O
93641	:	O
93642	ccu	O
93643	history	O
93644	of	O
93645	present	O
93646	illness	O
93647	:	O
93648	the	O
93649	patient	O
93650	is	O
93651	a	O
93652	47	O
93653	-	O
93654	year-old	O
93655	male	O
93656	with	O
93657	a	O
93658	past	O
93659	medical	O
93660	history	O
93661	of	O
93662	coronary	b-PROBLEM
93663	artery	i-PROBLEM
93664	disease	i-PROBLEM
93665	,	O
93666	status	b-TREATMENT
93667	post	i-TREATMENT
93668	2-vessel	i-TREATMENT
93669	percutaneous	i-TREATMENT
93670	transluminal	i-TREATMENT
93671	coronary	i-TREATMENT
93672	angioplasty	i-TREATMENT
93673	in	O
93674	2005	b-DATE
93675	,	O
93676	3-vessel	b-TREATMENT
93677	percutaneous	i-TREATMENT
93678	transluminal	i-TREATMENT
93679	coronary	i-TREATMENT
93680	angioplasty	i-TREATMENT
93681	in	O
93682	2009	b-DATE
93683	,	O
93684	hypertension	b-PROBLEM
93685	,	O
93686	new	b-PROBLEM
93687	onset	i-PROBLEM
93688	type	i-PROBLEM
93689	2	i-PROBLEM
93690	diabetes	i-PROBLEM
93691	,	O
93692	and	O
93693	hypercholesterolemia	b-PROBLEM
93694	who	O
93695	presents	b-OCCURRENCE
93696	with	O
93697	the	O
93698	sudden	O
93699	onset	O
93700	of	O
93701	substernal	b-PROBLEM
93702	chest	i-PROBLEM
93703	pain	i-PROBLEM
93704	status	O
93705	post	O
93706	exercise	b-OCCURRENCE
93707	.	O
93708	the	O
93709	patient	O
93710	presented	b-OCCURRENCE
93711	to	O
93712	bournewood	b-OCCURRENCE
93713	hospital	i-OCCURRENCE
93714	on	O
93715	the	b-DATE
93716	morning	i-DATE
93717	of	O
93718	admission	b-OCCURRENCE
93719	with	O
93720	a	O
93721	chief	O
93722	complaint	O
93723	of	O
93724	substernal	b-PROBLEM
93725	burning	i-PROBLEM
93726	without	O
93727	radiation	b-OCCURRENCE
93728	which	O
93729	developed	O
93730	while	O
93731	doing	O
93732	exercise	b-OCCURRENCE
93733	.	O
93734	of	O
93735	note	O
93736	,	O
93737	this	O
93738	is	O
93739	the	O
93740	second	O
93741	time	O
93742	the	O
93743	patient	O
93744	has	O
93745	exercised	b-OCCURRENCE
93746	in	O
93747	many	b-DURATION
93748	months	i-DURATION
93749	.	O
93750	the	b-PROBLEM
93751	pain	i-PROBLEM
93752	became	O
93753	worse	b-OCCURRENCE
93754	over	O
93755	the	b-DURATION
93756	next	i-DURATION
93757	few	i-DURATION
93758	minutes	i-DURATION
93759	to	O
93760	07-12	O
93761	and	O
93762	increased	b-OCCURRENCE
93763	to	O
93764	10-12	O
93765	while	O
93766	he	O
93767	was	O
93768	in	O
93769	the	b-OCCURRENCE
93770	ambulance	i-OCCURRENCE
93771	.	O
93772	his	b-TREATMENT
93773	nitroglycerin	i-TREATMENT
93774	patch	i-TREATMENT
93775	did	O
93776	not	O
93777	help	O
93778	,	O
93779	and	O
93780	he	O
93781	only	O
93782	had	O
93783	slight	O
93784	relief	b-OCCURRENCE
93785	with	O
93786	sublingual	b-TREATMENT
93787	nitroglycerin	i-TREATMENT
93788	times	b-FREQUENCY
93789	three	i-FREQUENCY
93790	.	O
93791	in	O
93792	addition	O
93793	,	O
93794	he	O
93795	had	O
93796	slight	b-PROBLEM
93797	shortness	i-PROBLEM
93798	of	i-PROBLEM
93799	breath	i-PROBLEM
93800	but	O
93801	denies	b-EVIDENTIAL
93802	headache	b-PROBLEM
93803	,	O
93804	change	b-PROBLEM
93805	in	i-PROBLEM
93806	vision	i-PROBLEM
93807	,	O
93808	dizziness	b-PROBLEM
93809	,	O
93810	nausea	b-PROBLEM
93811	,	O
93812	vomiting	b-PROBLEM
93813	,	O
93814	abdominal	b-PROBLEM
93815	pain	i-PROBLEM
93816	,	O
93817	change	b-PROBLEM
93818	in	i-PROBLEM
93819	bowel	i-PROBLEM
93820	or	i-PROBLEM
93821	urinary	i-PROBLEM
93822	habits	i-PROBLEM
93823	,	O
93824	or	O
93825	fevers	b-PROBLEM
93826	,	O
93827	chills	b-PROBLEM
93828	,	O
93829	and	O
93830	sweats	b-PROBLEM
93831	.	O
93832	of	O
93833	note	O
93834	,	O
93835	he	O
93836	had	O
93837	a	b-OCCURRENCE
93838	negative	i-OCCURRENCE
93839	stress	i-OCCURRENCE
93840	test	i-OCCURRENCE
93841	in	O
93842	2012-07-03	b-DATE
93843	.	O
93844	he	O
93845	was	O
93846	sent	O
93847	to	O
93848	bournewood	b-CLINICAL_DEPT
93849	hospital	i-CLINICAL_DEPT
93850	via	O
93851	ambulance	b-OCCURRENCE
93852	.	O
93853	in	O
93854	the	b-CLINICAL_DEPT
93855	emergency	i-CLINICAL_DEPT
93856	department	i-CLINICAL_DEPT
93857	he	O
93858	received	O
93859	aspirin	b-TREATMENT
93860	,	O
93861	nitroglycerin	b-TREATMENT
93862	drip	i-TREATMENT
93863	,	O
93864	heparin	b-TREATMENT
93865	drip	i-TREATMENT
93866	,	O
93867	dilaudid	b-TREATMENT
93868	,	O
93869	and	O
93870	tnk	b-TREATMENT
93871	with	O
93872	decreased	O
93873	in	O
93874	his	b-PROBLEM
93875	pain	i-PROBLEM
93876	but	O
93877	without	O
93878	resolution	O
93879	of	O
93880	symptoms	b-PROBLEM
93881	.	O
93882	electrocardiogram	b-TEST
93883	at	O
93884	that	O
93885	time	O
93886	showed	b-EVIDENTIAL
93887	st	b-PROBLEM
93888	elevations	i-PROBLEM
93889	and	O
93890	j	b-PROBLEM
93891	point	i-PROBLEM
93892	elevations	i-PROBLEM
93893	in	i-PROBLEM
93894	v2	i-PROBLEM
93895	through	i-PROBLEM
93896	v4	i-PROBLEM
93897	.	O
93898	the	O
93899	patient	O
93900	was	O
93901	transferred	b-OCCURRENCE
93902	to	O
93903	sturdy	b-OCCURRENCE
93904	memorial	i-OCCURRENCE
93905	where	O
93906	he	O
93907	underwent	O
93908	catheterization	b-TEST
93909	.	O
93910	catheterization	b-TEST
93911	results	i-TEST
93912	showed	b-EVIDENTIAL
93913	100%	b-PROBLEM
93914	occlusion	i-PROBLEM
93915	of	i-PROBLEM
93916	the	i-PROBLEM
93917	proximal	i-PROBLEM
93918	left	i-PROBLEM
93919	anterior	i-PROBLEM
93920	descending	i-PROBLEM
93921	artery	i-PROBLEM
93922	and	O
93923	50%	b-PROBLEM
93924	stenosis	i-PROBLEM
93925	of	i-PROBLEM
93926	first	i-PROBLEM
93927	diagonal	i-PROBLEM
93928	.	O
93929	angio-jet	b-TREATMENT
93930	percutaneous	i-TREATMENT
93931	transluminal	i-TREATMENT
93932	coronary	i-TREATMENT
93933	angioplasty	i-TREATMENT
93934	and	O
93935	stenting	b-TREATMENT
93936	was	O
93937	performed	O
93938	on	O
93939	proximal	O
93940	left	O
93941	anterior	O
93942	descending	O
93943	artery	O
93944	and	O
93945	the	b-TREATMENT
93946	percutaneous	i-TREATMENT
93947	transluminal	i-TREATMENT
93948	coronary	i-TREATMENT
93949	angioplasty	i-TREATMENT
93950	was	O
93951	performed	O
93952	on	O
93953	first	O
93954	diagonal	O
93955	with	O
93956	good	b-OCCURRENCE
93957	results	i-OCCURRENCE
93958	.	O
93959	an	b-TREATMENT
93960	intra-aortic	i-TREATMENT
93961	balloon	i-TREATMENT
93962	pump	i-TREATMENT
93963	was	O
93964	placed	O
93965	at	O
93966	this	O
93967	time	O
93968	as	O
93969	well	O
93970	.	O
93971	hospital	O
93972	course	O
93973	:	O
93974	the	b-OCCURRENCE
93975	mass.	i-OCCURRENCE
93976	mental	i-OCCURRENCE
93977	health	i-OCCURRENCE
93978	center	i-OCCURRENCE
93979	hospital	i-OCCURRENCE
93980	course	i-OCCURRENCE
93981	was	O
93982	unremarkable	b-OCCURRENCE
93983	.	O
93984	dopamine	b-TREATMENT
93985	was	O
93986	discontinued	O
93987	on	O
93988	day	b-DATE
93989	one	i-DATE
93990	.	O
93991	the	b-TREATMENT
93992	intra-aortic	i-TREATMENT
93993	balloon	i-TREATMENT
93994	pump	i-TREATMENT
93995	was	O
93996	discontinued	O
93997	on	O
93998	day	b-DATE
93999	two	i-DATE
94000	.	O
94001	the	O
94002	patient	O
94003	was	O
94004	continued	O
94005	on	O
94006	heparin	b-TREATMENT
94007	throughout	O
94008	his	b-OCCURRENCE
94009	hospital	i-OCCURRENCE
94010	course	i-OCCURRENCE
94011	and	O
94012	transitioned	O
94013	to	O
94014	coumadin	b-TREATMENT
94015	on	O
94016	hospital	b-DATE
94017	day	i-DATE
94018	four	i-DATE
94019	.	O
94020	the	O
94021	patient	O
94022	was	O
94023	continued	O
94024	on	O
94025	lipitor	b-TREATMENT
94026	and	O
94027	aspirin	b-TREATMENT
94028	,	O
94029	and	O
94030	plavix	b-TREATMENT
94031	was	O
94032	added	O
94033	and	O
94034	will	O
94035	be	O
94036	continued	O
94037	for	O
94038	30	b-DURATION
94039	days	i-DURATION
94040	post	O
94041	catheterization	b-TEST
94042	.	O
94043	the	O
94044	patient	O
94045	was	O
94046	continued	O
94047	on	O
94048	lopressor	b-TREATMENT
94049	and	O
94050	captopril	b-TREATMENT
94051	throughout	O
94052	his	b-OCCURRENCE
94053	hospital	i-OCCURRENCE
94054	course	i-OCCURRENCE
94055	,	O
94056	and	O
94057	changed	O
94058	to	O
94059	zestril	b-TREATMENT
94060	10	O
94061	mg	O
94062	q.d.	b-FREQUENCY
94063	and	O
94064	atenolol	b-TREATMENT
94065	25	O
94066	mg	O
94067	q.d.	b-FREQUENCY
94068	at	O
94069	discharge	b-OCCURRENCE
94070	.	O
94071	the	O
94072	patient	O
94073	was	O
94074	discharged	b-OCCURRENCE
94075	to	O
94076	the	b-CLINICAL_DEPT
94077	medical	i-CLINICAL_DEPT
94078	floor	i-CLINICAL_DEPT
94079	on	O
94080	hospital	b-DATE
94081	day	i-DATE
94082	three	i-DATE
94083	and	O
94084	discharged	b-OCCURRENCE
94085	from	O
94086	the	b-CLINICAL_DEPT
94087	hospital	i-CLINICAL_DEPT
94088	once	O
94089	his	b-TEST
94090	inr	i-TEST
94091	was	O
94092	within	O
94093	the	O
94094	2	O
94095	to	O
94096	2.5	O
94097	range	O
94098	.	O
94099		O
94100	admission	b-OCCURRENCE
94101	date:	O
94102	2011-02-08	b-ADMISSION
94103	discharge	b-OCCURRENCE
94104	date	O
94105	:	O
94106	2011-02-14	b-DISCHARGE
94107	service	O
94108	:	O
94109	cmed	O
94110	history	O
94111	of	O
94112	the	O
94113	present	O
94114	illness	O
94115	:	O
94116	briefly	O
94117	,	O
94118	this	O
94119	is	O
94120	a	O
94121	57-year-old	O
94122	gentleman	O
94123	with	O
94124	a	O
94125	history	O
94126	of	O
94127	copd	b-PROBLEM
94128	,	O
94129	status	O
94130	post	O
94131	intubation	b-TREATMENT
94132	six	b-DATE
94133	years	i-DATE
94134	ago	i-DATE
94135	but	O
94136	not	O
94137	on	O
94138	home	b-TREATMENT
94139	02	i-TREATMENT
94140	with	O
94141	recent	O
94142	fev1	b-TEST
94143	27%	O
94144	of	O
94145	predicted	O
94146	value	O
94147	,	O
94148	and	O
94149	fev1/fvc	b-TEST
94150	ratio	i-TEST
94151	56%	O
94152	of	O
94153	hypercholesterolemia	b-PROBLEM
94154	,	O
94155	who	O
94156	was	O
94157	admitted	b-OCCURRENCE
94158	for	O
94159	copd	b-PROBLEM
94160	exacerbation	i-PROBLEM
94161	and	O
94162	worsening	O
94163	of	O
94164	upper	b-PROBLEM
94165	respiratory	i-PROBLEM
94166	tract	i-PROBLEM
94167	infection	i-PROBLEM
94168	symptoms	i-PROBLEM
94169	for	O
94170	a	b-DURATION
94171	week	i-DURATION
94172	prior	O
94173	to	O
94174	admission	b-OCCURRENCE
94175	.	O
94176	he	O
94177	was	O
94178	afebrile	b-PROBLEM
94179	with	O
94180	stable	O
94181	vital	O
94182	signs	O
94183	on	O
94184	presentation	b-EVIDENTIAL
94185	to	O
94186	hospital	O
94187	course	O
94188	:	O
94189	he	O
94190	was	O
94191	started	O
94192	on	O
94193	p.o.	b-TREATMENT
94194	steroids	i-TREATMENT
94195	and	O
94196	to	O
94197	cmed	b-CLINICAL_DEPT
94198	for	O
94199	management	b-TREATMENT
94200	of	O
94201	copd	b-PROBLEM
94202	exacerbation	i-PROBLEM
94203	but	O
94204	he	O
94205	appeared	O
94206	in	O
94207	more	b-PROBLEM
94208	respiratory	i-PROBLEM
94209	distress	i-PROBLEM
94210	overnight	b-DURATION
94211	and	O
94212	was	O
94213	started	O
94214	on	O
94215	iv	b-TREATMENT
94216	solu-medrol	i-TREATMENT
94217	and	O
94218	more	b-TREATMENT
94219	frequent	i-TREATMENT
94220	nebulizers	i-TREATMENT
94221	for	O
94222	copd	b-PROBLEM
94223	.	O
94224	he	O
94225	was	O
94226	also	O
94227	started	O
94228	on	O
94229	antibiotics	b-TREATMENT
94230	for	O
94231	possible	O
94232	bronchitis	b-PROBLEM
94233	or	O
94234	community-acquired	b-PROBLEM
94235	pneumonia	i-PROBLEM
94236	.	O
94237	given	O
94238	his	b-PROBLEM
94239	tenuous	i-PROBLEM
94240	respiratory	i-PROBLEM
94241	status	i-PROBLEM
94242	,	O
94243	he	O
94244	was	O
94245	transferred	b-OCCURRENCE
94246	to	O
94247	the	b-CLINICAL_DEPT
94248	ficu	i-CLINICAL_DEPT
94249	with	O
94250	closer	b-TEST
94251	observation	i-TEST
94252	.	O
94253	he	O
94254	did	O
94255	not	O
94256	require	O
94257	intubation	b-TREATMENT
94258	and	O
94259	improved	b-OCCURRENCE
94260	with	O
94261	q.	b-FREQUENCY
94262	two	i-FREQUENCY
94263	hour	i-FREQUENCY
94264	nebulizers	b-TREATMENT
94265	and	O
94266	chest	b-TREATMENT
94267	pt	i-TREATMENT
94268	.	O
94269	he	O
94270	was	O
94271	again	O
94272	transferred	b-OCCURRENCE
94273	to	O
94274	the	b-CLINICAL_DEPT
94275	cmed	i-CLINICAL_DEPT
94276	service	i-CLINICAL_DEPT
94277	for	O
94278	further	b-TREATMENT
94279	management	i-TREATMENT
94280	of	O
94281	his	b-PROBLEM
94282	copd	i-PROBLEM
94283	exacerbation	i-PROBLEM
94284	.	O
94285	he	O
94286	was	O
94287	continued	O
94288	on	O
94289	p.o.	b-TREATMENT
94290	prednisone	i-TREATMENT
94291	and	O
94292	frequent	b-TREATMENT
94293	nebulizers	i-TREATMENT
94294	for	O
94295	copd	b-PROBLEM
94296	.	O
94297	he	O
94298	was	O
94299	evaluated	b-TEST
94300	by	O
94301	the	O
94302	physical	O
94303	therapist	O
94304	in	O
94305	the	O
94306	hospital	O
94307	and	O
94308	was	O
94309	found	O
94310	to	O
94311	desaturate	b-PROBLEM
94312	to	O
94313	84%	O
94314	with	O
94315	ambulating	b-OCCURRENCE
94316	on	O
94317	room	b-TREATMENT
94318	air	i-TREATMENT
94319	.	O
94320	therefore	O
94321	,	O
94322	home	b-TREATMENT
94323	02	i-TREATMENT
94324	was	O
94325	recommended	O
94326	on	O
94327	discharge	b-OCCURRENCE
94328	.	O
94329		O
94330		O
94331	admission	b-OCCURRENCE
94332	date	O
94333	:	O
94334	05/29/2000	b-ADMISSION
94335	discharge	b-OCCURRENCE
94336	date	O
94337	:	O
94338	05/30/2000	b-DISCHARGE
94339	history	O
94340	of	O
94341	present	O
94342	illness	O
94343	:	O
94344	the	O
94345	patient	O
94346	is	O
94347	a	O
94348	51	O
94349	year-old	O
94350	female	O
94351	,	O
94352	with	O
94353	a	b-PROBLEM
94354	non-toxic	i-PROBLEM
94355	multinodular	i-PROBLEM
94356	goiter	i-PROBLEM
94357	.	O
94358	she	O
94359	has	O
94360	developed	O
94361	symptoms	b-PROBLEM
94362	from	O
94363	a	b-PROBLEM
94364	right	i-PROBLEM
94365	lower	i-PROBLEM
94366	dominant	i-PROBLEM
94367	nodule	i-PROBLEM
94368	with	O
94369	pressure	b-PROBLEM
94370	discomfort	i-PROBLEM
94371	in	i-PROBLEM
94372	the	i-PROBLEM
94373	neck	i-PROBLEM
94374	.	O
94375	she	O
94376	has	O
94377	no	O
94378	dyspnea	b-PROBLEM
94379	or	O
94380	dysphagia	b-PROBLEM
94381	.	O
94382	she	O
94383	is	O
94384	euthyroid	b-OCCURRENCE
94385	.	O
94386	there	O
94387	is	O
94388	no	O
94389	family	b-OCCURRENCE
94390	history	i-OCCURRENCE
94391	of	i-OCCURRENCE
94392	thyroid	i-OCCURRENCE
94393	cancer	i-OCCURRENCE
94394	.	O
94395	she	O
94396	has	O
94397	not	O
94398	received	O
94399	prior	b-TREATMENT
94400	radiation	i-TREATMENT
94401	exposure	i-TREATMENT
94402	.	O
94403	hospital	O
94404	course	O
94405	:	O
94406	on	O
94407	5-29-00	b-DATE
94408	,	O
94409	she	O
94410	underwent	O
94411	thyroidectomy	b-TREATMENT
94412	with	O
94413	removal	b-TREATMENT
94414	of	O
94415	a	O
94416	3.3	O
94417	centimeter	O
94418	right	O
94419	lobe	O
94420	microfollicular	b-PROBLEM
94421	adenoma	i-PROBLEM
94422	and	O
94423	left	O
94424	lobe	O
94425	6	O
94426	mm	O
94427	.	O
94428	papillary	b-PROBLEM
94429	carcinoma	i-PROBLEM
94430	.	O
94431	there	O
94432	was	O
94433	no	O
94434	evidence	b-EVIDENTIAL
94435	of	O
94436	any	O
94437	middle	b-OCCURRENCE
94438	compartment	i-OCCURRENCE
94439	lymphadenopathy	i-OCCURRENCE
94440	or	O
94441	spread	b-PROBLEM
94442	of	O
94443	the	b-PROBLEM
94444	tumor	i-PROBLEM
94445	outside	O
94446	the	O
94447	thyroid	O
94448	.	O
94449	she	O
94450	had	O
94451	an	b-OCCURRENCE
94452	uncomplicated	i-OCCURRENCE
94453	postoperative	O
94454	recovery	b-OCCURRENCE
94455	period	i-OCCURRENCE
94456	.	O
94457	her	b-TREATMENT
94458	sutures	i-TREATMENT
94459	were	O
94460	removed	O
94461	on	O
94462	postoperative	b-DATE
94463	day	i-DATE
94464	#	i-DATE
94465	one	i-DATE
94466	,	O
94467	at	O
94468	which	O
94469	time	b-DATE
94470	she	O
94471	went	O
94472	home	b-OCCURRENCE
94473	in	O
94474	satisfactory	b-OCCURRENCE
94475	condition	i-OCCURRENCE
94476	.	O
94477		O
94478	admission	b-OCCURRENCE
94479	date	O
94480	:	O
94481	2017-08-14	b-ADMISSION
94482	discharge	b-OCCURRENCE
94483	date	O
94484	:	O
94485	2017-08-23	b-DISCHARGE
94486	service	O
94487	:	O
94488	medicine	O
94489	history	O
94490	of	O
94491	present	O
94492	illness	O
94493	:	O
94494	mr.	O
94495	lockley	O
94496	is	O
94497	a	O
94498	73	O
94499	yo	O
94500	male	O
94501	with	O
94502	a	O
94503	complicated	O
94504	past	O
94505	medical	O
94506	history	O
94507	,	O
94508	recently	O
94509	discharged	b-OCCURRENCE
94510	from	O
94511	st.	b-CLINICAL_DEPT
94512	margaret	i-CLINICAL_DEPT
94513	's	i-CLINICAL_DEPT
94514	center	i-CLINICAL_DEPT
94515	for	i-CLINICAL_DEPT
94516	women	i-CLINICAL_DEPT
94517	&	i-CLINICAL_DEPT
94518	infants	i-CLINICAL_DEPT
94519	on	O
94520	08-02	b-DATE
94521	following	O
94522	a	b-OCCURRENCE
94523	prolonged	i-OCCURRENCE
94524	admission	i-OCCURRENCE
94525	for	O
94526	stemi	b-PROBLEM
94527	,	O
94528	respiratory	b-PROBLEM
94529	failure	i-PROBLEM
94530	felt	O
94531	secondary	O
94532	to	O
94533	pulmonary	b-PROBLEM
94534	edema	i-PROBLEM
94535	requiring	O
94536	intubation	b-TREATMENT
94537	and	O
94538	subsequent	O
94539	tracheostomy	b-TREATMENT
94540	02-22	b-DATE
94541	failure	b-PROBLEM
94542	to	i-PROBLEM
94543	wean	i-PROBLEM
94544	,	O
94545	sepsis	b-PROBLEM
94546	and	O
94547	c.difficile	b-PROBLEM
94548	colitis	i-PROBLEM
94549	treated	O
94550	with	O
94551	vancomycin	b-TREATMENT
94552	and	O
94553	flagyl	b-TREATMENT
94554	with	O
94555	a	O
94556	course	O
94557	of	O
94558	levophed	b-TREATMENT
94559	.	O
94560	he	O
94561	was	O
94562	discharged	b-OCCURRENCE
94563	to	O
94564	athol	b-CLINICAL_DEPT
94565	memorial	i-CLINICAL_DEPT
94566	hospital	i-CLINICAL_DEPT
94567	for	O
94568	continued	b-TREATMENT
94569	weaning	i-TREATMENT
94570	.	O
94571	per	O
94572	doctor	O
94573	john	O
94574	c.	O
94575	corrigan	b-CLINICAL_DEPT
94576	mental	i-CLINICAL_DEPT
94577	health	i-CLINICAL_DEPT
94578	center	i-CLINICAL_DEPT
94579	,	O
94580	patient	O
94581	remained	O
94582	ventilator	b-PROBLEM
94583	dependent	i-PROBLEM
94584	,	O
94585	intermittently	O
94586	on	O
94587	ps	b-TREATMENT
94588	20/5	O
94589	and	O
94590	back	O
94591	on	O
94592	ac	b-TREATMENT
94593	15/5/500/0.35	O
94594	on	O
94595	08-08	b-DATE
94596	.	O
94597	at	O
94598	osh	b-CLINICAL_DEPT
94599	,	O
94600	sputum	b-TEST
94601	cultures	i-TEST
94602	grew	O
94603	pseudomonas	b-PROBLEM
94604	and	O
94605	mrsa	b-PROBLEM
94606	,	O
94607	and	O
94608	he	O
94609	was	O
94610	restarted	O
94611	on	O
94612	zosyn	b-TREATMENT
94613	(	O
94614	08-08	b-DATE
94615	)	O
94616	and	O
94617	vancomycin	b-TREATMENT
94618	(	O
94619	08-09	b-DATE
94620	).	O
94621	he	O
94622	completed	O
94623	his	O
94624	course	O
94625	of	O
94626	vancomycin	b-TREATMENT
94627	on	O
94628	2017-08-10	b-DATE
94629	.	O
94630	however	O
94631	,	O
94632	today	b-TIME
94633	around	i-TIME
94634	17:45	i-TIME
94635	,	O
94636	while	O
94637	being	O
94638	moved	O
94639	by	O
94640	the	O
94641	nursing	O
94642	staff	O
94643	,	O
94644	mr.	O
94645	lockley	O
94646	bosche	O
94647	started	O
94648	coughing	b-PROBLEM
94649	.	O
94650	suctioned	b-TREATMENT
94651	x	b-FREQUENCY
94652	1	i-FREQUENCY
94653	,	O
94654	mucus	b-PROBLEM
94655	not	O
94656	cleared	b-OCCURRENCE
94657	.	O
94658	he	O
94659	then	O
94660	became	O
94661	dusky	b-PROBLEM
94662	and	O
94663	cyanotic	b-PROBLEM
94664	,	O
94665	and	O
94666	stopped	b-PROBLEM
94667	breathing	i-PROBLEM
94668	on	O
94669	his	O
94670	own	O
94671	.	O
94672	a	b-PROBLEM
94673	code	i-PROBLEM
94674	was	O
94675	called	O
94676	,	O
94677	+	O
94678	pulse	b-TREATMENT
94679	.	O
94680	patient	O
94681	placed	O
94682	on	O
94683	fio2	b-TREATMENT
94684	100%	O
94685	.	O
94686	vitals	b-TEST
94687	reportedly	O
94688	hr	b-TEST
94689	88-98	O
94690	,	O
94691	bp	b-TEST
94692	150/80	O
94693	.	O
94694	abg	b-TEST
94695	done	O
94696	on	O
94697	fio2	b-TREATMENT
94698	100%	O
94699	7.36/66/417/98%	O
94700	.	O
94701	at	O
94702	vencor	b-CLINICAL_DEPT
94703	hospital	i-CLINICAL_DEPT
94704	,	O
94705	bp	b-PROBLEM
94706	dropped	i-PROBLEM
94707	to	O
94708	90	O
94709	,	O
94710	and	O
94711	patient	O
94712	was	O
94713	started	O
94714	on	O
94715	ns	b-TREATMENT
94716	ivf	i-TREATMENT
94717	,	O
94718	with	O
94719	improvement	b-OCCURRENCE
94720	in	O
94721	bp	b-TREATMENT
94722	.	O
94723	ekg	b-TEST
94724	without	O
94725	acute	b-PROBLEM
94726	changes	i-PROBLEM
94727	.	O
94728	he	O
94729	was	O
94730	transferred	b-OCCURRENCE
94731	to	O
94732	st.	b-CLINICAL_DEPT
94733	margaret	i-CLINICAL_DEPT
94734	's	i-CLINICAL_DEPT
94735	center	i-CLINICAL_DEPT
94736	for	i-CLINICAL_DEPT
94737	women	i-CLINICAL_DEPT
94738	&	i-CLINICAL_DEPT
94739	infants	i-CLINICAL_DEPT
94740	john	i-CLINICAL_DEPT
94741	for	O
94742	further	b-TREATMENT
94743	management	i-TREATMENT
94744	on	O
94745	ac	b-TREATMENT
94746	,	O
94747	rr	b-TREATMENT
94748	15	O
94749	,	O
94750	peep	b-TREATMENT
94751	5	O
94752	,	O
94753	vt	b-TREATMENT
94754	500	O
94755	,	O
94756	fi02	b-TREATMENT
94757	1.0	O
94758	.	O
94759	in	O
94760	john	b-CLINICAL_DEPT
94761	,	O
94762	bp	b-TEST
94763	80/60	O
94764	,	O
94765	hr	b-TEST
94766	80	O
94767	.	O
94768	continued	O
94769	on	O
94770	ivf	b-TREATMENT
94771	(	O
94772	received	O
94773	total	O
94774	2300	O
94775	cc	O
94776	)	O
94777	,	O
94778	with	O
94779	improved	O
94780	bp	b-TEST
94781	to	O
94782	sbp	b-TEST
94783	105-118	O
94784	.	O
94785	stool	b-TEST
94786	sent	O
94787	for	O
94788	c.diff	b-PROBLEM
94789	and	O
94790	given	O
94791	flagyl	b-TREATMENT
94792	500	O
94793	mg	O
94794	po	O
94795	x	b-FREQUENCY
94796	1	i-FREQUENCY
94797	dose	O
94798	.	O
94799	brief	O
94800	hospital	O
94801	course	O
94802	:	O
94803	mr.	O
94804	lockley	O
94805	was	O
94806	admitted	b-OCCURRENCE
94807	with	O
94808	respiratory	b-PROBLEM
94809	failure	i-PROBLEM
94810	,	O
94811	thought	O
94812	to	O
94813	be	O
94814	related	O
94815	to	O
94816	mucus	b-PROBLEM
94817	plugging	i-PROBLEM
94818	as	O
94819	well	O
94820	as	O
94821	a	b-PROBLEM
94822	pseudomonal	i-PROBLEM
94823	pneumonia	i-PROBLEM
94824	.	O
94825	both	O
94826	of	O
94827	these	O
94828	etiologies	O
94829	were	O
94830	treated	b-TREATMENT
94831	,	O
94832	and	O
94833	he	O
94834	continued	O
94835	to	O
94836	oxygenate	b-OCCURRENCE
94837	and	O
94838	ventilate	b-OCCURRENCE
94839	well	O
94840	on	O
94841	his	b-TREATMENT
94842	usual	i-TREATMENT
94843	ventilator	i-TREATMENT
94844	settings	i-TREATMENT
94845	.	O
94846	however	O
94847	,	O
94848	the	O
94849	issue	O
94850	that	O
94851	dominated	O
94852	the	b-OCCURRENCE
94853	admission	i-OCCURRENCE
94854	was	O
94855	his	O
94856	recent	O
94857	acute	b-PROBLEM
94858	decline	i-PROBLEM
94859	in	i-PROBLEM
94860	mental	i-PROBLEM
94861	status	i-PROBLEM
94862	.	O
94863	he	O
94864	was	O
94865	thoroughly	O
94866	evaluated	b-TEST
94867	by	O
94868	neurology	b-CLINICAL_DEPT
94869	and	O
94870	underwent	O
94871	head	b-TEST
94872	ct	i-TEST
94873	,	O
94874	mri	b-TEST
94875	,	O
94876	lp	b-TEST
94877	,	O
94878	and	O
94879	eeg	b-TEST
94880	.	O
94881	this	b-TEST
94882	work-up	i-TEST
94883	demonstrated	b-EVIDENTIAL
94884	a	b-PROBLEM
94885	small	i-PROBLEM
94886	left	i-PROBLEM
94887	basal	i-PROBLEM
94888	ganglia	i-PROBLEM
94889	infarct	i-PROBLEM
94890	,	O
94891	likely	O
94892	cardioembolic	b-PROBLEM
94893	.	O
94894	however	O
94895	,	O
94896	they	O
94897	felt	O
94898	this	b-PROBLEM
94899	event	i-PROBLEM
94900	could	O
94901	not	O
94902	account	b-OCCURRENCE
94903	for	i-OCCURRENCE
94904	his	O
94905	new	O
94906	,	O
94907	severe	b-PROBLEM
94908	global	i-PROBLEM
94909	deficit	i-PROBLEM
94910	;	O
94911	this	O
94912	was	O
94913	thought	O
94914	to	O
94915	be	O
94916	secondary	O
94917	to	O
94918	a	b-PROBLEM
94919	more	i-PROBLEM
94920	pervasive	i-PROBLEM
94921	process	i-PROBLEM
94922	,	O
94923	likely	O
94924	anoxic	b-PROBLEM
94925	encephalopathy	i-PROBLEM
94926	,	O
94927	for	O
94928	which	O
94929	the	b-OCCURRENCE
94930	prognosis	i-OCCURRENCE
94931	is	O
94932	extremely	b-OCCURRENCE
94933	grim	i-OCCURRENCE
94934	.	O
94935	this	O
94936	was	O
94937	discussed	b-OCCURRENCE
94938	at	O
94939	length	O
94940	in	O
94941	several	O
94942	family	b-OCCURRENCE
94943	meetings	i-OCCURRENCE
94944	involving	O
94945	the	O
94946	patient	O
94947	's	O
94948	wife	O
94949	,	O
94950	son	O
94951	,	O
94952	primary	O
94953	care	O
94954	doctor	O
94955	,	O
94956	icu	O
94957	attending	O
94958	,	O
94959	and	O
94960	neurology	O
94961	consultant	O
94962	in	O
94963	the	O
94964	presence	O
94965	of	O
94966	a	O
94967	asian	O
94968	interpreter	O
94969	.	O
94970	the	O
94971	end	O
94972	result	O
94973	of	O
94974	these	O
94975	discussion	O
94976	was	O
94977	that	O
94978	the	b-OCCURRENCE
94979	patient	i-OCCURRENCE
94980	's	i-OCCURRENCE
94981	wishes	i-OCCURRENCE
94982	would	O
94983	not	O
94984	be	O
94985	consistent	O
94986	with	O
94987	this	O
94988	new	O
94989	level	b-OCCURRENCE
94990	of	i-OCCURRENCE
94991	functioning	i-OCCURRENCE
94992	from	O
94993	which	O
94994	he	O
94995	had	O
94996	little	O
94997	hope	b-OCCURRENCE
94998	of	O
94999	recovery	b-OCCURRENCE
95000	;	O
95001	the	O
95002	family	O
95003	decided	O
95004	to	O
95005	make	O
95006	him	O
95007	comfort	b-TREATMENT
95008	measures	i-TREATMENT
95009	only	i-TREATMENT
95010	.	O
95011	he	O
95012	was	O
95013	disconnected	O
95014	from	O
95015	the	b-TREATMENT
95016	ventilator	i-TREATMENT
95017	and	O
95018	all	b-TREATMENT
95019	medications	i-TREATMENT
95020	beyond	O
95021	a	b-TREATMENT
95022	morphine	i-TREATMENT
95023	drip	i-TREATMENT
95024	were	O
95025	stopped	O
95026	,	O
95027	and	O
95028	he	O
95029	expired	b-OCCURRENCE
95030	shortly	O
95031	thereafter	O
95032	.	O
95033	the	O
95034	family	O
95035	was	O
95036	present	O
95037	.	O
95038		O
95039	admission	b-OCCURRENCE
95040	date	O
95041	:	O
95042	02/10/1998	b-ADMISSION
95043	discharge	b-OCCURRENCE
95044	date	O
95045	:	O
95046	02/26/1998	b-DISCHARGE
95047	history	O
95048	of	O
95049	present	O
95050	illness	O
95051	:	O
95052	the	O
95053	patient	O
95054	is	O
95055	a	O
95056	69	O
95057	year-old	O
95058	white	O
95059	gentleman	O
95060	who	O
95061	is	O
95062	status	O
95063	post	O
95064	a	b-TREATMENT
95065	coronary	i-TREATMENT
95066	artery	i-TREATMENT
95067	bypass	i-TREATMENT
95068	graft	i-TREATMENT
95069	in	O
95070	1985	b-DATE
95071	with	O
95072	a	b-PROBLEM
95073	large	i-PROBLEM
95074	anterior	i-PROBLEM
95075	septal	i-PROBLEM
95076	myocardial	i-PROBLEM
95077	infarction	i-PROBLEM
95078	intraoperatively	O
95079	.	O
95080	two	b-DURATION
95081	years	i-DURATION
95082	after	O
95083	this	b-TREATMENT
95084	operation	i-TREATMENT
95085	,	O
95086	he	O
95087	required	O
95088	a	b-TREATMENT
95089	pacer	i-TREATMENT
95090	implantation	i-TREATMENT
95091	for	O
95092	sick	b-PROBLEM
95093	sinus	i-PROBLEM
95094	syndrome	i-PROBLEM
95095	.	O
95096	the	O
95097	patient	O
95098	presents	b-OCCURRENCE
95099	now	O
95100	with	O
95101	progressive	b-PROBLEM
95102	dyspnea	i-PROBLEM
95103	,	O
95104	but	O
95105	no	O
95106	anginal	b-PROBLEM
95107	pain	i-PROBLEM
95108	.	O
95109	ejection	b-TEST
95110	fraction	i-TEST
95111	was	O
95112	noted	b-EVIDENTIAL
95113	to	O
95114	be	O
95115	20%	O
95116	.	O
95117	he	O
95118	is	O
95119	status	O
95120	post	O
95121	multiple	b-TREATMENT
95122	angioplasty	i-TREATMENT
95123	stents	i-TREATMENT
95124	.	O
95125	he	O
95126	presents	b-OCCURRENCE
95127	now	O
95128	for	O
95129	possible	O
95130	reoperative	b-TREATMENT
95131	coronary	i-TREATMENT
95132	artery	i-TREATMENT
95133	bypass	i-TREATMENT
95134	graft	i-TREATMENT
95135	.	O
95136	hospital	O
95137	course	O
95138	:	O
95139	the	O
95140	patient	O
95141	was	O
95142	admitted	b-OCCURRENCE
95143	to	O
95144	the	b-CLINICAL_DEPT
95145	verg	i-CLINICAL_DEPT
95146	medical	i-CLINICAL_DEPT
95147	center	i-CLINICAL_DEPT
95148	.	O
95149	subsequent	b-TEST
95150	exercise	i-TEST
95151	treadmill	i-TEST
95152	test	i-TEST
95153	demonstrated	b-EVIDENTIAL
95154	no	O
95155	evidence	O
95156	of	O
95157	ischemia	b-PROBLEM
95158	by	O
95159	ekg	b-TEST
95160	.	O
95161	the	O
95162	patient	O
95163	was	O
95164	subsequently	O
95165	taken	O
95166	to	O
95167	the	b-CLINICAL_DEPT
95168	operating	i-CLINICAL_DEPT
95169	room	i-CLINICAL_DEPT
95170	where	O
95171	he	O
95172	underwent	O
95173	a	b-TREATMENT
95174	reoperative	i-TREATMENT
95175	coronary	i-TREATMENT
95176	artery	i-TREATMENT
95177	bypass	i-TREATMENT
95178	graft	i-TREATMENT
95179	times	i-TREATMENT
95180	three	i-TREATMENT
95181	with	O
95182	a	b-TREATMENT
95183	subaortic	i-TREATMENT
95184	proximal	i-TREATMENT
95185	graft	i-TREATMENT
95186	from	O
95187	the	O
95188	aorta	O
95189	to	O
95190	the	O
95191	om1	O
95192	and	O
95193	then	O
95194	om2	O
95195	and	O
95196	aorta	O
95197	to	O
95198	the	O
95199	lad	O
95200	with	O
95201	a	b-TREATMENT
95202	wide	i-TREATMENT
95203	graft	i-TREATMENT
95204	per	O
95205	doctor	O
95206	lumar	O
95207	jongguild	O
95208	.	O
95209	postoperatively	O
95210	,	O
95211	the	O
95212	patient	O
95213	was	O
95214	ventilated	b-TREATMENT
95215	.	O
95216	the	O
95217	patient	O
95218	was	O
95219	weaned	b-OCCURRENCE
95220	off	O
95221	an	b-TREATMENT
95222	epinephrine	i-TREATMENT
95223	drip	i-TREATMENT
95224	.	O
95225	rhythm	b-TEST
95226	became	O
95227	more	b-OCCURRENCE
95228	stable	i-OCCURRENCE
95229	.	O
95230	balloon	b-TREATMENT
95231	was	O
95232	weaned	b-OCCURRENCE
95233	and	O
95234	finally	O
95235	discontinued	O
95236	.	O
95237	the	O
95238	patient	O
95239	was	O
95240	extubated	b-TREATMENT
95241	.	O
95242	his	b-TREATMENT
95243	melranon	i-TREATMENT
95244	was	O
95245	weaned	b-OCCURRENCE
95246	off	O
95247	and	O
95248	his	b-TREATMENT
95249	ace	i-TREATMENT
95250	inhibitor	i-TREATMENT
95251	began	O
95252	.	O
95253	the	O
95254	patient	O
95255	was	O
95256	started	O
95257	on	O
95258	amiodarone	b-TREATMENT
95259	and	O
95260	diuresed	b-TREATMENT
95261	.	O
95262	the	O
95263	patient	O
95264	&apos;s	O
95265	lower	O
95266	extremities	O
95267	began	O
95268	to	O
95269	swell	b-PROBLEM
95270	and	O
95271	the	O
95272	patient	O
95273	was	O
95274	begun	O
95275	on	O
95276	hirudin	b-TREATMENT
95277	for	O
95278	deep	b-PROBLEM
95279	venous	i-PROBLEM
95280	thrombosis	i-PROBLEM
95281	.	O
95282	the	b-PROBLEM
95283	patient	i-PROBLEM
95284	&apos;s	i-PROBLEM
95285	heparin	i-PROBLEM
95286	induced	i-PROBLEM
95287	thrombocytopenia	i-PROBLEM
95288	became	O
95289	positive	O
95290	and	O
95291	so	O
95292	he	O
95293	is	O
95294	allergic	b-PROBLEM
95295	to	O
95296	heparin	b-TREATMENT
95297	.	O
95298	the	O
95299	patient	O
95300	was	O
95301	begun	O
95302	on	O
95303	coumadin	b-TREATMENT
95304	and	O
95305	he	O
95306	stayed	O
95307	several	b-DURATION
95308	days	i-DURATION
95309	for	O
95310	coumadinization	b-TREATMENT
95311	and	O
95312	was	O
95313	finally	O
95314	discharged	b-OCCURRENCE
95315	on	O
95316	therapeutic	b-TREATMENT
95317	coumadin	i-TREATMENT
95318	.	O
95319	the	O
95320	patient	O
95321	tolerated	O
95322	a	b-OCCURRENCE
95323	regular	i-OCCURRENCE
95324	diet	i-OCCURRENCE
95325	on	O
95326	postoperative	O
95327	day	b-DATE
95328	number	i-DATE
95329	thirteen	i-DATE
95330	from	O
95331	his	b-TREATMENT
95332	reoperative	i-TREATMENT
95333	coronary	i-TREATMENT
95334	artery	i-TREATMENT
95335	bypass	i-TREATMENT
95336	graft	i-TREATMENT
95337	.	O
95338		O
95339	admission	b-OCCURRENCE
95340	date	O
95341	:	O
95342	08/31/1992	b-ADMISSION
95343	discharge	b-OCCURRENCE
95344	date	O
95345	:	O
95346	09/07/1992	b-DISCHARGE
95347	history	O
95348	of	O
95349	present	O
95350	illness	O
95351	:	O
95352	the	O
95353	patient	O
95354	is	O
95355	a	O
95356	37-year-old	O
95357	white	O
95358	male	O
95359	with	O
95360	aids	b-PROBLEM
95361	complicated	O
95362	by	O
95363	recurrent	b-PROBLEM
95364	pseudomonas	i-PROBLEM
95365	infections	i-PROBLEM
95366	presently	O
95367	on	O
95368	ceftazidime	b-TREATMENT
95369	and	O
95370	aztrenam	b-TREATMENT
95371	complicated	O
95372	by	O
95373	mai	b-PROBLEM
95374	who	O
95375	comes	b-OCCURRENCE
95376	in	i-OCCURRENCE
95377	with	O
95378	fever	b-PROBLEM
95379	,	O
95380	chills	b-PROBLEM
95381	and	O
95382	blood	b-TEST
95383	cultures	i-TEST
95384	positive	O
95385	for	O
95386	candida	b-PROBLEM
95387	species	i-PROBLEM
95388	.	O
95389	the	O
95390	patient	O
95391	has	O
95392	multiple	b-PROBLEM
95393	aids	i-PROBLEM
95394	illnesses	i-PROBLEM
95395	including	O
95396	mai	b-PROBLEM
95397	who	O
95398	has	O
95399	multiple	b-OCCURRENCE
95400	admissions	i-OCCURRENCE
95401	for	O
95402	pseudomonas	b-PROBLEM
95403	pneumonia	i-PROBLEM
95404	.	O
95405	his	b-OCCURRENCE
95406	most	i-OCCURRENCE
95407	recent	i-OCCURRENCE
95408	admission	i-OCCURRENCE
95409	was	O
95410	on	O
95411	08/23/92	b-DATE
95412	to	O
95413	08/25/92	b-DATE
95414	with	O
95415	fever	b-PROBLEM
95416	and	O
95417	chills	b-PROBLEM
95418	.	O
95419	he	O
95420	was	O
95421	again	O
95422	treated	O
95423	with	O
95424	iv	b-TREATMENT
95425	ceftazidime	i-TREATMENT
95426	for	O
95427	presumed	O
95428	pseudomonal	b-PROBLEM
95429	pneumonia	i-PROBLEM
95430	and	O
95431	discharged	b-OCCURRENCE
95432	home	O
95433	on	O
95434	iv	b-TREATMENT
95435	antibiotics	i-TREATMENT
95436	which	O
95437	he	O
95438	is	O
95439	presently	O
95440	on	O
95441	.	O
95442	the	O
95443	patient	O
95444	did	O
95445	well	b-OCCURRENCE
95446	at	O
95447	home	O
95448	with	O
95449	decreasing	O
95450	fever	b-PROBLEM
95451	and	O
95452	good	b-OCCURRENCE
95453	appetite	i-OCCURRENCE
95454	until	O
95455	the	b-TIME
95456	night	i-TIME
95457	prior	i-TIME
95458	to	i-TIME
95459	admission	i-TIME
95460	when	O
95461	he	O
95462	developed	O
95463	fever	b-PROBLEM
95464	and	O
95465	chills	b-PROBLEM
95466	.	O
95467	concurrent	b-TEST
95468	blood	i-TEST
95469	cultures	i-TEST
95470	grew	O
95471	out	O
95472	candida	b-PROBLEM
95473	species	i-PROBLEM
95474	at	O
95475	hchp	b-CLINICAL_DEPT
95476	.	O
95477	the	b-TEST
95478	patient	i-TEST
95479	&apos;s	i-TEST
95480	baseline	i-TEST
95481	o2	i-TEST
95482	saturation	i-TEST
95483	is	O
95484	92%	O
95485	on	O
95486	three	b-TREATMENT
95487	liters	i-TREATMENT
95488	.	O
95489	he	O
95490	has	O
95491	a	b-TREATMENT
95492	left	i-TREATMENT
95493	arm	i-TREATMENT
95494	graft	i-TREATMENT
95495	placed	O
95496	for	O
95497	access	O
95498	three	b-DURATION
95499	weeks	i-DURATION
95500	ago	O
95501	which	O
95502	is	O
95503	used	O
95504	for	O
95505	blood	b-TREATMENT
95506	drawing	i-TREATMENT
95507	and	O
95508	iv	b-TREATMENT
95509	medications	i-TREATMENT
95510	.	O
95511	he	O
95512	notes	b-EVIDENTIAL
95513	no	O
95514	tenderness	b-PROBLEM
95515	,	O
95516	erythema	b-PROBLEM
95517	,	O
95518	warmth	b-PROBLEM
95519	or	O
95520	exudate	b-PROBLEM
95521	from	O
95522	the	b-TREATMENT
95523	passport	i-TREATMENT
95524	site	i-TREATMENT
95525	.	O
95526	medications	b-TREATMENT
95527	at	O
95528	the	b-DATE
95529	time	i-DATE
95530	of	i-DATE
95531	admission	i-DATE
95532	include	O
95533	dapsone	b-TREATMENT
95534	50	O
95535	mg	O
95536	p.o.	b-FREQUENCY
95537	on	i-FREQUENCY
95538	monday	i-FREQUENCY
95539	,	i-FREQUENCY
95540	wednesday	i-FREQUENCY
95541	and	i-FREQUENCY
95542	friday	i-FREQUENCY
95543	,	O
95544	ceftazidime	b-TREATMENT
95545	1	O
95546	gram	O
95547	iv	O
95548	q.	b-FREQUENCY
95549	8	i-FREQUENCY
95550	hours	i-FREQUENCY
95551	,	O
95552	cipro	b-TREATMENT
95553	750	O
95554	mg	O
95555	p.o.	O
95556	b.i.d.	b-FREQUENCY
95557	,	O
95558	acyclovir	b-TREATMENT
95559	400	O
95560	mg	O
95561	p.o.	O
95562	q.	b-FREQUENCY
95563	day	i-FREQUENCY
95564	,	O
95565	megastrol	b-TREATMENT
95566	80	O
95567	mg	O
95568	p.o.	O
95569	t.i.d.	b-FREQUENCY
95570	and	O
95571	g-csf	b-TREATMENT
95572	150	O
95573	micrograms	O
95574	subcu	O
95575	b.i.d.	b-FREQUENCY
95576	hospital	O
95577	course	O
95578	:	O
95579	by	O
95580	problems	O
95581	:	O
95582	1.	O
95583	infectious	b-PROBLEM
95584	disease	i-PROBLEM
95585	.	O
95586	the	O
95587	patient	O
95588	was	O
95589	started	O
95590	on	O
95591	amphotericine	b-TREATMENT
95592	at	O
95593	.6	O
95594	mg	O
95595	/	O
95596	kg	O
95597	for	O
95598	a	O
95599	total	O
95600	of	O
95601	250	O
95602	mg	O
95603	for	O
95604	positive	b-PROBLEM
95605	blood	i-PROBLEM
95606	cultures	i-PROBLEM
95607	for	O
95608	candida	b-PROBLEM
95609	.	O
95610	the	b-TREATMENT
95611	passport	i-TREATMENT
95612	in	i-TREATMENT
95613	his	i-TREATMENT
95614	left	i-TREATMENT
95615	arm	i-TREATMENT
95616	was	O
95617	pulled	b-OCCURRENCE
95618	and	O
95619	will	O
95620	be	O
95621	replaced	O
95622	if	O
95623	needed	O
95624	after	O
95625	the	b-TREATMENT
95626	amphotericine	i-TREATMENT
95627	is	O
95628	completed	O
95629	.	O
95630	the	O
95631	patient	O
95632	will	O
95633	continue	O
95634	on	O
95635	his	b-TREATMENT
95636	antibiotics	i-TREATMENT
95637	for	O
95638	pseudomonas	b-PROBLEM
95639	pneumonia	i-PROBLEM
95640	to	O
95641	complete	O
95642	the	b-DURATION
95643	fourteen	i-DURATION
95644	day	i-DURATION
95645	course	O
95646	which	O
95647	was	O
95648	completed	O
95649	on	O
95650	09/06/92	b-DATE
95651	.	O
95652	the	O
95653	patient	O
95654	was	O
95655	continued	O
95656	on	O
95657	his	b-TREATMENT
95658	admission	i-TREATMENT
95659	medications	i-TREATMENT
95660	.	O
95661	2.	O
95662	hematology	O
95663	.	O
95664	the	O
95665	patient	O
95666	was	O
95667	continued	O
95668	on	O
95669	his	b-TREATMENT
95670	g-csf	i-TREATMENT
95671	with	O
95672	an	O
95673	increase	O
95674	in	O
95675	his	b-TEST
95676	white	i-TEST
95677	count	i-TEST
95678	to	O
95679	8	O
95680	from	O
95681	1.8	O
95682	.	O
95683	the	O
95684	patient	O
95685	required	O
95686	multiple	b-TREATMENT
95687	blood	i-TREATMENT
95688	transfusions	i-TREATMENT
95689	for	O
95690	a	b-PROBLEM
95691	low	i-PROBLEM
95692	hematocrit	i-PROBLEM
95693	.	O
95694		O
95695	admission	b-OCCURRENCE
95696	date	O
95697	:	O
95698	01/12/1991	b-ADMISSION
95699	discharge	b-OCCURRENCE
95700	date	O
95701	:	O
95702	01/20/1991	b-DISCHARGE
95703	history	O
95704	of	O
95705	present	O
95706	illness	O
95707	:	O
95708	the	O
95709	patient	O
95710	was	O
95711	in	O
95712	her	O
95713	usual	O
95714	state	O
95715	of	O
95716	excellent	b-OCCURRENCE
95717	health	i-OCCURRENCE
95718	until	O
95719	july	b-DATE
95720	of	i-DATE
95721	1991	i-DATE
95722	when	O
95723	she	O
95724	first	O
95725	noted	O
95726	a	b-PROBLEM
95727	left	i-PROBLEM
95728	clavicular	i-PROBLEM
95729	mass	i-PROBLEM
95730	.	O
95731	subsequently	O
95732	,	O
95733	the	b-PROBLEM
95734	mass	i-PROBLEM
95735	continued	O
95736	to	O
95737	increase	b-OCCURRENCE
95738	in	i-OCCURRENCE
95739	size	i-OCCURRENCE
95740	.	O
95741	on	O
95742	12/23	b-DATE
95743	,	O
95744	she	O
95745	was	O
95746	seen	O
95747	by	O
95748	doctor	O
95749	stonge	O
95750	at	O
95751	bri	b-CLINICAL_DEPT
95752	health	i-CLINICAL_DEPT
95753	where	O
95754	a	b-PROBLEM
95755	3	i-PROBLEM
95756	x	i-PROBLEM
95757	7	i-PROBLEM
95758	cm	i-PROBLEM
95759	left	i-PROBLEM
95760	mid	i-PROBLEM
95761	clavicular	i-PROBLEM
95762	mass	i-PROBLEM
95763	was	O
95764	noted	O
95765	.	O
95766	a	b-TEST
95767	fine	i-TEST
95768	needle	i-TEST
95769	aspirate	i-TEST
95770	of	O
95771	this	b-PROBLEM
95772	mass	i-PROBLEM
95773	reportedly	O
95774	revealed	b-EVIDENTIAL
95775	giant	b-PROBLEM
95776	cell	i-PROBLEM
95777	tumor	i-PROBLEM
95778	.	O
95779	the	O
95780	patient	O
95781	was	O
95782	initially	O
95783	told	O
95784	that	O
95785	this	O
95786	was	O
95787	a	b-PROBLEM
95788	benign	i-PROBLEM
95789	tumor	i-PROBLEM
95790	and	O
95791	that	O
95792	it	O
95793	could	O
95794	simply	O
95795	be	O
95796	watched	b-OCCURRENCE
95797	and	O
95798	definitively	b-TREATMENT
95799	treated	i-TREATMENT
95800	after	O
95801	the	b-OCCURRENCE
95802	delivery	i-OCCURRENCE
95803	of	i-OCCURRENCE
95804	her	i-OCCURRENCE
95805	baby	i-OCCURRENCE
95806	.	O
95807	subsequently	O
95808	,	O
95809	the	b-PROBLEM
95810	mass	i-PROBLEM
95811	progressively	O
95812	increased	b-OCCURRENCE
95813	in	i-OCCURRENCE
95814	size	i-OCCURRENCE
95815	and	O
95816	the	O
95817	patient	O
95818	had	O
95819	developed	O
95820	significant	b-PROBLEM
95821	discomfort	i-PROBLEM
95822	in	i-PROBLEM
95823	this	i-PROBLEM
95824	region	i-PROBLEM
95825	.	O
95826	on	O
95827	1/5	b-DATE
95828	,	O
95829	the	O
95830	patient	O
95831	underwent	O
95832	a	b-TREATMENT
95833	local	i-TREATMENT
95834	tumor	i-TREATMENT
95835	debulking	i-TREATMENT
95836	at	O
95837	bri	b-CLINICAL_DEPT
95838	health	i-CLINICAL_DEPT
95839	under	O
95840	local	b-TREATMENT
95841	anesthesia	i-TREATMENT
95842	.	O
95843	the	b-TEST
95844	pathology	i-TEST
95845	,	O
95846	unfortunately	O
95847	,	O
95848	revealed	b-EVIDENTIAL
95849	an	b-PROBLEM
95850	aggressive	i-PROBLEM
95851	adenocarcinoma	i-PROBLEM
95852	(	O
95853	micropapillary	O
95854	type	O
95855	;	O
95856	mucin	O
95857	producing	O
95858	)	O
95859	.	O
95860	this	O
95861	prompted	O
95862	further	b-TEST
95863	staging	i-TEST
95864	work-up	i-TEST
95865	.	O
95866	the	O
95867	patient	O
95868	subsequently	O
95869	had	O
95870	a	b-TEST
95871	limited	i-TEST
95872	chest	i-TEST
95873	ct	i-TEST
95874	at	O
95875	bri	b-CLINICAL_DEPT
95876	health	i-CLINICAL_DEPT
95877	which	O
95878	showed	b-EVIDENTIAL
95879	diffuse	b-PROBLEM
95880	bilateral	i-PROBLEM
95881	pulmonary	i-PROBLEM
95882	metastases	i-PROBLEM
95883	,	O
95884	metastases	b-PROBLEM
95885	to	i-PROBLEM
95886	the	i-PROBLEM
95887	sternum	i-PROBLEM
95888	,	i-PROBLEM
95889	rib	i-PROBLEM
95890	,	i-PROBLEM
95891	multiple	i-PROBLEM
95892	spinal	i-PROBLEM
95893	levels	i-PROBLEM
95894	;	O
95895	internal	b-PROBLEM
95896	mammary	i-PROBLEM
95897	lymphadenopathy	i-PROBLEM
95898	.	O
95899	the	O
95900	poor	O
95901	prognosis	O
95902	for	O
95903	the	O
95904	patient	O
95905	and	O
95906	child	O
95907	were	O
95908	discussed	O
95909	and	O
95910	after	O
95911	the	O
95912	patient	O
95913	decided	O
95914	to	O
95915	have	O
95916	an	b-TREATMENT
95917	elective	i-TREATMENT
95918	abortion	i-TREATMENT
95919	,	O
95920	an	b-TEST
95921	abdominal	i-TEST
95922	ct	i-TEST
95923	scan	i-TEST
95924	was	O
95925	obtained	O
95926	which	O
95927	revealed	b-EVIDENTIAL
95928	diffuse	b-PROBLEM
95929	metastatic	i-PROBLEM
95930	lesions	i-PROBLEM
95931	of	i-PROBLEM
95932	the	i-PROBLEM
95933	liverspine	i-PROBLEM
95934	,	i-PROBLEM
95935	ribs	i-PROBLEM
95936	and	i-PROBLEM
95937	most	i-PROBLEM
95938	of	i-PROBLEM
95939	the	i-PROBLEM
95940	lymph	i-PROBLEM
95941	nodes	i-PROBLEM
95942	.	O
95943	there	O
95944	was	O
95945	no	O
95946	obvious	b-PROBLEM
95947	gior	i-PROBLEM
95948	pancreatic	i-PROBLEM
95949	tumor	i-PROBLEM
95950	identified	O
95951	.	O
95952	the	O
95953	patient	O
95954	had	O
95955	a	b-PROBLEM
95956	very	i-PROBLEM
95957	firm	i-PROBLEM
95958	nodule	i-PROBLEM
95959	at	O
95960	the	O
95961	vertex	O
95962	of	O
95963	her	O
95964	calvarium	O
95965	.	O
95966	a	O
95967	specimen	O
95968	was	O
95969	obtained	O
95970	by	O
95971	fine	b-TEST
95972	needle	i-TEST
95973	aspiration	i-TEST
95974	and	O
95975	the	b-TEST
95976	pathology	i-TEST
95977	of	O
95978	this	O
95979	was	O
95980	consistent	O
95981	with	O
95982	adenocarcinoma	b-PROBLEM
95983	.	O
95984	the	O
95985	patient	O
95986	was	O
95987	transferred	b-OCCURRENCE
95988	to	O
95989	nimaconwood	b-CLINICAL_DEPT
95990	valley	i-CLINICAL_DEPT
95991	hospital	i-CLINICAL_DEPT
95992	for	O
95993	management	b-TREATMENT
95994	of	O
95995	her	b-PROBLEM
95996	cancer	i-PROBLEM
95997	and	O
95998	termination	b-TREATMENT
95999	of	O
96000	the	b-PROBLEM
96001	pregnancy	i-PROBLEM
96002	.	O
96003	over	O
96004	the	b-DURATION
96005	past	i-DURATION
96006	four	i-DURATION
96007	weeks	i-DURATION
96008	,	O
96009	the	O
96010	patient	O
96011	reported	b-EVIDENTIAL
96012	progressive	b-PROBLEM
96013	shortness	i-PROBLEM
96014	of	i-PROBLEM
96015	breath	i-PROBLEM
96016	and	O
96017	mid	b-PROBLEM
96018	thoracic	i-PROBLEM
96019	back	i-PROBLEM
96020	pain	i-PROBLEM
96021	.	O
96022	she	O
96023	has	O
96024	had	O
96025	no	O
96026	motor	b-PROBLEM
96027	weakness	i-PROBLEM
96028	,	O
96029	abnormal	b-PROBLEM
96030	sensation	i-PROBLEM
96031	,	O
96032	numbness	b-PROBLEM
96033	,	O
96034	tingling	b-PROBLEM
96035	or	O
96036	incontinence	b-PROBLEM
96037	of	i-PROBLEM
96038	bowel	i-PROBLEM
96039	or	i-PROBLEM
96040	bladder	i-PROBLEM
96041	.	O
96042	she	O
96043	denied	b-EVIDENTIAL
96044	fevers	b-PROBLEM
96045	,	O
96046	chills	b-PROBLEM
96047	or	O
96048	sweats	b-PROBLEM
96049	.	O
96050	there	O
96051	has	O
96052	been	O
96053	no	O
96054	gi	b-PROBLEM
96055	or	i-PROBLEM
96056	gu	i-PROBLEM
96057	symptoms	i-PROBLEM
96058	except	O
96059	for	O
96060	constipation	b-PROBLEM
96061	.	O
96062	hospital	O
96063	course	O
96064	:	O
96065	the	O
96066	patient	O
96067	had	O
96068	an	b-TREATMENT
96069	elective	i-TREATMENT
96070	termination	i-TREATMENT
96071	of	O
96072	her	b-OCCURRENCE
96073	pregnancy	i-OCCURRENCE
96074	on	O
96075	1/13/91	b-DATE
96076	.	O
96077	the	b-TEST
96078	work-up	i-TEST
96079	for	O
96080	the	O
96081	extent	O
96082	of	O
96083	the	b-PROBLEM
96084	patient	i-PROBLEM
96085	&apos;s	i-PROBLEM
96086	disease	i-PROBLEM
96087	included	O
96088	mri	b-TEST
96089	scan	i-TEST
96090	of	i-TEST
96091	the	i-TEST
96092	cervical	i-TEST
96093	and	i-TEST
96094	thoracic	i-TEST
96095	spine	i-TEST
96096	which	O
96097	revealed	b-EVIDENTIAL
96098	multiple	b-PROBLEM
96099	metastatic	i-PROBLEM
96100	lesions	i-PROBLEM
96101	in	i-PROBLEM
96102	the	i-PROBLEM
96103	vertebral	i-PROBLEM
96104	bodies	i-PROBLEM
96105	;	O
96106	a	b-PROBLEM
96107	t3	i-PROBLEM
96108	lesion	i-PROBLEM
96109	extending	O
96110	from	O
96111	the	O
96112	body	O
96113	to	O
96114	the	O
96115	right	O
96116	neural	O
96117	for	O
96118	amina	O
96119	with	O
96120	foraminal	b-PROBLEM
96121	obstruction	i-PROBLEM
96122	.	O
96123	an	b-PROBLEM
96124	epidural	i-PROBLEM
96125	mass	i-PROBLEM
96126	was	O
96127	present	O
96128	at	O
96129	t10	O
96130	which	O
96131	was	O
96132	extending	O
96133	from	O
96134	the	O
96135	lamina	O
96136	or	O
96137	spinous	O
96138	process	O
96139	anteriorly	O
96140	and	O
96141	almost	O
96142	compressing	b-PROBLEM
96143	the	i-PROBLEM
96144	spinal	i-PROBLEM
96145	cord	i-PROBLEM
96146	.	O
96147	an	b-TEST
96148	abdominal	i-TEST
96149	and	i-TEST
96150	pelvic	i-TEST
96151	ct	i-TEST
96152	scan	i-TEST
96153	with	i-TEST
96154	iv	i-TEST
96155	contrast	i-TEST
96156	revealed	b-EVIDENTIAL
96157	bilateral	b-PROBLEM
96158	pulmonary	i-PROBLEM
96159	nodules	i-PROBLEM
96160	and	O
96161	bilateral	b-PROBLEM
96162	pleural	i-PROBLEM
96163	effusions	i-PROBLEM
96164	,	O
96165	extensive	b-PROBLEM
96166	liver	i-PROBLEM
96167	metastases	i-PROBLEM
96168	,	O
96169	narrowing	b-PROBLEM
96170	of	i-PROBLEM
96171	the	i-PROBLEM
96172	intra	i-PROBLEM
96173	hepatic	i-PROBLEM
96174	ivc	i-PROBLEM
96175	and	O
96176	distention	b-PROBLEM
96177	of	i-PROBLEM
96178	the	i-PROBLEM
96179	azygous	i-PROBLEM
96180	system	i-PROBLEM
96181	suggestive	O
96182	of	O
96183	ivc	b-PROBLEM
96184	obstruction	i-PROBLEM
96185	by	O
96186	liver	b-PROBLEM
96187	metastases	i-PROBLEM
96188	;	O
96189	ascites	b-PROBLEM
96190	;	O
96191	multiple	b-PROBLEM
96192	bony	i-PROBLEM
96193	metastases	i-PROBLEM
96194	;	O
96195	and	O
96196	an	b-PROBLEM
96197	isolated	i-PROBLEM
96198	splenic	i-PROBLEM
96199	metastases	i-PROBLEM
96200	.	O
96201	a	b-TEST
96202	bone	i-TEST
96203	scan	i-TEST
96204	revealed	b-EVIDENTIAL
96205	increased	b-PROBLEM
96206	uptake	i-PROBLEM
96207	in	i-PROBLEM
96208	the	i-PROBLEM
96209	left	i-PROBLEM
96210	chest	i-PROBLEM
96211	wall	i-PROBLEM
96212	,	i-PROBLEM
96213	left	i-PROBLEM
96214	anterior	i-PROBLEM
96215	ribs	i-PROBLEM
96216	four	i-PROBLEM
96217	to	i-PROBLEM
96218	six	i-PROBLEM
96219	,	O
96220	and	O
96221	increased	b-PROBLEM
96222	uptake	i-PROBLEM
96223	in	i-PROBLEM
96224	the	i-PROBLEM
96225	left	i-PROBLEM
96226	and	i-PROBLEM
96227	right	i-PROBLEM
96228	lateral	i-PROBLEM
96229	skull	i-PROBLEM
96230	in	O
96231	the	O
96232	area	O
96233	of	O
96234	the	O
96235	parotids	O
96236	.	O
96237	ahead	b-TEST
96238	ct	i-TEST
96239	scan	i-TEST
96240	revealed	b-EVIDENTIAL
96241	a	b-PROBLEM
96242	metastatic	i-PROBLEM
96243	lesion	i-PROBLEM
96244	in	O
96245	the	O
96246	right	O
96247	vertex	O
96248	of	O
96249	the	O
96250	calvarium	O
96251	but	O
96252	no	O
96253	intracranial	b-PROBLEM
96254	abnormalities	i-PROBLEM
96255	.	O
96256	work-up	b-TEST
96257	for	O
96258	the	O
96259	source	O
96260	of	O
96261	the	b-PROBLEM
96262	primary	i-PROBLEM
96263	tumor	i-PROBLEM
96264	which	O
96265	is	O
96266	still	O
96267	unknown	O
96268	included	O
96269	a	b-TEST
96270	mammogram	i-TEST
96271	which	O
96272	identified	O
96273	no	O
96274	suspicious	b-PROBLEM
96275	microcalcifications	i-PROBLEM
96276	and	O
96277	no	O
96278	dominant	b-PROBLEM
96279	masses	i-PROBLEM
96280	.	O
96281	the	b-TEST
96282	abdominal	i-TEST
96283	and	i-TEST
96284	pelvic	i-TEST
96285	ct	i-TEST
96286	scans	i-TEST
96287	showed	b-EVIDENTIAL
96288	no	O
96289	suspicious	b-PROBLEM
96290	gi	i-PROBLEM
96291	masses	i-PROBLEM
96292	,	O
96293	no	O
96294	pancreatic	b-PROBLEM
96295	mass	i-PROBLEM
96296	;	O
96297	a	b-PROBLEM
96298	2	i-PROBLEM
96299	cm	i-PROBLEM
96300	ovarian	i-PROBLEM
96301	cyst	i-PROBLEM
96302	.	O
96303	the	O
96304	review	O
96305	of	O
96306	the	b-TEST
96307	pathology	i-TEST
96308	from	O
96309	bri	b-CLINICAL_DEPT
96310	health	i-CLINICAL_DEPT
96311	confirmed	O
96312	a	b-PROBLEM
96313	high	i-PROBLEM
96314	grade	i-PROBLEM
96315	adenocarcinoma	i-PROBLEM
96316	.	O
96317	erica	b-TEST
96318	and	i-TEST
96319	basic	i-TEST
96320	cystic	i-TEST
96321	protein	i-TEST
96322	stains	i-TEST
96323	are	O
96324	still	O
96325	pending	O
96326	.	O
96327	serum	b-TEST
96328	markers	i-TEST
96329	were	O
96330	normal	O
96331	.	O
96332	the	b-TEST
96333	cea	i-TEST
96334	was	O
96335	less	O
96336	than	O
96337	0.7	O
96338	.	O
96339	the	b-TEST
96340	hcg	i-TEST
96341	on	O
96342	admission	b-OCCURRENCE
96343	was	O
96344	30,710	O
96345	and	O
96346	on	O
96347	1/19	b-DATE
96348	was	O
96349	805	O
96350	.	O
96351	the	b-TEST
96352	ca-125	i-TEST
96353	was	O
96354	still	O
96355	pending	O
96356	and	O
96357	alphafeto	b-TEST
96358	protein	i-TEST
96359	is	O
96360	still	O
96361	pending	O
96362	.	O
96363	hypercalcemia	b-PROBLEM
96364	:	O
96365	the	O
96366	patient	O
96367	presented	b-OCCURRENCE
96368	with	O
96369	a	b-TEST
96370	serum	i-TEST
96371	calcium	i-TEST
96372	of	O
96373	11.8	O
96374	and	O
96375	an	b-TEST
96376	albumin	i-TEST
96377	of	O
96378	2.3	O
96379	on	O
96380	admission	b-OCCURRENCE
96381	.	O
96382	she	O
96383	received	O
96384	three	b-DURATION
96385	days	i-DURATION
96386	of	O
96387	intravenous	b-TREATMENT
96388	etidronate	i-TREATMENT
96389	with	O
96390	normal	b-TREATMENT
96391	saline	i-TREATMENT
96392	diuresis	i-TREATMENT
96393	and	O
96394	the	b-TEST
96395	serum	i-TEST
96396	calcium	i-TEST
96397	subsequently	O
96398	decreased	O
96399	to	O
96400	9.0	O
96401	.	O
96402	the	O
96403	patient	O
96404	was	O
96405	then	O
96406	switched	O
96407	to	O
96408	po	b-TREATMENT
96409	etidronate	i-TREATMENT
96410	.	O
96411	ivc	b-PROBLEM
96412	obstruction	i-PROBLEM
96413	:	O
96414	the	O
96415	patient	O
96416	has	O
96417	extensive	b-PROBLEM
96418	hepatic	i-PROBLEM
96419	metastases	i-PROBLEM
96420	and	O
96421	by	O
96422	ct	b-TEST
96423	scan	i-TEST
96424	there	O
96425	is	O
96426	obstruction	b-PROBLEM
96427	of	i-PROBLEM
96428	the	i-PROBLEM
96429	intrahepatic	i-PROBLEM
96430	ivc	i-PROBLEM
96431	.	O
96432	this	O
96433	has	O
96434	resulted	O
96435	in	O
96436	marked	b-PROBLEM
96437	bilateral	i-PROBLEM
96438	lower	i-PROBLEM
96439	extremity	i-PROBLEM
96440	and	i-PROBLEM
96441	presacral	i-PROBLEM
96442	edema	i-PROBLEM
96443	with	O
96444	ascites	b-PROBLEM
96445	.	O
96446	the	b-PROBLEM
96447	patient	i-PROBLEM
96448	&apos;s	i-PROBLEM
96449	low	i-PROBLEM
96450	serum	i-PROBLEM
96451	albumin	i-PROBLEM
96452	is	O
96453	also	O
96454	contributing	O
96455	to	O
96456	her	b-PROBLEM
96457	extensive	i-PROBLEM
96458	edema	i-PROBLEM
96459	.	O
96460	hypoxia	b-PROBLEM
96461	and	O
96462	shortness	b-PROBLEM
96463	of	i-PROBLEM
96464	breath	i-PROBLEM
96465	:	O
96466	although	O
96467	the	b-TEST
96468	patient	i-TEST
96469	&apos;s	i-TEST
96470	room	i-TEST
96471	air	i-TEST
96472	saturation	i-TEST
96473	was	O
96474	96%	O
96475	during	O
96476	this	b-OCCURRENCE
96477	admission	i-OCCURRENCE
96478	,	O
96479	she	O
96480	subjectively	O
96481	complained	b-EVIDENTIAL
96482	of	O
96483	increased	b-PROBLEM
96484	shortness	i-PROBLEM
96485	of	i-PROBLEM
96486	breath	i-PROBLEM
96487	.	O
96488	it	O
96489	was	O
96490	felt	O
96491	that	O
96492	the	b-PROBLEM
96493	patient	i-PROBLEM
96494	&apos;s	i-PROBLEM
96495	extensive	i-PROBLEM
96496	pulmonary	i-PROBLEM
96497	metastases	i-PROBLEM
96498	and	O
96499	bilateral	b-PROBLEM
96500	pleural	i-PROBLEM
96501	effusions	i-PROBLEM
96502	resulted	O
96503	in	O
96504	increased	b-PROBLEM
96505	work	i-PROBLEM
96506	of	i-PROBLEM
96507	respiration	i-PROBLEM
96508	and	O
96509	a	O
96510	sensation	O
96511	of	O
96512	shortness	b-PROBLEM
96513	of	i-PROBLEM
96514	breath	i-PROBLEM
96515	.	O
96516	impending	b-PROBLEM
96517	spinal	i-PROBLEM
96518	cord	i-PROBLEM
96519	compression	i-PROBLEM
96520	:	O
96521	the	O
96522	patient	O
96523	had	O
96524	back	b-PROBLEM
96525	pain	i-PROBLEM
96526	on	O
96527	admission	b-OCCURRENCE
96528	without	O
96529	any	b-PROBLEM
96530	focal	i-PROBLEM
96531	neurological	i-PROBLEM
96532	signs	i-PROBLEM
96533	.	O
96534	the	b-TEST
96535	mri	i-TEST
96536	scan	i-TEST
96537	on	O
96538	admission	b-OCCURRENCE
96539	revealed	b-EVIDENTIAL
96540	an	b-PROBLEM
96541	impending	i-PROBLEM
96542	cord	i-PROBLEM
96543	compression	i-PROBLEM
96544	at	O
96545	the	O
96546	level	O
96547	of	O
96548	t10	O
96549	.	O
96550	she	O
96551	was	O
96552	started	O
96553	on	O
96554	decadron	b-TREATMENT
96555	and	O
96556	on	O
96557	1/17	b-DATE
96558	began	O
96559	the	O
96560	first	O
96561	of	O
96562	ten	b-FREQUENCY
96563	radiation	b-TREATMENT
96564	treatments	i-TREATMENT
96565	to	O
96566	two	O
96567	fields	O
96568	(	O
96569	t2	O
96570	to	O
96571	t5	O
96572	and	O
96573	t9	O
96574	to	O
96575	t11	O
96576	)	O
96577	.	O
96578	per	O
96579	the	O
96580	patient	O
96581	&apos;s	O
96582	wishes	O
96583	,	O
96584	doctor	O
96585	dalywoo	O
96586	droreite	O
96587	the	O
96588	windgo	O
96589	hospital	O
96590	was	O
96591	consulted	O
96592	for	O
96593	a	O
96594	second	O
96595	opinion	O
96596	regarding	O
96597	the	b-TREATMENT
96598	management	i-TREATMENT
96599	of	O
96600	her	b-PROBLEM
96601	malignancy	i-PROBLEM
96602	.	O
96603	doctor	O
96604	linke	O
96605	recommended	O
96606	chemotherapy	b-TREATMENT
96607	with	i-TREATMENT
96608	pfl	i-TREATMENT
96609	.	O
96610	per	O
96611	the	O
96612	patient	O
96613	&apos;s	O
96614	wishes	O
96615	,	O
96616	she	O
96617	was	O
96618	transferred	b-OCCURRENCE
96619	to	O
96620	the	b-CLINICAL_DEPT
96621	windgo	i-CLINICAL_DEPT
96622	hospital	i-CLINICAL_DEPT
96623	for	O
96624	chemotherapy	b-TREATMENT
96625	.	O
96626	alt	b-TEST
96627	was	O
96628	53	O
96629	.	O
96630	ast	b-TEST
96631	was	O
96632	89	O
96633	.	O
96634	her	b-TEST
96635	ldh	i-TEST
96636	was	O
96637	394	O
96638	.	O
96639	her	b-TEST
96640	alkaline	i-TEST
96641	phosphatase	i-TEST
96642	was	O
96643	1514	O
96644	.	O
96645	total	b-TEST
96646	bilirubin	i-TEST
96647	was	O
96648	2.1	O
96649	.	O
96650	direct	b-TEST
96651	bilirubin	i-TEST
96652	was	O
96653	1.4	O
96654	.	O
96655	albumin	b-TEST
96656	was	O
96657	2.3	O
96658	.	O
96659	calcium	b-TEST
96660	9.1	O
96661	.	O
96662	hematocrit	b-TEST
96663	was	O
96664	32.5	O
96665	.	O
96666	white	b-TEST
96667	blood	i-TEST
96668	cell	i-TEST
96669	count	i-TEST
96670	was	O
96671	16.89	O
96672	.	O
96673	pt	b-TEST
96674	was	O
96675	12.9	O
96676	.	O
96677	ptt	b-TEST
96678	was	O
96679	27.3	O
96680	.	O
96681		O
96682	admission	b-OCCURRENCE
96683	date	O
96684	:	O
96685	12/13/2002	b-ADMISSION
96686	discharge	b-OCCURRENCE
96687	date	O
96688	:	O
96689	12/14/2002	b-DISCHARGE
96690	history	O
96691	of	O
96692	present	O
96693	illness	O
96694	:	O
96695	the	O
96696	patient	O
96697	is	O
96698	a	O
96699	30	O
96700	-year-old	O
96701	gravida	b-OCCURRENCE
96702	iii	O
96703	,	O
96704	para	b-OCCURRENCE
96705	ii	O
96706	who	O
96707	presented	b-EVIDENTIAL
96708	desiring	O
96709	definitive	b-TREATMENT
96710	surgical	i-TREATMENT
96711	sterilization	i-TREATMENT
96712	.	O
96713	she	O
96714	was	O
96715	extensively	b-OCCURRENCE
96716	counseled	i-OCCURRENCE
96717	regarding	O
96718	other	b-TREATMENT
96719	methods	i-TREATMENT
96720	of	O
96721	birth	b-TREATMENT
96722	control	i-TREATMENT
96723	and	O
96724	desired	O
96725	to	O
96726	proceed	O
96727	with	O
96728	definitive	b-TREATMENT
96729	surgical	i-TREATMENT
96730	therapy	i-TREATMENT
96731	.	O
96732	in	O
96733	addition	O
96734	,	O
96735	the	O
96736	patient	O
96737	desired	O
96738	liposuction	b-TREATMENT
96739	of	i-TREATMENT
96740	varying	i-TREATMENT
96741	areas	i-TREATMENT
96742	as	O
96743	well	O
96744	.	O
96745	the	O
96746	patient	O
96747	was	O
96748	consented	b-OCCURRENCE
96749	for	O
96750	both	b-TREATMENT
96751	procedures	i-TREATMENT
96752	and	O
96753	brought	O
96754	to	O
96755	the	b-CLINICAL_DEPT
96756	operating	i-CLINICAL_DEPT
96757	room	i-CLINICAL_DEPT
96758	.	O
96759	hospital	O
96760	course	O
96761	and	O
96762	treatment	O
96763	:	O
96764	the	O
96765	patient	O
96766	was	O
96767	admitted	b-OCCURRENCE
96768	to	O
96769	the	b-CLINICAL_DEPT
96770	operating	i-CLINICAL_DEPT
96771	room	i-CLINICAL_DEPT
96772	where	O
96773	she	O
96774	underwent	O
96775	an	b-TREATMENT
96776	unremarkable	i-TREATMENT
96777	laparoscopic	i-TREATMENT
96778	tubal	i-TREATMENT
96779	ligation	i-TREATMENT
96780	.	O
96781	this	O
96782	was	O
96783	done	O
96784	with	O
96785	falope	b-TREATMENT
96786	rings	i-TREATMENT
96787	.	O
96788	the	b-PROBLEM
96789	estimated	i-PROBLEM
96790	blood	i-PROBLEM
96791	loss	i-PROBLEM
96792	was	O
96793	minimal	O
96794	and	O
96795	the	O
96796	patient	O
96797	received	O
96798	600	O
96799	cc.	O
96800	of	O
96801	intravenous	b-TREATMENT
96802	fluid	i-TREATMENT
96803	.	O
96804	of	O
96805	note	O
96806	,	O
96807	the	O
96808	patient	O
96809	had	O
96810	a	O
96811	negative	O
96812	urine	b-TEST
96813	pregnancy	i-TEST
96814	test	i-TEST
96815	prior	O
96816	to	O
96817	the	b-TREATMENT
96818	surgery	i-TREATMENT
96819	.	O
96820	the	O
96821	patient	O
96822	then	O
96823	underwent	O
96824	liposuction	b-TREATMENT
96825	of	i-TREATMENT
96826	her	i-TREATMENT
96827	abdomen	i-TREATMENT
96828	,	i-TREATMENT
96829	inner	i-TREATMENT
96830	thighs	i-TREATMENT
96831	,	i-TREATMENT
96832	hips	i-TREATMENT
96833	,	i-TREATMENT
96834	flanks	i-TREATMENT
96835	,	i-TREATMENT
96836	chest	i-TREATMENT
96837	and	i-TREATMENT
96838	arms	i-TREATMENT
96839	with	O
96840	doctor	O
96841	chain	O
96842	.	O
96843	she	O
96844	did	b-OCCURRENCE
96845	well	i-OCCURRENCE
96846	and	O
96847	was	O
96848	admitted	b-OCCURRENCE
96849	to	O
96850	the	b-CLINICAL_DEPT
96851	gyn	i-CLINICAL_DEPT
96852	service	i-CLINICAL_DEPT
96853	postoperatively	O
96854	because	O
96855	the	O
96856	patient	O
96857	had	O
96858	persistent	b-PROBLEM
96859	pain	i-PROBLEM
96860	.	O
96861	on	O
96862	postoperative	b-DATE
96863	day	i-DATE
96864	#one	i-DATE
96865	,	O
96866	she	O
96867	was	O
96868	then	O
96869	stable	b-OCCURRENCE
96870	with	O
96871	no	O
96872	complaints	b-PROBLEM
96873	.	O
96874	she	O
96875	remained	O
96876	afebrile	b-PROBLEM
96877	.	O
96878	her	b-TREATMENT
96879	foley	i-TREATMENT
96880	was	O
96881	removed	O
96882	.	O
96883	her	O
96884	diet	O
96885	was	O
96886	advanced	b-OCCURRENCE
96887	without	O
96888	difficulty	b-PROBLEM
96889	and	O
96890	the	O
96891	patient	O
96892	was	O
96893	stable	b-OCCURRENCE
96894	for	O
96895	discharge	b-OCCURRENCE
96896	.	O
96897	the	O
96898	patient	O
96899	was	O
96900	to	O
96901	follow	b-OCCURRENCE
96902	up	i-OCCURRENCE
96903	in	O
96904	several	b-DURATION
96905	days	i-DURATION
96906	time	O
96907	with	O
96908	doctor	O
96909	chain	O
96910	of	O
96911	the	b-CLINICAL_DEPT
96912	plastics	i-CLINICAL_DEPT
96913	clinic	i-CLINICAL_DEPT
96914	.	O
96915		O
96916	admission	b-OCCURRENCE
96917	date	O
96918	:	O
96919	2013-02-12	b-ADMISSION
96920	discharge	b-OCCURRENCE
96921	date	O
96922	:	O
96923	2013-02-16	b-DISCHARGE
96924	service	O
96925	:	O
96926	cardiothoracic	O
96927	history	O
96928	of	O
96929	present	O
96930	illness	O
96931	:	O
96932	the	O
96933	patient	O
96934	was	O
96935	referred	b-OCCURRENCE
96936	from	O
96937	an	b-CLINICAL_DEPT
96938	outside	i-CLINICAL_DEPT
96939	hospital	i-CLINICAL_DEPT
96940	with	O
96941	a	O
96942	chief	O
96943	complaint	b-EVIDENTIAL
96944	of	O
96945	increasing	b-PROBLEM
96946	shortness	i-PROBLEM
96947	of	i-PROBLEM
96948	breath	i-PROBLEM
96949	and	O
96950	tires	b-PROBLEM
96951	easily	i-PROBLEM
96952	with	O
96953	exertion	b-OCCURRENCE
96954	.	O
96955	admitted	b-OCCURRENCE
96956	to	O
96957	bay	b-CLINICAL_DEPT
96958	state	i-CLINICAL_DEPT
96959	medical	i-CLINICAL_DEPT
96960	center	i-CLINICAL_DEPT
96961	hospital	i-CLINICAL_DEPT
96962	in	O
96963	2012-10-22	b-DATE
96964	in	O
96965	congestive	b-PROBLEM
96966	heart	i-PROBLEM
96967	failure	i-PROBLEM
96968	at	O
96969	that	O
96970	time	O
96971	.	O
96972	via	O
96973	echocardiogram	b-TEST
96974	,	O
96975	found	b-EVIDENTIAL
96976	to	O
96977	have	O
96978	aortic	b-PROBLEM
96979	stenosis	i-PROBLEM
96980	.	O
96981	referred	b-OCCURRENCE
96982	to	O
96983	memorial	b-CLINICAL_DEPT
96984	hospital	i-CLINICAL_DEPT
96985	(	i-CLINICAL_DEPT
96986	worcester	i-CLINICAL_DEPT
96987	)	i-CLINICAL_DEPT
96988	for	O
96989	cardiac	b-TEST
96990	catheterization	i-TEST
96991	to	O
96992	further	O
96993	evaluate	b-TEST
96994	her	b-PROBLEM
96995	aortic	i-PROBLEM
96996	stenosis	i-PROBLEM
96997	.	O
96998	cardiac	b-TEST
96999	catheterization	i-TEST
97000	done	O
97001	on	O
97002	01-07	b-DATE
97003	showed	b-EVIDENTIAL
97004	an	b-TEST
97005	aortic	i-TEST
97006	valve	i-TEST
97007	area	i-TEST
97008	of	O
97009	.38	O
97010	cm.sq.	O
97011	,	O
97012	with	O
97013	a	b-TEST
97014	mean	i-TEST
97015	gradient	i-TEST
97016	of	O
97017	62	O
97018	,	O
97019	and	O
97020	a	b-TEST
97021	peak	i-TEST
97022	gradient	i-TEST
97023	of	O
97024	85	O
97025	.	O
97026	moderate	b-PROBLEM
97027	pulmonary	i-PROBLEM
97028	hypertension	i-PROBLEM
97029	,	O
97030	pa	b-TEST
97031	pressure	i-TEST
97032	48/24	O
97033	,	O
97034	1+	b-PROBLEM
97035	mitral	i-PROBLEM
97036	regurgitation	i-PROBLEM
97037	,	O
97038	severe	b-PROBLEM
97039	aortic	i-PROBLEM
97040	stenosis	i-PROBLEM
97041	with	O
97042	an	b-TEST
97043	lvedp	i-TEST
97044	of	O
97045	19	O
97046	and	O
97047	an	b-TEST
97048	ejection	i-TEST
97049	fraction	i-TEST
97050	of	O
97051	43%	O
97052	.	O
97053	she	O
97054	was	O
97055	then	O
97056	referred	b-OCCURRENCE
97057	to	O
97058	cardiothoracic	b-CLINICAL_DEPT
97059	surgery	i-CLINICAL_DEPT
97060	for	O
97061	aortic	b-TREATMENT
97062	valve	i-TREATMENT
97063	replacement	i-TREATMENT
97064	.	O
97065	hospital	O
97066	course	O
97067	:	O
97068	the	O
97069	patient	O
97070	was	O
97071	a	b-OCCURRENCE
97072	direct	i-OCCURRENCE
97073	admission	i-OCCURRENCE
97074	to	O
97075	the	b-CLINICAL_DEPT
97076	operating	i-CLINICAL_DEPT
97077	room	i-CLINICAL_DEPT
97078	on	O
97079	02-12	b-DATE
97080	,	O
97081	at	O
97082	which	O
97083	time	O
97084	she	O
97085	underwent	O
97086	an	O
97087	aortic	b-TREATMENT
97088	valve	i-TREATMENT
97089	replacement	i-TREATMENT
97090	.	O
97091	please	O
97092	see	O
97093	the	O
97094	operative	O
97095	report	O
97096	for	O
97097	full	O
97098	details	O
97099	.	O
97100	in	O
97101	summary	O
97102	,	O
97103	she	O
97104	had	O
97105	an	b-TREATMENT
97106	aortic	i-TREATMENT
97107	valve	i-TREATMENT
97108	replacement	i-TREATMENT
97109	with	O
97110	a	b-TREATMENT
97111	#21	i-TREATMENT
97112	mosaic	i-TREATMENT
97113	porcine	i-TREATMENT
97114	valve	i-TREATMENT
97115	.	O
97116	she	O
97117	tolerated	b-OCCURRENCE
97118	the	b-TREATMENT
97119	operation	i-TREATMENT
97120	well	b-OCCURRENCE
97121	,	O
97122	and	O
97123	was	O
97124	transferred	b-OCCURRENCE
97125	from	O
97126	the	b-CLINICAL_DEPT
97127	operating	i-CLINICAL_DEPT
97128	room	i-CLINICAL_DEPT
97129	to	O
97130	the	b-CLINICAL_DEPT
97131	cardiothoracic	i-CLINICAL_DEPT
97132	intensive	i-CLINICAL_DEPT
97133	care	i-CLINICAL_DEPT
97134	unit	i-CLINICAL_DEPT
97135	.	O
97136	the	O
97137	patient	O
97138	did	O
97139	well	O
97140	in	O
97141	the	O
97142	immediate	O
97143	postoperative	O
97144	period	O
97145	,	O
97146	however	O
97147	,	O
97148	her	b-TEST
97149	blood	i-TEST
97150	pressure	i-TEST
97151	remained	O
97152	somewhat	b-PROBLEM
97153	labile	i-PROBLEM
97154	.	O
97155	therefore	O
97156	,	O
97157	she	O
97158	was	O
97159	continued	O
97160	on	O
97161	a	b-TREATMENT
97162	neo-synephrine	i-TREATMENT
97163	drip	i-TREATMENT
97164	to	O
97165	maintain	O
97166	a	b-TEST
97167	systolic	i-TEST
97168	blood	i-TEST
97169	pressure	i-TEST
97170	greater	O
97171	than	O
97172	110	O
97173	.	O
97174	in	O
97175	addition	O
97176	,	O
97177	she	O
97178	was	O
97179	slow	b-PROBLEM
97180	to	i-PROBLEM
97181	awaken	i-PROBLEM
97182	after	O
97183	her	b-TREATMENT
97184	anesthesia	i-TREATMENT
97185	was	O
97186	reversed	b-OCCURRENCE
97187	,	O
97188	and	O
97189	in	O
97190	several	O
97191	attempts	O
97192	to	O
97193	wean	b-OCCURRENCE
97194	from	O
97195	the	b-TREATMENT
97196	ventilator	i-TREATMENT
97197	,	O
97198	she	O
97199	developed	O
97200	a	b-PROBLEM
97201	respiratory	i-PROBLEM
97202	acidosis	i-PROBLEM
97203	.	O
97204	she	O
97205	therefore	O
97206	remained	O
97207	on	O
97208	the	b-TREATMENT
97209	ventilator	i-TREATMENT
97210	throughout	O
97211	the	b-DURATION
97212	day	i-DURATION
97213	of	i-DURATION
97214	postoperative	i-DURATION
97215	day	i-DURATION
97216	one	i-DURATION
97217	.	O
97218	on	O
97219	postoperative	b-DATE
97220	day	i-DATE
97221	two	i-DATE
97222	,	O
97223	the	O
97224	patient	O
97225	remained	O
97226	hemodynamically	b-OCCURRENCE
97227	stable	i-OCCURRENCE
97228	.	O
97229	her	b-TREATMENT
97230	neo-synephrine	i-TREATMENT
97231	drip	i-TREATMENT
97232	was	O
97233	weaned	b-TREATMENT
97234	to	i-TREATMENT
97235	off	i-TREATMENT
97236	.	O
97237	she	O
97238	was	O
97239	again	O
97240	weaned	b-TREATMENT
97241	from	O
97242	the	b-TREATMENT
97243	ventilator	i-TREATMENT
97244	,	O
97245	and	O
97246	successfully	b-TREATMENT
97247	extubated	i-TREATMENT
97248	.	O
97249	her	b-TREATMENT
97250	chest	i-TREATMENT
97251	tubes	i-TREATMENT
97252	were	O
97253	discontinued	b-OCCURRENCE
97254	and	O
97255	,	O
97256	at	O
97257	the	b-TIME
97258	end	i-TIME
97259	of	i-TIME
97260	the	i-TIME
97261	day	i-TIME
97262	,	O
97263	she	O
97264	was	O
97265	transferred	b-OCCURRENCE
97266	from	O
97267	the	b-CLINICAL_DEPT
97268	cardiothoracic	i-CLINICAL_DEPT
97269	intensive	i-CLINICAL_DEPT
97270	care	i-CLINICAL_DEPT
97271	unit	i-CLINICAL_DEPT
97272	to	O
97273	the	b-CLINICAL_DEPT
97274	floor	i-CLINICAL_DEPT
97275	for	O
97276	continuing	b-TREATMENT
97277	postoperative	i-TREATMENT
97278	care	i-TREATMENT
97279	and	O
97280	cardiac	b-TREATMENT
97281	rehabilitation	i-TREATMENT
97282	.	O
97283	after	O
97284	being	O
97285	transferred	b-OCCURRENCE
97286	to	O
97287	the	b-CLINICAL_DEPT
97288	floor	i-CLINICAL_DEPT
97289	,	O
97290	the	O
97291	patient	O
97292	did	O
97293	well	b-OCCURRENCE
97294	.	O
97295	over	O
97296	the	O
97297	next	O
97298	several	b-DURATION
97299	days	i-DURATION
97300	,	O
97301	her	b-OCCURRENCE
97302	activity	i-OCCURRENCE
97303	level	i-OCCURRENCE
97304	was	i-OCCURRENCE
97305	increased	i-OCCURRENCE
97306	with	O
97307	the	b-OCCURRENCE
97308	assistance	i-OCCURRENCE
97309	of	i-OCCURRENCE
97310	physical	i-OCCURRENCE
97311	therapy	i-OCCURRENCE
97312	and	O
97313	the	O
97314	nursing	O
97315	staff	O
97316	.	O
97317	she	O
97318	remained	O
97319	hemodynamically	b-OCCURRENCE
97320	stable	i-OCCURRENCE
97321	.	O
97322	her	O
97323	respiratory	O
97324	condition	O
97325	remained	O
97326	stable	b-OCCURRENCE
97327	and	O
97328	,	O
97329	on	O
97330	postoperative	b-DATE
97331	day	i-DATE
97332	four	i-DATE
97333	,	O
97334	she	O
97335	was	O
97336	deemed	O
97337	stable	b-OCCURRENCE
97338	and	O
97339	ready	O
97340	to	O
97341	be	O
97342	transferred	b-OCCURRENCE
97343	to	O
97344	rehabilitation	b-CLINICAL_DEPT
97345	for	O
97346	continuing	b-TREATMENT
97347	postoperative	i-TREATMENT
97348	care	i-TREATMENT
97349	and	O
97350	physical	b-TREATMENT
97351	therapy	i-TREATMENT
97352	.	O
97353		O
97354	admission	b-OCCURRENCE
97355	date	O
97356	:	O
97357	11/17/2003	b-ADMISSION
97358	discharge	b-OCCURRENCE
97359	date	O
97360	:	O
97361	12/22/2003	b-DISCHARGE
97362	history	O
97363	of	O
97364	present	O
97365	illness	O
97366	:	O
97367	this	O
97368	is	O
97369	a	O
97370	57-year-old	O
97371	female	O
97372	status	O
97373	post	O
97374	ert	b-TREATMENT
97375	with	O
97376	recurrence	O
97377	of	O
97378	a	b-PROBLEM
97379	pelvic	i-PROBLEM
97380	mass	i-PROBLEM
97381	and	O
97382	resection	b-TREATMENT
97383	at	O
97384	an	b-CLINICAL_DEPT
97385	outside	i-CLINICAL_DEPT
97386	hospital	i-CLINICAL_DEPT
97387	in	O
97388	06/22	b-DATE
97389	.	O
97390	per	b-EVIDENTIAL
97391	the	i-EVIDENTIAL
97392	patient	i-EVIDENTIAL
97393	,	O
97394	the	b-PROBLEM
97395	mass	i-PROBLEM
97396	was	O
97397	benign	b-TEST
97398	.	O
97399	the	O
97400	patient	O
97401	developed	O
97402	severe	b-PROBLEM
97403	left	i-PROBLEM
97404	lower	i-PROBLEM
97405	quadrant	i-PROBLEM
97406	pain	i-PROBLEM
97407	in	O
97408	07/24	b-DATE
97409	.	O
97410	an	b-TEST
97411	mri	i-TEST
97412	was	O
97413	done	O
97414	on	O
97415	08/27/03	b-DATE
97416	that	O
97417	showed	b-EVIDENTIAL
97418	an	b-PROBLEM
97419	8	i-PROBLEM
97420	cm	i-PROBLEM
97421	left	i-PROBLEM
97422	lower	i-PROBLEM
97423	quadrant	i-PROBLEM
97424	mass	i-PROBLEM
97425	with	O
97426	both	b-PROBLEM
97427	cystic	i-PROBLEM
97428	and	i-PROBLEM
97429	solid	i-PROBLEM
97430	components	i-PROBLEM
97431	.	O
97432	the	O
97433	patient	O
97434	was	O
97435	started	O
97436	on	O
97437	lupron	b-TREATMENT
97438	on	O
97439	10/18/03	b-DATE
97440	,	O
97441	but	O
97442	pain	b-PROBLEM
97443	was	O
97444	not	O
97445	affected	b-OCCURRENCE
97446	.	O
97447	she	O
97448	was	O
97449	put	O
97450	on	O
97451	vicodin	b-TREATMENT
97452	es	i-TREATMENT
97453	and	O
97454	ultram	b-TREATMENT
97455	with	O
97456	minimal	O
97457	relief	b-OCCURRENCE
97458	.	O
97459	on	O
97460	11/16/03	b-DATE
97461	,	O
97462	the	b-PROBLEM
97463	patient	i-PROBLEM
97464	&apos;s	i-PROBLEM
97465	pain	i-PROBLEM
97466	increased	b-PROBLEM
97467	and	O
97468	she	O
97469	presented	b-OCCURRENCE
97470	to	O
97471	an	b-CLINICAL_DEPT
97472	outside	i-CLINICAL_DEPT
97473	hospital	i-CLINICAL_DEPT
97474	with	O
97475	nausea	b-PROBLEM
97476	and	O
97477	vomiting	b-PROBLEM
97478	and	O
97479	an	b-PROBLEM
97480	inability	i-PROBLEM
97481	to	i-PROBLEM
97482	tolerate	i-PROBLEM
97483	p.o.	i-PROBLEM
97484	intake	i-PROBLEM
97485	.	O
97486	the	b-PROBLEM
97487	left	i-PROBLEM
97488	lower	i-PROBLEM
97489	quadrant	i-PROBLEM
97490	pain	i-PROBLEM
97491	in	i-PROBLEM
97492	the	i-PROBLEM
97493	groin	i-PROBLEM
97494	radiated	b-OCCURRENCE
97495	to	O
97496	the	b-PROBLEM
97497	left	i-PROBLEM
97498	knee	i-PROBLEM
97499	.	O
97500	no	O
97501	fevers	b-PROBLEM
97502	or	O
97503	chills	b-PROBLEM
97504	,	O
97505	no	O
97506	vaginal	b-PROBLEM
97507	discharge	i-PROBLEM
97508	or	O
97509	bleeding	b-PROBLEM
97510	.	O
97511	potassium	b-TEST
97512	at	O
97513	the	b-CLINICAL_DEPT
97514	outside	i-CLINICAL_DEPT
97515	hospital	i-CLINICAL_DEPT
97516	was	O
97517	3.1	O
97518	.	O
97519	white	b-TEST
97520	count	i-TEST
97521	was	O
97522	27.3	O
97523	with	O
97524	16%	b-TEST
97525	bands	i-TEST
97526	.	O
97527	hematocrit	b-TEST
97528	was	O
97529	28.7	O
97530	.	O
97531	the	O
97532	patient	O
97533	was	O
97534	transferred	b-OCCURRENCE
97535	to	O
97536	nvh	b-CLINICAL_DEPT
97537	after	O
97538	receiving	O
97539	intravenous	b-TREATMENT
97540	fluid	i-TREATMENT
97541	with	O
97542	potassium	b-TREATMENT
97543	,	O
97544	demerol	b-TREATMENT
97545	for	O
97546	pain	b-TREATMENT
97547	control	i-TREATMENT
97548	and	O
97549	clindamycin	b-TREATMENT
97550	,	O
97551	valium	b-TREATMENT
97552	and	O
97553	droperidol	b-TREATMENT
97554	.	O
97555		O
97556	admission	b-OCCURRENCE
97557	date	O
97558	:	O
97559	2015-09-16	b-ADMISSION
97560	discharge	b-OCCURRENCE
97561	date	O
97562	:	O
97563	2015-09-21	b-DISCHARGE
97564	service	O
97565	:	O
97566	cardiothor	O
97567	history	O
97568	of	O
97569	present	O
97570	illness	O
97571	:	O
97572	the	O
97573	patient	O
97574	is	O
97575	a	O
97576	52	O
97577	year	O
97578	old	O
97579	czech	O
97580	speaking	O
97581	gentleman	O
97582	with	O
97583	a	O
97584	history	O
97585	of	O
97586	severe	b-PROBLEM
97587	mitral	i-PROBLEM
97588	regurgitation	i-PROBLEM
97589	.	O
97590	for	O
97591	the	O
97592	past	O
97593	several	b-DURATION
97594	years	i-DURATION
97595	,	O
97596	the	O
97597	patient	O
97598	has	O
97599	continued	O
97600	to	O
97601	have	O
97602	significant	b-PROBLEM
97603	exercise	i-PROBLEM
97604	intolerance	i-PROBLEM
97605	which	O
97606	has	O
97607	limited	O
97608	his	b-OCCURRENCE
97609	ability	i-OCCURRENCE
97610	to	i-OCCURRENCE
97611	work	i-OCCURRENCE
97612	.	O
97613	he	O
97614	reports	b-EVIDENTIAL
97615	severe	b-PROBLEM
97616	dyspnea	i-PROBLEM
97617	on	O
97618	exertion	O
97619	.	O
97620	the	O
97621	patient	O
97622	had	O
97623	a	O
97624	recent	O
97625	admission	b-OCCURRENCE
97626	earlier	b-DATE
97627	in	i-DATE
97628	the	i-DATE
97629	month	i-DATE
97630	and	O
97631	he	O
97632	was	O
97633	discharged	b-OCCURRENCE
97634	on	O
97635	2015-09-10	b-DATE
97636	,	O
97637	after	O
97638	undergoing	O
97639	cardiac	b-TEST
97640	catheterization	i-TEST
97641	.	O
97642	this	O
97643	was	O
97644	significant	O
97645	for	O
97646	demonstrating	b-EVIDENTIAL
97647	no	O
97648	flow-limited	b-PROBLEM
97649	disease	i-PROBLEM
97650	in	i-PROBLEM
97651	the	i-PROBLEM
97652	coronaries	i-PROBLEM
97653	but	O
97654	several	b-PROBLEM
97655	fistulae	i-PROBLEM
97656	from	O
97657	the	O
97658	left	O
97659	anterior	O
97660	descending	O
97661	to	O
97662	the	O
97663	pa	O
97664	.	O
97665	several	O
97666	of	O
97667	these	O
97668	were	O
97669	coil	b-TREATMENT
97670	embolized	i-TREATMENT
97671	during	O
97672	this	b-OCCURRENCE
97673	admission	i-OCCURRENCE
97674	.	O
97675	he	O
97676	tolerated	O
97677	this	O
97678	well	O
97679	,	O
97680	was	O
97681	sent	O
97682	home	O
97683	,	O
97684	and	O
97685	now	b-DATE
97686	returns	b-OCCURRENCE
97687	for	O
97688	his	b-TREATMENT
97689	mitral	i-TREATMENT
97690	valve	i-TREATMENT
97691	repair	i-TREATMENT
97692	.	O
97693	hospital	O
97694	course	O
97695	:	O
97696	on	O
97697	the	b-DATE
97698	day	i-DATE
97699	of	O
97700	admission	b-OCCURRENCE
97701	,	O
97702	the	O
97703	patient	O
97704	went	O
97705	to	O
97706	the	b-CLINICAL_DEPT
97707	operating	i-CLINICAL_DEPT
97708	room	i-CLINICAL_DEPT
97709	and	O
97710	underwent	O
97711	a	O
97712	minimally	O
97713	invasive	O
97714	mitral	b-TREATMENT
97715	valve	i-TREATMENT
97716	repair	i-TREATMENT
97717	.	O
97718	he	O
97719	tolerated	O
97720	this	b-TREATMENT
97721	procedure	i-TREATMENT
97722	well	O
97723	.	O
97724	the	O
97725	patient	O
97726	was	O
97727	brought	O
97728	to	O
97729	the	b-CLINICAL_DEPT
97730	cardiothoracic	i-CLINICAL_DEPT
97731	intensive	i-CLINICAL_DEPT
97732	care	i-CLINICAL_DEPT
97733	unit	i-CLINICAL_DEPT
97734	in	O
97735	stable	b-OCCURRENCE
97736	condition	i-OCCURRENCE
97737	on	O
97738	minimal	b-TREATMENT
97739	pressor	i-TREATMENT
97740	support	i-TREATMENT
97741	.	O
97742	he	O
97743	was	O
97744	successfully	O
97745	weaned	b-OCCURRENCE
97746	off	i-OCCURRENCE
97747	this	b-TREATMENT
97748	support	i-TREATMENT
97749	.	O
97750	the	O
97751	patient	O
97752	was	O
97753	fully	O
97754	weaned	b-OCCURRENCE
97755	from	O
97756	ventilatory	b-TREATMENT
97757	support	i-TREATMENT
97758	secondary	O
97759	to	O
97760	a	b-PROBLEM
97761	persistent	i-PROBLEM
97762	acidemia	i-PROBLEM
97763	.	O
97764	this	O
97765	was	O
97766	treated	O
97767	with	O
97768	sodium	b-TREATMENT
97769	bicarbonate	i-TREATMENT
97770	and	O
97771	a	b-TREATMENT
97772	swan-ganz	i-TREATMENT
97773	was	O
97774	placed	O
97775	to	O
97776	provide	O
97777	close	b-TEST
97778	hemodynamic	i-TEST
97779	monitoring	i-TEST
97780	.	O
97781	the	O
97782	patient	O
97783	was	O
97784	found	b-EVIDENTIAL
97785	to	O
97786	have	O
97787	stable	b-TEST
97788	hemodynamics	i-TEST
97789	with	O
97790	appropriate	O
97791	mixed	O
97792	venous	b-TEST
97793	saturations	i-TEST
97794	in	O
97795	the	O
97796	70%	O
97797	range	O
97798	.	O
97799	the	O
97800	patient	O
97801	was	O
97802	corrected	O
97803	to	O
97804	a	O
97805	normal	O
97806	ph	b-TEST
97807	of	O
97808	7.41	O
97809	by	O
97810	the	b-DATE
97811	first	i-DATE
97812	postoperative	i-DATE
97813	night	i-DATE
97814	and	O
97815	remained	b-OCCURRENCE
97816	stable	i-OCCURRENCE
97817	.	O
97818	he	O
97819	was	O
97820	then	O
97821	weaned	O
97822	off	O
97823	of	O
97824	ventilatory	b-TREATMENT
97825	support	i-TREATMENT
97826	and	O
97827	was	O
97828	successfully	O
97829	extubated	b-TREATMENT
97830	.	O
97831	the	O
97832	patient	O
97833	did	O
97834	have	O
97835	a	O
97836	slight	O
97837	bit	O
97838	of	O
97839	confusion	b-PROBLEM
97840	early	O
97841	in	O
97842	post-extubation	b-DATE
97843	course	i-DATE
97844	which	O
97845	cleared	b-OCCURRENCE
97846	.	O
97847	this	O
97848	was	O
97849	also	O
97850	compounded	O
97851	by	O
97852	a	b-PROBLEM
97853	language	i-PROBLEM
97854	barrier	i-PROBLEM
97855	since	O
97856	the	O
97857	patient	O
97858	cannot	O
97859	speak	O
97860	english	O
97861	.	O
97862	in	O
97863	addition	O
97864	,	O
97865	the	O
97866	patient	O
97867	's	O
97868	early	b-DATE
97869	postoperative	i-DATE
97870	course	i-DATE
97871	had	O
97872	a	O
97873	tremendous	O
97874	urine	b-TEST
97875	output	i-TEST
97876	.	O
97877	it	O
97878	was	O
97879	equally	O
97880	up	O
97881	to	O
97882	700	O
97883	cc.	O
97884	an	b-FREQUENCY
97885	hour	i-FREQUENCY
97886	and	O
97887	a	b-OCCURRENCE
97888	renal	i-OCCURRENCE
97889	consultation	i-OCCURRENCE
97890	was	O
97891	obtained	O
97892	.	O
97893	he	O
97894	underwent	O
97895	a	b-TEST
97896	head	i-TEST
97897	ct	i-TEST
97898	scan	i-TEST
97899	to	O
97900	rule	O
97901	out	O
97902	intracranial	b-PROBLEM
97903	pathology	i-PROBLEM
97904	leading	O
97905	to	O
97906	diabetes	b-PROBLEM
97907	insipidus	i-PROBLEM
97908	.	O
97909	this	O
97910	was	O
97911	negative	O
97912	.	O
97913	the	b-TEST
97914	patient	i-TEST
97915	's	i-TEST
97916	serum	i-TEST
97917	and	O
97918	urine	b-TEST
97919	electrolytes	i-TEST
97920	indicated	O
97921	that	O
97922	this	b-TREATMENT
97923	diuresis	i-TREATMENT
97924	was	O
97925	appropriate	O
97926	.	O
97927	the	b-TEST
97928	patient	i-TEST
97929	's	i-TEST
97930	urine	i-TEST
97931	output	i-TEST
97932	has	O
97933	decreased	b-OCCURRENCE
97934	and	O
97935	his	b-TEST
97936	bun	i-TEST
97937	and	O
97938	creatinine	b-TEST
97939	remained	O
97940	normal	O
97941	.	O
97942	the	b-TREATMENT
97943	patient	i-TREATMENT
97944	's	i-TREATMENT
97945	foley	i-TREATMENT
97946	was	O
97947	discontinued	O
97948	.	O
97949	he	O
97950	had	O
97951	developed	O
97952	some	O
97953	hematuria	b-PROBLEM
97954	which	O
97955	has	O
97956	resolved	O
97957	.	O
97958	the	O
97959	patient	O
97960	has	O
97961	remained	b-OCCURRENCE
97962	stable	i-OCCURRENCE
97963	and	O
97964	is	O
97965	now	b-DATE
97966	ready	O
97967	for	O
97968	discharge	b-OCCURRENCE
97969	to	O
97970	home	O
97971	with	O
97972	follow-up	b-TREATMENT
97973	in	O
97974	approximately	O
97975	four	b-DATE
97976	weeks	i-DATE
97977	.	O
97978		O
